PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bennett, VC; Brandon, AD; Nutman, AP				Bennett, Vickie C.; Brandon, Alan D.; Nutman, Allen P.			Coupled Nd-142-Nd-143 isotopic evidence for Hadean mantle dynamics	SCIENCE			English	Article							SOUTHERN WEST GREENLAND; EARLY DIFFERENTIATION; ND-142 EVIDENCE; NUUK REGION; EVOLUTION; NEODYMIUM; CRUST; EARTH; HETEROGENEITY; GEOCHEMISTRY	The oldest rocks-3.85 billion years old- from southwest Greenland have coupled neodymium- 142 excesses ( from decay of now- extinct samarium- 146; half- life, 103 million years) and neodymium- 143 excesses ( from decay of samarium- 147; half- life, 106 billion years), relative to chondritic meteorites, that directly date the formation of chemically distinct silicate reservoirs in the first 30 million to 75 million years of Earth history. The differences in Nd-142 signatures of coeval rocks from the two most extensive crustal relicts more than 3.6 billion years old, in Western Australia and southwest Greenland, reveal early-formed large- scale chemical heterogeneities in Earth's mantle that persisted for at least the first billion years of Earth history. Temporal variations in Nd-142 signatures track the subsequent incomplete remixing of very- early- formed mantle chemical domains.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Lunar & Planetary Inst, Houston, TX 77058 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China	Australian National University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Chinese Academy of Geological Sciences	Bennett, VC (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.	vickie.bennett@anu.edu.au		Nutman, Allen/0000-0002-8393-9456; Bennett, Vickie/0000-0003-0937-3471				Abe Y, 1997, PHYS EARTH PLANET IN, V100, P27, DOI 10.1016/S0031-9201(96)03229-3; Amelin Y, 2005, GEOCHIM COSMOCHIM AC, V69, P505, DOI 10.1016/j.gca.2004.05.047; Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Andreasen R, 2006, SCIENCE, V314, P806, DOI 10.1126/science.1131708; BlichertToft J, 1997, EARTH PLANET SC LETT, V148, P243, DOI 10.1016/S0012-821X(97)00040-X; BORG L, 2003, METEORIT PLANET SCI, V34, P439; Boyet M, 2003, EARTH PLANET SC LETT, V214, P427, DOI 10.1016/S0012-821X(03)00423-0; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2007, EARTH PLANET SC LETT, V262, P505, DOI 10.1016/j.epsl.2007.08.009; Boyet M, 2006, EARTH PLANET SC LETT, V250, P254, DOI 10.1016/j.epsl.2006.07.046; Carlson RW, 2007, SCIENCE, V316, P1175, DOI 10.1126/science.1140189; Caro G, 2006, GEOCHIM COSMOCHIM AC, V70, P164, DOI 10.1016/j.gca.2005.08.015; Caro G, 2003, NATURE, V423, P428, DOI 10.1038/nature01668; CHASE CG, 1988, EARTH PLANET SC LETT, V91, P66, DOI 10.1016/0012-821X(88)90151-3; Foley CN, 2005, GEOCHIM COSMOCHIM AC, V69, P4557, DOI 10.1016/j.gca.2005.05.009; Frei R, 2002, GEOCHIM COSMOCHIM AC, V66, P467, DOI 10.1016/S0016-7037(01)00781-5; Friend CRL, 2005, J GEOL SOC LONDON, V162, P147, DOI 10.1144/0016-764903-161; HARPER CL, 1992, NATURE, V360, P728, DOI 10.1038/360728a0; Jacobsen SB, 2005, ANNU REV EARTH PL SC, V33, P531, DOI 10.1146/annurev.earth.33.092203.122614; Nutman AP, 2007, CONTRIB MINERAL PETR, V154, P385, DOI 10.1007/s00410-007-0199-3; Nutman AP, 1996, PRECAMBRIAN RES, V78, P1, DOI 10.1016/0301-9268(95)00066-6; NUTMAN AP, 1993, TECTONICS, V12, P971, DOI 10.1029/93TC00377; NYQUIST LE, 1995, GEOCHIM COSMOCHIM AC, V59, P2817, DOI 10.1016/0016-7037(95)00175-Y; Polat A, 2003, PRECAMBRIAN RES, V126, P197, DOI 10.1016/S0301-9268(03)00095-0; Rankenburg K, 2006, SCIENCE, V312, P1369, DOI 10.1126/science.1126114; Sharma M, 2004, PRECAMBRIAN RES, V135, P315, DOI 10.1016/j.precamres.2004.09.003; Smithies RH, 2003, PRECAMBRIAN RES, V127, P89, DOI 10.1016/S0301-9268(03)00182-7; Tolstikhin I, 2005, PHYS EARTH PLANET IN, V148, P109, DOI 10.1016/j.pepi.2004.05.011; TONKS WB, 1993, J GEOPHYS RES-PLANET, V98, P5319, DOI 10.1029/92JE02726	29	203	208	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1907	1910		10.1126/science.1145928	http://dx.doi.org/10.1126/science.1145928			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096803				2022-12-28	WOS:000251786600054
J	Gerken, T; Girard, CA; Tung, YCL; Webby, CJ; Saudek, V; Hewitson, KS; Yeo, GSH; McDonough, MA; Cunliffe, S; McNeill, LA; Galvanovskis, J; Rorsman, P; Robins, P; Prieur, X; Coll, AP; Ma, M; Jovanovic, Z; Farooqi, IS; Sedgwick, B; Barroso, I; Lindahl, T; Ponting, CP; Ashcroft, FM; O'Rahilly, S; Schofield, CJ				Gerken, Thomas; Girard, Christophe A.; Tung, Yi-Chun Loraine; Webby, Celia J.; Saudek, Vladimir; Hewitson, Kirsty S.; Yeo, Giles S. H.; McDonough, Michael A.; Cunliffe, Sharon; McNeill, Luke A.; Galvanovskis, Juris; Rorsman, Patrik; Robins, Peter; Prieur, Xavier; Coll, Anthony P.; Ma, Marcella; Jovanovic, Zorica; Farooqi, I. Sadaf; Sedgwick, Barbara; Barroso, Ines; Lindahl, Tomas; Ponting, Chris P.; Ashcroft, Frances M.; O'Rahilly, Stephen; Schofield, Christopher J.			The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; HIF-ALPHA; OXIDATIVE DEMETHYLATION; ALKYLATION DAMAGE; ESCHERICHIA-COLI; ADULT OBESITY; DNA; REPAIR; RNA; 3-METHYLTHYMINE	Variants in the FTO ( fat mass and obesity associated) gene are associated with increased body mass index in humans. Here, we show by bioinformatics analysis that FTO shares sequence motifs with Fe(II)- and 2-oxoglutarate-dependent oxygenases. We find that recombinant murine Fto catalyzes the Fe( II)- and 2OG-dependent demethylation of 3-methylthyminein single-stranded DNA, with concomitant production of succinate, formaldehyde, and carbon dioxide. Consistent with a potential role in nucleic acid demethylation, Fto localizes to the nucleus in transfected cells. Studies of wild-type mice indicate that Fto messenger RNA ( mRNA) is most abundant in the brain, particularly in hypothalamic nuclei governing energy balance, and that Fto mRNA levels in the arcuate nucleus are regulated by feeding and fasting. Studies can now be directed toward determining the physiologically relevant FTO substrate and how nucleic acid methylation status is linked to increased fat mass.	Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genet Unit, Oxford OX1 3QX, England; Univ Oxford, Chem Res Lab, Oxford OX1 3TA, Oxon, England; Univ Oxford, Oxford Ctr Integrat Syst, Oxford OX1 3TA, Oxon, England; Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge CB2 0QQ, England; ReOx Ltd, Magdalen Ctr, Oxford OX4 4GA, Oxon, England; Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Wellcome Trust Sanger Inst, Metab Dis Grp, Cambridge, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Cancer Research UK; Wellcome Trust Sanger Institute	Ponting, CP (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genet Unit, S Pks Rd, Oxford OX1 3QX, England.	chris.ponting@dpag.ox.ac.uk; so104@medschl.cam.ac.uk; christopher.schofield@chem.ox.ac.uk	Ponting, Chris/AAV-2621-2021; Girard, Christophe/O-8455-2016; O'Rahilly, Stephen/ABF-6509-2020; Rorsman, Patrik/A-4331-2016; McDonough, Michael A/G-2744-2013; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Prieur, Xavier/D-4760-2015; McDonough, Michael/N-8913-2019	Girard, Christophe/0000-0002-4560-4479; O'Rahilly, Stephen/0000-0003-2199-4449; Rorsman, Patrik/0000-0001-7578-0767; McDonough, Michael A/0000-0003-4664-6942; Prieur, Xavier/0000-0003-0215-5447; McDonough, Michael/0000-0003-4664-6942; Coll, Anthony Patrick/0000-0003-2594-7463; Barroso, Ines/0000-0001-5800-4520; Yeo, Giles See How/0000-0001-8823-3615; Ponting, Chris/0000-0003-0202-7816; Farooqi, Sadaf/0000-0001-7609-3504; Schofield, Christopher/0000-0002-0290-6565	Biotechnology and Biological Sciences Research Council [BB/D011523/1] Funding Source: Medline; Medical Research Council [MC_U137761446, G108/617, G9824984] Funding Source: Medline; NIGMS NIH HHS [U54 GM064346] Funding Source: Medline; Wellcome Trust [068086, 077016] Funding Source: Medline; BBSRC [BB/D011523/1] Funding Source: UKRI; MRC [G108/617, MC_U137761446, G9824984] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Aravind L, 2001, GENOME BIOL, V2; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Peters T, 2002, MAMM GENOME, V13, P186, DOI 10.1007/s00335-001-2142-7; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103	28	1117	1186	4	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1469	1472		10.1126/science.1151710	http://dx.doi.org/10.1126/science.1151710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	17991826	Green Accepted			2022-12-28	WOS:000251246100051
J	Brenner, DJ; Hall, EJ				Brenner, David J.; Hall, Eric J.			Current concepts - Computed tomography - An increasing source of radiation exposure	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ATOMIC-BOMB SURVIVORS; CANCER-RISKS; IONIZING-RADIATION; DOSE REDUCTION; PEDIATRIC CT; SOLID CANCER; HELICAL CT; X-RAY; CHILDREN; PATIENT		Columbia Univ, Med Ctr, Ctr Radiol Res, New York, NY 10032 USA	Columbia University	Brenner, DJ (corresponding author), Columbia Univ, Med Ctr, Ctr Radiol Res, 630 W 168th St, New York, NY 10032 USA.	djb3@columbia.edu	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789	NATIONAL CANCER INSTITUTE [R01CA088974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA088974] Funding Source: Medline; NIAID NIH HHS [U19AI67773] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Beinfeld MT, 2005, RADIOLOGY, V234, P415, DOI 10.1148/radiol.2342032061; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Brenner DJ, 2005, GASTROENTEROLOGY, V129, P328, DOI 10.1053/j.gastro.2005.05.021; Brenner DJ, 2006, MED PHYS, V33, P1189, DOI 10.1118/1.2173933; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Brenner DJ, 2004, RADIOLOGY, V231, P440, DOI 10.1148/radiol.2312030880; Brenner DJ, 2001, MED PHYS, V28, P2387, DOI 10.1118/1.1415074; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Cardis E, 2007, RADIAT RES, V167, P396, DOI 10.1667/RR0553.1; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; *DEP HLTH HUM SERV, 2006, C RAD CONTR PROGR DI; Donnelly LF, 2005, AM J ROENTGENOL, V184, P655, DOI 10.2214/ajr.184.2.01840655; Giles J, 2004, NATURE, V431, P391, DOI 10.1038/431391a; Groves AM, 2004, BRIT J RADIOL, V77, P662, DOI 10.1259/bjr/48307881; Heiken Jay P, 2005, Cancer Imaging, V5 Spec No A, pS133, DOI 10.1102/1470-7330.2005.0108; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; IMV, 2006, IMV 2006 CT MARK SUM; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Lewis DW, 2000, HEADACHE, V40, P629, DOI 10.1046/j.1526-4610.2000.040008629.x; Linton OW, 2003, AM J ROENTGENOL, V181, P321, DOI 10.2214/ajr.181.2.1810321; Martin CJ, 1999, APPL RADIAT ISOTOPES, V50, P1, DOI 10.1016/S0969-8043(98)00021-9; Maytal J, 2000, EPILEPSIA, V41, P950, DOI 10.1111/j.1528-1157.2000.tb00277.x; McCollough CH, 2006, RADIOGRAPHICS, V26, P503, DOI 10.1148/rg.262055138; McNitt-Gray MF, 2002, RADIOGRAPHICS, V22, P1541, DOI 10.1148/rg.226025128; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301; MITELMAN F, 2007, MITELMAN DATABASE CH; Naghavi M, 2006, AM J CARDIOL, V98, p2H, DOI 10.1016/j.amjcard.2006.03.002; National Cancer Institute, RAD RISKS PED COMP T; Navarro O, 2000, PEDIATR RADIOL, V30, P546, DOI 10.1007/s002470000257; Paterson A, 2001, AM J ROENTGENOL, V176, P297, DOI 10.2214/ajr.176.2.1760297; Pierce DA, 2000, RADIAT RES, V154, P178, DOI 10.1667/0033-7587(2000)154[0178:RRCRAL]2.0.CO;2; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Preston DL, 2004, RADIAT RES, V162, P377, DOI 10.1667/RR3232; Renton J, 2003, J PEDIATR SURG, V38, P793, DOI 10.1016/jpsu.2003.50169; Ruess L, 1997, AM J ROENTGENOL, V169, P1011, DOI 10.2214/ajr.169.4.9308453; Semelka RC, 2007, J MAGN RESON IMAGING, V25, P900, DOI 10.1002/jmri.20895; SLOVIS TL, 2002, PEDIATR RADIOL, V32, P242; Stamm G, 2002, ROFO-FORTSCHR RONTG, V174, P1570, DOI 10.1055/s-2002-35937; Stephen AE, 2003, J PEDIATR SURG, V38, P367, DOI 10.1053/jpsu.2003.50110; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, SOURC EFF ION RAD; White KS, 1996, PEDIATR RADIOL, V26, P5, DOI 10.1007/BF01403695; 2005, BEIR, V7	46	5930	6244	26	621	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2277	2284		10.1056/NEJMra072149	http://dx.doi.org/10.1056/NEJMra072149			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	18046031	Green Submitted, Green Accepted			2022-12-28	WOS:000251176400009
J	Kjekshus, J; Apetrei, E; Barrios, V; Bohm, M; Cleland, JGF; Cornel, JH; Dunselman, P; Fonseca, C; Goudev, A; Grande, P; Gullestad, L; Hjalmarson, A; Hradec, J; Janosi, A; Kamensky, G; Komajda, M; Korewicki, J; Kuusi, T; Mach, F; Mareev, V; McMurray, JJV; Ranjith, N; Schaufelberger, M; Vanhaecke, J; van Veldhuisen, DJ; Waagstein, F; Wedel, H; Wikstrand, J				Kjekshus, John; Apetrei, Eduard; Barrios, Vivencio; Boehm, Michael; Cleland, John G. F.; Cornel, Jan H.; Dunselman, Peter; Fonseca, Candida; Goudev, Assen; Grande, Peer; Gullestad, Lars; Hjalmarson, Ake; Hradec, Jaromir; Janosi, Andras; Kamensky, Gabriel; Komajda, Michel; Korewicki, Jerzy; Kuusi, Timo; Mach, Francois; Mareev, Vyacheslav; McMurray, John J. V.; Ranjith, Naresh; Schaufelberger, Maria; Vanhaecke, Johan; van Veldhuisen, Dirk J.; Waagstein, Finn; Wedel, Hans; Wikstrand, John		CORONA Grp	Rosuvastatin in older patients with systolic heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; STATINS; CHOLESTEROL; PRAVASTATIN; MORTALITY; SURVIVAL; THERAPY; DISEASE; EVENTS; DESIGN	Background Patients with systolic heart failure have generally been excluded from statin trials. Acute coronary events are uncommon in this population, and statins have theoretical risks in these patients. Methods A total of 5011 patients at least 60 years of age with New York Heart Association class II, III, or IV ischemic, systolic heart failure were randomly assigned to receive 10 mg of rosuvastatin or placebo per day. The primary composite outcome was death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. Secondary outcomes included death from any cause, any coronary event, death from cardiovascular causes, and the number of hospitalizations. Results As compared with the placebo group, patients in the rosuvastatin group had decreased levels of low-density lipoprotein cholesterol (difference between groups, 45.0%; P<0.001) and of high-sensitivity C-reactive protein (difference between groups, 37.1%; P<0.001). During a median follow-up of 32.8 months, the primary outcome occurred in 692 patients in the rosuvastatin group and 732 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.83 to 1.02; P=0.12), and 728 patients and 759 patients, respectively, died (hazard ratio, 0.95; 95% CI, 0.86 to 1.05; P=0.31). There were no significant differences between the two groups in the coronary outcome or death from cardiovascular causes. In a prespecified secondary analysis, there were fewer hospitalizations for cardiovascular causes in the rosuvastatin group (2193) than in the placebo group (2564) (P<0.001). No excessive episodes of muscle-related or other adverse events occurred in the rosuvastatin group. Conclusions Rosuvastatin did not reduce the primary outcome or the number of deaths from any cause in older patients with systolic heart failure, although the drug did reduce the number of cardiovascular hospitalizations. The drug did not cause safety problems. (ClinicalTrials.gov number, NCT00206310.).	Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway; Inst Cardiol, Bucharest, Romania; Univ Saarlandes Klinikum, Homburg, Germany; Univ Hull, Kingston Upon Hull, Yorks, England; Med Ctr, Alkmaar, Netherlands; Amphia Hosp, Breda, Netherlands; Univ Nova Lisboa, S Francisco Xavier Hosp, Lisbon, Portugal; Queen Giovanna Univ Hosp, Sofia, Bulgaria; Univ Copenhagen, Rigshosp, DK-2100 Copenhagen, Denmark; Univ Gothenburg, Sahlgrens Univ Hosp, Gothenburg, Sweden; Charles Univ Prague, Univ Gen Hosp, Prague, Czech Republic; Szent Janos Hosp, Budapest, Hungary; Univ Hosp Bratislava, Bratislava, Slovakia; Univ Paris 06, Pitie Salpetriere Hosp, Paris, France; Inst Cardiol, Warsaw, Poland; Univ Helsinki Hosp, Helsinki, Finland; Univ Hosp Geneva, Geneva, Switzerland; AL Myasnikov Cardiol Inst, Moscow, Russia; Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; Univ KwaZulw Natal, RK Khan Hosp, Nelson R Mandela Sch Med, Durban, South Africa; Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; Nordic Sch Publ Hlth, Gothenburg, Sweden; AstraZeneca, Molndal, Sweden	University of Oslo; National Hospital Norway; Universitatsklinikum des Saarlandes; University of Hull; Amphia Hospital; Universidade Nova de Lisboa; Medical University Sofia; Rigshospitalet; University of Copenhagen; Sahlgrenska University Hospital; University of Gothenburg; Charles University Prague; General University Hospital Prague; Slovak Medical University Bratislava; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institute of Cardiology - Poland; University of Helsinki; Helsinki University Central Hospital; University of Geneva; National Medical Research Center of Cardiology; University of Glasgow; University of Kwazulu Natal; University of Groningen; KU Leuven; University Hospital Leuven; AstraZeneca	Kjekshus, J (corresponding author), Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway.	john.kjekshus@medisin.uio.no	Cleland, John G./AAZ-4185-2020; mcmurray, John/B-2467-2013; cornel, jan hein/Y-7065-2019; Mareev, Vyacheslav Yurievich/Q-1375-2017; Hradec, Jaromir/S-2388-2016	Cleland, John G./0000-0002-1471-7016; mcmurray, John/0000-0002-6317-3975; cornel, jan hein/0000-0002-1006-2112; Mareev, Vyacheslav Yurievich/0000-0002-7285-2048; Hradec, Jaromir/0000-0001-7597-8239				Bohm M, 2005, Z KARDIOL, V94, P223, DOI 10.1007/s00392-005-0210-9; Cleland JGF, 2006, EUR HEART J, V27, P641, DOI 10.1093/eurheartj/ehi812; Collins R, 2004, LANCET, V363, P757; Go AS, 2006, JAMA-J AM MED ASSOC, V296, P2105, DOI 10.1001/jama.296.17.2105; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Horwich TB, 2002, J CARD FAIL, V8, P216, DOI 10.1054/jcaf.2002.126519a; Kjekshus J, 2005, EUR J HEART FAIL, V7, P1059, DOI 10.1016/j.ejheart.2005.09.005; Krum H, 2002, J AM COLL CARDIOL, V39, P1567, DOI 10.1016/S0735-1097(02)01827-2; Krum H, 2007, INT J CARDIOL, V119, P48, DOI 10.1016/j.ijcard.2006.07.106; Krum H, 2007, J CARD FAIL, V13, P1, DOI 10.1016/j.cardfail.2006.09.008; Marcoff L, 2007, J AM COLL CARDIOL, V49, P2231, DOI 10.1016/j.jacc.2007.02.049; Martin JH, 2007, CLIN SCI, V113, P119, DOI 10.1042/CS20070031; Moosmann B, 2004, LANCET, V363, P892, DOI 10.1016/S0140-6736(04)15739-5; Orn S, 2005, AM J MED, V118, P752, DOI 10.1016/j.amjmed.2005.02.010; PEDERSEN TR, 1994, LANCET, V344, P1383; Rauchhaus M, 2000, LANCET, V356, P930, DOI 10.1016/S0140-6736(00)02690-8; Rauchhaus M, 2003, J AM COLL CARDIOL, V42, P1933, DOI 10.1016/j.jacc.2003.07.016; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Tavazzi L, 2004, EUR J HEART FAIL, V6, P635, DOI 10.1016/j.ejheart.2004.03.001; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Uretsky BF, 2000, CIRCULATION, V102, P611, DOI 10.1161/01.CIR.102.6.611; van der Harst P, 2006, PLOS MED, V3, P1403, DOI 10.1371/journal.pmed.0030333; Wedel H, 2001, AM HEART J, V142, P502, DOI 10.1067/mhj.2001.117600	24	1104	1169	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2248	2261		10.1056/NEJMoa0706201	http://dx.doi.org/10.1056/NEJMoa0706201			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	17984166				2022-12-28	WOS:000251176400006
J	Mori, T; Vale, RD; Tomishige, M				Mori, Teppei; Vale, Ronald D.; Tomishige, Michio			How kinesin waits between steps	NATURE			English	Article							HAND-OVER-HAND; PROCESSIVE MOTOR; ATP HYDROLYSIS; BINDING; HEAD; COORDINATION; TRANSPORT; MOLECULE; PROTEIN; DOMAINS	Kinesin-1 ( conventional kinesin) is a dimeric motor protein that carries cellular cargoes along microtubules(1,2) by hydrolysing ATP(3) and moving processively in 8-nm steps(4). The mechanism of processive motility involves the hand-over-hand motion of the two motor domains ('heads')(5-7), a process driven by a conformational change in the neck-linker domain of kinesin(8-12.) However, the 'waiting conformation' of kinesin between steps remains controversial(13-16)-some models propose that kinesin adopts a one-head-bound intermediate(17-21), whereas others suggest that both the kinesin heads are bound to adjacent tubulin subunits(7,22,23). Addressing this question has proved challenging, in part because of a lack of tools to measure structural states of the kinesin dimer as it moves along a microtubule. Here we develop two different single-molecule fluorescence resonance energy transfer (smFRET) sensors to detect whether kinesin is bound to its microtubule track by one or two heads. Our FRET results indicate that, while moving in the presence of saturating ATP, kinesin spends most of its time bound to the microtubule with both heads. However, when nucleotide binding becomes rate-limiting at low ATP concentrations, kinesin waits for ATP in a one-head-bound state and makes brief transitions to a two-head-bound intermediate as it walks along the microtubule. On the basis of these results, we suggest a model for how transitions in the ATPase cycle position the two kinesin heads and drive their hand-over-hand motion.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Tokyo; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu						Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Asenjo AB, 2003, NAT STRUCT BIOL, V10, P836, DOI 10.1038/nsb984; Asenjo AB, 2006, NAT STRUCT MOL BIOL, V13, P648, DOI 10.1038/nsmb1109; Auerbach SD, 2005, J BIOL CHEM, V280, P37048, DOI 10.1074/jbc.M502984200; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Carter NJ, 2006, CURR OPIN CELL BIOL, V18, P61, DOI 10.1016/j.ceb.2005.12.009; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; Hackney DD, 2007, SCIENCE, V316, P58, DOI 10.1126/science.1141549; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kaseda K, 2002, P NATL ACAD SCI USA, V99, P16058, DOI 10.1073/pnas.252409199; Kawaguchi K, 2001, SCIENCE, V291, P667, DOI 10.1126/science.291.5504.667; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sablin EP, 2004, J BIOL CHEM, V279, P15707, DOI 10.1074/jbc.R300036200; Skiniotis G, 2003, EMBO J, V22, P1518, DOI 10.1093/emboj/cdg164; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Uemura S, 2002, P NATL ACAD SCI USA, V99, P5977, DOI 10.1073/pnas.092546199; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	28	123	127	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					750	U15		10.1038/nature06346	http://dx.doi.org/10.1038/nature06346			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18004302				2022-12-28	WOS:000251209700060
J	Fuchizaki, U; Machi, T; Kaneko, S				Fuchizaki, Uichiro; Machi, Toshibiko; Kaneko, Shuichi			Gastrobronchial fistula	LANCET			English	Editorial Material									Keiju Med Ctr, Dept Gastroenterol, Nanao, Ishikawa 9268605, Japan; Keiju Med Ctr, Dept Internal Med, Nanao, Ishikawa 9268605, Japan; Kanazawa Univ Hosp, Dept Gastroenterol, Ishikawa, Japan	Kanazawa University	Fuchizaki, U (corresponding author), Keiju Med Ctr, Dept Gastroenterol, 94 Tomioka Cho, Nanao, Ishikawa 9268605, Japan.	ufuchizaki@ybb.ne.jp							0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 24	2007	370	9601					1780	1780		10.1016/S0140-6736(07)61746-2	http://dx.doi.org/10.1016/S0140-6736(07)61746-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234DI	18037082				2022-12-28	WOS:000251140500022
J	Czechowicz, A; Kraft, D; Weissman, IL; Bhattacharya, D				Czechowicz, Agnieszka; Kraft, Daniel; Weissman, Irving L.; Bhattacharya, Deepta			Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches	SCIENCE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; BONE-MARROW-TRANSPLANTATION; MONOCLONAL-ANTIBODIES; PROGENITOR CELLS; MURINE MARROW; MICE; RECONSTITUTION; ENGRAFTMENT; IRRADIATION; RECIPIENTS	Upon intravenous transplantation, hematopoietic stem cells (HSCs) can home to specialized niches, yet most HSCs fail to engraft unless recipients are subjected to toxic preconditioning. We provide evidence that, aside from immune barriers, donor HSC engraftment is restricted by occupancy of appropriate niches by host HSCs. Administration of ACK2, an antibody that blocks c-kit function, led to the transient removal of > 98% of endogenous HSCs in immunodeficient mice. Subsequent transplantation of these mice with donor HSCs led to chimerism levels of up to 90%. Extrapolation of these methods to humans may enable mild but effective conditioning regimens for transplantation.	Stanford Univ, Sch Med, Dept Pathol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Weissman, IL (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	irv@stanford.edu			NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058770, K08HL076335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078318] Funding Source: NIH RePORTER; NCI NIH HHS [5R01CA086065, R01 CA086065-08, R01 CA086065, R01 CA086065-07, R01 CA086065-06] Funding Source: Medline; NHLBI NIH HHS [R01 HL058770-07, 5R01HL058770, R01 HL058770-08, K08 HL076335-03, R01 HL058770, 5K08HL076335, R01 HL058770-06, K08 HL076335-01A2, K08 HL076335-02] Funding Source: Medline; NIAID NIH HHS [T32 AI007290, T32AI0729022] Funding Source: Medline; NIDDK NIH HHS [K01 DK078318, K01 DK078318-01, 5K01DK078318] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACH FH, 1968, LANCET, V2, P1364; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; BRECHER G, 1982, P NATL ACAD SCI-BIOL, V79, P5085, DOI 10.1073/pnas.79.16.5085; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Cavazzana-Calvo M, 2007, BLOOD, V109, P4575, DOI 10.1182/blood-2006-07-029090; Colvin GA, 2004, LEUKEMIA, V18, P575, DOI 10.1038/sj.leu.2403268; COSIMI AB, 1981, NEW ENGL J MED, V305, P308, DOI 10.1056/NEJM198108063050603; Ferry C, 2003, EXP HEMATOL, V31, P1182, DOI 10.1016/j.exphem.2003.09.008; FLEISCHMAN RA, 1979, P NATL ACAD SCI USA, V76, P5736, DOI 10.1073/pnas.76.11.5736; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; GAMBEL P, 1984, TRANSPLANTATION, V38, P152, DOI 10.1097/00007890-198408000-00012; GATTI RA, 1968, LANCET, V2, P1366; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; MICKLEM HS, 1968, TRANSPLANTATION, V6, P299; Miller CL, 1996, EXP HEMATOL, V24, P185; Muller SM, 2000, BLOOD, V96, P4344, DOI 10.1182/blood.V96.13.4344.h8004344_4344_4349; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sarzotti M, 2003, J IMMUNOL, V170, P2711, DOI 10.4049/jimmunol.170.5.2711; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; STEWART FM, 1993, BLOOD, V81, P2566; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; TJONNFJORD GE, 1994, BLOOD, V84, P3584; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; WITTE ON, 1990, CELL, V63, P5, DOI 10.1016/0092-8674(90)90280-R; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	30	279	300	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1296	1299		10.1126/science.1149726	http://dx.doi.org/10.1126/science.1149726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033883	Green Accepted			2022-12-28	WOS:000251086600042
J	Liou, TG; Adler, FR; Cox, DR; Cahill, BC				Liou, Theodore G.; Adler, Frederick R.; Cox, David R.; Cahill, Barbara C.			Lung transplantation and survival in children with cystic fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; DONT DEPRIVE CHILDREN; OPTION; MODELS; HEART	Background The effects of lung transplantation on the survival and quality of life in children with cystic fibrosis are uncertain. Methods We used data from the U.S. Cystic Fibrosis Foundation Patient Registry and from the Organ Procurement and Transplantation Network to identify children with cystic fibrosis who were on the waiting list for lung transplantation during the period from 1992 through 2002. We performed proportional-hazards survival modeling, using multiple clinically relevant covariates that were available before the children were on the waiting list and the interactions of these covariates with lung transplantation as a time-dependent covariate. The data were insufficient in quality and quantity for a retrospective quality-of-life analysis. Results A total of 248 of the 514 children on the waiting list underwent lung transplantation in the United States during the period from 1992 through 2002. Proportional-hazards modeling identified four variables besides transplantation that were associated with changes in survival. Burkholderia cepacia infection decreased survival, regardless of whether the patient underwent transplantation. A diagnosis of diabetes before the patient was placed on the waiting list decreased survival while the patient was on the waiting list but did not decrease survival after transplantation, whereas older age did not affect waiting-list survival but decreased post-transplantation survival. Staphylococcus aureus infection increased waiting-list survival but decreased post-transplantation survival. Using age, diabetes status, and S. aureus infection status as covariates, we estimated the effect of transplantation on survival for each patient group, expressed as a hazard factor of less than 1 for a benefit and more than 1 for a risk of harm. Five patients had a significant estimated benefit, 315 patients had a significant risk of harm, 76 patients had an insignificant benefit, and 118 patients had an insignificant risk of harm associated with lung transplantation. Conclusions Our analyses estimated clearly improved survival for only 5 of 514 patients on the waiting list for lung transplantation. Prolongation of life by means of lung transplantation should not be expected in children with cystic fibrosis. A prospective, randomized trial is needed to clarify whether and when patients derive a survival and quality-of-life benefit from lung transplantation.	Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Utah, Intermt Cyst Fibrosis Ctr, Salt Lake City, UT 84112 USA; Univ Utah, Lung Transplant Program, Salt Lake City, UT 84112 USA; Univ Oxford Nuffield Coll, Oxford OX1 1NF, England	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Oxford	Liou, TG (corresponding author), Div Resp Crit Care & Occupat Pulm Med, 26 N Med Dr, Salt Lake City, UT 84132 USA.	ted.liou@utah.edu	Liou, Theodore/AAI-3667-2021	Liou, Theodore/0000-0003-0121-4847	NHLBI NIH HHS [R21 HL084341-01A1, R21 HL084341] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL084341] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1998, Am J Respir Crit Care Med, V158, P335; Aurora P, 1999, LANCET, V354, P1591, DOI 10.1016/S0140-6736(99)03031-7; BRITTON A, 1995, LANCET, V345, P1511, DOI 10.1016/S0140-6736(95)91071-9; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1992, J ROY STAT SOC A STA, V155, P353, DOI 10.2307/2982889; COX DR, 1972, J R STAT SOC B, V34, P187; CROWLEY J, 1977, J AM STAT ASSOC, V72, P27, DOI 10.2307/2286902; *CYST FIBR FDN PAT, 2003, 2002 ANN DAT REP CEN; Davison AC, 1997, BOOTSTRAP METHODS TH; *DEP HLTH HUM SERV, 2005, ANN REP US ORG PROC; Egan TM, 2006, AM J TRANSPLANT, V6, P1212, DOI 10.1111/j.1600-6143.2006.01276.x; Geertsma A, 1998, J HEART LUNG TRANSPL, V17, P511; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hosenpud JD, 1998, LANCET, V351, P24, DOI 10.1016/S0140-6736(97)06405-2; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Kugler C, 2005, J HEART LUNG TRANSPL, V24, P2262, DOI 10.1016/j.healun.2005.07.005; Liou TG, 2006, AM J RESP CRIT CARE, V173, P247, DOI 10.1164/ajrccm.173.2.247; Liou TG, 2005, AM J RESP CRIT CARE, V171, P1053, DOI 10.1164/rccm.200407-900OC; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Liou TG, 2001, JAMA-J AM MED ASSOC, V286, P2683, DOI 10.1001/jama.286.21.2683; SHARPLES L, 1993, J HEART LUNG TRANSPL, V12, P669; Smeritschnig B, 2005, J HEART LUNG TRANSPL, V24, P474, DOI 10.1016/j.healun.2003.12.013; Sweet SC, 2006, AM J RESP CRIT CARE, V173, P246; Therneau TM, 2000, MODELING SURVIVAL DA; Yankaskas JR, 1998, CHEST, V113, P217, DOI 10.1378/chest.113.1.217	26	136	137	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2143	2152		10.1056/NEJMoa066359	http://dx.doi.org/10.1056/NEJMoa066359			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	18032764	Green Accepted			2022-12-28	WOS:000251076500006
J	McGuire, H; Edmonds, M; Price, J				McGuire, Hugh; Edmonds, Melissa; Price, Jonathan			Data discrepancies in meta-analyses that use standarized mean differences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							RANDOMIZED CONTROLLED-TRIAL; GRADED-EXERCISE		Kings Coll London, Inst Psychiat, London WC2R 2LS, England; Lambeth Hosp, London, England; Univ Oxford, Dept Psychiat, Oxford, England	University of London; King's College London; University of Oxford	McGuire, H (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	h.mcguire@iop.kcl.ac.uk						Edmonds M, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003200.PUB2; Fulcher KY, 1997, BRIT MED J, V314, P1647, DOI 10.1136/bmj.314.7095.1647; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Moss-Morris R, 2005, J HEALTH PSYCHOL, V10, P245, DOI 10.1177/1359105305049774; Powell P, 2001, BMJ-BRIT MED J, V322, P387, DOI 10.1136/bmj.322.7283.387; Wallman KE, 2004, MED J AUSTRALIA, V180, P444, DOI 10.5694/j.1326-5377.2004.tb06019.x; Wearden AJ, 1998, BRIT J PSYCHIAT, V172, P485, DOI 10.1192/bjp.172.6.485	7	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2007	298	19					2261	2262		10.1001/jama.298.19.2261-b	http://dx.doi.org/10.1001/jama.298.19.2261-b			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232XV	18029827				2022-12-28	WOS:000251055900016
J	Proudfoot, N; Gullerova, M				Proudfoot, Nick; Gullerova, Monika			Gene silencing CUTs both ways	CELL			English	Editorial Material							TRANSCRIPTIONAL INTERFERENCE; SACCHAROMYCES-CEREVISIAE; HETEROCHROMATIN; YEAST	There is extensive transcription throughout the eukaryotic genome resulting in both antisense transcripts from coding regions and cryptic unstable transcripts (CUTs) from intergenic regions. In this issue, Camblong et al. (2007) demonstrate in the budding yeast that antisense transcripts, if stabilized by exosome impairment, are able to mediate gene silencing via the recruitment of histone deacetylases.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Proudfoot, N (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	nicholas.proudfoot@path.ox.ac.uk		Proudfoot, Nicholas/0000-0001-8646-3222; Gullerova, Monika/0000-0002-4512-2779				Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002	9	4	4	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					649	651		10.1016/j.cell.2007.11.003	http://dx.doi.org/10.1016/j.cell.2007.11.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022358	Bronze			2022-12-28	WOS:000250966300011
J	Vince, JE; Wong, WWL; Khan, N; Feltham, R; Chau, D; Ahmed, AU; Benetatos, CA; Chunduru, SK; Condon, SM; McKinlay, M; Brink, R; Leverkus, M; Tergaonkar, V; Schneider, P; Callus, BA; Koentgen, F; Vaux, DL; Silke, J				Vince, James E.; Wong, W. Wei-Lynn; Khan, Nufail; Feltham, Rebecca; Chau, Diep; Ahmed, Afsar U.; Benetatos, Christopher A.; Chunduru, Srinivas K.; Condon, Stephen M.; McKinlay, Mark; Brink, Robert; Leverkus, Martin; Tergaonkar, Vinay; Schneider, Pascal; Callus, Bernard A.; Koentgen, Frank; Vaux, David L.; Silke, John			IAP antagonists target cIAP1 to induce TNF alpha- dependent apoptosis	CELL			English	Article							KAPPA-B ACTIVATION; SIGNALING COMPLEX; GENE-EXPRESSION; CELL-DEATH; XIAP; CANCER; SMAC/DIABLO; INHIBITOR; PROTEINS; C-IAP1	XIAP prevents apoptosis by binding to and inhibiting caspases, and this inhibition can be relieved by IAP antagonists, such as Smac/DIA-BLO. IAP antagonist compounds (IACs) have therefore been designed to inhibit XIAP to kill tumor cells. Because XIAP inhibits post-mitochondrial caspases, caspase 8 inhibitors should not block killing by IACs. Instead, we show that apoptosis caused by an IAC is blocked by the caspase 8 inhibitor crmA and that IAP antagonists activate NF-kappa B signaling via inhibtion of cIAP1. In sensitive tumor lines, IAP antagonist induced NF-kappa B-stimulated production of TNF alpha that killed cells in an autocrine fashion. Inhibition of NF-kappa B reduced TNF alpha production, and blocking NF-kappa B activation or TNF alpha allowed tumor cells to survive IAC-induced apoptosis. Cells treated with an IAC, or those in which cIAP1 was deleted, became sensitive to apoptosis induced by exogenous TNF alpha, suggesting novel uses of these compounds in treating cancer.	La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; Tetralog Pharmaceut, Malvern, PA 19355 USA; Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; Univ Magdeburg, Dept Dermatol & Venerol, Lab Expt Dermatol, D-39106 Magdeburg, Germany; IMCB, Singapore 138673, Singapore; Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland; Ozgene Pty Ltd, Bentley, WA 6983, Australia	La Trobe University; Garvan Institute of Medical Research; Otto von Guericke University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Lausanne	Silke, J (corresponding author), La Trobe Univ, Dept Biochem, Kingsbury Dr, Melbourne, Vic 3086, Australia.	j.silke@latrobe.edu.au	Brink, Robert/B-7910-2010; Vaux, David L/C-7249-2013; Silke, John/B-7622-2008; Wong, W. Wei-Lynn/A-6851-2015; Ahmed, Afsar/I-7084-2013	Brink, Robert/0000-0002-9586-3655; Vaux, David L/0000-0003-2703-1651; Silke, John/0000-0002-7611-5774; Wong, W. Wei-Lynn/0000-0003-3155-1211; Ahmed, Afsar/0000-0001-9209-7089; Feltham, Rebecca/0000-0001-8376-6869; Ahmed, Afsar Uddin/0000-0001-8788-6518; Schneider, Pascal/0000-0003-0677-9409				Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Creagh EM, 2004, J BIOL CHEM, V279, P26906, DOI 10.1074/jbc.M313859200; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Nowakowski GS, 2006, CLIN CANCER RES, V12, P6087, DOI 10.1158/1078-0432.CCR-06-1015; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Silke J, 2004, J BIOL CHEM, V279, P4313, DOI 10.1074/jbc.M305661200; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Tenev T, 2005, NAT CELL BIOL, V7, P70, DOI 10.1038/ncb1204; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; VAN AD, 1996, SCIENCE, V274, P787; VAROLOMEEV E, 2006, J BIOL CHEM, V281, P29022; Wang X, 2006, CANCER RES, V66, P1089, DOI 10.1158/0008-5472.CAN-05-2698; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	35	868	899	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					682	693		10.1016/j.cell.2007.10.037	http://dx.doi.org/10.1016/j.cell.2007.10.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022363	Bronze			2022-12-28	WOS:000250966300016
J	Psaty, BM; Korn, D				Psaty, Bruce M.; Korn, David			Congress responds to the IOM drug safety report - In full	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK		Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Assoc Amer Med Coll, Div Biomed & Hlth Sci Res, Washington, DC USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Association of American Medical Colleges	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085251, R01HL068639, R01HL074745] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL74745, HL68639, HL085251] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BACIU A, 2006, FUTURE DRUG SAFETY P; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; *FOOD DRUG ADM, 2007, FUT DRUG SAF PROM PR; Friedman MA, 1999, JAMA-J AM MED ASSOC, V281, P1728, DOI 10.1001/jama.281.18.1728; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; *OFF INSP GEN, 2007, FOOD DRUG ADM OV CLI; Psaty BM, 2006, JAMA-J AM MED ASSOC, V295, P1704, DOI 10.1001/jama.295.14.1704; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622; Psaty BM, 2007, JAMA-J AM MED ASSOC, V297, P1917, DOI 10.1001/jama.297.17.1917; Steenburg C, 2006, FOOD DRUG LAW J, V61, P295; Wood AJJ, 2006, NEW ENGL J MED, V355, P618, DOI 10.1056/NEJMsb055203; 2007, FED REG, V72, P5069	13	21	21	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2185	2187		10.1001/jama.298.18.2185	http://dx.doi.org/10.1001/jama.298.18.2185			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230II	18000202				2022-12-28	WOS:000250869800025
J	Bellamy, L; Casas, JP; Hingorani, AD; Williams, DJ				Bellamy, Leanne; Casas, Juan-Pablo; Hingorani, Aroon D.; Williams, David J.			Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENDOTHELIAL DYSFUNCTION; HYPERTENSIVE DISORDERS; BLOOD-PRESSURE; PREGNANCY; THROMBOPHILIAS; SMOKING; WOMEN	Objective To quantify the risk of future cardiovascular diseases, cancer, and mortality after pre-eclampsia. Design Systematic review and meta-analysis. Data sources Embase and Medline without language restrictions, including papers published between 1960 and December 2006, and hand searching of reference lists of relevant articles and reviews for additional reports. Review methods Prospective and retrospective cohort studies were included, providing a dataset of 3 488 160 women with 198 252 affected by pre-eclampsia (exposure group) and 29 495 episodes of cardiovascular disease and cancer (study outcomes). Results After pre-eclampsia women have an increased risk of vascular disease. The relative risks (95% confidence intervals) for hypertension were 3.70 (2.70 to 5.05) after 14.1 years weighted mean follow-up, for ischaernic heart disease 2.16 (1.86 to 2.52) after 11.7 years, for stroke 1.81 (1.45 to 2.27) after 10.4 years, and for venous thromboembolism 1.79 (1.37 to 2.33) after 4.7 years. No increase in risk of any cancer was found (0.96, 0.73 to 1.27), including breast cancer (1.04, 0.78 to 1.39) 17 years after pre-eclampsia. Overall mortality after pre-eclampsia was increased: 1.49 (1.05 to 2.14) after 14.5 years. Conclusions A history of pre-eclampsia should be considered when evaluating risk of cardiovascular disease in women. This association might reflect a common cause for pre-eclampsia and cardiovascular disease, or an effect of pre-ecampsia on disease development, or both. No association was found between pre-eclampsia and future cancer.	UCL, Elizabeth Garrett Anderson Obstet Hosp, Inst Womens Hlth, London WC1E 6DH, England; Imperial Coll Sch Med, London, England; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; UCL, British Heart Fdn Labs, Dept Med, London WC1E 6DH, England	University of London; University College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Williams, DJ (corresponding author), UCL, Elizabeth Garrett Anderson Obstet Hosp, Inst Womens Hlth, London WC1E 6DH, England.	d.williams@uclh.nhs.uk	Williams, David/AFW-0581-2022	Williams, David/0000-0002-8186-9124; Hingorani, Aroon/0000-0001-8365-0081				Bosio PM, 1999, OBSTET GYNECOL, V94, P978, DOI 10.1016/S0029-7844(99)00430-5; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Castles A, 1999, AM J PREV MED, V16, P208, DOI 10.1016/S0749-3797(98)00089-0; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; CHESLEY LC, 1976, AM J OBSTET GYNECOL, V124, P446, DOI 10.1016/0002-9378(76)90168-X; Greer IA, 1999, LANCET, V353, P1258, DOI 10.1016/S0140-6736(98)10265-9; Hammoud AO, 2005, AM J OBSTET GYNECOL, V192, P1856, DOI 10.1016/j.ajog.2004.12.057; Herrmann J, 2006, ARTERIOSCL THROM VAS, V26, P1948, DOI 10.1161/01.ATV.0000233387.90257.9b; Lin J, 2005, OBSTET GYNECOL, V105, P182, DOI 10.1097/01.AOG.0000146250.85561.e9; Makkonen N, 1996, J PERINAT MED, V24, P641, DOI 10.1515/jpme.1996.24.6.641; Milne F, 2005, BRIT MED J, V330, P576, DOI 10.1136/bmj.330.7491.576; Paidas MJ, 2004, CLIN PERINATOL, V31, P783, DOI 10.1016/j.clp.2004.07.002; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Ray JG, 2006, BJOG-INT J OBSTET GY, V113, P379, DOI 10.1111/j.1471-0528.2006.00889.x; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Rodie VA, 2004, ATHEROSCLEROSIS, V175, P189, DOI 10.1016/j.atherosclerosis.2004.01.038; Ruschitzka F, 1996, Z GEBURTSH NEONATOL, V200, P100; Savvidou MD, 2003, LANCET, V361, P1511, DOI 10.1016/S0140-6736(03)13177-7; Seely EW, 2003, J CLIN ENDOCR METAB, V88, P2393, DOI 10.1210/jc.2003-030241; SINGH MM, 1974, J OBSTET GYN BR COMM, V81, P903; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Williams D, 2003, CURR OPIN OBSTET GYN, V15, P465, DOI 10.1097/00001703-200312000-00002; [No title captured]; [No title captured]; [No title captured]; [No title captured]	28	1638	1690	3	66	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2007	335	7627					974	977		10.1136/bmj.39335.385301.BE	http://dx.doi.org/10.1136/bmj.39335.385301.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232AL	17975258	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-28	WOS:000250990400042
J	Hancock, MJ; Maher, CG; Latimer, J; McLachlan, AJ; Cooper, CW; Day, RO; Spindler, MF; McAuley, JH				Hancock, Mark J.; Maher, Chris G.; Latimer, Jane; McLachlan, Andrew J.; Cooper, Chris W.; Day, Richard O.; Spindler, Megan F.; McAuley, James H.			Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trial	LANCET			English	Article							GUIDELINES; MANAGEMENT; DISABILITY; RISK	Background We aimed to investigate whether the addition of non-steroidal anti-inflammatory drugs or spinal manipulative therapy, or both, would result in faster recovery for patients with acute low back pain receiving recommended first-line care. Methods 240 patients with acute low back pain who had seen theirgeneral practitioner and had been given advice and paracetamol were randomly allocated to one of four groups in our community-based study: diclofenac 50 mg twice daily and placebo manipulative therapy (n=60); spinal manipulative therapy and placebo drug (n=60); didofenac 50 mg twice daily and spinal manipulative therapy (n=60); or double placebo (n=60). The primary outcome was days to recovery from pain assessed by survival curves (log-rank test) in an intention-to-treat analysis. This trial was registered with the Australian Clinical Trials Registry, ACTRN012605000036617. Findings Neither diclofenac nor spinal manipulative therapy appreciably reduced the number of days until recovery compared with placebo drug or placebo manipulative therapy (diclofenac hazard ratio 1.09, 95% CI 0.84-1-42, p=0.516; spinal manipulative therapy hazard ratio 1.01, 95% Cl 0.77-1-31, p=0.955). 237 patients (99%) either recovered or were censored 12 weeks after randomisation. 22 patients had possible adverse reactions including gastrointestinal disturbances, dizziness, and heart palpitations. Half of these patients were in the active diclofenac group, the other half were taking placebo. One patient taking active diclofenac had a suspected hypersensitivity reaction and ceased treatment. Interpretation Patients with acute low back pain receiving recommended first-line care do not recover more quickly with the addition of diclofenac or spinal manipulative therapy.	Univ Sydney, Back Pain Res Grp, Lidcombe, NSW 1825, Australia; Univ Sydney, Fac Pharm, Ctr Educ & Res Aging, Lidcombe, NSW 1825, Australia; Univ Sydney, Discipline Gen Practice, Lidcombe, NSW 1825, Australia; Univ Sydney, Dept Clin Pharmacol, Lidcombe, NSW 1825, Australia; Australia & St Vincents Hosp, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; St Vincents Hospital Sydney	Hancock, MJ (corresponding author), Univ Sydney, Back Pain Res Grp, POB 170, Lidcombe, NSW 1825, Australia.	M.Hancock@usyd.edu.au	Maher, Christopher/AAC-6267-2019; Hancock, Mark J/B-6999-2013; Day, Richard/D-8699-2011; McAuley, James Henry/HHC-3949-2022	Maher, Christopher/0000-0002-1628-7857; Hancock, Mark J/0000-0002-9277-5377; Day, Richard/0000-0002-6045-6937; McAuley, James Henry/0000-0002-0550-828X; McLachlan, Andrew/0000-0003-4674-0242				Assendelft WJJ, 2003, ANN INTERN MED, V138, P871, DOI 10.7326/0003-4819-138-11-200306030-00008; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Farrar JT, 2000, PAIN, V88, P287, DOI 10.1016/S0304-3959(00)00339-0; GRIEVE G, 1984, MOBILISATION SPINE N; Hancock MJ, 2006, AUST J PHYSIOTHER, V52, P135, DOI 10.1016/S0004-9514(06)70049-6; Hancock MJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-57; Jull G, 1994, GRIEVES MODERN MANUA; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; MAITLAND G, 1986, VERTEBRAL MANIPULATI; *MED OUTC TRUST, 1994, SF 36 HLTH SURV SCOR; Ngandu NH, 1997, STAT MED, V16, P611, DOI 10.1002/(SICI)1097-0258(19970330)16:6<611::AID-SIM437>3.0.CO;2-T; Pengel LHM, 2004, SPINE, V29, P879, DOI 10.1097/00007632-200404150-00011; Richy F, 2004, ANN RHEUM DIS, V63, P759, DOI 10.1136/ard.2003.015925; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Schaffer D, 2006, MED J AUSTRALIA, V185, P501, DOI 10.5694/j.1326-5377.2006.tb00665.x; Stratford P, 1995, PHYSIOTHER CAN, V47, P258, DOI [10.3138/ptc.47.4.258, DOI 10.3138/PTC.47.4.258]; TERRETT AGJ, 1992, CHIROPR J AUST, V22, P129; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; van Tulder MW, 2000, SPINE, V25, P2501, DOI 10.1097/00007632-200010010-00013	20	148	150	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2007	370	9599					1638	1643		10.1016/S0140-6736(07)61686-9	http://dx.doi.org/10.1016/S0140-6736(07)61686-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230NO	17993364				2022-12-28	WOS:000250883400023
J	Lecuit, T; Le Goff, L				Lecuit, Thomas; Le Goff, Loic			Orchestrating size and shape during morphogenesis	NATURE			English	Article							PLANAR CELL POLARITY; WING IMAGINAL DISC; GRADIENT FORMATION; DROSOPHILA-MELANOGASTER; SURFACE MECHANICS; TISSUE-GROWTH; DIVISION; DPP; PROLIFERATION; ORIENTATION	Living organisms exhibit tremendous diversity, evident in the large repertoire of forms and considerable size range. Scientists have discovered that conserved mechanisms control the development of all organisms. Drosophila has proved to be a particularly powerful model system with which to identify the signalling pathways that organize tissue patterns. More recently, much has been learned about the control of tissue growth, tissue shape and their coordination at the cellular and tissue levels. New models integrate how specific signals and mechanical forces shape tissues and may also control their size.	Univ Aix Marseille 2, Inst Biol Dev Marseille Luminy, F-13288 Marseille 09, France; CNRS, UMR6216, F-13288 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Lecuit, T (corresponding author), Univ Aix Marseille 2, Inst Biol Dev Marseille Luminy, Campus Luminy Case 907, F-13288 Marseille 09, France.	lecuit@ibdml.univ-mrs.fr		Le Goff, Loic/0000-0003-4114-971X				Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; BRYANT PJ, 1969, DEV BIOL, V20, P263, DOI 10.1016/0012-1606(69)90015-3; Burke R, 1996, DEVELOPMENT, V122, P2261; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Concha ML, 1998, DEVELOPMENT, V125, P983; COWAN R, 1988, J THEOR BIOL, V131, P33, DOI 10.1016/S0022-5193(88)80118-8; da Silva SM, 2007, DEVELOPMENT, V134, P3049, DOI 10.1242/dev.004911; Day SJ, 2000, DEVELOPMENT, V127, P2977; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; FRISTROM D, 1976, DEV BIOL, V54, P163, DOI 10.1016/0012-1606(76)90296-7; GARCIABELLIDO A, 1994, P NATL ACAD SCI USA, V91, P10222, DOI 10.1073/pnas.91.21.10222; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Kaltschmidt JA, 2002, NAT CELL BIOL, V4, P937, DOI 10.1038/ncb882; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; Lynch TM, 1997, DEV BIOL, V181, P246, DOI 10.1006/dbio.1996.8462; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Rolland-Lagan AG, 2003, NATURE, V422, P161, DOI 10.1038/nature01443; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Wang Y, 2007, CURR BIOL, V17, P1349, DOI 10.1016/j.cub.2007.06.067; Weigmann K, 1997, DEVELOPMENT, V124, P3555; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	49	150	153	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					189	192		10.1038/nature06304	http://dx.doi.org/10.1038/nature06304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994084	Bronze			2022-12-28	WOS:000250746200039
J	Rhodes, KV; Frankel, RM; Levinthal, N; Prenoveau, E; Bailey, J; Levinson, W				Rhodes, Karin V.; Frankel, Richard M.; Levinthal, Naomi; Prenoveau, Elizabeth; Bailey, Jeannine; Levinson, Wendy			"You're not a victim of domestic violence, are you?" Provider-patient communication about domestic violence	ANNALS OF INTERNAL MEDICINE			English	Article							INTIMATE PARTNER VIOLENCE; HEALTH-CARE PROVIDERS; BATTERED WOMEN; OPPORTUNITIES; PHYSICIANS; EMERGENCY; SURVIVORS; CLINICIAN; RESPONSES; MODEL	Background: Women who are victims of domestic violence frequently seek care in an emergency department. However, it is challenging to hold sensitive conversations in this environment. Objective: To describe communication about domestic violence between emergency providers and female patients. Design: Analysis of audiotapes made during a randomized, controlled trial of computerized screening for domestic violence. Setting: 2 socioeconomically diverse emergency departments: one urban and academic, the other suburban and community-based. Participants: 1281 English-speaking women age 16 to 69 years and 80 providers (30 attending physicians, 46 residents, and 4 nurse practitioners). Results: 871 audiotapes, including 293 that included provider screening for domestic violence, were analyzed. Providers typically asked about domestic violence in a perfunctory manner during the social history. Provider communication behaviors associated with women disclosing abuse included probing (defined as asking >= 1 additional topically related question), providing open-ended opportunities to talk, and being generally responsive to patient clues (any mention of a psychosocial issue). Chart documentation of domestic violence was present in one third of cases. Limitations: Nonverbal communication was not examined. Providers were aware that they were being audiotaped and may have tried to perform their best. Conclusion: Although hectic clinical environments present many obstacles to meaningful discussions about domestic violence, several provider communication behaviors seemed to facilitate patient disclosure of experiences with abuse. Illustrative examples highlight common pitfalls and exemplary practices in screening for abuse and response to disclosures of abuse.	Univ Penn, Sch Social Policy & Practice, Div Hlth Care Policy Res, Dept Emergency Med, Philadelphia, PA 19104 USA; Indiana Univ, Sch Med, Regenstrief Inst, Indianapolis, IN USA; Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; Univ Chicago, Chicago, IL 60637 USA; Univ Toronto, Toronto, ON, Canada	University of Pennsylvania; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; University of Chicago; University of Toronto	Rhodes, KV (corresponding author), Univ Penn, Sch Social Policy & Practice, Div Hlth Care Policy Res, Dept Emergency Med, 3815 Walnut St,Room 201, Philadelphia, PA 19104 USA.	kvr@sp2.upenn.edu			AHRQ HHS [R01 HS011096, R01 HS 11096-03] Funding Source: Medline; NIMH NIH HHS [K23 MH064572, K23 MH64572, K23 MH064572-05] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS011096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH064572] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABBOTT J, 1995, JAMA-J AM MED ASSOC, V273, P1763, DOI 10.1001/jama.273.22.1763; BRANCH WT, 1993, JAMA-J AM MED ASSOC, V269, P1667, DOI 10.1001/jama.269.13.1667; Chang JC, 2005, PATIENT EDUC COUNS, V59, P141, DOI 10.1016/j.pec.2004.10.008; Chang Judy C, 2003, J Am Med Womens Assoc (1972), V58, P76; Crabtree BF., 1999, DOING QUALITATIVE RE, V2nd ed; Dienemann J, 2005, CLIN NURS RES, V14, P234; Dienemann Jacqueline, 2005, Clin Nurs Res, V14, P215, DOI 10.1177/1054773805275287; Edwardsen EA, 2006, TEACH LEARN MED, V18, P62, DOI 10.1207/s15328015tlm1801_13; Eide H, 2004, PATIENT EDUC COUNS, V54, P291, DOI 10.1016/j.pec.2003.09.006; Epstein RM, 1998, ANN INTERN MED, V128, P435, DOI 10.7326/0003-4819-128-6-199803150-00003; Frankel R M, 2001, J Med Pract Manage, V16, P184; Gerbert B, 1999, WOMEN HEALTH, V29, P115, DOI 10.1300/J013v29n03_08; Gerbert B, 2002, WOMEN HEALTH, V35, P1, DOI 10.1300/J013v35n02_01; Gerbert B, 1999, ANN INTERN MED, V131, P578, DOI 10.7326/0003-4819-131-8-199910190-00005; Gilbert CL, 1996, WORLD DEV, V24, P1, DOI 10.1016/0305-750X(95)00121-R; Gremillion D H, 1994, N C Med J, V55, P428; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kothari CL, 2006, ANN EMERG MED, V47, P190, DOI 10.1016/j.annemergmed.2005.10.016; KURZ D, 1987, SOC PROBL, V34, P69, DOI 10.1525/sp.1987.34.1.03a00050; Levinson W, 2000, JAMA-J AM MED ASSOC, V284, P1021, DOI 10.1001/jama.284.8.1021; Limandri B J, 1989, Arch Psychiatr Nurs, V3, P69; McCauley J, 1998, J GEN INTERN MED, V13, P549, DOI 10.1046/j.1525-1497.1998.00166.x; Muelleman RL, 1998, AM J EMERG MED, V16, P128, DOI 10.1016/S0735-6757(98)90028-6; Nelson HD, 2004, ANN INTERN MED, V140, P387, DOI 10.7326/0003-4819-140-5-200403020-00015; Nicolaidis C, 2002, J GEN INTERN MED, V17, P117, DOI 10.1046/j.1525-1497.2002.10713.x; Ramsay J, 2002, BRIT MED J, V325, P314, DOI 10.1136/bmj.325.7359.314; Rhodes KV, 2006, ARCH INTERN MED, V166, P1107, DOI 10.1001/archinte.166.10.1107; Rodriguez MA, 2001, J FAM PRACTICE, V50, P338; Rodriguez MA, 1996, ARCH FAM MED, V5, P153, DOI 10.1001/archfami.5.3.153; Stewart M, 2000, J FAM PRACTICE, V49, P796; STEWART M, 1989, CAN FAM PHYSICIAN, V35, P159; Suchman AL, 1997, JAMA-J AM MED ASSOC, V277, P678, DOI 10.1001/jama.277.8.678; Yam M, 2000, J Emerg Nurs, V26, P464, DOI 10.1067/men.2000.110432	33	98	98	1	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2007	147	9					620	627		10.7326/0003-4819-147-9-200711060-00006	http://dx.doi.org/10.7326/0003-4819-147-9-200711060-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227QM	17975184	Green Accepted			2022-12-28	WOS:000250672900004
J	Chen, MS; White, MC				Chen, Mark S.; White, M. Christina			A predictably selective aliphatic C-H oxidation reaction for complex molecule synthesis	SCIENCE			English	Article							STEREOSPECIFIC ALKANE HYDROXYLATION; OXYGEN-ATOM INSERTION; HYDROCARBON OXIDATION; BONDS; ACTIVATION	Realizing the extraordinary potential of unactivated sp(3) C-H bond oxidation in organic synthesis requires the discovery of catalysts that are both highly reactive and predictably selective. We report an iron (Fe)-based small molecule catalyst that uses hydrogen peroxide (H2O2) to oxidize a broad range of substrates. Predictable selectivity is achieved solely on the basis of the electronic and steric properties of the C-H bonds, without the need for directing groups. Additionally, carboxylate directing groups may be used to furnish five-membered ring lactone products. We demonstrate that these three modes of selectivity enable the predictable oxidation of complex natural products and their derivatives at specific C-H bonds with preparatively useful yields. This type of general and predictable reactivity stands to enable aliphatic C-H oxidation as a method for streamlining complex molecule synthesis.	Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	White, MC (corresponding author), Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA.	white@scs.uiuc.edu	Chen, Mark/AAX-6131-2020	Chen, Mark/0000-0001-5415-4660				BACH RD, 1993, J AM CHEM SOC, V115, P5768, DOI 10.1021/ja00066a049; BRESLOW R, 1973, J AM CHEM SOC, V95, P3251, DOI 10.1021/ja00791a031; Brodsky BH, 2005, J AM CHEM SOC, V127, P15391, DOI 10.1021/ja055549i; Chen K, 1999, CHEM COMMUN, P1375, DOI 10.1039/a901678c; Covell DJ, 2006, ANGEW CHEM INT EDIT, V45, P8217, DOI 10.1002/anie.200603321; Das S, 2006, SCIENCE, V312, P1941, DOI 10.1126/science.1127899; Davies HML, 2003, CHEM REV, V103, P2861, DOI 10.1021/cr0200217; Davies HML, 2006, J AM CHEM SOC, V128, P2485, DOI 10.1021/ja056877l; Dick AR, 2006, TETRAHEDRON, V62, P2439, DOI 10.1016/j.tet.2005.11.027; England J, 2007, INORG CHEM, V46, P3752, DOI 10.1021/ic070062r; Fraunhoffer KJ, 2007, J AM CHEM SOC, V129, P7274, DOI 10.1021/ja071905g; Fraunhoffer KJ, 2005, ORG LETT, V7, P223, DOI 10.1021/ol047800p; Hinman A, 2003, J AM CHEM SOC, V125, P11510, DOI 10.1021/ja0368305; Hoffmann RW, 2006, SYNTHESIS-STUTTGART, P3531, DOI 10.1055/s-2006-950311; HU Z, 2000, BIOMIMETIC OXIDATION, V269; Kim C, 1997, J AM CHEM SOC, V119, P5964, DOI 10.1021/ja9642572; KOLB HC, 1991, CHEM REV, V94, P2183; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Lee SM, 2002, J AM CHEM SOC, V124, P13978, DOI 10.1021/ja026734o; Muller P, 2003, CHEM REV, V103, P2905, DOI 10.1021/cr020043t; MURRAY RW, 1986, J AM CHEM SOC, V108, P2470, DOI 10.1021/ja00269a069; Nicolaou K.C., 1996, CLASSICS TOTAL SYNTH; Okuno T, 1997, J CHEM SOC DALTON, P3547, DOI 10.1039/a700030h; SHARPLESS KB, 1994, TETRAHEDRON, V50, P4235, DOI 10.1016/S0040-4020(01)89364-9; Tshuva EY, 2004, CHEM REV, V104, P987, DOI 10.1021/cr020622y; Wender PA, 2005, ORG LETT, V7, P79, DOI 10.1021/ol047859w; White MC, 2001, J AM CHEM SOC, V123, P7194, DOI 10.1021/ja015884g; Zhan JX, 2002, TETRAHEDRON LETT, V43, P4519, DOI 10.1016/S0040-4039(02)00812-2	28	960	986	22	392	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					783	787		10.1126/science.1148597	http://dx.doi.org/10.1126/science.1148597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	226IY	17975062				2022-12-28	WOS:000250583900037
J	Otto, SP				Otto, Sarah P.			The evolutionary consequences of polyploidy	CELL			English	Review							ANTIFUNGAL DRUG-RESISTANCE; GENOME EVOLUTION; DUPLICATE GENES; FUNCTIONAL DIVERGENCE; EXPRESSION; SIZE; DNA; MECHANISMS; SELECTION; BRASSICA	Polyploidization, the addition of a complete set of chromosomes to the genome, represents one of the most dramatic mutations known to occur. Nevertheless, polyploidy is well tolerated in many groups of eukaryotes. Indeed, the majority of flowering plants and vertebrates have descended from polyploid ancestors. This Review examines the short-term effects of polyploidization on cell size, body size, genomic stability, and gene expression and the long-term effects on rates of evolution.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Otto, SP (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	otto@zoology.ubc.ca	Otto, Sarah Perin/K-5625-2012	Otto, Sarah Perin/0000-0003-3042-0818				ADAMS J, 1974, GENETICS, V76, P327; Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; AHN S, 1993, P NATL ACAD SCI USA, V90, P7980, DOI 10.1073/pnas.90.17.7980; Albertin W, 2005, PROTEOMICS, V5, P2131, DOI 10.1002/pmic.200401092; Albertin W, 2006, GENETICS, V173, P1101, DOI 10.1534/genetics.106.057554; Anderson JB, 2004, GENETICS, V168, P1915, DOI 10.1534/genetics.104.033266; Anderson JB, 2003, GENETICS, V163, P1287; BAILEY GS, 1978, P NATL ACAD SCI USA, V75, P5575, DOI 10.1073/pnas.75.11.5575; BEEMAN RW, 1987, NATURE, V327, P247, DOI 10.1038/327247a0; Bennett RJ, 2003, MOL CELL BIOL, V23, P8189, DOI 10.1128/MCB.23.22.8189-8201.2003; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; BLOOM SE, 1972, CHROMOSOMA, V37, P309, DOI 10.1007/BF00319873; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; CAVALIERSMITH T, 1978, J CELL SCI, V34, P247; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; CREASY MR, 1976, HUM GENET, V31, P177, DOI 10.1007/BF00296145; Day SJ, 2000, DEVELOPMENT, V127, P2977; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Devenport MP, 2000, EVOL DEV, V2, P326, DOI 10.1046/j.1525-142x.2000.00074.x; DONELSON JE, 1995, J BIOL CHEM, V270, P7783, DOI 10.1074/jbc.270.14.7783; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Fankhauser G, 1972, Am Sci, V60, P46; FERRIS SD, 1979, J MOL EVOL, V12, P267, DOI 10.1007/BF01732026; Force A, 1999, GENETICS, V151, P1531; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gallardo MH, 2004, BIOL J LINN SOC, V82, P443, DOI 10.1111/j.1095-8312.2004.00331.x; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Gerstein AC, 2006, PLOS GENET, V2, P1396, DOI 10.1371/journal.pgen.0020145; Goldblatt P., 1980, POLYPLOIDY BIOL RELE, P219, DOI DOI 10.1007/978-1-4613-3069-1_13; Grant V., 1963, ORIGIN ADAPTATIONS; Grant V, 1971, PLANT SPECIATION, V1st; Gregory T. R., 2011, EVOLUTION GENOME; Gregory T. Ryan, 2005, P427; Gregory TR, 2000, HEREDITY, V84, P201, DOI 10.1046/j.1365-2540.2000.00661.x; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guo M, 1996, GENETICS, V142, P1349; HAIG D, 1991, PHILOS T ROY SOC B, V333, P1, DOI 10.1098/rstb.1991.0057; Haldane J. B. S., 1990, CAUSES EVOLUTION; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Henry IM, 2005, GENETICS, V170, P1979, DOI 10.1534/genetics.104.037788; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; HUGHES MK, 1993, MOL BIOL EVOL, V10, P1360; Jackson JA, 2003, INT J PARASITOL, V33, P137, DOI 10.1016/S0020-7519(02)00255-2; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Liu B, 1998, GENOME, V41, P272, DOI 10.1139/gen-41-2-272; Love A., 1977, SYST BOT; Lynch M, 2000, GENETICS, V154, P459; LYNCH M, 2007, ORIGINS GENOME ARCH; Mable BK, 2001, GENET RES, V77, P9, DOI 10.1017/S0016672300004821; Mable BK, 2001, J EVOLUTION BIOL, V14, P157, DOI 10.1046/j.1420-9101.2001.00245.x; Malik HS, 2006, BIOCHEM SOC T, V34, P569, DOI 10.1042/BST0340569; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; MAYER VW, 1992, MUTAT RES, V279, P41, DOI 10.1016/0165-1218(92)90264-Z; McPeek MA, 2007, AM NAT, V169, pE97, DOI 10.1086/512135; Meyers LA, 2006, EVOLUTION, V60, P1198, DOI 10.1111/j.0014-3820.2006.tb01198.x; Nadeau JH, 1997, GENETICS, V147, P1259; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Ohno S., 1970, P1; ORR HA, 1994, GENETICS, V136, P1475; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Otto SP, 2002, ADV GENET, V46, P451; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Petit C, 1999, EVOL ECOL, V13, P45, DOI 10.1023/A:1006534130327; Powers TP, 2000, EVOL DEV, V2, P311, DOI 10.1046/j.1525-142x.2000.00072.x; Rajaraman R, 2005, CELL BIOL INT, V29, P1084, DOI 10.1016/j.cellbi.2005.10.003; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Ramsey J, 2002, ANNU REV ECOL SYST, V33, P589, DOI 10.1146/annurev.ecolsys.33.010802.150437; Riehle MM, 2001, P NATL ACAD SCI USA, V98, P525, DOI 10.1073/pnas.021448998; Ronfort J, 1999, GENET RES, V74, P31, DOI 10.1017/S0016672399003845; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Shavorskaya O, 2006, MOL PHYLOGENET EVOL, V39, P846, DOI 10.1016/j.ympev.2006.01.013; Soltis DE, 2007, TAXON, V56, P13, DOI 10.2307/25065732; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Stebbins G.L., 1971, PROCESSES ORGANIC EV; STEBBINS GL, 1984, BOT HELV, V94, P1; Stebbins GL, 1938, AM J BOT, V25, P189, DOI 10.2307/2436589; STEBBINS GL, 1950, VARIATION EVOLUTION; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Svard SG, 1998, MOL MICROBIOL, V30, P979, DOI 10.1046/j.1365-2958.1998.01125.x; Szafraniec K, 2003, GENET RES, V82, P19, DOI 10.1017/S001667230300630X; Tan Y, 1999, NATURE, V402, P36, DOI 10.1038/46947; Udall JA, 2006, GENETICS, V173, P1823, DOI 10.1534/genetics.106.058271; Vamosi JC, 2006, INT J PLANT SCI, V167, P349, DOI 10.1086/499251; WALSH JB, 1995, GENETICS, V139, P421; WEISS RL, 1975, P NATL ACAD SCI USA, V72, P794, DOI 10.1073/pnas.72.3.794; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Zeyl C, 2003, SCIENCE, V299, P555, DOI 10.1126/science.1078417	99	742	792	6	205	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					452	462		10.1016/j.cell.2007.10.022	http://dx.doi.org/10.1016/j.cell.2007.10.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981114	Bronze			2022-12-28	WOS:000250618500014
J	Martin, DR; Schlott, DW; Flynn, JA				Martin, Don R.; Schlott, D. William; Flynn, John A.			No respecter of age	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PARVOVIRUS B19; INFECTION; ARTHRITIS; ARTHROPATHY; DISEASE		Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Dept Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Div Rheumatol, Dept Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Martin, DR (corresponding author), Johns Hopkins Outpatient Ctr, Rm 7143,601 N Caroline St, Baltimore, MD 21287 USA.	drmartin@jhmi.edu						Barlow GD, 2000, J INFECTION, V40, P192, DOI 10.1016/S0163-4453(00)80018-3; BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117; Chen S, 2004, NEW ENGL J MED, V350, P598, DOI 10.1056/NEJMicm010759; COSSART YE, 1975, LANCET, V1, P72; Kerr JR, 2000, RHEUMATOLOGY, V39, P903, DOI 10.1093/rheumatology/39.8.903; Kerr JR, 2004, J MED VIROL, V74, P147, DOI 10.1002/jmv.20158; Kerr JR, 2000, ANN RHEUM DIS, V59, P672, DOI 10.1136/ard.59.9.672; Moore TL, 2000, CURR OPIN RHEUMATOL, V12, P289, DOI 10.1097/00002281-200007000-00010; PATTISON JR, 1981, LANCET, V1, P664; REID DM, 1985, LANCET, V1, P422; Scroggie DA, 2000, J RHEUMATOL, V27, P2444; WHITE DG, 1985, LANCET, V1, P419; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840	13	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2007	357	18					1856	1859		10.1056/NEJMcps051960	http://dx.doi.org/10.1056/NEJMcps051960			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	225OJ	17978295				2022-12-28	WOS:000250526900011
J	Leek, PJ; Fink, JM; Blais, A; Bianchetti, R; Goppl, M; Gambetta, JM; Schuster, DI; Frunzio, L; Schoelkopf, RJ; Wallraff, A				Leek, P. J.; Fink, J. M.; Blais, A.; Bianchetti, R.; Goeppl, M.; Gambetta, J. M.; Schuster, D. I.; Frunzio, L.; Schoelkopf, R. J.; Wallraff, A.			Observation of Berry's phase in a solid-state qubit	SCIENCE			English	Article							QUANTUM STATE; SUPERCONDUCTING QUBITS; PAIR	In quantum information science, the phase of a wave function plays an important role in encoding information. Although most experiments in this field rely on dynamic effects to manipulate this information, an alternative approach is to use geometric phase, which has been argued to have potential fault tolerance. We demonstrated the controlled accumulation of a geometric phase, Berry's phase, in a superconducting qubit; we manipulated the qubit geometrically by means of microwave radiation and observed the accumulated phase in an interference experiment. We found excellent agreement with Berry's predictions and also observed a geometry- dependent contribution to dephasing.	ETH, Dept Phys, Schafmattstr 16, CH-8093 Zurich, Switzerland; Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada; Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; Yale Univ, Dept Phys, New Haven, CT 06520 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Sherbrooke; University of Waterloo; University of Waterloo; Yale University; Yale University	Leek, PJ (corresponding author), ETH, Dept Phys, Schafmattstr 16, CH-8093 Zurich, Switzerland.	leek@phys.ethz.ch; andreas.wallraff@phys.ethz.ch	Wallraff, Andreas J/C-2130-2009; Bianchetti, Romeo/D-6836-2016; Frunzio, Luigi/O-1573-2019; Blais, Alexandre/E-3315-2010; Leek, Peter/C-7252-2016; Schoelkopf, Robert J/J-8178-2012; Fink, Johannes M/C-1919-2008	Wallraff, Andreas J/0000-0002-3476-4485; Frunzio, Luigi/0000-0002-0272-5481; Blais, Alexandre/0000-0002-0591-2012; Leek, Peter/0000-0002-1410-5642; Fink, Johannes M/0000-0001-8112-028X; schuster, david/0000-0002-0012-3874				Abragam A., 1961, PRINCIPLES NUCL MAGN; ANANDAN J, 1992, NATURE, V360, P307, DOI 10.1038/360307a0; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Blais A, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.012308; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Bouchiat V, 1998, PHYS SCRIPTA, VT76, P165, DOI 10.1238/Physica.Topical.076a00165; De Chiara G, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090404; Falci G, 2000, NATURE, V407, P355, DOI 10.1038/35030052; Ithier G, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.134519; Jones JA, 2000, NATURE, V403, P869, DOI 10.1038/35002528; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Mottonen M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.214523; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Nielsen M. A., 2000, QUANTUM COMPUTING QU; Niskanen AO, 2007, SCIENCE, V316, P723, DOI 10.1126/science.1141324; Peng ZH, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.020502; Plantenberg JH, 2007, NATURE, V447, P836, DOI 10.1038/nature05896; Shapere A., 1989, GEOMETRIC PHASES PHY; Shnirman A, 1997, PHYS REV LETT, V79, P2371, DOI 10.1103/PhysRevLett.79.2371; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Wallraff A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060501; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wang XB, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.172508; Yamamoto T, 2003, NATURE, V425, P941, DOI 10.1038/nature02015; [No title captured]	29	291	299	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1889	1892		10.1126/science.1149858	http://dx.doi.org/10.1126/science.1149858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18033851	Green Submitted			2022-12-28	WOS:000251786600049
J	Kayagaki, N; Phung, Q; Chan, S; Chaudhari, R; Quan, C; O'Rourke, KM; Eby, M; Pietras, E; Cheng, GH; Bazan, JF; Zhang, ZM; Arnott, D; Dixit, VM				Kayagaki, Nobuhiko; Phung, Qui; Chan, Salina; Chaudhari, Ruchir; Quan, Casey; O'Rourke, Karen M.; Eby, Michael; Pietras, Eric; Cheng, Genhong; Bazan, J. Fernando; Zhang, Zemin; Arnott, David; Dixit, Vishva M.			DUBA: A deubiquitinase that regulates type I interferon production	SCIENCE			English	Article							UBIQUITIN-BINDING DOMAINS; TOLL-LIKE RECEPTORS; ANTIVIRAL RESPONSES; RIG-I; RNA; INNATE; ACTIVATION; INDUCTION; TRAF3; RECOGNITION	Production of type I interferon (IFN-I) is a critical host defense triggered by pattern-recognition receptors (PRRs) of the innate immune system. Deubiquitinating enzyme A ( DUBA), an ovarian tumor domain-containing deubiquitinating enzyme, was discovered in a small interfering RNA-based screen as a regulator of IFN-I production. Reduction of DUBA augmented the PRR-induced IFN-I response, whereas ectopic expression of DUBA had the converse effect. DUBA bound tumor necrosis factor receptor-associated factor 3 ( TRAF3), an adaptor protein essential for the IFN-I response. TRAF3 is an E3 ubiquitin ligase that preferentially assembled lysine-63-linked polyubiquitin chains. DUBA selectively cleaved the lysine-63-linked polyubiquitin chains on TRAF3, resulting in its dissociation from the downstream signaling complex containing TANKbinding kinase 1. A discrete ubiquitin interaction motif within DUBA was required for efficient deubiquitination of TRAF3 and optimal suppression of IFN-I. Our data identify DUBA as a negative regulator of innate immune responses.	Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California Los Angeles; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA.	dixit@gene.com	Bazan, J. Fernando/B-4562-2010; dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bowie AG, 2007, TRENDS IMMUNOL, V28, P147, DOI 10.1016/j.it.2007.02.002; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Wullaert A, 2006, TRENDS IMMUNOL, V27, P533, DOI 10.1016/j.it.2006.09.003; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	26	355	380	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1628	1632		10.1126/science.1145918	http://dx.doi.org/10.1126/science.1145918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	17991829				2022-12-28	WOS:000251421700047
J	Ghavidel, A; Kislinger, T; Pogoutse, O; Sopko, R; Jurisica, I; Emili, A				Ghavidel, Ata; Kislinger, Thomas; Pogoutse, Oxana; Sopko, Richelle; Jurisica, Igor; Emili, Andrew			Impaired tRNA nuclear export links DNA damage and cell-cycle checkpoint	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; INITIATION FACTOR-2-ALPHA; TRANSLATIONAL CONTROL; MASTER REGULATOR; GENE-EXPRESSION; GLOBAL ANALYSIS; PROTEIN-KINASE; IN-VIVO; YEAST; PHOSPHORYLATION	In response to genotoxic stress, cells evoke a plethora of physiological responses collectively aimed at enhancing viability and maintaining the integrity of the genome. Here, we report that unspliced tRNA rapidly accumulates in the nuclei of yeast Saccharomyces cerevisiae after DNA damage. This response requires an intact MEC1- and RAD53-dependent signaling pathway that impedes the nuclear export of intron-containing tRNA via differential relocalization of the karyopherin Los1 to the cytoplasm. The accumulation of unspliced tRNA in the nucleus signals the activation of Gcn4 transcription factor, which, in turn, contributes to cell-cycle arrest in G1 in part by delaying accumulation of the cyclin Cln2. The regulated nucleocytoplasmic tRNA trafficking thus constitutes an integral physiological adaptation to DNA damage. These data further illustrate how signal-mediated crosstalk between distinct functional modules, namely, tRNA nucleocytoplasmic trafficking, protein synthesis, and checkpoint execution, allows for functional coupling of tRNA biogenesis and cell-cycle progression.	[Ghavidel, Ata; Jurisica, Igor] Ontario Canc Inst, Div Signaling Biol, Toronto, ON M4X 1K9, Canada; [Kislinger, Thomas; Pogoutse, Oxana] Ontario Canc Inst, Div Canc Genom & Prot, Toronto, ON, Canada; [Pogoutse, Oxana; Sopko, Richelle; Emili, Andrew] Univ Toronto, Donnely Ctr Cellular & Biomed Res, Toronto, ON, Canada; [Kislinger, Thomas; Jurisica, Igor] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Jurisica, Igor] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Pogoutse, Oxana; Sopko, Richelle; Emili, Andrew] Univ Toronto, Dept Med Genet, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Ghavidel, A (corresponding author), Ontario Canc Inst, Div Signaling Biol, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	aghavide@uhnres.utoronto.ca	Kislinger, Thomas/A-5934-2008	Kislinger, Thomas/0000-0003-3525-5540				Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; Begley TJ, 2004, MOL CELL, V16, P117, DOI 10.1016/j.molcel.2004.09.005; COLBY D, 1981, P NATL ACAD SCI-BIOL, V78, P415, DOI 10.1073/pnas.78.1.415; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; ENGELBERG D, 1994, CELL, V77, P381, DOI 10.1016/0092-8674(94)90153-8; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gerald JNF, 2002, J CELL SCI, V115, P1749; Germain D, 1997, J CELL SCI, V110, P1813; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghavidel A, 2001, CELL, V106, P575, DOI 10.1016/S0092-8674(01)00473-1; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; HOPPER AK, 1980, CELL, V19, P741, DOI 10.1016/S0092-8674(80)80050-X; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Majka J, 2005, DNA REPAIR, V4, P1189, DOI 10.1016/j.dnarep.2005.07.008; MANN C, 1992, MOL CELL BIOL, V12, P4314, DOI 10.1128/MCB.12.10.4314; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Niwa M, 2000, P NATL ACAD SCI USA, V97, P12396, DOI 10.1073/pnas.250476097; OCONNOR JP, 1991, MOL CELL BIOL, V11, P425, DOI 10.1128/MCB.11.1.425; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Paulovich AG, 1997, GENETICS, V145, P45; Polymenis M, 1999, CURR OPIN GENET DEV, V9, P76, DOI 10.1016/S0959-437X(99)80011-2; Qiu HF, 2000, MOL CELL BIOL, V20, P2505, DOI 10.1128/MCB.20.7.2505-2516.2000; REYES VM, 1987, ANAL BIOCHEM, V166, P90, DOI 10.1016/0003-2697(87)90551-3; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; SIEDE W, 1994, GENETICS, V138, P271; Simos G, 1999, CURR BIOL, V9, pR238, DOI 10.1016/S0960-9822(99)80152-3; Simos G, 1996, EMBO J, V15, P2270, DOI 10.1002/j.1460-2075.1996.tb00580.x; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; STUART D, 1994, MOL CELL BIOL, V14, P4788, DOI 10.1128/MCB.14.7.4788; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; TYERS M, 1991, COLD SH Q B, V56, P21; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Volta V, 2005, BIOCHEM BIOPH RES CO, V337, P89, DOI 10.1016/j.bbrc.2005.09.012; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757	49	67	73	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					915	926		10.1016/j.cell.2007.09.042	http://dx.doi.org/10.1016/j.cell.2007.09.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045534	Bronze			2022-12-28	WOS:000251800900014
J	Avorn, J				Avorn, Jerry			In defense of pharmacoepidemiology - Embracing the yin and yan of drug research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE; TRIAL		Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Barrett-Connor E, 1998, ANNU REV PUBL HEALTH, V19, P55, DOI 10.1146/annurev.publhealth.19.1.55; HARRIS G, 2007, NY TIMES        0920; MATHEWS AW, 2007, WALL STREET J   1105; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X	5	125	126	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2219	2221		10.1056/NEJMp0706892	http://dx.doi.org/10.1056/NEJMp0706892			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	18046025				2022-12-28	WOS:000251176400002
J	Ralph, TC; Boyd, RW				Ralph, Timothy C.; Boyd, Robert W.			Better computing with photons	SCIENCE			English	Editorial Material									Univ Queensland, Dept Phys, Brisbane, Qld 4072, Australia; Univ Rochester, Inst Opt, Rochester, NY 14627 USA	University of Queensland; University of Rochester	Ralph, TC (corresponding author), Univ Queensland, Dept Phys, Brisbane, Qld 4072, Australia.	boyd@optics.rochester.edu	Ralph, Timothy C/A-1858-2011	Ralph, Timothy C/0000-0003-0692-8427				Bachor H.A., 2004, GUIDE EXPT QUANTUM O; BIGELOW NP, 2007, COHERENCE QUANTUM OP, V9; BOUWMEESTER D, 2000, PHYS QUANTUM INFORMA; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Kimble HJ, 2004, NATURE, V429, P712, DOI 10.1038/429712a; Mandel L, 1999, REV MOD PHYS, V71, pS274, DOI 10.1103/RevModPhys.71.S274; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Zeilinger A, 2005, NATURE, V433, P230, DOI 10.1038/nature03280	8	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1251	1252		10.1126/science.1150968	http://dx.doi.org/10.1126/science.1150968			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033871	Green Submitted			2022-12-28	WOS:000251086600028
J	Byrne, JA; Pedersen, DA; Clepper, LL; Nelson, M; Sanger, WG; Gokhale, S; Wolf, DP; Mitalipov, SM				Byrne, J. A.; Pedersen, D. A.; Clepper, L. L.; Nelson, M.; Sanger, W. G.; Gokhale, S.; Wolf, D. P.; Mitalipov, S. M.			Producing primate embryonic stem cells by somatic cell nuclear transfer	NATURE			English	Article							RHESUS-MONKEY EMBRYOS; IN-VITRO; THERAPEUTIC CLONING; MICROSATELLITE LOCI; NONHUMAN PRIMATE; MACACA-MULATTA; MOUSE; LINES; DIFFERENTIATION; TRANSPLANTATION	Derivation of embryonic stem (ES) cells genetically identical to a patient by somatic cell nuclear transfer ( SCNT) holds the potential to cure or alleviate the symptoms of many degenerative diseases while circumventing concerns regarding rejection by the host immune system. However, the concept has only been achieved in the mouse, whereas inefficient reprogramming and poor embryonic development characterizes the results obtained in primates. Here, we used a modified SCNT approach to produce rhesus macaque blastocysts from adult skin fibroblasts, and successfully isolated two ES cell lines from these embryos. DNA analysis confirmed that nuclear DNA was identical to donor somatic cells and that mitochondrial DNA originated from oocytes. Both cell lines exhibited normal ES cell morphology, expressed key stem-cell markers, were transcriptionally similar to control ES cells and differentiated into multiple cell types in vitro and in vivo. Our results represent successful nuclear reprogramming of adult somatic cells into pluripotent ES cells and demonstrate proof-of-concept for therapeutic cloning in primates.	Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Beaverton, OR 97006 USA; Munroe Meyer Inst, Omaha, NE 68198 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Mitalipov, SM (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu		Byrne, James/0000-0002-2232-292X				Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; BAVISTER BD, 1977, BIOL REPROD, V16, P228, DOI 10.1095/biolreprod16.2.228; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bowles EJ, 2007, CURR TOP DEV BIOL, V77, P251, DOI 10.1016/S0070-2153(06)77010-7; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BYRNE JA, 2007, INT SOC STEM CELL RE, P52; Byrne James A, 2006, Curr Stem Cell Res Ther, V1, P127, DOI 10.2174/157488806776956913; Byrne JA, 2006, BIOL REPROD, V75, P908, DOI 10.1095/biolreprod.106.053868; DomingoRoura X, 1997, AM J PRIMATOL, V43, P357, DOI 10.1002/(SICI)1098-2345(1997)43:4<357::AID-AJP7>3.0.CO;2-W; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; Ferguson B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-43; Hall VJ, 2007, HUM REPROD, V22, P52, DOI 10.1093/humrep/del345; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Kuo HC, 2003, BIOL REPROD, V68, P1727, DOI 10.1095/biolreprod.102.012195; Lanza RP, 2002, NAT BIOTECHNOL, V20, P689, DOI 10.1038/nbt703; Martin MJ, 2003, CLONING STEM CELLS, V5, P117, DOI 10.1089/153623003322234713; McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186; McKiernan SH, 2000, HUM REPROD, V15, P157, DOI 10.1093/humrep/15.1.157; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Mitalipov SM, 2002, BIOL REPROD, V66, P1367, DOI 10.1095/biolreprod66.5.1367; Mombaerts P, 2003, P NATL ACAD SCI USA, V100, P11924, DOI 10.1073/pnas.1934141100; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; Ng SC, 2004, DEVELOPMENT, V131, P2475, DOI 10.1242/dev.01118; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PEARSON PL, 1979, CYTOGENET CELL GENET, V25, P82, DOI 10.1159/000131403; Penedo MCT, 2005, IMMUNOGENETICS, V57, P198, DOI 10.1007/s00251-005-0787-1; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Simerly C, 2004, DEV BIOL, V276, P237, DOI 10.1016/j.ydbio.2004.10.006; Simerly C, 2003, SCIENCE, V300, P297, DOI 10.1126/science.1082091; St John JC, 2004, GENETICS, V167, P897, DOI 10.1534/genetics.103.025049; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wakayama S, 2007, CURR BIOL, V17, pR120, DOI 10.1016/j.cub.2006.12.020; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; Yang JF, 2007, BIOL REPROD, V76, P36, DOI 10.1095/biolreprod.106.051383; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; ZELINSKIWOOTEN MB, 1995, HUM REPROD, V10, P1658, DOI 10.1093/oxfordjournals.humrep.a136151; Zhou Q, 2006, HUM REPROD, V21, P2564, DOI 10.1093/humrep/del216	43	392	434	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					497	U3		10.1038/nature06357	http://dx.doi.org/10.1038/nature06357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18004281				2022-12-28	WOS:000251158500036
J	Petrascheck, M; Ye, XL; Buck, LB				Petrascheck, Michael; Ye, Xiaolan; Buck, Linda B.			An antidepressant that extends lifespan in adult Caenorhabditis elegans	NATURE			English	Article							CALORIC RESTRICTION; SEROTONIN; RECEPTORS; EXTENSION; GENETICS; FLUOXETINE; OCTOPAMINE; MUTATIONS; LONGEVITY; FOOD	The mechanisms that determine the lifespan of an organism are still largely a mystery(1). One goal of ageing research is to find drugs that would increase lifespan and vitality when given to an adult animal. To this end, we tested 88,000 chemicals for the ability to extend the lifespan of adult Caenorhabditis elegans nematodes. Here we report that a drug used as an antidepressant in humans increases C. elegans lifespan. In humans, this drug blocks neural signalling by the neurotransmitter serotonin. In C. elegans, the effect of the drug on lifespan is reduced or eradicated by mutations that affect serotonin synthesis, serotonin re-uptake at synapses, or either of two G-protein-coupled receptors: one that recognizes serotonin and the other that detects another neurotransmitter, octopamine. In vitro studies show that the drug acts as an antagonist at both receptors. Testing of the drug on dietary-restricted animals or animals with mutations that affect lifespan indicates that its effect on lifespan involves mechanisms associated with lifespan extension by dietary restriction. These studies indicate that lifespan can be extended by blocking certain types of neurotransmission implicated in food sensing in the adult animal, possibly leading to a state of perceived, although not real, starvation.	Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Buck, LB (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	lbuck@fhcrc.org	Petrascheck, Michael/R-7832-2019	Petrascheck, Michael/0000-0002-1010-145X				BRENNER S, 1974, GENETICS, V77, P71; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Gillman PK, 2006, HUM PSYCHOPHARM CLIN, V21, P117, DOI 10.1002/hup.750; HARRIS B, 1980, LANCET, V1, P590; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Johnson TE, 2001, EXP GERONTOL, V36, P1609, DOI 10.1016/S0531-5565(01)00144-9; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Komuniecki RW, 2004, MOL BIOCHEM PARASIT, V137, P1, DOI 10.1016/j.molbiopara.2004.05.010; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Murakami H, 2007, AGING CELL, V6, P483, DOI 10.1111/j.1474-9726.2007.00303.x; Niacaris T, 2003, J EXP BIOL, V206, P223, DOI 10.1242/jeb.00101; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Ranganathan R, 2001, J NEUROSCI, V21, P5871, DOI 10.1523/JNEUROSCI.21-16-05871.2001; RODIN G, 2004, CURR ONCOL, V14, P180; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Suo S, 2006, J NEUROSCI, V26, P10082, DOI 10.1523/JNEUROSCI.0819-06.2006; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Terzibasi E, 2007, EXP GERONTOL, V42, P81, DOI 10.1016/j.exger.2006.06.039; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	29	192	217	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					553	U12		10.1038/nature05991	http://dx.doi.org/10.1038/nature05991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033297				2022-12-28	WOS:000251158500048
J	Bravata, DM; Smith-Spangler, C; Sundaram, V; Gienger, AL; Lin, N; Lewis, R; Stave, CD; Olkin, I; Sirard, JR				Bravata, Dena M.; Smith-Spangler, Crystal; Sundaram, Vandana; Gienger, Allison L.; Lin, Nancy; Lewis, Robyn; Stave, Christopher D.; Olkin, Ingram; Sirard, John R.			Using pedometers to increase physical activity and improve health - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RESTING BLOOD-PRESSURE; ACTIVITY INTERVENTION; ELECTRONIC PEDOMETERS; AEROBIC EXERCISE; WALKING PROGRAM; MEASURING STEPS; 3 GENERATIONS; ADULTS; METAANALYSIS; REHABILITATION	Context Without detailed evidence of their effectiveness, pedometers have recently become popular as a tool for motivating physical activity. Objective To evaluate the association of pedometer use with physical activity and health outcomes among outpatient adults. Data Sources English-language articles from MEDLINE, EMBASE, Sport Discus, PsychINFO, Cochrane Library, Thompson Scientific ( formerly known as Thompson ISI), and ERIC (1966-2007); bibliographies of retrieved articles; and conference proceedings. Study Selection Studies were eligible for inclusion if they reported an assessment of pedometer use among adult outpatients, reported a change in steps per day, and included more than 5 participants. Data Extraction and Data Synthesis Two investigators independently abstracted data about the intervention; participants; number of steps per day; and presence or absence of obesity, diabetes, hypertension, or hyperlipidemia. Data were pooled using random-effects calculations, and meta-regression was performed. Results Our searches identified 2246 citations; 26 studies with a total of 2767 participants met inclusion criteria (8 randomized controlled trials [RCTs] and 18 observational studies). The participants' mean (SD) age was 49 (9) years and 85% were women. The mean intervention duration was 18 weeks. In the RCTs, pedometer users significantly increased their physical activity by 2491 steps per day more than control participants (95% confidence interval [Cl], 1098-3885 steps per day, P <. 001). Among the observational studies, pedometer users significantly increased their physical activity by 2183 steps per day over baseline (95% Cl, 1571-2796 steps per day, P <. 0001). Overall, pedometer users increased their physical activity by 26.9% over baseline. An important predictor of increased physical activity was having a step goal such as 10 000 steps per day (P=.001). When data from all studies were combined, pedometer users significantly decreased their body mass index by 0.38 ( 95% Cl, 0.05-0.72; P=.03). This decrease was associated with older age (P=.001) and having a step goal (P=.04). Intervention participants significantly decreased their systolic blood pressure by 3.8 mmHg ( 95% Cl, 1.7-5.9 mm Hg, P <=. 001). This decrease was associated with greater baseline systolic blood pressure ( P=. 009) and change in steps per day (P=. 08). Conclusions The results suggest that the use of a pedometer is associated with significant increases in physical activity and significant decreases in body mass index and blood pressure. Whether these changes are durable over the long term is undetermined.	Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Internal Med, Lane Med Lib, Stanford, CA 94305 USA; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Calif Pacific Med Ctr, Dept Internal Med, San Francisco, CA USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	Stanford University; Stanford University; California Pacific Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Bravata, DM (corresponding author), Ctr Primary Care & Outcomes Res, 117 Encina Commons, Stanford, CA 94305 USA.	dbravata@stanford.edu	Stave, Christopher/P-1919-2018	Stave, Christopher/0000-0001-8232-3994	NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER; NIA NIH HHS [AG017253-06] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alevizos A, 2005, INT J CLIN PRACT, V59, P922, DOI 10.1111/j.1742-1241.2005.00536.x; Araiza P, 2006, METABOLISM, V55, P1382, DOI 10.1016/j.metabol.2006.06.009; Bassett DR, 1996, MED SCI SPORT EXER, V28, P1071, DOI 10.1097/00005768-199608000-00019; BROWN DR, 1992, CAN J SPORT SCI, V17, P185; Butler L, 2004, HLTH PROMOT J AUSTR, V2004, P134, DOI DOI 10.1071/HE04134; Chan CB, 2004, PREV MED, V39, P1215, DOI 10.1016/j.ypmed.2004.04.053; Croteau KA, 2004, AM J HEALTH PROMOT, V18, P217, DOI 10.4278/0890-1171-18.3.217; Crouter SE, 2003, MED SCI SPORT EXER, V35, P1455, DOI 10.1249/01.MSS.0000078932.61440.A2; de Blok BMJ, 2006, PATIENT EDUC COUNS, V61, P48, DOI 10.1016/j.pec.2005.02.005; Eastep E, 2004, PERCEPT MOTOR SKILL, V99, P392, DOI 10.2466/pms.99.2.392-402; Eden KB, 2002, ANN INTERN MED, V137, P208, DOI 10.7326/0003-4819-137-3-200208060-00015; Foster C., 2005, COCHRANE DB SYST REV, V1, P1, DOI 10.1002/14651858.cd003180.pub2; Gleser L.J., 1994, HDB RES SYNTHESIS, P339, DOI DOI 10.7758/9781610448864.16; Halbert JA, 1997, J HUM HYPERTENS, V11, P641, DOI 10.1038/sj.jhh.1000509; Hedges LV, 2014, STAT METHODS META AN; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hultquist CN, 2005, MED SCI SPORT EXER, V37, P676, DOI 10.1249/01.MSS.0000158993.39760.1B; Izawa KP, 2005, AM J PHYS MED REHAB, V84, P313, DOI 10.1097/01.PHM.0000156901.95289.09; Jensen GL, 2004, OBES RES, V12, P1814, DOI 10.1038/oby.2004.225; KELLEY G, 1995, MED SCI SPORT EXER, V27, P1371; Kelley GA, 2001, PREV MED, V33, P120, DOI 10.1006/pmed.2001.0860; Kilmer DD, 2005, ARCH PHYS MED REHAB, V86, P2150, DOI 10.1016/j.apmr.2005.07.288; Koulouri AA, 2006, J HUM NUTR DIET, V19, P263, DOI 10.1111/j.1365-277X.2006.00703.x; Le Masurier GC, 2003, MED SCI SPORT EXER, V35, P867, DOI 10.1249/01.MSS.0000064996.63632.10; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lindberg R, 2000, J AM DIET ASSOC, V100, P878, DOI 10.1016/S0002-8223(00)00251-0; Miller TD, 1997, ANN BEHAV MED, V19, P220, DOI 10.1007/BF02892287; Moreau KL, 2001, MED SCI SPORT EXER, V33, P1825, DOI 10.1097/00005768-200111000-00005; Murphy MH, 2007, PREV MED, V44, P377, DOI 10.1016/j.ypmed.2006.12.008; Ornes LL, 2005, PERCEPT MOTOR SKILL, V100, P579, DOI 10.2466/PMS.100.3.579-591; Orwin R.G., 1994, HDB RES SYNTHESIS; Ransdell LB, 2004, WOMEN HEALTH, V40, P77, DOI 10.1300/J013v40n03_06; Schneider PL, 2006, AM J HEALTH PROMOT, V21, P85, DOI 10.4278/0890-1171-21.2.85; Schneider PL, 2003, MED SCI SPORT EXER, V35, P1779, DOI 10.1249/01.MSS.0000089342.96098.C4; Sidman CL, 2004, RES Q EXERCISE SPORT, V75, P122, DOI 10.1080/02701367.2004.10609143; Speck BJ, 2001, NURS RES, V50, P374, DOI 10.1097/00006199-200111000-00008; Stovitz SD, 2005, J AM BOARD FAM PRACT, V18, P335, DOI 10.3122/jabfm.18.5.335; Sugiura Hiroko, 2002, BMC Womens Health, V2, P3, DOI 10.1186/1472-6874-2-3; Swartz AM, 2003, PREV MED, V37, P356, DOI 10.1016/S0091-7435(03)00144-0; Talbot LA, 2003, J AM GERIATR SOC, V51, P387, DOI 10.1046/j.1532-5415.2003.51113.x; Thomas Lyndall, 2006, Health Promot J Austr, V17, P97; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tudor-Locke C, 2004, INT J OBESITY, V28, P113, DOI 10.1038/sj.ijo.0802485; VanWormer JJ, 2004, J NUTR EDUC BEHAV, V36, P333, DOI 10.1016/S1499-4046(06)60406-5; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; Williams BR, 2005, TOP GERIATR REHABIL, V21, P332; Wilson Diane B, 2005, Prev Chronic Dis, V2, pA16; Wyatt HR, 2004, J PHYS ACT HEALTH, V1, P181, DOI DOI 10.1123/JPAH.1.3.181; 2004, CONSUM REP       OCT, P30	49	1431	1444	7	227	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2007	298	19					2296	2304		10.1001/jama.298.19.2296	http://dx.doi.org/10.1001/jama.298.19.2296			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232XV	18029834				2022-12-28	WOS:000251055900030
J	Bar-Ziv, R				Bar-Ziv, Roy			Materials science - DNA circuits get up to speed	SCIENCE			English	Editorial Material							DEVICES		Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Bar-Ziv, R (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.	roy.bar-ziv@weizmann.ac.il						ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Buxboim A, 2007, SMALL, V3, P500, DOI 10.1002/smll.200600489; Dittmer WU, 2005, SMALL, V1, P709, DOI 10.1002/smll.200500074; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Noireaux V, 2003, P NATL ACAD SCI USA, V100, P12672, DOI 10.1073/pnas.2135496100; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2005, TRENDS BIOCHEM SCI, V30, P119, DOI 10.1016/j.tibs.2005.01.007; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532	10	7	7	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1078	1079		10.1126/science.1150200	http://dx.doi.org/10.1126/science.1150200			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006730				2022-12-28	WOS:000250957900027
J	Pfeifer, R; Lungarella, M; Iida, F				Pfeifer, Rolf; Lungarella, Max; Iida, Fumiya			Self-organization, embodiment, and biologically inspired robotics	SCIENCE			English	Review							WALKING; CHALLENGES; SYSTEMS	Robotics researchers increasingly agree that ideas from biology and self-organization can strongly benefit the design of autonomous robots. Biological organisms have evolved to perform and survive in a world characterized by rapid changes, high uncertainty, indefinite richness, and limited availability of information. Industrial robots, in contrast, operate in highly controlled environments with no or very little uncertainty. Although many challenges remain, concepts from biologically inspired (bio-inspired) robotics will eventually enable researchers to engineer machines for the real world that possess at least some of the desirable properties of biological organisms, such as adaptivity, robustness, versatility, and agility.	Univ Zurich, Artificial Intelligence Lab, Dept Informat, Zurich, Switzerland; MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	University of Zurich; Massachusetts Institute of Technology (MIT)	Pfeifer, R (corresponding author), Univ Zurich, Artificial Intelligence Lab, Dept Informat, Zurich, Switzerland.	pfeifer@ifi.uzh.ch	Iida, Fumiya/D-3258-2012	Iida, Fumiya/0000-0001-9246-7190				Alben S, 2007, J R SOC INTERFACE, V4, P243, DOI 10.1098/rsif.2006.0181; [Anonymous], 2007, BODY SHAPES WAY WE T; ARBIB M, 2008, SPRINGER HDB ROBOTIC, pCH62; Autumn K, 2006, AM SCI, V94, P124, DOI 10.1511/2006.58.124; Ayers J, 2007, PHILOS T R SOC A, V365, P273, DOI 10.1098/rsta.2006.1910; Bekey GA., 2005, AUTONOMOUS ROBOTS BI; Billard A, 2006, NEURAL NETWORKS, V19, P251, DOI 10.1016/j.neunet.2006.02.001; Blickhan R, 2007, PHILOS T R SOC A, V365, P199, DOI 10.1098/rsta.2006.1911; BROOKS RA, 1991, SCIENCE, V253, P1227, DOI 10.1126/science.253.5025.1227; Cham JG, 2004, INT J ROBOT RES, V23, P141, DOI 10.1177/0278364904041323; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Cruse H, 2007, PHILOS T R SOC A, V365, P221, DOI 10.1098/rsta.2006.1913; Dautenhahn K, 2007, PHILOS T R SOC B, V362, P679, DOI 10.1098/rstb.2006.2004; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Fend M, 2006, ROBOT AUTON SYST, V54, P686, DOI 10.1016/j.robot.2006.02.014; Floreano D, 2007, CURR BIOL, V17, P514, DOI 10.1016/j.cub.2007.01.058; Griffith S, 2005, NATURE, V437, P636, DOI 10.1038/437636a; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hara F, 2003, MORPHOFUNCTIONAL MAC; Hirose S, 2004, INT J ROBOT RES, V23, P341, DOI [10.1177/0278364904042202, 10.1177/02783649040042202]; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Ishiguro A, 2006, ROBOT AUTON SYST, V54, P641, DOI 10.1016/j.robot.2006.02.011; Jones BA, 2006, IEEE T ROBOT, V22, P43, DOI 10.1109/TRO.2005.861458; Kemp CC, 2007, IEEE ROBOT AUTOM MAG, V14, P20, DOI 10.1109/MRA.2007.339604; Kimura H, 2007, INT J ROBOT RES, V26, P475, DOI 10.1177/0278364907078089; Krichmar JL, 2005, P NATL ACAD SCI USA, V102, P2111, DOI 10.1073/pnas.0409792102; Kuniyoshi Y, 2004, LECT NOTES ARTIF INT, V3139, P202; Lipson H, 2000, NATURE, V406, P974, DOI 10.1038/35023115; Lungarella M, 2003, CONNECT SCI, V15, P151, DOI 10.1080/09540090310001655110; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; Merleau-Ponty M., 1962, PHENOMENOLOGY PERCEP; MEYER JA, 2008, SPRINGER HDB ROBOTIC, pCH60; Murata S, 2007, IEEE ROBOT AUTOM MAG, V14, P71, DOI 10.1109/MRA.2007.339607; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Pfeifer R, 1997, ROBOT AUTON SYST, V20, P157, DOI 10.1016/S0921-8890(97)80707-5; Pfeifer R., 2006, INT C SER, V1291, P22, DOI DOI 10.1016/J.ICS.2005.12.080; Pfeiffer F, 2007, PHILOS T R SOC A, V365, P3, DOI [10.1098/rsta.2006.1918, 10.1098/rsta.200C.1918]; Rasmussen S, 2004, SCIENCE, V303, P963, DOI 10.1126/science.1093669; Reeve R, 2005, ROBOT AUTON SYST, V51, P41, DOI 10.1016/j.robot.2004.08.010; Sitti M, 2007, IEEE ROBOT AUTOM MAG, V14, P53, DOI 10.1109/MRA.2007.339606; Spagna JC, 2007, BIOINSPIR BIOMIM, V2, P9, DOI 10.1088/1748-3182/2/1/002; Thrun S., 2005, PROBABILISTIC ROBOTI; Tuci E, 2006, ACM T AUTON ADAP SYS, V1, P115, DOI 10.1145/1186778.1186779; Vardy A, 2005, CONNECT SCI, V17, P47, DOI 10.1080/09540090500140958; Varela F., 1991, EMBODIED MIND; Vincent JFV, 2006, J R SOC INTERFACE, V3, P471, DOI 10.1098/rsif.2006.0127; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Wood RJ, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P1582; Yim M, 2007, IEEE ROBOT AUTOM MAG, V14, P43, DOI 10.1109/MRA.2007.339623; Zykov V, 2007, IEEE T ROBOT, V23, P308, DOI 10.1109/TRO.2007.894685	50	699	713	22	380	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1088	1093		10.1126/science.1145803	http://dx.doi.org/10.1126/science.1145803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006736	Green Published			2022-12-28	WOS:000250957900033
J	Jonker, DJ; O'Callaghan, CJ; Karapetis, CS; Zalcberg, JR; Tu, DS; Au, HJ; Berry, SR; Krahn, M; Price, T; Simes, RJ; Tebbutt, NC; van Hazel, G; Wierzbicki, R; Langer, C; Moore, MJ				Jonker, Derek J.; O'Callaghan, Chris J.; Karapetis, Christos S.; Zalcberg, John R.; Tu, Dongsheng; Au, Heather-Jane; Berry, Scott R.; Krahn, Marianne; Price, Timothy; Simes, R. John; Tebbutt, Niall C.; van Hazel, Guy; Wierzbicki, Rafal; Langer, Christiane; Moore, Malcolm J.			Cetuximab for the treatment of colorectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; PHASE-II TRIAL; FLUOROURACIL FAILURE; RANDOMIZED-TRIAL; SUPPORTIVE CARE; PLUS IRINOTECAN; LEUCOVORIN; OXALIPLATIN; THERAPY	Background: Cetuximab, an IgG1 chimeric monoclonal antibody against epidermal growth factor receptor (EGFR), has activity against colorectal cancers that express EGFR. Methods: From December 2003 to August 2005, 572 patients who had colorectal cancer expressing immunohistochemically detectable EGFR and who had been previously treated with a fluoropyrimidine, irinotecan, and oxaliplatin or had contraindications to treatment with these drugs underwent randomization to an initial dose of 400 mg of cetuximab per square meter of body-surface area followed by a weekly infusion of 250 mg per square meter plus best supportive care (287 patients) or best supportive care alone (285 patients). The primary end point was overall survival. Results: In comparison with best supportive care alone, cetuximab treatment was associated with a significant improvement in overall survival (hazard ratio for death, 0.77; 95% confidence interval [CI], 0.64 to 0.92; P=0.005) and in progression-free survival (hazard ratio for disease progression or death, 0.68; 95% CI, 0.57 to 0.80; P<0.001). These benefits were robust after adjustment in a multivariable Cox proportional-hazards model. The median overall survival was 6.1 months in the cetuximab group and 4.6 months in the group assigned to supportive care alone. Partial responses occurred in 23 patients (8.0%) in the cetuximab group but in none in the group assigned to supportive care alone (P<0.001); the disease was stable in an additional 31.4% of patients assigned to cetuximab and in 10.9% of patients assigned to supportive care alone (P<0.001). Quality of life was better preserved in the cetuximab group, with less deterioration in physical function and global health status scores (both P<0.05). Cetuximab treatment was associated with a characteristic rash; a rash of grade 2 or higher was strongly associated with improved survival (hazard ratio for death, 0.33; 95% CI, 0.22 to 0.50; P<0.001). The incidence of any adverse event of grade 3 or higher was 78.5% in the cetuximab group and 59.1% in the group assigned to supportive care alone (P<0.001). Conclusions: Cetuximab improves overall survival and progression-free survival and preserves quality-of-life measures in patients with colorectal cancer in whom other treatments have failed. (ClinicalTrials.gov number, NCT00079066.).	Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; Queens Univ, NCI, Inst Canada Clin Trials Grp, Kingston, ON, Canada; Flinders Med Ctr, Adelaide, SA, Australia; Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; Univ Melbourne, Dept Med, Melbourne, Vic, Australia; Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada; St Boniface Gen Hosp, Winnipeg, MB R2H 2A6, Canada; Queen Elizabeth Hosp, Adelaide, SA, Australia; Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Sydney, NSW 2006, Australia; Austin Hlth, Melbourne, Vic, Australia; Sir Charles Gairdner Hosp, Perth, WA, Australia; Lakeridge Hlth, Oshawa, ON, Canada; Bristol Myers Squibb Co, Wallingford, CT 06492 USA; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada	University of Ottawa; Ottawa Hospital Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Queens University - Canada; Flinders Medical Centre; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; University of Alberta; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Sydney; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Western Australia; Bristol-Myers Squibb; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Jonker, DJ (corresponding author), Univ Ottawa, Ottawa Hosp Reg Canc Ctr, 501 Smyth Rd,Box 912, Ottawa, ON K1H 8L6, Canada.	djonker@ottawahospital.on.ca	Price, Timothy J/G-1404-2012; Simes, Robert John/P-1497-2014	Price, Timothy J/0000-0002-3922-2693; Zalcberg, John/0000-0002-6624-0782; Karapetis, Christos/0000-0003-1741-996X				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Cassidy J, 2002, ANN ONCOL, V13, P566, DOI 10.1093/annonc/mdf089; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Cunningham D, 1998, LANCET, V352, P1413, DOI 10.1016/S0140-6736(98)02309-5; Douillard JY, 2000, LANCET, V355, P1372; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; ENG C, 2007, J CLIN ONCOL, V25, pS18; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; Hebbar M, 2006, ANTI-CANCER DRUG, V17, P855, DOI 10.1097/01.cad.0000217425.44584.9f; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Klein JP., 2003, SURVIVAL ANAL TECHNI; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Mellstedt H, 2003, DRUG TODAY, V39, P1; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; NCCN, 2007, NCCN CLIN PRACT GUID; Nowacki M., 2007, J CLIN ONCOL S, V25, p18S; Rothenberg ML, 2005, J CLIN ONCOL, V23, P9265, DOI 10.1200/JCO.2005.03.0536; Rougier P, 1998, LANCET, V352, P1407, DOI 10.1016/S0140-6736(98)03085-2; Rougier P, 1998, LANCET, V352, P1634; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Saltz LB, 2007, J CLIN ONCOL, V25, P4557, DOI 10.1200/JCO.2007.12.0949; SOBRERO A, 2007, ANN M 2007 AM ASS CA; Townsley CA, 2006, BRIT J CANCER, V94, P1136, DOI 10.1038/sj.bjc.6603055; Tu D., 2003, ENCY BIOPHARMACEUTIC, P614; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620	29	1543	1620	0	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2007	357	20					2040	2048		10.1056/NEJMoa071834	http://dx.doi.org/10.1056/NEJMoa071834			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230RV	18003960				2022-12-28	WOS:000250894500006
J	Vaquero, A; Scher, M; Erdjument-Bromage, H; Tempst, P; Serrano, L; Reinberg, D				Vaquero, Alejandro; Scher, Michael; Erdjument-Bromage, Hediye; Tempst, Paul; Serrano, Lourdes; Reinberg, Danny			SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation	NATURE			English	Article							LYSINE-9 METHYLATION; DOMINANT ROLE; METHYLTRANSFERASE; DEACETYLASE; CHROMATIN; YEAST; H4	In contrast to stably repressive, constitutive heterochromatin and stably active, euchromatin, facultative heterochromatin has the capacity to alternate between repressive and activated states of transcription(1). As such, it is an instructive source to understand the molecular basis for changes in chromatin structure that correlate with transcriptional status. Sirtuin 1 (SIRT1) and suppressor of variegation 3-9 homologue 1 ( SUV39H1) are amongst the enzymes responsible for chromatin modulations associated with facultative heterochromatin formation. SUV39H1 is the principal enzyme responsible for the accumulation of histone H3 containing a trimethyl group at its lysine 9 position (H3K9me3) in regions of heterochromatin(2). SIRT1 is an NAD+-dependent deacetylase that targets histone H4 at lysine 16 (refs 3 and 4), and through an unknown mechanism facilitates increased levels of H3K9me3 (ref. 3). Here we show that the mammalian histone methyltransferase SUV39H1 is itself targeted by the histone deacetylase SIRT1 and that SUV39H1 activity is regulated by acetylation at lysine residue 266 in its catalytic SET domain. SIRT1 interacts directly with, recruits and deacetylates SUV39H1, and these activities independently contribute to elevated levels of SUV39H1 activity resulting in increased levels of the H3K9me3 modification. Loss of SIRT1 greatly affects SUV39H1-dependent H3K9me3 and impairs localization of heterochromatin protein 1. These findings demonstrate a functional link between the heterochromatin-related histone methyltransferase SUV39H1 and the histone deacetylase SIRT1.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst,Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA; Rutgers State Univ, Inst Human Genet, Dept Genet, Piscataway, NJ 08854 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; New York University; Memorial Sloan Kettering Cancer Center	Reinberg, D (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst,Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA.	reinbdO1@med.nyu.edu	Vaquero, Alejandro/I-9845-2014; Vaquero, Alejandro/ABG-8634-2020	Vaquero, Alejandro/0000-0002-8735-4156; Tempst, Paul/0000-0002-6680-3987; Reinberg, Danny/0000-0003-4288-2016; Erdjument-Bromage, Hediye/0000-0003-0224-3594				Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Craig JM, 2005, BIOESSAYS, V27, P17, DOI 10.1002/bies.20145; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Monneret C, 2005, EUR J MED CHEM, V40, P1, DOI 10.1016/j.ejmech.2004.10.001; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Sewalt RGAB, 2002, MOL CELL BIOL, V22, P5539, DOI 10.1128/MCB.22.15.5539-5553.2002; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0	17	299	321	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					440	444		10.1038/nature06268	http://dx.doi.org/10.1038/nature06268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004385				2022-12-28	WOS:000250918600059
J	Wong, SL; Ji, H; Hollenbeck, BK; Morris, AM; Baser, O; Birkmeyer, JD				Wong, Sandra L.; Ji, Hong; Hollenbeck, Brent K.; Morris, Arden M.; Baser, Onur; Birkmeyer, John D.			Hospital lymph node examination rates and survival after resection for colon cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEER-MEDICARE DATA; PROCEDURE VOLUME; RECTAL-CANCER; POPULATION; SURGERY; NUMBER	Context Several studies suggest improved survival among patients in whom a higher number of nodes are examined after colectomy for colon cancer. The National Quality Forum and other organizations recently endorsed a 12-node minimum as a measure of hospital quality. Objective To assess whether hospitals that examine more lymph nodes after resection for colon cancer have superior late survival rates. Design, Setting, and Patients Retrospective cohort study, using the national Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database (19952005), of US patients undergoing colectomy for nonmetastatic colon cancer (n=30 625). Hospitals were ranked according to the proportion of their patients in whom 12 or more lymph nodes were examined and then were sorted into 4 evenly sized groups. Late survival rates were assessed for each hospital group, adjusting for potentially confounding patient and clinician characteristics. Main Outcome Measures Hospitals' lymph node examination rates in association with cancer staging, use of adjuvant chemotherapy ( indicated for patients with node-positive disease), and 5-year survival rate. Results Hospitals with the highest proportions of patients with examination of 12 or more lymph nodes tended to treat lower-risk patients and had substantially higher procedure volumes. After adjusting for these and other factors, there remained no statistically significant relationship between hospital lymph node examination rates and survival after surgery (adjusted hazard ratio, highest vs lowest hospital quartile, 0.95; 95% confidence interval, 0.88-1.03). Although the 4 hospital groups varied widely in the number of lymph nodes examined, they were equally likely to find node-positive tumors and had very similar overall unadjusted rates of adjuvant chemotherapy (26% vs 25%, highest vs lowest hospital quartile). Conclusions The number of lymph nodes hospitals examine following colectomy for colon cancer is not associated with staging, use of adjuvant chemotherapy, or patient survival. Efforts by payers and professional organizations to increase node examination rates may have limited value as a public health intervention.	Univ Michigan, Michigan Surg Collaborat Outcomes Res & Evaluat, Dept Surg, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wong, SL (corresponding author), 1500 E Med Ctr Dr,3310 CCC, Ann Arbor, MI 48109 USA.	wongsl@umich.edu		Wong, Sandra/0000-0002-8594-6086; Morris, Arden/0000-0001-5795-2940	NCI NIH HHS [1 R01 CA098481-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098481] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Birkmeyer JD, 2007, ANN SURG, V245, P777, DOI 10.1097/01.sla.0000252402.33814.dd; Bui L, 2006, J SURG ONCOL, V93, P439, DOI 10.1002/jso.20499; Canessa CE, 2001, DIS COLON RECTUM, V44, P1333, DOI 10.1007/BF02234794; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Chen SL, 2006, ANN SURG, V244, P602, DOI 10.1097/01.sla.0000237655.11717.50; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; KELDER W, EUR J SURG ONCOL; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; *NAT QUAL FOR, SPEC NAT VOL CONS ST; National Cancer Institute, CANC COL RECT; OSTADI MA, SURG ENDOSC; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Porter GA, 1998, ANN SURG, V227, P157, DOI 10.1097/00000658-199802000-00001; Rieger NA, 2007, J CLIN ONCOL, V25, P463, DOI 10.1200/JCO.2006.09.2304; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Schrag D, 2002, ANN SURG, V236, P583, DOI 10.1097/00000658-200211000-00008; Swanson RS, 2003, ANN SURG ONCOL, V10, P65, DOI 10.1245/ASO.2003.03.058; Warren JL, 2002, MED CARE, V40, P3; Warren JL, 2002, MED CARE, V40, P55; World Health Organization, 1977, INT CLASS DIS	21	254	258	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2149	2154		10.1001/jama.298.18.2149	http://dx.doi.org/10.1001/jama.298.18.2149			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230II	18000198	Bronze			2022-12-28	WOS:000250869800020
J	Halstead, SB				Halstead, Scott B.			Dengue	LANCET			English	Review							NECROSIS-FACTOR-ALPHA; NONSTRUCTURAL PROTEIN NS1; MICROVASCULAR ENDOTHELIAL-CELLS; ANTIBODY-DEPENDENT ENHANCEMENT; HEMORRHAGIC-FEVER; VIRUS-INFECTION; EARLY-DIAGNOSIS; PLASMA LEAKAGE; SHOCK-SYNDROME; ADHESION MOLECULES	The four dengue viruses are transmitted in tropical countries that circle the globe. All can cause syndromes that are self-limited or severe. The common severe syndrome-dengue haernorrhagic fever/dengue shock syndrome (DHF/DSS)-is characterised. by sudden vascular permeability generated by cytokines released when T cells attack dengue-infected cells. Dengue 1 virus became prevalent in Hawaii where it was transmitted by Aedes albopictus, producing a classic virgin soil epidemic, with clinical disease seen largely in adults. In Cuba and Singapore, sequential 8 dengue infections at long intervals produced unusually severe disease in adults. Evidence suggests that enhancing and cross-reactive neutralising antibodies regulate dengue epidemics and disease severity. Classic DHF/DSS arises during initial dengue infections in infants with low circulating amounts of maternal dengue antibodies, an observation that precludes an exclusive causal role for secondary T-cell responses. Here, I review and discuss data on clinical diagnosis and pathophysiology of vascular permeability and coagulopathy, parenteral treatment of DHF/DSS, and new laboratory tests.	Internal Vaccine Inst, Pediat Dengue Vaccine Initiat, Seoul, South Korea		Halstead, SB (corresponding author), 5824 Edson Lane, Rockville, MD 20852 USA.	haisteads@erols.com	halabe pineda, luis ari/GRS-6055-2022					Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103; ALOANLANCASTER J, 1996, ANNU REV IMMUNOL, V14, P1; Alvarez M, 2006, AM J TROP MED HYG, V75, P1113, DOI 10.4269/ajtmh.2006.75.1113; Anderson R, 1997, J VIROL, V71, P4226, DOI 10.1128/JVI.71.6.4226-4232.1997; [Anonymous], 1973, B WORLD HEALTH ORGAN, V48, P117; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Avirutnan P, 1998, J IMMUNOL, V161, P6338; Balasubramanian S, 2006, INDIAN PEDIATR, V43, P334; Balmaseda A, 2005, AM J TROP MED HYG, V73, P1059, DOI 10.4269/ajtmh.2005.73.1059; Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; Bethell DB, 1998, J INFECT DIS, V177, P778, DOI 10.1086/517807; Bethell DB, 2001, CLIN INFECT DIS, V32, P243, DOI 10.1086/318453; Blacksell SD, 2006, CLIN INFECT DIS, V42, P1127, DOI 10.1086/501358; BURKEGAFFNEY A, 1993, IMMUNOPHARMACOLOGY, V25, P1, DOI 10.1016/0162-3109(93)90025-L; Cam BV, 2002, J TROP PEDIATRICS, V48, P335, DOI 10.1093/tropej/48.6.335; Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021; Cardier JE, 2006, ENDOTHELIUM-J ENDOTH, V13, P335, DOI 10.1080/10623320600972135; Carr JM, 2003, J MED VIROL, V69, P521, DOI 10.1002/jmv.10340; Chakravarti A, 2006, INDIAN J MED RES, V123, P25; Chan K., 1985, SINGAPORES DENGUE HA; CHAN YC, 1967, JPN J MED SCI BIOL, VS 20, P81; Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; Colbert JA, 2007, PEDIATR INFECT DIS J, V26, P850, DOI 10.1097/INF.0b013e3180619692; Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Deparis X, 1998, TROP MED INT HEALTH, V3, P859; Dewi BE, 2004, J VIROL METHODS, V121, P171, DOI 10.1016/j.jviromet.2004.06.013; Dung NM, 1999, CLIN INFECT DIS, V29, P787, DOI 10.1086/520435; Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06; Effler PV, 2005, EMERG INFECT DIS, V11, P742; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127; Fink J, 2006, REV MED VIROL, V16, P263, DOI 10.1002/rmv.507; Gamble J, 2000, CLIN SCI, V98, P211, DOI 10.1042/CS19990296; GOLDSMITH RS, 1965, LANCET, V1, P333; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Guzman MG, 2007, EMERG INFECT DIS, V13, P282, DOI 10.3201/eid1302.060539; Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X; Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170; Halstead SB, 2007, PEDIATR INFECT DIS J, V26, P291, DOI 10.1097/01.inf.0000258695.33178.c1; Hayes JM, 2006, T ROY SOC TROP MED H, V100, P559, DOI 10.1016/j.trstmh.2005.08.013; Hedin H, 1997, INT ARCH ALLERGY IMM, V113, P358, DOI 10.1159/000237601; Hung NT, 2006, AM J TROP MED HYG, V74, P684, DOI 10.4269/ajtmh.2006.74.684; Hung NT, 2005, AM J TROP MED HYG, V72, P370; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; Imrie A, 2006, ANN TROP MED PARASIT, V100, P327, DOI 10.1179/136485906X105589; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; Kalayanarooj Siripen, 2003, J Med Assoc Thai, V86 Suppl 3, pS673; Kittigul L, 2000, J VIROL METHODS, V90, P51, DOI 10.1016/S0166-0934(00)00215-9; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444; Kochel TJ, 2002, LANCET, V360, P310, DOI 10.1016/S0140-6736(02)09522-3; Kong YY, 2006, J VIROL METHODS, V138, P123, DOI 10.1016/j.jviromet.2006.08.003; Kouri G, 1986, Bull Pan Am Health Organ, V20, P24; Krishnamurti C, 2001, AM J TROP MED HYG, V65, P840, DOI 10.4269/ajtmh.2001.65.840; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; KURANE I, 1987, J EXP MED, V166, P999, DOI 10.1084/jem.166.4.999; KURANE I, 1993, AM J TROP MED HYG, V48, P222, DOI 10.4269/ajtmh.1993.48.222; KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457; Kurane I, 1994, Curr Top Microbiol Immunol, V189, P93; La Braga E, 2001, MEM I OSWALDO CRUZ, V96, P229, DOI 10.1590/S0074-02762001000200015; Laur F, 1998, T ROY SOC TROP MED H, V92, P654, DOI 10.1016/S0035-9203(98)90800-8; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395; Lin CF, 2003, J MED VIROL, V69, P82, DOI 10.1002/jmv.10261; Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657; Lin CF, 2001, J MED VIROL, V63, P143, DOI 10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L; Lin CF, 2006, VIRAL IMMUNOL, V19, P127, DOI 10.1089/vim.2006.19.127; Lin YS, 2004, CURR PHARM DESIGN, V10, P213, DOI 10.2174/1381612043453469; Lum LCSL, 2002, J PEDIATR-US, V140, P629, DOI 10.1067/mpd.2002.123665; Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814; Mahalingam S, 2002, P NATL ACAD SCI USA, V99, P13819, DOI 10.1073/pnas.202415999; MAS P, 1978, DENGUE CARIBBEAN 197, P1; MITRAKUL C, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P407; MITRAKUL C, 1977, AM J TROP MED HYG, V26, P975, DOI 10.4269/ajtmh.1977.26.975; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821; Okamoto Y, 1998, J GEN VIROL, V79, P697, DOI 10.1099/0022-1317-79-4-697; Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012; Ooi EE, 2001, LANCET, V357, P685, DOI 10.1016/S0140-6736(00)04137-4; Ooi Eng Eong, 2003, Int J Infect Dis, V7, P231, DOI 10.1016/S1201-9712(03)90057-9; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; Palmer DR, 2005, J VIROL, V79, P2432, DOI 10.1128/JVI.79.4.2432-2439.2005; Peyrefitte CN, 2006, J MED VIROL, V78, P229, DOI 10.1002/jmv.20532; PONGPANICH B, 1973, J PEDIATR-US, V83, P1073, DOI 10.1016/S0022-3476(73)80553-0; PONGPANICH B, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P326; Pries A. R., 2006, V176, P1; Rehm M, 2004, ANESTHESIOLOGY, V100, P1211, DOI 10.1097/00000542-200405000-00025; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; Rigau-Perez JG, 2006, LANCET INFECT DIS, V6, P297, DOI 10.1016/S1473-3099(06)70465-0; Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; SAHAPHONG S, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P194; Schwartz IB, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066201; Seynhaeve ALB, 2006, CELL BIOCHEM BIOPHYS, V44, P157, DOI 10.1385/CBB:44:1:157; Shu PY, 2003, CLIN DIAGN LAB IMMUN, V10, P622, DOI 10.1128/CDLI.10.4.622-630.2003; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Singh K, 2006, J MOL DIAGN, V8, P613, DOI 10.2353/jmoldx.2006.060019; Srikiatkhachorn A, 2007, PEDIATR INFECT DIS J, V26, P283, DOI 10.1097/01.inf.0000258612.26743.10; Tai DF, 2006, CLIN CHEM, V52, P1486, DOI 10.1373/clinchem.2005.064501; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; Thomas S, 2006, EXPERT REV VACCINES, V5, P409, DOI 10.1586/14760584.5.4.409; Tran TNT, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-13; TSAI CJ, 1991, AM J GASTROENTEROL, V86, P33; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Wahid S. Fadilah S. Abdul, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P259; Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704; Warke RV, 2003, J VIROL, V77, P11822, DOI 10.1128/JVI.77.21.11822-11832.2003; Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; WHO, 1997, DENG HAEM FEV DIAGN; Wichmann O, 2005, EMERG INFECT DIS, V11, P762, DOI 10.3201/eid1105.050097; Wilder-Smith A, 2004, TROP MED INT HEALTH, V9, P305, DOI 10.1046/j.1365-3156.2003.01177.x; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; Wills BA, 2004, J INFECT DIS, V190, P810, DOI 10.1086/422754; Wills BA, 2002, CLIN INFECT DIS, V35, P277, DOI 10.1086/341410; Witayathawornwong Prasonk, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P896; Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06; Yeh WT, 2006, FEMS IMMUNOL MED MIC, V48, P84, DOI 10.1111/j.1574-695X.2006.00127.x; Zhou Y, 2006, J GEN VIROL, V87, P2595, DOI 10.1099/vir.0.81994-0; Zivny J, 1999, J IMMUNOL, V163, P2754; 1990, EPIDEMIOL B, V11, P7	135	1099	1153	4	287	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2007	370	9599					1644	1652		10.1016/S0140-6736(07)61687-0	http://dx.doi.org/10.1016/S0140-6736(07)61687-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230NO	17993365				2022-12-28	WOS:000250883400024
J	Abraham, J; Abreu, P; Aglietta, M; Aguirre, C; Allard, D; Allekotte, I; Allen, J; Allison, P; Alvarez, C; Alvarez-Muniz, J; Ambrosio, M; Anchordoqui, L; Andringa, S; Anzalone, A; Aramo, C; Argiro, S; Arisaka, K; Armengaud, E; Arneodo, F; Arqueros, F; Asch, T; Asorey, H; Assis, P; Atulugama, BS; Aublin, J; Ave, M; Avila, G; Backer, T; Badagnani, D; Barbosa, AF; Barnhill, D; Barroso, SLC; Bauleo, P; Beatty, J; Beau, T; Becker, BR; Becker, KH; Bellido, JA; BenZvi, S; Berat, C; Bergmann, T; Bernardini, P; Bertou, X; Biermann, PL; Billoir, P; Blanch-Bigas, O; Blanco, F; Blasi, P; Bleve, C; Blumer, H; Bohacova, M; Bonifazi, C; Bonino, R; Boratav, M; Brack, J; Brogueira, P; Brown, WC; Buchholz, P; Bueno, A; Busca, NG; Caballero-Mora, KS; Cai, B; Camin, DV; Caruso, R; Carvalho, W; Castellina, A; Catalano, O; Cataldi, G; Cazon-Boado, L; Cester, R; Chauvin, J; Chiavassa, A; Chinellato, JA; Chou, A; Chye, J; Clark, PDJ; Clay, RW; Colombo, E; Conceicao, R; Connolly, B; Contreras, F; Coppens, J; Cordier, A; Cotti, U; Coutu, S; Covault, CE; Creusot, A; Cronin, J; Dagoret-Campagne, S; Daumiller, K; Dawson, BR; de Almeida, RM; De Donato, C; de Jong, SJ; De la Vega, G; de Mello, JM; de Mello, JRT; De Mitri, I; de Souza, V; del Peral, L; Deligny, O; Della Selva, A; Delle Fratte, C; Dembinski, H; Di Giulio, C; Diaz, JC; Dobrigkeit, C; D'Olivo, JC; Dornic, D; Dorofeev, A; dos Anjos, JC; Dova, MT; D'Urso, D; DuVernois, MA; Engel, R; Epele, L; Erdmann, M; Escobar, CO; Etchegoyen, A; San Luis, PF; Falcke, H; Farrar, G; Fauth, AC; Fazzini, N; Fernandez, A; Farrar, G; Fauth, AC; Fazzini, N; Fernandez, A; Ferrer, F; Ferry, S; Fick, B; Filevich, A; Filipcic, A; Fleck, I; Fonte, R; Fracchiolla, CE; Fulgione, W; Garcia, B; Gamez, DG; Garcia-Pinto, D; Garrido, X; Geenen, H; Gelmini, G; Gemmeke, H; Ghia, PL; Giller, M; Glass, H; Gold, MS; Golup, G; Albarracin, FG; Berisso, MG; Herrero, RG; Goncalves, P; do Amaral, MG; Gonzalez, D; Gonzalez, JG; Gonzalez, M; Gora, D; Gorgi, A; Gouffon, P; Grassi, V; Grillo, A; Grunfeld, C; Guardincerri, Y; Guarino, F; Guedes, GP; Gutierrez, J; Hague, JD; Hamilton, JC; Hansen, P; Harari, D; Harmsma, S; Harton, JL; Haungs, A; Hauschildt, T; Healy, MD; Hebbeker, T; Heck, D; Hojvat, C; Holmes, VC; Homola, P; Horandel, J; Horneffer, A; Horvat, M; Hrabovsky, M; Huege, T; Iarlori, M; Insolia, A; Ionita, F; Italiano, A; Kaducak, M; Kampert, KH; Keilhauer, B; Kemp, E; Kieckhafer, RM; Klages, HO; Kleifges, M; Kleinfeller, J; Knapik, R; Knapp, J; Koang, DH; Kopmann, A; Krieger, A; Kromer, D; Kumpel, D; Kunka, N; Kusenko, A; La Rosa, G; Lachaud, C; Lago, BL; Lebrun, D; LeBrun, P; Lee, J; Leigui de Oliveira, MA; Letessier-Selvon, A; Leuthold, M; Lhenry-Yvon, I; Lopez, R; Aguera, AL; Bahilo, JL; Maccarone, MC; Macolino, C; Maldera, S; Malek, M; Mancarella, G; Mancenido, ME; Mandat, D; Mantsch, P; Mariazzi, AG; Maris, IC; Martello, D; Martinez, J; Bravo, OM; Mathes, HJ; Matthiae, G; Maurizio, D; Mazur, PO; McCauley, T; McEwen, M; McNeil, RR; Medina, MC; Medina-Tanco, G; Meli, A; Melo, D; Menichetti, E; Menschikov, A; Meurer, C; Meyhandan, R; Micheletti, MI; Miele, G; Miller, W; Mollerach, S; Monasor, M; Ragaigne, DM; Montanet, F; Morales, B; Morello, C; Moreno, E; Moreno, JC; Morris, C; Mostafa, M; Muller, MA; Mussa, R; Navarra, G; Navarro, JL; Navas, S; Nellen, L; Newman-Holmes, C; Newton, D; Thi, TN; Nierstenhofer, N; Nitz, D; Nosek, D; Nozka, L; Oehlschlager, J; Ohnuki, T; Olinto, A; Olmos-Gilbaja, VM; Ortiz, M; Ostapchenko, S; Otero, L; Selmi-Dei, DP; Palatka, M; Pallotta, J; Parente, G; Parizot, E; Parlati, S; Pastor, S; Patel, M; Paul, T; Pavlidou, V; Payet, K; Pech, M; Pekala, J; Pelayo, R; Pepe, IM; Perrone, L; Petrera, S; Petrinca, P; Petrov, Y; Ngoc, DP; Ngoc, DP; Thi, TNP; Pichel, A; Piegaia, R; Pierog, T; Pimenta, M; Pinto, T; Pirronello, V; Pisanti, O; Platino, M; Pochon, J; Porter, TA; Privitera, P; Prouza, M; Quel, EJ; Rautenberg, J; Reucroft, S; Revenu, B; Rezende, FAS; Ridky, J; Riggi, S; Risse, M; Riviere, C; Rizi, V; Roberts, M; Robledo, C; Rodriguez, G; Frias, D; Martino, JR; Rojo, JR; Rodriguez-Cabo, I; Ros, G; Rosado, J; Roth, M; Rouille-d'Orfeuil, B; Roulet, E; Rovero, AC; Salamida, F; Salazar, H; Salina, G; Sanchez, F; Santander, M; Santo, CE; Santos, EM; Sarazin, F; Sarkar, S; Sato, R; Scherini, V; Schieler, H; Schmidt, F; Schmidt, T; Scholten, O; Schovanek, P; Schussler, F; Sciutto, SJ; Scuderi, M; Segreto, A; Semikoz, D; Settimo, M; Shellard, RC; Sidelnik, I; Siffert, BB; Sigl, G; De Grande, NS; Smialkowski, A; Smida, R; Smith, AGK; Smith, BE; Snow, GR; Sokolsky, P; Sommers, P; Sorokin, J; Spinka, H; Squartini, R; Strazzeri, E; Stutz, A; Suarez, F; Suomijarvi, T; Supanitsky, AD; Sutherland, MS; Swain, J; Szadkowski, Z; Takahashi, J; Tamashiro, A; Tamburro, A; Tascau, O; Tcaciuc, R; Thomas, D; Ticona, R; Tiffenberg, J; Timmermans, C; Tkaczyk, W; Peixoto, CJ; Tome, B; Tonachini, A; Torresi, D; Travnicek, P; Tripathi, A; Tristram, G; Tscherniakhovski, D; Tueros, M; Tunnicliffe, V; Ulrich, R; Unger, M; Urban, M; Galicia, JFV; Valino, I; Valore, L; van den Berg, AM; van Elewyck, V; Vazquez, RA; Veberic, D; Veiga, A; Velarde, A; Venters, T; Verzi, V; Videla, M; Villasenor, L; Vorobiov, S; Voyvodic, L; Wahlberg, H; Wainberg, O; Waldenmaier, T; Walker, P; Warner, D; Watson, AA; Westerhoff, S; Wieczorek, G; Wiencke, L; Wilczynska, B; Wilczynski, H; Wileman, C; Winnick, MG; Wu, H; Wundheiler, B; Xu, J; Yamamoto, T; Younk, P; Zas, E; Zavrtanik, D; Zavrtanik, M; Zech, A; Zepeda, A; Ziolkowski, M				Abraham, J.; Abreu, P.; Aglietta, M.; Aguirre, C.; Allard, D.; Allekotte, I.; Allen, J.; Allison, P.; Alvarez, C.; Alvarez-Muniz, J.; Ambrosio, M.; Anchordoqui, L.; Andringa, S.; Anzalone, A.; Aramo, C.; Argiro, S.; Arisaka, K.; Armengaud, E.; Arneodo, F.; Arqueros, F.; Asch, T.; Asorey, H.; Assis, P.; Atulugama, B. S.; Aublin, J.; Ave, M.; Avila, G.; Baecker, T.; Badagnani, D.; Barbosa, A. F.; Barnhill, D.; Barroso, S. L. C.; Bauleo, P.; Beatty, J.; Beau, T.; Becker, B. R.; Becker, K. H.; Bellido, J. A.; BenZvi, S.; Berat, C.; Bergmann, T.; Bernardini, P.; Bertou, X.; Biermann, P. L.; Billoir, P.; Blanch-Bigas, O.; Blanco, F.; Blasi, P.; Bleve, C.; Bluemer, H.; Bohacova, M.; Bonifazi, C.; Bonino, R.; Boratav, M.; Brack, J.; Brogueira, P.; Brown, W. C.; Buchholz, P.; Bueno, A.; Busca, N. G.; Caballero-Mora, K. S.; Cai, B.; Camin, D. V.; Caruso, R.; Carvalho, W.; Castellina, A.; Catalano, O.; Cataldi, G.; Cazon-Boado, L.; Cester, R.; Chauvin, J.; Chiavassa, A.; Chinellato, J. A.; Chou, A.; Chye, J.; Clark, P. D. J.; Clay, R. W.; Colombo, E.; Conceicao, R.; Connolly, B.; Contreras, F.; Coppens, J.; Cordier, A.; Cotti, U.; Coutu, S.; Covault, C. E.; Creusot, A.; Cronin, J.; Dagoret-Campagne, S.; Daumiller, K.; Dawson, B. R.; de Almeida, R. M.; De Donato, C.; de Jong, S. J.; De La Vega, G.; de Mello Junior, J. M.; de Mello Neto, J. R. T.; De Mitri, I.; de Souza, V.; del Peral, L.; Deligny, O.; Della Selva, A.; Delle Fratte, C.; Dembinski, H.; Di Giulio, C.; Diaz, J. C.; Dobrigkeit, C.; D'Olivo, J. C.; Dornic, D.; Dorofeev, A.; dos Anjos, J. C.; Dova, M. T.; D'Urso, D.; DuVernois, M. A.; Engel, R.; Epele, L.; Erdmann, M.; Escobar, C. O.; Etchegoyen, A.; San Luis, P. Facal; Falcke, H.; Farrar, G.; Fauth, A. C.; Fazzini, N.; Fernandez, A.; Farrar, G.; Fauth, A. C.; Fazzini, N.; Fernandez, A.; Ferrer, F.; Ferry, S.; Fick, B.; Filevich, A.; Filipcic, A.; Fleck, I.; Fonte, R.; Fracchiolla, C. E.; Fulgione, W.; Garcia, B.; Garcia Gamez, D.; Garcia-Pinto, D.; Garrido, X.; Geenen, H.; Gelmini, G.; Gemmeke, H.; Ghia, P. L.; Giller, M.; Glass, H.; Gold, M. S.; Golup, G.; Gomez Albarracin, F.; Gomez Berisso, M.; Gomez Herrero, R.; Goncalves, P.; Goncalves do Amaral, M.; Gonzalez, D.; Gonzalez, J. G.; Gonzalez, M.; Gora, D.; Gorgi, A.; Gouffon, P.; Grassi, V.; Grillo, A.; Grunfeld, C.; Guardincerri, Y.; Guarino, F.; Guedes, G. P.; Gutierrez, J.; Hague, J. D.; Hamilton, J. C.; Hansen, P.; Harari, D.; Harmsma, S.; Harton, J. L.; Haungs, A.; Hauschildt, T.; Healy, M. D.; Hebbeker, T.; Heck, D.; Hojvat, C.; Holmes, V. C.; Homola, P.; Hoerandel, J.; Horneffer, A.; Horvat, M.; Hrabovsky, M.; Huege, T.; Iarlori, M.; Insolia, A.; Ionita, F.; Italiano, A.; Kaducak, M.; Kampert, K. H.; Keilhauer, B.; Kemp, E.; Kieckhafer, R. M.; Klages, H. O.; Kleifges, M.; Kleinfeller, J.; Knapik, R.; Knapp, J.; Koang, D.-H.; Kopmann, A.; Krieger, A.; Kroemer, O.; Kuempel, D.; Kunka, N.; Kusenko, A.; La Rosa, G.; Lachaud, C.; Lago, B. L.; Lebrun, D.; LeBrun, P.; Lee, J.; Leigui de Oliveira, M. A.; Letessier-Selvon, A.; Leuthold, M.; Lhenry-Yvon, I.; Lopez, R.; Lopez Aguera, A.; Lozano Bahilo, J.; Maccarone, M. C.; Macolino, C.; Maldera, S.; Malek, M.; Mancarella, G.; Mancenido, M. E.; Mandat, D.; Mantsch, P.; Mariazzi, A. G.; Maris, I. C.; Martello, D.; Martinez, J.; Martinez Bravo, O.; Mathes, H. J.; Matthiae, G.; Maurizio, D.; Mazur, P. O.; McCauley, T.; McEwen, M.; McNeil, R. R.; Medina, M. C.; Medina-Tanco, G.; Meli, A.; Melo, D.; Menichetti, E.; Menschikov, A.; Meurer, Chr.; Meyhandan, R.; Micheletti, M. I.; Miele, G.; Miller, W.; Mollerach, S.; Monasor, M.; Ragaigne, D. Monnier; Montanet, F.; Morales, B.; Morello, C.; Moreno, E.; Moreno, J. C.; Morris, C.; Mostafa, M.; Muller, M. A.; Mussa, R.; Navarra, G.; Navarro, J. L.; Navas, S.; Nellen, L.; Newman-Holmes, C.; Newton, D.; Thi, T. Nguyen; Nierstenhoefer, N.; Nitz, D.; Nosek, D.; Nozka, L.; Oehlschlaeger, J.; Ohnuki, T.; Olinto, A.; Olmos-Gilbaja, V. M.; Ortiz, M.; Ostapchenko, S.; Otero, L.; Selmi-Dei, D. Pakk; Palatka, M.; Pallotta, J.; Parente, G.; Parizot, E.; Parlati, S.; Pastor, S.; Patel, M.; Paul, T.; Pavlidou, V.; Payet, K.; Pech, M.; Pekala, J.; Pelayo, R.; Pepe, I. M.; Perrone, L.; Petrera, S.; Petrinca, P.; Petrov, Y.; Ngoc, DiepPham; Ngoc, DongPham; Thi, T. N. Pham; Pichel, A.; Piegaia, R.; Pierog, T.; Pimenta, M.; Pinto, T.; Pirronello, V.; Pisanti, O.; Platino, M.; Pochon, J.; Porter, T. A.; Privitera, P.; Prouza, M.; Quel, E. J.; Rautenberg, J.; Reucroft, S.; Revenu, B.; Rezende, F. A. S.; Ridky, J.; Riggi, S.; Risse, M.; Riviere, C.; Rizi, V.; Roberts, M.; Robledo, C.; Rodriguez, G.; Rodriguez Frias, D.; Rodriguez Martino, J.; Rodriguez Rojo, J.; Rodriguez-Cabo, I.; Ros, G.; Rosado, J.; Roth, M.; Rouille-d'Orfeuil, B.; Roulet, E.; Rovero, A. C.; Salamida, F.; Salazar, H.; Salina, G.; Sanchez, F.; Santander, M.; Santo, C. E.; Santos, E. M.; Sarazin, F.; Sarkar, S.; Sato, R.; Scherini, V.; Schieler, H.; Schmidt, F.; Schmidt, T.; Scholten, O.; Schovanek, P.; Schuessler, F.; Sciutto, S. J.; Scuderi, M.; Segreto, A.; Semikoz, D.; Settimo, M.; Shellard, R. C.; Sidelnik, I.; Siffert, B. B.; Sigl, G.; De Grande, N. Smetniansky; Smialkowski, A.; Smida, R.; Smith, A. G. K.; Smith, B. E.; Snow, G. R.; Sokolsky, P.; Sommers, P.; Sorokin, J.; Spinka, H.; Squartini, R.; Strazzeri, E.; Stutz, A.; Suarez, F.; Suomijarvi, T.; Supanitsky, A. D.; Sutherland, M. S.; Swain, J.; Szadkowski, Z.; Takahashi, J.; Tamashiro, A.; Tamburro, A.; Tascau, O.; Tcaciuc, R.; Thomas, D.; Ticona, R.; Tiffenberg, J.; Timmermans, C.; Tkaczyk, W.; Todero Peixoto, C. J.; Tome, B.; Tonachini, A.; Torresi, D.; Travnicek, P.; Tripathi, A.; Tristram, G.; Tscherniakhovski, D.; Tueros, M.; Tunnicliffe, V.; Ulrich, R.; Unger, M.; Urban, M.; Valdes Galicia, J. F.; Valino, I.; Valore, L.; van den Berg, A. M.; van Elewyck, V.; Vazquez, R. A.; Veberic, D.; Veiga, A.; Velarde, A.; Venters, T.; Verzi, V.; Videla, M.; Villasenor, L.; Vorobiov, S.; Voyvodic, L.; Wahlberg, H.; Wainberg, O.; Waldenmaier, T.; Walker, P.; Warner, D.; Watson, A. A.; Westerhoff, S.; Wieczorek, G.; Wiencke, L.; Wilczynska, B.; Wilczynski, H.; Wileman, C.; Winnick, M. G.; Wu, H.; Wundheiler, B.; Xu, J.; Yamamoto, T.; Younk, P.; Zas, E.; Zavrtanik, D.; Zavrtanik, M.; Zech, A.; Zepeda, A.; Ziolkowski, M.		Pierre Auger Collaboration	Correlation of the highest-energy cosmic rays with nearby extragalactic objects	SCIENCE			English	Article								Using data collected at the Pierre Auger Observatory during the past 3.7 years, we demonstrated a correlation between the arrival directions of cosmic rays with energy above 6 x 10(19) electron volts and the positions of active galactic nuclei (AGN) lying within similar to 75 megaparsecs. We rejected the hypothesis of an isotropic distribution of these cosmic rays with at least a 99% confidence level from a prescribed a priori test. The correlation we observed is compatible with the hypothesis that the highest-energy particles originate from nearby extragalactic sources whose flux has not been substantially reduced by interaction with the cosmic background radiation. AGN or objects having a similar spatial distribution are possible sources.	Univ Tecnol Nacl Reg Mendoza & San Rafael, RA-5500 Mendoza, Argentina; Lab Instrumentacao & Fis Expt Particulas, P-1000119 Lisbon, Portugal; Inst Super Tecn, P-1000119 Lisbon, Portugal; Univ Turin, Ist Fis Spazio Interplanetario, I-10125 Turin, Italy; Sezione Ist Nazl Fis Nucl, I-10125 Turin, Italy; Univ Catolica Bolivia, La Paz, Bolivia; Univ Paris 07, Lab AstroParticule & Cosmol, IN2P3, CNRS, F-75231 Paris 05, France; Comis Nacl Energia Atom, Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; Inst Balseiro, UNCuyo, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; NYU, New York, NY 10027 USA; Ohio State Univ, Columbus, OH 43210 USA; Benernerita Univ Autonoma Puebla, Puebla, Mexico; Univ Santiago de Compostela, E-15782 Santiago De Compostela, Spain; Sez INFN Napoli, I-80126 Naples, Italy; Northeastern Univ, Boston, MA 02115 USA; Univ Wisconsin, Milwaukee, WI 53201 USA; Ist Astrofis Spaziale & Fis Cosm Palermo, INAF, I-90146 Palermo, Italy; Univ Calif Los Angeles, Los Angeles, CA 90095 USA; Ist Nazl Fis Nucl, Lab Nazl Gran Sasso, I-67010 Laquila, Italy; Univ Complutense Madrid, E-28040 Madrid, Spain; Forschungszentrum Karlsruhe, Inst Prozessdatenverarbeitung & Elekt, D-76021 Karlsruhe, Germany; Penn State Univ, University Pk, PA 16802 USA; Univ Paris 06, Lab Phys Nucl & Hautes Energies, F-75252 Paris 05, France; Univ Paris 07, F-75252 Paris 05, France; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Pierre Auger So Observ, RA-5613 Mendoza, Argentina; Univ Siegen, D-57068 Siegen, Germany; Natl Univ La Plata, Inst Fis Plata, Consejo Nacl Invest Cient & Tecn, RA-1900 La Plata, Argentina; Ctr Brasileiro Pesquisas Fis, BR-22290180 Rio De Janeiro, Brazil; Univ Estadual Sudoeste Bahia, BR-45083900 Vitoria da Conquista, BA, Brazil; Colorado State Univ, Ft Collins, CO 80523 USA; Univ New Mexico, Albuquerque, NM 87131 USA; Berg Univ Wuppertal, D-42097 Wuppertal, Germany; Columbia Univ, New York, NY 10027 USA; CNRS, IN2P3, Lab Phys Subatom & Cosmol, F-38026 Grenoble, France; Univ Karlsruhe TH, Inst Expt Kernphys, D-76128 Karlsruhe, Germany; Univ Salento, I-73100 Lecce, Italy; Sezione Ist Nazl Fis Nucl, I-73100 Lecce, Italy; Max Planck Inst Radioastron, D-53121 Bonn, Germany; Univ Aquila, I-67010 Coppito, Aquila, Italy; Sezione Ist Nazl Fis Nucl, I-67010 Coppito, Aquila, Italy; Osserv Astrofis Arcetri, I-50125 Florence, Italy; Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; Forschungszentrum Karlsruhe, Inst Kernphys, D-76021 Karlsruhe, Germany; Acad Sci Czech Republ, Inst Phys, CZ-18221 Prague 8, Czech Republic; Univ Colorado, Boulder, CO 80309 USA; Colorado State Univ, Pueblo, CO 81001 USA; Univ Granada, E-18071 Granada, Spain; Ctr Andaluz Fis Particulas Elementales, E-18071 Granada, Spain; Univ Minnesota, Minneapolis, MN 55455 USA; Univ Milan, I-20133 Milan, Italy; Sezione Ist Nazl Fis Nucl, I-20133 Milan, Italy; Univ Catania, I-95123 Catania, Italy; Sezione Ist Nazl Fis Nucl, I-95123 Catania, Italy; Univ Sao Paulo, Inst Fis, BR-05315970 Sao Paulo, Brazil; Univ Estadual Campinas, Inst Fis Gleb Wataghin, BR-13083970 Campinas, SP, Brazil; Fermilab Natl Accelerator Lab, Batavia, IL 60510 USA; Michigan Technol Univ, Houghton, MI 49931 USA; Univ Leeds, Inst Integrated Informat Syst, Leeds LS2 9JT, W Yorkshire, England; Univ Adelaide, Adelaide, SA 5005, Australia; Comis Nacl Energia Atom, Ctr Atom Constituyentes, RA-1650 Buenos Aires, DF, Argentina; Radboud Univ Nijmegen, Inst Math Astrophys & Particle Phys, NL-6500 GL Nijmegen, Netherlands; Natl Inst Subatom Phys, NL-1009 DB Amsterdam, Netherlands; Univ Paris Sud, CNRS, IN2P3, Lab Accelerateur Lineaire, F-91898 Orsay, France; Univ Michoacana, Morelia 58040, Michoacan, Mexico; Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ Nova Gorica, Lab Astroparticle Phys, SI-5000 Nova Gorica, Slovenia; Univ Fed Rio de Janeiro, Inst Fis, BR-21945970 Rio De Janeiro, Brazil; Univ Alcala de Henares, Madrid 28801, Spain; Univ Paris Sud, CNRS, IN2P3, Inst Phys Nucl, F-91898 Orsay, France; Univ Naples Federico II, I-80126 Naples, Italy; Sezione Ist Nazl Fis Nucl, I-80126 Naples, Italy; Univ Roma II Tor Vergata, I-00133 Rome, Italy; Sezione Ist Nazl Fis Nucl, I-00133 Rome, Italy; Rhein Westfal TH Aachen Univ, Inst Phys 3 A, D-52056 Aachen, Germany; Univ Nacl Autonoma Mexico, Mexico City 01000, DF, Mexico; Louisiana State Univ, Baton Rouge, LA 70803 USA; Univ Hawaii, Honolulu, HI 96822 USA; ASTRON, NL-7990 AA Dwingeloo, Netherlands; Pontificia Univ Catolica Rio de Janeiro, BR-22453500 Rio de Janeiro, Brazil; Univ Lodz, PL-90236 Lodz, Poland; Univ Fed Fluminense, Inst Fis, BR-24210340 Niteroi, RJ, Brazil; Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Mexico City 07000, DF, Mexico; PAN, Inst Nucl Phys, PL-31342 Krakow, Poland; Univ Estadual de Feira Santana, BR-44031460 Feira de Santana, Brazil; Univ Groningen, Kernfys Versneller Inst, NL-9747 AA Groningen, Netherlands; Univ Fed ABC, BR-09210170 Santo Andre, SP, Brazil; Southern Univ, Baton Rouge, LA 70813 USA; Univ Utah, Salt Lake City, UT 84112 USA; Inst Nucl Sci & Technol, Hanoi, Vietnam; Charles Univ Prague, Inst Nucl & Particle Phys, CZ-18000 Prague 8, Czech Republic; Univ Valencia, CSIC, Inst Fis Corpuscular, E-46071 Valencia, Spain; Univ Fed Bahia, BR-40210340 Salvador, BA, Brazil; Consejo Nacl Invest Cient & Tecn, Inst Astron & Fis Espacio, RA-1128 Buenos Aires, DF, Argentina; Colorado Sch Mines, Golden, CO 80401 USA; Univ Oxford, Rudolf Peierls Ctr Theoret Phys, Oxford OX1 3NP, England; Univ Nebraska, Lincoln, NE 68588 USA; Argonne Natl Lab, Argonne, IL 60439 USA; Univ Wisconsin, Madison, WI 53706 USA	Laboratorio de Instrumentacao e Fisica Experimental de Particulas; Universidade de Lisboa; Instituto Superior Tecnico; Istituto Nazionale Astrofisica (INAF); University of Turin; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro; New York University; University System of Ohio; Ohio State University; Benemerita Universidad Autonoma de Puebla; Universidade de Santiago de Compostela; Istituto Nazionale di Fisica Nucleare (INFN); Northeastern University; University of Wisconsin System; University of Wisconsin Milwaukee; Istituto Nazionale Astrofisica (INAF); University of California System; University of California Los Angeles; Gran Sasso Science Institute (GSSI); Istituto Nazionale di Fisica Nucleare (INFN); Complutense University of Madrid; Helmholtz Association; Karlsruhe Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Chicago; Universitat Siegen; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Centro Brasileiro de Pesquisas Fisicas; Universidade Estadual do Sudoeste da Bahia; Colorado State University; University of New Mexico; University of Wuppertal; Columbia University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Helmholtz Association; Karlsruhe Institute of Technology; University of Salento; Istituto Nazionale di Fisica Nucleare (INFN); Max Planck Society; University of L'Aquila; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale Astrofisica (INAF); University of Leeds; Helmholtz Association; Karlsruhe Institute of Technology; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; University of Colorado System; University of Colorado Boulder; Colorado State University; University of Granada; University of Minnesota System; University of Minnesota Twin Cities; University of Milan; Istituto Nazionale di Fisica Nucleare (INFN); University of Catania; Istituto Nazionale di Fisica Nucleare (INFN); Universidade de Sao Paulo; Universidade Estadual de Campinas; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; Michigan Technological University; University of Leeds; University of Adelaide; Comision Nacional de Energia Atomica (CNEA); Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Saclay; Universidad Michoacana de San Nicolas de Hidalgo; Case Western Reserve University; University of Nova Gorica; Universidade Federal do Rio de Janeiro; Universidad de Alcala; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Saclay; University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN); University of Rome Tor Vergata; Istituto Nazionale di Fisica Nucleare (INFN); RWTH Aachen University; Universidad Nacional Autonoma de Mexico; Louisiana State University System; Louisiana State University; University of Hawaii System; University of Lodz; Universidade Federal Fluminense; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; University of Groningen; Universidade Federal do ABC (UFABC); Southern University System; Southern University & A&M College; Utah System of Higher Education; University of Utah; Charles University Prague; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); University of Valencia; Universidade Federal da Bahia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto de Astronomia y Fisica del Espacio (IAFE); Colorado School of Mines; University of Oxford; University of Nebraska System; University of Nebraska Lincoln; United States Department of Energy (DOE); Argonne National Laboratory; University of Wisconsin System; University of Wisconsin Madison	Abraham, J (corresponding author), Pierre Auger So Observ, Avenida San Martin Norte 304, RA-5613 Mendoza, Argentina.	auger_collaboration2@fnal.gov	Schüssler, Fabian/G-5313-2013; Pastor, Sergio/J-6902-2014; Kopmann, Andreas/B-3454-2013; de Almeida, Rogerio/L-4584-2016; Clay, Roger/AFW-4973-2022; Bueno, Antonio/F-3875-2015; Nucleares, Instituto/AAK-6270-2020; Pękala, Jan/N-5423-2018; Fernandez, Gonzalo Rodriguez/C-1432-2014; Szadkowski, Zbigniew/AAD-5129-2019; Pinto, Diego García/M-3863-2019; Insolia, Antonio/M-3447-2015; Pavlidou, Vasiliki/C-2944-2011; Bellido, Jose/AAY-3452-2021; Fulgione, Walter/I-5232-2012; Ridky, Jan/H-6184-2014; Peixoto, Carlos José Todero/G-3873-2012; Knapp, Johannes/E-2227-2015; Mariangela, Settimo/AAR-9683-2020; Guarino, Fausto/I-3166-2012; Chinellato, Jose Augusto A/I-7972-2012; Falcke, Heino D. E./H-5262-2012; Santos, Edivaldo Moura/K-5313-2016; Hamilton, Jean-Christophe/AAW-8855-2020; Gelmini, Graciela B/AAW-7626-2021; Gómez Berisso, Mariano/GOJ-7746-2022; Arneodo, Francesco/B-8076-2013; Gómez-Herrero, Raúl/B-7346-2011; Villar, Antonio Bueno/X-4758-2019; Bonino, Raffaella/S-2367-2016; Lozano-Bahilo, Julio/F-4881-2016; Moreno-Barbosa, Eduardo/AAX-6669-2020; Zavrtanik, Danilo/A-1895-2019; Martello, Daniele/J-3131-2012; Del Peral, Luis/AAC-1377-2020; Palatka, Miroslav/G-5796-2014; Colombo, Eduardo H./I-1323-2015; Todero Peixoto, Carlos José/CAF-6635-2022; Pimenta, Mario J. M./M-1741-2013; Parlati, Sandra/K-8567-2018; Semikoz, Dmitri/F-7830-2019; Garcia Gamez, Diego/ABA-4141-2021; Blanch, Oscar/N-7147-2016; Ostapchenko, Sergey/L-5242-2017; Bateson, Jane Farrar/AAO-6147-2020; Chiavassa, Andrea/A-7597-2012; D'Urso, Domenico/I-5325-2012; Takahashi, Jun/B-2946-2012; Alvarez-Muniz, Jaime/H-1857-2015; Brogueira, Pedro/K-3868-2012; Aramo, Carla/D-4317-2011; Shellard, Ronald Cintra C/G-4825-2012; Homola, Piotr/W-4115-2018; Valiño, Ines/O-4910-2019; Fauth, Anderson Campos/F-9570-2012; Nellen, Lukas/AAH-2388-2020; Ulrich, Ralf/Q-3882-2019; Prouza, Michael/F-8514-2014; Chinellato, Carola Dobrigkeit/F-2540-2011; Valino, Ines/J-8324-2012; Parente, Gonzalo/G-8264-2015; Abreu, Pedro T./L-2220-2014; Beatty, James/D-9310-2011; Zavrtanik, Marko/A-1524-2008; Pech, Miroslav/G-5760-2014; Cazon, Lorenzo/G-6921-2014; de souza, Vitor/D-1381-2012; Rosado, Jaime/K-9109-2014; Garcia Pinto, Diego/J-6724-2014; Carvalho Jr., Washington/H-9855-2015; Torresi, Domenico/AAH-4634-2020; Salamida, Francesco/GOE-5140-2022; zas, enrique/I-5556-2015; Arqueros, Fernando/K-9460-2014; Gora, Dariusz/M-8695-2018; Venters, Tonia/D-2936-2012; Arneodo, Francesco/E-5061-2015; Tiffenberg, Javier S/A-3488-2019; de Mello Neto, Joao/C-5822-2013; Navas, Sergio/N-4649-2014; cotti, umberto/E-3800-2018; scuderi, mario/O-7019-2014; Nosek, Dalibor/F-1129-2017; Gonzalez, Javier G/G-2520-2017; Ramos, Francisco Blanco/F-1131-2015; Tanco, Gustavo Adolfo Medina/AAS-1447-2021; Conceição, Ruben/L-2971-2014; Mandat, Dusan/G-5580-2014; Gouffon, Philippe/I-4549-2012; Tomé, Bernardo A/J-4410-2013; Wilczyński, Henryk/N-7330-2018; Ros, Germán/L-4764-2014; De Donato, Cinzia/J-9132-2015; Blasi, Pasquale/O-9345-2015; Travnicek, Petr/G-8814-2014; Fulgione, Walter/C-8255-2016; Gamez, Diego Garcia/B-3460-2017; travnicek, petr/T-2962-2018; Anjos, Joao C/C-8335-2013; Frias, Maria Dolores Rodriguez/A-7608-2015; van den Berg, Adriaan M/C-4970-2017; Miele, Gennaro/AAG-6782-2020; Gonçalves, Patrícia/D-8229-2013; Schovanek, Petr/G-7117-2014; Bohacova, Martina/G-5898-2014; Bleve, Carla/J-2521-2012; Nierstenhöfer, Nils/H-3699-2013; Sarkar, Subir/GPT-4902-2022; Parente, Gonzalo/AAT-2889-2020; Muller, Marcio Aparecido/H-9112-2012; Assis, Pedro J S/D-9062-2013; De Mitri, Ivan/C-1728-2017; Salina, Gaetano/AAF-2021-2019; Bonino, Raffaella/AAT-7938-2020; Miele, Gennaro/F-3628-2010; Tamburro, Alessio/A-5703-2013; Nozka, Libor/G-5550-2014; Pelayo, Rodrigo/P-4807-2019; Di Giulio, Claudio/O-4022-2019; Smida, Radomir/G-6314-2014; Fauth, A. C./AAY-3433-2020; Sarkar, Subir/G-5978-2011; de Mello Neto, Joao/AAD-8312-2021; Gomez Berisso, Mariano/I-2931-2017; Andringa, Sofia/J-4092-2013; Martinez-Castro, Jesus/G-8495-2019; Castellina, Antonella/V-4748-2017; Espirito Santo, Maria Catarina/L-2341-2014; Hrabovsky, Miroslav/G-6714-2014; Petrera, Sergio/A-8895-2016	Schüssler, Fabian/0000-0003-1500-6571; Pastor, Sergio/0000-0003-0933-7710; Kopmann, Andreas/0000-0002-2362-3943; de Almeida, Rogerio/0000-0003-3104-2724; Bueno, Antonio/0000-0002-7439-4247; Pękala, Jan/0000-0002-1062-5595; Fernandez, Gonzalo Rodriguez/0000-0002-4683-230X; Szadkowski, Zbigniew/0000-0002-2690-9912; Pinto, Diego García/0000-0003-1348-6735; Insolia, Antonio/0000-0002-9040-1566; Pavlidou, Vasiliki/0000-0002-0870-1368; Bellido, Jose/0000-0002-0833-9194; Fulgione, Walter/0000-0002-2388-3809; Ridky, Jan/0000-0001-6697-1393; Peixoto, Carlos José Todero/0000-0003-3669-8212; Knapp, Johannes/0000-0003-1519-1383; Mariangela, Settimo/0000-0003-0650-5512; Guarino, Fausto/0000-0003-1427-9885; Chinellato, Jose Augusto A/0000-0002-3240-6270; Falcke, Heino D. E./0000-0002-2526-6724; Santos, Edivaldo Moura/0000-0002-2818-8813; Gelmini, Graciela B/0000-0001-8401-1505; Arneodo, Francesco/0000-0002-1061-0510; Gómez-Herrero, Raúl/0000-0002-5705-9236; Villar, Antonio Bueno/0000-0002-7439-4247; Bonino, Raffaella/0000-0002-4264-1215; Lozano-Bahilo, Julio/0000-0003-0613-140X; Moreno-Barbosa, Eduardo/0000-0002-1114-2640; Martello, Daniele/0000-0003-2046-3910; Del Peral, Luis/0000-0003-2580-5668; Palatka, Miroslav/0000-0003-2061-6059; Colombo, Eduardo H./0000-0002-3700-3745; Todero Peixoto, Carlos José/0000-0003-3669-8212; Pimenta, Mario J. M./0000-0002-2590-0908; Parlati, Sandra/0000-0001-7099-0378; Semikoz, Dmitri/0000-0001-6417-1560; Garcia Gamez, Diego/0000-0003-3452-3478; Blanch, Oscar/0000-0002-8380-1633; D'Urso, Domenico/0000-0002-8215-4542; Takahashi, Jun/0000-0002-4091-1779; Alvarez-Muniz, Jaime/0000-0002-2367-0803; Brogueira, Pedro/0000-0001-6069-4073; Aramo, Carla/0000-0002-8412-3846; Shellard, Ronald Cintra C/0000-0002-2983-1815; Homola, Piotr/0000-0002-1956-9948; Valiño, Ines/0000-0001-7823-0154; Fauth, Anderson Campos/0000-0001-7239-0288; Nellen, Lukas/0000-0003-1059-8731; Ulrich, Ralf/0000-0002-2535-402X; Prouza, Michael/0000-0002-3238-9597; Chinellato, Carola Dobrigkeit/0000-0002-1236-0789; Valino, Ines/0000-0001-7823-0154; Parente, Gonzalo/0000-0003-2847-0461; Abreu, Pedro T./0000-0002-9973-7314; Beatty, James/0000-0003-0481-4952; Zavrtanik, Marko/0000-0001-5606-6912; Pech, Miroslav/0000-0002-8421-0456; Cazon, Lorenzo/0000-0001-6748-8395; de souza, Vitor/0000-0003-0865-233X; Rosado, Jaime/0000-0001-8208-9480; Garcia Pinto, Diego/0000-0003-1348-6735; Carvalho Jr., Washington/0000-0002-2328-7628; Torresi, Domenico/0000-0002-6043-6178; Salamida, Francesco/0000-0002-9306-8447; zas, enrique/0000-0002-4430-8117; Arqueros, Fernando/0000-0002-4930-9282; Gora, Dariusz/0000-0002-4853-5974; Venters, Tonia/0000-0002-4188-627X; Arneodo, Francesco/0000-0002-1061-0510; Tiffenberg, Javier S/0000-0002-1126-2941; de Mello Neto, Joao/0000-0002-3234-6634; Navas, Sergio/0000-0003-1688-5758; cotti, umberto/0000-0002-7607-9582; scuderi, mario/0000-0001-9026-5317; Nosek, Dalibor/0000-0001-6219-200X; Gonzalez, Javier G/0000-0001-8746-2846; Ramos, Francisco Blanco/0000-0003-4332-434X; Conceição, Ruben/0000-0003-4945-5340; Mandat, Dusan/0000-0001-7748-7468; Gouffon, Philippe/0000-0001-7511-4115; Tomé, Bernardo A/0000-0002-7564-8392; Wilczyński, Henryk/0000-0003-2652-9685; Ros, Germán/0000-0001-6623-1483; De Donato, Cinzia/0000-0002-9725-1281; Blasi, Pasquale/0000-0003-2480-599X; Fulgione, Walter/0000-0002-2388-3809; Gamez, Diego Garcia/0000-0003-3452-3478; travnicek, petr/0000-0002-1655-9584; Frias, Maria Dolores Rodriguez/0000-0002-2550-4462; van den Berg, Adriaan M/0000-0001-9285-3956; Miele, Gennaro/0000-0002-2028-0578; Gonçalves, Patrícia/0000-0003-2042-3759; Schovanek, Petr/0000-0002-5344-7645; Bleve, Carla/0000-0001-6841-3280; Parente, Gonzalo/0000-0003-2847-0461; Assis, Pedro J S/0000-0001-7765-3606; De Mitri, Ivan/0000-0002-8665-1730; Salina, Gaetano/0000-0003-1767-0724; Miele, Gennaro/0000-0002-2028-0578; Pelayo, Rodrigo/0000-0001-6973-1731; Di Giulio, Claudio/0000-0002-0597-4547; Fauth, A. C./0000-0001-7239-0288; Sarkar, Subir/0000-0002-3542-858X; de Mello Neto, Joao/0000-0002-3234-6634; Kothandan, Divay/0000-0001-9048-7518; Maccarone, Maria Concetta/0000-0001-8722-0361; Maris, Ioana/0000-0002-5771-1124; Valdes Galicia, Jose Francisco/0000-0002-8917-9259; Badagnani, Daniel/0000-0001-9766-4222; Covault, Corbin/0000-0001-5405-5371; Navarro Quirante, Jose Luis/0000-0002-9915-1735; Lachaud, Cyril/0000-0002-3732-854X; Kampert, Karl-Heinz/0000-0002-2805-0195; Segreto, Alberto/0000-0001-7341-6603; Vazquez Lopez, Ricardo/0000-0003-4025-5262; Verzi, Valerio/0000-0003-2291-9387; Gomez Berisso, Mariano/0000-0001-5530-0180; Kunka, Danays/0000-0001-6500-7201; Santander, Juan Marcos/0000-0001-7297-8217; martinez, oscar/0000-0001-9052-856X; Clay, Roger/0000-0002-9040-9648; Kusenko, Alexander/0000-0002-8619-1260; Dembinski, Hans/0000-0003-3337-3850; Pierog, Tanguy/0000-0002-7472-8710; McCauley, Thomas/0000-0001-6589-8286; Mantsch, Paul/0000-0002-8382-7745; Brack, Jeffrey/0000-0003-4096-2063; Tueros, Matias/0000-0003-1570-1419; Roth, Markus/0000-0003-1281-4477; Porter, Troy/0000-0002-2621-4440; Petrinca, Paolo/0000-0003-2779-3787; Zepeda, Arnulfo/0000-0001-9976-2387; Leigui de Oliveira, Marcelo Augusto/0000-0001-9067-1577; Erdmann, Martin/0000-0002-1653-1303; Rizi, Vincenzo/0000-0002-5277-6527; Sarazin, Frederic/0000-0001-5614-1986; Horandel, Jorg/0000-0001-6604-547X; Dawson, Bruce/0000-0002-4271-3055; Smialkowski, Andrzej/0000-0002-2462-9570; Asorey, Hernan/0000-0002-4559-8785; Smida, Radomir/0000-0003-0122-1123; Allekotte, Ingomar/0000-0002-9624-3044; Scherini, Viviana/0000-0003-3762-4063; Hamilton, Jean-Christophe/0000-0002-7820-8405; DAGORET, Sylvie/0000-0003-1131-7030; Cataldi, Gabriella/0000-0001-8066-7718; Matthews, James/0000-0002-1832-4420; Andringa, Sofia/0000-0002-6397-9207; Caruso, Rossella/0000-0003-1622-8731; BenZvi, Segev/0000-0001-5537-4710; Scholten, Olaf/0000-0003-3649-1254; Catalano, Osvaldo/0000-0002-9554-4128; Sidelnik, Ivan/0000-0003-4115-3129; Mussa, Roberto/0000-0002-0294-9071; Armengaud, Eric/0000-0001-7600-5148; Daumiller, Kai/0000-0002-0527-4823; robledo-sanchez, carlos/0000-0002-9163-0627; Van Elewyck, Veronique/0000-0002-8242-5453; Garcia, Beatriz/0000-0003-0919-2734; Martinez-Castro, Jesus/0000-0002-2824-3544; Gorgi, Alessio/0000-0002-8085-2304; Allison, Patrick/0000-0001-8141-2653; Biermann, Peter/0000-0003-3948-6143; Castellina, Antonella/0000-0002-0045-2467; Beau, Tristan/0000-0002-2022-2140; Unger, Michael/0000-0002-7651-0272; Vorobiov, Serguei/0000-0001-8679-3424; Sigl, Guenter/0000-0002-4396-645X; Veiga, Alejandro/0000-0002-1694-2348; La Rosa, Giovanni/0000-0002-3931-2269; Aglietta, Marco/0000-0001-8354-5388; Espirito Santo, Maria Catarina/0000-0003-1286-7288; Hrabovsky, Miroslav/0000-0003-4223-7316; Menichetti, Ezio/0000-0001-7143-8200; de Jong, Sijbrand/0000-0002-3120-3367; maldera, simone/0000-0002-0698-4421; Huege, Tim/0000-0002-2783-4772; Petrera, Sergio/0000-0002-6029-1255; Anzalone, Anna/0000-0003-1849-198X; Coutu, Stephane/0000-0003-2923-2246; GARRIDO, Xavier/0000-0002-7088-5831; Patel, Mitesh/0000-0003-3871-5602; Caballero Mora, Karen Salome/0000-0002-4042-3855; Riggi, Simone/0000-0001-6368-8330	STFC [PP/C506205/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/C506205/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [0969400] Funding Source: National Science Foundation	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Abbasi RU, 2004, ASTROPHYS J, V610, pL73, DOI 10.1086/423303; Abraham J, 2004, NUCL INSTRUM METH A, V523, P50, DOI 10.1016/j.nima.2003.12.012; ALLARD D, ASTROPHYSICS; AVE M, ASTROPHYSICS; BEREZINSKY VS, 1988, ASTRON ASTROPHYS, V199, P1; Bonifazi C, 2005, PROCEEDINGS OF THE 29TH INTERNATIONAL COSMIC RAY CONFERENCE VOL 7: HE 1.4, P17; BONIFAZI C, ASTROPHYSICS; CLAY RW, 2003, P 28 INT COSM RAY C, V1, P421; Cronin JW, 1997, SCI AM, V276, P44, DOI 10.1038/scientificamerican0197-44; DAWSON BR, ASTROPHYSICS; Ginzburg V. L., 1964, ORIGIN COSMIC RAYS; GREISEN K, 1966, PHYS REV LETT, V16, P748, DOI 10.1103/PhysRevLett.16.748; Han JL, 2006, ASTROPHYS J, V642, P868, DOI 10.1086/501444; Hayashida N, 1996, PHYS REV LETT, V77, P1000, DOI 10.1103/PhysRevLett.77.1000; HILLAS AM, 1984, ANNU REV ASTRON ASTR, V22, P425, DOI 10.1146/annurev.aa.22.090184.002233; LINSLEY J, 1963, PHYS REV LETT, V10, P146, DOI 10.1103/PhysRevLett.10.146; MOLLERACH S, ASTROPHYSICS; Revenu B, 2005, Proceedings of the 29th International Cosmic Ray Conference Vol 7: HE 1.4, P75; ROTH M, ASTROPHYSICS; STANEV T, 1995, PHYS REV LETT, V75, P3056, DOI 10.1103/PhysRevLett.75.3056; Uchihori Y, 2000, ASTROPART PHYS, V13, P151, DOI 10.1016/S0927-6505(99)00119-X; Veron-Cetty MP, 2006, ASTRON ASTROPHYS, V455, P773, DOI 10.1051/0004-6361:20065177; ZATSEPIN GT, 1966, JETP LETT-USSR, V4, P78	23	623	636	6	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					938	943		10.1126/science.1151124	http://dx.doi.org/10.1126/science.1151124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991855	Green Published, Green Submitted			2022-12-28	WOS:000250788500033
J	Arakawa, K; Ono, K; Isshiki, M; Mimura, K; Uchikoshi, M; Mori, H				Arakawa, K.; Ono, K.; Isshiki, M.; Mimura, K.; Uchikoshi, M.; Mori, H.			Observation of the one-dimensional diffusion of nanometer-sized dislocation loops	SCIENCE			English	Article							SELF-INTERSTITIAL ATOM; CLUSTERS; IRON; TEMPERATURE; MOBILITY; METALS; ENERGY; COPPER; FE	Dislocations are ubiquitous linear defects and are responsible for many of the properties of crystalline materials. Studies on the glide process of dislocations in bulk materials have mostly focused on the response of dislocations with macroscopic lengths to external loading or unloading. Using in situ transmission electron microscopy, we show that nanometer-sized loops with a Burgers vector of 1/2 < 111 > in alpha-Fe can undergo one-dimensional diffusion even in the absence of stresses that are effective in driving the loops. The loop size dependence of the loop diffusivity obtained is explained by the stochastic thermal fluctuation in the numbers of double kinks.	Osaka Univ, Ultra High Voltage Electron Microscopy Res Ctr, Osaka 5670047, Japan; Shimane Univ, Dept Mat Sci, Matsue, Shimane 6908504, Japan; Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Osaka University; Shimane University; Tohoku University	Arakawa, K (corresponding author), Osaka Univ, Ultra High Voltage Electron Microscopy Res Ctr, 7-1 Mihogaoka, Osaka 5670047, Japan.	arakawak@uhvem.osaka-u.ac.jp	Arakawa, Kazuto/AAA-2494-2020; Uchikoshi, Masahito/H-4693-2018	Arakawa, Kazuto/0000-0001-8421-5698; Uchikoshi, Masahito/0000-0002-4030-0628				Abe H, 2003, J NUCL MATER, V323, P220, DOI 10.1016/j.jnucmat.2003.08.006; ALSHITS VI, 1986, DISLOCATIONS SOLIDS, V7, P43; Arakawa K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.125506; Barashev AV, 2000, PHILOS MAG A, V80, P2709, DOI 10.1080/01418610008216500; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Cottrell A.H., 1948, REPORT STRENGTH SOLI, P30; COTTRELL AH, 1949, PROC R SOC LON SER-A, V199, P104, DOI 10.1098/rspa.1949.0128; Cottrell GA, 2004, J NUCL MATER, V325, P195, DOI 10.1016/j.jnucmat.2003.12.001; DEHOSSON JTM, 1975, SOLID STATE COMMUN, V17, P747, DOI 10.1016/0038-1098(75)90400-7; Dudarev SL, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.224105; Heumann T., 1992, DIFFUSION METALLEN G, V1, P128; Hirth J. P., 1972, THEORY DISLOCATIONS; Kiritani M, 1997, J NUCL MATER, V251, P237, DOI 10.1016/S0022-3115(97)00278-X; LORD AE, 1966, ACTA METALL MATER, V14, P1659, DOI 10.1016/0001-6160(66)90018-6; LOUAT N, 1956, P PHYS SOC LOND B, V69, P459, DOI 10.1088/0370-1301/69/4/305; MANNING JR, 1968, DIFFUSION KINETICS A; Marian J, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144102; Ohsawa K, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.054105; Osetsky YN, 2003, PHILOS MAG, V83, P61, DOI 10.1080/0141861021000016793; Schock G., 1980, Dislocations in solids, vol.3. Moving dislocations, P63; Seeger A., 1966, PHYS ACOUSTICS, VIIIA, P361; Soneda N, 2001, PHILOS MAG A, V81, P331, DOI 10.1080/01418610108214307; SPEICH GR, 1972, METALL TRANS, V3, P2031, DOI 10.1007/BF02643211; Terentyev DA, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.104108; Trinkaus H, 2000, J NUCL MATER, V283, P89, DOI 10.1016/S0022-3115(00)00332-9; Walgraef D, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.064103; Wirth BD, 2000, J NUCL MATER, V276, P33, DOI 10.1016/S0022-3115(99)00166-X; YOSHINAGA H, 1971, PHILOS MAG, V23, P1367, DOI 10.1080/14786437108217008	28	262	266	3	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					956	959		10.1126/science.1145386	http://dx.doi.org/10.1126/science.1145386			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991859				2022-12-28	WOS:000250788500037
J	Chang, WL; Smith, RB; Wicks, C; Farrell, JM; Puskas, CM				Chang, Wu-Lung; Smith, Robert B.; Wicks, Charles; Farrell, Jamie M.; Puskas, Christine M.			Accelerated uplift and magmatic intrusion of the Yellowstone caldera, 2004 to 2006	SCIENCE			English	Article							LONG VALLEY CALDERA; BENEATH; UNREST; SUBSIDENCE; MECHANISMS; MODELS	The Yellowstone caldera began a rapid episode of ground uplift in mid-2004, revealed by Global Positioning System and interferometric synthetic aperture radar measurements, at rates up to 7 centimeters per year, which is over three times faster than previously observed inflation rates. Source modeling of the deformation data suggests an expanding volcanic sill of similar to 1200 square kilometers at a 10-kilometer depth beneath the caldera, coincident with the top of a seismically imaged crustal magma chamber. The modeled rate of source volume increase is 0.1 cubic kilometer per year, similar to the amount of magma intrusion required to supply the observed high heat flow of the caldera. This evidence suggests magma recharge as the main mechanism for the accelerated uplift, although pressurization of magmatic fluids cannot be ruled out.	Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; US Geol Survey, Menlo Pk, CA 94025 USA	Utah System of Higher Education; University of Utah; United States Department of the Interior; United States Geological Survey	Chang, WL (corresponding author), Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA.	wchang@earth.utah.edu; Smith@earth.utah.edu		Puskas, Christine/0000-0001-9388-0200				Battaglia M, 1999, SCIENCE, V285, P2119, DOI 10.1126/science.285.5436.2119; Cervelli P, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000602; Christiansen RL., 2001, QUATERNARY PLIOCENE; De Natale G, 2006, GEOL SOC SPEC PUBL, V269, P25, DOI 10.1144/GSL.SP.2006.269.01.03; DZURISIN D, 1994, B VOLCANOL, V56, P261, DOI 10.1007/BF00302079; DZURISIN D, 1990, B VOLCANOL, V52, P247, DOI 10.1007/BF00304098; FOURNIER RO, 1989, ANNU REV EARTH PL SC, V17, P13, DOI 10.1146/annurev.ea.17.050189.000305; Gottsmann J, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003745; Hill DP, 2006, GEOL SOC SPEC PUBL, V269, P1, DOI 10.1144/GSL.SP.2006.269.01.02; Husen S, 2004, B SEISMOL SOC AM, V94, P880, DOI 10.1785/0120030170; Husen S, 2004, J VOLCANOL GEOTH RES, V131, P397, DOI 10.1016/S0377-0273(03)00416-5; MORGAN P, 1977, J GEOPHYS RES, V82, P3719, DOI 10.1029/JB082i026p03719; Puskas CM, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004325; SMITH RB, 1984, J GEOPHYS RES, V89, P5733, DOI 10.1029/JB089iB07p05733; SMITH RB, 1994, J VOLCANOL GEOTH RES, V61, P121, DOI 10.1016/0377-0273(94)90002-7; Vasco DW, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004641; Waite GP, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000586; Wicks C, 1998, SCIENCE, V282, P458, DOI 10.1126/science.282.5388.458; Wicks CW, 2006, NATURE, V440, P72, DOI 10.1038/nature04507	19	104	106	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					952	956		10.1126/science.1146842	http://dx.doi.org/10.1126/science.1146842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991858				2022-12-28	WOS:000250788500036
J	Nelson, EC; Braun, PV				Nelson, Erik C.; Braun, Paul V.			Enhancing colloids through the surface	SCIENCE			English	Editorial Material							PARTICLES; NANOPARTICLES; BIDISPERSE; CRYSTALS		Univ Illinois, Beckman Inst, Dept Mat Sci & Engn, Urbana, IL 61801 USA; Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nelson, EC (corresponding author), Univ Illinois, Beckman Inst, Dept Mat Sci & Engn, Urbana, IL 61801 USA.	pbraun@uiuc.edu						Biancaniello PL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058302; Cho YS, 2005, J AM CHEM SOC, V127, P15968, DOI 10.1021/ja0550632; DeVries GA, 2007, SCIENCE, V315, P358, DOI 10.1126/science.1133162; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Hermanson KD, 2001, SCIENCE, V294, P1082, DOI 10.1126/science.1063821; Hong L, 2006, NANO LETT, V6, P2510, DOI 10.1021/nl061857i; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; Maier SA, 2003, NAT MATER, V2, P229, DOI 10.1038/nmat852; Milam VT, 2003, LANGMUIR, V19, P10317, DOI 10.1021/la034376c; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Piech M, 2006, LANGMUIR, V22, P1379, DOI 10.1021/la051636c; Plunkett KN, 2005, J AM CHEM SOC, V127, P14574, DOI 10.1021/ja054666a; Zhang G, 2005, NANO LETT, V5, P143, DOI 10.1012/nl048121a; Zhang ZL, 2005, LANGMUIR, V21, P11547, DOI 10.1021/la0513611	15	34	35	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					924	925		10.1126/science.1148009	http://dx.doi.org/10.1126/science.1148009			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991849				2022-12-28	WOS:000250788500027
J	Wirth, BD				Wirth, Brian D.			How does radiation damage materials?	SCIENCE			English	Editorial Material							CLUSTERS		Univ Calif Berkeley, Dept Nucl Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Wirth, BD (corresponding author), Univ Calif Berkeley, Dept Nucl Engn, Berkeley, CA 94720 USA.	bdwirth@nuc.berkeley.edu	Wirth, Brian/O-4878-2015	Wirth, Brian/0000-0002-0395-0285				Arakawa K, 2007, SCIENCE, V318, P956, DOI 10.1126/science.1145386; Bacon DJ, 2003, J NUCL MATER, V323, P152, DOI 10.1016/j.jnucmat.2003.08.002; COTTRELL AH, 1949, P PHYS SOC LOND A, V62, P49, DOI 10.1088/0370-1298/62/1/308; Marian J, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144102; Matsukawa Y, 2007, SCIENCE, V318, P959, DOI 10.1126/science.1148336; Osetsky YN, 2002, J NUCL MATER, V307, P852, DOI 10.1016/S0022-3115(02)01094-2; Soneda N, 2001, PHILOS MAG A, V81, P331, DOI 10.1080/01418610108214307; WIGNER EP, 1942, CP387 US AT EN COMM	8	99	102	6	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					923	924		10.1126/science.1150394	http://dx.doi.org/10.1126/science.1150394			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991848				2022-12-28	WOS:000250788500026
J	Andrews, NC				Andrews, Nancy C.			Climbing through medicine's glass ceiling	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Duke Univ, Sch Med, Durham, NC 27706 USA	Duke University	Andrews, NC (corresponding author), Duke Univ, Sch Med, Durham, NC 27706 USA.			Andrews, Nancy/0000-0003-0243-4462				Andrews NC, 2002, NAT MED, V8, P439, DOI 10.1038/nm0502-439; BENNETT D, 2007, BOSTON GLOBE    0902	2	33	34	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1887	1889		10.1056/NEJMp078198	http://dx.doi.org/10.1056/NEJMp078198			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989380				2022-12-28	WOS:000250732500002
J	Dorr, M; Hummel, A				Doerr, Marcus; Hummel, Astrid			Paradoxical embolism - Thrombus in a patent foramen ovale	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ernst Moritz Arndt Univ Greifswald, D-17487 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald	Dorr, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, D-17487 Greifswald, Germany.	mdoerr@uni-greifswald.de	Dörr, Marcus/F-1919-2010	Dörr, Marcus/0000-0001-7471-475X					0	16	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2285	2285		10.1056/NEJMicm066931	http://dx.doi.org/10.1056/NEJMicm066931			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	18046032				2022-12-28	WOS:000251176400010
J	Unutzer, J				Unuetzer, Juergen			Late-life depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REDUCING SUICIDAL IDEATION; PRIMARY-CARE PRACTICE; MAJOR DEPRESSION; OLDER-ADULTS; ELDERLY-PATIENTS; ELECTROCONVULSIVE-THERAPY; CONSENSUS STATEMENT; COLLABORATIVE CARE; ANTIDEPRESSANTS; MANAGEMENT		Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Unutzer, J (corresponding author), Box 356560, Seattle, WA 98195 USA.	unutzer@u.washington.edu	Unutzer, Jurgen/N-4048-2018					Alexopoulos G S, 2001, J Psychiatr Pract, V7, P361; Baldwin RC, 2003, INT J GERIATR PSYCH, V18, P829, DOI 10.1002/gps.940; Boyer EW, 2007, NEW ENGL J MED, V356, P2437; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Bruce ML, 2002, BIOL PSYCHIAT, V52, P175, DOI 10.1016/S0006-3223(02)01410-5; Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; Charney DS, 2003, ARCH GEN PSYCHIAT, V60, P664, DOI 10.1001/archpsyc.60.7.664; Cuijpers P, 2006, INT J GERIATR PSYCH, V21, P1139, DOI 10.1002/gps.1620; *DEPR GUID PAN, 1993, AHCPR PUBL; Dew MA, 2007, AM J PSYCHIAT, V164, P892, DOI 10.1176/appi.ajp.164.6.892; Dombrovski Alexandre Y, 2007, Int Psychogeriatr, V19, P10, DOI 10.1017/S1041610206224384; Dombrovski AY, 2007, INT PSYCHOGERIATR, V19, P24; Fabian TJ, 2004, ARCH INTERN MED, V164, P327, DOI 10.1001/archinte.164.3.327; Fraser SA, 2004, GEN HOSP PSYCHIAT, V26, P302, DOI 10.1016/j.genhosppsych.2004.03.007; Frazer CJ, 2005, MED J AUSTRALIA, V182, P627, DOI 10.5694/j.1326-5377.2005.tb06849.x; Gallo JJ, 2007, ANN INTERN MED, V146, P689, DOI 10.7326/0003-4819-146-10-200705150-00002; Givens JL, 2006, J GEN INTERN MED, V21, P146, DOI 10.1111/j.1525-1497.2005.00296.x; Hegel MT, 2006, GEN HOSP PSYCHIAT, V28, P205, DOI 10.1016/j.genhosppsych.2006.02.008; Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873; Katon WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7; Keller MB, 2001, NEW ENGL J MED, V345, P232; Keller MB, 2000, NEW ENGL J MED, V342, P1462, DOI 10.1056/NEJM200005183422001; Kennedy GJ, 2005, DRUG AGING, V22, P273, DOI 10.2165/00002512-200522040-00001; Klap R, 2003, AM J GERIAT PSYCHIAT, V11, P517, DOI 10.1176/appi.ajgp.11.5.517; Klysner R, 2002, BRIT J PSYCHIAT, V181, P29, DOI 10.1192/bjp.181.1.29; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V297, P573, DOI 10.1001/jama.297.6.573; Kujala I, 2002, J GERIATR PSYCH NEUR, V15, P73, DOI 10.1177/089198870201500204; Lebowitz BD, 1997, JAMA-J AM MED ASSOC, V278, P1186, DOI 10.1001/jama.278.14.1186; Li CY, 2007, J AM GERIATR SOC, V55, P596, DOI 10.1111/j.1532-5415.2007.01103.x; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Lyness JM, 1999, J GEN INTERN MED, V14, P249, DOI 10.1046/j.1525-1497.1999.00326.x; Lyness JM, 2006, ANN INTERN MED, V144, P496, DOI 10.7326/0003-4819-144-7-200604040-00008; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; Mulsant BH, 2006, J CLIN PSYCHOPHARM, V26, P113, DOI 10.1097/01.jcp.0000204471.07214.94; NIERENBERG AA, 1994, AM J PSYCHIAT, V151, P1069; Oslin DW, 2003, J CLIN PSYCHIAT, V64, P875, DOI 10.4088/JCP.v64n0804; Oxman TE, 2005, PSYCHIAT CLIN N AM, V28, P1061, DOI 10.1016/j.psc.2005.09.007; Pinquart M, 2006, AM J PSYCHIAT, V163, P1493, DOI 10.1176/appi.ajp.163.9.1493; *PUBL HLTH SERV, 2001, NAT STRAT SUIC PREV; Reynolds CF, 2006, NEW ENGL J MED, V354, P1130, DOI 10.1056/NEJMoa052619; Reynolds CF, 1999, JAMA-J AM MED ASSOC, V281, P39, DOI 10.1001/jama.281.1.39; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Sackeim HA, 2001, JAMA-J AM MED ASSOC, V285, P1299, DOI 10.1001/jama.285.10.1299; SACKEIM HA, 2004, CLIN GERIATRIC PSYCH, P385; Sarkisian CA, 2003, J GEN INTERN MED, V18, P1001, DOI 10.1111/j.1525-1497.2003.30215.x; Schulberg HC, 1998, ARCH GEN PSYCHIAT, V55, P1121, DOI 10.1001/archpsyc.55.12.1121; Sirey JA, 2001, PSYCHIAT SERV, V52, P1615, DOI 10.1176/appi.ps.52.12.1615; Sjosten N, 2006, INT J GERIATR PSYCH, V21, P410, DOI 10.1002/gps.1494; Spina E, 2002, DRUG AGING, V19, P299, DOI 10.2165/00002512-200219040-00004; STEFFENS DC, IN PRESS PSYCHOL MED; Thielke SM, 2007, AM J GERIAT PSYCHIAT, V15, P699, DOI 10.1097/JGP.0b013e3180325a2d; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Unutzer J, 2003, J AM GERIATR SOC, V51, P505, DOI 10.1046/j.1532-5415.2003.51159.x; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Unutzer J, 2006, J AM GERIATR SOC, V54, P1550, DOI 10.1111/j.1532-5415.2006.00882.x; van der Wurff FB, 2003, INT J GERIATR PSYCH, V18, P894, DOI 10.1002/gps.944; Wilson K, 2004, INT J GERIATR PSYCH, V19, P754, DOI 10.1002/gps.1156	58	106	115	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2269	2276		10.1056/NEJMcp073754	http://dx.doi.org/10.1056/NEJMcp073754			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	234PQ	18046030				2022-12-28	WOS:000251176400008
J	Oldham, ML; Khare, D; Quiocho, FA; Davidson, AL; Chen, J				Oldham, Michael L.; Khare, Dheeraj; Quiocho, Florante A.; Davidson, Amy L.; Chen, Jue			Crystal structure of a catalytic intermediate of the maltose transporter	NATURE			English	Article							BINDING CASSETTE TRANSPORTER; ATP-BINDING; ABC TRANSPORTER; ESCHERICHIA-COLI; ACTIVE-TRANSPORT; CYTOPLASMIC MEMBRANE; MACROMOLECULAR STRUCTURES; MUTATIONAL ANALYSIS; TRANSITION-STATE; P-GLYCOPROTEIN	The maltose uptake system of Escherichia coli is a well-characterized member of the ATP-binding cassette transporter superfamily. Here we present the 2.8-angstrom crystal structure of the intact maltose transporter in complex with the maltose-binding protein, maltose and ATP. This structure, stabilized by a mutation that prevents ATP hydrolysis, captures the ATP-binding cassette dimer in a closed, ATP-bound conformation. Maltose is occluded within a solvent-filled cavity at the interface of the two transmembrane subunits, about halfway into the lipid bilayer. The binding protein docks onto the entrance of the cavity in an open conformation and serves as a cap to ensure unidirectional translocation of the sugar molecule. These results provide direct evidence for a concerted mechanism of transport in which solute is transferred from the binding protein to the transmembrane subunits when the cassette dimer closes to hydrolyse ATP.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Baylor College of Medicine	Chen, J (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	chenjue@purdue.edu						[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; BOOS W, 1996, ESCHERICHIA COLI SAL, P1175; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Busch W, 2002, CRIT REV BIOCHEM MOL, V37, P287, DOI 10.1080/10409230290771528; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; DASSA E, 1985, EMBO J, V4, P2287, DOI 10.1002/j.1460-2075.1985.tb03928.x; DASSA E, 1993, MOL MICROBIOL, V7, P29, DOI 10.1111/j.1365-2958.1993.tb01094.x; DAVIDSON AL, 1991, J BIOL CHEM, V266, P8946; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; DAVIDSON AL, 1990, J BIOL CHEM, V265, P4254; Davidson AL, 1996, J BIOL CHEM, V271, P4858; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DEAN DA, 1989, J BACTERIOL, V171, P503, DOI 10.1128/jb.171.1.503-510.1989; DeLano W.L, PYMOL MOL GRAPHICS S; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; Ehrle R, 1996, J BACTERIOL, V178, P2255, DOI 10.1128/jb.178.8.2255-2262.1996; EHRMANN M, 1991, J BIOL CHEM, V266, P16530; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERENCI T, 1980, EUR J BIOCHEM, V108, P613; Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499; FROSHAUER S, 1988, J MOL BIOL, V200, P501, DOI 10.1016/0022-2836(88)90539-6; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; MILLER DM, 1983, J BIOL CHEM, V258, P3665; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Nelson BD, 1998, J BACTERIOL, V180, P2507, DOI 10.1128/JB.180.9.2507-2514.1998; Neuhard J, 1987, ESCHERICHIA COLI SAL, P445; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RAIBAUD O, 1979, MOL GEN GENET, V174, P241, DOI 10.1007/BF00267796; ROSSMANN MG, 1990, ACTA CRYSTALLOGR A, V46, P73, DOI 10.1107/S0108767389009815; SAURIN W, 1994, MOL MICROBIOL, V12, P993, DOI 10.1111/j.1365-2958.1994.tb01087.x; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; SHUMAN HA, 1982, J BIOL CHEM, V257, P5455; SILHAVY TJ, 1979, MOL GEN GENET, V174, P249, DOI 10.1007/BF00267797; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Steinke A, 2001, J BACTERIOL, V183, P375, DOI 10.1128/JB.183.1.375-381.2001; Sun H, 2001, J BIOENERG BIOMEMBR, V33, P523, DOI 10.1023/A:1012883306823; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	61	412	417	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					515	U7		10.1038/nature06264	http://dx.doi.org/10.1038/nature06264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033289				2022-12-28	WOS:000251158500039
J	Brown, H				Brown, Hannah			Abortion round the world	BRITISH MEDICAL JOURNAL			English	Editorial Material												hannah@two-cultures.com						FAUNDES A, 2007, WOM DEL C LOND 19 OC; VANLOOK P, 2007, WOM DEL C LOND 19 OC; World Health Organization, 2007, UNS AB GLOB REG EST	3	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 17	2007	335	7628					1018	1019		10.1136/bmj.39393.491968.94	http://dx.doi.org/10.1136/bmj.39393.491968.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	237UV	18007001	Green Published			2022-12-28	WOS:000251402800026
J	Pielke, R				Pielke, Roger, Jr.			Who has the ear of the president?	NATURE			English	Editorial Material									Univ Colorado, Ctr Sci & Technol Policy Res, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Pielke, R (corresponding author), Univ Colorado, Ctr Sci & Technol Policy Res, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	pielke@colorado.edu						Garwin R, 2007, NATURE, V449, P543, DOI 10.1038/449543a; Jasanoff S., 1990, 5 BRANCH SCI ADVISER; Pielke R.A.J., 2007, HONEST BROKER MAKING; Rigden JS, 2007, PHYS TODAY, V60, P47, DOI 10.1063/1.2754603; Sarewitz D, 2004, ENVIRON SCI POLICY, V7, P385, DOI 10.1016/j.envsci.2004.06.001	5	3	3	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					347	348		10.1038/450347a	http://dx.doi.org/10.1038/450347a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231AM	18004359				2022-12-28	WOS:000250918600023
J	Shapiro, D				Shapiro, Daniel			The last gift	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												shapiro@u.arizona.edu		Shapiro, Daniel/0000-0002-7166-7705					0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2116	2116		10.1001/jama.298.18.2116	http://dx.doi.org/10.1001/jama.298.18.2116			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230II	18000188				2022-12-28	WOS:000250869800001
J	de Groot, H; Brand, PLP; Fokkens, WF; Berger, MY				de Groot, Hans; Brand, Pau L. P.; Fokkens, Wytske F.; Berger, Marjolein Y.			Allergic rhinoconjunctivitis in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SUBLINGUAL IMMUNOTHERAPY; FLUTICASONE PROPIONATE; RHINITIS; INTRANASAL; ASTHMA; BUDESONIDE; LIFE		Erasmus MC, Dept Internal Med, Sect Allergol, NL-3000 CA Rotterdam, Netherlands; Isala Klin, Princess Amalia Childrens Clin, NL-8000 GK Zwolle, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1100 DE Amsterdam, Netherlands; Erasmus MC, Dept Gen Practice, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Isala Clinics; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	de Groot, H (corresponding author), Erasmus MC, Dept Internal Med, Sect Allergol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	h.degroot@erasmusmc.nl	Fokkens, Wytske WJ/ABF-2185-2020; Brand, Paul/ABB-3693-2021					Allen DB, 2002, ALLERGY ASTHMA PROC, V23, P407; ALSAYYAD IJ, 2007, COCHRANE DB SYST REV; Arshad SH, 2002, ACTA PAEDIATR, V91, P1334; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bousquet J, 2006, ALLERGY, V61, P1086, DOI 10.1111/j.1398-9995.2006.01144.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Cox LS, 2006, J ALLERGY CLIN IMMUN, V117, P1021, DOI 10.1016/j.jaci.2006.02.040; Custovic A, 2005, ALLERGY, V60, P1112, DOI 10.1111/j.1398-9995.2005.00934.x; de Jong A Baatenburg, 2005, Ned Tijdschr Geneeskd, V149, P1545; Dykewicz MS, 1998, ANN ALLERG ASTHMA IM, V81, P478, DOI 10.1016/S1081-1206(10)63155-9; Fokkens W, 2005, ALLERGY, V60, P583, DOI 10.1111/j.1398-9995.2005.00830.x; Gendo K, 2004, ANN INTERN MED, V140, P278, DOI 10.7326/0003-4819-140-4-200402170-00010; Hakansson K, 2007, PEDIAT ALLERG IMM-UK, V18, P154, DOI 10.1111/j.1399-3038.2006.00503.x; Juniper EF, 1998, J ALLERGY CLIN IMMUN, V101, P163, DOI 10.1016/S0091-6749(98)70380-X; Kocevar VS, 2005, ALLERGY, V60, P338, DOI 10.1111/j.1398-9995.2005.00712.x; Moller C, 2003, CLIN EXP ALLERGY, V33, P816, DOI 10.1046/j.1365-2222.2003.01689.x; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Murphy K, 2006, ANN ALLERG ASTHMA IM, V96, P723, DOI 10.1016/S1081-1206(10)61072-1; Razi C, 2006, ANN ALLERG ASTHMA IM, V97, P767, DOI 10.1016/S1081-1206(10)60968-4; RODER E, 2007, IN PRESS PEDIAT ALLE; Roder E, 2007, J ALLERGY CLIN IMMUN, V119, P892, DOI 10.1016/j.jaci.2006.12.651; Schenkel EJ, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e22; Sheikh A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001563.pub2; Sheth KK, 2004, ALLERGY ASTHMA PROC, V25, P115; Simons FER, 2005, J ALLERGY CLIN IMMUN, V116, P355, DOI 10.1016/j.jaci.2005.04.010; Skoner DP, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.2.e23; Sopo SM, 2004, ARCH DIS CHILD, V89, P620, DOI 10.1136/adc.2003.030411; Terreehorst I, 2003, NEW ENGL J MED, V349, P237, DOI 10.1056/NEJMoa023171; Waddell AN, 2003, J LARYNGOL OTOL, V117, P843, DOI 10.1258/002221503322542818; Weiner JM, 1998, BMJ-BRIT MED J, V317, P1624, DOI 10.1136/bmj.317.7173.1624; Wilson DR, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002893	31	21	22	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2007	335	7627					985	988		10.1136/bmj.39365.617905.BE	http://dx.doi.org/10.1136/bmj.39365.617905.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232AL	17991980	Green Published			2022-12-28	WOS:000250990400045
J	Collinge, J; Clarke, AR				Collinge, John; Clarke, Anthony R.			A general model of prion strains and their pathogenicity	SCIENCE			English	Review							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; FATAL FAMILIAL INSOMNIA; TRANSGENIC MICE; VARIANT CJD; MOLECULAR-BASIS; PROTEIN GENE; WILD-TYPE; IN-VITRO; SCRAPIE	Prions are lethal mammalian pathogens composed of aggregated conformational isomers of a host-encoded glycoprotein and which appear to lack nucleic acids. Their unique biology, allied with the public-health risks posed by prion zoonoses such as bovine spongiform encephalopathy, has focused much attention on the molecular basis of prion propagation and the "species barrier" that controls cross-species transmission. Both are intimately linked to understanding how multiple prion "strains" are encoded by a protein-only agent. The underlying mechanisms are clearly of much wider importance, and analogous protein-based inheritance mechanisms are recognized in yeast and fungi. Recent advances suggest that prions themselves are not directly neurotoxic, but rather their propagation involves production of toxic species, which may be uncoupled from infectivity.	UCL, Inst Neurol, Dept Neurodegenerat Dis, MRC,Prion Unit, London WC1N 3BG, England	University of London; University College London	Collinge, J (corresponding author), UCL, Inst Neurol, Dept Neurodegenerat Dis, MRC,Prion Unit, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk			Medical Research Council [MC_U123192748, MC_U123160656] Funding Source: Medline; MRC [MC_U123160656] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; COLLINGE J, 1995, LANCET, V346, P569, DOI 10.1016/S0140-6736(95)91405-6; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; COLLINGE J, 1995, NATURE, V378, P779, DOI 10.1038/378779a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; FRASER H, 1992, PRION DIS HUMANS ANI, pCH22; GAJDUSEK DC, 1988, J NEUROIMMUNOL, V20, P95; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill AF, 2003, TRENDS MICROBIOL, V11, P578, DOI 10.1016/j.tim.2003.10.007; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Khalili-Shirazi A, 2005, J GEN VIROL, V86, P2635, DOI 10.1099/vir.0.80375-0; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kuczius T, 1999, MOL MED, V5, P406, DOI 10.1007/BF03402129; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lloyd SE, 2004, J GEN VIROL, V85, P2471, DOI 10.1099/vir.0.79889-0; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; MEDORI R, 1992, NEUROLOGY, V42, P669, DOI 10.1212/WNL.42.3.669; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Pattison I. H., 1965, NINDB MONOGRAPH, V2, P249; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Safar J, 2000, ARCH VIROL, P227; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TAYLOR DM, 1994, ARCH VIROL, V139, P313, DOI 10.1007/BF01310794; Taylor DM, 1998, VET MICROBIOL, V64, P33, DOI 10.1016/S0378-1135(98)00257-0; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Wickner RB, 2004, ANNU REV GENET, V38, P681, DOI 10.1146/annurev.genet.38.072902.092200; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; YUII HM, 2006, AM J PATHOL, V168, P151	83	758	769	0	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					930	936		10.1126/science.1138718	http://dx.doi.org/10.1126/science.1138718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991853				2022-12-28	WOS:000250788500031
J	Lisanby, SH				Lisanby, Sarah H.			Electroconvulsive therapy for depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LATE-LIFE DEPRESSION; EXECUTIVE DYSFUNCTION; MAJOR DEPRESSION; COGNITIVE CONSEQUENCES; MOOD DISORDERS; TERM OUTCOMES; ECT; PREVENTION; REMISSION; PHARMACOTHERAPY	An 82-year-old widowed woman with a history of recurrent unipolar major depression is referred to the electroconvulsive therapy (ECT) service of an academic medical center. During her illness, she has had four episodes of major depression consisting of periods of depressed mood, crying spells, loss of interest in usual activities, insomnia, loss of appetite and weight, difficulty with concentration, feelings of helplessness and hopelessness, and thoughts of suicide. During the current episode, which has lasted for 6 months, she has had typical symptoms of melancholic depression, as well as psychotic symptoms (e.g., a somatic delusion that she has terminal cancer), with suicidal ideation and a plan for taking a drug overdose. Previous treatment during this episode has included citalopram (Celexa), duloxetine (Cymbalta), and the combination of olanzepine (Zyprexa) and duloxetine, but the patient did not have a response to any of these agents. She could not tolerate the anticholinergic side effects of tricyclic antidepressants. Her psychiatrist seeks specialty consultation regarding the appropriateness and safety of ECT for this patient.	New York State Psychiat Inst & Hosp, Div Brain Stimulat & Therapeut Modulat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	New York State Psychiatry Institute; Columbia University	Lisanby, SH (corresponding author), New York State Psychiat Inst & Hosp, Div Brain Stimulat & Therapeut Modulat, 1051 Riverside Dr,Unit 21, New York, NY 10032 USA.	depression@columbia.edu	Bajbouj, Malek/B-3579-2012; Lisanby, Sarah Hollingsworth/ABE-9003-2020; Bajbouj, Malek/ABD-6241-2021; Lisanby, Sarah Hollingsworth/T-3918-2019	Lisanby, Sarah Hollingsworth/0000-0003-2037-6470; Bajbouj, Malek/0000-0002-0073-3322; Lisanby, Sarah Hollingsworth/0000-0003-2037-6470				Adler CM, 2006, CNS SPECTRUMS, V11, P312, DOI 10.1017/S1092852900020800; *AG HLTH CAR POL R, 1999, 5 AG HLTH CAR POL RE; Agelink MW, 2001, J NEUROL NEUROSUR PS, V71, P394, DOI 10.1136/jnnp.71.3.394; Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Alexopoulos GS, 2004, NEUROPSYCHOPHARMACOL, V29, P2278, DOI 10.1038/sj.npp.1300557; Alexopoulos GS, 1997, AM J PSYCHIAT, V154, P562; Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; Alexopoulos GS, 2002, AM J GERIAT PSYCHIAT, V10, P98, DOI 10.1176/appi.ajgp.10.1.98; Alexopoulos GS, 2005, BIOL PSYCHIAT, V58, P204, DOI 10.1016/j.biopsych.2005.04.024; Alexopoulos GS, 2000, ARCH GEN PSYCHIAT, V57, P285, DOI 10.1001/archpsyc.57.3.285; Alexopoulos GS, 1996, AM J PSYCHIAT, V153, P877; *AM PSYCH ASS, 2006, EL THER ECT; Avery DH, 2006, BIOL PSYCHIAT, V59, P187, DOI 10.1016/j.biopsych.2005.07.003; Bajbouj MK, 2006, J PSYCHIATR RES, V40, P322, DOI 10.1016/j.jpsychires.2005.07.002; Carney S, 2003, LANCET, V361, P799; Charney DS, 2003, ARCH GEN PSYCHIAT, V60, P664, DOI 10.1001/archpsyc.60.7.664; COFFEY CE, 1991, ARCH GEN PSYCHIAT, V48, P1013; DEVANAND DP, 1994, AM J PSYCHIAT, V151, P957; Dolenc TJ, 2004, PACE, V27, P1257, DOI 10.1111/j.1540-8159.2004.00617.x; Donahue AB, 2000, J ECT, V16, P133, DOI 10.1097/00124509-200006000-00005; Dukakis K, 2006, SHOCK HEALING POWER; Dwork AJ, 2004, AM J PSYCHIAT, V161, P576, DOI 10.1176/appi.ajp.161.3.576; Fergusson GM, 2004, J ECT, V20, P166, DOI 10.1097/00124509-200409000-00008; Folk JW, 2000, J ECT, V16, P157, DOI 10.1097/00124509-200006000-00007; Greenwald BS, 1996, AM J PSYCHIAT, V153, P1212; HAYAKAWA H, 1994, NEUROPSYCHOBIOLOGY, V30, P53, DOI 10.1159/000119413; Husain MM, 2004, J CLIN PSYCHIAT, V65, P485; Kellner CH, 2006, ARCH GEN PSYCHIAT, V63, P1337, DOI 10.1001/archpsyc.63.12.1337; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Krishnan KRR, 1997, AM J PSYCHIAT, V154, P497; Krishnan KRR, 2002, BIOL PSYCHIAT, V52, P185, DOI 10.1016/S0006-3223(02)01349-5; Lisanby SH, 2000, ARCH GEN PSYCHIAT, V57, P581, DOI 10.1001/archpsyc.57.6.581; Lisanby SH, 2003, NEUROPSYCHOPHARMACOL, V28, P1852, DOI 10.1038/sj.npp.1300229; Lisanby SH, 1996, CONVULSIVE THER, V12, P156; Marangell LB, 2002, BIOL PSYCHIAT, V51, P280, DOI 10.1016/S0006-3223(01)01343-9; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; McCall WV, 2000, ARCH GEN PSYCHIAT, V57, P438, DOI 10.1001/archpsyc.57.5.438; Michaud CM, 2001, JAMA-J AM MED ASSOC, V285, P535, DOI 10.1001/jama.285.5.535; Mulsant B H, 1991, J Geriatr Psychiatry Neurol, V4, P3, DOI 10.1177/089198879100400102; *NAT I CLIN EV, 2003, 59 NAT I CLIN EV; NOWAK G, 1991, PHARMACOL BIOCHEM BE, V38, P691, DOI 10.1016/0091-3057(91)90037-3; O'Connor MK, 2001, AM J GERIAT PSYCHIAT, V9, P382, DOI 10.1176/appi.ajgp.9.4.382; PARKER G, 1992, J AFFECT DISORDERS, V24, P17, DOI 10.1016/0165-0327(92)90056-C; Penninx BWJH, 1999, AM J PUBLIC HEALTH, V89, P1346, DOI 10.2105/AJPH.89.9.1346; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Petrides G, 2001, J ECT, V17, P244, DOI 10.1097/00124509-200112000-00003; Prudic J, 2004, BIOL PSYCHIAT, V55, P301, DOI 10.1016/j.biopsych.2003.09.015; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; SACKEIM HA, 1993, NEW ENGL J MED, V328, P839, DOI 10.1056/NEJM199303253281204; Sackeim HA, 2001, JAMA-J AM MED ASSOC, V285, P1299, DOI 10.1001/jama.285.10.1299; SACKEIM HA, 1986, ANN NY ACAD SCI, V462, P326, DOI 10.1111/j.1749-6632.1986.tb51267.x; Sackeim HA, 2000, ARCH GEN PSYCHIAT, V57, P425, DOI 10.1001/archpsyc.57.5.425; Sackeim HA, 2001, J ECT, V17, P77; Sanacora G, 2003, AM J PSYCHIAT, V160, P577, DOI 10.1176/appi.ajp.160.3.577; Smith GS, 2007, NEUROPSYCHOPHARMACOL, V32, P1857, DOI 10.1038/sj.npp.1301333; *TASK FORS EL THER, 2001, PRACT EL THER REC TR; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Taylor WD, 2005, PSYCHIAT RES-NEUROIM, V139, P1, DOI 10.1016/j.pscychresns.2004.08.004	59	288	305	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1939	1945		10.1056/NEJMct075234	http://dx.doi.org/10.1056/NEJMct075234			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989386				2022-12-28	WOS:000250732500008
J	Qaseem, A; Snow, V; Shekelle, P; Sherif, K; Wilt, TJ; Weinberger, S; Owens, DK				Qaseem, Amir; Snow, Vincenza; Shekelle, Paul; Sherif, Katherine; Wilt, Timothy J.; Weinberger, Steven; Owens, Douglas K.		C E A S A C P	Diagnosis and management of stable chronic obstructive pulmonary disease: A clinical practice guideline from the American college of physicians	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; INHALED ANTICHOLINERGIC BRONCHODILATOR; LOW LUNG-FUNCTION; FLUTICASONE PROPIONATE; MEDICAL HISTORY; HEALTH OUTCOMES; OXYGEN-THERAPY; BETA-AGONISTS; AIR-FLOW; COPD	Recommendation 1: In patients with respiratory symptoms, particularly dyspnea, spirometry should be performed to diagnose airflow obstruction. Spirometry should not be used to screen for airflow obstruction in asymptomatic individuals. (Grade: strong recommendation, moderate-quality evidence.) Recommendation 2: Treatment for stable chronic obstructive pulmonary disease (COPD) should be reserved for patients who have respiratory symptoms and FEV1 less than 60% predicted, as documented by spirometry. (Grade: strong recommendation, moderate-quality evidence.) Recommendation 3: Clinicians should prescribe 1 of the following maintenance monotherapies for symptomatic patients with COPD and FEV1 less than 60% predicted: long-acting inhaled beta-agonists, long-acting inhaled anticholinergics, or inhaled corticosteroids. (Grade: strong recommendation, high-quality evidence.) Recommendation 4: Clinicians may consider combination inhaled therapies for symptomatic patients with COPD and FEV1 less than 60% predicted. (Grade: weak recommendation, moderate-quality evidence.) Recommendation 5: Clinicians should prescribe oxygen therapy in patients with COPD and resting hypoxemia (Pao(2) <= 55 mm Hg). (Grade: strong recommendation, moderate-quality evidence.) Recommendation 6: Clinicians should consider prescribing pulmonary rehabilitation in symptomatic individuals with COPD who have an FEV1 less than 50% predicted. (Grade: weak recommendation, moderate-quality evidence.)	Amer Coll Physicians, Philadelphia, PA 19106 USA; Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Santa Monica, CA USA; RAND, Santa Monica, CA USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA; Stanford Univ, Stanford, CA 94305 USA; Minnesota Vet Affairs Med Ctr, Minneapolis, MN USA	American College of Physicians; Drexel University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org						Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; Altose MD, 2000, NEW ENGL J MED, V343, P1902; [Anonymous], 1980, Ann Intern Med, V93, P391; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Auerbach D, 1997, CHEST, V112, P1514; BADGETT RG, 1993, AM J MED, V94, P188, DOI 10.1016/0002-9343(93)90182-O; Barr RG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002876.pub2; Bohadana A B, 1982, Indian J Chest Dis Allied Sci, V24, P133; Brusasco V, 2003, THORAX, V58, P399, DOI 10.1136/thorax.58.5.399; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Chaouat A, 1999, EUR RESPIR J, V14, P1002, DOI 10.1183/09031936.99.14510029; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dusser D, 2006, EUR RESPIR J, V27, P547, DOI 10.1183/09031936.06.00062705; Eaton T, 2002, EUR RESPIR J, V20, P306, DOI 10.1183/09031936.02.00301002; Finnerty JP, 2001, CHEST, V119, P1705, DOI 10.1378/chest.119.6.1705; FLENLEY DC, 1981, LANCET, V1, P681; Gorecka D, 1997, THORAX, V52, P674, DOI 10.1136/thx.52.8.674; Griffiths TL, 2000, LANCET, V355, P362, DOI 10.1016/S0140-6736(99)07042-7; Hanania NA, 2003, CHEST, V124, P834, DOI 10.1378/chest.124.3.834; HEPPER NG, 1969, ARCH ENVIRON HEALTH, V19, P806, DOI 10.1080/00039896.1969.10666934; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOLLEMAN DR, 1993, J GEN INTERN MED, V8, P63, DOI 10.1007/BF02599985; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Mahler DA, 2002, AM J RESP CRIT CARE, V166, P1084, DOI 10.1164/rccm.2112055; Mannino DM, 2000, ARCH INTERN MED, V160, P1683, DOI 10.1001/archinte.160.11.1683; MANNINO DM, 1993, ARCH INTERN MED, V153, P1892, DOI 10.1001/archinte.153.16.1892; MCDONALD CF, 1995, AM J RESP CRIT CARE, V152, P1616, DOI 10.1164/ajrccm.152.5.7582304; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; National Heart Lung and Blood Institute, 2007, NIH PUBL; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; PARDEE NE, 1980, CHEST, V77, P354, DOI 10.1378/chest.77.3.354; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Puhan MA, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-54; Rossi A, 2002, CHEST, V121, P1058, DOI 10.1378/chest.121.4.1058; Salpeter SR, 2006, J GEN INTERN MED, V21, P1011, DOI 10.1111/j.1525-1497.2006.00507.x; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Stockley RA, 2006, THORAX, V61, P122, DOI 10.1136/thx.2004.033266; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; TASHKIN DP, 1986, AM J MED, V81, P81, DOI 10.1016/0002-9343(86)90468-7; Taylor SJC, 2005, BMJ-BRIT MED J, V331, P485, DOI 10.1136/bmj.38512.664167.8F; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702; Wedzicha JA, 1998, EUR RESPIR J, V12, P363, DOI 10.1183/09031936.98.12020363; Wilt TJ, 2007, ANN INTERN MED, V147, P639, DOI 10.7326/0003-4819-147-9-200711060-00009; Wilt TJ, 2005, AHRQ PUBLICATION; Wouters EFM, 2005, THORAX, V60, P480, DOI 10.1136/thx.2004.034280	52	135	139	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2007	147	9					633	638		10.7326/0003-4819-147-9-200711060-00008	http://dx.doi.org/10.7326/0003-4819-147-9-200711060-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227QM	17975186				2022-12-28	WOS:000250672900006
J	Cavalleri, A				Cavalleri, Andrea			All at once	SCIENCE			English	Editorial Material							ELECTRON-DIFFRACTION; TRANSITION; MANGANITE		Univ Oxford, Dept Phys, Oxford OX1 3PU, England	University of Oxford	Cavalleri, A (corresponding author), Univ Oxford, Dept Phys, Oxford OX1 3PU, England.	a.cavalleri1@physics.ox.ac.uk						Baum P, 2007, SCIENCE, V318, P788, DOI 10.1126/science.1147724; Cavalleri A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.067405; CAVALLERI A, 2001, PHYS REV LETT, V87; Dagotto E, 2002, NANOSCALE PHASE SEPA; Gedik N, 2007, SCIENCE, V316, P425, DOI 10.1126/science.1138834; KOSHIHARA S, 1991, PHYS REV B, V44, P431, DOI 10.1103/PhysRevB.44.431; Kubler C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.116401; Lobastov VA, 2005, P NATL ACAD SCI USA, V102, P7069, DOI 10.1073/pnas.0502607102; Miyano K, 1997, PHYS REV LETT, V78, P4257, DOI 10.1103/PhysRevLett.78.4257; Polli D, 2007, NAT MATER, V6, P643, DOI 10.1038/nmat1979; Rischel C, 1997, NATURE, V390, P490, DOI 10.1038/37317; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; WILLIAMSON S, 1984, PHYS REV LETT, V52, P2364, DOI 10.1103/PhysRevLett.52.2364	13	14	14	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					755	756		10.1126/science.1150672	http://dx.doi.org/10.1126/science.1150672			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975054				2022-12-28	WOS:000250583900026
J	Janecka, JE; Miller, W; Pringle, TH; Wiens, F; Zitzmann, A; Helgen, KM; Springer, MS; Murphy, WJ				Janecka, Jan E.; Miller, Webb; Pringle, Thomas H.; Wiens, Frank; Zitzmann, Annette; Helgen, Kristofer M.; Springer, Mark S.; Murphy, William J.			Molecular and genomic data identify the closest living relative of primates	SCIENCE			English	Article							PLACENTAL MAMMALS; TREE; PHYLOGENY; ORIGINS; FOSSIL; RNA	A full understanding of primate morphological and genomic evolution requires the identification of their closest living relative. In order to resolve the ancestral relationships among primates and their closest relatives, we searched multispecies genome alignments for phylogenetically informative rare genomic changes within the superordinal group Euarchonta, which includes the orders Primates, Dermoptera (colugos), and Scandentia (treeshrews). We also constructed phylogenetic trees from 14 kilobases of nuclear genes for representatives from most major primate lineages, both extant colugos, and multiple treeshrews, including the pentail treeshrew, Ptilocercus lowii, the only living member of the family Ptilocercidae. A relaxed molecular clock analysis including Ptilocercus suggests that treeshrews arose approximately 63 million years ago. Our data show that colugos are the closest living relatives of primates and indicate that their divergence occurred in the Cretaceous.	Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Sperling Fdn, Eugene, OR 97405 USA; Univ Bayreuth, Dept Anim Physiol, D-95440 Bayreuth, Germany; Univ Frankfurt, Inst Zool, D-60054 Frankfurt, Germany; Smithsonian Inst, Natl Museum Amer Hist, Washington, DC 20013 USA; Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	Texas A&M University System; Texas A&M University College Station; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Bayreuth; Goethe University Frankfurt; Smithsonian Institution; Smithsonian National Museum of Natural History; University of California System; University of California Riverside	Murphy, WJ (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, Vet Med Adm Bldg,Room 107, College Stn, TX 77843 USA.	wmurphy@cvm.tamu.edu	Helgen, Kristofer M./AAB-8348-2019	Helgen, Kristofer M./0000-0002-8776-4040	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002238] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG02238] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ADKINS RM, 1991, P NATL ACAD SCI USA, V88, P10317, DOI 10.1073/pnas.88.22.10317; BEARD KC, 1993, MAMMAL PHYLOGENY : PLACENTALS, P129; Bloch JI, 2007, P NATL ACAD SCI USA, V104, P1159, DOI 10.1073/pnas.0610579104; Emmons L.H., 2000, TUPAI FIELD STUDY BO; Goodman M, 2005, TRENDS GENET, V21, P511, DOI 10.1016/j.tig.2005.06.012; Helgen K.M., 2005, MAMMAL SPECIES WORLD, P104; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Liu FGR, 2001, SCIENCE, V291, P1786, DOI 10.1126/science.1056346; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Martin R.D., 1990, PRIMATE ORIGINS EVOL; McKenna MC, 1997, CLASSIFICATION MAMMA; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Pennisi E, 2007, SCIENCE, V316, P218, DOI 10.1126/science.316.5822.218; Sargis EJ, 2004, EVOL ANTHROPOL, V13, P56, DOI 10.1002/evan.10131; Sargis EJ, 2002, SCIENCE, V298, P1564, DOI 10.1126/science.1079034; Schmitz J, 2002, MOL BIOL EVOL, V19, P2308, DOI 10.1093/oxfordjournals.molbev.a004054; Shoshani J, 1998, MOL PHYLOGENET EVOL, V9, P572, DOI 10.1006/mpev.1998.0520; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; Tavare S, 2002, NATURE, V416, P726, DOI 10.1038/416726a; Waddell P J, 2001, Genome Inform, V12, P141; Waddell PJ, 2003, MOL PHYLOGENET EVOL, V28, P197, DOI 10.1016/S1055-7903(03)00115-5	28	215	235	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					792	794		10.1126/science.1147555	http://dx.doi.org/10.1126/science.1147555			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975064				2022-12-28	WOS:000250583900039
J	Singh, AP; Buscaglia, CA; Wang, Q; Levay, A; Nussenzweig, DR; Walker, JR; Winzeler, EA; Fujii, H; Fontoura, BMA; Nussenzweig, V				Singh, Agam Prasad; Buscaglia, Carlos A.; Wang, Qian; Levay, Agata; Nussenzweig, Daniel R.; Walker, John R.; Winzeler, Elizabeth A.; Fujii, Hodaka; Fontoura, Beatriz M. A.; Nussenzweig, Victor			Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite	CELL			English	Article							NF-KAPPA-B; NUCLEAR-LOCALIZATION SIGNALS; MALARIA PARASITES; TOXOPLASMA-GONDII; HOST ERYTHROCYTE; MAMMALIAN-CELLS; GENE-EXPRESSION; SPOROZOITES; VIRULENCE; INNATE	The liver stages of malaria are clinically silent but have a central role in the Plasmodium life cycle. Liver stages of the parasite containing thousands of merozoites grow inside hepatocytes for several days without triggering an inflammatory response. We show here that Plasmodium uses a PEXEL/VTS motif to introduce the circumsporozoite (CS) protein into the hepatocyte cytoplasm and a nuclear localization signal (NLS) to enter its nucleus. CS outcompetes NFkB nuclear import, thus downregulating the expression of many genes controlled by NFkB, including those involved in inflammation. CS also influences the expression of over one thousand host genes involved in diverse metabolic processes to create a favorable niche for the parasite growth. The presence of CS in the hepatocyte enhances parasite growth of the liver stages in vitro and in vivo. These findings have far reaching implications for drug and vaccine development against the liver stages of the malaria parasite.	NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Inst Canc, New York, NY 10016 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Novartis Res Fdn, Genom Inst, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, ICND202, La Jolla, CA 92037 USA	New York University; New York University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Novartis; Scripps Research Institute	Singh, AP (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	singha05@med.nyu.edu	singh, Agam prasad/F-2532-2012; Fujii, Hodaka/N-9792-2019; Singh, Agam/AAH-2031-2020; Fujii, Hodaka/A-2420-2008; Levay, Agata/R-5392-2019; Winzeler, Elizabeth/AAP-6752-2020	singh, Agam prasad/0000-0003-4262-2556; Fujii, Hodaka/0000-0003-1296-4256; Singh, Agam/0000-0003-4262-2556; Fujii, Hodaka/0000-0003-1296-4256; Winzeler, Elizabeth/0000-0002-4049-2113; Levay, Agata/0000-0001-9404-4503; Buscaglia, Carlos/0000-0001-6466-4138	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067159] Funding Source: NIH RePORTER; NIAID NIH HHS [AI059315] Funding Source: Medline; NIGMS NIH HHS [GM067159] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM SA, 1992, METHOD ENZYMOL, V219, P97; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Chabicovsky M, 2003, ENDOCRINOLOGY, V144, P3497, DOI 10.1210/en.2003-0388; Chung KM, 2000, J VIROL, V74, P5233, DOI 10.1128/JVI.74.11.5233-5241.2000; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Denkers EY, 2003, FEMS IMMUNOL MED MIC, V39, P193, DOI 10.1016/S0928-8244(03)00279-7; Desai SA, 1997, P NATL ACAD SCI USA, V94, P2045, DOI 10.1073/pnas.94.5.2045; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Frevert U, 1998, EMBO J, V17, P3816, DOI 10.1093/emboj/17.14.3816; GILBERT LA, 2006, CELL, V6, P73; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; HOLLINGDALE MR, 1983, AM J TROP MED HYG, V32, P24, DOI 10.4269/ajtmh.1983.32.24; Hoshino A, 2004, MOL CELL, V15, P153, DOI 10.1016/j.molcel.2004.06.017; Hoshino A, 2006, BIOCHEM BIOPH RES CO, V346, P1062, DOI 10.1016/j.bbrc.2006.06.026; Hugel FU, 1996, MOL BIOCHEM PARASIT, V81, P151, DOI 10.1016/0166-6851(96)02701-6; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; Myung JM, 2004, MOL BIOCHEM PARASIT, V133, P53, DOI 10.1016/j.molbiopara.2003.09.002; PIED S, 1992, J IMMUNOL, V148, P197; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; RENIA L, 1988, J IMMUNOL METHODS, V112, P201, DOI 10.1016/0022-1759(88)90358-4; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Shapira S, 2004, INT J PARASITOL, V34, P393, DOI 10.1016/j.ijpara.2003.12.005; SHORTT HE, 1954, T ROY SOC TROP MED H, V48, P122, DOI 10.1016/0035-9203(54)90004-8; STEWART MJ, 1991, J PROTOZOOL, V38, P411, DOI 10.1111/j.1550-7408.1991.tb01379.x; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Talcott B, 2000, J BIOL CHEM, V275, P10099, DOI 10.1074/jbc.275.14.10099; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; Wang Q, 2005, PLOS PATHOG, V1, P72, DOI 10.1371/journal.ppat.0010009; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209	49	159	168	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					492	504		10.1016/j.cell.2007.09.013	http://dx.doi.org/10.1016/j.cell.2007.09.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981117	Bronze			2022-12-28	WOS:000250618500017
J	Tang, JW; Chan, PKS				Tang, Julian W.; Chan, Paul K. S.			Herpes labialis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Tang, JW (corresponding author), Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China.	julian.tang@cuhk.edu.hk	, Julian W Tang/H-2348-2014; Chan, Paul KS/J-9360-2013	Chan, Paul KS/0000-0002-6360-4608; Tang, Julian/0000-0002-4963-1028					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2007	357	18					1855	1855		10.1056/NEJMicm063204	http://dx.doi.org/10.1056/NEJMicm063204			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	225OJ	17978294				2022-12-28	WOS:000250526900009
J	Imaizumi, T; Kay, SA; Schroeder, JI				Imaizumi, Takato; Kay, Steve A.; Schroeder, Julian I.			Circadian rhythms - Daily watch on metabolism	SCIENCE			English	Editorial Material							CYCLIC ADP-RIBOSE; KEY PATHWAYS; ARABIDOPSIS; CLOCK; OSCILLATIONS; CALCIUM; TRANSCRIPTION; PLANTS		Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Imaizumi, T (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	timaizumi@ucsd.edu	Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; Schroeder, Julian/0000-0002-3283-5972	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079712] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM079712, R01 GM079712-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Hanano S, 2006, GENES CELLS, V11, P1381, DOI 10.1111/j.1365-2443.2006.01026.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Imaizumi T., 2007, SCI STKE, ppe32; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Love J, 2004, PLANT CELL, V16, P956, DOI 10.1105/tpc.020214; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Sanchez JP, 2004, PLANT J, V38, P381, DOI 10.1111/j.1365-313X.2004.02055.x; Tang RH, 2007, SCIENCE, V315, P1423, DOI 10.1126/science.1134457; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	15	15	18	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1730	1731		10.1126/science.1151360	http://dx.doi.org/10.1126/science.1151360			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18006706	Green Accepted			2022-12-28	WOS:000251616800023
J	White, E				White, Eileen			Entosis: It's a cell-eat-cell world	CELL			English	Editorial Material							APOPTOSIS	In this issue, Overholtzer et al. (2007) describe a new nonapoptotic cell death pathway termed "entosis" in mammary epithelial cells that have detached from the extracellular matrix (ECM). Given that surviving detachment from the ECM is an event associated with the progression of epithelial cancers, entosis-along with apoptosis-may contribute to tumor suppression by promoting the elimination of cancer cells.	[White, Eileen] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [White, Eileen] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	White, E (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, 679 Hoes Lane, Piscataway, NJ 08854 USA.	ewhite@cabm.rutgers.edu	White, Eileen/ABD-6745-2021	White, Eileen/0000-0003-2961-3065	NATIONAL CANCER INSTITUTE [R37CA053370] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA053370-17, R37 CA053370-16, R37 CA053370] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abodief WT, 2006, CYTOPATHOLOGY, V17, P304, DOI 10.1111/j.1365-2303.2006.00326.x; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; OVERHOLTZER M, 2007, CELL	8	32	34	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 30	2007	131	5					840	842		10.1016/j.cell.2007.11.015	http://dx.doi.org/10.1016/j.cell.2007.11.015			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045529	Green Accepted, Bronze			2022-12-28	WOS:000251800900006
J	Lowe, GDO				Lowe, Gordon D. O.			Is venous thrombosis a risk factor for arterial thrombosis?	LANCET			English	Editorial Material							ACUTE INFECTION; THROMBOEMBOLISM; METAANALYSIS; DISEASE; EVENTS		Univ Glasgow, Royal Infirm, Glasgow G31 2ER, Lanark, Scotland	Royal Infirmary of Edinburgh; University of Glasgow	Lowe, GDO (corresponding author), Univ Glasgow, Royal Infirm, Glasgow G31 2ER, Lanark, Scotland.	g.d.lowe@clinmed.gla.ac.uk						AGENO W, 2007, J THROMB HAEMOST S2, V5; Agnelli G, 2006, J THROMB HAEMOST, V4, P1886, DOI 10.1111/j.1538-7836.2006.02138.x; Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; *BRIT CARD SOC BRI, 2005, HEART S5, V92, pV1; Kim RJ, 2003, AM HEART J, V146, P948, DOI 10.1016/S0002-8703(03)00519-2; Lowe GDO, 2006, J THROMB HAEMOST, V4, P1882, DOI 10.1111/j.1538-7836.2006.02130.x; Lowe Gordon D O, 2005, Semin Vasc Med, V5, P387, DOI 10.1055/s-2005-922485; Meade TW, 1998, LANCET, V351, P233; POMP ER, 2007, J THROMB HAEMOST S2, V5; Scottish Intercollegiate Guidelines Network, 2007, RISK EST PREV CARD D; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Smeeth L, 2006, LANCET, V367, P1075, DOI 10.1016/S0140-6736(06)68474-2; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Ye Z, 2006, LANCET, V367, P651, DOI 10.1016/S0140-6736(06)68263-9	15	15	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2007	370	9601					1742	1744		10.1016/S0140-6736(07)61731-0	http://dx.doi.org/10.1016/S0140-6736(07)61731-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234DI	18037072				2022-12-28	WOS:000251140500006
J	Rowe, CM; Loope, DB; Oglesby, RJ; Van der Voo, R; Broadwater, CE				Rowe, Clinton M.; Loope, David B.; Oglesby, Robert J.; Van der Voo, Rob; Broadwater, Charles E.			Inconsistencies between pangean reconstructions and basic climate controls	SCIENCE			English	Article							WESTERN UNITED-STATES; APPARENT POLAR WANDER; CCSM3; DUNES	The supercontinent Pangea dominated our planet from the Permian into the Jurassic. Paleomagnetic reconstructions have been used to estimate the latitudinal position of Pangea during this 100-million-year period. Atmospheric circulation, recorded by eolian sandstones in the southwestern United States, shows a broad sweep of northeasterly winds over their northernmost extent, curving to become northwesterly in the south: This evidence is consistent with paleomagnetic reconstructions of the region straddling the equator in the Early Permian but is at odds with its northward movement to about 20 degrees N by the Early Jurassic. At least one of the following scenarios must be true: The latitude based on paleomagnetism is incorrect; the interpretation of how winds shaped the dunes is mistaken; the basic climate controls in the Jurassic were different from those of today; or the paleogeographic reconstructions available are insufficient to adequately reproduce the wind fields responsible for dune formation.	Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA; Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA	University of Nebraska System; University of Nebraska Lincoln; University of Michigan System; University of Michigan	Rowe, CM (corresponding author), Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA.	crowe1@unl.edu						[Anonymous], 1993, PALEOMAGNETISM ATLAN, DOI 10.1017/CBO9780511524936; BAZARD DR, 1991, J GEOPHYS RES-SOLID, V96, P9847, DOI 10.1029/91JB00336; BESSE J, 2002, J GEOPHYS RES, V107; BLAKEY RC, 1988, SEDIMENT GEOL, V56, P3, DOI 10.1016/0037-0738(88)90050-4; Blumberg DG, 1996, J CLIMATE, V9, P3248, DOI 10.1175/1520-0442(1996)009<3248:ACOGCM>2.0.CO;2; CHANDLER MA, 1992, GEOL SOC AM BULL, V104, P543, DOI 10.1130/0016-7606(1992)104<0543:PCDTEJ>2.3.CO;2; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Fluteau F, 2001, PALAEOGEOGR PALAEOCL, V167, P39, DOI 10.1016/S0031-0182(00)00230-3; Heckel P. H., 1979, DEVONIAN SYSTEM, V23, P99; Irving E, 2005, P NATL ACAD SCI USA, V102, P1821, DOI 10.1073/pnas.0408162101; Kent DV, 2005, SCIENCE, V307, P240, DOI 10.1126/science.1105826; KOCUREK G, 1991, ANNU REV EARTH PL SC, V19, P43, DOI 10.1146/annurev.earth.19.1.43; Loope DB, 2004, SEDIMENTOLOGY, V51, P315, DOI 10.1046/j.1365-3091.2003.00623.x; Loope DB, 2003, J GEOL, V111, P223, DOI 10.1086/345843; Loope DB, 2001, NATURE, V412, P64, DOI 10.1038/35083554; MAY SR, 1986, J GEOPHYS RES-SOLID, V91, P1519, DOI 10.1029/JB091iB11p11519; OPDYKE ND, 1960, GEOL SOC AM BULL, V71, P959, DOI 10.1130/0016-7606(1960)71[959:WDITWU]2.0.CO;2; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; PETERSON F, 1988, SEDIMENT GEOL, V56, P207, DOI 10.1016/0037-0738(88)90055-3; SCOTESE CR, PALEOMAP; Sridhar V, 2006, SCIENCE, V313, P345, DOI 10.1126/science.1128941; Steiner MB, 2003, TECTONICS, V22, DOI 10.1029/2001TC001284; STEINER MB, 1983, MESOZOIC PALEOGEOGRA, P1; Tauxe L, 2005, EARTH PLANET SC LETT, V233, P247, DOI 10.1016/j.epsl.2005.01.027	24	20	20	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2007	318	5854					1284	1286		10.1126/science.1146639	http://dx.doi.org/10.1126/science.1146639			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033879	Green Published			2022-12-28	WOS:000251086600038
J	Debaille, V; Brandon, AD; Yin, QZ; Jacobsen, B				Debaille, V.; Brandon, A. D.; Yin, Q. Z.; Jacobsen, B.			Coupled Nd-142-Nd-143 evidence for a protracted magma ocean in Mars	NATURE			English	Article							ND ISOTOPIC SYSTEMATICS; EARLY DIFFERENTIATION; MARTIAN METEORITES; SM-ND; CORE FORMATION; RB-SR; MANTLE; CONSTRAINTS; PETROGENESIS; SHERGOTTITES	Resolving early silicate differentiation timescales is crucial for understanding the chemical evolution and thermal histories of terrestrial planets(1). Planetary-scale magma oceans are thought to have formed during early stages of differentiation, but the longevity of such magma oceans is poorly constrained. In Mars, the absence of vigorous convection and plate tectonics has limited the scale of compositional mixing within its interior(2), thus preserving the early stages of planetary differentiation. The SNC ( Shergotty-Nakhla-Chassigny) meteorites from Mars retain 'memory' of these events(3-5). Here we apply the short-lived Sm-146-Nd-142 and the long-lived Sm-147-Nd-143 chronometers to a suite of shergottites to unravel the history of early silicate differentiation in Mars. Our data are best explained by progressive crystallization of a magma ocean with a duration of similar to 100 million years after core formation. This prolonged solidification requires the existence of a primitive thick atmosphere on Mars that reduces the cooling rate of the interior(6) .	Lunar & Planetary Inst, Houston, TX 77058 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of California System; University of California Davis	Debaille, V (corresponding author), Lunar & Planetary Inst, 3600 Bay Area Blvd, Houston, TX 77058 USA.	debaille@lpi.usra.edu	Yin, Qing-Zhu/B-8198-2009	Yin, Qing-Zhu/0000-0002-4445-5096; Debaille, Vinciane/0000-0002-6544-4564				Abe Y, 1997, PHYS EARTH PLANET IN, V100, P27, DOI 10.1016/S0031-9201(96)03229-3; Andreasen R, 2006, SCIENCE, V314, P806, DOI 10.1126/science.1131708; Blichert-Toft J, 1999, EARTH PLANET SC LETT, V173, P25, DOI 10.1016/S0012-821X(99)00222-8; Borg LE, 1997, GEOCHIM COSMOCHIM AC, V61, P4915, DOI 10.1016/S0016-7037(97)00276-7; Borg LE, 2003, METEORIT PLANET SCI, V38, P1713, DOI 10.1111/j.1945-5100.2003.tb00011.x; Borg LE, 2003, GEOCHIM COSMOCHIM AC, V67, P3519, DOI 10.1016/S0016-7037(03)00094-2; Borg LE, 2002, GEOCHIM COSMOCHIM AC, V66, P2037, DOI 10.1016/S0016-7037(02)00835-9; Bouvier A, 2005, EARTH PLANET SC LETT, V240, P221, DOI 10.1016/j.epsl.2005.09.007; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2006, EARTH PLANET SC LETT, V250, P254, DOI 10.1016/j.epsl.2006.07.046; BRANDON A, 2004, LUNAR PLANET SCI, V35; Brandon AD, 2000, GEOCHIM COSMOCHIM AC, V64, P4083, DOI 10.1016/S0016-7037(00)00482-8; Caro G, 2006, GEOCHIM COSMOCHIM AC, V70, P164, DOI 10.1016/j.gca.2005.08.015; Elkins-Tanton LT, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002480; Foley CN, 2005, GEOCHIM COSMOCHIM AC, V69, P4557, DOI 10.1016/j.gca.2005.05.009; HARPER CL, 1995, SCIENCE, V267, P213, DOI 10.1126/science.7809625; Jagoutz E, 2003, GEOCHIM COSMOCHIM AC, V67, pA184; JAGOUTZ E, 1986, GEOCHIM COSMOCHIM AC, V50, P939, DOI 10.1016/0016-7037(86)90375-3; JAGOUTZ E, 2000, METEORIT PLANET SC S, V35; JONES JH, 1989, P LUNAR PLANET SCI C, V19, P465; Kiefer WS, 2003, METEORIT PLANET SCI, V38, P1815, DOI 10.1111/j.1945-5100.2003.tb00017.x; Kleine T, 2004, GEOCHIM COSMOCHIM AC, V68, P2935, DOI 10.1016/j.gca.2004.01.009; Lee DC, 1997, NATURE, V388, P854, DOI 10.1038/42206; LONGHI J, 1991, P LUNAR PLANET SCI, V21, P695; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; Rehkamper M, 1996, CHEM GEOL, V129, P201, DOI 10.1016/0009-2541(95)00143-3; SHIH CY, 1982, GEOCHIM COSMOCHIM AC, V46, P2323, DOI 10.1016/0016-7037(82)90205-8; SHIH CY, 2007, LUNAR PLANET SCI, V38; SHIH CY, 2003, LUNAR PLANET SCI, V34; Tonks W.B., 1990, ORIGIN EARTH, P151; WARREN PH, 1979, REV GEOPHYS, V17, P73, DOI 10.1029/RG017i001p00073; ZHANG MHG, 1993, J GEOPHYS RES-PLANET, V98, P10915, DOI 10.1029/93JE00231	32	159	161	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					525	528		10.1038/nature06317	http://dx.doi.org/10.1038/nature06317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033291				2022-12-28	WOS:000251158500041
J	Till, S; Ladurner, AG				Till, Susanne; Ladurner, Andreas G.			RNA Pol IV plays catch with argonaute 4	CELL			English	Editorial Material							PROCESSING CENTER; HETEROCHROMATIN; BODIES; DNA	Small-interfering RNAs regulate gene expression by affecting chromatin structure, transcription, translation, and RNA stability. In a recent report in Genes & Development, El-Shami et al. (2007) show that in plants, Argonaute 4 - which is involved in RNA-directed DNA methylation-directly associates with RNA polymerase IVb through a repeat motif, establishing an intimate molecular link between RNAi and transcription.	European Mol Biol Lab, Struct & Computat Biol Unit, Gene Express Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, EMBL Int PhD Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Ladurner, AG (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Gene Express Unit, D-69117 Heidelberg, Germany.	ladurner@embl.de		Ladurner, Andreas/0000-0003-3835-232X				Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Partridge JF, 2007, MOL CELL, V26, P593, DOI 10.1016/j.molcel.2007.05.004; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302	10	15	20	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					643	645		10.1016/j.cell.2007.10.044	http://dx.doi.org/10.1016/j.cell.2007.10.044			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022355	Bronze			2022-12-28	WOS:000250966300008
J	Diggle, SP; Griffin, AS; Campbell, GS; West, SA				Diggle, Stephen P.; Griffin, Ashleigh S.; Campbell, Genevieve S.; West, Stuart A.			Cooperation and conflict in quorum-sensing bacterial populations	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA; COMPETITION; EVOLUTION; LACTONE; SIGNAL; IDENTIFICATION; COMMUNICATION; EXPRESSION; VIRULENCE; ALTRUISM	It has been suggested that bacterial cells communicate by releasing and sensing small diffusible signal molecules in a process commonly known as quorum sensing (QS)(1-4). It is generally assumed that QS is used to coordinate cooperative behaviours at the population level(3,5). However, evolutionary theory predicts that individuals who communicate and cooperate can be exploited(6-10). Here we examine the social evolution of QS experimentally in the opportunistic pathogen Pseudomonas aeruginosa, and show that although QS can provide a benefit at the group level, exploitative individuals can avoid the cost of producing the QS signal or of performing the cooperative behaviour that is coordinated by QS, and can therefore spread. We also show that a solution to the problem of exploitation is kin selection, if interacting bacterial cells tend to be close relatives. These results show that the problem of exploitation, which has been the focus of considerable attention in animal communication, also arises in bacteria.	Univ Nottingham, Ctr Biomol Sci, Inst Infect Immun & Inflammat, Nottingham NG7 2RD, England; Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Nottingham; University of Edinburgh	Diggle, SP (corresponding author), Univ Nottingham, Ctr Biomol Sci, Inst Infect Immun & Inflammat, Univ Pk, Nottingham NG7 2RD, England.	steve.diggle@nottingham.ac.uk; stu.west@ed.ac.uk	West, Stuart A/M-3608-2014; Griffin, Ashleigh/C-6244-2014	West, Stuart A/0000-0003-2152-3153; Griffin, Ashleigh/0000-0001-7674-9825				Brown SP, 2001, P ROY SOC B-BIOL SCI, V268, P961, DOI 10.1098/rspb.2001.1609; CHHABRA SR, 1993, J ANTIBIOT, V46, P441, DOI 10.7164/antibiotics.46.441; Chhabra SR, 2003, J MED CHEM, V46, P97, DOI 10.1021/jm020909n; Denervaud V, 2004, J CLIN MICROBIOL, V42, P554, DOI 10.1128/JCM.42.2.554-562.2004; Diggle SP, 2002, J BACTERIOL, V184, P2576, DOI 10.1128/JB.184.10.2576-2586.2002; Diggle SP, 2007, PHILOS T R SOC B, V362, P1241, DOI 10.1098/rstb.2007.2049; Fletcher MP, 2007, ENVIRON MICROBIOL, V9, P2683, DOI 10.1111/j.1462-2920.2007.01380.x; Frank, 1998, FDN SOCIAL EVOLUTION; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; Heurlier K, 2005, J BACTERIOL, V187, P4875, DOI 10.1128/JB.187.14.4875-4883.2005; Jones AM, 2003, THORAX, V58, P525, DOI 10.1136/thorax.58.6.525; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; MacLean RC, 2006, NATURE, V441, P498, DOI 10.1038/nature04624; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Ross-Gillespie A, 2007, AM NAT, V170, P331, DOI 10.1086/519860; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Schaber JA, 2004, J MED MICROBIOL, V53, P841, DOI 10.1099/jmm.0.45617-0; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Winzer K, 2000, J BACTERIOL, V182, P6401, DOI 10.1128/JB.182.22.6401-6411.2000	33	544	558	4	244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					411	U7		10.1038/nature06279	http://dx.doi.org/10.1038/nature06279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004383				2022-12-28	WOS:000250918600053
J	Bai, XC; Ma, DZ; Liu, AL; Shen, XY; Wang, QJM; Liu, YJ; Jiang, Y				Bai, Xiaochun; Ma, Dongzhu; Liu, Anling; Shen, Xiaoyun; Wang, Qiming J.; Liu, Yongjian; Jiang, Yu			Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38	SCIENCE			English	Article							SMALL GTPASE RHEB; TSC2 GAP ACTIVITY; DIRECT TARGET; TOR; BINDING; GROWTH; PROTEINS; RAPTOR; BCL-2	The mammalian target of rapamycin, mTOR, is a central regulator of cell growth. Its activity is regulated by Rheb, a Ras-like small guanosine triphosphatase ( GTPase), in response to growth factor stimulation and nutrient availability. We show that Rheb regulates mTOR through FKBP38, a member of the FK506-binding protein ( FKBP) family that is structurally related to FKBP12. FKBP38 binds to mTOR and inhibits its activity in a manner similar to that of the FKBP12-rapamycin complex. Rheb interacts directly with FKBP38 and prevents its association with mTOR in a guanosine 5'-triphosphate (GTP)-dependent manner. Our findings suggest that FKBP38 is an endogenous inhibitor of mTOR, whose inhibitory activity is antagonized by Rheb in response to growth factor stimulation and nutrient availability.	Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; So Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510515, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Southern Medical University - China	Jiang, Y (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol, E1357 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15213 USA.	jiang@server.pharm.pitt.edu	Liu, Yongjian/J-7852-2018; Wang, Qiming Jane/B-6064-2012	Wang, Qiming Jane/0000-0002-9502-4851; Bai, Xiaochun/0000-0001-9631-4781	NATIONAL CANCER INSTITUTE [R01CA129821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068832] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA129821] Funding Source: Medline; NIGMS NIH HHS [GM068832, R01 GM068832] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2006, J BIOL CHEM, V281, P14961, DOI 10.1074/jbc.M600452200; Fischer G, 1998, FEBS LETT, V426, P17, DOI 10.1016/S0014-5793(98)00242-7; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	20	295	301	2	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					977	980		10.1126/science.1147379	http://dx.doi.org/10.1126/science.1147379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991864				2022-12-28	WOS:000250788500044
J	Pfennig, KS				Pfennig, Karin S.			Facultative mate choice drives adaptive hybridization	SCIENCE			English	Article							SPADEFOOT TOADS; TREE FROGS; SPECIATION; REINFORCEMENT; WOODHOUSII; SELECTION	Mating with another species ( hybridization) is often maladaptive. Consequently, females typically avoid heterospecifics as mates. Contrary to these expectations, female spadefoot toads were more likely to choose heterospecific males when exposed to environmental conditions that favor hybridization. Indeed, those females with phenotypic characteristics for which hybridization is most favorable were most likely to switch from choosing conspecifics to heterospecifics. Moreover, environmentally dependent mate choice has evolved only in populations and species that risk engaging in, and can potentially benefit from, hybridization. Thus, when the benefits of mate choice vary, females may radically alter their mate selection in response to their own phenotype and their environment, even to the point of choosing males of other species.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Pfennig, KS (corresponding author), Univ N Carolina, Dept Biol, Campus Box 3280,Coker Hall, Chapel Hill, NC 27599 USA.	kpfennig@email.unc.edu						Andersson Malte, 1994; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Britch SC, 2001, MOL ECOL, V10, P627, DOI 10.1046/j.1365-294x.2001.01215.x; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Coyne J.A., 2004, SPECIATION; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; FORESTER D C, 1975, Herpetologica, V31, P282; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; JONES JM, 1973, EVOLUTION, V27, P435, DOI 10.1111/j.1558-5646.1973.tb00690.x; LAMB T, 1986, P NATL ACAD SCI USA, V83, P2526, DOI 10.1073/pnas.83.8.2526; Lesna I, 1999, NATURE, V401, P581, DOI 10.1038/44125; LEVINS RICHARD, 1968; Malmos KB, 2001, EVOLUTION, V55, P626, DOI 10.1554/0014-3820(2001)055[0626:CBADHB]2.0.CO;2; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; NOOR MA, 1995, NATURE, V375, P674, DOI 10.1038/375674a0; PFENNIG DW, 1992, EVOLUTION, V46, P1408, DOI 10.1111/j.1558-5646.1992.tb01133.x; Pfennig KS, 2003, EVOLUTION, V57, P2842; PFENNIG KS, 2002, EVOL INT J ORG EVOL, V56, P1810; Saetre GP, 1997, NATURE, V387, P589; SATTLER PW, 1985, COPEIA, P324; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; SIMOVICH M A, 1991, Proceedings of the San Diego Society of Natural History, P1; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Welch AM, 2003, EVOLUTION, V57, P883; Widemo F, 1999, TRENDS ECOL EVOL, V14, P26, DOI 10.1016/S0169-5347(98)01531-6; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144	27	170	175	1	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					965	967		10.1126/science.1146035	http://dx.doi.org/10.1126/science.1146035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991861				2022-12-28	WOS:000250788500040
J	Prasad, GVR; Verma, O; Sahni, A; Parmar, V; Khosla, A				Prasad, G. V. R.; Verma, O.; Sahni, A.; Parmar, V.; Khosla, A.			A cretaceous hoofed mammal from India	SCIENCE			English	Article							ORIGIN		Univ Jammu, Dept Geol, Jammu 180006, India; Panjab Univ, Ctr Adv Study Geol, Chandigarh 160014, India	University of Jammu; Panjab University	Prasad, GVR (corresponding author), Univ Jammu, Dept Geol, Jammu 180006, India.	guntupalli.vrprasad@gmail.com	PARMAR, VARUN/T-6965-2017	PARMAR, VARUN/0000-0001-6896-5341; Prasad, Guntupalli/0000-0002-0620-4712; Khosla, Ashu/0000-0002-6237-7765; Verma, Omkar/0000-0003-4655-9216				ARCHIBALD J D, 1982, University of California Publications in Geological Sciences, V122, P1; Archibald JD, 1996, SCIENCE, V272, P1150, DOI 10.1126/science.272.5265.1150; de Muizon Christian, 2000, Geodiversitas, V22, P47; Eberle Jaelyn J., 1998, Rocky Mountain Geology, V33, P49; van Valen L., 1978, Evolutionary Theory, V4, P45; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854	6	45	47	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					937	937		10.1126/science.1149267	http://dx.doi.org/10.1126/science.1149267			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991854				2022-12-28	WOS:000250788500032
J	Okonjo-Iweala, N; Osafo-Kwaako, P				Okonjo-Iweala, Ngozi; Osafo-Kwaako, Philip			Improving health statistics in Africa	LANCET			English	Editorial Material									Brookings Inst, Washington, DC 20036 USA	Brookings Institution	Okonjo-Iweala, N (corresponding author), Brookings Inst, Washington, DC 20036 USA.	nokonjoiweala@brookings.edu						ABOUZAHR C, 2007, LANCET          1029; [Anonymous], 2007, WORLD DEV IND DAT; HILL K, 2007, LANCET          1029; MAHAPATRA P, 2007, LANCET          1029; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; World Bank, 2002, BUILD STAT CAP MON D BUILD STAT CAP MON D	6	12	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2007	370	9598					1527	1528		10.1016/S0140-6736(07)61644-4	http://dx.doi.org/10.1016/S0140-6736(07)61644-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227AE	17980722				2022-12-28	WOS:000250628800007
J	Bouwer, LM; Crompton, RP; Faust, E; Hoppe, P; Pielke, RA				Bouwer, Laurens M.; Crompton, Ryan P.; Faust, Eberhard; Hoeppe, Peter; Pielke, Roger A., Jr.			Confronting disaster losses	SCIENCE			English	Editorial Material									Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands; Macquarie Univ, Risk Frontiers, Sydney, NSW 2109, Australia; Geo Risks Res Dept, Munich, Germany; Univ Colorado, Ctr Sci & Technol Policy Res, Boulder, CO 80309 USA	Vrije Universiteit Amsterdam; Macquarie University; University of Colorado System; University of Colorado Boulder	Bouwer, LM (corresponding author), Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands.	laurens.bouwer@ivm.falw.vu.nl	Bouwer, Laurens/E-8080-2010; Bouwer, Laurens/ABE-7170-2021; Bouwer, Laurens/AAV-7628-2021	Bouwer, Laurens/0000-0003-3498-2586; Bouwer, Laurens/0000-0003-3498-2586; 				Benson C, 2004, MEASURING MITIGATION; Few Roger, 2006, LINKING CLIMATE CHAN, P1; IPCC, 2007, CLIM CHANG 2007; Linnerooth-Bayer J, 2005, SCIENCE, V309, P1044, DOI 10.1126/science.1116783; Mechler R., 2005, COST BENEFIT ANAL NA; Pielke RA, 1999, B AM METEOROL SOC, V80, P2027, DOI 10.1175/1520-0477(1999)080<2027:LNAENO>2.0.CO;2; Warner K., 2007, Environmental Hazards, V7, P32, DOI 10.1016/j.envhaz.2007.04.006	7	136	139	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					753	753		10.1126/science.1149628	http://dx.doi.org/10.1126/science.1149628			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975052				2022-12-28	WOS:000250583900024
J	Joshi, R; Passner, JM; Rohs, R; Jain, R; Sosinsky, A; Crickmore, MA; Jacob, V; Aggarwal, AK; Honig, B; Mann, RS				Joshi, Rohit; Passner, Jonathan M.; Rohs, Remo; Jain, Rinku; Sosinsky, Alona; Crickmore, Michael A.; Jacob, Vinitha; Aggarwal, Aneel K.; Honig, Barry; Mann, Richard S.			Functional specificity of a Hox protein mediated by the recognition of minor groove structure	CELL			English	Article							HOMEODOMAIN-DNA COMPLEX; MONTE-CARLO SIMULATIONS; HOMEOTIC GENE-FUNCTION; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; BINDING MECHANISM; TARGET GENE; DROSOPHILA; EXTRADENTICLE; TRACT	The recognition of specific DNA-binding sites by transcription factors is a critical yet poorly understood step in the control of gene expression. Members of the Hox family of transcription factors bind DNA by making nearly identical major groove contacts via the recognition helices of their homeodomains. In vivo specificity, however, often depends on extended and unstructured regions that link Hox homeodomains to a DNA-bound cofactor, Extradenticle (Exd). Using a combination of structure determination, computational analysis, and in vitro and in vivo assays, we show that Hox proteins recognize specific Hox-Exd binding sites via residues located in these extended regions that insert into the minor groove but only when presented with the correct DNA sequence. Our results suggest that these residues, which are conserved in a paralog-specific manner, confer specificity by recognizing a sequence-dependent DNA structure instead of directly reading a specific DNA sequence.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10032 USA; Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Icahn School of Medicine at Mount Sinai	Aggarwal, AK (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 701 W 168th St,HHSC 1104, New York, NY 10032 USA.	aneel.aggarwal@mssm.edu; bh6@columbia.edu; rsm10@columbia.edu	Joshi, Rohit/AAH-3941-2019; Rohs, Remo/F-5752-2011	Joshi, Rohit/0000-0001-9151-1372; 	NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510, R24GM074105, R01GM062947] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA121852] Funding Source: Medline; NIAID NIH HHS [R01 AI041706, AI41706] Funding Source: Medline; NIGMS NIH HHS [R01 GM062947, R01 GM054510-15, R24 GM074105-03, R01 GM054510-13, GM074105, R01 GM054510-16, GM54510, R24 GM074105-04, GM62947, R01 GM054510, R01 GM054510-14, R24 GM074105] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; ANDREW DJ, 1994, EMBO J, V13, P1132, DOI 10.1002/j.1460-2075.1994.tb06362.x; BILLETER M, 1993, J MOL BIOL, V234, P1084, DOI 10.1006/jmbi.1993.1661; BURKHOFF AM, 1988, NATURE, V331, P455, DOI 10.1038/331455a0; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Chauvet S, 2000, P NATL ACAD SCI USA, V97, P4064, DOI 10.1073/pnas.070046997; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Faiger H, 2007, NUCLEIC ACIDS RES, V35, P4409, DOI 10.1093/nar/gkm451; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; Fraenkel E, 1998, NAT STRUCT BIOL, V5, P692, DOI 10.1038/1382; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Galant R, 2002, DEVELOPMENT, V129, P3115; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gearhart MD, 2003, J MOL BIOL, V327, P819, DOI 10.1016/S0022-2836(03)00183-9; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GIBSON G, 1990, CELL, V62, P1087, DOI 10.1016/0092-8674(90)90386-S; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; Hirsch JA, 1995, EMBO J, V14, P6280, DOI 10.1002/j.1460-2075.1995.tb00318.x; Hizver J, 2001, P NATL ACAD SCI USA, V98, P8490, DOI 10.1073/pnas.151247298; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hovde S, 2001, BIOCHEMISTRY-US, V40, P12013, DOI 10.1021/bi0108148; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Lavery R, 2005, Q REV BIOPHYS, V38, P339, DOI 10.1017/S0033583505004105; LI T, 1995, SCIENCE, V270, P262, DOI 10.1126/science.270.5234.262; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Meinke G, 1999, NAT STRUCT BIOL, V6, P471; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; PANZER S, 1992, DEVELOPMENT, V114, P49; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rohs R, 2005, NUCLEIC ACIDS RES, V33, P7048, DOI 10.1093/nar/gki1008; Rohs R, 2005, STRUCTURE, V13, P1499, DOI 10.1016/j.str.2005.07.005; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Shakked Z., 1999, OXFORD HDB NUCL ACID, P455; Sharkey M, 1997, TRENDS GENET, V13, P145, DOI 10.1016/S0168-9525(97)01096-2; Sklenar H, 2006, J COMPUT CHEM, V27, P309, DOI 10.1002/jcc.20345; Stefl R, 2004, P NATL ACAD SCI USA, V101, P1177, DOI 10.1073/pnas.0308143100; TuckerKellogg L, 1997, STRUCTURE, V5, P1047, DOI 10.1016/S0969-2126(97)00256-6; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Yao LC, 1999, DEV BIOL, V211, P268, DOI 10.1006/dbio.1999.9309; Zhao YX, 2002, DEV BIOL, V244, P21, DOI 10.1006/dbio.2002.0595; ZHURKIN VB, 2005, DNA CONFORMATION TRA	60	261	264	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					530	543		10.1016/j.cell.2007.09.024	http://dx.doi.org/10.1016/j.cell.2007.09.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981120	Green Accepted, Bronze			2022-12-28	WOS:000250618500020
J	Fuentealba, LC; Eivers, E; Ikeda, A; Hurtado, C; Kuroda, H; Pera, EM; De Robertis, EM				Fuentealba, Luis C.; Eivers, Edward; Ikeda, Atsushi; Hurtado, Cecilia; Kuroda, Hiroki; Pera, Edgar M.; De Robertis, Edward M.			Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal	CELL			English	Article							NEURAL INDUCTION; BETA-CATENIN; SMAD1 PHOSPHORYLATION; SPEMANNS ORGANIZER; XENOPUS EMBRYOS; BMP; WNT; PATHWAYS; ACTIVATION; DIFFERENTIATION	BMP receptors determine the intensity of BMP signals via Smad1 C-terminal phosphorylations. Here we show that a finely controlled cell biological pathway terminates this activity. The duration of the activated pSmad1(Cter) signal was regulated by sequential Smad1 linker region phosphorylations at conserved MAPK and GSK3 sites required for its polyubiquitinylation and transport to the centrosome. Proteasomal degradation of activated Smad1 and total polyubiquitinated proteins took place in the centrosome. Inhibitors of the Erk, p38, and JNK MAPKs, as well as GSK3 inhibitors, prolonged the duration of a pulse of BMP7. Wnt signaling decreased pSmad1(GSK3) antigen levels and redistributed it from the centrosome to cytoplasmic LRP6 signalosomes. In Xenopus embryos, it was found that Wnts induce epidermis and that this required an active BMP-Smad pathway. Epistatic experiments suggested that the dorsoventral (BMP) and anteroposterior (Wnt/GSK3) patterning gradients are integrated at the level of Smad1 phosphorylations during embryonic pattern formation.	[Fuentealba, Luis C.; Eivers, Edward; Ikeda, Atsushi; Hurtado, Cecilia; Kuroda, Hiroki; Pera, Edgar M.; De Robertis, Edward M.] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles	De Robertis, EM (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	ederobertis@mednet.ucla.edu		De Robertis, Edward/0000-0002-7843-1869	NICHD NIH HHS [R01 HD021502, R37 HD021502, R01 HD021502-21A1, HD21502-21] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021502, R37HD021502] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Beck CW, 2001, DEV BIOL, V238, P303, DOI 10.1006/dbio.2001.0407; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Koay MA, 2005, TRENDS MOL MED, V11, P129, DOI 10.1016/j.molmed.2005.01.004; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kuroda H, 2005, GENE DEV, V19, P1022, DOI 10.1101/gad.1306605; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marcus EA, 1998, MOL CELL NEUROSCI, V12, P269, DOI 10.1006/mcne.1998.0713; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Wilson E.B., 1906, CELL DEV INHERITANCE; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	40	405	420	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					980	993		10.1016/j.cell.2007.09.027	http://dx.doi.org/10.1016/j.cell.2007.09.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045539	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000251800900019
J	Huen, MSY; Grant, R; Manke, I; Minn, K; Yu, XC; Yaffe, MB; Chen, JJ				Huen, Michael S. Y.; Grant, Robert; Manke, Isaac; Minn, Kay; Yu, Xiaochun; Yaffe, Michael B.; Chen, Junjie			RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly	CELL			English	Article							DOUBLE-STRAND BREAKS; RING FINGER PROTEIN; FHA DOMAIN; FANCONI-ANEMIA; UBIQUITIN STRUCTURES; GENOMIC STABILITY; REPAIR; BRCA1; MDC1; H2AX	DNA-damage signaling utilizes a multitude of posttranslational modifiers as molecular switches to regulate cell-cycle checkpoints, DNA repair, cellular senescence, and apoptosis. Here we show that RNF8, a FHA/RING domain-containing protein, plays a critical role in the early DNA-damage response. We have solved the X-ray crystal structure of the FHA domain structure at 1.35 angstrom. We have shown that RNF8 facilitates the accumulation of checkpoint mediator proteins BRCA1 and 53BP1 to the damaged chromatin, on one hand through the phospho-dependent FHA domain-mediated binding of RNF8 to MDC1, on the other hand via its role in ubiquitylating H2AX and possibly other substrates at damage sites. Moreover, RNF8-depleted cells displayed a defective G2/M checkpoint and increased IR sensitivity. Together, our study implicates RNF8 as a novel DNA-damage-responsive protein that integrates protein phosphorylation and ubiquitylation signaling and plays a critical role in the cellular response to genotoxic stress.	[Huen, Michael S. Y.; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Grant, Robert; Manke, Isaac; Yaffe, Michael B.] Ctr Canc Res, MIT, Dept Biol & Biol Engn, Cambridge, MA 02132 USA; [Minn, Kay] Mayo Clin, Coll Med, Dept Oncol Res, Rochester, MN 55905 USA; [Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA	Yale University; Massachusetts Institute of Technology (MIT); Mayo Clinic; University of Michigan System; University of Michigan	Yu, XC (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	xiayu@med.umich.edu; myaffe@mit.edu; junjie.chen@yale.edu	Huen, Michael Shing Yan/E-9862-2010	Huen, Michael Shing-Yan/0000-0003-1774-2425	NATIONAL CANCER INSTITUTE [R01CA092312, R01CA089239, R01CA100109, P50CA116201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060594] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA116201, R01 CA089239, CA100109, CA92312, R01 CA100109, CA89239, R01 CA089239-08, R01 CA100109-06, R01 CA092312, R01 CA092312-08] Funding Source: Medline; NIGMS NIH HHS [GM 60594, R01 GM060594] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ito K, 2001, EUR J BIOCHEM, V268, P2725, DOI 10.1046/j.1432-1327.2001.02169.x; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Li J, 2000, J CELL SCI, V113, P4143; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Takano Y, 2004, J BIOL CHEM, V279, P18926, DOI 10.1074/jbc.M309148200; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	47	798	833	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					901	914		10.1016/j.cell.2007.09.041	http://dx.doi.org/10.1016/j.cell.2007.09.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18001825	Green Accepted, Bronze			2022-12-28	WOS:000251800900013
J	Robbins, J; Aragaki, AK; Kooperberg, C; Watts, N; Wactawski-Wende, J; Jackson, RD; LeBoff, MS; Lewis, CE; Chen, Z; Stefanick, ML; Cauley, J				Robbins, John; Aragaki, Aaron K.; Kooperberg, Charles; Watts, Nelson; Wactawski-Wende, Jean; Jackson, Rebecca D.; LeBoff, Meryl S.; Lewis, Cora E.; Chen, Zhao; Stefanick, Marcia L.; Cauley, Jane			Factors associated with 5-year risk of hip fracture in postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BASE-LINE CHARACTERISTICS; PHYSICAL-ACTIVITY; TRIAL; PARTICIPANTS; QUESTIONNAIRE; PREDICTION; ESTROGEN; VALIDITY; DISEASE; DESIGN	Context The 329 000 hip fractures that annually occur in the United States are associated with high morbidity, mortality, and cost. Identification of those at high risk is a step toward prevention. Objective To develop an algorithm to predict the 5-year risk of hip fracture in postmenopausal women. Design, Setting, and Participants A total of 93 676 women who participated in the observational component of the Women's Health Initiative (WHI), a multiethnic longitudinal study, were used to develop a predictive algorithm based on commonly available clinical features. Selected factors that predicted hip fracture were then validated by 68 132 women who participated in the clinical trial. The model was tested in a subset of 10 750 women who had undergone dual-energy x-ray absorptiometry (DXA) scans for bone mass density assessment. Main Outcome Measure The prediction of centrally adjudicated hip fracture, measured by the area under the receiver operator characteristic (ROC) curves. Results During a mean (SD) follow-up of 7.6 ( 1.7) years, 1132 hip fractures were identified among women participating in the observational study (annualized rate, 0.16%), whereas during a mean follow-up of 8.0 ( 1.7) years, 791 hip fractures occurred among women participating in the clinical trial ( annualized rate, 0.14%). Eleven factors predicted hip fracture within 5 years: age, self-reported health, weight, height, race/ethnicity, self-reported physical activity, history of fracture after age 54 years, parental hip fracture, current smoking, current corticosteroid use, and treated diabetes. Receiver operating characteristic curves showed that the algorithm had an area under the curve of 80% (95% confidence interval [Cl], 0.77%-0.82%) when tested in the cohort of different women who were in the clinical trial. A simplified point score was developed for the probability of hip fracture. Receiver operating characteristic curves comparing DXA-scan prediction based on a 10% subset of the cohort and the algorithm among those who participated the clinical trial were similar, with an area under the curve of 79% ( 95% Cl, 73%-85%) vs 71% ( 95% Cl, 66%-76%). Conclusion This algorithm, based on 11 clinical factors, may be useful to predict the 5-year risk of hip fracture among postmenopausal women of various ethnic backgrounds. Further studies are needed to assess the clinical implication of the algorithm in general and specifically to identify treatment benefits.	Univ Calif Davis, Sch Med, Dept Internal Med, Sacramento, CA 95817 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA; Univ Buffalo, Div Endocrinol Diabet & Metab, Buffalo, NY USA; Ohio State Univ, Dept Internal Med & Phys Med, Columbus, OH 43210 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Univ Alabama, Div Prevent Med, Birmingham, AL USA; Univ Arizona, Dept Epidemiol & Biostat, Tucson, AZ USA; Stanford Prevent Res Ctr, Stanford, CA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	University of California System; University of California Davis; Fred Hutchinson Cancer Center; University System of Ohio; University of Cincinnati; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Ohio; Ohio State University; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; University of Arizona; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Robbins, J (corresponding author), Univ Calif Davis, Sch Med, Dept Internal Med, 4150 V St,Ste 2400, Sacramento, CA 95817 USA.	jarobbins@ucdavis.edu	Wactawski-Wende, Jean/AGH-5457-2022; Cauley, Jane A/N-4836-2015	Wactawski-Wende, Jean/0000-0003-3096-9595; Cauley, Jane A/0000-0003-0752-4408				AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Buist DSM, 2002, J AM GERIATR SOC, V50, P1031, DOI 10.1046/j.1532-5415.2002.50257.x; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Chen Z, 2004, MENOPAUSE, V11, P264, DOI 10.1097/01.GME.0000094210.15096.FD; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Fang J, 2004, ETHNIC DIS, V14, P280; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hsia J, 2005, AM J PREV MED, V28, P19, DOI 10.1016/j.amepre.2004.09.012; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jackson RD, 2003, ANN EPIDEMIOL, V13, pS98, DOI 10.1016/S1047-2797(03)00046-2; KOOPERBERG C, 2007, POLSPLINE POLYNOMIAL; Langer RD, 2003, ANN EPIDEMIOL, V13, pS107, DOI 10.1016/S1047-2797(03)00047-4; Lloyd-Jones DM, 2006, ANN INTERN MED, V145, P35, DOI 10.7326/0003-4819-145-1-200607040-00129; McGrother CW, 2002, OSTEOPOROSIS INT, V13, P89, DOI 10.1007/s198-002-8343-6; National Center for Health Statistics, NAT HOSP DISCH AMB S; Neuhouser ML, 2003, PUBLIC HEALTH NUTR, V6, P703, DOI 10.1079/PHN2003486; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; R Development Core Team, 2007, R LANG ENV STAT COMP; Ritenbaugh C, 2003, ANN EPIDEMIOL, V13, pS87, DOI 10.1016/S1047-2797(03)00044-9; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stefanick ML, 2003, ANN EPIDEMIOL, V13, pS78, DOI 10.1016/S1047-2797(03)00045-0; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; van Staa TP, 2002, BONE, V31, P508, DOI 10.1016/S8756-3282(02)00848-7; Wainwright SA, 2005, J CLIN ENDOCR METAB, V90, P2787, DOI 10.1210/jc.2004-1568; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	33	185	188	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2389	2398		10.1001/jama.298.20.2389	http://dx.doi.org/10.1001/jama.298.20.2389			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	18042916				2022-12-28	WOS:000251163400019
J	Barter, PJ; Caulfield, M; Eriksson, M; Grundy, SM; Kastelein, JJP; Komajda, M; Lopez-Sendon, J; Mosca, L; Tardif, J; Waters, DD; Shear, CL; Revkin, JH; Buhr, KA; Fisher, MR; Tall, AR; Brewer, B				Barter, Philip J.; Caulfield, Mark; Eriksson, Mats; Grundy, Scott M.; Kastelein, John J. P.; Komajda, Michel; Lopez-Sendon, Jose; Mosca, Lori; Tardif, Jean-Claude; Waters, David D.; Shear, Charles L.; Revkin, James H.; Buhr, Kevin A.; Fisher, Marian R.; Tall, Alan R.; Brewer, Bryan		ILLUMINATE Investigators	Effects of torcetrapib in patients at high risk for coronary events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ESTER TRANSFER PROTEIN; HIGH-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; HDL-CHOLESTEROL; ATHEROSCLEROSIS; TARGET; INHIBITOR	Background Inhibition of cholesteryl ester transfer protein (CETP) has been shown to have a substantial effect on plasma lipoprotein levels. We investigated whether torcetrapib, a potent CETP inhibitor, might reduce major cardiovascular events. The trial was terminated prematurely because of an increased risk of death and cardiac events in patients receiving torcetrapib. Methods We conducted a randomized, double-blind study involving 15,067 patients at high cardiovascular risk. The patients received either torcetrapib plus atorvastatin or atorvastatin alone. The primary outcome was the time to the first major cardiovascular event, which was defined as death from coronary heart disease, nonfatal myocardial infarction, stroke, or hospitalization for unstable angina. Results At 12 months in patients who received torcetrapib, there was an increase of 72.1% in high-density lipoprotein cholesterol and a decrease of 24.9% in low-density lipoprotein cholesterol, as compared with baseline (P<0.001 for both comparisons), in addition to an increase of 5.4 mm Hg in systolic blood pressure, a decrease in serum potassium, and increases in serum sodium, bicarbonate, and aldosterone (P<0.001 for all comparisons). There was also an increased risk of cardiovascular events (hazard ratio, 1.25; 95% confidence interval [CI], 1.09 to 1.44; P=0.001) and death from any cause (hazard ratio, 1.58; 95% CI, 1.14 to 2.19; P=0.006). Post hoc analyses showed an increased risk of death in patients treated with torcetrapib whose reduction in potassium or increase in bicarbonate was greater than the median change. Conclusions Torcetrapib therapy resulted in an increased risk of mortality and morbidity of unknown mechanism. Although there was evidence of an off-target effect of torcetrapib, we cannot rule out adverse effects related to CETP inhibition. (ClinicalTrials.gov number, NCT00134264.).	Heart Res Inst, Sydney, NSW 2050, Australia; St Bartholomews Hosp, London, England; Karolinska Univ Hosp, Stockholm, Sweden; Univ Texas, SW Med Ctr, Dallas, TX USA; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Univ Paris 06, Paris, France; Hop La Pitie Salpetriere, Paris, France; Hosp Univ La Paz, Madrid, Spain; Columbia Univ, New York, NY USA; Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; San Francisco Gen Hosp, San Francisco, CA 94110 USA; Pfizer, New London, CT USA; Univ Wisconsin, Madison, WI USA; Columbia Univ, Med Ctr, New York, NY USA; Medstar Inst, Washington, DC USA	University of Sydney; Heart Research Institute; University of London; Queen Mary University London; Karolinska Institutet; Karolinska University Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Amsterdam; Academic Medical Center Amsterdam; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Hospital Universitario La Paz; Columbia University; Universite de Montreal; San Francisco General Hospital Medical Center; Pfizer; University of Wisconsin System; University of Wisconsin Madison; Columbia University	Barter, PJ (corresponding author), Heart Res Inst, 145 Missenden Rd, Sydney, NSW 2050, Australia.	barterp@hri.org.au	Kastelein, John/AAF-7950-2020; Tall, Alan/AAT-8528-2021	Caulfield, Mark/0000-0001-9295-3594				Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barter PJ, 2006, J AM COLL CARDIOL, V47, P492, DOI 10.1016/j.jacc.2005.09.042; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Bots ML, 2007, LANCET, V370, P153, DOI 10.1016/S0140-6736(07)61088-5; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Chapman MJ, 2006, PHARMACOL THERAPEUT, V111, P893, DOI 10.1016/j.pharmthera.2006.02.003; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Hirano K, 2000, CURR OPIN LIPIDOL, V11, P589, DOI 10.1097/00041433-200012000-00004; Kastelein JJP, 2007, NEW ENGL J MED, V356, P1620, DOI 10.1056/NEJMoa071359; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; McKenney JM, 2006, J AM COLL CARDIOL, V48, P1782, DOI 10.1016/j.jacc.2006.06.066; Morehouse LA, 2007, J LIPID RES, V48, P1263, DOI 10.1194/jlr.M600332-JLR200; Nissen SE, 2007, NEW ENGL J MED, V357, P835; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P1516; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786	17	2380	2447	1	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2109	2122		10.1056/NEJMoa0706628	http://dx.doi.org/10.1056/NEJMoa0706628			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	17984165	Bronze			2022-12-28	WOS:000251076500003
J	Winter, EC				Winter, Elizabeth Caroline			Perceptions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												etuffial@jhmi.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2007	298	19					2237	2237		10.1001/jama.298.19.2237	http://dx.doi.org/10.1001/jama.298.19.2237			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232XV	18029820				2022-12-28	WOS:000251055900001
J	Elwyn, G; Buetow, S; Hibbard, J; Wensing, M				Elwyn, Glyn; Buetow, Stephen; Hibbard, Judith; Wensing, Michel			Respecting the subjective: quality measurement from the patient's perspective	BRITISH MEDICAL JOURNAL			English	Editorial Material									Cardiff Univ, Dept Publ Hlth & Primary Care, Cardiff CF14 4YS, Wales; Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand; Univ Oregon, Dept Planning Publ Policy & Management, Eugene, OR 97403 USA; Radboud Univ Nijmegen Med Ctr, Ctr Qual Care Res, Nijmegen, Netherlands	Cardiff University; University of Auckland; University of Oregon; Radboud University Nijmegen	Elwyn, G (corresponding author), Cardiff Univ, Dept Publ Hlth & Primary Care, Cardiff CF14 4YS, Wales.	elwyng@cardiff.ac.uk	Elwyn, G./L-4292-2015; Elwyn, Glyn/B-4798-2009; Wensing, Michel/H-8113-2014; Wensing, Michel/D-3998-2009	Elwyn, Glyn/0000-0002-0917-6286; Wensing, Michel/0000-0001-6569-8137; Buetow, Stephen/0000-0002-9771-248X					0	60	60	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 17	2007	335	7628					1021	1022		10.1136/bmj.39339.490301.AD	http://dx.doi.org/10.1136/bmj.39339.490301.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	237UV	18007003	Green Published			2022-12-28	WOS:000251402800028
J	[Anonymous]				[Anonymous]			STEP study: disappointing, but not a failure	LANCET			English	Editorial Material																			0	13	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2007	370	9600					1665	1665						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	18022020				2022-12-28	WOS:000251091200001
J	Doma, MK; Parker, R				Doma, Meenakshi K.; Parker, Roy			RNA quality control in eukaryotes	CELL			English	Review							PRE-MESSENGER-RNA; 5S RIBOSOMAL-RNA; NUCLEAR EXOSOME; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; RO AUTOANTIGEN; DEGRADATION; DECAY; SURVEILLANCE; TRANSCRIPTS	Eukaryotic cells contain numerous RNA quality-control systems that are important for shaping the transcriptome of eukaryotic cells. These systems not only prevent accumulation of nonfunctional RNAs but also regulate normal mRNAs, repress viral and parasitic RNAs, and potentially contribute to the evolution of new RNAs and hence proteins. These quality-control circuits can be viewed as a series of kinetic competitions between steps in normal RNA biogenesis or function and RNA degradation pathways. These RNA quality-control circuits depend on specific adaptor proteins that target aberrant RNAs for degradation as well as the coupling of individual steps in mRNA biogenesis and function.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@email.arizona.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045443, R37GM045443] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM045443, GM45443] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; ALLMANG C, 2000, NUCLEIC ACIDS RES, V15, P1684; Bickel KS, 2006, MOL CELL, V22, P309, DOI 10.1016/j.molcel.2006.04.010; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Custodio N, 1999, EMBO J, V18, P2855, DOI 10.1093/emboj/18.10.2855; Danin-Kreiselman M, 2003, MOL CELL, V11, P1279, DOI 10.1016/S1097-2765(03)00137-0; Das B, 2003, MOL CELL BIOL, V23, P5502, DOI 10.1128/MCB.23.16.5502-5515.2003; Das B, 2006, P NATL ACAD SCI USA, V103, P10871, DOI 10.1073/pnas.0604562103; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; DeCerbo J, 2005, CURR OPIN CELL BIOL, V17, P302, DOI 10.1016/j.ceb.2005.04.008; Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035; Dez C, 2007, RNA, V13, P1516, DOI 10.1261/rna.609807; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Falnes PO, 2007, NEUROSCIENCE, V145, P1222, DOI 10.1016/j.neuroscience.2006.11.018; Fang F, 2005, RNA, V11, P1571, DOI 10.1261/rna.2900205; Fang F, 2004, MOL CELL BIOL, V24, P10766, DOI 10.1128/MCB.24.24.10766-10776.2004; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Fuchs G, 2006, NAT STRUCT MOL BIOL, V13, P1002, DOI 10.1038/nsmb1156; Garcia MA, 2006, EMBO J, V25, P4284, DOI 10.1038/sj.emboj.7601302; Graber JH, 1999, P NATL ACAD SCI USA, V96, P14055, DOI 10.1073/pnas.96.24.14055; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Hartig JV, 2007, GENE DEV, V21, P1707, DOI 10.1101/gad.1567007; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Hilleren P, 2001, RNA, V7, P753, DOI 10.1017/S1355838201010147; Hilleren PJ, 2003, MOL CELL, V12, P1453, DOI 10.1016/S1097-2765(03)00488-X; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Ibrahim F, 2006, SCIENCE, V314, P1893, DOI 10.1126/science.1135268; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Jungwirth H, 2001, J BIOL CHEM, V276, P36419, DOI 10.1074/jbc.M104487200; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kong J, 2007, NAT STRUCT MOL BIOL, V14, P670, DOI 10.1038/nsmb1256; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; LaRiviere FJ, 2006, MOL CELL, V24, P619, DOI 10.1016/j.molcel.2006.10.008; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; MANDART E, 1995, MOL CELL BIOL, V15, P6979; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nazar RN, 2004, IUBMB LIFE, V56, P457, DOI 10.1080/15216540400010867; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Reis CC, 2007, GENETICS, V175, P993, DOI 10.1534/genetics.106.065987; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; Schwer B, 1998, NUCLEIC ACIDS RES, V26, P2050, DOI 10.1093/nar/26.9.2050; Shi H, 1996, RNA, V2, P769; Sommer P, 2005, CURR OPIN CELL BIOL, V17, P294, DOI 10.1016/j.ceb.2005.04.007; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; Thompson DM, 2007, MOL CELL BIOL, V27, P92, DOI 10.1128/MCB.01023-06; Thomsen R, 2003, RNA, V9, P1049, DOI 10.1261/rna.5170303; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006; Wolin SL, 1999, GENE DEV, V13, P1, DOI 10.1101/gad.13.1.1; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	85	262	263	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					660	668		10.1016/j.cell.2007.10.041	http://dx.doi.org/10.1016/j.cell.2007.10.041			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022361	Bronze			2022-12-28	WOS:000250966300014
J	Madden, JD				Madden, John D.			Mobile robots: Motor challenges and materials solutions	SCIENCE			English	Review							ACTUATORS; STRENGTH; STRAIN	Bolted-down robots labor in our factories, performing the same task over and over again. Where are the robots that run and jump? Equaling human performance is very difficult for many reasons, including the basic challenge of demonstrating motors and transmissions that efficiently match the power per unit mass of muscle. In order to exceed animal agility, new actuators are needed. Materials that change dimension in response to applied voltage, so-called artificial muscle technologies, outperform muscle in most respects and so provide a promising means of improving robots. In the longer term, robots powered by atomically perfect fibers will outrun us all.	Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Madden, JD (corresponding author), Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V6T 1Z4, Canada.	jmadden@ece.ubc.ca	Madden, John DW/B-8948-2009	Madden, John DW/0000-0002-0014-4712				AMUNDSON K, 2005, P IEEE INT C INT ROB, P3453; ANQUETIL PA, 2007, HDB ORGANIC ELECT PH, V1, P447; Bar-Cohen Y., 2004, ELECTROACTIVE POLYM, P765; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Baughman RH, 2003, SCIENCE, V300, P268, DOI 10.1126/science.1082270; BEVK J, 1978, J APPL PHYS, V49, P6031, DOI 10.1063/1.324573; *C MAX MOT, RE40 GRAPH BRUSH DC; Cooper GM, 2000, CELL MOL APPROACH; Ebron VH, 2006, SCIENCE, V311, P1580, DOI 10.1126/science.1120182; HIRAI K, 1998, P INT C ROB AUT 1998; HODGINS JK, 1990, INT J ROBOT RES, V9, P115, DOI 10.1177/027836499000900209; Hollerbach J., 1991, ROBOTICS REV, P301; Huang GT, 2004, TECHNOL REV, V107, P24; Hugel T, 2002, SCIENCE, V296, P1103, DOI 10.1126/science.1069856; Hunter I. W., 1992, Technical Digest. IEEE Solid-State Sensor and Actuator Workshop (Cat. No.92TH0403-X), P178, DOI 10.1109/SOLSEN.1992.228297; Jacobsen SC, 2004, INT J ROBOT RES, V23, P319, DOI 10.1177/0278364904042198; JACOBSEN SC, 2005, Patent No. 6957631; JOSEPHSON RK, 1993, ANNU REV PHYSIOL, V55, P527, DOI 10.1146/annurev.ph.55.030193.002523; Kanehira N, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P2455, DOI 10.1109/IRDS.2002.1041636; Kaneko K, 2004, IEEE INT CONF ROBOT, P1083, DOI 10.1109/ROBOT.2004.1307969; KING AM, 2001, IEEE J OCEANIC ENG, V29, P681; Kovacs G, 2007, SMART MATER STRUCT, V16, pS306, DOI 10.1088/0964-1726/16/2/S16; Kuroki Y, 2003, IEEE INT CONF ROBOT, P471; LEE C, 2006, SOL STAT ACT SENS MI; Lu SX, 2006, NANOTECHNOLOGY, V17, P888, DOI 10.1088/0957-4484/17/3/045; Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135; MOK HS, 2006, P SMART STRUCT MAT 2, V6168; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Pelrine R, 2002, P SOC PHOTO-OPT INS, V4695, P126, DOI 10.1117/12.475157; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Robinson D. W., 1999, 1999 IEEE/ASME International Conference on Advanced Intelligent Mechatronics (Cat. No.99TH8399), P561, DOI 10.1109/AIM.1999.803231; Sakagami Y, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P2478, DOI 10.1109/IRDS.2002.1041641; Shahinpoor M., 2007, ARTIFICIAL MUSCLES A; Sinclair CW, 2005, J CRYST GROWTH, V276, P321, DOI 10.1016/j.jcrysgro.2004.11.374; Vidal V, 2007, SCRIPTA MATER, V57, P245, DOI 10.1016/j.scriptamat.2007.04.001; Weissmuller J, 2003, SCIENCE, V300, P312, DOI 10.1126/science.1081024; Zhang Q.M., 2004, ELECTROACTIVE POLYM, P95; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101; ZOSS A, 2005, P INT C INT ROB SYST; [No title captured]	40	138	141	9	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1094	1097		10.1126/science.1146351	http://dx.doi.org/10.1126/science.1146351			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006737	Green Submitted			2022-12-28	WOS:000250957900034
J	Babyatsky, MW; Keroack, MD; Blake, MA; Rosenberg, ES; Mino-Kenudson, M				Babyatsky, Mark W.; Keroack, Myles D.; Blake, Michael A.; Rosenberg, Eric S.; Mino-Kenudson, Mari			A 30-year-old man with inflammatory bowel disease and recent onset of fever and bloody diarrhea - Acute CMV infection in a patient with inflammatory bowel disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PORTAL-VEIN THROMBOSIS; ULCERATIVE-COLITIS PATIENTS; CYTOMEGALOVIRUS-INFECTION; RELATIVE BRADYCARDIA; CROHNS-DISEASE; TYPHOID-FEVER; PREVALENCE; SALMONELLA; EXPRESSION; AMEBIASIS		Mt Sinai Med Ctr, Dept Med, New York, NY 10029 USA; Mt Sinai Sch Med, New York, NY USA; Massachusetts Gen Hosp, Dept Gastroenterol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Babyatsky, MW (corresponding author), Mt Sinai Med Ctr, Dept Med, New York, NY 10029 USA.							Basnyat B, 2005, CLIN INFECT DIS, V41, P1467, DOI 10.1086/497136; BOLTON RP, 1980, LANCET, V1, P383; BRINBERG DE, 1991, GASTROINTEST RADIOL, V16, P245, DOI 10.1007/BF01887357; Chaudhuri A, 2002, INT J COLORECTAL DIS, V17, P275, DOI 10.1007/s00384-001-0374-3; Criscuoli V, 2004, DIGEST LIVER DIS, V36, P818, DOI 10.1016/j.dld.2004.05.013; Danese S, 2007, AM J GASTROENTEROL, V102, P174, DOI 10.1111/j.1572-0241.2006.00943.x; Dimitroulia E, 2006, INFLAMM BOWEL DIS, V12, P879, DOI 10.1097/01.mib.0000231576.11678.57; Dionisio D, 2003, CURR OPIN INFECT DIS, V16, P383, DOI 10.1097/00001432-200310000-00003; Galiatsatos P, 2005, DIGEST DIS SCI, V50, P609, DOI 10.1007/s10620-005-2544-6; Hommes DW, 2004, INFLAMM BOWEL DIS, V10, P245, DOI 10.1097/00054725-200405000-00011; Inacio C, 1997, J GASTROEN HEPATOL, V12, P287, DOI 10.1111/j.1440-1746.1997.tb00423.x; IWAMOTO GK, 1990, J CLIN INVEST, V85, P1853, DOI 10.1172/JCI114645; Kandiel A, 2006, AM J GASTROENTEROL, V101, P2857, DOI 10.1111/j.1572-0241.2006.00869.x; Kishore J, 2004, J MED MICROBIOL, V53, P1155, DOI 10.1099/jmm.0.45629-0; Kojima T, 2006, SCAND J GASTROENTERO, V41, P706, DOI 10.1080/00365520500408584; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Makharia GK, 2006, J GASTROEN HEPATOL, V21, P929, DOI 10.1111/j.1440-1746.2006.04471.x; Malipeddi AS, 2007, LANCET, V369, P162, DOI 10.1016/S0140-6736(07)60078-6; Matsuoka K, 2007, AM J GASTROENTEROL, V102, P331, DOI 10.1111/j.1572-0241.2006.00989.x; Meyer AM, 2004, J CLIN GASTROENTEROL, V38, P772, DOI 10.1097/01.mcg.0000139057.05297.d6; Minami M, 2007, WORLD J GASTROENTERO, V13, P754, DOI 10.3748/wjg.v13.i5.754; Mylonaki M, 2004, EUR J GASTROEN HEPAT, V16, P775, DOI 10.1097/01.meg.0000131040.38607.09; ORDA K, 1990, J R SOC MED, V83, P15; Ostergaard L, 1996, J INFECTION, V33, P185, DOI 10.1016/S0163-4453(96)92225-2; Papadakis KA, 2001, AM J GASTROENTEROL, V96, P2137, DOI 10.1111/j.1572-0241.2001.03949.x; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; POWELL RD, 1961, AM J MED, V30, P334, DOI 10.1016/0002-9343(61)90105-X; Rodemann JF, 2007, CLIN GASTROENTEROL H, V5, P339, DOI 10.1016/j.cgh.2006.12.027; Spahr L, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-10; Squizzato A, 2007, CLIN INFECT DIS, V44, pE13, DOI 10.1086/509641; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; SZILAGYI A, 1985, J CLIN GASTROENTEROL, V7, P251, DOI 10.1097/00004836-198506000-00013; Twig G, 2005, ANN NY ACAD SCI, V1051, P166, DOI 10.1196/annals.1361.058; Ustun S, 2003, WORLD J GASTROENTERO, V9, P1834, DOI 10.3748/wjg.v9.i8.1834; VANDORP WT, 1989, TRANSPLANTATION, V48, P469, DOI 10.1097/00007890-198909000-00024; WEBER P, 1992, J CLIN GASTROENTEROL, V14, P302, DOI 10.1097/00004836-199206000-00008; Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927; Wittesjo B, 1999, J INFECTION, V39, P246, DOI 10.1016/S0163-4453(99)90063-4	38	14	15	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2007	357	20					2068	2076		10.1056/NEJMcpc079029	http://dx.doi.org/10.1056/NEJMcpc079029			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230RV	18003964				2022-12-28	WOS:000250894500011
J	Zwart, SF; van den Heuvel, EPJ				Zwart, Simon F. Portegies; van den Heuvel, Edward P. J.			A runaway collision in a young star cluster as the origin of the brightest supernova	NATURE			English	Article							MASSIVE BLACK-HOLES; GALACTIC-CENTER; GALAXIES; ECOLOGY; MODELS	Supernova SN 2006gy in the galaxy NGC1260 is the most luminous recorded(1-4). Its progenitor might have been a very massive (>100M(circle dot), where M-circle dot is the mass of the Sun) star(5), but that interpretation is incompatible with hydrogen in the spectrum of the supernova; stars>40M(circle dot) are believed to have shed their hydrogen envelopes several hundred thousand years before the explosion(6). Alternatively, the progenitor might have arisen from the merger of two massive stars(7). Here we show that the collision frequency of massive stars in a dense and young cluster (of the kind to be expected near the centre of a galaxy) is sufficient to provide a reasonable chance that SN 2006gy resulted from such a bombardment. If this is the correct explanation, then we predict that when the supernova fades (in a year or so) a dense cluster of massive stars will become visible at the site of the explosion.	Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1012 WX Amsterdam, Netherlands; Univ Amsterdam, Inst Comp Sci, NL-1012 WX Amsterdam, Netherlands; Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	University of Amsterdam; University of Amsterdam; University of California System; University of California Santa Barbara	Zwart, SF (corresponding author), Univ Amsterdam, Astron Inst Anton Pannekoek, Kruislaan 403, NL-1012 WX Amsterdam, Netherlands.	spz@science.uva.nl; edvdh@science.uva.nl	van den Heuvel, Edward P.J./C-1262-2018					BINNEY J, 1987, GALACTIC DYNAMICS, P747; Brunzendorf J, 1999, ASTRON ASTROPHYS SUP, V139, P141, DOI 10.1051/aas:1999111; Cotera AS, 1996, ASTROPHYS J, V461, P750, DOI 10.1086/177099; COTERA AS, 1992, B AM ASTRON SOC, P1262; Dutra CM, 2000, ASTRON ASTROPHYS, V359, pL9; Dutra CM, 2003, ASTRON ASTROPHYS, V408, P127, DOI [10.1051/0004-6361:20030944, 10.1015/0004-6361:20030944]; Foley R.J., 2006, CBET, V695, P1; Freitag M, 2006, MON NOT R ASTRON SOC, V368, P141, DOI 10.1111/j.1365-2966.2006.10096.x; Fryer CL, 2001, ASTROPHYS J, V554, P548, DOI 10.1086/321359; Gurkan MA, 2004, ASTROPHYS J, V604, P632, DOI 10.1086/381968; HARUTYUNYAN A, 2006, CBET, V647, P1; KING IR, 1966, ASTRON J, V71, P64, DOI 10.1086/109857; Lee HK, 2000, PHYS REP, V325, P83, DOI 10.1016/S0370-1573(99)00084-8; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; Maillard JP, 2004, ASTRON ASTROPHYS, V423, P155, DOI 10.1051/0004-6361:20034147; Meynet G, 2005, ASTRON ASTROPHYS, V429, P581, DOI 10.1051/0004-6361:20047106; Ofek EO, 2007, ASTROPHYS J, V659, pL13, DOI 10.1086/516749; Portegies Zwart S, 1999, ASTRON ASTROPHYS, V348, P117; Portegies Zwart S, 2006, ASTROPHYS J, V641, P319, DOI 10.1086/500361; Portegies Zwart S, 2002, ASTROPHYS J, V576, P899, DOI 10.1086/341798; Prieto J. L., 2006, CENTRAL BUREAU ELECT, V648, P1; Quimby R., 2006, CENT BUR ELECT TEL, V644, P1; SALUCCI P, 1991, ASTROPHYS J, V379, P89, DOI 10.1086/170485; SANDERS RH, 1972, ASTRON J, V77, P292, DOI 10.1086/111281; SMITH N, 2006, SN 2006GY DISCOVERY; SUZUKI TK, 2007, EVOLUTION COLLISIONA; Wegner G, 2003, ASTRON J, V126, P2268, DOI 10.1086/378959; YUNGELSON LR, 2006, 26 GEN ASS IAU JOINT; YUNGELSON LR, 2007, IN PRESS ASTRON ASTR; Zwart SFP, 2004, NATURE, V428, P724, DOI 10.1038/nature02448	30	32	32	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					388	389		10.1038/nature06276	http://dx.doi.org/10.1038/nature06276			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004377	Green Submitted			2022-12-28	WOS:000250918600047
J	Appleby, P; Beral, V; de Gonzalez, AB; Colin, D; Franceschi, S; Goodhill, A; Green, J; Peto, J; Plummer, M; Sweetland, S				Appleby, Paul; Beral, Valerie; de Gonzalez, Amy Berrington; Colin, Didier; Franceschi, Silvia; Goodhill, Adrian; Green, Jane; Peto, Julian; Plummer, Martyn; Sweetland, Sian		Int Collaboration Epidemiologis	Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies	LANCET			English	Article							CARCINOMA IN-SITU; MEDROXYPROGESTERONE ACETATE DMPA; HUMAN-PAPILLOMAVIRUS INFECTION; COMBINED ORAL-CONTRACEPTIVES; SQUAMOUS-CELL CARCINOMA; RISK-FACTORS; INTRAEPITHELIAL NEOPLASIA; INVASIVE ADENOCARCINOMAS; ADENOSQUAMOUS CARCINOMAS; REPRODUCTIVE FACTORS	Background Combined oral contraceptives are classified by the International Agency for Research on Cancer as a cause of cervical cancer. As the incidence of cervical cancer increases with age, the public-health implications of this association depend largely on the persistence of effects long after use of oral contraceptives has ceased. Information from 24 studies worldwide is pooled here to investigate the association between cervical carcinoma and pattern of oral contraceptive use. Methods Individual data for 16 573 women with cervical cancer and 35 509 without cervical cancer were reanalysed centrally. Relative risks of cervical cancer were estimated by conditional logistic regression, stratifying by study, age, number of sexual partners, age at first intercourse, parity, smoking, and screening. Findings Among current users of oral contraceptives the risk of invasive cervical cancer increased with increasing duration of use (relative risk for 5 or more years' use versus never use, 1-90 [95% Cl 1-69-2-13]). The risk declined after use ceased, and by 10 or more years had returned to that of never users. A similar pattern of risk was seen both for invasive and in-situ cancer, and in women who tested positive for high-risk human papillornavirus. Relative risk did not vary substantially between women with different characteristics. Interpretation The relative risk of cervical cancer is increased in current users of oral contraceptives and declines after use ceases. 10 years' use of oral contraceptives from around age 20 to 30 years is estimated to increase the cumulative incidence of invasive cervical cancer by age 50 from 7.3 to 8.3 per 1000 in less developed countries and from 3.8 to 4.5 per 1000 in more developed countries.	Natl Hlth Lab Serv, Canc Epidemiol Res Grp, Johannesburg, South Africa; Canc Inst WIA, Madras, Tamil Nadu, India; Canc Res UK, Epidemiol Grp, Wolfson Inst Prevent Med, London, England; Canc Res UK, Epidemiol Unit, Oxford, England; Dept Publ Hlth, Oxford, England; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Karolinska Inst, Dept Med Epidemiol & Biostat, S-10401 Stockholm, Sweden; Inst Nacl Sante Publ, Algiers, Algeria; Inst Canc Res, Sutton, Surrey, England; London Sch Hyg & Trop Med, London WC1, England; Inst Nacl Enfermedades Neoplascias Dr Eduardo Cac, Lima, Peru; Int Agcy Res Canc, F-69372 Lyon, France; Ist Ric Farmacol Mario Negri, Milan, Italy; Lund Univ, Malmo, Sweden; Minist Sante Publ & Affaires Sociales, Bamako, Mali; Prince Songkla Univ, Hat Yai, Thailand; NSW Canc Council, Sydney, NSW, Australia; Univ Sao Paulo, BR-05508 Sao Paulo, Brazil; Univ Milan, I-20122 Milan, Italy; Univ Otago, Dunedin, New Zealand; Univ So Calif, Los Angeles, CA 90089 USA; Univ Philippines, Manila, Philippines; Univ Tromso, N-9001 Tromso, Norway; WHO, CH-1211 Geneva, Switzerland	National Health Laboratory Service; Cancer Research UK; University of London; Queen Mary University London; Cancer Research UK; Fred Hutchinson Cancer Center; Karolinska Institutet; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; Instituto Nacional de Enfermedades Neoplasicas; World Health Organization; International Agency for Research on Cancer (IARC); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Lund University; Prince of Songkla University; Cancer Council New South Wales; Universidade de Sao Paulo; University of Milan; University of Otago; University of Southern California; University of the Philippines System; University of the Philippines Manila; UiT The Arctic University of Tromso; World Health Organization	Green, J (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Richard Doll Bldg,Roosevelt Dr, Oxford OX3 7LF, England.	jane.green@ceu.ox.ac.uk	de gonzalez, amy berrington/L-7017-2017; franceschi, silvia/M-2452-2014; Eluf-Neto, Jose/B-2522-2009	de gonzalez, amy berrington/0000-0002-7332-8387; franceschi, silvia/0000-0003-4181-8071; Eluf-Neto, Jose/0000-0001-7504-2115; Plummer, Martyn/0000-0001-5130-6497	Medical Research Council [G0700474] Funding Source: Medline; MRC [G0700474] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2003, WHO CLASSIFICATION T; Appleby P, 2006, INT J CANCER, V119, P1108, DOI 10.1002/ijc.21953; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bayo S, 2002, INT J EPIDEMIOL, V31, P202, DOI 10.1093/ije/31.1.202; BERAL V, 1988, LANCET, V2, P1331; BERRY G, 1993, INT J CANCER, V55, P228; BOSCH FX, 1992, INT J CANCER, V52, P750, DOI 10.1002/ijc.2910520514; BOYCE JG, 1977, AM J OBSTET GYNECOL, V128, P761, DOI 10.1016/0002-9378(77)90717-7; BRINTON LA, 1990, INT J EPIDEMIOL, V19, P4, DOI 10.1093/ije/19.1.4; BRINTON LA, 1986, INT J CANCER, V38, P399; CELENTANO DD, 1987, AM J EPIDEMIOL, V126, P592, DOI 10.1093/oxfordjournals.aje.a114699; Chaouki N, 1998, INT J CANCER, V75, P546, DOI 10.1002/(SICI)1097-0215(19980209)75:4&lt;546::AID-IJC9&gt;3.0.CO;2-T; Chichareon S, 1998, J NATL CANCER I, V90, P50, DOI 10.1093/jnci/90.1.50; Cogliano V, 2005, LANCET ONCOL, V6, P552, DOI 10.1016/S1470-2045(05)70273-4; *COLL GROUP HORM F, 1996, CONTRACEPTION, V54, pS13; Cuzick J, 1996, EUR J CANCER, V32A, P836, DOI 10.1016/0959-8049(95)00650-8; CUZICK J, 1990, EUR J CANCER, V26, P684, DOI 10.1016/0277-5379(90)90117-C; Daling JR, 1996, CANCER EPIDEM BIOMAR, V5, P541; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; Deacon JM, 2000, BRIT J CANCER, V83, P1565, DOI 10.1054/bjoc.2000.1523; EBELING K, 1987, INT J CANCER, V39, P427, DOI 10.1002/ijc.2910390402; ELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Franceschi S, 2003, INT J CANCER, V107, P127, DOI 10.1002/ijc.11350; GRAM IT, 1992, AM J OBSTET GYNECOL, V167, P40, DOI 10.1016/S0002-9378(11)91622-6; Green J, 2003, BRIT J CANCER, V89, P2078, DOI 10.1038/sj.bjc.6601296; Hammouda D, 2005, INT J CANCER, V113, P483, DOI 10.1002/ijc.20600; HERRERO R, 1990, INT J CANCER, V46, P5, DOI 10.1002/ijc.2910460103; Hildesheim A, 2001, BRIT J CANCER, V84, P1219, DOI 10.1054/bjoc.2001.1779; Hsieh CY, 1999, ANTICANCER RES, V19, P4495; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1999, IARC MON EV CARC RIS, V72; IRWIN KL, 1988, JAMA-J AM MED ASSOC, V259, P59, DOI 10.1001/jama.259.1.59; JONES CJ, 1990, CANCER RES, V50, P3657; Kjaer SK, 1996, INT J CANCER, V65, P601, DOI 10.1002/(SICI)1097-0215(19960301)65:5<601::AID-IJC8>3.0.CO;2-6; KJAER SK, 1993, CANCER CAUSE CONTROL, V4, P513, DOI 10.1007/BF00052426; Lacey JV, 1999, CANCER EPIDEM BIOMAR, V8, P1079; LAZCANOPONCE EC, 1995, REV INVEST CLIN, V47, P377; Madeleine MM, 2001, CANCER EPIDEM BIOMAR, V10, P171; MELAMED MR, 1969, BMJ-BRIT MED J, V3, P195, DOI 10.1136/bmj.3.5664.195; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; MUNOZ N, 1993, CANCER EPIDEM BIOMAR, V2, P423; Ngelangel C, 1998, JNCI-J NATL CANCER I, V90, P43, DOI 10.1093/jnci/90.1.43; PARAZZINI F, 1988, BRIT J CANCER, V57, P201, DOI 10.1038/bjc.1988.43; Parazzini F, 1998, EUR J CANCER, V34, P884, DOI 10.1016/S0959-8049(97)10139-3; PARAZZINI F, 1992, CANCER-AM CANCER SOC, V69, P2276, DOI 10.1002/1097-0142(19920501)69:9<2276::AID-CNCR2820690912>3.0.CO;2-Q; Parkin DM, 2002, IARC SCI PUBLICATION, VVIII; PETERS RK, 1986, JNCI-J NATL CANCER I, V77, P1063; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Rajkumar T, 2006, INT J CANCER, V118, P1481; Rolon PA, 2000, INT J CANCER, V85, P486, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;486::AID-IJC7&gt;3.0.CO;2-S; Santos C, 2001, BRIT J CANCER, V85, P966, DOI 10.1054/bjoc.2001.1948; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; Shapiro S, 2003, CANCER CAUSE CONTROL, V14, P485, DOI 10.1023/A:1024910808307; Sitas F, 2000, INT J CANCER, V88, P489, DOI 10.1002/1097-0215(20001101)88:3&lt;489::AID-IJC25&gt;3.0.CO;2-Q; SLATTERY ML, 1989, AM J EPIDEMIOL, V130, P248, DOI 10.1093/oxfordjournals.aje.a115331; Smith JS, 2003, LANCET, V361, P1159, DOI 10.1016/S0140-6736(03)12949-2; TALBOTT EO, 1995, J WOMENS HLTH LARCHM, V4, P387; Thomas DB, 2001, AM J EPIDEMIOL, V153, P732, DOI 10.1093/aje/153.8.732; THOMAS DB, 1995, CONTRACEPTION, V52, P307, DOI 10.1016/0010-7824(95)00215-V; THOMAS DB, 1995, CONTRACEPTION, V51, P25, DOI 10.1016/0010-7824(94)00007-J; THOMAS DB, 1992, CONTRACEPTION, V45, P299; Thomas DB, 1996, AM J EPIDEMIOL, V144, P281, DOI 10.1093/oxfordjournals.aje.a008923; Ursin G, 1996, CANCER CAUSE CONTROL, V7, P391, DOI 10.1007/BF00052946; URSIN G, 1994, LANCET, V344, P1390, DOI 10.1016/S0140-6736(94)90567-3; WORTH AJ, 1972, J OBSTET GYN BR COMM, V79, P673; Yang BH, 2004, INT J CANCER, V109, P418, DOI 10.1002/ijc.11719; YE Z, 1995, INT J EPIDEMIOL, V24, P19, DOI 10.1093/ije/24.1.19; Ylitalo N, 1999, INT J CANCER, V81, P357, DOI 10.1002/(SICI)1097-0215(19990505)81:3<357::AID-IJC8>3.3.CO;2-T; Zondervan KT, 1996, BRIT J CANCER, V73, P1291, DOI 10.1038/bjc.1996.247	70	299	313	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2007	370	9599					1609	1621		10.1016/s0140-6736(07)61684-5	http://dx.doi.org/10.1016/s0140-6736(07)61684-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230NO	17993361				2022-12-28	WOS:000250883400020
J	Mihas, C; Alevizos, A; Arapaki, A; Mariolis, A				Mihas, Constantinos; Alevizos, Alevizos; Arapaki, Angeliki; Mariolis, Anargiros			Warfarin versus aspirin for stroke prevention (BAFTA)	LANCET			English	Letter							ATRIAL-FIBRILLATION; TRIAL		1st Hlth Care Reg Adm Attica, Hlth Ctr Vyronas, Athens 16231, Greece		Mihas, C (corresponding author), 1st Hlth Care Reg Adm Attica, Hlth Ctr Vyronas, 3 Korytsas St, Athens 16231, Greece.	gas52l@yahoo.co.uk						Lowery S, 2005, PROF CASE MANAG, V10, P39; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Mariolis Anargiros, 2007, Eur J Gen Pract, V13, P94, DOI 10.1080/13814780701379469; Matchar DB, 2002, AM J MED, V113, P42, DOI 10.1016/S0002-9343(02)01131-2; Neree Claes, 2006, Eur J Gen Pract, V12, P163, DOI 10.1080/13814780600780783	5	6	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2007	370	9599					1606	1606		10.1016/S0140-6736(07)61679-1	http://dx.doi.org/10.1016/S0140-6736(07)61679-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230NO	17993356	Bronze			2022-12-28	WOS:000250883400015
J	Matsukawa, Y; Zinkle, SJ				Matsukawa, Yoshitaka; Zinkle, Steven J.			One-dimensional fast migration of vacancy clusters in metals	SCIENCE			English	Article							STACKING-FAULT TETRAHEDRA; SELF-ORGANIZATION; DEFECTS; COPPER; ACCUMULATION; CASCADES; MOBILITY; ENERGY; GLIDE; LOOPS	The migration of point defects, for example, crystal lattice vacancies and self-interstitial atoms (SIAs), typically occurs through three-dimensional random walk in crystalline solids. However, when vacancies and SIAs agglomerate to form planar clusters, the migration mode may change. We observed nanometer-sized clusters of vacancies exhibiting one-dimensional (1D) fast migration. The 1D migration transported a vacancy cluster containing several hundred vacancies with a mobility higher than that of a single vacancy random walk and a mobility comparable to a single SIA random walk. Moreover, we found that the 1D migration may be a key physical mechanism for self-organization of nanometer-sized sessile vacancy cluster ( stacking fault tetrahedron) arrays. Harnessing this 1D migration mode may enable new control of defect microstructures such as effective defect removal and introduction of ordered nanostructures in materials, including semiconductors.	Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA; Univ Tennessee, Ctr Mat Proc, Knoxville, TN 37996 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Matsukawa, Y (corresponding author), Univ Illinois, Dept Mat Sci & Engn, Bldg 408A,1304 W Green St, Urbana, IL 61801 USA.	ym2@uiuc.edu	Matsukawa, Yoshitaka/C-2274-2011	Matsukawa, Yoshitaka/0000-0002-7888-3478; Zinkle, Steven/0000-0003-2890-6915				Abe H, 2003, J NUCL MATER, V323, P220, DOI 10.1016/j.jnucmat.2003.08.006; Arakawa K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.125506; BAUERLE JE, 1957, PHYS REV, V107, P1493, DOI 10.1103/PhysRev.107.1493; Dudarev SL, 2003, PHILOS MAG, V83, P3577, DOI 10.1080/14786430310001599388; Fisher S. B., 1970, Radiation Effects, V5, P239, DOI 10.1080/00337577008235027; FOREMAN AJE, 1992, PHILOS MAG A, V66, P655, DOI 10.1080/01418619208201583; Ghoniem NM, 2001, J COMPUT-AIDED MATER, V8, P1, DOI 10.1023/A:1015062218246; Hayashi T, 2002, J NUCL MATER, V307, P993, DOI 10.1016/S0022-3115(02)01105-4; Hirth J. P., 1972, THEORY DISLOCATIONS; Kiritani M, 1999, PHIL MAG LETT, V79, P797, DOI 10.1080/095008399176616; Kiritani M, 1997, J NUCL MATER, V251, P237, DOI 10.1016/S0022-3115(97)00278-X; KIRITANI M, 1976, J PHYS SOC JPN, V40, P1035, DOI 10.1143/JPSJ.40.1035; KOJIMA S, 1989, PHILOS MAG A, V59, P519, DOI 10.1080/01418618908229782; KUHLMANN.D, 1965, ACTA METALL MATER, V13, P257, DOI 10.1016/0001-6160(65)90203-8; Kuramoto E, 2000, J NUCL MATER, V276, P143, DOI 10.1016/S0022-3115(99)00174-9; Marian J, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144102; Ohsawa K, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.054105; Osetsky YN, 1999, PHIL MAG LETT, V79, P273, DOI 10.1080/095008399177345; Osetsky YN, 2003, PHILOS MAG, V83, P61, DOI 10.1080/0141861021000016793; Osetsky YN, 2001, NUCL INSTRUM METH B, V180, P85, DOI 10.1016/S0168-583X(01)00400-1; SEEGER A, 1991, ULTRAMICROSCOPY, V39, P342, DOI 10.1016/0304-3991(91)90214-Q; SEITZ F, 1950, PHYS REV, V79, P723, DOI 10.1103/PhysRev.79.723; SINGH BN, 2001, ENCY MAT SCI TECHNOL, P7957; TOLG C, 1994, APPL PHYS A-MATER, V58, P3, DOI 10.1007/BF00331511; TRINKAUS H, 1993, J NUCL MATER, V206, P200, DOI 10.1016/0022-3115(93)90124-H; Wirth BD, 2000, J NUCL MATER, V276, P33, DOI 10.1016/S0022-3115(99)00166-X	26	141	152	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					959	962		10.1126/science.1148336	http://dx.doi.org/10.1126/science.1148336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991860				2022-12-28	WOS:000250788500038
J	Lypka, MA; Urata, MM				Lypka, Michael A.; Urata, Mark M.			Cocaine-induced palatal perforation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ So Calif, Med Ctr, Los Angeles, CA 90033 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Southern California	Lypka, MA (corresponding author), Univ So Calif, Med Ctr, Los Angeles, CA 90033 USA.								0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1956	1956		10.1056/NEJMicm066935	http://dx.doi.org/10.1056/NEJMicm066935			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989388				2022-12-28	WOS:000250732500011
J	Hassan, MHA				Hassan, Mohamed H. A.			Building capacity in the life sciences in the developing world	CELL			English	Editorial Material								The fundamental challenge facing the scientific community is how to devise innovative strategies that will bring all developing countries into the "biological fold" and to do so in ways that will take full advantage of advances in the biological sciences to curb poverty, improve public health, and promote human development.	TWAS, Acad Sci Developing World, I-34014 Trieste, Italy		Hassan, MHA (corresponding author), TWAS, Acad Sci Developing World, I-34014 Trieste, Italy.	mhassan@twas.org						*BIOSPECTRUM IND, 2007, BIOPHARMA REC 1 45 B; Charlafti I, 2003, EMBO REP, V4, P454, DOI 10.1038/sj.embor.embor839; CHEGE K, 2005, AFRICAN UNION SETS B; ERNST, 2004, BIOTECHNOLOGY REPORT; Frew SE, 2007, NAT BIOTECHNOL, V25, P403, DOI 10.1038/nbt0407-403; Hassan MHA, 2007, SCIENCE, V316, P1813, DOI 10.1126/science.1146049; JAMES C, 2006, ISAAA BRIEFS, V35, P1; JUMA C, 2007, FREEDOM INNOVATIVE B; Kumar NK, 2004, NAT BIOTECHNOL, V22, pDC31, DOI 10.1038/nbt1204supp-DC31; Louet S, 2004, NAT BIOTECHNOL, V22, P1497, DOI 10.1038/nbt1204-1497; Motari M, 2004, NAT BIOTECHNOL, V22, pDC37, DOI 10.1038/nbt1204supp-DC37; MUGABE J, 2003, BIOTECHNOLOGY SUSTAI; Niosi J, 2007, WORLD DEV, V35, P426, DOI 10.1016/j.worlddev.2006.11.004; *PAN, 2005, 49 PAN; ROCA W, 2004, AGBIOL FORUM; SHAH F, 2006, TWAS NEWSLETTER, V18, P36; THOMPSON JA, 2004, AGBIOL; Thorsteinsdottir H, 2004, NAT BIOTECHNOL, V22, pDC19, DOI 10.1038/nbt1204supp-DC19; 2006, TWAS NEWSLETTER, V18, P35	19	15	15	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					433	436		10.1016/j.cell.2007.10.020	http://dx.doi.org/10.1016/j.cell.2007.10.020			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981107	Bronze			2022-12-28	WOS:000250618500007
J	Matchar, DB; McCrory, DC; Orlando, LA; Patel, MR; Patel, UD; Patwardhan, MB; Powers, B; Samsa, GP; Gray, RN				Matchar, David B.; McCrory, Douglas C.; Orlando, Lori A.; Patel, Manesh R.; Patel, Uptal D.; Patwardhan, Meenal B.; Powers, Benjamin; Samsa, Gregory P.; Gray, Rebecca N.			Systematic review: Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension	ANNALS OF INTERNAL MEDICINE			English	Review							AMBULATORY BLOOD-PRESSURE; LEFT-VENTRICULAR HYPERTROPHY; DOUBLE-BLIND; CANDESARTAN CILEXETIL; ELDERLY-PATIENTS; ANTIHYPERTENSIVE MEDICATIONS; ANTAGONIST LOSARTAN; COMBINATION THERAPY; CARDIAC-HYPERTROPHY; ARTERIAL STIFFNESS	Background: The relative effectiveness of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) for lowering blood pressure is unknown. Purpose: To compare the benefits and harms of ACE inhibitors versus ARBs for treating essential hypertension in adults. Data Sources: MEDLINE (1966 to May 2006), the Cochrane Central Register of Controlled Trials (Issue 2, 2006), and selected reference lists were searched for relevant English-language trials. The MEDLINE search was updated to August 2007 to identify head-to-head trials that reported blood pressure outcomes and major cardiovascular events. Study Selection: 61 clinical studies that directly compared ACE inhibitors versus ARBs in adult patients with essential hypertension, reported an outcome of interest, lasted at least 12 weeks, and included at least 20 patients. Data Extraction: A standardized protocol with predefined criteria was used to extract data on study design, interventions, population characteristics, and outcomes; evaluate study quality and applicability; and assess the strength of the body of evidence for key outcomes. Data Synthesis: ACE inhibitors and ARBs had similar long-term effects on blood pressure (50 studies; strength of evidence, high). No consistent differential effects were observed for other outcomes (few studies reported long-term outcomes), including death, cardiovascular events, quality of life, rate of single anti hypertensive agent use, lipid levels, progression to diabetes, left ventricular mass or function, and kidney disease. Consistent fair- to good-quality evidence showed that ACE inhibitors were associated with a greater risk for cough. There were fewer withdrawals due to adverse events and greater persistence with therapy for ARBs than for ACE inhibitors, although this evidence was not definitive. Patient subgroups for whom ACE inhibitors or ARBs were more effective, associated with fewer adverse events, or better tolerated were not identified. Limitations: Few studies involved a representative sample treated in a typical clinical setting over a long duration, treatment protocols had marked heterogeneity, and substantive amounts of data about important outcomes and patient subgroups were missing. Conclusion: Available evidence shows that ACE inhibitors and ARBs have similar effects on blood pressure control, and that ACE inhibitors have higher rates of cough than ARBs. Data regarding other outcomes are limited.	[Matchar, David B.; McCrory, Douglas C.; Orlando, Lori A.; Patel, Manesh R.; Patel, Uptal D.; Patwardhan, Meenal B.; Powers, Benjamin; Samsa, Gregory P.; Gray, Rebecca N.] Duke Univ, Duke Clin Res Inst, Duke Ctr Clin Hlth Policy Res, Durham, NC 27705 USA; [Matchar, David B.; McCrory, Douglas C.; Orlando, Lori A.; Patel, Manesh R.; Patel, Uptal D.; Patwardhan, Meenal B.; Powers, Benjamin; Samsa, Gregory P.; Gray, Rebecca N.] Durham US Dept Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA	Duke University	Matchar, DB (corresponding author), Duke Univ, Duke Clin Res Inst, Duke Ctr Clin Hlth Policy Res, 2200 W Main St,Suite 220, Durham, NC 27705 USA.	david.matchar@duke.edu	Matchar, David/M-3951-2019; Patel, Manesh/AAC-5385-2019	McCrory, Douglas/0000-0003-2093-0611; Orlando, Lori/0000-0003-2534-7855; Matchar, David/0000-0003-3020-2108				Amerena J, 2002, J INT MED RES, V30, P543, DOI 10.1177/147323000203000601; Anan F, 2005, EUR J CLIN PHARMACOL, V61, P353, DOI 10.1007/s00228-005-0931-8; Andersen NH, 2006, CLIN SCI, V111, P53, DOI 10.1042/CS20050367; Argenziano L, 1999, CURR MED RES OPIN, V15, P9, DOI 10.1185/03007999909115168; Avanza A C Jr, 2000, Arq Bras Cardiol, V74, P103; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Black HR, 1997, J HUM HYPERTENS, V11, P483, DOI 10.1038/sj.jhh.1000482; Bloom BS, 1998, CLIN THER, V20, P671, DOI 10.1016/S0149-2918(98)80130-6; Bourgault C, 2005, J HUM HYPERTENS, V19, P607, DOI 10.1038/sj.jhh.1001873; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Breeze E, 2001, J HUM HYPERTENS, V15, P857, DOI 10.1038/sj.jhh.1001282; Burke TA, 2006, J HYPERTENS, V24, P1193, DOI 10.1097/01.hjh.0000226211.95936.f5; Celik T, 2005, CLIN CARDIOL, V28, P298, DOI 10.1002/clc.4960280609; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CHOU R, 2005, DRUG CLASS REV ANGIO; Coca A, 2002, CLIN THER, V24, P126, DOI 10.1016/S0149-2918(02)85010-X; Conlin PR, 2001, CLIN THER, V23, P1999, DOI 10.1016/S0149-2918(01)80152-1; Cuspidi C, 2002, J HYPERTENS, V20, P2293, DOI 10.1097/00004872-200211000-00030; De Rosa ML, 2002, J HUM HYPERTENS, V16, P133, DOI 10.1038/sj.jhh.1001305; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Derosa G, 2003, CLIN THER, V25, P2006, DOI 10.1016/S0149-2918(03)80201-1; Eguchi K, 2003, AM J CARDIOL, V92, P621, DOI 10.1016/S0002-9149(03)00739-2; Elliott WJ, 1999, J HUM HYPERTENS, V13, P413, DOI 10.1038/sj.jhh.1000816; EPOSTI LD, 2002, CLIN THER, V24, P1347; Erkens JA, 2005, PHARMACOEPIDEM DR S, V14, P795, DOI 10.1002/pds.1156; Esposti ED, 2002, J HUM HYPERTENS, V16, P439, DOI 10.1038/sj/jhh/1001418; Esposti LD, 2002, CLIN THER, V24, P1347, DOI 10.1016/S0149-2918(02)80039-X; Fogari R, 2006, J HUM HYPERTENS, V20, P177, DOI 10.1038/sj.jhh.1001964; Fogari R, 2004, EUR J CLIN PHARMACOL, V59, P863, DOI 10.1007/s00228-003-0717-9; Fogari R, 2002, AM J HYPERTENS, V15, P316, DOI 10.1016/S0895-7061(01)02340-8; Fogari R, 2001, AM J HYPERTENS, V14, P921, DOI 10.1016/S0895-7061(01)02140-9; Franke H, 1997, J HUM HYPERTENS, V11, pS61; FURMAGA E, 2006, DRUG CLASS REV ANGIO, V2; Gavras I, 1999, CURR MED RES OPIN, V15, P15, DOI 10.1185/03007999909115169; Ghiadoni L, 2003, HYPERTENSION, V41, P1281, DOI 10.1161/01.HYP.0000070956.57418.22; Gregoire JP, 2001, CLIN THER, V23, P715, DOI 10.1016/S0149-2918(01)80021-7; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hasford J, 2002, J HUM HYPERTENS, V16, P569, DOI 10.1038/sj.jhh.1001451; Hosohata K, 2007, CLIN EXP HYPERTENS, V29, P69, DOI 10.1080/10641960601096976; ISRAILI ZH, 1992, ANN INTERN MED, V117, P234, DOI 10.7326/0003-4819-117-3-234; Karlberg BE, 1999, J HYPERTENS, V17, P293, DOI 10.1097/00004872-199917020-00015; Kavgaci H, 2002, DIABETES RES CLIN PR, V58, P19, DOI 10.1016/S0168-8227(02)00102-X; Koylan N, 2005, BLOOD PRESSURE, V14, P23, DOI 10.1080/08038020510040649; KYVELOU SM, 2006, J CARDIOL, V47, P21; Lacourciere Y, 2000, KIDNEY INT, V58, P762, DOI 10.1046/j.1523-1755.2000.00224.x; Lacourciere Y, 2006, AM J HYPERTENS, V19, P104, DOI 10.1016/j.amjhyper.2005.10.001; Larochelle P, 1997, AM J CARDIOL, V80, P1613, DOI 10.1016/S0002-9149(97)00784-4; Levine B, 1999, CURR MED RES OPIN, V15, P25, DOI 10.1185/03007999909115170; Mackay FJ, 1999, BRIT J CLIN PHARMACO, V47, P111; Malacco E, 2004, CLIN THER, V26, P855, DOI 10.1016/S0149-2918(04)90129-4; MALLION JM, 1995, J HYPERTENS, V13, pS35, DOI 10.1097/00004872-199507001-00005; Malmqvist K, 2000, AM J HYPERTENS, V13, P504, DOI 10.1016/S0895-7061(99)00264-2; Marentette MA, 2002, CAN J CARDIOL, V18, P649; MATCHAR DB, COMPARATIVE EFFECTIV, V2; Matsuda H, 2003, J HUM HYPERTENS, V17, P271, DOI 10.1038/sj.jhh.1001543; Mazzaglia G, 2005, J HYPERTENS, V23, P2093, DOI 10.1097/01.hjh.0000186832.41125.8a; McInnes GT, 2000, J HUM HYPERTENS, V14, P263, DOI 10.1038/sj.jhh.1000997; Mimran A, 1998, J HUM HYPERTENS, V12, P203, DOI 10.1038/sj.jhh.1000591; Mochizuki S, 2007, LANCET, V369, P1431, DOI 10.1016/S0140-6736(07)60669-2; Mogensen CE, 2000, BRIT MED J, V321, P1440, DOI 10.1136/bmj.321.7274.1440; Naidoo DP, 1999, ADV THER, V16, P187; Neutel J M, 1999, Am J Ther, V6, P161, DOI 10.1097/00045391-199905000-00007; NHS Centre for Reviews and Dissemination, 2001, 4 CRD; Nielsen S, 1997, NEPHROL DIAL TRANSPL, V12, P19; Ogawa S, 2007, HYPERTENS RES, V30, P325, DOI 10.1291/hypres.30.325; Gamiz JLP, 2006, CLIN THER, V28, P2040, DOI 10.1016/j.clinthera.2006.12.006; Palma-Gamiz JL, 2007, CLIN DRUG INVEST, V27, P407, DOI 10.2165/00044011-200727060-00004; Palmas W, 2007, AM J HYPERTENS, V20, P233, DOI 10.1016/j.amjhyper.2006.08.006; Rabbia F, 2004, CLIN DRUG INVEST, V24, P651, DOI 10.2165/00044011-200424110-00004; Ragot S, 2002, J HUM HYPERTENS, V16, P865, DOI 10.1038/sj.jhh.1001494; Rajzer M, 2003, AM J HYPERTENS, V16, P439, DOI 10.1016/S0895-7061(03)00052-9; Rehman A, 2007, AM J HYPERTENS, V20, P184, DOI 10.1016/j.amjhyper.2006.07.015; Robles NR, 2004, RENAL FAILURE, V26, P399, DOI 10.1081/JDI-120039824; Roca-Cusachs A, 1997, ACTA CARDIOL, V52, P495; Rosei EA, 2005, J HYPERTENS, V23, P435, DOI 10.1097/00004872-200502000-00027; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Ruff D, 1996, J HYPERTENS, V14, P263, DOI 10.1097/00004872-199602000-00017; Ruilope L, 2001, BLOOD PRESSURE, V10, P223, DOI 10.1080/08037050152669747; Saito S, 2004, BLOOD PRESS MONIT, V9, P243, DOI 10.1097/00126097-200410000-00003; Sato Atsuhisa, 2003, Clin Exp Nephrol, V7, P215, DOI 10.1007/s10157-003-0227-1; Scaglione R, 2007, J HUM HYPERTENS, V21, P307, DOI 10.1038/sj.jhh.1002161; Schieffer B, 2004, J AM COLL CARDIOL, V44, P362, DOI 10.1016/j.jacc.2004.03.065; Schram MT, 2005, J HUM HYPERTENS, V19, P429, DOI 10.1038/sj.jhh.1001812; Sengul AM, 2006, DIABETES RES CLIN PR, V71, P210, DOI 10.1016/j.diabres.2005.06.010; Shand BI, 2000, CLIN NEPHROL, V54, P427; Shand BI, 2000, J HUM HYPERTENS, V14, P305, DOI 10.1038/sj.jhh.1001011; Shibasaki Y, 2002, NEPHRON, V90, P256, DOI 10.1159/000049060; Spoelstra-de Man AME, 2006, J HUM HYPERTENS, V20, P599, DOI 10.1038/sj.jhh.1002025; Tedesco Michele Adolfo, 2006, J Clin Hypertens (Greenwich), V8, P634, DOI 10.1111/j.1524-6175.2006.05504.x; Tikkanen I, 1995, J HYPERTENS, V13, P1343, DOI 10.1097/00004872-199511000-00017; TOWNSEND R, 1995, CLIN THER, V17, P911, DOI 10.1016/0149-2918(95)80069-7; Uchiyama-Tanaka Y, 2005, KIDNEY BLOOD PRESS R, V28, P111, DOI 10.1159/000084254; Verdecchia P, 2000, BLOOD PRESS MONIT, V5, P187, DOI 10.1097/00126097-200006000-00008; WHO, 2002, RED RISKS PROM HLTH; Williams B, 2006, J HYPERTENS, V24, P193, DOI 10.1097/01.hjh.0000194364.11516.ab; Wogen Jennifer, 2003, J Manag Care Pharm, V9, P424	96	253	260	3	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2008	148	1					16	29		10.7326/0003-4819-148-1-200801010-00189	http://dx.doi.org/10.7326/0003-4819-148-1-200801010-00189			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248JJ	17984484	Green Published			2022-12-28	WOS:000252149300003
J	Yin, L; Wu, N; Curtin, JC; Qatanani, M; Szwergold, NR; Reid, RA; Waitt, GM; Parks, DJ; Pearce, KH; Wisely, GB; Lazar, MA				Yin, Lei; Wu, Nan; Curtin, Joshua C.; Qatanani, Mohammed; Szwergold, Nava R.; Reid, Robert A.; Waitt, Gregory M.; Parks, Derek J.; Pearce, Kenneth H.; Wisely, G. Bruce; Lazar, Mitchell A.			Rev-erb alpha, a heme sensor that coordinates metabolic and circadian pathways	SCIENCE			English	Article							WIDE EXPRESSION ANALYSIS; NUCLEAR RECEPTOR E75; CLOCK; TRANSCRIPTION; BIOSYNTHESIS; COMPONENT; BIOLOGY; OBESITY; BMAL1; MOUSE	The circadian clock temporally coordinates metabolic homeostasis in mammals. Central to this is heme, an iron- containing porphyrin that serves as prosthetic group for enzymes involved in oxidative metabolism as well as transcription factors that regulate circadian rhythmicity. The circadian factor that integrates this dual function of heme is not known. We show that heme binds reversibly to the orphan nuclear receptor Rev-erb alpha, a critical negative component of the circadian core clock, and regulates its interaction with a nuclear receptor corepressor complex. Furthermore, heme suppresses hepatic gluconeogenic gene expression and glucose output through Rev-erb alpha-mediated gene repression. Thus, Rev-erb alpha serves as a heme sensor that coordinates the cellular clock, glucose homeostasis, and energy metabolism.	Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; GlaxoSmithKline, Mol Discovery Res, Dept Computat & Struct Chem, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, Mol Discovery Res, Dept Biol Reagents & Assay Dev, Res Triangle Pk, NC 27709 USA	University of Pennsylvania; University of Pennsylvania; GlaxoSmithKline; GlaxoSmithKline	Lazar, MA (corresponding author), Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019		NIDDK NIH HHS [R01 DK45586] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045586] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Atamna H, 2004, AGEING RES REV, V3, P303, DOI 10.1016/j.arr.2004.02.002; Boehning D, 2002, SCIENCE, V298, P2339, DOI 10.1126/science.1080339; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; de Rosny E, 2006, BIOCHEMISTRY-US, V45, P9727, DOI 10.1021/bi060537a; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger Jurgen A, 2006, Chronobiol Int, V23, P135, DOI 10.1080/07420520500464411; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; SASSA S, 1983, J CLIN INVEST, V71, P625, DOI 10.1172/JCI110809; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Zhu YH, 2002, CELL GROWTH DIFFER, V13, P431	30	537	562	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1786	1789		10.1126/science.1150179	http://dx.doi.org/10.1126/science.1150179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18006707				2022-12-28	WOS:000251616800045
J	Schmidt, H				Schmidt, Harald			Patients' charters and health responsibilities	BRITISH MEDICAL JOURNAL			English	Editorial Material							PERSONAL RESPONSIBILITY		Nuffield Council Bioeth, London WC1B 3JS, England		Schmidt, H (corresponding author), Nuffield Council Bioeth, London WC1B 3JS, England.	hschmidt@nuffieldbioethics.org						Bishop G, 2006, NEW ENGL J MED, V355, P756, DOI 10.1056/NEJMp068170; BMA (British Medical Association), 2007, RAT WAY FORW NHS ENG; Cappelen AW, 2005, J MED ETHICS, V31, P476, DOI 10.1136/jme.2004.010421; CHAPMAN J, DAILY MAIN      0501; DANIELS N, 2007, JUST HLTH M HLTH FAI; EYRE E, 2007, CHARLESTON GAZE 0921; Halpern D., 2004, PERSONAL RESPONSIBIL; Harris J, 2005, J MED ETHICS, V31, P242, DOI 10.1136/jme.2005.011973; Lord Darzi A., 2007, OUR NHS OUR FUTURE N; MINKLER M, 2000, PROMOTING HLTH BEHAV, P1; *NHS SCOTL, 2006, NHS YOU VERS 1; Roemer J, 1998, EQUALITY OPPORTUNITY; SCHMIDT H, 2007, EUR J HLTH LAW, V14, P1; Steinbrook R, 2006, NEW ENGL J MED, V355, P753, DOI 10.1056/NEJMp068141; Waller BN, 2005, CAMB Q HEALTHC ETHIC, V14, P177; Wanless, 2002, SECURING OUR FUTURE; Wikler D, 2005, PUBLIC HLTH ETHICS E, P109; *WV DEP HLTH HUM R, IMP NOT CHANG YOUR M; *WV DEP HLTH HUM R, W VIRG MED MEMB AGR; [No title captured]; 2007, BBC NEWS ONLINE 0704	21	26	27	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 8	2007	335	7631					1187	1189		10.1136/bmj.39387.393160.AD	http://dx.doi.org/10.1136/bmj.39387.393160.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242ER	18003858	Green Published			2022-12-28	WOS:000251707800031
J	Reeves, GK; Pirie, K; Beral, V; Green, J; Spencer, E; Bull, D				Reeves, Gillian K.; Pirie, Kirstin; Beral, Valerie; Green, Jane; Spencer, Elizabeth; Bull, Diana		Million Women Study Collaboration	Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study	BRITISH MEDICAL JOURNAL			English	Article							CUTANEOUS MALIGNANT-MELANOMA; NON-HODGKINS-LYMPHOMA; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; GASTRIC CARDIA; OVARIAN-CANCER; ALCOHOL INTAKE; BREAST-CANCER; US ADULTS; RISK	Objective To examine the relation between body mass index (kg/m(2)) and cancer incidence and mortality. Design Prospective cohort study. Participants 1.2 million UK women recruited into the Million Women Study, aged 50-64 during 1996-2001, and followed up, on average, for 5.4 years for cancer incidence and 7.0 years for cancer mortality. Main outcome measures Relative risks of incidence and mortality for all cancers, and for 17 specific types of cancer, according to body mass index, adjusted forage, geographical region, socioeconomic status, age at first birth, parity, smoking status, alcohol intake, physical activity, years since menopause, and use of hormone replacement therapy. Results 45 037 incident cancers and 17 203 deaths from cancer occurred over the follow-up period. Increasing body mass index was associated with an increased incidence of endometrial cancer (trend in relative risk per 10 units=2.89, 95% confidence interval 2.62 to 3.18), adenocarcinoma of the oesophagus (2.38, 1.59 to 3.56), kidney cancer (1.53, 1.27 to 1.84), leukaemia (1.50, 1.23 to 1.83), multiple myeloma (1.31, 1.04 to 1.65), pancreatic cancer (1.24, 1.03 to 1.48), non-Hodgkin's lymphoma (1.17, 1.03 to 1.34), ovarian cancer (1.14, 1.03 to 1.27), all cancers combined (1.12, 1.09 to 1.14), breast cancer in postmenopausal women (1.40, 1.31 to 1.49) and colorectal cancer in premenopausal women (1.61, 1.05 to 2.48). In general, the relation between body mass index and mortality was similar to that for incidence. For colorectal cancer, malignant melanoma, breast cancer, and enclometrial cancer, the effect of body mass index on risk differed significantly according to menopausal status. Conclusions Increasing body mass index is associated with a significant increase in the risk of cancer for 10 out of 17 specific types examined. Among postmenopausal women in the UK, 5% of all cancers (about 6060 annually) are attributable to being overweight or obese. For endometrial cancer and adenocarcinorna of the oesophagus, body mass index represents a major modifiable risk factor; about half of all cases in postmenopausal women are attributable to overweight or obesity.			Reeves, GK (corresponding author), Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England.	gill.reeves@ceu.ox.ac.uk		Spencer, Elizabeth/0000-0002-9079-8006; Pirie, Kirstin/0000-0002-0561-4904	Medical Research Council [G0700474] Funding Source: Medline; MRC [G0700474] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Calle EE, 2005, NEW ENGL J MED, V353, P2197, DOI 10.1056/NEJM200511173532020; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; *DEP HLTH, 2005, HLTH SURV ENGL 2004; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; FARROW DC, 1989, AM J EPIDEMIOL, V129, P1300, DOI 10.1093/oxfordjournals.aje.a115249; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; FRANCESCHI S, 1989, NUTR CANCER, V12, P333, DOI 10.1080/01635588909514034; Freedman DM, 2003, CANCER CAUSE CONTROL, V14, P847, DOI 10.1023/B:CACO.0000003839.56954.73; Gallus S, 2006, MELANOMA RES, V16, P83, DOI 10.1097/01.cmr.0000194429.77643.76; Holly EA, 1999, AM J EPIDEMIOL, V150, P375, DOI 10.1093/oxfordjournals.aje.a010017; International Agency for Research on Cancer, 2002, IARC HDB CANC PREV W; KABAT GC, 1993, CANCER CAUSE CONTROL, V4, P123, DOI 10.1007/BF00053153; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Magnusson CMK, 2005, BREAST CANCER RES, V7, P83, DOI 10.1186/bcr1014; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Martinez ME, 1997, J NATL CANCER I, V89, P948, DOI 10.1093/jnci/89.13.948; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Organization WH, 1998, WELLB MEAS PRIM HLTH; Patel AV, 2005, CANCER EPIDEM BIOMAR, V14, P459, DOI 10.1158/1055-9965.EPI-04-0583; PHILLIPS RL, 1985, JNCI-J NATL CANCER I, V74, P307; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Purdie DM, 2001, CANCER CAUSE CONTROL, V12, P855, DOI 10.1023/A:1012267619561; Ross JA, 2004, CANCER EPIDEM BIOMAR, V13, P1810; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Shors AR, 2001, CANCER CAUSE CONTROL, V12, P599, DOI 10.1023/A:1011211615524; Spencer EA, 2004, PUBLIC HEALTH NUTR, V7, P723, DOI 10.1079/PHN2004600; Terry P, 2001, BRIT J CANCER, V85, P346, DOI 10.1054/bjoc.2001.1894; Terry PD, 2002, GUT, V51, P191, DOI 10.1136/gut.51.2.191; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; THUNE I, 1993, INT J CANCER, V55, P555, DOI 10.1002/ijc.2910550406; TOMBERG SA, 1994, BRIT J CANCER, V69, P358; Townsend PP., 1988, HLTH DEPRIVATION INE; Veierod MB, 1997, INT J CANCER, V71, P600, DOI 10.1002/(SICI)1097-0215(19970516)71:4&lt;600::AID-IJC15&gt;3.0.CO;2-F; Whitlock G, 2001, EUR J EPIDEMIOL, V17, P907, DOI 10.1023/A:1016228410194; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; World Health Organization Expert Committee, 1995, WHO TECHN REP SER	42	939	958	0	74	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1134	1139		10.1136/bmj.39367.495995.AE	http://dx.doi.org/10.1136/bmj.39367.495995.AE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	17986716	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000251596100034
J	Merriam, LC; Chess, A				Merriam, Lillian C.; Chess, Andrew			cis-regulatory elements within the odorant receptor coding region	CELL			English	Editorial Material							MOUSE; EXPRESSION; CHOICE	Complex regulatory mechanisms lead to the expression in each olfactory neuron of one allele of only one of the 1000 odorant receptor (OR) genes. In this issue, Nguyen et al. (2007) provide evidence that regulatory elements residing within the coding region of OR genes are involved in the singularity of OR gene expression.	[Merriam, Lillian C.; Chess, Andrew] Massachusetts Gen Hosp, Ctr Human Genet Res, Harvard Med Sch, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Chess, A (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Harvard Med Sch, Dept Med, Simchess Res Bldg,185 Cambridge St, Boston, MA 02114 USA.	chess@chgr.mgh.harvard.edu						BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Lane RP, 2002, GENOME RES, V12, P81, DOI 10.1101/gr.197901; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; NGUYEN MQ, 2007, CELL; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015	9	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 30	2007	131	5					844	846		10.1016/j.cell.2007.11.016	http://dx.doi.org/10.1016/j.cell.2007.11.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045531	Bronze			2022-12-28	WOS:000251800900008
J	Wan, FY; Anderson, DE; Barnitz, RA; Snow, A; Bidere, N; Zheng, LX; Hegde, V; Lam, LT; Staudt, LM; Levens, D; Deutsch, WA; Lenardo, MJ				Wan, Fengyi; Anderson, D. Eric; Barnitz, Robert A.; Snow, Andrew; Bidere, Nicolas; Zheng, Lixin; Hegde, Vijay; Lam, Lloyd T.; Staudt, Louis M.; Levens, David; Deutsch, Walter A.; Lenardo, Michael J.			Ribosomal protein S3: A KH domain subunit in NF-kappa B complexes that mediates selective gene regulation	CELL			English	Article							RIBOSOMAL-PROTEIN S3; NUCLEAR RIBONUCLEOPROTEIN-K; BINDING SITES; DNA-BINDING; HUMAN-CELLS; TRANSCRIPTION; INDUCTION; ACTIVATION; COACTIVATORS; HETERODIMER	NF-kappa B is a DNA-binding protein complex that transduces a variety of activating signals from the cytoplasm to specific sets of target genes. To understand the preferential recruitment of NF-kappa B to specific gene regulatory sites, we used NF-kappa B p65 in a tandem affinity purification and mass spectrometry proteomic screen. We identified ribosomal protein S3 (RPS3), a KH domain protein, as a non-Rel subunit of p65 homodimer and p65-p50 heterodimer DNA-binding complexes that synergistically enhances DNA binding. RPS3 knockdown impaired NF-kappa B-mediated transcription of selected p65 target genes but not nuclear shuttling or global protein translation. Rather, lymphocyte-activating stimuli caused nuclear translocation of RPS3, parallel to p65, to form part of NF-kappa B bound to specific regulatory sites in chromatin. Thus, RPS3 is an essential but previously unknown subunit of NF-kappa B involved in the regulation of key genes in rapid cellular activation responses. Our observations provide insight into how NF-kappa B selectively controls gene expression.	[Wan, Fengyi; Barnitz, Robert A.; Snow, Andrew; Bidere, Nicolas; Zheng, Lixin; Lenardo, Michael J.] NIAID, Immunol Lab, Bethesda, MD 20892 USA; [Anderson, D. Eric] Natl Inst Diabet & Digesti & Kidney Dis, Prot & Mass Spectrometry Facil, Bethesda, MD 20892 USA; [Lam, Lloyd T.; Staudt, Louis M.] Ctr Canc Res, Natl Canc Inst, Metabolism Branch, Bethesda, MD 20892 USA; [Levens, David] Ctr Canc Res, Natl Canc Inst, Pathol Lab, Bethesda, MD 20892 USA; [Hegde, Vijay; Deutsch, Walter A.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, Bethesda, MD 20892 USA.	lenardo@nih.gov	Staudt, Louis/AAC-5324-2019; Levens, David/C-9216-2009; Bidère, Nicolas/K-8887-2015	Levens, David/0000-0002-7616-922X; Bidère, Nicolas/0000-0001-9177-0008; Barnitz, Tony/0000-0002-9634-4558; Snow, Andrew/0000-0002-8728-6691	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA 109798] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000565] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; BRISKIN M, 1988, SCIENCE, V242, P1036, DOI 10.1126/science.3143155; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen WJ, 2004, J BIOL CHEM, V279, P13496, DOI 10.1074/jbc.M212390200; Furumoto Y, 2006, J IMMUNOL, V176, P5167, DOI 10.4049/jimmunol.176.9.5167; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hegde V, 2004, DNA REPAIR, V3, P121, DOI 10.1016/j.dnarep.2003.10.004; Hegde V, 2007, DNA REPAIR, V6, P94, DOI 10.1016/j.dnarep.2006.09.004; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; Lam LT, 2005, CLIN CANCER RES, V11, P28; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P5056, DOI 10.1073/pnas.91.11.5056; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Phelps CB, 2000, J BIOL CHEM, V275, P24392, DOI 10.1074/jbc.M003784200; Sathe SS, 2004, P NATL ACAD SCI USA, V101, P192, DOI 10.1073/pnas.0306812101; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Sen R, 2006, IMMUNITY, V25, P871, DOI 10.1016/j.immuni.2006.12.003; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; TOMONAGA T, 1995, J BIOL CHEM, V270, P4875, DOI 10.1074/jbc.270.9.4875; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; URBAN MB, 1991, EMBO J, V10, P1817, DOI 10.1002/j.1460-2075.1991.tb07707.x; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009	34	256	275	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					927	939		10.1016/j.cell.2007.10.009	http://dx.doi.org/10.1016/j.cell.2007.10.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045535	Bronze			2022-12-28	WOS:000251800900015
J	Handke, M; Harloff, A; Olschewski, M; Hetzel, A; Geibel, A				Handke, Michael; Harloff, Andreas; Olschewski, Manfred; Hetzel, Andreas; Geibel, Annette			Patent foramen ovale and cryptogenic stroke in older patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATRIAL SEPTAL ANEURYSM; ISCHEMIC-STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; PULMONARY-EMBOLISM; RISK FACTOR; ATHEROSCLEROTIC DISEASE; PERCUTANEOUS CLOSURE; AORTIC-ARCH; POPULATION; EVENTS	Background Studies to date have shown an association between the presence of patent foramen ovale and cryptogenic stroke in patients younger than 55 years of age. This association has not been established in patients 55 years of age or older. Methods We prospectively examined 503 consecutive patients who had had a stroke, and we compared the 227 patients with cryptogenic stroke and the 276 control patients with stroke of known cause. We examined the prevalences of patent foramen ovale and of patent foramen ovale with concomitant atrial septal aneurysm in all patients, using transesophageal echocardiography. We also compared data for the 131 younger patients (<55 years of age) and those for the 372 older patients (>= 55 years of age). Results The prevalence of patent foramen ovale was significantly greater among patients with cryptogenic stroke than among those with stroke of known cause, for both younger patients (43.9% vs. 14.3%; odds ratio, 4.70; 95% confidence interval [CI], 1.89 to 11.68; P<0.001) and older patients (28.3% vs. 11.9%; odds ratio, 2.92; 95% CI, 1.70 to 5.01; P<0.001). Even stronger was the association between the presence of patent foramen ovale with concomitant atrial septal aneurysm and cryptogenic stroke, as compared with stroke of known cause, among both younger patients (13.4% vs. 2.0%; odds ratio, 7.36; 95% CI, 1.01 to 326.60; P=0.049) and older patients (15.2% vs. 4.4%; odds ratio, 3.88; 95% CI, 1.78 to 8.46; P<0.001). Multivariate analysis adjusted for age, plaque thickness, and presence or absence of coronary artery disease and hypertension showed that the presence of patent foramen ovale was independently associated with cryptogenic stroke in both the younger group (odds ratio, 3.70; 95% CI, 1.42 to 9.65; P=0.008) and the older group (odds ratio, 3.00; 95% CI, 1.73 to 5.23; P<0.001). Conclusions There is an association between the presence of patent foramen ovale and cryptogenic stroke in both older patients and younger patients. These data suggest that paradoxical embolism is a cause of stroke in both age groups.	Univ Hosp Freiburg, Dept Cardiol & Angiol, Freiburg, Germany; Univ Hosp Freiburg, Dept Neurol & Neurophysiol, Freiburg, Germany; Univ Hosp Freiburg, Dept Med Biometry & Stat, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Handke, M (corresponding author), Univ Basel Hosp, Dept Cardiol, Petersgraben 4, CH-4031 Basel, Switzerland.	handkem@uhbs.ch						ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; AMARENCO P, 1994, NEW ENGL J MED, V331, P1474, DOI 10.1056/NEJM199412013312202; Amarenco P, 1996, NEW ENGL J MED, V334, P1216; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; CABANES L, 1993, STROKE, V24, P1865, DOI 10.1161/01.STR.24.12.1865; De Castro S, 2006, J CARDIOVASC MED, V7, P191, DOI 10.2459/01.JCM.0000215272.32273.b9; Di Tullio MR, 2007, J AM COLL CARDIOL, V49, P797, DOI 10.1016/j.jacc.2006.08.063; DITULLIO M, 1992, ANN INTERN MED, V117, P461, DOI 10.7326/0003-4819-117-6-461; Fraticelli A, 1998, ARCH GERONTOL GERIAT, V27, P41, DOI 10.1016/S0167-4943(98)00016-8; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Homma S, 2004, STROKE, V35, P2145, DOI 10.1161/01.STR.0000135773.24116.18; Iwanaga T, 2007, J NEUROL SCI, V254, P102, DOI 10.1016/j.jns.2007.01.006; JOB FP, 1994, AM J CARDIOL, V74, P381, DOI 10.1016/0002-9149(94)90407-3; JONES EF, 1994, AM J CARDIOL, V74, P596, DOI 10.1016/0002-9149(94)90750-1; KASPER W, 1992, LANCET, V340, P561, DOI 10.1016/0140-6736(92)92102-L; Kessel-Schaefer A, 2001, CIRCULATION, V103, P1928; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; Meier B, 2006, J AM COLL CARDIOL, V47, P446, DOI 10.1016/j.jacc.2005.11.024; Nomura E, 2005, INTERNAL MED, V44, P401, DOI 10.2169/internalmedicine.44.401; Overell JR, 2000, NEUROLOGY, V55, P1172, DOI 10.1212/WNL.55.8.1172; Petty GW, 1999, STROKE, V30, P2513, DOI 10.1161/01.STR.30.12.2513; SACCO RL, 1989, ANN NEUROL, V25, P382, DOI 10.1002/ana.410250410; Stone DA, 1996, AM HEART J, V131, P158, DOI 10.1016/S0002-8703(96)90065-4; Wahl A, 2001, NEUROLOGY, V57, P1330, DOI 10.1212/WNL.57.7.1330; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; WEBSTER MWI, 1988, LANCET, V2, P11; Windecker S, 2004, J AM COLL CARDIOL, V44, P750, DOI 10.1016/j.jacc.2004.05.044; Yeung M, 1996, J NEUROL NEUROSUR PS, V61, P445, DOI 10.1136/jnnp.61.5.445	30	396	422	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2262	2268		10.1056/NEJMoa071422	http://dx.doi.org/10.1056/NEJMoa071422			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	18046029				2022-12-28	WOS:000251176400007
J	AbouZahr, C; Cleland, J; Coullare, F; Macfarlane, SB; Notzon, FC; Setel, P; Szreter, S				AbouZahr, Carla; Cleland, John; Coullare, Francesca; Macfarlane, Sarah B.; Notzon, Francis C.; Setel, Philip; Szreter, Simon		MiVE Writing Grp	Who counts? 4 - The way forward	LANCET			English	Article							NEONATAL DEATHS	Good public-health decisionmaking is dependent on reliable and timely statistics on births and deaths (including the medical causes of death). All high-income countries, without exception, have national civil registration systems that record these events and generate regular, frequent, and timely vital statistics. By contrast, these statistics are not available in many low-income and lower-middle-income countries, even though it is in such settings that premature mortality is most severe and the need for robust evidence to back decisionmaking most critical. Civil registration also has a range of benefits for individuals in terms of legal status, and the protection of economic, social, and human rights. However, over the past 30 years, the global health and development community has failed to provide the needed technical and financial support to countries to develop civil registration systems. There is no single blueprint for establishing and maintaining such systems and ensuring the availability of sound vital statistics. Each country faces a different set of challenges, and strategies must be tailored accordingly. There are steps that can be taken, however, and we propose an approach that couples the application of methods to generate better vital statistics in the short term with capacity-building for comprehensive civil registration systems in the long run.	WHO, Hlth Metr Network, CH-1211 Geneva 27, Switzerland; London Sch Hyg & Trop Med, London WC1, England; UN Stat Div, New York, NY USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Atlanta, GA USA; Univ N Carolina, Dept Epidemiol & Anthropol, Chapel Hill, NC 27515 USA; Univ Cambridge, Hist Fac, Cambridge, England; Univ Cambridge, St Johns Coll, Cambridge, England	World Health Organization; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); University of North Carolina; University of North Carolina Chapel Hill; University of Cambridge; University of Cambridge	AbouZahr, C (corresponding author), WHO, Hlth Metr Network, Ave Appia, CH-1211 Geneva 27, Switzerland.	abouzahrc@who.int	Cleland, John G./AAZ-4185-2020; Setel, Philip/ABD-6362-2020; Rao, Chalapati/H-7645-2012	Cleland, John G./0000-0002-1471-7016; Setel, Philip/0000-0002-9042-5699; Nien, Jyh Kae/0000-0002-2572-9653; Rao, Chalapati/0000-0002-9554-0581; Jakob, Robert/0000-0001-6542-7548; Shibuya, Kenji/0000-0003-2528-7530; Szreter, Simon/0000-0001-6903-2447				[Anonymous], INT STAT CLASS DIS; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; Campbell C, 2005, B WORLD HEALTH ORGAN, V83, P462; DABABNEH AM, 2004, HASHEMITE KINGDOM JO; HILL K, 2007, LANCET; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn J, 1998, IMPROVING VITAL REGI; LEWIS G, 2001, 5 CONF ENQ MAT DEATH; LOZANO RA, 2006, POSIBLE SEUIR MEJORA; *LTH METR NETW, 2007, IN PRESS MON VIT EV; Lu TH, 2002, SOC SCI MED, V55, P1663, DOI 10.1016/S0277-9536(01)00298-2; Mahapatra P, 2007, LANCET; MCCARTHY BJ, 1980, AM J PUBLIC HEALTH, V70, P977, DOI 10.2105/AJPH.70.9.977; MORIYAMA IM, 1990, MEASUREMENT BIRTH DE; Mozumder K A, 1990, Asia Pac Popul J, V5, P63; Padmanabha P, 1993, REV EVALUATION UNFPA; *PANAMERICAN HLTH, 2007, IN PRESS CERT INT PR; Powell N, 1981, MAJOR OBSTACLES ACHI; *PRIA, 2005, CONC PAP BIRTH DEATH; Rao C, 2005, B WORLD HEALTH ORGAN, V83, P618; Rao C, 2004, SO AFR J DEMOGRAPHY, P81; Rommelmann V, 2005, B WORLD HEALTH ORGAN, V83, P569; ROSENBERG HM, 1991, IMP CAUS DEATH QUEY; SETAL PW, 2007, LANCET; SOLEMAN N, 2006, B WORLD HEALTH ORGAN, V84, P161; *UN DEP EC SOC AFF, 2004, REP WORKSH IMPR FERT; *UN STAT DIV, 1998, UN STAT DIV HDB CI F; *UN STAT DIV, 2000, WORKSH STRENGTH CIV; *UN STAT DIV, 2001, PRINC REC VIT STAT S, P3; *UNICEF, CHILD PROT INF SHEET; UNICEF, 2002, BIRTH REG RIGHT STAR; *WHO, 2007, VERB AUT STAND ASC A; *WHO REG OFF EUR, 2007, EUR075063181 WHO REG; *WHO SEARO, 2007, SRI LANK STAT MORT S; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; [No title captured]	37	58	58	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 24	2007	370	9601					1791	1799		10.1016/S0140-6736(07)61310-5	http://dx.doi.org/10.1016/S0140-6736(07)61310-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234DI	18029003	Green Submitted			2022-12-28	WOS:000251140500024
J	McCartney, M				McCartney, Margaret			Medicine and the media - Mixed messages over breast milk and brainy babies	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				DER G, 2006, BRIT MED J, V333, P945; 2007, PNAS	2	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 24	2007	335	7629					1074	1074		10.1136/bmj.39401.651146.0F	http://dx.doi.org/10.1136/bmj.39401.651146.0F			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UX	18033929	Green Published			2022-12-28	WOS:000251403000033
J	Ratnam, LA; Nelson, SR; Belli, AM				Ratnam, L. A.; Nelson, S. R.; Belli, A. M.			Rational imaging - Investigating progressive unexplained renal impairment and hypertension	BRITISH MEDICAL JOURNAL			English	Article							ARTERY STENOSIS	Diagnosing renal artery stenosis can be difficult. This article explores possible types of imaging for this, ranging from safe, inexpensive tests to more invasive procedures.	Gen Hosp St Georg, Dept Radiol, London SW17 0QT, England	St Georges University London	Belli, AM (corresponding author), Gen Hosp St Georg, Dept Radiol, London SW17 0QT, England.	Anna.Belli@stgeorges.nhs.uk	Ratnam, Lakshmi/W-3996-2019					Bongers V, 2000, CLIN RADIOL, V55, P346, DOI 10.1053/crad.2000.0435; Broome DR, 2007, AM J ROENTGENOL, V188, P586, DOI 10.2214/AJR.06.1094; McLaughlin K, 2000, BRIT MED J, V320, P1124, DOI 10.1136/bmj.320.7242.1124; Paven G, 2006, NEPHROLOGY, V11, P68, DOI 10.1111/j.1440-1797.2006.00546.x; Scoble JE, 1999, J ROY SOC MED, V92, P505, DOI 10.1177/014107689909201004	5	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 24	2007	335	7629					1094	1096		10.1136/bmj.39363.672743.AD	http://dx.doi.org/10.1136/bmj.39363.672743.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UX	18033932	Green Published			2022-12-28	WOS:000251403000039
J	Jorgensen, C; Enberg, K; Dunlop, ES; Arlinghaus, R; Boukal, DS; Brander, K; Ernande, B; Gardmark, A; Johnston, F; Matsumura, S; Pardoe, H; Raab, K; Silva, A; Vainikka, A; Dieckmann, U; Heino, M; Rijnsdorp, AD				Jorgensen, Christian; Enberg, Katja; Dunlop, Erin S.; Arlinghaus, Robert; Boukal, David S.; Brander, Keith; Ernande, Bruno; Gaerdmark, Anna; Johnston, Fiona; Matsumura, Shuichi; Pardoe, Heidi; Raab, Kristina; Silva, Alexandra; Vainikka, Anssi; Dieckmann, Ulf; Heino, Mikko; Rijnsdorp, Adriaan D.			Ecology - Managing evolving fish stocks	SCIENCE			English	Editorial Material							FISHERIES; MANAGEMENT; EVOLUTION; MATURATION; HISTORY; TRAITS; YIELDS		Univ Bergen, Dept Biol, N-5020 Bergen, Norway; Inst Marine Res, N-5024 Bergen, Norway; Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; Humboldt Univ, Inst Anim Sci, Berlin, Germany; Int Council Explorat Sea, Copenhagen, Denmark; IFREMER, F-14520 Port En Bessin, France; Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; Swedish Board Fisheries, Inst Coastal Res, Oregrund, Sweden; Marine Res Inst, IS-121 Reykjavik, Iceland; Univ Iceland, Inst Biol, Reykjavik, Iceland; Holaskoli, Saudarkrokur, Iceland; INRB IPIMAR, Natl Inst Agr & Fisheries, Lisbon, Portugal; Wageningen Inst Marine Resources & Ecosyst Studie, Ijmuiden, Netherlands	University of Bergen; Institute of Marine Research - Norway; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin; Ifremer; International Institute for Applied Systems Analysis (IIASA); Marine & Freshwater Research Institute (MFRI); University of Iceland; Portuguese Institute of Sea & Fisheries Research (IPIMAR); Wageningen University & Research	Jorgensen, C (corresponding author), Univ Bergen, Dept Biol, N-5020 Bergen, Norway.	christian.jorgensen@bio.uib.no	Enberg, Katja/C-8630-2009; Brander, Keith/AAN-6278-2021; Dieckmann, Ulf/E-1424-2011; Rijnsdorp, Adriaan/A-4217-2008; SILVA, MARIA ALEXANDRA/I-4326-2017; Boukal, David/H-4762-2014; Pardoe, Heidi/B-6581-2008; Jørgensen, Christian/B-4453-2009; Arlinghaus, Robert/E-3340-2010; Ernande, Bruno/C-1182-2008; Heino, Mikko P/C-7241-2009; Arlinghaus, Robert/J-6171-2019; Gårdmark, Anna/AAC-3909-2021; Matsumura, Shuichi/C-7986-2013; Dunlop, Erin/HGA-8508-2022	Enberg, Katja/0000-0002-0045-7604; Dieckmann, Ulf/0000-0001-7089-0393; Rijnsdorp, Adriaan/0000-0003-0785-9662; SILVA, MARIA ALEXANDRA/0000-0002-2950-1429; Boukal, David/0000-0001-8181-7458; Jørgensen, Christian/0000-0001-7087-4625; Arlinghaus, Robert/0000-0003-2861-527X; Ernande, Bruno/0000-0002-0727-5774; Heino, Mikko P/0000-0003-2928-3940; Matsumura, Shuichi/0000-0002-0368-006X; Brander, Keith/0000-0001-9927-9600; Vainikka, Anssi/0000-0002-0172-5615				Ashley MV, 2003, BIOL CONSERV, V111, P115, DOI 10.1016/S0006-3207(02)00279-3; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; CLARK CW, 2006, WORLDWIDE CRISIS FIS; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Dieckmann U, 2007, MAR ECOL PROG SER, V335, P253, DOI 10.3354/meps335253; FAO, 1996, 2 FAO; Francis RC, 2007, FISHERIES, V32, P217, DOI 10.1577/1548-8446(2007)32[217:TCFBFS]2.0.CO;2; GJEDREM T, 1983, AQUACULTURE, V33, P51, DOI 10.1016/0044-8486(83)90386-1; Heino M, 2002, B MAR SCI, V70, P639; LAW R, 1989, EVOL ECOL, V3, P343, DOI 10.1007/BF02285264; Law R, 2007, MAR ECOL PROG SER, V335, P271, DOI 10.3354/meps335271; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Mertz G, 1998, CAN J FISH AQUAT SCI, V55, P478, DOI 10.1139/cjfas-55-2-478; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; RIJNSDORP AD, 1993, OECOLOGIA, V96, P391, DOI 10.1007/BF00317510; Scheffer M, 2005, TRENDS ECOL EVOL, V20, P579, DOI 10.1016/j.tree.2005.08.018; *US FAO, 2003, 4 FAO S, V2; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x	20	489	502	1	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1247	1248		10.1126/science.1148089	http://dx.doi.org/10.1126/science.1148089			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033868	Green Published, Green Submitted			2022-12-28	WOS:000251086600025
J	Rosenbaum, RS; Stuss, DT; Levine, B; Tuiving, E				Rosenbaum, R. Shayna; Stuss, Donald T.; Levine, Brian; Tuiving, Endel			Theory of mind is independent of episodic memory	SCIENCE			English	Article							AMNESIA; SELF		York Univ, Dept Psychol, Toronto, ON M3J 1P3, Canada; Rotman Res Inst, Toronto, ON M3J 1P3, Canada	York University - Canada; University of Toronto; University Toronto Affiliates; Baycrest	Rosenbaum, RS (corresponding author), York Univ, Dept Psychol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	shaynar@yorku.ca	Levine, Brian/G-4328-2010; Levine, Brian/O-2725-2019	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X				Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; PERNER J, 1995, J EXP CHILD PSYCHOL, V59, P516, DOI 10.1006/jecp.1995.1024; Rosenbaum RS, 2005, NEUROPSYCHOLOGIA, V43, P989, DOI 10.1016/j.neuropsychologia.2004.10.007; Schacter DL, 2007, NATURE, V445, P27, DOI 10.1038/445027a	7	93	92	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1257	1257		10.1126/science.1148763	http://dx.doi.org/10.1126/science.1148763			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033875	Green Submitted			2022-12-28	WOS:000251086600032
J	Leach, M				Leach, Melissa			Accommodating dissent	NATURE			English	Editorial Material									Univ Sussex, Inst Dev Studies, ESRC STEPS Ctr, Brighton BN1 9RE, E Sussex, England	UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Sussex	Leach, M (corresponding author), Univ Sussex, Inst Dev Studies, ESRC STEPS Ctr, Brighton BN1 9RE, E Sussex, England.				Economic and Social Research Council [ES/D004594/1] Funding Source: researchfish; ESRC [ES/D004594/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))			0	7	8	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					483	483		10.1038/450483a	http://dx.doi.org/10.1038/450483a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033281	Bronze			2022-12-28	WOS:000251158500024
J	Levy, RM; Komanduri, S				Levy, Ronald M.; Komanduri, Srinadh			Trichobezoar	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Rush Univ, Med Ctr, Chicago, IL 60612 USA	Rush University	Levy, RM (corresponding author), Rush Univ, Med Ctr, Chicago, IL 60612 USA.			Komanduri, Srinadh/0000-0002-3666-7654					0	5	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					E23	E23		10.1056/NEJMicm067796	http://dx.doi.org/10.1056/NEJMicm067796			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	18032760				2022-12-28	WOS:000251076500009
J	Caceres, JF; Misteli, T				Caceres, Javier F.; Misteli, Tom			Division of labor: Minor splicing in the cytoplasm	CELL			English	Editorial Material							SPLICEOSOME; PROTEINS; INTRONS; U12	There are two molecular machineries for pre-mRNA splicing - the major spliceosome and the minor spliceosome. In this issue of Cell, Konig et al. (2007) demonstrate that the two splicing pathways are spatially separated in the cell and may have distinct functions.	MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; NCI, NIH, Bethesda, MD 20892 USA	University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Caceres, JF (corresponding author), MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland.	javier.caceres@hgu.mrc.ac.uk; mistelit@mail.nih.gov	Caceres, Javier F/D-5260-2013	Caceres, Javier F/0000-0001-8025-6169	Medical Research Council [MC_U127584479] Funding Source: Medline; MRC [MC_U127584479] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Russell AG, 2006, NATURE, V443, P863, DOI 10.1038/nature05228; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604	9	7	7	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					645	647		10.1016/j.cell.2007.11.001	http://dx.doi.org/10.1016/j.cell.2007.11.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022356	Bronze			2022-12-28	WOS:000250966300009
J	Kerr, E; Fleming, B				Kerr, Eve; Fleming, Barbara			Making performance indicators work: experiences of US Veterans Health Administration	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY-OF-CARE; DIABETES CARE; LESSONS; SYSTEM; PAY		Vet Affairs Ann Arbor Healthcare Syst, Ctr Practice Management Res, Ann Arbor, MI 48113 USA; Vet Hlth Adm, Washington, DC 20420 USA; Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Michigan System; University of Michigan	Kerr, E (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, Ctr Practice Management Res, POB 130170, Ann Arbor, MI 48113 USA.	ekerr@umich.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NIDDK NIH HHS [P60DK-20572] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Demakis JG, 2000, MED CARE, V38, pS17; Hayward RA, 2005, HEALTH AFFAIR, V24, P1571, DOI 10.1377/hlthaff.24.6.1571; Hayward RA, 2007, NEW ENGL J MED, V356, P951, DOI 10.1056/NEJMe068285; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; Kerr EA, 2003, MED CARE, V41, P1173, DOI 10.1097/01.MLR.0000088453.57269.29; Kerr EA, 2001, AM J MANAG CARE, V7, P1033; Kupersmith J, 2007, HEALTH AFFAIR, V26, pW156, DOI 10.1377/hlthaff.26.2.w156; Lomas J, 2003, BMJ-BRIT MED J, V327, P1301, DOI 10.1136/bmj.327.7427.1301; LONGMAN P, 2005, WASHINGTON MONTHLY, V37, P38; MacLean CH, 2006, MED CARE, V44, P141, DOI 10.1097/01.mlr.0000196960.12860.de; Oliver A, 2007, MILBANK Q, V85, P5, DOI 10.1111/j.1468-0009.2007.00475.x; Perlin JB, 2004, AM J MANAG CARE, V10, P828; Pogach L, 2007, JAMA-J AM MED ASSOC, V297, P520, DOI 10.1001/jama.297.5.520; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09	20	63	63	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2007	335	7627					971	973		10.1136/bmj.39358.498889.94	http://dx.doi.org/10.1136/bmj.39358.498889.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	232AL	17991979	Green Published			2022-12-28	WOS:000250990400036
J	Koes, BW				Koes, Bart W.			Evidence-based management of acute low back pain	LANCET			English	Editorial Material							EUROPEAN GUIDELINES; PRIMARY-CARE		Erasmus Univ, Med Ctr, Dept Gen Practice, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Koes, BW (corresponding author), Erasmus Univ, Med Ctr, Dept Gen Practice, NL-3000 DR Rotterdam, Netherlands.	b.koes@erasmusmc.nl	Koes, Bart w/K-4614-2016	Koes, Bart w/0000-0002-0450-9969				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Assendelft WJJ, 2003, ANN INTERN MED, V138, P871, DOI 10.7326/0003-4819-138-11-200306030-00008; Hancock MJ, 2007, LANCET, V370, P1638, DOI 10.1016/S0140-6736(07)61686-9; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; van Tulder MW, 2000, SPINE, V25, P2501, DOI 10.1097/00007632-200010010-00013; COCHRANE LIB COCHRAN	8	9	9	1	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 10	2007	370	9599					1595	1596		10.1016/S0140-6736(07)61670-5	http://dx.doi.org/10.1016/S0140-6736(07)61670-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230NO	17993348				2022-12-28	WOS:000250883400007
J	Rojas, G; Fritsch, R; Solis, J; Jadresic, E; Castillo, C; Gonzalez, M; Guojardo, V; Lewis, G; Peters, TJ; Araya, R				Rojas, Graciela; Fritsch, Rosemarie; Solis, Jaime; Jadresic, Enrique; Castillo, Cristobal; Gonzalez, Marco; Guojardo, Viviana; Lewis, Glyn; Peters, Tim J.; Araya, Ricardo			Treatment of postnatal depression in low-income mothers in primary-care clinics in Santiago, Chile: a randomised controlled trial	LANCET			English	Article							POSTPARTUM DEPRESSION; GROUP INTERVENTION; WOMEN; SUPPORT; IMPACT; PSYCHOTHERAPY; PREVALENCE; VALIDATION; PROGRAM; SCALE	Background The optimum way to improve the recognition and treatment of postnatal depression in developing countries is uncertain. We compared the effectiveness of a multicomponent intervention with usual care to treat postnatal depression in low-income mothers in primary-care clinics in Santiago, Chile. Methods 230 mothers with major depression attending postnatal clinics were randomly allocated to either a multicomponent intervention (n=114) or usual care (n=116). The multicomponent intervention involved a psychoeducational group, treatment adherence support, and pharmacotherapy if needed. Usual care included all services normally available in the clinics, including antidepressant drugs, brief psychotherapeutic interventions, medical consultations, or external referral for specialty treatment. The primary outcome measure was the Edinburgh postnatal depression scale (EPDS) score at 3 and 6 months after randomisation. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00518830. Findings 208 (90%) of women randomly assigned to treatment groups completed assessments. The crude mean EPDS score was lower for the multicomponent intervention group than for the usual care group at 3 months (8-5 [95% CI 7.2-9-7.1 vs 12.8 [11.3-14.1]). Although these differences between groups decreased by 6 months, EPDS score remained better in multicomponent intervention group than in usual care group (10.9 [9.6-12.2] vs 12.5 [11.1-13.8J]). The adjusted difference in mean EPDS between the two groups at 3 months was -4.5 (95% CI -6.3 to -2.7; p<O.0001). The decrease in the number of women taking antidepressants after 3 months was greater in the intervention group than in the usual care group (multicomponent intervention from 60/101 [59%; 95% CI 49-69%] to 38/106 [36%; 27-46%]; usual care from 18/108 [17%; 10-25%] to 11/102 [11%; 6-19%]). Interpretation Our findings suggest that low-income mothers with depression and who have newly born children could be effectively helped, even in low-income settings, through multicomponent interventions. Further refinements to this intervention are needed to ensure treatment compliance after the acute phase.	Univ Bristol, Dept Community Based Med, Acad Surg Psychiat, Bristol BS6 6JL, Avon, England; Univ Chile, Fac Med, Hosp Clin, Santiago 7, Chile; Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England	University of Bristol; Universidad de Chile; University of Bristol	Araya, R (corresponding author), Univ Bristol, Dept Community Based Med, Acad Surg Psychiat, Cotham House,Cotham Hill, Bristol BS6 6JL, Avon, England.	R.Araya@bristol.ac.uk	Rojas, Graciela/G-2971-2012; Araya, Ricardo/S-3144-2019; Montero, Rosemarie Fritsch/C-3519-2009; Lewis, Glyn/E-9944-2012	Araya, Ricardo/0000-0002-0420-5148; Montero, Rosemarie Fritsch/0000-0001-7694-1470; Lewis, Glyn/0000-0001-5205-8245; Jadresic, Enrique/0000-0002-1436-998X; Peters, Tim/0000-0003-2881-4180				Affonso DD, 2000, J PSYCHOSOM RES, V49, P207, DOI 10.1016/S0022-3999(00)00176-8; ALVARADO R, 1992, REV PSIQUIATRIA, V34, P1171; Appleby L, 1997, BRIT MED J, V314, P932, DOI 10.1136/bmj.314.7085.932; Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; ARAYA R, 2000, COMMON MENTAL DISORD; Araya R, 2006, AM J PSYCHIAT, V163, P1379, DOI 10.1176/appi.ajp.163.8.1379; Brockington I, 2004, LANCET, V363, P303, DOI 10.1016/S0140-6736(03)15390-1; Chen CH, 2000, J PSYCHOSOM RES, V49, P395, DOI 10.1016/S0022-3999(00)00180-X; Clark R, 2003, AM J ORTHOPSYCHIAT, V73, P441, DOI 10.1037/0002-9432.73.4.441; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Cohen LS, 2001, J CLIN PSYCHIAT, V62, P592, DOI 10.4088/JCP.v62n0803; Cooper Peter J., 1997, P201; Cooper PJ, 2003, BRIT J PSYCHIAT, V182, P412, DOI 10.1192/bjp.182.5.412; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Eberhard-Gran M, 2001, ACTA PSYCHIAT SCAND, V104, P243, DOI 10.1034/j.1600-0447.2001.00187.x; Halbreich U, 2006, J AFFECT DISORDERS, V91, P97, DOI 10.1016/j.jad.2005.12.051; Honey KL, 2002, BRIT J CLIN PSYCHOL, V41, P405, DOI 10.1348/014466502760387515; *I NAC EST, 2000, AN EST VIT; JADRESIC E, 1995, REV MED CHILE, V123, P694; Jadresic E, 1995, J PSYCHOSOM OBST GYN, V16, P187, DOI 10.3109/01674829509024468; JADRESIC E, 1992, REV CHIL NEURO-PSIQU, V30, P99; Lumley J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-37; Matthey S, 2006, ARCH WOMEN MENT HLTH, V9, P309, DOI 10.1007/s00737-006-0152-x; Matthey S, 2004, J AFFECT DISORDERS, V78, P269, DOI 10.1016/S0165-0327(02)00313-0; Milgrom J, 2005, BRIT J CLIN PSYCHOL, V44, P529, DOI 10.1348/014466505X34200; MILLER L, 2002, JAMA-J AM MED ASSOC, P762; *MIN SAL, 2001, GUIA CLIN AT PRIM DE; *MIN SAL, 1997, PROGR SAULD MUJ; Misri S, 2004, J CLIN PSYCHIAT, V65, P1236, DOI 10.4088/JCP.v65n0913; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray L, 1996, INT REV PSYCHIATR, V8, P55, DOI 10.3109/09540269609037817; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.2307/1131637; O'Hara M. W., 1988, MOTHERHOOD MENTAL IL, P17; O'Hara MW, 2000, ARCH GEN PSYCHIAT, V57, P1039, DOI 10.1001/archpsyc.57.11.1039; Reay R, 2005, ARCH WOMEN MENT HLTH, V9, P31, DOI 10.1007/s00737-005-0104-x; Rojas G, 2005, SOC SCI MED, V60, P1693, DOI 10.1016/j.socscimed.2004.08.030; Shao J, 2003, STAT MED, V22, P2429, DOI 10.1002/sim.1519; Sheehan D. V., 1994, MINIINTERNATIONAL NE; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; STEIN A, 1991, BRIT MED J, V292, P1165; STOWE ZN, 1995, DEPRESSION, V158, P1739; Suri R, 2001, AM J PSYCHIAT, V158, P1739, DOI 10.1176/appi.ajp.158.10.1739; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; WARE J, 1993, SF 36 PHYS MENT COMP; Wiggins M, 2005, J EPIDEMIOL COMMUN H, V59, P288, DOI 10.1136/jech.2004.021808	46	119	121	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2007	370	9599					1629	1637		10.1016/S0140-6736(07)61685-7	http://dx.doi.org/10.1016/S0140-6736(07)61685-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230NO	17993363				2022-12-28	WOS:000250883400022
J	Hayashi, Y; Lo, N; Miyata, H; Kitade, O				Hayashi, Yoshinobu; Lo, Nathan; Miyata, Hitoshi; Kitade, Osamu			Sex-linked genetic influence on caste determination in a termite	SCIENCE			English	Article							RETICULITERMES-SPERATUS ISOPTERA; RHINOTERMITIDAE; PARTHENOGENESIS; WORKER; ANT; HYMENOPTERA; EVOLUTION; ORIGIN	The most ecologically successful and destructive termite species are those with both a nymph caste and an irreversibly wingless worker caste. The early developmental bifurcation separating these castes is widely accepted to be strictly environmentally determined. We present evidence that genotype also influences this process. Offspring from four different crosses of nymph-and worker-derived secondary reproductive individuals had strongly differentiated caste and sex ratios, despite uniform rearing conditions. These data fit an X-linked, one-locus-two-allele model. Of five possible genotypes, one was lethal, two resulted in workers, and two resulted in either nymphs or environmentally determined workers. Caste is thus controlled both by environment and by a complex genetic inheritance pattern.	Ibaraki Univ, Coll Sci, Nat Hist Lab, Ibaraki 3108512, Japan; Univ Sydney, Sch Biol Sci, Behav & Genet Social Insects Lab, Sydney, NSW 2006, Australia	Ibaraki University; University of Sydney	Kitade, O (corresponding author), Ibaraki Univ, Coll Sci, Nat Hist Lab, Ibaraki 3108512, Japan.	kitade@mx.ibaraki.ac.jp	Lo, Nathan/E-6115-2010	Lo, Nathan/0000-0003-2176-2840				[Anonymous], 1971, INSECT SOC; Cahan SH, 2003, NATURE, V424, P306, DOI 10.1038/nature01744; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Hayashi Y, 2006, SOCIOBIOLOGY, V48, P849; Hayashi Yoshinobu, 2003, Entomological Science, V6, P253, DOI 10.1046/j.1343-8786.2003.00030.x; HIGASHI M, 1996, BIODIVERSITY ECOLOGI, P83; Julian GE, 2002, P NATL ACAD SCI USA, V99, P8157, DOI 10.1073/pnas.112222099; Korb J, 2004, EVOL DEV, V6, P342, DOI 10.1111/j.1525-142X.2004.04042.x; Lo N, 2007, BIOL LETTERS, V3, P562, DOI 10.1098/rsbl.2007.0264; Long CE, 2003, B ENTOMOL RES, V93, P439, DOI 10.1079/BER2003258; LUYKX P, 1990, GENOME, V33, P80, DOI 10.1139/g90-013; Matsuura K, 2004, INSECT SOC, V51, P325, DOI 10.1007/s00040-004-0746-0; Miyata H, 2004, ENTOMOL SCI, V7, P309, DOI 10.1111/j.1479-8298.2004.00078.x; Pearcy M, 2004, SCIENCE, V306, P1780, DOI 10.1126/science.1105453; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Reeve HK, 1997, EVOL ECOL, V11, P357, DOI 10.1023/A:1018472521277; Roisin Y, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P95; SEGER J, 1981, J THEOR BIOL, V91, P191, DOI 10.1016/0022-5193(81)90380-5; Thompson GJ, 2000, J EVOLUTION BIOL, V13, P869, DOI 10.1046/j.1420-9101.2000.00237.x; Thorne BL, 1997, ANNU REV ECOL SYST, V28, P27, DOI 10.1146/annurev.ecolsys.28.1.27; Volny VP, 2002, P NATL ACAD SCI USA, V99, P6108, DOI 10.1073/pnas.092066699; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; WINTER U, 1986, ENTOMOL GEN, V11, P125	24	66	70	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					985	987		10.1126/science.1146711	http://dx.doi.org/10.1126/science.1146711			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991866				2022-12-28	WOS:000250788500046
J	Wisse, BE; Kim, F; Schwartz, MW				Wisse, Brent E.; Kim, Francis; Schwartz, Michael W.			An integrative view of obesity	SCIENCE			English	Editorial Material							INSULIN; HYPOTHALAMUS; RESISTANCE; LEPTIN; BETA		Harborview Med Ctr, Dept Med, Seattle, WA 98104 USA; Univ Washington, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle	Wisse, BE (corresponding author), Harborview Med Ctr, Dept Med, Seattle, WA 98104 USA.	mschwart@u.washington.edu	Schwartz, Michael W/H-9950-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK061384, R01DK073878, R01DK012829, P01DK068384, R01DK074758] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK61384, DK073878, R01 DK074758, P01-DK 068384, DK12829] Funding Source: Medline; NINDS NIH HHS [NS3227] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kim F, 2005, ARTERIOSCL THROM VAS, V25, P989, DOI 10.1161/01.ATV.0000160549.60980.a8; Levin BE, 2002, AM J PHYSIOL-REG I, V282, pR46, DOI 10.1152/ajpregu.2002.282.1.R46; LILLIOJA S, 1988, NEW ENGL J MED, V318, P1217, DOI 10.1056/NEJM198805123181901; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Niswender KD, 2004, TRENDS ENDOCRIN MET, V15, P362, DOI 10.1016/j.tem.2004.07.009; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345	10	99	103	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					928	929		10.1126/science.1148032	http://dx.doi.org/10.1126/science.1148032			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991852				2022-12-28	WOS:000250788500030
J	Desplan, C				Desplan, Claude			Time to pick the fly's brain	NATURE			English	Editorial Material									NYU, Dept Biol, New York, NY 10003 USA	New York University	Desplan, C (corresponding author), NYU, Dept Biol, 1009 Silver Ctr,100 Washington Sq E, New York, NY 10003 USA.			Desplan, Claude/0000-0002-6914-1413					0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					173	173		10.1038/450173a	http://dx.doi.org/10.1038/450173a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994071	Bronze			2022-12-28	WOS:000250746200026
J	Jagsi, R; Tarbell, NJ; Weinstein, DF				Jagsi, Reshma; Tarbell, Nancy J.; Weinstein, Debra F.			Becoming a doctor, starting a family - Leave of absence from graduate medical education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Ctr Fac Dev, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Off Womens Careers, Cambridge, MA 02138 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Partners HealthCare Syst, Boston, MA USA	University of Michigan System; University of Michigan; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Partners Healthcare System	Jagsi, R (corresponding author), Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA.			Jagsi, Reshma/0000-0001-6562-1228				BICKEL J, 1989, ACAD MED, V64, P498, DOI 10.1097/00001888-198909000-00002; *DEP LAB, COMPL ASS FAM MED LE; Jagsi R, 2006, ACAD MED, V81, P1059, DOI 10.1097/01.ACM.0000246685.96372.5e; Potee RA, 1999, ACAD MED, V74, P911, DOI 10.1097/00001888-199908000-00017; SAYRES M, 1986, NEW ENGL J MED, V314, P418, DOI 10.1056/NEJM198602133140705	5	41	41	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1889	1891		10.1056/NEJMp078163	http://dx.doi.org/10.1056/NEJMp078163			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228LX	17989381				2022-12-28	WOS:000250732500003
J	Taylor, PL				Taylor, Patrick L.			Rules of engagement	NATURE			English	Editorial Material									Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Taylor, PL (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.							Jasanoff S., 2005, DESIGNS NATURE SCI D	1	14	14	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					163	164		10.1038/450163a	http://dx.doi.org/10.1038/450163a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994064				2022-12-28	WOS:000250746200020
J	Yashiro, K; Shiratori, H; Hamada, H				Yashiro, Kenta; Shiratori, Hidetaka; Hamada, Hiroshi			Haemodynamics determined by a genetic programme govern asymmetric development of the aortic arch	NATURE			English	Article							PHARYNGEAL ARCH; PITX2; EXPRESSION; ALPHA; HEART	Laterality of the internal organs of vertebrates is determined by asymmetric Nodal signalling in the lateral plate mesoderm(1). A deficiency of such signalling results in heterotaxia syndrome, characterized by anomalous laterality of visceral organs and complex congenital heart conditions(1). Pitx2, the transcription factor induced by the Nodal signal, regulates left-right asymmetric morphogenesis(1-4). The cellular and molecular bases of asymmetric morphogenesis remain largely unknown, however. Here we show that ablation of unilateral Pitx2 expression in mice impairs asymmetric remodelling of the branchial arch artery (BAA) system, resulting in randomized laterality of the aortic arch. Pitx2-positive cells were found not to contribute to asymmetrically remodelled arteries. Instead, Pitx2 functions in the secondary heart field(5) and induces a dynamic morphological change in the outflow tract of the heart, which results in the provision of an asymmetric blood supply to the sixth BAA. This uneven distribution of blood flow results in differential signalling by both the platelet-derived growth factor receptor and vascular endothelial growth factor receptor 2. The consequent stabilization of the left sixth BAA and regression of its right counterpart underlie left-sided formation of the aortic arch. Our results therefore indicate that haemodynamics, generated by a Pitx2-induced morphological change in the outflow tract, is responsible for the asymmetric remodelling of the great arteries.	Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Osaka 5650871, Japan	Osaka University; Japan Science & Technology Agency (JST)	Yashiro, K (corresponding author), Univ London, Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	k.yashiro@qmul.ac.uk; hamada@fbs.osaka-u.ac.jp	Hamada, Hiroshi/N-6374-2015	Hamada, Hiroshi/0000-0002-7196-5948				Abu-Issa R, 2002, DEVELOPMENT, V129, P4613; Ai D, 2006, DEV BIOL, V296, P437, DOI 10.1016/j.ydbio.2006.06.009; Bajolle F, 2006, CIRC RES, V98, P421, DOI 10.1161/01.RES.0000202800.85341.6e; BECKER AE, 1981, PATHOLOGY CONGENITAL, P321; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Groot ACGD, 2006, TRENDS CARDIOVAS MED, V16, P1; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Liu CY, 2002, DEVELOPMENT, V129, P5081; Liu CY, 2001, DEVELOPMENT, V128, P2039; Phillips HM, 2005, CIRC RES, V96, P292, DOI 10.1161/01.RES.0000154912.08695.88; Phoon CKL, 2000, ULTRASOUND MED BIOL, V26, P1275, DOI 10.1016/S0301-5629(00)00278-7; RYCHTER Z., 1962, ADVANCES MORPHOGENESIS, V2, P333; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Shiratori H, 2006, DEVELOPMENT, V133, P3015, DOI 10.1242/dev.02470; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Uehara M, 2007, DEV BIOL, V302, P399, DOI 10.1016/j.ydbio.2006.09.045; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Waldo K, 1998, CARDIOVAS MOL MORPH, P187; Yanagisawa H, 1998, J CLIN INVEST, V102, P22, DOI 10.1172/JCI2698; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0	27	164	171	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					285	U11		10.1038/nature06254	http://dx.doi.org/10.1038/nature06254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994097				2022-12-28	WOS:000250746200058
J	Zhang, Y; Sturgill, D; Parisi, M; Kumar, S; Oliver, B				Zhang, Yu; Sturgill, David; Parisi, Michael; Kumar, Sudhir; Oliver, Brian			Constraint and turnover in sex-biased gene expression in the genus Drosophila	NATURE			English	Article							EVOLUTIONARY SIGNIFICANCE; MUTATION; RATES; ACCUMULATION; SELECTION; PATTERNS; SEQUENCE; MODEL	Both genome content and deployment contribute to phenotypic differences between species(1-5). Sex is the most important difference between individuals in a species and has long been posited to be rapidly evolving. Indeed, in the Drosophila genus, traits such as sperm length, genitalia, and gonad size are the most obvious differences between species(6). Comparative analysis of sex-biased expression should deepen our understanding of the relationship between genome content and deployment during evolution. Using existing(7,8) and newly assembled genomes(9), we designed species-specific microarrays to examine sex-biased expression of orthologues and species-restricted genes in D. melanogaster, D. simulans, D. yakuba, D. ananassae, D. pseudoobscura, D. virilis and D. mojavensis. We show that averaged sex-biased expression changes accumulate monotonically over time within the genus. However, different genes contribute to expression variance within species groups compared to between groups. We observed greater turnover of species-restricted genes with male-biased expression, indicating that gene formation and extinction may play a significant part in species differences. Genes with male-biased expression also show the greatest expression and DNA sequence divergence. This higher divergence and turnover of genes with male-biased expression may be due to high transcription rates in the male germline, greater functional pleiotropy of genes expressed in females, and/or sexual competition.	NIDDKD, Cellular & Dev Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA; Arizona State Univ, Ctr Evolutionary Funct Genom, Biodesign Inst, Tempe, AZ 85287 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Arizona State University; Arizona State University-Tempe	Zhang, Y (corresponding author), NIDDKD, Cellular & Dev Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA.	yuzhang@mail.nih.gov; oliver@helix.nih.gov	Kumar, Sudhir/F-1411-2011	Kumar, Sudhir/0000-0002-9918-8212; Sturgill, David/0000-0002-7902-3605	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015600] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; CHARIF D, 2006, STRUCTURAL APPROACHE; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; FitzGerald PC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r53; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hsieh WP, 2003, GENETICS, V165, P747; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jordan IK, 2005, GENE, V345, P119, DOI 10.1016/j.gene.2004.11.034; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2005, GENETICS, V170, P929, DOI 10.1534/genetics.104.037135; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Lemos B, 2005, EVOLUTION, V59, P126; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Ohta T, 1996, THEOR POPUL BIOL, V49, P128, DOI 10.1006/tpbi.1996.0007; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; PERRIMON N, 1986, GENETICS, V113, P695; Powell J. R., 1997, PROGR PROSPECTS EVOL; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Rifkin SA, 2005, NATURE, V438, P220, DOI 10.1038/nature04114; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; SCHMIDT EE, 1995, DEVELOPMENT, V121, P2373; Singh Shree Ram, 2002, Genetics and Molecular Research, V1, P178; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	39	216	218	2	46	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					233	U2		10.1038/nature06323	http://dx.doi.org/10.1038/nature06323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994089	Green Accepted, Bronze			2022-12-28	WOS:000250746200044
J	Setel, PW; Macfarlane, SB; Szreter, S; Mikkelsen, L; Jha, P; Stout, S; AbouZahr, C				Setel, Philip W.; Macfarlane, Sarah B.; Szreter, Simon; Mikkelsen, Lene; Jha, Prabhat; Stout, Susan; AbouZahr, Carla		MoVE Writing Grp	Who Counts? 1 - A scandal of invisibility: making everyone count by counting everyone	LANCET			English	Article							HEALTH-STATISTICS; SOUTH-AFRICA; IDENTIFYING DEATHS; SEX-RATIO; REGISTRATION; MORTALITY; AIDS; INFORMATION; INDICATORS; MILLENNIUM	Most people in Africa and Asia are born and die without leaving a trace in any legal record or official statistic. Absence of reliable data for births, deaths, and causes of death are at the root of this scandal of invisibility which renders most of the world's poor as unseen, uncountable, and hence uncounted. This situation has arisen because, in some countries, civil registration systems that log crucial statistics have stagnated over the past 30 years. Net of debt relief, official development assistance reached US$80 billion in 2004. Yet because of the weakness in recording vital statistics, we have little authoritative evidence that these funds have their desired effects on either mortality or poverty reduction. Sound recording of vital statistics and cause of death data are public goods that enable progress towards Millennium Development Goals and other development objectives that need to be measured, not only modelled. Vital statistics are most effectively generated by comprehensive civil registration. Civil registration has a dual function, both statistical and legal; it also helps with economic development. 30 years of stagnation will not be overcome quickly, although new efforts to develop national statistical capacities offer a unique opportunity to refocus attention on civil registration. Now is the time to make the long-term goal of comprehensive civil registration in developing countries the expectation rather than the exception. The international health community can assist by sharing information and methods to ensure both the quality of vital statistics and cause of death data, and the appropriate use of complementary and interim registration systems and sources of such data. The continued cost of ignorance home by countries without civil registration far outweighs the affordable necessity of action.	Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27516 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27516 USA; Univ N Carolina, Dept Anthropol, Chapel Hill, NC 27516 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Hist Fac, Cambridge, England; St Johns Coll, Cambridge, England; Hlth Metr Network, Brisbane, Qld, Australia; Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON, Canada; World Bank, Results Secretariat, Washington, DC 20433 USA; Hlth Metr Network, Geneva, Switzerland	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; University of Cambridge; University of Cambridge; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; The World Bank	Setel, PW (corresponding author), Univ N Carolina, Carolina Populat Ctr, 206 W Franklin St, Chapel Hill, NC 27516 USA.	setel@email.unc.edu	Setel, Philip/ABD-6362-2020	Setel, Philip/0000-0002-9042-5699; Szreter, Simon/0000-0001-6903-2447				ABOUZAHR C, 2007, LANCET          1029, DOI DOI 10.1016/S0140-6736(07)61310-5; Baiden F, 2006, B WORLD HEALTH ORGAN, V84, P163, DOI 10.2471/BLT.05.025577; Bchir A, 2006, LANCET, V367, P190, DOI 10.1016/S0140-6736(06)68011-2; Bhat M, 2006, LANCET, V367, P1725, DOI 10.1016/S0140-6736(06)68759-X; Bhopal R, 2006, LANCET, V367, P1728, DOI 10.1016/S0140-6736(06)68763-1; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; BRADSHAW D, 1992, S AFR MED J, V82, P237; Bradshaw D, 2006, B WORLD HEALTH ORGAN, V84, P211, DOI 10.2471/BLT.05.028589; Bradshaw D, 1998, S AFR MED J, V88, P971; Bradshaw D, 2005, SAMJ S AFR MED J, V95, P496; Bradshaw D, 2002, SAMJ S AFR MED J, V92, P618; Bradshaw Debbie, 2005, Cardiovasc J S Afr, V16, P140; *DEP FAM WELF, 1997, REPR CHILD HLTH PROG; *DEP FAM WELF WELF, 2000, NAT POP POL 2000; DESAVIGNY D, 2004, FIXING HLTH SYSTEMS; DESAVIGNY D, 1999, LINKING DEMOGRAPHIC; Diaz T, 2005, AIDS, V19, pS31, DOI 10.1097/01.aids.0000172875.67262.21; DONOSO E, 1999, REV CHIL OBSTET GINE, V64, P286; Evans T, 2003, B WORLD HEALTH ORGAN, V81, P856; George SM, 2006, LANCET, V367, P1725, DOI 10.1016/S0140-6736(06)68758-8; *GLOB FOR HLTH RES, 1999, 1090 WHO GLOB FOR HL; Gonzalez R, 2006, PEDIATRICS, V117, pE949, DOI 10.1542/peds.2005-2354; Groenewald P, 2005, AIDS, V19, P744, DOI 10.1097/01.aids.0000166105.74756.62; Groenewald P, 2005, AIDS, V19, P193, DOI 10.1097/00002030-200501280-00012; Higgs Edward, 2004, LIFE DEATH STAT; JAMISON DT, 2006, DIS CONTROL PRIORI 1; Jewkes R, 1998, SOC SCI MED, V46, P1043, DOI 10.1016/S0277-9536(97)10036-3; Jha P, 2006, LANCET, V367, P211, DOI 10.1016/S0140-6736(06)67930-0; Kapiriri L, 2003, SOC SCI MED, V56, P2433, DOI 10.1016/S0277-9536(02)00246-0; Lange JMA, 2004, AIDS, V18, pS69, DOI 10.1097/00002030-200406003-00013; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lewando-Hundt G, 1999, SOC SCI MED, V48, P833, DOI 10.1016/S0277-9536(98)00404-3; Longman T., 2001, DOCUMENTING INDIVIDU, P345; LOPEZ AD, 1990, ANN NY ACAD SCI, V609, P58, DOI 10.1111/j.1749-6632.1990.tb32057.x; MAHAPATRA P, 2007, LANCET          1029, DOI DOI 10.1016/S0140-6736(07)61308-7; MATHERS C, 2003, OVERVIEW GLOBAL MORT; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; *MIN HLTH, 2004, POL IMPL TANZ MORT B; *MIN HLTH FAM WELF, 1997, ANN REP MIN HLTH FAM; *MIN HLTH FAM WELF, 1999, ANN REP MIN LTH FAM; *MIN HLTH FAM WELF, 1998, ANN REP MIN HLTH FAM; MKUSA V, 2002, 4 INT C PRIOR HLTH C; Moore B., 1997, VICTIMS SURVIVORS NA; Morgues Mónica, 2002, Rev. chil. obstet. ginecol., V67, P100; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; *PARIS21 SECR, 2004, OECDPARIS21 NSDS; POWELL NP, 1981, 15 INT I VIT REG STA; POWELL NP, 1977, 1 INT I VIT REG STAT; Rao C, 2004, SO AFR J DEMOGRAPHY, P81; *REG GEN IND, 1999, COMP IND FERT MORT I; Robins S, 2004, J S AFR STUD, V30, P651, DOI 10.1080/0305707042000254146; Rommelmann V, 2005, B WORLD HEALTH ORGAN, V83, P569; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; SEN A, 1992, BRIT MED J, V304, P587, DOI 10.1136/bmj.304.6827.587; SETEL P, 1998, GLOB FOR HLTH RES FO; Setel PW, 2005, B WORLD HEALTH ORGAN, V83, P611; Stansfield SK, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1017; Szot J, 2002, REV MED CHILE, V130, P107; Szreter S, 2007, WORLD DEV, V35, P67, DOI 10.1016/j.worlddev.2006.09.004; Tollman SM, 2000, B WORLD HEALTH ORGAN, V78, P125; UN, 2006, MILL DEV GOALS REP 2; *UN DEP EC SOC AFF, 1998, HDB CIV REG VIT ST F; *UN DEP INT EC SOC, 1998, HDB CIV REG VIT STAT; UNICEF, 2005, RIGHTS START LIF STA; *UNICEF, 2005, BIRTH REG REC TSUN A; UNICEF, 2002, BIRTH REG RIGHT STAR; United Nations Department of Economic and Social Affairs SD, 2001, PRINC REC VIT STAT S; Walker N, 2007, LANCET, V369, P956, DOI 10.1016/S0140-6736(07)60454-1; World Bank, 2006, GLOB MON REP 2006 ST; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2007, WORLD HLTH STAT 2007	71	278	283	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2007	370	9598					1569	1577		10.1016/S0140-6736(07)61307-5	http://dx.doi.org/10.1016/S0140-6736(07)61307-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AE	17992727				2022-12-28	WOS:000250628800027
J	Ganem, NJ; Pellman, D				Ganem, Neil J.; Pellman, David			Limiting the proliferation of polyploid cells	CELL			English	Article							MAMMALIAN-CELLS; CYCLE PROGRESSION; TETRAPLOIDY; ANEUPLOIDY; CHECKPOINTS; INHIBITION; DIVISION; FAILURE; CANCER; ARREST	Many errors in cell division lead to failure of cytokinesis and the generation of tetraploid cells. Given that tetraploidy can have deleterious consequences, such as genetic instability, we discuss the mechanisms that may have evolved to directly or indirectly prevent the proliferation of these cells.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Pediat Hematol Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Pellman, D (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu		Ganem, Neil/0000-0003-0269-6585				Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; CARTER SB, 1967, NATURE, V213, P261, DOI 10.1038/213261a0; Castedo M, 2006, EMBO J, V25, P2584, DOI 10.1038/sj.emboj.7601127; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Lohez OD, 2003, J CELL BIOL, V161, P67, DOI 10.1083/jcb.200208140; Mable BK, 2001, J EVOLUTION BIOL, V14, P157, DOI 10.1046/j.1420-9101.2001.00245.x; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; NAGY A, 1990, DEVELOPMENT, V110, P815; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; WRIGHT WE, 1972, EXP CELL RES, V74, P187, DOI 10.1016/0014-4827(72)90496-X; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	22	131	133	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					437	440		10.1016/j.cell.2007.10.024	http://dx.doi.org/10.1016/j.cell.2007.10.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981108	Bronze			2022-12-28	WOS:000250618500008
J	Lai, CW; Kim, NY; Utsunomiya, S; Roumpos, G; Deng, H; Fraser, MD; Byrnes, T; Recher, P; Kumada, N; Fujisawa, T; Yamamoto, Y				Lai, C. W.; Kim, N. Y.; Utsunomiya, S.; Roumpos, G.; Deng, H.; Fraser, M. D.; Byrnes, T.; Recher, P.; Kumada, N.; Fujisawa, T.; Yamamoto, Y.			Coherent zero-state and p-state in an exciton-polariton condensate array	NATURE			English	Article							BOSE-EINSTEIN CONDENSATION; SPATIAL COHERENCE; PHASE-TRANSITION; SUPERFLUID; MICROCAVITY; GAS	The effect of quantum statistics in quantum gases and liquids results in observable collective properties among many-particle systems. One prime example is Bose-Einstein condensation, whose onset in a quantum liquid leads to phenomena such as superfluidity and superconductivity. A Bose-Einstein condensate is generally defined as a macroscopic occupation of a single-particle quantum state, a phenomenon technically referred to as off-diagonal long-range order due to non-vanishing off-diagonal components of the single-particle density matrix(1-3). The wave-function of the condensate is an order parameter whose phase is essential in characterizing the coherence and superfluid phenomena(4-11). The long-range spatial coherence leads to the existence of phase-locked multiple condensates in an array of superfluid helium(12), superconducting Josephson junctions(13-15) or atomic Bose-Einstein condensates(15-18). Under certain circumstances, a quantum phase difference of p is predicted to develop among weakly coupled Josephson junctions(19). Such a meta-stable pi-state was discovered in a weak link of superfluid 3 He, which is characterized by a 'p-wave' order parameter(20). The possible existence of such a pi-state in weakly coupled atomic Bose-Einstein condensates has also been proposed(21), but remains undiscovered. Here we report the observation of spontaneous build-up of in-phase ('zero-state') and antiphase ('pi-state') 'superfluid' states in a solid-state system; an array of exciton-polariton condensates connected by weak periodic potential barriers within a semiconductor microcavity. These in-phase and antiphase states reflect the band structure of the one-dimensional polariton array and the dynamic characteristics of metastable exciton-polariton condensates.	Stanford Univ, Edward L Ginzton Lab, Stanford, CA 94305 USA; Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; NTT Corp, NTT Basic Res Labs, Kanagawa 2430198, Japan	Stanford University; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Nippon Telegraph & Telephone Corporation	Lai, CW (corresponding author), Stanford Univ, Edward L Ginzton Lab, Stanford, CA 94305 USA.	cwlai@stanford.edu; yyamamoto@stanford.edu	Deng, Hui/E-8950-2010; Kumada, Norio/V-9410-2019; Kim, Na Young/A-8115-2008; Lai, Chih Wei/E-4945-2010; Fujisawa, Toshimasa/M-2428-2013; Deng, Hui/AAD-6979-2020; Yamamoto, Yoshihisa/A-2811-2012; Deng, Hui/A-7115-2009; Fraser, Michael D/D-8603-2017	Deng, Hui/0000-0003-0629-3230; Kumada, Norio/0000-0001-7826-6894; Lai, Chih Wei/0000-0003-3571-4671; Fujisawa, Toshimasa/0000-0002-0451-6579; Deng, Hui/0000-0003-0629-3230; Yamamoto, Yoshihisa/0000-0002-4150-6804; 	Grants-in-Aid for Scientific Research [18001002] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ANDEREWS MR, 1997, SCIENCE, V275, P637; Anderson BP, 1998, SCIENCE, V282, P1686, DOI 10.1126/science.282.5394.1686; [Anonymous], 2003, BOSE EINSTEIN CONDEN; Backhaus S, 1998, NATURE, V392, P687, DOI 10.1038/33629; BELIAEV ST, 1958, SOV PHYS JETP, V34, P417; Bloch I, 2000, NATURE, V403, P166, DOI 10.1038/35003132; BULAEVSKII LN, 1977, JETP LETT+, V25, P290; Castin Y, 1997, PHYS REV A, V55, P4330, DOI 10.1103/PhysRevA.55.4330; Cataliotti FS, 2001, SCIENCE, V293, P843, DOI 10.1126/science.1062612; Davis JC, 2002, REV MOD PHYS, V74, P741, DOI 10.1103/RevModPhys.74.741; Deng H, 2003, P NATL ACAD SCI USA, V100, P15318, DOI 10.1073/pnas.2634328100; Deng H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.146402; HADLEY P, 1988, PHYS REV B, V38, P8712, DOI 10.1103/PhysRevB.38.8712; Hagley EW, 1999, PHYS REV LETT, V83, P3112, DOI 10.1103/PhysRevLett.83.3112; HANSEN JB, 1984, REV MOD PHYS, V56, P431, DOI 10.1103/RevModPhys.56.431; HOUDRE R, 1994, PHYS REV LETT, V73, P2043, DOI 10.1103/PhysRevLett.73.2043; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; LEGGETT AJ, 2006, QUANTUM LIQUIDS BOSE, pCH1; MADELUNG O, 1996, INTRO SOLID STATE TH, pCH2; Naraschewski M, 1999, PHYS REV A, V59, P4595, DOI 10.1103/PhysRevA.59.4595; Orzel C, 2001, SCIENCE, V291, P2386, DOI 10.1126/science.1058149; Pedri P, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.220401; PENROSE O, 1956, PHYS REV, V104, P576, DOI 10.1103/PhysRev.104.576; Smerzi A, 1997, PHYS REV LETT, V79, P4950, DOI 10.1103/PhysRevLett.79.4950; TILLEY DR, 1990, SUPERFLUIDITY SUPERC, pCH1; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314; YANG CN, 1962, REV MOD PHYS, V34, P694, DOI 10.1103/RevModPhys.34.694; Yeh P., 2005, OPTICAL WAVES LAYERE	29	338	341	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					529	U8		10.1038/nature06334	http://dx.doi.org/10.1038/nature06334			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033292				2022-12-28	WOS:000251158500042
J	Sharek, PJ; Parast, LM; Leong, K; Coombs, J; Earnest, K; Sullivan, J; Frankel, LR; Roth, SJ				Sharek, Paul J.; Parast, Layla M.; Leong, Kit; Coombs, Jodi; Earnest, Karla; Sullivan, Jill; Frankel, Lorry R.; Roth, Stephen J.			Effect of a rapid response team on hospital-wide mortality and code rates outside the ICU in a children's hospital	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL EMERGENCY TEAM; PEDIATRIC CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; CARE; IMPACT; TRIAL; ANTECEDENTS; DISPARITIES; REDUCTION; EDUCATION	Context Introduction of a rapid response team (RRT) has been shown to decrease mortality and cardiopulmonary arrests outside of the intensive care unit (ICU) in adult inpatients. No published studies to date show significant reductions in mortality or cardiopulmonary arrests in pediatric inpatients. Objective To determine the effect on hospital-wide mortality rates and code rates outside of the ICU setting after RRT implementation at an academic children's hospital. Design, Setting, and Participants A cohort study design with historical controls at a 264-bed, free-standing, quaternary care academic children's hospital. Pediatric inpatients who spent at least 1 day on a medical or surgical ward between January 1, 2001, and March 31, 2007, were included. A total of 22 037 patient admissions and 102 537 patient-days were evaluated preintervention ( before September 1, 2005), and 7257 patient admissions and 34 420 patient-days were evaluated postintervention ( on or after September 1, 2005). Intervention The RRT included a pediatric ICU-trained fellow or attending physician, ICU nurse, ICU respiratory therapist, and nursing supervisor. This team was activated using standard criteria and was available at all times to assess, treat, and triage decompensating pediatric inpatients. Main Outcome Measures Hospital-wide mortality rates and code ( respiratory and cardiopulmonary arrests) rates outside of the ICU setting. All outcomes were adjusted for case mix index values. Results After RRT implementation, the mean monthly mortality rate decreased by 18% (1.01 to 0.83 deaths per 100 discharges; 95% confidence interval [CI], 5%30%; P=.007), the mean monthly code rate per 1000 admissions decreased by 71.7% (2.45 to 0.69 codes per 1000 admissions), and the mean monthly code rate per 1000 patient-days decreased by 71.2% (0.52 to 0.15 codes per 1000 patient-days). The estimated code rate per 1000 admissions for the postintervention group was 0.29 times that for the preintervention group ( 95% likelihood ratio CI, 0.10-0.65; P=. 008), and the estimated code rate per 1000 patient-days for the postintervention group was 0.28 times that for the preintervention group ( 95% likelihood ratio CI, 0.10-0.64; P=. 007). Conclusion Implementation of an RRT was associated with a statistically significant reduction in hospital-wide mortality rate and code rate outside of the pediatric ICU setting.	Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; Lucile Packard Childrens Hosp, Dept Qual Management, Palo Alto, CA 94304 USA; Lucile Packard Childrens Hosp, Dept Nursing, Palo Alto, CA 94304 USA; Stanford Univ, Dept Stat, Palo Alto, CA 94304 USA	Stanford University; Lucile Packard Children's Hospital (LPCH); Lucile Packard Children's Hospital (LPCH); Stanford University	Sharek, PJ (corresponding author), Stanford Univ, Sch Med, Dept Pediat, 700 Welch Rd,Ste 227, Palo Alto, CA 94304 USA.	psharek@lpch.org		Parast, Layla/0000-0002-7288-1009				*AG HEALTHC RES QU, PARTN IMPL PAT SAF G; Agresti A, 2003, CATEGORICAL DATA ANA; *AM HEART ASS, 2005, CIRCULATION, V12, P167, DOI DOI 10.1161/CIRCXULATIONAHA.105.166573; ASPDEN P, 2003, COMMITTEE DATA STAND; Averill Richard F, 2002, J AHIMA, V73, P46; Bellomo R, 2004, CRIT CARE MED, V32, P916, DOI 10.1097/01.CCM.0000119428.02968.9E; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Buist M, 2004, Crit Care Resusc, V6, P88; Buist MD, 1999, MED J AUSTRALIA, V171, P22, DOI 10.5694/j.1326-5377.1999.tb123492.x; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; Catalano Kathleen, 2006, J Perianesth Nurs, V21, P6, DOI 10.1016/j.jopan.2005.11.005; Coffey RM, 2005, MED CARE, V43, P48; Cook T.D., 1979, QUASIEXPERIMENTATIO; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; DeVita MA, 2004, QUAL SAF HEALTH CARE, V13, P251, DOI 10.1136/qshc.2003.006585; Flores G, 2006, PEDIATR CLIN N AM, V53, P1197, DOI 10.1016/j.pcl.2006.09.003; FRANKLIN C, 1994, CRIT CARE MED, V22, P244, DOI 10.1097/00003246-199402000-00014; Friedman LS, 2007, INJURY PREV, V13, P156, DOI 10.1136/ip.2006.014027; GIBBS N, 2006, TIME MAGAZINE   0501; Grimshaw Jeremy M, 2002, J Contin Educ Health Prof, V22, P237, DOI 10.1002/chp.1340220408; GRIMSHAW JM, 2001, MED CARE S2, V39, P2, DOI DOI 10.1097/00005650-200108002-00002; Hillman K, 2005, LANCET, V365, P2091; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; *I HEALTHC IMPR, GETT START KIT RAP R; *JOINT COMM ACCR H, FACTS PAT SAF; Khuder SA, 2007, PREV MED, V45, P3, DOI 10.1016/j.ypmed.2007.03.011; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; LEMONICK MD, 1999, TIME MAGAZINE   1213; Luk R, 2006, ADDICTION, V101, P738, DOI 10.1111/j.1360-0443.2006.01434.x; Luria JW, 2006, PEDIATR CLIN N AM, V53, P1121, DOI 10.1016/j.pcl.2006.09.007; Milstein A, 2000, Eff Clin Pract, V3, P313; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Polk HC, 2006, MAYO CLIN PROC, V81, P345, DOI 10.4065/81.3.345; Priestley G, 2004, INTENS CARE MED, V30, P1398, DOI 10.1007/s00134-004-2268-7; Reis AG, 2002, PEDIATRICS, V109, P200, DOI 10.1542/peds.109.2.200; *SAS I INC, PROM AN FOR DEM PLAN; SCHEIN RMH, 1990, CHEST, V98, P1388, DOI 10.1378/chest.98.6.1388; SCHMIDT K, 2006, DRG EXPERT COMPREHEN; Tamura T, 2000, CIRCULATION, V102, P253, DOI 10.1161/01.CIR.102.2.253; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401; TIBBALLS J, 2007, PEDIATR CRIT CARE ME, V8, P236; Winters BD, 2006, JAMA-J AM MED ASSOC, V296, P1645, DOI 10.1001/jama.296.13.1645; Winters BD, 2007, CRIT CARE MED, V35, P1238, DOI 10.1097/01.CCM.0000262388.85669.68; Young KD, 1999, ANN EMERG MED, V33, P195, DOI 10.1016/S0196-0644(99)70394-X	47	257	264	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2007	298	19					2267	2274		10.1001/jama.298.19.2267	http://dx.doi.org/10.1001/jama.298.19.2267			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232XV	18029830	Bronze			2022-12-28	WOS:000251055900026
J	Keech, AC; Mitchell, P; Summonen, PA; O'Day, J; Davis, TME; Moffitt, MS; Taskinen, MR; Simes, RJ; Tse, D; Williamson, E; Merrifield, A; Laatikainen, LT; d'Emden, MC; Crimet, DC; O'Connell, RL; Colman, PG				Keech, A. C.; Mitchell, P.; Summonen, P. A.; O'Day, J.; Davis, T. M. E.; Moffitt, M. S.; Taskinen, M. R.; Simes, R. J.; Tse, D.; Williamson, E.; Merrifield, A.; Laatikainen, L. T.; d'Emden, M. C.; Crimet, D. C.; O'Connell, R. L.; Colman, P. G.		FIELD Study Investigators	Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial	LANCET			English	Article							SERUM-LIPIDS; MACULAR EDEMA; RISK-FACTORS; PERSPECTIVES; ATORVASTATIN; ASSOCIATION; CLOFIBRATE; MANAGEMENT	Background laser treatment for diabetic retinopathy is often associated with visual field reduction and other ocular side-effects. Our aim was to assess whether long-term lipid-lowering therapy with fenofibrate could reduce the progression of retinopathy and the need for laser treatment in patients with type 2 diabetes mellitus. Methods The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study was a multinational randomised trial of 9795 patients aged 50-75 years with type 2 diabetes mellitus. Eligible patients were randomly assigned to receive fenofibrate 200 mg/day (n=4895) or matching placebo (n=4900). At each clinic visit, information concerning laser treatment for diabetic retinopathy-a prespecified tertiary endpoint of the main study-was gathered. Adjudication by ophthalmologists masked to treatment allocation defined instances of laser treatment for macular oedema, proliferative retinopathy, or other eye conditions. In a substudy of 1012 patients, standardised retinal photography was done and photographs graded with Early Treatment Diabetic Retinopathy Study (ETDRS) criteria to determine the cumulative incidence of diabetic retinopathy and its component lesions. Analyses were by intention to treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN64783481. Findings Laser treatment was needed more frequently in participants with poorer glycaemic or blood pressure control than in those with good control of these factors, and in those with a greater burden of clinical microvascular disease, but the need for such treatment was not affected by plasma lipid concentrations. The requirement for first laser treatment for all retinopathy was significantly lower in the fenofibrate group than in the placebo group (164 [3.4%] patients on fenofibrate vs 238 [4.9%] on placebo; hazard ratio [HR] 0.69, 95% Cl 0.56.0.84; p=0.0002; absolute risk reduction 1.5% [0.7-2.3]). In the ophthalmology substudy, the primary endpoint of 2-step progression of retinopathy grade did not differ significantly between the two groups overall (46 [9.6%] patients on fenofibrate vs 57 [12.3%] on placebo; p=0.19) or in the subset of patients without pre-existing retinopathy (43 [11.4%] vs 43 [11.7%]; p=0.87). By contrast, in patients with pre-existing retinopathy, significantly fewer patients on fenofibrate had a 2-step progression than did those on placebo (three [3.1%] patients vs 14 [14.6%]; p=0.004). An exploratory composite endpoint of 2-step progression of retinopathy grade, macular oedema, or laser treatments was significantly lower in the fenofibrate group than in the placebo group (HR 0.66, 95% CI 0.47-0.94; p=0.022). Interpretation Treatment with fenofibrate in individuals with type 2 diabetes mellitus reduces the need for laser treatment for diabetic retinopathy, although the mechanism of this effect does not seem to be related to plasma concentrations of lipids.	Univ Sydney, NHMRC, Clin Trials Ctr, Camperdown, NSW 2050, Australia; Univ Sydney, Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; Univ Sydney, Dept Ophthalmol, Camperdown, NSW 2050, Australia; Univ Sydney, Millennium Inst, Camperdown, NSW 2050, Australia; Univ Helsinki, Cent Hosp, Hosp Eye, Helsinki, Finland; Univ Melbourne, Dept Ophthalmol, Parkville, Vic 3052, Australia; Univ Melbourne, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; Univ Western Australia, Sch Med & Pharmacol, Fremantle, WA, Australia; Univ Helsinki, Dept Med, Helsinki, Finland; Univ Helsinki, Dept Ophthalmol, Helsinki, Finland; Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; Labs Fournier SCA, Dijon, France	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Helsinki; Helsinki University Central Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Western Australia; University of Helsinki; University of Helsinki; Royal Brisbane & Women's Hospital	Keech, AC (corresponding author), Univ Sydney, NHMRC, Clin Trials Ctr, Bldg F,88 Mallet St, Camperdown, NSW 2050, Australia.	tony@ctc.usyd.edu.au	Summanen, Paula/D-5897-2014; d'Emden, Michael/G-3388-2015; Summanen, P/D-3999-2009; Simes, Robert John/P-1497-2014; Mitchell, Paul/P-1498-2014; Taskinen, Marja-Riitta/AAN-5432-2020; Williamson, Elizabeth/H-3876-2019; Davis, Timothy ME/M-5144-2014	d'Emden, Michael/0000-0002-0149-639X; Summanen, P/0000-0003-1198-4394; Taskinen, Marja-Riitta/0000-0002-6229-3588; Williamson, Elizabeth/0000-0001-6905-876X; Colman, Peter/0000-0001-8718-6175; Davis, Timothy/0000-0003-0749-7411				Abraham P, 2006, OPHTHALMOLOGY, V113, P2221, DOI 10.1016/j.ophtha.2006.07.032; Aiello LP, 2007, ARCH OPHTHALMOL-CHIC, V125, P318; Aiello LM, 2003, AM J OPHTHALMOL, V136, P122, DOI 10.1016/S0002-9394(03)00219-8; Aiello LP, 2005, DIABETES, V54, P2188; ALDINGTON SJ, 1995, DIABETOLOGIA, V38, P437, DOI 10.1007/BF00410281; [Anonymous], 1996, DIABETES, V45, P1289; [Anonymous], 1991, Ophthalmology, V98, P786; Caldwell RB, 2005, CURR DRUG TARGETS, V6, P511, DOI 10.2174/1389450054021981; Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; Chew EY, 2007, AM J CARDIOL, V99, p103I, DOI 10.1016/j.amjcard.2007.03.028; Chew EY, 1996, ARCH OPHTHALMOL-CHIC, V114, P1079, DOI 10.1001/archopht.1996.01100140281004; Chowdhury T, 2002, EYE, V16, P689, DOI 10.1038/sj.eye.6700205; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Cullen J F, 1964, Trans Ophthalmol Soc U K, V84, P281; Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233; de Lorgeril M, 2005, NUTR METAB CARDIOVAS, V15, P36, DOI 10.1016/j.numecd.2004.09.001; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; DODSON P M, 1991, Eye (London), V5, P699; DORNAN TL, 1982, DIABETOLOGIA, V22, P167, DOI 10.1007/BF00283746; DORNE PA, 1977, ARCH OPHTALMOL-PARIS, V37, P393; DUNCAN LJP, 1968, DIABETES, V17, P458, DOI 10.2337/diab.17.7.458; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; Ferris FL, 1996, DIABETES CARE, V19, P1291, DOI 10.2337/diacare.19.11.1291; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; FREYBERGER H, 1994, MED KLIN, V89, P594; Goetze S, 2002, BIOCHEM BIOPH RES CO, V293, P1431, DOI 10.1016/S0006-291X(02)00385-6; GORDON B, 1991, AM J OPHTHALMOL, V112, P385, DOI 10.1016/S0002-9394(14)76244-0; Gupta A, 2004, AM J OPHTHALMOL, V137, P675, DOI 10.1016/j.ajo.2003.11.017; HARROLD BP, 1969, DIABETES, V18, P285, DOI 10.2337/diab.18.5.285; *HEART PROT STUD C, LANCET, V361, P2005; Hirano F, 2003, INT IMMUNOPHARMACOL, V3, P225, DOI 10.1016/S1567-5769(02)00275-8; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Kim J, 2007, EXP EYE RES, V84, P886, DOI 10.1016/j.exer.2007.01.009; Leung H, 2005, EYE, V19, P861, DOI 10.1038/sj.eye.6701668; Losada M, 1997, DOC OPHTHALMOL, V93, P223, DOI 10.1007/BF02569062; Lyons TJ, 2004, INVEST OPHTH VIS SCI, V45, P910, DOI 10.1167/iovs.02-0648; Malik J, 2001, CARDIOVASC RES, V52, P290, DOI 10.1016/S0008-6363(01)00382-0; Meleth AD, 2005, INVEST OPHTH VIS SCI, V46, P4295, DOI 10.1167/iovs.04-1057; Miljanovic B, 2004, DIABETES, V53, P2883, DOI 10.2337/diabetes.53.11.2883; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Neubauer AS, 2007, OPHTHALMOLOGICA, V221, P95, DOI 10.1159/000098254; Ozkiris A, 2007, BRIT J OPHTHALMOL, V91, P69, DOI 10.1136/bjo.2006.098285; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Porta M, 2004, PHARMACOL THERAPEUT, V103, P167, DOI 10.1016/j.pharmthera.2004.07.001; Rencova E, 1992, Cesk Oftalmol, V48, P37; ROSENSON RS, 2007, DIABETES CARE, V17, P31; Ryan KE, 2007, ATHEROSCLEROSIS, V194, pE123, DOI 10.1016/j.atherosclerosis.2006.11.007; Scott R, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-13; Skrha J, 2004, EUR J PHARMACOL, V493, P183, DOI 10.1016/j.ejphar.2004.04.025; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Tserentsoodol N, 2006, MOL VIS, V12, P1319; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ucgun NI, 2007, ANN NY ACAD SCI, V1100, P213, DOI 10.1196/annals.1395.021; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; ZHANG J, 2003, ARCH OPHTHALMOL-CHIC, V125, P1096	58	714	756	1	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2007	370	9600					1687	1697		10.1016/S0140-6736(07)61607-9	http://dx.doi.org/10.1016/S0140-6736(07)61607-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	17988728				2022-12-28	WOS:000251091200019
J	Euston, DR; Tatsuno, M; McNaughton, BL				Euston, David R.; Tatsuno, Masami; McNaughton, Bruce L.			Fast-forward playback of recent memory sequences in prefrontal cortex during sleep	SCIENCE			English	Article							SLOW-WAVE SLEEP; REM-SLEEP; CONSOLIDATION; REACTIVATION; HIPPOCAMPUS; EXPERIENCE; REPLAY; TRACE; REORGANIZATION; COMPRESSION	As previously shown in the hippocampus and other brain areas, patterns of firing-rate correlations between neurons in the rat medial prefrontal cortex during a repetitive sequence task were preserved during subsequent sleep, suggesting that waking patterns are reactivated. We found that, during sleep, reactivation of spatiotemporal patterns was coherent across the network and compressed in time by a factor of 6 to 7. Thus, when behavioral constraints are removed, the brain's intrinsic processing speed may be much faster than it is in real time. Given recent evidence implicating the medial prefrontal cortex in retrieval of long-term memories, the observed replay may play a role in the process of memory consolidation.	Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA	University of Arizona	McNaughton, BL (corresponding author), Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA.	bruce@nsma.arizona.edu		Tatsuno, Masami/0000-0003-2698-2762	NIMH NIH HHS [MH046823] Funding Source: Medline; NINDS NIH HHS [NS020331] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046823, R01MH046823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020331, R37NS020331] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McNaughton, 2003, SLEEP BRAIN PLASTICI, P225, DOI DOI 10.1093/ACPROF:OSO/9780198574002.003.0013; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SKAGGS WE, 1998, MULTIPLE CHANNEL REC, P235; Squire L. R., 1984, MEMORY CONSOLIDATION, P185; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Takehara K, 2003, J NEUROSCI, V23, P9897; Takehara-Nishiuchi K, 2005, LEARN MEMORY, V12, P606, DOI 10.1101/lm.5905; Takehara-Nishiuchi K, 2006, J NEUROSCI, V26, P5049, DOI 10.1523/JNEUROSCI.4381-05.2006; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	33	356	364	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1147	1150		10.1126/science.1148979	http://dx.doi.org/10.1126/science.1148979			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006749				2022-12-28	WOS:000250957900049
J	Galloway, LF; Etterson, JR				Galloway, Laura F.; Etterson, Julie R.			Transgenerational plasticity is adaptive in the wild	SCIENCE			English	Article							SHADE-AVOIDANCE RESPONSES; GERMINATION	Plants exhibit adaptive responses to light, but it is not known whether parental plants transmit environmental cues that elicit adaptive responses in offspring. We show that offspring life history (annual versus biennial) is influenced by the maternal light environment (understory versus light gap). This transgenerational plasticity is adaptive when offspring are grown in their maternal light environment, where seeds typically disperse. Projections of population growth show that plants that are appropriately cued for their light environment through maternal effects have 3.4 times greater fitness than otherwise. Transgenerational plasticity has evolved in response to natural variation in light and provides a flexible mechanism by which sedentary organisms cope with heterogeneous environments.	Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Univ Minnesota, Dept Biol, Duluth, MN 55812 USA	University of Virginia; University of Minnesota System; University of Minnesota Duluth	Galloway, LF (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	lgalloway@virginia.edu; jetterso@d.umn.edu		Etterson, Julie/0000-0001-6657-0610				Bell DL, 2007, FUNCT ECOL, V21, P1146, DOI 10.1111/j.1365-2435.2007.01327.x; COLEMAN JS, 1994, TRENDS ECOL EVOL, V9, P187, DOI 10.1016/0169-5347(94)90087-6; Donohue K, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P137; Donohue K, 2005, EVOLUTION, V59, P740, DOI 10.1111/j.0014-3820.2005.tb01752.x; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; Galloway LF, 2003, HEREDITY, V90, P308, DOI 10.1038/sj.hdy.6800242; Galloway LF, 2002, INT J PLANT SCI, V163, P133, DOI 10.1086/324556; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Lacey EP, 2000, EVOLUTION, V54, P1207, DOI 10.1111/j.0014-3820.2000.tb00555.x; Levin D. A., 1974, EVOL BIOL, V7, P139, DOI DOI 10.1007/978-1-4615-6944-2_5; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Metcalf JC, 2003, TRENDS ECOL EVOL, V18, P471, DOI 10.1016/S0169-5347(03)00162-9; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Roff Derek, 2002, pi; Schmitt J, 2003, INTEGR COMP BIOL, V43, P459, DOI 10.1093/icb/43.3.459; Schmitt J, 1995, AM NAT, V146, P937, DOI 10.1086/285832; Wardle GM, 1998, ECOLOGY, V79, P2539, DOI 10.1890/0012-9658(1998)079[2539:AGTATD]2.0.CO;2; Weinig C, 2000, EVOLUTION, V54, P124, DOI 10.1111/j.0014-3820.2000.tb00013.x; WILLSON MF, 1993, VEGETATIO, V108, P261	21	386	401	9	246	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1134	1136		10.1126/science.1148766	http://dx.doi.org/10.1126/science.1148766			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006745				2022-12-28	WOS:000250957900045
J	Akimov, AV; Mukherjee, A; Yu, CL; Chang, DE; Zibrov, AS; Hemmer, PR; Park, H; Lukin, MD				Akimov, A. V.; Mukherjee, A.; Yu, C. L.; Chang, D. E.; Zibrov, A. S.; Hemmer, P. R.; Park, H.; Lukin, M. D.			Generation of single optical plasmons in metallic nanowires coupled to quantum dots	NATURE			English	Article							SILVER NANOWIRES; CAVITY; FLUORESCENCE; LUMINESCENCE; PROPAGATION; ATOM	Control over the interaction between single photons and individual optical emitters is an outstanding problem in quantum science and engineering. It is of interest for ultimate control over light quanta(1), as well as for potential applications such as efficient photon collection(2), single-photon switching(3) and transistors(4), and long-range optical coupling of quantum bits(5,6). Recently, substantial advances have been made towards these goals, based on modifying photon fields around an emitter using high-finesse optical cavities(2,3,5-8). Here we demonstrate a cavity-free, broadband approach for engineering photon-emitter interactions(4,9) via subwavelength confinement of optical fields near metallic nanostructures(10-13). When a single CdSe quantum dot is optically excited in close proximity to a silver nanowire, emission from the quantum dot couples directly to guided surface plasmons in the nanowire, causing the wire's ends to light up. Non-classical photon correlations between the emission from the quantum dot and the ends of the nanowire demonstrate that the latter stems from the generation of single, quantized plasmons. Results from a large number of devices show that efficient coupling is accompanied by more than 2.5-fold enhancement of the quantum dot spontaneous emission, in good agreement with theoretical predictions.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; RAS, PN Lebedev Phys Inst, Moscow 119991, Russia	Harvard University; Harvard University; Texas A&M University System; Texas A&M University College Station; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute	Park, H (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	Hongkun_Park@harvard.edu	Akimov, Alexey/J-6385-2015; Zibrov, Alexander S/G-7419-2014; Park, Hongkun/R-9842-2019	Akimov, Alexey/0000-0002-4167-5085; Park, Hongkun/0000-0001-9576-8829				Atwater HA, 2007, SCI AM, V296, P56, DOI 10.1038/scientificamerican0407-56; Bellessa J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036404; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Biteen JS, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2191411; CHANCE RR, 1978, ADV CHEM PHYS, V37, P1, DOI DOI 10.1002/9780470142561.CH1; Chang DE, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035420; Chang DE, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.053002; CHANG DE, 2007, NATURE PHYS     0826; Chung I, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011106; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Dickson RM, 2000, J PHYS CHEM B, V104, P6095, DOI [10.1021/jp001435b, 10.1021/jp00143b]; Dintinger J, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.035424; Ditlbacher H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257403; Englund D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.013904; Genet C, 2007, NATURE, V445, P39, DOI 10.1038/nature05350; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Hochberg M, 2004, OPT EXPRESS, V12, P5481, DOI 10.1364/OPEX.12.005481; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Klimov VV, 2002, CHEM PHYS LETT, V358, P192, DOI 10.1016/S0009-2614(02)00496-7; Lounis B, 2000, CHEM PHYS LETT, V329, P399, DOI 10.1016/S0009-2614(00)01042-3; Mertens H, 2006, NANO LETT, V6, P2622, DOI 10.1021/nl061494m; Nayak KP, 2007, OPT EXPRESS, V15, P5431, DOI 10.1364/OE.15.005431; SAGUE G, 2007, COLD ATOM PHYS USING; Sanders AW, 2006, NANO LETT, V6, P1822, DOI 10.1021/nl052471v; Smolyaninov II, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.057401; Sun YG, 2002, NANO LETT, V2, P165, DOI 10.1021/nl010093y; Takahara J, 1997, OPT LETT, V22, P475, DOI 10.1364/OL.22.000475; Tao A, 2003, NANO LETT, V3, P1229, DOI 10.1021/nl0344209; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835; Zhang JY, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.201306; [No title captured]	31	1198	1209	3	546	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					402	406		10.1038/nature06230	http://dx.doi.org/10.1038/nature06230			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004381				2022-12-28	WOS:000250918600051
J	Ness, RB				Ness, Roberta B.		Soc Epidemiology	Influence of the HIPAA privacy rule on health research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSURANCE PORTABILITY; ACCOUNTABILITY ACT; RECORDS; REGULATIONS; IMPACT	Context Anecdotal reports suggest that the Health Insurance Portability and Accountability Act Privacy Rule (HIPAA Privacy Rule) may be affecting health research in the United States. Objective To survey epidemiologists about their experiences with the HIPAA Privacy Rule. Design, Setting, and Participants Thirteen societies of epidemiology distributed a national Web-based survey; 2805 respondents accessed the survey Web site and 1527 eligible professionals anonymously answered questions. Main Outcome Measures Responses related influences such as research delays and added cost after Privacy Rule implementation, frequency and type of Privacy Rule related institutional review board modifications, level of difficulty obtaining deidentified data and waivers, experiences with multisite studies, and perceived participant privacy benefits under the rule. Respondents ranked their perceptions of Privacy Rule influence on 5-point Likert scales. Results A total of 875 (67.8%) respondents reported that the HIPAA Privacy Rule has made research more difficult at a level of 4 to 5 on a Likert scale, in which 5 indicates a great deal of added cost and time to study completion. A total of 684 (52.1%) of respondents identified a "most affected" protocol. Respondents indicated that the proportion of institutional review board applications in which the Privacy Rule had a negative influence on human subjects ( participants) protection was significantly greater than the proportion in which it had a positive influence ( P <. 001). Conclusion In this national survey of clinical scientists, only a quarter perceived that the rule has enhanced participants' confidentiality and privacy, whereas the HIPAA Privacy Rule was perceived to have a substantial, negative influence on the conduct of human subjects health research, often adding uncertainty, cost, and delay.	Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ness, RB (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, 130 DeSoto St,A530 Crabtree Hall, Pittsburgh, PA 15261 USA.	repro@edc.pitt.edu						Annas GJ, 2002, NEW ENGL J MED, V346, P216, DOI 10.1056/NEJM200201173460320; Armstrong D, 2005, ARCH INTERN MED, V165, P1125, DOI 10.1001/archinte.165.10.1125; Beskow LM, 2006, AM J PUBLIC HEALTH, V96, P1920, DOI 10.2105/AJPH.2004.061556; Damschroder LJ, 2007, SOC SCI MED, V64, P223, DOI 10.1016/j.socscimed.2006.08.045; Herdman R, 2006, EFFECT HIPAA PRIVACY; Hodge JG, 2004, J LAW MED ETHICS, V32, P670, DOI 10.1111/j.1748-720X.2004.tb01972.x; Kaiser J, 2006, SCIENCE, V311, P1547, DOI 10.1126/science.311.5767.1547; Kaiser J, 2004, SCIENCE, V305, P168, DOI 10.1126/science.305.5681.168; Ness RB, 2005, ANN EPIDEMIOL, V15, P85, DOI 10.1016/j.annepidem.2004.12.001; Nosowsky R, 2006, ANNU REV MED, V57, P575, DOI 10.1146/annurev.med.57.121304.131257; O'Herrin JK, 2004, ANN SURG, V239, P772, DOI 10.1097/01.sla.0000128307.98274.dc; Office of Civil Rights U. S. Departmrnt of Health and Human Services, 2000, FED REGISTER, V65, P82462; Paasche-Orlow MK, 2005, MED CARE, V43, P558, DOI 10.1097/01.mlr.0000163646.90393.e4; RUSSELL S, 2004, SAN FRANCISCO C 0626; SMITH VA, 2005, DOCTORS PATIENTS GRA; SMITH VA, 2005, BILLINGS GAZETT 0316; TOKARSKI C, 2005, MEDSCAPE MED NE 0215; Wolf MS, 2006, CANCER-AM CANCER SOC, V106, P474, DOI 10.1002/cncr.21599; 2004, WASHINGTON TIME 0914	19	101	102	2	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2164	2170		10.1001/jama.298.18.2164	http://dx.doi.org/10.1001/jama.298.18.2164			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230II	18000200				2022-12-28	WOS:000250869800022
J	Diniz, SG; Bick, D; Bastos, MH; Riesco, ML				Diniz, Simone Grilo; Bick, Debra; Bastos, Maria Helena; Riesco, Maria Luiza			Empowering women in Brazil	LANCET			English	Editorial Material							NEONATAL-MORTALITY		Univ Sao Paulo, Fac Saude Publ, BR-01246 Sao Paulo, Brazil; Thames Valley Univ, Ctr Res Midwifery & Childbirth, London, England; Univ Sao Paulo, Sch Nursing, Sao Paulo, Brazil	Universidade de Sao Paulo; University of West London; Universidade de Sao Paulo	Diniz, SG (corresponding author), Univ Sao Paulo, Fac Saude Publ, BR-01246 Sao Paulo, Brazil.	sidiniz@usp.br	Diniz, Carmen S G/H-4129-2013; Bick, Debra/P-9575-2018; Bastos, Maria Helena/AAS-3664-2020; Riesco, Maria Luiza G/D-7752-2012	Bick, Debra/0000-0002-8557-7276; Bastos, Maria Helena/0000-0002-1001-1083; Riesco, Maria Luiza G/0000-0001-9036-5641				Barros FC, 2005, LANCET, V365, P847, DOI 10.1016/S0140-6736(05)71042-4; Behague DP, 2002, BMJ-BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942; Costello A, 2005, LANCET, V365, P825, DOI 10.1016/S0140-6736(05)71017-5; d'Oliveira AFPL, 2002, LANCET, V359, P1681, DOI 10.1016/S0140-6736(02)08592-6; Diniz SG, 2004, REPROD HEALTH MATTER, V12, P100, DOI 10.1016/S0968-8080(04)23112-3; *FED REP BRAZ, 2004, BRAZ MON REP MILL DE; Hodnett ED, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003766.pub2; HOTIMSKY SN, 2007, THESIS U SAO PAULO S; Laurenti Ruy, 2004, Rev. bras. epidemiol., V7, P449, DOI 10.1590/S1415-790X2004000400008; Martins Alaerte Leandro, 2006, Cad. Saúde Pública, V22, P2473, DOI 10.1590/S0102-311X2006001100022; *MIN SAUD BRAS, 2005, GEST SUS GANH DIR AC; Sousa Maria Helena de, 2007, Rev. Saúde Pública, V41, P181; World Health Organization, 2007, COR HLTH IND	13	8	8	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2007	370	9599					1596	1598		10.1016/S0140-6736(07)61671-7	http://dx.doi.org/10.1016/S0140-6736(07)61671-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230NO	17993349				2022-12-28	WOS:000250883400008
J	Proud, CG				Proud, Christopher G.			mTOR, unleashed	SCIENCE			English	Editorial Material							TOR; PROTEINS; INSULIN; GROWTH; FKBP38; KINASE; TSC		Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Proud, CG (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.			Proud, Christopher/0000-0003-0704-6442				Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	13	36	36	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					926	927		10.1126/science.1150653	http://dx.doi.org/10.1126/science.1150653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991850				2022-12-28	WOS:000250788500028
J	Gostin, LO				Gostin, Lawrence O.			Global regulatory strategies for tobacco control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Alamar B, 2007, AM J PUBLIC HEALTH, V97, P1400, DOI 10.2105/AJPH.2006.095315; [Anonymous], FEDERAL TRADE COMMIS; Brandt AM., 2007, CIGARETTE CENTURY RI; *FRAM CONV ALL, 2 C PART WHO FCTC JU; Gilpin EA, 2007, AM J PUBLIC HEALTH, V97, P1489, DOI 10.2105/AJPH.2005.070359; *GLOB VOIC SMOK WO, 2007, MOV SMOK FUT GLOB S; JAH P, 1999, CURBING EPIDEMIC GOV; Mackay J, 2002, TOBACCO ATLAS; Prokhorov AV, 2006, PEDIATRICS, V118, pE890, DOI 10.1542/peds.2005-0810; Roemer R, 2005, AM J PUBLIC HEALTH, V95, P936, DOI 10.2105/AJPH.2003.025908; Warren CW, 2006, TOB CONTROL, V15, pII4, DOI 10.1136/tc.2006.015685; *WHO, TOB POV VIC CIRCL; *WHO, 2007, PROT EXP 2 HAND TOB; *WHO TOB FREE IN, FACTS FIG TOB	14	18	19	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2007	298	17					2057	2059		10.1001/jama.298.17.2057	http://dx.doi.org/10.1001/jama.298.17.2057			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228GP	17986700	Green Published			2022-12-28	WOS:000250718200027
J	McMurray, JJV; Teerlink, JR; Cotter, G; Bourge, RC; Cleland, JGF; Jondeau, G; Krum, H; Metra, M; O'Connor, CM; Parker, JD; Torre-Amione, G; van Veldhuisen, DJ; Lewsey, J; Frey, A; Rainisio, M; Kobrin, I				McMurray, John J. V.; Teerlink, John R.; Cotter, Gadi; Bourge, Robert C.; Cleland, John G. F.; Jondeau, Guillaume; Krum, Henry; Metra, Marco; O'Connor, Christopher M.; Parker, John D.; Torre-Amione, Guillermo; van Veldhuisen, Dirk J.; Lewsey, Jim; Frey, Aline; Rainisio, Maurizio; Kobrin, Isaac		VERITAS Investigators	Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure - The VERITAS Randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOTHELIN RECEPTOR ANTAGONIST; COLLEGE-OF-CARDIOLOGY; DOUBLE-BLIND; INTRAVENOUS TEZOSENTAN; SCIENTIFIC SESSIONS; BIG ENDOTHELIN-1; NESIRITIDE; UPDATE; LEVOSIMENDAN; MULTICENTER	Context Plasma concentrations of the vasoconstrictor peptide endothelin-1 are increased in patients with heart failure, and higher concentrations are associated with worse outcomes. Tezosentan is an intravenous short-acting endothelin receptor antagonist that has favorable hemodynamic actions in heart failure. Objective To determine if tezosentan improves outcomes in patients with acute heart failure. Design, Setting, and Participants The Value of Endothelin Receptor Inhibition With Tezosentan in Acute Heart Failure Studies, 2 independent, identical, and concurrent randomized, double-blind, placebo-controlled, parallel-group trials conducted from April 2003 through January 2005 at sites in Australia, Europe, Israel, and North America. Patients admitted within the previous 24 hours with persisting dyspnea and a respiratory rate of 24/min or greater were eligible provided they fulfilled 2 of 4 criteria: (1) elevated plasma concentrations of B-type or N-terminal pro-B-type natriuretic peptide, (2) clinical pulmonary edema, (3) radiologic pulmonary congestion or edema, or (4) left ventricular systolic dysfunction. Intervention Infusion of tezosentan (5 mg/h for 30 minutes, followed by 1 mg/h for 24 to 72 hours [n = 730]) or placebo (n = 718). Main Outcome Measures The coprimary end points were change in dyspnea (measured at 3, 6, and 24 hours using a visual analog scale from 0-100) over 24 hours (as area under the curve) in the individual trials and incidence of death or worsening heart failure at 7 days in both trials combined. Results Of the 1435 patients who received treatment as assigned, 855 (60%) were men; mean age was 70 years. Mean left ventricular ejection fraction (measured in 779 patients [54%]) was 29% (SD, 11%). Baseline dyspnea scores were similar in the 2 treatment groups. Tezosentan did not improve dyspnea more than placebo in either trial, with a mean treatment difference of -12 (95% confidence interval [CI], -105 to 81) mm . h (P = .80) in the first trial and -25 (95% CI, -119 to 69) mm . h (P = .60) in the second. The incidence of death or worsening heart failure at 7 days in the combined trials was 26% in each treatment group (odds ratio, 0.99; 95% confidence interval, 0.82-1.21; P = .95). Conclusion The endothelin receptor antagonist tezosentan did not improve symptoms or clinical outcomes in patients with acute heart failure.	Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G12 8QQ, Lanark, Scotland; San Francisco VA Med Ctr, Cardiol Sect, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; Duke Clin Res Inst, Durham, NC USA; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Hull, Castlehill Hosp, Dept Cardiol, Kingston Upon Hull HU6 7RX, N Humberside, England; Hop Ambroise Pare, Dept Cardiol, Boulogne, France; Monash Univ, Cent & Eastern Clin Sch, Dept Med, Melbourne, Vic 3004, Australia; Monash Univ, Cent & Eastern Clin Sch, Dept Epidemiol, Melbourne, Vic 3004, Australia; Monash Univ, Cent & Eastern Clin Sch, Dept Cardiol, Melbourne, Vic 3004, Australia; Univ Brescia, Dept Expt & Appl Med, Sect Cardiovasc Dis, Brescia, Italy; Mt Sinai & Univ Hlth Network Hosp, Toronto, ON, Canada; Baylor Coll Med, Winters Ctr Heart Failure Res, Methodist DeBakey Heart Ctr, Houston, TX 77030 USA; Univ Groningen Hosp, Ctr Thorax, Dept Cardiol, Groningen, Netherlands; Univ Glasgow, Dept Publ Hlth & Hlth Policy, Glasgow, Lanark, Scotland; Actelion Pharmaceut Ltd, Allschwil, Switzerland	University of Glasgow; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Duke University; Duke University; University of Alabama System; University of Alabama Birmingham; University of Hull; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Monash University; Monash University; Monash University; University of Brescia; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; University of Groningen; University of Glasgow; Actelion Pharmaceuticals Ltd	McMurray, JJV (corresponding author), Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G12 8QQ, Lanark, Scotland.	j.mcmurray@bio.gla.ac.uk	van Veldhuisen, Dirk Jan/E-8967-2014; mcmurray, John/B-2467-2013; Cleland, John G./AAZ-4185-2020; Lewsey, James/F-7546-2010; Teerlink, John R/D-2986-2012; Metra, marco/E-7101-2010	mcmurray, John/0000-0002-6317-3975; Cleland, John G./0000-0002-1471-7016; Torre-Amione, Guillermo/0000-0001-9950-0416; Metra, Marco/0000-0001-6691-8568; Rainisio, Maurizio/0000-0002-4450-5751; Parker, John/0000-0003-1949-2669; Cotter, Gad/0000-0002-9613-3339				Anand I, 2004, LANCET, V364, P347, DOI 10.1016/S0140-6736(04)16723-8; Cleland JGF, 2006, EUR J HEART FAIL, V8, P105, DOI 10.1016/j.ejheart.2005.12.003; Coletta A, 2002, EUR J HEART FAIL, V4, P381, DOI 10.1016/S1388-9842(02)00040-5; Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; Cotter G, 2004, EUR J HEART FAIL, V6, P601, DOI 10.1016/j.ejheart.2004.05.004; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332; Grant S, 1999, CHEST, V116, P1208, DOI 10.1378/chest.116.5.1208; Kaluski E, 2003, J AM COLL CARDIOL, V41, P204, DOI 10.1016/S0735-1097(02)02708-0; Louis A, 2001, EUR J HEART FAIL, V3, P381, DOI 10.1016/S1388-9842(01)00149-0; Masson S, 2006, J CARD FAIL, V12, P375, DOI 10.1016/j.cardfail.2006.02.013; MCMURRAY JJ, 1992, CIRCULATION, V85, P1374, DOI 10.1161/01.CIR.85.4.1374; Moiseyev VS, 2002, EUR HEART J, V23, P1422, DOI 10.1053/euhj.2001.3158; Nieminen MS, 2005, AM J CARDIOL, V96, p5G, DOI 10.1016/j.amjcard.2005.07.015; Nieminen MS, 2005, EUR HEART J, V26, P384; O'Connor CM, 2003, J AM COLL CARDIOL, V41, P1452, DOI 10.1016/S0735-1097(03)00194-3; Packer M, 2005, J CARD FAIL, V11, P12, DOI 10.1016/j.cardfail.2004.05.006; Prasad SK, 2006, HEART, V92, P798, DOI 10.1136/hrt.2004.049734; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4; Sharma M, 2004, CURR OPIN CARDIOL, V19, P254, DOI 10.1097/00001573-200405000-00011; Slawsky MT, 2000, CIRCULATION, V102, P2222; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Teerlink JR, 2005, AM HEART J, V150, P46, DOI 10.1016/j.ahj.2005.04.035; Teerlink JR, 2003, AM HEART J, V145, pS26, DOI 10.1067/mhj.2003.151; Teerlink JR, 2001, CIRCULATION, V104, P526; Torre-Amione G, 2003, J AM COLL CARDIOL, V42, P140, DOI 10.1016/S0735-1097(03)00556-4; Torre-Amione G, 2001, CIRCULATION, V103, P973; *US FDA, 20920 NDA US FDA; van Beneden R, 2004, J CARD FAIL, V10, P490, DOI 10.1016/j.cardfail.2004.04.001; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531; Zannad F, 2006, HEART FAIL REV, V11, P135, DOI 10.1007/s10741-006-9484-x	33	278	283	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2007	298	17					2009	2019		10.1001/jama.298.17.2009	http://dx.doi.org/10.1001/jama.298.17.2009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228GP	17986694				2022-12-28	WOS:000250718200021
J	Cheng, MH				Cheng, Margaret Harris			Aboriginal workers key to indigenous health in Australia	LANCET			English	Editorial Material								As a group, indigenous Australians are much less healthy and more likely to die at younger ages than their non-indigenous counterparts. Training more indigenous people as health workers could help to reduce these startling inequalities, say experts. Margaret Harris Cheng reports.											0	7	7	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 3	2007	370	9598					1533	1536		10.1016/S0140-6736(07)61648-1	http://dx.doi.org/10.1016/S0140-6736(07)61648-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227AE	17992724				2022-12-28	WOS:000250628800011
J	Rubin, GJ; Page, L; Morgan, O; Pinder, RJ; Riley, P; Hatch, S; Maguire, H; Catchpole, M; Simpson, J; Wessely, S				Rubin, G. James; Page, Lisa; Morgan, Oliver; Pinder, Richard J.; Riley, Paul; Hatch, Stephani; Maguire, Helen; Catchpole, Mike; Simpson, John; Wessely, Simon			Public information needs after the poisoning of Alexander Litvinenko with polonium-210 in London: cross sectional telephone survey and qualitative analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMMUNICATION	Objectives To identify public perceptions of the risk to health after the poisoning of Alexander Litvinenko with polonium-210 (Po-210) in London and to assess the impact of public health communications. Design Cross sectional telephone survey and qualitative interviews. Setting London, United Kingdom. Participants 1000 people completed the cross sectional survey and 86 potentially exposed people completed the qualitative interviews. Main outcome measures Perception of risk to personal health after the Po-210 incident. Qualitative interviews were analysed with an emphasis on information needs. Results 11.7% of the survey sample (n=117) perceived their health to be at risk. Aside from personal variables the main predictors of perceived risk to health were believing that the incident was related to terrorism (odds ratio 2.7, 95% confidence interval 1.5 to 4.6) rather than to espionage, that it was targeted at the wider public rather than one person (5.9, 3.2 to 10.9), and that it could affect people who had not been in the contaminated area (3.2, 2.1 to 5.1). Participants in the qualitative interviews were generally satisfied with the information they had received, although they would have preferred more information about their individual risk of exposure, the results of their urine tests, and the health implications of the incident. Conclusions Perceptions of the public that the Po-210 incident in London 2006 was related to espionage helped to reassure them that the risks to personal health were low. In the event of future incidents it is important to ensure that detailed, comprehensible information about the risks of any exposure is available.	Kings Coll London, Inst Psychiat, Dept Psychol Med, London SE5 9RJ, England; Hlth Protect Agcy, London Reg, London, England; Hlth Protect Agcy, Ctr Infect, London, England; Hlth Protect Agcy, Ctr Emergency Preparedness & Response, Porton Down, Wilts, England	University of London; King's College London; Health Protection Agency; Health Protection Agency; Health Protection Agency	Rubin, GJ (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychol Med, London SE5 9RJ, England.	g.rubin@iop.kcl.ac.uk	Pinder, Richard/K-6200-2019; Hatch, Stephani L/B-4235-2010; Wessely, Simon C/A-8713-2008	Pinder, Richard/0000-0002-7010-6009; Hatch, Stephani/0000-0001-9103-2427				Becker SM, 2004, BIOSECUR BIOTERROR, V2, P195, DOI 10.1089/15387130460759263; BLENDON RJ, 2003, MEDSCAPE GEN MED, V4; Bryman A., 2016, SOCIAL RES METHODS; BRYMAN A, 2004, SOCIAL RES METHODS E, V2; Covello V.T., 1989, EFFECTIVE RISK COMMU; Fischhoff B, 2004, RISK ANAL, V24, P1301, DOI 10.1111/j.0272-4332.2004.00527.x; Freimuth VS, 2006, HEALTH COMMUN, V20, P141, DOI 10.1207/s15327027hc2002_5; GILK DC, 2007, ANNU REV PUBL HEALTH, V28; GLIK DC, 2007, ANNU REV PUBL HEALTH, V28; GRAVES R, 2000, PUBLIC OPIN QUART, V64, P288; GROVES RM, 2000, PUBLIC OPIN QUART, V64, P288; Harrison DE, 1999, PATIENT EDUC COUNS, V38, P217, DOI 10.1016/S0738-3991(99)00009-9; Hunter N, 2006, RADIAT ENVIRON BIOPH, V45, P17, DOI 10.1007/s00411-006-0040-9; Keselman A, 2005, J BIOMED INFORM, V38, P331, DOI 10.1016/j.jbi.2005.05.001; LaRossa R, 2005, J MARRIAGE FAM, V67, P837, DOI 10.1111/j.1741-3737.2005.00179.x; Petrie KJ, 2007, BRIT MED J, V334, P352, DOI 10.1136/bmj.39093.464190.55; Rubin GJ, 2005, BRIT MED J, V331, P606, DOI 10.1136/bmj.38583.728484.3A; Slovic P., 2001, PERCEPTION RISK; Stather JW, 2007, J RADIOL PROT, V27, P1, DOI 10.1088/0952-4746/27/1/E02; Vanderford ML, 2004, BIOSECUR BIOTERROR, V2, P193, DOI 10.1089/bsp.2004.2.193; 2002, COMMUNICATING CRISIS	21	44	45	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2007	335	7630					1143	1146B		10.1136/bmj.39367.455243.BE	http://dx.doi.org/10.1136/bmj.39367.455243.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240OE	17975252	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000251596100036
J	Lopez, AD; AbouZahr, C; Shibuya, K; Gollogly, L				Lopez, Alan D.; AbouZahr, Carla; Shibuya, Kenji; Gollogly, Laragh			Keeping count: births, deaths, and causes of death	LANCET			English	Editorial Material									Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia; Hlth Metr Network, Geneva, Switzerland; WHO, CH-1211 Geneva, Switzerland	University of Queensland; World Health Organization	Lopez, AD (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia.	a.lopez@sph.uq.edu.au	Lopez, Alan/AAA-2734-2022; Lopez, Alan D/F-1487-2010	Lopez, Alan D/0000-0001-5818-6512; Shibuya, Kenji/0000-0003-2528-7530				[Anonymous], 1996, GLOBAL BURDEN DIS CO; HILL K, 2007, LANCET; Mahapatra P, 2007, LANCET; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Murray CJL, 2004, BMJ-BRIT MED J, V329, P1096, DOI 10.1136/bmj.329.7474.1096; Sen A, 1998, ECON J, V108, P1, DOI 10.1111/1468-0297.00270; Setel PW, 2007, LANCET; Statistics South Africa, 2007, MORT CAUS DEATH S AF; World Health Organization, 2005, INT CLASS DIS REL HL	9	30	31	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 24	2007	370	9601					1744	1746		10.1016/S0140-6736(07)61419-6	http://dx.doi.org/10.1016/S0140-6736(07)61419-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	234DI	18029004				2022-12-28	WOS:000251140500007
J	Anderson, DL; Natland, JH				Anderson, Don L.; Natland, James H.			Evidence for mantle plumes?	NATURE			English	Letter									CALTECH, Seismol Lab, Pasadena, CA 91125 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	California Institute of Technology; University of Miami	Anderson, DL (corresponding author), CALTECH, Seismol Lab, MC 252-21, Pasadena, CA 91125 USA.	dla@gps.caltech.edu						ANDERSON DL, 2005, PLATES PLUMES PARADI, P31, DOI DOI 10.2230/2005.2388(04); Anderson DL, 2007, GEOL SOC AM SPEC PAP, V430, P47, DOI 10.1130/2007.2430(03); Bourdon B, 2006, NATURE, V444, P713, DOI 10.1038/nature05341; Brady R, 2000, GEOCHEM GEOPHY GEOSY, V1; Clift P.D., 2005, PLATES PLUMES PARADI, P279; Falloon TJ, 2007, GEOL SOC AM SPEC PAP, V430, P235, DOI 10.1130/2007.2430(12); Herzberg C, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001390; Larsen TB, 1997, GEOPHYS RES LETT, V24, P1995, DOI 10.1029/97GL01886; PRESNALL DC, IN PRESS J PETROL; Raddick MJ, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000617; Sen G, 2005, AM MINERAL, V90, P871, DOI 10.2138/am.2005.1731; Sleep NH, 2007, GEOL SOC AM SPEC PAP, V430, P29, DOI 10.1130/2007.2430(02); Stein CA, 2007, GEOL SOC AM SPEC PAP, V430, P261, DOI 10.1130/2007.2430(13); WINTERER EL, 2007, PLATES PLUMES PLANET, P230; Yamamoto M., 2007, PLATES PLUMES PLANET, V430, P165	15	8	8	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					E15	E15		10.1038/nature06376	http://dx.doi.org/10.1038/nature06376			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033248				2022-12-28	WOS:000251158500034
J	Friis, EM; Crane, PR; Pedersen, KR; Bengtson, S; Donoghue, PCJ; Grimm, GW; Stampanoni, M				Friis, Else Marie; Crane, Peter R.; Pedersen, Kaj Raunsgaard; Bengtson, Stefan; Donoghue, Philip C. J.; Grimm, Guido W.; Stampanoni, Marco			Phase-contrast x-ray microtomography links cretaceous seeds with Gnetales and Bennettitales	NATURE			English	Article							SYNCHROTRON MICROTOMOGRAPHY; ANGIOSPERMS; TOMOGRAPHY; ORIGIN; MORPHOLOGY; FLOWERS; PLANTS	Over the past 25 years the discovery and study of Cretaceous plant mesofossils has yielded diverse and exquisitely preserved fossil flowers that have revolutionized our knowledge of early angiosperms(1), but remains of other seed plants in the same mesofossil assemblages(2,3) have so far received little attention. These fossils, typically only a few millimetres long, have often been charred in natural fires and preserve both three-dimensional morphology and cellular detail. Here we use phase-contrast-enhanced synchrotron-radiation X-ray tomographic microscopy to clarify the structure of small charcoalified gymnosperm seeds from the Early Cretaceous of Portugal and North America. The new information links these seeds to Gnetales ( including Erdtmanithecales, a putatively closely related fossil group(2)), and to Bennettitales-important extinct Mesozoic seed plants with cycad-like leaves and flower-like reproductive structures. The results suggest that the distinctive seed architecture of Gnetales, Erdtmanithecales and Bennettitales defines a clade containing these taxa. This has significant consequences for hypotheses of seed plant phylogeny by providing support for key elements of the controversial anthophyte hypothesis, which links angiosperms, Bennettitales and Gnetales.	Swedish Museum Nat Hist, Dept Palaeobot & Palaeozool, SE-10405 Stockholm, Sweden; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Aarhus Univ, Dept Earth Sci, DK-8000 Aarhus, Denmark; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Univ Tubingen, Inst Geosci, D-72076 Tubingen, Germany; Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland	Swedish Museum of Natural History; University of Chicago; Aarhus University; University of Bristol; Eberhard Karls University of Tubingen; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Stampanoni, M (corresponding author), Swedish Museum Nat Hist, Dept Palaeobot & Palaeozool, SE-10405 Stockholm, Sweden.	marco.stampanoni@psi.ch	Stampanoni, Marco/J-4099-2013; Stampanoni, Marco/GRR-9695-2022; Pedersen, Kaj Raunsgaard/L-4105-2013; Stampanoni, Marco/AAZ-3033-2021; Donoghue, Philip/A-3873-2008	Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Donoghue, Philip/0000-0003-3116-7463; Bengtson, Stefan/0000-0003-0206-5791; Friis, Else Marie/0000-0001-7587-9687; Grimm, Guido/0000-0003-0674-3553; Crane, Peter/0000-0003-4331-6948	Natural Environment Research Council [NE/C511256/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Arber EAN, 1907, J LINN SOC BOT, V38, P29, DOI [10.1111/j.1095-8339.1907.tb01074.x, DOI 10.1111/J.1095-8339.1907.TB01074.X]; Bateman RM, 2006, J EXP BOT, V57, P3471, DOI 10.1093/jxb/erl128; Berridge EM, 1911, NEW PHYTOL, V10, P140, DOI DOI 10.1111/J.1469-8137.1911.TB04959.X; Bronnikov AV, 2002, J OPT SOC AM A, V19, P472, DOI 10.1364/JOSAA.19.000472; Bronnikov AV, 1999, OPT COMMUN, V171, P239, DOI 10.1016/S0030-4018(99)00575-1; Burleigh JG, 2004, AM J BOT, V91, P1599, DOI 10.3732/ajb.91.10.1599; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; CRANE PR, 1985, ANN MO BOT GARD, V72, P716, DOI 10.2307/2399221; Donoghue PCJ, 2006, NATURE, V442, P680, DOI 10.1038/nature04890; DOYLE JA, 1994, ANN MO BOT GARD, V81, P419, DOI 10.2307/2399899; Doyle JA, 2006, J TORREY BOT SOC, V133, P169, DOI 10.3159/1095-5674(2006)133[169:SFATOO]2.0.CO;2; Friis EM, 2006, PALAEOGEOGR PALAEOCL, V232, P251, DOI 10.1016/j.palaeo.2005.07.006; FRIIS EM, 1994, PL SYST EVOL S, V8, P31; Groso A, 2006, OPT EXPRESS, V14, P8103, DOI 10.1364/OE.14.008103; GUREYEV TE, 2006, APPL PHYS LETT, V89; HARRIS TM, 1932, MEDD GRONL, V85, P1; Hilton J, 2006, J TORREY BOT SOC, V133, P119, DOI 10.3159/1095-5674(2006)133[119:PATBOS]2.0.CO;2; LIGNIER O, 1894, VEGETAUX FOSSILES NO, P1; MARTENS P, 1971, HDB PFLANZENANATOM 2, V12; Pearson HHW, 1929, GNETALES; PEDERSEN KR, 1989, REV PALAEOBOT PALYNO, V60, P7; PEDERSEN KR, 1989, GRANA, V28, P279, DOI 10.1080/00173138909427441; Rothwell GW, 2002, AM J BOT, V89, P1447, DOI 10.3732/ajb.89.9.1447; Rydin C, 2006, ANN BOT-LONDON, V98, P123, DOI 10.1093/aob/mcl078; Stopes MC, 1918, PHILOS T R SOC LON B, V208, P389, DOI 10.1098/rstb.1918.0011; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tafforeau P, 2007, PALAEOGEOGR PALAEOCL, V246, P206, DOI 10.1016/j.palaeo.2006.10.001; Thoday MG, 1911, ANN BOT-LONDON, V25, P1101, DOI 10.1093/oxfordjournals.aob.a089365; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Yang Y, 2005, AM J BOT, V92, P231, DOI 10.3732/ajb.92.2.231	30	145	161	3	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					549	U11		10.1038/nature06278	http://dx.doi.org/10.1038/nature06278			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033296				2022-12-28	WOS:000251158500047
J	Monteith, DT; Stoddard, JL; Evans, CD; de Wit, HA; Forsius, M; Hogasen, T; Wilander, A; Skjelkvale, BL; Jeffries, DS; Vuorenmaa, J; Keller, B; Kopacek, J; Vesely, J				Monteith, Donald T.; Stoddard, John L.; Evans, Christopher D.; de Wit, Heleen A.; Forsius, Martin; Hogasen, Tore; Wilander, Anders; Skjelkvale, Brit Lisa; Jeffries, Dean S.; Vuorenmaa, Jussi; Keller, Bill; Kopacek, Jiri; Vesely, Josef			Dissolved organic carbon trends resulting from changes in atmospheric deposition chemistry	NATURE			English	Article							FOREST; EXPORT; SOILS; CLIMATE; SULFATE; STREAMS; MODEL; LAKES	Several hypotheses have been proposed to explain recent, widespread increases in concentrations of dissolved organic carbon (DOC) in the surface waters of glaciated landscapes across eastern North America and northern and central Europe(1-3). Some invoke anthropogenic forcing through mechanisms related to climate change(3-5), nitrogen deposition(6) or changes in land use(7), and by implication suggest that current concentrations and fluxes are without precedent. All of these hypotheses imply that DOC levels will continue to rise, with unpredictable consequences for the global carbon cycle. Alternatively, it has been proposed that DOC concentrations are returning toward pre-industrial levels as a result of a gradual decline in the sulphate content of atmospheric deposition(8-10). Here we show, through the assessment of time series data from 522 remote lakes and streams in North America and northern Europe, that rising trends in DOC between 1990 and 2004 can be concisely explained by a simple model based solely on changes in deposition chemistry and catchment acid-sensitivity. We demonstrate that DOC concentrations have increased in proportion to the rates at which atmospherically deposited anthropogenic sulphur and sea salt have declined. We conclude that acid deposition to these ecosystems has been partially buffered by changes in organic acidity and that the rise in DOC is integral to recovery from acidification. Over recent decades, deposition-driven increases in organic matter solubility may have increased the export of DOC to the oceans, a potentially important component of regional carbon balances(11). The increase in DOC concentrations in these regions appears unrelated to other climatic factors.	UCL, Environm Change Res Ctr, London WC1E 6BT, England; US EPA, Corvallis, OR 97333 USA; Ctr Ecol & Hydrol, Bangor LL57 2UW, Gwynedd, Wales; Norwegian Inst Water Res, N-0349 Oslo, Norway; Finnish Environm Inst, FI-00251 Helsinki, Finland; Dept Environm Assessment SLU, SE-75007 Uppsala, Sweden; Environm Canada, Burlington, ON L7R 4A6, Canada; Laurentian Univ, Ontario Minist Environm, Sudbury, ON P3E 2C6, Canada; Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Ceske Budejovice 37005, Czech Republic; Czech Geol Survey, Prague 15200, Czech Republic	University of London; University College London; United States Environmental Protection Agency; UK Centre for Ecology & Hydrology (UKCEH); Norwegian Institute for Water Research (NIVA); Finnish Environment Institute; Swedish University of Agricultural Sciences; Environment & Climate Change Canada; Laurentian University; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Geological Survey	Monteith, DT (corresponding author), UCL, Environm Change Res Ctr, Mortimer St, London WC1E 6BT, England.	dmonteit@geog.ucl.ac.uk	Keller, Wendel/G-1533-2012; Kopacek, Jiri/A-7373-2014; Stoddard, John L/H-5594-2013; Evans, Christopher D/F-2087-2010; Monteith, Donald/C-1534-2008; de Wit, Heleen A/ABE-9776-2020	Kopacek, Jiri/0000-0002-4409-4032; Evans, Christopher D/0000-0002-7052-354X; Monteith, Donald/0000-0003-3219-1772; de Wit, Heleen A/0000-0001-5646-5390; Stoddard, John/0000-0002-2537-6130; Forsius, Martin/0000-0003-0125-5120	Natural Environment Research Council [ceh010023, NE/D005973/1, NE/E011837/1, NE/D00599X/1] Funding Source: researchfish; NERC [NE/D00599X/1, NE/E011837/1, NE/D005973/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alewell C, 1999, BIOGEOCHEMISTRY, V44, P281, DOI 10.1007/BF00996994; Clark JM, 2006, ENVIRON SCI TECHNOL, V40, P1776, DOI 10.1021/es051488c; de Wit HA, 2001, SOIL SCI SOC AM J, V65, P1089, DOI 10.2136/sssaj2001.6541089x; DEWIT HA, 2007, HYDROL EARTH SYST SC, V4, P3055; EVANS A, 1988, SOIL SCI SOC AM J, V52, P1789, DOI 10.2136/sssaj1988.03615995005200060049x; Evans CD, 2005, ENVIRON POLLUT, V137, P55, DOI 10.1016/j.envpol.2004.12.031; Evans CD, 2001, HYDROL EARTH SYST SC, V5, P351, DOI 10.5194/hess-5-351-2001; Evans WK, 2006, J THORAC ONCOL, V1, P10, DOI 10.1097/01243894-200601000-00005; Findlay SEG, 2005, FRONT ECOL ENVIRON, V3, P133, DOI 10.1890/1540-9295(2005)003[0133:ICTITH]2.0.CO;2; Freeman C, 2001, NATURE, V412, P785, DOI 10.1038/35090628; Freeman C, 2004, NATURE, V430, P195, DOI 10.1038/nature02707; Garnett MH, 2000, HOLOCENE, V10, P729, DOI 10.1191/09596830094971; Hejzlar J, 2003, SCI TOTAL ENVIRON, V310, P143, DOI 10.1016/S0048-9697(02)00634-4; Hyvarinen V, 2003, NORD HYDROL, V34, P71; KRUG EC, 1983, SCIENCE, V221, P520, DOI 10.1126/science.221.4610.520; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; SEN PK, 1968, ANN MATH STAT, V39, P1115, DOI 10.1214/aoms/1177698236; Siemens J, 2003, SCIENCE, V302, P1681, DOI 10.1126/science.302.5651.1681a; Skjelkvale BL, 2005, ENVIRON POLLUT, V137, P165, DOI 10.1016/j.envpol.2004.12.023; SOKAL RR, 1969, BIOMETRY, P532; STODDARD JL, 2003, EPA620R03001 US EPA; TIPPING E, 1988, J SOIL SCI, V39, P505, DOI 10.1111/j.1365-2389.1988.tb01235.x; TIPPING E, 1991, J SOIL SCI, V42, P437, DOI 10.1111/j.1365-2389.1991.tb00421.x; Tranvik LJ, 2002, NATURE, V415, P861, DOI 10.1038/415861b; VOGT RD, 1994, ENVIRON INT, V3, P277; Vuorenmaa J, 2006, SCI TOTAL ENVIRON, V365, P47, DOI 10.1016/j.scitotenv.2006.02.038; Whitfield P. H., 2000, CAN WATER RESOUR J, V25, P19, DOI DOI 10.4296/CWRJ2501019; Worrall F, 2003, BIOGEOCHEMISTRY, V64, P165, DOI 10.1023/A:1024924216148; Wright RF, 2001, HYDROL EARTH SYST SC, V5, P299, DOI 10.5194/hess-5-299-2001; Zhu Y, 2005, J AM WATER RESOUR AS, V41, P1393, DOI 10.1111/j.1752-1688.2005.tb03807.x	30	1228	1256	30	983	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					537	U9		10.1038/nature06316	http://dx.doi.org/10.1038/nature06316			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033294				2022-12-28	WOS:000251158500044
J	Simo, R; Hernandez, C				Simo, Rafael; Hernandez, Cristina			Fenofibrate for diabetic retinopathy	LANCET			English	Editorial Material							CLINICAL-TRIAL; VISUAL-LOSS; RUBOXISTAURIN		Vall Hebron Univ Hosp, Diabet Res Unit, Barcelona 08035, Spain	Hospital Universitari Vall d'Hebron	Simo, R (corresponding author), Vall Hebron Univ Hosp, Diabet Res Unit, Barcelona 08035, Spain.	rsimo@ir.vhebron.net		Hernandez, Cristina/0000-0002-3109-1721; Simo Canonge, Rafael/0000-0003-0475-3096				Abraham P, 2006, OPHTHALMOLOGY, V113, P2221, DOI 10.1016/j.ophtha.2006.07.032; Aiello LP, 2007, ARCH OPHTHALMOL-CHIC, V125, P318; Aiello LP, 2005, DIABETES, V54, P2188; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Garcia-Ramirez M, 2007, DIABETOLOGIA, V50, P1294, DOI 10.1007/s00125-007-0627-y; Hernandez C, 2007, EXPERT OPIN INV DRUG, V16, P1209, DOI 10.1517/13543784.16.8.1209; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; KEECH A, 2007, LANCET; Tserentsoodol N, 2006, MOL VIS, V12, P1319; Wong TY, 2007, LANCET, V370, P204, DOI 10.1016/S0140-6736(07)61104-0	10	35	35	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 17	2007	370	9600					1667	1668		10.1016/S0140-6736(07)61608-0	http://dx.doi.org/10.1016/S0140-6736(07)61608-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	17988727				2022-12-28	WOS:000251091200004
J	Dagotto, E				Dagotto, Elbio			Physics - When oxides meet face to face	SCIENCE			English	Editorial Material							INTERFACES		Univ Tennessee, Dept Phys, Knoxville, TN 37996 USA; Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory	Dagotto, E (corresponding author), Univ Tennessee, Dept Phys, Knoxville, TN 37996 USA.	edagotto@utk.edu						Chakhalian J, 2007, SCIENCE, V318, P1114, DOI 10.1126/science.1149338; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; Huijben M, 2006, NAT MATER, V5, P556, DOI 10.1038/nmat1675; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Okamoto S, 2004, NATURE, V428, P630, DOI 10.1038/nature02450; Ramirez AP, 2007, SCIENCE, V315, P1377, DOI 10.1126/science.1138578; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Yamada H, 2004, SCIENCE, V305, P646, DOI 10.1126/science.1098867; Yunoki S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064532	10	140	145	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1076	1077		10.1126/science.1151094	http://dx.doi.org/10.1126/science.1151094			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006728				2022-12-28	WOS:000250957900025
J	Chupp, GL; Lee, CG; Jarjour, N; Shim, YM; Holm, CT; He, S; Dziura, JD; Reed, J; Coyle, AJ; Kiener, P; Cullen, M; Grandsaigne, M; Dombret, M; Aubier, M; Pretolani, M; Elias, JA				Chupp, Geoffrey L.; Lee, Chun Geun; Jarjour, Nizar; Shim, Yun Michael; Holm, Carole T.; He, Susan; Dziura, James D.; Reed, Jennifer; Coyle, Anthony J.; Kiener, Peter; Cullen, Mark; Grandsaigne, Martine; Dombret, Marie-Christine; Aubier, Michel; Pretolani, Marina; Elias, Jack A.			A chitinase-like protein in the lung and circulation of patients with severe asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACIDIC MAMMALIAN CHITINASE; BRUGIA-MALAYI; SERUM; YKL-40; CHITOTRIOSIDASE; IDENTIFICATION; MICROFILARIAE; INFLAMMATION; MEMBER; FAMILY	Background: The evolutionarily conserved 18-glycosyl-hydrolase family contains true chitinases and chitinase-like proteins that lack enzymatic activity. Acidic mammalian chitinase has recently been associated with animal models of asthma. The related chitinase-like protein, YKL-40 (also called human cartilage glycoprotein 39 [HCgp-39] and chitinase 3-like 1), can be readily measured in the serum. However, its relationship to asthma has not been evaluated. Methods: We quantified serum YKL-40 levels in three cohorts of patients with asthma-one recruited from the patient population at Yale University, one from the University of Paris, and one from the University of Wisconsin-as well as in controls from the surrounding communities. In the Paris cohort, immunohistochemical analysis and morphometric quantitation were used to evaluate the locus of expression of YKL-40 in the lung. The clinical characteristics of the patients with high serum or lung YKL-40 levels were also evaluated. Results: Serum YKL-40 levels were significantly elevated in patients with asthma as compared with controls. In the Paris cohort, lung YKL-40 levels were elevated and were correlated with circulating YKL-40 levels (r=0.55, P<0.001) and with airway remodeling (measured as the thickness of the subepithelial basement membrane) (r=0.51, P=0.003). In all three cohorts, serum YKL-40 levels correlated positively with the severity of asthma and inversely with the forced expiratory volume in 1 second. Patients with elevated levels of YKL-40 had significantly more frequent rescue-inhaler use, greater oral corticosteroid use, and a greater rate of hospitalization than patients with lower levels. Conclusions: YKL-40 is found in increased quantities in the serum and lungs in a subgroup of patients with asthma, in whom expression of chitinase in both compartments correlates with the severity of asthma. The recovery of YKL-40 from these patients indicates either a causative or a sentinel role for this molecule in asthma.	Yale Univ, Sch Med, Pulm & Crit Care Med Sect, New Haven, CT 06520 USA; Univ Wisconsin, Sch Med, Madison, WI USA; MedImmune, Gaithersburg, MD USA; Univ Paris 07, INSERM, U700, F-75221 Paris 05, France; Ctr Hosp Univ Bichat Claude Bernard, Paris, France	Yale University; University of Wisconsin System; University of Wisconsin Madison; AstraZeneca; Medimmune; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP	Chupp, GL (corresponding author), Yale Univ, Sch Med, Pulm & Crit Care Med Sect, POB 208057,300 Cedar St,TAC 441, New Haven, CT 06520 USA.	geoffrey.chupp@yale.edu; jack.elias@yale.edu	Shim, Yun Michael/N-2049-2017; Pretolani, Marina/G-6643-2017; Lee, Chun Geun/AAC-2838-2021	Shim, Yun Michael/0000-0002-3780-3371; Lee, Chun Geun/0000-0002-9514-3658; cullen, mark/0000-0001-7996-1864	NHLBI NIH HHS [K08 HL091127, R01-HL-081639] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081639] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2000, AM J RESP CRIT CARE, V162, P2341; ARAUJO ACG, 1993, J HISTOCHEM CYTOCHEM, V41, P571, DOI 10.1177/41.4.8450196; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Couzin J, 2004, SCIENCE, V304, P1577, DOI 10.1126/science.304.5677.1577; de Marco R, 2006, J ALLERGY CLIN IMMUN, V117, P1249, DOI 10.1016/j.jaci.2006.03.019; DEBONO M, 1994, ANNU REV MICROBIOL, V48, P471, DOI 10.1146/annurev.mi.48.100194.002351; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; FUHRMAN JA, 1985, MOL BIOCHEM PARASIT, V17, P93, DOI 10.1016/0166-6851(85)90130-6; GOLDSTEIN RA, 1985, AM REV RESPIR DIS, V132, P180; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; JOHANSEN JS, 1993, BRIT J RHEUMATOL, V32, P949; JOHANSEN JS, 1992, J BONE MINER RES, V7, P501; Johansen JS, 2006, DAN MED BULL, V53, P172; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; Kelleher TB, 2005, J HEPATOL, V43, P78, DOI 10.1016/j.jhep.2005.02.025; LEE CG, 2007, AM J RESP CRIT CARE, V175, pA253; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Nordenbaek C, 1999, J INFECT DIS, V180, P1722, DOI 10.1086/315050; Ostergaard C, 2002, CLIN DIAGN LAB IMMUN, V9, P598, DOI 10.1128/CDLI.9.3.598-604.2002; RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198; SHAHABUDDIN M, 1994, EXP PARASITOL, V79, P85, DOI 10.1006/expr.1994.1066; Suzuki M, 2001, FEBS LETT, V506, P127, DOI 10.1016/S0014-5793(01)02893-9; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336; 2003, J ALLERGY CLIN IMMUN, V111, P466; 2002, J ALLERGY CLIN IM S5, V110, pS141	26	432	454	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2007	357	20					2016	2027		10.1056/NEJMoa073600	http://dx.doi.org/10.1056/NEJMoa073600			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230RV	18003958				2022-12-28	WOS:000250894500004
J	Long, SB; Tao, X; Campbell, EB; MacKinnon, R				Long, Stephen B.; Tao, Xiao; Campbell, Ernest B.; MacKinnon, Roderick			Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment	NATURE			English	Article							POTASSIUM CHANNEL; GATING-CHARGE; S4 SEGMENT; SHAKER; ACTIVATION; MOVEMENT; PROTEIN; FAMILY; SENSOR; PORE	Voltage-dependent K+ (Kv) channels repolarize the action potential in neurons and muscle. This type of channel is gated directly by membrane voltage through protein domains known as voltage sensors, which are molecular voltmeters that read the membrane voltage and regulate the pore. Here we describe the structure of a chimaeric voltage-dependent K+ channel, which we call the 'paddle-chimaera channel', in which the voltage-sensor paddle has been transferred from Kv2.1 to Kv1.2. Crystallized in complex with lipids, the complete structure at 2.4 angstrom resolution reveals the pore and voltage sensors embedded in a membrane-like arrangement of lipid molecules. The detailed structure, which can be compared directly to a large body of functional data, explains charge stabilization within the membrane and suggests a mechanism for voltage-sensor movements and pore gating.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@mail.rockefeller.edu		Long, Stephen/0000-0002-8144-1398	NIGMS NIH HHS [R01 GM043949] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Branden C.-I., 1999, INTRO PROTEIN STRUCT, V2nd, P15; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KING GI, 1986, BIOPHYS J, V49, P1047, DOI 10.1016/S0006-3495(86)83733-X; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; Miller C., 1986, ION CHANNEL RECONSTI; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; NISHIDAM, 2007, EMBO J, V26, P4005; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	44	1125	1148	2	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					376	U3		10.1038/nature06265	http://dx.doi.org/10.1038/nature06265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004376				2022-12-28	WOS:000250918600045
J	Kamerow, D				Kamerow, Dowelas			Paying for promising but unproven technologies	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@bmj.com		Kamerow, Douglas/0000-0001-7000-9957					0	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 10	2007	335	7627					965	965		10.1136/bmj.39391.630822.59	http://dx.doi.org/10.1136/bmj.39391.630822.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232AL	17991975	Green Published			2022-12-28	WOS:000250990400033
J	Fontaine, S; Barot, S; Barre, P; Bdioui, N; Mary, B; Rumpel, C				Fontaine, Sebastien; Barot, Sebastien; Barre, Pierre; Bdioui, Nadia; Mary, Bruno; Rumpel, Cornelia			Stability of organic carbon in deep soil layers controlled by fresh carbon supply	NATURE			English	Article							VERTICAL-DISTRIBUTION; CHEMICAL-COMPOSITION; ELEVATED CO2; CLIMATE; MATTER; DECOMPOSITION; TURNOVER; DROUGHT; INPUT; C-13	The world's soils store more carbon than is present in biomass and in the atmosphere(1). Little is known, however, about the factors controlling the stability of soil organic carbon stocks(2-4) and the response of the soil carbon pool to climate change remains uncertain(5,6). We investigated the stability of carbon in deep soil layers in one soil profile by combining physical and chemical characterization of organic carbon, soil incubations and radiocarbon dating. Here we show that the supply of fresh plant-derived carbon to the subsoil (0.6-0.8 m depth) stimulated the microbial mineralization of 2,567 +/- 226-year-old carbon. Our results support the previously suggested idea(7) that in the absence of fresh organic carbon, an essential source of energy for soil microbes, the stability of organic carbon in deep soil layers is maintained. We propose that a lack of supply of fresh carbon may prevent the decomposition of the organic carbon pool in deep soil layers in response to future changes in temperature. Any change in land use and agricultural practice that increases the distribution of fresh carbon along the soil profile(1,8,9) could however stimulate the loss of ancient buried carbon.	INRA, UR Agron 874, F-63100 Clermont Ferrand, France; IRD, UMR 137, F-93143 Bondy, France; CNRS INRA ENS Paris 6, UMR 7618, BIOEMCO, F-78820 Thiverval Grignon, France; INRA, UR Agron 1158, F-02007 Laon, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); INRAE; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); INRAE	Fontaine, S (corresponding author), INRA, UR Agron 874, 234 Ave Brezet, F-63100 Clermont Ferrand, France.	fontaine@clermont.inra.fr	barot, sébastien/A-8447-2012; Rumpel, Cornelia/A-2001-2015	barot, sébastien/0000-0002-5910-538X; Rumpel, Cornelia/0000-0003-2131-9451; Barre, Pierre/0000-0002-0822-0556				Baldock JA, 2000, ORG GEOCHEM, V31, P697, DOI 10.1016/S0146-6380(00)00049-8; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Boivin P., 2004, VOLCANOLOGIE CHAINE; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Cheng WX, 2003, SOIL SCI SOC AM J, V67, P1418, DOI 10.2136/sssaj2003.1418; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Eusterhues K, 2003, ORG GEOCHEM, V34, P1591, DOI 10.1016/j.orggeochem.2003.08.007; Fontaine S, 2005, ECOL LETT, V8, P1075, DOI 10.1111/j.1461-0248.2005.00813.x; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; HSIEH YP, 1993, SOIL SCI SOC AM J, V57, P1020, DOI 10.2136/sssaj1993.03615995005700040023x; HURD EA, 1974, AGR METEOROL, V14, P39, DOI 10.1016/0002-1571(74)90009-0; JENKINSON DS, 1992, SOIL BIOL BIOCHEM, V24, P295, DOI 10.1016/0038-0717(92)90189-5; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Klumpp K, 2007, AGR ECOSYST ENVIRON, V121, P59, DOI 10.1016/j.agee.2006.12.005; Kogel-Knabner I, 1997, GEODERMA, V80, P243, DOI 10.1016/S0016-7061(97)00055-4; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Loiseau P, 1999, PLANT SOIL, V210, P233, DOI 10.1023/A:1004681028245; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Malosso E, 2004, SOIL BIOL BIOCHEM, V36, P165, DOI 10.1016/j.soilbio.2003.09.004; MARTEL YA, 1974, SOIL SCI SOC AM J, V38, P501, DOI 10.2136/sssaj1974.03615995003800030033x; MEHRA OP, 1960, CLAYS CLAY MINER, V32, P557; Rumpel C, 2002, ORG GEOCHEM, V33, P1131, DOI 10.1016/S0146-6380(02)00088-8; Schmidt MWI, 1997, EUR J SOIL SCI, V48, P319, DOI 10.1111/j.1365-2389.1997.tb00552.x; Schoening I, 2006, SOIL BIOL BIOCHEM, V38, P2411, DOI 10.1016/j.soilbio.2006.03.005; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wattel-Koekkoek EJW, 2003, EUR J SOIL SCI, V54, P269, DOI 10.1046/j.1365-2389.2003.00512.x	29	1387	1528	97	1443	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					277	U10		10.1038/nature06275	http://dx.doi.org/10.1038/nature06275			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994095				2022-12-28	WOS:000250746200056
J	Brunner-La Rocca, HP; Kaiser, C; Bernheim, A; Zellweger, MJ; Jeger, R; Buser, PT; Osswald, S; Pfisterer, M				Brunner-La Rocca, Hans Peter; Kaiser, Christoph; Bernheim, Alain; Zellweger, Michael J.; Jeger, Raban; Buser, Peter T.; Osswald, Stefan; Pfisterer, Matthias		BASKET Investigators	Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitats Trial (BASKET): an 18-month analysis	LANCET			English	Article							BARE-METAL STENTS; OFF-LABEL; THROMBOSIS; OUTCOMES; HEALTH; RESTENOSIS	Background Our aim was to determine whether drug-eluting stents are good value for money in long-term, everyday practice. Methods We did an 18-month cost-effectiveness analysis of the Basel Stent KostenEffektivitats Trial (BASKET), which randomised 826 patients 2:1 to drug-eluting stents (n=545) or to bare-metal stents (281). We used non-parametric bootstrap techniques to determine incremental cost-effectiveness ratios (ICERs) of drug-eluting versus bare-metal stents, to compare low-risk (>= 3.0 mm stents in native vessels; n=558, 68%) and high-risk pa ents (<3.0 mm stents/bypass graft stenting; n=268, 32%), and to do sensitivity analyses by altering costs and event rates in the whole Study sample and in predefined subgroups. Quality-adjusted fife-years (QALYs) were assessed by EQ-5D questionnaire (available in 703/826 patients). Findings Overall costs were higher for patients with drug-eluting stents than in those with bare-metal stents ((sic)11808 [SD 400] per patient with drug-eluting stents and (sic)10 450 [592] per patient with bare-metal stents, mean difference (sic)1358 [717], p<0.0001), due to higher stent costs. We calculated an ICER of (sic)64732 to prevent one major adverse cardiac event, and of (sic)40 467 per QALY gained. Stent costs, number of events, and QALYs affected ICERs most, but unrealistic alterations would have been required to achieve acceptable cost-effectiveness. In low-risk patients, the probability of drug-eluting stents achieving an arbitrary ICER of (sic)10 000 or less to prevent one major adverse cardiac event was 0.016; by contrast, it was 0.874 in high-risk patients. Interpretation if used in all patients, drug-eluting stents are not good value for money, even if prices were substantially reduced. Drug-eluting stents are cost effective in patients needing small vessel or bypass graft stenting, but not in those who require large native vessel stenting.	Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland	University of Basel	Pfisterer, M (corresponding author), Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland.	pfisterer@email.ch	Osswald, Stefan/A-6904-2018; Zellweger, Michael/AAB-4859-2022; Brunner-La Rocca, Hans-Peter/AAF-7330-2021; Jeger, Raban/ABG-1678-2021; Kaiser, Christoph/AAA-9284-2022	Osswald, Stefan/0000-0002-9240-6731; Jeger, Raban/0000-0003-1290-5491; 				Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Bakhai A, 2006, J AM COLL CARDIOL, V48, P253, DOI 10.1016/j.jacc.2006.02.063; Beohar N, 2007, JAMA-J AM MED ASSOC, V297, P1992, DOI 10.1001/jama.297.18.1992; Cohen DJ, 2004, CIRCULATION, V110, P508, DOI 10.1161/01.CIR.0000136821.99814.43; Cooper LM, 2006, EXPERT OPIN DRUG DEL, V3, P305, DOI 10.1517/17425247.3.3.305; Daemen J, 2007, CIRCULATION, V116, P961, DOI 10.1161/CIRCULATIONAHA.107.691451; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Eisenberg MJ, 2006, CIRCULATION, V114, P1745, DOI 10.1161/CIRCULATIONAHA.106.646190; Elezi S, 2006, J AM COLL CARDIOL, V48, P262, DOI 10.1016/j.jacc.2006.01.080; Gold MR, 1996, COST EFFECTIVENESS H; Greenberg D, 2004, J AM COLL CARDIOL, V43, P513, DOI 10.1016/j.jacc.2003.11.020; Greiner W, 2005, Eur J Health Econ, V6, P124, DOI 10.1007/s10198-004-0264-z; Kaiser C, 2005, LANCET, V366, P921, DOI 10.1016/S0140-6736(05)67221-2; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; LAROCCA HPB, 2007, EUR HEART J, V28, P719; Ligthart S, 2007, CAN MED ASSOC J, V176, P199, DOI 10.1503/cmaj.061020; Little R.J.A., 2002, STAT ANAL MISSING DA; Ong ATL, 2006, EUR HEART J, V27, P2996, DOI 10.1093/eurheartj/ehl357; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Polsky D, 1997, HEALTH ECON, V6, P243, DOI 10.1002/(SICI)1099-1050(199705)6:3<243::AID-HEC269>3.0.CO;2-Z; Ryan J, 2006, CIRCULATION, V114, P1736, DOI 10.1161/CIRCULATIONAHA.105.546010; Shuchman M, 2006, NEW ENGL J MED, V355, P1949, DOI 10.1056/NEJMp068234; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304; Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001; UPDATE FDA STATEMENT	29	74	75	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 3	2007	370	9598					1552	1559						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AE	17980734				2022-12-28	WOS:000250628800024
J	Fischer, C; Jonckx, B; Mazzone, M; Zacchigna, S; Loges, S; Pattarini, L; Chorianopoulos, E; Liesenborghs, L; Koch, M; De Mol, M; Autiero, M; Wyns, S; Plaisance, S; Moons, L; van Rooijen, N; Giacca, M; Stassen, JM; Dewerchin, M; Collen, D; Carmeliet, P				Fischer, Christian; Jonckx, Bart; Mazzone, Massimiliano; Zacchigna, Serena; Loges, Sonja; Pattarini, Lucia; Chorianopoulos, Emmanuel; Liesenborghs, Laurens; Koch, Marta; De Mol, Maria; Autiero, Monica; Wyns, Sabine; Plaisance, Stephane; Moons, Lieve; van Rooijen, Nico; Giacca, Mauro; Stassen, Jean-Marie; Dewerchin, Mieke; Collen, Desire; Carmeliet, Peter			Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels	CELL			English	Article							HUMAN BREAST-CANCER; COLORECTAL-CANCER; FACTOR-RECEPTOR; PATHOLOGICAL CONDITIONS; ANTIANGIOGENIC THERAPY; TARGETED INACTIVATION; FACTOR-A; ANGIOGENESIS; MICE; METASTASIS	Novel antiangiogenic strategies with complementary mechanisms are needed to maximize efficacy and minimize resistance to current angiogenesis inhibitors. We explored the therapeutic potential and mechanisms of alpha PIGF, an antibody against placental growth factor (PIGF), a VEGF homolog, which regulates the angiogenic switch in disease, but not in health. alpha PIGF inhibited growth and metastasis of various tumors, including those resistant to VEGF(R) inhibitors (VEGF(R)Is), and enhanced the efficacy of chemotherapy and VEGF(R)Is. alpha PIGF inhibited angiogenesis, lymphangiogenesis, and tumor cell motility. Distinct from VEGF(R)Is, alpha PIGF prevented infiltration of angiogenic macrophages and severe tumor hypoxia, and thus, did not switch on the angiogenic rescue program responsible for resistance to VEGF(R)Is. Moreover, it did not cause or enhance VEGF(R)I-related side effects. The efficacy and safety of alpha PIGF, its pleiotropic and complementary mechanism to VEGF(R)Is, and the negligible induction of an angiogenic rescue program suggest that alpha PIGF may constitute a novel approach for cancer treatment.	Katholieke Univ Leuven VIB, Dept Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; VUMC, Dept Mol Cell Biol, NL-1007 Amsterdam, Netherlands; ThromboGenics NV, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; International Center for Genetic Engineering & Biotechnology (ICGEB)	Carmeliet, P (corresponding author), Katholieke Univ Leuven VIB, Dept Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium.	carmeliet@med.kuleuven.be	Van Rooijen, Nico/Z-1578-2019; Carmeliet, Peter/AAQ-5140-2020; Loges, Sonja/ABE-9868-2021; Giacca, Mauro/J-9287-2016; Plaisance, Stephane/ABI-6307-2020; Plaisance, Stephane/B-3488-2009; ZACCHIGNA, SERENA/E-9496-2017	Carmeliet, Peter/0000-0001-7961-1821; Loges, Sonja/0000-0002-7650-8527; Giacca, Mauro/0000-0003-2927-7225; Plaisance, Stephane/0000-0002-1651-241X; Plaisance, Stephane/0000-0002-1651-241X; Mazzone, Massimiliano/0000-0001-8824-4015; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Liesenborghs, Laurens/0000-0001-5616-8548; ZACCHIGNA, SERENA/0000-0001-6705-3076				Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Carmeliet P, 1997, ANN NY ACAD SCI, V811, P191, DOI 10.1111/j.1749-6632.1997.tb52002.x; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chen CN, 2004, CANCER LETT, V213, P73, DOI 10.1016/j.canlet.2004.05.020; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Davidoff AM, 2002, CANCER RES, V62, P3077; DECLERCK PJ, 1995, THROMB HAEMOSTASIS, V74, P1305; Errico M, 2004, J BIOL CHEM, V279, P43929, DOI 10.1074/jbc.M401418200; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2001, CANCER RES, V61, P1207; Ho MC, 2007, CANCER LETT, V250, P237, DOI 10.1016/j.canlet.2006.10.005; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kramer I, 2007, J CLIN PHARM THER, V32, P1, DOI 10.1111/j.1365-2710.2007.00800.x; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Luttun A, 2002, BIOCHEM BIOPH RES CO, V295, P428, DOI 10.1016/S0006-291X(02)00677-0; Malik AK, 2006, BLOOD, V107, P550, DOI 10.1182/blood-2005-05-2047; Marcellini M, 2006, AM J PATHOL, V169, P643, DOI 10.2353/ajpath.2006.051041; Matsumoto K, 2003, ANTICANCER RES, V23, P4953; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; PARK JE, 1994, J BIOL CHEM, V269, P25646; Parr C, 2005, EUR J CANCER, V41, P2819, DOI 10.1016/j.ejca.2005.07.022; Pipp F, 2003, CIRC RES, V92, P378, DOI 10.1161/01.RES.0000057997.77714.72; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Rosen LS, 2007, J CLIN ONCOL, V25, P2369, DOI 10.1200/JCO.2006.07.8170; Roy H, 2005, HUM GENE THER, V16, P1422, DOI 10.1089/hum.2005.16.1422; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sweeney CJ, 2003, TRENDS MOL MED, V9, P24, DOI 10.1016/S1471-4914(02)00007-2; Taylor AP, 2007, MOL CANCER THER, V6, P524, DOI 10.1158/1535-7163.MCT-06-0461; Taylor AP, 2003, INT J CANCER, V105, P158, DOI 10.1002/ijc.11059; Wei SC, 2005, GUT, V54, P666, DOI 10.1136/gut.2004.050831; Willett CG, 2005, J CLIN ONCOL, V23, P8136, DOI 10.1200/JCO.2005.02.5635; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240	40	640	678	1	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					463	475		10.1016/j.cell.2007.08.038	http://dx.doi.org/10.1016/j.cell.2007.08.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981115	Green Submitted, Bronze			2022-12-28	WOS:000250618500015
J	Stocum, DL				Stocum, David L.			Acceptable nAGging	SCIENCE			English	Editorial Material							LIMB REGENERATION		Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Stocum, DL (corresponding author), Indiana Univ Purdue Univ, Dept Biol, 723 W Michigan St, Indianapolis, IN 46202 USA.	dstocum@iupui.edu						Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; GLOBUS M, 1990, J EXP ZOOL, V254, P165, DOI 10.1002/jez.1402540208; Hill RE, 2007, DEV GROWTH DIFFER, V49, P439, DOI 10.1111/j.1440-169x.2007.00943.x; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Mescher AL, 1997, DEV GROWTH DIFFER, V39, P677; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Stocum DL, 2006, REGENERATIVE BIOL ME; Tickle C, 2006, NAT REV MOL CELL BIO, V7, P45, DOI 10.1038/nrm1830; Wang LS, 2000, J NEUROBIOL, V43, P150, DOI 10.1002/(SICI)1097-4695(200005)43:2<150::AID-NEU5>3.0.CO;2-G	12	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					754	755		10.1126/science.1150795	http://dx.doi.org/10.1126/science.1150795			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975053				2022-12-28	WOS:000250583900025
J	Gomberg, J; Rubinstein, JL; Peng, ZG; Creager, KC; Vidale, JE; Bodin, P				Gomberg, Joan; Rubinstein, Justin L.; Peng, Zhigang; Creager, Kenneth C.; Vidale, John E.; Bodin, Paul			Widespread triggering of nonvolcanic tremor in California	SCIENCE			English	Article							SUBDUCTION; FAULT		[Gomberg, Joan] US Geol Survey, Seattle, WA 98195 USA; [Rubinstein, Justin L.; Creager, Kenneth C.; Vidale, John E.; Bodin, Paul] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Peng, Zhigang] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; University System of Georgia; Georgia Institute of Technology	Gomberg, J (corresponding author), US Geol Survey, Box 351310, Seattle, WA 98195 USA.	gomberg@usgs.gov	Vidale, John/H-4965-2011	Vidale, John/0000-0002-3658-818X; Rubinstein, Justin/0000-0003-1274-6785				LIU Y, 2005, J GEOPHYS RES, V110; Nadeau RM, 2005, SCIENCE, V307, P389, DOI 10.1126/science.1107142; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Prejean SG, 2004, B SEISMOL SOC AM, V94, pS348, DOI 10.1785/0120040610; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Rubinstein JL, 2007, NATURE, V448, P579, DOI 10.1038/nature06017	6	112	117	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					173	173		10.1126/science.1149164	http://dx.doi.org/10.1126/science.1149164			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18033850	Green Submitted			2022-12-28	WOS:000252246400031
J	Koziol, K; Vilatela, J; Moisala, A; Motta, M; Cunniff, P; Sennett, M; Windle, A				Koziol, Krzysztof; Vilatela, Juan; Moisala, Anna; Motta, Marcelo; Cunniff, Philip; Sennett, Michael; Windle, Alan			High-performance carbon nanotube fiber	SCIENCE			English	Article							MODULUS POLYETHYLENE FIBERS; STRENGTH; ARRAYS; YARNS	With their impressive individual properties, carbon nanotubes should form high-performance fibers. We explored the roles of nanotube length and structure, fiber density, and nanotube orientation in achieving optimum mechanical properties. We found that carbon nanotube fiber, spun directly and continuously from gas phase as an aerogel, combines high strength and high stiffness ( axial elastic modulus), with an energy to breakage ( toughness) considerably greater than that of any commercial high- strength fiber. Different levels of carbon nanotube orientation, fiber density, and mechanical properties can be achieved by drawing the aerogel at various winding rates. The mechanical data obtained demonstrate the considerable potential of carbon nanotube assemblies in the quest for maximal mechanical performance. The statistical aspects of the mechanical data reveal the deleterious effect of defects and indicate strategies for future work.	Univ Cambridge, Dept Mat Sci, Cambridge CB2 3QZ, England; USA, Natick Res Dev & Engn Ctr, Natick, MA 01760 USA	University of Cambridge	Windle, A (corresponding author), Univ Cambridge, Dept Mat Sci, Pembroke St, Cambridge CB2 3QZ, England.	ahw1@hermes.cam.ac.uk	Funde, Adinath M./D-8169-2012; Koziol, Krzysztof/E-3626-2010; Vilatela, Juan/E-2418-2012	Koziol, Krzysztof/0000-0002-8360-1121; , Anna/0000-0002-9060-8452				ADAMS WS, COMMUNICATION; AMORNSAKCHAI T, 1993, J MATER SCI, V28, P1689, DOI 10.1007/BF00363369; Belytschko T, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.235430; Demczyk BG, 2002, MAT SCI ENG A-STRUCT, V334, P173, DOI 10.1016/S0921-5093(01)01807-X; Dumitrica T, 2006, P NATL ACAD SCI USA, V103, P6105, DOI 10.1073/pnas.0600945103; Ericson LM, 2004, SCIENCE, V305, P1447, DOI 10.1126/science.1101398; HUGHES JDH, 1980, J PHYS D APPL PHYS, V13, P921, DOI 10.1088/0022-3727/13/6/005; Jiang KL, 2002, NATURE, V419, P801, DOI 10.1038/419801a; Li QW, 2006, ADV MATER, V18, P3160, DOI 10.1002/adma.200601344; Li YL, 2004, SCIENCE, V304, P276, DOI 10.1126/science.1094982; Lissart N, 1997, J MATER SCI, V32, P6107, DOI 10.1023/A:1018600119250; Liu T, 2003, NANO LETT, V3, P647, DOI 10.1021/nl034071i; Maurer R.D, 1985, STRENGTH INORGANIC G; Motta M, 2007, ADV MATER, V19, P3721, DOI 10.1002/adma.200700516; Natsuki T, 2004, CARBON, V42, P39, DOI 10.1016/j.carbon.2003.09.011; Treacy MMJ, 1996, NATURE, V381, P678, DOI 10.1038/381678a0; VANDERWERFF H, 1991, COLLOID POLYM SCI, V269, P747, DOI 10.1007/BF00657441; Vigolo B, 2000, SCIENCE, V290, P1331, DOI 10.1126/science.290.5495.1331; Ward I., 2000, SOLID PHASE PROCESSI, P133; Ward I. M., 1975, STRUCTURE PROPERTIES; Yu MF, 2000, PHYS REV LETT, V84, P5552, DOI 10.1103/PhysRevLett.84.5552; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhang XF, 2007, SMALL, V3, P244, DOI 10.1002/smll.200600368	23	823	849	25	703	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1892	1895		10.1126/science.1147635	http://dx.doi.org/10.1126/science.1147635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18006708				2022-12-28	WOS:000251786600050
J	Horton, R				Horton, Richard			Managing risk: identifying environmental causes of disease	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							*AC MED SCI, 2007, ID ENV CAUS DIS REP; *DEP BUS ENT REG R, 2007, FUND FOR INTR; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	4	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					1986	1987		10.1016/S0140-6736(07)61725-5	http://dx.doi.org/10.1016/S0140-6736(07)61725-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18045682				2022-12-28	WOS:000251698600010
J	Loewenstein, G; Brennan, T; Volpp, KG				Loewenstein, George; Brennan, Troyen; Volpp, Kevin G.			Asymmetric paternalism to improve health behaviors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING-CESSATION; ADHERENCE; ECONOMICS		Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; Aetna Inc, Hartford, CT USA; Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Wharton Sch, Dept Hlth Care Syst, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	Carnegie Mellon University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Loewenstein, G (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA.	gl20@andrew.cmu.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474; Volpp, Kevin/0000-0003-1423-4599				Baumeister RF, 2003, WILLPOWER CHOICE SEL; Camerer C, 2003, U PENN LAW REV, V151, P1211, DOI 10.2307/3312889; Camerer CF, 2004, ROUNDTABLE SER BEHAV, P1; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Higgins ST, 2000, J CONSULT CLIN PSYCH, V68, P64, DOI 10.1037/0022-006X.68.1.64; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; JOHNSON EJ, 1993, J RISK UNCERTAINTY, V7, P35, DOI 10.1007/BF01065313; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Madrian BC, 2001, Q J ECON, V116, P1149, DOI 10.1162/003355301753265543; MARTIN A, 2007, NY TIMES        0905; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Thaler RH, 2004, J POLIT ECON, V112, pS164, DOI 10.1086/380085; Thaler RH, 2003, AM ECON REV, V93, P175, DOI 10.1257/000282803321947001; Volpp KG, 2006, CANCER EPIDEM BIOMAR, V15, P12, DOI 10.1158/1055-9965.EPI-05-0314; Warner KE, 1996, J OCCUP ENVIRON MED, V38, P981, DOI 10.1097/00043764-199610000-00008; Weber BJ, 2005, ORGAN BEHAV HUM DEC, V97, P31, DOI 10.1016/j.obhdp.2005.03.001	18	338	340	4	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2415	2417		10.1001/jama.298.20.2415	http://dx.doi.org/10.1001/jama.298.20.2415			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	18042920				2022-12-28	WOS:000251163400024
J	Gudde, J; Rohleder, M; Meier, T; Koch, SW; Hofer, U				Guedde, J.; Rohleder, M.; Meier, T.; Koch, S. W.; Hoefer, U.			Time-resolved investigation of coherently controlled electric currents at a metal surface	SCIENCE			English	Article							IMAGE-POTENTIAL STATES; 2-PHOTON PHOTOEMISSION; DYNAMICS; FEMTOSECOND; CU(100); SEMICONDUCTORS; LOCALIZATION; LIFETIMES; SYSTEMS; GAAS	Studies of current dynamics in solids have been hindered by insufficiently brief trigger signals and electronic detection speeds. By combining a coherent control scheme with photoelectron spectroscopy, we generated and detected lateral electron currents at a metal surface on a femtosecond time scale with a contact-free experimental setup. We used coherent optical excitation at the light frequencies omega(a) and omega(a)/2 to induce the current, whose direction was controlled by the relative phase between the phase-locked laser excitation pulses. Time- and angle-resolved photoelectron spectroscopy afforded a direct image of the momentum distribution of the excited electrons as a function of time. For the first (n = 1) image-potential state of Cu(100), we found a decay time of 10 femtoseconds, attributable to electron scattering with steps and surface defects.	Univ Marburg, Fachbereich Phys, D-35032 Marburg, Germany; Univ Marburg, Zentrum Mat Wissensch, D-35032 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Hofer, U (corresponding author), Univ Marburg, Fachbereich Phys, Renthof 5, D-35032 Marburg, Germany.	hoefer@physik.uni-marburg.de	Hofer, Ulrich/A-1310-2009	Hofer, Ulrich/0000-0002-5706-1205; Gudde, Jens/0000-0002-0243-7877; Meier, Torsten/0000-0001-8864-2072				Ashcroft N.W., 1976, SOLID STATE PHYS; Boger K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126803; BRUMER P, 1986, CHEM PHYS LETT, V126, P541, DOI 10.1016/S0009-2614(86)80171-3; Cote D, 1999, APPL PHYS LETT, V75, P3959, DOI 10.1063/1.125531; Duc HT, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.086606; DUPONT E, 1995, PHYS REV LETT, V74, P3596, DOI 10.1103/PhysRevLett.74.3596; Echenique PM, 2004, SURF SCI REP, V52, P219, DOI 10.1016/j.surfrep.2004.02.002; ECHENIQUE PM, 1978, J PHYS C SOLID STATE, V11, P2065, DOI 10.1088/0022-3719/11/10/017; Fraser JM, 1999, PHYS REV LETT, V83, P4192, DOI 10.1103/PhysRevLett.83.4192; Ge NH, 1998, SCIENCE, V279, P202, DOI 10.1126/science.279.5348.202; GIESEN K, 1987, PHYS REV B, V35, P975, DOI 10.1103/PhysRevB.35.975; Gudde J, 2006, APPL PHYS A-MATER, V85, P345, DOI 10.1007/s00339-006-3711-0; Hache A, 1997, PHYS REV LETT, V78, P306, DOI 10.1103/PhysRevLett.78.306; Heinz T. F., 1991, NONLINEAR SURFACE EL, P353; Hofer U, 1997, SCIENCE, V277, P1480, DOI 10.1126/science.277.5331.1480; Hufner S., 2003, SPECTROSCOPY PRINCIP, V3rd; Knoesel E, 1998, J ELECTRON SPECTROSC, V88, P577, DOI 10.1016/S0368-2048(97)00178-3; MEIER T, 1995, PHYS REV LETT, V75, P2558, DOI 10.1103/PhysRevLett.75.2558; Ogawa S, 1997, PHYS REV LETT, V78, P1339, DOI 10.1103/PhysRevLett.78.1339; Olsson FE, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.205417; Petek H, 1997, PHYS REV LETT, V79, P4649, DOI 10.1103/PhysRevLett.79.4649; Reuss C, 1999, PHYS REV LETT, V82, P153, DOI 10.1103/PhysRevLett.82.153; Rohleder M, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/103; Roth M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.096802; SCHOENLEIN RW, 1988, PHYS REV LETT, V61, P2596, DOI 10.1103/PhysRevLett.61.2596; Shah J., 1996, ULTRAFAST SPECTROSCO; Shumay IL, 1998, PHYS REV B, V58, P13974, DOI 10.1103/PhysRevB.58.13974; Weida MJ, 2000, J OPT SOC AM B, V17, P1443, DOI 10.1364/JOSAB.17.001443	28	113	113	3	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2007	318	5854					1287	1291		10.1126/science.1146764	http://dx.doi.org/10.1126/science.1146764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033880				2022-12-28	WOS:000251086600039
J	Dimopoulos, M; Spencer, A; Attal, M; Prince, HM; Harousseau, J; Dmoszynska, A; San Miguel, J; Hellmann, A; Facon, T; Foa, R; Corso, A; Masliak, Z; Olesnyckyj, M; Yu, ZN; Patin, J; Zeldis, JB; Knight, RD				Dimopoulos, Meletios; Spencer, Andrew; Attal, Michael; Prince, H. Miles; Harousseau, Jean-Luc; Dmoszynska, Anna; San Miguel, Jesus; Hellmann, Andrzej; Facon, Thierry; Foa, Robin; Corso, Alessandro; Masliak, Zvenyslava; Olesnyckyj, Marta; Yu, Zhinuan; Patin, John; Zeldis, Jerome B.; Knight, Robert D.		Multiple Myeloma 010 Study	Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DRUG-RESISTANCE; THALIDOMIDE; COMBINATION; THERAPY; ANALOGS; CELLS	Background Lenalidomide is a structural analogue of thalidomide with similar but more potent biologic activity. This phase 3, placebo-controlled trial investigated the efficacy of lenalidomide plus dexamethasone in the treatment of relapsed or refractory multiple myeloma. Methods Of 351 patients who had received at least one previous antimyeloma therapy, 176 were randomly assigned to receive 25 mg of oral lenalidomide and 175 to receive placebo on days 1 to 21 of a 28-day cycle. In addition, all patients received 40 mg of oral dexamethasone on days 1 to 4, 9 to 12, and 17 to 20 for the first four cycles and subsequently, after the fourth cycle, only on days 1 to 4. Patients continued in the study until the occurrence of disease progression or unacceptable toxic effects. The primary end point was time to progression. Results The time to progression was significantly longer in the patients who received lenalidomide plus dexamethasone (lenalidomide group) than in those who received placebo plus dexamethasone (placebo group) (median, 11.3 months vs. 4.7 months; P<0.001). A complete or partial response occurred in 106 patients in the lenalidomide group (60.2%) and in 42 patients in the placebo group (24.0%, P<0.001), with a complete response in 15.9% and 3.4% of patients, respectively (P<0.001). Overall survival was significantly improved in the lenalidomide group (hazard ratio for death, 0.66; P=0.03). Grade 3 or 4 adverse events that occurred in more than 10% of patients in the lenalidomide group were neutropenia (29.5%, vs. 2.3% in the placebo group), thrombocytopenia (11.4% vs. 5.7%), and venous thromboembolism (11.4% vs. 4.6%). Conclusions Lenalidomide plus dexamethasone is more effective than high-dose dexamethasone alone in relapsed or refractory multiple myeloma. (ClinicalTrials.gov number, NCT00424047.).	Univ Athens, Sch Med, GR-11527 Athens, Greece; Alfred Hosp, Melbourne, Vic, Australia; Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia; CHU Purpan, Toulouse, France; CHR Hotel Dieu, Nantes, France; Univ Sch Med, Lublin, Poland; Hosp Univ Salamanca, Salamanca, Spain; Med Univ Gdansk, Gdansk, Poland; Hop Claude Huriez, Lille, France; Univ Roma La Sapienza, Rome, Italy; Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, I-27100 Pavia, Italy; Inst Blood Pathol & Transfus Med, Lvov, Ukraine; Celgene, Summit, NJ USA	Athens Medical School; National & Kapodistrian University of Athens; Florey Institute of Neuroscience & Mental Health; Peter Maccallum Cancer Center; CHU de Toulouse; Nantes Universite; CHU de Nantes; Medical University of Lublin; University of Salamanca; Fahrenheit Universities; Medical University Gdansk; Universite de Lille - ISITE; CHU Lille; Sapienza University Rome; IRCCS Fondazione San Matteo; National Academy of Medical Sciences of Ukraine; Institute of Blood Pathology & Transfusion Medicine; Bristol-Myers Squibb; Celgene Corporation	Dimopoulos, M (corresponding author), Univ Athens, Sch Med, Alexandra Hosp, Vas Sophias 80, Athens 11528, Greece.	mdimop@med.uoa.gr	San-Miguel, Jesús F./V-8977-2018; 2007, Secribsal/A-1556-2012; Dimopoulos, Meletios Athanasios/AAD-4130-2019	San-Miguel, Jesús F./0000-0002-9183-4857; Dimopoulos, Meletios/0000-0001-8990-3254				Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Dimopoulos MA, 2001, ANN ONCOL, V12, P991, DOI 10.1023/A:1011132808904; Dimopoulos MA, 2004, AM J MED, V117, P508, DOI 10.1016/j.amjmed.2004.03.040; Garcia-Sanz R, 2004, LEUKEMIA, V18, P856, DOI 10.1038/sj.leu.2403322; Hideshima T, 2000, BLOOD, V96, P2943, DOI 10.1182/blood.V96.9.2943; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Kumar S, 2005, NAT CLIN PRACT ONCOL, V2, P262, DOI 10.1038/ncponc0174; Marriott JB, 2002, CLIN EXP IMMUNOL, V130, P75, DOI 10.1046/j.1365-2249.2002.01954.x; Richardson PG, 2006, BLOOD, V108, P3458, DOI 10.1182/blood-2006-04-015909; Richardson PG, 2002, BLOOD, V100, P3063, DOI 10.1182/blood-2002-03-0996; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Singhal S, 2000, NEW ENGL J MED, V342, P364	13	1138	1209	1	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2123	2132		10.1056/NEJMoa070594	http://dx.doi.org/10.1056/NEJMoa070594			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	18032762	Bronze			2022-12-28	WOS:000251076500004
J	Vinet, E; Tangri, N; Pineau, CA				Vinet, Evelyne; Tangri, Navdeep; Pineau, Christian A.			Not arthritis	LANCET			English	Editorial Material							ANTI-HU; NEUROPATHY		McGill Univ, Ctr Hlth, Div Rheumatol, Dept Internal Med, Montreal, PQ H3G 1A4, Canada	McGill University	Vinet, E (corresponding author), McGill Univ, Ctr Hlth, Div Rheumatol, Dept Med, Montreal, PQ H3G 1A4, Canada.	evelyne.vinet@mail.mcgill.ca		Vinet, Evelyne/0000-0001-7727-5879; Tangri, Navdeep/0000-0002-5075-6370				Aguirre-Cruz L, 2005, J NEURO-ONCOL, V71, P39, DOI 10.1007/s11060-004-4536-3; DAS A, 2003, TXB CLIN NEUROLOGY, P1041; De Beukelaar JW, 2006, ONCOLOGIST, V11, P292, DOI 10.1634/theoncologist.11-3-292; Freeman R, 2005, LANCET, V365, P1259, DOI 10.1016/S0140-6736(05)74815-7; Molinuevo JL, 1998, ANN NEUROL, V44, P976, DOI 10.1002/ana.410440620	5	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 17	2007	370	9600					1736	1736		10.1016/S0140-6736(07)61724-3	http://dx.doi.org/10.1016/S0140-6736(07)61724-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	18022036				2022-12-28	WOS:000251091200025
J	Anderson, AC; Anderson, DE; Bregoli, L; Hastings, WD; Kassam, N; Lei, C; Chandwaskar, R; Karman, J; Su, EW; Hirashima, M; Bruce, JN; Kane, LP; Kuchroo, VK; Hafler, DA				Anderson, Ana C.; Anderson, David E.; Bregoli, Lisa; Hastings, William D.; Kassam, Nasim; Lei, Charles; Chandwaskar, Rucha; Karman, Jozsef; Su, Ee W.; Hirashima, Mitsuomi; Bruce, Jeffrey N.; Kane, Lawrence P.; Kuchroo, Vijay K.; Hafler, David A.			Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells	SCIENCE			English	Article							MULTIPLE-SCLEROSIS; MICROGLIA; GALECTIN-9; BRAIN; ASTROCYTES; AUTOIMMUNE; TOLERANCE; RESPONSES; DISEASE	CD4(+) T helper 1 (T(H)1) cells are important mediators of inflammation and are regulated by numerous pathways, including the negative immune receptor Tim-3. We found that Tim-3 is constitutively expressed on cells of the innate immune system in both mice and humans, and that it can synergize with Toll-like receptors. Moreover, an antibody agonist of Tim-3 acted as an adjuvant during induced immune responses, and Tim-3 ligation induced distinct signaling events in T cells and dendritic cells; the latter finding could explain the apparent divergent functions of Tim-3 in these cell types. Thus, by virtue of differential expression on innate versus adaptive immune cells, Tim-3 can either promote or terminate T(H)1 immunity and may be able to influence a range of inflammatory conditions.	Brigham & Womens Hosp, Ctr Neurol Dis, Div Mol Immunol, Boston, MA 02115 USA; Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA; Kagawa Univ, Sch Med, Takamatsu, Kagawa 760, Japan; Columbia Univ Coll Phys & Surg, Dept Neurol Surg, Neurol Inst, Gabriele Bartoli Brain Tumor Res Lab, New York, NY 10032 USA	Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kagawa University; Columbia University	Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Div Mol Immunol, 75 Francis St, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu	Bruce, Jeffrey N/AAC-5307-2022; Anderson, Ana C/ABD-6829-2021	Anderson, Ana C/0000-0002-0877-2932; Kane, Lawrence/0000-0001-5198-516X; Bregoli, Lisa/0000-0001-9376-1914	NIAID NIH HHS [R56 AI067544-02, R56 AI067544-01A1, R01 AI067544-01A2, R01 AI067544, R56 AI067544] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067544, R01AI067544] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvord EC, 1984, EXPT ALLERGIC ENCEPH; Baranzini SE, 2000, J IMMUNOL, V165, P6576, DOI 10.4049/jimmunol.165.11.6576; FORD AL, 1995, J IMMUNOL, V154, P4309; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gielen AW, 2005, J NEUROIMMUNOL, V164, P93, DOI 10.1016/j.jneuroim.2005.04.004; Hirofumi A, 2002, J IMMUNOL, V169, P5912, DOI 10.4049/jimmunol.169.10.5912; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Khademi M, 2004, J IMMUNOL, V172, P7169, DOI 10.4049/jimmunol.172.11.7169; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; LASSMANN H, 1993, GLIA, V7, P19, DOI 10.1002/glia.440070106; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Roussel E, 1996, CLIN EXP IMMUNOL, V105, P344, DOI 10.1046/j.1365-2249.1996.d01-753.x; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sui L, 2006, INT J MOL MED, V17, P1093; WILLIAMS K, 1992, J NEUROPATH EXP NEUR, V51, P538, DOI 10.1097/00005072-199209000-00009; Yoshida H, 2001, NEUROREPORT, V12, P3755, DOI 10.1097/00001756-200112040-00030; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	19	510	588	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1141	1143		10.1126/science.1148536	http://dx.doi.org/10.1126/science.1148536			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006747				2022-12-28	WOS:000250957900047
J	Martinez-Pomares, L; Gordon, S				Martinez-Pomares, Luisa; Gordon, Siamon			Antigen presentation the macrophage way	CELL			English	Editorial Material							NODE B-CELLS; LYMPH-NODE; DENDRITIC CELLS; RECOGNITION; FOLLICLES; RECEPTOR	Multiphoton intravital microscopy of lymph nodes has revolutionized the study of the early events leading to induction of acquired immunity. Using this technique, Junt et al. (2007) report in a recent issue of Nature that macrophages of the mouse lymph node subcapsular sinus facilitate B cell activation in vivo by collecting and displaying native antigen.	Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Inst Infect Immun & Inflammat, Nottingham NG7 2UH, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Nottingham; University of Oxford	Martinez-Pomares, L (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Inst Infect Immun & Inflammat, Floor A,W Block,Room 1323, Nottingham NG7 2UH, England.	luisa.martinez-pomares@nottingham.ac.uk; siamon.gordon@path.ox.ac.uk	Eckhardt, Erik/G-1567-2010	Martinez-Pomares, Luisa/0000-0002-2331-127X				Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; JUNT T, 2007, NATURE          1014; Kumamoto Y, 2004, J BIOL CHEM, V279, P49274, DOI 10.1074/jbc.M409300200; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Yu P, 2002, J IMMUNOL, V168, P5117, DOI 10.4049/jimmunol.168.10.5117	9	55	58	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					641	643		10.1016/j.cell.2007.10.046	http://dx.doi.org/10.1016/j.cell.2007.10.046			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022354	Bronze			2022-12-28	WOS:000250966300007
J	Wiviott, SD; Braunwald, E; McCabe, CH; Montalescot, G; Ruzyllo, W; Gottlieb, S; Neumann, F; Ardissino, D; De Servi, S; Murphy, SA; Riesmeyer, J; Weerakkody, G; Gibson, CM; Antman, EM				Wiviott, Stephen D.; Braunwald, Eugene; McCabe, Carolyn H.; Montalescot, Gilles; Ruzyllo, Witold; Gottlieb, Shmuel; Neumann, Franz-Joseph; Ardissino, Diego; De Servi, Stefano; Murphy, Sabina A.; Riesmeyer, Jeffrey; Weerakkody, Govinda; Gibson, C. Michael; Antman, Elliott M.		TRITON TIMI 38 Investigators	Prasugrel versus clopidogrel in patients with acute coronary syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL ANTIPLATELET THERAPY; MYOCARDIAL-INFARCTION; PLATELET INHIBITION; GLYCOPROTEIN IIB/IIIA; GREATER INHIBITION; STENT THROMBOSIS; UNSTABLE ANGINA; TASK-FORCE; ASPIRIN; INTERVENTION	Background: Dual-antiplatelet therapy with aspirin and a thienopyridine is a cornerstone of treatment to prevent thrombotic complications of acute coronary syndromes and percutaneous coronary intervention. Methods: To compare prasugrel, a new thienopyridine, with clopidogrel, we randomly assigned 13,608 patients with moderate-to-high-risk acute coronary syndromes with scheduled percutaneous coronary intervention to receive prasugrel (a 60-mg loading dose and a 10-mg daily maintenance dose) or clopidogrel (a 300-mg loading dose and a 75-mg daily maintenance dose), for 6 to 15 months. The primary efficacy end point was death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. The key safety end point was major bleeding. Results: The primary efficacy end point occurred in 12.1% of patients receiving clopidogrel and 9.9% of patients receiving prasugrel (hazard ratio for prasugrel vs. clopidogrel, 0.81; 95% confidence interval [CI], 0.73 to 0.90; P<0.001). We also found significant reductions in the prasugrel group in the rates of myocardial infarction (9.7% for clopidogrel vs. 7.4% for prasugrel; P<0.001), urgent target-vessel revascularization (3.7% vs. 2.5%; P<0.001), and stent thrombosis (2.4% vs. 1.1%; P<0.001). Major bleeding was observed in 2.4% of patients receiving prasugrel and in 1.8% of patients receiving clopidogrel (hazard ratio, 1.32; 95% CI, 1.03 to 1.68; P=0.03). Also greater in the prasugrel group was the rate of life-threatening bleeding (1.4% vs. 0.9%; P=0.01), including nonfatal bleeding (1.1% vs. 0.9%; hazard ratio, 1.25; P=0.23) and fatal bleeding (0.4% vs. 0.1%; P=0.002). Conclusions: In patients with acute coronary syndromes with scheduled percutaneous coronary intervention, prasugrel therapy was associated with significantly reduced rates of ischemic events, including stent thrombosis, but with an increased risk of major bleeding, including fatal bleeding. Overall mortality did not differ significantly between treatment groups. (ClinicalTrials.gov number, NCT00097591.).	Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Pitie Salpetriere Univ Hosp, Inst Cardiol, Paris, France; Pitie Salpetriere Univ Hosp, INSERM, U856, Paris, France; Inst Kardiol, Warsaw, Poland; Bikur Cholim Hosp, Jerusalem, Israel; Herz Zentrum Bad Krozingen, Bad Krozingen, Germany; Univ Parma, Azienda Osped, I-43100 Parma, Italy; Azienda Osped Civile Legano, Legnano, Italy; Eli Lilly Res Labs, Indianapolis, IN USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institute of Cardiology - Poland; University of Parma; University Hospital of Parma; Eli Lilly	Antman, EM (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, 350 Longwood Ave,1st Fl, Boston, MA 02115 USA.	eantman@rics.bwh.harvard.edu	Gibson, C. Michael/AAE-8212-2019; Wiviott, Stephen/HIK-2534-2022; Ardissino, Diego/AAC-4041-2022; De+Servi, Stefano/AAT-2631-2021	solinas, emilia/0000-0003-3532-1317				Alexander KP, 2005, JAMA-J AM MED ASSOC, V294, P3108, DOI 10.1001/jama.294.24.3108; Antithrombotic Trialists' Collaboration, 2002, BMJ-BRIT MED J, V324, P141, DOI DOI 10.1136/BMJ.324.7330.141; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Campbell CL, 2007, JAMA-J AM MED ASSOC, V297, P2018, DOI 10.1001/jama.297.18.2018; Cannon CP, 2000, CLIN CARDIOL, V23, P14, DOI 10.1002/clc.4960231105; CAREY RJ, 1984, LANCET, V1, P505; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1716; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1506; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Fox KAA, 2004, CIRCULATION, V110, P1202, DOI 10.1161/01.CIR.0000140675.85342.1B; Gurbel PA, 2003, AM J CARDIOL, V91, P1123, DOI 10.1016/S0002-9149(03)00163-2; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; JAFFIN BW, 1987, AM J MED, V83, P269, DOI 10.1016/0002-9343(87)90697-8; Jernberg T, 2006, EUR HEART J, V27, P1166, DOI 10.1093/eurheartj/ehi877; Mahaffey KW, 1999, CIRCULATION, V99, P2371, DOI 10.1161/01.CIR.99.18.2371; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mehta SR, 2003, J AM COLL CARDIOL, V41, p79S, DOI 10.1016/S0735-1097(02)02831-0; Montalescot G, 2006, J AM COLL CARDIOL, V48, P931, DOI 10.1016/j.jacc.2006.04.090; Niitsu Y, 2005, SEMIN THROMB HEMOST, V31, P184, DOI 10.1055/s-2005-869524; Patti G, 2005, CIRCULATION, V111, P2099, DOI 10.1161/01.CIR.0000161383.06692.D4; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Simoons ML, 1997, LANCET, V349, P1429; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2003, JAMA-J AM MED ASSOC, V289, P987; The PRISM-PLUS Investigators, 1998, NEW ENGL J MED, V339, P415; Topol E, 1998, NEW ENGL J MED, V339, P436; Varenhorst C, 2007, EUR HEART J, V28, P189; von Beckerath N, 2005, CIRCULATION, V112, P2946, DOI 10.1161/CIRCULATIONAHA.105.559088; Wiviott SD, 2005, CIRCULATION, V111, P3366, DOI 10.1161/CIRCULATIONAHA.104.502815; WIVIOTT SD, IN PRESS CIRCULATION; Wiviott SD, 2006, AM HEART J, V152, P627, DOI 10.1016/j.ahj.2006.04.012; Wolfram RM, 2006, AM J CARDIOL, V97, P984, DOI 10.1016/j.amjcard.2005.10.064; Yusuf S, 2001, NEW ENGL J MED, V345, P494; 1997, LANCET, V350, P744	44	4881	5067	5	178	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2007	357	20					2001	2015		10.1056/NEJMoa0706482	http://dx.doi.org/10.1056/NEJMoa0706482			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230RV	17982182				2022-12-28	WOS:000250894500003
J	Charbonnel, C; Talon, S				Charbonnel, Corinne; Talon, Suzanne			Mixing a stellar cocktail	SCIENCE			English	Editorial Material							INTERNAL WAVES; ANGULAR-MOMENTUM; SOLAR; TRANSPORT; ROTATION; STARS; SUN		Univ Geneva, Observ Geneva, CH-1290 Sauverny, Switzerland; Univ Toulouse 3, CNRS, Lab Astrophys Toulouse & Tarbes, F-31400 Toulouse, France; Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada	University of Geneva; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Montreal	Charbonnel, C (corresponding author), Univ Geneva, Observ Geneva, CH-1290 Sauverny, Switzerland.	Corinne.Charbonnel@obs.unige.ch; talon@astro.umontreal.ca						CHAPLIN WJ, 1999, MON NOT R ASTRON SOC, V308, P45; Charbonnel C, 2005, SCIENCE, V309, P2189, DOI 10.1126/science.1116849; Couvidat S, 2003, ASTROPHYS J, V597, pL77, DOI 10.1086/379698; GOLDREICH P, 1994, ASTROPHYS J, V424, P466, DOI 10.1086/173904; GOLDREICH P, 1989, ASTROPHYS J, V342, P1079, DOI 10.1086/167665; Kumar P, 1999, ASTROPHYS J, V520, P859, DOI 10.1086/307464; KUMAR P, 1997, APJL, V475, P143; LINDZEN RS, 1968, J ATMOS SCI, V25, P1095, DOI 10.1175/1520-0469(1968)025<1095:ATOTQB>2.0.CO;2; LOPEZ RJG, 1991, ASTROPHYS J, V377, P268, DOI 10.1086/170356; MONTALBAN J, 1994, ASTRON ASTROPHYS, V281, P421; Pantillon FP, 2007, ASTRON ASTROPHYS, V474, P155, DOI 10.1051/0004-6361:20078078; PRESS WH, 1981, ASTROPHYS J, V245, P286, DOI 10.1086/158809; SCHATZMAN E, 1993, ASTRON ASTROPHYS, V279, P431; Shepherd TG, 2000, J ATMOS SOL-TERR PHY, V62, P1587, DOI 10.1016/S1364-6826(00)00114-0; Young PA, 2003, ASTROPHYS J, V595, P1114, DOI 10.1086/377428; ZAHN JP, 1975, ASTRON ASTROPHYS, V41, P329; Zahn JP, 1997, ASTRON ASTROPHYS, V322, P320	17	9	9	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					922	923		10.1126/science.1148251	http://dx.doi.org/10.1126/science.1148251			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991847				2022-12-28	WOS:000250788500025
J	Colombe, Y; Steinmetz, T; Dubois, G; Linke, F; Hunger, D; Reichel, J				Colombe, Yves; Steinmetz, Tilo; Dubois, Guilhem; Linke, Felix; Hunger, David; Reichel, Jakob			Strong atom-field coupling for Bose-Einstein condensates in an optical cavity on a chip	NATURE			English	Article							SINGLE ATOMS; LATTICES	An optical cavity enhances the interaction between atoms and light, and the rate of coherent atom-photon coupling can be made larger than all decoherence rates of the system. For single atoms, this 'strong coupling regime' of cavity quantum electrodynamics(1,2) has been the subject of many experimental advances. Efforts have been made to control the coupling rate by trapping(3,4) the atom and cooling(5,6) it towards the motional ground state; the latter has been achieved in one dimension so far(5). For systems of many atoms, the three-dimensional ground state of motion is routinely achieved(7) in atomic Bose-Einstein condensates (BECs). Although experiments combining BECs and optical cavities have been reported recently(8,9), coupling BECs to cavities that are in the strong-coupling regime for single atoms has remained an elusive goal. Here we report such an experiment, made possible by combining a fibre-based cavity(10) with atom-chip technology(11). This enables single-atom cavity quantum electrodynamics experiments with a simplified set-up and realizes the situation of many atoms in a cavity, each of which is identically and strongly coupled to the cavity mode(12). Moreover, the BEC can be positioned deterministically anywhere within the cavity and localized entirely within a single antinode of the standing-wave cavity field; we demonstrate that this gives rise to a controlled, tunable coupling rate. We study the heating rate caused by a cavity transmission measurement as a function of the coupling rate and find no measurable heating for strongly coupled BECs. The spectrum of the coupled atoms-cavity system, which we map out over a wide range of atom numbers and cavity-atom detunings, shows vacuum Rabi splittings exceeding 20 gigahertz, as well as an unpredicted additional splitting, which we attribute to the atomic hyperfine structure. We anticipate that the system will be suitable as a light-matter quantum interface for quantum information(13).	Univ Paris 06, CNRS, ENS, Lab Kastler Brossel, F-75005 Paris, France; LMU, Max Planck Inst Quantenopt, D-80799 Munich, Germany	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Max Planck Society; University of Munich	Reichel, J (corresponding author), Univ Paris 06, CNRS, ENS, Lab Kastler Brossel, 24 Rue Lhomond, F-75005 Paris, France.	jakob.reichel@ens.fr	Reichel, Jakob/AAW-1107-2021; Hunger, David/A-7673-2012	Reichel, Jakob/0000-0003-3420-4178; Hunger, David/0000-0001-6156-6145				Anglin JR, 2002, NATURE, V416, P211, DOI 10.1038/416211a; Aoki T, 2006, NATURE, V443, P671, DOI 10.1038/nature05147; Boozer AD, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083602; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Du SW, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.053606; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Fischer T, 2001, NEW J PHYS, V3, P111; Fortagh J, 2007, REV MOD PHYS, V79, P235, DOI 10.1103/RevModPhys.79.235; Gerbier F, 2004, EUROPHYS LETT, V66, P771, DOI 10.1209/epl/i2004-10035-7; Greiner M, 2002, NATURE, V419, P51, DOI 10.1038/nature00968; Hansel W, 2001, NATURE, V413, P498, DOI 10.1038/35097032; Harber DM, 2003, J LOW TEMP PHYS, V133, P229, DOI 10.1023/A:1026084606385; Haroche S., 2006, EXPLORING QUANTUM; Inouye S, 1999, SCIENCE, V285, P571, DOI 10.1126/science.285.5427.571; Ketterle W, 2001, PHYS REV LETT, V86, P4203, DOI 10.1103/PhysRevLett.86.4203; Kimble HJ, 1998, PHYS SCRIPTA, VT76, P127, DOI 10.1238/Physica.Topical.076a00127; Lye JE, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.043609; Maunz P, 2004, NATURE, V428, P50, DOI 10.1038/nature02387; Mekhov IB, 2007, NAT PHYS, V3, P319, DOI 10.1038/nphys571; Mohring B, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.053601; MORICE O, 1995, PHYS REV A, V51, P3896, DOI 10.1103/PhysRevA.51.3896; MURCH KW, 2007, ARXIVORGABS07061005; Ottl A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.090404; Pinkse PWH, 2000, NATURE, V404, P365, DOI 10.1038/35006006; Reichel J, 1999, PHYS REV LETT, V83, P3398, DOI 10.1103/PhysRevLett.83.3398; Reichel J, 2002, APPL PHYS B-LASERS O, V74, P469, DOI 10.1007/s003400200861; Sherson J, 2007, ADV ATOM MOL OPT PHY, V54, P81, DOI 10.1016/S1049-250X(06)54002-9; Simon J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.183601; Slama S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.053603; Steinmetz T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2347892; TAVIS M, 1969, PHYS REV, V188, P692, DOI 10.1103/PhysRev.188.692; THOMPSON RJ, 1992, PHYS REV LETT, V68, P1132, DOI 10.1103/PhysRevLett.68.1132; Treutlein P, 2006, FORTSCHR PHYS, V54, P702, DOI 10.1002/prop.200610325; Ye J, 1999, PHYS REV LETT, V83, P4987, DOI 10.1103/PhysRevLett.83.4987	34	555	564	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					272	U9		10.1038/nature06331	http://dx.doi.org/10.1038/nature06331			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994094	Green Submitted			2022-12-28	WOS:000250746200055
J	Leopold, P; Perrimon, N				Leopold, Pierre; Perrimon, Norbert			Drosophila and the genetics of the internal milieu	NATURE			English	Article							INSULIN-LIKE PEPTIDES; METABOLIC SYNDROME; AMINO-ACIDS; FOOD-INTAKE; LIFE-SPAN; GROWTH; CELLS; MELANOGASTER; FLIES; HOMEOSTASIS	'Homeostasis', from the Greek words for 'same' and 'steady', refers to ways in which the body acts to maintain a stable internal environment despite perturbations. Recent studies in Drosophila exemplify the conservation of regulatory mechanisms involved in metabolic homeostasis. These new findings underscore the use of Drosophila as a model for the study of various human disorders.	Univ Nice, CNRS, UMR6543, F-06108 Nice 2, France; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Leopold, P (corresponding author), Univ Nice, CNRS, UMR6543, Parc Valrose, F-06108 Nice 2, France.	leopold@unice.fr; perrimon@receptor.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X				Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Gade G, 1997, PHYSIOL REV, V77, P963, DOI 10.1152/physrev.1997.77.4.963; Geminard C, 2006, DIABETES, V55, pS5, DOI 10.2337/db06-S001; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Grundy SM, 2007, J CLIN ENDOCR METAB, V92, P399, DOI 10.1210/jc.2006-0513; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Mirth C, 2005, DEV BIOL, V278, P163, DOI 10.1016/j.ydbio.2004.10.026; Nagashima K, 2004, DIABETES RES CLIN PR, V66, pS75, DOI 10.1016/j.diabres.2003.12.011; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; PERRIMON, 2007, GENETICS, V175, P7; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Tatar Marc, 2007, V35, P115; Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Wigglesworth VB, 1972, PRINCIPLES INSECT PH; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102; Zinke I, 1999, DEVELOPMENT, V126, P5275	33	134	135	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					186	188		10.1038/nature06286	http://dx.doi.org/10.1038/nature06286			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994083	Bronze			2022-12-28	WOS:000250746200038
J	Udwadia, ZF; Jain, S				Udwadia, Zarir F.; Jain, Sushil			Pulmonary alveolar proteinosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									PD Hinduja Natl Hosp, Bombay 400016, Maharashtra, India		Udwadia, ZF (corresponding author), PD Hinduja Natl Hosp, Bombay 400016, Maharashtra, India.	zfu@hindujahospital.com							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					E21	E21		10.1056/NEJMicm067256	http://dx.doi.org/10.1056/NEJMicm067256			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989378				2022-12-28	WOS:000250732500012
J	Wands, J				Wands, Jack			Hepatocellular carcinoma and sex	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Wands, J (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.							BRUIX J, 2006, ZAKIM BOYERS HEPATOL, V2, P1109; Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Tennant BC, 2004, GASTROENTEROLOGY, V127, pS283, DOI 10.1053/j.gastro.2004.09.043	4	81	86	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1974	1976		10.1056/NEJMcibr075652	http://dx.doi.org/10.1056/NEJMcibr075652			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989393				2022-12-28	WOS:000250732500017
J	Mahmoud, RA; Pandina, GJ; Turkoz, I; Kosik-Gonzalez, C; Canuso, CM; Kujawa, MJ; Gharabawi-Garibaldi, GM				Mahmoud, Ramy A.; Pandina, Gahan J.; Turkoz, Ibrahim; Kosik-Gonzalez, Colette; Canuso, Carla M.; Kujawa, Mary J.; Gharabawi-Garibaldi, Georges M.			Risperidone for treatment-refractory major depressive disorder - A Randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							SEROTONIN REUPTAKE INHIBITORS; SEQUENCED TREATMENT ALTERNATIVES; STAR-ASTERISK-D; DOUBLE-BLIND; ADJUNCTIVE RISPERIDONE; AUGMENTATION; RESISTANT; MEDICATION; BUPROPION; SSRIS	Background: Major depressive disorder has high prevalence, morbidity, and mortality. Inadequate results with antidepressants have prompts addition of a nonstandard treatment (augmentation therapy). Objective: To assess whether augmentation therapy with risperidone reduces symptoms and increases response to antidepressant therapy and remission of depression in adults. Design: Multicenter, double-blind, placebo-controlled, randomized trial conducted from 19 October 2004 to 17 November 2005. Setting: 75 primary care and psychiatric centers. Patients: 274 outpatient adults with major depressive disorder that was suboptimally responsive to antidepressant therapy. Intervention: After a 4-week run-in period to ensure insufficient response to standard antidepressants, patients were randomly assigned to receive risperidone, 1 mg/d, or placebo for 6 weeks. After 4 weeks, the dosage of risperidone was increased to 2 mg/d in some cases. Measurements: Symptoms were measured by using the 17-item Hamilton Rating Scale for Depression (HRSD-17). Other outcomes were response to therapy, remission of depression, and various clinician- and patient-rated assessments. Results: Of the intention-to-treat population (268 patients), 81% (111 of 137) who received risperidone and 87.8% (115 of 131) who received placebo completed 6 weeks of double-blind treatment. Mean (+/- SE) HRSD-17 scores improved more in the risperidone augmentation group than in the placebo group (13.4 +/- 0.54 vs. 16.2 +/- 0.53; difference, -2.8 +/- 0.72 (95% CI, -4.2 to -1.4]; P <0.001). More risperidone recipients than placebo recipients experienced remission of depression (24.5% [26 of 106] vs. 10.7% [12 of 112]; P = 0.004) and had a response (46.2% [49 of 106] vs. 29.5% [33 of 112]; P = 0.004). Headache (8.8% of risperidone recipients vs. 14.5% of placebo recipients), somnolence (5.1% vs. 1.5%), and dry mouth (5.1% vs. 0.8%) were the most frequently reported adverse events. Limitations: Patients were receiving many different antidepressants, and the duration of augmentation therapy was limited. Conclusion: Risperidone augmentation produced a statistically significant mean reduction in depression symptoms, substantially increased remission and response, and improved other patient- and clinician-rated measures.	OrthoMcNeil Janssen Sci Affairs, Titusville, NJ USA	Johnson & Johnson; Johnson & Johnson USA	Mahmoud, RA (corresponding author), ETHICON Inc, POB 151,US Highway 22 W,Room E314, Somerville, NJ 08876 USA.	rmahmou@ethus.jnj.com	Pandina, Gahan/W-5566-2019					Alpert JE, 2004, J CLIN PSYCHOPHARM, V24, P661, DOI 10.1097/01.jcp.0000145339.45794.cd; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Appelberg BG, 2001, J CLIN PSYCHIAT, V62, P448, DOI 10.4088/JCP.v62n0608; Bartzokis G, 2005, BIOL PSYCHIAT, V57, P474, DOI 10.1016/j.biopsych.2004.11.039; Blier P, 2001, J PSYCHIATR NEUROSCI, V26, pS3; Brawman-Mintzer O, 2005, J CLIN PSYCHIAT, V66, P1321, DOI 10.4088/JCP.v66n1016; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; Farabaugh A, 2005, INT CLIN PSYCHOPHARM, V20, P87, DOI 10.1097/00004850-200503000-00004; Fatemi SH, 1999, ANN PHARMACOTHER, V33, P701, DOI 10.1345/aph.18249; Fava M, 2003, PSYCHIAT CLIN N AM, V26, P457, DOI 10.1016/S0193-953X(02)00107-7; Fava M, 2003, J CLIN PSYCHIAT, V64, P13; Gallo JJ, 2007, ANN INTERN MED, V146, P689, DOI 10.7326/0003-4819-146-10-200705150-00002; Guy W., 1976, ASSESSMENT MANUAL PS, P218, DOI DOI 10.1186/1471-244X-7-7; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V163, P28; Iosifescu DV, 2005, J CLIN PSYCHIAT, V66, P1038, DOI 10.4088/JCP.v66n0812; Joffe RT, 1996, J CLIN PSYCHIAT, V57, P114; Judd LL, 1999, ARCH GEN PSYCHIAT, V56, P764; KALALI A, 2002, INT J NEUROPSYCHOPH, V5, pS147; Leon AC, 2001, J CLIN PSYCHIAT, V62, P34; Marangell LB, 2001, J CLIN PSYCHIAT, V62, P12; Miller IW, 1998, J CLIN PSYCHIAT, V59, P608, DOI 10.4088/JCP.v59n1108; Muller N, 2006, MOL PSYCHIATR, V11, P680, DOI 10.1038/sj.mp.4001805; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; NASR SJ, 1984, J CLIN PSYCHIAT, V45, P167; Nierenberg AA, 2006, AM J PSYCHIAT, V163, P210, DOI 10.1176/appi.ajp.163.2.210; Nierenberg AA, 2003, J CLIN PSYCHOPHARM, V23, P92, DOI 10.1097/00004714-200302000-00013; Ostroff RB, 1999, J CLIN PSYCHIAT, V60, P256, DOI 10.4088/JCP.v60n0410; Papakostas GI, 2006, DEPRESS ANXIETY, V23, P178, DOI 10.1002/da.20181; Papakostas GI, 2005, J CLIN PSYCHIAT, V66, P1326, DOI 10.4088/JCP.v66n1017; Papakostas GI, 2004, J CLIN PSYCHIAT, V65, P217; Pratt LA, 1996, CIRCULATION, V94, P3123, DOI 10.1161/01.CIR.94.12.3123; Rapaport MH, 2006, NEUROPSYCHOPHARMACOL, V31, P2505, DOI 10.1038/sj.npp.1301113; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Simon NM, 2006, J CLIN PSYCHIAT, V67, P381, DOI 10.4088/JCP.v67n0307; Spier S A, 1998, Depress Anxiety, V7, P73, DOI 10.1002/(SICI)1520-6394(1998)7:2<73::AID-DA4>3.0.CO;2-6; STAHL SM, 2000, ESSENTIAL PSYCHOPHAR, P401; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Tani K, 2004, INT J NEUROPSYCHOPH, V7, P55, DOI 10.1017/S146114570300381X; Thase ME, 1997, J CLIN PSYCHIAT, V58, P16, DOI 10.4088/JCP.v58n0103; Trivedi MH, 2004, ARCH GEN PSYCHIAT, V61, P669, DOI 10.1001/archpsyc.61.7.669; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; *WHO, 2001, 265 WHO; World Health Organization, 2001, WORLD HLTH REP 2001; Zarate CA, 1996, J CLIN PSYCHIAT, V57, P67; 1998, BANDOLIER        AUG; 1997, BANDOLIER        JUL; 1997, BANDOLIER        APR	49	107	110	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2007	147	9					593	602		10.7326/0003-4819-147-9-200711060-00003	http://dx.doi.org/10.7326/0003-4819-147-9-200711060-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227QM	17975181				2022-12-28	WOS:000250672900001
J	Aravin, AA; Hannon, GJ; Brennecke, J				Aravin, Alexei A.; Hannon, Gregory J.; Brennecke, Julius			The Piwi-piRNA pathway provides an adaptive defense in the transposon arms race	SCIENCE			English	Review							CELL SELF-RENEWAL; SMALL RNAS; DROSOPHILA-MELANOGASTER; GENOME REARRANGEMENT; STEM-CELLS; GERMLINE; PROTEIN; TETRAHYMENA; MECHANISM; ELEMENTS	Increasingly complex networks of small RNAs act through RNA-interference (RNAi) pathways to regulate gene expression, to mediate antiviral responses, to organize chromosomal domains, and to restrain the spread of selfish genetic elements. Historically, RNAi has been defined as a response to double-stranded RNA. However, some small RNA species may not arise from double-stranded RNA precursors. Yet, like microRNAs and small interfering RNAs, such species guide Argonaute proteins to silencing targets through complementary base-pairing. Silencing can be achieved by corecruitment of accessory factors or through the activity of Argonaute itself, which often has endonucleolytic activity. As a specific and adaptive regulatory system, RNAi is used throughout eukarya, which indicates a long evolutionary history. A likely function of RNAi throughout that history is to protect the genome from both pathogenic and parasitic invaders.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Brennecke, Julius/C-1626-2015; Brennecke, Julius/T-5883-2019; Hannon, Gregory/AAB-3568-2019	Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814; 				Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Desset S, 2003, GENETICS, V164, P501; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hartig JV, 2007, GENE DEV, V21, P1707, DOI 10.1101/gad.1567007; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; PRUDHOMME N, 1995, GENETICS, V139, P697; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wilson JE, 1996, DEVELOPMENT, V122, P1631	37	747	794	7	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					761	764		10.1126/science.1146484	http://dx.doi.org/10.1126/science.1146484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975059				2022-12-28	WOS:000250583900031
J	Brady, SM; Orlando, DA; Lee, JY; Wang, JY; Koch, J; Dinneny, JR; Mace, D; Ohler, U; Benfey, PN				Brady, Siobhan M.; Orlando, David A.; Lee, Ji-Young; Wang, Jean Y.; Koch, Jeremy; Dinneny, Jose R.; Mace, Daniel; Ohler, Uwe; Benfey, Philip N.			A high-resolution root spatiotemporal map reveals dominant expression patterns	SCIENCE			English	Article							CELL; GENES; IDENTITY	Transcriptional programs that regulate development are exquisitely controlled in space and time. Elucidating these programs that underlie development is essential to understanding the acquisition of cell and tissue identity. We present microarray expression profiles of a high-resolution set of developmental time points within a single Arabidopsis root and a comprehensive map of nearly all root cell types. These cell type-specific transcriptional signatures often predict previously unknown cellular functions. A computational pipeline identified dominant expression patterns that demonstrate transcriptional similarity between disparate cell types. Dominant expression patterns along the root's longitudinal axis do not strictly correlate with previously defined developmental zones, and in many cases, we observed expression fluctuation along this axis. Both robust co-regulation of gene expression and potential phasing of gene expression were identified between individual roots. Methods that combine these profiles demonstrate transcriptionally rich and complex programs that define Arabidopsis root development in both space and time.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Inst Genome Sci & Policy, Program Computat Biol & Bioinformat, Durham, NC 27708 USA; Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27708 USA; Duke Univ, Dept Comp Sci, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	benfeyp@duke.edu	Brady, Siobhan/AAY-1729-2021; Dinneny, Jose/J-8312-2012; Lee, Ji-Young/E-2196-2012; Lee, Ji-Young/F-7455-2013	Dinneny, Jose/0000-0002-3998-724X; Lee, Ji-Young/0000-0002-7631-5127; Brady, Siobhan/0000-0001-9424-8055				Benfey PN, 2000, CURR BIOL, V10, pR813, DOI 10.1016/S0960-9822(00)00814-9; Birnbaum K, 2005, NAT METHODS, V2, P615, DOI 10.1038/nmeth0805-615; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Brady SM, 2007, PLANT PHYSIOL, V143, P172, DOI 10.1104/pp.106.087262; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Imlau A, 1999, PLANT CELL, V11, P309, DOI 10.1105/tpc.11.3.309; Jones MA, 2006, PLANT J, V45, P83, DOI 10.1111/j.1365-313X.2005.02609.x; Laplaze L, 2005, J EXP BOT, V56, P2433, DOI 10.1093/jxb/eri236; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; O'Connor TR, 2005, BIOINFORMATICS, V21, P4411, DOI 10.1093/bioinformatics/bti714; Saslowsky D, 2001, PLANT J, V27, P37, DOI 10.1046/j.1365-313x.2001.01073.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; Yakir E, 2007, FEBS J, V274, P335, DOI 10.1111/j.1742-4658.2006.05616.x	23	814	833	8	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					801	806		10.1126/science.1146265	http://dx.doi.org/10.1126/science.1146265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975066				2022-12-28	WOS:000250583900042
J	Menuz, K; Stroud, RM; Nicoll, RA; Hays, FA				Menuz, Karen; Stroud, Robert M.; Nicoll, Roger A.; Hays, Franklin A.			TARP auxiliary subunits switch AMPA receptor antagonists into partial agonists	SCIENCE			English	Article							GLUTAMATE-RECEPTOR; DESENSITIZATION; CNQX; ACTIVATION; STARGAZIN; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; CYCLOTHIAZIDE; INTERNEURONS; TRAFFICKING; NEURONS	Quinoxalinedione compounds such as 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) are the most commonly used alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists. However, we find that in the presence of transmembrane AMPA receptor regulatory proteins (TARPs), which are AMPA receptor auxiliary subunits, CNQX acts as a partial agonist. CNQX induced small depolarizing currents in neurons of the central nervous system, and reconstitution of this agonist activity required coexpression of TARPs. A crystal structure of CNQX bound to the TARP-less AMPA receptor ligand-binding domain showed that, although CNQX induces partial domain closure, this movement is not transduced into linker separation, suggesting that TARPs may increase agonist efficacy by strengthening the coupling between domain closure and channel opening. Our results demonstrate that the presence of an auxiliary subunit can determine whether a compound functions as an agonist or antagonist.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	stroud@msg.ucsf.edu; nicoll@cmp.ucsf.edu		Menuz, Karen/0000-0001-8163-0941	NIGMS NIH HHS [P50 GM73210, GM078754] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078754, P50GM073210] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; BERTOLINO M, 1993, RECEPTOR CHANNEL, V1, P267; Bialer M, 2007, EPILEPSY RES, V73, P1, DOI 10.1016/j.eplepsyres.2006.10.008; Brickley SG, 2001, NEUROPHARMACOLOGY, V41, P730, DOI 10.1016/S0028-3908(01)00135-6; Catarzi D, 2007, MED RES REV, V27, P239, DOI 10.1002/med.20084; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hansen KB, 2007, CURR OPIN NEUROBIOL, V17, P281, DOI 10.1016/j.conb.2007.03.014; Hashimoto Y, 2004, NEUROSCI LETT, V358, P33, DOI 10.1016/j.neulet.2003.12.083; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LESTER RAJ, 1989, MOL PHARMACOL, V35, P565; Maccaferri G, 2002, NEUROPHARMACOLOGY, V43, P523, DOI 10.1016/S0028-3908(02)00161-2; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; MCBAIN CJ, 1992, BRAIN RES, V592, P255, DOI 10.1016/0006-8993(92)91683-6; Mitchell NA, 2007, BIOPHYS J, V92, P2392, DOI 10.1529/biophysj.106.095091; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Osten P, 2006, CURR OPIN NEUROBIOL, V16, P275, DOI 10.1016/j.conb.2006.04.002; Palay S. L., 1974, CEREBELLAR CORTEX CY; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Rogawski MA, 2006, EPILEPSY RES, V68, P22, DOI 10.1016/j.eplepsyres.2005.09.012; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; TARNAWA I, 1993, BIOORG MED CHEM LETT, V3, P99, DOI 10.1016/S0960-894X(00)80100-6; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	32	117	118	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					815	817		10.1126/science.1146317	http://dx.doi.org/10.1126/science.1146317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975069				2022-12-28	WOS:000250583900046
J	Henzler-Wildman, KA; Lei, M; Thai, V; Kerns, SJ; Karplus, M; Kern, D				Henzler-Wildman, Katherine A.; Lei, Ming; Thai, Vu; Kerns, S. Jordan; Karplus, Martin; Kern, Dorothee			A hierarchy of timescales in protein dynamics is linked to enzyme catalysis	NATURE			English	Article							COLI ADENYLATE KINASE; N-15 NMR RELAXATION; MODEL-FREE APPROACH; TEMPERATURE-DEPENDENCE; GLOBULAR-PROTEINS; BACKBONE DYNAMICS; HYDRODYNAMIC CALCULATIONS; CONFORMATIONAL-CHANGE; DOMAIN FLEXIBILITY; ORDER PARAMETERS	The synergy between structure and dynamics is essential to the function of biological macromolecules. Thermally driven dynamics on different timescales have been experimentally observed or simulated, and a direct link between micro- to millisecond domain motions and enzymatic function has been established(1-4). However, very little is understood about the connection of these functionally relevant, collective movements with local atomic fluctuations, which are much faster. Here we show that pico- to nano-second timescale atomic fluctuations in hinge regions of adenylate kinase facilitate the large-scale, slower lid motions that produce a catalytically competent state. The fast, local mobilities differ between a mesophilic and hyperthermophilic adenylate kinase, but are strikingly similar at temperatures at which enzymatic activity and free energy of folding are matched. The connection between different timescales and the corresponding amplitudes of motions in adenylate kinase and their linkage to catalytic function is likely to be a general characteristic of protein energy landscapes.	Brandeis Univ, Dept Biochem, Howard Hughes Med Inst, Waltham, MA 02454 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Univ Strasbourg 1, Lab Chim Biophys, Inst Sci & Ingn Supramol, F-67000 Strasbourg, France	Brandeis University; Howard Hughes Medical Institute; Harvard University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kern, D (corresponding author), Brandeis Univ, Dept Biochem, Howard Hughes Med Inst, Waltham, MA 02454 USA.	dkern@brandeis.edu		Henzler-Wildman, Katherine/0000-0002-5295-2121	NIGMS NIH HHS [F32 GM070251, T32 GM007596] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070251, T32GM007596] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Bae E, 2006, P NATL ACAD SCI USA, V103, P2132, DOI 10.1073/pnas.0507527103; Bernado P, 2002, J BIOMOL NMR, V23, P139, DOI 10.1023/A:1016359412284; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Butterwick JA, 2004, J MOL BIOL, V339, P855, DOI 10.1016/j.jmb.2004.03.055; Chang SL, 2005, J MAGN RESON, V174, P43, DOI 10.1016/j.jmr.2005.01.008; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clore GM, 2006, J MOL BIOL, V355, P879, DOI 10.1016/j.jmb.2005.11.042; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; Evenas J, 1999, J MOL BIOL, V289, P603, DOI 10.1006/jmbi.1999.2770; Fenimore PW, 2002, P NATL ACAD SCI USA, V99, P16047, DOI 10.1073/pnas.212637899; Hall JB, 2003, J BIOMOL NMR, V27, P261, DOI 10.1023/A:1025467918856; Halle B, 2002, P NATL ACAD SCI USA, V99, P1274, DOI 10.1073/pnas.032522499; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HENZLERWILDMAN KA, 2007, NATURE; Hollien J, 1999, P NATL ACAD SCI USA, V96, P13674, DOI 10.1073/pnas.96.24.13674; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; KARPLUS M, 1981, CRC CR REV BIOCH MOL, V9, P293, DOI 10.3109/10409238109105437; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lee AL, 1999, J BIOMOL NMR, V13, P101, DOI 10.1023/A:1008304220445; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lou HF, 2006, J PHYS CHEM B, V110, P12796, DOI 10.1021/jp061976m; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mandel AM, 1996, BIOCHEMISTRY-US, V35, P16009, DOI 10.1021/bi962089k; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; MONNOT M, 1987, J BIOL CHEM, V262, P2502; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; Petsko GA, 2001, METHOD ENZYMOL, V334, P469; Prompers JJ, 2000, J PHYS CHEM B, V104, P11416, DOI 10.1021/jp0026033; Seewald MJ, 2000, PROTEIN SCI, V9, P1177, DOI 10.1110/ps.9.6.1177; Shapiro YE, 2002, BIOCHEMISTRY-US, V41, P6271, DOI 10.1021/bi012132q; Spyracopoulos L, 2001, BIOCHEMISTRY-US, V40, P12541, DOI 10.1021/bi010903k; Temiz NA, 2004, PROTEINS, V57, P468, DOI 10.1002/prot.20226; Tugarinov V, 2002, J MOL BIOL, V315, P155, DOI 10.1006/jmbi.2001.5231; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; Vugmeyster L, 2003, J AM CHEM SOC, V125, P8400, DOI 10.1021/ja029480f; Wang TZ, 2003, J AM CHEM SOC, V125, P8639, DOI 10.1021/ja034077+; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Zhang FL, 2002, J AM CHEM SOC, V124, P12654, DOI 10.1021/ja027847a; Zhang Q, 2006, SCIENCE, V311, P653, DOI 10.1126/science.1119488; Zhuravleva AV, 2004, J MOL BIOL, V342, P1599, DOI 10.1016/j.jmb.2004.08.001	47	801	809	6	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					913	U27		10.1038/nature06407	http://dx.doi.org/10.1038/nature06407			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18026087				2022-12-28	WOS:000251394900063
J	Yang, YG; Lindahl, T; Barnes, DE				Yang, Yun-Gui; Lindahl, Tomas; Barnes, Deborah E.			Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease	CELL			English	Article							AICARDI-GOUTIERES-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; STALLED REPLICATION FORKS; DNA-DAMAGE-RESPONSE; SACCHAROMYCES-CEREVISIAE; MUTATIONS; EXCISION; RIBONUCLEOTIDES; IDENTIFICATION; ENDONUCLEASE	Trex1 is the major 3' DNA exonuclease in mammalian cells, and mutations in the human TREX1 gene can cause Aicardi-Goutieres syndrome, characterized by perturbed immunity. Similarly, Trex1(-/-) mice have an autoinflammatory phenotype; however, the mechanism of Trex1-deficient disease is unknown. We report that Trex1, ordinarily associated with the endoplasmic reticulum (ER), relocalizes to the S phase nucleus after gamma irradiation or hydroxyurea treatment. Notably, Trex1-deficient cells show defective G1/S transition and chronic ATM-dependent checkpoint activation, even in the absence of exogenous stress, correlating with persistent single-stranded DNA molecules produced in S phase, which accumulate in the ER. Our data indicate that Trex1 acts on a single-stranded DNA polynucleotide species generated from processing of aberrant replication intermediates to attenuate DNA damage checkpoint signaling and prevent pathological immune activation.	[Yang, Yun-Gui; Lindahl, Tomas; Barnes, Deborah E.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Barnes, DE (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, So Mimms, S Mimms EN6 3LD, Herts, England.	deborah.barnes@cancer.org.uk	Yang, Yungui/ABF-2507-2021					Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Aicardi J, 2000, NEUROPEDIATRICS, V31, P113, DOI 10.1055/s-2000-7533; Alarcon-Riquelme ME, 2006, NAT GENET, V38, P866, DOI 10.1038/ng0806-866; Arudchandran A, 2000, GENES CELLS, V5, P789, DOI 10.1046/j.1365-2443.2000.00373.x; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; BJURSELL G, 1979, NATURE, V280, P420, DOI 10.1038/280420a0; BLUMENTHAL AB, 1977, CELL, V12, P183, DOI 10.1016/0092-8674(77)90196-9; Bourdon JC, 2002, J CELL BIOL, V158, P235, DOI 10.1083/jcb.200203006; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Brucet M, 2007, J BIOL CHEM, V282, P14547, DOI 10.1074/jbc.M700236200; Chi HB, 2007, NATURE, V448, P423, DOI 10.1038/448423a; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Cuadrado M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-7; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gasser S, 2006, SEMIN CANCER BIOL, V16, P344, DOI 10.1016/j.semcancer.2006.07.004; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; HARPER JW, 1993, CELL, V75, P805; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Inamdar KV, 2002, RADIAT RES, V157, P306, DOI 10.1667/0033-7587(2002)157[0306:ROPDET]2.0.CO;2; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	56	407	422	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					873	886		10.1016/j.cell.2007.10.017	http://dx.doi.org/10.1016/j.cell.2007.10.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045533	Bronze			2022-12-28	WOS:000251800900011
J	Schultz, WB				Schultz, William B.			Bolstering the FDA's drug-safety authority	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Zuckerman Spaeder LLP, Washington, DC USA		Schultz, WB (corresponding author), Zuckerman Spaeder LLP, Washington, DC USA.							HARRIS G, 2005, NY TIMES        0302; Institute of Medicine, 2007, FUT DRUG SAF PROM PR	2	23	23	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2217	2219		10.1056/NEJMp078212	http://dx.doi.org/10.1056/NEJMp078212			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	18046024				2022-12-28	WOS:000251176400001
J	Vesikari, T; Karvonen, A; Prymula, R; Schuster, V; Tejedor, JC; Cohen, R; Meurice, F; Han, HH; Damaso, S; Bouckenooghe, A				Vesikari, T.; Karvonen, A.; Prymula, R.; Schuster, V.; Tejedor, J. C.; Cohen, R.; Meurice, F.; Han, H. H.; Damaso, S.; Bouckenooghe, A.			Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study	LANCET			English	Article							LIVE; SAFETY; IMMUNOGENICITY; SURVEILLANCE; PROTECTION; DISEASE; ADULTS	Background We aimed to assess the efficacy of the oral live attenuated human rotavirus vaccine Rotarix (RIX4414) for prevention of rotavirus gastroenteritis in European infants during their first 2 years of life. Methods 3994 study participants were enrolled from six countries and were randomly assigned two oral doses of either RIX4414 (n=2646) or placebo (n=1348), which were coadministered with the first two doses of specific childhood vaccinations. Follow-up for gastroenteritis episodes was undertaken from 2 weeks post-dose two through the two consecutive rotavirus seasons following vaccinations (combined efficacy follow-up period; mean duration 17 months [SD 1.6]). Our primary endpoint was vaccine efficacy against rotavirus gastroenteritis of any severity during the first efficacy follow-up period (2 weeks post-dose two to the end of the first rotavirus season). Stool specimens obtained during gastroenteritis episodes were tested for rotavirus by ELISA and typed by RT-PCR. Episodes scoring 11 or greater on the 20-point Vesikari scale were classified as severe. Analysis was according to protocol. This study is registered with ClinicalTrials.gov, number NCT00140686 (eTrack102247). Findings 120 infants were excluded from the according-to-protocol analysis. During the first efficacy follow-up period (mean duration 5.7 months [SD 1-2]), 24 of 2572 infants allocated RIX4414 versus 94 of 1302 given placebo had rotavirus gastroenteritis episodes of any severity, resulting in a vaccine efficacy of 87.1% (95% CI 79.6-92.1; p < O.0001). For the combined efficacy follow-up period, vaccine efficacy against severe rotavirus gastroenteritis was 90.4% (85.1-94. 1; p < 0.0001), for admission owing to rotavirus gastroenteritis 96.0% (83.8-99.5; p < 0 . 0001), and for rotavirus-related medical attention 83.8% (76.8-88.9; p<0.0001), and significant protection against severe rotavirus gastroenteritis by circulating G1, G2, G3, G4, and G9 rotavirus types was shown. Interpretation In a European setting, two doses of RIX4414 coadministered with childhood vaccines provided high protection against any and severe rotavirus gastroenteritis, with an overall reduction of admissions for gastroenteritis over two consecutive rotavirus epidemic seasons.	Univ Tampere, Sch Med, Vaccine Res Ctr, Tampere 33014, Finland; Univ Def, Fac Mil Hlth Sci, Hradec Kralove, Czech Republic; Univ Leipzig, Hosp Children & Adolescents, D-7010 Leipzig, Germany; Hosp Mostoles, Madrid, Spain; Med Facil, St Maur des Fosses, France; GlaxoSmithKline Biol, Rixensart, Belgium	Tampere University; University of Defence - Czech Republic; Leipzig University; GlaxoSmithKline	Vesikari, T (corresponding author), Univ Tampere, Sch Med, Vaccine Res Ctr, Biokatu 10, Tampere 33014, Finland.	timo.vesikari@uta.fi	Tejedor, Juan Carlos/G-5111-2015; Prymula, Roman/AEG-7401-2022; Cohen, Robert/AAM-4426-2021	Tejedor, Juan Carlos/0000-0002-1748-6663; Cohen, Robert/0000-0001-6151-0686; Prymula, Roman/0000-0003-1567-2259				Bernstein DI, 2002, J INFECT DIS, V186, P1487, DOI 10.1086/344732; Bernstein DI, 1999, LANCET, V354, P287, DOI 10.1016/S0140-6736(98)12106-2; Bernstein DI, 1998, VACCINE, V16, P381, DOI 10.1016/S0264-410X(97)00210-7; Bresee J, 2004, EMERG INFECT DIS, V10, P988, DOI 10.3201/eid1006.030519; Dennehy PH, 2005, PEDIATR INFECT DIS J, V24, P481, DOI 10.1097/01.inf.0000164763.55558.71; Desselberger U, 2006, PEDIATR INFECT DIS J, V25, pS30, DOI 10.1097/01.inf.0000197707.70835.f3; DEVOS B, 2006, 46 ANN INT C ANT AG; Griffin DD, 2000, J CLIN MICROBIOL, V38, P2784, DOI 10.1128/JCM.38.7.2784-2787.2000; Hsu VP, 2005, PEDIATRICS, V115, P78, DOI 10.1542/peds.2004-0860; Joensuu J, 1997, LANCET, V350, P1205, DOI 10.1016/S0140-6736(97)05118-0; Midthun K, 1996, CLIN MICROBIOL REV, V9, P423, DOI 10.1128/CMR.9.3.423; OFFIT PA, 1994, ADV VIRUS RES, V44, P161, DOI 10.1016/S0065-3527(08)60329-2; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Salinas M, 2005, PEDIATR INFECT DIS J, V24, P807, DOI 10.1097/01.inf.0000178294.13954.a1; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Soriano-Gabarro M, 2006, PEDIATR INFECT DIS J, V25, pS7, DOI 10.1097/01.inf.0000197622.98559.01; Tang ML, 2004, STAT MED, V23, P3593, DOI 10.1002/sim.1906; Van Damme P, 2007, J INFECT DIS, V195, pS17, DOI 10.1086/516715; VANDOORN LJ, 2006, 9 DSRNA VIR M CAP TO; VELAZQUEZ FR, 2006, 46 ANN INT C ANT AG; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2004, VACCINE, V22, P2836, DOI 10.1016/j.vaccine.2004.01.044; Vesikari T, 2004, PEDIATR INFECT DIS J, V23, P937, DOI 10.1097/01.inf.0000141722.10130.50; VESIKARI T, 1992, PEDIATR INFECT DIS J, V11, P535, DOI 10.1097/00006454-199207000-00006; WARD RL, 1993, J VIROL, V67, P464, DOI 10.1128/JVI.67.1.464-468.1993; WARD RL, 1989, J INFECT DIS, V159, P79, DOI 10.1093/infdis/159.1.79	28	487	505	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2007	370	9601					1757	1763		10.1016/S0140-6736(07)61744-9	http://dx.doi.org/10.1016/S0140-6736(07)61744-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234DI	18037080				2022-12-28	WOS:000251140500019
J	Collison, LW; Workman, CJ; Kuo, TT; Boyd, K; Wang, Y; Vignali, KM; Cross, R; Sehy, D; Blumberg, RS; Vignali, DAA				Collison, Lauren W.; Workman, Creg J.; Kuo, Timothy T.; Boyd, Kelli; Wang, Yao; Vignali, Kate M.; Cross, Richard; Sehy, David; Blumberg, Richard S.; Vignali, Dario A. A.			The inhibitory cytokine IL-35 contributes to regulatory T-cell function	NATURE			English	Article							TRANSCRIPTION FACTOR FOXP3; IN-VIVO; INTESTINAL INFLAMMATION; LEISHMANIA-MAJOR; TH1 RESPONSES; ACTIVATION; MICE; PROTEIN; GENE; INTERLEUKIN-12	Regulatory T (T-reg) cells are a critical sub-population of CD4(+) T cells that are essential for maintaining self tolerance and preventing autoimmunity(1,2), for limiting chronic inflammatory diseases, such as asthma and inflammatory bowel disease(3,4), and for regulating homeostatic lymphocyte expansion(5). However, they also suppress natural immune responses to parasites(6) and viruses(7) as well as anti-tumour immunity induced by therapeutic vaccines(8). Although the manipulation of T-reg function is an important goal of immunotherapy, the molecules that mediate their suppressive activity remain largely unknown. Here we demonstrate that Epstein-Barr-virus-induced gene 3 (Ebi3, which encodes IL-27 beta) and interleukin-12 alpha (Il12a, which encodes IL-2 alpha/p35) are highly expressed by mouse Foxp3(+) ( forkhead box P3) Treg cells but not by resting or activated effector CD4(+) T (T-eff) cells, and that an Ebi3-IL-12 alpha heterodimer is constitutively secreted by T-reg but not T-eff cells. Both Ebi3 and Il12a messenger RNA are markedly upregulated in T-reg cells co-cultured with T-eff cells, thereby boosting Ebi3 and IL-12 alpha production in trans. T-reg-cell restriction of this cytokine occurs because Ebi3 is a downstream target of Foxp3, a transcription factor that is required for T-reg-cell development and function. Ebi3(-/-) and Il12a(-/-) T-reg cells have significantly reduced regulatory activity in vitro and fail to control homeostatic proliferation and to cure inflammatory bowel disease in vivo. Because these phenotypic characteristics are distinct from those of other IL-12 family members, this novel Ebi3-IL-12 alpha heterodimeric cytokine has been designated interleukin-35 ( IL-35). Ectopic expression of IL-35 confers regulatory activity on naive T cells, whereas recombinant IL-35 suppresses T-cell proliferation. Taken together, these data identify IL-35 as a novel inhibitory cytokine that may be specifically produced by T-reg cells and is required for maximal suppressive activity.	St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; eBiosci, San Diego, CA 92121 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Vignali, DAA (corresponding author), St Jude Childrens Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	dario.vignali@stjude.org						Annacker O, 2001, IMMUNOL REV, V182, P5, DOI 10.1034/j.1600-065X.2001.1820101.x; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Belkaid Y, 2006, IMMUNOL REV, V212, P287, DOI 10.1111/j.0105-2896.2006.00409.x; Brombacher F, 2003, TRENDS IMMUNOL, V24, P207, DOI 10.1016/S1471-4906(03)00067-X; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jooss K, 2001, P NATL ACAD SCI USA, V98, P8738, DOI 10.1073/pnas.151088898; Kaplan D, 1996, IMMUNOL TODAY, V17, P303, DOI 10.1016/0167-5699(96)30017-0; Kretschmer K, 2006, IMMUNOL REV, V212, P163, DOI 10.1111/j.0105-2896.2006.00411.x; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Li NY, 2004, J IMMUNOL, V173, P6806, DOI 10.4049/jimmunol.173.11.6806; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; Persons DA, 1998, BLOOD CELL MOL DIS, V24, P167, DOI 10.1006/bcmd.1998.0184; Persons DA, 1997, BLOOD, V90, P1777, DOI 10.1182/blood.V90.5.1777; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Schrader JW, 2002, TRENDS IMMUNOL, V23, P573, DOI 10.1016/S1471-4906(02)02336-0; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; SZYMCZAKWORKMAN AL, 2006, GENE TRANSFER DELIVE, P137; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vignali DAA, 1999, J IMMUNOL, V162, P1431; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Xystrakis E, 2006, EXPERT OPIN BIOL TH, V6, P121, DOI 10.1517/14712598.6.2.121; Zahn S, 2005, EUR J IMMUNOL, V35, P1106, DOI 10.1002/eji.200425926	43	1378	1516	6	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					566	U19		10.1038/nature06306	http://dx.doi.org/10.1038/nature06306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033300				2022-12-28	WOS:000251158500051
J	LeBoeuf, D; Doiron-Leyraud, N; Levallois, J; Daou, R; Bonnemaison, JB; Hussey, NE; Balicas, L; Ramshaw, BJ; Liang, RX; Bonn, DA; Hardy, WN; Adachi, S; Proust, C; Taillefer, L				LeBoeuf, David; Doiron-Leyraud, Nicolas; Levallois, Julien; Daou, R.; Bonnemaison, J.-B.; Hussey, N. E.; Balicas, L.; Ramshaw, B. J.; Liang, Ruixing; Bonn, D. A.; Hardy, W. N.; Adachi, S.; Proust, Cyril; Taillefer, Louis			Electron pockets in the Fermi surface of hole-doped high-T-c superconductors	NATURE			English	Article							TRANSPORT-PROPERTIES; ORDER	High-temperature superconductivity in copper oxides occurs when the materials are chemically tuned to have a carrier concentration intermediate between their metallic state at high doping and their insulating state at zero doping. The underlying evolution of the electron system in the absence of superconductivity is still unclear, and a question of central importance is whether it involves any intermediate phase with broken symmetry(1). The Fermi surface of the electronic states in the underdoped 'YBCO' materials YBa2Cu3Oy and YBa2Cu4O8 was recently shown to include small pockets(2-4), in contrast with the large cylinder that characterizes the overdoped regime(5), pointing to a topological change in the Fermi surface. Here we report the observation of a negative Hall resistance in the magnetic-field-induced normal state of YBa2Cu3Oy and YBa2Cu4O8, which reveals that these pockets are electron-like rather than hole-like. We propose that these electron pockets most probably arise from a reconstruction of the Fermi surface caused by the onset of a density-wave phase, as is thought to occur in the electron-doped copper oxides near the onset of antiferromagnetic order(6,7). Comparison with materials of the La2CuO4 family that exhibit spin/charge density-wave order(8-11) suggests that a Fermi surface reconstruction also occurs in those materials, pointing to a generic property of high-transition-temperature (T-c) superconductors.	INSA, UPS, CNRS, UMR 5147,LNCMP, F-31400 Toulouse, France; Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada; Univ Sherbrooke, RQMP, Sherbrooke, PQ J1K 2R1, Canada; Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; Florida State Univ, MHMFL, Tallahassee, FL 32306 USA; Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z4, Canada; Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; Int Superconduct Technol Ctr, Superconduct Res Lab, Koto Ku, Tokyo 1350062, Japan	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; University of Sherbrooke; University of Sherbrooke; University of Bristol; State University System of Florida; Florida State University; University of British Columbia; Canadian Institute for Advanced Research (CIFAR); International Superconductivity Technology Center (ISTEC)	Proust, C (corresponding author), INSA, UPS, CNRS, UMR 5147,LNCMP, F-31400 Toulouse, France.	proust@lncmp.org; louis.taillefer@physique.usherbrooke.ca	Hardy, Walter Newbold/AAN-7827-2020; Balicas, Luis/A-3110-2008; Ramshaw, Brad/J-3121-2013; Ramshaw, Brad/AAU-5603-2020; Hussey, Nigel E/F-9699-2015	Ramshaw, Brad/0000-0002-3222-5007; Hussey, Nigel/0000-0002-8590-8979	Engineering and Physical Sciences Research Council [EP/C511778/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Adachi S, 1998, PHYSICA C, V301, P123, DOI 10.1016/S0921-4534(98)00135-X; Adachi T, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.144524; ASHCROFT NW, 1969, PHYS KONDENS MATER, V9, P45, DOI 10.1007/BF02422531; Balakirev FF, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/9/194; Balakirev FF, 2003, NATURE, V424, P912, DOI 10.1038/nature01890; BANGURA AF, 2007, SHUBNIKOV DE HAAS OS; Baumberger F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.107601; Chakravarty S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.277003; CHEN WQ, 2007, QUANTUM OSCILLATIONS; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; HARRIS JM, 1994, PHYS REV LETT, V73, P1711, DOI 10.1103/PhysRevLett.73.1711; Horii S, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.054530; Hucker M, 1998, J PHYS CHEM SOLIDS, V59, P1821, DOI 10.1016/S0022-3697(98)00115-2; HUNTLEY DJ, 1974, CAN J PHYS, V52, P861, DOI 10.1139/p74-117; Hussey NE, 2003, NATURE, V425, P814, DOI 10.1038/nature01981; Ichikawa N, 2000, PHYS REV LETT, V85, P1738, DOI 10.1103/PhysRevLett.85.1738; ITO T, 1993, PHYS REV LETT, V70, P3995, DOI 10.1103/PhysRevLett.70.3995; Julian SR, 2007, NATURE, V447, P537, DOI 10.1038/447537a; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Lin J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.214506; LIPP, 2007, PHYS REV LETT, V99; MILLIS AJ, 2007, ANTIPHASE STRIPE ORD; Noda T, 1999, SCIENCE, V286, P265, DOI 10.1126/science.286.5438.265; Segawa K, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.104521; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Wang YY, 2001, P NATL ACAD SCI USA, V98, P11091, DOI 10.1073/pnas.201228498; YELLAND EA, 2007, QUANTUM OSCILLATIONS	30	409	409	5	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					533	536		10.1038/nature06332	http://dx.doi.org/10.1038/nature06332			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033293	Green Submitted			2022-12-28	WOS:000251158500043
J	Lockman, S; McIntyre, JA				Lockman, Shohin; McIntyre, James Alasdair			Reduction of HIV-1 drug resistance after intrapartum single-dose nevirapine	LANCET			English	Editorial Material							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; SUBTYPE-A; WOMEN; PREVENTION; HIVNET-012; MUTATIONS; VIRUS		Harvard Univ, Brigham & Womens Hosp, Sch Publ Hlth, Boston, MA 02115 USA; Univ Witwatersrand, Chris Hani Baragwanath Hosp, Dept Obstet & Gynecol, Johannesburg, South Africa	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; University of Witwatersrand	Lockman, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Publ Hlth, Boston, MA 02115 USA.	slockman@hsph.harvard.edu	McIntyre, James/V-7115-2019					CHAIX ML, 2004, ANTIVIR THER, V9, pS176; CHI BH, 2007, LANCET; COOVADIA H, 2006, 13 C RETR OPP INF DE; Cunningham CK, 2002, J INFECT DIS, V186, P181, DOI 10.1086/341300; Eshleman SH, 2005, AIDS, V19, P2167, DOI 10.1097/01.aids.0000194800.43799.94; Eshleman SH, 2005, J INFECT DIS, V192, P30, DOI 10.1086/430764; Eshleman SH, 2004, JAIDS-J ACQ IMM DEF, V35, P126, DOI 10.1097/00126334-200402010-00004; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; JOURDAIN G, 2004, 11 C RETR OPP INF SA; KANTOR R, 2003, ANTIVIR THER, V8, pS85; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; MARTINSON N, 2004, 11 C RETR OPP INF SA; McIntyre J, 2005, ANTIVIR THER, V10, pS4; PILLAY CCN, 2004, 15 INT AIDS C BANGK; Shapiro RL, 2006, AIDS, V20, P1281, DOI 10.1097/01.aids.0000232236.26630.35; Sripipatana T, 2007, AM J OBSTET GYNECOL, V197, pS107, DOI 10.1016/j.ajog.2007.03.069; SULLIVAN J, 2007, 16 INT C AIDS BARC S; WHO, 2006, ANT DRUGS TREAT PREG; *WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; World Health Organization UNICEF, 2003, ANT CAR DEV COUNTR P	22	8	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 17	2007	370	9600					1668	1670		10.1016/S0140-6736(07)61606-7	http://dx.doi.org/10.1016/S0140-6736(07)61606-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	17997152				2022-12-28	WOS:000251091200005
J	Gelis, I; Bonvin, AMJJ; Keramisanou, D; Koukaki, M; Gouridis, G; Karamanou, S; Economou, A; Kalodimos, CG				Gelis, Ioannis; Bonvin, Alexandre M. J. J.; Keramisanou, Dimitra; Koukaki, Marina; Gouridis, Giorgos; Karamanou, Spyridoula; Economou, Anastassios; Kalodimos, Charalampos G.			Structural basis for signal-sequence recognition by the translocase motor SecA as determined by NMR	CELL			English	Article							PROTEIN TRANSLOCATION; CRYSTAL-STRUCTURE; BINDING DOMAIN; PEPTIDE; COMPLEX; CYCLE; SITE; IDENTIFICATION; CONFORMATION; INTERACTS	Recognition of signal sequences by cognate receptors controls the entry of virtually all proteins to export pathways. Despite its importance, this process remains poorly understood. Here, we present the solution structure of a signal peptide bound to SecA, the 204 kDa ATPase motor of the Sec translocase. Upon encounter, the signal peptide forms an alpha-helix that inserts into a flexible and elongated groove in SecA. The mode of binding is bimodal, with both hydrophobic and electrostatic interactions mediating recognition. The same groove is used by SecA to recognize a diverse set of signal sequences. Impairment of the signal-peptide binding to SecA results in significant translocation defects. The C-terminal tail of SecA occludes the groove and inhibits signal-peptide binding, but autoinhibition is relieved by the SecB chaperone. Finally, it is shown that SecA interconverts between two conformations in solution, suggesting a simple mechanism for polypeptide translocation.	Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; FORTH, Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Greece; Univ Crete, Dept Biol, GR-71110 Iraklion, Greece	Rutgers State University Newark; Rutgers State University New Brunswick; Utrecht University; Foundation for Research & Technology - Hellas (FORTH); University of Crete	Kalodimos, CG (corresponding author), Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA.	babis@rutgers.edu	Kalodimos, Charalampos/Q-9846-2018; Bonvin, Alexandre M.J.J./A-5420-2009; Gouridis, GIORGOS/ABF-7948-2021; Economou, Anastassios/P-8292-2017; Kalodimos, Charalampos/C-5380-2008; Karamanou, Spyridoula/H-7485-2018	Kalodimos, Charalampos/0000-0001-6354-2796; Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Gouridis, GIORGOS/0000-0002-2255-0455; Economou, Anastassios/0000-0002-1770-507X; Karamanou, Spyridoula/0000-0002-8803-1404	NIGMS NIH HHS [R01 GM073854, GM-73854, R01 GM073854-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073854] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; AKITA M, 1990, J BIOL CHEM, V265, P8164; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chou YT, 2005, J BIOL CHEM, V280, P32753, DOI 10.1074/jbc.M507532200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fak JJ, 2004, BIOCHEMISTRY-US, V43, P7307, DOI 10.1021/BI0357208; Fekkes P, 1997, EMBO J, V16, P6105, DOI 10.1093/emboj/16.20.6105; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Karamanou S, 2007, EMBO J, V26, P2904, DOI 10.1038/sj.emboj.7601721; Karamyshev AL, 2005, J BIOL CHEM, V280, P37930, DOI 10.1074/jbc.M509100200; Keramisanou D, 2006, NAT STRUCT MOL BIOL, V13, P594, DOI 10.1038/nsmb1108; KIMURA E, 1991, J BIOL CHEM, V266, P6600; Kourtz L, 2000, MOL MICROBIOL, V37, P1342, DOI 10.1046/j.1365-2958.2000.02078.x; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Mori H, 1997, BBA-BIOMEMBRANES, V1326, P23, DOI 10.1016/S0005-2736(97)00004-7; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Musial-Siwek M, 2007, J MOL BIOL, V365, P637, DOI 10.1016/j.jmb.2006.10.027; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Papanikou E, 2005, J BIOL CHEM, V280, P43209, DOI 10.1074/jbc.M509990200; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Randall LL, 1997, P NATL ACAD SCI USA, V94, P802, DOI 10.1073/pnas.94.3.802; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; Sianidis G, 2001, EMBO J, V20, P961, DOI 10.1093/emboj/20.5.961; Sprangers R, 2007, NAT METHODS, V4, P697, DOI 10.1038/NMETH1080; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Triplett TL, 2001, J BIOL CHEM, V276, P19648, DOI 10.1074/jbc.M100098200; Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wang LG, 2000, J BIOL CHEM, V275, P10154, DOI 10.1074/jbc.275.14.10154; Wang LG, 2004, BIOCHEMISTRY-US, V43, P13185, DOI 10.1021/bi049485k; WANG ZL, 1993, BIOCHEMISTRY-US, V32, P13991, DOI 10.1021/bi00213a032; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Zhou JH, 2003, NAT STRUCT BIOL, V10, P942, DOI 10.1038/nsb980	50	319	322	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					756	769		10.1016/j.cell.2007.09.039	http://dx.doi.org/10.1016/j.cell.2007.09.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022369	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000250966300022
J	Moore, GF; Bangs, NL; Taira, A; Kuramoto, S; Pangborn, E; Tobin, HJ				Moore, G. F.; Bangs, N. L.; Taira, A.; Kuramoto, S.; Pangborn, E.; Tobin, H. J.			Three-dimensional splay fault geometry and implications for tsunami generation	SCIENCE			English	Article							1944 TONANKAI EARTHQUAKE; TROUGH SEISMOGENIC ZONE; NANKAI TROUGH; SLIP DISTRIBUTION; MECHANICS	Megasplay faults, very long thrust faults that rise from the subduction plate boundary megathrust and intersect the sea floor at the landward edge of the accretionary prism, are thought to play a role in tsunami genesis. We imaged a megasplay thrust system along the Nankai Trough in three dimensions, which allowed us to map the splay fault geometry and its lateral continuity. The megasplay is continuous from the main plate interface fault upwards to the sea floor, where it cuts older thrust slices of the frontal accretionary prism. The thrust geometry and evidence of large-scale slumping of surficial sediments show that the fault is active and that the activity has evolved toward the landward direction with time, contrary to the usual seaward progression of accretionary thrusts. The megasplay fault has progressively steepened, substantially increasing the potential for vertical uplift of the sea floor with slip. We conclude that slip on the megasplay fault most likely contributed to generating devastating historic tsunamis, such as the 1944 moment magnitude 8.1 Tonankai event, and it is this geometry that makes this margin and others like it particularly prone to tsunami genesis.	Japan Agcy Marine Earth Sci & Technol, Ctr Deep Earth Explorat, Kanazawa Ku, Yokohama, Kanagawa, Japan; Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA; Univ Texas, Inst Geophys, Austin, TX 78758 USA; Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Hawaii System; University of Texas System; University of Texas Austin; University of Wisconsin System; University of Wisconsin Madison	Moore, GF (corresponding author), Japan Agcy Marine Earth Sci & Technol, Ctr Deep Earth Explorat, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa, Japan.	gmoore@jamstec.go.jp	Moore, Gregory F/A-2860-2009; Bangs, Nathan/A-1584-2009	Moore, Gregory F/0000-0002-9649-3174; Bangs, Nathan/0000-0002-4377-3463	Directorate For Geosciences [0800653] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Ammon CJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028005; Ammon CJ, 2005, SCIENCE, V308, P1133, DOI 10.1126/science.1112260; ANDO M, 1975, TECTONOPHYSICS, V27, P119, DOI 10.1016/0040-1951(75)90102-X; Baba T, 2006, TECTONOPHYSICS, V426, P119, DOI 10.1016/j.tecto.2006.02.015; BYRNE DE, 1988, TECTONICS, V7, P833, DOI 10.1029/TC007i004p00833; Collot JY, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003060; Cummins PR, 2000, GEOPHYS RES LETT, V27, P2725, DOI 10.1029/1999GL011139; FUKAO Y, 1979, J GEOPHYS RES, V84, P2303, DOI 10.1029/JB084iB05p02303; Geist EL, 2006, EARTH PLANETS SPACE, V58, P185, DOI 10.1186/BF03353377; Geist EL, 1999, PURE APPL GEOPHYS, V154, P485, DOI 10.1007/s000240050241; Hyndman RD, 1997, ISL ARC, V6, P244, DOI 10.1111/j.1440-1738.1997.tb00175.x; Ichinose GA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002393; Kame N, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002189; Kikuchi M, 2003, EARTH PLANETS SPACE, V55, P159, DOI 10.1186/BF03351745; Kopp H, 2003, TECTONICS, V22, DOI 10.1029/2002TC001420; LAY T, 1989, PHYS EARTH PLANET IN, V54, P258, DOI 10.1016/0031-9201(89)90247-1; Moore J.C, 2007, SEISMOGENIC ZONE SUB, P288, DOI DOI 10.7312/DIXO13866-010; Nakanishi A, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000424; Park JO, 2002, SCIENCE, V297, P1157, DOI 10.1126/science.1074111; PLAFKER G, 1972, J GEOPHYS RES, V77, P901, DOI 10.1029/JB077i005p00901; RUFF L, 1983, TECTONOPHYSICS, V99, P99, DOI 10.1016/0040-1951(83)90097-5; Shaw JH, 1999, GEOL SOC AM BULL, V111, P1140, DOI 10.1130/0016-7606(1999)111<1140:POIT>2.3.CO;2; Tanioka Y, 1996, GEOPHYS RES LETT, V23, P861, DOI 10.1029/96GL00736; Tanioka Y, 2001, EARTH PLANETS SPACE, V53, P235, DOI 10.1186/BF03352380; Tobin HJ, 2006, SCI DRILL, V2, P23, DOI 10.5194/sd-2-23-2006; Wang KL, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004094; Yilmaz O, 2001, SEISMIC DATA ANAL PR	27	301	306	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1128	1131		10.1126/science.1147195	http://dx.doi.org/10.1126/science.1147195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006743				2022-12-28	WOS:000250957900043
J	Reczek, D; Schwake, M; Schroder, J; Hughes, H; Blanz, J; Jin, XY; Brondyk, W; Van Patten, S; Edmunds, T; Saftig, P				Reczek, David; Schwake, Michael; Schroeder, Jenny; Hughes, Heather; Blanz, Judith; Jin, Xiaoying; Brondyk, William; Van Patten, Scott; Edmunds, Tim; Saftig, Paul			LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-Glucocerebrosidase	CELL			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; GAUCHER-DISEASE; CYTOPLASMIC TAIL; IN-VITRO; PROTEIN; ENZYMES; BINDING; SIALOGLYCOPROTEIN; PURIFICATION; TRAFFICKING	beta-glucocerebrosidase, the enzyme defective in Gaucher disease, is targeted to the lysosome independently of the mannose-6-phosphate receptor. Affinity-chromatography experiments revealed that the lysosomal integral membrane protein LIMP-2 is a specific binding partner of beta-glucocerebrosidase. This interaction involves a coiled-coil domain within the lumenal domain. beta-glucocerebrosidase activity and protein levels were severely decreased in LIMP-2-deficient mouse tissues. Analysis of fibroblasts and macrophages isolated from these mice indicated that the majority of beta-glucocerebrosidase was secreted. Missorting of beta-glucocerebrosidase was also evident in vivo, as protein and activity levels were significantly higher in sera from LIMP-2-deficient mice compared to wild-type. Reconstitution of LIMP-2 in LIMP-2-deficient fibroblasts led to a rescue of beta-glucocerebrosidase levels and distribution. LIMP-2 expression also led to lysosomal transport of a beta-glucocerebrosidase endoplasmic reticulum retention mutant. These data support a role for LIMP-2 as the mannose-6-phosphate-independent trafficking receptor for beta-glucocerebrosidase.	Genzyme Corp, Framingham, MA 01701 USA; Univ Kiel, Inst Biochem, D-24098 Kiel, Germany	Sanofi-Aventis; Genzyme Corporation; University of Kiel	Reczek, D (corresponding author), Genzyme Corp, 1 Mt Rd, Framingham, MA 01701 USA.	david.reczek@genzyme.com; psaftig@biochem.uni-kiel.de		Schwake, Michael/0000-0002-4173-2166				AERTS JMFG, 1988, BIOCHIM BIOPHYS ACTA, V964, P303, DOI 10.1016/0304-4165(88)90030-X; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; BEUTLER E, 1991, NEW ENGL J MED, V325, P1354; BEUTLER E, 1986, P NATL ACAD SCI USA, V83, P7472, DOI 10.1073/pnas.83.19.7472; Beutler E, 2006, ACTA PAEDIATR, V95, P103, DOI 10.1080/08035320600619039; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; Crombie R, 1998, J BIOL CHEM, V273, P4855, DOI 10.1074/jbc.273.9.4855; Dittmer F, 1999, J CELL SCI, V112, P1591; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Fujita H, 1999, BIOCHEM BIOPH RES CO, V255, P54, DOI 10.1006/bbrc.1998.0140; FUJITA H, 1991, BIOCHEM BIOPH RES CO, V178, P444, DOI 10.1016/0006-291X(91)90127-S; Gamp AC, 2003, HUM MOL GENET, V12, P631, DOI 10.1093/hmg/ddg062; GINSEL LA, 1991, CELL BIOL INT REP, V15, P1167, DOI 10.1016/0309-1651(91)90088-Z; GLICKMAN JN, 1993, J CELL BIOL, V123, P99, DOI 10.1083/jcb.123.1.99; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Kasper D, 1996, J CELL BIOL, V134, P615, DOI 10.1083/jcb.134.3.615; Knipper M, 2006, J PHYSIOL-LONDON, V576, P73, DOI 10.1113/jphysiol.2006.116889; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Kuronita T, 2005, TRAFFIC, V6, P895, DOI 10.1111/j.1600-0854.2005.00325.x; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; Leonova T, 2000, MOL GENET METAB, V70, P281, DOI 10.1006/mgme.2000.3035; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; LUDWIG T, 1995, TRENDS CELL BIOL, V5, P202, DOI 10.1016/S0962-8924(00)89000-5; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marshall J, 2002, MOL THER, V6, P179, DOI 10.1006/mthe.2002.0650; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; NILSSON O, 1982, J NEUROCHEM, V39, P709, DOI 10.1111/j.1471-4159.1982.tb07950.x; NILSSON O, 1985, CLIN GENET, V27, P443; OKAZAKI I, 1992, J BIOCHEM, V111, P763, DOI 10.1093/oxfordjournals.jbchem.a123833; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P4862; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Schmitz M, 2005, INT J BIOCHEM CELL B, V37, P2310, DOI 10.1016/j.biocel.2005.05.008; Sidransky E, 2004, MOL GENET METAB, V83, P6, DOI 10.1016/j.ymgme.2004.08.015; SUAREZQUIAN CA, 1987, TISSUE CELL, V19, P495, DOI 10.1016/0040-8166(87)90043-7; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; VANDONGEN JM, 1985, EUR J CELL BIOL, V39, P179; VEGA MA, 1991, J BIOL CHEM, V266, P16269; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797	44	345	366	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					770	783		10.1016/j.cell.2007.10.018	http://dx.doi.org/10.1016/j.cell.2007.10.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022370	Bronze			2022-12-28	WOS:000250966300023
J	Yang, MJ; Li, B; Tomchick, DR; Machius, M; Rizo, J; Yu, HT; Luo, XL				Yang, Maojun; Li, Bing; Tomchick, Diana R.; Machius, Mischa; Rizo, Josep; Yu, Hongtao; Luo, Xuelian			p31(comet) blocks Mad2 activation through structural mimicry	CELL			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX; PROTEIN; CDC20; BINDING; MODEL; UBIQUITINATION; REFINEMENT; INITIATION; TEMPLATE	The status of spindle checkpoint signaling depends on the balance of two opposing dynamic processes that regulate the highly unusual two-state behavior of Mad2. In mitosis, a Mad1-Mad2 core complex recruits cytosolic Mad2 to kinetochores through Mad2 dimerization and converts Mad2 to a conformer amenable to Cdc20 binding, thereby facilitating checkpoint activation. p31(comet) inactivates the checkpoint through binding to Mad1- or Cdc20-bound Mad2, thereby preventing Mad2 activation and promoting the dissociation of the Mad2-Cdc20 complex. Here, we report the crystal structure of the Mad2-p31(comet) complex. The C-terminal region of Mad2 that undergoes rearrangement in different Mad2 conformers is a major structural determinant for p31(comet) binding, explaining the specificity of p31(comet) toward Mad1- or Cdc20-bound Mad2. p31(comet) adopts a fold strikingly similar to that of Mad2 and binds at the dimerization interface of Mad2. Thus, p31(comet) exploits the two-state behavior of Mad2 to block its activation by acting as an "anti-Mad2.''	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Luo, XL (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	xuelian.luo@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022	Yu, Hongtao/0000-0002-8861-049X; Yang, Maojun/0000-0002-6798-3094; Tomchick, Diana/0000-0002-7529-4643	NATIONAL CANCER INSTITUTE [K01CA100292] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA100292, K01 CA100292-05] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; *CONS TC, 1994, ACTA CRYSTALLOGR D, V50, P760; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4	33	149	154	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					744	755		10.1016/j.cell.2007.08.048	http://dx.doi.org/10.1016/j.cell.2007.08.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022368	Green Accepted, Bronze			2022-12-28	WOS:000250966300021
J	Higgins, BL; Berry, DW; Bartlett, SD; Wiseman, HM; Pryde, GJ				Higgins, B. L.; Berry, D. W.; Bartlett, S. D.; Wiseman, H. M.; Pryde, G. J.			Entanglement-free heisenberg-limited phase estimation	NATURE			English	Article							STANDARD QUANTUM LIMIT; BROGLIE WAVELENGTH; STATE; INTERFEROMETRY	Measurement underpins all quantitative science. A key example is the measurement of optical phase, used in length metrology and many other applications. Advances in precision measurement have consistently led to important scientific discoveries. At the fundamental level, measurement precision is limited by the number N of quantum resources (such as photons) that are used. Standard measurement schemes, using each resource independently, lead to a phase uncertainty that scales as 1/root N-known as the standard quantum limit. However, it has long been conjectured(1,2) that it should be possible to achieve a precision limited only by the Heisenberg uncertainty principle, dramatically improving the scaling to 1/N (ref. 3). It is commonly thought that achieving this improvement requires the use of exotic quantum entangled states, such as the NOON state(4,5). These states are extremely difficult to generate. Measurement schemes with counted photons or ions have been performed with N <= 6 (refs 6 - 15), but few have surpassed the standard quantum limit(12,14) and none have shown Heisenberg-limited scaling. Here we demonstrate experimentally a Heisenberg-limited phase estimation procedure. We replace entangled input states with multiple applications of the phase shift on unentangled single-photon states. We generalize Kitaev's phase estimation algorithm(16) using adaptive measurement theory(17-20) to achieve a standard deviation scaling at the Heisenberg limit. For the largest number of resources used ( N=378), we estimate an unknown phase with a variance more than 10 dB below the standard quantum limit; achieving this variance would require more than 4,000 resources using standard interferometry. Our results represent a drastic reduction in the complexity of achieving quantum-enhanced measurement precision.	Griffith Univ, Ctr Quantum Dynam, Brisbane, Qld 4111, Australia; Macquarie Univ, Ctr Quantum Comp Technol, Sydney, NSW 2109, Australia; Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; Griffith Univ, Ctr Quantum Comp Technol, Brisbane, Qld 4111, Australia	Griffith University; Macquarie University; University of Sydney; Griffith University	Pryde, GJ (corresponding author), Griffith Univ, Ctr Quantum Dynam, Brisbane, Qld 4111, Australia.	g.pryde@griffith.edu.au	Berry, Dominic/AAC-5385-2020; Pryde, Geoff J/A-8067-2008; Wiseman, Howard M/A-7266-2008; Bartlett, Stephen D/A-4163-2008	Pryde, Geoff J/0000-0003-3324-6579; Wiseman, Howard M/0000-0001-6815-854X; Bartlett, Stephen D/0000-0003-4387-670X; Berry, Dominic/0000-0003-3446-1449				Armen MA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.133602; Berry DW, 2000, PHYS REV LETT, V85, P5098, DOI 10.1103/PhysRevLett.85.5098; Bollinger JJ, 1996, PHYS REV A, V54, pR4649, DOI 10.1103/PhysRevA.54.R4649; CAVES CM, 1981, PHYS REV D, V23, P1693, DOI 10.1103/PhysRevD.23.1693; Cook RL, 2007, NATURE, V446, P774, DOI 10.1038/nature05655; Davison A.C., 1997, BOOTSTRAP METHODS TH, P5; de Burgh M, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.042301; Edamatsu K, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.213601; Eisenberg HS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.090502; Fonseca EJS, 1999, PHYS REV LETT, V82, P2868, DOI 10.1103/PhysRevLett.82.2868; Giovannetti V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.010401; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Griffiths RB, 1996, PHYS REV LETT, V76, P3228, DOI 10.1103/PhysRevLett.76.3228; Hradil Z, 1996, PHYS REV LETT, V76, P4295, DOI 10.1103/PhysRevLett.76.4295; Kitaev A. Y., 1996, ELECT COLL COMPUT CO, V3; Lee H, 2002, J MOD OPTIC, V49, P2325, DOI 10.1080/0950034021000011536; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Mitchell M. W., 2005, Proceedings of the SPIE - The International Society for Optical Engineering, V5893, P1, DOI 10.1117/12.621353; Mitchell MW, 2004, NATURE, V429, P161, DOI 10.1038/nature02493; Nagata T, 2007, SCIENCE, V316, P726, DOI 10.1126/science.1138007; Nielsen Michael A., 2002, QUANTUM COMPUTATION; RARITY JG, 1990, PHYS REV LETT, V65, P1348, DOI 10.1103/PhysRevLett.65.1348; Resch KJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.223601; Rudolph T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.217905; SCHENKER N, 1985, J AM STAT ASSOC, V80, P360, DOI 10.2307/2287897; Sun FW, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.033812; van Dam W, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.090501; Walther P, 2004, NATURE, V429, P158, DOI 10.1038/nature02552; Wiseman HM, 1997, PHYS REV A, V56, P944, DOI 10.1103/PhysRevA.56.944; WISEMAN HM, 1995, PHYS REV LETT, V75, P4587, DOI 10.1103/PhysRevLett.75.4587; YURKE B, 1986, PHYS REV A, V33, P4033, DOI 10.1103/PhysRevA.33.4033	31	411	414	5	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					393	U5		10.1038/nature06257	http://dx.doi.org/10.1038/nature06257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004379	Green Published, Green Submitted			2022-12-28	WOS:000250918600049
J	Zhang, D; Lu, LH				Zhang, De'er; Lu, Longhua			Anti-correlation of summer/winter monsoons?	NATURE			English	Letter									China Meteorol Adm, Natl Climate Ctr, Beijing 100081, Peoples R China; Chinese Acad Meteorol Sci, Beijing 100081, Peoples R China	China Meteorological Administration; Chinese Academy of Meteorological Sciences (CAMS)	Zhang, D (corresponding author), China Meteorol Adm, Natl Climate Ctr, Beijing 100081, Peoples R China.	derzhang@cma.gov.cn						FAN WL, 1978, GEN HIST CHINA, V3, P113; MAN ZM, 1998, QUAT SCI, V22, P20; Yancheva G, 2007, NATURE, V445, P74, DOI 10.1038/nature05431; Zhang D., 2006, ADV CLIM CHANGE R S1, V2, P28; ZHANG DE, 2004, COMPENDIUM CHINESE M, P327; Zheng SZ, 1977, COLLECTION PAPERS CL, P29	6	51	69	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					E7	E8		10.1038/nature06338	http://dx.doi.org/10.1038/nature06338			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004320				2022-12-28	WOS:000250918600038
J	Jimenez, J; Kalergis, A				Jimenez, Jorge; Kalergis, Alexis			Improving translational biomedical research in Chile	LANCET			English	Editorial Material									Pontificia Univ Catolica Chile, Fac Med, Dept Salud Publ, Santiago, Chile; Pontificia Univ Catolica Chile, Fac Med, Dept Reumatol, Santiago, Chile; Pontificia Univ Catolica Chile, Fac Ciencias Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Jimenez, J (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Dept Salud Publ, Casilla 114-D, Santiago, Chile.	jjimenez@med.puc.cl		Kalergis, Alexis/0000-0001-7622-5263				*CORFO INNOVA CHIL, 2006, SUBD BIOT BIOM CHIL; *COUNC HLTH RES DE, HLTH RES GETT PRIOR; *DEP EST INF SAL, SER CRON MORT INF; Jimenez J, 2007, HEALTH AFFAIR, V26, P458, DOI 10.1377/hlthaff.26.2.458; Letelier LM, 2006, LANCET, V368, P2197, DOI 10.1016/S0140-6736(06)69875-9; 2007, ECONOMIST       1024	6	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 10	2007	370	9599					1598	1599		10.1016/S0140-6736(07)61672-9	http://dx.doi.org/10.1016/S0140-6736(07)61672-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230NO	17993350				2022-12-28	WOS:000250883400009
J	Akoury, D; Kreidi, K; Jahnke, T; Weber, T; Staudte, A; Schoffler, M; Neumann, N; Titze, J; Schmidt, LPH; Czasch, A; Jagutzki, O; Fraga, RAC; Grisenti, RE; Muino, RD; Cherepkov, NA; Semenov, SK; Ranitovic, P; Cocke, CL; Osipov, T; Adaniya, H; Thompson, JC; Prior, MH; Belkacem, A; Landers, AL; Schmidt-Bocking, H; Dorner, R				Akoury, D.; Kreidi, K.; Jahnke, T.; Weber, Th.; Staudte, A.; Schoeffler, M.; Neumann, N.; Titze, J.; Schmidt, L. Ph. H.; Czasch, A.; Jagutzki, O.; Costa Fraga, R. A.; Grisenti, R. E.; Diez Muino, R.; Cherepkov, N. A.; Semenov, S. K.; Ranitovic, P.; Cocke, C. L.; Osipov, T.; Adaniya, H.; Thompson, J. C.; Prior, M. H.; Belkacem, A.; Landers, A. L.; Schmidt-Boecking, H.; Doerner, R.			The simplest double slit: Interference and entanglement in double photoionization of H-2	SCIENCE			English	Article							SINGLE-PHOTON; MOLECULE; DECOHERENCE; ATOM; DISSOCIATION; ELECTRONS; DYNAMICS; PARTICLE; N-2	The wave nature of particles is rarely observed, in part because of their very short de Broglie wavelengths in most situations. However, even with wavelengths close to the size of their surroundings, the particles couple to their environment (for example, by gravity, Coulomb interaction, or thermal radiation). These couplings shift the wave phases, often in an uncontrolled way, and the resulting decoherence, or loss of phase integrity, is thought to be a main cause of the transition from quantum to classical behavior. How much interaction is needed to induce this transition? Here we show that a photoelectron and two protons form a minimum particle/ slit system and that a single additional electron constitutes a minimum environment. Interference fringes observed in the angular distribution of a single electron are lost through its Coulomb interaction with a second electron, though the correlated momenta of the entangled electron pair continue to exhibit quantum interference.	Univ Frankfurt, Inst Kernphys, D-60438 Frankfurt, Germany; Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Ctr Fis Mat, San Sebastian 20018, Spain; Donostia Int Phys Ctr, San Sebastian 20018, Spain; State Univ Aerosp Instrumentat, St Petersburg 190000, Russia; Kansas State Univ, Dept Phys, Manhattan, KS 66506 USA; Auburn Univ, Dept Phys, Auburn, AL 36849 USA	Goethe University Frankfurt; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Centro de Fisica de Materiales (CFM); Saint Petersburg State University of Aerospace Instrumentation; Kansas State University; Auburn University System; Auburn University	Dorner, R (corresponding author), Univ Frankfurt, Inst Kernphys, Max von Laue Str 1, D-60438 Frankfurt, Germany.	doerner@atom.uni-frankfurt.de	Weber, Thorsten/K-2586-2013; Doerner, Reinhard/A-5340-2008; Schoeffler, Markus S/B-6261-2008; Jahnke, Till/AGE-4901-2022; ranitovic, predrag/A-2282-2014; Ranitovic, Predrag/AAG-5692-2020; Muino, Ricardo Diez/C-9203-2009; Landers, Allen/C-1213-2013	Weber, Thorsten/0000-0003-3756-2704; Doerner, Reinhard/0000-0002-3728-4268; Schoeffler, Markus S/0000-0001-9214-6848; Muino, Ricardo Diez/0000-0001-8593-0327; Staudte, Andre/0000-0002-8284-3831				Arndt M, 1999, NATURE, V401, P680, DOI 10.1038/44348; COHEN HD, 1966, PHYS REV, V150, P30, DOI 10.1103/PhysRev.150.30; Colgan J, 2004, J PHYS B-AT MOL OPT, V37, pL377, DOI 10.1088/0953-4075/37/23/L01; Dorner R, 2000, PHYS REP, V330, P95, DOI 10.1016/S0370-1573(99)00109-X; Dundas D, 2004, J PHYS B-AT MOL OPT, V37, P2883, DOI 10.1088/0953-4075/37/14/004; Fernandez J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.043005; Hackermuller L, 2004, NATURE, V427, P711, DOI 10.1038/nature02276; Hornberger K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.160401; Jagutzki O, 2002, NUCL INSTRUM METH A, V477, P244, DOI 10.1016/S0168-9002(01)01839-3; JONNSON C, 1961, Z PHYS A, V161, P454; JOOS E, 1985, Z PHYS B CON MAT, V59, P223, DOI 10.1007/BF01725541; Kaplan I. G., 1969, Soviet Physics - Doklady, V14, P36; Knapp A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.033004; Kokorowski DA, 2001, PHYS REV LETT, V86, P2191, DOI 10.1103/PhysRevLett.86.2191; Liu XJ, 2006, J PHYS B-AT MOL OPT, V39, P4801, DOI 10.1088/0953-4075/39/23/001; Martin F, 2007, SCIENCE, V315, P629, DOI 10.1126/science.1136598; Misra D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.153201; Muino RD, 2002, J PHYS B-AT MOL OPT, V35, pL359, DOI 10.1088/0953-4075/35/15/104; NOEL MW, 1995, PHYS REV LETT, V75, P1252, DOI 10.1103/PhysRevLett.75.1252; Opatrny T, 2001, PHYS REV LETT, V86, P3180, DOI 10.1103/PhysRevLett.86.3180; Pisharody SN, 2004, SCIENCE, V303, P813, DOI 10.1126/science.1092220; PONT M, 1995, PHYS REV A, V51, pR2676, DOI 10.1103/PhysRevA.51.R2676; Rolles D, 2005, NATURE, V437, P711, DOI 10.1038/nature04040; Semenov SK, 2003, J PHYS B-AT MOL OPT, V36, P1409, DOI 10.1088/0953-4075/36/7/310; Stolterfoht N, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.023201; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203; Vanroose W, 2005, SCIENCE, V310, P1787, DOI 10.1126/science.1120263; Walter M, 1999, J PHYS B-AT MOL OPT, V32, P2487, DOI 10.1088/0953-4075/32/11/302; Weber T, 2004, NATURE, V431, P437, DOI 10.1038/nature02839; WOOTTERS WK, 1979, PHYS REV D, V19, P473, DOI 10.1103/PhysRevD.19.473; Yudin GL, 2006, J PHYS B-AT MOL OPT, V39, pL17, DOI 10.1088/0953-4075/39/2/L01; Zurek WH, 2003, REV MOD PHYS, V75, P715, DOI 10.1103/RevModPhys.75.715	32	188	188	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					949	952		10.1126/science.1144959	http://dx.doi.org/10.1126/science.1144959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991857	Green Submitted			2022-12-28	WOS:000250788500035
J	Hocking, WK; Carey-Smith, T; Tarasick, DW; Argall, PS; Strong, K; Rochon, Y; Zawadzki, I; Taylor, PA				Hocking, W. K.; Carey-Smith, T.; Tarasick, D. W.; Argall, P. S.; Strong, K.; Rochon, Y.; Zawadzki, I.; Taylor, P. A.			Detection of stratospheric ozone intrusions by windprofiler radars	NATURE			English	Article							CROSS-TROPOPAUSE EXCHANGE; DISPERSION MODEL FLEXPART; TROPOSPHERE EXCHANGE; BACKGROUND OZONE; UNITED-STATES; VHF; AIR	Stratospheric ozone attenuates harmful ultraviolet radiation and protects the Earth's biosphere(1). Ozone is also of fundamental importance for the chemistry of the lowermost part of the atmosphere, the troposphere(1-8). At ground level, ozone is an important by-product of anthropogenic pollution(7), damaging forests and crops(5,6), and negatively affecting human health(9). Ozone is critical to the chemical and thermal balance of the troposphere(10) because, via the formation of hydroxyl radicals, it controls the capacity of tropospheric air to oxidize and remove other pollutants(1). Moreover, ozone is an important greenhouse gas, particularly in the upper troposphere(1). Although photochemistry in the lower troposphere is the major source of tropospheric ozone(2,7,11), the stratosphere-troposphere transport of ozone(12-19) is important to the overall climatology, budget and long-term trends of tropospheric ozone(3,4,8,12). Stratospheric intrusion events, however, are still poorly understood. Here we introduce the use of modern windprofiler radars(20-22) to assist in such transport investigations. By hourly monitoring the radar-derived tropopause height(23-25) in combination with a series of frequent ozonesonde balloon launches, we find numerous intrusions of ozone from the stratosphere into the troposphere in southeastern Canada. On some occasions, ozone is dispersed at altitudes of two to four kilometres, but on other occasions it reaches the ground, where it can dominate the ozone density variability. We observe rapid changes in radar tropopause height immediately preceding these intrusion events. Such changes therefore serve as a valuable diagnostic for the occurrence of ozone intrusion events. Our studies emphasize the impact that stratospheric ozone can have on tropospheric ozone, and show that windprofiler data can be used to infer the possibility of ozone intrusions, as well as better represent tropopause motions in association with stratosphere-troposphere transport.	Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada; Environm Canada, Toronto, ON M3H 5T4, Canada; Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; McGill Univ, Dept Atmospher & Ocean Sci, Montreal, PQ H3A 2K6, Canada; York Univ, Dept Earth & Space Sci & Engn, Toronto, ON M3J 1P3, Canada	Western University (University of Western Ontario); Environment & Climate Change Canada; University of Toronto; McGill University; York University - Canada	Hocking, WK (corresponding author), Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada.	whocking@uwo.ca	Strong, Kimberly/D-2563-2012	Strong, Kimberly/0000-0001-9947-1053; Tarasick, David/0000-0001-9869-0692				Altshuller AP, 1996, J AIR WASTE MANAGE, V46, P134, DOI 10.1080/10473289.1996.10467445; Ashmore MR, 2005, PLANT CELL ENVIRON, V28, P949, DOI 10.1111/j.1365-3040.2005.01341.x; Beekmann M, 1997, J ATMOS CHEM, V28, P29, DOI 10.1023/A:1005897314623; Cooper OR, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007306; Cote J, 1998, MON WEATHER REV, V126, P1373, DOI 10.1175/1520-0493(1998)126<1373:TOCMGE>2.0.CO;2; Forster C, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003589; Gage K.S., 1990, RADAR METEOROLOGY, P534, DOI [10.1007/978-1-935704-15-7_37, DOI 10.1007/978-1-935704-15-7_37]; GAGE KS, 1982, J APPL METEOROL, V21, P1150, DOI 10.1175/1520-0450(1982)021<1150:AOMFTD>2.0.CO;2; Hirsch AI, 1996, J GEOPHYS RES-ATMOS, V101, P12659, DOI 10.1029/96JD00557; HOCKING WK, 1986, J ATMOS TERR PHYS, V48, P131, DOI 10.1016/0021-9169(86)90077-2; Hocking WK, 1997, RADIO SCI, V32, P2241, DOI 10.1029/97RS02781; Hogrefe C, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004690; HOLTON JR, 1995, REV GEOPHYS, V33, P403, DOI 10.1029/95RG02097; LARSEN MF, 1982, B AM METEOROL SOC, V63, P996, DOI 10.1175/1520-0477(1982)063<0996:VAUDRA>2.0.CO;2; Lelieveld J, 2000, J GEOPHYS RES-ATMOS, V105, P3531, DOI 10.1029/1999JD901011; Lin CYC, 2000, GEOPHYS RES LETT, V27, P3465, DOI 10.1029/2000GL011762; Naja M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002477; ROETTGER J, 1990, RADAR METEOROLOGY, P235; Sprenger M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002587; Stevenson DS, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006338; Stohl A, 2000, ATMOS ENVIRON, V34, P1323, DOI 10.1016/S1352-2310(99)00320-9; Stohl A, 2005, ATMOS CHEM PHYS, V5, P2461, DOI 10.5194/acp-5-2461-2005; Stohl A, 2003, B AM METEOROL SOC, V84, P1565, DOI 10.1175/BAMS-84-11-1565; Stohl A, 2002, ATMOS ENVIRON, V36, P4635, DOI 10.1016/S1352-2310(02)00416-8; Stohl A, 1998, ATMOS ENVIRON, V32, P4245, DOI 10.1016/S1352-2310(98)00184-8; Tarasick DW, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004643; Wang XP, 2004, ATMOS ENVIRON, V38, P4383, DOI 10.1016/j.atmosenv.2004.03.067; Wernli H, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000812; WHO World Health Organization, 2003, HLTH ASP AIR POLL PA; *WMO, 1999, 44 WMO GLOB OZ RES	30	64	67	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					281	284		10.1038/nature06312	http://dx.doi.org/10.1038/nature06312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994096				2022-12-28	WOS:000250746200057
J	Baum, P; Yang, DS; Zewail, AH				Baum, Peter; Yang, Ding-Shyue; Zewail, Ahmed H.			4D visualization of transitional structures in phase transformations by electron diffraction	SCIENCE			English	Article							INSULATOR-TRANSITION; MICROSCOPY; CRYSTALLOGRAPHY; DYNAMICS; VO2; TEMPERATURE	Complex systems in condensed phases involve a multidimensional energy landscape, and knowledge of transitional structures and separation of time scales for atomic movements is critical to understanding their dynamical behavior. Here, we report, using four-dimensional (4D) femtosecond electron diffraction, the visualization of transitional structures from the initial monoclinic to the final tetragonal phase in crystalline vanadium dioxide; the change was initiated by a near-infrared excitation. By revealing the spatiotemporal behavior from all observed Bragg diffractions in 3D, the femtosecond primary vanadium-vanadium bond dilation, the displacements of atoms in picoseconds, and the sound wave shear motion on hundreds of picoseconds were resolved, elucidating the nature of the structural pathways and the nonconcerted mechanism of the transformation.	CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu	Yang, Ding-Shyue/A-8648-2010; Baum, Peter/B-7637-2008	Yang, Ding-Shyue/0000-0003-2713-9128; Baum, Peter/0000-0002-1521-8729; gaber, sarah/0000-0002-5995-7291				Bargheer M, 2006, CHEMPHYSCHEM, V7, P783, DOI 10.1002/cphc.200500591; Baum P, 2006, P NATL ACAD SCI USA, V103, P16105, DOI 10.1073/pnas.0607451103; BERGLUND CN, 1969, PHYS REV, V185, P1022, DOI 10.1103/PhysRev.185.1022; Bressler C, 2004, CHEM REV, V104, P1781, DOI 10.1021/cr0206667; Caspersen KJ, 2005, P NATL ACAD SCI USA, V102, P6738, DOI 10.1073/pnas.0408127102; Cavalleri A, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.011004; Cavalleri A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.067405; CAVALLERI A, 2001, PHYS REV LETT, V87; ELSAYEDALI HE, 1988, APPL PHYS LETT, V52, P103, DOI 10.1063/1.99063; Ertl G, 2000, ADV CATAL, V45, P1; Gaffney KJ, 2007, SCIENCE, V316, P1444, DOI 10.1126/science.1135923; Gedik N, 2007, SCIENCE, V316, P425, DOI 10.1126/science.1138834; GOODENOUGH JB, 1960, PHYS REV, V120, P67, DOI 10.1103/PhysRev.120.67; Grinolds MS, 2006, P NATL ACAD SCI USA, V103, P18427, DOI 10.1073/pnas.0609233103; Kim HT, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266401; Koethe TC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.116402; KUCHARCZYK D, 1979, J APPL CRYSTALLOGR, V12, P370, DOI 10.1107/S0021889879012711; Lobastov VA, 2005, P NATL ACAD SCI USA, V102, P7069, DOI 10.1073/pnas.0502607102; LOBASTOV VA, 2001, SPRINGER SERIES OPTI, V95, P119; Lobastov VA, 2007, NANO LETT, V7, P2552, DOI 10.1021/nl071341e; Maurer D, 1999, PHYS REV B, V60, P13249, DOI 10.1103/PhysRevB.60.13249; MORIN FJ, 1959, PHYS REV LETT, V3, P34, DOI 10.1103/PhysRevLett.3.34; Park H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.100301; Park HS, 2007, NANO LETT, V7, P2545, DOI 10.1021/nl071369q; Petrov GI, 2002, OPT LETT, V27, P655, DOI 10.1364/OL.27.000655; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; Rogers K.D, 1993, POWDER DIFFR, V8, P240; Rousse A, 2001, REV MOD PHYS, V73, P17, DOI 10.1103/RevModPhys.73.17; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Sokolowski-Tinten K, 2004, J PHYS-CONDENS MAT, V16, pR1517, DOI 10.1088/0953-8984/16/49/R04; THOMAS JM, 1970, CHEM BRIT, V6, P60; Trinkle DR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.025701; Yang DS, 2007, J PHYS CHEM C, V111, P4889, DOI 10.1021/jp067466+; ZEWAIL AH, 1988, SCIENCE, V242, P1645, DOI 10.1126/science.242.4886.1645; Zewail AH, 2006, ANNU REV PHYS CHEM, V57, P65, DOI 10.1146/annurev.physchem.57.032905.104748	35	413	418	8	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					788	792		10.1126/science.1147724	http://dx.doi.org/10.1126/science.1147724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975063				2022-12-28	WOS:000250583900038
J	Bohannon, J				Bohannon, John			A Linnean feast	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					752	752		10.1126/science.1152652	http://dx.doi.org/10.1126/science.1152652			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975051				2022-12-28	WOS:000250583900023
J	Bower, GC				Bower, Geoffrey C.			Mining for the ephemeral	SCIENCE			English	Editorial Material									Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bower, GC (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	gbower@astro.berkeley.edu	Bower, Geoffrey/ABC-8386-2020	Bower, Geoffrey/0000-0003-4056-9982				Bower GC, 2007, ASTROPHYS J, V666, P346, DOI 10.1086/519831; Carilli CL, 2004, NEW ASTRON REV, V48, P979, DOI 10.1016/j.newar.2004.09.001; Cordes JM, 2004, NEW ASTRON REV, V48, P1459, DOI 10.1016/j.newar.2004.09.038; DeBoer D, 2004, P SOC PHOTO-OPT INS, V5489, P1021, DOI 10.1117/12.551737; Hyman SD, 2005, NATURE, V434, P50, DOI 10.1038/nature03400; Lorimer DR, 2007, SCIENCE, V318, P777, DOI 10.1126/science.1147532; LORIMER DR, 2007, SCIENCE         0927; McLaughlin MA, 2006, NATURE, V439, P817, DOI 10.1038/nature04440; van Paradijs J, 2000, ANNU REV ASTRON ASTR, V38, P379, DOI 10.1146/annurev.astro.38.1.379	9	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					759	760		10.1126/science.1149084	http://dx.doi.org/10.1126/science.1149084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975058				2022-12-28	WOS:000250583900030
J	Liu, SS; De Barro, PJ; Xu, J; Luan, JB; Zang, LS; Ruan, YM; Wan, FH				Liu, Shu-Sheng; De Barro, P. J.; Xu, Jing; Luan, Jun-Bo; Zang, Lian-Sheng; Ruan, Yong-Ming; Wan, Fang-Hao			Asymmetric mating interactions drive widespread invasion and displacement in a whitefly	SCIENCE			English	Article							BEMISIA-TABACI HEMIPTERA; NON-B-BIOTYPE; ALEYRODIDAE; INSECTS; POPULATIONS; COMPETITION; AUSTRALIA; BEHAVIOR; ZHEJIANG; BIOLOGY		Zhejiang Univ, Inst Insect Sci, Hangzhou 310029, Peoples R China; CSIRO Entomol, Indooroopilly, Qld 4068, Australia; Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100081, Peoples R China	Zhejiang University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Liu, SS (corresponding author), Zhejiang Univ, Inst Insect Sci, Hangzhou 310029, Peoples R China.	shshliu@zju.edu.cn	De Barro, Paul J/C-1724-2008; Liu, Shu-Sheng/D-2300-2013	Liu, Shu-Sheng/0000-0001-7711-6405				Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Butlin Roger, 1995, P327; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; De Barro PJ, 2006, BIOL INVASIONS, V8, P287, DOI 10.1007/s10530-005-1261-6; De Barro PJ, 2005, B ENTOMOL RES, V95, P193, DOI 10.1079/BER2004351; De Barro PJ, 2000, B ENTOMOL RES, V90, P103, DOI 10.1017/S0007485300000201; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; GUNNING RV, 1995, J AUST ENTOMOL SOC, V34, P116; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; LAWTON JH, 1981, NATURE, V289, P793, DOI 10.1038/289793a0; Lima LHC, 2002, GENET MOL BIOL, V25, P217, DOI 10.1590/S1415-47572002000200016; Lookwood J.L., 2007, INVASION ECOLOGY; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; MCLAIN DK, 1987, OIKOS, V49, P291, DOI 10.2307/3565763; Perring Thomas M., 1996, P3; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; Rekha AR, 2005, ENTOMOL EXP APPL, V117, P221, DOI 10.1111/j.1570-7458.2005.00352.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Ruan YM, 2007, ENTOMOL EXP APPL, V124, P229, DOI 10.1111/j.1570-7458.2007.00575.x; Takafuji A, 1997, EXP APPL ACAROL, V21, P379, DOI 10.1023/A:1018423711166; Yoshimura J, 1997, RES POPUL ECOL, V39, P191, DOI 10.1007/BF02765265; Zang LS, 2007, J INSECT BEHAV, V20, P157, DOI 10.1007/s10905-006-9066-8; Zang LS, 2006, ENTOMOL EXP APPL, V121, P221, DOI 10.1111/j.1570-8703.2006.00482.x	26	342	432	10	226	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1769	1772		10.1126/science.1149887	http://dx.doi.org/10.1126/science.1149887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	17991828				2022-12-28	WOS:000251616800039
J	Weir, BA; Woo, MS; Getz, G; Perner, S; Ding, L; Beroukhim, R; Lin, WM; Province, MA; Kraja, A; Johnson, LA; Shah, K; Sato, M; Thomas, RK; Barletta, JA; Borecki, IB; Broderick, S; Chang, AC; Chiang, DY; Chirieac, LR; Cho, J; Fujii, Y; Gazdar, AF; Giordano, T; Greulich, H; Hanna, M; Johnson, BE; Kris, MG; Lash, A; Lin, L; Lindeman, N; Mardis, ER; McPherson, JD; Minna, JD; Morgan, MB; Nadel, M; Orringer, MB; Osborne, JR; Ozenberger, B; Ramos, AH; Robinson, J; Roth, JA; Rusch, V; Sasaki, H; Shepherd, F; Sougnez, C; Spitz, MR; Tsao, MS; Twomey, D; Verhaak, RGW; Weinstock, GM; Wheeler, DA; Winckler, W; Yoshizawa, A; Yu, SY; Zakowski, MF; Zhang, QY; Beer, DG; Wistuba, II; Watson, MA; Garraway, LA; Ladanyi, M; Travis, WD; Pao, W; Rubin, MA; Gabriel, SB; Gibbs, RA; Varmus, HE; Wilson, RK; Lander, ES; Meyerson, M				Weir, Barbara A.; Woo, Michele S.; Getz, Gad; Perner, Sven; Ding, Li; Beroukhim, Rameen; Lin, William M.; Province, Michael A.; Kraja, Aldi; Johnson, Laura A.; Shah, Kinjal; Sato, Mitsuo; Thomas, Roman K.; Barletta, Justine A.; Borecki, Ingrid B.; Broderick, Stephen; Chang, Andrew C.; Chiang, Derek Y.; Chirieac, Lucian R.; Cho, Jeonghee; Fujii, Yoshitaka; Gazdar, Adi F.; Giordano, Thomas; Greulich, Heidi; Hanna, Megan; Johnson, Bruce E.; Kris, Mark G.; Lash, Alex; Lin, Ling; Lindeman, Neal; Mardis, Elaine R.; McPherson, John D.; Minna, John D.; Morgan, Margaret B.; Nadel, Mark; Orringer, Mark B.; Osborne, John R.; Ozenberger, Brad; Ramos, Alex H.; Robinson, James; Roth, Jack A.; Rusch, Valerie; Sasaki, Hidefumi; Shepherd, Frances; Sougnez, Carrie; Spitz, Margaret R.; Tsao, Ming-Sound; Twomey, David; Verhaak, Roel G. W.; Weinstock, George M.; Wheeler, David A.; Winckler, Wendy; Yoshizawa, Akihiko; Yu, Soyoung; Zakowski, Maureen F.; Zhang, Qunyuan; Beer, David G.; Wistuba, Ignacio I.; Watson, Mark A.; Garraway, Levi A.; Ladanyi, Marc; Travis, William D.; Pao, William; Rubin, Mark A.; Gabriel, Stacey B.; Gibbs, Richard A.; Varmus, Harold E.; Wilson, Richard K.; Lander, Eric S.; Meyerson, Matthew			Characterizing the cancer genome in lung adenocarcinoma	NATURE			English	Article							HIGH-RESOLUTION ANALYSIS; COPY-NUMBER; HOMOZYGOUS DELETIONS; SOMATIC MUTATIONS; FREQUENT TARGET; GENE DELIVERY; WIDE ANALYSIS; AMPLIFICATION; BEVACIZUMAB; CARBOPLATIN	Somatic alterations in cellular DNA underlie almost all human cancers(1). The prospect of targeted therapies(2) and the development of high-resolution, genome-wide approaches(3-8) are now spurring systematic efforts to characterize cancer genomes. Here we report a large-scale project to characterize copy-number alterations in primary lung adenocarcinomas. By analysis of a large collection of tumours ( n = 371) using dense single nucleotide polymorphism arrays, we identify a total of 57 significantly recurrent events. We find that 26 of 39 autosomal chromosome arms show consistent large-scale copy-number gain or loss, of which only a handful have been linked to a specific gene. We also identify 31 recurrent focal events, including 24 amplifications and 7 homozygous deletions. Only six of these focal events are currently associated with known mutations in lung carcinomas. The most common event, amplification of chromosome 14q13.3, is found in similar to 12% of samples. On the basis of genomic and functional analyses, we identify NKX2-1 ( NK2 homeobox 1, also called TITF1), which lies in the minimal 14q13.3 amplification interval and encodes a lineage-specific transcription factor, as a novel candidate proto-oncogene involved in a significant fraction of lung adenocarcinomas. More generally, our results indicate that many of the genes that are involved in lung adenocarcinoma remain to be discovered.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; Harvard Univ, Canc Program, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Genome Biol Program, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Ulm, Inst Pathol, D-89081 Ulm, Germany; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63130 USA; Washington Univ, Div Stat Genom, St Louis, MO 63130 USA; Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA; Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; Univ Cologne, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, Max Planck Soc, D-50931 Cologne, Germany; Univ Cologne, Fac Med, D-50931 Cologne, Germany; Univ Cologne, Ctr Integrated Oncol, D-50931 Cologne, Germany; Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Dept Computat Biol, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; Univ Michigan, Thorac Surg Sect, Dept Surg, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Nagoya City Univ, Sch Med, Dept Surg, Nagoya, Aichi 4678602, Japan; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; Univ Hlth Network, Toronto, ON M5G 2C4, Canada; Princess Margaret Hosp, Toronto, ON M5G 2C4, Canada; MIT, Dept Biol, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Ulm University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Nagoya City University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Massachusetts Institute of Technology (MIT)	Meyerson, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	McPherson, John D/D-2633-2017; Sato, MITSUO/I-7280-2014; Meyerson, Matthew L/E-7123-2012; Verhaak, Roel/ABE-7058-2020; Chirieac, Lucian R./AAD-2030-2019; Wheeler, David A/M-9740-2018; Tsao, Ming Sound/AFQ-7332-2022; Chiang, Derek/L-6452-2019; Yoshizawa, Akihiko/AAM-9519-2020; Wilson, Richard K./AAF-4139-2019; Ladanyi, Marc/AAG-8585-2019; Mardis, Elaine/W-2202-2019; Weinstock, George M/C-6314-2013; Tsao, Ming-Sound/M-3503-2017	McPherson, John D/0000-0001-8049-9347; Sato, MITSUO/0000-0001-5458-9576; Wheeler, David A/0000-0002-9056-6299; Tsao, Ming Sound/0000-0002-9160-5405; Wilson, Richard K./0000-0002-1992-1358; Weinstock, George M/0000-0002-2997-4592; Giordano, Thomas/0000-0003-0641-8873; Lash, Alex/0000-0003-3787-1590; Chang, Andrew/0000-0001-9506-0425; Rubin, Mark/0000-0002-8321-9950; Rusch, Valerie/0000-0003-2345-6900; Kris, Mark/0000-0002-7317-5341	NCI NIH HHS [P50 CA070907, K08 CA122833-01A1, F32 CA113126-02, F32 CA113126-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA113126, P50CA070907, K08CA122833] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; BEROUKHIM R, IN PRESS P NATL ACAD; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Bingle CD, 1997, INT J BIOCHEM CELL B, V29, P1471, DOI 10.1016/S1357-2725(97)00007-1; Cox C, 2005, P NATL ACAD SCI USA, V102, P4542, DOI 10.1073/pnas.0408593102; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; HAYASHI N, 1994, BIOCHEM BIOPH RES CO, V202, P1426, DOI 10.1006/bbrc.1994.2090; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; IKEDA K, 1995, J BIOL CHEM, V270, P8108, DOI 10.1074/jbc.270.14.8108; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Phelps RM, 1996, J CELL BIOCHEM, P32; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubin MA, 2004, CANCER RES, V64, P3814, DOI 10.1158/0008-5472.CAN-03-3881; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sato M, 2005, GENE CHROMOSOME CANC, V44, P405, DOI 10.1002/gcc.20253; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Weir B, 2004, CANCER CELL, V6, P433, DOI 10.1016/j.ccr.2004.11.004; Yuan BB, 2000, DEV DYNAM, V217, P180, DOI 10.1002/(SICI)1097-0177(200002)217:2<180::AID-DVDY5>3.0.CO;2-3; Zhang AJ, 2000, CANCER RES, V60, P6230; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603; Zhu CQ, 2006, BRIT J CANCER, V94, P1452, DOI 10.1038/sj.bjc.6603110; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	40	844	873	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					893	U22		10.1038/nature06358	http://dx.doi.org/10.1038/nature06358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	17982442	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000251394900059
J	Zaehres, H; Scholer, HR				Zaehres, Holm; Schoeler, Hans R.			Induction of pluripotency: From mouse to human	CELL			English	Editorial Material							STEM-CELLS; FIBROBLASTS; GENERATION; EMBRYOS	In this issue of Cell, Takahashi et al. (2007) transfer their seminal work on somatic cell reprogramming from the mouse to human. By overexpressing the transcription factor quartet of Oct4, Sox2, Klf4, and c-Myc in adult human fibroblasts, they successfully isolate human pluripotent stem cells that resemble human embryonic stem cells by all measured criteria. This is a significant turning point in nuclear reprogramming research with broad implications for generating patient-specific pluripotent stem cells for research and therapeutic applications.	[Zaehres, Holm; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany	Max Planck Society	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany.	schoeler@mpi-muenster.mpg.de	, HS/AAB-4434-2019	, HS/0000-0003-2643-5136				Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012	11	45	56	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					834	835		10.1016/j.cell.2007.11.020	http://dx.doi.org/10.1016/j.cell.2007.11.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045526	Bronze			2022-12-28	WOS:000251800900003
J	McHutchison, JG; Dusheiko, G; Shiffman, ML; Rodriguez-Torres, M; Sigal, S; Bourliere, M; Berg, T; Gordon, SC; Campbell, FM; Theodore, D; Blackman, N; Jenkins, J; Afdhal, NH				McHutchison, John G.; Dusheiko, Geoffrey; Shiffman, Mitchell L.; Rodriguez-Torres, Maribel; Sigal, Samuel; Bourliere, Marc; Berg, Thomas; Gordon, Stuart C.; Campbell, Fiona M.; Theodore, Dickens; Blackman, Nicole; Jenkins, Julian; Afdhal, Nezam H.		TPL102357 Study Grp	Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THROMBOPOIETIN; HYPERSPLENISM	Background Eltrombopag is a new, orally active thrombopoietin-receptor agonist that stimulates thrombopoiesis. We evaluated its ability to increase platelet counts and facilitate treatment for hepatitis C virus (HCV) infection in patients with thrombocytopenia associated with HCV-related cirrhosis. Methods Seventy-four patients with HCV-related cirrhosis and platelet counts of 20,000 to less than 70,000 per cubic millimeter were randomly assigned to receive eltrombopag (30, 50, or 75 mg daily) or placebo daily for 4 weeks. The primary end point was a platelet count of 100,000 per cubic millimeter or more at week 4. Peginterferon and ribavirin could then be initiated, with continuation of eltrombopag or placebo for 12 additional weeks. Results At week 4, platelet counts were increased to 100,000 per cubic millimeter or more in a dose-dependent manner among patients for whom these data were available: in 0 of the 17 patients receiving placebo, in 9 of 12 (75%) receiving 30 mg of eltrombopag, in 15 of 19 (79%) receiving 50 mg of eltrombopag, and in 20 of 21 (95%) receiving 75 mg of eltrombopag (P<0.001). Antiviral therapy was initiated in 49 patients (in 4 of 18 patients receiving placebo, 10 of 14 receiving 30 mg of eltrombopag, 14 of 19 receiving 50 mg of eltrombopag, and 21 of 23 receiving 75 mg of eltrombopag) while the administration of eltrombopag or placebo was continued. Twelve weeks of antiviral therapy, with concurrent receipt of eltrombopag or placebo, were completed by 36%, 53%, and 65% of patients receiving 30 mg, 50 mg, and 75 mg of eltrombopag, respectively, and by 6% of patients in the placebo group. The most common adverse event during the initial 4 weeks was headache; thereafter, the adverse events were those expected with interferon-based therapy. Conclusions Eltrombopag therapy increases platelet counts in patients with thrombocytopenia due to HCV-related cirrhosis, thereby permitting the initiation of antiviral therapy. (ClinicalTrials.gov number, NCT00110799.).	Duke Univ, Durham, NC 27705 USA; Duke Clin Res Inst, Durham, NC 27705 USA; Royal Free Hosp, London NW3 2QG, England; Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA; Fdn Invest Diego, San Juan, PR USA; Cornell Univ, Weill Med Coll, New York, NY USA; Hop St Joseph, Marseille, France; Henry Ford Hosp & Hlth Syst, Detroit, MI USA; GlaxoSmithKline, Greenford, Middx, England; GlaxoSmithKline, Res Triangle Pk, NC USA; GlaxoSmithKline, Philadelphia, PA USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Duke University; Duke University; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Virginia Commonwealth University; Cornell University; Henry Ford Health System; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Harvard University; Beth Israel Deaconess Medical Center	McHutchison, JG (corresponding author), Duke Univ, POB 17969, Durham, NC 27705 USA.	mchut001@mc.duke.edu	Dusheiko, Geoffrey M/C-7677-2010; Sigal, Samuel/AGF-2841-2022	Berg, Thomas/0000-0003-0003-6241; Afdhal, Nezam/0000-0002-7342-6593				Adinolfi LE, 2001, BRIT J HAEMATOL, V113, P590, DOI 10.1046/j.1365-2141.2001.02824.x; BALLARD HS, 1989, ALCOHOL CLIN EXP RES, V13, P706, DOI 10.1111/j.1530-0277.1989.tb00408.x; Bashour FN, 2000, AM J GASTROENTEROL, V95, P2936, DOI 10.1016/S0002-9270(00)01117-5; Bordin G, 1995, CLIN EXP RHEUMATOL, V13, pS39; Bussel JB, 2007, NEW ENGL J MED, V357, P2237, DOI 10.1056/NEJMoa073275; Erhardt J, 2004, BLOOD, V104, p59B, DOI 10.1182/blood.V104.11.3888.3888; ERICKSONMILLER CL, 2005, 96 AM ASS CANC RES A; Giannini EG, 2006, ALIMENT PHARM THER, V23, P1055, DOI 10.1111/j.1365-2036.2006.02889.x; Gutfreund KS, 2000, CAN MED ASSOC J, V162, P827; Jenkins JM, 2007, BLOOD, V109, P4739, DOI 10.1182/blood-2006-11-057968; Luengo JI, 2004, BLOOD, V104, p795A; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; McCormick PA, 2000, BEST PRACT RES CL GA, V14, P1009, DOI 10.1053/bega.2000.0144; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Peck-Radosavljevic M, 2000, Can J Gastroenterol, V14 Suppl D, p60D; PROVAN D, 2006, J CLIN ONCOL S, V24, pS18; Rios R, 2005, AM J GASTROENTEROL, V100, P1311, DOI 10.1111/j.1572-0241.2005.41543.x; Sellers T, 2004, BLOOD, V104, p568A, DOI 10.1182/blood.V104.11.2063.2063; Shiffman ML, 2007, GASTROENTEROLOGY, V132, P103, DOI 10.1053/j.gastro.2006.11.011	20	332	347	2	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2227	2236		10.1056/NEJMoa073255	http://dx.doi.org/10.1056/NEJMoa073255			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	18046027	Green Published			2022-12-28	WOS:000251176400004
J	Barreto, ML; Genser, B; Strina, A; Teixeira, MG; Assis, AMO; Rego, RF; Teles, CA; Prado, MS; Matos, SMA; Santos, DN; dos Santos, LA; Caimcross, S				Barreto, Mauricio L.; Genser, Bernd; Strina, Agostino; Teixeira, Maria Gloria; Assis, Ana Marlucia O.; Rego, Rita F.; Teles, Carlos A.; Prado, Matildes S.; Matos, Sheila M. A.; Santos, Darci N.; dos Santos, Lenaldo A.; Caimcross, Sandy			Effect of city-wide sanitation programme on reduction in rate of childhood diarrhoea in northeast Brazil: assessment by two cohort studies	LANCET			English	Article							HYGIENE BEHAVIOR; WATER; PREVALENCE; DISEASES; SALVADOR; BURDEN; IMPACT	Background A city-wide sanitation intervention was started in Salvador, Brazil, in 1997 to improve sewerage coverage from 26% of households to 80%. Our aim was to investigate the epidemiological effect of this city-wide sanitation programme on diarrhoea morbidity in children less than 3 years of age. Methods The investigation was composed of two longitudinal studies done in 1997-98 before the intervention (the sanitation programme) and in 2003-04 after the intervention had been completed. Each study consisted of a cohort of children (841 in the preintervention study and 1007 in the postintervention. study; age 0-36 months at baseline) who were followed up for a maximum of 8 months. Children were sampled from 24 sentinel areas that were randomly chosen to represent the range of environmental conditions in the study site. At the start of each study an individual or household questionnaire was applied by trained fieldworkers; an environmental survey was done in each area before and after introduction of the sanitation programme to assess basic neighbourhood and household sanitation conditions. Daily diarrhoea data were obtained during home visits twice per week. The effect of the intervention was estimated by a hierarchical modelling approach fitting a sequence of multivariate regression models. Findings Diarrhoea prevalence fell by 21% (95% CI 18-25%)-from 9.2 (9-0-9-5) days per child-year before the intervention to 7.3 (7.0-7.5) days per child-year afterwards. After adjustment for baseline sewerage coverage and potential confounding variables, we estimated an overall prevalence reduction of 22% (19-26%). Interpretation Our results show that urban sanitation is a highly effective health measure that can no longer be ignored, and they provide a timely support for the launch of 2008 as the International Year of Sanitation.	Univ Fed Bahia, Inst Saude Coletiva, BR-40110040 Salvador, BA, Brazil; London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1, England; Univ Fed Bahia, Sch Nutr, Salvador, BA, Brazil; Univ Fed Bahia, Sch Med, Dept Prevent Med, Salvador, BA, Brazil	Universidade Federal da Bahia; University of London; London School of Hygiene & Tropical Medicine; Universidade Federal da Bahia; Universidade Federal da Bahia	Barreto, ML (corresponding author), Univ Fed Bahia, Inst Saude Coletiva, Rua Basilio Gama S-N, BR-40110040 Salvador, BA, Brazil.	mauricio@ufba.br	Teixeira, Maria Gloria L C/G-4808-2012; /ABH-9107-2020; Barreto, Mauricio L/B-1752-2008; rego, rita f/P-7061-2015	Teixeira, Maria Gloria L C/0000-0003-3318-3408; /0000-0002-0632-4546; Barreto, Mauricio L/0000-0002-0215-4930; rego, rita f/0000-0001-9350-722X; Genser, Bernd/0000-0001-5787-0902	Wellcome Trust [072405/Z/03/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alderman H, 2003, SOC SCI MED, V56, P2019, DOI 10.1016/S0277-9536(02)00183-1; BAQUI AH, 1991, INT J EPIDEMIOL, V20, P1057, DOI 10.1093/ije/20.4.1057; BARRETO ML, 1997, SANEAMENTO SAUDE PAI, P7; BLUM D, 1983, INT J EPIDEMIOL, V12, P357, DOI 10.1093/ije/12.3.357; Briscoe J., 1986, EVALUATING HLTH IMPA; Cairncross S, 1996, TROP MED INT HEALTH, V1, P27, DOI 10.1046/j.1365-3156.1996.d01-9.x; Cairncross S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P771; CURTIS V, 1995, SOC SCI MED, V41, P383, DOI 10.1016/0277-9536(94)00341-P; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Genser B, 2006, EPIDEMIOLOGY, V17, P658, DOI 10.1097/01.ede.0000239728.75215.86; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; Milroy CA, 2001, ENVIRON URBAN, V13, P235, DOI 10.1177/095624780101300117; Moraes LRS, 2003, T ROY SOC TROP MED H, V97, P153, DOI 10.1016/S0035-9203(03)90104-0; Morris SS, 1996, AM J EPIDEMIOL, V144, P582, DOI 10.1093/oxfordjournals.aje.a008968; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Sastry N, 2005, SOC SCI MED, V60, P923, DOI 10.1016/j.socscimed.2004.06.051; Schmid J E, 1991, J Biopharm Stat, V1, P103; Schmidt WP, 2007, EPIDEMIOLOGY, V18, P537, DOI 10.1097/EDE.0b013e318093f3ce; Strina A, 2005, T ROY SOC TROP MED H, V99, P407, DOI 10.1016/j.trstmh.2004.07.007; Strina A, 2003, AM J EPIDEMIOL, V157, P1032, DOI 10.1093/aje/kwg075; *TCEB, 2005, AV PROGR SAN AMB BAH; Teixeira Maria da Glória, 2002, Cad. Saúde Pública, V18, P1189, DOI 10.1590/S0102-311X2002000500011; United Nations Development Programme, 2006, HUMAN DEV REPORT 200; *WHO UNICEF, 2005, WAT LIF MAK IT HAPP; WHO/ UNICEF, 2000, GLOB WAT SUPPL SAN A	27	182	186	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2007	370	9599					1622	1628		10.1016/S0140-6736(07)61638-9	http://dx.doi.org/10.1016/S0140-6736(07)61638-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230NO	17993362	Green Published, Green Accepted			2022-12-28	WOS:000250883400021
J	Yermiyahu, U; Tal, A; Ben-Gal, A; Bar-Tal, A; Tarchitzky, J; Lahav, O				Yermiyahu, U.; Tal, A.; Ben-Gal, A.; Bar-Tal, A.; Tarchitzky, J.; Lahav, O.			Environmental science - Rethinking desalinated water quality and agriculture	SCIENCE			English	Editorial Material							BORON		Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, IL-84990 Sede Boqer, Israel; Agr Res Org, Gilat Res Ctr, IL-85280 Negev 2, Israel; Agr Res Org, Inst Soil Water & Environm Sci, Volcani Ctr, IL-50250 Bet Dagan, Israel; Minist Agr, Extens Serv, IL-50250 Bet Dagan, Israel; Fac Civil & Environm Engn, IL-32000 Haifa, Israel	Ben Gurion University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Tal, A (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Sede Boqer Campus, IL-84990 Sede Boqer, Israel.	alontal@bgu.ac.il	Bar-Tal, Asher/A-8144-2012; Lahav, Ori/E-4801-2011; Ben-Gal, Alon/F-5190-2013; Lahav, Ori/N-2932-2019	Lahav, Ori/0000-0002-0654-352X; Ben-Gal, Alon/0000-0003-4105-7807; 				BELTRAN JM, 2006, WATER DESALINATION A; Ben-Gal A, 2002, PLANT SOIL, V247, P211, DOI 10.1023/A:1021556808595; Birnhack L, 2007, WATER RES, V41, P3989, DOI 10.1016/j.watres.2007.06.007; de Kreij C., 1992, GUIDE VALUES NUTR EL, V3rd; DOLNICAR S, 2006, P AWWA AM WAST WAT A; *EUR COMM, 2006, ENV TECHN ACT PLAN W; Gleick PH, 2002, WORLDS WATER 2002 20; *IDA, 2004, 18 IDA WANGN CONS; *ISR MIN AGR RUR D, 2007, QUAL DES WAT AGR; Lahav O, 2007, DESALINATION, V207, P286, DOI 10.1016/j.desal.2006.05.022; Murray FJ, 1995, REGUL TOXICOL PHARM, V22, P221, DOI 10.1006/rtph.1995.0004; Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886; Postel S., 1999, PILLAR SAND CAN IRRI; Service RF, 2006, SCIENCE, V313, P1088, DOI 10.1126/science.313.5790.1088; Tal A, 2006, SCIENCE, V313, P1081, DOI 10.1126/science.1126011; von Medeazza GM, 2004, DESALINATION, V169, P287, DOI 10.1016/j.desal.2004.04.001; WHO, 2005, NUTR DRINK WAT; WHO, 2004, GUID DRINK WAT QUAL; Yermiyahu U, 2006, PLANT PATHOL, V55, P544, DOI 10.1111/j.1365-3059.2006.01388.x; YERMIYAHU U., 2006, WORLD C SOIL SCI PHI; YERMIYAHU U, 2007, UNPUB IRRIGATION CRO	21	162	167	5	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					920	921		10.1126/science.1146339	http://dx.doi.org/10.1126/science.1146339			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991846				2022-12-28	WOS:000250788500024
J	Liu, L; Li, YH; Wang, RO; Yin, C; Dong, Q; Hing, H; Kim, C; Welsh, MJ				Liu, Lei; Li, Yuhong; Wang, Runping; Yin, Chong; Dong, Qian; Hing, Huey; Kim, Changsoo; Welsh, Michael J.			Drosophila hygrosensation requires the TRP channels water witch and nanchung	NATURE			English	Article							PERIPLANETA-AMERICANA; THERMORECEPTIVE SENSILLA; COCKROACH PERIPLANETA; OLFACTORY SENSILLA; ION CHANNELS; NEURONS; ANTENNA; IDENTIFICATION; ORGANIZATION; EXPRESSION	The ability to detect variations in humidity is critical for many animals. Birds, reptiles and insects all show preferences for specific humidities that influence their mating, reproduction and geographic distribution(1,2). Because of their large surface area to volume ratio, insects are particularly sensitive to humidity, and its detection can influence their survival(3-7). Two types of hygroreceptors exist in insects: one responds to an increase (moist receptor) and the other to a reduction (dry receptor) in humidity(4,6,8). Although previous data indicated that mechanosensation might contribute to hygrosensation(6,9), the cellular basis of hygrosensation and the genes involved in detecting humidity remain unknown. To understand better the molecular bases of humidity sensing, we investigated several genes encoding channels associated with mechanosensation, thermosensing or water transport. Here we identify two Drosophila melanogaster transient receptor potential channels needed for sensing humidity: CG31284, named by us water witch (wtrw), which is required to detect moist air, and nanchung (nan), which is involved in detecting dry air. Neurons associated with specialized sensory hairs in the third segment of the antenna express these channels, and neurons expressing wtrw and nan project to central nervous system regions associated with mechanosensation. Construction of the hygrosensing system with opposing receptors may allow an organism to very sensitively detect changes in environmental humidity.	Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Illinois System; University of Illinois Urbana-Champaign; Chonnam National University	Welsh, MJ (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Internal Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu	li, yu/HGL-9518-2022; li, Yu/HCI-9086-2022	Liu, Lei/0000-0002-6387-7745; Welsh, Michael/0000-0002-1646-6206				ALTNER H, 1977, CELL TISSUE RES, V176, P389, DOI 10.1007/BF00221796; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Desbordes SC, 2005, GENETICS, V170, P749, DOI 10.1534/genetics.105.040667; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; ITOH T, 1984, ZOOL SCI, V1, P533; Iwasaki M, 1995, ZOOL SCI, V12, P725, DOI 10.2108/zsj.12.725; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Montell C, 2005, PFLUG ARCH EUR J PHY, V451, P19, DOI 10.1007/s00424-005-1426-2; Niemeyer BA, 2005, N-S ARCH PHARMACOL, V371, P285, DOI 10.1007/s00210-005-1053-7; NISHIKAWA M, 1995, J COMP NEUROL, V361, P165, DOI 10.1002/cne.903610113; Rein K, 1999, CURR BIOL, V9, P93, DOI 10.1016/S0960-9822(99)80021-9; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shelford VE, 1918, SCIENCE, V48, P225, DOI 10.1126/science.48.1235.225; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TICHY H, 1979, J COMP PHYSIOL, V132, P149, DOI 10.1007/BF00610718; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Welsh MJ, 2002, J BIOL CHEM, V277, P2369, DOI 10.1074/jbc.R100060200; Wolff T, 2000, DROSOPHILA PROTOCOLS, P229; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; YOKOHARI F, 1976, J COMP PHYSIOL, V106, P137, DOI 10.1007/BF00620495; YOKOHARI F, 1978, J COMP PHYSIOL, V124, P53, DOI 10.1007/BF00656391; YOKOHARI F, 1983, CELL TISSUE RES, V233, P355, DOI 10.1007/BF00238302	30	141	143	6	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					294	U14		10.1038/nature06223	http://dx.doi.org/10.1038/nature06223			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994098				2022-12-28	WOS:000250746200060
J	Vosshall, LB				Vosshall, Leslie B.			Into the mind of a fly	NATURE			English	Review							CYCLIC-AMP PHOSPHODIESTERASE; DROSOPHILA ANTENNAL LOBE; MALE COURTSHIP BEHAVIOR; MALE SEXUAL-BEHAVIOR; LONG-TERM-MEMORY; MUSHROOM BODY; MOLECULAR ANALYSIS; NEURAL CIRCUITRY; CIRCADIAN CLOCK; SENSORY NEURONS	Where do animal behaviours come from and are they controlled by genes? This is the fundamental question posed by the field of neurogenetics. Pioneering work from the 1960s in Seymour Benzer's laboratory demonstrated for the first time that Drosophila melanogaster fruitflies could be mutated to obtain animals with insomnia, learning disabilities and homosexual courtship behaviours.	Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA	Rockefeller University	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	leslie@mail.rockefeller.edu		Vosshall, Leslie/0000-0002-6060-8099				AYYUB C, 1990, J NEUROGENET, V6, P243, DOI 10.3109/01677069009107114; BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BENZER S, 1955, P NATL ACAD SCI USA, V41, P344, DOI 10.1073/pnas.41.6.344; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CARLSON J, 1991, TRENDS NEUROSCI, V14, P520, DOI 10.1016/0166-2236(91)90004-E; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; HALL JC, 1979, GENETICS, V92, P437; HALL JC, 1978, BEHAV GENET, V8, P125, DOI 10.1007/BF01066870; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HOTTA Y, 1976, P NATL ACAD SCI USA, V73, P4154, DOI 10.1073/pnas.73.11.4154; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Meyer P, 2006, SCIENCE, V311, P226, DOI 10.1126/science.1118126; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; PAK WL, 1970, NATURE, V227, P518, DOI 10.1038/227518b0; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Pick S, 2005, CURR BIOL, V15, P1473, DOI 10.1016/j.cub.2005.07.022; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SEHGAL A, 1992, P NATL ACAD SCI USA, V89, P1423, DOI 10.1073/pnas.89.4.1423; SMITH DP, 1991, ANNU REV CELL BIOL, V7, P161; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Weiner J., 1999, TIME LOVE MEMORY GRE; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wolf FW, 2002, J NEUROSCI, V22, P11035; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1	66	55	56	3	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					193	197		10.1038/nature06335	http://dx.doi.org/10.1038/nature06335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994085	Bronze			2022-12-28	WOS:000250746200040
J	Fauci, AS				Fauci, Anthony S.			25 years of HIV/AIDS science: Reaching the poor with research advances	CELL			English	Editorial Material							GLOBAL HEALTH; HIV; AIDS; COUNTRIES	Last year marked the 25th anniversary of the recognition of what we now call AIDS. The AIDS pandemic has claimed more than 25 million lives, the majority of them in the developing world, and has exacerbated poverty and slowed human development. Although much has been accomplished in HIV/AIDS research, much remains to be done, especially regarding delivery of HIV/AIDS therapies and care and prevention interventions to the poorest countries that need them most.	NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						Alnwick D., 2007, BRINGING HIV PREVENT; BERTOZZI S, 2006, DIS CONTROL PRIORITE, pCH18; Fauci AS, 2006, SCIENCE, V313, P409, DOI 10.1126/science.1131993; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; Folkers GK, 2001, JAMA-J AM MED ASSOC, V286, P458, DOI 10.1001/jama.286.4.458; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kim JY, 2006, NEW ENGL J MED, V355, P645, DOI 10.1056/NEJMp068166; Koenig SP, 2006, BMJ-BRIT MED J, V332, P602, DOI 10.1136/bmj.332.7541.602; Kumar P, 2007, NEW ENGL J MED, V356, P2564, DOI 10.1056/NEJMp078091; Mukherjee JS, 2003, BMJ-BRIT MED J, V327, P1104, DOI 10.1136/bmj.327.7423.1104; Siegel Lawrence, 2007, Curr Infect Dis Rep, V9, P243, DOI 10.1007/s11908-007-0038-8; UNAIDS, 2006, REP GLOB AIDS EP; United Nations Population Division, 2006, WORLD POP PROSP 2006; *WHO UNAIDS, 2006, AIDS EP UPD SPEC REP; *WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI	15	14	15	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					429	432		10.1016/j.cell.2007.10.019	http://dx.doi.org/10.1016/j.cell.2007.10.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981106	Bronze			2022-12-28	WOS:000250618500006
J	Hayashi, T; Su, TP				Hayashi, Teruo; Su, Tsung-Ping			Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival	CELL			English	Article							INOSITOL TRISPHOSPHATE RECEPTORS; SIGMA(1) BINDING-SITES; ENDOPLASMIC-RETICULUM; CALCIUM OSCILLATIONS; MEMBRANE-FRACTION; DYNAMICS; MICRODOMAINS; AGONISTS; TARGET; ROLES	Communication between the endoplasmic reticulum (ER) and mitochondrion is important for bioenergetics and cellular survival. The ER supplies Ca2+ directly to mitochondria via inositol 1,4,5- trisphosphate receptors (IP3Rs) at close contacts between the two organelles referred to as mitochondrion-associated ER membrane (MAM). We found here that the ER protein sigma-1 receptor (Sig-1R), which is implicated in neuroprotection, carcinogenesis, and neuroplasticity, is a Ca2+- sensitive and ligand-operated receptor chaperone at MAM. Normally, Sig-1Rs form a complex at MAM with another chaperone, BiP. Upon ER Ca2+ depletion or via ligand stimulation, Sig-1Rs dissociate from BiP, leading to a prolonged Ca2+ signaling into mitochondria via IP3Rs. Sig-1Rs can translocate under chronic ER stress. Increasing Sig-1Rs in cells counteracts ER stress response, whereas decreasing them enhances apoptosis. These results reveal that the orchestrated ER chaperone machinery at MAM, by sensing ER Ca2+ concentrations, regulates ER-mitochondrial interorganellar Ca2+ signaling and cell survival.	NIDA, Cellular Pathobiol Unit, Plast & Dev Sect, Cellular Neurobiol Res Branch,Intramural Res Prog, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Hayashi, T (corresponding author), NIDA, Cellular Pathobiol Unit, Plast & Dev Sect, Cellular Neurobiol Res Branch,Intramural Res Prog, Room 3418,Room 3304,Triad Bldg,333 Cassell Dr, Baltimore, MD 21224 USA.	thayashi@intra.nida.nih.gov; tsu@intra.nida.nih.gov	Hayashi, Teruo/A-9690-2008		Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000206, ZIADA000206] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alzayady KJ, 2005, BIOCHEM J, V392, P601, DOI 10.1042/BJ20050949; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Bhanumathy CD, 2006, J BIOL CHEM, V281, P3722, DOI 10.1074/jbc.M509966200; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Hagar RE, 1998, NATURE, V396, P81, DOI 10.1038/23954; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Hayashi T, 2004, CNS DRUGS, V18, P269, DOI 10.2165/00023210-200418050-00001; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Joseph SK, 1999, BIOCHEM J, V342, P153, DOI 10.1042/0264-6021:3420153; Kauffman FC, 1998, CHEM-BIOL INTERACT, V109, P169, DOI 10.1016/S0009-2797(97)00131-2; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Marrazzo A, 2005, NEUROREPORT, V16, P1223, DOI 10.1097/00001756-200508010-00018; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; Matsumoto RR, 2003, EUR J PHARMACOL, V469, P1, DOI 10.1016/S0014-2999(03)01723-0; MATTSON MP, 1999, NEUROCHEM RES, V57, P557; Maurice T, 1997, PROG NEURO-PSYCHOPH, V21, P69, DOI 10.1016/S0278-5846(96)00160-1; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; RIZZUTO R, 2004, FLIRTING LITTLE SPAC; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Snyder S H, 1989, J Neuropsychiatry Clin Neurosci, V1, P7; Spruce BA, 2004, CANCER RES, V64, P4875, DOI 10.1158/0008-5472.CAN-03-3180; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; SU TP, 1982, J PHARMACOL EXP THER, V223, P284; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Vagnerova K, 2006, ANESTH ANALG, V103, P430, DOI 10.1213/01.ane.0000226133.85114.91; VANCE JE, 1990, J BIOL CHEM, V265, P7248; VILNER BJ, 1995, CANCER RES, V55, P408; Walter L, 2005, J BIOENERG BIOMEMBR, V37, P191, DOI 10.1007/s10863-005-6600-x	38	1240	1285	9	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					596	610		10.1016/j.cell.2007.08.036	http://dx.doi.org/10.1016/j.cell.2007.08.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981125	Bronze			2022-12-28	WOS:000250618500025
J	Nachman, I; Regev, A; Ramanathan, S				Nachman, Iftach; Regev, Aviv; Ramanathan, Sharad			Dissecting timing variability in yeast meiosis	CELL			English	Article							MEIOTIC GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATOR; POSITIVE REGULATOR; PROTEIN-KINASE; BUDDING YEAST; FLUCTUATING ENVIRONMENTS; FILAMENTOUS GROWTH; SIGNAL PATHWAY; MESSENGER-RNA	Cell-to-cell variability in the timing of cell-fate changes can be advantageous for a population of single-celled organisms growing in a fluctuating environment. We study timing variability during meiosis in Saccharomyces cerevisiae, initiated upon nutritional starvation. We use time-lapse fluorescence microscopy to measure the timing of meiotic events in single cells and find that the duration of meiosis is highly variable between cells. This variability is concentrated between the beginning of starvation and the onset of early meiosis genes. Cell-cycle variability and nutritional history have little effect on this timing variability. Rather, variation in the production rate of the meiotic master regulator Ime1 and its gradual increase over time govern this variability, and cell size effects are channeled through Ime1. These results tie phenotypic variability with expression dynamics of a transcriptional regulator and provide a general framework for the study of temporal developmental processes.	Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Bell Labs, Murray Hill, NJ 07974 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); AT&T	Ramanathan, S (corresponding author), Harvard Univ, FAS Ctr Syst Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	sharad@cmt.harvard.edu	Nachman, Iftach/E-6750-2010; Nachman, Iftach/AAK-2051-2020	Nachman, Iftach/0000-0002-4667-0398; 	NIGMS NIH HHS [P50 GM068763] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amir A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100113; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; BOWDISH KS, 1994, MOL CELL BIOL, V14, P7909, DOI 10.1128/MCB.14.12.7909; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Colomina N, 2003, MOL CELL BIOL, V23, P7415, DOI 10.1128/MCB.23.20.7415-7424.2003; Colomina N, 1999, EMBO J, V18, P320, DOI 10.1093/emboj/18.2.320; Day A, 2004, CELL CYCLE, V3, P1433, DOI 10.4161/cc.3.11.1205; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Gerke JP, 2006, GENETICS, V174, P985, DOI 10.1534/genetics.106.058453; Gilbert SF, 2006, DEV BIOL; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; GRANOT D, 1989, MOL GEN GENET, V218, P308, DOI 10.1007/BF00331283; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Griffioen G, 2000, J BIOL CHEM, V275, P1449, DOI 10.1074/jbc.275.2.1449; Guttmann-Raviv N, 2002, MOL CELL BIOL, V22, P2047, DOI 10.1128/MCB.22.7.2047-2056.2002; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; HORESH O, 1979, CHROMOSOMA, V75, P101, DOI 10.1007/BF00330628; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; MANDEL S, 1994, DEV GENET, V15, P139, DOI 10.1002/dvg.1020150204; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pedraza JM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100121; Pnueli L, 2004, MOL CELL BIOL, V24, P5197, DOI 10.1128/MCB.24.12.5197-5208.2004; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Rubin-Bejerano I, 2004, MOL CELL BIOL, V24, P6967, DOI 10.1128/MCB.24.16.6967-6979.2004; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Sagee S, 1998, MOL CELL BIOL, V18, P1985, DOI 10.1128/MCB.18.4.1985; SHEFERVAIDA M, 1995, DEV GENET, V16, P219, DOI 10.1002/dvg.1020160302; Shenhar G, 2001, MOL CELL BIOL, V21, P1603, DOI 10.1128/MCB.21.5.1603-1612.2001; SHERMAN A, 1993, MOL GEN GENET, V237, P375, DOI 10.1007/BF00279441; SIMCHEN G, 1972, EXP CELL RES, V75, P207, DOI 10.1016/0014-4827(72)90538-1; SIMCHEN G, 1989, GENOME, V31, P95, DOI 10.1139/g89-018; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Vidan S, 1997, MOL CELL BIOL, V17, P2688, DOI 10.1128/MCB.17.5.2688; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Williams RM, 2002, P NATL ACAD SCI USA, V99, P13431, DOI 10.1073/pnas.202495299; WILLIAMSON DH, 1983, EXP CELL RES, V145, P209, DOI 10.1016/S0014-4827(83)80022-6; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Xiao Y, 2000, MOL CELL BIOL, V20, P5447, DOI 10.1128/MCB.20.15.5447-5453.2000	46	101	101	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					544	556		10.1016/j.cell.2007.09.044	http://dx.doi.org/10.1016/j.cell.2007.09.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981121	Bronze			2022-12-28	WOS:000250618500021
J	Yan, N; Shi, YG				Yan, Nieng; Shi, Yigong			Allosteric activation of a bacterial stress sensor	CELL			English	Editorial Material							ESCHERICHIA-COLI; PDZ DOMAIN; ENVELOPE; PROTEASE; INHIBITION	In Gram-negative bacteria, envelope stress signals such as unfolded outer membrane proteins (OMP) activate the periplasmic protease DegS. This protease then triggers a cellular pathway to alleviate the stress. Now Sohn et al. (2007) show conclusively that inhibition of DegS is relieved allosterically by binding of the C-terminal sequences in unfolded OMPs to the PDZ domain of DegS.	Tsing Hua Univ, Inst Biomed, Ctr Struct Biol, Beijing 100084, Peoples R China; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Tsinghua University; Princeton University	Yan, N (corresponding author), Tsing Hua Univ, Inst Biomed, Ctr Struct Biol, Beijing 100084, Peoples R China.	structure@tsinghua.edu.cn; ygshi@princeton.edu		Shi, Yigong/0000-0003-2030-168X				Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Cezairliyan BO, 2007, P NATL ACAD SCI USA, V104, P3771, DOI 10.1073/pnas.0611567104; Chaba R, 2007, GENE DEV, V21, P124, DOI 10.1101/gad.1496707; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4	8	3	3	3	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					441	443		10.1016/j.cell.2007.10.021	http://dx.doi.org/10.1016/j.cell.2007.10.021			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981109	Bronze			2022-12-28	WOS:000250618500009
J	Matthews, AGW; Kuo, AJ; Ramon-Maiques, S; Han, SM; Champagne, KS; Ivanov, D; Gallardo, M; Carney, D; Cheung, P; Ciccone, DN; Walter, KL; Utz, PJ; Shi, Y; Kutateladze, TG; Yang, W; Gozani, O; Oettinger, MA				Matthews, Adam G. W.; Kuo, Alex J.; Ramon-Maiques, Santiago; Han, Sunmi; Champagne, Karen S.; Ivanov, Dmitri; Gallardo, Mercedes; Carney, Dylan; Cheung, Peggie; Ciccone, David N.; Walter, Kay L.; Utz, Paul J.; Shi, Yang; Kutateladze, Tatiana G.; Yang, Wei; Gozani, Or; Oettinger, Marjorie A.			RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination	NATURE			English	Article							C-TERMINUS; B-CELL; GENE REARRANGEMENT; PLANT HOMEODOMAIN; PRE-B; METHYLATION; BINDING; TRANSPOSITION; TRANSCRIPTION; ACTIVATION	Nuclear processes such as transcription, DNA replication and recombination are dynamically regulated by chromatin structure. Eukaryotic transcription is known to be regulated by chromatin-associated proteins containing conserved protein domains that specifically recognize distinct covalent post- translational modifications on histones. However, it has been unclear whether similar mechanisms are involved in mammalian DNA recombination. Here we show that RAG2 - an essential component of the RAG1/2 V(D)J recombinase, which mediates antigen- receptor gene assembly(1) - contains a plant homeodomain ( PHD) finger that specifically recognizes histone H3 trimethylated at lysine 4 ( H3K4me3). The high- resolution crystal structure of the mouse RAG2 PHD finger bound to H3K4me3 reveals the molecular basis of H3K4me3- recognition by RAG2. Mutations that abrogate RAG2's recognition of H3K4me3 severely impair V( D) J recombination in vivo. Reducing the level of H3K4me3 similarly leads to a decrease in V(D)J recombination in vivo. Notably, a conserved tryptophan residue ( W453) that constitutes a key structural component of the K4me3- binding surface and is essential for RAG2's recognition of H3K4me3 is mutated in patients with immunodeficiency syndromes. Together, our results identify a new function for histone methylation in mammalian DNA recombination. Furthermore, our results provide the first evidence indicating that disrupting the read- out of histone modifications can cause an inherited human disease.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Colorado, Hlth Sci Ctr, Aurora, CO 80045 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard Medical School; Stanford University; Harvard University; Harvard Medical School	Oettinger, MA (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ogozani@stanford.edu; oettinger@frodo.mgh.harvard.edu	Kuo, Alex/AAL-2845-2020; Yang, Wei/ABB-4785-2020; Glass, Karen C./AAV-1076-2021	Yang, Wei/0000-0002-3591-2195; Glass, Karen C./0000-0002-2761-733X; Gozani, Or/0000-0002-1365-4463; Ramon-Maiques, Santiago/0000-0001-9674-8088; Kutateladze, Tatiana/0000-0001-7375-6990	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048026] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI060354] Funding Source: Medline; NIGMS NIH HHS [R01 GM048026-12, R01 GM048026] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P1209, DOI 10.1073/pnas.0237043100; Baumann M, 2003, EMBO J, V22, P5197, DOI 10.1093/emboj/cdg487; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Callebaut I, 1998, CELL MOL LIFE SCI, V54, P880, DOI 10.1007/s000180050216; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; Elkin SK, 2005, J BIOL CHEM, V280, P28701, DOI 10.1074/jbc.M504731200; Elkin SK, 2003, EMBO J, V22, P1931, DOI 10.1093/emboj/cdg184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GAUSS GH, 1993, MOL CELL BIOL, V13, P3900, DOI 10.1128/MCB.13.7.3900; Gomez CA, 2000, MOL CELL BIOL, V20, P5653, DOI 10.1128/MCB.20.15.5653-5664.2000; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Kirch SA, 1998, EMBO J, V17, P4881, DOI 10.1093/emboj/17.16.4881; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Matthews AGW, 2004, EMBO J, V23, P1198, DOI 10.1038/sj.emboj.7600131; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Oettinger MA, 2004, IMMUNOL REV, V200, P165, DOI 10.1111/j.0105-2896.2004.00172.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perkins EJ, 2004, NUCLEIC ACIDS RES, V32, P1942, DOI 10.1093/nar/gkh523; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; West KL, 2005, IMMUNITY, V23, P203, DOI 10.1016/j.immuni.2005.07.004; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	40	361	369	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1106	U18		10.1038/nature06431	http://dx.doi.org/10.1038/nature06431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18033247	Green Accepted			2022-12-28	WOS:000251579900092
J	Mitchell, SL; Burns, RB				Mitchell, Susan L.; Burns, Risa B.			A 93-year-old man with advanced dementia and eating problems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NURSING-HOME RESIDENTS; OF-LIFE CARE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; SEVERE COGNITIVE IMPAIRMENT; END-STAGE DEMENTIA; ADVANCED ALZHEIMERS-DISEASE; ARTIFICIAL NUTRITION; FEEDING TUBES; HOSPICE CARE; OLDER-ADULTS	More than 5 million Americans have dementia, a leading cause of death among persons older than 65 years in the United States. Eating problems typically develop during the advanced stage of dementia, which requires decision making to direct care toward either palliation or more aggressive measures, such as tube feeding. The case of Mr P, a 93-year-old man with end-stage dementia and recent hip fracture, illustrates the issues involved in this challenging crossroads when his daughter is confronted with his failure to orally maintain adequate hydration and nutrition. The discussion reviews the epidemiology and natural history of advanced dementia, the barriers to providing palliative care to patients with this condition, the role of pharmacotherapy, and the treatment options for feeding problems and the advantages and disadvantages of each option, and suggests an approach to help clinicians provide effective and compassionate decision support to patients with advanced dementia and their family members.	Harvard Univ, Sch Med, Boston, MA USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Hebrew Sr Life Inst Aging Res, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Mitchell, SL (corresponding author), Hebrew Rehabil Ctr Aged, 1200 Ctr St, Boston, MA 02131 USA.	smitchell@hrca.harvard.edu						Ahronheim JC, 1996, ARCH INTERN MED, V156, P2094, DOI 10.1001/archinte.156.18.2094; Ahronheim JC, 2001, J AM GERIATR SOC, V49, P148, DOI 10.1046/j.1532-5415.2001.49035.x; *AM AC HOSP PALL M, POS STAT STAT ART NU; [Anonymous], ALZH DIS FACTS FIG 2; Beard CM, 1996, ANN EPIDEMIOL, V6, P195, DOI 10.1016/1047-2797(95)00068-2; Berger A, 2001, J AM GERIATR SOC, V49, P1570, DOI 10.1046/j.1532-5415.2001.4911257.x; BourdelMarchasson I, 1997, INT J QUAL HEALTH C, V9, P297, DOI 10.1093/intqhc/9.4.297; Brickner Leslea, 2004, J Palliat Med, V7, P411, DOI 10.1089/1096621041349518; BUCHANAN A, 1986, MILBANK Q, V64, P17, DOI 10.2307/3349960; Callahan CM, 2000, J AM GERIATR SOC, V48, P1048, DOI 10.1111/j.1532-5415.2000.tb04779.x; Callahan CM, 1999, J AM GERIATR SOC, V47, P1105, DOI 10.1111/j.1532-5415.1999.tb05235.x; Carey TS, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.11.021; Casarett D, 2005, NEW ENGL J MED, V353, P2607, DOI 10.1056/NEJMsb052907; Casarett DJ, 2001, J AM GERIATR SOC, V49, P1493, DOI 10.1046/j.1532-5415.2001.4911242.x; Chen JH, 2007, J GERONTOL A-BIOL, V62, P531, DOI 10.1093/gerona/62.5.531; Chen JH, 2006, J AM GERIATR SOC, V54, P290, DOI 10.1111/j.1532-5415.2005.00524.x; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Christakis NA, 1996, J GEN INTERN MED, V11, P422, DOI 10.1007/BF02600190; Clarfield AM, 2006, J GERONTOL A-BIOL, V61, P621, DOI 10.1093/gerona/61.6.621; *DHHS CTR MED MED, NURS HOM COMP; Engel SE, 2006, J AM GERIATR SOC, V54, P1567, DOI 10.1111/j.1532-5415.2006.00900.x; Farlow MR, 2007, AM J MED, V120, P388, DOI 10.1016/j.amjmed.2006.08.036; FINUCANE TE, 1995, J AM GERIATR SOC, V43, P447, DOI 10.1111/j.1532-5415.1995.tb05822.x; Finucane TE, 1996, LANCET, V348, P1421, DOI 10.1016/S0140-6736(96)03369-7; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; FRIED TR, 1995, J GEN INTERN MED, V10, P246, DOI 10.1007/BF02599879; Ganguli M, 1999, J AM GERIATR SOC, V47, P842, DOI 10.1111/j.1532-5415.1999.tb03842.x; Gessert CE, 2000, J AM GERIATR SOC, V48, P1593, DOI 10.1111/j.1532-5415.2000.tb03869.x; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; Gillick M R, 2001, J Am Med Dir Assoc, V2, P305, DOI 10.1016/S1525-8610(04)70227-3; Gillick M. R., 2002, ALZHEIMERS CARE QUAR, V3, P227; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; Gillick Muriel R, 2004, J Aging Soc Policy, V16, P1, DOI 10.1300/J031v16n03_01; GROBER ME, 1995, J AM GERIATR SOC, V43, P528, DOI 10.1111/j.1532-5415.1995.tb06100.x; HANRAHAN P, 1995, J AM GERIATR SOC, V43, P56, DOI 10.1111/j.1532-5415.1995.tb06243.x; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hoffer LJ, 2006, BRIT MED J, V333, P1214, DOI 10.1136/bmj.39021.785197.47; Kayser-Jones J, 1999, J AM GERIATR SOC, V47, P1187, DOI 10.1111/j.1532-5415.1999.tb05198.x; Kiely DK, 2006, ALZ DIS ASSOC DIS, V20, P176, DOI 10.1097/00002093-200607000-00009; Kovach CR, 1996, AM J ALZHEIMERS DIS, V11, P7, DOI DOI 10.1177/153331759601100402; Langmore SE, 2007, ARCH NEUROL-CHICAGO, V64, P58, DOI 10.1001/archneur.64.1.58; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; LONGMAN AJ, 1994, OMEGA, V27, P163; LUCHINS DJ, 1993, J AM GERIATR SOC, V41, P25; Luchins DJ, 1997, J AM GERIATR SOC, V45, P1054, DOI 10.1111/j.1532-5415.1997.tb05966.x; Marsh GW, 2000, APPL NURS RES, V13, P187, DOI 10.1053/apnr.2000.7654; MCCANN RM, 1994, JAMA-J AM MED ASSOC, V272, P1263, DOI 10.1001/jama.272.16.1263; MCCANN RM, FEEDING TUBE PLACEME; Meier DE, 2001, ARCH INTERN MED, V161, P594, DOI 10.1001/archinte.161.4.594; Miller SC, 2001, AM J MED, V111, P38, DOI 10.1016/S0002-9343(01)00747-1; Miller SC, 2002, J AM GERIATR SOC, V50, P507, DOI 10.1046/j.1532-5415.2002.50118.x; Mitchell S L, 2001, J Am Med Dir Assoc, V2, P10, DOI 10.1097/00130535-200101000-00003; Mitchell SL, 1997, ARCH INTERN MED, V157, P327, DOI 10.1001/archinte.157.3.327; Mitchell SL, 2004, ARCH INTERN MED, V164, P321, DOI 10.1001/archinte.164.3.321; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Mitchell SL, 2003, JAMA-J AM MED ASSOC, V290, P73, DOI 10.1001/jama.290.1.73; Mitchell SL, 2003, J AM GERIATR SOC, V51, P129, DOI 10.1034/j.1601-5215.2002.51021.x; Mitchell SL, 2001, J AM GERIATR SOC, V49, P313, DOI 10.1046/j.1532-5415.2001.4930313.x; Mitchell SL, 2000, J AM GERIATR SOC, V48, P391, DOI 10.1111/j.1532-5415.2000.tb04696.x; Mitchell SL, 2004, JAMA-J AM MED ASSOC, V291, P2734, DOI 10.1001/jama.291.22.2734; MITCHELL SL, 2000, MAKING CHOICES LONG; Mitchell SL, 2007, J PAIN SYMPTOM MANAG, V34, P7, DOI 10.1016/j.jpainsymman.2007.01.003; Mitchell SL, 2006, ALZ DIS ASSOC DIS, V20, P166, DOI 10.1097/00002093-200607000-00008; Mitchell Susan L, 2003, J Am Med Dir Assoc, V4, P27, DOI 10.1097/00130535-200301000-00005; Mitchell Susan L, 2004, J Palliat Med, V7, P808, DOI 10.1089/jpm.2004.7.808; Monteleoni C, 2004, BMJ-BRIT MED J, V329, P491, DOI 10.1136/bmj.329.7464.491; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murphy K, 1997, J AM GERIATR SOC, V45, P1104, DOI 10.1111/j.1532-5415.1997.tb05974.x; *NAT CTR HLTH STAT, TABL 2 PERC TOT DEAT; *NAT CTR HLTH STAT, 2000, DEATHS PERC TOT DEAT; *NAT CTR HLTH STAT, 2005, NAT VIT STAT REP, V53, P29; *NAT HOSP PALL CAR, NHPCOS FACT FIG 2005; National Hospice Organization, 1996, MED GUID DET PROGN S; National Institutes of Health, 2005, STAT OF THE SCI C ST; Pasman HRW, 2005, ARCH INTERN MED, V165, P1729, DOI 10.1001/archinte.165.15.1729; PECK A, 1990, J AM GERIATR SOC, V38, P1195, DOI 10.1111/j.1532-5415.1990.tb01498.x; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P653; Sachs GA, 2004, J GEN INTERN MED, V19, P1057, DOI 10.1111/j.1525-1497.2004.30329.x; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; Schonwetter Ronald S, 2003, Am J Hosp Palliat Care, V20, P105, DOI 10.1177/104990910302000208; Shega Joseph W, 2003, J Palliat Med, V6, P885, DOI 10.1089/109662103322654767; Sieger CE, 2002, J AM GERIATR SOC, V50, P544, DOI 10.1046/j.1532-5415.2002.50124.x; Teno JM, 2002, JAMA-J AM MED ASSOC, V287, P3211, DOI 10.1001/jama.287.24.3211; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; The AM, 2002, BRIT MED J, V325, P1326, DOI 10.1136/bmj.325.7376.1326; van der Steen JT, 2005, MED DECIS MAKING, V25, P210, DOI 10.1177/0272989X05275400; Volandes AE, 2007, ARCH INTERN MED, V167, P828, DOI 10.1001/archinte.167.8.828; VOLICER BJ, 1993, J AM GERIATR SOC, V41, P535, DOI 10.1111/j.1532-5415.1993.tb01891.x; Volicer L, 1997, J AM GERIATR SOC, V45, P1147, DOI 10.1111/j.1532-5415.1997.tb05982.x; VOLICER L, 1994, J GERIATR PSYCH NEUR, V7, P227, DOI 10.1177/089198879400700406; Volicer L, 2001, ALZ DIS ASSOC DIS, V15, P194, DOI 10.1097/00002093-200110000-00005; Volicer L, 2001, CLIN GERIATR MED, V17, P377, DOI 10.1016/S0749-0690(05)70074-4; Wang SY, 1997, J AM GERIATR SOC, V45, P1189, DOI 10.1111/j.1532-5415.1997.tb03768.x; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1097/00130535-200301000-00002; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501; Won A, 1999, J AM GERIATR SOC, V47, P936, DOI 10.1111/j.1532-5415.1999.tb01287.x	101	28	28	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2007	298	21					2527	2536		10.1001/jama.298.17.jrr70001	http://dx.doi.org/10.1001/jama.298.17.jrr70001			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	237GJ	17986683				2022-12-28	WOS:000251361900018
J	Cram, DS; Song, B; Trounson, AO				Cram, David S.; Song, Bi; Trounson, Alan O.			Genotyping of Rhesus SCNT pluripotent stem cell lines	NATURE			English	Letter							LINKAGE; LOCI		Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia	Monash University	Cram, DS (corresponding author), Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia.	david.cram@med.monash.edu.au		Trounson, Alan/0000-0001-5469-0500				Budowle B, 2005, FORENSIC SCI INT, V150, P1, DOI 10.1016/j.forsciint.2005.01.010; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Raveendran M, 2006, GENOMICS, V88, P706, DOI 10.1016/j.ygeno.2006.08.009; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004	4	9	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					E12	E14		10.1038/nature06456	http://dx.doi.org/10.1038/nature06456			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004280				2022-12-28	WOS:000250918600042
J	Galy, V; France-Lanord, C; Beyssac, O; Faure, P; Kudrass, H; Palhol, F				Galy, Valier; France-Lanord, Christian; Beyssac, Olivier; Faure, Pierre; Kudrass, Hermann; Palhol, Fabien			Efficient organic carbon burial in the Bengal fan sustained by the Himalayan erosional system	NATURE			English	Article							MATTER; BAY; TRANSPORT; SEDIMENTS; CONSTRAINTS; EVOLUTION; RIVERS; OCEAN; CYCLE; C-13	Continental erosion controls atmospheric carbon dioxide levels on geological timescales through silicate weathering, riverine transport and subsequent burial of organic carbon in oceanic sediments(1). The efficiency of organic carbon deposition in sedimentary basins is however limited by the organic carbon load capacity of the sediments and organic carbon oxidation in continental margins. At the global scale, previous studies have suggested that about 70 per cent of riverine organic carbon is returned to the atmosphere, such as in the Amazon basin(2-4). Here we present a comprehensive organic carbon budget for the Himalayan erosional system, including source rocks, river sediments and marine sediments buried in the Bengal fan. We show that organic carbon export is controlled by sediment properties, and that oxidative loss is negligible during transport and deposition to the ocean. Our results indicate that 70 to 85 per cent of the organic carbon is recent organic matter captured during transport, which serves as a net sink for atmospheric carbon dioxide. The amount of organic carbon deposited in the Bengal basin represents about 10 to 20 per cent of the total terrestrial organic carbon buried in oceanic sediments. High erosion rates in the Himalayas generate high sedimentation rates and low oxygen availability in the Bay of Bengal that sustain the observed extreme organic carbon burial efficiency. Active orogenic systems generate enhanced physical erosion and the resulting organic carbon burial buffers atmospheric carbon dioxide levels, thereby exerting a negative feedback on climate over geological timescales.	CNRS, ENS Paris, Geol Lab, INSU, F-75005 Paris 5, France; Nancy Univ, CNRS, G2R INSU, F-54506 Vandoeuvre Les Nancy, France; Fed Inst Geosci & Nat Resources, D-30655 Hannover, Germany; Nancy Univ, CRPG, CNRS, INSU, F-54501 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine	Galy, V (corresponding author), Woods Hole Oceanog Inst, 360 Woods Hole Rd, Woods Hole, MA 02543 USA.	vgaly@whoi.edu	galy, valier/I-6185-2012; France-Lanord, Christian/F-8848-2010; IMPMC, ROCKS @/U-8478-2017; Galy, valier/AAD-2248-2021; Beyssac, Olivier/A-8647-2008; Beyssac, Olivier/F-6811-2012	galy, valier/0000-0003-0385-8443; France-Lanord, Christian/0000-0002-4873-5546; Galy, valier/0000-0003-0385-8443; 				Aucour AM, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002324; BECK RA, 1995, GEOLOGY, V23, P387, DOI 10.1130/0091-7613(1995)023<0387:OCEAGW>2.3.CO;2; BERNER RA, 1990, SCIENCE, V249, P1382, DOI 10.1126/science.249.4975.1382; Berner U, 2003, DEEP-SEA RES PT II, V50, P925, DOI 10.1016/S0967-0645(02)00613-6; Beyssac O, 2003, SPECTROCHIM ACTA A, V59, P2267, DOI 10.1016/S1386-1425(03)00070-2; Beyssac O, 2002, CONTRIB MINERAL PETR, V143, P19, DOI 10.1007/s00410-001-0324-7; BROECKER WS, 1980, EARTH PLANET SC LETT, V49, P506, DOI 10.1016/0012-821X(80)90091-6; Burdige DJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002368; Cai WJ, 1996, MAR CHEM, V52, P123, DOI 10.1016/0304-4203(95)00081-X; COCHRAN JR, 1989, P OCEAN DRILLING PRO, V116, P388; Curray JR, 2002, MAR PETROL GEOL, V19, P1191, DOI 10.1016/S0264-8172(03)00035-7; Drenzek NJ, 2007, MAR CHEM, V103, P146, DOI 10.1016/j.marchem.2006.06.017; FRANCELANORD C, 1994, GEOCHIM COSMOCHIM AC, V58, P4809, DOI 10.1016/0016-7037(94)90210-0; FranceLanord C, 1997, NATURE, V390, P65, DOI 10.1038/36324; Freeman KH, 2001, GEOCHIM COSMOCHIM AC, V65, P1439, DOI 10.1016/S0016-7037(00)00573-1; Galy A, 1999, GEOCHIM COSMOCHIM AC, V63, P1905, DOI 10.1016/S0016-7037(99)00081-2; Galy A, 2001, GEOLOGY, V29, P23, DOI 10.1130/0091-7613(2001)029<0023:HERITH>2.0.CO;2; Goni MA, 2006, ESTUAR COAST SHELF S, V69, P225, DOI 10.1016/j.ecss.2006.04.012; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Ittekkot V, 2003, DEEP-SEA RES PT II, V50, P853, DOI 10.1016/S0967-0645(02)00608-2; KUDRASS H, 1996, BENGAL FAN, P45; Mackenzie F.T., 1981, FLUX ORGANIC CARBON, P360; MEYERS PA, 1992, GEOPHYS MONOGR SER, V70, P295; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Pierson-Wickmann AC, 2001, PALEOCEANOGRAPHY, V16, P435, DOI 10.1029/2000PA000532; RSP, 1996, 24 RSP FAP WARPO; Schlunz B, 2000, INT J EARTH SCI, V88, P599, DOI 10.1007/s005310050290; Schwenk T, 2005, MAR PETROL GEOL, V22, P637, DOI 10.1016/j.marpetgeo.2005.01.007; SUBRAMANIAN V, 1991, BIOGEOCHEMISTRY MAJO, P157; Suckow A, 2001, RADIOCARBON, V43, P917; VONDERBORCH CC, 1974, INITIAL REPORT DEEP, V22; Wagai R, 2007, GEOCHIM COSMOCHIM AC, V71, P25, DOI 10.1016/j.gca.2006.08.047; Weber ME, 1997, GEOLOGY, V25, P315, DOI 10.1130/0091-7613(1997)025<0315:AGOTBF>2.3.CO;2	35	427	447	12	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					407	U6		10.1038/nature06273	http://dx.doi.org/10.1038/nature06273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004382	Green Submitted			2022-12-28	WOS:000250918600052
J	Bern, C; Montgomery, SP; Herwaldt, BL; Rassi, A; Marin, JA; Dantas, RO; Maguire, JH; Acquatella, H; Morillo, C; Kirchhoff, LV; Gilman, RH; Reyes, PA; Salvatella, R; Moore, AC				Bern, Caryn; Montgomery, Susan P.; Herwaldt, Barbara L.; Rassi, Anis, Jr.; Marin-Neto, Jose Antonio; Dantas, Roberto O.; Maguire, James H.; Acquatella, Harry; Morillo, Carlos; Kirchhoff, Louis V.; Gilman, Robert H.; Reyes, Pedro A.; Salvatella, Roberto; Moore, Anne C.			Evaluation and treatment of Chagas disease in the United States - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TRYPANOSOMA-CRUZI INFECTION; POLYMERASE-CHAIN-REACTION; EARLY MYOCARDIAL DAMAGE; HEART-DISEASE; AMERICAN TRYPANOSOMIASIS; ELECTROCARDIOGRAPHIC ABNORMALITIES; AUTOCHTHONOUS TRANSMISSION; PROGNOSTIC IMPLICATIONS; ESOPHAGEAL CANCER; NORTHEAST BRAZIL	Context Because of population migration from endemic areas and newly instituted blood bank screening, US clinicians are likely to see an increasing number of patients with suspected or confirmed chronic Trypanosoma cruzi infection (Chagas disease). Objective To examine the evidence base and provide practical recommendations for evaluation, counseling, and etiologic treatment of patients with chronic T cruzi infection. Evidence Acquisition Literature review conducted based on a systematic MEDLINE search for all available years through 2007; review of additional articles, reports, and book chapters; and input from experts in the field. Evidence Synthesis The patient newly diagnosed with Chagas disease should undergo a medical history, physical examination, and resting 12-lead electrocardiogram ( ECG) with a 30-second lead II rhythm strip. If this evaluation is normal, no further testing is indicated; history, physical examination, and ECG should be repeated annually. If findings suggest Chagas heart disease, a comprehensive cardiac evaluation, including 24-hour ambulatory ECG monitoring, echocardiography, and exercise testing, is recommended. If gastrointestinal tract symptoms are present, barium contrast studies should be performed. Antitrypanosomal treatment is recommended for all cases of acute and congenital Chagas disease, reactivated infection, and chronic T cruzi infection in individuals 18 years or younger. In adults aged 19 to 50 years without advanced heart disease, etiologic treatment may slow development and progression of cardiomyopathy and should generally be offered; treatment is considered optional for those older than 50 years. Individualized treatment decisions for adults should balance the potential benefit, prolonged course, and frequent adverse effects of the drugs. Strong consideration should be given to treatment of previously untreated patients with human immunodeficiency virus infection or those expecting to undergo organ transplantation. Conclusions Chagas disease presents an increasing challenge for clinicians in the United States. Despite gaps in the evidence base, current knowledge is sufficient to make practical recommendations to guide appropriate evaluation, management, and etiologic treatment of Chagas disease.	Ctr Dis Control & Prevent, Parasit Dis Branch, Div Parasit Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Atlanta, GA 30341 USA; Anis Rassi Hosp, Goiania, Go, Brazil; Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil; Univ Maryland, Baltimore, MD 21201 USA; Cent Univ Venezuela, Caracas, Venezuela; McMaster Univ, Hamilton, ON, Canada; Univ Iowa, Iowa City, IA USA; Johns Hopkins Univ, Baltimore, MD USA; L Chavez Natl Inst Cardiol, Mexico City, DF, Mexico; Pan Amer Hlth Org, Montevideo, Uruguay	Centers for Disease Control & Prevention - USA; Universidade de Sao Paulo; University System of Maryland; University of Maryland Baltimore; University of Central Venezuela; McMaster University; University of Iowa; Johns Hopkins University; National Institute of Cardiology - Mexico; Pan American Health Organization	Bern, C (corresponding author), Ctr Dis Control & Prevent, Parasit Dis Branch, Div Parasit Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, 4770 Buford Hwy NE,MS F-22, Atlanta, GA 30341 USA.	cbern@cdc.gov	Oliveira, Claudia DL/G-8618-2011; Marin-Neto, Jose Antonio/F-6099-2012; Rassi, Anis/AAJ-3368-2020	Bern, Caryn/0000-0001-8195-7303; Moore, Anne/0000-0003-3656-4230; Marin-Neto, Jose Antonio/0000-0002-8651-8833; Acquatella, Harry/0000-0002-5115-8495				ACQUATELLA H, 1987, CIRCULATION, V76, P556, DOI 10.1161/01.CIR.76.3.556; ACQUATELLA H, 1980, CIRCULATION, V62, P787, DOI 10.1161/01.CIR.62.4.787; Acquatella H, 2007, CIRCULATION, V115, P1124, DOI 10.1161/CIRCULATIONAHA.106.627323; Altcheh J, 2005, REV SOC BRAS MED TRO, V38, P41; Altclas J, 2005, BONE MARROW TRANSPL, V36, P123, DOI 10.1038/sj.bmt.1705006; Andersson J, 2003, IMMUNOL LETT, V86, P207, DOI 10.1016/S0165-2478(03)00019-1; Carlier Yves, 2003, Rev. Soc. Bras. Med. Trop., V36, P767, DOI 10.1590/S0037-86822003000600024; [Anonymous], [No title captured]; ATIAS A, 1994, REV MED CHILE, V122, P319; Barbosa PRB, 2006, INT J CARDIOL, V112, P132, DOI 10.1016/j.ijcard.2005.11.087; *BENEFIT TRIAL, EV US ANT DRUG BENZ; BITTENCOURT AL, 1976, AM J DIS CHILD, V130, P97, DOI 10.1001/archpedi.1976.02120020099020; Boainain E., 1979, Revista Goiana de Medicina, V25, P1; Bocchi EA, 1996, ANN THORAC SURG, V61, P1727, DOI 10.1016/0003-4975(96)00141-5; Bocchi EA, 2001, ANN THORAC SURG, V71, P1833, DOI 10.1016/S0003-4975(01)02587-5; Bocchi EA, 1998, J HEART LUNG TRANSPL, V17, P399; Bradley KK, 2000, J AM VET MED ASSOC, V217, P1853, DOI 10.2460/javma.2000.217.1853; Brucher BLDM, 2001, WORLD J SURG, V25, P745; Bustamante JM, 2003, CLIN SCI, V104, P415, DOI 10.1042/CS20020245; Camandaroba Edson L.P., 2003, Rev. Soc. Bras. Med. Trop., V36, P201, DOI 10.1590/S0037-86822003000200002; Campbell DA, 2004, CURR MOL MED, V4, P549, DOI 10.2174/1566524043360249; Carod-Artal Francisco Javier, 2006, Expert Rev Cardiovasc Ther, V4, P119, DOI 10.1586/14779072.4.1.119; CARRASCO HA, 1994, INT J CARDIOL, V43, P27, DOI 10.1016/0167-5273(94)90087-6; CARRASCO HA, 1982, AM HEART J, V104, P595, DOI 10.1016/0002-8703(82)90232-0; Castro AM, 2002, PARASITOL RES, V88, P894, DOI 10.1007/s00436-002-0679-3; Castro C, 1999, MEM I OSWALDO CRUZ, V94, P329, DOI 10.1590/S0074-02761999000700063; Castro C, 1994, Rev Soc Bras Med Trop, V27, P227, DOI 10.1590/S0037-86821994000400005; Coura J R, 1997, Rev Soc Bras Med Trop, V30, P139, DOI 10.1590/S0037-86821997000200009; Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001; Dantas RO, 1998, DYSPHAGIA, V13, P53, DOI 10.1007/PL00009549; Dantas RO, 1999, J CLIN GASTROENTEROL, V28, P245, DOI 10.1097/00004836-199904000-00012; de Oliveira RB, 1998, AM J GASTROENTEROL, V93, P884, DOI 10.1111/j.1572-0241.1998.270_r.x; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; DEOLIVEIRA RB, 1995, AM J GASTROENTEROL, V90, P1119; Dorn PL, 2007, EMERG INFECT DIS, V13, P605, DOI 10.3201/eid1304.061002; Estani SS, 1998, AM J TROP MED HYG, V59, P526, DOI 10.4269/ajtmh.1998.59.526; Estani SS, 1999, MEM I OSWALDO CRUZ, V94, P363, DOI 10.1590/S0074-02761999000700070; FERREIRA RCC, 1986, BRAZ J MED BIOL RES, V19, P19; Fiorelli AI, 2005, TRANSPLANT P, V37, P2793, DOI 10.1016/j.transproceed.2005.05.038; FREILIJ H, 1995, CLIN INFECT DIS, V21, P551, DOI 10.1093/clinids/21.3.551; Gascon J, 2007, REV ESP CARDIOL, V60, P285, DOI 10.1157/13100280; GORLA NB, 1989, MUTAT RES, V224, P263, DOI 10.1016/0165-1218(89)90165-1; GROSS PA, 1994, CLIN INFECT DIS, V18, P421, DOI 10.1093/clinids/18.3.421; Herwaldt BL, 2000, J INFECT DIS, V181, P395, DOI 10.1086/315212; Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022; Kirchhoff Louis V., 2003, Curr Infect Dis Rep, V5, P59, DOI 10.1007/s11908-003-0066-y; KIRCHHOFF LV, 1993, INFECT DIS CLIN N AM, V7, P487; Kirchhoff LV, 2006, TROPICAL INFECT DIS, P1082; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Lazzari J O, 1998, Rev Panam Salud Publica, V4, P317; Leiby DA, 2002, TRANSFUSION, V42, P549, DOI 10.1046/j.1537-2995.2002.00077.x; MADY C, 1994, CIRCULATION, V90, P3098, DOI 10.1161/01.CIR.90.6.3098; MAGILL AJ, 2000, HUNTERS TROPICAL MED, P653; Maguire J H, 1982, Bull Pan Am Health Organ, V16, P47; MAGUIRE JH, 1987, CIRCULATION, V75, P1140, DOI 10.1161/01.CIR.75.6.1140; MAGUIRE JH, 1983, AM HEART J, V105, P287, DOI 10.1016/0002-8703(83)90529-X; Maguire JH, 2004, INFECT DIS, P2327; Maldonado C, 2004, J HEART LUNG TRANSPL, V23, P1345, DOI 10.1016/j.healun.2003.09.027; Marin-Neto JA, 1998, INT J CARDIOL, V65, P261, DOI 10.1016/S0167-5273(98)00132-6; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; MARINNETO JA, 1992, AM J CARDIOL, V69, P780, DOI 10.1016/0002-9149(92)90505-S; Meneghelli UG, 2005, DYSPHAGIA, V20, P40, DOI 10.1007/s00455-004-0023-4; Miles M., 2003, MANSON TROPICAL DIS, P1325; Miles MA, 2003, BMJ-BRIT MED J, V326, P1444, DOI 10.1136/bmj.326.7404.1444; Ministerio da Saude. Secretaria de Vigilancia em Saude, 2005, Rev Soc Bras Med Trop, V38 Suppl 3, P7; MOTA E, 1984, AM J TROP MED HYG, V33, P820, DOI 10.4269/ajtmh.1984.33.820; *ORG PAN SAL, 2006, OPSHDMCD42506; OROURKE RA, 1995, CURR PROB CARDIOLOGY, V20, P829, DOI 10.1016/S0146-2806(06)80001-0; Pazin A, 2006, BRAZ J MED BIOL RES, V39, P483, DOI 10.1590/S0100-879X2006000400008; Pinto Dias J C, 1995, Arq Bras Cardiol, V65, P359; Prineas R., 1982, MINNESOTA CODE MANUA; PUNG OJ, 1995, J PARASITOL, V81, P324, DOI 10.2307/3283947; RASSI A., 1971, Revista da Sociedade Brasileira de Medicina Tropical, V5, P235, DOI 10.1590/S0037-86821971000500001; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; Rassi A., 2003, AM TRYPANOSOMIASIS, P117; Rassi A Jr, 2001, Arq Bras Cardiol, V76, P75; Rassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Remme JHF, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P433; REZENDE J M D, 1988, Arquivos de Gastroenterologia, V25, P32; Riarte A, 1999, CLIN INFECT DIS, V29, P561, DOI 10.1086/598634; Russomando G, 1998, AM J TROP MED HYG, V59, P487, DOI 10.4269/ajtmh.1998.59.487; Salles G, 2003, CIRCULATION, V108, P305, DOI 10.1161/01.CIR.0000079174.13444.9C; Sartori AMC, 2007, ANN TROP MED PARASIT, V101, P31, DOI 10.1179/136485907X154629; Simoes M V, 1995, Arq Bras Cardiol, V64, P103; *SOC ARG CARD, 2002, REV ARGENT CARDIO S1, V70, P1; Sosa-Estani S, 2006, CURR OPIN INFECT DIS, V19, P583, DOI 10.1097/01.qco.0000247592.21295.a5; Stramer S. L., 2007, Morbidity and Mortality Weekly Report, V56, P141; TEIXEIRA ARL, 1990, J COMP PATHOL, V103, P37, DOI 10.1016/S0021-9975(08)80133-8; TEIXEIRA ARL, 1990, AM J TROP MED HYG, V43, P146, DOI 10.4269/ajtmh.1990.43.146; Torrico F, 2004, AM J TROP MED HYG, V70, P201, DOI 10.4269/ajtmh.2004.70.201; Vaidian Anil K, 2004, Kinetoplastid Biol Dis, V3, P2, DOI 10.1186/1475-9292-3-2; Veloso VM, 2001, MEM I OSWALDO CRUZ, V96, P1005, DOI 10.1590/S0074-02762001000700021; Viotti R, 2006, HEART, V92, P403, DOI 10.1136/hrt.2005.064444; Viotti R, 2005, REV ESP CARDIOL, V58, P1037, DOI 10.1157/13078551; Viotti RJ, 2004, HEART, V90, P655, DOI 10.1136/hrt.2003.018960; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; WEGNER DHG, 1972, ARZNEI-FORSCHUNG, V22, P1624; WHO, 2002, WHO TECHN REP SER, V905	100	524	544	1	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2171	2181		10.1001/jama.298.18.2171	http://dx.doi.org/10.1001/jama.298.18.2171			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230II	18000201				2022-12-28	WOS:000250869800023
J	Roush, SW; Murphy, TV				Roush, Sandra W.; Murphy, Trudy V.		Vaccine Preventable Dis Tabl	Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							IMMUNIZATION PRACTICES ACIP; B-VIRUS INFECTION; ADVISORY-COMMITTEE; ELIMINATE TRANSMISSION; INFLUENZA VACCINATION; VARICELLA VACCINATION; MEASLES; CARE; HOSPITALIZATIONS; RECOMMENDATIONS	Context National vaccine recommendations in the United States target an increasing number of vaccine-preventable diseases for reduction, elimination, or eradication. Objective To compare morbidity and mortality before and after widespread implementation of national vaccine recommendations for 13 vaccine-preventable diseases for which recommendations were in place prior to 2005. Design, Setting, and Participants For the United States, prevaccine baselines were assessed based on representative historical data from primary sources and were compared to the most recent morbidity (2006) and mortality (2004) data for diphtheria, pertussis, tetanus, poliomyelitis, measles, mumps, rubella ( including congenital rubella syndrome), invasive Haemophilus influenzae type b (Hib), acute hepatitis B, hepatitis A, varicella, Streptococcus pneumoniae, and smallpox. Main Outcome Measures Number of cases, deaths, and hospitalizations for 13 vaccine-preventable diseases. Estimates of the percent reductions from baseline to recent were made without adjustment for factors that could affect vaccine-preventable disease morbidity, mortality, or reporting. Results A greater than 92% decline in cases and a 99% or greater decline in deaths due to diseases prevented by vaccines recommended before 1980 were shown for diphtheria, mumps, pertussis, and tetanus. Endemic transmission of poliovirus and measles and rubella viruses has been eliminated in the United States; smallpox has been eradicated worldwide. Declines were 80% or greater for cases and deaths of most vaccine-preventable diseases targeted since 1980 including hepatitis A, acute hepatitis B, Hib, and varicella. Declines in cases and deaths of invasive S pneumoniae were 34% and 25%, respectively. Conclusions The number of cases of most vaccine-preventable diseases is at an all-time low; hospitalizations and deaths have also shown striking decreases.	Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Roush, SW (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd,MS C-25, Atlanta, GA 30333 USA.	sroush@cdc.gov						Alexander L, 2004, ARCH PEDIAT ADOL MED, V158, P1106, DOI 10.1001/archpedi.158.12.1106; Alexander LN, 2004, JAMA-J AM MED ASSOC, V292, P1696, DOI 10.1001/jama.292.14.1696; *AM AC PED COMM IN, 2007, RED BOOK 2006 REP CO; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P817; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P717; [Anonymous], NAT HLTH INT SURV NH; Armstrong GL, 2002, PEDIATRICS, V109, P839, DOI 10.1542/peds.109.5.839; Armstrong GL, 2001, PEDIATRICS, V108, P1123, DOI 10.1542/peds.108.5.1123; Ballard J E, 1997, Jt Comm J Qual Improv, V23, P434; Bocchini JA, 2007, PEDIATRICS, V119, P207, DOI 10.1542/peds.2006-3309; Calugar A, 2006, CLIN INFECT DIS, V42, P981, DOI 10.1086/500321; Canavan B. C., 2006, Morbidity and Mortality Weekly Report, V55, P1327; CDC, 1999, MMWR MORB MORTAL WKL, V48, P243; *CDCP, 2007, MMWR-MORBID MORTAL W, V56, P851; *CDCP, 2004, PERT SURV REP WEEKS; *CDCP, 1980, MMWR-MORBID MORTAL W, V28, P12; *CDCP, DIV BACT MYC DIS ACT; *CDCP, TOT DEATHS EACH CAUS; *CDCP, 1981, MMWR-MORBID MORTAL W, V29, P1; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P1041; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P706; *CDCP, 2005, HAEMOPHILUS INFLUENZ; *CDCP, 2006, MMWR-MORBID MORTAL W, V56, P885; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P241; *CDCP, 1996, MMWR-MORBID MORTAL W, V44, P940; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P234; *CDCP, 1969, CDC RUBELLA SURVEILL, V1, P2; *CDCP, 2006, MMWR-MORBID MORTAL W, V53, P1; *CDCP, 1972, CDC RUBELLA SURV JAN; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P535; *CDCP, 2002, MAN SURV VACC PREV D; *CDCP, 2005, ACT BACT COR SURV AB; *CDCP, 1972, MUMPS SURV; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, pQ1; *CDCP, 2002, 2001 2002 STAT IMM R; Centers for Disease C., 2005, MMWR MORB MORTAL WKL, V54, P279; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P511; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1019; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P958; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P660; Chen RT, 2001, CLIN INFECT DIS, V33, pS327, DOI 10.1086/322569; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; COCHI SL, 1985, JAMA-J AM MED ASSOC, V253, P521, DOI 10.1001/jama.253.4.521; *COMM EV VACC PURC, 2004, FIN VACC 21 CENT ASS, P45; *COUNC STAT TERR E, 2004, NNDSS ASS 2004 REP P; Crowcroft NS, 2002, BMJ-BRIT MED J, V324, P1537, DOI 10.1136/bmj.324.7353.1537; Darling N., 2006, Morbidity and Mortality Weekly Report, V55, P988; Davis MM, 2005, VACCINE, V23, P3053, DOI 10.1016/j.vaccine.2004.10.047; Davis MM, 2004, PEDIATRICS, V114, P786, DOI 10.1542/peds.2004-0012; Dayan GH, 2005, PEDIATRICS, V116, pE1, DOI 10.1542/peds.2004-2512; DeStefano F, 2001, PHARMACOEPIDEM DR S, V10, P403, DOI 10.1002/pds.613; Ellenberg SS, 2005, AM J PUBLIC HEALTH, V95, P800, DOI 10.2105/AJPH.2004.039438; Ellenberg SS, 2002, DRUG SAFETY, V25, P145, DOI 10.2165/00002018-200225030-00001; Ellenberg SS, 1997, PUBLIC HEALTH REP, V112, P10; FENNER F, 1988, SMALLPOX ITS ERADICA, P330; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Galil K, 2002, PEDIATR INFECT DIS J, V21, P931, DOI 10.1097/00006454-200210000-00009; Gindler J, 2004, J INFECT DIS, V189, pS69, DOI 10.1086/378565; GORDON JE, 1951, AM J MED SCI, V222, P333, DOI 10.1097/00000441-195109000-00011; Grijalva CG, 2006, EMERG INFECT DIS, V12, P103; GROVE RD, 1968, VITAL STAT RATES US, V1677; Halsey NA, 1997, PEDIATRICS, V99, P479, DOI 10.1542/peds.99.3.479; Harpaz R, 2004, J INFECT DIS, V189, pS196, DOI 10.1086/381127; Harpaz R, 2004, J INFECT DIS, V189, pS185, DOI 10.1086/378501; Hinman AR, 2005, HEALTH AFFAIR, V24, P701, DOI 10.1377/hlthaff.24.3.701; Hoyert Donna L, 2006, Natl Vital Stat Rep, V54, P1; Iskander John, 2005, Yale J Biol Med, V78, P265; Iskander J, 2006, DRUG SAFETY, V29, P375, DOI 10.2165/00002018-200629050-00002; Kretsinger Katrina, 2006, Morbidity and Mortality Weekly Report, V55, P1; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Lewis N., 2005, Morbidity and Mortality Weekly Report, V54, P676; Lieu TA, 2005, HEALTH AFFAIR, V24, P666, DOI 10.1377/hlthaff.24.3.666; Linder Forrest, 1947, VITAL STAT RATES US; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; McKibben L J, 2000, MMWR Recomm Rep, V49, P15; McNabb Scott J N, 2007, MMWR Morb Mortal Wkly Rep, V54, P1; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; Millar EV, 2000, AM J PUBLIC HEALTH, V90, P1550, DOI 10.2105/AJPH.90.10.1550; Nguyen HQ, 2005, NEW ENGL J MED, V352, P450, DOI 10.1056/NEJMoa042271; Nordin JD, 2004, J INFECT DIS, V189, pS222, DOI 10.1086/378775; O'Brien MA, 2004, PEDIATRICS, V113, P585, DOI 10.1542/peds.113.3.585; Orenstein WA, 2005, HEALTH AFFAIR, V24, P599, DOI 10.1377/hlthaff.24.3.599; Orenstein WA, 2004, J INFECT DIS, V189, pS1, DOI 10.1086/377693; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Parker AA, 2006, NEW ENGL J MED, V355, P447, DOI 10.1056/NEJMoa060775; PLOTKIN SA, 2004, VACCINES; Poland GA, 2003, AM J PREV MED, V25, P144, DOI 10.1016/S0749-3797(03)00120-X; Prevots D R, 2000, MMWR Recomm Rep, V49, P1; Rota PA, 2004, J INFECT DIS, V189, pS160, DOI 10.1086/374607; Roush S, 1999, JAMA-J AM MED ASSOC, V282, P164, DOI 10.1001/jama.282.2.164; Salmon DA, 2005, AM J PUBLIC HEALTH, V95, P436, DOI 10.2105/AJPH.2004.046201; Salmon DA, 1999, JAMA-J AM MED ASSOC, V282, P47, DOI 10.1001/jama.282.1.47; Sanford J. P., 1993, CHILDRENS VACCINE IN; Sansom SL, 2003, AM J PREV MED, V25, P343, DOI 10.1016/S0749-3797(03)00209-5; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; Singleton JA, 2004, TEX HEART I J, V31, P22; SIROTKIN B, 2006, REPORTED NUMBER DEAT; Smith P J, 2001, Vital Health Stat 2, P1; SMITH PJ, 2005, VITAL HLTH STAT, V2, P1; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; *US BUR CENS, 1989, STAT ABSTR US 1989; *US BUR CENS, US CENS BUR STAT COU; *US DEP HHS, VACC INJ COMP; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; Vitek CR, 1998, EMERG INFECT DIS, V4, P539, DOI 10.3201/eid0404.980404; Walker FJ, 2006, INFECT CONT HOSP EP, V27, P257, DOI 10.1086/501538; Weinbaum C., 2006, Morbidity and Mortality Weekly Report, V55, P509; Williams W W, 1989, J Am Coll Health, V37, P197; Willis Bayo C., 2005, Morbidity and Mortality Weekly Report, V54, P1; Wilson TR, 2005, J ADOLESCENT HEALTH, V37, P511, DOI 10.1016/j.jadohealth.2005.07.009; Woo E. J., 2006, Morbidity and Mortality Weekly Report, V55, P1120; Zell ER, 2000, PUBLIC HEALTH REP, V115, P65, DOI 10.1093/phr/115.1.65; Zhou FJ, 2005, ARCH PEDIAT ADOL MED, V159, P1136, DOI 10.1001/archpedi.159.12.1136; Zhou FJ, 2005, JAMA-J AM MED ASSOC, V294, P797, DOI 10.1001/jama.294.7.797; Zhou Weigong, 2003, MMWR Surveill Summ, V52, P1	122	375	393	2	79	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2155	2163		10.1001/jama.298.18.2155	http://dx.doi.org/10.1001/jama.298.18.2155			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230II	18000199				2022-12-28	WOS:000250869800021
J	Cross, M				Cross, Michael			Policing plagiarism	BRITISH MEDICAL JOURNAL			English	Article												michaelcross@fastmail.fm	jalali, fatemeh/AAV-9835-2021					Gerhardt Deborah R., 2006, RICH J L TECH, V12, P10; GLOD M, 2007, WASHINGTON POST 0329; LANCASTER T, 2004, COMFORT ZONE, P520; Scaife B, 2007, IT CONSULTANCY PLAGI	4	11	13	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 10	2007	335	7627					963	964		10.1136/bmj.39388.668773.47	http://dx.doi.org/10.1136/bmj.39388.668773.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232AL	17991974	Green Published			2022-12-28	WOS:000250990400032
J	Joly, PB; Rip, A				Joly, Pierre-Benoit; Rip, Arie			A timely harvest	NATURE			English	Editorial Material									INRA, F-94205 Ivry, France; Univ Twente, NL-7500 AE Enschede, Netherlands	INRAE; University of Twente	Joly, PB (corresponding author), INRA, 65 Blvd Brandebourg, F-94205 Ivry, France.								0	17	17	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					174	174		10.1038/450174a	http://dx.doi.org/10.1038/450174a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994073	Bronze			2022-12-28	WOS:000250746200027
J	Flegal, KM; Graubard, BI; Williamson, DF; Gail, MH				Flegal, Katherine M.; Graubard, Barry I.; Williamson, David F.; Gail, Mitchell H.			Cause-specific excess deaths associated with underweight, overweight, and obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; CAUSE-SPECIFIC MORTALITY; FOLLOW-UP; CANCER; COHORT; RISK; MEN; OUTCOMES; WEIGHT; PARADOX	Context The association of body mass index (BMI) with cause-specific mortality has not been reported for the US population. Objective To estimate cause-specific excess deaths associated with underweight (BMI < 18.5), overweight (BMI 25- <30), and obesity (BMI >= 30). Design, Setting, and Participants Cause-specific relative risks of mortality from the National Health and Nutrition Examination Survey (NHANES) I, 1971-1975; II, 19761980; and III, 1988-1994, with mortality follow-up through 2000 (571 042 person-years of follow-up) were combined with data on BMI and other covariates from NHANES 1999-2002 with underlying cause of death information for 2.3 million adults 25 years and older from 2004 vital statistics data for the United States. Main Outcome Measures Cause-specific excess deaths in 2004 by BMI levels for categories of cardiovascular disease (CVD), cancer, and all other causes (noncancer, non-CVD causes). Results Based on total follow-up, underweight was associated with significantly increased mortality from noncancer, non-CVD causes (23 455 excess deaths; 95% confidence interval [CI], 11 848 to 35 061) but not associated with cancer or CVD mortality. Overweight was associated with significantly decreased mortality from noncancer, non-CVD causes (-69 299 excess deaths; 95% CI, -100 702 to -37 897) but not associated with cancer or CVD mortality. Obesity was associated with significantly increased CVD mortality (112 159 excess deaths; 95% CI, 87 842 to 136 476) but not associated with cancer mortality or with noncancer, non-CVD mortality. In further analyses, overweight and obesity combined were associated with increased mortality from diabetes and kidney disease (61 248 excess deaths; 95% CI, 49 685 to 72 811) and decreased mortality from other noncancer, non-CVD causes (-105 572 excess deaths; 95% CI, -161 816 to -49 328). Obesity was associated with increased mortality from cancers considered obesity-related (13 839 excess deaths; 95% CI, 1920 to 25 758) but not associated with mortality from other cancers. Comparisons across surveys suggested a decrease in the association of obesity with CVD mortality over time. Conclusions The BMI-mortality association varies by cause of death. These results help to clarify the associations of BMI with all-cause mortality.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA	Flegal, KM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4201, Hyattsville, MD 20782 USA.	kmf2@cdc.gov	Flegal, Katherine M/A-4608-2013	Flegal, Katherine/0000-0002-0838-469X				*3 NAT HLTH NUTR E, 1994, VIT HLTH STAT, V1, P1; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Batty GD, 2005, INT J OBESITY, V29, P1267, DOI 10.1038/sj.ijo.0803020; Bender R, 2006, J CLIN EPIDEMIOL, V59, P1064, DOI 10.1016/j.jclinepi.2006.01.006; Breeze E, 2006, INT J EPIDEMIOL, V35, P169, DOI 10.1093/ije/dyi212; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; COHEN JS, 1987, TRADITION, V22, P1; Cox C S, 1997, Vital Health Stat 1, P1; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Engel A, 1978, Vital Health Stat 1, P1; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Flegal KM, 2006, INT J OBESITY, V30, P1171, DOI 10.1038/sj.ijo.0803313; Flegal KM, 2003, NEW ENGL J MED, V349, P502; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Fonarow GC, 2007, AM HEART J, V153, P74, DOI 10.1016/j.ahj.2006.09.007; Garrouste-Orgeas M, 2004, INTENS CARE MED, V30, P437, DOI 10.1007/s00134-003-2095-2; Graubard BI, 2007, STAT MED, V26, P2639, DOI 10.1002/sim.2734; Gregg EW, 2005, JAMA-J AM MED ASSOC, V294, P182; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hu FB, 2005, AM J PUBLIC HEALTH, V95, P932, DOI 10.2105/AJPH.2005.062836; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Korn EL., 1999, ANAL HLTH SURVEYS; Krueger PM, 2004, RES AGING, V26, P82, DOI 10.1177/0164027503258518; Kuriyama S, 2006, J EPIDEMIOL, V16, P139, DOI 10.2188/jea.16.139; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; LEE IM, 1993, JAMA-J AM MED ASSOC, V270, P2823, DOI 10.1001/jama.270.23.2823; Loria C M, 1999, Vital Health Stat 1, P1; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; McDowell A, 1981, Vital Health Stat 1, P1; McEwen LN, 2006, DIABETES CARE, V29, P247, DOI 10.2337/diacare.29.02.06.dc05-0998; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; Mhurchu CN, 2005, PUBLIC HEALTH NUTR, V8, P402, DOI 10.1079/PHN2004704; MILLIMAN JD, 1973, BIOL GEOLOGY CORAL R, V1, P1; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; National Heart Lung and Blood Institute National Institutes of Health, CLIN GUID ID EV TREA; *NCI, 2004, NCI FACT SHEET; O'Brien JM, 2006, CRIT CARE MED, V34, P738, DOI 10.1097/01.CCM.0000202207.87891.FC; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Seidell JC, 1996, ARCH INTERN MED, V156, P958, DOI 10.1001/archinte.156.9.958; SHAH BV, 2004, SURV METHODOL, V30, P29; Shaper AG, 1997, BRIT MED J, V314, P1311, DOI 10.1136/bmj.314.7090.1311; Thorogood M, 2003, J EPIDEMIOL COMMUN H, V57, P130, DOI 10.1136/jech.57.2.130; Tremblay A, 2003, CHEST, V123, P1202, DOI 10.1378/chest.123.4.1202; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P190, DOI 10.1001/jama.295.2.190	55	1057	1099	0	71	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2007	298	17					2028	2037		10.1001/jama.298.17.2028	http://dx.doi.org/10.1001/jama.298.17.2028			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228GP	17986696	Bronze			2022-12-28	WOS:000250718200023
J	Psaty, BM; Arnett, D; Burke, G				Psaty, Bruce M.; Arnett, Donna; Burke, Gregory			A new era of cardiovascular disease epidemiology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; BIG		Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; Grp Hlth, Ctr Hlth Studies, Seattle, WA USA; Univ Alabama, Dept Epidemiol, Birmingham, AL USA; Wake Forest Univ, Div Publ Hlth Sci, Winston Salem, NC 27109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; Wake Forest University	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu						*FRAM SNP HLTH ASS, NAT CTR BIOT INF; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kaplan GA, 2007, EPIDEMIOLOGY, V18, P18, DOI 10.1097/01.ede.0000249507.52550.90; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019; *NAT HEART LUNG BL, NHLBI LTD ACC DAT PR; Ness RB, 2007, EPIDEMIOLOGY, V18, P9, DOI 10.1097/01.ede.0000249529.86885.5a; *NHLBI DAT US C, INSTR APPL NHLBI AUT; Seminara D, 2007, EPIDEMIOLOGY, V18, P1, DOI 10.1097/01.ede.0000249540.17855.b7; Topol EJ, 2007, JAMA-J AM MED ASSOC, V298, P218, DOI 10.1001/jama.298.2.218; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	13	5	6	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2007	298	17					2060	2062		10.1001/jama.298.17.2060	http://dx.doi.org/10.1001/jama.298.17.2060			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228GP	17986701				2022-12-28	WOS:000250718200028
J	Engstler, M; Pfohl, T; Herminghaus, S; Boshart, M; Wiegertjes, G; Heddergott, N; Overath, P				Engstler, Markus; Pfohl, Thomas; Herminghaus, Stephan; Boshart, Michael; Wiegertjes, Geert; Heddergott, Niko; Overath, Peter			Hydrodynamic flow-mediated protein sorting on the cell surface of trypanosomes	CELL			English	Article							BLOOD-STREAM FORMS; ANTIGENIC VARIATION; DNA-MOLECULES; BRUCEI; GLYCOPROTEIN; ENDOCYTOSIS; MEMBRANE; MOVEMENT; MOTILITY; ANTIBODY	The unicellular parasite Trypanosoma brucei rapidly removes host-derived immunoglobulin (Ig) from its cell surface, which is dominated by a single type of glycosylphosphatidylinositol-anchored variant surface glycoprotein (VSG). We have determined the mechanism of antibody clearance and found that Ig-VSG immune complexes are passively sorted to the posterior cell pole, where they are endocytosed. The backward movement of immune complexes requires forward cellular motility but is independent of endocytosis and of actin function. We suggest that the hydrodynamic flow acting on swimming trypanosomes causes directional movement of Ig-VSG immune complexes in the plane of the plasmamembrane, that is, immunoglobulins attached to VSG function as molecular sails. Protein sorting by hydrodynamic forces helps to protect trypanosomes against complement-mediated immune destruction in culture and possibly in infected mammals but likewise may be of functional significance at the surface of other cell types such as epithelial cells lining blood vessels.	Tech Univ Darmstadt, Inst Mikrobiol & Genet, D-64287 Darmstadt, Germany; Max Planck Inst Dynam & Selbstorganisat, D-37073 Gottingen, Germany; Univ Munich, Dept Biol 1, D-80638 Munich, Germany; Wageningen Inst Anim Sci, Cell Biol & Immunol Grp, NL-6709 PG Wageningen, Netherlands; Univ Tubingen, Immunol Abt, Interfak Inst Zellbiol, D-72076 Tubingen, Germany	Technical University of Darmstadt; Max Planck Society; University of Munich; Wageningen University & Research; Eberhard Karls University of Tubingen	Engstler, M (corresponding author), Tech Univ Darmstadt, Inst Mikrobiol & Genet, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	engstler@bio.tu-darmstadt.de	Engstler, Markus/E-6054-2010; Boshart, Michael/A-2700-2011; Wiegertjes, Geert F/E-3330-2012; Pfohl, Thomas/D-7296-2016; Herminghaus, Stephan/D-1904-2009	Boshart, Michael/0000-0002-5070-2663; Pfohl, Thomas/0000-0002-7879-5216; wiegertjes, geert/0000-0001-9265-3436				Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; BALBER AE, 1979, INFECT IMMUN, V24, P617, DOI 10.1128/IAI.24.3.617-627.1979; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; BARRY JD, 1979, J CELL SCI, V37, P287; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; BENSIMON D, 1995, PHYS REV LETT, V74, P4754, DOI 10.1103/PhysRevLett.74.4754; Bocquet L, 1996, J PHYS-CONDENS MAT, V8, P9297, DOI 10.1088/0953-8984/8/47/019; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BULOW R, 1988, BIOCHEMISTRY-US, V27, P2384; Chan TF, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl593; Cottin-Bizonne C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.056102; CROSS GAM, 1973, PARASITOLOGY, V67, P315, DOI 10.1017/S0031182000046540; Cross GAM, 1996, BIOESSAYS, V18, P283, DOI 10.1002/bies.950180406; DELAUW MF, 1985, EMBO J, V4, P989, DOI 10.1002/j.1460-2075.1985.tb03728.x; Donelson JE, 1998, MOL BIOCHEM PARASIT, V91, P51, DOI 10.1016/S0166-6851(97)00209-0; Dukkipati VR, 2006, NANO LETT, V6, P2499, DOI 10.1021/nl0617484; Engstler M, 2005, J CELL SCI, V118, P2105, DOI 10.1242/jcs.02327; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Fache S, 2005, J CELL SCI, V118, P3445, DOI 10.1242/jcs.02461; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Grunfelder CG, 2002, TRAFFIC, V3, P547, DOI 10.1034/j.1600-0854.2002.30805.x; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Kadau K, 2004, P NATL ACAD SCI USA, V101, P5851, DOI 10.1073/pnas.0401228101; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; LEVINE S, 1983, BIOPHYS J, V42, P127, DOI 10.1016/S0006-3495(83)84378-1; MANSFIELD JM, 1994, PARASITOL TODAY, V10, P267, DOI 10.1016/0169-4758(94)90143-0; MCCLOSKEY MA, 1984, J CELL BIOL, V99, P778, DOI 10.1083/jcb.99.3.778; MCLAUGHLIN S, 1981, BIOPHYS J, V34, P85, DOI 10.1016/S0006-3495(81)84838-2; MCLINTOCK LML, 1993, PARASITE IMMUNOL, V15, P475, DOI 10.1111/j.1365-3024.1993.tb00633.x; O'Beirne C, 1998, MOL BIOCHEM PARASIT, V91, P165, DOI 10.1016/S0166-6851(97)00191-6; Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Priezjev NV, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041608; QIAN T, 2003, PHYS REV E, V68; RICHARDSON S, 1973, J FLUID MECH, V59, P707, DOI 10.1017/S0022112073001801; ROSEN R, 1979, J THEOR BIOL, V80, P149, DOI 10.1016/0022-5193(79)90186-3; RUSSO DCW, 1993, EUR J CELL BIOL, V62, P432; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; STEVENS DR, 1978, INFECT IMMUN, V19, P972, DOI 10.1128/IAI.19.3.972-982.1978; TAYLOR RB, 1971, NATURE-NEW BIOL, V233, P225, DOI 10.1038/newbio233225a0; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; WEBSTER P, 1990, J CELL SCI, V96, P249	46	272	273	0	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					505	515		10.1016/j.cell.2007.08.046	http://dx.doi.org/10.1016/j.cell.2007.08.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981118	Bronze			2022-12-28	WOS:000250618500018
J	Donahue, KE; Gartlehner, G; Jonas, DE; Lux, LJ; Thieda, P; Jonas, BL; Hansen, RA; Morgan, LC; Lohr, KN				Donahue, Katrina E.; Gartlehner, Gerald; Jonas, Daniel E.; Lux, Linda J.; Thieda, Patricia; Jonas, Beth L.; Hansen, Richard A.; Morgan, Laura C.; Lohr, Kathleen N.			Systematic review: Comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis	ANNALS OF INTERNAL MEDICINE			English	Review							ADALIMUMAB PLUS METHOTREXATE; NECROSIS FACTOR THERAPY; LONG-TERM SAFETY; DOUBLE-BLIND; COMBINATION THERAPY; ETANERCEPT TREATMENT; CLINICAL-TRIAL; TREATMENT STRATEGIES; ANTIRHEUMATIC DRUGS; FOLLOW-UP	Background: The comparative effectiveness of rheumatoid arthritis therapies is uncertain. Purpose: To compare the benefits and harms of disease-modifying antirheumatic drugs (DMARDs) for adults with rheumatoid arthritis. Data Sources: Records limited to the English language and studies of adults were identified by using MEDLINE, EMBASE, The Cochrane Library, and International Pharmaceutical Abstracts from 1980 to September 2007. Study Selection: Two persons independently selected relevant head-to-head trials and prospective cohort studies with at least 100 participants and 12-week follow-up and relevant good- or fair-quality meta-analyses that compared benefits or harms of 11 drug therapies. For harms, they included retrospective cohort studies. Data Extraction: Information on study design, interventions, outcomes, and quality were extracted according to a standard protocol. Data Synthesis: Head-to-head trials (n = 23), mostly examining synthetic DMARDs, showed no clinically important differences in efficacy among synthetic DMARDs (limited to methotrexate, leflunomide, and sulfasalazine) or among anti-tumor necrosis factor drugs (adalimumab, etanercept, and infliximab). Monotherapy with anti-tumor necrosis factor drugs resulted in better radiographic outcomes than did methotrexate but no important differences in clinical outcomes (for example, 20%, 50%, or 70% improvement according to American College of Rheumatology response criteria). Various combinations of biological DMARDs plus methotrexate improved clinical response rates and functional outcomes more than monotherapy with either methotrexate or biological DMARDs. In patients whose monotherapy failed, combination therapy with synthetic DMARDs improved response rates. Numbers and types of short-term adverse events were similar for biological and synthetic DMARDs. The evidence was insufficient to draw conclusions about differences for rare but serious adverse events for biological DMARDs. Limitation: Most studies were short-term efficacy trials conducted in selected populations with few comorbid conditions. Conclusion: Limited available comparative evidence does not support one monotherapy over another for adults with rheumatoid arthritis. Although combination therapy is more effective for patients whose monotherapy fails, the evidence is insufficient to draw firm conclusions about whether one combination or treatment strategy is better than another or is the best treatment for early rheumatoid arthritis.	[Donahue, Katrina E.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Donahue, KE (corresponding author), Univ N Carolina, Dept Family Med, CB 7595,590 Manning Dr, Chapel Hill, NC 27599 USA.		Gartlehner, Gerald/AAY-2801-2021; Donahue, Katrina/E-7486-2012; Lux, Linda/GPX-3639-2022	Gartlehner, Gerald/0000-0001-5531-3678; Donahue, Katrina/0000-0003-4075-2875; Hansen, Richard/0000-0002-4578-6698; Lohr, Kathleen/0000-0002-3825-0713	PHS HHS [290-02-0016] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Bathon JM, 2006, J RHEUMATOL, V33, P234; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Burmester GR, 2007, ANN RHEUM DIS, V66, P732, DOI 10.1136/ard.2006.066761; Capell HA, 2007, ANN RHEUM DIS, V66, P235, DOI 10.1136/ard.2006.057133; Centre for Reviews and Dissemination: Undertaking systematic reviews of research on effectiveness, 2001, UND SYST REV RES EFF; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Clark W, 2004, HEALTH TECHNOL ASSES, V8, P1; CLARK W, 2004, HEALTH TECHNOL ASSES, V8, pR9; Combe B, 2006, ANN RHEUM DIS, V65, P1357, DOI 10.1136/ard.2005.049650; Deeks J J, 2003, Health Technol Assess, V7, piii; Dixon WG, 2006, ARTHRITIS RHEUM-US, V54, P2368, DOI 10.1002/art.21978; DONAHUE KE, 290020016 RTI U N CA; Dougados M, 1999, ANN RHEUM DIS, V58, P220, DOI 10.1136/ard.58.4.220; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Emery P, 2000, RHEUMATOLOGY, V39, P655, DOI 10.1093/rheumatology/39.6.655; Feltelius N, 2005, ANN RHEUM DIS, V64, P246, DOI 10.1136/ard.2004.023473; Fleischmann RM, 2006, ANN RHEUM DIS, V65, P1006, DOI 10.1136/ard.2005.048371; Fleischmann RM, 2003, J RHEUMATOL, V30, P691; Gartlehner G, 2006, J RHEUMATOL, V33, P2398; Geborek P, 2005, ANN RHEUM DIS, V64, P699, DOI 10.1136/ard.2004.030528; Geborek P, 2002, ANN RHEUM DIS, V61, P793, DOI 10.1136/ard.61.9.793; Genovese MC, 2005, J RHEUMATOL, V32, P1232; Genovese MC, 2002, ARTHRITIS RHEUM, V46, P1443, DOI 10.1002/art.10308; Genovese MC, 2004, ARTHRITIS RHEUM-US, V50, P1412, DOI 10.1002/art.20221; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Goekoop-Ruiterman YPM, 2007, ANN INTERN MED, V146, P406, DOI 10.7326/0003-4819-146-6-200703200-00005; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; Haagsma CJ, 1997, BRIT J RHEUMATOL, V36, P1082; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hochberg MC, 2003, ANN RHEUM DIS, V62, P13, DOI 10.1136/ard.62.suppl_2.ii13; Hyrich KL, 2006, ARTHRITIS RHEUM-US, V54, P1786, DOI 10.1002/art.21830; Klareskog L, 2006, ANN RHEUM DIS, V65, P1578, DOI 10.1136/ard.2005.038349; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kristensen LE, 2006, ARTHRITIS RHEUM, V54, P600, DOI 10.1002/art.21570; Kwoh CK, 2002, ARTHRITIS RHEUM-US, V46, P328; Landewe RBM, 2002, ARTHRITIS RHEUM-US, V46, P347, DOI 10.1002/art.10083; Larsen A, 2001, SCAND J RHEUMATOL, V30, P135; Lee JH, 2002, ARTHRITIS RHEUM-US, V46, P2565, DOI 10.1002/art.10583; Listing J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1933; Maetzel A, 2000, RHEUMATOLOGY, V39, P975, DOI 10.1093/rheumatology/39.9.975; Maini RN, 2004, ARTHRITIS RHEUM-US, V50, P1051, DOI 10.1002/art.20159; Moreland LW, 2006, J RHEUMATOL, V33, P854; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; Nuki G, 2002, ARTHRITIS RHEUM, V46, P2838, DOI 10.1002/art.10578; O'Dell JR, 2002, ARTHRITIS RHEUM, V46, P1164, DOI 10.1002/art.10228; ODell JR, 1996, NEW ENGL J MED, V334, P1287, DOI 10.1056/NEJM199605163342002; Osiri M, 2003, COCHRANE DB SYST REV, DOI DOI 10.1517/14656566.2015.1056735; Schiff MH, 2006, ANN RHEUM DIS, V65, P889, DOI 10.1136/ard.2005.043166; Scott DL, 2001, ANN RHEUM DIS, V60, P913, DOI 10.1136/ard.60.10.913; Slifman NR, 2003, ARTHRITIS RHEUM, V48, P319, DOI 10.1002/art.10758; Smolen JS, 1999, LANCET, V353, P259, DOI 10.1016/S0140-6736(98)09403-3; Strand V, 1999, ARCH INTERN MED, V159, P2542, DOI 10.1001/archinte.159.21.2542; Svensson B, 2005, ARTHRITIS RHEUM-US, V52, P3360, DOI 10.1002/art.21298; van der Heijde D, 2006, ANN RHEUM DIS, V65, P328, DOI 10.1136/ard.2005.035709; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P1063, DOI 10.1002/art.21655; van Riel PLCM, 2006, ANN RHEUM DIS, V65, P1478, DOI 10.1136/ard.2005.043299; Wailoo A, 2006, MODELING COST EFFECT; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Weaver AL, 2006, CURR MED RES OPIN, V22, P185, DOI 10.1185/030079905X65510; Weinblatt M, 2006, ARTHRITIS RHEUM, V54, P2807, DOI 10.1002/art.22070; Weinblatt ME, 2006, ANN RHEUM DIS, V65, P753, DOI 10.1136/ard.2005.044404; Westhovens R, 2006, ARTHRITIS RHEUM-US, V54, P1075, DOI 10.1002/art.21734; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P1433, DOI 10.1002/art.22579; Zink A, 2005, ANN RHEUM DIS, V64, P1274, DOI 10.1136/ard.2004.031476	67	203	220	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2008	148	2					124	134		10.7326/0003-4819-148-2-200801150-00192	http://dx.doi.org/10.7326/0003-4819-148-2-200801150-00192			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254NZ	18025440				2022-12-28	WOS:000252594600005
J	Green, SP; Jones, C; Stasch, A				Green, Shaun P.; Jones, Cameron; Stasch, Andreas			Stable magnesium(I) compounds with Mg-Mg bonds	SCIENCE			English	Article							GRIGNARD-REAGENTS; COMPLEXES; CHEMISTRY; HYDRIDE; DIMERS	The chemistry of the group 2 metals ( beryllium, magnesium, calcium, strontium, and barium) is dominated by the +2 oxidation state. Here, we report the reductions of two magnesium(II) iodide complexes with potassium metal in toluene, leading to thermally stable magnesium( I) compounds, ( L) MgMg( L) ( where L is [( Ar) NC(NPr2i) N( Ar)](-) or {[( Ar) NC( Me)](2)CH}(-), Ar is 2,6- diisopropylphenyl, Me is methyl, and Pr-i is isopropyl) in moderate yields. The results of x- ray crystallographic and theoretical studies are consistent with central Mg-2(2+) units that have single, covalent magnesium- magnesium bonding interactions with 2.8508 +/- 0.0012 ( standard deviation) and 2.8457 +/- 0.0008 angstrom bond lengths, respectively, and predominantly ionic interactions with the anionic ligands ( L).	Monash Univ, Sch Chem, Clayton, Vic 3800, Australia; Cardiff Univ, Sch Chem, Cardiff CF10 3AT, Wales	Monash University; Cardiff University	Jones, C (corresponding author), Monash Univ, Sch Chem, POB 23, Clayton, Vic 3800, Australia.	cameron.jones@sci.monash.edu.au; andreas.stasch@sci.monash.edu.au	Jones, Cameron/W-8992-2019	Jones, Cameron/0000-0002-7269-1045; Stasch, Andreas/0000-0002-7407-8287				ASHBY EC, 1979, INORG CHEM, V18, P1306, DOI 10.1021/ic50195a028; Baik MH, 2004, POLYHEDRON, V23, P2879, DOI 10.1016/j.poly.2004.08.004; Bourget-Merle L, 2002, CHEM REV, V102, P3031, DOI 10.1021/cr010424r; Chai JF, 2005, J AM CHEM SOC, V127, P9201, DOI 10.1021/ja042269e; Emsley J., 1995, ELEMENTS; Frisch M. J., 2001, GAUSSIAN 98 REVISION; Gallagher DJ, 2002, CHEM COMMUN, P376, DOI 10.1039/b110117j; Green SP, 2006, CHEM COMMUN, P3978, DOI 10.1039/b610645e; HUBER KP, 1979, CONSTANTS DIATOMIC M, P116; JASIEN PG, 1983, J AM CHEM SOC, V105, P2089, DOI 10.1021/ja00345a083; Jones C, 2006, J AM CHEM SOC, V128, P2206, DOI 10.1021/ja057967t; Kaim W., 1994, BIOINORGANIC CHEM IN; Nguyen T, 2005, SCIENCE, V310, P844, DOI 10.1126/science.1116789; Petrie S, 2003, AUST J CHEM, V56, P259, DOI 10.1071/CH03006; Pierce GA, 2007, ANGEW CHEM INT EDIT, V46, P2043, DOI 10.1002/anie.200604838; Prust J, 2001, Z ANORG ALLG CHEM, V627, P2032, DOI 10.1002/1521-3749(200108)627:8<2032::AID-ZAAC2032>3.0.CO;2-6; Resa I, 2004, SCIENCE, V305, P1136, DOI 10.1126/science.1101356; TINGA MAGM, 1993, J AM CHEM SOC, V115, P2808, DOI 10.1021/ja00060a030; Tjurina LA, 2004, ORGANOMETALLICS, V23, P1349, DOI 10.1021/om030633x; Velazquez A, 2007, ORGANOMETALLICS, V26, P4731, DOI 10.1021/om700477b; Wang XF, 2004, J PHYS CHEM A, V108, P11511, DOI 10.1021/jp046410h; Wang YZ, 2005, J AM CHEM SOC, V127, P11944, DOI 10.1021/ja053819r; Westerhausen M, 2007, CHEM-EUR J, V13, P6292, DOI 10.1002/chem.200700558; Xie YM, 2005, CHEM PHYS LETT, V402, P414, DOI 10.1016/j.cplett.2004.11.106; Zhu ZL, 2006, ANGEW CHEM INT EDIT, V45, P5807, DOI 10.1002/anie.200601926	25	519	526	16	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1754	1757		10.1126/science.1150856	http://dx.doi.org/10.1126/science.1150856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	17991827				2022-12-28	WOS:000251616800034
J	Moar, WJ; Anilkumar, KJ				Moar, William J.; Anilkumar, Konasale J.			Plant science - The power of the pyramid	SCIENCE			English	Editorial Material							BACILLUS-THURINGIENSIS; HELIOTHIS-VIRESCENS; DELTA-ENDOTOXIN; RESISTANCE; BOLLWORM; RECEPTOR; TOXIN		Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	Auburn University System; Auburn University	Moar, WJ (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	moarwil@auburn.edu						Ali MI, 2007, J ECON ENTOMOL, V100, P921, DOI 10.1603/0022-0493(2007)100[921:SOBATB]2.0.CO;2; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gao Y, 2006, J AGR FOOD CHEM, V54, P829, DOI 10.1021/jf0523869; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; JAMES C, 2006, BRIEF 35 GLOBAL STAT; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Moar WJ, 2003, NAT BIOTECHNOL, V21, P1152, DOI 10.1038/nbt1003-1152; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005	11	24	24	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1561	1562		10.1126/science.1151313	http://dx.doi.org/10.1126/science.1151313			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	17975032				2022-12-28	WOS:000251421700023
J	Brayne, C; Fox, C; Boustani, M				Brayne, Carol; Fox, Chris; Boustani, Malaz			Dementia screening in primary care - Is it time?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALZHEIMERS-DISEASE; OLDER-ADULTS; MANAGEMENT; DIAGNOSIS		Indiana Univ, Ctr Aging Res, Regenstrief Inst Inc, Indianapolis, IN 46202 USA; Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; Univ Kent, Kent Inst Med & Hlth Sci, Canterbury CT2 7NZ, Kent, England	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; University of Cambridge; University of Kent	Boustani, M (corresponding author), Indiana Univ, Ctr Aging Res, Regenstrief Inst Inc, 410 W 10th St,Ste 2000, Indianapolis, IN 46202 USA.	mboustani@regenstrief.org	Brayne, Carol/AAA-4285-2020	Brayne, Carol/0000-0001-5307-663X; Fox, Chris/0000-0001-9480-5704; Robinson, Louise/0000-0003-0209-2503	NATIONAL INSTITUTE ON AGING [R01AG029884, K23AG026770] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG029884, R01AG029884-01, K23 AG 26770-01, K23 AG026770] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alzheimer's Association, ALZH DIS FACTS FIG; Alzheimer's Foundation of America, 2005, ACT HOM PLANN DAY PE, P1; Ashford JW, 2007, ALZHEIMERS DEMENT, V3, P75, DOI 10.1016/j.jalz.2006.02.005; Bates J, 2004, J ADV NURS, V45, P644, DOI 10.1046/j.1365-2648.2003.02959.x; Boise L, 1999, GERONTOLOGIST, V39, P457, DOI 10.1093/geront/39.4.457; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Boustani M, 2003, INT J GERIATR PSYCH, V18, P780, DOI 10.1002/gps.918; BOUSTANI M, SCREENING DEMENTIA S; Boustani M, 2006, INT J GERIATR PSYCH, V21, P556, DOI 10.1002/gps.1524; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Chiu HFK, 2000, INT J GERIATR PSYCH, V15, P947, DOI 10.1002/1099-1166(200010)15:10<947::AID-GPS222>3.3.CO;2-D; Chong MS, 2005, LANCET NEUROL, V4, P576, DOI 10.1016/S1474-4422(05)70168-X; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Galasko D, 2005, J ALZHEIMERS DIS, V8, P339; Gureje O, 2006, J PSYCHOSOM RES, V61, P327, DOI 10.1016/j.jpsychores.2006.07.016; Hopkins JS, 2006, J AM GERIATR SOC, V54, pS189; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Iliffe S, 2006, FAM PRACT, V23, P353, DOI 10.1093/fampra/cmi116; ILLIFFE S, 2004, LEARN HLTH SOC CARE, V3, P5; Livingston G, 2005, AM J PSYCHIAT, V162, P1996, DOI 10.1176/appi.ajp.162.11.1996; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Solomon PR, 2005, GERIATRICS-US, V60, P26	24	94	94	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2409	2411		10.1001/jama.298.20.2409	http://dx.doi.org/10.1001/jama.298.20.2409			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	18042918				2022-12-28	WOS:000251163400022
J	Diaz, R; Goyal, A; Mehta, SR; Afzal, R; Xavier, D; Pais, P; Chrolavicius, S; Zhu, J; Kazmi, K; Liu, LS; Budaj, A; Zubaid, M; Avezum, A; Ruda, M; Yusuf, S				Diaz, Rafael; Goyal, Abhinav; Mehta, Shamir R.; Afzal, Rizwan; Xavier, Denis; Pais, Prem; Chrolavicius, Susan; Zhu, Jun; Kazmi, Khawar; Liu, Lisheng; Budaj, Andrzej; Zubaid, Mohammad; Avezum, Alvaro; Ruda, Mikhail; Yusuf, Salim			Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METABOLIC CHANGES; RANDOMIZED-TRIAL; INFUSION; MORTALITY; REINFARCTION; HEPARIN; CREATE	Context The clinical benefit of glucose-insulin-potassium (GIK) infusion in patients with ST-segment elevation myocardial infarction (STEMI) is unclear. While some smaller trials suggest benefit, in the CREATE-ECLA trial, GIK infusion had no effect on 30-day mortality in 20 201 patients. Objectives To determine the association between GIK infusion therapy and 30-day and 6-month outcomes in patients with STEMI. Design, Setting, and Participants Primary analysis of the OASIS-6 GIK randomized controlled trial of 2748 patients with acute STEMI; prespecified analyses of the combined trial data from the OASIS-6 GIK and CREATE-ECLA GIK trial populations of 22 943 patients with acute STEMI; subgroup analysis on the timing of initiation of GIK infusion therapy and outcomes; and post hoc analyses exploring whether GIK infusion may cause early harm by increasing glucose and potassium levels and net fluid gain. Intervention High-dose GIK solution consisting of 25% glucose, 50 U/L of regular insulin, and 80 mEq/L of potassium infused at 1.5 mL/kg per hour for 24 hours. Main Outcome Measures Mortality rates at 30 days and 6 months in the OASIS-6 GIK trial and rates of death, heart failure, and the composite of death or heart failure at 3 and 30 days in the combined OASIS-6 GIK and CREATE-ECLA GIK trial populations. Results At 6 months, 148 (10.8%) GIK infusion patients and 143 (10.4%) control patients died in the OASIS-6 trial ( hazard ratio [HR], 1.04; 95% CI, 0.83-1.31; P=.72); 153 (11.1%) GIK patients and 185 (13.5%) control patients had heart failure ( HR, 0.83; 95% CI, 0.67-1.02; P=.08); and 240 (17.5%) GIK patients and 264 (19.2%) control patients had a composite of death or heart failure ( HR, 0.91; 95% CI, 0.76-1.08; P=.27). In the prespecified analyses of the combined trial data, there were 712 deaths (6.2%) in the GIK group and 632 deaths (5.5%) in the control group at 3 days ( HR, 1.13; 95% CI, 1.02-1.26; P=.03). This difference disappeared by 30 days, with 1108 deaths (9.7%) in the GIK group and 1068 (9.3%) in the control group ( HR, 1.04; 95% CI, 0.96-1.13; P=.33). GIK therapy increased levels of glucose, potassium, and net fluid gain postinfusion, all 3 of which predicted death after adjusting for multiple confounders. Adjusting for glucose, potassium, and net fluid gain eliminated the apparent increase in mortality at 3 days observed with GIK infusion, suggesting a direct association with these factors. Administration of GIK infusion within 4 hours of symptom onset yielded no benefit compared with later initiation. Conclusions Infusion of GIK provided no benefit and may cause early harm following STEMI. Avoidance of infusion-related hyperglycemia, hyperkalemia, and net fluid gain may be advisable in future studies of metabolic modulation in patients with STEMI. Trial Registration clinicaltrials.gov Identifier: NCT00064428.	Emory Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; Etud Cardiol Latin Amer, Rosario, Argentina; Emory Sch Med, Atlanta, GA USA; Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada; Natl Acad Hlth Sci, St Johns Med Coll, Bangalore, Karnataka, India; Chinese Hypertens League Inst, Cardiovasc Inst, Beijing, Peoples R China; Chinese Hypertens League Inst, Fu Wai Hosp, Beijing, Peoples R China; Aga Khan Univ, Karachi, Pakistan; Grochowski Hosp, Dept Cardiol, Postgrad Med Sch, Warsaw, Poland; Mubarak Al Kabeer Hosp, Safat, Kuwait; Dante Pazzanese Cardiol Inst, Sao Paulo, Brazil; Cardiol Res Ctr, Moscow 121552, Russia	Emory University; Rollins School Public Health; Emory University; McMaster University; Population Health Research Institute; McMaster University; St. John's National Academy of Health Sciences; St. John's Medical College; Chinese Hypertension League; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Hypertension League; Aga Khan University; Centre of Postgraduate Medical Education - Poland; Mubarak Al-Kabeer Hospital; Instituto Dante Pazzanese de Cardiologia; National Medical Research Center of Cardiology	Goyal, A (corresponding author), Emory Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd NE,Room 456, Atlanta, GA 30322 USA.	agoyal4@sph.emory.edu	Lutay, Yaroslav/GLT-9262-2022; Avezum, Alvaro AA/K-6137-2016; Goyal, Abhinav/J-5086-2012; Avezum, Alvaro/AAP-7687-2020	Avezum, Alvaro AA/0000-0002-3073-6890; Goyal, Abhinav/0000-0002-6286-2349; Budaj, Andrzej/0000-0002-6395-2098; Yusuf, Salim/0000-0003-4776-5601				DALBY AJ, 1981, CARDIOVASC RES, V15, P588, DOI 10.1093/cvr/15.10.588; FathOrdoubadi F, 1997, CIRCULATION, V96, P1152, DOI 10.1161/01.CIR.96.4.1152; *IMMEDIATE TRIAL, IMM MYOC MET ENH IN; MAROKO PR, 1972, CIRCULATION, V45, P1160, DOI 10.1161/01.CIR.45.6.1160; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437; OPIE LH, 1975, CIRCULATION, V52, P49, DOI 10.1161/01.CIR.52.1.49; RACKLEY CE, 1981, AM HEART J, V102, P1038, DOI 10.1016/0002-8703(81)90488-9; ROGERS WJ, 1976, AM HEART J, V92, P441, DOI 10.1016/S0002-8703(76)80043-9; ROGERS WJ, 1979, AM J CARDIOL, V43, P801, DOI 10.1016/0002-9149(79)90081-X; WHITLOW PL, 1982, AM J CARDIOL, V49, P811, DOI 10.1016/0002-9149(82)91963-4; Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519; Yusuf S, 2005, JAMA-J AM MED ASSOC, V293, P427; Yusuf S, 2004, AM HEART J, V148, P1068, DOI 10.1016/j.ahj.2004.08.033	13	138	146	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2399	2405		10.1001/jama.298.20.2399	http://dx.doi.org/10.1001/jama.298.20.2399			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	18042917				2022-12-28	WOS:000251163400020
J	Banez, LL; Hamilton, RJ; Partin, AW; Vollmer, RT; Sun, L; Rodriguez, C; Wang, YT; Terris, MK; Aronson, WJ; Presti, JC; Kane, CJ; Amling, CL; Moul, JW; Freedland, SJ				Banez, Lionel L.; Hamilton, Robert J.; Partin, Alan W.; Vollmer, Robin T.; Sun, Leon; Rodriguez, Carmen; Wang, Yiting; Terris, Martha K.; Aronson, William J.; Presti, Joseph C., Jr.; Kane, Christopher J.; Amling, Christopher L.; Moul, Judd W.; Freedland, Stephen J.			Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; RADICAL PROSTATECTOMY; RACIAL-DIFFERENCES; AFRICAN-AMERICAN; WEIGHT CHANGE; SERUM-LEVELS; ANTIGEN PSA; RISK; HEIGHT; RECURRENCE	Context Recent studies have suggested that obese men have lower serum prostate-specific antigen (PSA) concentrations than nonobese men. Because men with higher body mass index (BMI) have greater circulating plasma volumes, lower PSA concentrations among obese men may be due to hemodilution. Objective To determine the association between hemodilution and PSA concentration in obese men with prostate cancer. Design, Setting, and Participants Retrospective study of men who underwent radical prostatectomy for prostate adenocarcinoma from 1988 to 2006, using data from the databases of the Shared Equal Access Regional Cancer Hospital (n=1373), Duke Prostate Center (n=1974), and Johns Hopkins Hospital (n=10 287). Multivariate linear regression models adjusting for clinicopathological characteristics were used to analyze the main outcome measures. Main Outcome Measures Associations between BMI and mean adjusted PSA concentrations, mean plasma volume, and mean adjusted PSA mass ( total circulating PSA protein, calculated as PSA concentration multiplied by plasma volume), assessed by determining P values for trend. Results After controlling for clinicopathological characteristics, higher BMI was significantly associated with higher plasma volume ( P < .001 for trend) and lower PSA concentrations ( P <= .02 for trend) in all cohorts. In 2 of the 3 cohorts, PSA mass did not change significantly with increasing BMI. In the third cohort, higher BMI was associated with increased PSA mass ( P <. 001 for trend), but only between BMI category less than 25 and the other categories. Conclusions In men undergoing radical prostatectomy, higher BMI was associated with higher plasma volume hemodilution may therefore be responsible for the lower serum PSA concentrations among obese men with prostate cancer. Prospective studies are needed to evaluate this association in screened populations.	Duke Univ, Med Ctr, Div Urol Surg, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Surg, Duke Prostate Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Vet Affairs Med Ctr, Urol Sect, Durham, NC USA; Vet Affairs Med Ctr, Dept Pathol, Durham, NC USA; Univ Toronto, Dept Surg, Div Urol, Toronto, ON, Canada; Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD 21205 USA; Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; Vet Affairs Med Ctr, Urol Sect, Augusta, GA USA; Med Coll Georgia, Urol Sect, Augusta, GA 30912 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Urol Sect, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Urol, Los Angeles, CA USA; Stanford Univ, Sch Med, Dept Urol, Palo Alto, CA 94304 USA; Vet Affairs Med Ctr, Urol Sect, Palo Alto, CA 94304 USA; Vet Affairs Med Ctr, Urol Sect, San Francisco, CA 94121 USA; Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA; Univ Alabama Birmingham, Dept Urol, Birmingham, AL USA	Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Toronto; Johns Hopkins University; Johns Hopkins Medicine; American Cancer Society; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham	Freedland, SJ (corresponding author), Duke Univ, Med Ctr, Div Urol Surg, Box 2626, Durham, NC 27710 USA.	steve.freedland@duke.edu	wang, yiting/GYU-5306-2022; FENTON, MIRIAM C/B-6430-2011	Terris, Martha/0000-0002-3843-7270; Hamilton, Robert/0000-0002-6715-5934	NCI NIH HHS [R01CA100938, P50 CA92131-01A1, P50 CA58236] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA058236, R01CA100938, P50CA092131] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amling CL, 2004, J CLIN ONCOL, V22, P439, DOI 10.1200/JCO.2004.03.132; Baillargeon J, 2005, CANCER-AM CANCER SOC, V103, P1092, DOI 10.1002/cncr.20856; Barqawi AB, 2005, UROLOGY, V65, P708, DOI 10.1016/j.urology.2004.10.074; Bassett WW, 2005, UROLOGY, V66, P1060, DOI 10.1016/j.urology.2005.05.040; BOER P, 1984, AM J PHYSIOL, V247, pF632, DOI 10.1152/ajprenal.1984.247.4.F632; Bray GA, 2002, J NUTR, V132, p3451S, DOI 10.1093/jn/132.11.3451S; Bray GA, 2006, J MED CHEM, V49, P4001, DOI 10.1021/jm0680124; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; D'Amico AV, 2004, NEW ENGL J MED, V351, P125, DOI 10.1056/NEJMoa032975; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fowke JH, 2006, CANCER-AM CANCER SOC, V107, P2361, DOI 10.1002/cncr.22249; Freedland SJ, 2006, J UROLOGY, V175, P500, DOI 10.1016/S0022-5347(05)00162-X; Freedland SJ, 2005, J UROLOGY, V174, P1798, DOI 10.1097/01.ju.0000177077.53037.72; Freedland SJ, 2004, J CLIN ONCOL, V22, P446, DOI 10.1200/JCO.2004.04.181; Giovannucci E, 2003, J NATL CANCER I, V95, P1240, DOI 10.1093/jnci/djg009; Gray MA, 2004, ANTICANCER RES, V24, P2069; HAKIM R, 1994, HDB DIALYSIS; Henderson RJ, 1997, J NATL CANCER I, V89, P134, DOI 10.1093/jnci/89.2.134; Ku JH, 2003, UROLOGY, V61, P132, DOI 10.1016/S0090-4295(02)02001-0; Mavropoulos JC, 2007, UROLOGY, V69, P1138, DOI 10.1016/j.urology.2007.01.102; MOUL JW, 1995, JAMA-J AM MED ASSOC, V274, P1277, DOI 10.1001/jama.274.16.1277; NYHOLM HCJ, 1993, BRIT J OBSTET GYNAEC, V100, P1115, DOI 10.1111/j.1471-0528.1993.tb15176.x; Porter MP, 2005, PROSTATE, V62, P316, DOI 10.1002/pros.20121; Purohit A, 2002, STEROIDS, V67, P979, DOI 10.1016/S0039-128X(02)00046-6; Rodriguez C, 2001, CANCER EPIDEM BIOMAR, V10, P345; Rodriguez C, 2007, CANCER EPIDEM BIOMAR, V16, P63, DOI 10.1158/1055-9965.EPI-06-0754; SCHWARTZ LM, 2004, JAMA-J AM MED ASSOC, V291, P711; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Tzanakis I, 2002, NEPHRON, V90, P230, DOI 10.1159/000049051; Vollmer RT, 2003, AM J CLIN PATHOL, V119, P80, DOI 10.1309/UNAQJTFPB1RQBQD4; Werny DM, 2007, CANCER EPIDEM BIOMAR, V16, P70, DOI 10.1158/1055-9965.EPI-06-0588; Wolff JM, 2000, ANTICANCER RES, V20, P5191; Wright ME, 2007, CANCER-AM CANCER SOC, V109, P675, DOI 10.1002/cncr.22443	37	261	272	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2007	298	19					2275	2280		10.1001/jama.298.19.2275	http://dx.doi.org/10.1001/jama.298.19.2275			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232XV	18029831	Bronze			2022-12-28	WOS:000251055900027
J	Schwarz, JK; Siegel, BA; Dehdashti, F; Grigsby, PW				Schwarz, Julie K.; Siegel, Barry A.; Dehdashti, Farrokh; Grigsby, Perry W.			Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CELL LUNG-CANCER; NON-HODGKINS-LYMPHOMA; FDG-PET; PROGNOSTIC VALUE; PREOPERATIVE CHEMOTHERAPY; F-18 FLUORODEOXYGLUCOSE; RADICAL RADIOTHERAPY; RADIATION-THERAPY; CLINICAL IMPACT; SURVEILLANCE	Context Retrospective studies have demonstrated that the use of positron emission tomography ( PET) with F-18 fluorodeoxyglucose (FDG) in the posttherapy evaluation of patients with cervical carcinoma is predictive of survival outcome. Objective To validate the association between the metabolic response on the 3-month posttherapy FDG-PET and long-term survival outcome. Design, Setting, and Patients A prospective cohort study designed to validate our previous finding that the results of a 3-month posttherapy FDG-PET are predictive of long-term clinical outcome. A total of 92 women were treated with external irradiation, brachytherapy, and concurrent chemotherapy from January 2003 through September 2006. Posttherapy whole-body FDG-PET was performed 2 to 4 months ( mean, 3 months) after completion of therapy. Main Outcome Measures The primary outcome end points were metabolic response, progression-free survival, and cause-specific survival. Results Posttherapy FDG-PET showed a complete metabolic response in 65 patients (70%), a partial metabolic response in 15 (16%),and progressive disease in 12 (13%). Their 3-year progression-free survival rates were 78%, 33%, and 0%, respectively ( P <. 001). Multivariate analysis demonstrated that the hazard ratio (HR) for risk of recurrence based on the posttherapy metabolic response showing progressive disease was 32.57 (95% confidence interval [Cl], 10.22-103.82). A partial metabolic response had an HR of 6.30 ( 95% Cl, 2.73-14.56). These were more predictive of survival outcome than the pretreatment lymph node status ( HR, 3.54; 95% Cl, 1.54-8.09). Conclusion In this single-site study population of women with cervical cancer, 3-month posttherapy FDG uptake, as detected by whole-body PET, was predictive of survival.	Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Nucl Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Grigsby, PW (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Nucl Med, 4921 Parkview Pl,Box 8224, St Louis, MO 63110 USA.	pgrigsby@wustl.edu						Bodurka-Bevers D, 2000, GYNECOL ONCOL, V78, P187, DOI 10.1006/gyno.2000.5860; BRESLOW N, 1970, BIOMETRIKA, V57, P579, DOI 10.2307/2334776; Brun E, 2002, HEAD NECK-J SCI SPEC, V24, P127, DOI 10.1002/hed.10037.abs; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Chien CR, 2005, EUR J GYNAECOL ONCOL, V26, P619; Chung HH, 2007, GYNECOL ONCOL, V104, P529, DOI 10.1016/j.ygyno.2006.09.009; Chung HH, 2006, GYNECOL ONCOL, V103, P165, DOI 10.1016/j.ygyno.2006.02.016; COX DR, 1972, J R STAT SOC B, V34, P187; Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; Ellenson LH, 2004, CANCER CELL, V5, P533, DOI 10.1016/j.ccr.2004.05.029; Greven KM, 2001, HEAD NECK-J SCI SPEC, V23, P942, DOI 10.1002/hed.1136; Grigsby PW, 2004, J CLIN ONCOL, V22, P2167, DOI 10.1200/JCO.2004.09.035; Grigsby PW, 2003, INT J RADIAT ONCOL, V55, P907, DOI 10.1016/S0360-3016(02)04287-6; Grigsby PW, 2001, J CLIN ONCOL, V19, P3745, DOI 10.1200/JCO.2001.19.17.3745; GRIGSBY PW, 1994, INT J RADIAT ONCOL, V28, P451, DOI 10.1016/0360-3016(94)90070-1; Hicks RJ, 2004, INT J RADIAT ONCOL, V60, P412, DOI 10.1016/j.ijrobp.2004.03.036; Hong JH, 2004, INT J RADIAT ONCOL, V60, P249, DOI 10.1016/j.ijrobp.2004.02.044; JACOBS AJ, 1986, CANCER, V57, P944, DOI 10.1002/1097-0142(19860301)57:5<944::AID-CNCR2820570512>3.0.CO;2-2; Jerusalem G, 1999, BLOOD, V94, P429, DOI 10.1182/blood.V94.2.429.414k26_429_433; Juweid ME, 2007, J CLIN ONCOL, V25, P571, DOI 10.1200/JCO.2006.08.2305; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P901; Kostakoglu L, 2002, J NUCL MED, V43, P1018; Mac Manus MP, 2005, LUNG CANCER, V49, P95, DOI 10.1016/j.lungcan.2004.11.024; Mac Manus MP, 2003, J CLIN ONCOL, V21, P1285, DOI 10.1200/JCO.2003.07.054; Naumann R, 2001, BRIT J HAEMATOL, V115, P793, DOI 10.1046/j.1365-2141.2001.03147.x; (NCI) NCI, SURV EP END RES SEER; Ott K, 2003, J CLIN ONCOL, V21, P4604, DOI 10.1200/JCO.2003.06.574; Plummer M, 2002, VIRUS RES, V89, P285, DOI 10.1016/S0168-1702(02)00197-1; Porceddu SV, 2005, HEAD NECK-J SCI SPEC, V27, P175, DOI 10.1002/hed.20130; Schelling M, 2000, J CLIN ONCOL, V18, P1689, DOI 10.1200/JCO.2000.18.8.1689; SHIELD PW, 1992, CYTOPATHOLOGY, V3, P167, DOI 10.1111/j.1365-2303.1992.tb00043.x; Singh AK, 2005, INT J RADIAT ONCOL, V61, P450, DOI 10.1016/j.ijrobp.2004.06.207; Smith IC, 2000, J CLIN ONCOL, V18, P1676, DOI 10.1200/JCO.2000.18.8.1676; SOMMERS GM, 1989, GYNECOL ONCOL, V35, P150, DOI 10.1016/0090-8258(89)90033-4; Spaepen K, 2003, EUR J NUCL MED MOL I, V30, P682, DOI 10.1007/s00259-003-1120-6; Spaepen K, 2001, J CLIN ONCOL, V19, P414, DOI 10.1200/JCO.2001.19.2.414; Tewari D, 2005, GYNECOL ONCOL, V99, P84, DOI 10.1016/j.ygyno.2005.05.043; Weber WA, 2003, J CLIN ONCOL, V21, P2651, DOI 10.1200/JCO.2003.12.004; Weber WA, 2001, J CLIN ONCOL, V19, P3058, DOI 10.1200/JCO.2001.19.12.3058; Weihrauch MR, 2001, BLOOD, V98, P2930, DOI 10.1182/blood.V98.10.2930; Wright JD, 2005, CANCER, V104, P2484, DOI 10.1002/cncr.21527; Yao M, 2004, INT J RADIAT ONCOL, V60, P1410, DOI 10.1016/j.ijrobp.2004.05.058; Yen TC, 2004, J NUCL MED, V45, P1632	44	222	227	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2007	298	19					2289	2295		10.1001/jama.298.19.2289	http://dx.doi.org/10.1001/jama.298.19.2289			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232XV	18029833	Bronze			2022-12-28	WOS:000251055900029
J	DeLoughery, TG				DeLoughery, Thomas G.			Update in Hematology	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEMODIALYSIS-PATIENTS; ANEMIA CORRECTION		Oregon Hlth & Sci Univ, Lab Med, Div Hematol Med Oncol, Portland, OR 97239 USA	Oregon Health & Science University	DeLoughery, TG (corresponding author), Oregon Hlth & Sci Univ, Lab Med, Div Hematol Med Oncol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	delought@ohsu.edu						[Anonymous], 1987, LANCET, V2, P1351; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Christiansen SC, 2005, JAMA-J AM MED ASSOC, V293, P2352, DOI 10.1001/jama.293.19.2352; DAMESHEK W, 1946, BLOOD, V1, P27, DOI 10.1182/blood.V1.1.27.27; Foley RN, 2000, KIDNEY INT, V58, P1325, DOI 10.1046/j.1523-1755.2000.00289.x; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Jenkins JM, 2007, BLOOD, V109, P4739, DOI 10.1182/blood-2006-11-057968; Newland A, 2006, BRIT J HAEMATOL, V135, P547, DOI 10.1111/j.1365-2141.2006.06339.x; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Pfeffer MA, 2007, NEW ENGL J MED, V356, P959, DOI 10.1056/NEJMc066568; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003	13	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2007	147	10					717	724		10.7326/0003-4819-147-10-200711200-00008	http://dx.doi.org/10.7326/0003-4819-147-10-200711200-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235UJ	18025447				2022-12-28	WOS:000251259500006
J	Roberts, SE; Williams, JG; Yeates, D; Goldacre, MJ				Roberts, Stephen E.; Williams, John G.; Yeates, David; Goldacre, Michael J.			Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFLAMMATORY-BOWEL-DISEASE; RESTORATIVE PROCTOCOLECTOMY; MEDICAL THERAPY; EPIDEMIOLOGY; POPULATION; SURGERY; CARDIFF; COPENHAGEN; EXPERIENCE; MANAGEMENT	Objective To compare mortality outcomes in the three years after elective colectommy, no colectomy, and emergency colectomy among people admitted to hospital for inflammatory bowel disease, to inform whether the threshold for elective colectomy in clinical practice is appropriate. Design Record linkage studies. Setting Oxford region (1968-99) and England (1998-2003). Participants 23 464 people with hospital stay for more than three days for inflammatory bowel disease, including 5480 who had colectomy. Main outcome measures Case fatality, relative survival, and standardised mortality ratios. Results In the Oxford region, three year mortality was lower after elective colectomy than after either no colectomy or emergency colectomy, although this was not significant. For England, mortality three years after elective colectomy for ulcerative colitis (3.7%) and Crohn's disease (3.3%) was significantly lower than that after either admission without colectomy (13.6% and 10.1%; both P<0.001) or emergency colectomy (13.2% and 9.9%; P<0.001 for colitis and P<0.01 for Crohn's disease). Three or more months after elective colectomy, mortality was similar to that in the general population. Adjustment for comorbidity did not affect the findings. Conclusions In England, the clinical threshold for elective colectomy in people with inflammatory bowel disease may be too high. Further research is now required to establish the threshold criteria and optimal timing of elective surgery for people with poorly controlled inflammatory bowel disease.	Swansea Univ, Sch Med, Swansea SA2 8PP, W Glam, Wales; Univ Oxford, Dept Publ Hlth, Oxford OX1 2JD, England	Swansea University; University of Oxford	Roberts, SE (corresponding author), Swansea Univ, Sch Med, Swansea SA2 8PP, W Glam, Wales.	stephen.e.roberts@swansea.ac.uk						ANDREWS HA, 1989, BRIT J SURG, V76, P1184, DOI 10.1002/bjs.1800761123; Armitage E, 1999, LANCET, V353, P1496, DOI 10.1016/S0140-6736(99)00333-5; BJOMSSON S, 1998, SCAND J GASTROENTERO, V33, P71; Caprilli R, 2000, AM J GASTROENTEROL, V95, P1258; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; Cosgrove M, 1996, ARCH DIS CHILD, V74, P460, DOI 10.1136/adc.74.5.460; FELLOWS IW, 1990, GUT, V31, P1262, DOI 10.1136/gut.31.11.1262; Fonager K, 1997, INT J EPIDEMIOL, V26, P1003, DOI 10.1093/ije/26.5.1003; Jess T, 2007, INFLAMM BOWEL DIS, V13, P481, DOI 10.1002/ibd.20036; KYLE J, 1992, GASTROENTEROLOGY, V103, P392, DOI 10.1016/0016-5085(92)90826-K; Lakatos L, 2004, WORLD J GASTROENTERO, V10, P404; Lapidus A, 1997, GUT, V41, P480, DOI 10.1136/gut.41.4.480; Logan RFA, 1998, GUT, V42, P309, DOI 10.1136/gut.42.3.309; MELVILLE DM, 1994, GUT, V35, P1076, DOI 10.1136/gut.35.8.1076; Michelassi F, 2003, ANN SURG, V238, P433, DOI 10.1097/01.sla.0000086658.60555.ea; MILLER DS, 1974, LANCET, V2, P691; Molinie F, 2004, GUT, V53, P843, DOI 10.1136/gut.2003.025346; MUNKHOLM P, 1992, SCAND J GASTROENTERO, V27, P609, DOI 10.3109/00365529209000127; Oresland T, 2006, ALIMENT PHARM THERAP, V24, P74, DOI 10.1111/j.1365-2036.2006.03065.x; Pebody RG, 1998, BRIT MED J, V316, P1745; PRIMATESTA P, 1995, INT J EPIDEMIOL, V24, P922, DOI 10.1093/ije/24.5.922; Romanos J, 1997, BRIT J SURG, V84, P814, DOI 10.1002/bjs.1800840623; Rubin GP, 2000, ALIMENT PHARM THER, V14, P1553, DOI 10.1046/j.1365-2036.2000.00886.x; SCAMMELL BE, 1987, BRIT J SURG, V74, P671, DOI 10.1002/bjs.1800740805; Seagroatt V, 2003, J EPIDEMIOL COMMUN H, V57, P883, DOI 10.1136/jech.57.11.883; Smart NJ, 2006, BRIT MED J, V333, P501, DOI 10.1136/bmj.333.7566.501-b; SRIVASTAVA ED, 1992, GUT, V33, P256, DOI 10.1136/gut.33.2.256; THOMAS GAO, 1995, EUR J GASTROEN HEPAT, V7, P401; Travis S, 2006, ALIMENT PHARM THER, V24, P68, DOI 10.1111/j.1365-2036.2006.03064.x; Travis SPL, 1996, GUT, V38, P905, DOI 10.1136/gut.38.6.905; TSIANOS EV, 1994, GUT, V35, P369, DOI 10.1136/gut.35.3.369; TYSK C, 1992, SCAND J GASTROENTERO, V27, P945, DOI 10.3109/00365529209000168; Yapp TR, 2000, EUR J GASTROEN HEPAT, V12, P907, DOI 10.1097/00042737-200012080-00010	33	118	121	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2007	335	7628					1033	1036B		10.1136/bmj.39345.714039.55	http://dx.doi.org/10.1136/bmj.39345.714039.55			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UV	17977817	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000251402800032
J	Konig, H; Matter, N; Bader, R; Thiele, W; Muller, F				Koenig, Harald; Matter, Nathalie; Bader, Ruediger; Thiele, Wilko; Mueller, Ferenc			Splicing segregation: The minor spliceosome acts outside the nucleus and controls cell proliferation	CELL			English	Article							POLYMERASE-II TRANSCRIPTION; U12-TYPE INTRONS; EMBRYONIC-DEVELOPMENT; MORPHOLINO OLIGOMERS; GENE-EXPRESSION; ZEBRAFISH; PROTEINS; ABUNDANCE; INSIGHTS; SNRNA	The functional relevance and the evolution of two parallel mRNA splicing systems in eukaryotes - a major and minor spliceosome that differ in abundance and splicing rate - are poorly understood. We report here that partially spliced pre-mRNAs containing minor-class introns undergo nuclear export and that minor-class snRNAs are predominantly cytoplasmic in vertebrates. Cytoplasmic interference with the minor spliceosome further indicated its functional segregation from the nucleus. In keeping with this, minor splicing was only weakly affected during mitosis. By selectively interfering with snRNA function in zebrafish development and in mammalian cells, we revealed a conserved role for minor splicing in cell-cycle progression. We argue that the segregation of the splicing systems allows for processing of partially unspliced cytoplasmic transcripts, emerging as a result of different splicing rates. The segregation offers a mechanism accounting for spliceosome evolution in a single lineage and provides a means for nucleus-independent control of gene expression.	Forschungszentrum Karlsruhe, Inst Genet & Toxikol, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Muller, F (corresponding author), Forschungszentrum Karlsruhe, Inst Genet & Toxikol, Postfach 3640, D-76021 Karlsruhe, Germany.	harald.koenig@itg.fzk.de; f.mueller@bham.ac.uk	Thiele, Wilko/AAF-7856-2020; Muller, Ferenc/C-6426-2009	Thiele, Wilko/0000-0002-8978-4192; Konig, Harald/0000-0002-0117-0939; mueller, ferenc/0000-0002-0996-774X				Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; CARMOFONSECA M, 1991, EMBO J, V10, P195, DOI 10.1002/j.1460-2075.1991.tb07936.x; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; HALL SL, 1994, J MOL BIOL, V239, P357, DOI 10.1006/jmbi.1994.1377; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; HUANG S, 1992, P NATL ACAD SCI USA, V89, P305, DOI 10.1073/pnas.89.1.305; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kane DA, 1996, DEVELOPMENT, V123, P57; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kim H, 2004, NAT GENET, V36, P915, DOI 10.1038/ng0904-915; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Matter N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni041; Meunier L, 1999, NUCLEIC ACIDS RES, V27, P2730, DOI 10.1093/nar/27.13.2730; MONTZKA KA, 1988, P NATL ACAD SCI USA, V85, P8885, DOI 10.1073/pnas.85.23.8885; Moulton HM, 2004, BIOCONJUGATE CHEM, V15, P290, DOI 10.1021/bc034221g; Muller F, 2001, CURR BIOL, V11, P282, DOI 10.1016/S0960-9822(01)00076-8; Nelson MH, 2005, BIOCONJUGATE CHEM, V16, P959, DOI 10.1021/bc0501045; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Parsons GG, 1997, MOL CELL BIOL, V17, P5791, DOI 10.1128/MCB.17.10.5791; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Patel AA, 2002, EMBO J, V21, P3804, DOI 10.1093/emboj/cdf297; Pessa HKJ, 2006, RNA, V12, P1883, DOI 10.1261/rna.213906; Russell AG, 2006, NATURE, V443, P863, DOI 10.1038/nature05228; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; Tarng YS, 1996, INT J ADV MANUF TECH, V11, P12, DOI 10.1007/BF01177179; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604; Will CL, 1999, SCIENCE, V284, P2003, DOI 10.1126/science.284.5422.2003; ZHUANG Y, 1989, GENE DEV, V3, P1545, DOI 10.1101/gad.3.10.1545	42	75	77	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					718	729		10.1016/j.cell.2007.09.043	http://dx.doi.org/10.1016/j.cell.2007.09.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022366	Bronze			2022-12-28	WOS:000250966300019
J	Kouzarides, T				Kouzarides, Tony			SnapShot: Histone-modifying enzymes	CELL			English	Editorial Material							LYSINE METHYLATION; TRANSCRIPTION; CODE		Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England	University of Cambridge	Kouzarides, T (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.			Kouzarides, Tony/0000-0002-8918-4162				HSILATIFARD A, 2006, ANNU REV BIOCHEM, V75, P243; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Thompson PR, 2006, ACS CHEM BIOL, V1, P433, DOI 10.1021/cb6002306; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	10	99	102	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4							822.e1	10.1016/j.cell.2007.11.005	http://dx.doi.org/10.1016/j.cell.2007.11.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022374	Bronze			2022-12-28	WOS:000250966300027
J	Drell, SD				Drell, Sidney D.			Wolfgang K. H. Panofsky (1919-2007) - Obituary	NATURE			English	Biographical-Item									Stanford Univ, Stanford Linear Accelerator Ctr, Menlo Pk, CA 94025 USA; Hoover Inst War Revolut & Peace, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Drell, SD (corresponding author), Stanford Univ, Stanford Linear Accelerator Ctr, Menlo Pk, CA 94025 USA.	drell@slac.stanford.edu						PANOFSKY WKH, PUBLICATION LIST	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					182	182		10.1038/450182a	http://dx.doi.org/10.1038/450182a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994080				2022-12-28	WOS:000250746200035
J	Kunz, R; Friedrich, C; Wolbers, M; Mann, JFE				Kunz, Regina; Friedrich, Chris; Wolbers, Marcel; Mann, Johannes F. E.			Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease	ANNALS OF INTERNAL MEDICINE			English	Review							TYPE-2 DIABETIC-PATIENTS; II RECEPTOR BLOCKER; CONVERTING ENZYME-INHIBITORS; RANDOMIZED CONTROLLED-TRIAL; CALCIUM-CHANNEL BLOCKER; DOSE DUAL BLOCKADE; DOUBLE-BLIND; ACE-INHIBITION; NORMOTENSIVE PATIENTS; BLOOD-PRESSURE	Background: Reduction of proteinuria is associated with delayed progression of chronic kidney disease. Reports suggest that angiotensin-receptor blockers (ARBs) reduce proteinuria, but results are variable. The relative effect of ARBs and angiotensin-converting enzyme (ACE) inhibitors, and their combined administration, remains uncertain. Purpose: To establish the effect of ARBs versus placebo and alternative treatments, and the effect of combined treatment with ARBs and ACE inhibitors, on proteinuria. Data Sources: English-language studies in MEDLINE and the Cochrane Library Central Register of Controlled Trials (January 1990 to September 2006), reference lists, and expert contacts. Study Selection: Randomized trials of ARBs versus placebo, ACE inhibitors, calcium-channel blockers, or the combination of ARBs and ACE inhibitors in patients with or without diabetes and with microalbuminuria or proteinuria for whom data were available on urinary protein excretion at baseline and at 1 to 12 months. Data Extraction: Two investigators independently searched and abstracted studies. Data Synthesis: Forty-nine studies involving 6181 participants reported results of 72 comparisons with 1 to 4 months of follow-up and 38 comparisons with 5 to 12 months of follow-up. The ARBs reduced proteinuria compared with placebo or calcium-channel blockers over 1 to 4 months (ratio of means, 0.57 [95% Cl, 0.47 to 0.68] and 0.69 [Cl, 0.62 to 0.77], respectively) and 5 to 12 months (ratio of means, 0.66 [Cl, 0.63 to 0.69] and 0.62 [Cl, 0.55 to 0.70], respectively). The ARBs and ACE inhibitors reduced proteinuria to a similar degree. The combination of ARBs and ACE inhibitors further reduced proteinuria more than either agent alone: The ratio of means for combination therapy versus ARBs was 0.76 (Cl, 0.68 to 0.85) over 1 to 4 months and 0.75 (Cl, 0.61 to 0.92) over 5 to 12 months; for combination therapy versus ACE inhibitors, the ratio of means was 0.78 (Cl, 0.72 to 0.84) over 1 to 4 months and 0.82 (Cl, 0.67 to 1.01) over 5 to 12 months. The antiproteinuric effect was consistent across subgroups. Limitations: Most studies were small, varied in quality, and did not provide reliable data on adverse drug reactions. Proteinuria reduction is only a surrogate for important progression of renal failure. Conclusion: The ARBs reduce proteinuria, independent of the degree of proteinuria and of underlying disease. The magnitude of effect is similar regardless of whether the comparator is placebo or calcium-channel blocker. Reduction in proteinuria from ARBs and ACE inhibitors is similar, but their combination is more effective than either drug alone. Uncertainty concerning adverse effects and outcomes that are important to patients limits applicability of findings to clinical practice.	[Kunz, Regina; Friedrich, Chris; Wolbers, Marcel; Mann, Johannes F. E.] Univ Basel Hosp, Clin Transplantat Immunol & Nephrol, CH-4031 Basel, Switzerland; [Kunz, Regina; Friedrich, Chris; Wolbers, Marcel; Mann, Johannes F. E.] Univ Munich, Munich Gen Hosp, Munich, Germany; [Kunz, Regina; Friedrich, Chris; Wolbers, Marcel; Mann, Johannes F. E.] Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland	University of Basel; University of Munich; University of Basel	Kunz, R (corresponding author), Univ Basel Hosp, Basel Inst Clin Epidemiol, Hebelstr 10, CH-4031 Basel, Switzerland.	rkunz@uhbs.ch	Mann, Johannes/AAI-8803-2020					Agarwal R, 2001, KIDNEY INT, V59, P2282, DOI 10.1046/j.1523-1755.2001.00745.x; Andersen S, 2000, KIDNEY INT, V57, P601, DOI 10.1046/j.1523-1755.2000.t01-1-00880.x; Atkins RC, 2005, AM J KIDNEY DIS, V45, P281, DOI 10.1053/j.ajkd.2004.10.019; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Berger ED, 2002, J HYPERTENS, V20, P739, DOI 10.1097/00004872-200204000-00033; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; BUCHER HC, 2007, USERS GUIDES MED LIT; Campbell R, 2003, KIDNEY INT, V63, P1094, DOI 10.1046/j.1523-1755.2003.00832.x; Cetinkaya R, 2004, INT J CLIN PRACT, V58, P432, DOI 10.1111/j.1368-5031.2004.00004.x; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Curtin F, 2002, STAT MED, V21, P2161, DOI 10.1002/sim.1207; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Deeks JJ, 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Esnault VLM, 2005, J AM SOC NEPHROL, V16, P474, DOI 10.1681/ASN.2004060505; Ferrari P, 2002, J HYPERTENS, V20, P125, DOI 10.1097/00004872-200201000-00018; Friedrich JO, 2005, ANN INTERN MED, V142, P510, DOI 10.7326/0003-4819-142-7-200504050-00010; GANSEVOORT RT, 1994, KIDNEY INT, V45, P861, DOI 10.1038/ki.1994.113; Gartenmann AC, 2003, KIDNEY INT, V64, P1450, DOI 10.1046/j.1523-1755.2003.00238.x; Haneda M, 2004, DIABETES RES CLIN PR, V66, P87, DOI 10.1016/j.diabres.2004.02.015; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hilgers KF, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341100; Holdaas H, 1998, NEPHROL DIAL TRANSPL, V13, P3096, DOI 10.1093/ndt/13.12.3096; Horita Y, 2004, HYPERTENS RES, V27, P963, DOI 10.1291/hypres.27.963; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Iino Y, 2004, HYPERTENS RES, V27, P21, DOI 10.1291/hypres.27.21; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Ishimitsu T, 2005, HYPERTENS RES, V28, P865, DOI 10.1291/hypres.28.865; Jacobsen P, 2003, J AM SOC NEPHROL, V14, P992, DOI 10.1097/01.ASN.0000054495.96193.BF; Jacobsen P, 2003, KIDNEY INT, V63, P1874, DOI 10.1046/j.1523-1755.2003.00940.x; Jacobsen P, 2002, NEPHROL DIAL TRANSPL, V17, P1019, DOI 10.1093/ndt/17.6.1019; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kim MJ, 2003, YONSEI MED J, V44, P463, DOI 10.3349/ymj.2003.44.3.463; Kincaid-Smith P, 2002, NEPHROL DIAL TRANSPL, V17, P597, DOI 10.1093/ndt/17.4.597; Lacourciere Y, 2000, KIDNEY INT, V58, P762, DOI 10.1046/j.1523-1755.2000.00224.x; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Laverman GD, 2002, KIDNEY INT, V62, P1020, DOI 10.1046/j.1523-1755.2002.00536.x; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Li PKT, 2006, AM J KIDNEY DIS, V47, P751, DOI 10.1053/j.ajkd.2006.01.017; Luno J, 2002, KIDNEY INT, V62, pS47, DOI 10.1046/j.1523-1755.62.s82.10.x; Matos JPS, 2005, CLIN NEPHROL, V64, P180; Matsuda H, 2003, HYPERTENS RES, V26, P875, DOI 10.1291/hypres.26.875; Mogensen CE, 2000, BRIT MED J, V321, P1440, DOI 10.1136/bmj.321.7274.1440; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Muirhead N, 1999, CURR THER RES CLIN E, V60, P650, DOI 10.1016/S0011-393X(99)90003-6; Nakao N, 2003, LANCET, V361, P117, DOI 10.1016/S0140-6736(03)12229-5; Nutahara K, 2005, NEPHRON CLIN PRACT, V99, pC18, DOI 10.1159/000081790; Park HC, 2003, NEPHROL DIAL TRANSPL, V18, P1115, DOI 10.1093/ndt/gfg090; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Praga M, 2003, NEPHROL DIAL TRANSPL, V18, P1806, DOI 10.1093/ndt/gfg284; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Renke M, 2004, SCAND J UROL NEPHROL, V38, P427, DOI 10.1080/00365590410015687; Rossing K, 2003, DIABETES CARE, V26, P2268, DOI 10.2337/diacare.26.8.2268; Rossing K, 2003, DIABETES CARE, V26, P150, DOI 10.2337/diacare.26.1.150; Rossing K, 2002, DIABETES CARE, V25, P95, DOI 10.2337/diacare.25.1.95; Ruilope LM, 2000, J HYPERTENS, V18, P89, DOI 10.1097/00004872-200018010-00013; Russo D, 2001, AM J KIDNEY DIS, V38, P18, DOI 10.1053/ajkd.2001.25176; Rutkowski P, 2004, AM J KIDNEY DIS, V43, P260, DOI 10.1053/j.ajkd.2003.10.032; Sasso FC, 2002, DIABETES CARE, V25, P1909, DOI 10.2337/diacare.25.11.1909; Schmieder RE, 2005, J AM SOC NEPHROL, V16, P3038, DOI 10.1681/ASN.2005020138; Schulz E, 2000, CLIN DRUG INVEST, V19, P183, DOI 10.2165/00044011-200019030-00003; Segura J, 2003, J RENIN-ANGIO-ALDO S, V4, P43, DOI 10.3317/jraas.2003.007; Sengul AM, 2006, DIABETES RES CLIN PR, V71, P210, DOI 10.1016/j.diabres.2005.06.010; Song JH, 2006, NEPHROL DIAL TRANSPL, V21, P683, DOI 10.1093/ndt/gfi310; Tutuncu NB, 2001, ACTA DIABETOL, V38, P157, DOI 10.1007/s592-001-8073-2; Tylicki L, 2005, MED SCI MONITOR, V11, pP131; Viberti G, 2002, CIRCULATION, V106, P672, DOI 10.1161/01.CIR.0000024416.33113.0A; Wilmer WA, 2003, J AM SOC NEPHROL, V14, P3217, DOI 10.1097/01.ASN.0000100145.27188.33; Yasuda G, 2005, DIABETES CARE, V28, P1862, DOI 10.2337/diacare.28.8.1862; Zandbergen AAM, 2003, ANN INTERN MED, V139, P90, DOI 10.7326/0003-4819-139-2-200307150-00008	74	489	528	0	51	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2008	148	1					30	48		10.7326/0003-4819-148-1-200801010-00190	http://dx.doi.org/10.7326/0003-4819-148-1-200801010-00190			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248JJ	17984482				2022-12-28	WOS:000252149300004
J	Heath, I; Hippisley-Cox, J; Smeeth, L				Heath, Iona; Hippisley-Cox, Julia; Smeeth, Liam			Measuring performance and missing the point?	BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; ASSOCIATION; DEPRIVATION; QUALITY		Caversham Grp Practice, London NW5 2UP, England; Univ Nottingham, Nottingham NG7 2RD, England; London Sch Hyg & Trop Med, London, England	University of Nottingham; University of London; London School of Hygiene & Tropical Medicine	Heath, I (corresponding author), Caversham Grp Practice, London NW5 2UP, England.	iona.heath@dsl.pipex.com	Hippisley-Cox, Julia/AAY-2788-2020; Smeeth, Liam/X-5862-2018	Hippisley-Cox, Julia/0000-0002-2479-7283; Smeeth, Liam/0000-0002-9168-6022	Wellcome Trust [082178] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Fairbrother G, 1999, AM J PUBLIC HEALTH, V89, P171, DOI 10.2105/AJPH.89.2.171; Feinstein AR, 1998, J CLIN EPIDEMIOL, V51, P297, DOI 10.1016/S0895-4356(98)00004-3; Fleetcroft Robert, 2006, J Health Serv Res Policy, V11, P27, DOI 10.1258/135581906775094316; Goodwin JS, 2003, J GERONTOL A-BIOL, V58, P653; Hippisley-Cox J, 2004, BRIT MED J, V329, P1267, DOI 10.1136/bmj.38279.588125.7C; Jeffries D, 2006, BRIT J GEN PRACT, V56, P392; McLean G, 2006, J EPIDEMIOL COMMUN H, V60, P917, DOI 10.1136/jech.2005.044628; *QRES, COM DIS NEW GEN MED; Rastas S, 2006, J AM GERIATR SOC, V54, P912, DOI 10.1111/j.1532-5415.2006.00742.x; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788	10	58	59	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 24	2007	335	7629					1075	1076		10.1136/bmj.39377.387373.AD	http://dx.doi.org/10.1136/bmj.39377.387373.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	237UX	18033930	Green Submitted, Green Published			2022-12-28	WOS:000251403000034
J	Nakata, M; Zanchetta, G; Chapman, BD; Jones, CD; Cross, JO; Pindak, R; Bellini, T; Clark, NA				Nakata, Michi; Zanchetta, Giuliano; Chapman, Brandon D.; Jones, Christopher D.; Cross, Julie O.; Pindak, Ronald; Bellini, Tommaso; Clark, Noel A.			End-to-end stacking and liquid crystal condensation of 6-to 20-base pair DNA duplexes	SCIENCE			English	Article							ORDERED PHASES; POLYDISPERSITY; BEHAVIOR; LENGTH	Short complementary B-form DNA oligomers, 6 to 20 base pairs in length, are found to exhibit nematic and columnar liquid crystal phases, even though such duplexes lack the shape anisotropy required for liquid crystal ordering. Structural study shows that these phases are produced by the end-to-end adhesion and consequent stacking of the duplex oligomers into polydisperse anisotropic rod-shaped aggregates, which can order into liquid crystals. Upon cooling mixed solutions of short DNA oligomers, in which only a small fraction of the DNA present is complementary, the duplex-forming oligomers phase-separate into liquid crystal droplets, leaving the unpaired single strands in isotropic solution. In a chemical environment where oligomer ligation is possible, such ordering and condensation would provide an autocatalytic link whereby complementarity promotes the extended polymerization of complementary oligomers.	Univ Colorado, Dept Phys, Boulder, CO 80309 USA; Univ Colorado, Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA; Univ Milan, Dipartimento Chim Biochim & Biotecnol Med, Milan, Italy; Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Milan; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Bellini, T (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	tommaso.bellini@unimi.it; noel.clark@colorado.edu	Bellini, Tommaso/M-5510-2014; Zanchetta, Giuliano/C-5952-2008; Clark, Noel A/AAP-9116-2020; Clark, Noel A./E-9011-2010	Bellini, Tommaso/0000-0003-4898-4400; Zanchetta, Giuliano/0000-0002-6650-0353; Clark, Noel A./0000-0001-9301-5540				ALAM TM, 1990, J CHEM PHYS, V92, P6840, DOI 10.1063/1.458270; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Bates MA, 1998, J CHEM PHYS, V109, P6193, DOI 10.1063/1.477248; Bohle AM, 1996, PHYS REV LETT, V76, P1396, DOI 10.1103/PhysRevLett.76.1396; Bolhuis P, 1997, J CHEM PHYS, V106, P666, DOI 10.1063/1.473404; BRANDES R, 1986, BIOCHEMISTRY-US, V25, P5890, DOI 10.1021/bi00368a008; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, pCH3; FERRIS JP, 1992, SCIENCE, V257, P1387, DOI 10.1126/science.1529338; FLORY PJ, 1978, MACROMOLECULES, V11, P1138, DOI 10.1021/ma60066a015; FRANKLIN RE, 1953, NATURE, V171, P740, DOI 10.1038/171740a0; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; HENTSCHKE R, 1991, PHYS REV A, V44, P1148, DOI 10.1103/PhysRevA.44.1148; Horowitz VR, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041710; LIVOLANT F, 1989, NATURE, V339, P724, DOI 10.1038/339724a0; Livolant F, 1996, PROG POLYM SCI, V21, P1115, DOI 10.1016/S0079-6700(96)00016-0; Lu XJ, 2004, J CHEM PHYS, V120, P10328, DOI 10.1063/1.1729855; LUZZATI V, 1959, J MOL BIOL, V1, P127, DOI 10.1016/S0022-2836(59)80041-3; LYDON JE, 2001, CURR OPIN COLLOID IN, V8, P480; LYDON JE, 2003, LIQ CRYST TODAY, V12, P1, DOI DOI 10.1080/14645180310001603962; MANDELKERN M, 1981, J MOL BIOL, V152, P153, DOI 10.1016/0022-2836(81)90099-1; Merchant K, 1997, BIOPHYS J, V73, P3154, DOI 10.1016/S0006-3495(97)78341-3; ONSAGER L, 1949, ANN NY ACAD SCI, V51, P627, DOI 10.1111/j.1749-6632.1949.tb27296.x; Podgornik R, 1998, CURR OPIN COLLOID IN, V3, P534, DOI 10.1016/S1359-0294(98)80029-0; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; RILL RL, 1991, PHYSICA A, V176, P87, DOI 10.1016/0378-4371(91)90435-F; ROBINSON C, 1961, TETRAHEDRON, V13, P219, DOI 10.1016/S0040-4020(01)92215-X; SELINGER JV, 1991, PHYS REV A, V43, P2922, DOI 10.1103/PhysRevA.43.2922; TAYLOR MP, 1990, LANGMUIR, V6, P911, DOI 10.1021/la00095a004; Teixeira PIC, 2000, J PHYS-CONDENS MAT, V12, pR411, DOI 10.1088/0953-8984/12/33/201; Tinland B, 1997, MACROMOLECULES, V30, P5763, DOI 10.1021/ma970381+; VANDERSCHOOT P, 1994, LANGMUIR, V10, P670, DOI 10.1021/la00015a014; WILKINS MHF, 1953, NATURE, V171, P738, DOI 10.1038/171738a0; WING R, 1980, NATURE, V287, P755, DOI 10.1038/287755a0	35	313	314	5	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1276	1279		10.1126/science.1143826	http://dx.doi.org/10.1126/science.1143826			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033877				2022-12-28	WOS:000251086600036
J	Chan, BL; Witt, R; Charrow, AP; Magee, A; Howard, R; Pasquina, PF; Heilman, KM; Tsao, JW				Chan, Brenda L.; Witt, Richard; Charrow, Alexandra P.; Magee, Amanda; Howard, Robin; Pasquina, Paul F.; Heilman, Kenneth M.; Tsao, Jack W.			Mirror therapy for phantom limb pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Walter Reed Army Med Ctr, Washington, DC 20307 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA	Chan, BL (corresponding author), Walter Reed Army Med Ctr, Washington, DC 20307 USA.	jtsao@usuhs.mil						HENSON RA, 1977, BRIT MED BULL, V33, P91, DOI 10.1093/oxfordjournals.bmb.a071431; MELZACK R, 1990, TRENDS NEUROSCI, V13, P88, DOI 10.1016/0166-2236(90)90179-E; Ramachandran VS, 1996, P ROY SOC B-BIOL SCI, V263, P377, DOI 10.1098/rspb.1996.0058; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rossi S, 2002, CLIN NEUROPHYSIOL, V113, P16, DOI 10.1016/S1388-2457(01)00725-8	5	343	352	3	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2206	2207		10.1056/NEJMc071927	http://dx.doi.org/10.1056/NEJMc071927			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	18032777	Bronze			2022-12-28	WOS:000251076500030
J	Mamkin, I; Elkoustof, RA; Ramanan, SV				Mamkin, Igor; Elkoustof, Rachid A.; Ramanan, Sundaram V.			Apparently untreatable hypertension	LANCET			English	Editorial Material									Cornell Univ, Weill Med Coll, New York Methodist Hosp, Div Cardiol, Brooklyn, NY 11215 USA; Univ Connecticut, Ctr Hlth, Dept Internal Med, Farmington, CT USA; Hartford Hosp, Henry Low Ctr Heart, Div Cardiol, Hartford, CT 06115 USA; St Francis Hosp & Med Ctr, Dept Internal Med, Hartford, CT USA	Cornell University; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; University of Connecticut; Hartford Hospital; Saint Francis Hospital & Medical Center	Mamkin, I (corresponding author), Cornell Univ, Weill Med Coll, New York Methodist Hosp, Div Cardiol, 506 6th St, Brooklyn, NY 11215 USA.	igor_mamkin@yahoo.com							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 17	2007	370	9600					1714	1714		10.1016/S0140-6736(07)61722-X	http://dx.doi.org/10.1016/S0140-6736(07)61722-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	18022034				2022-12-28	WOS:000251091200022
J	Qureshi, NN; Hatcher, J; Chaturvedi, N; Jafar, TH				Qureshi, Nudrat Noor; Hatcher, Juanita; Chaturvedi, Nish; Jafar, Tazeen H.			Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE CONTROL; MEDICATION ADHERENCE; RISK-FACTORS; HYPERTENSION; PREVALENCE; GUIDELINES; DISEASE; TRENDS; POPULATION; MANAGEMENT	Objective To determine the impact of a simple educational package for general practitioners on adherence to antihypertensive drugs. Design Cluster randomised controlled trial. Setting Six randomly selected communities in Karachi, Pakistan. Participants 200 patients with hypertension taking antihypertensive drugs; 78 general practitioners. Intervention Care by general practitioners specially trained in management of hypertension compared with usual care. Main outcome measure Correct dosing, defined as percentage of prescribed doses taken, measured with electronic medication event monitoring system (MEMS) bottle. Results 200 patients were enrolled, and 178 (89%) successfully completed six weeks of follow-up. Adherence was significantly greater in the special care group than in the usual care group (unadjusted mean percentage days with correct dose 48.1%, 95% confidence interval 35.8% to 60.4%, versus 32.4%, 22.6% to 42.3%; P=0.048). Adherence was also higher among patients who had higher levels of education P<0.001), were encouraged by family members P<0.001), believed in the effect of drugs (P<0.001), and had the purpose of the drugs explained to them (P<0.001). Conclusions Special training of general practitioners in management of hypertension, emphasising good communication between doctors and patients, is more effective than usual care provided in the communities in Karachi. Such simple interventions should be adopted by other developing countries that are now facing an increasing burden of hypertension.	Aga Khan Univ, Dept Community Hlth Sci, Clin Epidemiol Unit, Karachi 74800, Pakistan; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London, England	Aga Khan University; Imperial College London	Jafar, TH (corresponding author), Aga Khan Univ, Dept Community Hlth Sci, Clin Epidemiol Unit, POB 3500,Stadium Rd, Karachi 74800, Pakistan.	tazeen.jafar@aku.edu						Ahmad K, 2005, J HYPERTENS, V23, P1979, DOI 10.1097/01.hjh.0000187258.86824.00; Aucott JN, 1996, J GEN INTERN MED, V11, P139, DOI 10.1007/BF02600265; Bansal N, 2003, AM J HYPERTENS, V16, P878, DOI 10.1016/S0895-7061(03)01030-6; BEAGLEHOLE R, 2004, ASIA PAC J CLIN NU S, V13, pS1; Campbell M, 2000, J Health Serv Res Policy, V5, P12; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COCHRAN GW, 1980, STAT METODS; COCHRAN GW, 1980, STAT METHODS; Degli Esposti E, 2004, J HUM HYPERTENS, V18, P207, DOI 10.1038/sj.jhh.1001656; Dusing R, 2006, CURR MED RES OPIN, V22, P1545, DOI 10.1185/030079906X120995; Eldridge Sandra M, 2004, Clin Trials, V1, P80, DOI 10.1191/1740774504cn006rr; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Goeman DP, 2005, MED J AUSTRALIA, V183, P457, DOI 10.5694/j.1326-5377.2005.tb07122.x; Hagemeister J, 2001, J HYPERTENS, V19, P2079, DOI 10.1097/00004872-200111000-00020; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hamilton Glenys A, 2003, Eur J Cardiovasc Nurs, V2, P219, DOI 10.1016/S1474-5151(03)00058-6; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hyman David J., 2000, J Clin Hypertens (Greenwich), V2, P324; Jafar TH, 2005, AM HEART J, V150, P221, DOI 10.1016/j.ahj.2004.09.025; Jafar TH, 2005, CIRCULATION, V111, P1278, DOI 10.1161/01.CIR.0000157698.78949.D7; Jafar TH, 2003, J HYPERTENS, V21, P905, DOI 10.1097/00004872-200305000-00014; Krakoff LR, 2002, AM J HYPERTENS, V15, P577, DOI 10.1016/S0895-7061(02)02938-2; Krousel-Wood M, 2004, CURR OPIN CARDIOL, V19, P357, DOI 10.1097/01.hco.0000126978.03828.9e; Lane DA, 2001, QJM-MON J ASSOC PHYS, V94, P391, DOI 10.1093/qjmed/94.7.391; Lee JY, 1996, AM J HYPERTENS, V9, P719, DOI 10.1016/0895-7061(96)00056-8; Liu GG, 2002, SOC SCI MED, V55, P1779, DOI 10.1016/S0277-9536(01)00306-9; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mechanic D, 2001, BRIT MED J, V323, P266, DOI 10.1136/bmj.323.7307.266; Shapiro AP, 1997, JAMA-J AM MED ASSOC, V277, P157; Singh P, 2005, INDIAN J MED RES, V122, P137; Sisson Stephen D, 2006, J Clin Hypertens (Greenwich), V8, P344, DOI 10.1111/j.1524-6175.2006.05335.x; Wang ZW, 2004, HYPERTENS RES, V27, P703, DOI 10.1291/hypres.27.703; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10	34	50	50	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2007	335	7628					1030	1033		10.1136/bmj.39360.617986.AE	http://dx.doi.org/10.1136/bmj.39360.617986.AE			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UV	17991935	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000251402800031
J	Schultz, PH				Schultz, Peter H.			Planetary science - Hidden Mars	SCIENCE			English	Editorial Material							WIND EROSION; ICE; RECORD		Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Brown University	Schultz, PH (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	Peter_schultz@brown.edu						AKANIAHMED J, 2001, GEOPHYS RES LETT, V28, P3409; ARVIDSON RE, 1976, ICARUS, V27, P503, DOI 10.1016/0019-1035(76)90166-4; Bradley BA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001537; Hood LL, 2005, ICARUS, V177, P144, DOI 10.1016/j.icarus.2005.02.008; HYNEK BM, 2003, J GEOPHYS RES, V108; Jakosky BM, 2005, ICARUS, V175, P58, DOI 10.1016/j.icarus.2004.11.014; JAKOSKY BM, 1985, NATURE, V315, P559, DOI 10.1038/315559a0; JURDY D, 2001, EOS T AGU B, V82, DOI UNSP T51A-11; MCCAULEY JF, 1973, J GEOPHYS RES, V78, P4123, DOI 10.1029/JB078i020p04123; SCHULTZ PH, 1982, J GEOPHYS RES, V87, pA84, DOI 10.1029/JB087iS01p00A84; SCHULTZ PH, 1988, ICARUS, V73, P91, DOI 10.1016/0019-1035(88)90087-5; SCOTT DH, 1982, J GEOPHYS RES, V87, P1179, DOI 10.1029/JB087iB02p01179; Sprenke KF, 2000, ICARUS, V147, P26, DOI 10.1006/icar.2000.6439; Tanaka KL, 2000, ICARUS, V144, P254, DOI 10.1006/icar.1999.6297; THOMSON BJ, IN PRESS ICARUS; WARD AW, 1979, J GEOPHYS RES, V84, P814; Watters TR, 2007, SCIENCE, V318, P1125, DOI 10.1126/science.1148112; Wrobel K, 2006, METEORIT PLANET SCI, V41, P1539, DOI 10.1111/j.1945-5100.2006.tb00434.x	18	6	6	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1080	1081		10.1126/science.1151412	http://dx.doi.org/10.1126/science.1151412			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231OC	18006732				2022-12-28	WOS:000250957900029
J	Zhang, DY; Turberfield, AJ; Yurke, B; Winfree, E				Zhang, David Yu; Turberfield, Andrew J.; Yurke, Bernard; Winfree, Erik			Engineering entropy-driven reactions and networks catalyzed by DNA	SCIENCE			English	Article							LOGIC GATES; AMPLIFICATION; HAIRPINS; DESIGN	Artificial biochemical circuits are likely to play as large a role in biological engineering as electrical circuits have played in the engineering of electromechanical devices. Toward that end, nucleic acids provide a designable substrate for the regulation of biochemical reactions. However, it has been difficult to incorporate signal amplification components. We introduce a design strategy that allows a specified input oligonucleotide to catalyze the release of a specified output oligonucleotide, which in turn can serve as a catalyst for other reactions. This reaction, which is driven forward by the configurational entropy of the released molecule, provides an amplifying circuit element that is simple, fast, modular, composable, and robust. We have constructed and characterized several circuits that amplify nucleic acid signals, including a feedforward cascade with quadratic kinetics and a positive feedback circuit with exponential growth kinetics.	CALTECH, Pasadena, CA 91125 USA; Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; Bell Labs, Alcatel Lucent, Murray Hill, NJ 07974 USA	California Institute of Technology; University of Oxford; Alcatel-Lucent; AT&T	Zhang, DY (corresponding author), CALTECH, MC 136-93,1200 E Calif Blvd, Pasadena, CA 91125 USA.	dzhang@dna.caltech.edu; winfree@caltech.edu	Turberfield, Andrew J/O-2135-2017; Winfree, Erik/L-4002-2013	Turberfield, Andrew J/0000-0002-3876-0190; Winfree, Erik/0000-0002-5899-7523	Engineering and Physical Sciences Research Council [GR/A10274/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Bois JS, 2005, NUCLEIC ACIDS RES, V33, P4090, DOI 10.1093/nar/gki721; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gesteland R.F., 2006, RNA WORLD NATURE MOD, V3rd; GREEN C, 1981, NUCLEIC ACIDS RES, V9, P1905, DOI 10.1093/nar/9.8.1905; Green SJ, 2006, BIOPHYS J, V91, P2966, DOI 10.1529/biophysj.106.084681; Hagiya M, 2006, NAT COMP SER, P293, DOI 10.1007/3-540-30296-4_18; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Lederman H, 2006, BIOCHEMISTRY-US, V45, P1194, DOI 10.1021/bi051871u; Levy M, 2003, P NATL ACAD SCI USA, V100, P6416, DOI 10.1073/pnas.1130145100; Li XY, 2004, ANGEW CHEM INT EDIT, V43, P4848, DOI 10.1002/anie.200400656; Macdonald J, 2006, NANO LETT, V6, P2598, DOI 10.1021/nl0620864; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; MIR KU, 1999, DNA BASED COMPUTERS, V2, P243; Muller S, 2006, IEE P-NANOBIOTECHNOL, V153, P31, DOI 10.1049/ip-nbt:20050047; PANYUTIN IG, 1993, J MOL BIOL, V230, P413, DOI 10.1006/jmbi.1993.1159; Paul N, 2004, CURR OPIN CHEM BIOL, V8, P634, DOI 10.1016/j.cbpa.2004.09.005; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Penchovsky R, 2005, NAT BIOTECHNOL, V23, P1424, DOI 10.1038/nbt1155; Sager J, 2006, LECT NOTES COMPUT SC, V3892, P275; Seelig G, 2006, J AM CHEM SOC, V128, P12211, DOI 10.1021/ja0635635; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Seeman NC, 2005, TRENDS BIOCHEM SCI, V30, P119, DOI 10.1016/j.tibs.2005.01.007; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Stojanovic MN, 2005, J AM CHEM SOC, V127, P6914, DOI 10.1021/ja043003a; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; TUBERFIELD AJ, 2003, PHYS REV LETT, V90; YIN P, IN PRESS NATURE; Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	769	798	36	515	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1121	1125		10.1126/science.1148532	http://dx.doi.org/10.1126/science.1148532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006742				2022-12-28	WOS:000250957900041
J	Saag, KG; Shane, E; Boonen, S; Marin, F; Donley, DW; Taylor, KA; Dalsky, GP; Marcus, R				Saag, Kenneth G.; Shane, Elizabeth; Boonen, Steven; Marin, Fernando; Donley, David W.; Taylor, Kathleen A.; Dalsky, Gail P.; Marcus, Robert			Teriparatide or alendronate in glucocorticoid-induced osteoporosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORTICOSTEROID-INDUCED OSTEOPOROSIS; BONE-MINERAL DENSITY; VERTEBRAL FRACTURE RISK; PARATHYROID-HORMONE; DOUBLE-BLIND; POSTMENOPAUSAL WOMEN; PREVENTION; RISEDRONATE; MANAGEMENT; APOPTOSIS	Background: Bisphosphonate therapy is the current standard of care for the prevention and treatment of glucocorticoid-induced osteoporosis. Studies of anabolic therapy in patients who are receiving long-term glucocorticoids and are at high risk for fracture are lacking. Methods: In an 18-month randomized, double-blind, controlled trial, we compared teriparatide with alendronate in 428 women and men with osteoporosis (ages, 22 to 89 years) who had received glucocorticoids for at least 3 months (prednisone equivalent, 5 mg daily or more). A total of 214 patients received 20 mu g of teriparatide once daily, and 214 received 10 mg of alendronate once daily. The primary outcome was the change in bone mineral density at the lumbar spine. Secondary outcomes included changes in bone mineral density at the total hip and in markers of bone turnover, the time to changes in bone mineral density, the incidence of fractures, and safety. Results: At the last measurement, the mean (+/-SE) bone mineral density at the lumbar spine had increased more in the teriparatide group than in the alendronate group (7.2+/-0.7% vs. 3.4+/-0.7%, P<0.001). A significant difference between the groups was reached by 6 months (P<0.001). At 12 months, bone mineral density at the total hip had increased more in the teriparatide group. Fewer new vertebral fractures occurred in the teriparatide group than in the alendronate group (0.6% vs. 6.1%, P=0.004); the incidence of nonvertebral fractures was similar in the two groups (5.6% vs. 3.7%, P=0.36). Significantly more patients in the teriparatide group had at least one elevated measure of serum calcium. Conclusions: Among patients with osteoporosis who were at high risk for fracture, bone mineral density increased more in patients receiving teriparatide than in those receiving alendronate. (ClinicalTrials.gov number, NCT00051558.).	Univ Alabama Birmingham, Birmingham, AL 35294 USA; Columbia Univ, Coll Phys & Surg, New York, NY USA; Katholieke Univ Leuven, Louvain, Belgium; Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	University of Alabama System; University of Alabama Birmingham; Columbia University; KU Leuven; Eli Lilly	Saag, KG (corresponding author), Univ Alabama Birmingham, FOT 820,1530 3rd Ave S, Birmingham, AL 35294 USA.	ksaag@uab.edu	Agarwal, Anil/H-3095-2019; Marin, Fernando/K-7666-2019; Pereira, Rosa M R/C-5192-2012	Agarwal, Anil/0000-0003-3608-2848; Pereira, Rosa M R/0000-0002-3723-5028				Adachi JD, 2001, ARTHRITIS RHEUM, V44, P202, DOI 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W; Adachi JD, 2000, SEMIN ARTHRITIS RHEU, V29, P228, DOI 10.1016/S0049-0172(00)80011-6; Adler RA, 2003, ARCH INTERN MED, V163, P2619, DOI 10.1001/archinte.163.21.2619; [Anonymous], 2002, GLUC IND OST GUID PR; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Body JJ, 2002, J CLIN ENDOCR METAB, V87, P4528, DOI 10.1210/jc.2002-020334; Buckley L, 2001, ARTHRITIS RHEUM, V44, P1496; Cohen S, 1999, ARTHRITIS RHEUM, V42, P2309, DOI 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K; Curtis JR, 2005, ARTHRITIS RHEUM-US, V52, P2485, DOI 10.1002/art.21194; de Nijs RNJ, 2006, NEW ENGL J MED, V355, P675, DOI 10.1056/NEJMoa053569; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Genant HK, 1996, J BONE MINER RES, V11, P984; Geusens PP, 2004, ANN RHEUM DIS, V63, P324, DOI 10.1136/ard.2003.008060; Girotra M, 2006, REV ENDOCR METAB DIS, V7, P113, DOI 10.1007/s11154-006-9007-z; Gourlay M, 2007, CLIN RHEUMATOL, V26, P144, DOI 10.1007/s10067-006-0315-1; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Kanis JA, 2004, J BONE MINER RES, V19, P893, DOI 10.1359/JBMR.040134; Keaveny TM, 2007, J BONE MINER RES, V22, P149, DOI 10.1359/JBMR.061011; Lane NE, 1998, J CLIN INVEST, V102, P1627, DOI 10.1172/JCI3914; McClung, 2005, ARCH INTERN MED, V165, P2120; McClung M, 1998, ANN INTERN MED, V128, P253, DOI 10.7326/0003-4819-128-4-199802150-00001; McClung MR, 2005, ARCH INTERN MED, V165, P1762, DOI 10.1001/archinte.165.15.1762; Mudano A, 2001, J RHEUMATOL, V28, P1298; Nawata H, 2005, J BONE MINER METAB, V23, P105, DOI 10.1007/s00774-004-0596-x; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Reid DM, 2000, J BONE MINER RES, V15, P1006, DOI 10.1359/jbmr.2000.15.6.1006; Reid DM, 2001, CALCIFIED TISSUE INT, V69, P242, DOI 10.1007/s00223-001-1060-8; Ringe JD, 2003, OSTEOPOROSIS INT, V14, P801, DOI 10.1007/s00198-003-1425-0; SAAG K, 2004, ARTHRITIS ALLIED CON, P2473; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; Sambrook P N, 2001, Aust Fam Physician, V30, P793; Sambrook PN, 2003, J BONE MINER RES, V18, P919, DOI 10.1359/jbmr.2003.18.5.919; Steinbuch M, 2004, OSTEOPOROSIS INT, V15, P323, DOI 10.1007/s00198-003-1548-3; van Staa TP, 2006, CALCIFIED TISSUE INT, V79, P129, DOI 10.1007/s00223-006-0019-1; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P777, DOI 10.1007/s001980200108; Wallach S, 2000, CALCIFIED TISSUE INT, V67, P277, DOI 10.1007/s002230001146; Walsh LJ, 2002, AM J RESP CRIT CARE, V166, P691, DOI 10.1164/rccm.2110047; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Westfall PH, 2001, J STAT PLAN INFER, V99, P25, DOI 10.1016/S0378-3758(01)00077-5	40	569	595	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2007	357	20					2028	2039		10.1056/NEJMoa071408	http://dx.doi.org/10.1056/NEJMoa071408			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230RV	18003959				2022-12-28	WOS:000250894500005
J	Fischer, JE				Fischer, Josef E.			The impending disappearance of the general surgeon	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HOSPITALS		Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University	Fischer, JE (corresponding author), Beth Israel Deaconess Med Ctr, Dept Surg, 110 Francis St,Ste 9F, Boston, MA 02215 USA.	jfische1@bidmc.harvard.edu						*AM COLL EM PHYS E, 2006, ON CALL SPEC COV US; Centers for Medicare & Medicaid Services (CMS) HHS, 2006, FED REG, V71, P69623; Chappel AR, 2006, J AM COLL SURGEONS, V203, P599, DOI 10.1016/j.jamcollsurg.2006.07.009; DOTY B, 2007, AM ASS MED COLL WORK; Evenson AR, 2006, J GASTROINTEST SURG, V10, P455, DOI 10.1016/j.gassur.2005.08.001; HSIAO WC, 1988, NATL STUDY RESOURCE; Hsiao WC, 1992, NATL STUDY RESOURCE; Jonasson O, 1996, ANN SURG, V224, P574, DOI 10.1097/00000658-199610000-00015; SMART D, 2007, PHYS CHARACTERISTICS; Stitzenberg KB, 2005, J AM COLL SURGEONS, V201, P925, DOI 10.1016/j.jamcollsurg.2005.06.253; Zuckerman R, 2006, J RURAL HEALTH, V22, P339, DOI 10.1111/j.1748-0361.2006.00055.x; 1990, FED REG, V55, P36178; 1991, FED REG, V56, P59502; 1993, FED REG, V58, P31964; 2006, FED REG, V71, P37170; 2004, FED REG, V69, P22065	16	118	122	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2191	2193		10.1001/jama.298.18.2191	http://dx.doi.org/10.1001/jama.298.18.2191			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230II	18000204				2022-12-28	WOS:000250869800027
J	Bennett, JT; Stickney, HL; Choi, WY; Ciruna, B; Talbot, WS; Schier, AF				Bennett, James T.; Stickney, Heather L.; Choi, Wen-Yee; Ciruna, Brian; Talbot, William S.; Schier, Alexander F.			Maternal nodal and zebrafish embryogenesis	NATURE			English	Letter							SQUINT; AXIS		NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Harvard Univ, Dept Mol & Cellular Biol, Harvard Stem Cell Inst, Ctr Brain Sci,Broad Inst, Cambridge, MA 02138 USA; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L7, Canada; Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada	New York University; New York University; Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Bennett, JT (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA.	schier@fas.harvard.edu		Bennett, James/0000-0003-2843-5594; Schier, Alexander Franz/0000-0001-7645-5325				Aoki TO, 2002, DEV BIOL, V241, P273, DOI 10.1006/dbio.2001.0510; Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Gore AV, 2005, NATURE, V438, P1030, DOI 10.1038/nature04184; Gore AV, 2002, MECH DEVELOP, V112, P153, DOI 10.1016/S0925-4773(01)00622-0; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Pei W, 2007, DEV BIOL, V308, P368, DOI 10.1016/j.ydbio.2007.05.026; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Sirotkin HI, 2000, DEVELOPMENT, V127, P2583	12	25	25	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					E1	E2		10.1038/nature06314	http://dx.doi.org/10.1038/nature06314			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994032				2022-12-28	WOS:000250746200046
J	Smith, WR; Betancourt, JR; Wynia, MK; Bussey-Jones, J; Stone, VE; Phillips, CO; Fernandez, A; Jacobs, E; Bowles, J				Smith, Wally R.; Betancourt, Joseph R.; Wynia, Matthew K.; Bussey-Jones, Jada; Stone, Valerie E.; Phillips, Christopher O.; Fernandez, Alicia; Jacobs, Elizabeth; Bowles, Jacqueline			Recommendations for teaching about racial and ethnic disparities in health and health care	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY-HEART-DISEASE; CROSS-CULTURAL CARE; UNITED-STATES; PATIENT PREFERENCES; CARDIAC-CATHETERIZATION; MEDICAL-CARE; RACE; PHYSICIANS; COMPETENCE; EDUCATION	Racial and ethnic minorities often receive lower-quality health care than white patients, even when socioeconomic status, education, access, and other factors are used as controls. To address these pervasive disparities, health care professionals should learn more about them and the roles they can play in eliminating them, but few curricula are focused on understanding and addressing racial and ethnic health disparities, and well-accepted guidelines on what and how to teach in this complex area are lacking. The Society of General Internal Medicine Health Disparities Task Force used a review and consensus process to develop specific recommendations and guidelines for curricula focusing on health disparities. Learning objectives, content, methods for teaching, and useful resources are provided. Although the guidelines were developed primarily for teaching medical students, residents, and practitioners in primary care, the Task Force's general recommendations can apply to learners in any specialty. The Task Force recommends that a curricula address 3 areas of racial and ethnic health disparities and focus on the following specific learning objectives: 1) examining and understanding attitudes, such as mistrust, subconscious bias, and stereotyping, which practitioners and patients may bring to clinical encounters; 2) gaining knowledge of the existence and magnitude of health disparities, including the multifactorial causes of health disparities and the many solutions required to diminish or eliminate them; and 3) acquiring the skills to effectively communicate and negotiate across cultures, languages, and literacy levels, including the use of key tools to improve communication. The broad goal of a curriculum on disparities should be for learners to develop a commitment to eliminating inequities in health care quality by understanding and assuming their professional role in addressing this pressing health care crisis.	Virginia Commonwealth Univ, Ctr Hlth Dispar, Div Qual Hlth Care, Richmond, VA 23298 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Amer Med Assoc, Inst Eth, Chicago, IL 60610 USA; Stronger Hosp Cook County, Chicago, IL USA; Rush Univ, Med Ctr, Chicago, IL 60612 USA; Emory Univ, Sch Med, Atlanta, GA USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA; Sepulveda Ambulatory Care Ctr, North Hills, CA USA	Virginia Commonwealth University; Harvard University; Massachusetts General Hospital; American Medical Association; Rush University; Emory University; Cleveland Clinic Foundation; San Francisco General Hospital Medical Center	Smith, WR (corresponding author), Virginia Commonwealth Univ, Ctr Hlth Dispar, Div Qual Hlth Care, Box 980306,1200 E Broad St,Room W10W-402, Richmond, VA 23298 USA.		Wynia, Matthew/T-2210-2019					*ACGME COMP, 2000, SUGG BEST METH EV AC; *ACGME GEN COMP, ACGME GEN COMP VERS; *AM MED ASS, ETH HLTH DISP; Amer College Physicians, 2004, ANN INTERN MED, V141, P226, DOI 10.7326/0003-4819-141-3-200408030-00015; Andrulis DP, 1998, ANN INTERN MED, V129, P412, DOI 10.7326/0003-4819-129-5-199809010-00012; ANTONOVSKY A, 1968, J CHRON DIS, V21, P65, DOI 10.1016/0021-9681(68)90098-2; Armstrong K, 2007, AM J PUBLIC HEALTH, V97, P1283, DOI 10.2105/AJPH.2005.080762; Armstrong K, 2006, ARCH INTERN MED, V166, P950, DOI 10.1001/archinte.166.9.950; Ayanian JZ, 1999, MED CARE, V37, P1260, DOI 10.1097/00005650-199912000-00009; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; Ayanian JZ, 1999, NEW ENGL J MED, V341, P1661, DOI 10.1056/NEJM199911253412206; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Beach MC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-104; Beach MC, 2005, MED CARE, V43, P356, DOI 10.1097/01.mlr.0000156861.58905.96; BERLIN EA, 1983, WESTERN J MED, V139, P934; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; Betancourt JR, 2003, PUBLIC HEALTH REP, V118, P293, DOI 10.1093/phr/118.4.293; Betancourt JR, 2015, RESIDENT PHYS PREPAR; Byrd W M, 1990, J Health Care Poor Underserved, V1, P278; Byrd WM., 2000, AM HLTH DILEMMA MEDI; Campinha-Bacote J, 1999, J NURS EDUC, V38, P203; CAMPINHABACOTE J, 1994, PROCESS CULTURAL COM; Carrillo JE, 1999, ANN INTERN MED, V130, P829, DOI 10.7326/0003-4819-130-10-199905180-00017; *CCHCP, CCHCP CROSS CULT HLT; CHARON R, 1995, ANN INTERN MED, V122, P599, DOI 10.7326/0003-4819-122-8-199504150-00008; Commission to End Health Care Disparities, 2015, PHYS AR BEC ENG ADDR; Cooper LA, 2003, ANN INTERN MED, V139, P907, DOI 10.7326/0003-4819-139-11-200312020-00009; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Fiscella K, 2004, MED CARE, V42, P1049, DOI 10.1097/00005650-200411000-00003; Flores G, 2000, ACAD MED, V75, P451, DOI 10.1097/00001888-200005000-00015; Flores G, 2002, JAMA-J AM MED ASSOC, V288, P82, DOI 10.1001/jama.288.1.82; Flores G, 2005, MED CARE RES REV, V62, P255, DOI 10.1177/1077558705275416; Flores G, 2006, NEW ENGL J MED, V355, P229, DOI 10.1056/NEJMp058316; Fortier JP, 1998, J HEALTH CARE POOR U, V9, pS81; Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773; GILBERT MJ, RESOURCES CULTURAL C; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; GraingerMonsen M, WORLDS APART 4 PART; Green AR, 2002, ACAD MED, V77, P193, DOI 10.1097/00001888-200203000-00003; GREICO E, 2007, CENSUS 2000 BRIEF OV; *HABL JUNT, WE SPEAK TOG; HARDT EJ, 1987, BILINGUAL MED INTERV; Harris D. Robert, 1997, Ethnicity and Disease, V7, P91; Haynes MA, 1999, UNEQUAL BURDEN CANC, DOI 10.17226/6377; HINKLE LE, 1968, SCIENCE, V161, P238, DOI 10.1126/science.161.3838.238; *INT PUBL LIB, ETHN CULT RAC; Jacobs EA, 2003, PUBLIC HEALTH REP, V118, P349, DOI 10.1093/phr/118.4.349; JENKINS S, 2003, AFRICAN AM HLTH DISP; JOHNSON PA, 1993, ANN INTERN MED, V118, P593, DOI 10.7326/0003-4819-118-8-199304150-00004; *JOINT COMM ACCR H, 2005, STAND REL PROV CULT; Junod T., 2000, TUSKEGEES TRUTHS RET, P509; *KAIS PERM MULT CO, 2001, KAIS PERM CARE ACT C; Kaiser Family Foundation, NAT SURV PHYS 1; Katz JN, 2001, JAMA-J AM MED ASSOC, V286, P1506, DOI 10.1001/jama.286.12.1506; King TE, 2004, ANN INTERN MED, V141, P815, DOI 10.7326/0003-4819-141-10-200411160-00015; Kleinman A., 1980, PATIENTS HEALERS CON; KLEINMAN A, 1981, PATIENTS HEALERS CON, P106; Komaromy M, 1996, NEW ENGL J MED, V334, P1305, DOI 10.1056/NEJM199605163342006; Kressin NR, 2004, AM J PUBLIC HEALTH, V94, P2091, DOI 10.2105/AJPH.94.12.2091; LaVeist T.A., 2005, MINORITY POPULATIONS; LaVeist TA, 2002, RACE ETHNICITY HLTH; Lavizzo-Mourey Risa, 2004, Ann Intern Med, V141, P221; *LIAIS COMM MED ED, 2007, LIAIS COMM MED ED AC; *LIAIS COMM MED ED, ED21 LIAIS COMM MED; Lieberman JA, 1997, J CLIN PSYCHIAT, V58, P3; Like R C, 1996, Fam Med, V28, P291; London RF, 1999, JAMA-J AM MED ASSOC, V282, P875, DOI 10.1001/jama.282.9.875; Long JA, 2004, ANN INTERN MED, V141, P805, DOI 10.7326/0003-4819-141-10-200411160-00013; Lurie N, 2005, CIRCULATION, V111, P1264, DOI 10.1161/01.CIR.0000157738.12783.71; Lurie N, 2007, JAMA-J AM MED ASSOC, V297, P1118, DOI 10.1001/jama.297.10.1118; MATTHEWSJUAREZ P, 2004, CULTURAL COMPETENCE; Mayberry RM, 2000, MED CARE RES REV, V57, P108, DOI 10.1177/107755800773743628; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; NIELSENBOHLMAN L, 2004, HLTH LIT PRESCRIPTIO, P112; ORENTLICHER D, 1990, JAMA-J AM MED ASSOC, V263, P2344; PACHTER LM, 1994, JAMA-J AM MED ASSOC, V271, P690, DOI 10.1001/jama.271.9.690; Park ER, 2005, ACAD MED, V80, P874, DOI 10.1097/00001888-200509000-00019; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; Pincus T, 1998, ANN INTERN MED, V129, P406, DOI 10.7326/0003-4819-129-5-199809010-00011; Price EG, 2005, ACAD MED, V80, P578, DOI 10.1097/00001888-200506000-00013; PUTSCH RW, 1984, JAMA-J AM MED ASSOC, V254, P3344; Rathore SS, 2004, ANN INTERN MED, V141, P635, DOI 10.7326/0003-4819-141-8-200410190-00011; Riddick S, 1998, J HEALTH CARE POOR U, V9, pS40; SANCHEZHUCLEZ J, 1999, 1 SESS AFR AM CLIENT; Satcher David, 2006, MULTICULTURAL MED HL; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; SINGH GK, 1995, AM J PUBLIC HEALTH, V85, P957, DOI 10.2105/AJPH.85.7.957; Smedley BD, 2004, NATIONS COMPELLING I; Smith DB, 2005, HEALTH AFFAIR, V24, P317, DOI 10.1377/hlthaff.24.2.317; STUART MR, 1993, 15 MIN HOUR APPL PSY; *SULL COMM, 2005, MISS PERS MIN HLTH P; *TAACT, ASS AM MED COLL TOOL; Tang TS, 2002, ACAD MED, V77, P578, DOI 10.1097/00001888-200206000-00019; Tervalon M, 1998, J HEALTH CARE POOR U, V9, P117; Tervalon M, 2003, ACAD MED, V78, P570, DOI 10.1097/00001888-200306000-00005; Thom DH, 2001, J FAM PRACTICE, V50, P323; TODD KH, 1993, JAMA-J AM MED ASSOC, V269, P1537, DOI 10.1001/jama.269.12.1537; Todd KH, 2000, ANN EMERG MED, V35, P11, DOI 10.1016/S0196-0644(00)70099-0; Turner BJ, 2000, ARCH INTERN MED, V160, P2614, DOI 10.1001/archinte.160.17.2614; U.S. Census Bureau, 2004, US INT PROJ AG SEX R; U.S. Department of Health & Human Services, NAT STAND CULT LING; *US CENS BUR, 2004, EST POP RAC AL COMB; *US CENS BUR, CENS POP HOUS DAT; *US DEP HHS, STRAT RED HLTH DISP; *US DEP HHS, DAT 2010; *US DEP HHS, 2006, HLTH US 2006 CHARTB; *US DEP HHS, ASS CULT COMP HLTH C; *US DEP HHSIB, 2001, NAT STAND CULT LING; *US DEP HLTH HUM S, 1985, REP SECR TASK FORC B; US Department of Health and Human Services, 2005, NAT HEALTHC DISP REP; Weissman JS, 2005, JAMA-J AM MED ASSOC, V294, P1058, DOI 10.1001/jama.294.9.1058; Whittle J, 1997, J GEN INTERN MED, V12, P267, DOI 10.1046/j.1525-1497.1997.012005267.x; Witzig R, 1996, ANN INTERN MED, V125, P675, DOI 10.7326/0003-4819-125-8-199610150-00008; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Woolf SH, 2004, AM J PUBLIC HEALTH, V94, P2078, DOI 10.2105/AJPH.94.12.2078; WYATT GE, 1978, J MED EDUC, V53, P627; 1968, REPORT NATL ADV COMM	119	128	130	0	40	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2007	147	9					654	665		10.7326/0003-4819-147-9-200711060-00010	http://dx.doi.org/10.7326/0003-4819-147-9-200711060-00010			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227QM	17975188				2022-12-28	WOS:000250672900008
J	Cheng, J; Kang, XL; Zhang, S; Yeh, ETH				Cheng, Jinke; Kang, Xunlei; Zhang, Sui; Yeh, Edward T. H.			SUMO-Specific protease 1 is essential for stabilization of HIF1 alpha during hypoxia	CELL			English	Article							TUMOR-SUPPRESSOR PROTEIN; INDUCIBLE FACTOR 1-ALPHA; DEPENDENT TRANSCRIPTION; DIFFERENTIAL REGULATION; PROLYL HYDROXYLATION/; O-2 TENSION; HIF-ALPHA; DEGRADATION; VHL; HIF-1-ALPHA	SUMOylation is a dynamic process, catalyzed by SUMO-specific ligases and reversed by Sentrin/SUMO-specific proteases (SENPs). The physiologic consequences of SUMOylation and deSUMOylation are not fully understood. Here we investigate the phenotypes of mice lacking SENP1 and find that SENP1(-/-) embryos show severe fetal anemia stemming from deficient erythropoietin (Epo) production and die midgestation. We determine that SENP1 controls Epo production by regulating the stability of hypoxia-inducible factor 1 alpha (HIF1 alpha) during hypoxia. Hypoxia induces SUMOylation of HIF1a, which promotes its binding to a ubiquitin ligase, von Hippel-Lindau (VHL) protein, through a proline hydroxylation-independent mechanism, leading to its ubiquitination and degradation. In SENP1(-/-) MEFs, hypoxia-induced transcription of HIF1 alpha-dependent genes such as vascular endothelial growth factor (VEGF) and glucose transporter 1 (Glut-1) is markedly reduced. These results show that SENP1 plays a key role in the regulation of the hypoxic response through regulation of HIF1a stability and that SUMOylation can serve as a direct signal for ubiquitin-dependent degradation.	Univ Texas, MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Brown Fdn Inst Mol Med, Cardiovasc Res Ctr, Houston, TX 77030 USA; Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Shanghai Jiao Tong University	Yeh, ETH (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Cardiol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	etyeh@mdanderson.org		Kang, Xunlei/0000-0003-1853-1881	NCI NIH HHS [R01 CA080089-05, P30 CA016672, R01 CA080089-03, CA16672, R01 CA139520, R01 CA080089, R01 CA080089-04, R01 CA080089-01A1, R01 CA80089, R01 CA080089-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080089, P30CA016672, R01CA139520] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Brahimi-Horn C, 2005, CELL SIGNAL, V17, P1, DOI 10.1016/j.cellsig.2004.04.010; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Ebert BL, 1999, BLOOD, V94, P1864; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yamashita K, 2001, BIOMACROMOLECULES, V2, P25, DOI 10.1021/bm0000844; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	41	481	516	2	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					584	595		10.1016/j.cell.2007.08.045	http://dx.doi.org/10.1016/j.cell.2007.08.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981124	Green Accepted, Bronze			2022-12-28	WOS:000250618500024
J	Peters-Golden, M; Henderson, WR				Peters-Golden, Marc; Henderson, William R., Jr.			Mechanisms of disease: Leukotrienes	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							5-LIPOXYGENASE ACTIVATING PROTEIN; C-4 SYNTHASE GENE; DOUBLE-BLIND; CLINICAL-RESPONSE; CYSTEINYL LEUKOTRIENES; MYOCARDIAL-INFARCTION; CHRONIC ASTHMA; RECEPTOR ANTAGONISTS; ALLERGIC RHINITIS; ORAL MONTELUKAST		Univ Michigan Hlth Syst, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; Univ Washington, Dept Med, Div Allergy & Infect Dis, Ctr Allergy & Inflammat, Seattle, WA USA	University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle	Peters-Golden, M (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, Div Pulm & Crit Care Med, 6301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	petersm@umich.edu						Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Asano K, 2002, PHARMACOGENETICS, V12, P565, DOI 10.1097/00008571-200210000-00009; Avis IM, 1996, J CLIN INVEST, V97, P806, DOI 10.1172/JCI118480; Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Barnes N, 2005, J ALLERGY CLIN IMMUN, V115, P47, DOI 10.1016/j.jaci.2004.10.011; Beierschmitt WP, 2001, TOXICOL SCI, V63, P15, DOI 10.1093/toxsci/63.1.15; Beller TC, 2004, J BIOL CHEM, V279, P46129, DOI 10.1074/jbc.M407057200; Berger W, 2007, INT J CLIN PRACT, V61, P663, DOI 10.1111/j.1742-1241.2007.01320.x; Bergeron C, 2006, CHEST, V129, P1068, DOI 10.1378/chest.129.4.1068; Bisgaard H, 2003, AM J RESP CRIT CARE, V167, P379, DOI 10.1164/rccm.200207-747OC; Bjermer L, 2003, BMJ-BRIT MED J, V327, P891, DOI 10.1136/bmj.327.7420.891; Cai C, 2007, LUNG, V185, P105, DOI 10.1007/s00408-006-0001-8; Camargo CA, 2003, AM J RESP CRIT CARE, V167, P528, DOI 10.1164/rccm.200208-802OC; Cederholm T, 2000, J INTERN MED, V247, P715, DOI 10.1046/j.1365-2796.2000.00691.x; Chen XX, 2003, J NATL CANCER I, V95, P1053, DOI 10.1093/jnci/95.14.1053; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Coffey MJ, 1996, J IMMUNOL, V157, P393; Coffey MJ, 2000, J IMMUNOL, V165, P3592, DOI 10.4049/jimmunol.165.7.3592; Coreno A, 2000, J ALLERGY CLIN IMMUN, V106, P500; Covar RA, 2004, AM J RESP CRIT CARE, V170, P234, DOI 10.1164/rccm.200308-1174OC; Cowburn AS, 1999, J IMMUNOL, V163, P456; Currie GP, 2003, BRIT J CLIN PHARMACO, V56, P422, DOI 10.1046/j.1365-2125.2003.01952.x; Dahlen B, 1998, AM J RESP CRIT CARE, V157, P1187, DOI 10.1164/ajrccm.157.4.9707089; Dahlen SE, 2002, AM J RESP CRIT CARE, V165, P9, DOI 10.1164/ajrccm.165.1.2010080; Dempsey OJ, 2002, J ALLERGY CLIN IMMUN, V109, P68, DOI 10.1067/mai.2002.120559; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Drazen JM, 1999, NEW ENGL J MED, V340, P663; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Dube LM, 1999, CLIN REV ALLERG IMMU, V17, P213, DOI 10.1007/BF02737605; Ducharme FM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003137.pub3; Ducharme FM., 2000, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD003133, DOI 10.1002/14651858.CD003133]; DWORSKI R, 1994, AM J RESP CRIT CARE, V149, P953, DOI 10.1164/ajrccm.149.4.8143061; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; Edelman JM, 2000, ANN INTERN MED, V132, P97, DOI 10.7326/0003-4819-132-2-200001180-00002; Espinosa K, 2003, J ALLERGY CLIN IMMUN, V111, P1032, DOI 10.1067/mai.2003.1451; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; FROLICH JC, 1994, J LIPID MEDIAT CELL, V9, P75; Gonzalez P, 2007, INT J IMMUNOGENET, V34, P127, DOI 10.1111/j.1744-313X.2007.00671.x; GRIFFITHS RJ, 1995, P NATL ACAD SCI USA, V92, P517, DOI 10.1073/pnas.92.2.517; Gyllfors P, 2006, J ALLERGY CLIN IMMUN, V118, P78, DOI 10.1016/j.jaci.2006.03.040; Hakonarson H, 2005, JAMA-J AM MED ASSOC, V293, P2245, DOI 10.1001/jama.293.18.2245; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P586, DOI 10.1016/j.jaci.2005.04.035; Harmanci K, 2006, ANN ALLERG ASTHMA IM, V96, P731, DOI 10.1016/S1081-1206(10)61073-3; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Henderson WR, 2006, AM J RESP CRIT CARE, V173, P718, DOI 10.1164/rccm.200501-088OC; Hoque A, 2005, CARCINOGENESIS, V26, P785, DOI 10.1093/carcin/bgi026; Hsieh FH, 2001, J EXP MED, V193, P123, DOI 10.1084/jem.193.1.123; Hui YQ, 2004, CIRCULATION, V110, P3360, DOI 10.1161/01.CIR.0000147775.50954.AA; Ihara A, 2007, J PHARMACOL SCI, V103, P24, DOI 10.1254/jphs.FP0060651; Ilowite J, 2004, ANN ALLERG ASTHMA IM, V92, P641, DOI 10.1016/S1081-1206(10)61430-5; In KH, 1997, J CLIN INVEST, V99, P1130, DOI 10.1172/JCI119241; Iovannisci DM, 2007, ARTERIOSCL THROM VAS, V27, P394, DOI 10.1161/01.ATV.0000252680.72734.10; Israel E, 2002, J ALLERGY CLIN IMMUN, V110, P847, DOI 10.1067/mai.2002.129413; ISRAEL E, 1993, ANN INTERN MED, V119, P1059, DOI 10.7326/0003-4819-119-11-199312010-00001; Kajimoto K, 2005, CIRC J, V69, P1029, DOI 10.1253/circj.69.1029; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kaushal R, 2007, HUM GENET, V121, P601, DOI 10.1007/s00439-007-0338-y; Kelly MM, 2006, CHEST, V130, P741, DOI 10.1378/chest.130.3.741; Klotsman M, 2007, PHARMACOGENET GENOM, V17, P189, DOI 10.1097/FPC.0b013e3280120043; Knorr B, 1998, JAMA-J AM MED ASSOC, V279, P1181, DOI 10.1001/jama.279.15.1181; Konstan Mw D.G., 2005, PEDIAT PULMONOL, V40, P125; Laviolette M, 1999, AM J RESP CRIT CARE, V160, P1862, DOI 10.1164/ajrccm.160.6.9803042; Lazarus SC, 2007, AM J RESP CRIT CARE, V175, P783, DOI 10.1164/rccm.200511-1746OC; Lee E, 1999, AM J RESP CRIT CARE, V160, P2079, DOI 10.1164/ajrccm.160.6.9903136; Lee E, 2000, AM J RESP CRIT CARE, V161, P1881, DOI 10.1164/ajrccm.161.6.9907054; Luo M, 2004, J BIOL CHEM, V279, P41512, DOI 10.1074/jbc.M312568200; Luo M, 2003, P NATL ACAD SCI USA, V100, P12165, DOI 10.1073/pnas.2133253100; Lynch KR, 1999, NATURE, V399, P789; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Mayatepek E, 2000, EUR J PEDIATR, V159, P811, DOI 10.1007/s004310000601; Meschia JF, 2005, ANN NEUROL, V58, P351, DOI 10.1002/ana.20585; Mezhybovska M, 2006, J BIOL CHEM, V281, P6776, DOI 10.1074/jbc.M509999200; Montuschi P, 2005, THORAX, V60, P827, DOI 10.1136/thx.2004.035592; Nayak A, 2007, DRUGS, V67, P887, DOI 10.2165/00003495-200767060-00005; Nielsen CK, 2005, CANCER RES, V65, P732; Okunishi K, 2004, J IMMUNOL, V173, P6393, DOI 10.4049/jimmunol.173.10.6393; ORR VL, 2003, NAT IMMUNOL, V4, P974; Parameswaran K, 2004, J ALLERGY CLIN IMMUN, V114, P73, DOI 10.1016/j.jaci.2004.03.054; Peters SP, 2007, NEW ENGL J MED, V357, P728; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Peters-Golden M, 2005, ANN ALLERG ASTHMA IM, V94, P609, DOI 10.1016/S1081-1206(10)61317-8; Peters-Golden M, 2003, PROSTAG LEUKOTR ESS, V69, P99, DOI 10.1016/S0952-3278(03)00070-X; Peters-Golden M, 2001, FEBS LETT, V487, P323, DOI 10.1016/S0014-5793(00)02374-7; Philip G, 2002, CLIN EXP ALLERGY, V32, P1020, DOI 10.1046/j.1365-2222.2002.01422.x; Powell WS, 2005, PROG LIPID RES, V44, P154, DOI 10.1016/j.plipres.2005.04.002; Price DB, 2006, ALLERGY, V61, P1153, DOI 10.1111/j.1398-9995.2006.01218.x; Price DB, 2006, ALLERGY, V61, P737, DOI 10.1111/j.1398-9995.2006.01007.x; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; Reiss TF, 1998, ARCH INTERN MED, V158, P1213, DOI 10.1001/archinte.158.11.1213; Rioux N, 1998, CARCINOGENESIS, V19, P1393, DOI 10.1093/carcin/19.8.1393; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Romano M, 2001, FASEB J, V15, P2326, DOI 10.1096/fj.01-0150com; Runarsson G, 2005, BLOOD, V105, P1274, DOI 10.1182/blood-2004-07-2546; Sampson AP, 2000, THORAX, V55, pS28, DOI 10.1136/thorax.55.suppl_2.S28; Sanak M, 1997, LANCET, V350, P1599, DOI 10.1016/S0140-6736(05)64015-9; Sandrini A, 2003, CHEST, V124, P1334, DOI 10.1378/chest.124.4.1334; Schwab JM, 2006, CURR OPIN PHARMACOL, V6, P414, DOI 10.1016/j.coph.2006.02.006; Serio KJ, 2003, J IMMUNOL, V170, P2121, DOI 10.4049/jimmunol.170.4.2121; Sousa AR, 2002, NEW ENGL J MED, V347, P1493, DOI 10.1056/NEJMoa013508; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Stankova J, 2002, J IMMUNOL, V168, P3570, DOI 10.4049/jimmunol.168.7.3570; Stelmach I, 2005, PULM PHARMACOL THER, V18, P374, DOI 10.1016/j.pupt.2005.02.002; Stempel DA, 2006, CURR MED RES OPIN, V22, P2279, DOI 10.1185/030079906X148409; Suissa S, 1997, ANN INTERN MED, V126, P177, DOI 10.7326/0003-4819-126-3-199702010-00001; Sun Z, 2006, CARCINOGENESIS, V27, P1902, DOI 10.1093/carcin/bgl039; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Tanaka H, 1999, ALLERGY, V54, P489, DOI 10.1034/j.1398-9995.1999.00011.x; Terashima T, 2002, CHEST, V122, P1566, DOI 10.1378/chest.122.5.1566; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Uzonyi B, 2006, P NATL ACAD SCI USA, V103, P6326, DOI 10.1073/pnas.0601223103; Virchow JC, 2006, RESP MED, V100, P1952, DOI 10.1016/j.rmed.2006.02.026; Volkman JA, 2002, ANN PHARMACOTHER, V36, P1457; WENZEL SE, 1995, AM J RESP CRIT CARE, V152, P897, DOI 10.1164/ajrccm.152.3.7663802; Yoshisue H, 2007, J ALLERGY CLIN IMMUN, V119, P132, DOI 10.1016/j.jaci.2006.08.028; Zee RYL, 2006, STROKE, V37, P2007, DOI 10.1161/01.STR.0000229905.25080.01; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	123	805	849	5	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2007	357	18					1841	1854		10.1056/NEJMra071371	http://dx.doi.org/10.1056/NEJMra071371			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	225OJ	17978293				2022-12-28	WOS:000250526900008
J	Fliessbach, K; Weber, B; Trautner, P; Dohmen, T; Sunde, U; Elger, CE; Falk, A				Fliessbach, K.; Weber, B.; Trautner, P.; Dohmen, T.; Sunde, U.; Elger, C. E.; Falk, A.			Social comparison affects reward-related brain activity in the human ventral striatum	SCIENCE			English	Article							NEURAL RESPONSES; FAIRNESS; INCOME; GAINS	Whether social comparison affects individual well-being is of central importance for understanding behavior in any social environment. Traditional economic theories focus on the role of absolute rewards, whereas behavioral evidence suggests that social comparisons influence well-being and decisions. We investigated the impact of social comparisons on reward-related brain activity using functional magnetic resonance imaging ( fMRI). While being scanned in two adjacent MRI scanners, pairs of subjects had to simultaneously perform a simple estimation task that entailed monetary rewards for correct answers. We show that a variation in the comparison subject's payment affects blood oxygenation level-dependent responses in the ventral striatum. Our results provide neurophysiological evidence for the importance of social comparison on reward processing in the human brain.	Univ Bonn, Dept Econ, D-5300 Bonn, Germany; Life & Brain Ctr Bonn, Dept NeuroCognit, Bonn, Germany; Clin Epileptol, Bonn, Germany; Inst Study Labor, Bonn, Germany; Univ Bonn, Dept Econ, D-5300 Bonn, Germany	University of Bonn; University of Bonn; IZA Institute Labor Economics; University of Bonn	Falk, A (corresponding author), Univ Bonn, Dept Econ, D-5300 Bonn, Germany.	armin.falk@uni-bonn.de	Weber, Bernd/H-5244-2012	Weber, Bernd/0000-0002-7811-9605				Akitsuki Y, 2003, NEUROIMAGE, V19, P1674, DOI 10.1016/S1053-8119(03)00250-7; BOSKIN MJ, 1978, Q J ECON, V92, P589, DOI 10.2307/1883177; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Carroll Christopher D., 2000, DOES ATLAS SHRUG EC; Clark AE, 1996, J PUBLIC ECON, V61, P359, DOI 10.1016/0047-2727(95)01564-7; CLARK AE, IN PRESS J EC LIT; Cromwell HC, 2005, EXP BRAIN RES, V162, P520, DOI 10.1007/s00221-005-2223-z; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fehr E, 2000, J ECON PERSPECT, V14, P159, DOI 10.1257/jep.14.3.159; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Ferrer-i-Carbonell A, 2005, J PUBLIC ECON, V89, P997, DOI 10.1016/j.jpubeco.2004.06.003; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Frank RH, 2005, AM ECON REV, V95, P137, DOI 10.1257/000282805774670392; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Neumark D, 1998, J PUBLIC ECON, V70, P157, DOI 10.1016/S0047-2727(98)00065-6; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Olson James M., 1986, RELATIVE DEPRIVATION; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525	25	369	376	7	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1305	1308		10.1126/science.1145876	http://dx.doi.org/10.1126/science.1145876			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033886	Green Published			2022-12-28	WOS:000251086600045
J	Dufour, P; Liebert, J; Fontaine, G; Behara, N				Dufour, P.; Liebert, J.; Fontaine, G.; Behara, N.			White dwarf stars with carbon atmospheres	NATURE			English	Article							EVOLUTION; HYDROGEN	White dwarfs represent the endpoint of stellar evolution for stars with initial masses between approximately 0.07 and 8-10M(circle dot), where M-circle dot is the mass of the Sun (more massive stars end their life as either black holes or neutron stars). The theory of stellar evolution predicts that the majority of white dwarfs have a core made of carbon and oxygen, which itself is surrounded by a helium layer and, for similar to 80 per cent of known white dwarfs, by an additional hydrogen layer(1-3). All white dwarfs therefore have been traditionally found to belong to one of two categories: those with a hydrogen-rich atmosphere ( the DA spectral type) and those with a helium-rich atmosphere (the non-DAs). Here we report the discovery of several white dwarfs with atmospheres primarily composed of carbon, with little or no trace of hydrogen or helium. Our analysis shows that the atmospheric parameters found for these stars do not fit satisfactorily in any of the currently known theories of post-asymptotic giant branch evolution, although these objects might be the cooler counterpart of the unique and extensively studied PG 1159 star H15041+65 (refs 4-7). These stars, together with H1504+65, might accordingly form a new evolutionary sequence that follows the asymptotic giant branch.	Univ Arizona, Dept Astron, Tucson, AZ 85721 USA; Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; Observ Paris, GEPI, CIFIST, F-92195 Meudon, France	University of Arizona; University of Arizona; Universite de Montreal; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite	Dufour, P (corresponding author), Univ Arizona, Dept Astron, 933 N Cherry Ave, Tucson, AZ 85721 USA.	dufourpa@as.arizona.edu						BEAUCHAMP A, 1995, THESIS MONTREAL; Behara NT, 2006, ASTRON ASTROPHYS, V451, P643, DOI 10.1051/0004-6361:20053978; Desharnais S, 2007, ASTR SOC P, V372, P265; Dufour P, 2005, ASTROPHYS J, V627, P404, DOI 10.1086/430373; Eisenstein DJ, 2006, ASTROPHYS J SUPPL S, V167, P40, DOI 10.1086/507110; GARCIABERRO E, 1994, ASTROPHYS J, V434, P306, DOI 10.1086/174729; GarciaBerro E, 1997, ASTROPHYS J, V485, P765, DOI 10.1086/304444; Herwig F, 1999, ASTRON ASTROPHYS, V349, pL5; Holberg JB, 2002, ASTROPHYS J, V571, P512, DOI 10.1086/339842; IBEN I, 1984, ASTROPHYS J, V277, P333, DOI 10.1086/161700; Koester D, 2006, ASTRON ASTROPHYS, V454, P951, DOI 10.1051/0004-6361:20065287; KOESTER D, 1986, ASTRON ASTROPHYS, V154, P125; Liebert J, 2003, ASTRON J, V126, P2521, DOI 10.1086/378911; NOUSEK JA, 1986, ASTROPHYS J, V309, P230, DOI 10.1086/164594; PELLETIER C, 1986, ASTROPHYS J, V307, P242, DOI 10.1086/164410; Ritossa C, 1999, ASTROPHYS J, V515, P381, DOI 10.1086/307017; THEJLL P, 1990, ASTROPHYS J, V361, P197, DOI 10.1086/169183; WEGNER G, 1985, ASTROPHYS J, V288, P746, DOI 10.1086/162842; Werner K, 2006, PUBL ASTRON SOC PAC, V118, P183, DOI 10.1086/500443; Werner K, 2004, ASTRON ASTROPHYS, V421, P1169, DOI 10.1051/0004-6361:20047154; WERNER K, 1991, ASTRON ASTROPHYS, V251, P147; Werner K, 1999, ASTRON ASTROPHYS, V347, pL9; [No title captured]	23	119	119	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					522	524		10.1038/nature06318	http://dx.doi.org/10.1038/nature06318			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033290	Green Submitted			2022-12-28	WOS:000251158500040
J	Sabatine, MS; Poh, K; Mega, JL; Shepard, JO; Stone, JR; Frosch, MP; Greenberg, JO; Baggish, A				Sabatine, Marc S.; Poh, Kian-Keong; Mega, Jessica L.; Shepard, Jo-Anne O.; Stone, James R.; Frosch, Matthew P.; Greenberg, Jeffrey O.; Baggish, Aaron			A 31-year-old woman with rash, fever, and hypotension - Acute necrotizing eosinophilic myocarditis associated with a systemic necrotizing inflammatory process also involving skeletal muscle, the liver, and the spinal cord, most consistent with a severe drug-induced hypersensitivity reaction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GIANT-CELL MYOCARDITIS; DIAGNOSIS; MANIFESTATION; THERAPY		Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Sabatine, MS (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.		Sabatine, Marc/AAJ-6751-2020; Frosch, Matthew P/ABD-7456-2021	Sabatine, Marc/0000-0002-0691-3359; Frosch, Matthew P/0000-0002-3940-9861				Adachi Y, 2001, PATHOL INT, V51, P113, DOI 10.1046/j.1440-1827.2001.01166.x; Aggarwal A, 2001, J HEART LUNG TRANSPL, V20, P1241, DOI 10.1016/S1053-2498(01)00313-8; Ansari A, 2003, TEX HEART I J, V30, P76; BARRETT DA, 1971, ARCH PATHOL, V91, P201; BURKE AP, 1991, ARCH PATHOL LAB MED, V115, P764; BURKE JS, 1969, ARCH PATHOL, V88, P359; Cooper LT, 2005, NAT CLIN PRACT CARD, V2, P544, DOI 10.1038/ncpcardio0322; Cooper LT, 1997, NEW ENGL J MED, V336, P1860, DOI 10.1056/NEJM199706263362603; Daniels PR, 2000, CARDIOVASC PATHOL, V9, P287, DOI 10.1016/S1054-8807(00)00049-1; DAVIES JNP, 1948, E AFR MED J, V25, P10; DEMELLO DE, 1990, NEW ENGL J MED, V323, P1542, DOI 10.1056/NEJM199011293232207; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; FENOGLIO JJ, 1981, HUM PATHOL, V12, P900, DOI 10.1016/S0046-8177(81)80195-5; French AJ, 1942, AM J PATHOL, V18, P109; Galiuto L, 1997, MAYO CLIN PROC, V72, P603; GETZ MA, 1991, ANN INTERN MED, V115, P201, DOI 10.7326/0003-4819-115-3-201; GRAVANIS MB, 1991, J HEART LUNG TRANSPL, V10, P688; HERZOG CA, 1984, BRIT HEART J, V52, P343; ISHIKAWA H, 1987, ACTA PATHOL JAPON, V37, P639; Kazama R, 2003, MAYO CLIN PROC, V78, P901, DOI 10.4065/78.7.901; Kilian JG, 1999, LANCET, V354, P1841, DOI 10.1016/S0140-6736(99)10385-4; KIM CH, 1984, AM J CARDIOL, V53, P1472, DOI 10.1016/S0002-9149(84)91473-5; LANGSJOEN PH, 1965, DIS CHEST, V48, P440, DOI 10.1378/chest.48.4.440; Lee CW, 2005, ANN ALLERG ASTHMA IM, V95, P229, DOI 10.1016/S1081-1206(10)61218-5; LIEBERMAN EB, 1991, J AM COLL CARDIOL, V18, P1617, DOI 10.1016/0735-1097(91)90493-S; Litovsky SH, 1996, MODERN PATHOL, V9, P1126; Loeffler W., 1936, SCHWEIZ MED WSCHR, V66, P817; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; NAMBA T, 1974, ARCH NEUROL-CHICAGO, V31, P27, DOI 10.1001/archneur.1974.00490370053007; ROBERTS WC, 1969, AM J MED, V46, P28, DOI 10.1016/0002-9343(69)90055-2; Rosenstein ED, 2000, SEMIN ARTHRITIS RHEU, V30, P1, DOI 10.1053/sarh.2000.8367; Salzman MB, 1997, NEW ENGL J MED, V336, P878, DOI 10.1056/NEJM199703203361216; TALIERCIO CP, 1985, MAYO CLIN PROC, V60, P463, DOI 10.1016/S0025-6196(12)60870-2	33	35	36	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2167	2178		10.1056/NEJMcpc079030	http://dx.doi.org/10.1056/NEJMcpc079030			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	18032767				2022-12-28	WOS:000251076500010
J	Christensen, R; Kristensen, PK; Bartels, EM; Blidda, H; Astrup, A				Christensen, Robin; Kristensen, Pernelle Kruse; Bartels, Else Marie; Blidda, Henning; Astrup, Arne			Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials	LANCET			English	Article							CANNABINOID-1 RECEPTOR BLOCKER; CARDIOVASCULAR RISK-FACTORS; OVERWEIGHT PATIENTS; OBESITY; DEPRESSION; ANTAGONIST; HEALTH; ASSOCIATION	Background Since the prevalence of obesity continues to increase, there is a demand for effective and safe anti-obesity agents that can produce and maintain weight loss and improve comorbidity. We did a meta-analysis of all published randomised controlled trials to assess the efficacy and safety of the newly approved anti-obesity agent rimonabant. Methods We searched The Cochrane database and Controlled Trials Register, Medline via Pubmed, Embase via WebSpirs, Web of Science, Scopus, and reference lists up to July, 2007. We collected data from four double-blind, randomised controlled trials (including 4105 participants) that compared 20 mg per day rimonabant with placebo. Findings Patients given rimonabant had a 4 .7 kg (95% CI 4.1-5.3 kg; p<0-0001) greater weight reduction after 1 year than did those given placebo. Rimonabant caused significantly more adverse events than did placebo (OR=1.4; p=0.0007; number needed to harm=25 individuals [95% CI 17-58]), and 1.4 times more serious adverse events (OR=1.4; p=0.03; number needed to harm=59 [27-830]). Patients given rimonabant were 2.5 times more likely to discontinue the treatment because of depressive mood disorders than were those given placebo (OR=2.5; p=0.01; number needed to harm=49 [19-316]). Furthermore, anxiety caused more patients to discontinue treatment in rimonabant groups than in placebo groups (OR=3.0; p=0.03; number needed to harm=166 [47-3716]). Interpretation Our findings suggest that 20 mg per day rimonabant increases the risk of psychiatric adverse events-ie, depressed mood disorders and anxiety-despite depressed mood being an exclusion criterion in these trials. Taken together with the recent US Food and Drug Administration finding of increased risk of suicide during treatment with rimonabant, we recommend increased alertness by physicians to these potentially severe psychiatric adverse reactions.	Univ Copenhagen, Fac Life Sci, Dept Human Nutr, DK-1958 Frederiksberg, Denmark; Frederiksberg Univ Hosp, Musculoskeletal Stat Unit, Frederiksberg, Denmark; Copenhagen Univ Lib, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Astrup, A (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Human Nutr, Rolighedsvej 30, DK-1958 Frederiksberg, Denmark.	ast@life.ku.dk	Bliddal, Henning/AAB-3168-2019; Astrup, Arne/B-1407-2015	Bliddal, Henning/0000-0002-7951-1668; Astrup, Arne/0000-0001-8968-8996; Christensen, Robin/0000-0002-6600-0631				AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Almeida OP, 2007, AM J GERIAT PSYCHIAT, V15, P506, DOI 10.1097/01.JGP.0000246869.49892.77; Altman Douglas G, 2002, BMC Med Res Methodol, V2, P3, DOI 10.1186/1471-2288-2-3; Astrup A, 2000, Obes Rev, V1, P17, DOI 10.1046/j.1467-789x.2000.00004.x; ASTRUP A, 2004, INT TXB DIABETES MEL, P673; Astrup A, 2007, OBESITY, V15, P1717, DOI 10.1038/oby.2007.205; Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1; Chen Chien-Chin, 2006, Chang Gung Med J, V29, P325; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006162.pub2; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Dixon JB, 2003, ARCH INTERN MED, V163, P2058, DOI 10.1001/archinte.163.17.2058; Fabricatore A. N., 2003, Diabetes Spectrum, V16, P245, DOI 10.2337/diaspect.16.4.245; Gadde KM, 2006, CIRCULATION, V114, P974, DOI 10.1161/CIRCULATIONAHA.105.596130; GOLDSMITH SJ, 1992, INT J EAT DISORDER, V12, P63, DOI 10.1002/1098-108X(199207)12:1&lt;63::AID-EAT2260120109&gt;3.0.CO;2-5; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Higgins JPT, 2001, STAT MED, V20, P2219, DOI 10.1002/sim.918; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Onyike CU, 2003, AM J EPIDEMIOL, V158, P1139, DOI 10.1093/aje/kwg275; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Padwal RS, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004094.pub2, DOI 10.1002/14651858.CD004094.PUB2]; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Rinaldi-Carmona M, 2004, J PHARMACOL EXP THER, V310, P905, DOI 10.1124/jpet.104.067884; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; THOMAS DG, 1971, APPLIED STATISTICS, V20, P105, DOI DOI 10.2307/2346643; Thompson SG, 2005, LANCET, V365, P341, DOI 10.1016/S0140-6736(05)17790-3; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; WADDEN TA, 1993, ANN INTERN MED, V119, P688, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00012; Wadden TA, 2001, SURG CLIN N AM, V81, P1001, DOI 10.1016/S0039-6109(05)70181-X; WING RR, 1987, DIABETES CARE, V10, P563, DOI 10.2337/diacare.10.5.563; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	773	790	1	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2007	370	9600					1706	1713		10.1016/S0140-6736(07)61721-8	http://dx.doi.org/10.1016/S0140-6736(07)61721-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	18022033				2022-12-28	WOS:000251091200021
J	Gelson, E; Gatzoulis, M; Johnson, M				Gelson, E.; Gatzoulis, M.; Johnson, M.			Pregnancy plus - Valvular heart disease	BRITISH MEDICAL JOURNAL			English	Article							STENOSIS; WOMEN	Valvular disease may be unmasked in pregnancy when physiological changes increase demands on the heart. Women with valvular heart disease require close follow-up during pregnancy, delivery, and postpartum.	Univ London Imperial Coll Sci Technol & Med, Acad Dept Obstet & Gynaecol, London SW10 9NH, England; Royal Brompton Hosp, Natl Heart & Lung Inst, Adult Congenital Heart Ctr, London SW3 6NP, England	Imperial College London; Imperial College London; Royal Brompton Hospital	Gelson, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Acad Dept Obstet & Gynaecol, London SW10 9NH, England.	egelson@imperial.ac.uk						Bastos Barbosa PJ, 2000, ARQ BRAS CARDIOL, V75, P220, DOI DOI 10.1590/S0066-782X2000000900003; Bonow RO, 1998, J AM COLL CARDIOL, V32, P1486, DOI 10.1016/S0735-1097(98)00454-9; Gei AF, 2001, OBSTET GYN CLIN N AM, V28, P465, DOI 10.1016/S0889-8545(05)70214-X; Hameed A, 2001, J AM COLL CARDIOL, V37, P893, DOI 10.1016/S0735-1097(00)01198-0; Lesniak-Sobelga A, 2004, INT J CARDIOL, V94, P15, DOI 10.1016/j.ijcard.2003.03.017; Sawhney H, 2003, INT J GYNECOL OBSTET, V80, P9, DOI 10.1016/S0020-7292(02)00029-2; Silversides CK, 2003, AM J CARDIOL, V91, P1386, DOI 10.1016/S0002-9149(03)00340-0; Silversides CK, 2003, AM J CARDIOL, V91, P1382, DOI 10.1016/S0002-9149(03)00339-4; Soler-Soler J, 2000, HEART, V83, P721, DOI 10.1136/heart.83.6.721; Uebing A, 2006, BMJ-BRIT MED J, V332, P401, DOI 10.1136/bmj.332.7538.401	10	11	12	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 17	2007	335	7628					1042	1045		10.1136/bmj.39365.655833.AE	http://dx.doi.org/10.1136/bmj.39365.655833.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UV	18007005	Green Published			2022-12-28	WOS:000251402800034
J	Mapelli, M; Massimiliano, L; Santaguida, S; Musacchio, A				Mapelli, Marina; Massimiliano, Lucia; Santaguida, Stefano; Musacchio, Andrea			The mad2 conformational dimer: Structure and implications for the spindle assembly checkpoint	CELL			English	Article							PROMOTING COMPLEX; PROTEIN; BINDING; ACTIVATION; ANAPHASE; MECHANISM; MODEL; OLIGOMERIZATION; UBIQUITINATION; IDENTIFICATION	The 25 kDa Mad2 protein is a key player in the spindle assembly checkpoint, a safeguard against chromosome segregation errors in mitosis. Mad2 combines three unusual properties. First, Mad2 adopts two conformations with distinct topologies, open (O) and closed (C) Mad2. Second, C-Mad2 forms topological links with its two best-characterized protein ligands, Mad1 and Cdc20. Third, O-Mad2 and C-Mad2 engage in a "conformational'' dimer that is essential for spindle checkpoint function in different organisms. The crystal structure of the O-Mad2-C-Mad2 conformational dimer, reported here, reveals an asymmetric interface that explains the selective dimerization of the O-Mad2 and C-Mad2 conformers. The structure also identifies several buried hydrophobic residues whose rearrangement correlates with the Mad2 topological change. The structure of the O-Mad2-C-Mad2 conformational dimer is consistent with a catalytic model in which a C-Mad2 template facilitates the binding of O-Mad2 to Cdc20, the target of Mad2 in the spindle checkpoint.	European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; Italian Inst Technol Consortium Genom Technol Cog, Res Unit, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO); Istituto Italiano di Tecnologia - IIT	Mapelli, M (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	marina.mapelli@ifom-ieo-campus.it; andrea.musacchio@ifom-ieo-campus.it	Santaguida, Stefano/ABH-5433-2020; Massimiliano, Lucia/AAP-5179-2020; santaguida, stefano/G-2716-2010; Mapelli, Marina/AAC-7346-2022	Santaguida, Stefano/0000-0002-1501-6190; Mapelli, Marina/0000-0001-8502-0649; Musacchio, Andrea/0000-0003-2362-8784; Massimiliano, Lucia/0000-0001-9128-4317				Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown JH, 2006, PROTEIN SCI, V15, P1, DOI 10.1110/ps.051658406; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Canman JC, 2002, CELL MOTIL CYTOSKEL, V52, P61, DOI 10.1002/cm.10032; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chung EN, 2002, MOL BIOL CELL, V13, P1501, DOI 10.1091/mbc.02-01-0003; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; DeAntoni A, 2005, PHILOS T R SOC B, V360, P637, DOI 10.1098/rstb.2004.1618; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Nezi L, 2006, J CELL BIOL, V174, P39, DOI 10.1083/jcb.200602109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Vink M, 2006, CURR BIOL, V16, P755, DOI 10.1016/j.cub.2006.03.057; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	44	180	185	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					730	743		10.1016/j.cell.2007.08.049	http://dx.doi.org/10.1016/j.cell.2007.08.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022367	Green Submitted, Bronze			2022-12-28	WOS:000250966300020
J	Sparks, S				Sparks, Steve			Use the calm between the storms	NATURE			English	Editorial Material									Univ Bristol, Bristol BS8 1RJ, Avon, England	University of Bristol	Sparks, S (corresponding author), Univ Bristol, Bristol BS8 1RJ, Avon, England.								0	6	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					354	354		10.1038/450354a	http://dx.doi.org/10.1038/450354a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004366	Bronze			2022-12-28	WOS:000250918600030
J	Zarka, P; Lamy, L; Cecconi, B; Prange, R; Rucker, HO				Zarka, Philippe; Lamy, Laurent; Cecconi, Baptiste; Prange, Renee; Rucker, Helmut O.			Modulation of Saturn's radio clock by solar wind speed	NATURE			English	Article							HIGH-FREQUENCY LIMIT; ROTATION PERIOD; KILOMETRIC RADIATION; MAGNETIC-FIELD; VOYAGER-1	The internal rotation rates of the giant planets can be estimated by cloud motions, but such an approach is not very precise because absolute wind speeds are not known a priori and depend on latitude(1): periodicities in the radio emissions, thought to be tied to the internal planetary magnetic field, are used instead(2-5). Saturn, despite an apparently axisymmetric magnetic field(6), emits kilometre-wavelength (radio) photons from auroral sources. This emission is modulated at a period initially identified as 10 h 39 min 24 +/- 7 s, and this has been adopted as Saturn's rotation period(3). Subsequent observations(7,8), however, revealed that this period varies by +/-6 min on a timescale of several months to years. Here we report that the kilometric radiation period varies systematically by +/-1% with a characteristic timescale of 20-30 days. Here we show that these fluctuations are correlated with solar wind speed at Saturn, meaning that Saturn's radio clock is controlled, at least in part, by conditions external to the planet's magnetosphere. No correlation is found with the solar wind density, dynamic pressure or magnetic field; the solar wind speed therefore has a special function. We also show that the long-term fluctuations are simply an average of the short-term ones, and therefore the long-term variations are probably also driven by changes in the solar wind.	Univ Paris 06, CNRS, Observ Paris, Lab Etud Spatiales & Instruemntat Astrophys, F-92190 Meudon, France; Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Austrian Academy of Sciences	Zarka, P (corresponding author), Univ Paris 06, CNRS, Observ Paris, Lab Etud Spatiales & Instruemntat Astrophys, F-92190 Meudon, France.	philippe.zarka@obspm.fr	Cecconi, Baptiste/ABF-3912-2020	Cecconi, Baptiste/0000-0001-7915-5571				Bevington PR, 1992, DATA REDUCTION ERROR, P198; Cecconi B, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011085; CECCONI B, 2006, PLANETARY RADIO EMIS, V6, P37; Clarke KE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027821; CONNERNEY JEP, 1982, NATURE, V298, P44, DOI 10.1038/298044a0; CONNERNEY JEP, 1992, J GEOPHYS RES-SPACE, V97, P8713, DOI 10.1029/92JA00139; Cowley SWH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025522; DESCH MD, 1982, J GEOPHYS RES-SPACE, V87, P4549, DOI 10.1029/JA087iA06p04549; DESCH MD, 1981, GEOPHYS RES LETT, V8, P253, DOI 10.1029/GL008i003p00253; DESCH MD, 1986, NATURE, V322, P42, DOI 10.1038/322042a0; DESCH MD, 1983, J GEOPHYS RES-SPACE, V88, P8999, DOI 10.1029/JA088iA11p08999; Espinosa SA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2001JA005084; GALOPEAU P, 1991, J GEOPHYS RES-SPACE, V96, P14129, DOI 10.1029/91JA00696; GALOPEAU P, 1992, J GEOPHYS RES-SPACE, V97, P12291, DOI 10.1029/92JA00323; Galopeau PHM, 1995, J GEOPHYS RES-PLANET, V100, P26397, DOI 10.1029/95JE02132; Galopeau PHM, 2000, J GEOPHYS RES-SPACE, V105, P13089, DOI 10.1029/1999JA005089; Gurnett DA, 2007, SCIENCE, V316, P442, DOI 10.1126/science.1138562; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; Hanlon PG, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010112; Higgins CA, 1997, J GEOPHYS RES-SPACE, V102, P22033, DOI 10.1029/97JA02090; Kurth WS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028336; LECACHEUX A, 1993, GEOPHYS RES LETT, V20, P2711, DOI 10.1029/93GL03117; NESS NF, 1988, PLANETARY RADIO EMIS, V2, P3; Prange R, 2004, NATURE, V432, P78, DOI 10.1038/nature02986; Sanchez-Lavega A, 2005, SCIENCE, V307, P1223, DOI 10.1126/science.1104956; SOUTHWOOD DJ, 2006, AM GEOPH UN FALL M 2; Tao C, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010959; WARWICK JW, 1981, SCIENCE, V212, P239, DOI 10.1126/science.212.4491.239; Zarka P, 1998, J GEOPHYS RES-PLANET, V103, P20159, DOI 10.1029/98JE01323; ZARKA P, 1988, PLANETARY RADIO EMIS, V2, P327	30	62	62	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					265	267		10.1038/nature06237	http://dx.doi.org/10.1038/nature06237			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994092				2022-12-28	WOS:000250746200053
J	Finkielman, JD; Merkel, PA; Schroeder, D; Hoffman, GS; Spiera, R; Clair, EW; Davis, JC; McCune, WJ; Lears, AK; Ytterberg, SR; Hummel, AM; Viss, MA; Peikert, T; Stone, JH; Specks, U				Finkielman, Javier D.; Merkel, Peter A.; Schroeder, Darrell; Hoffman, Gary S.; Spiera, Robert; St. Clair, E. William; Davis, John C., Jr.; McCune, W. Joseph; Lears, Andrea K.; Ytterberg, Steven R.; Hummel, Amber M.; Viss, Margaret A.; Peikert, Tobias; Stone, John H.; Specks, Ulrich		Wget Research Group	Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis	ANNALS OF INTERNAL MEDICINE			English	Article							CAPTURE-ELISA; ANCA TITERS; PROTEINASE-3 PR3; RANDOMIZED-TRIAL; RELAPSES; VASCULITIS; METHOTREXATE; AUTOANTIBODIES; CYCLOPHOSPHAMIDE; RECOGNITION	Background: The utility of antineutrophil cytoplasmic antibody (ANCA) levels to guide the management of patients with Wegener granulomatosis remains controversial. Objective: To determine whether pro-proteinase 3 (PR3)-ANCA levels are a better measure of disease activity than mature-PR3-ANCA levels, whether decreases in either level are associated with shorter time to remission, and whether increases are followed by relapse. Design: Prospective, observational cohort study. Setting: 8 United States medical centers that participated in a treatment trial for Wegener granulomatosis. Patients: 156 patients with Wegener granulomatosis enrolled during periods of active disease. Measurements: PR3-ANCA levels (by capture enzyme-linked immunosorbent assay) and disease activity (by the Birmingham Vasculitis Activity Score for Wegener granulomatosis). Results: The ANCA levels were only weakly associated with disease activity across patients. The longitudinal association within patients was stronger, but changes in ANCA levels explained less than 10% of the variation in disease activity. Decreases in mature- and pro-PR3-ANCA levels were not statistically significantly associated with shorter time to remission, and increases in mature-PR3-ANCA levels (adjusted hazard ratio, 0.8 [95% CI, 0.4 to 1.9]; P = 0.67) and pro-PR3-ANCA levels (adjusted hazard ratio, 1.0 [CI, 0.5 to 2.1]; P = 0.99) were not associated with relapse. The proportion of patients who had relapse within 1 year of an increase in PR3-ANCA levels was 40% for mature-PR3 (CI, 18% to 56%) and 43% for pro-PR3 (CI, 22% to 58%). Limitations: Samples were collected approximately every 3 months. Sensitivity and specificity of ANCA levels for detecting remission and relapse could not be calculated because each patient had different follow-up times. Conclusion: Pro-PR3-ANCA is no better than mature-PR3-ANCA as a measure of Wegener granulomatosis activity. Decreases in PR3-ANCA levels are not associated with shorter time to remission, and increases are not associated with relapse. These findings suggest that ANCA levels cannot be used to guide immunosuppressive therapy.	Mayo Clin & Mayo Fdn, Thorac Dis Res Unit, Div Pulm & Crit Care Med, Rochester, MN 55905 USA; Boston Univ, Boston, MA 02215 USA; Cleveland Clin Fdn Ctr Vasculitis Res & Care, Cleveland, OH USA; Hosp Special Surg, New York, NY 10021 USA; Duke Univ, Durham, NC USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Johns Hopkins Univ, Ctr Clin Trials, Baltimore, MD USA	Mayo Clinic; Boston University; Cleveland Clinic Foundation; Duke University; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; Johns Hopkins University	Specks, U (corresponding author), Mayo Clin & Mayo Fdn, Thorac Dis Res Unit, Div Pulm & Crit Care Med, Stabile Bldg 8-56,200 1st St SW, Rochester, MN 55905 USA.	specks.ulrich@mayo.edu	Spiera, Robert/W-7479-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR002224, R01AR049806, N01AR092240, K24AR049185, K24AR002126] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32-HL07897] Funding Source: Medline; NIAMS NIH HHS [R01-AR49806, N01-AR92240, K24 AR2224-01A1, K24 AR02126-04, K24 AR049185-01] Funding Source: Medline; PHS HHS [M01-RRO-2719, M01-RRO-00533, M01-RRO-0042] Funding Source: Medline; FDA HHS [FD-R-001652] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); FDA HHS		BASLUND B, 1995, CLIN EXP IMMUNOL, V99, P486; Boomsma MM, 2000, ARTHRITIS RHEUM-US, V43, P2025, DOI 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O; Booth AD, 2003, AM J KIDNEY DIS, V41, P776, DOI 10.1016/S0272-6386(03)00025-8; Csernok E, 2004, RHEUMATOLOGY, V43, P174, DOI 10.1093/rheumatology.keh028; de Groot K, 2005, ARTHRITIS RHEUM-US, V52, P2461, DOI 10.1002/art.21142; Franssen CFM, 2000, KIDNEY INT, V57, P2195, DOI 10.1046/j.1523-1755.2000.00080.x; Girard T, 2001, RHEUMATOLOGY, V40, P147, DOI 10.1093/rheumatology/40.2.147; GUPTA SK, 1990, BLOOD, V76, P2162; Han WK, 2003, KIDNEY INT, V63, P1079, DOI 10.1046/j.1523-1755.2003.00821.x; Hoffman GS, 2005, ARTHRIT RHEUM-ARTHR, V53, P1, DOI 10.1002/art.20921; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Hoffman GS, 1998, ARTHRITIS RHEUM-US, V41, P1521, DOI 10.1002/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A; Hopkins J, 2003, ARTHRITIS RHEUM-US, V48, P2299, DOI 10.1002/art.11075; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; JAYNE DRW, 1995, QJM-MON J ASSOC PHYS, V88, P127; JENNE DE, 1990, NATURE, V346, P520, DOI 10.1038/346520a0; KERR GS, 1993, ARTHRITIS RHEUM, V36, P365, DOI 10.1002/art.1780360312; Kyndt X, 1999, AM J MED, V106, P527, DOI 10.1016/S0002-9343(99)00064-9; Langford CA, 2004, CLIN EXP RHEUMATOL, V22, pS3; Langford CA, 2003, AM J MED, V114, P463, DOI 10.1016/S0002-9343(03)00077-9; Lee AS, 2005, J IMMUNOL METHODS, V307, P62, DOI 10.1016/j.jim.2005.09.004; NOLLE B, 1989, ANN INTERN MED, V111, P28, DOI 10.7326/0003-4819-111-1-28; Nowack R, 2001, NEPHROL DIAL TRANSPL, V16, P1631, DOI 10.1093/ndt/16.8.1631; Reinhold-Keller E, 2000, ARTHRITIS RHEUM, V43, P1021, DOI 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J; Russell KA, 2002, CLIN IMMUNOL, V103, P196, DOI 10.1006/clim.2001.5200; Russell KA, 2001, ARTHRITIS RHEUM, V44, P463, DOI 10.1002/1529-0131(200102)44:2<463::AID-ANR65>3.3.CO;2-0; Sanders JSF, 2006, RHEUMATOLOGY, V45, P724, DOI 10.1093/rheumatology/kei272; Savige J, 2000, KIDNEY INT, V57, P846, DOI 10.1046/j.1523-1755.2000.057003846.x; Segelmark W, 2003, CLIN DIAGN LAB IMMUN, V10, P769, DOI 10.1128/CDLI.10.5.769-774.2003; Seo P, 2005, ARTHRITIS RHEUM-US, V52, P2168, DOI 10.1002/art.21117; SNELLER MC, 1995, ARTHRITIS RHEUM, V38, P608, DOI 10.1002/art.1780380505; Specks U, 1997, CLIN EXP IMMUNOL, V109, P286, DOI 10.1046/j.1365-2249.1997.4561353.x; Specks U, 2000, ARTHRITIS RES, V2, P263, DOI 10.1186/ar99; Stegeman CA, 2005, J RHEUMATOL, V32, P2075; Stegeman CA, 2002, NEPHROL DIAL TRANSPL, V17, P2077, DOI 10.1093/ndt/17.12.2077; Stone JH, 1999, J RHEUMATOL, V26, P1134; Stone JH, 2002, CONTROL CLIN TRIALS, V23, P450; Stone JH, 2001, ARTHRITIS RHEUM, V44, P912, DOI 10.1002/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5; Sun J, 1998, CLIN EXP IMMUNOL, V114, P320; Sun JY, 1998, J IMMUNOL METHODS, V211, P111, DOI 10.1016/S0022-1759(97)00203-2; TERVAERT JWC, 1989, ARCH INTERN MED, V149, P2461, DOI 10.1001/archinte.149.11.2461; TERVAERT JWC, 1990, LANCET, V336, P709; Therneau TM, 2000, MODELING SURVIVAL DA; VANDERWOUDE FJ, 1985, LANCET, V1, P425; *WEG GRAN ET TRIAL, 2005, NEW ENGL J MED, V352, P352; Westman KWA, 1998, KIDNEY INT, V53, P1230, DOI 10.1046/j.1523-1755.1998.00873.x	46	186	196	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2007	147	9					611	619		10.7326/0003-4819-147-9-200711060-00005	http://dx.doi.org/10.7326/0003-4819-147-9-200711060-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227QM	17975183				2022-12-28	WOS:000250672900003
J	Spence, MS; Balaratnam, MS; Gatzoulis, MA				Spence, Mark S.; Balaratnam, Michelle S.; Gatzoulis, Michael A.			Clinical update: cyanotic adult congenital heart disease	LANCET			English	Article							BLOOD-VISCOSITY; POLYCYTHEMIA; SURVIVAL; INDEXES		Royal Brompton Hosp, Adult Congenital Heart Ctr, London SW3 6NP, England; Imperial Coll, Natl Heart & Lung Inst, London SW3 6NP, England; Royal Jubilee Hosp, Victoria Heart Inst Fdn, Victoria, BC, Canada	Royal Brompton Hospital; Imperial College London	Spence, MS (corresponding author), Royal Brompton Hosp, Adult Congenital Heart Ctr, London SW3 6NP, England.	markspence1@yahoo.co.uk						Ammash N, 1996, J AM COLL CARDIOL, V28, P768, DOI 10.1016/0735-1097(96)00196-9; BERK PD, 1986, SEMIN HEMATOL, V23, P132; Brickner ME, 2000, NEW ENGL J MED, V342, P256, DOI 10.1056/NEJM200001273420407; Broberg CS, 2006, J AM COLL CARDIOL, V48, P356, DOI 10.1016/j.jacc.2006.03.040; Dedkov EI, 2006, CIRCULATION, V114, P196, DOI 10.1161/CIRCULATIONAHA.105.602771; Diller GP, 2007, CIRCULATION, V115, P1039, DOI 10.1161/CIRCULATIONAHA.105.592386; Diller GP, 2006, EUR HEART J, V27, P1737, DOI 10.1093/eurheartj/ehl116; FAIRBANKS VF, 1995, WILLIAMS HEMATOLOGY, P490; Kaemmerer H, 2004, AM J CARDIOL, V94, P825, DOI 10.1016/j.amjcard.2004.06.014; Katayama Y, 2006, CLIN HEMORHEOL MICRO, V35, P499; MILLIGAN DW, 1982, BRIT J HAEMATOL, V50, P467, DOI 10.1111/j.1365-2141.1982.tb01942.x; MOLLER JH, 1994, CIRCULATION, V89, P923, DOI 10.1161/01.CIR.89.2.923; Niwa K, 2004, INT J CARDIOL, V96, P211, DOI 10.1016/j.ijcard.2003.06.019; Oechslin E, 2003, DIAGNOSIS MANAGEMENT, P363; Perloff JK, 2001, CIRCULATION, V103, P2637; PERLOFF JK, 1993, CIRCULATION, V87, P1954, DOI 10.1161/01.CIR.87.6.1954; ROSOVE MH, 1986, LANCET, V2, P313; Thorne SA, 1998, HEART, V79, P315, DOI 10.1136/hrt.79.4.315; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4; Wren C, 2001, HEART, V85, P438, DOI 10.1136/heart.85.4.438	20	43	43	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2007	370	9598					1530	1532		10.1016/S0140-6736(07)61647-X	http://dx.doi.org/10.1016/S0140-6736(07)61647-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AE	17980725				2022-12-28	WOS:000250628800010
J	Mertens, C; Darnell, JE				Mertens, Claudia; Darnell, James E., Jr.			SnapShot: JAK-STAT signaling	CELL			English	Editorial Material							IMMUNE-SYSTEM; TRANSCRIPTION; PROTEINS		Rockefeller Univ, Mol Cell Biol Lab, New York, NY 10065 USA	Rockefeller University	Mertens, C (corresponding author), Rockefeller Univ, Mol Cell Biol Lab, New York, NY 10065 USA.							Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Nusinzon I, 2005, J INTERF CYTOK RES, V25, P745, DOI 10.1089/jir.2005.25.745; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226	9	90	91	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3							612.e1	10.1016/j.cell.2007.10.033	http://dx.doi.org/10.1016/j.cell.2007.10.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981126	Bronze			2022-12-28	WOS:000250618500026
J	Campbell, EG				Campbell, Eric G.			Doctors and drug companies - Scrutinizing influential relationships	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Campbell, EG (corresponding author), Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA.							Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Chren MM, 1999, AM J MED, V107, P182	3	84	87	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2007	357	18					1796	1797		10.1056/NEJMp078141	http://dx.doi.org/10.1056/NEJMp078141			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	225OJ	17978288				2022-12-28	WOS:000250526900002
J	Kang, HC; Chung, MY				Kang, Ho-Cheol; Chung, Min-Young			Peripheral artery disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Chonnam Natl Univ, Sch Med, Kwangju 501746, South Korea	Chonnam National University	Kang, HC (corresponding author), Chonnam Natl Univ, Sch Med, Kwangju 501746, South Korea.	drkang@chonnam.ac.kr	Kang, Ho-Cheol/E-7969-2011	Kang, Ho-Cheol/0000-0002-0448-1345					0	4	4	2	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2007	357	18					E19	E19		10.1056/NEJMicm064659	http://dx.doi.org/10.1056/NEJMicm064659			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	225OJ	17978286				2022-12-28	WOS:000250526900010
J	Gennerich, A; Carter, AP; Reck-Peterson, SL; Vale, RD				Gennerich, Arne; Carter, Andrew P.; Reck-Peterson, Samara L.; Vale, Ronald D.			Force-induced bidirectional stepping of cytoplasmic dynein	CELL			English	Article							MOLECULAR MOTOR; MYOSIN-V; MICROTUBULE-BINDING; FLAGELLAR AXONEMES; HEAVY-CHAIN; IN-VITRO; TRANSPORT; KINESIN; ACTIN; SIZE	Cytoplasmic dynein is a minus-end-directed microtubule motor whose mechanism of movement remains poorly understood. Here, we use optical tweezers to examine the force-dependent stepping behavior of yeast cytoplasmic dynein. We find that dynein primarily advances in 8 nm increments but takes other sized steps (4-24 nm) as well. An opposing force induces more frequent backward stepping by dynein, and the motor walks backward toward the microtubule plus end at loads above its stall force of 7 pN. Remarkably, in the absence of ATP, dynein steps processively along microtubules under an external load, with less force required for minus-end-than for plus-end-directed movement. This nucleotide-independent walking reveals that force alone can drive repetitive microtubule detachment-attachment cycles of dynein's motor domains. These results suggest a model for how dynein's two motor domains coordinate their activities during normal processive motility and provide new clues for understanding dynein-based motility in living cells.	[Gennerich, Arne; Carter, Andrew P.; Reck-Peterson, Samara L.; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	Gennerich, Arne/W-5488-2019	Carter, Andrew/0000-0001-7292-5430; Reck-Peterson, Samara/0000-0002-1553-465X	Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [P01 AR042895-140004, P01-AR42895, P01 AR042895] Funding Source: Medline; NIGMS NIH HHS [F32 GM067403, F32-GM67403-02] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067403] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; GEE MA, 1997, NATURE, V390, P639; Gennerich A, 2006, PHYS BIOL, V3, P45, DOI 10.1088/1478-3975/3/1/005; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; KAMIMURA S, 1992, J CELL BIOL, V116, P1443, DOI 10.1083/jcb.116.6.1443; KAMIMURA S, 1989, NATURE, V340, P476, DOI 10.1038/340476a0; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kliche W, 2001, EMBO J, V20, P40, DOI 10.1093/emboj/20.1.40; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Shingyoji C, 1998, NATURE, V393, P711, DOI 10.1038/31520; Silvanovich A, 2003, MOL BIOL CELL, V14, P1355, DOI 10.1091/mbc.E02-10-0675; Spudich JA, 2006, CELL, V126, P242, DOI 10.1016/j.cell.2006.07.009; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Takahashi Y, 2004, P NATL ACAD SCI USA, V101, P12865, DOI 10.1073/pnas.0403429101; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Yeh E, 2000, MOL BIOL CELL, V11, P3949, DOI 10.1091/mbc.11.11.3949	42	289	291	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 30	2007	131	5					952	965		10.1016/j.cell.2007.10.016	http://dx.doi.org/10.1016/j.cell.2007.10.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045537	Green Accepted, Bronze			2022-12-28	WOS:000251800900017
J	Monath, TP				Monath, Thomas P.			Dengue and yellow fever - Challenges for the developments and use of vaccines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS		Kleiner Perkins Caulfield & Byers, Menlo Pk, CA 94025 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Monath, TP (corresponding author), Kleiner Perkins Caulfield & Byers, Menlo Pk, CA 94025 USA.							Edelman R, 2007, CLIN INFECT DIS, V45, pS56, DOI 10.1086/518148; Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; MONATH TP, IN PRESS VACCINES	5	61	70	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2222	2225		10.1056/NEJMp0707161	http://dx.doi.org/10.1056/NEJMp0707161			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	18046026	Bronze			2022-12-28	WOS:000251176400003
J	Nagamatsu, S; Ohara-Imaizumi, M				Nagamatsu, Shinya; Ohara-Imaizumi, Mica			IP7 debut in insulin release	SCIENCE			English	Editorial Material							INOSITOL PYROPHOSPHATES; SECRETION; EXOCYTOSIS; PATHWAYS; PROTEINS; DYNAMICS; GLUCOSE		Kyorin Univ, Sch Med, Dept Biochem, Tokyo 1818611, Japan	Kyorin University	Nagamatsu, S (corresponding author), Kyorin Univ, Sch Med, Dept Biochem, Shinkawa 6-20-2, Tokyo 1818611, Japan.	shinya@kyorin-u.ac.jp						Barker CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1113, DOI 10.1152/ajpendo.00088.2002; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; CERASI E, 1994, INSULIN MOL BIOL PAT, P347; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; Fukuda M, 1997, BIOESSAYS, V19, P593, DOI 10.1002/bies.950190710; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; GRODSKY GM, 1972, J CLIN INVEST, V51, P2047, DOI 10.1172/JCI107011; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Kamimura J, 2004, J HUM GENET, V49, P360, DOI 10.1007/s10038-004-0158-z; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329	18	3	5	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1249	1250		10.1126/science.1151361	http://dx.doi.org/10.1126/science.1151361			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033869				2022-12-28	WOS:000251086600026
J	Camblong, J; Iglesias, N; Fickentscher, C; Dieppois, G; Stutz, F				Camblong, Jurgi; Iglesias, Nahid; Fickentscher, Celine; Dieppois, Guennaelle; Stutz, Francoise			Antisense RNA stabilization induces transcriptional gene silencing via histone deacetylation in s. cerevisiae	CELL			English	Article							EXOSOME SUBUNIT RRP6P; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; POLY(A) POLYMERASE; HDA1 DEACETYLASE; YEAST; GENOME; DEGRADATION; COMPLEX; EXPRESSION	Genome-wide studies in S. cerevisiae reveal that the transcriptome includes numerous antisense RNAs as well as intergenic transcripts regulated by the exosome component Rrp6. We observed that upon the loss of Rrp6 function, two PHO84 antisense transcripts are stabilized, and PHO84 gene transcription is repressed. Interestingly, the same phenotype is observed in wild-type cells during chronological aging. Epistasis and chromatin immunoprecipitation experiments indicate that the loss of Rrp6 function is paralleled by the recruitment of Hda1 histone deacetylase to PHO84 and neighboring genes. However, histone deacetylation is restricted to PHO84, suggesting that Hda1 activity depends on antisense RNA. Accordingly, the knockdown of antisense production prevents PHO84 gene repression, even in the absence of Rrp6. Together, our data indicate that the stabilization of antisense transcripts results in PHO84 gene repression via a mechanism distinct from transcription interference and that the modulation of Rrp6 function contributes to gene regulation by inducing RNA-dependent epigenetic modifications.	Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland	University of Geneva	Stutz, F (corresponding author), Univ Geneva, Dept Cell Biol, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.	francoise.stutz@cellbio.unige.ch	Stutz, Françoise C/N-4329-2017	Iglesias, Nahid/0000-0001-5185-846X				Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Ciaudo C, 2006, PLOS GENET, V2, P874, DOI 10.1371/journal.pgen.0020094; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Ekwall K, 2005, TRENDS GENET, V21, P608, DOI 10.1016/j.tig.2005.08.009; Escusa S, 2006, MOL MICROBIOL, V60, P1014, DOI 10.1111/j.1365-2958.2006.05153.x; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Green SR, 2004, MOL BIOL CELL, V15, P4191, DOI 10.1091/mbc.E04-05-0412; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hieronymus H, 2004, GENE DEV, V18, P2652, DOI 10.1101/gad.1241204; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; MOAZED D, 2006, QUANT BIOL, V71, P461; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Phillips S, 2003, RNA, V9, P1098, DOI 10.1261/rna.5560903; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Roth KM, 2005, MOL CELL BIOL, V25, P1577, DOI 10.1128/MCB.25.5.1577-1585.2005; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103; Wu JS, 2001, P NATL ACAD SCI USA, V98, P4391, DOI 10.1073/pnas.081560698; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Yang PK, 2007, CELL, V128, P777, DOI 10.1016/j.cell.2007.01.032; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002	38	287	295	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					706	717		10.1016/j.cell.2007.09.014	http://dx.doi.org/10.1016/j.cell.2007.09.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022365	Bronze			2022-12-28	WOS:000250966300018
J	Lavine, MS; Voss, D; Coontz, R				Lavine, Marc S.; Voss, David; Coontz, Robert			Introduction - A robotic future	SCIENCE			English	Editorial Material																			0	0	1	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1083	1083		10.1126/science.318.5853.1083	http://dx.doi.org/10.1126/science.318.5853.1083			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006733				2022-12-28	WOS:000250957900030
J	Steinbrook, R				Steinbrook, Robert			Closing the affordability gap for drugs in low-income countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Danzon PM, 2007, NATURE, V449, P176, DOI 10.1038/449176a; Gelders S., 2006, PRICE AVAILABILITY A; *MED SANS FRONT, 2007, UNT WEB PRIC RED; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Steinbrook R, 2007, NEW ENGL J MED, V356, P544, DOI 10.1056/NEJMp068297	5	28	30	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2007	357	20					1996	1999		10.1056/NEJMp0706918	http://dx.doi.org/10.1056/NEJMp0706918			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230RV	18003957				2022-12-28	WOS:000250894500002
J	Woosley, SE; Blinnikov, S; Heger, A				Woosley, S. E.; Blinnikov, S.; Heger, Alexander			Pulsational pair instability as an explanation for the most luminous supernovae	NATURE			English	Article							GAMMA-RAY BURSTS; MASS-LOSS; EVOLUTION; STARS; METALLICITY; EXPLOSION; SN-2006GY; RATES	The extremely luminous supernova SN 2006gy (ref. 1) challenges the traditional view that the collapse of a stellar core is the only mechanism by which a massive star makes a supernova, because it seems too luminous by more than a factor of ten. Here we report that the brightest supernovae in the modern Universe arise from collisions between shells of matter ejected by massive stars that undergo an interior instability arising from the production of electron - positron pairs(2). This `pair instability' leads to explosive burning that is insufficient to unbind the star, but ejects many solar masses of the envelope. After the first explosion, the remaining core contracts and searches for a stable burning state. When the next explosion occurs, several solar masses of material are again ejected, which collide with the earlier ejecta. This collision can radiate 10(50) erg of light, about a factor of ten more than an ordinary supernova. Our model is in good agreement with the observed light curve for SN 2006gy and also shows that some massive stars can produce more than one supernova-like outburst.	Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; ITEP, Moscow 117218, Russia; Max Planck Inst Astrophys, D-85741 Garching, Germany; Los Alamos Natl Lab, Theoret Astrophys Grp, Los Alamos, NM 87544 USA	University of California System; University of California Santa Cruz; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; Max Planck Society; United States Department of Energy (DOE); Los Alamos National Laboratory	Woosley, SE (corresponding author), Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA.	woosley@ucolick.org	Blinnikov, Sergei I/L-2623-2017	Blinnikov, Sergei I/0000-0002-5726-538X; Heger, Alexander/0000-0002-3684-1325				BARKAT Z, 1967, PHYS REV LETT, V18, P379, DOI 10.1103/PhysRevLett.18.379; Blinnikov SI, 2006, ASTRON ASTROPHYS, V453, P229, DOI 10.1051/0004-6361:20054594; BOND JR, 1984, ASTROPHYS J, V280, P825, DOI 10.1086/162057; CHEVALIER RA, 1995, ASTROPHYS J, V444, P312, DOI 10.1086/175606; Chugai NN, 2004, MON NOT R ASTRON SOC, V352, P1213, DOI 10.1111/j.1365-2966.2004.08011.x; DEJAGER C, 1988, ASTRON ASTROPHYS SUP, V72, P259; DUNCAN RC, 1992, ASTROPHYS J, V392, pL9, DOI 10.1086/186413; Figer DF, 2005, NATURE, V434, P192, DOI 10.1038/nature03293; Foley RJ, 2007, ASTROPHYS J, V657, pL105, DOI 10.1086/513145; GRASBERG EK, 1986, SOV ASTRON LETT+, V12, P68; Heger A, 2005, ASTROPHYS J, V626, P350, DOI 10.1086/429868; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Kudritzki RP, 2002, ASTROPHYS J, V577, P389, DOI 10.1086/342178; MacFadyen AI, 1999, ASTROPHYS J, V524, P262, DOI 10.1086/307790; NIEUWENHUIJZEN H, 1990, ASTRON ASTROPHYS, V231, P134; NOMOTO K, 2007, IN PRESS SUPERNOVA 1; Ofek EO, 2007, ASTROPHYS J, V659, pL13, DOI 10.1086/516749; Scannapieco E, 2005, ASTROPHYS J, V633, P1031, DOI 10.1086/444450; SMITH N, 2006, IN PRESS MASSIVE STA; Smith N, 2007, ASTROPHYS J, V666, P1116, DOI 10.1086/519949; Smith N, 2006, ASTROPHYS J, V645, pL45, DOI 10.1086/506523; UMEDAH, 2007, UNPUB ASTROPHYS J; USOV VV, 1992, NATURE, V357, P472, DOI 10.1038/357472a0; Van Dyk SD, 2005, PUBL ASTRON SOC PAC, V117, P553, DOI 10.1086/430238; Vink JS, 2005, ASTRON ASTROPHYS, V442, P587, DOI 10.1051/0004-6361:20052862; Vink JS, 2002, ASTRON ASTROPHYS, V393, P543, DOI 10.1051/0004-6361:20021009; WEAVER TA, 1978, ASTROPHYS J, V225, P1021, DOI 10.1086/156569; Woosley S. E., 1982, NATO ADV SCI I ASI C, V90, P79; Woosley SE, 2002, REV MOD PHYS, V74, P1015, DOI 10.1103/RevModPhys.74.1015; WOOSLEY SE, 1993, ASTROPHYS J, V405, P273, DOI 10.1086/172359; [No title captured]	31	429	434	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					390	392		10.1038/nature06333	http://dx.doi.org/10.1038/nature06333			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004378	Green Submitted			2022-12-28	WOS:000250918600048
J	Dooldeniya, MD; Khafagy, R; Mashaly, H; Browning, AJ; Sundaram, SK; Biyani, CS				Dooldeniya, M. D.; Khafagy, R.; Mashaly, H.; Browning, A. J.; Sundaram, S. K.; Biyani, C. S.			Lesson of the week - Lower abdominal pain in women after binge drinking	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BLADDER; RUPTURE		Pinderfields Gen Hosp, Wakefield WF1 4EE, W Yorkshire, England	Pinderfields Hospital	Dooldeniya, MD (corresponding author), Pinderfields Gen Hosp, Wakefield WF1 4EE, W Yorkshire, England.	modool@btinternet.com	Biyani, Chandra/AAN-6172-2021	Biyani, Chandra/0000-0003-3443-8425				BENNETT AH, 1980, J UROLOGY, V124, P429, DOI 10.1016/S0022-5347(17)55482-8; FESTINI G, 1991, ANN EMERG MED, V20, P1371, DOI 10.1016/S0196-0644(05)81082-0; Gomez RG, 2004, BJU INT, V94, P27, DOI 10.1111/j.1464-410X.2004.04896.x; HADDAD FS, 1987, UROL INT, V42, P467, DOI 10.1159/000282019; Herd Anthony M., 1994, Journal of Emergency Medicine, V12, P409, DOI 10.1016/0736-4679(94)90287-9; MARDONES GB, 2002, ARCH ESP UROL, V55, P849; MOKOENA T, 1995, BRIT J SURG, V82, P69, DOI 10.1002/bjs.1800820124; *NAT STAT, 2004, FOC HLTH DRINK; Neel KF, 2004, SAUDI MED J, V25, P220; *PRIM MIN STRAT UN, 2003, ALC MIS MUCH DOES IT; *WORK PART ROYAL C, 2001, ALC CAN NHS AFF IT	11	23	23	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2007	335	7627					992	993		10.1136/bmj.39247.454005.BE	http://dx.doi.org/10.1136/bmj.39247.454005.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232AL	17991983	Green Published			2022-12-28	WOS:000250990400049
J	McElreath, R; Luttbeg, B; Fogarty, SP; Brodin, T; Sih, A				McElreath, Richard; Luttbeg, Barney; Fogarty, Sean P.; Brodin, Tomas; Sih, Andrew			Evolution of animal personalities	NATURE			English	Letter							BEHAVIORAL SYNDROMES		Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	McElreath, R (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	btluttbeg@ucdavis.edu	Sih, Andrew/P-7985-2015	Sih, Andrew/0000-0001-6161-1663; Brodin, Tomas/0000-0003-1086-7567				CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835	5	45	45	3	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					E5	E5		10.1038/nature06326	http://dx.doi.org/10.1038/nature06326			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994035	Bronze			2022-12-28	WOS:000250746200048
J	Crabtree, RH				Crabtree, Robert H.			No protection required	SCIENCE			English	Editorial Material							BONDS		Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Crabtree, RH (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	robert.crabtree@yale.edu						Anastas PT, 2002, ACCOUNTS CHEM RES, V35, P686, DOI 10.1021/ar010065m; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Das S, 2006, SCIENCE, V312, P1941, DOI 10.1126/science.1127899; Dick AR, 2006, TETRAHEDRON, V62, P2439, DOI 10.1016/j.tet.2005.11.027; Dyker G, 2005, HANDBOOK OF C-H TRANSFORMATIONS: APPLICATIONS IN ORGANIC SYNTHESIS, VOL 1, pV; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a	6	6	6	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					756	757		10.1126/science.1150982	http://dx.doi.org/10.1126/science.1150982			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975055				2022-12-28	WOS:000250583900027
J	Karnik, SK; Chen, HN; McLean, GW; Heit, JJ; Gu, XY; Zhang, AY; Fontaine, M; Yen, MH; Kim, SK				Karnik, Satyajit K.; Chen, Hainan; McLean, Graeme W.; Heit, Jeremy J.; Gu, Xueying; Zhang, Andrew Y.; Fontaine, Magali; Yen, Michael H.; Kim, Seung K.			Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus	SCIENCE			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; DEPENDENT KINASE INHIBITORS; INSULIN-SECRETION; PLACENTAL-LACTOGEN; ISLET FUNCTION; EXPRESSION; GENE; PROLACTIN; PROLIFERATION; BCL-6	During pregnancy, maternal pancreatic islets grow to match dynamic physiological demands, but the mechanisms regulating adaptive islet growth in this setting are poorly understood. Here we show that menin, a protein previously characterized as an endocrine tumor suppressor and transcriptional regulator, controls islet growth in pregnant mice. Pregnancy stimulated proliferation of maternal pancreatic islet beta-cells that was accompanied by reduced islet levels of menin and its targets. Transgenic expression of menin in maternal beta-cells prevented islet expansion and led to hyperglycemia and impaired glucose tolerance, hallmark features of gestational diabetes. Prolactin, a hormonal regulator of pregnancy, repressed islet menin levels and stimulated beta-cell proliferation. These results expand our understanding of mechanisms underlying diabetes pathogenesis and reveal potential targets for therapy in diabetes.	Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	seungkim@stanford.edu		Zhang, Andrew/0000-0002-6309-9947; Kim, Seung/0000-0001-6135-7810; Heit, Jeremy/0000-0003-1055-8000	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007217] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32DK007217-32] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agarwal SK, 2004, ANN NY ACAD SCI, V1014, P189, DOI 10.1196/annals.1294.020; Boloker J, 2002, DIABETES, V51, P1499, DOI 10.2337/diabetes.51.5.1499; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Franklin DS, 2000, MOL CELL BIOL, V20, P6147, DOI 10.1128/MCB.20.16.6147-6158.2000; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Horvath E, 1999, Pituitary, V1, P169, DOI 10.1023/A:1009952930425; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Labriola L, 2007, MOL CELL ENDOCRINOL, V264, P16, DOI 10.1016/j.mce.2006.10.004; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; NIELSEN JH, 1982, ENDOCRINOLOGY, V110, P600, DOI 10.1210/endo-110-2-600; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; SCAGLIA L, 1995, ENDOCRINOLOGY, V136, P5461, DOI 10.1210/en.136.12.5461; Scheeren FA, 2005, NAT IMMUNOL, V6, P303, DOI 10.1038/ni1172; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; VANASSCHE FA, 1978, BRIT J OBSTET GYNAEC, V85, P818; Weinhaus AJ, 2000, ENDOCRINOLOGY, V141, P1384, DOI 10.1210/en.141.4.1384; Yao JC, 2007, BEST PRACT RES CL EN, V21, P163, DOI 10.1016/j.beem.2007.01.006; YEN TT, 1994, FASEB J, V8, P479, DOI 10.1096/fasebj.8.8.8181666; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	27	267	282	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					806	809		10.1126/science.1146812	http://dx.doi.org/10.1126/science.1146812			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975067				2022-12-28	WOS:000250583900043
J	Sohn, J; Grant, RA; Sauer, RT				Sohn, Jungsan; Grant, Robert A.; Sauer, Robert T.			Allosteric activation of DegS, a stress sensor PDZ protease	CELL			English	Article							ESCHERICHIA-COLI SIGMA(E); CRYSTAL-STRUCTURE; SERINE-PROTEASE; HTRA FAMILY; PROTEOLYSIS; PROTEINS; BINDING; DOMAIN; YAEL; SUBSTRATE	Regulated intramembrane proteolysis is a method for transducing signals between cellular compartments. When protein folding is compromised in the periplasm of E. coli, the C termini of outer-membrane proteins (OMPs) bind to the PDZ domains of the trimeric DegS protease and activate cleavage of RseA, a transmembrane transcriptional regulator. We show here that DegS is an allosteric enzyme. OMP binding shifts the equilibrium from a nonfunctional state, in which the active sites are unreactive, to the functional proteolytic conformation. Crystallographic, biochemical, and mutagenic experiments show that the unliganded PDZ domains are inhibitory and suggest that OMP binding per se is sufficient to stabilize the relaxed conformation and activate DegS. OMP-induced activation and RseA binding are both positively cooperative, allowing switch-like behavior of the OMP-DegS-RseA system. Residues involved in the DegS allosteric switch are conserved in the DegP/HtrA and HtrA2/Omi families, suggesting that many PDZ proteases use a common mechanism of allosteric activation.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER; NCRR NIH HHS [RR15301] Funding Source: Medline; NIAID NIH HHS [AI16892] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Alba BM, 2001, MOL MICROBIOL, V40, P1323, DOI 10.1046/j.1365-2958.2001.02475.x; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Cezairliyan BO, 2007, P NATL ACAD SCI USA, V104, P3771, DOI 10.1073/pnas.0611567104; Chaba R, 2007, GENE DEV, V21, P124, DOI 10.1101/gad.1496707; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; DeLano W.L, PYMOL MOL GRAPHICS S; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Ehrmann M, 2004, ANNU REV GENET, V38, P709, DOI 10.1146/annurev.genet.38.072902.093416; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Grigorova IL, 2006, P NATL ACAD SCI USA, V103, P5332, DOI 10.1073/pnas.0600828103; Gupta S, 2004, J BIOL CHEM, V279, P45844, DOI 10.1074/jbc.M404940200; Jones CH, 2002, J BACTERIOL, V184, P5762, DOI 10.1128/JB.184.20.5762-5771.2002; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; Kim DY, 2003, J BIOL CHEM, V278, P6543, DOI 10.1074/jbc.M208148200; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Zeth K, 2004, FEBS LETT, V569, P351, DOI 10.1016/j.febslet.2004.06.012	40	99	101	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					572	583		10.1016/j.cell.2007.08.044	http://dx.doi.org/10.1016/j.cell.2007.08.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981123	Bronze			2022-12-28	WOS:000250618500023
J	De Ridder, D; Van Laere, K; Dupont, P; Menovsky, T; Van de Heyning, P				De Ridder, Dirk; Van Laere, Koen; Dupont, Patrick; Menovsky, Tomas; Van de Heyning, Pal			Visualizing out-of-body experience in the brain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SELF-CONSCIOUSNESS; STIMULATION; MECHANISMS; AWARENESS; PET	An out-of-body experience was repeatedly elicited during stimulation of the posterior part of the superior temporal gyrus on the right side in a patient in whom electrodes had been implanted to suppress tinnitus. Position-emission tomographic scanning showed brain activation at the temporoparietal junction - more specifically, at the angular - supramarginal gyrus junction and the superior temporal gyrus - sulcus on the right side. Activation was also noted at the right precuneus and posterior thalamus, extending into the superior vermis. We suggest that activation of these regions is the neural correlate of the disembodiment that is part of the out-of-body experience.	Univ Antwerp, Univ Antwerp Hosp, Dept Neurosurg & Ear Nose & Throat, B-2020 Antwerp, Belgium; Univ Hosp Leuven, Dept Nucl Med, Louvain, Belgium	University of Antwerp; KU Leuven; University Hospital Leuven	De Ridder, D (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.	dirk.de.ridder@neurosurgery.be	Heyning, Paul H Vande/I-8278-2017; Dupont, Patrick/B-8044-2009	Heyning, Paul H Vande/0000-0002-8424-3717; Dupont, Patrick/0000-0003-1980-2540				Blanke O, 2005, BRAIN RES REV, V50, P184, DOI 10.1016/j.brainresrev.2005.05.008; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2005, J NEUROSCI, V25, P550, DOI 10.1523/JNEUROSCI.2612-04.2005; Blanke O, 2004, BRAIN, V127, P719; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; De Ridder D, 2004, J NEUROSURG, V100, P560, DOI 10.3171/jns.2004.100.3.0560; DERIDDER D, 2006, ORL J OTORHINOLARYNG, V68, P458; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Sang FYP, 2006, J NEUROL NEUROSUR PS, V77, P760, DOI 10.1136/jnnp.2005.075473; Simeon D, 2000, AM J PSYCHIAT, V157, P1782, DOI 10.1176/appi.ajp.157.11.1782; Stephan T, 2005, NEUROIMAGE, V26, P721, DOI 10.1016/j.neuroimage.2005.02.049; Sutula TP, 2004, EPILEPSY RES, V60, P161, DOI 10.1016/j.eplepsyres.2004.07.001; Tong F, 2003, TRENDS COGN SCI, V7, P104, DOI 10.1016/S1364-6613(03)00027-5; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799	15	131	134	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2007	357	18					1829	1833		10.1056/NEJMoa070010	http://dx.doi.org/10.1056/NEJMoa070010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	225OJ	17978291	Bronze, Green Published			2022-12-28	WOS:000250526900006
J	Armitage, JN; Sibanda, N; Cathcart, PJ; Emberton, M; van der Meulen, JHP				Armitage, James N.; Sibanda, Nokuthaba; Cathcart, Paul J.; Emberton, Mark; van der Meulen, Jan H. P.			Mortality in men admitted to hospital with acute urinary retention: database analysis	BRITISH MEDICAL JOURNAL			English	Article							BENIGN PROSTATIC HYPERPLASIA; ICD-9-CM ADMINISTRATIVE DATA; CLINICAL COMORBIDITY INDEX; RISK-FACTORS; POPULATION; MANAGEMENT; HEALTH; SCORES; BPH	Objectives To investigate mortality in men admitted to hospital with acute urinary retention and to report on the effects of comorbidity on mortality. Design Analysis of the hospital episode statistics database linked to the mortality database of the Office for National Statistics. Setting NHS hospital trusts in England, 1998-2005. Participants All men aged over 45 who were admitted to NHS hospitals in England with a first episode of acute urinary retention. Main outcome measures Mortality in the first year after acute urinary retention and standardised mortality ratio against the general population. Results During the study period, 176 046 men aged over 45 were admitted to hospital with a first episode of acute urinary retention. In 100 067 men with spontaneous acute urinary retention, the one year mortality was 4.1% in men aged 45-54 and 32.8% in those 85 and over. In 75 979 men with precipitated acute urinary retention, mortality was 9.5% and 45.4%, respectively. In men with spontaneous acute urinary retention aged 75-84, the most prevalent age group, the one year mortality was 12.5% in men without comorbidity and 28.8% in men with comorbidity. The corresponding figures for men with precipitated acute urinary retention were 18.1% and 40.5%. Compared with the general population, the highest relative increase in mortality was in men aged 4554 (standardised mortality ratio 10.0 for spontaneous and 23.6 for precipitated acute urinary retention) and the lowest for men 85 and over (1.7 and 2.4, respectivety). Conclusions Mortality in men admitted to hospital with acute urinary retention is high and increases strongly with age and comorbidity. Patients might benefit from multidisciplinary care to identify and treat comorbid conditions.	Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England; Royal Coll Surgeons England, Clin Effectiveness Unit, London WC2A 3PE, England; UCL Hosp, Div Surg & Intervent Sci, London NW1 2BU, England	University of London; London School of Hygiene & Tropical Medicine; Royal College of Surgeons of England; University College London Hospitals NHS Foundation Trust; University of London; University College London	van der Meulen, JHP (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England.	jan.vandermeulen@lshtm.ac.uk		Sibanda, Nokuthaba/0000-0003-2283-7277; van der Meulen, Jan/0000-0002-9451-2335				Breslow N E, 1987, IARC Sci Publ, P1; Cathcart P, 2006, J UROLOGY, V176, P200, DOI 10.1016/S0022-5347(06)00509-X; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Jacobsen SJ, 1997, J UROLOGY, V158, P481, DOI 10.1016/S0022-5347(01)64508-7; Kirby RS, 2005, UROLOGY, V66, P52, DOI 10.1016/j.urology.2005.07.004; Manikandan R, 2004, BJU INT, V93, P84, DOI 10.1111/j.1464-410X.2004.04562.x; McNeill SA, 2004, J UROLOGY, V171, P2316, DOI 10.1097/01.ju.0000127743.80759.7a; McVary KT, 2006, AM J MANAG CARE, V12, pS122; Meigs JB, 1999, J UROLOGY, V162, P376, DOI 10.1016/S0022-5347(05)68563-1; Michel MC, 2004, J UROLOGY, V172, P1390, DOI 10.1097/01.ju.0000139995.85780.d8; *NAT CTR HLTH OUTC, HOSP EP STAT HES CON; Nuttall M, 2006, J CLIN EPIDEMIOL, V59, P265, DOI 10.1016/j.jclinepi.2005.07.015; *OFF NAT STAT, HOM OFF UK STAT; *OFF POP CENS SURV, 1987, CLASS SURG OP PROC; Ozden C, 2007, EUR UROL, V51, P199, DOI 10.1016/j.eururo.2006.05.040; Pickard R, 1998, BRIT J UROL, V81, P712; Roberts SE, 2003, BRIT MED J, V327, P771, DOI 10.1136/bmj.327.7418.771; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Roehrborn CG, 2000, EUR UROL, V37, P528, DOI 10.1159/000020189; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1085, DOI 10.1016/0895-4356(93)90106-B; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Schneeweiss S, 2000, INT J EPIDEMIOL, V29, P891, DOI 10.1093/ije/29.5.891; Verhamme KMC, 2005, EUR UROL, V47, P494, DOI 10.1016/j.eururo.200411.011	23	40	40	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2007	335	7631					1199	+		10.1136/bmj.39377.617269.55	http://dx.doi.org/10.1136/bmj.39377.617269.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242ER	17991937	Bronze, Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000251707800034
J	Henzler-Wildman, KA; Thai, V; Lei, M; Ott, M; Wolf-Watz, M; Fenn, T; Pozharski, E; Wilson, MA; Petsko, GA; Karplus, M; Hubner, CG; Kern, D				Henzler-Wildman, Katherine A.; Thai, Vu; Lei, Ming; Ott, Maria; Wolf-Watz, Magnus; Fenn, Tim; Pozharski, Ed; Wilson, Mark A.; Petsko, Gregory A.; Karplus, Martin; Huebner, Christian G.; Kern, Dorothee			Intrinsic motions along an enzymatic reaction trajectory	NATURE			English	Article							RESONANCE ENERGY-TRANSFER; MOLECULE FLUORESCENCE SPECTROSCOPY; SINGLE-MOLECULE; ADENYLATE KINASE; NORMAL-MODE; TRIOSEPHOSPHATE ISOMERASE; CONFORMATIONAL DYNAMICS; DIHYDROFOLATE-REDUCTASE; CHEMICAL-EXCHANGE; PROTEIN MOTION	The mechanisms by which enzymes achieve extraordinary rate acceleration and specificity have long been of key interest in biochemistry. It is generally recognized that substrate binding coupled to conformational changes of the substrate - enzyme complex aligns the reactive groups in an optimal environment for efficient chemistry. Although chemical mechanisms have been elucidated for many enzymes, the question of how enzymes achieve the catalytically competent state has only recently become approachable by experiment and computation. Here we show crystallographic evidence for conformational substates along the trajectory towards the catalytically competent 'closed' state in the ligand- free form of the enzyme adenylate kinase. Molecular dynamics simulations indicate that these partially closed conformations are sampled in nanoseconds, whereas nuclear magnetic resonance and single- molecule fluorescence resonance energy transfer reveal rare sampling of a fully closed conformation occurring on the microsecond- to- millisecond timescale. Thus, the larger- scale motions in substrate- free adenylate kinase are not random, but preferentially follow the pathways that create the configuration capable of proficient chemistry. Such preferred directionality, encoded in the fold, may contribute to catalysis in many enzymes.	Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; Univ Halle Wittenberg, Inst Phys, D-06120 Halle, Germany; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Univ Strasbourg, ISIS, Lab Chim Biophys, F-67000 Strasbourg, France	Brandeis University; Brandeis University; Howard Hughes Medical Institute; Martin Luther University Halle Wittenberg; Harvard University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kern, D (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	huebner@physik.uni-luebeck.de; dkern@brandeis.edu	Pozharski, Edwin/AAM-7692-2020; Hübner, Christian/C-9512-2011; Petsko, Gregory/AAO-7962-2020	Pozharski, Edwin/0000-0001-7012-5376; Henzler-Wildman, Katherine/0000-0002-5295-2121	NIGMS NIH HHS [F32 GM070251] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070251] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blaszczyk J, 2001, J MOL BIOL, V307, P247, DOI 10.1006/jmbi.2000.4427; BLATZ AL, 1986, BIOPHYS J, V49, P967, DOI 10.1016/S0006-3495(86)83725-0; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROOKS CL, 1983, J CHEM PHYS, V79, P6312, DOI 10.1063/1.445724; Bruice TC, 2006, CHEM REV, V106, P3119, DOI 10.1021/cr050283j; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Cui Q, 2003, ADV PROTEIN CHEM, V66, P315; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Donaldson LW, 2001, J AM CHEM SOC, V123, P9843, DOI 10.1021/ja011241p; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FABER HR, 1990, NATURE, V348, P263, DOI 10.1038/348263a0; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Frauenfelder H, 2003, P NATL ACAD SCI USA, V100, P8615, DOI 10.1073/pnas.1633688100; Gardberg A, 2003, STRUCTURE, V11, P1265, DOI 10.1016/j.str.2003.09.003; GERSTEIN M, 1993, J MOL BIOL, V229, P494, DOI 10.1006/jmbi.1993.1048; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Hubner CG, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.093903; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; IMMIRZI A, 1976, CRYSTALLOGRAPHIC COM, P399; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaim G, 2002, FEBS LETT, V525, P156, DOI 10.1016/S0014-5793(02)03097-1; KARPLUS M, 1981, CRC CR REV BIOCH MOL, V9, P293, DOI 10.3109/10409238109105437; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; KURIYAN J, 1991, P NATL ACAD SCI USA, V88, P2773, DOI 10.1073/pnas.88.7.2773; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P446; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Lou HF, 2006, J PHYS CHEM B, V110, P12796, DOI 10.1021/jp061976m; Ma JP, 1997, J MOL BIOL, V274, P114, DOI 10.1006/jmbi.1997.1313; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myong S, 2006, STRUCTURE, V14, P633, DOI 10.1016/j.str.2006.02.005; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NIE SM, 1994, SCIENCE, V266, P1018, DOI 10.1126/science.7973650; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Odintsov SG, 2005, J MOL BIOL, V354, P403, DOI 10.1016/j.jmb.2005.09.042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; RHOADS DG, 1968, J BIOL CHEM, V243, P3963; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; SOLOMON I, 1956, J CHEM PHYS, V25, P261, DOI 10.1063/1.1742867; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vendruscolo M, 2006, SCIENCE, V313, P1586, DOI 10.1126/science.1132851; VONRHEIN C, 1995, STRUCTURE, V3, P483, DOI 10.1016/S0969-2126(01)00181-2; Vosch T, 2003, J PHYS CHEM A, V107, P6920, DOI 10.1021/jp034906d; WILLIAMS JC, 1995, BIOCHEMISTRY-US, V34, P8309, DOI 10.1021/bi00026a012; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P2764, DOI 10.1073/pnas.0400091101; Zondervan R, 2003, J PHYS CHEM A, V107, P6770, DOI 10.1021/jp034723r	84	675	685	5	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					838	U13		10.1038/nature06410	http://dx.doi.org/10.1038/nature06410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18026086				2022-12-28	WOS:000251394900047
J	ten Hacken, NHT; Wijkstra, PJ; Kerstjens, HAM				ten Hacken, Nick H. T.; Wijkstra, Peter J.; Kerstjens, Huib A. M.			Treatment of bronchiectasis in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							THERAPY		Univ Groningen, Dept Pulm, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands	University of Groningen	ten Hacken, NHT (corresponding author), Univ Groningen, Dept Pulm, Univ Med Ctr Groningen, Postbox 30001, NL-9700 RB Groningen, Netherlands.	n.h.t.ten.hacken@int.umcg.nl	Kerstjens, Huib/N-4754-2017	Kerstjens, Huib/0000-0001-7705-7927				Barker AF, 2000, AM J RESP CRIT CARE, V162, P481, DOI 10.1164/ajrccm.162.2.9910086; COLE PJ, 1986, EUR J RESPIR DIS, V69, P6; Corless JA, 2000, COCHRANE DB SYST REV; Corless JA, 2000, COCHRANE DB SYST REV; Cymbala Alicia A, 2005, Treat Respir Med, V4, P117, DOI 10.2165/00151829-200504020-00005; DOGAN R, 1989, THORAC CARDIOV SURG, V37, P183, DOI 10.1055/s-2007-1020314; Evans DJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001392.pub2; Franco F, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003572; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Jones A, 2000, HEART LUNG, V29, P125; JONES AP, 2000, COCHRANE DB SYST REV; KOLBE J, 2000, COCHRANE DB SYST REV; Lasserson T, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD002162, 10.1002/14651858.CD002162]; Lasserson T, 2001, COCHRANE DB SYST REV; Lin HC, 1997, AM J RESP CRIT CARE, V155, P2024, DOI 10.1164/ajrccm.155.6.9196111; O'Donnell AE, 1998, CHEST, V113, P1329, DOI 10.1378/chest.113.5.1329; OLIVIERI D, 1991, RESPIRATION, V58, P117; Orriols R, 1999, RESP MED, V93, P476, DOI 10.1016/S0954-6111(99)90090-2; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Sheikh A, 2001, COCHRANE DB SYST REV; Steele K, 2001, COCHRANE DB SYST REV; Tsang KW, 2005, THORAX, V60, P239, DOI 10.1136/thx.2002.003236; WILLS P, 2002, COCHRANE DB SYST REV; Wills PJ, 1996, AM J RESP CRIT CARE, V154, P413, DOI 10.1164/ajrccm.154.2.8756815; Wilson Robert, 2001, P347	25	34	34	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2007	335	7629					1089	1093		10.1136/bmj.39384.657118.80	http://dx.doi.org/10.1136/bmj.39384.657118.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UX	18033931	Green Published			2022-12-28	WOS:000251403000038
J	Kleiner, R				Kleiner, Reinhold			Filling the terahertz gap	SCIENCE			English	Editorial Material							THZ RADIATION; JOSEPHSON		Univ Tubingen, Inst Phys, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Kleiner, R (corresponding author), Univ Tubingen, Inst Phys, D-72076 Tubingen, Germany.	kleiner@uni-tuebingen.de						Bae MH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.027002; Batov IE, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2214157; Clauss T, 2004, APPL PHYS LETT, V85, P3166, DOI 10.1063/1.1806272; DARULA M, 1999, SUPERCOND SCI TECH, V12, P1; Koshelets VP, 2000, SUPERCOND SCI TECH, V13, pR53, DOI 10.1088/0953-2048/13/5/201; Ozyuzer L, 2007, SCIENCE, V318, P1291, DOI 10.1126/science.1149802; Wang HB, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2420791; Wang HB, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.107002; Yurgens AA, 2000, SUPERCOND SCI TECH, V13, pR85, DOI 10.1088/0953-2048/13/8/201	10	60	66	4	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1254	1255		10.1126/science.1151373	http://dx.doi.org/10.1126/science.1151373			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033873				2022-12-28	WOS:000251086600030
J	Riebesell, U; Schulz, KG; Bellerby, RGJ; Botros, M; Fritsche, P; Meyerhofer, M; Neill, C; Nondal, G; Oschlies, A; Wohlers, J; Zollner, E				Riebesell, U.; Schulz, K. G.; Bellerby, R. G. J.; Botros, M.; Fritsche, P.; Meyerhoefer, M.; Neill, C.; Nondal, G.; Oschlies, A.; Wohlers, J.; Zoellner, E.			Enhanced biological carbon consumption in a high CO2 ocean	NATURE			English	Article							MARINE; TEMPERATURE; SEAWATER; SINK	The oceans have absorbed nearly half of the fossil-fuel carbon dioxide (CO2) emitted into the atmosphere since pre-industrial times(1), causing a measurable reduction in seawater pH and carbonate saturation(2). If CO2 emissions continue to rise at current rates, upper-ocean pH will decrease to levels lower than have existed for tens of millions of years and, critically, at a rate of change 100 times greater than at any time over this period(3). Recent studies have shown effects of ocean acidification on a variety of marine life forms, in particular calcifying organisms(4-6). Consequences at the community to ecosystem level, in contrast, are largely unknown. Here we show that dissolved inorganic carbon consumption of a natural plankton community maintained in mesocosm enclosures at initial CO2 partial pressures of 350, 700 and 1,050 mu atm increases with rising CO2. The community consumed up to 39% more dissolved inorganic carbon at increased CO2 partial pressures compared to present levels, whereas nutrient uptake remained the same. The stoichiometry of carbon to nitrogen drawdown increased from 6.0 at low CO2 to 8.0 at high CO2, thus exceeding the Redfield carbon:nitrogen ratio of 6.6 in today's ocean(7). This excess carbon consumption was associated with higher loss of organic carbon from the upper layer of the stratified mesocosms. If applicable to the natural environment, the observed responses have implications for a variety of marine biological and biogeochemical processes, and underscore the importance of biologically driven feedbacks in the ocean to global change.	IFM, GEOMAR, Leibniz Inst Marine Sci, D-24105 Kiel, Germany; Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; Univ Bergen, Inst Geophys, N-5007 Bergen, Norway	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Bjerknes Centre for Climate Research; University of Bergen; University of Bergen	Riebesell, U (corresponding author), IFM, GEOMAR, Leibniz Inst Marine Sci, D-24105 Kiel, Germany.	uriebesell@ifm-geomar.de	Riebesell, Ulf/AAC-9717-2020; Bellerby, Richard/ABD-6590-2021; Bellerby, Richard/B-5277-2012; Schulz, Kai G./Q-5608-2017; Schulz, Kai/AEZ-9073-2022; Oschlies, Andreas/F-9749-2012	Bellerby, Richard/0000-0003-3598-4006; Schulz, Kai G./0000-0002-8481-4639; Schulz, Kai/0000-0002-8481-4639; Oschlies, Andreas/0000-0002-8295-4013; Riebesell, Ulf/0000-0002-9442-452X				ANTIA NJ, 1963, LIMNOL OCEANOGR, V8, P166, DOI 10.4319/lo.1963.8.2.0166; BANSE K, 1994, GLOBAL BIOGEOCHEM CY, V8, P81, DOI 10.1029/93GB02865; Barlow RG, 1997, MAR ECOL PROG SER, V161, P303, DOI 10.3354/meps161303; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Delille B, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002318; Diehl S, 2005, ECOLOGY, V86, P2931, DOI 10.1890/04-1512; Engel A, 2005, LIMNOL OCEANOGR, V50, P493, DOI 10.4319/lo.2005.50.2.0493; Engel A, 2004, NATURE, V428, P929, DOI 10.1038/nature02453; Engel A, 2002, J PLANKTON RES, V24, P49, DOI 10.1093/plankt/24.1.49; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gran G, 1952, OCEANOL ACTA, V5, P209; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; HEEMANN C, 2002, THESIS U BREMEN; Hein M, 1997, NATURE, V388, P526, DOI 10.1038/41457; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Houghton J. T., 2001, CLIMATE CHANGE 2001; JOHNSON KM, 1987, MAR CHEM, V21, P117, DOI 10.1016/0304-4203(87)90033-8; Kortzinger A, 2001, DEEP-SEA RES PT I, V48, P661, DOI 10.1016/S0967-0637(00)00051-0; Kuss J, 2004, MAR CHEM, V91, P165, DOI 10.1016/j.marchem.2004.06.007; Langdon C, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001941; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; MaierReimer E, 1996, CLIM DYNAM, V12, P711, DOI 10.1007/s003820050138; Oschlies A, 2001, DEEP-SEA RES PT II, V48, P2173, DOI 10.1016/S0967-0645(00)00184-3; Qian JG, 1996, ANAL CHEM, V68, P3090, DOI 10.1021/ac960370z; RAVEN J, 2005, 12 ROY SOC; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Riebesell U., 2000, NATURE, V407, P634, DOI DOI 10.1038/35030078; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SAMBROTTO RN, 1993, NATURE, V363, P248, DOI 10.1038/363248a0; Sarmiento JL, 2002, SEA BIOL PHYSICAL IN, V12, P337; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; TOGGWEILER JR, 1993, NATURE, V363, P210, DOI 10.1038/363210a0; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; WANNINKHOF R, 1993, MAR CHEM, V44, P189, DOI 10.1016/0304-4203(93)90202-Y; Woods HA, 2003, FUNCT ECOL, V17, P237, DOI 10.1046/j.1365-2435.2003.00724.x; Zeebe RE, 2001, ELSEVIER OCEANOGR SE, V65	38	564	596	12	398	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					545	U10		10.1038/nature06267	http://dx.doi.org/10.1038/nature06267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	17994008				2022-12-28	WOS:000251158500046
J	Smith, GCS; Fretts, RC				Smith, Gordon C. S.; Fretts, Ruth C.			Stillbirth	LANCET			English	Review							INTRAUTERINE GROWTH RESTRICTION; COST-EFFECTIVENESS ANALYSIS; DIASTOLIC FLOW VELOCITY; UTERINE ARTERY DOPPLER; FETAL-DEATH; GESTATIONAL-AGE; MATERNAL AGE; PERINATAL-MORTALITY; CESAREAN DELIVERY; UNITED-STATES	In the UK, about one in 200 infants is stillborn, and rates of stillbirth have recently slightly increased. This recent rise might reflect increasing frequency of some important maternal risk factors for stillbirth, including nilliparity, advanced age, and obesity. Most stillbirths are related to placental dysfunction, which in many women is evident from the first half of pregnancy and is associated with fetal growth restriction. There is no effective screening test that has clearly shown a reduction in stillbirth rates in the general population. However, assessments of novel screening methods have generally failed to distinguish between effective identification of high-risk women and successful intervention for such women. Future research into stillbirth will probably focus on understanding the pathophysiology of impaired placentation to establish screening tests for stillbirth, and assessment of interventions to prevent stillbirth in women who screen positive.	Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 2QQ, England; Harvard Vanguard Med Associates, Wellesley, MA USA; Harvard Univ, Sch Med, Boston, MA USA	University of Cambridge; Harvard Vanguard Medical Associates; Harvard University; Harvard Medical School	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Box 223,Robinson Way, Cambridge CB2 2QQ, England.	gcss2@cam.ac.uk	Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997				ACOG, 2000, INT J GYNECOL OBSTET, V68, P165; Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Baschat AA, 2003, ULTRASOUND OBST GYN, V22, P240, DOI 10.1002/uog.149; Bates SA, 2004, CHEST, V126, p627S, DOI 10.1378/chest.126.3_suppl.627S; Bell R, 2004, ARCH DIS CHILD-FETAL, V89, pF531, DOI 10.1136/adc.2003.038414; Blickstein I., 2005, MULTIPLE PREGNANCY E; Bonnici F, 2002, BMJ-BRIT MED J, V325, P517, DOI 10.1136/bmj.325.7363.517; Bricker L, 2000, COCHRANE DB SYST REV, V2; Bricker L, 2000, COCHRANE DB SYST REV, V2; *CEMACH, 2006, PER MORT SURV 2004 E; Chan A, 2004, J PAEDIATR CHILD H, V40, P340, DOI 10.1111/j.1440-1754.2004.00398.x; Cnattingius S, 1998, BRIT MED J, V316, P1483, DOI 10.1136/bmj.316.7143.1483; Cnattingius S, 2002, SEMIN PERINATOL, V26, P286, DOI 10.1053/sper.2002.34771; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; COPPENS M, 2006, HIGH RISK PREGNANCY, P67; CREASY RK, 1997, MANAGEMENT LABOR DEL; Crowley P, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858; Dugoff L, 2004, AM J OBSTET GYNECOL, V191, P1446, DOI 10.1016/j.ajog.2004.06.052; FLEMING K, 2004, CONFIDENTIAL ENQUIRY; Fretts RC, 2005, AM J OBSTET GYNECOL, V193, P1923, DOI 10.1016/j.ajog.2005.03.074; FRETTS RC, 1992, OBSTET GYNECOL, V79, P35; Fretts RC, 2004, OBSTET GYNECOL, V104, P56, DOI 10.1097/01.AOG.0000129237.93777.1a; FRETTS RC, 1995, NEW ENGL J MED, V333, P953, DOI 10.1056/NEJM199510123331501; Fretts RC, 1997, OBSTET GYNECOL, V89, P40, DOI 10.1016/S0029-7844(96)00427-9; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Froen JF, 2004, J PERINAT MED, V32, P13, DOI 10.1515/JPM.2004.003; Froen JF, 2001, AM J OBSTET GYNECOL, V184, P694, DOI 10.1067/mob.2001.110697; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gibbs RS, 2002, SEMIN PERINATOL, V26, P75, DOI 10.1053/sper.2002.29839; Goldenberg RL, 2003, AM J OBSTET GYNECOL, V189, P861, DOI 10.1067/S0002-9378(03)00470-8; GRANT A, 1989, LANCET, V2, P345; Griffiths PD, 2005, LANCET, V365, P1271, DOI 10.1016/S0140-6736(05)74816-9; Healy AJ, 2006, OBSTET GYNECOL, V107, P625, DOI 10.1097/01.AOG.0000201978.83607.96; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; HOOK EB, 1981, OBSTET GYNECOL, V58, P282; Huang DY, 2000, OBSTET GYNECOL, V95, P215, DOI 10.1016/S0029-7844(99)00536-0; Hughes P, 2002, LANCET, V360, P114, DOI 10.1016/S0140-6736(02)09410-2; *INF STAT DIV NHS, 2001, SCOTT PER INF MORT R; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Kallan JE, 2001, JAMA-J AM MED ASSOC, V285, P2978, DOI 10.1001/jama.285.23.2978; KALTER H, 1991, INT J EPIDEMIOL, V20, P173, DOI 10.1093/ije/20.1.173; Kanagalingam MG, 2005, BJOG-INT J OBSTET GY, V112, P1431, DOI 10.1111/j.1471-0528.2005.00685.x; Kiely J L, 2001, Twin Res, V4, P131; Korteweg FJ, 2006, BJOG-INT J OBSTET GY, V113, P393, DOI 10.1111/j.1471-0528.2006.00881.x; Kowaleski J, 1997, STATE DEFINITIONS RE; Krebs C, 1996, AM J OBSTET GYNECOL, V175, P1534, DOI 10.1016/S0002-9378(96)70103-5; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lees C, 2001, OBSTET GYNECOL, V98, P369, DOI 10.1016/S0029-7844(01)01474-0; Liu SL, 2002, JAMA-J AM MED ASSOC, V287, P1561, DOI 10.1001/jama.287.12.1561; Lyall F, 2002, PLACENTA, V23, P555, DOI 10.1053/plac.2002.0850; Macintosh MCM, 2006, BRIT MED J, V333, P177, DOI 10.1136/bmj.38856.692986.AE; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Martin Joyce A, 2006, Natl Vital Stat Rep, V55, P1; McClure EM, 2006, INT J GYNECOL OBSTET, V94, P82, DOI 10.1016/j.ijgo.2006.03.023; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Neilson JP, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002253.PUB3; Neilson JP, 2000, COCHRANE DB SYST REV, V2; Neilson JP, 2000, COCHRANE DB SYST REV, V4; Odlind V, 2003, ACTA OBSTET GYN SCAN, V82, P516, DOI 10.1034/j.1600-0412.2003.00112.x; PARRISH KM, 1994, JAMA-J AM MED ASSOC, V271, P443, DOI 10.1001/jama.271.6.443; PARSONS L, 1990, BRIT J OBSTET GYNAEC, V97, P237, DOI 10.1111/j.1471-0528.1990.tb01788.x; PROUD J, 1987, BRIT MED J, V294, P1641, DOI 10.1136/bmj.294.6588.1641; Raleigh V S, 1990, Indian J Pediatr, V57, P551, DOI 10.1007/BF02726768; RAYMOND EG, 1994, BRIT J OBSTET GYNAEC, V101, P301, DOI 10.1111/j.1471-0528.1994.tb13614.x; Reddy UM, 2006, AM J OBSTET GYNECOL, V195, P764, DOI 10.1016/j.ajog.2006.06.019; Redline RW, 2006, CLIN OBSTET GYNECOL, V49, P885, DOI 10.1097/01.grf.0000211957.68745.6b; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Richter R, 2007, EUR J OBSTET GYN R B, V132, P51, DOI 10.1016/j.ejogrb.2006.06.002; Saade GR, 2002, SEMIN PERINATOL, V26, P51, DOI 10.1053/sper.2002.29858; SACHS BP, 1995, OBSTET GYNECOL, V85, P941, DOI 10.1016/0029-7844(95)00056-W; Salihu HM, 2006, OBSTET GYNECOL, V107, P383, DOI 10.1097/01.AOG.0000195103.46999.32; Salihu HM, 2003, OBSTET GYNECOL, V102, P679, DOI 10.1016/S0029-7844(03)00768-3; SAMUELOFF A, 1993, J REPROD MED, V38, P883; Say L., 2003, COCHRANE DB SYST REV, V1, DOI 10.1002/14651858.CD000137; Say Lale, 2006, Reprod Health, V3, P1, DOI 10.1186/1742-4755-3-1; Schott J., 2007, PREGNANCY LOSS DEATH; Setel PW, 2005, B WORLD HEALTH ORGAN, V83, P611; Simpson LL, 2002, SEMIN PERINATOL, V26, P42, DOI 10.1053/sper.2002.29838; Smith GCS, 2007, BJOG-INT J OBSTET GY, V114, P705, DOI 10.1111/j.1471-0528.2007.01343.x; Smith GCS, 2005, AM J OBSTET GYNECOL, V192, P17, DOI 10.1016/j.ajog.2004.08.014; Smith GCS, 2002, NATURE, V417, P916, DOI 10.1038/417916a; Smith GCS, 2004, JAMA-J AM MED ASSOC, V292, P2249, DOI 10.1001/jama.292.18.2249; Smith GCS, 2004, NEW ENGL J MED, V351, P978, DOI 10.1056/NEJMoa040963; Smith GCS, 2004, SEMIN PERINATOL, V28, P41, DOI 10.1053/j.semperi.2003.10.012; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Smith GCS, 1998, NEW ENGL J MED, V339, P1817, DOI 10.1056/NEJM199812173392504; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Smith GCS, 2002, J CLIN ENDOCR METAB, V87, P1762, DOI 10.1210/jc.87.4.1762; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; Smith GCS, 2007, OBSTET GYNECOL, V109, P144, DOI 10.1097/01.AOG.0000248536.94919.e3; Smith GCS, 2007, AM J EPIDEMIOL, V165, P194, DOI 10.1093/aje/kwj354; Smulian JC, 2004, OBSTET GYNECOL, V104, P278, DOI 10.1097/01.AOG.0000134524.58795.bd; Smulian JC, 2002, OBSTET GYNECOL, V100, P1183, DOI 10.1016/S0029-7844(02)02389-X; Stallmach T, 2001, OBSTET GYNECOL, V97, P505, DOI 10.1016/S0029-7844(00)01208-4; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Stephansson O, 2001, AM J OBSTET GYNECOL, V184, P463, DOI 10.1067/mob.2001.109591; Surkan PJ, 2004, NEW ENGL J MED, V350, P777, DOI 10.1056/NEJMoa031587; Taylor LK, 2005, MED J AUSTRALIA, V183, P515, DOI 10.5694/j.1326-5377.2005.tb07152.x; Viero S, 2004, PLACENTA, V25, P735, DOI 10.1016/j.placenta.2004.03.002; Vintzileos AM, 2002, OBSTET GYNECOL, V99, P483, DOI 10.1016/S0029-7844(01)01758-6; WALLER DK, 1993, EPIDEMIOLOGY, V4, P471, DOI 10.1097/00001648-199309000-00014; WIGGLESWORTH JS, 1980, LANCET, V2, P684; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2001, DEF IND FAM PLANN MA; Wu O, 2006, HEALTH TECHNOL ASSES, V10, P1; YUDKIN PL, 1987, LANCET, V1, P1192	108	244	256	1	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2007	370	9600					1715	1725		10.1016/S0140-6736(07)61723-1	http://dx.doi.org/10.1016/S0140-6736(07)61723-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	18022035				2022-12-28	WOS:000251091200023
J	Villar, J; Carroli, G; Zavaleta, N; Donner, A; Wojdyla, D; Faundes, A; Velazco, A; Bataglia, V; Langer, A; Narvaez, A; Valladares, E; Shah, A; Campodonico, L; Romero, M; Reynoso, S; de Padua, KS; Giordano, D; Kublickas, M; Acosta, A				Villar, Jose; Carroli, Guillermo; Zavaleta, Nelly; Donner, Allan; Wojdyla, Daniel; Faundes, Anibal; Velazco, Alejandro; Bataglia, Vicente; Langer, Ana; Narvaez, Alberto; Valladares, Ellette; Shah, Archana; Campodonico, Liana; Romero, Mariana; Reynoso, Sofia; de Padua, Karla Simonia; Giordano, Daniel; Kublickas, Marius; Acosta, Arnaldo		World Hlth Org	Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective study	BRITISH MEDICAL JOURNAL			English	Article							DECISION-MAKING; VAGINAL BIRTHS; LATIN-AMERICA; SECTION; WOMEN; MODE; INCONTINENCE; TRIAL; EXPERIENCE; PREGNANCY	Objective To assess the risks and benefits associated with Caesarean delivery compared with vaginal delivery. Design Prospective cohort study within the 2005 WHO global survey on maternal and perinatal health. Setting 410 health facilities in 24 areas in eight randomly selected Latin American countries; 123 were randomly selected and 120 participated and provided data Participants 106 546 deliveries reported during the three month study period, with data available for 97 095 (91% coverage). Main outcome measures Maternal, fetal, and neonatal morbidity and mortality associated with intrapartum or elective caesarean delivery, adjusted for clinical, demographic, pregnancy, and institutional characteristics. Results Women undergoing caesarean delivery had an increased risk of severe maternal morbidity compared with women undergoing vaginal delivery (odds ratio 2.0 (95% confidence interval 1.6 to 2.5) for intrapartum caesarean and 2.3 (1.7 to 3.1) for elective Caesarean). The risk of antibiotic treatment after delivery for women having either type of Caesarean was five times that of women having vaginal deliveries. With cephalic presentation, there was a trend towards a reduced odds ratio for fetal death with elective Caesarean, after adjustment for possible confounding variables and gestational age (0.7, 0.4 to 1.0). With breech presentation, Caesarean delivery had a large protective effect for fetal death. With cephalic presentation, however, independent of possible confounding variables and gestational age, intrapartum and elective Caesarean increased the risk for a stay of seven or more days in neonatal intensive care (2.1 (1.8 to 2.6) and 1.9 (1.6 to 2.3), respectively) and the risk of neonatal mortality up to hospital discharge (1.7 (1.3 to 2.2) and 1.9 (1.5 to 2.6), respectively), which remained higher even after exclusion of all caesarean deliveries for fetal distress. Such increased risk was not seen for breech presentation. Lack of tabour was a risk factor for a stay of seven or more days in neonatal intensive care and neonatal mortality up to hospital discharge for babies delivered by elective Caesarean delivery, but rupturing of membranes may be protective. Conclusions Caesarean delivery independently reduces overall risk in breech presentations and risk of intrapartum fetal death in cephalic presentations but increases the risk of severe maternal and neonatal morbidity and mortality in cephalic presentations.	Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Oxford	Villar, J (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.	jose.villar@obs-gyn.ox.ac.uk		Zavaleta, Nelly/0000-0002-6929-5834; Romero, Mariana/0000-0003-4272-3138				Althabe F, 2004, LANCET, V363, P1934, DOI 10.1016/S0140-6736(04)16406-4; Bloom SL, 2006, NEW ENGL J MED, V355, P2195, DOI 10.1056/NEJMoa061170; Buchsbaum GM, 2005, OBSTET GYNECOL, V106, P1253, DOI 10.1097/01.AOG.0000187309.46650.b2; Chou YJ, 2006, BIRTH-ISS PERINAT C, V33, P195, DOI 10.1111/j.1523-536X.2006.00104.x; Declercq E, 2007, OBSTET GYNECOL, V109, P669, DOI 10.1097/01.AOG.0000255668.20639.40; *DEP REPR HLTH RES, 2004, WHO GLOB SURV MAT PE; *DEP RHR, 2004, WHO GLOB SURV MAT PE; Emmett CL, 2006, BJOG-INT J OBSTET GY, V113, P1438, DOI 10.1111/j.1471-0528.2006.01112.x; Faas-Fehervary P, 2005, EUR J OBSTET GYN R B, V122, P162, DOI 10.1016/j.ejogrb.2005.01.016; Fritel X, 2005, BJOG-INT J OBSTET GY, V112, P1646, DOI 10.1111/j.1471-0528.2005.00763.x; Hamilton BE, 2007, PEDIATRICS, V119, P345, DOI 10.1542/peds.2006-3226; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Kalish RB, 2004, OBSTET GYNECOL, V103, P1137, DOI 10.1097/01.AOG.0000128118.37737.df; Lavender T, 2005, BMJ-BRIT MED J, V331, P490, DOI 10.1136/bmj.38560.572639.3A; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MacDorman MF, 2006, BIRTH-ISS PERINAT C, V33, P175, DOI 10.1111/j.1523-536X.2006.00102.x; McKinnie V, 2005, AM J OBSTET GYNECOL, V193, P512, DOI 10.1016/j.ajog.2005.03.056; Minkoff H, 2004, OBSTET GYNECOL, V103, P387, DOI 10.1097/01.AOG.0000107288.44622.2a; Moffat MA, 2007, BJOG-INT J OBSTET GY, V114, P86, DOI 10.1111/j.1471-0528.2006.01154.x; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7	20	398	427	0	19	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 17	2007	335	7628					1025	1029		10.1136/bmj.39363.706956.55	http://dx.doi.org/10.1136/bmj.39363.706956.55			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UV	17977819	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000251402800030
J	Sgaier, SK; Jha, P; Mony, P; Kurpad, A; Lakshmi, V; Kumar, R; Ganguly, NK				Sgaier, S. K.; Jha, P.; Mony, P.; Kurpad, A.; Lakshmi, V.; Kumar, R.; Ganguly, N. K.			Public health - Biobanks in developing countries: Needs and feasibility	SCIENCE			English	Editorial Material							MORTALITY; DISEASES; INDIA; TUBERCULOSIS; DEATHS		Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, LKSKI KRC, Toronto, ON M5B 1C5, Canada; St Johns Res Inst, Bangalore 560034, Karnataka, India; Nizams Inst Med Sci, Hyderabad 500082, Andhra Pradesh, India; Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India; Indian Council Med Res, New Delhi 110029, India	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; St. John's National Academy of Health Sciences; St. John's Research Institute; Nizam's Institute of Medical Sciences; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Indian Council of Medical Research (ICMR)	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, LKSKI KRC, Toronto, ON M5B 1C5, Canada.	Prabhat.jha@utoronto.ca	Mony, Prem K./GRF-4752-2022	Mony, Prem K./0000-0002-1399-0520				Al Kubaisy W, 2003, East Mediterr Health J, V9, P675; Cambon-Thomsen A, 2004, NAT REV GENET, V5, P866, DOI 10.1038/nrg1473; Chen ZM, 2006, INT J EPIDEMIOL, V35, P141, DOI 10.1093/ije/dyi215; Chen ZM, 2005, INT J EPIDEMIOL, V34, P1243, DOI 10.1093/ije/dyi174; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Hagen HE, 2004, NAT MED, V10, P665, DOI 10.1038/nm0704-665; Heeney JL, 2006, SCIENCE, V313, P462, DOI 10.1126/science.1123016; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Paynter RA, 2006, CANCER EPIDEM BIOMAR, V15, P2533, DOI 10.1158/1055-9965.EPI-06-0219; Shetty N, 2006, INT J TUBERC LUNG D, V10, P80; Sirugo G, 2004, NAT GENET, V36, P785, DOI 10.1038/ng0804-785; Steinberg K, 2002, EPIDEMIOLOGY, V13, P246, DOI 10.1097/00001648-200205000-00003; Tapia-Conyer R, 2006, INT J EPIDEMIOL, V35, P243, DOI 10.1093/ije/dyl042; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; Varmus H, 2003, SCIENCE, V302, P398, DOI 10.1126/science.1091769	16	37	41	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1074	1075		10.1126/science.1149157	http://dx.doi.org/10.1126/science.1149157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006727				2022-12-28	WOS:000250957900024
J	Frescas, D; Guardavaccaro, D; Bassermann, F; Koyama-Nasu, R; Pagano, M				Frescas, David; Guardavaccaro, Daniele; Bassermann, Florian; Koyama-Nasu, Ryo; Pagano, Michele			JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes	NATURE			English	Article							POLYMERASE-I TRANSCRIPTION; DOMAIN-CONTAINING PROTEINS; INSERTIONAL MUTAGENESIS; HISTONE DEMETHYLATION; MEDIATED DEGRADATION; UBIQUITIN LIGASE; CELL-GROWTH; DNA; IDENTIFICATION; METHYLATION	JHDM1B is an evolutionarily conserved and ubiquitously expressed member of the JHDM (JmjC-domain-containing histone demethylase) family(1-3). Because it contains an F-box motif, this protein is also known as FBXL10 (ref. 4). With the use of a genome-wide RNAi screen, the JHDM1B worm orthologue (T26A5.5) was identified as a gene that regulates growth(5). In the mouse, four independent screens have identified JHDM1B as a putative tumour suppressor by retroviral insertion analysis(6-9). Here we identify human JHDM1B as a nucleolar protein and show that JHDM1B preferentially binds the transcribed region of ribosomal DNA to repress the transcription of ribosomal RNA genes. We also show that repression of ribosomal RNA genes by JHDM1B is dependent on its JmjC domain, which is necessary for the specific demethylation of trimethylated lysine 4 on histone H3 in the nucleolus. In agreement with the notion that ribosomal RNA synthesis and cell growth are coupled processes, we show a JmjC-domain-dependent negative effect of JHDM1B on cell size and cell proliferation. Because aberrant ribosome biogenesis and the disruption of epigenetic control mechanisms contribute to cellular transformation, these results, together with the low levels of JHDM1B expression found in aggressive brain tumours, suggest a role for JHDM1B in cancer development.	NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY 10016 USA	New York University	Pagano, M (corresponding author), NYU, Sch Med, Dept Pathol, Inst Canc, 550 1st Ave, New York, NY 10016 USA.	michele.pagano@nyumc.org	Hu, Ruogu/B-2203-2008	pagano, michele/0000-0003-3210-2442; Guardavaccaro, Daniele/0000-0002-4517-1765				Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Brock GJR, 1997, HUM MOL GENET, V6, P451, DOI 10.1093/hmg/6.3.451; Bukhari MH, 2007, PAK J MED SCI, V23, P206; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Dousset T, 2000, MOL BIOL CELL, V11, P2705, DOI 10.1091/mbc.11.8.2705; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Frescas D, 2006, J CELL BIOL, V173, P219, DOI 10.1083/jcb.200601156; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Koyama-Nasu R, 2007, NAT CELL BIOL, V9, P1074, DOI 10.1038/ncb1628; Leung AKL, 2004, J CELL BIOL, V166, P787, DOI 10.1083/jcb.200405013; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4	31	204	218	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					309	U17		10.1038/nature06255	http://dx.doi.org/10.1038/nature06255			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994099				2022-12-28	WOS:000250746200063
J	Farag, N; Ship, A; Lonner, JH				Farag, Nadine; Ship, Amy; Lonner, Jess H.			A 57-year-old man with osteoarthritis of the knee	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-EXPERIENCE; FOLLOW-UP; ARTHROPLASTY; REPLACEMENT; INCISION		Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Penn Hosp, Philadelphia, PA 19107 USA	Harvard University; Beth Israel Deaconess Medical Center; University of Pennsylvania	Farag, N (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Berger RA, 2005, J BONE JOINT SURG AM, V87A, P999, DOI 10.2106/JBJS.C.00568; Diduch DR, 1997, J BONE JOINT SURG AM, V79A, P575, DOI 10.2106/00004623-199704000-00015; Duffy GP, 1998, CLIN ORTHOP RELAT R, P22; Healy WL, 2000, CLIN ORTHOP RELAT R, P65; Kolisek FR, 2007, J ARTHROPLASTY, V22, P8, DOI 10.1016/j.arth.2006.06.004; Laskin RS, 2004, CLIN ORTHOP RELAT R, P74, DOI 10.1097/01.blo.0000148582.86102.47; Lonner Jess H, 2006, Am J Orthop (Belle Mead NJ), V35, P3; Lonner JH, 2007, J AM ACAD ORTHOP SUR, V15, P495, DOI 10.5435/00124635-200708000-00006; Mont MA, 2007, CLIN ORTHOP RELAT R, P165, DOI 10.1097/BLO.0b013e318042b5e7; Noble PC, 2006, CLIN ORTHOP RELAT R, P35, DOI 10.1097/011.blo.0000238825.63648.1e; Pagnano MW, 2006, J ARTHROPLASTY, V21, P22, DOI 10.1016/j.arth.2006.02.081; Rodgers JA, 1998, J ARTHROPLASTY, V13, P414, DOI 10.1016/S0883-5403(98)90007-9; Rooks DS, 2006, ARTHRIT RHEUM-ARTHR, V55, P700, DOI 10.1002/art.22223; Rosenberg Aaron G, 2006, Am J Orthop (Belle Mead NJ), V35, P30; Ship AN, 2003, JAMA-J AM MED ASSOC, V289, P1016, DOI 10.1001/jama.289.8.1016; Tenholder M, 2005, CLIN ORTHOP RELAT R, P67, DOI 10.1097/01.blo.0000185450.89364.10	16	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2007	298	17					2055	2056		10.1001/jama.298.17.2055	http://dx.doi.org/10.1001/jama.298.17.2055			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228GP	17986699				2022-12-28	WOS:000250718200026
J	Freyer, C; Larsson, NG				Freyer, Christoph; Larsson, Nils-Goran			Is energy deficiency good in moderation?	CELL			English	Editorial Material							SKELETAL-MUSCLE; MITOCHONDRIAL; DYSFUNCTION; INSULIN	In this issue, Pospisilik et al. (2007) demonstrate that a reduction in mitochondrial oxidative phosphorylation protects mice against obesity and diabetes. This finding suggests that the moderate deficiency in oxidative phosphorylation that is observed in peripheral tissues of insulin-resistant humans is not a causative factor in diabetes but may instead be a compensatory response.	Karolinska Inst, Dept Lab Med, S-14186 Huddinge, Sweden	Karolinska Institutet	Larsson, NG (corresponding author), Karolinska Inst, Dept Lab Med, S-14186 Huddinge, Sweden.	nils-goran.larsson@ki.se	Larsson, Nils-Göran/GVS-5578-2022	Larsson, Nils-Göran/0000-0001-5100-996X; Freyer, Christoph/0000-0003-0418-1673				Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029	9	11	11	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					448	450		10.1016/j.cell.2007.10.027	http://dx.doi.org/10.1016/j.cell.2007.10.027			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981112	Bronze			2022-12-28	WOS:000250618500012
J	Jain, RK; Xu, L				Jain, Rakesh K.; Xu, Lei			alpha PIGF: A new kid on the antiangiogenesis block	CELL			English	Editorial Material							VASCULAR-PERMEABILITY FACTOR; ENDOTHELIAL GROWTH-FACTOR; ANGIOGENESIS; CANCER; BEVACIZUMAB; INHIBITION; DISCOVERY; CARCINOMA; RECEPTOR; THERAPY	An agent that blocks tumor angiogenesis, growth, and metastasis without affecting normal tissues-whether used alone or in combination with currently approved drugs-would change the way we treat cancer. In this issue, Fischer et al. (2007) offer compelling evidence that a monoclonal antibody against placental growth factor (PIGF), a member of the VEGF family, has such potential in mice.	Massachusetts Gen Hosp, Dept Radiat Oncol, Steele Lab Turnor Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Jain, RK (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Steele Lab Turnor Biol, Boston, MA 02114 USA.	jain@steele.mgh.harvard.edu	Jain, Rakesh K/I-1384-2017; Xu, Lei/GRR-9174-2022	Jain, Rakesh K/0000-0001-7571-3548; 	NATIONAL CANCER INSTITUTE [P01CA080124] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA080124] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Dvorak HF, 2006, EXP CELL RES, V312, P522, DOI 10.1016/j.yexcr.2005.11.026; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Xu L, 2007, MOL CANCER RES, V5, P873, DOI 10.1158/1541-7786.MCR-06-0141; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Verheul HMW, 2007, NAT REV CANCER, V7, P475, DOI 10.1038/nrc2152; Willett CG, 2005, J CLIN ONCOL, V23, P8136, DOI 10.1200/JCO.2005.02.5635	12	22	27	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					443	445		10.1016/j.cell.2007.10.023	http://dx.doi.org/10.1016/j.cell.2007.10.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981110	Bronze			2022-12-28	WOS:000250618500010
J	Mclntosh, KB; Warner, JR				Mclntosh, Kerri B.; Warner, Jonathan R.			Yeast ribosomes: Variety is the spice of life	CELL			English	Editorial Material							PROTEIN GENES; PHOSPHORYLATION; GENOME	In the budding yeast Saccharomyces cerevisiae, 59 of the 79 cytoplasmic ribosomal proteins are encoded by two genes, stemming from an ancient genome duplication event. Komili et al. (2007) now report that these paralogous genes are not functionally equivalent, suggesting the possible existence of a "ribosome code."	Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Warner, JR (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	warner@aecom.yu.edu			NCI NIH HHS [CA13330] Funding Source: Medline; NIGMS NIH HHS [GM25532] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025532] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; Darzacq X, 2003, CURR OPIN MICROBIOL, V6, P614, DOI 10.1016/j.mib.2003.10.005; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Szick-Miranda K, 2001, J BIOL CHEM, V276, P10921, DOI 10.1074/jbc.M011002200; Uechi T, 2001, GENOMICS, V72, P223, DOI 10.1006/geno.2000.6470; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Yacoub A, 1996, EMBO J, V15, P2306, DOI 10.1002/j.1460-2075.1996.tb00584.x	10	11	11	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					450	451		10.1016/j.cell.2007.10.028	http://dx.doi.org/10.1016/j.cell.2007.10.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981113	Bronze			2022-12-28	WOS:000250618500013
J	Afshari, A; Wetterslev, J; Brok, J; Moller, A				Afshari, Arash; Wetterslev, Jorn; Brok, Jesper; Moller, Ann			Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FEMORAL-NECK FRACTURES; TOTAL HIP-ARTHROPLASTY; INTERNAL-FIXATION; DISPLACED FRACTURES; RANDOMIZED-TRIAL; WORLDWIDE PREVALENCE; ELDERLY-PATIENTS; FOLLOW-UP; HEMIARTHROPLASTY; FEMUR	Objective To evaluate the benefits and harms of antithrombin III in critically ill patients. Design Systematic review and meta-analysis of randomised trials. Data sources CENTRAL, Medline, Embase, International Web of Science, LILACS, the Chinese Biomedical Literature Database, and CINHAL (to November 2006); hand search of reference lists, contact with authors and experts, and search of registers of ongoing trials. Review methods Two reviewers independently selected parallel group randomised clinical trials comparing antithrombin with placebo or no intervention and extracted data related to study methods, interventions, outcomes, bias risk, and adverse events. Disagreements were resolved by discussion. Trials in any type of critically ill patients in intensive care were eligible. All trials, irrespective of blinding or language status, that compared any antithrombin III regimen with no intervention or placebo were included. Trials were considered to be at low risk of bias if they had adequate randomisation procedure, blinding, and used intention to treat analysis. Risk ratios with 95% confidence intervals were estimated with fixed and random effects models according to heterogeneity. Main outcome measures Mortality, length of stay in intensive care or hospital, quality of life, severity of sepsis, respiratory failure, duration of mechanical ventilation, incidence of surgical intervention, intervention effect among various populations and adverse events (such as bleeding). Results 20 trials randomly assigning 3458 patients met inclusion criteria. Eight trials had low risk of bias. Compared with placebo or no intervention, antithrombin III did not reduce overall mortality (relative risk 0.96, 95% confidence interval 0.89 to 1.03). No subgroup analyses on risk of bias, populations of patients, or with and without adjuvant heparin yielded significant results. Antithrombin III increased the risk of bleeding events (1.52, 1.30 to 1.78). Heterogeneity was observed in only a few analyses. Conclusion Antithrombin III cannot be recommended for critically ill patients based on the available evidence.	Univ Copenhagen, Rigshosp, Dept Anaesthesiol, Juliane Marie Ctr, DK-2100 Copenhagen, Denmark; Copenhagen Univ Hosp, Rigshosp, Copenhagen Trial Unit, Ctr Clin Intervent Res, Copenhagen, Denmark; Copenhagen Univ Hosp, Cochrane Anaesthesia Grp, Rigshosp, Copenhagen 2100 O, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Afshari, A (corresponding author), Univ Copenhagen, Rigshosp, Dept Anaesthesiol, Juliane Marie Ctr, DK-2100 Copenhagen, Denmark.	arriba_a@yahoo.dk	Wetterslev, Jørn/ABF-1251-2020; Afshari, Arash/ABD-2969-2021	Wetterslev, Jørn/0000-0001-7778-1771; 				Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Ankri J, 2003, J CLIN EPIDEMIOL, V56, P1055, DOI 10.1016/S0895-4356(03)00175-6; Bassler D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005383.pub2; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bhandari M, 2003, J BONE JOINT SURG AM, V85A, P1673, DOI 10.2106/00004623-200309000-00004; Blomfeldt R, 2005, J BONE JOINT SURG AM, V87A, P1680, DOI 10.2106/JBJS.D.02655; Blomfeldt R, 2005, J BONE JOINT SURG BR, V87B, P523, DOI 10.1302/0301-620X.87B4; BRAEKHUS A, 1992, J AM GERIATR SOC, V40, P1139, DOI 10.1111/j.1532-5415.1992.tb01804.x; Davison JNS, 2001, J BONE JOINT SURG BR, V83B, P206, DOI 10.1302/0301-620X.83B2.11128; Dolan P, 1996, HEALTH ECON, V5, P141, DOI 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Freeman BD, 2003, SHOCK, V20, P5, DOI 10.1097/01.shk.0000068327.26733.10; Frihagen F, 2007, INJURY, V38, P815, DOI 10.1016/j.injury.2006.09.020; GARDEN RS, 1961, J BONE JOINT SURG BR, V43, P647, DOI 10.1302/0301-620X.43B4.647; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Gotzsche PC, 2000, BRIT MED J, V321, P585, DOI 10.1136/bmj.321.7261.585; HARDINGE K, 1982, J BONE JOINT SURG BR, V64, P17, DOI 10.1302/0301-620X.64B1.7068713; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoeksma HL, 2003, ANN RHEUM DIS, V62, P935, DOI 10.1136/ard.62.10.935; Johansson T, 2000, ACTA ORTHOP SCAND, V71, P597, DOI 10.1080/000164700317362235; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; Jonsson L, 2006, ALZ DIS ASSOC DIS, V20, P49; Keating JF, 2006, J BONE JOINT SURG AM, V88A, P249, DOI 10.2106/JBJS.E.00215; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Levi M, 2004, ANN MED, V36, P41, DOI 10.1080/07853890310017251; Lofthus CM, 2001, BONE, V29, P413, DOI 10.1016/S8756-3282(01)00603-2; LUYAO GL, 1994, J BONE JOINT SURG AM, V76A, P15, DOI 10.2106/00004623-199401000-00003; MAHONEY F I, 1965, Md State Med J, V14, P61; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MASSON M, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001708; Naglie G, 2006, QUAL LIFE RES, V15, P631, DOI 10.1007/s11136-005-4364-8; OISHI CS, 1994, J BONE JOINT SURG AM, V76A, P1130, DOI 10.2106/00004623-199408000-00003; Opal SM, 2002, CRIT CARE MED, V30, pS325, DOI 10.1097/00003246-200205001-00024; Osnes EK, 2004, OSTEOPOROSIS INT, V15, P567, DOI 10.1007/s00198-003-1583-0; Parker MJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001706.pub3; Parker M.J., 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858, 10.1002/14651858.CD001467, DOI 10.1002/14651858.CD001467]; Parker M, 2006, BMJ-BRIT MED J, V333, P27, DOI 10.1136/bmj.333.7557.27; Parker MJ, 2002, J BONE JOINT SURG BR, V84B, P1150, DOI 10.1302/0301-620X.84B8.13522; Periti P, 2000, Expert Opin Pharmacother, V1, P1203, DOI 10.1517/14656566.1.6.1203; Ravikumar KJ, 2000, INJURY, V31, P793, DOI 10.1016/S0020-1383(00)00125-X; Roberts C, 2002, INJURY, V33, P423, DOI 10.1016/S0020-1383(02)00055-4; Roden M, 2003, ACTA ORTHOP SCAND, V74, P42, DOI 10.1080/00016470310013635; Rogmark C, 2002, J BONE JOINT SURG BR, V84B, P183, DOI 10.1302/0301-620X.84B2.11923; Rogmark C, 2006, ACTA ORTHOP, V77, P359, DOI 10.1080/17453670610046262; Rublee D, 2002, CRIT CARE, V6, P349, DOI 10.1186/cc1529; Shepherd SM, 1996, J ROY COLL PHYS LOND, V30, P335; Soderman P, 2001, CLIN ORTHOP RELAT R, P189; Tidermark J, 2007, QUAL LIFE RES, V16, P321, DOI 10.1007/s11136-006-9004-4; Uyttenboogaart M, 2005, STROKE, V36, P1984, DOI 10.1161/01.STR.0000177872.87960.61; van Balen R, 2001, CLIN ORTHOP RELAT R, P232; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wiedermann CJ, 2002, ACTA MED AUST, V29, P89, DOI 10.1046/j.1563-2571.2002.02012.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	56	66	71	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2007	335	7632					1248	1251		10.1136/bmj.39398.682500.25	http://dx.doi.org/10.1136/bmj.39398.682500.25			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243YC	18037615	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000251832200035
J	Kolas, NK; Chapman, JR; Nakada, S; Ylanko, J; Chahwan, R; Sweeney, FD; Panier, S; Mendez, M; Wildenhain, J; Thomson, TM; Pelletier, L; Jackson, SP; Durocher, D				Kolas, Nadine K.; Chapman, J. Ross; Nakada, Shinichiro; Ylanko, Jarkko; Chahwan, Richard; Sweeney, Frederic D.; Panier, Stephanie; Mendez, Megan; Wildenhain, Jan; Thomson, Timothy M.; Pelletier, Laurence; Jackson, Stephen P.; Durocher, Daniel			Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX; CELLULAR-RESPONSE; NUCLEAR FOCI; MDC1; ATM; CHECKPOINT; BRCA1; 53BP1; RECOGNITION	Cells respond to DNA double-strand breaks by recruiting factors such as the DNA-damage mediator protein MDC1, the p53-binding protein 1 (53BP1), and the breast cancer susceptibility protein BRCA1 to sites of damaged DNA. Here, we reveal that the ubiquitin ligase RNF8 mediates ubiquitin conjugation and 53BP1 and BRCA1 focal accumulation at sites of DNA lesions. Moreover, we establish that MDC1 recruits RNF8 through phosphodependent interactions between the RNF8 forkhead-associated domain and motifs in MDC1 that are phosphorylated by the DNA-damage activated protein kinase ataxia telangiectasia mutated ( ATM). We also show that depletion of the E2 enzyme UBC13 impairs 53BP1 recruitment to sites of damage, which suggests that it cooperates with RNF8. Finally, we reveal that RNF8 promotes the G(2)/M DNA damage checkpoint and resistance to ionizing radiation. These results demonstrate how the DNA-damage response is orchestrated by ATM- dependent phosphorylation of MDC1 and RNF8-mediated ubiquitination.	Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England; Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; Inst Biol Mol Barcelona, Dept Mol & Cellular Biol, Barcelona 08034, Spain	University of Cambridge; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Cambridge; University of Toronto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk; durocher@mshri.on.ca	Thomson, Timothy/Z-6271-2019; Durocher, Daniel/A-7733-2010; Pelletier, Laurence/F-8858-2013; Chahwan, Richard/AAQ-9381-2021; Wildenhain, Jan/E-5597-2011; Jackson, Stephen Philip/R-4548-2019; Chapman, J Ross/C-7973-2012; OsakaU/AAY-3661-2020; 高, 雨莉/HGU-8187-2022; Wildenhain, Jan/Q-6596-2019; Dry, Kate/I-2328-2014; Panier, Stephanie/GVT-6365-2022	Thomson, Timothy/0000-0002-4670-9440; Durocher, Daniel/0000-0003-3863-8635; Chahwan, Richard/0000-0002-8672-7790; Wildenhain, Jan/0000-0002-5461-3828; Jackson, Stephen Philip/0000-0001-9317-7937; Wildenhain, Jan/0000-0002-5461-3828; Chapman, Ross/0000-0002-6477-4254; Nakada, Shinichiro/0000-0001-9297-1565	Cancer Research UK [A5290] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ito K, 2001, EUR J BIOCHEM, V268, P2725, DOI 10.1046/j.1432-1327.2001.02169.x; KIM, 2007, SCIENCE, V316, P1202; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; PLANS V, 2007, IN PRESS ONCOGENE; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	27	694	712	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1637	1640		10.1126/science.1150034	http://dx.doi.org/10.1126/science.1150034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18006705	Green Accepted			2022-12-28	WOS:000251421700049
J	Wildman, MJ; Sanderson, C; Groves, J; Reeves, BC; Ayres, J; Harrison, D; Young, D; Rowan, K				Wildman, Martin J.; Sanderson, Colin; Groves, Jayne; Reeves, Barnaby C.; Ayres, Jon; Harrison, David; Young, Duncan; Rowan, Kathy			Implications of prognostic pessimism in patients with chronic obstructive pulmonary disease (COPD) or asthma admitted to intensive care in the UK within the COPD and asthma outcome study (CAOS): multicentre observational cohort study	BRITISH MEDICAL JOURNAL			English	Article							MIX PROGRAM DATABASE; ADMISSIONS; DECISIONS; ADULT; UNITS	Objective To determine whether clinicians' prognoses in patients with severe acute exacerbations of obstructive lung disease admitted to intensive care match observed outcomes in terms of survival. Design Prospective cohort study. Setting 92 intensive care units and three respiratory high dependency units in the United Kingdom. Participants 832 patients aged 45 years and older with breathlessness, respiratory failure, or change in mental status because of an exacerbation of COPD, asthma, or a combination of the two. Main outcome measures Outcome predicted by clinicians. Observed survival at 180 days. Results 517 patients (621/6) survived to 180 days. Clinicians' prognoses were pessimistic, with a mean predicted survival of 49% at 180 days. For the fifth of patients with the poorest prognosis according to the clinician, the predicted survival rate was 10% and the actual rate was 40%. Information from a database covering 74% of intensive care units in the UK suggested no material difference between units that participated and those that did not. Patients recruited were similar to those not recruited in the same units. Conclusions Because decisions on whether to admit patients with COPD or asthma to intensive care for intubation depend on clinicians' prognoses, some patients who might otherwise survive are probably being denied admission because of unwarranted prognostic pessimism.	No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England; London Sch Hyg & Trop Med, London WC1, England; Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England; Intens Care Natl Audit & Res Ctr, London, England; John Radcliffe Hosp, Adult Intens Care Unit, Oxford OX3 9DU, England	Northern General Hospital; University of London; London School of Hygiene & Tropical Medicine; Heart of England NHS Foundation Trust; University of Birmingham; Intensive Care National Audit & Research Centre; University of Oxford	Wildman, MJ (corresponding author), No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England.	martin.wildman@sth.nhs.uk	Sanderson, Colin F/O-9877-2014; Harrison, David A/O-4355-2018; Young, John D/M-9756-2016	Harrison, David A/0000-0002-9002-9098; Rowan, Kathryn/0000-0001-8217-5602; Young, John Duncan/0000-0002-6838-4835; Sanderson, Colin/0000-0002-4838-6112				Britton M, 2003, RESP MED, V97, pS71, DOI 10.1016/S0954-6111(03)80027-6; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Escher M, 2004, BRIT MED J, V329, P425, DOI 10.1136/bmj.329.7463.425; Harrison DA, 2004, CRIT CARE, V8, pR99, DOI 10.1186/cc2834; Joynt GM, 2001, INTENS CARE MED, V27, P1459, DOI 10.1007/s001340101041; PARSONS V, 1980, J MED ETHICS, V6, P173, DOI 10.1136/jme.6.4.173; PEARLMAN RA, 1987, CHEST, V91, P515, DOI 10.1378/chest.91.4.515; Wildman MJ, 2005, CRIT CARE, V9, DOI 10.1186/cc3719; Wildman MJ, 2007, RESP MED, V101, P1994, DOI 10.1016/j.rmed.2007.04.002; Wildman MJ, 2003, QJM-INT J MED, V96, P583, DOI 10.1093/qjmed/hcg104	10	85	91	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1132	1134		10.1136/bmj.39371.524271.55	http://dx.doi.org/10.1136/bmj.39371.524271.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	17975254	Green Published, Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000251596100033
J	Oberlander, J				Oberlander, Jonathan			Presidential politics and the resurgence of health care reform	NEW ENGLAND JOURNAL OF MEDICINE			English	News Item									Univ N Carolina, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.								0	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2101	2104		10.1056/NEJMp078202	http://dx.doi.org/10.1056/NEJMp078202			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	18032761	Bronze			2022-12-28	WOS:000251076500001
J	Talling, PJ; Wynn, RB; Masson, DG; Frenz, M; Cronin, BT; Schiebel, R; Akhmetzhanov, AM; Dallmeier-Tiessen, S; Benetti, S; Weaver, PPE; Georgiopoulou, A; Zuhlsdorff, C; Amy, LA				Talling, P. J.; Wynn, R. B.; Masson, D. G.; Frenz, M.; Cronin, B. T.; Schiebel, R.; Akhmetzhanov, A. M.; Dallmeier-Tiessen, S.; Benetti, S.; Weaver, P. P. E.; Georgiopoulou, A.; Zuehlsdorff, C.; Amy, L. A.			Onset of submarine debris flow deposition far from original giant landslide	NATURE			English	Article							TURBIDITY CURRENTS; INITIATION; DYNAMICS; LOBE; MUDS	Submarine landslides can generate sediment-laden flows whose scale is impressive. Individual flow deposits have been mapped that extend for 1,500 km offshore from northwest Africa(1-7). These are the longest run-out sediment density flow deposits yet documented on Earth. This contribution analyses one of these deposits, which contains ten times the mass of sediment transported annually by all of the world's rivers(8). Understanding how this type of submarine flow evolves is a significant problem, because they are extremely difficult to monitor directly(9). Previous work has shown how progressive disintegration of landslide blocks can generate debris flow, the deposit of which extends downslope from the original landslide(10) (10-13). We provide evidence that submarine flows can produce giant debris flow deposits that start several hundred kilometres from the original landslide, encased within deposits of a more dilute flow type called turbidity current. Very little sediment was deposited across the intervening large expanse of sea floor, where the flow was locally very erosive. Sediment deposition was finally triggered by a remarkably small but abrupt decrease in sea-floor gradient from 0.05 degrees to 0.01 degrees. This debris flow was probably generated by flow transformation from the decelerating turbidity current. The alternative is that non-channelized debris flow left almost no trace of its passage across one hundred kilometres of flat (0.2 degrees to 0.05 degrees) sea floor. Our work shows that initially well-mixed and highly erosive submarine flows can produce extensive debris flow deposits beyond subtle slope breaks located far out in the deep ocean.	Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; Univ Aberdeen, Sch Geosci, Aberdeen AB24 3UE, Scotland; Univ Bremen, Dept Sedimentol & Paleoceanog, D-28334 Bremen, Germany	University of Bristol; NERC National Oceanography Centre; University of Southampton; University of Aberdeen; University of Bremen	Talling, PJ (corresponding author), Univ Bristol, Dept Earth Sci, Queens Rd, Bristol BS8 1RJ, Avon, England.	peter.talling@bris.ac.uk	Masson, Douglas/AAR-9436-2020	Schiebel, Ralf/0000-0002-6252-7647; Dallmeier-Tiessen, Suenje/0000-0002-6137-2348; Talling, Peter/0000-0001-5234-0398; Georgiopoulou, Aggeliki/0000-0003-4298-5090; Benetti, Sara/0000-0001-6286-9842; Weaver, Philip/0000-0002-9541-3830	Natural Environment Research Council [soc010009, NER/T/S/2003/00110] Funding Source: researchfish; NERC [soc010009] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Amy LA, 2006, SEDIMENTOLOGY, V53, P1411, DOI 10.1111/j.1365-3091.2006.00815.x; Baas JH, 2002, J SEDIMENT RES, V72, P336, DOI 10.1306/120601720336; Barley B., 1999, LEADING EDGE, V18, P488, DOI [DOI 10.1190/1.1438319, 10.1190/1.1438319]; BOWEN AJ, 1984, SEDIMENTOLOGY, V31, P169, DOI 10.1111/j.1365-3091.1984.tb01957.x; Costa J. E, 1984, 84606 USGS; Dadson S, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000244; EYTON D, 2005, LEADING EDGE, V24, P902; Gee MJR, 1999, SEDIMENTOLOGY, V46, P317, DOI 10.1046/j.1365-3091.1999.00215.x; HAMPTON MA, 1972, J SEDIMENT PETROL, V42, P775, DOI 10.1306/74D7262B-2B21-11D7-8648000102C1865D; Iverson RM, 1997, REV GEOPHYS, V35, P245, DOI 10.1029/97RG00426; Khripounoff A, 2003, MAR GEOL, V194, P151, DOI 10.1016/S0025-3227(02)00677-1; Kuhlmann H, 2004, MAR GEOL, V207, P209, DOI 10.1016/j.margeo.2004.03.017; LUTZE G, 1983, MAR MICROPALEONTOL, V8, P361; Masson DG, 2006, PHILOS T R SOC A, V364, P2009, DOI 10.1098/rsta.2006.1810; Masson DG, 1994, BASIN RES, V6, P17, DOI 10.1111/j.1365-2117.1994.tb00072.x; MCCAVE IN, 1988, NATURE, V333, P250, DOI 10.1038/333250a0; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Mulder T, 1997, SEDIMENTOLOGY, V44, P305, DOI 10.1111/j.1365-3091.1997.tb01526.x; Mulder T, 2001, SEDIMENTOLOGY, V48, P269, DOI 10.1046/j.1365-3091.2001.00360.x; Piper DJW, 1999, SEDIMENTOLOGY, V46, P79, DOI 10.1046/j.1365-3091.1999.00204.x; Schwab WC, 1996, J SEDIMENT RES, V66, P916; SPARKMAN G, 2000, LEAD EDGE, V19, P381; Talling PJ, 2004, SEDIMENTOLOGY, V51, P163, DOI 10.1111/j.1365-3091.2004.00617.x; TROWBRIDGE JH, 1994, J GEOPHYS RES-OCEANS, V99, P865, DOI 10.1029/93JC02860; WEAVER PPE, 1992, MAR GEOL, V109, P1, DOI 10.1016/0025-3227(92)90218-7; WEAVER PPE, 1994, SEDIMENTOLOGY, V41, P1025, DOI 10.1111/j.1365-3091.1994.tb01438.x; WEAVER PPE, 1993, NATURE, V364, P136, DOI 10.1038/364136a0; Winterwerp JC, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003019; Wynn RB, 2002, AAPG BULL, V86, P1441; Wynn RB, 2002, SEDIMENTOLOGY, V49, P669, DOI 10.1046/j.1365-3091.2002.00471.x	30	238	260	13	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					541	544		10.1038/nature06313	http://dx.doi.org/10.1038/nature06313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033295				2022-12-28	WOS:000251158500045
J	Bush, A; Thomson, AH				Bush, Andrew; Thomson, Anne H.			Acute bronchiolitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RESPIRATORY SYNCYTIAL VIRUS; CHILDREN; INFANTS; ALLERGY; TRIAL; AGE		Natl Heart & Lung Inst, Imperial Sch Med, London SW3 6NP, England; Oxford Childrens Hosp, Oxford OX3 9DU, England	Imperial College London	Bush, A (corresponding author), Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England.	a.bush@rbh.nthames.nhs.uk			Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bisgaard H, 2003, AM J RESP CRIT CARE, V167, P379, DOI 10.1164/rccm.200207-747OC; Cade A, 2000, ARCH DIS CHILD, V82, P126, DOI 10.1136/adc.82.2.126; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; Deshpande SA, 2003, ARCH DIS CHILD, V88, P1065, DOI 10.1136/adc.88.12.1065; Embleton ND, 2005, ARCH DIS CHILD-FETAL, V90, pF286, DOI 10.1136/adc.2004.058081; Fitzgerald DA, 2004, MED J AUSTRALIA, V180, P399, DOI 10.5694/j.1326-5377.2004.tb05993.x; Fuller H, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004883; Gadomski AM, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001266.pub2, 10.1002/14651858.CD001266.pub3]; Hartling L, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003123.PUB2; HENDERSON FW, 1992, AM REV RESPIR DIS, V145, P283, DOI 10.1164/ajrccm/145.2_Pt_1.283; Lakhanpaul M, 2002, EVIDENCE BASED GUIDE; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; MOLER FW, 1991, J PEDIATR-US, V119, P509, DOI 10.1016/S0022-3476(05)82091-8; Noakes PS, 2006, EUR RESPIR J, V28, P721, DOI 10.1183/09031936.06.00050206; *PAED SOC NZ, 2005, WHEEZ CHEST INF INF; Patel H, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004878; Perrotta C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004873.pub2; Prat C, 2003, PEDIATR INFECT DIS J, V22, P963, DOI 10.1097/01.inf.0000095197.72976.4f; *SIGN, 2006, BRONCH CHILDR; SIGURS N, 1995, PEDIATRICS, V95, P500; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Teeratakulpisarn J, 2007, PEDIATR PULM, V42, P433, DOI 10.1002/ppul.20585; THIA LP, 2007, ARCH DIS CHILD; Turner SW, 2002, ARCH DIS CHILD, V87, P417, DOI 10.1136/adc.87.5.417; VENTRE K, 1997, COCHRANE DB SYST REV; VISWANATHAN M, 2003, 69 US DEP HHS AG HEA; Wong JYW, 2000, EUR RESPIR J, V15, P388, DOI 10.1034/j.1399-3003.2000.15b27.x	27	59	59	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2007	335	7628					1037	1041		10.1136/bmj.39374.600081.AD	http://dx.doi.org/10.1136/bmj.39374.600081.AD			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UV	18007004	Green Published			2022-12-28	WOS:000251402800033
J	Chi, BH; Sinkala, M; Mbewe, F; Cantrell, RA; Kruse, G; Chintu, N; Aldrovandi, GM; Stringer, EM; Kankasa, C; Safrit, JT; Stringer, JSA				Chi, Benjamin H.; Sinkala, Moses; Mbewe, Felistas; Cantrell, Ronald A.; Kruse, Gina; Chintu, Namwinga; Aldrovandi, Grace M.; Stringer, Elizabeth M.; Kankasa, Chipepo; Safrit, Jeffrey T.; Stringer, Jeffrey S. A.			Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial	LANCET			English	Article							TO-CHILD TRANSMISSION; RESOURCE-POOR SETTINGS; ANTIRETROVIRAL THERAPY; INFECTED CHILDREN; NVP RESISTANCE; PILOT PROGRAM; SUBTYPE-A; HIVNET-012; ZAMBIA; VIRUS	Background Intraparturn and neonatal single-dose nevirapine are essential components of perinatal HIV prevention in resource-constrained settings, but can induce resistance to other non-nucleoside reverse transcriptase inhibitor drugs. We aimed to investigate whether this complication would be reduced with a single peripartum intervention of tenofovir and erntricitabine. Methods We randomly assigned 400 HIV-infected pregnant women who sought care at two public-sector primary health facilities in Lusaka, Zambia. One was excluded, 200 were assigned to receive a single oral dose of 300 mg tenofovir disoproxil fumarate with 200 mg erntricitabine under direct observation, and 199 to receive no study drug. Short-course zidovudine and intrapartum nevirapine were offered to all HIV-infected women, according to the local standard of care. Women who met national criteria for antiretroviral therapy were referred for care and not enrolled. Our pnmary study outcome was resistance to non-nucleoside reverse transcriptase inhibitors at 6 weeks after delivery. We used standard population sequencing to determine HIV genotypes. Analysis was per protocol. This study is registered with ClinicalTrials.gov, number NCT00204308. Findings Of the 200 women who were randomly assigned to the intervention, 14 were lost to follow-up or withdrew from the study, two did not take study drug according to protocol, and one specimen was lost; 23 of 199 controls were lost to follow-up or withdrew from the study, and three specimens were lost. Women given the intervention were 53% less likely than controls to have a mutation that conferred resistance to non-nudeoside reverse transcriptase inhibitors at 6 weeks after delivery (20/173 [12%] vs 41/166 [25%;; risk ratio [RR] 0.47, 95% CI 0.29-0.76). We noted postpartum anaernia, the most common serious adverse event in mothers, in four women in each group. 20 of 198 (10%) infants in the intervention group and 23 of 199 (12%) controls had a serious adverse event, mostly due to septicaernia (n=22) or pneumonia (n=8); these events did not differ between groups, and none were judged to be caused by the study intervention. Interpretation A single dose of tenofovir and erntricitabine at delivery reduced resistance to non-nucleoside reverse transcriptase inhibitors at 6 weeks after delivery by half, therefore this treatment should be considered as an adjuvant to intrapartum nevirapine.	Ctr Infect Dis Res Zambia, Lusaka, Zambia; Univ Alabama, Sch Med, Birmingham, AL USA; Univ Alabama, Sch Publ Hlth, Birmingham, AL 35294 USA; Catholic Med Missions Board, Lusaka, Zambia; Univ So Calif, Keck Sch Med, Saban Res Inst, Los Angeles, CA USA; Univ Teaching Hosp, Lusaka, Zambia; Elizabeth Glaser Pediat AIDS Fdn, Santa Monica, CA USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Southern California; University of Zambia	Chi, BH (corresponding author), Plot 1275 Lubutu Rd,POB 34681, Lusaka, Zambia.	bchi@uab.edu	Stringer, Jeffrey S. A./AAU-2342-2021	Stringer, Jeffrey/0000-0002-9590-7216	FIC NIH HHS [K01-TW05708, K01-TW06670] Funding Source: Medline; NIAID NIH HHS [K23-AI01411] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [K01TW006670, K01TW005708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001411] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ayouba A, 2003, JAIDS-J ACQ IMM DEF, V34, P274, DOI 10.1097/00126334-200311010-00003; Barditch-Crovo P, 2001, ANTIMICROB AGENTS CH, V45, P2733, DOI 10.1128/AAC.45.10.2733-2739.2001; BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718; Chaix ML, 2007, ANTIMICROB AGENTS CH, V51, P896, DOI 10.1128/AAC.00910-06; Chaix ML, 2006, J INFECT DIS, V193, P482, DOI 10.1086/499966; Chi BH, 2007, AIDS, V21, P957, DOI 10.1097/QAD.0b013e32810996b2; Chi BH, 2007, JAIDS-J ACQ IMM DEF, V45, P125, DOI 10.1097/QAI.0b013e318050d28f; Coffie P., 2007, 14 C RETR OPP INF LO; COOVADIA A, 2006, 13 C RETR OPP INF DE; Dabis F, 2005, AIDS, V19, P309; Eshleman SH, 2005, AIDS, V19, P2167, DOI 10.1097/01.aids.0000194800.43799.94; Eshleman SH, 2005, JAIDS-J ACQ IMM DEF, V40, P24, DOI 10.1097/01.qai.0000174656.71276.d6; Eshleman SH, 2005, J INFECT DIS, V192, P30, DOI 10.1086/430764; Eshleman SH, 2004, AIDS RES HUM RETROV, V20, P595, DOI 10.1089/0889222041217518; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Johnson Victoria A, 2006, Top HIV Med, V14, P125; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Kiarie JN, 2003, AIDS, V17, P65, DOI 10.1097/00002030-200301030-00009; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Laurito TL, 2002, J MASS SPECTROM, V37, P434, DOI 10.1002/jms.300; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Loubser S, 2006, AIDS, V20, P995, DOI 10.1097/01.aids.0000222071.60620.1d; Martinson NA, 2007, JAIDS-J ACQ IMM DEF, V44, P148, DOI 10.1097/QAI.0b013e31802b920e; MCINTYRE JA, 2005, 3 IAS C HIV PATH TRE; NIH DAIDS, 2004, TABL GRAD SEV AD PED; Perez F, 2004, BRIT MED J, V329, P1147, DOI 10.1136/bmj.329.7475.1147; Rousseau FS, 2003, J INFECT DIS, V188, P1652, DOI 10.1086/379667; Shapiro RL, 2006, AIDS, V20, P1281, DOI 10.1097/01.aids.0000232236.26630.35; SPENSLEY AN, 2006, 16 INT AIDS C TOR CA; Stanford University, HIV DRUG RES DAT; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Stringer JSA, 2005, AIDS, V19, P1309, DOI 10.1097/01.aids.0000180102.88511.7d; Stringer JSA, 2003, AIDS, V17, P1659, DOI 10.1097/00002030-200307250-00010; Stringer JSA, 2003, LANCET, V362, P667, DOI 10.1016/S0140-6736(03)14172-4; Stringer JSA, 2003, JAIDS-J ACQ IMM DEF, V32, P506, DOI 10.1097/00126334-200304150-00007; Temmerman M, 2003, AIDS, V17, P1239, DOI 10.1097/00002030-200305230-00016; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; van't Hoog AH, 2005, JAIDS-J ACQ IMM DEF, V40, P344, DOI 10.1097/01.qai.0000160712.86580.ff; Welty TK, 2005, JAIDS-J ACQ IMM DEF, V40, P486, DOI 10.1097/01.qai.0000163196.36199.89; World Health Organization, 2006, ANT THER HIV INF AD; Zambian Ministry of Health, 2007, ANT THER CHRON HIV I	45	88	88	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 17	2007	370	9600					1698	1705		10.1016/S0140-6736(07)61605-5	http://dx.doi.org/10.1016/S0140-6736(07)61605-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	17997151				2022-12-28	WOS:000251091200020
J	Ohlsson, R				Ohlsson, Rolf			Genetics - Widespread monoallelic expression	SCIENCE			English	Editorial Material							CLUSTER		Uppsala Univ, Dept Genet & Dev, S-75236 Uppsala, Sweden	Uppsala University	Ohlsson, R (corresponding author), Uppsala Univ, Dept Genet & Dev, Norbyvagen 18A, S-75236 Uppsala, Sweden.	rolf.ohlsson@ebc.uu.se						Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Goldmit M, 2004, IMMUNOL REV, V200, P197, DOI 10.1111/j.0105-2896.2004.00158.x; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Ohlsson R, 1998, TRENDS GENET, V14, P435, DOI 10.1016/S0168-9525(98)01583-2; Ohlsson R, 2007, CURR OPIN CELL BIOL, V19, P321, DOI 10.1016/j.ceb.2007.04.008; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Raslova H, 2004, J CLIN INVEST, V114, P77, DOI 10.1172/JCI200421197; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Yang PK, 2007, CELL, V128, P777, DOI 10.1016/j.cell.2007.01.032	11	18	19	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1077	1078		10.1126/science.1150705	http://dx.doi.org/10.1126/science.1150705			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006729				2022-12-28	WOS:000250957900026
J	Watters, TR; Campbell, B; Carter, L; Leuschen, CJ; Plaut, JJ; Picardi, G; Orosei, R; Safaeinili, A; Clifford, SM; Farrell, WM; Ivanov, AB; Phillips, RJ; Stofan, ER				Watters, Thomas R.; Campbell, Bruce; Carter, Lynn; Leuschen, Carl J.; Plaut, Jeffrey J.; Picardi, Giovanni; Orosei, Roberto; Safaeinili, Ali; Clifford, Stephen M.; Farrell, William M.; Ivanov, Anton B.; Phillips, Roger J.; Stofan, Ellen R.			Radar sounding of the Medusae Fossae Formation Mars: Equatorial ice or dry, low-density deposits?	SCIENCE			English	Article							GLOBAL SURVEYOR; ORBITER CAMERA; THARSIS; REGION; SUBSURFACE; RECORD	The equatorial Medusae Fossae Formation (MFF) is enigmatic and perhaps among the youngest geologic deposits on Mars. They are thought to be composed of volcanic ash, eolian sediments, or an ice-rich material analogous to polar layered deposits. The Mars Advanced Radar for Subsurface and Ionospheric Sounding (MARSIS) instrument aboard the Mars Express Spacecraft has detected nadir echoes offset in time-delay from the surface return in orbits over MFF material. These echoes are interpreted to be from the subsurface interface between the MFF material and the underlying terrain. The delay time between the MFF surface and subsurface echoes is consistent with massive deposits emplaced on generally planar lowlands materials with a real dielectric constant of similar to 2.9 +/- 0.4. The real dielectric constant and the estimated dielectric losses are consistent with a substantial component of water ice. However, an anomalously low-density, ice-poor material cannot be ruled out. If ice-rich, the MFF must have a higher percentage of dust and sand than polar layered deposits. The volume of water in an ice-rich MFF deposit would be comparable to that of the south polar layered deposits.	Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; Univ Kansas, Ctr Remote Sensing Ice Sheets, Lawrence, KS 66045 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Roma La Sapienza, Infocom Dept, I-00184 Rome, Italy; Lunar & Planetary Inst, Houston, TX 77058 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Proxemy Res, Laytonville, MD 20882 USA	Smithsonian Institution; University of Kansas; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Sapienza University Rome; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Washington University (WUSTL)	Watters, TR (corresponding author), Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA.	watterst@si.edu	Carter, Lynn/D-2937-2012; Ivanov, Anton B/C-8944-2014; Farrell, William/I-4865-2013	Carter, Lynn/0000-0002-6245-4142; Ivanov, Anton B/0000-0001-8376-8581; 				Bradley BA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001537; Carr M.H, 1996, WATER MARS; Carrier I., 1991, LUNAR SOURCEBOOK USE, P475; Dohm JM, 2001, J GEOPHYS RES-PLANET, V106, P12301, DOI 10.1029/2000JE001352; Edgett KS, 1997, J GEOPHYS RES-PLANET, V102, P21545, DOI 10.1029/97JE01685; ELBAZ F, 1979, J GEOPHYS RES, V84, P8205, DOI 10.1029/JB084iB14p08205; Harmon JK, 1999, J GEOPHYS RES-PLANET, V104, P14065, DOI 10.1029/1998JE900042; Head J.W., 2004, LUNAR PLANETARY SCI, V35, P1635; Hynek BM, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002062; Lanagan PD, 2001, GEOPHYS RES LETT, V28, P2365, DOI 10.1029/2001GL012932; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Malin MC, 1998, SCIENCE, V279, P1681, DOI 10.1126/science.279.5357.1681; MCEWEN AS, 2007, LUNAR PLANET SCI, V38, P2031; MUHLEMAN DO, 1991, SCIENCE, V253, P1508, DOI 10.1126/science.253.5027.1508; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; PORCELLO LJ, 1974, P IEEE, V62, P769, DOI 10.1109/PROC.1974.9517; Sakimoto SEH, 1999, J GEOPHYS RES-PLANET, V104, P24141, DOI 10.1029/1999JE001044; SCHULTZ PH, 1988, ICARUS, V73, P91, DOI 10.1016/0019-1035(88)90087-5; SCOTT DH, 1982, J GEOPHYS RES, V87, P1179, DOI 10.1029/JB087iB02p01179; Ulaby F. T., 1988, MICROWAVE DIELECTRIC; WARD AW, 1979, J GEOPHYS RES, V84, P814; WELLS GL, 1997, ARID ZONE GEOMORPHOL, P659; ZIMBELMAN J, 1999, LUNAR PLANET SCI, V30, P1652	24	109	115	4	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1125	1128		10.1126/science.1148112	http://dx.doi.org/10.1126/science.1148112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	17975034				2022-12-28	WOS:000250957900042
J	Sasieni, P				Sasieni, Peter			Cervical cancer prevention and hormonal contraception	LANCET			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; CONDOM USE; WOMEN; CARCINOMA; CELLS		Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Epidemiol Math & Stat, London EC1M 6BQ, England	University of London; Queen Mary University London	Sasieni, P (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Epidemiol Math & Stat, London EC1M 6BQ, England.	peter.sasieni@cancer.org.uk		Sasieni, Peter/0000-0003-1509-8744				Appleby P, 2006, INT J CANCER, V119, P1108, DOI 10.1002/ijc.21953; Brake T, 2005, P NATL ACAD SCI USA, V102, P2490, DOI 10.1073/pnas.0409883102; Cogliano V, 2005, LANCET ONCOL, V6, P552, DOI 10.1016/S1470-2045(05)70273-4; Hogewoning CJA, 2003, INT J CANCER, V107, P811, DOI 10.1002/ijc.11474; Milam MR, 2005, AM J OBSTET GYNECOL, V192, P1368, DOI 10.1016/j.ajog.2005.01.003; MITRANIROSENBAUM S, 1989, J GEN VIROL, V70, P2227, DOI 10.1099/0022-1317-70-8-2227; Morrison CS, 2004, SEX TRANSM DIS, V31, P561, DOI 10.1097/01.olq.0000137904.56037.70; Riley RR, 2003, CANCER RES, V63, P4862; Skegg DCG, 2002, LANCET, V359, P1080, DOI 10.1016/S0140-6736(02)08125-4; Stopinska-Gluszak U, 2006, J REPROD IMMUNOL, V69, P65, DOI 10.1016/j.jri.2005.07.006; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; 2007, LANCET, V370, P1609	12	9	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 10	2007	370	9599					1591	1592		10.1016/S0140-6736(07)61667-5	http://dx.doi.org/10.1016/S0140-6736(07)61667-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230NO	17993345				2022-12-28	WOS:000250883400004
J	Clark, AG; Eisen, MB; Smith, DR; Bergman, CM; Oliver, B; Markow, TA; Kaufman, TC; Kellis, M; Gelbart, W; Iyer, VN; Pollard, DA; Sackton, TB; Larracuente, AM; Singh, ND; Abad, JP; Abt, DN; Adryan, B; Aguade, M; Akashi, H; Anderson, WW; Aquadro, CF; Ardell, DH; Arguello, R; Artieri, CG; Barbash, DA; Barker, D; Barsanti, P; Batterham, P; Batzoglou, S; Begun, D; Bhutkar, A; Blanco, E; Bosak, SA; Bradley, RK; Brand, AD; Brent, MR; Brooks, AN; Brown, RH; Butlin, RK; Caggese, C; Calvi, BR; de Carvalho, AB; Caspi, A; Castrezana, S; Celniker, SE; Chang, JL; Chapple, C; Chatterji, S; Chinwalla, A; Civetta, A; Clifton, SW; Comeron, JM; Costello, JC; Coyne, JA; Daub, J; David, RG; Delcher, AL; Delehaunty, K; Do, CB; Ebling, H; Edwards, K; Eickbush, T; Evans, JD; Filipski, A; Findeiss, S; Freyhult, E; Fulton, L; Fulton, R; Garcia, ACL; Gardiner, A; Garfield, DA; Garvin, BE; Gibson, G; Gilbert, D; Gnerre, S; Godfrey, J; Good, R; Gotea, V; Gravely, B; Greenberg, AJ; Griffiths-Jones, S; Gross, S; Guigo, R; Gustafson, EA; Haerty, W; Hahn, MW; Halligan, DL; Halpern, AL; Halter, GM; Han, MV; Heger, A; Hillier, L; Hinrichs, AS; Holmes, I; Hoskins, RA; Hubisz, MJ; Hultmark, D; Huntley, MA; Jaffe, DB; Jagadeeshan, S; Jeck, WR; Johnson, J; Jones, CD; Jordan, WC; Karpen, GH; Kataoka, E; Keightley, PD; Kheradpour, P; Kirkness, EF; Koerich, LB; Kristiansen, K; Kudrna, D; Kulathinal, RJ; Kumar, S; Kwok, R; Lander, E; Langley, CH; Lapoint, R; Lazzaro, BP; Lee, SJ; Levesque, L; Li, RQ; Lin, CF; Lin, MF; Lindblad-Toh, K; Llopart, A; Long, MY; Low, L; Lozovsky, E; Lu, J; Luo, MH; Machado, CA; Makalowski, W; Marzo, M; Matsuda, M; Matzkin, L; McAllister, B; McBride, CS; McKernan, B; McKernan, K; Mendez-Lago, M; Minx, P; Mollenhauer, MU; Montooth, K; Mount, SM; Mu, X; Myers, E; Negre, B; Newfeld, S; Nielsen, R; Noor, MAF; O'Grady, P; Pachter, L; Papaceit, M; Parisi, MJ; Parisi, M; Parts, L; Pedersen, JS; Pesole, G; Phillippy, AM; Ponting, CP; Pop, M; Porcelli, D; Powell, JR; Prohaska, S; Pruitt, K; Puig, M; Quesneville, H; Ram, KR; Rand, D; Rasmussen, MD; Reed, LK; Reenan, R; Reily, A; Remington, KA; Rieger, TT; Ritchie, MG; Robin, C; Rogers, YH; Rohde, C; Rozas, J; Rubenfield, MJ; Ruiz, A; Russo, S; Salzberg, SL; Sanchez-Gracia, A; Saranga, DJ; Sato, H; Schaeffer, SW; Schatz, MC; Schlenke, T; Schwartz, R; Segarra, C; Singh, RS; Sirot, L; Sirota, M; Sisneros, NB; Smith, CD; Smith, TF; Spieth, J; Stage, DE; Stark, A; Stephan, W; Strausberg, RL; Strempel, S; Sturgill, D; Sutton, G; Sutton, GG; Tao, W; Teichmann, S; Tobari, YN; Tomimura, Y; Tsolas, JM; Valente, VLS; Venter, E; Venter, JC; Vicario, S; Vieira, FG; Vilella, AJ; Villasante, A; Walenz, B; Wang, J; Wasserman, M; Watts, T; Wilson, D; Wilson, RK; Wing, RA; Wolfner, MF; Wong, A; Wong, GKS; Wu, CI; Wu, G; Yamamoto, D; Yang, HP; Yang, SP; Yorke, JA; Yoshida, K; Zdobnov, E; Zhang, PL; Zhang, Y; Zimin, AV; Baldwin, J; Abdouelleil, A; Abdulkadir, J; Abebe, A; Abera, B; Abreu, J; Acer, SC; Aftuck, L; Alexander, A; An, P; Anderson, E; Anderson, S; Arachi, H; Azer, M; Bachantsang, P; Barry, A; Bayul, T; Berlin, A; Bessette, D; Bloom, T; Blye, J; Boguslavskiy, L; Bonnet, C; Boukhgalter, B; Bourzgui, I; Brown, A; Cahill, P; Channer, S; Cheshatsang, Y; Chuda, L; Citroen, M; Collymore, A; Cooke, P; Costello, M; D'Aco, K; Daza, R; De Haan, G; DeGray, S; DeMaso, C; Dhargay, N; Dooley, K; Dooley, E; Doricent, M; Dorje, P; Dorjee, K; Dupes, A; Elong, R; Falk, J; Farina, A; Faro, S; Ferguson, D; Fisher, S; Foley, CD; Franke, A; Friedrich, D; Gadbois, L; Gearin, G; Gearin, CR; Giannoukos, G; Goode, T; Graham, J; Grandbois, E; Grewal, S; Gyaltsen, K; Hafez, N; Hagos, B; Hall, J; Henson, C; Hollinger, A; Honan, T; Huard, MD; Hughes, L; Hurhula, B; Husby, ME; Kamat, A; Kanga, B; Kashin, S; Khazanovich, D; Kisner, P; Lance, K; Lara, M; Lee, W; Lennon, N; Letendre, F; LeVine, R; Lipovsky, A; Liu, XH; Liu, JL; Liu, ST; Lokyitsang, T; Lokyitsang, Y; Lubonja, R; Lui, A; MacDonald, P; Magnisalis, V; Maru, K; Matthews, C; McCusker, W; McDonough, S; Mehta, T; Meldrim, J; Meneus, L; Mihai, O; Mihalev, A; Mihova, T; Mittelman, R; Mlenga, V; Montmayeur, A; Mulrain, L; Navidi, A; Naylor, J; Negash, T; Nguyen, T; Nguyen, N; Nicol, R; Norbu, C; Norbu, N; Novod, N; O'Neill, B; Osman, S; Markiewicz, E; Oyono, OL; Patti, C; Phunkhang, P; Pierre, F; Priest, M; Raghuraman, S; Rege, F; Reyes, R; Rise, C; Rogov, P; Ross, K; Ryan, E; Settipalli, S; Shea, T; Sherpa, N; Shi, L; Shih, D; Sparrow, T; Spaulding, J; Stalker, J; Stange-Thomann, N; Stavropoulos, S; Stone, C; Strader, C; Tesfaye, S; Thomson, T; Thoulutsang, Y; Thoulutsang, D; Topham, K; Topping, I; Tsamla, T; Vassiliev, H; Vo, A; Wangchuk, T; Wangdi, T; Weiand, M; Wilkinson, J; Wilson, A; Yadav, S; Young, G; Yu, Q; Zembek, L; Zhong, D; Zimmer, A; Zwirko, Z; Jaffe, DB; Alvarez, P; Brockman, W; Butler, J; Chin, C; Gnerre, S; Grabherr, M; Kleber, M; Mauceli, E; MacCallum, I				Clark, Andrew G.; Eisen, Michael B.; Smith, Douglas R.; Bergman, Casey M.; Oliver, Brian; Markow, Therese A.; Kaufman, Thomas C.; Kellis, Manolis; Gelbart, William; Iyer, Venky N.; Pollard, Daniel A.; Sackton, Timothy B.; Larracuente, Amanda M.; Singh, Nadia D.; Abad, Jose P.; Abt, Dawn N.; Adryan, Boris; Aguade, Montserrat; Akashi, Hiroshi; Anderson, Wyatt W.; Aquadro, Charles F.; Ardell, David H.; Arguello, Roman; Artieri, Carlo G.; Barbash, Daniel A.; Barker, Daniel; Barsanti, Paolo; Batterham, Phil; Batzoglou, Serafim; Begun, Dave; Bhutkar, Arjun; Blanco, Enrico; Bosak, Stephanie A.; Bradley, Robert K.; Brand, Adrianne D.; Brent, Michael R.; Brooks, Angela N.; Brown, Randall H.; Butlin, Roger K.; Caggese, Corrado; Calvi, Brian R.; de Carvalho, A. Bernardo; Caspi, Anat; Castrezana, Sergio; Celniker, Susan E.; Chang, Jean L.; Chapple, Charles; Chatterji, Sourav; Chinwalla, Asif; Civetta, Alberto; Clifton, Sandra W.; Comeron, Josep M.; Costello, James C.; Coyne, Jerry A.; Daub, Jennifer; David, Robert G.; Delcher, Arthur L.; Delehaunty, Kim; Do, Chuong B.; Ebling, Heather; Edwards, Kevin; Eickbush, Thomas; Evans, Jay D.; Filipski, Alan; Findeiss, Sven; Freyhult, Eva; Fulton, Lucinda; Fulton, Robert; Garcia, Ana C. L.; Gardiner, Anastasia; Garfield, David A.; Garvin, Barry E.; Gibson, Greg; Gilbert, Don; Gnerre, Sante; Godfrey, Jennifer; Good, Robert; Gotea, Valer; Gravely, Brenton; Greenberg, Anthony J.; Griffiths-Jones, Sam; Gross, Samuel; Guigo, Roderic; Gustafson, Erik A.; Haerty, Wilfried; Hahn, Matthew W.; Halligan, Daniel L.; Halpern, Aaron L.; Halter, Gillian M.; Han, Mira V.; Heger, Andreas; Hillier, LaDeana; Hinrichs, Angie S.; Holmes, Ian; Hoskins, Roger A.; Hubisz, Melissa J.; Hultmark, Dan; Huntley, Melanie A.; Jaffe, David B.; Jagadeeshan, Santosh; Jeck, William R.; Johnson, Justin; Jones, Corbin D.; Jordan, William C.; Karpen, Gary H.; Kataoka, Eiko; Keightley, Peter D.; Kheradpour, Pouya; Kirkness, Ewen F.; Koerich, Leonardo B.; Kristiansen, Karsten; Kudrna, Dave; Kulathinal, Rob J.; Kumar, Sudhir; Kwok, Roberta; Lander, Eric; Langley, Charles H.; Lapoint, Richard; Lazzaro, Brian P.; Lee, So-Jeong; Levesque, Lisa; Li, Ruiqiang; Lin, Chiao-Feng; Lin, Michael F.; Lindblad-Toh, Kerstin; Llopart, Ana; Long, Manyuan; Low, Lloyd; Lozovsky, Elena; Lu, Jian; Luo, Meizhong; Machado, Carlos A.; Makalowski, Wojciech; Marzo, Mar; Matsuda, Muneo; Matzkin, Luciano; McAllister, Bryant; McBride, Carolyn S.; McKernan, Brendan; McKernan, Kevin; Mendez-Lago, Maria; Minx, Patrick; Mollenhauer, Michael U.; Montooth, Kristi; Mount, Stephen M.; Mu, Xu; Myers, Eugene; Negre, Barbara; Newfeld, Stuart; Nielsen, Rasmus; Noor, Mohamed A. F.; O'Grady, Patrick; Pachter, Lior; Papaceit, Montserrat; Parisi, Matthew J.; Parisi, Michael; Parts, Leopold; Pedersen, Jakob S.; Pesole, Graziano; Phillippy, Adam M.; Ponting, Chris P.; Pop, Mihai; Porcelli, Damiano; Powell, Jeffrey R.; Prohaska, Sonja; Pruitt, Kim; Puig, Marta; Quesneville, Hadi; Ram, Kristipati Ravi; Rand, David; Rasmussen, Matthew D.; Reed, Laura K.; Reenan, Robert; Reily, Amy; Remington, Karin A.; Rieger, Tania T.; Ritchie, Michael G.; Robin, Charles; Rogers, Yu-Hui; Rohde, Claudia; Rozas, Julio; Rubenfield, Marc J.; Ruiz, Alfredo; Russo, Susan; Salzberg, Steven L.; Sanchez-Gracia, Alejandro; Saranga, David J.; Sato, Hajime; Schaeffer, Stephen W.; Schatz, Michael C.; Schlenke, Todd; Schwartz, Russell; Segarra, Carmen; Singh, Rama S.; Sirot, Laura; Sirota, Marina; Sisneros, Nicholas B.; Smith, Chris D.; Smith, Temple F.; Spieth, John; Stage, Deborah E.; Stark, Alexander; Stephan, Wolfgang; Strausberg, Robert L.; Strempel, Sebastian; Sturgill, David; Sutton, Granger; Sutton, Granger G.; Tao, Wei; Teichmann, Sarah; Tobari, Yoshiko N.; Tomimura, Yoshihiko; Tsolas, Jason M.; Valente, Vera L. S.; Venter, Eli; Venter, J. Craig; Vicario, Saverio; Vieira, Filipe G.; Vilella, Albert J.; Villasante, Alfredo; Walenz, Brian; Wang, Jun; Wasserman, Marvin; Watts, Thomas; Wilson, Derek; Wilson, Richard K.; Wing, Rod A.; Wolfner, Mariana F.; Wong, Alex; Wong, Gane Ka-Shu; Wu, Chung-I; Wu, Gabriel; Yamamoto, Daisuke; Yang, Hsiao-Pei; Yang, Shiaw-Pyng; Yorke, James A.; Yoshida, Kiyohito; Zdobnov, Evgeny; Zhang, Peili; Zhang, Yu; Zimin, Aleksey V.; Baldwin, Jennifer; Abdouelleil, Amr; Abdulkadir, Jamal; Abebe, Adal; Abera, Brikti; Abreu, Justin; Acer, St Christophe; Aftuck, Lynne; Alexander, Allen; An, Peter; Anderson, Erica; Anderson, Scott; Arachi, Harindra; Azer, Marc; Bachantsang, Pasang; Barry, Andrew; Bayul, Tashi; Berlin, Aaron; Bessette, Daniel; Bloom, Toby; Blye, Jason; Boguslavskiy, Leonid; Bonnet, Claude; Boukhgalter, Boris; Bourzgui, Imane; Brown, Adam; Cahill, Patrick; Channer, Sheridon; Cheshatsang, Yama; Chuda, Lisa; Citroen, Mieke; Collymore, Alville; Cooke, Patrick; Costello, Maura; D'Aco, Katie; Daza, Riza; De Haan, Georgius; DeGray, Stuart; DeMaso, Christina; Dhargay, Norbu; Dooley, Kimberly; Dooley, Erin; Doricent, Missole; Dorje, Passang; Dorjee, Kunsang; Dupes, Alan; Elong, Richard; Falk, Jill; Farina, Abderrahim; Faro, Susan; Ferguson, Diallo; Fisher, Sheila; Foley, Chelsea D.; Franke, Alicia; Friedrich, Dennis; Gadbois, Loryn; Gearin, Gary; Gearin, Christina R.; Giannoukos, Georgia; Goode, Tina; Graham, Joseph; Grandbois, Edward; Grewal, Sharleen; Gyaltsen, Kunsang; Hafez, Nabil; Hagos, Birhane; Hall, Jennifer; Henson, Charlotte; Hollinger, Andrew; Honan, Tracey; Huard, Monika D.; Hughes, Leanne; Hurhula, Brian; Husby, M. Erii; Kamat, Asha; Kanga, Ben; Kashin, Seva; Khazanovich, Dmitry; Kisner, Peter; Lance, Krista; Lara, Marcia; Lee, William; Lennon, Niall; Letendre, Frances; LeVine, Rosie; Lipovsky, Alex; Liu, Xiaohong; Liu, Jinlei; Liu, Shangtao; Lokyitsang, Tashi; Lokyitsang, Yeshi; Lubonja, Rakela; Lui, Annie; MacDonald, Pen; Magnisalis, Vasilia; Maru, Kebede; Matthews, Charles; McCusker, William; McDonough, Susan; Mehta, Teena; Meldrim, James; Meneus, Louis; Mihai, Oana; Mihalev, Atanas; Mihova, Tanya; Mittelman, Rachel; Mlenga, Valentine; Montmayeur, Anna; Mulrain, Leonidas; Navidi, Adam; Naylor, Jerome; Negash, Tamrat; Nguyen, Thu; Nguyen, Nga; Nicol, Robert; Norbu, Choe; Norbu, Nyima; Novod, Nathaniel; O'Neill, Barry; Osman, Sahal; Markiewicz, Eva; Oyono, Otero L.; Patti, Christopher; Phunkhang, Pema; Pierre, Fritz; Priest, Margaret; Raghuraman, Sujaa; Rege, Filip; Reyes, Rebecca; Rise, Cecil; Rogov, Peter; Ross, Keenan; Ryan, Elizabeth; Settipalli, Sampath; Shea, Terry; Sherpa, Ngawang; Shi, Lu; Shih, Diana; Sparrow, Todd; Spaulding, Jessica; Stalker, John; Stange-Thomann, Nicole; Stavropoulos, Sharon; Stone, Catherine; Strader, Christopher; Tesfaye, Senait; Thomson, Talene; Thoulutsang, Yama; Thoulutsang, Dawa; Topham, Kerri; Topping, Ira; Tsamla, Tsamla; Vassiliev, Helen; Vo, Andy; Wangchuk, Tsering; Wangdi, Tsering; Weiand, Michael; Wilkinson, Jane; Wilson, Adam; Yadav, Shailendra; Young, Geneva; Yu, Qing; Zembek, Lisa; Zhong, Danni; Zimmer, Andrew; Zwirko, Zac; Jaffe, David B.; Alvarez, Pablo; Brockman, Will; Butler, Jonathan; Chin, CheeWhye; Gnerre, Sante; Grabherr, Manfred; Kleber, Michael; Mauceli, Evan; MacCallum, Iain		Drosophila 12 Genomes Consor; Broad Inst Genome Sequencing; Broad Inst Whole Genome Ass	Evolution of genes and genomes on the Drosophila phylogeny	NATURE			English	Article							AMINO-ACID SUBSTITUTION; ADAPTIVE PROTEIN EVOLUTION; SYNONYMOUS CODON USAGE; FRUIT-FLY; MOLECULAR EVOLUTION; MITOCHONDRIAL-DNA; NATURAL-SELECTION; FAMILY EVOLUTION; NONCODING DNA; HOST-DEFENSE	Comparative analysis of multiple genomes in a phylogenetic framework dramatically improves the precision and sensitivity of evolutionary inference, producing more robust results than single-genome analyses can provide. The genomes of 12 Drosophila species, ten of which are presented here for the first time (sechellia, simulans, yakuba, erecta, ananassae, persimilis, willistoni, mojavensis, virilis and grimshawi), illustrate how rates and patterns of sequence divergence across taxa can illuminate evolutionary processes on a genomic scale. These genome sequences augment the formidable genetic tools that have made Drosophila melanogaster a pre-eminent model for animal genetics, and will further catalyse fundamental research on mechanisms of development, cell biology, genetics, disease, neurobiology, behaviour, physiology and evolution. Despite remarkable similarities among these Drosophila species, we identified many putatively non-neutral changes in protein-coding genes, non-coding RNA genes, and cis-regulatory regions. These may prove to underlie differences in the ecology and behaviour of these diverse species.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Berkeley, CA 94720 USA; Agencourt Biosci Corp, Beverly, MA 01915 USA; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; NIH, Cellular & Dev Biol Lab, Bethesda, MD 20892 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Harvard Univ, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA; Harvard Univ, Biol Labs, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Cornell Univ, Field Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; MRC, Mol Biol Lab, Struct Studies Div, Cambridge CB2 2QH, England; Univ Barcelona, Dept Genet, Barcelona 08071, Spain; Uppsala Univ, Linnaeus Ctr Bioinformat, SE-75124 Uppsala, Sweden; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; Univ St Andrews, Sch Biol, St Andrews KY16 9TH, Fife, Scotland; Univ Bari, Dipartimento Genet & Microbiol, I-70126 Bari, Italy; Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; Boston Univ, BioMol Engn Res Ctr, Boston, MA 02215 USA; Univ Pompeu Fabra, Inst Municipal Invest Med, Res Grp Biomed Informat, Barcelona 08003, Catalonia, Spain; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; Washington Univ, Lab Computat Genom, St Louis, MO 63108 USA; Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; Univ Fed Rio de Janeiro, Dept Genet, BR-21944970 Rio De Janeiro, Brazil; Tucson Stock Ctr, Tucson, AZ 85721 USA; Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Univ Winnipeg, Dept Biol, Winnipeg, MB R3B 2E9, Canada; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Indiana Univ, Sch Informat, Bloomington, IN 47405 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; Illinois State Univ, Dept Biol Sci, Normal, IL 61790 USA; Univ Rochester, Dept Biol, Rochester, NY 14627 USA; USDA ARS, Bee Res Lab, Beltsville, MD 20705 USA; Arizona State Univ, Ctr Evolutionary Funct Genom, Biodesign Inst, Tempe, AZ 85287 USA; Univ Leipzig, Dept Comp Sci, D-04107 Leipzig, Germany; Univ Fed Rio Grande do Sul, Dept Genet, BR-68011 Porto Alegre, RS, Brazil; Duke Univ, Dept Biol, Durham, NC 27708 USA; N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA; Ctr Genom Regulat, Barcelona 08003, Catalonia, Spain; Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; J Craig Venter Inst, Rockville, MD 20850 USA; Univ Oxford, MRC, Funct Genet Unit, Oxford OX1 3QX, England; Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; Zool Soc London, Inst Zool, London NW1 4RY, England; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome & Computat Biol, Drosophila Heterochromatin Genome Project, Berkeley, CA 94720 USA; Kyorin Univ, Sch Med, Tokyo 1818611, Japan; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; Univ Arizona, Dept Plant Sci, Arizona Genom Inst, Tucson, AZ 85721 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; Beijing Genom Inst ShenZhen, ShenZhen 518083, Peoples R China; Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra 08193, Spain; Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; Howard Hughes Med Inst, Ashburn, VA 20147 USA; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Copenhagen, Inst Biol, DK-2100 Copenhagen O, Denmark; Univ Copenhagen, Dept Mol Biol, Bioinformat Ctr, DK-2200 Copenhagen N, Denmark; Univ Bari, Dipartmento Biochim & Biol Mol, I-70126 Bari, Italy; CNR, Ist Tecnol Biomed, I-70126 Bari, Italy; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Arizona State Univ, Dept Biomed Informat, Tempe, AZ 85287 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Inst Jacques Monod, Bioinformat & Genom Lab, F-75251 Paris, France; Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Genet, BR-68011 Recife, PE, Brazil; Univ Fed Pernambuco, Ctr Acad Vitoria, Vitoria de Santo Antao, PE, Brazil; CSIC, Inst Cajal, E-28002 Madrid, Spain; Emory Univ, Dept Biol, Atlanta, GA 30322 USA; Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; Stanford Univ, Stanford, CA 94305 USA; San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; Univ Munich, Dept Biol, D-82152 Planegg Martinsried, Germany; Inst Evolutionary Biol, Setagaya Ku, Tokyo 1580098, Japan; Shiba Gakuen, Minato Ku, Tokyo 1050011, Japan; European Bioinformat Inst, Hinxton CB10 1SD, England; CUNY Queens Coll, Dept Biol, Flushing, NY 11367 USA; Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Alberta, Dept Med, Edmonton, AB T6G 2E9, Canada; Tohoku Univ, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808578, Japan; Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; Hokkaido Univ, EESBIO, Sapporo, Hokkaido 0600810, Japan; Univ Geneva, Fac Med, CH-1211 Geneva, Switzerland	Cornell University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Manchester; National Institutes of Health (NIH) - USA; University of Arizona; Indiana University System; Indiana University Bloomington; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Cornell University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Brown University; MRC Laboratory Molecular Biology; University of Barcelona; Uppsala University; University of Chicago; McMaster University; University of St Andrews; Universita degli Studi di Bari Aldo Moro; University of Melbourne; Stanford University; University of California System; University of California Davis; University of California System; University of California Davis; Boston University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of California System; University of California Berkeley; Washington University (WUSTL); University of Sheffield; Syracuse University; Universidade Federal do Rio de Janeiro; University of California System; University of California Berkeley; University of California System; University of California Davis; Washington University (WUSTL); University of Winnipeg; University of Iowa; Indiana University System; Indiana University Bloomington; Wellcome Trust Sanger Institute; University System of Maryland; University of Maryland College Park; Illinois State University; University of Rochester; United States Department of Agriculture (USDA); Arizona State University; Arizona State University-Tempe; Leipzig University; Universidade Federal do Rio Grande do Sul; Duke University; University of North Carolina; North Carolina State University; University of Connecticut; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Edinburgh; J. Craig Venter Institute; University of Oxford; University of Oxford; University of California System; University of California Santa Cruz; University of Chicago; Umea University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Zoological Society of London; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Kyorin University; University of Southern Denmark; University of Arizona; Harvard University; Arizona State University; Arizona State University-Tempe; University of California System; University of California Berkeley; Cornell University; Beijing Genomics Institute (BGI); Autonomous University of Barcelona; University System of Maryland; University of Maryland College Park; Howard Hughes Medical Institute; University of Cambridge; University of Copenhagen; University of Copenhagen; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Yale University; Arizona State University; Arizona State University-Tempe; National Institutes of Health (NIH) - USA; UDICE-French Research Universities; Universite Paris Cite; Brown University; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Emory University; Carnegie Mellon University; Stanford University; California State University System; San Francisco State University; University of Munich; European Molecular Biology Laboratory (EMBL); City University of New York (CUNY) System; Queens College NY (CUNY); University of Alberta; University of Alberta; Tohoku University; University System of Maryland; University of Maryland College Park; Hokkaido University; University of Geneva	Clark, AG (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	ac347@cornell.edu; mbeisen@lbl.gov; douglas.smith@agencourt.com; gelbart@morgan.harvard.edu; oliver@helix.nih.gov; tmarkow@public.arl.arizona.edu; kaufman@indiana.edu; manoli@mit.edu; venky@berkeley.edu; danielapollard@alum.bowdoin.edu; tbs7@cornell.edu; aml69@cornell.edu; nds25@cornell.edu	Pop, Mihai/A-7987-2013; Stark, Alexander/D-1473-2012; WONG, Gane Ka-Shu/G-5784-2013; Vilella, Albert/A-8586-2008; Negre, Barbara/F-2540-2013; McAllister, Bryant/A-3015-2008; Salzberg, Steven L/F-6162-2011; Wilson, Richard K./AAF-4139-2019; vicario, saverio/C-4427-2015; Garrett Vieira, Filipe/B-9464-2015; Evans, Jay D/C-8408-2012; Bergman, Casey/F-7854-2010; Comeron, Josep/G-6630-2012; Nielsen, Rasmus/D-4405-2009; Puig, Marta/F-7885-2016; Matzkin, Luciano/B-3168-2013; Zdobnov, Evgeny M/K-1133-2012; Stephan, Wolfgang/GOV-6503-2022; Butlin, Roger K/F-7709-2013; Ponting, Chris/AAV-2621-2021; Phillippy, Adam M/U-5731-2018; Guigo, Roderic/D-1303-2010; Pedersen, Jakob/C-4985-2009; Caggese, Corrado/B-8787-2011; Graveley, Brenton R/C-3108-2013; Batterham, Philip/G-5914-2012; Schaeffer, Stephen/AAA-2303-2021; Larracuente, Amanda M./AAH-6198-2021; Schaeffer, Stephen W/B-1662-2010; Kristiansen, Karsten/J-5148-2014; Pedersen, Jakob/G-3382-2012; Barker, David JP/A-5671-2013; Ruiz, Alfredo/ABH-2402-2020; Berlin, Aaron M/AFY-6549-2022; low, waiyee/AAM-2200-2021; Valente, Vera LS/N-9031-2013; YOSHIDA, Kiyohito/F-8475-2012; Brent, Michael/AAK-3702-2020; Rohde, Claudia/D-9457-2013; Pesole, Graziano/C-1408-2009; Ruiz, Alfredo/AAB-2759-2019; Matzkin, Luciano/AAI-2913-2020; Wing, Rod A/Z-2885-2019; Azer, Samy A./C-8485-2009; Rozas, Julio/A-1733-2009; Han, Mira/A-1808-2011; Kellis, Manolis/ABE-7385-2020; Daza, Riza M./HCH-4047-2022; Zdobnov, Evgeny/AAB-2745-2022; O'Grady, Patrick/J-3421-2019; Schwartz, Russell/A-1998-2016; Makalowski, Wojciech/I-2843-2016; Robin, Charles/F-7786-2010; Ritchie, Michael G/F-7055-2013; vicario, saverio/AAX-8105-2020; Machado, Carlos A/B-8855-2009; Edwards, Kevin Andrew/GOE-3539-2022; Salzberg, Steven/Q-6514-2019; Koerich, Leonardo/J-7004-2014; Pesole, Graziano/E-9051-2014; Lorenzo, Jose Pascual Abad/Y-3871-2019; Garfield, David/AAG-1524-2020; Hultmark, Dan/C-5058-2013; Koerich, Leonardo/B-8554-2008; Hinrichs, Angie S./H-9159-2019; Ritchie, Michael/B-7714-2008; Jagadeeshan, Santosh/AAN-9568-2021; Brooks, Angela/B-6173-2011; Schatz, Michael/L-2690-2019; Carvalho, Antonio/D-5402-2013; Sanchez-Gracia, Alejandro/F-4686-2014; Quesneville, Hadi/AAG-1048-2020; Pesole, Graziano/K-5283-2019; Wang, Jun/A-7261-2013; Kumar, Sudhir/F-1411-2011; Halligan, Daniel/H-4459-2011; Griffiths-Jones, Sam/H-2998-2014; Blanco, Enrique/I-5902-2015; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Pop, Mihai/0000-0001-9617-5304; Stark, Alexander/0000-0003-2611-0841; WONG, Gane Ka-Shu/0000-0001-6108-5560; Negre, Barbara/0000-0002-7333-3979; Salzberg, Steven L/0000-0002-8859-7432; Wilson, Richard K./0000-0002-1992-1358; vicario, saverio/0000-0003-1140-0483; Garrett Vieira, Filipe/0000-0002-8464-7770; Evans, Jay D/0000-0002-0036-4651; Bergman, Casey/0000-0002-5462-9854; Nielsen, Rasmus/0000-0003-0513-6591; Puig, Marta/0000-0002-4439-6372; Butlin, Roger K/0000-0003-4736-0954; Phillippy, Adam M/0000-0003-2983-8934; Guigo, Roderic/0000-0002-5738-4477; Batterham, Philip/0000-0001-9840-9119; Schaeffer, Stephen/0000-0003-2070-5342; Larracuente, Amanda M./0000-0001-5944-5686; Kristiansen, Karsten/0000-0002-6024-0917; Pedersen, Jakob/0000-0002-7236-4001; Berlin, Aaron M/0000-0002-0714-2808; low, waiyee/0000-0002-0749-765X; Brent, Michael/0000-0002-8689-0299; Rohde, Claudia/0000-0002-0977-9239; Pesole, Graziano/0000-0003-3663-0859; Matzkin, Luciano/0000-0002-3580-9171; Wing, Rod A/0000-0001-6633-6226; Azer, Samy A./0000-0001-5638-3256; Rozas, Julio/0000-0002-6839-9148; Kellis, Manolis/0000-0001-7113-9630; Zdobnov, Evgeny/0000-0002-5178-1498; O'Grady, Patrick/0000-0002-6075-8951; Schwartz, Russell/0000-0002-4970-2252; Robin, Charles/0000-0002-7733-6763; Ritchie, Michael G/0000-0001-7913-8675; vicario, saverio/0000-0003-1140-0483; Machado, Carlos A/0000-0003-1546-7415; Edwards, Kevin Andrew/0000-0003-4721-5626; Salzberg, Steven/0000-0002-8859-7432; Koerich, Leonardo/0000-0002-5668-3934; Pesole, Graziano/0000-0003-3663-0859; Lorenzo, Jose Pascual Abad/0000-0002-5284-5772; Hultmark, Dan/0000-0002-6506-5855; Koerich, Leonardo/0000-0002-5668-3934; Hinrichs, Angie S./0000-0002-1697-1130; Jagadeeshan, Santosh/0000-0002-4285-9281; Schatz, Michael/0000-0002-4118-4446; Carvalho, Antonio/0000-0001-8959-6469; Sanchez-Gracia, Alejandro/0000-0003-4543-4577; Quesneville, Hadi/0000-0003-3001-4908; Kumar, Sudhir/0000-0002-9918-8212; Nicol, Robert/0000-0003-1932-1392; Chinwalla, Asif/0000-0001-7831-3996; Holmes, Ian/0000-0001-7639-5369; Griffiths-Jones, Sam/0000-0001-6043-807X; Makalowski, Wojciech/0000-0003-2303-9541; Blanco, Enrique/0000-0001-6261-7370; Segarra, Carmen/0000-0002-3201-5405; Mount, Steve/0000-0003-2748-8205; Greenberg, Anthony/0000-0003-3296-5811; Costello, James/0000-0003-3158-9682; Pachter, Lior/0000-0002-9164-6231; Ravi Ram, Kristipati/0000-0002-7285-0077; Wang, Jun/0000-0002-8540-8931; Parts, Leopold/0000-0002-2618-670X; Sirota, Marina/0000-0002-7246-6083; Montmayeur, Anna/0000-0002-8132-1716; Eisen, Michael/0000-0002-7528-738X; Clark, Andrew/0000-0001-7159-8511; Daub, Jennifer/0000-0001-6022-563X; Halligan, Daniel/0000-0003-4726-6343; Ponting, Chris/0000-0003-0202-7816; Findeiss, Sven/0000-0002-3311-7745; Wang, Jun/0000-0002-2113-5874; Sackton, Timothy/0000-0003-1673-9216; Hahn, Matthew/0000-0002-5731-8808; Han, Mira/0000-0002-0488-1170; Arguello, J. Roman/0000-0001-7353-6023; Schlenke, Todd/0000-0003-3091-3057; Heger, Andreas/0000-0001-7720-0447; Grabherr, Manfred/0000-0001-8792-6508; , Daisuke/0000-0002-4623-0106; Gotea, Valer/0000-0001-7857-3309; Noor, Mohamed/0000-0002-5400-4408; Falk, Jill/0000-0003-2910-9803; Vilella, Albert/0000-0002-2005-2516; Sturgill, David/0000-0002-7902-3605; Haerty, Wilfried/0000-0003-0111-191X; McKernan, Kevin/0000-0002-3908-1122; Montooth, Kristi/0000-0001-9456-6694; Adryan, Boris/0000-0003-4588-7867; Valente, Vera/0000-0001-8661-6284; Pruitt, Kim/0000-0001-7950-1374; Bradley, Robert/0000-0002-8046-1063; Lin, Chiao-Feng/0000-0002-6177-8807; Hubisz, Melissa/0000-0002-9561-6830; Teichmann, Sarah/0000-0002-6294-6366; Marzo, Mar/0000-0003-1591-0309	Biotechnology and Biological Sciences Research Council [BB/D015480/1] Funding Source: Medline; Intramural NIH HHS [Z01 DK015600-12] Funding Source: Medline; Medical Research Council [MC_U137761446, MC_U105161047] Funding Source: Medline; NHGRI NIH HHS [R01 HG002779-05, R01 HG004037, R01 HG000747, R01 HG000747-16, R01 HG002779-06] Funding Source: Medline; NICHD NIH HHS [R01 HD038921] Funding Source: Medline; NIGMS NIH HHS [F32 GM067504, R01 GM036431, R01 GM074813-04] Funding Source: Medline; NLM NIH HHS [R01 LM006845-09, R01 LM006845-08, T15 LM007033] Funding Source: Medline; BBSRC [BB/D015480/1] Funding Source: UKRI; MRC [MC_U105161047, MC_U137761446] Funding Source: UKRI; NERC [NE/C003187/1] Funding Source: UKRI; Natural Environment Research Council [NE/C003187/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038921] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000747, R01HG002779, R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036431, F32GM067504, R01GM074813] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Abad JP, 2004, MOL BIOL EVOL, V21, P1620, DOI 10.1093/molbev/msh180; Abad JP, 2004, MOL BIOL EVOL, V21, P1613, DOI 10.1093/molbev/msh174; Adams M., 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Akashi H, 1998, GENETICA, V102-3, P49, DOI 10.1023/A:1017078607465; Akashi H, 2006, GENETICS, V172, P1711, DOI 10.1534/genetics.105.049676; Akashi H, 1997, GENETICS, V146, P295; AKASHI H, 1995, GENETICS, V139, P1067; Akashi H, 1996, GENETICS, V144, P1297; Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Amrein H, 1997, CELL, V88, P459, DOI 10.1016/S0092-8674(00)81886-3; ANDERSON CL, 1993, MOL BIOL EVOL, V10, P605; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Arguello JR, 2006, PLOS GENET, V2, P745, DOI 10.1371/journal.pgen.0020077; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballard JWO, 2000, MOL BIOL EVOL, V17, P1126, DOI 10.1093/oxfordjournals.molbev.a026394; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Begun DJ, 2006, GENETICS, V172, P1675, DOI 10.1534/genetics.105.050336; Begun DJ, 2001, MOL BIOL EVOL, V18, P1343, DOI 10.1093/oxfordjournals.molbev.a003918; Bergman C. M., 2002, GENOME BIOL, V3; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; BHUTKAR A, IN PRESS GENOME RES; BHUTKAR A, IN PRESS GENOME BIOL; Bhutkar Arjun, 2006, Genome Inform, V17, P152; Bierne N, 2004, MOL BIOL EVOL, V21, P1350, DOI 10.1093/molbev/msh134; Bird CP, 2006, CURR OPIN GENET DEV, V16, P559, DOI 10.1016/j.gde.2006.10.003; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; BLACKBURN EH, 1992, ANNU REV BIOCHEM, V61, P113, DOI 10.1146/annurev.bi.61.070192.000553; BOSCO G, IN PRESS GENETICS, DOI DOI 10.1534/GENETICS107.075069; BULMER M, 1991, GENETICS, V129, P897; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Casola C, 2007, MOL BIOL EVOL, V24, P1872, DOI 10.1093/molbev/msm116; Castellano S, 2001, EMBO REP, V2, P697, DOI 10.1093/embo-reports/kve151; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Chatterji S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r29; Civetta A, 1995, J MOL EVOL, V41, P1085, DOI 10.1007/BF00173190; Civetta A, 2003, GENOME, V46, P925, DOI 10.1139/G03-109; Clark NL, 2006, REPRODUCTION, V131, P11, DOI 10.1530/rep.1.00357; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Deng XX, 2006, TRENDS BIOCHEM SCI, V31, P526, DOI 10.1016/j.tibs.2006.07.007; Down TA, 2007, PLOS COMPUT BIOL, V3, P95, DOI 10.1371/journal.pcbi.0030007; DOWSETT AP, 1982, P NATL ACAD SCI-BIOL, V79, P4570, DOI 10.1073/pnas.79.15.4570; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; DuMont VB, 2004, GENETICS, V167, P171, DOI 10.1534/genetics.167.1.171; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gallo SM, 2006, BIOINFORMATICS, V22, P381, DOI 10.1093/bioinformatics/bti794; GARDINER A, UNPUB GENOME BIOL; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gordo I, 2001, CURR BIOL, V11, pR684, DOI 10.1016/S0960-9822(01)00408-0; Gross SS, 2006, J COMPUT BIOL, V13, P379, DOI 10.1089/cmb.2006.13.379; GROSS SS, 2005, BIOM COMP STANF S P, P82; GUIGO R, 1992, J MOL BIOL, V226, P141, DOI 10.1016/0022-2836(92)90130-C; HAERTY W, IN PRESS GENETICS; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Harrison PM, 2003, NUCLEIC ACIDS RES, V31, P1033, DOI 10.1093/nar/gkg169; HEGER A, IN PRESS GENETICS; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUNTLEY MA, IN PRESS MOL BIOL EV; Kapitonov V.V., 1999, DNAREP1 DM REPBASE U; Kapitonov VV, 2003, P NATL ACAD SCI USA, V100, P6569, DOI 10.1073/pnas.0732024100; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LARRACUENTE AM, UNPUB TRENDS GENET; Larsson J, 2006, CHROMOSOME RES, V14, P417, DOI 10.1007/s10577-006-1064-3; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li RQ, 2005, PLOS COMPUT BIOL, V1, P313, DOI 10.1371/journal.pcbi.0010043; LOW WL, IN PRESS GENETICS; LU J, UNPUB MOL BIOL EVOL; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Markow TA, 2007, GENETICS, V177, P1269, DOI 10.1534/genetics.107.074112; Martin-Romero FJ, 2001, J BIOL CHEM, V276, P29798, DOI 10.1074/jbc.M100422200; MARZO M, UNPUB P NATL ACAD SC; McBride CS, 2007, P NATL ACAD SCI USA, V104, P4996, DOI 10.1073/pnas.0608424104; McVean GAT, 1999, J MOL EVOL, V49, P63, DOI 10.1007/PL00006535; McVean GAT, 1999, GENET RES, V74, P145, DOI 10.1017/S0016672399003912; MONTOOTH KL, UNPUB MOL BIOL EVOL; Mount SM, 2007, RNA, V13, P5, DOI 10.1261/rna.259207; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Negre B, 2003, MOL BIOL EVOL, V20, P2042, DOI 10.1093/molbev/msg238; Negre B, 2007, TRENDS GENET, V23, P55, DOI 10.1016/j.tig.2006.12.001; Nielsen R, 2007, MOL BIOL EVOL, V24, P228, DOI 10.1093/molbev/msl146; Noor MAF, 2007, GENETICS, V177, P1417, DOI 10.1534/genetics.107.070672; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Pal C, 2001, GENETICS, V158, P927; PARK SW, IN PRESS GENETICS; Parsch J, 2000, GENETICS, V154, P909; POLALRD DA, 2006, PLOS GENET, V2, pE173; Ponce R, 2006, GENE, V376, P174, DOI 10.1016/j.gene.2006.02.011; Powell J. R., 1997, PROGR PROSPECTS EVOL; Power IL, 2003, AGROFOREST SYST, V57, P225, DOI 10.1023/A:1024838311287; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranz JM, 2007, PLOS BIOL, V5, P1366, DOI 10.1371/journal.pbio.0050152; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Riddle NC, 2006, CHROMOSOME RES, V14, P405, DOI 10.1007/s10577-006-1061-6; Rocha EPC, 2006, TRENDS GENET, V22, P412, DOI 10.1016/j.tig.2006.06.004; Rodriguez-Trelles F, 2000, J MOL EVOL, V50, P1; Rodriguez-Trelles F, 1999, GENETICS, V153, P339; Rodriguez-Trelles F, 2000, MOL BIOL EVOL, V17, P1710, DOI 10.1093/oxfordjournals.molbev.a026269; SACKTON TB, UNPUB NATURE GENET; Salzberg SL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r23; Sawyer SA, 2003, J MOL EVOL, V57, pS154, DOI 10.1007/s00239-003-0022-3; Sawyer SA, 2007, P NATL ACAD SCI USA, V104, P6504, DOI 10.1073/pnas.0701572104; Schlenke TA, 2003, GENETICS, V164, P1471; Schneider C, 2004, P NATL ACAD SCI USA, V101, P9584, DOI 10.1073/pnas.0403400101; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; Singh ND, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-37; Singh ND, 2005, GENETICS, V169, P709, DOI 10.1534/genetics.104.032250; SINGH ND, UNPUB MOL BIOL EVOL; SINGH NS, IN PRESS MOL BIOL EV, DOI DOI 10.1093/MOBEV.MSM196; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smith CD, 2007, GENE, V389, P1, DOI 10.1016/j.gene.2006.09.011; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; SOUVOROV A, 2006, 043272 NIH; STAGE DE, IN PRESS GENOME RES; Stephan W, 1996, GENETICS, V144, P419; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; VICARIO S, UNPUB BMC EVOL BIOL; Vieira FG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r235; VILLASANTE A, IN PRESS GENOME RES; VonAllmen G, 1996, NATURE, V380, P116, DOI 10.1038/380116a0; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Welch JJ, 2006, GENETICS, V173, P821, DOI 10.1534/genetics.106.056911; Wilder J, 2001, MOL BIOL EVOL, V18, P384, DOI 10.1093/oxfordjournals.molbev.a003814; Wittkopp PJ, 2006, HEREDITY, V97, P139, DOI 10.1038/sj.hdy.6800869; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; YANG HP, UNPUB GENOME BIOL; Yang HP, 2006, GENETICS, V173, P189, DOI 10.1534/genetics.105.051714; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; ZIMIN AV, IN PRESS BIOINFORMAT	151	1481	3783	19	522	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					203	218		10.1038/nature06341	http://dx.doi.org/10.1038/nature06341			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994087	Bronze, Green Published			2022-12-28	WOS:000250746200042
J	Lis, JT				Lis, John T.			Imaging Drosophila gene activation and polymerase pausing in vivo	NATURE			English	Review							HEAT-SHOCK; P-TEFB; TRANSCRIPTION ELONGATION; LIVING CELLS; HUMAN GENOME; HSP70 GENE; PROMOTER; MELANOGASTER; PROTEIN; INVIVO	Since the early 1960s, imaging studies of Drosophila sp. polytene chromosomes have provided unique views of gene transcription in vivo. The dramatic changes in chromatin structure that accompany gene activation can be visualized as chromosome puffs. Now, live-cell imaging techniques coupled with protein-DNA crosslinking assays on a genome-wide scale allow more detailed mechanistic questions to be addressed and are prompting the re-evaluation of models of transcription regulation in both Drosophila and mammals.	Cornell Univ, Ithaca, NY 14853 USA	Cornell University	Lis, JT (corresponding author), Cornell Univ, 416 Biotechnol Bldg, Ithaca, NY 14853 USA.	jtl10@cornell.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025232] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM025232-31, R01 GM025232] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Albert T, 1997, MOL CELL BIOL, V17, P4363, DOI 10.1128/MCB.17.8.4363; Ashburner M, 1972, Results Probl Cell Differ, V4, P101; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; GARIGLIO P, 1981, NUCLEIC ACIDS RES, V9, P2589, DOI 10.1093/nar/9.11.2589; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; GILMOUR DS, 1985, MOL CELL BIOL, V5, P2009, DOI 10.1128/MCB.5.8.2009; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hager GL, 2002, CURR OPIN GENET DEV, V12, P137, DOI 10.1016/S0959-437X(02)00278-2; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Lis JT, 2000, GENE DEV, V14, P792; MATHOG D, 1984, NATURE, V308, P414, DOI 10.1038/308414a0; MUSE, IN PRESS NATURE GENE, P17002; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SILVER LM, 1978, CHROMOSOMA, V68, P101, DOI 10.1007/BF00287143; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Wang YV, 2005, MOL CELL BIOL, V25, P3543, DOI 10.1128/MCB.25.9.3543-3552.2005; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; ZEITLINGER J, IN PRESS NATURE GENE, P17002; Zhang ZQ, 2007, GENE DEV, V21, P1609, DOI 10.1101/gad.1542707; Zhu WY, 2007, NUCLEIC ACIDS RES, V35, P4064, DOI 10.1093/nar/gkm430	40	55	56	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					198	202		10.1038/nature06324	http://dx.doi.org/10.1038/nature06324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994086	Bronze			2022-12-28	WOS:000250746200041
J	Alley, DE; Chang, VW				Alley, Dawn E.; Chang, Virginia W.			The changing relationship of obesity and disability, 1988-2004	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS-INDEX; UNITED-STATES; RECENT TRENDS; RISK-FACTORS; PREVALENCE; OVERWEIGHT; AGE; DISEASE; HEALTH; POPULATION	Context Recent studies suggest that the obese population may have been growing healthier since the 1960s, as indicated by a decrease in mortality and cardiovascular risk factors. However, whether these improvements have conferred decreased risk for disability is unknown. The obese population may be living longer with better-controlled risk factors but paradoxically experiencing more disability. Objective To determine whether the association between obesity and disability has changed over time. Design, Setting, and Participants Adults aged 60 years and older (N = 9928) with measured body mass index from 2 waves of the nationally representative National Health and Nutrition Examination Surveys (NHANES III [1988-1994] and NHANES 19992004). Main Outcome Measures Reports of much difficulty or inability to perform tasks in 2 disability domains: functional limitations (walking one-fourth mile, walking up 10 steps, stooping, lifting 10 lb, walking between rooms, and standing from an armless chair) and activities of daily living (ADL) limitations (transferring, eating, and dressing). Results Among obese individuals, the prevalence of functional impairment increased 5.4% (from 36.8%-42.2%; P = .03) between the 2 surveys, and ADL impairment did not change. At time 1 (1988-1994), the odds of functional impairment for obese individuals were 1.78 times greater than for normal-weight individuals (95% confidence interval [CI], 1.47-2.16). At time 2 (1999-2004), this odds ratio increased to 2.75 (95% CI, 2.39-3.17), because the odds of functional impairment increased by 43% (OR 1.43; 95% CI, 1.18-1.75) among obese individuals during this period, but did not change among nonobese individuals. With respect to ADL impairment, odds for obese individuals were not significantly greater than for individuals with normal weight (OR, 1.31; 95% CI, 0.92-1.88) at time 1, but increased to 2.05 (95% CI, 1.45-2.88) at time 2. This was because the odds of ADL impairment did not change for obese individuals but decreased by 34% among nonobese individuals (OR, 0.66; 95% CI, 0.50-0.88). Conclusions Recent cardiovascular improvements have not been accompanied by reduced disability within the obese older population. Rather, obese participants surveyed during 1999-2004 were more likely to report functional impairments than obese participants surveyed during 1988-1994, and reductions in ADL impairment observed for nonobese older individuals did not occur in those who were obese. Over time, declines in obesity-related mortality, along with a younger age at onset of obesity, could lead to an increased burden of disability within the obese older population.	Univ Penn, Robert Wood Johnson Hlth & Soc Scholars Program, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia Vet Affairs Med Ctr, Dept Med,Sch Med, Dept Sociol, Philadelphia, PA 19104 USA	Robert Wood Johnson Foundation (RWJF); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Alley, DE (corresponding author), Univ Penn, Robert Wood Johnson Hlth & Soc Scholars Program, 3641 Locust Walk,Ste 302, Philadelphia, PA 19104 USA.	alley@wharton.upenn.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043459] Funding Source: NIH RePORTER; NICHD NIH HHS [K12-HD043459] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Callahan D, 1999, JAMA-J AM MED ASSOC, V282, P2077, DOI 10.1001/jama.282.21.2077; Calle EE, 2005, NEW ENGL J MED, V353, P2197, DOI 10.1056/NEJM200511173532020; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Doshi JA, 2007, HEALTH AFFAIR, V26, P1111, DOI 10.1377/hlthaff.26.4.1111; Ferraro KF, 2002, AM J PUBLIC HEALTH, V92, P834, DOI 10.2105/AJPH.92.5.834; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Freedman VA, 1999, DEMOGRAPHY, V36, P461, DOI 10.2307/2648084; Freedman VA, 2004, DEMOGRAPHY, V41, P417, DOI 10.1353/dem.2004.0022; Freedman VA, 2003, HEALTH AFFAIR, V22, P154, DOI 10.1377/hlthaff.22.4.154; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Fried TR, 2001, ARCH INTERN MED, V161, P2602, DOI 10.1001/archinte.161.21.2602; GELMAN A, 2007, DATA ANAL USING REGR, P533; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Himes CL, 2000, DEMOGRAPHY, V37, P73, DOI 10.2307/2648097; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P94, DOI DOI 10.1001/JAMA.1963.03060120024016; Kramarow E, 2007, HEALTH AFFAIR, V26, P1417, DOI 10.1377/hlthaff.26.5.1417; Krauss R M, 1998, Circulation, V98, P1472; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Manton KG, 2001, P NATL ACAD SCI USA, V98, P6354, DOI 10.1073/pnas.111152298; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Preston SH, 2005, NEW ENGL J MED, V352, P1135, DOI 10.1056/NEJMe058009; Reynolds SL, 2005, GERONTOLOGIST, V45, P438, DOI 10.1093/geront/45.4.438; Schoeni RF, 2001, J GERONTOL B-PSYCHOL, V56, pS206, DOI 10.1093/geronb/56.4.S206; Sturm R, 2004, HEALTH AFFAIR, V23, P199, DOI 10.1377/hlthaff.23.2.199; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1	32	317	319	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2007	298	17					2020	2027		10.1001/jama.298.17.2020	http://dx.doi.org/10.1001/jama.298.17.2020			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228GP	17986695	Bronze			2022-12-28	WOS:000250718200022
J	Wilt, TJ; Niewoehner, D; MacDonald, R; Kane, RL				Wilt, Timothy J.; Niewoehner, Dennis; MacDonald, Roderick; Kane, Robert L.			Management of stable chronic obstructive pulmonary disease: A systematic review for a clinical practice guideline	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; INHALED ANTICHOLINERGIC BRONCHODILATOR; RESPIRATORY HEALTH WORKER; VIOZAN(TM) SIBENADET HCL; FORMOTEROL DRY POWDER; CHRONIC LUNG-DISEASE; FLUTICASONE PROPIONATE; SELF-MANAGEMENT; COPD PATIENTS	Background: Chronic obstructive pulmonary disease (COPD) is a common and disabling condition in adults. Information about therapeutic effectiveness and adverse effects of common treatment options and how clinical and spirometric characteristics affect outcomes is not well known but is important for clinicians caring for patients with stable COPD. Purpose: To evaluate the effectiveness of COPD management strategies. Data Sources: English-language publications in MEDLINE and the Cochrane Library through March 2007. Study Selection: Randomized, controlled trials (RCTs) and previous systematic reviews of inhaled therapies, pulmonary rehabilitation, disease management, and supplemental oxygen in adults with COPD. Data Extraction: Participant, study, and intervention characteristics; exacerbations; deaths; respiratory health status; exercise capacity; hospitalizations; and adverse effects. Data Synthesis: Eight meta-analyses and 42 RCTs examined inhaled therapies: short-acting anticholinergics (n = 7), long-acting anticholinergics (n = 10), long-acting beta(2)-agonists (n = 22), corticosteroids (n = 14), dual D-2 dopamine receptor-beta(2)-agonist (n = 3), or short-acting beta(2)-agonist plus ipratropium (n = 3). Evidence for nonpharmacologic therapies included 3 reviews of 39 RCTs plus 6 additional RCTs of pulmonary rehabilitation, 2 reviews of 13 RCTs plus 2 additional RCTs of disease management, and 8 RCTs of oxygen. Overall, long-acting inhaled therapies, used alone or in combination, reduced exacerbations more than placebo by 13% to 25% and had similar effectiveness to each other. Average improvements in health status scores were less than what is considered to be clinically noticeable. Inhaled monotherapy did not reduce mortality rates. Inhaled corticosteroids plus long-acting beta(2)-agonists reduced deaths in relative terms compared with placebo (relative risk, 0.82 [95% CI, 0.69 to 0.98]) and inhaled corticosteroids alone (relative risk, 0.79 [CI, 0.67 to 0.94]) but not compared with long-acting beta(2)-agonists alone (relative risk, 0.82 [CI, 0.52 to 1.28]). Absolute reductions were 1% or less and were not statistically significant. Pulmonary rehabilitation improved health status and dyspnea but not walking distance. Neither disease management nor ambulatory oxygen improved measured outcomes. Supplemental oxygen reduced mortality rates among symptomatic patients with resting hypoxia (relative risk, 0.61 [CI, 0.46 to 0.82]). Insufficient evidence supports using spirometry to guide therapy. Limitations: Articles were limited to those in the English language. Treatment adherence, adverse effects, and effectiveness may differ among clinical settings. Short-acting inhalers for "rescue therapy" were not evaluated. Conclusion: Long-acting inhaled therapies, supplemental oxygen, and pulmonary rehabilitation are beneficial in adults who have bothersome respiratory symptoms, especially dyspnea, and FEV1 less than 60% predicted.	Vet Affairs Med Ctr 111 0, Minneapolis, MN 55417 USA		Wilt, TJ (corresponding author), Vet Affairs Med Ctr 111 0, Minneapolis, MN 55417 USA.	tim.wilt@med.va.gov			PHS HHS [290-02-0009] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aalbers R, 2002, EUR RESPIR J, V19, P936, DOI 10.1183/09031936.02.00240902; Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; Altose MD, 2000, NEW ENGL J MED, V343, P1902; [Anonymous], 1980, Ann Intern Med, V93, P391; [Anonymous], 2006, GLOB STRAT DIAGN MAN; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Auerbach D, 1997, CHEST, V112, P1514; Barr RG, 2006, THORAX, V61, P854, DOI 10.1136/thx.2006.063271; Beckerman M, 2005, CHEST, V128, P3177, DOI 10.1378/chest.128.5.3177; Behnke M, 2003, Monaldi Arch Chest Dis, V59, P44; Behnke M, 2000, RESP MED, V94, P1184, DOI 10.1053/rmed.2000.0949; Bendstrup KE, 1997, EUR RESPIR J, V10, P2801, DOI 10.1183/09031936.97.10122801; BERGNER M, 1988, MED CARE, V26, P566, DOI 10.1097/00005650-198806000-00005; BONE R, 1994, CHEST, V105, P1411; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Boyd G, 1997, EUR RESPIR J, V10, P815; Briggs DD, 2005, PULM PHARMACOL THER, V18, P397, DOI 10.1016/j.pupt.2005.02.013; Brusasco V, 2003, THORAX, V58, P399, DOI 10.1136/thorax.58.5.399; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Campbell M, 2005, RESP MED, V99, P1511, DOI 10.1016/j.rmed.2005.08.016; Carrieri-Kohlman Virginia, 2005, J Cardiopulm Rehabil, V25, P275, DOI 10.1097/00008483-200509000-00009; Casaburi R, 2005, CHEST, V127, P809, DOI 10.1378/chest.127.3.809; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Celli B, 2003, RESP MED, V97, pS35, DOI 10.1016/S0954-6111(03)80013-6; Chaouat A, 1999, EUR RESPIR J, V14, P1002, DOI 10.1183/09031936.99.14510029; Chapman Kenneth R, 2002, Can Respir J, V9, P178; COCKCROFT A, 1987, BRIT MED J, V294, P225, DOI 10.1136/bmj.294.6566.225; Dahl R, 2001, AM J RESP CRIT CARE, V164, P778, DOI 10.1164/ajrccm.164.5.2007006; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Donohue JF, 2002, CHEST, V122, P47, DOI 10.1378/chest.122.1.47; Dusser D, 2006, EUR RESPIR J, V27, P547, DOI 10.1183/09031936.06.00062705; Eaton T, 2006, EUR RESPIR J, V27, P697, DOI 10.1183/09031936.06.00098805; Eaton T, 2002, EUR RESPIR J, V20, P306, DOI 10.1183/09031936.02.00301002; Ebell MH, 2004, J AM BOARD FAM PRACT, V17, P59, DOI 10.3122/jabfm.17.1.59; Egan Elizabeth, 2002, Lippincotts Case Manag, V7, P170, DOI 10.1097/00129234-200209000-00002; Engstrom CP, 1999, SCAND J REHABIL MED, V31, P207; Farrero E, 2001, CHEST, V119, P364, DOI 10.1378/chest.119.2.364; Finnerty JP, 2001, CHEST, V119, P1705, DOI 10.1378/chest.119.6.1705; FLENLEY DC, 1981, LANCET, V1, P681; Gallefoss F, 2000, RESP MED, V94, P279, DOI 10.1053/rmed.1999.0749; GOLDSTEIN RS, 1994, LANCET, V344, P1394, DOI 10.1016/S0140-6736(94)90568-1; Gorecka D, 1997, THORAX, V52, P674, DOI 10.1136/thx.52.8.674; Griffiths TL, 2000, LANCET, V355, P362, DOI 10.1016/S0140-6736(99)07042-7; Guell R, 2006, CHEST, V129, P899, DOI 10.1378/chest.129.4.899; Guell R, 2000, CHEST, V117, P976, DOI 10.1378/chest.117.4.976; Hanania NA, 2003, CHEST, V124, P834, DOI 10.1378/chest.124.3.834; Hermiz O, 2002, BRIT MED J, V325, P938, DOI 10.1136/bmj.325.7370.938; Hernandez MTE, 2000, CHEST, V118, P106, DOI 10.1378/chest.118.1.106; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Highland KB, 2003, ANN INTERN MED, V138, P969, DOI 10.7326/0003-4819-138-12-200306170-00008; Hill K, 2006, EUR RESPIR J, V27, P1119, DOI 10.1183/09031936.06.00105205; Hiller FC, 2003, RESP MED, V97, pS45, DOI 10.1016/S0954-6111(03)90060-6; Jones PW, 1997, AM J RESP CRIT CARE, V155, P1283, DOI 10.1164/ajrccm.155.4.9105068; Jones PW, 2001, THORAX, V56, P880, DOI 10.1136/thorax.56.11.880; Kardos P, 2007, AM J RESP CRIT CARE, V175, P144, DOI 10.1164/rccm.200602-244OC; Kirsten DK, 1998, RESP MED, V92, P1191, DOI 10.1016/S0954-6111(98)90420-6; Kopper RJH, 2006, CHEST, V129, P886, DOI 10.1378/chest.129.4.886; Lacasse Y, 2005, EUR RESPIR J, V25, P1032, DOI 10.1183/09031936.05.00113504; Lacasse Y, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003793.PUB2; LAKE FR, 1990, CHEST, V97, P1077, DOI 10.1378/chest.97.5.1077; Larson JL, 1999, AM J RESP CRIT CARE, V160, P500, DOI 10.1164/ajrccm.160.2.9804067; Laursen LC, 2003, RESP MED, V97, pS23, DOI 10.1016/S0954-6111(03)90058-8; Lindsay M, 2005, J CLIN PHARM THER, V30, P567, DOI 10.1111/j.1365-2710.2005.00686.x; LITTLEJOHNS P, 1991, THORAX, V46, P559, DOI 10.1136/thx.46.8.559; Mahler DA, 1999, CHEST, V115, P957, DOI 10.1378/chest.115.4.957; Mahler DA, 2002, AM J RESP CRIT CARE, V166, P1084, DOI 10.1164/rccm.2112055; Man WDC, 2004, BMJ-BRIT MED J, V329, P1209, DOI 10.1136/bmj.38258.662720.3A; MCDONALD CF, 1995, AM J RESP CRIT CARE, V152, P1616, DOI 10.1164/ajrccm.152.5.7582304; McGeoch GRB, 2006, RESPIROLOGY, V11, P611, DOI 10.1111/j.1440-1843.2006.00892.x; Monninkhof E, 2003, EUR RESPIR J, V22, P815, DOI 10.1183/09031936.03.00047003; Murphy N, 2005, RESP MED, V99, P1297, DOI 10.1016/j.rmed.2005.02.033; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nannini L., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003794.PUB2; National Heart Lung and Blood Institute, 2007, NIH PUBL; Nava S, 1998, ARCH PHYS MED REHAB, V79, P849, DOI 10.1016/S0003-9993(98)90369-0; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; Paggiaro PL, 1998, LANCET, V351, P773, DOI 10.1016/S0140-6736(97)03471-5; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Puhan MA, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-54; Qaseem A, 2007, ANN INTERN MED, V147, P633, DOI 10.7326/0003-4819-147-9-200711060-00008; Rennard SI, 2001, AM J RESP CRIT CARE, V163, P1087, DOI 10.1164/ajrccm.163.5.9903053; Ries AL, 2003, AM J RESP CRIT CARE, V167, P880, DOI 10.1164/rccm.200204-318OC; Ringbaek TJ, 2000, RESP MED, V94, P150, DOI 10.1053/rmed.1999.0704; Rossi A, 2002, CHEST, V121, P1058, DOI 10.1378/chest.121.4.1058; Salpeter SR, 2006, J GEN INTERN MED, V21, P1011, DOI 10.1111/j.1525-1497.2006.00507.x; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SIMPSON K, 1992, THORAX, V47, P70, DOI 10.1136/thx.47.2.70; Sin DD, 2005, THORAX, V60, P992, DOI 10.1136/thx.2005.045385; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Smith BJ, 1999, AUST NZ J MED, V29, P718, DOI 10.1111/j.1445-5994.1999.tb01621.x; Stockley RA, 2006, THORAX, V61, P122, DOI 10.1136/thx.2004.033266; Stulbarg Michael S, 2002, J Cardiopulm Rehabil, V22, P109, DOI 10.1097/00008483-200203000-00010; Sutherland ER, 2003, THORAX, V58, P937, DOI 10.1136/thorax.58.11.937; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; TASHKIN DP, 1986, AM J MED, V81, P81, DOI 10.1016/0002-9343(86)90468-7; Taylor SJC, 2005, BMJ-BRIT MED J, V331, P485, DOI 10.1136/bmj.38512.664167.8F; Troosters T, 2000, AM J MED, V109, P207, DOI 10.1016/S0002-9343(00)00472-1; van der Valk P, 2002, AM J RESP CRIT CARE, V166, P1358, DOI 10.1164/rccm.200206-512OC; van Noord JA, 2000, THORAX, V55, P289, DOI 10.1136/thorax.55.4.289; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702; Wadbo M, 2002, EUR RESPIR J, V20, P1138, DOI 10.1183/09031936.02.00301702; Watson PB, 1997, EUR RESPIR J, V10, P1267, DOI 10.1183/09031936.97.10061267; Wedzicha JA, 1998, EUR RESPIR J, V12, P363, DOI 10.1183/09031936.98.12020363; Weinberger M, 2002, JAMA-J AM MED ASSOC, V288, P1594, DOI 10.1001/jama.288.13.1594; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; WIJKSTRA PJ, 1994, EUR RESPIR J, V7, P269, DOI 10.1183/09031936.94.07020269; Wood-Baker R, 2006, RESPIROLOGY, V11, P619, DOI 10.1111/j.1440-1843.2006.00902.x; Wouters EFM, 2005, THORAX, V60, P480, DOI 10.1136/thx.2004.034280	113	85	87	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2007	147	9					639	653		10.7326/0003-4819-147-9-200711060-00009	http://dx.doi.org/10.7326/0003-4819-147-9-200711060-00009			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227QM	17975187				2022-12-28	WOS:000250672900007
J	Koebel, CM; Vermi, W; Swann, JB; Zerafa, N; Rodig, SJ; Old, LJ; Smyth, MJ; Schreiber, RD				Koebel, Catherine M.; Vermi, William; Swann, Jeremy B.; Zerafa, Nadeen; Rodig, Scott J.; Old, Lloyd J.; Smyth, Mark J.; Schreiber, Robert D.			Adaptive immunity maintains occult cancer in an equilibrium state	NATURE			English	Article							INTERFERON-GAMMA; MONOCLONAL-ANTIBODIES; TUMOR IMMUNOGENICITY; CELLS; IMMUNOSURVEILLANCE; NK; LYMPHOCYTES; ACTIVATION; EXPRESSION; LYMPHOMA	The capacity of immunity to control and shape cancer, that is, cancer immunoediting, is the result of three processes(1-8) that function either independently or in sequence(9): elimination ( cancer immunosurveillance, in which immunity functions as an extrinsic tumour suppressor in naive hosts); equilibrium ( expansion of transformed cells is held in check by immunity); and escape ( tumour cell variants with dampened immunogenicity or the capacity to attenuate immune responses grow into clinically apparent cancers). Extensive experimental support now exists for the elimination and escape processes because immunodeficient mice develop more carcinogen-induced and spontaneous cancers than wild-type mice, and tumour cells from immunodeficient mice are more immunogenic than those from immunocompetent mice. In contrast, the equilibrium process was inferred largely from clinical observations, including reports of transplantation of undetected ( occult) cancer from organ donor into immuno-suppressed recipients(10). Herein we use a mouse model of primary chemical carcinogenesis and demonstrate that equilibrium occurs, is mechanistically distinguishable from elimination and escape, and that neoplastic cells in equilibrium are transformed but proliferate poorly in vivo. We also show that tumour cells in equilibrium are unedited but become edited when they spontaneously escape immune control and grow into clinically apparent tumours. These results reveal that, in addition to destroying tumour cells and sculpting tumour immunogenicity, the immune system of a naive mouse can also restrain cancer growth for extended time periods.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Univ Brescia, Spedali Civili, Dept Pathol, I-25123 Brescia, Italy; Peter MacCallum Canc Ctr, Canc Immunol Program, Sir Donald & Lady Trescowthick Labs, Melbourne, Vic 3002, Australia; Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York, NY 10021 USA	Washington University (WUSTL); Hospital Spedali Civili Brescia; University of Brescia; Peter Maccallum Cancer Center; University of Melbourne; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mark.smyth@petermac.org; schreiber@immunology.wustl.edu	Rodig, Scott/Y-3889-2019; Schreiber, Robert/Q-7550-2019; Smyth, Mark J/H-8709-2014; Schreiber, Robert D/A-1276-2013	Smyth, Mark J/0000-0001-7098-7240; Schreiber, Robert D/0000-0001-6311-0432; Schreiber, Robert/0000-0003-1590-2341; VERMI, WILLIAM/0000-0002-2291-2997				Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ho EL, 2002, J IMMUNOL, V169, P3667, DOI 10.4049/jimmunol.169.7.3667; Kayagaki N, 1999, J IMMUNOL, V163, P1906; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; MacKie RM, 2003, NEW ENGL J MED, V348, P567, DOI 10.1056/NEJM200302063480620; Mutter GL, 2001, CANCER RES, V61, P4311; Ohtani Haruo, 2007, Cancer Immun, V7, P4; Qin ZH, 2002, J EXP MED, V195, P1479, DOI 10.1084/jem.20011887; Sakr WA, 2001, UROLOGY, V57, P115, DOI 10.1016/S0090-4295(00)00953-5; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; SIU H, 1986, J IMMUNOL, V137, P1376; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Smyth MJ, 2004, J EXP MED, V200, P1325, DOI 10.1084/jem.20041522; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; WEINHOLD KJ, 1977, NATURE, V270, P59, DOI 10.1038/270059a0; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; WYSOCKA M, 1995, EUR J IMMUNOL, V25, P672, DOI 10.1002/eji.1830250307	32	975	1011	6	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					903	U24		10.1038/nature06309	http://dx.doi.org/10.1038/nature06309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18026089				2022-12-28	WOS:000251394900061
J	Daar, AS; Singer, PA; Persad, DL; Pramming, SK; Matthews, DR; Beaglehole, R; Bernstein, A; Borysiewicz, LK; Colagiuri, S; Ganguly, N; Glass, RI; Finegood, DT; Koplan, J; Nabel, EG; Sarna, G; Sarrafzadegan, N; Smith, R; Yach, D; Bell, J				Daar, Abdallah S.; Singer, Peter A.; Persad, Deepa Leah; Pramming, Stig K.; Matthews, David R.; Beaglehole, Robert; Bernstein, Alan; Borysiewicz, Leszek K.; Colagiuri, Stephen; Ganguly, Nirmal; Glass, Roger I.; Finegood, Diane T.; Koplan, Jeffrey; Nabel, Elizabeth G.; Sarna, George; Sarrafzadegan, Nizal; Smith, Richard; Yach, Derek; Bell, John			Grand challenges in chronic non-communicable diseases	NATURE			English	Article							HEALTH		Univ Toronto, Univ Hlth Network, Program Life Sci Eth & Policy, Toronto, ON M5G 1L7, Canada; Oxford Hlth Alliance, London W1W 8RZ, England; Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Univ Auckland, Fac Med & Hlth Sci, Auckland 1142, New Zealand; Canadian Inst Hlth Res, Ottawa, ON K1A 0W9, Canada; MRC, London W1B 1AL, England; Univ Sydney, Prince Wales Hosp, Ctr Diabet, Randwick, NSW 2031, Australia; Univ Sydney, Prince Wales Hosp, Dept Diabet Endocrinol & Metab, Randwick, NSW 2031, Australia; Indian Council Med Res, New Delhi 110029, India; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; Canadian Inst Hlth Res, Inst Nutr Metab & Diabet, Ottawa, ON K1A 0W9, Canada; Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA; NHLBI, NIH, Bethesda, MD 20892 USA; Isfahan Univ Med Sci, Seddigheh Tahereh Res & Treatment Hosp, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; Unitedhlth Europe, Ovat Chron Dis Initiat, London SW1P 1SB, England; PepsiCo, Purchase, NY 10577 USA; Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Oxford; University of Auckland; Institute for Work & Health; University of Sydney; University of Sydney; Indian Council of Medical Research (ICMR); National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Institute for Work & Health; Emory University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Isfahan University Medical Science; PepsiCo; University of Oxford	Daar, AS (corresponding author), Univ Toronto, Univ Hlth Network, Program Life Sci Eth & Policy, 101 Coll St, Toronto, ON M5G 1L7, Canada.		Sarrafzadegan, Nizal/V-5826-2017	Sarrafzadegan, Nizal/0000-0002-8352-0540; Colagiuri, Stephen/0000-0002-2398-4781	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200334] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2007, LANCET, V370, P630; [Anonymous], 2005, PREV CHRON DIS VIT I; Berndtson K, 2007, PLOS MED, V4, P1445, DOI 10.1371/journal.pmed.0040268; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Hilbert D., 1902, B AM MATH SOC, V8, P437, DOI [DOI 10.1090/S0002-9904-1902-00923-3, 10.1090/S0002-9904-1902-00923-3]; Jamison DT, 2006, PRIORITIES HLTH; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MARTIN BR, 1995, TECHNOL ANAL STRATEG, V7, P139, DOI 10.1080/09537329508524202; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Rowe G, 2001, INT SER OPER RES MAN, V30, P125, DOI 10.1007/978-0-306-47630-3_7; Singer PA, 2007, NATURE, V449, P160, DOI 10.1038/449160a; Suhrcke M., 2006, CHRONIC DIS EC PERSP; *UNAIDS AIDS EP UP, 2006, SPEC REP HIV AIDS; Varmus H, 2003, SCIENCE, V302, P398, DOI 10.1126/science.1091769	16	450	461	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					494	496		10.1038/450494a	http://dx.doi.org/10.1038/450494a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033288				2022-12-28	WOS:000251158500032
J	Wang, R; Lagakos, SW; Ware, JH; Hunter, DJ; Drazen, JM				Wang, Rui; Lagakos, Stephen W.; Ware, James H.; Hunter, David J.; Drazen, Jeffrey M.			Statistics in medicine - Reporting of subgroup analyses in clinical trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PATIENT SUBSETS; RISKS						Drazen, Jeffrey M/E-5841-2012; Wang, Rui/X-1699-2019	Wang, Rui/0000-0001-5007-193X; Drazen, Jeffrey/0000-0003-2715-9890				Al-Marzouki S, 2005, CONTEMP CLIN TRIALS, V26, P331, DOI 10.1016/j.cct.2005.01.011; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Bailar JC., 1992, MED USES STAT; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Cuzick J, 2005, LANCET, V365, P1308, DOI 10.1016/S0140-6736(05)61026-4; GAIL M, 1985, BIOMETRICS, V41, P361, DOI 10.2307/2530862; HALPERIN M, 1977, BIOMETRIKA, V64, P271; Hernandez AV, 2006, AM HEART J, V151, P257, DOI 10.1016/j.ahj.2005.04.020; *ICH, 1998, GUID IND E9 STAT PRI; Jackson RD, 2006, NEW ENGL J MED, V354, P1102; Lagakos SW, 2006, NEW ENGL J MED, V354, P1667, DOI 10.1056/NEJMp068070; LAGAKOS SW, 2000, NEW ENGL J MED, V355, P533; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; LONN E, 2006, NEW ENGL J MED, V355, P746; MOHER D, CONSORT STATEMENT RE; Parker AB, 2000, AM HEART J, V139, P952, DOI 10.1067/mhj.2000.106610; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SIMON R, 1982, BRIT J CLIN PHARMACO, V14, P473, DOI 10.1111/j.1365-2125.1982.tb02015.x; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	24	934	945	3	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2189	2194		10.1056/NEJMsr077003	http://dx.doi.org/10.1056/NEJMsr077003			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	18032770				2022-12-28	WOS:000251076500014
J	Goldacre, B				Goldacre, Ben			Benefits and risks of homoeopathy	LANCET			English	Editorial Material							CONTROLLED-TRIALS; CLINICAL-TRIALS		The Guardian, London EC1R 3ER, England		Goldacre, B (corresponding author), The Guardian, London EC1R 3ER, England.	ben@badscience.net		Goldacre, Ben/0000-0002-5127-4728				Boissel JP, 1996, CRITICAL LIT REV EFF, V1996, P195; Cucherat M, 2000, EUR J CLIN PHARMACOL, V56, P27, DOI 10.1007/s002280050716; Evans I, 2006, TESTING TREATMENTS B; *GEN MED COUNC FIT, 2007, M VIEGAS; Giles J, 2007, NATURE, V446, P352, DOI 10.1038/446352a; GOLDACRE B, 2007, GUARDIAN        1020; GRICE E, 2005, DAILY TELEGRAPH 1125; HEMPEL S, 2006, MED DETECTIVE; KLEIJNEN J, 1991, BRIT MED J, V302, P316, DOI 10.1136/bmj.302.6772.316; Linde K, 1998, J ALTERN COMPLEM MED, V4, P371, DOI 10.1089/acm.1998.4.371; Schmidt K, 2002, BMJ-BRIT MED J, V325, P597, DOI 10.1136/bmj.325.7364.597; Schmidt K, 2001, BRIT MED J, V323, P1071, DOI 10.1136/bmj.323.7320.1071a; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; Sheldon T, 2007, BRIT MED J, V335, P13, DOI 10.1136/bmj.39262.561134.DB; Spence DS, 2005, J ALTERN COMPLEM MED, V11, P793, DOI 10.1089/acm.2005.11.793	15	27	34	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 17	2007	370	9600					1672	1673		10.1016/S0140-6736(07)61706-1	http://dx.doi.org/10.1016/S0140-6736(07)61706-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	18022024				2022-12-28	WOS:000251091200007
J	Gimelbrant, A; Hutchinson, JN; Thompson, BR; Chess, A				Gimelbrant, Alexander; Hutchinson, John N.; Thompson, Benjamin R.; Chess, Andrew			Widespread monoallelic expression on human autosomes	SCIENCE			English	Article							X-LINKED GENE; ASYNCHRONOUS REPLICATION; INACTIVATION; INTERLEUKIN-2; DUPLICATION; CHROMOSOME; LOCUS; MOUSE; CELLS	Monoallelic expression with random choice between the maternal and paternal alleles defines an unusual class of genes comprising X-inactivated genes and a few autosomal gene families. Using a genome-wide approach, we assessed allele-specific transcription of about 4000 human genes in clonal cell lines and found that more than 300 were subject to random monoallelic expression. For a majority of monoallelic genes, we also observed some clonal lines displaying biallelic expression. Clonal cell lines reflect an independent choice to express the maternal, the paternal, or both alleles for each of these genes. This can lead to differences in expressed protein sequence and to differences in levels of gene expression. Unexpectedly widespread monoallelic expression suggests a mechanism that generates diversity in individual cells and their clonal descendants.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Chess, A (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.	chess@chgr.mgh.harvard.edu	Hutchinson, John/AAA-1976-2020	Hutchinson, John/0000-0002-7804-7576; Gimelbrant, Alexander/0000-0001-6986-0285; Edsall, Lee Elizabeth/0000-0002-0326-2829				Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Boumil RM, 2001, HUM MOL GENET, V10, P2225; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carrel L, 1999, P NATL ACAD SCI USA, V96, P7364, DOI 10.1073/pnas.96.13.7364; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Ensminger AW, 2004, HUM MOL GENET, V13, P651, DOI 10.1093/hmg/ddh062; Gimelbrant AA, 2005, J BIOL CHEM, V280, P1354, DOI 10.1074/jbc.M411283200; Gimelbrant AA, 2006, GENOME RES, V16, P723, DOI 10.1101/gr.5023706; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; LYON MF, 1986, NATURE, V320, P313, DOI 10.1038/320313b0; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; Rouhi A, 2006, J IMMUNOL, V176, P2991, DOI 10.4049/jimmunol.176.5.2991; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199	24	431	437	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1136	1140		10.1126/science.1148910	http://dx.doi.org/10.1126/science.1148910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006746				2022-12-28	WOS:000250957900046
J	Colby, SM; Gwaltney, CJ				Colby, Suzanne M.; Gwaltney, Chad J.			Pharmacotherapy for adolescent smoking cessation - Commentary	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SUSTAINED-RELEASE BUPROPION; NICOTINE PATCH THERAPY; CIGARETTE-SMOKING; CONTROLLED-TRIAL; EFFICACY; SMOKERS; BOYS		Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA; Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA; Brown Univ, Dept Community Hlth, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Colby, SM (corresponding author), Brown Univ, Ctr Alcohol & Addict Studies, Box G-S121-5, Providence, RI 02912 USA.	Suzanne_Colby@brown.edu		/0000-0003-2027-5936	NIDA NIH HHS [R01 DA021677, R01 DA016737] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021677, R01DA016737] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P297; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P724; ARDAY DR, 1995, AM J HEALTH PROMOT, V10, P111, DOI 10.4278/0890-1171-10.2.111; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P490; Gold DR, 1996, NEW ENGL J MED, V335, P931, DOI 10.1056/NEJM199609263351304; Hanson K, 2003, NICOTINE TOB RES, V5, P515, DOI 10.1080/1462220031000118559; Hurt RD, 2000, ARCH PEDIAT ADOL MED, V154, P31; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Killen JD, 2004, J CONSULT CLIN PSYCH, V72, P729, DOI 10.1037/0022-006X.72.4.729; MERMELSTEIN R, 2003, TOBACCO CONTROL S1, V12, P25; MILTON MH, 2004, YUOUTH TOBACCO CESSA; Moolchan ET, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1894; Muramoto ML, 2007, ARCH PEDIAT ADOL MED, V161, P1068, DOI 10.1001/archpedi.161.11.1068; RAPOPORT JL, 1980, ARCH GEN PSYCHIAT, V37, P933; RAVEIS VH, 1987, AM J PUBLIC HEALTH, V77, P607, DOI 10.2105/AJPH.77.5.607; Smith TA, 1996, PEDIATRICS, V98, P659; Stanton WR, 1996, ADDICTION, V91, P1705; Stanton WR, 1996, DRUG ALCOHOL DEPEN, V43, P63, DOI 10.1016/S0376-8716(97)84351-7; *SUBST AB MENT HLT, 2005, RES 2005 NAT SURV DR; Sussman S, 2002, Tob Induc Dis, V1, P35, DOI 10.1186/1617-9625-1-1-35; Upadhyaya HP, 2004, J AM ACAD CHILD PSY, V43, P199, DOI 10.1097/00004583-200402000-00016; *US DEP HHS, 2003, TREAT TOB US DEP CLI; *US DEP HHS, 1994, PREV TOB US YOUNG PE; Zhu SH, 1999, AM J PREV MED, V16, P202, DOI 10.1016/S0749-3797(98)00157-3	24	14	14	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2182	2184		10.1001/jama.298.18.2182	http://dx.doi.org/10.1001/jama.298.18.2182			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230II	18027441				2022-12-28	WOS:000250869800024
J	Bawaskar, HS				Bawaskar, Himmatrao Saluba			Can scorpions be useful?	LANCET			English	Editorial Material							BRUGADA-SYNDROME		Bawaskar Hosp & Res Ctr, Mahad 402301, Maharashtra, India		Bawaskar, HS (corresponding author), Bawaskar Hosp & Res Ctr, Mahad 402301, Maharashtra, India.	himmatbawaskar@rediffmail.com						Bawaskar H S, 2007, J Assoc Physicians India, V55, P14; Gwee MC, 2002, CLIN EXP PHARMACOL P, V29, P795, DOI 10.1046/j.1440-1681.2002.03726.x; Herbert E, 2006, CAN J PHYSIOL PHARM, V84, P795, DOI 10.1139/Y06-038; ISMAIL M, 1995, TOXICON, V33, P825, DOI 10.1016/0041-0101(95)00005-7; Wilde AAM, 2002, CIRCULATION, V106, P2514, DOI 10.1161/01.CIR.0000034169.45752.4A	5	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 10	2007	370	9599					1664	1664		10.1016/S0140-6736(07)61688-2	http://dx.doi.org/10.1016/S0140-6736(07)61688-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230NO	17993366				2022-12-28	WOS:000250883400026
J	Baraldi, E; Filippone, M				Baraldi, Eugenio; Filippone, Marco			Current concepts: Chronic lung disease after premature birth	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SCHOOL-AGE-CHILDREN; BRONCHOPULMONARY DYSPLASIA; PULMONARY-FUNCTION; RESPIRATORY HEALTH; PRETERM BIRTH; FOLLOW-UP; EXERCISE PERFORMANCE; PRESCHOOL-CHILDREN; FLOW LIMITATION; BORN		Univ Padua, Dept Pediat, Sch Med, Unit Resp Med & Allergy, I-35128 Padua, Italy; Univ Padua, Sch Med, Neonatal Intens Care Unit, I-35128 Padua, Italy	University of Padua; University of Padua	Baraldi, E (corresponding author), Univ Padua, Dept Pediat, Sch Med, Unit Resp Med & Allergy, Via Giustiniani 3, I-35128 Padua, Italy.	baraldi@pediatria.unipd.it	baraldi, eugenio/AAC-5233-2022	BARALDI, EUGENIO/0000-0002-1829-3652				ABMAN SH, 2006, DISORDERS RESP TRACT, P342; Allen J, 2003, AM J RESP CRIT CARE, V168, P356, DOI 10.1164/rccm.168.3.356; American Academy of Pediatrics, 2006, RED BOOK 2006 REP CO; Anand D, 2003, ARCH DIS CHILD, V88, P135, DOI 10.1136/adc.88.2.135; Aukland SM, 2006, AM J ROENTGENOL, V187, P1012, DOI 10.2214/AJR.05.0383; Bancalari E, 2006, SEMIN PERINATOL, V30, P164, DOI 10.1053/j.semperi.2006.05.002; Baraldi E, 1997, AM J RESP CRIT CARE, V155, P149, DOI 10.1164/ajrccm.155.1.9001304; Baraldi E, 2005, AM J RESP CRIT CARE, V171, P68, DOI 10.1164/rccm.200403-298Oc; Bhandari V, 2006, PEDIATRICS, V117, P1901, DOI 10.1542/peds.2005-1414; Blackmon LR, 2002, PEDIATRICS, V109, P330; BLAYNEY M, 1991, J PEDIATR-US, V118, P201, DOI 10.1016/S0022-3476(05)80483-4; *CDCP, 2005, BIRTHS FIN DAT 2003; CHAN KN, 1989, ARCH DIS CHILD, V64, P1294, DOI 10.1136/adc.64.9.1294; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; Doyle LW, 2006, PEDIATRICS, V118, P108, DOI 10.1542/peds.2005-2522; Doyle LW, 2006, PEDIATR PULM, V41, P570, DOI 10.1002/ppul.20412; Doyle LW, 2003, PEDIATRICS, V112, P565, DOI 10.1542/peds.112.3.565; Doyle LW, 2001, ARCH DIS CHILD, V84, P40, DOI 10.1136/adc.84.1.40; Dugas MA, 2005, PEDIATRICS, V115, pE566, DOI 10.1542/peds.2004-0951; Eber E, 2001, THORAX, V56, P317, DOI 10.1136/thorax.56.4.317; Filippone M, 2003, LANCET, V361, P753, DOI 10.1016/S0140-6736(03)12633-5; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gappa M, 2003, AM J RESP CRIT CARE, V168, P399, DOI 10.1164/ajrccm.168.3.955; GERHARDT T, 1987, J PEDIATR-US, V110, P448, DOI 10.1016/S0022-3476(87)80516-4; Giacoia GP, 1997, J PEDIATR-US, V130, P400, DOI 10.1016/S0022-3476(97)70231-2; Greenough A, 1996, ACTA PAEDIATR, V85, P772, DOI 10.1111/j.1651-2227.1996.tb14150.x; Gross SJ, 1998, J PEDIATR-US, V133, P188, DOI 10.1016/S0022-3476(98)70219-7; HAKULINEN AL, 1990, PEDIATR PULM, V8, P226, DOI 10.1002/ppul.1950080404; Halvorsen T, 2004, ACTA PAEDIATR, V93, P1294, DOI 10.1080/08035250410028101; Halvorsen T, 2005, PEDIAT ALLERG IMM-UK, V16, P487, DOI 10.1111/j.1399-3038.2005.00314.x; Halvorsen T, 2006, ACTA PAEDIATR, V95, P547, DOI 10.1080/08035250500477529; Hofhuis W, 2002, AM J RESP CRIT CARE, V166, P1539, DOI 10.1164/rccm.2202046; Ireys HT, 1997, PEDIATRICS, V100, P197, DOI 10.1542/peds.100.2.197; Jacob SV, 1997, AM J RESP CRIT CARE, V155, P1925, DOI 10.1164/ajrccm.155.6.9196097; Jobe AH, 2002, AM J RESP CRIT CARE, V166, P1529, DOI 10.1164/rccm.2209012; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Jobe Alan H, 2003, Semin Neonatol, V8, P9, DOI 10.1016/S1084-2756(02)00188-4; Kennedy JD, 2000, PEDIATR PULM, V30, P32, DOI 10.1002/1099-0496(200007)30:1<32::AID-PPUL6>3.0.CO;2-9; Kilbride HW, 2003, J PEDIATR-US, V143, P488, DOI 10.1067/S0022-3476(03)00413-X; Kinsella JP, 2006, LANCET, V367, P1421, DOI 10.1016/S0140-6736(06)68615-7; Korhonen P, 2004, ACTA PAEDIATR, V93, P316, DOI 10.1080/08035250410023593; Koumbourlis AC, 1996, PEDIATR PULM, V21, P28, DOI 10.1002/(SICI)1099-0496(199601)21:1<28::AID-PPUL5>3.0.CO;2-M; Lamarche-Vadel A, 2004, ACTA PAEDIATR, V93, P1340, DOI 10.1080/08035250410032926; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Mitchell SH, 1998, AM J RESP CRIT CARE, V157, P1406, DOI 10.1164/ajrccm.157.5.9605025; Narang I, 2006, PEDIATR PULM, V41, P497, DOI 10.1002/ppul.20385; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Palta M, 2001, AM J EPIDEMIOL, V154, P521, DOI 10.1093/aje/154.6.521; Pantalitschka T, 2006, PEDIATR PULM, V41, P703, DOI 10.1002/ppul.20467; Pelkonen AS, 1997, AM J RESP CRIT CARE, V156, P1178, DOI 10.1164/ajrccm.156.4.9610028; Pelkonen AS, 2001, RESP MED, V95, P565, DOI 10.1053/rmed.2001.1104; Pianosi PT, 2000, PEDIATR RES, V47, P653, DOI 10.1203/00006450-200005000-00016; RONA RJ, 1993, BMJ-BRIT MED J, V306, P817, DOI 10.1136/bmj.306.6881.817; SANTUZ P, 1995, AM J RESP CRIT CARE, V152, P1284, DOI 10.1164/ajrccm.152.4.7551383; Smith VC, 2005, J PEDIATR-US, V146, P469, DOI 10.1016/j.jpeds.2004.12.023; TEPPER RS, 1986, J PEDIATR-US, V109, P1040, DOI 10.1016/S0022-3476(86)80296-7; Vrijlandt EJLE, 2007, J PEDIATR-US, V150, P256, DOI 10.1016/j.jpeds.2006.12.007; Vrijlandt EJLE, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-117; Vrijlandt EJLE, 2006, AM J RESP CRIT CARE, V173, P890, DOI 10.1164/rccm.200507-1140OC; Walsh MC, 2006, PEDIATRICS, V117, pS52, DOI 10.1542/peds.2005-0620I; WEIGAND E, 1993, J ANIM PHYSIOL AN N, V69, P120, DOI 10.1111/j.1439-0396.1993.tb00796.x	62	695	724	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1946	1955		10.1056/NEJMra067279	http://dx.doi.org/10.1056/NEJMra067279			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989387				2022-12-28	WOS:000250732500009
J	Baumgart, DC; Fischer, A				Baumgart, Daniel C.; Fischer, Andreas			Virchow's node	LANCET			English	Editorial Material									Humboldt Univ, Sch Med, Charite Med Ctr,Virchow Hosp, Dept Med,Div Gastroenterol & Hepatol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Baumgart, DC (corresponding author), Humboldt Univ, Sch Med, Charite Med Ctr,Virchow Hosp, Dept Med,Div Gastroenterol & Hepatol, Augustenburger Pl 1, D-13353 Berlin, Germany.	daniel.baumgart@charite.de	Baumgart, Daniel C./AAU-2930-2021; Fischer, Andreas/E-9202-2012	Baumgart, Daniel C./0000-0003-2146-507X; Fischer, Andreas/0000-0002-5968-4262					0	7	7	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 3	2007	370	9598					1568	1568		10.1016/S0140-6736(07)61661-4	http://dx.doi.org/10.1016/S0140-6736(07)61661-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AE	17980735	Bronze			2022-12-28	WOS:000250628800026
J	Rubinstein, JL; La Rocca, M; Vidale, JE; Creager, KC; Wech, AG				Rubinstein, Justin L.; La Rocca, Mario; Vidale, John E.; Creager, Kenneth C.; Wech, Aaron G.			Tidal modulation of nonvolcanic tremor	SCIENCE			English	Article							NON-VOLCANIC TREMOR; EARTH TIDES; EARTHQUAKES; SUBDUCTION; DEPTH	Episodes of nonvolcanic tremor and accompanying slow slip recently have been observed in the subduction zones of Japan and Cascadia. In Cascadia, such episodes typically last a few weeks and differ from "normal" earthquakes in their source location and moment- duration scaling. The three most recent episodes in the Puget Sound/ southern Vancouver Island portion of the Cascadia subduction zone were exceptionally well recorded. In each episode, we saw clear pulsing of tremor activity with periods of 12.4 and 24 to 25 hours, the same as the principal lunar and lunisolar tides. This indicates that the small stresses associated with the solid- earth and ocean tides influence the genesis of tremor much more effectively than they do the genesis of normal earthquakes. Because the lithostatic stresses are 10(5) times larger than those associated with the tides, we argue that tremor occurs on very weak faults.	[Rubinstein, Justin L.; Vidale, John E.; Creager, Kenneth C.; Wech, Aaron G.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [La Rocca, Mario] Osserv Vesuviano, Ist Nazl Geofis & Vulcanol, I-80124 Naples, Italy	University of Washington; University of Washington Seattle; Istituto Nazionale Geofisica e Vulcanologia (INGV)	Rubinstein, JL (corresponding author), Univ Washington, Dept Earth & Space Sci, Box 351310, Seattle, WA 98195 USA.	justin@ess.washington.edu	Vidale, John/H-4965-2011	Vidale, John/0000-0002-3658-818X; La Rocca, Mario/0000-0002-2059-5350; Rubinstein, Justin/0000-0003-1274-6785; Wech, Aaron/0000-0003-4983-1991				Cochran ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026951; Cochran ES, 2004, SCIENCE, V306, P1164, DOI 10.1126/science.1103961; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Emter D, 1997, LECT NOTES EARTH SCI, V66, P293; Gomberg J, 2008, SCIENCE, V319, P173, DOI 10.1126/science.1149164; Houston H, 2001, J GEOPHYS RES-SOL EA, V106, P11137, DOI 10.1029/2000JB900468; Ide S, 2007, NATURE, V447, P76, DOI 10.1038/nature05780; Kao H, 2005, NATURE, V436, P841, DOI 10.1038/nature03903; Kennedy M, 2004, SEISMOL RES LETT, V75, P607, DOI 10.1785/gssrl.75.5.607; MCNUTT M, 1981, CALIF GEOL, V34, P12; MCNUTT SR, 1981, NATURE, V294, P615, DOI 10.1038/294615a0; Miller MM, 2002, SCIENCE, V295, P2423, DOI 10.1126/science.1071193; Miyazawa M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025087; Miyazawa M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022539; MIYAZAWA M, 2007, SEISM SOC JAP 2007 F; Nadeau RM, 2005, SCIENCE, V307, P389, DOI 10.1126/science.1107142; NAKATA R, EOS, V87; Obara K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020848; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Rubinstein JL, 2007, NATURE, V448, P579, DOI 10.1038/nature06017; Shelly DR, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001640; Shelly DR, 2007, NATURE, V446, P305, DOI 10.1038/nature05666; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Stroup DF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030088; Tolstoy M, 2002, GEOLOGY, V30, P503, DOI 10.1130/0091-7613(2002)030<0503:BOTSTC>2.0.CO;2; ULBERG CW, 2007, THESIS CARLETON COLL; Vidale JE, 1998, J GEOPHYS RES-SOL EA, V103, P24567, DOI 10.1029/98JB00594; Wilcock WSD, 2001, GEOPHYS RES LETT, V28, P3999, DOI 10.1029/2001GL013370	28	183	187	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2008	319	5860					186	189		10.1126/science.1150558	http://dx.doi.org/10.1126/science.1150558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18033849				2022-12-28	WOS:000252246400036
J	Dunfield, PF; Yuryev, A; Senin, P; Smirnova, AV; Stott, MB; Hou, SB; Ly, B; Saw, JH; Zhou, ZM; Ren, Y; Wang, JM; Mountain, BW; Crowe, MA; Weatherby, TM; Bodelier, PLE; Liesack, W; Feng, L; Wang, L; Alam, M				Dunfield, Peter F.; Yuryev, Anton; Senin, Pavel; Smirnova, Angela V.; Stott, Matthew B.; Hou, Shaobin; Ly, Binh; Saw, Jimmy H.; Zhou, Zhemin; Ren, Yan; Wang, Jianmei; Mountain, Bruce W.; Crowe, Michelle A.; Weatherby, Tina M.; Bodelier, Paul L. E.; Liesack, Werner; Feng, Lu; Wang, Lei; Alam, Maqsudul			Methane oxidation by an extremely acidophilic bacterium of the phylum Verrucomicrobia	NATURE			English	Article							METHANOTROPHIC BACTERIA; MONOOXYGENASE OPERONS; IDENTIFICATION; METHYLOTROPHY; POPULATIONS; DIVERSITY; GENOME; KEY	Aerobic methanotrophic bacteria consume methane as it diffuses away from methanogenic zones of soil and sediment(1). They act as a biofilter to reduce methane emissions to the atmosphere, and they are therefore targets in strategies to combat global climate change. No cultured methanotroph grows optimally below pH 5, but some environments with active methane cycles are very acidic(2,3). Here we describe an extremely acidophilic methanotroph that grows optimally at pH 2.0-2.5. Unlike the known methanotrophs, it does not belong to the phylum Proteobacteria but rather to the Verrucomicrobia, a widespread and diverse bacterial phylum that primarily comprises uncultivated species with unknown genotypes. Analysis of its draft genome detected genes encoding particulate methane monooxygenase that were homologous to genes found in methanotrophic proteobacteria. However, known genetic modules for methanol and formaldehyde oxidation were incomplete or missing, suggesting that the bacterium uses some novel methylotrophic pathways. Phylogenetic analysis of its three pmoA genes ( encoding a subunit of particulate methane monooxygenase) placed them into a distinct cluster from proteobacterial homologues. This indicates an ancient divergence of Verrucomicrobia and Proteobacteria methanotrophs rather than a recent horizontal gene transfer of methanotrophic ability. The findings show that methanotrophy in the Bacteria is more taxonomically, ecologically and genetically diverse than previously thought, and that previous studies have failed to assess the full diversity of methanotrophs in acidic environments.	GNS Sci, Extremophile Res Grp, Taupo, New Zealand; Ariadne Genom Inc, Rockville, MD 20850 USA; Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA; Coll Nat Sci, Honolulu, HI 96822 USA; Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300457, Peoples R China; Univ Hawaii Manoa, Biol Elect Microscopy Facil, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; Netherlands Inst Ecol, NIOO KNAW, Ctr Limnol, Dept Microbial Wetland Ecol, NL-3631 AC Nieuwersluis, Netherlands; Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	GNS Science - New Zealand; University of Hawaii System; Nankai University; University of Hawaii System; University of Hawaii Manoa; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Max Planck Society	Dunfield, PF (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	p.dunfield@gns.cri.nz; wanglei@nankai.edu.cn; alam@hawaii.edu	Saw, Jimmy/J-1360-2019; Bodelier, Paul/AAF-8353-2020; feng, lu/M-5113-2015; Bodelier, Paul L/A-9591-2011; Saw, Jimmy HW/A-9972-2009; Zhou, Zhemin/AAX-5539-2020; Wang, Jianmei/HHZ-0585-2022; Dunfield, Peter F/C-3105-2009; Wang, Lei/C-5176-2009	Saw, Jimmy/0000-0001-8353-3854; Bodelier, Paul/0000-0002-5757-5572; Bodelier, Paul L/0000-0002-5757-5572; Saw, Jimmy HW/0000-0001-8353-3854; Zhou, Zhemin/0000-0001-9783-0366; Wang, Lei/0000-0003-4427-0881; Liesack, Werner/0000-0002-9533-1552; Stott, Matthew/0000-0002-2082-9460; Smirnova, Angela/0000-0002-3410-8349; Senin, Pavel/0000-0001-5517-7768; Hou, Shaobin/0000-0003-3467-8242; Dunfield, Peter/0000-0002-9319-4697; Yuryev, Anton/0000-0003-1021-4849				Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Castaldi S, 2005, CHEMOSPHERE, V58, P131, DOI 10.1016/j.chemosphere.2004.08.023; Chistoserdova L, 2004, MOL BIOL EVOL, V21, P1234, DOI 10.1093/molbev/msh113; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova L, 2007, J BACTERIOL, V189, P4020, DOI 10.1128/JB.00045-07; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Dedysh SN, 2002, MICROBIOLOGY+, V71, P638, DOI 10.1023/A:1021467520274; Dedysh SN, 1998, SCIENCE, V282, P281, DOI 10.1126/science.282.5387.281; Dedysh SN, 2007, INT J SYST EVOL MICR, V57, P472, DOI 10.1099/ijs.0.64623-0; Dumont MG, 2005, METHOD ENZYMOL, V397, P413, DOI 10.1016/S0076-6879(05)97025-0; GIGGENBACH WF, 1994, GEOTHERMICS, V23, P599, DOI 10.1016/0375-6505(94)90022-1; Gilbert B, 2000, APPL ENVIRON MICROB, V66, P966, DOI 10.1128/AEM.66.3.966-975.2000; Holmes AJ, 1999, APPL ENVIRON MICROB, V65, P3312; Hou SB, 2004, P NATL ACAD SCI USA, V101, P18036, DOI 10.1073/pnas.0407638102; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kane SR, 2007, J BACTERIOL, V189, P1931, DOI 10.1128/JB.01259-06; Kelly DP, 2005, TRENDS MICROBIOL, V13, P195, DOI 10.1016/j.tim.2005.03.003; Knief C, 2003, APPL ENVIRON MICROB, V69, P6703, DOI 10.1128/AEM.69.11.6703-6714.2003; Kvenvolden KA, 2005, MAR PETROL GEOL, V22, P579, DOI 10.1016/j.marpetgeo.2004.08.004; Lin JL, 2004, ENVIRON MICROBIOL, V6, P1049, DOI 10.1111/j.1462-2920.2004.00635.x; Morris SA, 2002, APPL ENVIRON MICROB, V68, P1446, DOI 10.1128/AEM.68.3.1446-1453.2002; Ricke P, 2004, APPL ENVIRON MICROB, V70, P3055, DOI 10.1128/AEM.70.5.3055-3063.2004; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Theisen AR, 2005, MOL MICROBIOL, V58, P682, DOI 10.1111/j.1365-2958.2005.04861.x; TROTSENKO YA, 1983, ACTA BIOTECHNOL, V3, P269, DOI 10.1002/abio.370030311; Ward N, 2004, PLOS BIOL, V2, P1616, DOI 10.1371/journal.pbio.0020303; Weatherby TM, 2000, ARTHROPOD STRUCT DEV, V29, P275, DOI 10.1016/S1467-8039(01)00011-1	29	382	424	12	279	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					879	U18		10.1038/nature06411	http://dx.doi.org/10.1038/nature06411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18004300				2022-12-28	WOS:000251394900056
J	Lane, JA; Howson, J; Donovan, JL; Goepel, JR; Dedman, DJ; Down, L; Turner, EL; Neal, DE; Hamdy, FC				Lane, J. Athene; Howson, Joanne; Donovan, Jenny L.; Goepel, John R.; Dedman, Daniel J.; Down, Liz; Turner, Emma L.; Neal, David E.; Hamdy, Freddie C.			Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RADICAL PROSTATECTOMY; RISK; SURVEILLANCE; DESIGN	Objective To investigate the feasibility of testing for prostate cancer and the prevalence and characteristics of the disease in unselected young men. Design Prospective cohort nested within a randomised controlled trial, with two years of follow-up. Setting Eight general practices in a UK city. Participants 1299 unselected men aged 45-49. Intervention Prostate biopsies for participants with a prostate specific antigen level of 1.5 ng/ml or more and the possibility of randomisation to three treatments for those with localised prostate cancer. Main outcome measures Uptake of testing for prostate specific antigen; positive predictive value of prostate specific antigen; and prevalence of prostate cancer, TNM disease stage, and histological grade (Gleason score 6-10). Results 442 of 1299 men agreed to be tested for prostate specific antigen (34%) and 54 (12%) had a raised level. The positive predictive value for prostate specific antigen was 21.3%. Ten cases of prostate cancer were detected (2.31/6) with eight having at least two positive results in biopsy cores and three showing perineural invasion. One tumour was of high volume (cT2c), Gleason score 7, with a positive result on digital rectal examination; nine tumours were cT1c, Gleason score 6, and eight had a negative result on digital rectal examination. Five of the nine eligible participants (55%) agreed to be randomised. No biochemical disease progression occurred in two years of follow-up. Conclusions Men younger than 50 will accept testing for prostate cancer but at a much tower rate than older men. Using an age based threshold of 1.5 ng/ml, the prevalence of prostate cancer was similar to that in older men (3.0 ng/ml threshold) and some cancers of potential clinical significance were found.	Univ Sheffield, Royal Hallamshire Hosp, Sect Oncol, Acad Urol Unit, Sheffield S10 2JF, S Yorkshire, England; Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England; Royal Hallamshire Hosp, Sheffield Teaching Hosp NHS Fdn Trust, Sheffield S10 2JF, S Yorkshire, England; Liverpool John Moores Univ, N W Publ Hlth Observ, Liverpool L3 5UX, Merseyside, England; Addenbrookes Hosp, Ctr Oncol, Cambridge, England	University of Sheffield; University of Bristol; University of Sheffield; Liverpool John Moores University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Hamdy, FC (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Sect Oncol, Acad Urol Unit, Sheffield S10 2JF, S Yorkshire, England.	f.c.hamdy@sheffield.ac.uk	Turner, Emma/AAC-1828-2022; DEDMAN, DANIEL/AAC-9156-2020	Turner, Emma/0000-0003-2575-387X; Hamdy, Freddie/0000-0003-2627-2154; Down, Liz/0000-0002-2738-2710; Neal, David/0000-0002-6033-5086	MRC [G0500966] Funding Source: UKRI; Medical Research Council [G0500966] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Catalona WJ, 2006, ANN INTERN MED, V144, P441, DOI 10.7326/0003-4819-144-6-200603210-00012; Catalona WJ, 2002, J UROLOGY, V168, P1980, DOI 10.1016/S0022-5347(05)64276-0; de Koning HJ, 2002, INT J CANCER, V97, P237, DOI 10.1002/ijc.1588; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; DONOVAN JL, 2003, HEALTH TECHNOL ASSES, V7, P88; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Eichler K, 2006, J UROLOGY, V175, P1605, DOI 10.1016/S0022-5347(05)00957-2; Fang JY, 2001, UROLOGY, V58, P411, DOI 10.1016/S0090-4295(01)01304-8; Giovannucci E, 2006, COMPREHENSIVE TXB GE, P9; Donovan Jenny, 2007, Int J Epidemiol, V36, P30; Klotz L, 2005, J CLIN ONCOL, V23, P8165, DOI 10.1200/JCO.2005.03.3134; LANE A, 2004, BR J CANC S124, V91, pS80; Lane JA, 2002, CONTROL CLIN TRIALS, V23, P321, DOI 10.1016/S0197-2456(01)00208-2; Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351; Loeb S, 2006, J UROLOGY, V175, P902, DOI 10.1016/S0022-5347(05)00327-7; Loeb S, 2007, J UROLOGY, V177, P899, DOI 10.1016/j.juro.2006.10.028; Melia J, 2005, BJU INT, V95, P4, DOI 10.1111/j.1464-410X.2005.05439.x; REISSIGL A, 1995, UROLOGY, V46, P662, DOI 10.1016/S0090-4295(99)80297-0; Reissigl A, 1997, PROSTATE, V30, P20; ROEMELING S, 2007, EUR UROL SUPPL, V6, P1026; Ross KS, 2000, JAMA-J AM MED ASSOC, V284, P1399, DOI 10.1001/jama.284.11.1399; Smith CV, 2000, J UROLOGY, V164, P1964, DOI 10.1016/S0022-5347(05)66929-7; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; Whittemore AS, 2005, J UROLOGY, V174, P872, DOI 10.1097/01.ju.0000169262.18000.8a; WILT TJ, 1994, J UROLOGY, V152, P1910, DOI 10.1016/S0022-5347(17)32413-8	27	14	14	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2007	335	7630					1139	1143		10.1136/bmj.39381.436829.BE	http://dx.doi.org/10.1136/bmj.39381.436829.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	18006969	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000251596100035
J	Mailand, N; Bekker-Jensen, S; Faustrup, H; Melander, F; Bartek, J; Lukas, C; Lukas, J				Mailand, Niels; Bekker-Jensen, Simon; Faustrup, Helene; Melander, Fredrik; Bartek, Jiri; Lukas, Claudia; Lukas, Jiri			RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins	CELL			English	Article							DAMAGE CHECKPOINT; H2A UBIQUITINATION; TUMOR-SUPPRESSOR; MDC1; CHROMATIN; SITES; BRCA1; 53BP1; ATM; BINDING	Accumulation of repair proteins on damaged chromosomes is required to restore genomic integrity. However, the mechanisms of protein retention at the most destructive chromosomal lesions, the DNA double-strand breaks (DSBs), are poorly understood. We show that RNF8, a RING-finger ubiquitin ligase, rapidly assembles at DSBs via interaction of its FHA domain with the phosphorylated adaptor protein MDC1. This is accompanied by an increase in DSB-associated ubiquitylations and followed by accumulation of 53BP1 and BRCA1 repair proteins. Knockdown of RNF8 or disruption of its FHA or RING domains impaired DSB-associated ubiquitylation and inhibited retention of 53BP1 and BRCA1 at the DSB sites. In addition, we show that RNF8 can ubiquitylate histone H2A and H2AX, and that its depletion sensitizes cells to ionizing radiation. These data suggest that MDC1-mediated and RNF8-executed histone ubiquitylation protects genome integrity by licensing the DSB-flanking chromatin to concentrate repair factors near the DNA lesions.	[Mailand, Niels; Bekker-Jensen, Simon; Faustrup, Helene; Melander, Fredrik; Bartek, Jiri; Lukas, Claudia; Lukas, Jiri] Ctr Genotoxic Stress Res, Inst Canc Biol, Danish Canc Soc, DK-2100 Copenhagen, Denmark	Danish Cancer Society	Lukas, J (corresponding author), Ctr Genotoxic Stress Res, Inst Canc Biol, Danish Canc Soc, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	jil@cancer.dk	Bartek, Jiri/G-5870-2014	Lukas, Claudia/0000-0001-7169-6883; Kildegaard, Helene Faustrup/0000-0003-3727-5721; Lukas, Jiri/0000-0001-9087-506X; Bekker-Jensen, Simon/0000-0002-7308-4597; Melander, Fredrik/0000-0002-3670-6633				Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ito K, 2001, EUR J BIOCHEM, V268, P2725, DOI 10.1046/j.1432-1327.2001.02169.x; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Morales JC, 2006, P NATL ACAD SCI USA, V103, P3310, DOI 10.1073/pnas.0511259103; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Scott, 2001, APPL HRM RES, V6, P13; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; STRACKER TH, 2004, DNA REPAIR AMST, V3, P345; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005	43	890	922	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					887	900		10.1016/j.cell.2007.09.040	http://dx.doi.org/10.1016/j.cell.2007.09.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18001824	Bronze			2022-12-28	WOS:000251800900012
J	Fusar-Poli, P; Valmaggia, L; McGuire, P				Fusar-Poli, Paolo; Valmaggia, Lucia; McGuire, Philip			Can antidepressants prevent psychoses?	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; SCHIZOPHRENIA PRODROME; CLINICAL-SAMPLE; MENTAL-HEALTH; RISK; EXPERIENCES; PEOPLE		S London & Maudsley NHS Trust, Outreach & Support S London, London, England; Kings Coll London, Inst Psychiat, London SE5 8AF, England; Univ Pavia, Dept Psychobehav Hlth Sci, I-27100 Pavia, Italy	South London & Maudsley NHS Trust; University of London; King's College London; University of Pavia	Fusar-Poli, P (corresponding author), S London & Maudsley NHS Trust, Outreach & Support S London, London, England.	p.fusar@libero.it	Valmaggia, Lucia/E-9653-2012; Valmaggia, Lucia R./O-1377-2019; Fusar-Poli, Paolo/D-8605-2011	Valmaggia, Lucia/0000-0001-6099-8464; Valmaggia, Lucia R./0000-0001-6099-8464; Fusar-Poli, Paolo/0000-0003-3582-6788; McGuire, Philip/0000-0003-4381-0532				Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Broome MR, 2005, EUR PSYCHIAT, V20, P372, DOI 10.1016/j.eurpsy.2005.03.001; Cantor-Graae E, 2007, CAN J PSYCHIAT, V52, P277, DOI 10.1177/070674370705200502; Cornblatt BA, 2007, J CLIN PSYCHIAT, V68, P546, DOI 10.4088/JCP.v68n0410; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Insel TR, 2006, MOL PSYCHIATR, V11, P11, DOI 10.1038/sj.mp.4001777; Krabbendam L, 2005, BRIT J CLIN PSYCHOL, V44, P113, DOI 10.1348/014466504X19767; McGlashan TH, 2006, AM J PSYCHIAT, V163, P790, DOI 10.1176/appi.ajp.163.5.790; McGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921, DOI 10.1001/archpsyc.59.10.921; Morrison AP, 2007, SCHIZOPHRENIA BULL, V33, P682, DOI 10.1093/schbul/sbl042; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Rosen JL, 2006, SCHIZOPHR RES, V85, P124, DOI 10.1016/j.schres.2006.03.034; Yung AR, 2007, SCHIZOPHR RES, V91, P246, DOI 10.1016/j.schres.2006.11.026; Yung AR, 2004, SCHIZOPHR RES, V67, P131, DOI 10.1016/S0920-9964(03)00192-0	14	68	75	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2007	370	9601					1746	1748		10.1016/S0140-6736(07)61732-2	http://dx.doi.org/10.1016/S0140-6736(07)61732-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234DI	18037073				2022-12-28	WOS:000251140500008
J	Ruban, AV; Berera, R; Ilioaia, C; van Stokkum, IHM; Kennis, JTM; Pascal, AA; van Amerongen, H; Robert, B; Horton, P; van Grondelle, R				Ruban, Alexander V.; Berera, Rudi; Ilioaia, Cristian; van Stokkum, Ivo H. M.; Kennis, John T. M.; Pascal, Andrew A.; van Amerongen, Herbert; Robert, Bruno; Horton, Peter; van Grondelle, Rienk			Identification of a mechanism of photoprotective energy dissipation in higher plants	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-II; PROTEINS; BINDING; PHOTOSYNTHESIS; XANTHOPHYLLS; AGGREGATION; INSIGHTS; LHCII; DYNAMICS	Under conditions of excess sunlight the efficient light-harvesting antenna(1) found in the chloroplast membranes of plants is rapidly and reversibly switched into a photoprotected quenched state in which potentially harmful absorbed energy is dissipated as heat(2,3), a process measured as the non-photochemical quenching of chlorophyll fluorescence or qE. Although the biological significance of qE is established(4-6), the molecular mechanisms involved are not(7-9). LHCII, the main light-harvesting complex, has an inbuilt capability to undergo transformation into a dissipative state by conformational change(10) and it was suggested that this provides a molecular basis for qE, but it is not known if such events occur in vivo or how energy is dissipated in this state. The transition into the dissipative state is associated with a twist in the configuration of the LHCII-bound carotenoid neoxanthin, identified using resonance Raman spectroscopy(11). Applying this technique to study isolated chloroplasts and whole leaves, we show here that the same change in neoxanthin configuration occurs in vivo, to an extent consistent with the magnitude of energy dissipation. Femtosecond transient absorption spectroscopy(12), performed on purified LHCII in the dissipative state, shows that energy is transferred from chlorophyll a to a low-lying carotenoid excited state, identified as one of the two luteins (lutein 1) in LHCII. Hence, it is experimentally demonstrated that a change in conformation of LHCII occurs in vivo, which opens a channel for energy dissipation by transfer to a bound carotenoid. We suggest that this is the principal mechanism of photoprotection.	Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; CEA, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France; CNRS, F-91191 Gif Sur Yvette, France; Univ Wageningen & Res Ctr, Biophys Lab, NL-6700 ET Wageningen, Netherlands	University of Sheffield; University of London; Queen Mary University London; Vrije Universiteit Amsterdam; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Wageningen University & Research	Horton, P (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	bruno.robert@cea.fr; p.horton@sheffield.ac.uk; rienk@few.vu.nl	pascal, andrew a/B-6186-2014; Robert, Bruno/D-1264-2012; van Amerongen, Herbert/J-9483-2016; van Stokkum, Ivo HM/E-7175-2015; Horton, Peter/A-3958-2012	pascal, andrew a/0000-0002-1844-6065; Robert, Bruno/0000-0001-5999-4538; van Amerongen, Herbert/0000-0002-9783-2895; van Stokkum, Ivo HM/0000-0002-6143-2021; Horton, Peter/0000-0002-6095-1460; ILIOAIA, Cristian/0000-0001-7505-1900				BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; Berera R, 2006, P NATL ACAD SCI USA, V103, P5343, DOI 10.1073/pnas.0508530103; Crouchman S, 2006, FEBS LETT, V580, P2053, DOI 10.1016/j.febslet.2006.03.005; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Demmig-Adams B, 2006, NEW PHYTOL, V172, P11, DOI 10.1111/j.1469-8137.2006.01835.x; Frank HA, 2000, BIOCHEMISTRY-US, V39, P2831, DOI 10.1021/bi9924664; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Lampoura SS, 2002, BIOCHEMISTRY-US, V41, P9139, DOI 10.1021/bi025724x; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Ma YZ, 2003, P NATL ACAD SCI USA, V100, P4377, DOI 10.1073/pnas.0736959100; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Tang YL, 2007, PLANT PHYSIOL, V143, P629, DOI 10.1104/pp.106.090712; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; VANGRONDELLE R, 1994, BBA-BIOENERGETICS, V1187, P1, DOI 10.1016/0005-2728(94)90166-X; Wentworth M, 2003, J BIOL CHEM, V278, P21845, DOI 10.1074/jbc.M302586200; Yan HC, 2007, BIOCHEM BIOPH RES CO, V355, P457, DOI 10.1016/j.bbrc.2007.01.172	30	705	718	16	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					575	U22		10.1038/nature06262	http://dx.doi.org/10.1038/nature06262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033302				2022-12-28	WOS:000251158500053
J	Manganas, LN; Zhang, XY; Li, Y; Hazel, RD; Smith, SD; Wagshul, ME; Henn, F; Benveniste, H; Djuric, PM; Enikolopov, G; Maletic-Savatic, M				Manganas, Louis N.; Zhang, Xueying; Li, Yao; Hazel, Raphael D.; Smith, S. David; Wagshul, Mark E.; Henn, Fritz; Benveniste, Helene; Djuric, Petar M.; Enikolopov, Grigori; Maletic-Savatic, Mirjana			Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; N-ACETYLASPARTATE; DENTATE GYRUS; ADULT BRAIN; NEUROGENESIS; STEM; PROLIFERATION; HIPPOCAMPUS; DECREASE; THERAPY	The identification of neural stem and progenitor cells (NPCs) by in vivo brain imaging could have important implications for diagnostic, prognostic, and therapeutic purposes. We describe a metabolic biomarker for the detection and quantification of NPCs in the human brain in vivo. We used proton nuclear magnetic resonance spectroscopy to identify and characterize a biomarker in which NPCs are enriched and demonstrated its use as a reference for monitoring neurogenesis. To detect low concentrations of NPCs in vivo, we developed a signal processing method that enabled the use of magnetic resonance spectroscopy for the analysis of the NPC biomarker in both the rodent brain and the hippocampus of live humans. Our findings thus open the possibility of investigating the role of NPCs and neurogenesis in a wide variety of human brain disorders.	SUNY Stony Brook, Stony Brook, NY 11794 USA; Brookhaven Natl Lab, Upton, NY 11719 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory; Cold Spring Harbor Laboratory	Enikolopov, G (corresponding author), SUNY Stony Brook, Stony Brook, NY 11794 USA.	enikolop@cshl.edu; mmaleticsava@notes.cc.sunysb.edu	Enikolopov, Grigori/P-5731-2019; Enikolopov, Grigori N/B-7771-2009; Mordwinkin, Nicholas M/A-4347-2010	Enikolopov, Grigori/0000-0001-8178-8917; Enikolopov, Grigori N/0000-0001-8178-8917; Djuric, Petar M./0000-0001-7791-3199; Maletic-Savatic, Mirjana/0000-0002-6548-4662	NIDDK NIH HHS [T32DK07521-16, T32 DK007521] Funding Source: Medline; NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NINDS NIH HHS [R01 NS032764, K08 NS044276-01, R01-NS32764, R21 NS053875-01A1, 5K08 NS044276, R21 NS053875, R21NS05875-1, K08 NS044276] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032764, R21NS053875, K08NS044276] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arbab AS, 2006, EXPERT REV MED DEVIC, V3, P427, DOI 10.1586/17434440.3.4.427; BARKHUIJSEN H, 1987, J MAGN RESON, V73, P553, DOI 10.1016/0022-2364(87)90023-0; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; CAVASSILA S, 1997, J MAGN RESON ANAL, V3, P87; Chin BB, 2003, NUCL MED COMMUN, V24, P1149, DOI 10.1097/00006231-200311000-00005; Cicchetti F, 2007, CONTRAST MEDIA MOL I, V2, P130, DOI 10.1002/cmmi.138; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Goldman SA, 2006, PHILOS T R SOC B, V361, P1463, DOI 10.1098/rstb.2006.1886; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mignone JL, 2007, CELL CYCLE, V6, P2161, DOI 10.4161/cc.6.17.4593; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Narayana PA, 2005, J NEUROIMAGING, V15, p46S, DOI 10.1177/1051228405284200; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; Shinno H, 2007, J NEUROL SCI, V260, P132, DOI 10.1016/j.jns.2007.04.017; SPARLING ML, 1989, ANAL BIOCHEM, V178, P67, DOI 10.1016/0003-2697(89)90358-8; Stengel A, 2004, MAGN RESON MED, V52, P228, DOI 10.1002/mrm.20171; Stoica P, 2003, J MAGN RESON, V165, P80, DOI 10.1016/S1090-7807(03)00188-5; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Viant Mark R., 2007, V358, P229, DOI 10.1007/978-1-59745-244-1_13; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156	28	328	350	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					980	985		10.1126/science.1147851	http://dx.doi.org/10.1126/science.1147851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991865	Green Accepted			2022-12-28	WOS:000250788500045
J	Guptha, SH; Han, T; Arafat, Q; Deyo, O				Guptha, Sunku Hemanth; Han, Tha; Arafat, Qais; Deyo, Okubadejo			Orange and green monkeys jumping around the room	LANCET			English	Editorial Material							VISUAL HALLUCINATIONS; PARKINSONS-DISEASE		Edith Cavell Hosp, Dept Med Older People, Peterborough, ON PE3 9GZ, Canada; Peterborough & Stamford NHS Trust, Dept Radiol, Peterborough, ON PE3 9GZ, Canada		Guptha, SH (corresponding author), Edith Cavell Hosp, Dept Med Older People, Bretton Gate, Peterborough, ON PE3 9GZ, Canada.	sunku.guptha@pbh-tr.nhs.uk		Han, Tha/0000-0003-3535-8582				Fenelon G, 2000, BRAIN, V123, P733, DOI 10.1093/brain/123.4.733; Manford M, 1998, BRAIN, V121, P1819, DOI 10.1093/brain/121.10.1819; Matsui H, 2006, J GERIATR PSYCH NEUR, V19, P36, DOI 10.1177/0891988705284739; SanchezRamos JR, 1996, ARCH NEUROL-CHICAGO, V53, P1265, DOI 10.1001/archneur.1996.00550120077019	4	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 3	2007	370	9598					1588	1588		10.1016/S0140-6736(07)61663-8	http://dx.doi.org/10.1016/S0140-6736(07)61663-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AE	17980737				2022-12-28	WOS:000250628800029
J	Cannara, RJ; Brukman, MJ; Cimatu, K; Sumant, AV; Baldelli, S; Carpick, RW				Cannara, Rachel J.; Brukman, Matthew J.; Cimatu, Katherine; Sumant, Anirudha V.; Baldelli, Steven; Carpick, Robert W.			Nanoscale friction varied by isotopic shifting of surface vibrational frequencies	SCIENCE			English	Article							ATOMIC-SCALE FRICTION; CONTACT AREA; DIAMOND; HYDROGEN; PHONONS; SPECTROSCOPY; RELAXATION; STRETCHES; DYNAMICS; FORCE	Friction converts kinetic energy at sliding interfaces into lattice vibrations, but the detailed mechanisms of this process remain unresolved. Atomic force microscopy measurements reveal that changing the mass of the terminating atoms on a surface, and thus their vibrational frequencies, affects nanoscale friction substantially. We compared hydrogen- and deuterium-terminated single-crystal diamond and silicon surfaces, and in all cases the hydrogenated surface exhibited higher friction. This result implies that the lower natural frequency of chemisorbed deuterium reduces the rate at which the tip's kinetic energy is dissipated. This discovery is consistent with a model describing energy transfer to adsorbates from a moving surface.	Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; Univ Wisconsin, Dept Engn Phys, Madison, WI 53706 USA; Univ Houston, Dept Chem, Houston, TX 77004 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Houston System; University of Houston	Cannara, RJ (corresponding author), IBM Res GmbH, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland.		Cimatu, Katherine Leslee Asetre/AAZ-3163-2021; Cannara, Rachel/C-9128-2013	Cannara, Rachel/0000-0002-2984-5475; Cimatu, Katherine Leslee/0000-0002-4216-9715				ANDO T, 1995, DIAM RELAT MATER, V4, P607, DOI 10.1016/0925-9635(94)05242-5; [Anonymous], 1992, INTERMOLECULAR SURFA; ANZAI T, 1995, J MOL STRUCT, V352, P455, DOI 10.1016/0022-2860(94)08518-M; BATES FS, 1985, PHYS REV LETT, V55, P2425, DOI 10.1103/PhysRevLett.55.2425; BRUKMAN MJ, 2005, THESIS U WISCONSIN M; Carpick RW, 1999, J COLLOID INTERF SCI, V211, P395, DOI 10.1006/jcis.1998.6027; CHANG HC, 1995, J PHYS CHEM-US, V99, P11081, DOI 10.1021/j100028a007; Cheng CL, 1996, J CHEM PHYS, V105, P8977, DOI 10.1063/1.472938; CHIN RP, 1995, PHYS REV B, V52, P5985, DOI 10.1103/PhysRevB.52.5985; CHIN RP, 1992, PHYS REV B, V45, P1522, DOI 10.1103/PhysRevB.45.1522; CIEPLAK M, 1994, SCIENCE, V265, P1209, DOI 10.1126/science.265.5176.1209; Enachescu M, 1999, TRIBOL LETT, V7, P73, DOI 10.1023/A:1019173404538; Gao GT, 2007, LANGMUIR, V23, P5394, DOI 10.1021/la062254p; Glebov A, 1998, PHYS REV B, V57, P10082, DOI 10.1103/PhysRevB.57.10082; Graschus V, 1996, SURF SCI, V368, P179, DOI 10.1016/S0039-6028(96)01047-3; Grierson DS, 2005, J ADHES SCI TECHNOL, V19, P291, DOI 10.1163/1568561054352685; HARRISON JA, 1995, THIN SOLID FILMS, V260, P205, DOI 10.1016/0040-6090(94)06511-X; Luan BQ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026111; Luan BQ, 2005, NATURE, V435, P929, DOI 10.1038/nature03700; MAK C, 1994, THIN SOLID FILMS, V253, P190, DOI 10.1016/0040-6090(94)90318-2; Park JY, 2006, SCIENCE, V313, P186, DOI 10.1126/science.1125017; Persson B. N. J., 1997, NANOSCI TECHNOL, V1; PERSSON BNJ, 1995, J CHEM PHYS, V103, P8679, DOI 10.1063/1.470125; Persson BNJ, 1999, PHYS REV B, V59, P11777, DOI 10.1103/PhysRevB.59.11777; SANDFORT B, 1995, PHYS REV B, V51, P7139, DOI 10.1103/PhysRevB.51.7139; Schwarz UD, 1997, PHYS REV B, V56, P6987, DOI 10.1103/PhysRevB.56.6987; SOKOLOFF JB, 1995, PHYS REV B, V52, P5318, DOI 10.1103/PhysRevB.52.5318; Sorensen MR, 1996, PHYS REV B, V53, P2101, DOI 10.1103/PhysRevB.53.2101; STUHLMANN C, 1992, PHYS REV B, V45, P6786, DOI 10.1103/PhysRevB.45.6786; Sumant AV, 2005, ADV MATER, V17, P1039, DOI 10.1002/adma.200401264; Thachepan S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.041401; Tomlinson GA, 1929, PHILOS MAG, V7, P905, DOI 10.1080/14786440608564819; WALKUP RE, 1993, ATOMIC NANOMETER SCA, P100; Ye S, 2001, SURF SCI, V476, P121, DOI 10.1016/S0039-6028(01)00690-2; Zhao XY, 2007, TRIBOL LETT, V27, P113, DOI 10.1007/s11249-007-9220-2; Zhigilei LV, 1997, SURF SCI, V374, P333, DOI 10.1016/S0039-6028(96)01230-7	36	103	105	6	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					780	783		10.1126/science.1147550	http://dx.doi.org/10.1126/science.1147550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975061				2022-12-28	WOS:000250583900036
J	Sakuramoto, S; Sasako, M; Yamaguchi, T; Kinoshita, T; Fujii, M; Nashimoto, A; Furukawa, H; Nakajima, T; Ohashi, Y; Imamura, H; Higashino, M; Yamamura, Y; Kurita, A; Arai, K				Sakuramoto, Shinichi; Sasako, Mitsuru; Yamaguchi, Toshiharu; Kinoshita, Taira; Fujii, Masashi; Nashimoto, Atsushi; Furukawa, Hiroshi; Nakajima, Toshifusa; Ohashi, Yasuo; Imamura, Hiroshi; Higashino, Masayuki; Yamamura, Yoshitaka; Kurita, Akira; Arai, Kuniyoshi		ACTS GC Grp	Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CURATIVE RESECTION; PHASE-II; RANDOMIZED-TRIALS; METAANALYSIS; CHEMORADIOTHERAPY; 5-FLUOROURACIL; FLUOROURACIL; GASTRECTOMY; MITOMYCIN; SURGERY	Background: Advanced gastric cancer can respond to S-1, an oral fluoropyrimidine. We tested S-1 as adjuvant chemotherapy in patients with curatively resected gastric cancer. Methods: Patients in Japan with stage II or III gastric cancer who underwent gastrectomy with extended (D2) lymph-node dissection were randomly assigned to undergo surgery followed by adjuvant therapy with S-1 or to undergo surgery only. In the S-1 group, administration of S-1 was started within 6 weeks after surgery and continued for 1 year. The treatment regimen consisted of 6-week cycles in which, in principle, 80 mg of oral S-1 per square meter of body-surface area per day was given for 4 weeks and no chemotherapy was given for the following 2 weeks. The primary end point was overall survival. Results: We randomly assigned 529 patients to the S-1 group and 530 patients to the surgery-only group between October 2001 and December 2004. The trial was stopped on the recommendation of the independent data and safety monitoring committee, because the first interim analysis, performed 1 year after enrollment was completed, showed that the S-1 group had a higher rate of overall survival than the surgery-only group (P=0.002). Analysis of follow-up data showed that the 3-year overall survival rate was 80.1% in the S-1 group and 70.1% in the surgery-only group. The hazard ratio for death in the S-1 group, as compared with the surgery-only group, was 0.68 (95% confidence interval, 0.52 to 0.87; P=0.003). Adverse events of grade 3 or grade 4 (defined according to the Common Toxicity Criteria of the National Cancer Institute) that were relatively common in the S-1 group were anorexia (6.0%), nausea (3.7%), and diarrhea (3.1%). Conclusions: S-1 is an effective adjuvant treatment for East Asian patients who have undergone a D2 dissection for locally advanced gastric cancer. (ClinicalTrials.gov number, NCT00152217.).	Kitasato Univ, Sch Med, Dept Surg, Kanagawa 2288520, Japan; Natl Canc Ctr, Tokyo, Japan; Canc Inst Hosp, Tokyo, Japan; Nihon Univ, Sch Med, Tokyo, Japan; Univ Tokyo, Tokyo, Japan; Tokyo Metropolitan Komagome Hosp, Tokyo, Japan; Natl Canc Ctr Hosp E, Kashiwa, Chiba, Japan; Niigata Canc Ctr Hosp, Niigata, Japan; Sakai City Hosp, Sakai, Osaka, Japan; Osaka City Gen Hosp, Osaka, Japan; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; Natl Hosp Org, Shikoku Canc Ctr, Matsuyama, Ehime, Japan	Kitasato University; National Cancer Center - Japan; Japanese Foundation for Cancer Research; Nihon University; University of Tokyo; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; National Cancer Center - Japan; Osaka City General Hospital; Aichi Cancer Center	Sakuramoto, S (corresponding author), Kitasato Univ, Sch Med, Dept Surg, 2-1-1 Asamizodai, Kanagawa 2288520, Japan.	sakura@med.kitasato-u.ac.jp						BOLLSCHWEILER E, 1992, BRIT J SURG, V79, P156, DOI 10.1002/bjs.1800790221; BONENKAMP JJ, 1993, WORLD J SURG, V17, P410, DOI 10.1007/BF01658714; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Degiuli M, 2004, BRIT J CANCER, V90, P1727, DOI 10.1038/sj.bjc.6601761; Diasio RB, 1999, ONCOLOGY-NY, V13, P17; Earle CC, 1999, EUR J CANCER, V35, P1059, DOI 10.1016/S0959-8049(99)00076-3; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; HERMANS J, 1994, J CLIN ONCOL, V12, P879; HERMANS J, 1993, J CLIN ONCOL, V11, P1441, DOI 10.1200/JCO.1993.11.8.1441; Hundahl SA, 2002, ANN SURG ONCOL, V9, P278, DOI 10.1007/BF02573066; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Kinoshita T, 2005, J CLIN ONCOL, V23, p313S; Kinoshita Taira, 2004, Gastric Cancer, V7, P104; Kochi M, 2007, CANCER CHEMOTH PHARM, V60, P693, DOI 10.1007/s00280-007-0415-x; Koizumi W, 2000, ONCOLOGY-BASEL, V58, P191, DOI 10.1159/000012099; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; MACDONALD JS, 2004, 2004 GASTR CANC S SA; Mari E, 2000, ANN ONCOL, V11, P837, DOI 10.1023/A:1008377101672; MCCULLOCH PG, 1995, CANCER, V75, P920, DOI 10.1002/1097-0142(19950215)75:4<920::AID-CNCR2820750405>3.0.CO;2-E; MIYASHIRO I, 2005, 2005 GASTR CANC S HO; Nakajima T, 1999, LANCET, V354, P273, DOI 10.1016/S0140-6736(99)01048-X; Nakajima T, 1999, MULTIMODALITY THERAP, P27; Nakajima Toshifusa, 2002, Gastric Cancer, V5, P1, DOI 10.1007/s101200200000; Nashimoto A, 2003, J CLIN ONCOL, V21, P2282, DOI 10.1200/JCO.2003.06.103; Panzini I, 2002, TUMORI J, V88, P21; Sakata Y, 1998, EUR J CANCER, V34, P1715, DOI 10.1016/S0959-8049(98)00211-1; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; SPIEGELHALTER DJ, 1994, J R STAT SOC A STAT, V157, P357, DOI 10.2307/2983527; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	30	1889	2013	2	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2007	357	18					1810	1820		10.1056/NEJMoa072252	http://dx.doi.org/10.1056/NEJMoa072252			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	225OJ	17978289				2022-12-28	WOS:000250526900004
J	Vernooij, MW; Ikram, MA; Tanghe, HL; Vincent, AJPE; Hofman, A; Krestin, GP; Niessen, WJ; Breteler, MMB; van der Lugt, A				Vernooij, Meike W.; Ikram, M. Arfan; Tanghe, Herve L.; Vincent, Arnaud J. P. E.; Hofman, Albert; Krestin, Gabriel P.; Niessen, Wiro J.; Breteler, Monique M. B.; van der Lugt, Aad			Incidental findings on brain MRI in the general population	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WHITE-MATTER LESIONS; UNRUPTURED INTRACRANIAL ANEURYSMS; CARDIOVASCULAR-HEALTH; NATURAL-HISTORY; ELDERLY-PEOPLE; ROTTERDAM SCAN; ASYMPTOMATIC MENINGIOMAS; CEREBRAL INFARCTION; RISK-FACTORS; STROKE	Background: Magnetic resonance imaging (MRI) of the brain is increasingly used both in research and in clinical medicine, and scanner hardware and MRI sequences are continually being improved. These advances are likely to result in the detection of unexpected, asymptomatic brain abnormalities, such as brain tumors, aneurysms, and subclinical vascular pathologic changes. We conducted a study to determine the prevalence of such incidental brain findings in the general population. Methods: The subjects were 2000 persons (mean age, 63.3 years; range, 45.7 to 96.7) from the population-based Rotterdam Study in whom high-resolution, structural brain MRI (1.5 T) was performed according to a standardized protocol. Two trained reviewers recorded all brain abnormalities, including asymptomatic brain infarcts. The volume of white-matter lesions was quantified in milliliters with the use of automated postprocessing techniques. Two experienced neuroradiologists reviewed all incidental findings. All diagnoses were based on MRI findings, and additional histologic confirmation was not obtained. Results: Asymptomatic brain infarcts were present in 145 persons (7.2%). Among findings other than infarcts, cerebral aneurysms (1.8%) and benign primary tumors (1.6%), mainly meningiomas, were the most frequent. The prevalence of asymptomatic brain infarcts and meningiomas increased with age, as did the volume of white-matter lesions, whereas aneurysms showed no age-related increase in prevalence. Conclusions: Incidental brain findings on MRI, including subclinical vascular pathologic changes, are common in the general population. The most frequent are brain infarcts, followed by cerebral aneurysms and benign primary tumors. Information on the natural course of these lesions is needed to inform clinical management.	Erasmus MC Univ Med Ctr, Dept Radiol, NL-3015 CE Rotterdam, Netherlands; Erasmus MC Univ Med Ctr, Dept Epidemiol & Biostat, NL-3015 CE Rotterdam, Netherlands; Erasmus MC Univ Med Ctr, Dept Neurosurg, NL-3015 CE Rotterdam, Netherlands; Erasmus MC Univ Med Ctr, Dept Med Informat, NL-3015 CE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van der Lugt, A (corresponding author), Erasmus MC Univ Med Ctr, Dept Radiol, Sgravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	a.vanderlugt@erasmusmc.nl	Ikram, M. Arfan/AAM-5225-2021; Kennedy, Kristen M/B-4699-2008; Breteler, Monique M.B./J-5058-2014; Vernooij, Meike Willemijn/E-4061-2016	Kennedy, Kristen M/0000-0001-5373-9026; Breteler, Monique M.B./0000-0002-0626-9305; Vernooij, Meike/0000-0003-4658-2176; Niessen, Wiro/0000-0002-5822-1995; Ikram, Mohammad Arfan/0000-0003-0372-8585				Bernick C, 2001, NEUROLOGY, V57, P1222, DOI 10.1212/WNL.57.7.1222; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; de Groot JC, 2000, ARCH GEN PSYCHIAT, V57, P1071, DOI 10.1001/archpsyc.57.11.1071; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Hollander M, 2002, CIRCULATION, V105, P2872, DOI 10.1161/01.CIR.0000018650.58984.75; Howard G, 1998, STROKE, V29, P913, DOI 10.1161/01.STR.29.5.913; IKRAM MA, IN PRESS NEUROBIOL A; Illes J, 2006, SCIENCE, V311, P783, DOI 10.1126/science.1124665; Illes J, 2004, J MAGN RESON IMAGING, V20, P743, DOI 10.1002/jmri.20180; Illes J, 2002, BRAIN COGNITION, V50, P358, DOI 10.1016/S0278-2626(02)00532-8; INAGAWA T, 1990, SURG NEUROL, V34, P361, DOI 10.1016/0090-3019(90)90237-J; Jack CR, 1997, RADIOLOGY, V202, P17, DOI 10.1148/radiology.202.1.8988183; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Kim BS, 2002, AM J NEURORADIOL, V23, P1674; Korf ESC, 2006, DIABETES CARE, V29, P2268, DOI 10.2337/dc06-0243; Leow AD, 2006, NEUROIMAGE, V31, P627, DOI 10.1016/j.neuroimage.2005.12.013; Liao DP, 1996, STROKE, V27, P2262, DOI 10.1161/01.STR.27.12.2262; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P1217, DOI 10.1001/archneur.55.9.1217; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Longstreth WT, 2002, STROKE, V33, P2376, DOI 10.1161/01.STR.0000032241.58727.49; Lubman DI, 2002, ACTA PSYCHIAT SCAND, V106, P331, DOI 10.1034/j.1600-0447.2002.02217.x; Meadows J, 2000, J NEUROSURG, V92, P920, DOI 10.3171/jns.2000.92.6.0920; MOSER FG, 1991, CLIN RADIOL, V43, P252, DOI 10.1016/S0009-9260(05)80249-1; Nakamura M, 2003, NEUROSURGERY, V53, P62, DOI 10.1227/01.NEU.0000068730.76856.58; NAKASU S, 1987, SURG NEUROL, V27, P319, DOI 10.1016/0090-3019(87)90005-X; Niiro M, 2000, J NEUROL NEUROSUR PS, V68, P25, DOI 10.1136/jnnp.68.1.25; OLIVERO WC, 1995, J NEUROSURG, V83, P222, DOI 10.3171/jns.1995.83.2.0222; Onizuka M, 2001, NEUROL MED-CHIR, V41, P431, DOI 10.2176/nmc.41.431; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Price TR, 1997, STROKE, V28, P1158, DOI 10.1161/01.STR.28.6.1158; Prins ND, 2004, ARCH NEUROL-CHICAGO, V61, P1531, DOI 10.1001/archneur.61.10.1531; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Schmidt R, 1999, NEUROLOGY, V53, P132, DOI 10.1212/WNL.53.1.132; STANECZEK W, 1992, CLIN NEUROPATHOL, V11, P135; Takanashi J, 2005, AM J NEURORADIOL, V26, P2144; Tsushima Y, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-18; VANROSSUM C, 1999, THESIS ERASMUS U ROT; Vermeer SE, 2002, STROKE, V33, P21, DOI 10.1161/hs0102.101629; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Weber F, 2006, J NEUROL SCI, V240, P81, DOI 10.1016/j.jns.2005.09.008; White PM, 2003, LANCET, V362, P90, DOI 10.1016/S0140-6736(03)13891-3; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Yue NC, 1997, RADIOLOGY, V202, P41, DOI 10.1148/radiology.202.1.8988190	45	998	1018	2	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2007	357	18					1821	1828		10.1056/NEJMoa070972	http://dx.doi.org/10.1056/NEJMoa070972			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	225OJ	17978290				2022-12-28	WOS:000250526900005
J	Yu, JY; Vodyanik, MA; Smuga-Otto, K; Antosiewicz-Bourget, J; Frane, JL; Tian, S; Nie, J; Jonsdottir, GA; Ruotti, V; Stewart, R; Slukvin, II; Thomson, JA				Yu, Junying; Vodyanik, Maxim A.; Smuga-Otto, Kim; Antosiewicz-Bourget, Jessica; Frane, Jennifer L.; Tian, Shulan; Nie, Jeff; Jonsdottir, Gudrun A.; Ruotti, Victor; Stewart, Ron; Slukvin, Igor I.; Thomson, James A.			Induced pluripotent stem cell lines derived from human somatic cells	SCIENCE			English	Article							FIBROBLASTS; NANOG	Somatic cell nuclear transfer allows trans- acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors ( OCT4, SOX2, NANOG, and LIN28) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem ( ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations ( for example, mutation through viral integration) are eliminated.	Genome Ctr Wisconsin, Madison, WI 53706 USA; Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; WiCell Res Inst, Madison, WI 53707 USA; Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Yu, JY (corresponding author), Genome Ctr Wisconsin, Madison, WI 53706 USA.	jyu@primate.wisc.edu; thomson@primate.wisc.edu	Wilson, Matthew H/K-3193-2013		NCRR NIH HHS [P51 RR000167] Funding Source: Medline; NIGMS NIH HHS [P20 GM069981] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM069981] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Sumi T, 2007, ONCOGENE, V26, P5564, DOI 10.1038/sj.onc.1210353; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yu JY, 2006, STEM CELLS, V24, P168, DOI 10.1634/stemcells.2005-0292; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	14	7274	8280	62	1876	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1917	1920		10.1126/science.1151526	http://dx.doi.org/10.1126/science.1151526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18029452				2022-12-28	WOS:000251786600057
J	Coscoy, L; Raulet, DH				Coscoy, Laurent; Raulet, David H.			DNA mismanagement leads to immune system oversight	CELL			English	Editorial Material							EXONUCLEASE TREX1; RECOGNITION; RECEPTOR; LOCUS; NKG2D	Trex1, a major 3 ' DNA exonuclease in mammalian cells, has been thought to act primarily in DNA replication or repair. Surprisingly, the major phenotype resulting from Trex1 deficiency in humans and mice is a chronic inflammatory disease. In this issue, Yang et al. (2007) report that Trex1 deficiency causes chronic activation of the ATM-dependent DNA-damage checkpoint and accumulation of a discrete single-stranded DNA species in the cytoplasm, either of which could contribute to chronic inflammation.	[Coscoy, Laurent; Raulet, David H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Coscoy, L (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Canc Res Lab, 229 Stanley Hall, Berkeley, CA 94720 USA.	lcoscoy@berkeley.edu; raulet@berkeley.edu		Raulet, David/0000-0002-1257-8649	NIAID NIH HHS [R01 AI039642] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039642] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Janka GE, 2007, EUR J PEDIATR, V166, P95, DOI 10.1007/s00431-006-0258-1; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Ogasawara K, 2005, J CLIN IMMUNOL, V25, P534, DOI 10.1007/s10875-005-8786-4; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Vacchio MS, 2007, P NATL ACAD SCI USA, V104, P6323, DOI 10.1073/pnas.0611222104; YANG Y, 2007, CELL	11	15	15	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 30	2007	131	5					836	838		10.1016/j.cell.2007.11.012	http://dx.doi.org/10.1016/j.cell.2007.11.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045527	Bronze, Green Accepted			2022-12-28	WOS:000251800900004
J	Sorensen, HT; Horvath-Puho, E; Pedersen, L; Baron, JA; Prandoni, P				Sorensen, Henrik Toft; Horvath-Puho, Erzsebet; Pedersen, Lars; Baron, John A.; Prandoni, Paolo			Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study	LANCET			English	Article							DEEP-VEIN THROMBOSIS; ACUTE MYOCARDIAL-INFARCTION; PULMONARY-EMBOLISM; RISK-FACTORS; GENERAL-POPULATION; SUBCLINICAL ATHEROSCLEROSIS; DISEASE; EPIDEMIOLOGY; STROKE; DIAGNOSIS	Background In some studies, venous thromboembolism has been associated with atherosclerosis and with the risk of arterial cardiovascular events such as myocardial infarction and stroke. Other studies, however, do not show this association. To help clarify these discrepant findings, we aimed to investigate the risk of arterial cardiovascular events in patients who were diagnosed with venous thromboembolism. Methods We undertook a 20-year population-based cohort study using data from nationwide Danish medical databases. After excluding those with known cardiovascular disease, we assessed the risk of myocardial infarction and stroke in 25199 patients with deep venous thrombosis, 16925 patients with pulmonary embolism, and 163 566 population controls. Findings For patients with deep venous thrombosis, the relative risks varied from 1.60 for myocardial infarction (95% Cl 1.35-1-91) to 2.19 (1.85-2.60) for stroke in the first year after the thrombotic event. For patients with pulmonary embolism, the relative risks in that year were 2.60 (2.14-3.14) for myocardial infarction and 2.93 (2.34-3.66) for stroke. The relative risks were also raised, though less markedly, during the subsequent 20 years of follow-up, with 20-40% increases in risk for arterial cardiovascular events. Relative risks were similar for those with provoked and unprovoked deep venous thrombosis and pulmonary embolism. Interpretation Patients with venous thromboembolism have a substantially increased long-term risk of subsequent arterial cardiovascular events.	Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; Dartmouth Med Sch, Dept Med, Hanover, NH USA; Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH USA; Univ Padua, Dept Med & Surg Sci, Thromboembolism Unit, I-35100 Padua, Italy	Aarhus University; Boston University; Dartmouth College; Dartmouth College; University of Padua	Sorensen, HT (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Ole Worms Alle 1150, DK-8000 Aarhus C, Denmark.	hts@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Horvath-Puho, Erzsebet/0000-0002-3594-2212				Ageno W, 2006, J THROMB HAEMOST, V4, P1914, DOI 10.1111/j.1538-7836.2006.02132.x; Agnelli G, 2006, J THROMB HAEMOST, V4, P1886, DOI 10.1111/j.1538-7836.2006.02138.x; Anand SS, 1999, JAMA-J AM MED ASSOC, V282, P2058, DOI 10.1001/jama.282.21.2058; Andersen TF, 1999, DAN MED BULL, V46, P263; Becattini C, 2005, EUR HEART J, V26, P77, DOI 10.1093/eurheartj/ehi018; Boersma E, 2003, LANCET, V361, P847, DOI 10.1016/S0140-6736(03)12712-2; Bova C, 2006, THROMB HAEMOSTASIS, V96, P132, DOI 10.1160/TH-06-05-0231; *DAN SOC THROMB HE, 2000, 3 DAN SOC THROMB HEM; Eliasson A, 2006, J THROMB HAEMOST, V4, P1897, DOI 10.1111/j.1538-7836.2006.02152.x; Fowkes FJI, 2003, EUR J VASC ENDOVASC, V25, P1, DOI 10.1053/ejvs.2002.1778; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; GOLDHABER SZ, 1983, AM J MED, V74, P1023, DOI 10.1016/0002-9343(83)90805-7; Goon PKY, 2006, THROMB HAEMOSTASIS, V96, P111, DOI 10.1160/TH06-07-0380; Hansson PO, 1997, ARCH INTERN MED, V157, P1665, DOI 10.1001/archinte.157.15.1665; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Hong C, 2005, ATHEROSCLEROSIS, V183, P169, DOI 10.1016/j.atherosclerosis.2005.03.047; Johnsen SP, 2002, J CLIN EPIDEMIOL, V55, P602, DOI 10.1016/S0895-4356(02)00391-8; KNIFFIN WD, 1994, ARCH INTERN MED, V154, P861, DOI 10.1001/archinte.154.8.861; Kyrle PA, 2005, LANCET, V365, P1163, DOI 10.1016/S0140-6736(05)71880-8; Leppala JM, 1999, EUR J EPIDEMIOL, V15, P155, DOI 10.1023/A:1007504310431; Libby P, 2000, CLIN CARDIOL, V23, P3, DOI 10.1002/clc.4960231103; Lowe GDO, 2006, J THROMB HAEMOST, V4, P1882, DOI 10.1111/j.1538-7836.2006.02130.x; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Prandoni P, 2006, J THROMB HAEMOST, V4, P1891, DOI 10.1111/j.1538-7836.2006.02058.x; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Ray JG, 2004, J THROMB HAEMOST, V2, P695, DOI 10.1111/j.1538-7836.2004.00705.x; Reich LM, 2006, J THROMB HAEMOST, V4, P1909, DOI 10.1111/j.1538-7836.2006.02121.x; SAMKOFF JS, 1981, AM J EPIDEMIOL, V114, P488, DOI 10.1093/oxfordjournals.aje.a113214; Schulman S, 2000, NEW ENGL J MED, V342, P1953, DOI 10.1056/NEJM200006293422604; Schulman S, 2006, J THROMB HAEMOST, V4, P734, DOI 10.1111/j.1538-7836.2006.01795.x; Sorensen H T, 1997, Int J Risk Saf Med, V10, P1, DOI 10.3233/JRS-1997-10101; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056/NEJM199804233381701; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; van der Hagen PB, 2006, J THROMB HAEMOST, V4, P1903, DOI 10.1111/j.1538-7836.2006.02096.x; Warlow C, 2003, LANCET, V362, P1211, DOI 10.1016/S0140-6736(03)14544-8; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	41	300	311	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2007	370	9601					1773	1779						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234DI	18037081				2022-12-28	WOS:000251140500021
J	Flatt, T; Promislow, DEL				Flatt, Thomas; Promislow, Daniel E. L.			Still pondering an age-old question	SCIENCE			English	Editorial Material							LIFE-SPAN; LONGEVITY; COST		Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; Univ Georgia, Dept Genet, Athens, GA 30602 USA	Brown University; University System of Georgia; University of Georgia	Flatt, T (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	thomas_flatt@brown.edu; promislow@uga.edu	Flatt, Thomas/AAE-7329-2019; Flatt, Thomas/A-7384-2009	Flatt, Thomas/0000-0002-5990-1503; Promislow, Daniel/0000-0001-7088-4495				Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Fisher R.A., 1930, GENETICAL THEORY NAT; Gems D, 1998, GENETICS, V150, P129; Jenkins NL, 2004, P ROY SOC B-BIOL SCI, V271, P2523, DOI 10.1098/rspb.2004.2897; Leroi AM, 2005, MECH AGEING DEV, V126, P421, DOI 10.1016/j.mad.2004.07.012; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Medawar P., 1952, UNSOLVED PROBLEM BIO; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0; ROSE M. R., 1991, EVOLUTIONARY BIOL AG; Silbermann R, 2000, EVOLUTION, V54, P2038; Stearns SC, 2001, HDB BIOL AGING, P353; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Walker DW, 2000, NATURE, V405, P296, DOI 10.1038/35012693; Westendorp RGJ, 1998, NATURE, V396, P743, DOI 10.1038/25519; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	17	37	38	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1255	1256		10.1126/science.1147491	http://dx.doi.org/10.1126/science.1147491			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033874	Green Submitted			2022-12-28	WOS:000251086600031
J	Stewart, MD; Yin, A; Xu, JM; Valles, JM				Stewart, M. D., Jr.; Yin, Aijun; Xu, J. M.; Valles, James M., Jr.			Superconducting pair correlations in an amorphous insulating nanohoneycomb film	SCIENCE			English	Article							QUANTUM PHASE-TRANSITIONS; MAGNETIC-FIELD; FLUX; FLUCTUATIONS; AMPLITUDE; VORTICES; ARRAYS; ONSET	The Cooper pairing mechanism that binds single electrons to form pairs in metals allows electrons to circumvent the exclusion principle and condense into a single superconducting or zero-resistance state. We present results from an amorphous bismuth film system patterned with a nanohoneycomb array of holes, which undergoes a thickness-tuned insulator-superconductor transition. The insulating films exhibit activated resistances and magnetoresistance oscillations dictated by the superconducting flux quantum h/2e. This 2e period is direct evidence indicating that Cooper pairing is also responsible for electrically insulating behavior.	Brown Univ, Dept Phys, Providence, RI 02912 USA; Brown Univ, Div Engn, Providence, RI 02912 USA	Brown University; Brown University	Valles, JM (corresponding author), Brown Univ, Dept Phys, 182 Hope St, Providence, RI 02912 USA.	valles@physics.brown.edu	Valles, James M./G-4570-2011; Stewart, Michael/AAV-3215-2021	Valles, James M./0000-0002-9786-0730; Stewart, Michael/0000-0003-1126-0038				ARONOV AG, 1987, REV MOD PHYS, V59, P755, DOI 10.1103/RevModPhys.59.755; Barber RP, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.134516; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BELITZ D, 1994, REV MOD PHYS, V66, P261, DOI 10.1103/RevModPhys.66.261; Bezryadin A, 2000, NATURE, V404, P971, DOI 10.1038/35010060; Chervenak JA, 1999, PHYS REV B, V59, P11209, DOI 10.1103/PhysRevB.59.11209; Christiansen C, 2002, PHYS REV LETT, V88, DOI [10.1103/PhysRevLett.88.037004, 10.1103/PhysRevB.88.037004]; Crane R, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.184530; DEAVER BS, 1961, PHYS REV LETT, V7, P43, DOI 10.1103/PhysRevLett.7.43; DELSING P, 1994, PHYS REV B, V50, P3959, DOI 10.1103/PhysRevB.50.3959; DOLL R, 1961, PHYS REV LETT, V7, P51, DOI 10.1103/PhysRevLett.7.51; FISHER MPA, 1990, PHYS REV LETT, V65, P923, DOI 10.1103/PhysRevLett.65.923; Gantmakher VF, 1998, JETP LETT+, V68, P363, DOI 10.1134/1.567874; GEERLIGS LJ, 1989, PHYS REV LETT, V63, P326, DOI 10.1103/PhysRevLett.63.326; Ghosal A, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.014501; HAVILAND DB, 1989, PHYS REV LETT, V62, P2180, DOI 10.1103/PhysRevLett.62.2180; HEBARD AF, 1990, PHYS REV LETT, V65, P927, DOI 10.1103/PhysRevLett.65.927; KOWAL D, 1994, SOLID STATE COMMUN, V90, P783, DOI 10.1016/0038-1098(94)90242-9; LEGGETT AJ, 1975, REV MOD PHYS, V47, P331, DOI 10.1103/RevModPhys.47.331; LITTLE WA, 1962, PHYS REV LETT, V9, P9, DOI 10.1103/PhysRevLett.9.9; Markovic N, 1998, PHYS REV LETT, V81, P701, DOI 10.1103/PhysRevLett.81.701; Parker JS, 2006, EUROPHYS LETT, V75, P950, DOI 10.1209/epl/i2006-10198-1; Sambandamurthy G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.107005; Steiner MA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.107008; VALLES JM, 1992, PHYS REV LETT, V69, P3567, DOI 10.1103/PhysRevLett.69.3567; Xu ZA, 2000, NATURE, V406, P486, DOI 10.1038/35020016; YAZDANI A, 1995, PHYS REV LETT, V74, P3037, DOI 10.1103/PhysRevLett.74.3037; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858	28	121	121	7	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1273	1275		10.1126/science.1149587	http://dx.doi.org/10.1126/science.1149587			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033876				2022-12-28	WOS:000251086600035
J	Cram, DS; Song, B; Trounson, AO				Cram, David S.; Song, Bi; Trounson, Alan O.			Genotyping of Rhesus SCNT pluripotent stem cell lines	NATURE			English	Letter							LINKAGE; LOCI		Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia	Monash University	Cram, DS (corresponding author), Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia.	david.cram@med.monash.edu.au		Trounson, Alan/0000-0001-5469-0500				Budowle B, 2005, FORENSIC SCI INT, V150, P1, DOI 10.1016/j.forsciint.2005.01.010; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Raveendran M, 2006, GENOMICS, V88, P706, DOI 10.1016/j.ygeno.2006.08.009; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004	4	9	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					E12	E14		10.1038/nature06456	http://dx.doi.org/10.1038/nature06456			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18004280				2022-12-28	WOS:000251158500033
J	Hamlin, JK; Wynn, K; Bloom, P				Hamlin, J. Kiley; Wynn, Karen; Bloom, Paul			Social evaluation by preverbal infants	NATURE			English	Article							FACES; INFERENCES	The capacity to evaluate other people is essential for navigating the social world. Humans must be able to assess the actions and intentions of the people around them, and make accurate decisions about who is friend and who is foe, who is an appropriate social partner and who is not. Indeed, all social animals benefit from the capacity to identify individual conspecifics that may help them, and to distinguish these individuals from others that may harm them. Human adults evaluate people rapidly and automatically on the basis of both behaviour and physical features(1-6), but the ontogenetic origins and development of this capacity are not well understood. Here we show that 6- and 10-month-old infants take into account an individual's actions towards others in evaluating that individual as appealing or aversive: infants prefer an individual who helps another to one who hinders another, prefer a helping individual to a neutral individual, and prefer a neutral individual to a hindering individual. These findings constitute evidence that preverbal infants assess individuals on the basis of their behaviour towards others. This capacity may serve as the foundation for moral thought and action, and its early developmental emergence supports the view that social evaluation is a biological adaptation.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Hamlin, JK (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	kiley.hamlin@yale.edu; karen.wynn@yale.edu	Wynn, Karen/C-8067-2013	Wynn, Karen/0000-0001-8908-6258				AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; CHERIES EW, IN PRESS DEV SCI; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Feigenson L, 2002, COGNITIVE PSYCHOL, V44, P33, DOI 10.1006/cogp.2001.0760; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Haidt J, 2004, DAEDALUS-US, V133, P55, DOI 10.1162/0011526042365555; HAMLIN JK, IN PRESS DEV SCI; Hauser M., 2006, MORAL MINDS; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; Kuhlmeier V., 2004, INT C INF STUD CHIC; LANGLOIS JH, 1986, PHYS APPEARANCE STIG, V3; Piaget, 1954, CONSTR REALITY CHILD; Pinker S., 2002, BLANK SLATE; Premack D, 1997, J COGNITIVE NEUROSCI, V9, P848, DOI 10.1162/jocn.1997.9.6.848; Repacholi BM, 1997, DEV PSYCHOL, V33, P12, DOI 10.1037/0012-1649.33.1.12; Shepherd J, 1981, PERCEIVING REMEMBERI; Slater A, 1998, INFANT BEHAV DEV, V21, P345, DOI 10.1016/S0163-6383(98)90011-X; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; WINTER L, 1984, J PERS SOC PSYCHOL, V47, P237, DOI 10.1037/0022-3514.47.2.237; Wood P L, 1998, Curr Opin Drug Discov Devel, V1, P34	24	780	793	13	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					557	U13		10.1038/nature06288	http://dx.doi.org/10.1038/nature06288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	234JW	18033298				2022-12-28	WOS:000251158500049
J	Raval, A; Akhavan-Toyserkani, G; Brinker, A; Avigan, M				Raval, Angela; Akhavan-Toyserkani, Gita; Brinker, Allen; Avigan, Mark			Brief communication: Characteristics of spontaneous cases of tuberculosis associated with infliximab	ANNALS OF INTERNAL MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; MANAGEMENT	Background: A warning for tuberculosis was added to the approved labeling for infliximab in October 2001. Objective: To describe adverse event reports of tuberculosis during infliximab therapy after labeling changes. Design: Case series. Setting: Spontaneous adverse event reports maintained in the Adverse Event Reporting System database in the United States. Patients: 130 patients with infliximab-associated tuberculosis. Measurements: Clinical and laboratory data. Results: The U. S. Food and Drug Administration received 130 domestic, spontaneous reports of tuberculosis in patients treated with infliximab between 1 November 2001 and 30 May 2006, including 59 (45%) with extrapulmonary disease. The most commonly reported risk factors included concomitant immunosuppressant use (n = 89), history of latent or active tuberculosis (n = 33), and being born into or having spent extensive time in an area where tuberculosis is endemic (n = 25). In the subset of 67 cases with documented initiation of infliximab therapy after the drug labeling change, 34 patients with a negative tuberculin skin test result before initiation of infliximab therapy developed tuberculosis after receiving infliximab. Limitation: Conclusions from spontaneous case reports may not be generalizable to the entire infliximab-receiving population. Conclusion: Clinicians should be vigilant in screening and monitoring for tuberculosis in patients receiving infliximab.	Ctr Drug Evaluat & Res Food & Drug Adm, Div Drug Risk Evaluat, Off Surveillance & Epidemiol, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Akhavan-Toyserkani, G (corresponding author), Ctr Drug Evaluat & Res Food & Drug Adm, Div Drug Risk Evaluat, Off Surveillance & Epidemiol, 10903 New Hampshire Ave,Bldg 22,Rm 3469, Silver Spring, MD 20993 USA.							Brinker A, 2002, CLIN PHARMACOL THER, V71, P99, DOI 10.1067/mcp.2002.120677; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Goldman SA, 1998, CLIN THER, V20, pC40, DOI 10.1016/S0149-2918(98)80007-6; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; KESSLER DA, 1993, JAMA-J AM MED ASSOC, V269, P2765, DOI 10.1001/jama.269.21.2765; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Small PM, 2001, NEW ENGL J MED, V345, P189, DOI 10.1056/NEJM200107193450307	7	58	61	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2007	147	10					699	U124		10.7326/0003-4819-147-10-200711200-00006	http://dx.doi.org/10.7326/0003-4819-147-10-200711200-00006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235UJ	18025446				2022-12-28	WOS:000251259500004
J	Roelofs, PDDM; Bierma-Zeinstra, SMA; van Poppel, MNM; Jellema, P; Willemsen, SP; van Tulder, MW; van Mechelen, W; Koes, BW				Roelofs, Pepijn D. D. M.; Bierma-Zeinstra, Sita M. A.; van Poppel, Mireille N. M.; Jellema, Petra; Willemsen, Sten P.; van Tulder, Maurits W.; van Mechelen, Willem; Koes, Bart W.			Lumbar supports to prevent recurrent low back pain among home care workers - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL IMPORTANCE; INDUSTRY	Background: People use lumbar supports to prevent low back pain. Secondary analyses from primary preventive studies suggest benefit among workers with previous low back pain, but definitive studies on the effectiveness of supports for the secondary prevention of low back pain are lacking. Objective: To determine the effectiveness of lumbar supports in the secondary prevention of low back pain. Design: Randomized, controlled trial. Setting: Home care organization in the Netherlands. Patients: 360 home care workers with self-reported history of low back pain. Intervention: Short course on healthy working methods, with or without patient-directed use of 1 of 4 types of lumbar support. Measurements: Primary outcomes were the number of days of low back pain and sick leave over 12 months. Secondary outcomes were the average severity of low back pain and function (Quebec Back Pain Disability scale) in the previous week. Results: Over 12 months, participants in the lumbar support group reported an average of -52.7 days (CI, -59.6 to -45.1 days) fewer days with low back pain than participants who received only the short course. However, the total sick days in the lumbar support group did not decrease (-5 days [CI, -21.1 to 6.8 days]). Small but statistically significant differences in pain intensity and function favored lumbar support. Limitations: Study participants were unblinded, and a substantial amount of missing data required imputation. Objective data on sick days due to low back pain were not available. Conclusion: Adding patient-directed use of lumbar supports to a short course on healthy working methods may reduce the number of days when low back pain occurs, but not overall work absenteeism, among home care workers with previous low back pain. Further study of lumbar supports is warranted.	Erasmus MC, Univ Med Ctr, Rotterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Amsterdam, Netherlands; TNO VU Univ Med Ctr, Res Ctr Phys Activ, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Roelofs, PDDM (corresponding author), Erasmus MC, Dept Gen Practice, PO Box 2040, NL-3000 CA Rotterdam, Netherlands.	p.roelofs@erasmusmc.nl	van Mechelen, Willem/C-8463-2013; Van Poppel, Mireille/AAL-8228-2020; Roelofs, Pepijn D.D.M./P-9479-2018; Koes, Bart w/K-4614-2016; Bierma-Zeinstra, Sita/AAF-2122-2019; van Tulder, Maurits/AAB-9785-2022	Van Poppel, Mireille/0000-0001-5694-4324; Roelofs, Pepijn D.D.M./0000-0003-2037-1370; Koes, Bart w/0000-0002-0450-9969; van Tulder, Maurits/0000-0002-7589-8471; van Mechelen, Willem/0000-0001-7136-6382				Andersson Gunnar B. J., 1997, P93; Dillingham TR, 1998, JAMA-J AM MED ASSOC, V279, P1826, DOI 10.1001/jama.279.22.1826; Dionne CE, 1999, SPINE, V24, P2339, DOI 10.1097/00007632-199911150-00009; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; *DUTCH COLL GEN PR, 1996, LOW BACK PAIN LAG RU; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Farrar JT, 2003, J PAIN SYMPTOM MANAG, V25, P406, DOI 10.1016/S0885-3924(03)00162-3; Hagg O, 2003, EUR SPINE J, V12, P12, DOI 10.1007/s00586-002-0464-0; Jellema P, 2002, OCCUP MED-OXFORD, V52, P317, DOI 10.1093/occmed/52.6.317; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Knibbe JJ, 1996, ERGONOMICS, V39, P186, DOI 10.1080/00140139608964450; Kopec JA, 1996, J CLIN EPIDEMIOL, V49, P151, DOI 10.1016/0895-4356(96)00526-4; MOENS GF, 1993, OCCUP MED-OXFORD, V43, P78, DOI 10.1093/occmed/43.2.78; Rafacz W, 1996, J OCCUP ENVIRON MED, V38, P925, DOI 10.1097/00043764-199609000-00016; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Schoppink LEM, 1996, PHYS THER, V76, P268, DOI 10.1093/ptj/76.3.268; Smedley J, 1997, BRIT MED J, V314, P1225, DOI 10.1136/bmj.314.7089.1225; van Poppel MNM, 2000, SPINE, V25, P2103, DOI 10.1097/00007632-200008150-00016; van Poppel MNM, 2004, OCCUP MED-OXFORD, V54, P345, DOI 10.1093/occmed/kqh065; van Poppel MNM, 1998, JAMA-J AM MED ASSOC, V279, P1789, DOI 10.1001/jama.279.22.1789; van Poppel MNM, 1998, PAIN, V77, P81, DOI 10.1016/S0304-3959(98)00085-2; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; VANTULDER MW, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001823; VENNING PJ, 1998, J OCCUP MED, V77, P81; VONKORFF M, 1999, SPINE, V21, P2838; WALSH NE, 1990, AM J PHYS MED REHAB, V69, P245, DOI 10.1097/00002060-199010000-00004	26	27	28	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2007	147	10					685	U112		10.7326/0003-4819-147-10-200711200-00004	http://dx.doi.org/10.7326/0003-4819-147-10-200711200-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235UJ	18025444				2022-12-28	WOS:000251259500002
J	Veldt, BJ; Heathcote, EJ; Wedemeyer, H; Reichen, J; Hofmann, P; Zeuzem, S; Manns, MP; Hansen, BE; Schalm, SW; Janssen, HLA				Veldt, Bart J.; Heathcote, E. Jenny; Wedemeyer, Heiner; Reichen, Juerg; Hofmann, Peter; Zeuzem, Stefan; Manns, Michael P.; Hansen, Bettina E.; Schalm, Solko W.; Janssen, Harry L. A.			Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis	ANNALS OF INTERNAL MEDICINE			English	Article							HEPATOCELLULAR-CARCINOMA; INTERFERON-ALPHA; VIRUS-INFECTION; THERAPY; CIRRHOSIS; RISK; SURVIVAL; IMPACT	Background: Clinical outcomes of chronic hepatitis C infection in patients with advanced fibrosis include liver failure, hepatocellular carcinoma, and death. Objective: To investigate whether sustained virologic response to treatment for hepatitis C is associated with improved clinical outcomes. Design: Retrospective cohort study. Setting: 5 hepatology units of tertiary care centers in Europe and Canada caring for patients with chronic hepatitis C treated between 1990 and 2003. Patients: Consecutively treated patients with chronic hepatitis C who had biopsy-proven advanced fibrosis or cirrhosis (Ishak score, 4 to 6). Measurements: Sustained virologic response, defined as absence of detectable hepatitis C virus RNA at 24 weeks after the end of treatment, and clinical outcomes, defined as death (liver-related or non-liver-related), liver failure, and hepatocellular carcinoma. Results: Of 479 patients, 29.6% had sustained virologic response and 70.3% did not. Median follow-up was 2.1 years (interquartile range, 0.8 to 4.9 years). Four patients with and 83 without sustained virologic response had at least 1 outcome event. Sustained virologic response was associated with a statistically significant reduction in the hazard of events (adjusted hazard ratio, 0.21 [95% CI, 0.07 to 0.58]; P = 0.003). The effect was largely attributable to a reduction in liver failure, which developed in no patients with and 42 patients without sustained virologic response (5-year occurrence, 0% vs. 13.3% [CI, 8.4% to 18.2%]; unadjusted hazard ratio, 0.03 [CI, 0.00 to 0.91]). Limitations: Because few events occurred in the sustained virologic response group, the study had limited ability to detect differences between groups in individual outcomes. In addition, the study was retrospective; selection and survival biases may therefore influence estimates of effect. Conclusion: Sustained virologic response to treatment is associated with improved clinical outcomes, mainly prevention of liver failure, in patients with chronic hepatitis C and advanced fibrosis.				h.janssen@erasmusmc.nl	Zeuzem, Stefan/AAE-7435-2019; Hansen, Bettina/P-5468-2014	Hansen, Bettina/0000-0001-8307-3341				BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bruno S, 2001, J HEPATOL, V34, P748, DOI 10.1016/S0168-8278(01)00062-9; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Camma C, 2004, HEPATOLOGY, V39, P333, DOI 10.1002/hep.20073; Chou R, 2004, ANN INTERN MED, V140, P465, DOI 10.7326/0003-4819-140-6-200403160-00014; Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167; Desombere I, 2005, J CLIN MICROBIOL, V43, P2590, DOI 10.1128/JCM.43.6.2590-2597.2005; Dutta U, 1999, AUST NZ J MED, V29, P300, DOI 10.1111/j.1445-5994.1999.tb00710.x; Fattovich G, 1997, J HEPATOL, V27, P201, DOI 10.1016/S0168-8278(97)80302-9; Hepatitis C-globalprevalence(update), 1999, WKLY EPIDEMIOL REC, V74, P425; Hiraoka T, 2003, INTERVIROLOGY, V46, P171, DOI 10.1159/000071458; KLETER GEM, 1994, J CLIN MICROBIOL, V32, P306, DOI 10.1128/JCM.32.2.306-310.1994; KRAJDEN M, 1995, CLIN DIAGN VIROL, V3, P113, DOI 10.1016/0928-0197(94)00031-O; Little R. J. A., 1987, STAT ANAL MISSING DA; Marusawa H, 1999, GUT, V45, P284, DOI 10.1136/gut.45.2.284; McHutchison JG, 2001, HEPATOLOGY, V34, p244A; MICHITAKA K, 1994, GASTROENTEROLOGY, V106, P1603, DOI 10.1016/0016-5085(94)90417-0; Okanoue T, 1999, J HEPATOL, V30, P653, DOI 10.1016/S0168-8278(99)80196-2; Okanoue T, 2002, HEPATOL RES, V23, P62, DOI 10.1016/S1386-6346(02)00016-5; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; REICHEN J, 1993, CLIN INVESTIGATOR, V71, P888; Sarrazin C, 2001, J CLIN MICROBIOL, V39, P2850, DOI 10.1128/JCM.39.8.2850-2855.2001; Shiratori Y, 2005, ANN INTERN MED, V142, P105, DOI 10.7326/0003-4819-142-2-200501180-00009; Valla DC, 1999, HEPATOLOGY, V29, P1870, DOI 10.1002/hep.510290616; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Veldt BJ, 2004, GUT, V53, P1504, DOI 10.1136/gut.2003.038257; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Yoshida H, 2002, GASTROENTEROLOGY, V123, P483, DOI 10.1053/gast.2002.34785	28	475	484	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2007	147	10					677	U103		10.7326/0003-4819-147-10-200711200-00003	http://dx.doi.org/10.7326/0003-4819-147-10-200711200-00003			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235UJ	18025443				2022-12-28	WOS:000251259500001
J	Mitchell, PB; Morris, M				Mitchell, Philip B.; Morris, MargaretJ			Depression and anxiety with rimonabant	LANCET			English	Editorial Material							ENDOCANNABINOID SYSTEM; OBESITY		Univ New S Wales, Sch Psychiat, Sydney, NSW 2052, Australia; Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Mitchell, PB (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW 2052, Australia.	phil.mitchell@unsw.edu.au	Samaan, M. Constantine/R-1456-2017	Samaan, M. Constantine/0000-0002-6403-4715; Morris, Margaret/0000-0003-2285-5117; Mitchell, Philip/0000-0002-7954-5235				Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Cooke D, 2006, NAT REV DRUG DISCOV, V5, P919, DOI 10.1038/nrd2136; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006162.pub2; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Gobbi G, 2005, P NATL ACAD SCI USA, V102, P18620, DOI 10.1073/pnas.0509591102; Griebel G, 2005, BIOL PSYCHIAT, V57, P261, DOI 10.1016/j.biopsych.2004.10.032; Hill MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2591, DOI 10.1038/sj.npp.1301092; Lu XY, 2006, P NATL ACAD SCI USA, V103, P1593, DOI 10.1073/pnas.0508901103; Moreira FA, 2008, NEUROPHARMACOLOGY, V54, P141, DOI 10.1016/j.neuropharm.2007.07.005; Onyike CU, 2003, AM J EPIDEMIOL, V158, P1139, DOI 10.1093/aje/kwg275; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Vinod KY, 2006, TRENDS PHARMACOL SCI, V27, P539, DOI 10.1016/j.tips.2006.08.006	12	65	66	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2007	370	9600					1671	1672		10.1016/S0140-6736(07)61705-X	http://dx.doi.org/10.1016/S0140-6736(07)61705-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	18022023				2022-12-28	WOS:000251091200006
J	Reinhardt, UE				Reinhardt, Uwe E.			US health care stands Adam Smith on his head	BRITISH MEDICAL JOURNAL			English	Editorial Material									Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Reinhardt, UE (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	reinhard@princeton.edu							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 17	2007	335	7628					1020	1020		10.1136/bmj.39398.601655.59	http://dx.doi.org/10.1136/bmj.39398.601655.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	237UV	18007002	Green Published			2022-12-28	WOS:000251402800027
J	Wu, H; Tschopp, J; Lin, SC				Wu, Hao; Tschopp, Jurg; Lin, Su-Chang			Smac mimetics and TNF alpha: A dangerous liaison?	CELL			English	Review							CELL-DEATH; KINASE RIP; APOPTOSIS; INDUCTION; MOLECULE; PATHWAY; DOMAIN; CD95	Inhibitor of apoptosis proteins (IAPs) such as XIAP, cIAP1, and cIAP2 are upregulated in many cancer cells. It has been thought that small-molecule mimetics of Smac, an endogenous IAP antagonist, might potentiate apoptosis in cancer cells by promoting caspase activation. However, three recent papers, two in Cell (Vince et al., 2007; Varfolomeev et al., 2007) and one in Cancer Cell (Petersen et al., 2007), now report that Smac mimetics primarily kill cancer cells via a different mechanism, the induction of autoubiquitination and degradation of cIAPs, which culminates in TNF alpha-mediated cell death.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Cornell University; University of Lausanne	Wu, H (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA.	haowu@med.cornell.edu	Lin, Su-Chang/F-2899-2016	Lin, Su-Chang/0000-0003-0687-3139	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045937] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1	11	109	116	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					655	658		10.1016/j.cell.2007.10.042	http://dx.doi.org/10.1016/j.cell.2007.10.042			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022360	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000250966300013
J	Duddy, ME; Baker, MR				Duddy, Martin E.; Baker, Mark R.			Harlequin's darker side	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Duddy, ME (corresponding author), Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	martin.duddy@nuth.nhs.uk		Baker, Mark/0000-0001-6916-1329					0	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2007	357	20					E22	E22		10.1056/NEJMicm067851	http://dx.doi.org/10.1056/NEJMicm067851			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230RV	18003955				2022-12-28	WOS:000250894500010
J	Brennecke, F; Donner, T; Ritter, S; Bourdel, T; Kohl, M; Esslinger, T				Brennecke, Ferdinand; Donner, Tobias; Ritter, Stephan; Bourdel, Thomas; Koehl, Michael; Esslinger, Tilman			Cavity QED with a Bose-Einstein condensate	NATURE			English	Article							SINGLE ATOMS; QUANTUM ELECTRODYNAMICS; ULTRACOLD ATOMS; ENTANGLEMENT; PHOTONS; OPTICS; FIELD	Cavity quantum electrodynamics (cavity QED) describes the coherent interaction between matter and an electromagnetic field confined within a resonator structure, and is providing a useful platform for developing concepts in quantum information processing(1). By using high-quality resonators, a strong coupling regime can be reached experimentally in which atoms coherently exchange a photon with a single light-field mode many times before dissipation sets in. This has led to fundamental studies with both microwave(2,3) and optical resonators(4). To meet the challenges posed by quantum state engineering(5) and quantum information processing, recent experiments have focused on laser cooling and trapping of atoms inside an optical cavity(6-8). However, the tremendous degree of control over atomic gases achieved with Bose-Einstein condensation(9) has so far not been used for cavity QED. Here we achieve the strong coupling of a Bose-Einstein condensate to the quantized field of an ultrahigh-finesse optical cavity and present a measurement of its eigenenergy spectrum. This is a conceptually new regime of cavity QED, in which all atoms occupy a single mode of a matter-wave field and couple identically to the light field, sharing a single excitation. This opens possibilities ranging from quantum communication(10-12) to a wealth of new phenomena that can be expected in the many-body physics of quantum gases with cavity-mediated interactions(13,14).	ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; Inst Opt, Lab Charles Fabry, F-91127 Palaiseau, France; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; UDICE-French Research Universities; Universite Paris Saclay; University of Cambridge	Esslinger, T (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	esslinger@phys.ethz.ch	Donner, Tobias/A-2845-2011; Esslinger, Tilman/M-9022-2016; Ritter, Stephan/F-1579-2010; Kohl, Michael/C-6114-2009	Donner, Tobias/0000-0001-7016-587X; Esslinger, Tilman/0000-0002-8333-107X; Ritter, Stephan/0000-0001-9002-7407; Kohl, Michael/0000-0003-4055-713X				ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Boozer AD, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083602; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; COLOMBE Y, 2007, ARXIVORGABS07061390; Daley AJ, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.022306; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; GUPTA S, 2007, ARXIVORGABS07061052; Horak P, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.033609; JAYNES ET, 1963, P IEEE, V51, P89, DOI 10.1109/PROC.1963.1664; Kimble HJ, 1998, PHYS SCRIPTA, VT76, P127, DOI 10.1238/Physica.Topical.076a00127; Kuhr S, 2001, SCIENCE, V293, P278, DOI 10.1126/science.1062725; Leslie S, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.043805; Lewenstein M, 2006, AIP CONF PROC, V869, P201; Mabuchi H, 2002, SCIENCE, V298, P1372, DOI 10.1126/science.1078446; Meiser D, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.065801; Mekhov IB, 2007, NAT PHYS, V3, P319, DOI 10.1038/nphys571; Moore MG, 1999, PHYS REV A, V60, P1491, DOI 10.1103/PhysRevA.60.1491; MURCH KW, 2007, ARXIVORGABS07061005; Nussmann S, 2005, NAT PHYS, V1, P122, DOI 10.1038/nphys120; Ottl A, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2216907; Ottl A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.090404; PELLIZZARI T, 1995, PHYS REV LETT, V75, P3788, DOI 10.1103/PhysRevLett.75.3788; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; RAIZEN MG, 1989, PHYS REV LETT, V63, P240, DOI 10.1103/PhysRevLett.63.240; Sauer JA, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.051804; Slama S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.053603; TAVIS M, 1968, PHYS REV, V170, P379, DOI 10.1103/PhysRev.170.379; Tuchman AK, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.053821; van Enk SJ, 2004, QUANTUM INF PROCESS, V3, P75, DOI 10.1007/s11128-004-3104-2; Walther H, 2002, ADV CHEM PHYS, V122, P167	30	453	459	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					268	U8		10.1038/nature06120	http://dx.doi.org/10.1038/nature06120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994093	Green Submitted			2022-12-28	WOS:000250746200054
J	Samuels, MA; Gonzalez, RG; Kim, AY; Stemmer-Rachamimov, A				Samuels, Martin A.; Gonzalez, R. Gilberto; Kim, Arthur Y.; Stemmer-Rachamimov, Anat			A 77-year-old man with ear pain, difficulty speaking, and altered mental status	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CEREBROSPINAL-FLUID OTORRHEA; BACTERIAL-MENINGITIS; ARACHNOID GRANULATIONS; CLINICAL-FEATURES; ADULTS; MANAGEMENT; THROMBOSIS; SINUSES		Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Samuels, MA (corresponding author), Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA.							ANDREWS JC, 1986, LARYNGOSCOPE, V96, P521, DOI 10.1288/00005537-198605000-00010; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; Brodie HA, 1997, AM J OTOL, V18, P188; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; GACEK RR, 1992, ARCH OTOLARYNGOL, V118, P327; GACEK RR, 1990, ANN OTO RHINOL LARYN, V99, P854, DOI 10.1177/000348949009901102; Merchant SN, 2000, AM J OTOL, V21, P234, DOI 10.1016/S0196-0709(00)80015-0; OBERASCHER G, 1988, AM J OTOL, V9, P102; Parmar M S, 2004, J Postgrad Med, V50, P272; ROSENBERG AE, 1993, HUM PATHOL, V24, P438, DOI 10.1016/0046-8177(93)90094-W; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Segal N, 2005, CLIN INFECT DIS, V41, P35, DOI 10.1086/430605; Sommer R, 1999, CLIN INFECT DIS, V29, P929, DOI 10.1086/520461; SOUTHWICK FS, 1986, MEDICINE, V65, P82, DOI 10.1097/00005792-198603000-00002; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354; SWARTZ MN, 1965, NEW ENGL J MED, V272, P725, DOI 10.1056/NEJM196504082721406; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2005, NEW ENGL J MED, V352, P950; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2002, CLIN INFECT DIS, V34, pE32, DOI 10.1086/339941	20	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1957	1965		10.1056/NEJMcpc079028	http://dx.doi.org/10.1056/NEJMcpc079028			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989389				2022-12-28	WOS:000250732500013
J	Shim, JH; Haule, K; Kotliar, G				Shim, J. H.; Haule, K.; Kotliar, G.			Modeling the localized-to-itinerant electronic transition in the heavy fermion system CeIrIn5	SCIENCE			English	Article							MEAN-FIELD THEORY; RESONANCE	We address the fundamental question of crossover from the localized to the itinerant state of a paradigmatic heavy fermion material: CeIrIn5. The temperature evolution of the one-electron spectra and the optical conductivity are predicted from first-principles calculation. The buildup of coherence in the form of a dispersive many- body feature is followed in detail, and its effects on the conduction electrons of the material are revealed. We find multiple hybridization gaps and link them to the crystal structure of the material. Our theoretical approach explains the multiple peak structures observed in optical experiments and the sensitivity of CeIrIn5 to substitutions of the transition metal element and may provide a microscopic basis for the more phenomenological descriptions currently used to interpret experiments in heavy fermion systems.	Rutgers State Univ, Dept Phys & Astron, Ctr Mat Theory, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Shim, JH (corresponding author), Rutgers State Univ, Dept Phys & Astron, Ctr Mat Theory, POB 849, Piscataway, NJ 08854 USA.	jishim@physics.rutgers.edu	Shim, Ji Hoon/F-5375-2013	Haule, Kristjan/0000-0002-2284-1551				Allen JW, 2005, J PHYS SOC JPN, V74, P34, DOI 10.1143/JPSJ.74.34; Burch KS, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.054523; COWAN RD, 1981, THEORY ATOMIC SPECTR; Degiorgi L, 1999, REV MOD PHYS, V71, P687, DOI 10.1103/RevModPhys.71.687; Fujimori S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.144507; Fujimori S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.224517; Grin' Yu. N., 1979, Soviet Physics - Crystallography, V24, P137; Haule K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.036401; HAULE K, 2007, PHYS REV B, V75; Kotliar G, 2006, REV MOD PHYS, V78, P865, DOI 10.1103/RevModPhys.78.865; Kotliar G, 2004, PHYS TODAY, V57, P53, DOI 10.1063/1.1712502; McMahan A. K., 1998, Journal of Computer-Aided Materials Design, V5, P131, DOI 10.1023/A:1008698422183; Mena FP, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045119; Moshopoulou EG, 2001, J SOLID STATE CHEM, V158, P25, DOI 10.1006/jssc.2000.9052; Nakatsuji S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.016401; Petrovic C, 2001, EUROPHYS LETT, V53, P354, DOI 10.1209/epl/i2001-00161-8; Sekiyama A, 2000, NATURE, V403, P396, DOI 10.1038/35000140; Singley EJ, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.161101; STEWART GR, 1984, REV MOD PHYS, V56, P755, DOI 10.1103/RevModPhys.56.755; Toropova A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.155126; Werner P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.076405	22	161	165	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1615	1617		10.1126/science.1149064	http://dx.doi.org/10.1126/science.1149064			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	17975033	Green Submitted			2022-12-28	WOS:000251421700043
J	Nguyen, MQ; Zhou, ZS; Marks, CA; Ryba, NJP; Belluscio, L				Nguyen, Minh Q.; Zhou, Zhishang; Marks, Carolyn A.; Ryba, Nicholas J. P.; Belluscio, Leonardo			Prominent roles for odorant receptor coding sequences in allelic exclusion	CELL			English	Article							OLFACTORY MARKER PROTEIN; MOLECULAR-CLONING; TOPOGRAPHIC MAP; AXON GUIDANCE; SENSORY MAP; EXPRESSION; MOUSE; BULB; NEURONS; SYSTEM	Mammalian odorant receptors (ORs) are crucial for establishing the functional organization of the olfactory system, but the mechanisms controlling their expression remain largely unexplained. Here, we utilized a transgenic approach to explore OR gene regulation. We determined that although olfactory sensory neurons (OSNs) are capable of supporting expression of multiple functional ORs, several levels of control ensure that each neuron normally expresses only a single odorant receptor. Surprisingly, this regulation extends beyond endogenous ORs even preventing expression of transgenes consisting of OR-coding sequences driven by synthetic promoters. Thus, part of the intrinsic feedback system must rely on elements present in the OR-coding sequence. Notably, by expressing the same transgenic ORs precociously in immature neurons, we have overcome this suppression and established a generic method to express any OR in similar to 90% of OSNs. These results provide important insights into the hierarchy of OR gene expression and the vital role of the OR-coding sequence in this regulation.	[Nguyen, Minh Q.; Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA; [Zhou, Zhishang; Marks, Carolyn A.; Belluscio, Leonardo] NIH, NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Ryba, NJP (corresponding author), Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA.	nick.ryba@nih.gov		Marks, Carolyn/0000-0002-6665-8572; Ryba, Nicholas/0000-0002-2060-8393	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003002] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DE000561-15, Z01 NS003002-05] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Acharya S, 1996, J BIOL CHEM, V271, P25406, DOI 10.1074/jbc.271.41.25406; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cheng LE, 2007, NEURON, V54, P547, DOI 10.1016/j.neuron.2007.04.029; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Ma MH, 1999, J NEUROSCI METH, V92, P31, DOI 10.1016/S0165-0270(99)00089-8; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Qasba P, 1998, J NEUROSCI, V18, P227; Redfern CH, 2000, P NATL ACAD SCI USA, V97, P4826, DOI 10.1073/pnas.97.9.4826; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; ROGERS KE, 1987, P NATL ACAD SCI USA, V84, P1704, DOI 10.1073/pnas.84.6.1704; RYBA NJP, 1995, J BIOL CHEM, V270, P6757, DOI 10.1074/jbc.270.12.6757; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Walters E, 1996, J NEUROSCI RES, V43, P146; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	40	102	105	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					1009	1017		10.1016/j.cell.2007.10.050	http://dx.doi.org/10.1016/j.cell.2007.10.050			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045541	Bronze, Green Accepted			2022-12-28	WOS:000251800900021
J	Ranganathan, R				Ranganathan, Rama			Signaling across the cell membrane	SCIENCE			English	Editorial Material							PROTEIN-COUPLED RECEPTORS; RHODOPSIN		Univ Texas, SW Med Ctr, Green Ctr Syst Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas, SW Med Ctr, Green Ctr Syst Biol, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu						Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Day PW, 2007, NAT METHODS, V4, P927, DOI 10.1038/NMETH1112; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; McCusker EC, 2007, BIOTECHNOL PROGR, V23, P540, DOI 10.1021/bp060349b; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PARK PS, 2007, ANN REV PHARM TOXICO; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013	13	16	17	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1253	1254		10.1126/science.1151656	http://dx.doi.org/10.1126/science.1151656			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033872				2022-12-28	WOS:000251086600029
J	Warnecke, F; Luginbuhl, P; Ivanova, N; Ghassemian, M; Richardson, TH; Stege, JT; Cayouette, M; McHardy, AC; Djordjevic, G; Aboushadi, N; Sorek, R; Tringe, SG; Podar, M; Martin, HG; Kunin, V; Dalevi, D; Madejska, J; Kirton, E; Platt, D; Szeto, E; Salamov, A; Barry, K; Mikhailova, N; Kyrpides, NC; Matson, EG; Ottesen, EA; Zhang, XN; Hernandez, M; Murillo, C; Acosta, LG; Rigoutsos, I; Tamayo, G; Green, BD; Chang, C; Rubin, EM; Mathur, EJ; Robertson, DE; Hugenholtz, P; Leadbetter, JR				Warnecke, Falk; Luginbuehl, Peter; Ivanova, Natalia; Ghassemian, Majid; Richardson, Toby H.; Stege, Justin T.; Cayouette, Michelle; McHardy, Alice C.; Djordjevic, Gordana; Aboushadi, Nahla; Sorek, Rotem; Tringe, Susannah G.; Podar, Mircea; Martin, Hector Garcia; Kunin, Victor; Dalevi, Daniel; Madejska, Julita; Kirton, Edward; Platt, Darren; Szeto, Ernest; Salamov, Asaf; Barry, Kerrie; Mikhailova, Natalia; Kyrpides, Nikos C.; Matson, Eric G.; Ottesen, Elizabeth A.; Zhang, Xinning; Hernandez, Myriam; Murillo, Catalina; Acosta, Luis G.; Rigoutsos, Isidore; Tamayo, Giselle; Green, Brian D.; Chang, Cathy; Rubin, Edward M.; Mathur, Eric J.; Robertson, Dan E.; Hugenholtz, Philip; Leadbetter, Jared R.			Metagenomic and functional analysis of hindgut microbiota of a wood-feeding higher termite	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC ANALYSIS; NITROGEN-FIXATION; GUT; CELLULASES; LIGNOCELLULOSE; CLASSIFICATION; DEGRADATION; ISOPTERA; DATABASE	From the standpoints of both basic research and biotechnology, there is considerable interest in reaching a clearer understanding of the diversity of biological mechanisms employed during lignocellulose degradation. Globally, termites are an extremely successful group of wood-degrading organisms(1) and are therefore important both for their roles in carbon turnover in the environment and as potential sources of biochemical catalysts for efforts aimed at converting wood into biofuels. Only recently have data supported any direct role for the symbiotic bacteria in the gut of the termite in cellulose and xylan hydrolysis(2). Here we use a metagenomic analysis of the bacterial community resident in the hindgut paunch of a wood-feeding 'higher' Nasutitermes species ( which do not contain cellulose-fermenting protozoa) to show the presence of a large, diverse set of bacterial genes for cellulose and xylan hydrolysis. Many of these genes were expressed in vivo or had cellulase activity in vitro, and further analyses implicate spirochete and fibrobacter species in gut lignocellulose degradation. New insights into other important symbiotic functions including H-2 metabolism, CO2-reductive acetogenesis and N-2 fixation are also provided by this first system-wide gene analysis of a microbial community specialized towards plant lignocellulose degradation. Our results underscore how complex even a 1-mu l environment can be.	CALTECH, Dept Environm Sci & Engn, Pasadena, CA 91125 USA; DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; Verenium Corp, San Diego, CA 92121 USA; IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Inst Nacl Biodiversidad, INBio, Santo Domingo De Heredia, Costa Rica	California Institute of Technology; United States Department of Energy (DOE); International Business Machines (IBM); United States Department of Energy (DOE); Oak Ridge National Laboratory; California Institute of Technology	Leadbetter, JR (corresponding author), CALTECH, Dept Environm Sci & Engn, Mailcode 138-78, Pasadena, CA 91125 USA.	jleadbetter@caltech.edu	Rigoutsos, Isidore/C-5381-2012; Martin, Hector Garcia/B-5357-2009; McHardy, Alice C/K-9377-2018; McHardy, Alice/ABF-2322-2020; Kyrpides, Nikos C./A-6305-2014; Podar, Mircea/B-7299-2012; Tamayo, Giselle/J-3609-2015; Barry, Kerrie Whitelaw/AAA-5500-2020; Tringe, Susannah Green/T-9431-2019; Hugenholtz, Philip/AAD-9138-2019	Martin, Hector Garcia/0000-0002-4556-9685; McHardy, Alice C/0000-0003-2370-3430; McHardy, Alice/0000-0003-2370-3430; Kyrpides, Nikos C./0000-0002-6131-0462; Podar, Mircea/0000-0003-2776-0205; Tamayo, Giselle/0000-0002-4912-8895; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Tringe, Susannah Green/0000-0001-6479-8427; Hugenholtz, Philip/0000-0001-5386-7925; Zhang, Xinning/0000-0003-2763-1526; Kunin, Victor/0000-0002-8741-7866; Leadbetter, Jared/0000-0002-7033-0844; Ivanova, Natalia/0000-0002-5802-9485; Rigoutsos, Isidore/0000-0003-1529-8631				Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Austin JW, 2004, ANN ENTOMOL SOC AM, V97, P548, DOI 10.1603/0013-8746(2004)097[0548:PAOTST]2.0.CO;2; Bates PA, 2001, PROTEINS, P39; Beckwith TD, 1927, SCIENCE, V65, P165, DOI 10.1126/science.65.1676.165; Brennan Y, 2004, APPL ENVIRON MICROB, V70, P3609, DOI 10.1128/AEM.70.6.3609-3617.2004; BREZNAK JA, 1986, APPL ENVIRON MICROB, V52, P623, DOI 10.1128/AEM.52.4.623-630.1986; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Brune A, 2000, CURR OPIN MICROBIOL, V3, P263, DOI 10.1016/S1369-5274(00)00087-4; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681, DOI 10.1128/AEM.61.7.2681-2687.1995; Brune A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P439, DOI 10.1007/0-387-30741-9_17; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DAVIES DG, 1995, APPL ENVIRON MICROB, V61, P860, DOI 10.1128/AEM.61.3.860-867.1995; Davies GJ, 2002, BIOCHEM SOC T, V30, P291, DOI 10.1042/BST0300291; DECAPRARIIS P, 1976, J INT ASS MATH GEOL, V8, P575; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Efron B., 1994, MONOGRAPHS STAT APPL; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JOHNSTON D, 2002, HDB FOOD ENZYMOLOGY, P761; Kambhampati S, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P1; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marchler-Bauer A, 2002, PROTEINS, V48, P439, DOI 10.1002/prot.10163; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Markowitz VM, 2006, BIOINFORMATICS, V22, pE359, DOI 10.1093/bioinformatics/btl217; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; ODELSON DA, 1985, APPL ENVIRON MICROB, V49, P614, DOI 10.1128/AEM.49.3.614-621.1985; Ohkuma M, 1999, APPL ENVIRON MICROB, V65, P4926; Ohkuma M, 2004, MOL PHYLOGENET EVOL, V31, P701, DOI 10.1016/j.ympev.2003.09.009; Pester M, 2007, ISME J, V1, P551, DOI 10.1038/ismej.2007.62; Pester M, 2006, ENVIRON MICROBIOL, V8, P1261, DOI 10.1111/j.1462-2920.2006.01020.x; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; POTRIKUS CJ, 1980, APPL ENVIRON MICROB, V40, P125, DOI 10.1128/AEM.40.1.125-132.1980; PRESTWICH GD, 1980, OECOLOGIA, V46, P397, DOI 10.1007/BF00346270; Qi M, 2005, J BACTERIOL, V187, P3739, DOI 10.1128/JB.187.11.3739-3751.2005; Ragsdale SW, 1997, BIOFACTORS, V6, P3, DOI 10.1002/biof.5520060102; Robertson DE, 2004, APPL ENVIRON MICROB, V70, P2429, DOI 10.1128/AEM.70.4.2429-2436.2004; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sugimoto A, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P409; Taylor LE, 2006, J BACTERIOL, V188, P3849, DOI 10.1128/JB.01348-05; Tokuda G, 2004, MOL ECOL, V13, P3219, DOI 10.1111/j.1365-294X.2004.02276.x; Tokuda G, 2007, BIOL LETTERS, V3, P336, DOI 10.1098/rsbl.2007.0073; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wei J, 2005, J PROTEOME RES, V4, P801, DOI 10.1021/pr0497632; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Xie G, 2007, APPL ENVIRON MICROB, V73, P3536, DOI 10.1128/AEM.00225-07	66	952	1018	21	506	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					560	U17		10.1038/nature06269	http://dx.doi.org/10.1038/nature06269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033299	Green Submitted			2022-12-28	WOS:000251158500050
J	Goodson, JD				Goodson, John D.			Unintended consequences of resource-based relative value scale reimbursement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY-CARE; HEALTH-CARE; PHYSICIANS; PREVENTION; SYSTEMS; COSTS		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Goodson, JD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, 15 Parkman St, Boston, MA 02114 USA.	jgoodson1@partners.org						*AM MED ASS RVS UP, AMA SPEC SOC RVS UPD; Baicker K, 2004, HLTH AFF MILLWOOD S; Beasley JW, 2004, ANN FAM MED, V2, P405, DOI 10.1370/afm.94; Bodenheimer T, 2005, ANN INTERN MED, V143, P26, DOI 10.7326/0003-4819-143-1-200507050-00007; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Forrest CB, 2006, JAMA-J AM MED ASSOC, V295, P1062, DOI 10.1001/jama.295.9.1062; Garibaldi RA, 2005, ACAD MED, V80, P507, DOI 10.1097/00001888-200505000-00021; Ginsburg PB, 2007, NEW ENGL J MED, V356, P1201, DOI 10.1056/NEJMp068272; GINSBURG PB, 2005, HLTH AFF MILLWOOD S; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; HSIAO WC, 1988, NEW ENGL J MED, V319, P835, DOI 10.1056/NEJM198809293191305; *HYP DET FOLL UP P, 1979, JAMA-J AM MED ASSOC, V242, P2562; Maxwell S, 2007, NEW ENGL J MED, V356, P1853, DOI 10.1056/NEJMsa063258; Medicare Payment Advisory Commission (MedPAC), 2007, REP C PROM GREAT EFF; *MEDPAC, 2007, REP C ASS ALT SUST G; Newhouse JP, 2007, NEW ENGL J MED, V356, P1883, DOI 10.1056/NEJMe078031; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Sox HC, 2006, ANN INTERN MED, V144, P57, DOI 10.7326/0003-4819-144-1-200601030-00010; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; TOLKOFF M, 2006, MED EC           OCT; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742; West CP, 2006, ANN INTERN MED, V145, P774, DOI 10.7326/0003-4819-145-10-200611210-00010; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	25	45	45	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2007	298	19					2308	2310		10.1001/jama.298.19.2308	http://dx.doi.org/10.1001/jama.298.19.2308			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232XV	18029836				2022-12-28	WOS:000251055900032
J	Lin, OS				Lin, Otto S.			Clinical update: postpolypectomy colonoscopy surveillance	LANCET			English	Article							COLORECTAL-CANCER; POLYP; POLYPECTOMY; PREVENTION; GUIDELINES; ADENOMAS		Virginia Mason Med Ctr, Seattle, WA 98101 USA; Univ Washington, Sch Med, Seattle, WA USA	Virginia Mason Medical Center; University of Washington; University of Washington Seattle	Lin, OS (corresponding author), Virginia Mason Med Ctr, Seattle, WA 98101 USA.	Otto.Lin@vmmc.org						Atkin WS, 2002, GUT, V51, pV6, DOI 10.1136/gut.51.suppl_5.v6; Bampton PA, 2005, GUT, V54, P803, DOI 10.1136/gut.2004.043786; Bensen S, 1999, AM J GASTROENTEROL, V94, P194; Bond JH, 2000, AM J GASTROENTEROL, V95, P3053; Boolchand V, 2006, ANN INTERN MED, V145, P654, DOI 10.7326/0003-4819-145-9-200611070-00007; BRENNER H, 2007, AM J GASTROENTEROL, V102, P1; Colquhoun P, 2004, Colorectal Dis, V6, P158, DOI 10.1111/j.1463-1318.2004.00585.x; Davila RE, 2006, GASTROINTEST ENDOSC, V63, P546, DOI 10.1016/j.gie.2006.02.002; Hawk ET, 2004, GASTROENTEROLOGY, V126, P1423, DOI 10.1053/j.gastro.2004.03.002; JORGENSEN OD, 1995, SCAND J GASTROENTERO, V30, P686, DOI 10.3109/00365529509096314; Pabby A, 2005, GASTROINTEST ENDOSC, V61, P385, DOI 10.1016/S0016-5107(04)02765-8; Ransohoff DF, 2005, GASTROENTEROLOGY, V128, P1685, DOI 10.1053/j.gastro.2005.04.005; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Saini SD, 2006, GASTROINTEST ENDOSC, V64, P614, DOI 10.1016/j.gie.2006.06.057; Sanaka MR, 2006, GASTROINTEST ENDOSC, V63, P97, DOI 10.1016/j.gie.2005.08.048; Taupin D, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-82; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	20	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2007	370	9600					1674	1676		10.1016/S0140-6736(07)61707-3	http://dx.doi.org/10.1016/S0140-6736(07)61707-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	18022025				2022-12-28	WOS:000251091200008
J	Edelman, GM				Edelman, Gerald M.			Perspective - Learning in and from brain-based devices	SCIENCE			English	Editorial Material							SYSTEMS	Biologically based mobile devices have been constructed that differ from robots based on artificial intelligence. These brain-based devices (BBDs) contain simulated brains that autonomously categorize signals from the environment without a priori instruction. Two such BBDs, Darwin VII and Darwin X, are described here. Darwin VII recognizes objects and links categories to behavior through instrumental conditioning. Darwin X puts together the "what," "when," and "where" from cues in the environment into an episodic memory that allows it to find a desired target. Although these BBDs are designed to provide insights into how the brain works, their principles may find uses in building hybrid machines. These machines would combine the learning ability of BBDs with explicitly programmed control systems.	Inst Neurosci, San Diego, CA 92121 USA		Edelman, GM (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.	edelman@nsi.edu						Edelman GM, 2003, P NATL ACAD SCI USA, V100, P5520, DOI 10.1073/pnas.0931349100; EDELMAN GM, 1992, P NATL ACAD SCI USA, V89, P7267, DOI 10.1073/pnas.89.15.7267; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Holland O., 2003, MACHINE CONSCIOUSNES; Krichmar JL, 2005, ARTIF LIFE, V11, P63, DOI 10.1162/1064546053278946; Krichmar JL, 2005, P NATL ACAD SCI USA, V102, P2111, DOI 10.1073/pnas.0409792102; NOLFE S, 2000, EVOLUTIONARY ROBOTIC; Seth AK, 2005, NEUROINFORMATICS, V3, P167, DOI 10.1385/NI:3:3:167; Thrun S., 2005, PROBABILISTIC ROBOTI; Thrun S., 2005, ROBOTICS SCI SYSTEMS, VMassachusetts, P2005	10	44	50	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1103	1105		10.1126/science.1148677	http://dx.doi.org/10.1126/science.1148677			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006739				2022-12-28	WOS:000250957900036
J	Griffiths, GM				Griffiths, Gillian M.			Gaucher disease: Forging a new path to the lysosome	CELL			English	Editorial Material								Most lysosomal proteins are tagged with a carbohydrate modification that allows their recognition and transport to the lysosome. In this issue, Reczek et al. (2007) identify a new pathway for protein sorting to the lysosome. They show that beta- glucocerebrosidase - the lysosomal enzyme defective in patients with Gaucher disease - is delivered to the lysosome through its interaction with the transmembrane protein LIMP-2.	Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Addenbrooke's Hospital; University of Cambridge	Griffiths, GM (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Wellcome MRC Bldg,Box139,Hills Rd, Cambridge CB2 0XY, England.	gg305@cam.ac.uk		Griffiths, Gillian/0000-0003-0434-5842	Wellcome Trust [075880] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; KORNFELD S, 1990, BIOCHEM SOC T, V18, P367, DOI 10.1042/bst0180367; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P4862	3	9	10	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					647	649		10.1016/j.cell.2007.10.043	http://dx.doi.org/10.1016/j.cell.2007.10.043			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022357	Bronze			2022-12-28	WOS:000250966300010
J	Jockusch, WJ; Speidel, D; Sigler, A; Sorensen, JB; Varoqueaux, F; Rhee, JS; Brose, N				Jockusch, Wolf J.; Speidel, Dina; Sigler, Albrecht; Sorensen, Jakob B.; Varoqueaux, Frederique; Rhee, Jeong-Seop; Brose, Nils			CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins	CELL			English	Article							DENSE-CORE VESICLE; UNC-31 CAPS; RELEASE; EXOCYTOSIS; MUNC13-1; CELL; EXPRESSION; SECRETION; DEFINITION; MECHANISMS	Before transmitter-filled synaptic vesicles can fuse with the plasma membrane upon stimulation they have to be primed to fusion competence. The regulation of this priming process controls the strength and plasticity of synaptic transmission between neurons, which in turn determines many complex brain functions. We show that CAPS-1 and CAPS-2 are essential components of the synaptic vesicle priming machinery. CAPS-deficient neurons contain no or very few fusion competent synaptic vesicles, which causes a selective impairment of fast phasic transmitter release. Increases in the intracellular Ca2+ levels can transiently revert this defect. Our findings demonstrate that CAPS proteins generate and maintain a highly fusion competent synaptic vesicle pool that supports phasic Ca2+ triggered release of transmitters.	Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society	Rhee, JS (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	rhee@em.mpg.de; brose@em.mpg.de	Varoqueaux, Frederique/AAC-1834-2021	Varoqueaux, Frederique/0000-0002-3614-3121; Sorensen, Jakob/0000-0001-5465-3769				Andrews-Zwilling YS, 2006, J BIOL CHEM, V281, P19720, DOI 10.1074/jbc.M601421200; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Beinfeld MC, 2005, J BIOL CHEM, V280, P38410, DOI 10.1074/jbc.M500055200; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Charlie NK, 2006, GENETICS, V172, P943, DOI 10.1534/genetics.105.049577; Dimova K, 2006, BBA-MOL CELL RES, V1763, P1256, DOI 10.1016/j.bbamcr.2006.09.017; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Gracheva EO, 2007, J NEUROSCI, V27, P10176, DOI 10.1523/JNEUROSCI.2339-07.2007; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Morgan A, 1997, SEMIN CELL DEV BIOL, V8, P141, DOI 10.1006/scdb.1996.0133; Otsu Y, 2004, J NEUROSCI, V24, P9076, DOI 10.1523/JNEUROSCI.2060-04.2004; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rupnik M, 2000, P NATL ACAD SCI USA, V97, P5627, DOI 10.1073/pnas.090359097; Sadakata T, 2006, J COMP NEUROL, V495, P735, DOI 10.1002/cne.20947; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens DR, 2005, CURR BIOL, V15, P2243, DOI 10.1016/j.cub.2005.10.055; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	48	134	136	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					796	808		10.1016/j.cell.2007.11.002	http://dx.doi.org/10.1016/j.cell.2007.11.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022372	Bronze, Green Submitted			2022-12-28	WOS:000250966300025
J	Piazzesi, G; Reconditi, M; Linari, M; Lucii, L; Bianco, P; Brunello, E; Decostre, V; Stewart, A; Gore, DB; Irving, TC; Irving, M; Lombardi, V				Piazzesi, Gabriella; Reconditi, Massimo; Linari, Marco; Lucii, Leonardo; Bianco, Pasquale; Brunello, Elisabetta; Decostre, Valerie; Stewart, Alex; Gore, David B.; Irving, Thomas C.; Irving, Malcolm; Lombardi, Vincenzo			Skeletal muscle performance determined by modulation of number of myosin motors rather than motor force or stroke size	CELL			English	Article							X-RAY-DIFFRACTION; WORKING STROKE; ISOMETRIC CONTRACTION; POWER STROKE; ACTIN; HEADS; MECHANISM; FROG; GENERATION; STIFFNESS	Skeletal muscle can bear a high load at constant length, or shorten rapidly when the load is low. This force-velocity relationship is the primary determinant of muscle performance in vivo. Here we exploited the quasi-crystalline order of myosin II motors in muscle filaments to determine the molecular basis of this relationship by X-ray interference and mechanical measurements on intact single cells. We found that, during muscle shortening at a wide range of velocities, individual myosin motors maintain a force of about 6 pN while pulling an actin filament through a 6 nm stroke, then quickly detach when the motor reaches a critical conformation. Thus we show that the force-velocity relationship is primarily a result of a reduction in the number of motors attached to actin in each filament in proportion to the filament load. These results explain muscle performance and efficiency in terms of the molecular mechanism of the myosin motor.	Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; Univ Florence, Dipartimento Biol Anim & Genet, Lab Fisiol, I-50019 Sesto Fiorentino, Italy; Univ Roma La Sapienza, CRS SOFT INFM CNR, I-00185 Rome, Italy; Dexela Ltd, Spitfire Studios, London N1 9BE, England; BioCAT, Adv Photon Source, Argonne, IL 60439 USA	University of London; King's College London; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Sapienza University Rome; United States Department of Energy (DOE); Argonne National Laboratory	Irving, M (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England.	malcolm.irving@kcl.ac.uk		RECONDITI, MASSIMO/0000-0001-5065-924X; Brunello, Elisabetta/0000-0003-3167-4828; Bianco, Pasquale/0000-0002-0705-4349; LINARI, MARCO/0000-0001-6512-4897	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049033] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-08630] Funding Source: Medline; NIAMS NIH HHS [R01AR049033.03] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Barclay CJ, 1998, J MUSCLE RES CELL M, V19, P855, DOI 10.1023/A:1005409708838; Capitanio M, 2006, P NATL ACAD SCI USA, V103, P87, DOI 10.1073/pnas.0506830102; COOKE R, 1980, BIOCHEMISTRY-US, V19, P2265, DOI 10.1021/bi00551a042; Cooke R, 1997, PHYSIOL REV, V77, P671, DOI 10.1152/physrev.1997.77.3.671; CRAIG R, 1977, J MOL BIOL, V109, P69, DOI 10.1016/S0022-2836(77)80046-6; DAWSON MJ, 1978, NATURE, V274, P861, DOI 10.1038/274861a0; Decostre V, 2005, P NATL ACAD SCI USA, V102, P13927, DOI 10.1073/pnas.0506795102; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; HANSON J, 1953, NATURE, V172, P530, DOI 10.1038/172530b0; Holmes KC, 1997, CURR BIOL, V7, pR112, DOI 10.1016/S0960-9822(06)00051-0; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1981, J PHYSIOL-LONDON, V317, pP12; Huxley AF, 1996, J MUSCLE RES CELL M, V17, P507, DOI 10.1007/BF00123366; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1983, J MOL BIOL, V169, P469, DOI 10.1016/S0022-2836(83)80062-X; HUXLEY HE, 1967, J MOL BIOL, V30, P383, DOI 10.1016/S0022-2836(67)80046-9; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Huxley H, 2006, J MOL BIOL, V363, P743, DOI 10.1016/j.jmb.2006.08.075; Huxley H, 2006, J MOL BIOL, V363, P762, DOI 10.1016/j.jmb.2006.08.055; Irving M, 2000, NAT STRUCT BIOL, V7, P482, DOI 10.1038/75890; Irving TC, 2000, NUCL INSTRUM METH A, V448, P250, DOI 10.1016/S0168-9002(99)00732-9; Lan GH, 2005, BIOPHYS J, V88, P4107, DOI 10.1529/biophysj.104.056846; Linari M, 2000, P NATL ACAD SCI USA, V97, P7226, DOI 10.1073/pnas.97.13.7226; Linari M, 1998, BIOPHYS J, V74, P2459, DOI 10.1016/S0006-3495(98)77954-8; LINARI M, 1995, J PHYSIOL-LONDON, V487, P699, DOI 10.1113/jphysiol.1995.sp020911; LOMBARDI V, 1990, J PHYSIOL-LONDON, V431, P141, DOI 10.1113/jphysiol.1990.sp018324; LOMBARDI V, 1992, NATURE, V355, P638, DOI 10.1038/355638a0; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Phillips WC, 2002, J SYNCHROTRON RADIAT, V9, P36; PIAZZESI G, 1995, BIOPHYS J, V68, P1966, DOI 10.1016/S0006-3495(95)80374-7; Piazzesi G, 1999, J PHYSIOL-LONDON, V514, P305, DOI 10.1111/j.1469-7793.1999.305ae.x; Piazzesi G, 2002, NATURE, V415, P659, DOI 10.1038/415659a; Piazzesi G, 2002, J PHYSIOL-LONDON, V545, P145, DOI 10.1113/jphysiol.2002.028969; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reconditi M, 2004, NATURE, V428, P578, DOI 10.1038/nature02380; Reconditi M, 2006, REP PROG PHYS, V69, P2709, DOI 10.1088/0034-4885/69/10/R01; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Sleep J, 2006, P NATL ACAD SCI USA, V103, P1278, DOI 10.1073/pnas.0506272103; Smith DA, 2001, BIOPHYS J, V81, P2795, DOI 10.1016/S0006-3495(01)75922-X; Steffen W, 2001, P NATL ACAD SCI USA, V98, P14949, DOI 10.1073/pnas.261560698; Takagi Y, 2006, BIOPHYS J, V90, P1295, DOI 10.1529/biophysj.105.068429; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5	53	222	224	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					784	795		10.1016/j.cell.2007.09.045	http://dx.doi.org/10.1016/j.cell.2007.09.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022371	Bronze			2022-12-28	WOS:000250966300024
J	Jacobs, DO				Jacobs, Danny O.			Diverticulitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE COLONIC DIVERTICULITIS; SIGMOID DIVERTICULITIS; PERCUTANEOUS DRAINAGE; SURGICAL-MANAGEMENT; HARTMANNS PROCEDURE; DISEASE; ABSCESSES; CT; PERITONITIS; ANASTOMOSIS		Duke Univ, Med Ctr, Dept Surg, Sch Med, Durham, NC 27710 USA; Duke Univ Hosp, Durham, NC USA	Duke University; Duke University	Jacobs, DO (corresponding author), Duke Univ, Med Ctr, Dept Surg, Sch Med, DUMC Box 3704, Durham, NC 27710 USA.							AMBROSETTI P, 1994, SURGERY, V115, P546; Ambrosetti P, 1997, BRIT J SURG, V84, P532, DOI 10.1046/j.1365-2168.1997.02576.x; AMBROSETTI P, 1992, DIS COLON RECTUM, V35, P1072, DOI 10.1007/BF02252998; Anaya DA, 2005, ARCH SURG-CHICAGO, V140, P681, DOI 10.1001/archsurg.140.7.681; Belmonte C, 1996, ARCH SURG-CHICAGO, V131, P612; Berthou JC, 1999, SURG ENDOSC-ULTRAS, V13, P457, DOI 10.1007/s004649901012; Biondo S, 2002, BRIT J SURG, V89, P1137, DOI 10.1046/j.1365-2168.2002.02195.x; Blair NP, 2002, AM J SURG, V183, P525, DOI 10.1016/S0002-9610(02)00830-9; Broderick-Villa G, 2005, ARCH SURG-CHICAGO, V140, P576, DOI 10.1001/archsurg.140.6.576; Brook I, 2000, J MED MICROBIOL, V49, P827, DOI 10.1099/0022-1317-49-9-827; BURKITT DP, 1974, JAMA-J AM MED ASSOC, V229, P1068, DOI 10.1001/jama.229.8.1068; Chapman JR, 2006, ANN SURG, V243, P876, DOI 10.1097/01.sla.0000219682.98158.11; CHO KC, 1990, RADIOLOGY, V176, P111, DOI 10.1148/radiology.176.1.2191360; Constantinides VA, 2006, DIS COLON RECTUM, V49, P966, DOI 10.1007/s10350-006-0547-9; Ferzoco LB, 1998, NEW ENGL J MED, V338, P1521, DOI 10.1056/NEJM199805213382107; Floch MH, 2006, WORLD J GASTROENTERO, V12, P3225, DOI 10.3748/wjg.v12.i20.3225; Graves H A Jr, 1973, Am Surg, V39, P142; Harisinghani MG, 2003, RADIOLOGY, V228, P701, DOI 10.1148/radiol.2283020924; Kaiser AM, 2005, AM J GASTROENTEROL, V100, P910, DOI 10.1111/j.1572-0241.2005.41154.x; Klarenbeek Bastiaan R, 2007, BMC Surg, V7, P16, DOI 10.1186/1471-2482-7-16; Kohler L, 1999, SURG ENDOSC-ULTRAS, V13, P430, DOI 10.1007/s004649901007; Korzenik JR, 2006, J CLIN GASTROENTEROL, V40, pS112, DOI 10.1097/01.mcg.0000225503.59923.6c; KRUKOWSKI ZH, 1984, BRIT J SURG, V71, P921, DOI 10.1002/bjs.1800711202; Kumar RR, 2006, DIS COLON RECTUM, V49, P183, DOI 10.1007/s10350-005-0274-7; Machicado G A, 1997, Gastroenterologist, V5, P189; Mazuski John E, 2002, Surg Infect (Larchmt), V3, P161, DOI 10.1089/109629602761624171; MCKEE RF, 1993, BRIT J SURG, V80, P560, DOI 10.1002/bjs.1800800506; Mueller MH, 2005, EUR J GASTROEN HEPAT, V17, P649, DOI 10.1097/00042737-200506000-00009; Munson KD, 1996, DIS COLON RECTUM, V39, P318, DOI 10.1007/BF02049475; PADIDAR AM, 1994, AM J ROENTGENOL, V163, P81, DOI 10.2214/ajr.163.1.8010253; Parra-Blanco A, 2006, DIGESTION, V73, P47, DOI 10.1159/000089779; Rafferty J, 2006, DIS COLON RECTUM, V49, P939, DOI 10.1007/s10350-006-0578-2; Salem L, 2004, DIS COLON RECTUM, V47, P1953, DOI 10.1007/s10350-004-0701-1; Salem TA, 2006, COLORECTAL DIS, V8, P173, DOI 10.1111/j.1463-1318.2005.00865.x; Salzman H, 2005, AM FAM PHYSICIAN, V72, P1229; Schechter S, 1999, DIS COLON RECTUM, V42, P470, DOI 10.1007/BF02234169; Schwesinger WH, 2000, ARCH SURG-CHICAGO, V135, P558, DOI 10.1001/archsurg.135.5.558; Siewert B, 2006, AM J ROENTGENOL, V186, P680, DOI 10.2214/AJR.04.1708; Siewert B, 2007, AM J ROENTGENOL, V189, P512; Somasekar K, 2002, J ROY COLL SURG EDIN, V47, P481; STABILE BE, 1990, AM J SURG, V159, P99, DOI 10.1016/S0002-9610(05)80613-0; Stollman N, 2004, LANCET, V363, P631, DOI 10.1016/S0140-6736(04)15597-9; Stollman NH, 1999, J CLIN GASTROENTEROL, V29, P241, DOI 10.1097/00004836-199910000-00004; TRUELOVE SC, 1966, PHYSIOL REV, V46, P457; Tursi A, 2004, EXPERT OPIN PHARMACO, V5, P55, DOI 10.1517/14656566.5.1.55; TYAU ES, 1991, ARCH SURG-CHICAGO, V126, P855; Wedell J, 1997, BRIT J SURG, V84, P380, DOI 10.1046/j.1365-2168.1997.02566.x; Wexner SD, 2000, SURG CLIN N AM, V80, P1299, DOI 10.1016/S0039-6109(05)70226-7; Zaidi E, 2006, AM J ROENTGENOL, V187, P689, DOI 10.2214/AJR.05.0033; Zorcolo L, 2003, Colorectal Dis, V5, P262, DOI 10.1046/j.1463-1318.2003.00432.x	50	299	307	3	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2007	357	20					2057	2066		10.1056/NEJMcp073228	http://dx.doi.org/10.1056/NEJMcp073228			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230RV	18003962				2022-12-28	WOS:000250894500008
J	Lehmann, E; Brueckner, F; Cramer, P				Lehmann, Elisabeth; Brueckner, Florian; Cramer, Patrick			Molecular basis of RNA-dependent RNA polymerase II activity	NATURE			English	Article							HEPATITIS-DELTA ANTIGEN; ELONGATION COMPLEX; ESCHERICHIA-COLI; STRUCTURAL BASIS; LID ELEMENT; DNA HYBRID; IN-VITRO; TRANSCRIPTION; TFIIS; ARCHITECTURE	RNA polymerase (Pol) II catalyses DNA-dependent RNA synthesis during gene transcription. There is, however, evidence that Pol II also possesses RNA-dependent RNA polymerase (RdRP) activity. Pol II can use a homopolymeric RNA template(1), can extend RNA by several nucleotides in the absence of DNA(2), and has been implicated in the replication of the RNA genomes of hepatitis delta virus (HDV)(3,4) and plant viroids(5). Here we show the intrinsic RdRP activity of Pol II with only pure polymerase, an RNA template-product scaffold and nucleoside triphosphates (NTPs). Crystallography reveals the template-product duplex in the site occupied by the DNA-RNA hybrid during transcription. RdRP activity resides at the active site used during transcription, but it is slower and less processive than DNA-dependent activity. RdRP activity is also obtained with part of the HDV antigenome. The complex of transcription factor IIS (TFIIS) with Pol II can cleave one HDV strand, create a reactive stem-loop in the hybrid site, and extend the new RNA 3' end. Short RNA stem-loops with a 5' extension suffice for activity, but their growth to a critical length apparently impairs processivity. The RdRP activity of Pol II provides a missing link in molecular evolution, because it suggests that Pol II evolved from an ancient replicase that duplicated RNA genomes.	Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; Univ Munich, Ctr Integrated Prot Sci, Dept Chem & Biochem, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de						Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; DEZELEE S, 1974, J BIOL CHEM, V249, P5978; Filipovska J, 2000, RNA, V6, P41, DOI 10.1017/S1355838200991167; Gildehaus N, 2007, NUCLEIC ACIDS RES, V35, P1885, DOI 10.1093/nar/gkm085; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; JOHNSON TL, 1994, CELL, V77, P217, DOI 10.1016/0092-8674(94)90314-X; Kashlev M, 2002, J BIOL CHEM, V277, P14501, DOI 10.1074/jbc.M200215200; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2006, NAT STRUCT MOL BIOL, V13, P44, DOI 10.1038/nsmb1032; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2000, J MOL BIOL, V299, P325, DOI 10.1006/jmbi.2000.3755; Lai MMC, 2005, J VIROL, V79, P7951, DOI 10.1128/JVI.79.13.7951-7958.2005; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Poole AM, 2005, MOL BIOL EVOL, V22, P1444, DOI 10.1093/molbev/msi132; RACKWITZ HR, 1981, NATURE, V291, P297, DOI 10.1038/291297a0; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Taylor JM, 2003, TRENDS MICROBIOL, V11, P185, DOI 10.1016/S0966-842X(03)00045-3; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; Wassarman KM, 2006, SCIENCE, V314, P1601, DOI 10.1126/science.1134830; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Yamaguchi Y, 2001, SCIENCE, V293, P124, DOI 10.1126/science.1057925; Yamaguchi Y, 2007, GENES CELLS, V12, P863, DOI 10.1111/j.1365-2443.2007.01094.x; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422	24	95	96	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					445	449		10.1038/nature06290	http://dx.doi.org/10.1038/nature06290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004386	Green Published			2022-12-28	WOS:000250918600060
J	Tsakmakidis, KL; Boardman, AD; Hess, O				Tsakmakidis, Kosmas L.; Boardman, Allan D.; Hess, Ortwin			'Trapped rainbow' storage of light in metamaterials	NATURE			English	Article							SLOW LIGHT	Light usually propagates inside transparent materials in well known ways(1). However, recent research(2-6) has examined the possibility of modifying the way the light travels by taking a normal transparent dielectric and inserting tiny metallic inclusions of various shapes and arrangements. As light passes through these structures, oscillating electric currents are set up that generate electromagnetic field moments; these can lead to dramatic effects on the light propagation, such as negative refraction. Possible applications include lenses that break traditional diffraction limits(3,4) and `invisibility cloaks' (refs 5, 6). Significantly less research has focused on the potential of such structures for slowing, trapping and releasing light signals. Here we demonstrate theoretically that an axially varying heterostructure with a metamaterial core of negative refractive index can be used to efficiently and coherently bring light to a complete standstill. In contrast to previous approaches for decelerating and storing light(7-13), the present scheme simultaneously allows for high in-coupling efficiencies and broadband, room-temperature operation. Surprisingly, our analysis reveals a critical point at which the effective thickness of the waveguide is reduced to zero, preventing the light wave from propagating further. At this point, the light ray is permanently trapped, its trajectory forming a double light-cone that we call an `optical clepsydra'. Each frequency component of the wave packet is stopped at a different guide thickness, leading to the spatial separation of its spectrum and the formation of a `trapped rainbow'. Our results bridge the gap between two important contemporary realms of science-metamaterials and slow light. Combined investigations may lead to applications in optical data processing and storage or the realization of quantum optical memories.	Univ Surrey, Fac Engn & Phys Sci, Adv Technol Inst, Guildford GU7 1QR, Surrey, England; Univ Surrey, Fac Engn & Phys Sci, Dept Phys, Guildford GU7 1QR, Surrey, England; Univ Salford, Dept Phys, Joule Lab, Photon & Nonlinear Sci Grp, Salford M5 4WT, Lancs, England	University of Surrey; University of Surrey; University of Salford	Hess, O (corresponding author), Univ Surrey, Fac Engn & Phys Sci, Adv Technol Inst, Guildford GU7 1QR, Surrey, England.	O.Hess@surrey.ac.uk	Tsakmakidis, Kosmas L./I-7651-2019; Tsakmakidis, Kosmas/K-6202-2012; Hess, Ortwin/O-1345-2019; Hess, Ortwin/H-7542-2012	Tsakmakidis, Kosmas L./0000-0003-2141-1338; Tsakmakidis, Kosmas/0000-0003-2141-1338; Hess, Ortwin/0000-0002-6024-0677; 	Engineering and Physical Sciences Research Council [EP/E031684/1, EP/E033601/1] Funding Source: researchfish; EPSRC [EP/E031684/1, EP/E033601/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Alu A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.024304; Bigelow MS, 2003, SCIENCE, V301, P200, DOI 10.1126/science.1084429; BLUMENTHAL DJ, 1994, P IEEE, V82, P1650, DOI 10.1109/5.333744; Boardman AD, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.165110; Born M., 1980, PRINCIPLES OPTICS; BRERMAN PR, 2002, PHYS REV E, V66; Cheianov VV, 2007, SCIENCE, V315, P1252, DOI 10.1126/science.1138020; Chen HT, 2006, NATURE, V444, P597, DOI 10.1038/nature05343; Gehrig E, 2006, IEEE J QUANTUM ELECT, V42, P1047, DOI 10.1109/JQE.2006.881632; Gersen H, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.073903; Grigorenko AN, 2005, NATURE, V438, P335, DOI 10.1038/nature04242; Helszajn J., 2000, RIDGE WAVEGUIDES PAS; Karalis A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063901; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Milonni P. W., 2005, SER OPT OPTOELECTRON; Okawachi Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.153902; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Povinelli ML, 2005, OPT LETT, V30, P3042, DOI 10.1364/OL.30.003042; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; SNYDERA, 1983, OPTICAL WAVEGUIDE TH, pCH5; Stockman MI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.137404; TAMIR T, 1979, INTEGRATED OPTICS, pCH2; Tsakmakidis KL, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.085104; Tsakmakidis KL, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2387873; Vlasov YA, 2005, NATURE, V438, P65, DOI 10.1038/nature04210; Vlasov YA, 2006, OPT LETT, V31, P50, DOI 10.1364/OL.31.000050	30	648	668	8	329	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					397	401		10.1038/nature06285	http://dx.doi.org/10.1038/nature06285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004380				2022-12-28	WOS:000250918600050
J	Kaji, AH; Koenig, KL; Lewis, RJ				Kaji, Amy H.; Koenig, Kristi L.; Lewis, Roger J.			Current hospital disaster preparedness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SURGE CAPACITY; SHORTAGE		Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA; Los Angeles Biomed Res Inst, Torrance, CA USA; Harbor UCLA Med Ctr, S Bay Disaster Resource Ctr, Torrance, CA 90509 USA; Univ Calif Irvine, Sch Med, Orange, CA 92668 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Irvine	Kaji, AH (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, 1000 W Carson St,Box 21, Torrance, CA 90509 USA.	akaji@emedharbor.edu						American Association of Colleges of Nursing, FACT SHEET NURS SHOR; American College of Emergency Physicians, 2005, Ann Emerg Med, V45, P239; Auf der Heide E, 2006, ANN EMERG MED, V47, P34, DOI 10.1016/j.annemergmed.2005.05.009; Barbisch DF, 2006, ACAD EMERG MED, V13, P1098, DOI 10.1197/j.aem.2006.06.041; *CA MED ASS, HEALTHC LANDSC CAL; DeYoung S, 2002, J PROF NURS, V18, P313, DOI 10.1053/jpnu.2002.129978; HARBAGE P, 2006, PREMIUM PRICE HIDDEN; Kaji A, 2006, ACAD EMERG MED, V13, P1157, DOI 10.1197/j.aem.2006.06.032; Koenig KL, 2006, ACAD EMERG MED, V13, P195, DOI 10.1197/j.aem.2005.10.007; Koenig Kristi L, 2003, Prehosp Disaster Med, V18, P327; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V298, P1623, DOI 10.1001/jama.298.14.1623; *LEW GROUP, 2002, EM DEP OV GROW CRIS; Schneider SM, 2003, ANN EMERG MED, V42, P167, DOI 10.1067/mem.2003.258; Schultz CH, 2007, ANN EMERG MED, V49, P602, DOI 10.1016/j.annemergmed.2006.10.003; *US DEP HHS, ANN AV FUNDS HOSP PR; 2006, US TODAY        0601	16	66	68	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2188	2190		10.1001/jama.298.18.2188	http://dx.doi.org/10.1001/jama.298.18.2188			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230II	18000203				2022-12-28	WOS:000250869800026
J	Helsing, E				Helsing, Elisabet			A patient's journey - The reluctant patient: Parkinson's disease	BRITISH MEDICAL JOURNAL			English	Editorial Material												Helsing.ehel@online.no							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 10	2007	335	7627					989	990		10.1136/bmj.39329.606840.AD	http://dx.doi.org/10.1136/bmj.39329.606840.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232AL	17991981	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000250990400046
J	Schelhaas, M; Malmstrom, J; Pelkmans, L; Haugstetter, J; Ellgaard, L; Grunewald, K; Helenius, A				Schelhaas, Mario; Malmstrom, Johan; Pelkmans, Lucas; Haugstetter, Johannes; Ellgaard, Lars; Gruenewald, Kay; Helenius, Ari			Simian virus 40 depends on ER protein folding and quality control factors for entry into host cells	CELL			English	Article							ENDOPLASMIC-RETICULUM; SIMIAN VIRUS-40; CAVEOLAR ENDOCYTOSIS; RETRO-TRANSLOCATION; CRYSTAL-STRUCTURE; TRANSPORT; VP1; POLYOMAVIRUS; RESOLUTION; COMPLEXES	Cell entry of Simian Virus 40 (SV40) involves caveolar/lipid raft-mediated endocytosis, vesicular transport to the endoplasmic reticulum (ER), translocation into the cytosol, and import into the nucleus. We analyzed the effects of ER-associated processes and factors on infection and on isolated viruses and found that SV40 makes use of the thiol-disulfide oxidoreductases, ERp57 and PDI, as well as the retrotranslocation proteins Derlin-1 and SeI1L. ERp57 isomerizes specific interchain disulfides connecting the major capsid protein, VP1, to a crosslinked network of neighbors, thus uncoupling about 12 of 72 VP1 pentamers. Cryo-electron tomography indicated that loss of interchain disulfides coupled with calcium depletion induces selective dissociation of the 12 vertex pentamers, a step likely to mimic uncoating of the virus in the cytosol. Thus, the virus utilizes the protein folding machinery for initial uncoating before exploiting the ER-associated degradation machinery presumably to escape from the ER lumen into the cytosol.	ETH, Inst Biochem, ETH Honggerberg, CH-8093 Zurich, Switzerland; ETH, Inst Mol Syst Biol, ETH Honggerberg, CH-8093 Zurich, Switzerland; Univ Copenhagen, Dept Mol Biol, DK-2100 Copenhagen, Denmark; Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Copenhagen; Max Planck Society	Helenius, A (corresponding author), ETH, Inst Biochem, ETH Honggerberg, Schafmattstr 18, CH-8093 Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch	Grünewald, Kay/AAW-3652-2020; Ellgaard, Lars/I-9034-2014; Malmström, Johan A/B-7660-2009	Grünewald, Kay/0000-0002-4788-2691; Ellgaard, Lars/0000-0002-7018-0137; Malmström, Johan A/0000-0002-2889-7169; Schelhaas, Mario/0000-0002-6735-583X; Pelkmans, Lucas/0000-0002-6754-9730				CLEVER J, 1991, P NATL ACAD SCI USA, V88, P7333, DOI 10.1073/pnas.88.16.7333; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Daniels R, 2006, MOL CELL, V24, P955, DOI 10.1016/j.molcel.2006.11.001; ESTES MK, 1971, J VIROL, V7, P635, DOI 10.1128/JVI.7.5.635-641.1971; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Gharakhanian E, 2001, J GEN VIROL, V82, P1935, DOI 10.1099/0022-1317-82-8-1935; HARTMANN JP, 1981, J VIROL, V37, P908, DOI 10.1128/JVI.37.3.908-915.1981; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Hirsch C, 2000, TRENDS CELL BIOL, V10, P268, DOI 10.1016/S0962-8924(00)01768-2; ISHII N, 1994, J VIROL, V68, P8209, DOI 10.1128/JVI.68.12.8209-8216.1994; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774; Li PP, 2003, J VIROL, V77, P7527, DOI 10.1128/JVI.77.13.7527-7538.2003; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Magnuson B, 2005, MOL CELL, V20, P289, DOI 10.1016/j.molcel.2005.08.034; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nakanishi A, 1996, P NATL ACAD SCI USA, V93, P96, DOI 10.1073/pnas.93.1.96; Norkin LC, 2002, J VIROL, V76, P5156, DOI 10.1128/JVI.76.10.5156-5166.2002; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Rainey-Barger EK, 2007, MOL BIOL CELL, V18, P1253, DOI 10.1091/mbc.E06-11-1004; SCHARFF O, 1988, BIOCHIM BIOPHYS ACTA, V972, P257, DOI 10.1016/0167-4889(88)90200-5; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; VARSHAVSKY AJ, 1977, NUCLEIC ACIDS RES, V4, P3303, DOI 10.1093/nar/4.10.3303; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	35	251	258	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					516	529		10.1016/j.cell.2007.09.038	http://dx.doi.org/10.1016/j.cell.2007.09.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981119	Bronze			2022-12-28	WOS:000250618500019
J	Rucker, D; Padwal, R; Li, SK; Curioni, C; Lau, DCW				Rucker, Diana; Padwal, Raj; Li, Stephanie K.; Curioni, Cintia; Lau, David C. W.			Long term pharmacotherapy for obesity and overweight: updated meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-PRACTICE GUIDELINES; SIBUTRAMINE; PREVENTION; MANAGEMENT; ORLISTAT; QUALITY; ADULTS; DELAY	Objective To summarise the long term efficacy of anti-obesity drugs in reducing weight and improving health status. Design Updated meta-anaiysis of randomised trials. Data sources Medline, Embase, the Cochrane controlled trials register, the Current Science meta-register of controlled trials, and reference lists of identified articles. All data sources were searched from December 2002 (end date of last search) to December 2006. Studies reviewed Double blind randomised placebo controlled trials of approved anti-obesity dugs used in adults (age over 18) for one year or longer. Results 30 trials of one to four years' duration met the inclusion criteria: 16 orlistat (n=10 631 participants), 10 sibutramine (n=2623), and four rimonabant (n=6365). Of these, 14 trials were new and 16 had previously been identified. Attrition rates averaged 30-40%. Compared with placebo, orlistat reduced weight by 2.9 kg (95% confidence interval 2.5 kg to 3.2 kg), sibutramine by 4.2 kg(3.6 kg to 4.7 kg), and rimonabant by 4.7 kg (4.1 kg to 5.3 kg). Patients receiving active drug treatment were significantly more likely to achieve 5% and 10% weight loss thresholds. Orlistat reduced the incidence of diabetes and improved concentrations of total cholesterol and low density lipoprotein cholesterol, blood pressure, and glycaemic control in patients with diabetes but increased rates of gastrointestinal side effects and slightly lowered concentrations of high density lipoprotein. Sibutramine improved concentrations of high density lipoprotein cholesterol and triglycerides but raised blood pressure and pulse rate. Rimonabant improved concentrations of high density lipoprotein cholesterol and triglycerides, blood pressure, and glycaemic control in patients with diabetes but increased the risk of mood disorders. Conclusions Orlistat, sibutramine, and rimonabant modestly reduce weight, have differing effects on cardiovascular risk profiles, and have specific adverse effects.	Univ Alberta, Dept Med, Edmonton, AB, Canada; Fac Arthur Sa Earp Neto, Dept Nutr, Rio De Janeiro, Brazil; Univ Calgary, Dept Med, Calgary, AB, Canada	University of Alberta; University of Calgary	Padwal, R (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	rpadwal@ualberta.ca	Curioni, Cintia/X-9075-2019; Curioni, Cintia Chaves/H-6557-2013; Padwal, Raj/G-6903-2016	Curioni, Cintia Chaves/0000-0002-5160-9567; Padwal, Raj/0000-0003-3541-2817				Colman E, 2005, ANN INTERN MED, V143, P380, DOI 10.7326/0003-4819-143-5-200509060-00013; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006162.pub2; CURIONI C, 2006, COCHRANE DATABASE SY; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Juni P, 2001, SYSTEMATIC REV HLTH, P87; Lau DCW, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.061409; Lau DCW, 2007, CAN MED ASSOC J, V176, P1103, DOI 10.1503/cmaj.070306; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012; *NIH CLIN EXC, 2006, CG43 OB FULL GUID; O'Meara S, 2002, Health Technol Assess, V6, P1; O'Meara S, 2001, Health Technol Assess, V5, P1; Padwal R, 2007, INT J OBESITY, V31, P1567, DOI 10.1038/sj.ijo.0803631; Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736; PADWAL R, IN PRESS COCHRANE DA; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; PADWAL RS, 2007, THERAPY, V4, P221; Padwal RS, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004094.pub2, DOI 10.1002/14651858.CD004094.PUB2]; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; WING RR, 1987, DIABETES CARE, V10, P563, DOI 10.2337/diacare.10.5.563	23	536	558	0	48	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2007	335	7631					1194	1199		10.1136/bmj.39385.413113.25	http://dx.doi.org/10.1136/bmj.39385.413113.25			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242ER	18006966	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000251707800033
J	Welner, RS; Kincade, PW				Welner, Robert S.; Kincade, Paul W.			Stem cells on patrol	CELL			English	Editorial Material							HEMATOPOIETIC STEM; PROGENITOR CELLS; RECEPTORS; BLOOD	Hematopoietic stem cells (HSCs) exist in the bone marrow and circulate in the blood. In this issue, Massberg et al. (2007) report that HSCs also travel through the lymphatic system. Furthermore, migration of HSCs-which express Toll-like receptors-allows the recognition of pathogenic molecules in peripheral tissues thereby promoting the local generation of innate immune cells at the site of infection.	[Welner, Robert S.; Kincade, Paul W.] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Kincade, PW (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kincade@omrf.ouhsc.edu			NIAID NIH HHS [R01 AI058162-05, R21 AI069024, R01 AI058162-04, R01 AI020069-23, R01 AI020069, R21 AI069024-01A1, R01 AI058162, R01 AI020069-24, T32 AI007633] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069024, R01AI020069, R01AI058162, T32AI007633] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; MASSBERG S, 2007, CELL; Muller-Sieburg CE, 2006, CELL CYCLE, V5, P394, DOI 10.4161/cc.5.4.2487; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Rossi DJ, 2007, EXP GERONTOL, V42, P385, DOI 10.1016/j.exger.2006.11.019; Winkler IG, 2006, EXP HEMATOL, V34, P996, DOI 10.1016/j.exphem.2006.04.005; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006	11	17	17	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 30	2007	131	5					842	844		10.1016/j.cell.2007.11.010	http://dx.doi.org/10.1016/j.cell.2007.11.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045530	Green Accepted, Bronze			2022-12-28	WOS:000251800900007
J	Miaudet, P; Derre, A; Maugey, M; Zakri, C; Piccione, PM; Inoubli, R; Poulin, P				Miaudet, Pierre; Derre, Alain; Maugey, Maryse; Zakri, Cecile; Piccione, Patrick M.; Inoubli, Rabi; Poulin, Philippe			Shape and temperature memory of nanocomposites with broadened glass transition	SCIENCE			English	Article							CARBON-NANOTUBE FIBERS; POLYMERS; ALLOYS; STRESS; THERMOMECHANICS; POLYURETHANES; SINGLE	Shape-memory polymers can revert to their original shape when they are reheated. The stress generated by shape recovery is a growing function of the energy absorbed during deformation at a high temperature; thus, high energy to failure is a necessary condition for strong shape-memory materials. We report on the properties of composite nanotube fibers that exhibit this particular feature. We observed that these composites can generate a stress upon shape recovery up to two orders of magnitude greater than that generated by conventional polymers. In addition, the nanoparticles induce a broadening of the glass transition and a temperature memory with a peak of recovery stress at the temperature of their initial deformation.	Univ Bordeaux 1, Ctr Rech Paul Pascal, CNRS, F-33600 Pessac, France; Arkema, Groupement Rech Lacq, F-64170 Artix, France	Centre de Recherche Paul Pascal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Arkema	Poulin, P (corresponding author), Univ Bordeaux 1, Ctr Rech Paul Pascal, CNRS, 115 Ave Schweitzer, F-33600 Pessac, France.	poulin@crpp-bordeaux.cnrs.fr	Zakri, Cecile/K-2116-2013	Poulin, Philippe/0000-0001-7748-8671				Ahir SV, 2005, NAT MATER, V4, P491, DOI 10.1038/nmat1391; Berriot J, 2003, EUROPHYS LETT, V64, P50, DOI 10.1209/epl/i2003-00124-7; Cadek M, 2004, NANO LETT, V4, P353, DOI 10.1021/nl035009o; Dalton AB, 2003, NATURE, V423, P703, DOI 10.1038/423703a; Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296; Gall K, 2004, APPL PHYS LETT, V85, P290, DOI 10.1063/1.1769087; Gall K, 2002, ACTA MATER, V50, P5115, DOI 10.1016/S1359-6454(02)00368-3; GUPTA VB, 1994, POLYMER, V35, P2560, DOI 10.1016/0032-3861(94)90379-4; Hornbogen E, 2006, ADV ENG MATER, V8, P101, DOI 10.1002/adem.200500193; Hu JL, 2005, POLYM INT, V54, P854, DOI 10.1002/pi.1785; Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9; Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059; Kornbluh R, 2002, P SOC PHOTO-OPT INS, V4698, P254, DOI 10.1117/12.475072; Lagoudas DC, 2006, MECH MATER, V38, P430, DOI 10.1016/j.mechmat.2005.08.003; Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102; Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M; Liu YP, 2004, MECH MATER, V36, P929, DOI 10.1016/j.mechmat.2003.08.012; Meng QH, 2007, J APPL POLYM SCI, V106, P837, DOI 10.1002/app.26517; Miaudet P, 2005, NANO LETT, V5, P2212, DOI 10.1021/nl051419w; Miyamoto Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.225504; Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103; Morshedian J, 2003, ADV POLYM TECH, V22, P112, DOI 10.1002/adv.10041; Ohki T, 2004, COMPOS PART A-APPL S, V35, P1065, DOI 10.1016/j.compositesa.2004.03.001; Park JS, 2001, J APPL POLYM SCI, V82, P1816, DOI 10.1002/app.2023.abs; Patoor E, 2006, MECH MATER, V38, P391, DOI 10.1016/j.mechmat.2005.05.027; Spinks GM, 2006, ADV MATER, V18, P637, DOI 10.1002/adma.200502366; Van Humbeeck J, 2001, ADV ENG MATER, V3, P837, DOI 10.1002/1527-2648(200111)3:11<837::AID-ADEM837>3.0.CO;2-0; Vigolo B, 2000, SCIENCE, V290, P1331, DOI 10.1126/science.290.5495.1331; Yakobson BI., 2004, DEKKER ENCY NANOSCIE, P587	29	331	339	16	351	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1294	1296		10.1126/science.1145593	http://dx.doi.org/10.1126/science.1145593			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033882				2022-12-28	WOS:000251086600041
J	Ozyuzer, L; Koshelev, AE; Kurter, C; Gopalsami, N; Li, Q; Tachiki, M; Kadowaki, K; Yamamoto, T; Minami, H; Yamaguchi, H; Tachiki, T; Gray, KE; Kwok, WK; Welp, U				Ozyuzer, L.; Koshelev, A. E.; Kurter, C.; Gopalsami, N.; Li, Q.; Tachiki, M.; Kadowaki, K.; Yamamoto, T.; Minami, H.; Yamaguchi, H.; Tachiki, T.; Gray, K. E.; Kwok, W.-K.; Welp, U.			Emission of coherent THz radiation from superconductors	SCIENCE			English	Article							INTRINSIC JOSEPHSON-JUNCTIONS; TERAHERTZ TECHNOLOGY; RESONANT MODES; FLUX-FLOW; BI2SR2CACU2O8+DELTA; ARRAYS; FISKE	Compact solid-state sources of terahertz (THz) radiation are being sought for sensing, imaging, and spectroscopy applications across the physical and biological sciences. We demonstrate that coherent continuous-wave THz radiation of sizable power can be extracted from intrinsic Josephson junctions in the layered high-temperature superconductor Bi2Sr2CaCu2O8. In analogy to a laser cavity, the excitation of an electromagnetic cavity resonance inside the sample generates a macroscopic coherent state in which a large number of junctions are synchronized to oscillate in phase. The emission power is found to increase as the square of the number of junctions reaching values of 0.5 microwatt at frequencies up to 0.85 THz, and persists up to similar to 50 kelvin. These results should stimulate the development of superconducting compact sources of THz radiation.	Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; Izmir Inst Technol, Dept Phys, TR-35430 Izmir, Turkey; IIT, Div Phys, Chicago, IL 60616 USA; Argonne Natl Lab, Nucl Engn Div, Argonne, IL 60439 USA; Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778568, Japan; Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058577, Japan; Natl Def Acad, Dept Elect & Elect Engn, Kanagawa 2398686, Japan	United States Department of Energy (DOE); Argonne National Laboratory; Izmir Institute of Technology; Illinois Institute of Technology; United States Department of Energy (DOE); Argonne National Laboratory; University of Tokyo; University of Tsukuba; National Defence Academy - Japan	Welp, U (corresponding author), Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.	welp@anl.gov	Li, Qingan/L-3778-2013; Kadowaki, Kazuo/L-8660-2017; Ozyuzer, Lutfi/H-3142-2011; Yamamoto, Takashi/AAC-8889-2019; Koshelev, Alexei E/K-3971-2013	Kadowaki, Kazuo/0000-0002-9899-0094; Koshelev, Alexei E/0000-0002-1167-5906; Kwok, Wai-Kwong/0000-0003-0030-084X				Bae MH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.027002; Barbara P, 1999, PHYS REV LETT, V82, P1963, DOI 10.1103/PhysRevLett.82.1963; Batov IE, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2214157; Borak A, 2005, SCIENCE, V308, P638, DOI 10.1126/science.1109831; Bulaevskii LN, 2006, J SUPERCOND NOV MAGN, V19, P349, DOI 10.1007/s10948-006-0176-5; BULAEVSKII LN, 1994, PHYS REV B, V50, P12831, DOI 10.1103/PhysRevB.50.12831; Darula M, 1999, SUPERCOND SCI TECH, V12, pR1, DOI 10.1088/0953-2048/12/1/001; FULTON TA, 1973, SOLID STATE COMMUN, V12, P57, DOI 10.1016/0038-1098(73)90345-1; Gaifullin MB, 2000, PHYS REV LETT, V84, P2945, DOI 10.1103/PhysRevLett.84.2945; Irie A, 1998, APPL PHYS LETT, V72, P2159, DOI 10.1063/1.121319; JAIN AK, 1984, PHYS REP, V109, P309, DOI 10.1016/0370-1573(84)90002-4; Kadowaki K, 2006, PHYSICA C, V437-38, P111, DOI 10.1016/j.physc.2005.12.054; Kim SM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.140504; KOSHELEV AE, CONDMAT07083269; KOYAMA T, 1995, SOLID STATE COMMUN, V96, P367, DOI 10.1016/0038-1098(95)00474-2; Krasnov VM, 1999, PHYS REV B, V59, P8463, DOI 10.1103/PhysRevB.59.8463; Lee M, 2007, SCIENCE, V316, P64, DOI 10.1126/science.1141012; Machida M, 1999, PHYS REV LETT, V83, P4618, DOI 10.1103/PhysRevLett.83.4618; Madsen S, 2004, EUR PHYS J B, V40, P209, DOI 10.1140/epjb/e2004-00259-9; Pedersen NF, 1998, PHYS REV B, V58, P2820, DOI 10.1103/PhysRevB.58.2820; RUSSO M, 1978, PHYS REV B, V17, P2171, DOI 10.1103/PhysRevB.17.2171; Tachiki M, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.134515; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Walther C, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2404598; Wang HB, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2420791; Yurgens A, 1997, PHYS REV LETT, V79, P5122, DOI 10.1103/PhysRevLett.79.5122	28	587	604	10	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2007	318	5854					1291	1293		10.1126/science.1149802	http://dx.doi.org/10.1126/science.1149802			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033881	Green Published			2022-12-28	WOS:000251086600040
J	Rawashdeh, O; de Borsetti, NH; Roman, G; Cahill, GM				Rawashdeh, Oliver; de Borsetti, Nancy Hernandez; Roman, Gregg; Cahill, Gregory M.			Melatonin suppresses nighttime memory formation in zebrafish	SCIENCE			English	Article							LONG-TERM POTENTIATION; CIRCADIAN-RHYTHMS; MODULATION; PINEALECTOMY; RECEPTORS	Memory processes are modulated by the biological clock, although the mechanisms are unknown. Here, we report that in the diurnal zebrafish both learning and memory formation of an operant conditioning paradigm occur better during the day than during the night. Melatonin treatment during the day mimics the nighttime suppression of memory formation. Training in constant light improves nighttime memory formation while reducing endogenous melatonin concentrations. Treatment with melatonin receptor antagonists at night dramatically improves memory. Pinealectomy also significantly improves nighttime memory formation. We adduce that melatonin is both sufficient and necessary for poor memory formation during the night.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston	Roman, G (corresponding author), Univ Houston, Dept Biol & Biochem, 369 Sci & Res 2, Houston, TX 77204 USA.	gwroman@central.uh.edu	Rawashdeh, Oliver/N-7400-2016; Roman, Gregg/W-1586-2019	Rawashdeh, Oliver/0000-0002-7147-4778; Roman, Gregg/0000-0003-1519-4699	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060939] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60939] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BOLLIET V, 1995, J NEUROENDOCRINOL, V7, P535, DOI 10.1111/j.1365-2826.1995.tb00790.x; Cahill GM, 1996, BRAIN RES, V708, P177, DOI 10.1016/0006-8993(95)01365-2; Chaudhury D, 2005, J BIOL RHYTHM, V20, P225, DOI 10.1177/0748730405276352; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; DUBOCOVICH ML, 1988, J PHARMACOL EXP THER, V246, P902; FEKETE M, 1985, PHYSIOL BEHAV, V34, P883, DOI 10.1016/0031-9384(85)90008-3; FOA A, 1992, J PINEAL RES, V12, P109, DOI 10.1111/j.1600-079X.1992.tb00036.x; Hogan MV, 2001, J PINEAL RES, V30, P87, DOI 10.1034/j.1600-079X.2001.300204.x; Hurd MW, 1998, PHYSIOL BEHAV, V65, P465, DOI 10.1016/S0031-9384(98)00183-8; KEZUKA H, 1992, ZOOL SCI, V9, P1047; Lyon LC, 2005, P NATL ACAD SCI USA, V102, P12589, DOI 10.1073/pnas.0503847102; MELKE J, 2007, MOL PSYCHIAT, V1; MORGAN PJ, 1994, NEUROCHEM INT, V24, P101, DOI 10.1016/0197-0186(94)90100-7; Okimoto DK, 1999, GEN COMP ENDOCR, V114, P293, DOI 10.1006/gcen.1999.7258; Ozcan M, 2006, BRAIN RES, V1111, P90, DOI 10.1016/j.brainres.2006.06.117; Wan Q, 1999, NAT NEUROSCI, V2, P401, DOI 10.1038/8062; Wang LM, 2005, EUR J NEUROSCI, V22, P2231, DOI 10.1111/j.1460-9568.2005.04408.x; Zhdanova IV, 2001, BRAIN RES, V903, P263, DOI 10.1016/S0006-8993(01)02444-1	18	111	116	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1144	1146		10.1126/science.1148564	http://dx.doi.org/10.1126/science.1148564			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006748				2022-12-28	WOS:000250957900048
J	Froemke, RC; Merzenich, MM; Schreiner, CE				Froemke, Robert C.; Merzenich, Michael M.; Schreiner, Christoph E.			A synaptic memory trace for cortical receptive field plasticity	NATURE			English	Article							PRIMARY AUDITORY-CORTEX; BASAL FOREBRAIN NEURONS; NUCLEUS BASALIS; ACETYLCHOLINE; MODULATION; MECHANISMS; ATTENTION; RAT	Receptive fields of sensory cortical neurons are plastic, changing in response to alterations of neural activity or sensory experience(1-12). In this way, cortical representations of the sensory environment can incorporate new information about the world, depending on the relevance or value of particular stimuli(1,6,9). Neuromodulation is required for cortical plasticity, but it is uncertain how subcortical neuromodulatory systems, such as the cholinergic nucleus basalis, interact with and refine cortical circuits(13-24). Here we determine the dynamics of synaptic receptive field plasticity in the adult primary auditory cortex ( also known as AI) using in vivo whole-cell recording. Pairing sensory stimulation with nucleus basalis activation shifted the preferred stimuli of cortical neurons by inducing a rapid reduction of synaptic inhibition within seconds, which was followed by a large increase in excitation, both specific to the paired stimulus. Although nucleus basalis was stimulated only for a few minutes, reorganization of synaptic tuning curves progressed for hours thereafter: inhibition slowly increased in an activity-dependent manner to rebalance the persistent enhancement of excitation, leading to a retuned receptive field with new preference for the paired stimulus. This restricted period of disinhibition may be a fundamental mechanism for receptive field plasticity, and could serve as a memory trace(9,25) for stimuli or episodes that have acquired new behavioural significance.	Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Otolaryngol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Froemke, RC (corresponding author), Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA.	rfroemke@phy.ucsf.edu		Schreiner, Christoph/0000-0002-4571-4328; Froemke, Robert/0000-0002-1230-6811	NIDCD NIH HHS [R01 DC002260-12, R01 DC002260] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; Debanne D, 1998, J PHYSIOL-LONDON, V508, P523, DOI 10.1111/j.1469-7793.1998.00523.x; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Gritti I, 2003, J COMP NEUROL, V458, P11, DOI 10.1002/cne.10505; Hromadka T, 2007, HEARING RES, V229, P180, DOI 10.1016/j.heares.2007.01.002; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Metherate R, 2005, HEARING RES, V206, P146, DOI 10.1016/j.heares.2005.01.014; METHERATE R, 1992, J NEUROSCI, V12, P4701; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; RICHARDSON RT, 1988, TRENDS NEUROSCI, V11, P264, DOI 10.1016/0166-2236(88)90107-5; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; WOODY CD, 1987, BRAIN RES, V424, P193, DOI 10.1016/0006-8993(87)91210-8; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Zhang YF, 2006, CEREB CORTEX, V16, P1258, DOI 10.1093/cercor/bhj067	30	406	408	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					425	429		10.1038/nature06289	http://dx.doi.org/10.1038/nature06289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004384	Green Submitted			2022-12-28	WOS:000250918600056
J	Small, R; Lumley, J				Small, Rhonda; Lumley, Judith			Reduction of maternal depression: much remains to be done	LANCET			English	Editorial Material							POSTPARTUM DEPRESSION; POSTNATAL DEPRESSION; INTERVENTION; RISK		La Trobe Univ, Melbourne, Vic 3086, Australia	La Trobe University	Small, R (corresponding author), La Trobe Univ, Melbourne, Vic 3086, Australia.	R.Small@latrobe.edu.au		Small, Rhonda/0000-0003-0345-4676				Appleby L, 1997, BRIT MED J, V314, P932, DOI 10.1136/bmj.314.7085.932; Austin MP, 2003, ACTA PSYCHIAT SCAND, V107, P10, DOI 10.1034/j.1600-0447.2003.02024.x; Brugha TS, 2000, PSYCHOL MED, V30, P1273, DOI 10.1017/S0033291799002937; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dennis CL, 2006, BIRTH-ISS PERINAT C, V33, P323, DOI 10.1111/j.1523-536X.2006.00130.x; DENNIS CL, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001134.PUB2; Halbreich U, 2006, J AFFECT DISORDERS, V91, P97, DOI 10.1016/j.jad.2005.12.051; HOWARD L, 2006, CLIN EVID, V15, P1919; Lumley J, 2004, INT J TECHNOL ASSESS, V20, P128, DOI 10.1017/S0266462304000911; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Rojas G, 2007, LANCET, V370, P1629, DOI 10.1016/S0140-6736(07)61685-7; *SCREEN SPEC LIB, 2006, NAT SCREEN COMM POL; Zlotnick C, 2001, AM J PSYCHIAT, V158, P638, DOI 10.1176/appi.ajp.158.4.638	13	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 10	2007	370	9599					1593	1595		10.1016/S0140-6736(07)61669-9	http://dx.doi.org/10.1016/S0140-6736(07)61669-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230NO	17993347				2022-12-28	WOS:000250883400006
J	Wilks, Y				Wilks, Yorick			Is there progress on talking sensibly to machines?	SCIENCE			English	Editorial Material									Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England	University of Sheffield	Wilks, Y (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England.	y.wilks@dcs.shef.ac.uk						Brown P. F., 1990, Computational Linguistics, V16, P79; Colby K., 1972, ARTIF INTELL, V2, P1; WEIZENBAUM J, 1966, COMMUN ACM, V9, P36, DOI 10.1145/357980.357991; Wilks Y, 2005, INTERDISCIPL SCI REV, V30, P145, DOI 10.1179/030801805X25945; WILKS Y, 2005, RECENT ADV NATURAL L, V3, P111; YOUNG S, 2002, INT C SPEECH LANG PR	6	14	19	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					927	928		10.1126/science.1148895	http://dx.doi.org/10.1126/science.1148895			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991851				2022-12-28	WOS:000250788500029
J	Amanna, IJ; Carlson, NE; Slifka, MK				Amanna, Ian J.; Carlson, Nichole E.; Slifka, Mark K.			Duration of humoral immunity to common viral and vaccine antigens	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEMORY B-CELLS; SERUM ANTIBODY-LEVELS; IMMUNOLOGICAL MEMORY; PLASMA-CELLS; SMALLPOX VACCINATION; RHEUMATOID-ARTHRITIS; BONE-MARROW; IMMUNIZATION; TETANUS; MAINTENANCE	Background Maintenance of long-term antibody responses is critical for protective immunity against many pathogens. However, the duration of humoral immunity and the role played by memory B cells remain poorly defined. Methods We performed a longitudinal analysis of antibody titers specific for viral antigens (vaccinia, measles, mumps, rubella, varicella-zoster virus, and Epstein-Barr virus) and nonreplicating antigens (tetanus and diphtheria) in 45 subjects for a period of up to 26 years. In addition, we measured antigen-specific memory B cells by means of limiting-dilution analysis, and we compared memory B-cell frequencies to their corresponding serum antibody levels. Results Antiviral antibody responses were remarkably stable, with half-lives ranging from an estimated 50 years for varicella-zoster virus to more than 200 years for other viruses such as measles and mumps. Antibody responses against tetanus and diphtheria antigens waned more quickly, with estimated half-lives of 11 years and 19 years, respectively. B-cell memory was long-lived, but there was no significant correlation between peripheral memory B-cell numbers and antibody levels for five of the eight antigens tested. Conclusions These studies provide quantitative analysis of serologic memory for multiple antigens in subjects followed longitudinally over the course of more than one decade. In cases in which multiple exposures or repeated vaccinations were common, memory B-cell numbers did not correlate with antibody titers. This finding suggests that peripheral memory B cells and antibody-secreting plasma cells may represent independently regulated cell populations and may play different roles in the maintenance of protective immunity.	Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Dept Publ Hlth & Preventat Med, Div Biostat, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University	Slifka, MK (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, 505 NW 185th Ave, Beaverton, OR 97006 USA.	slifkam@ohsu.edu	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Amanna, Ian/0000-0001-7545-4013	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG023664] Funding Source: NIH RePORTER; NCRR NIH HHS [RR024140, UL1 RR024140, RR000334, P51 RR000163, RR000163, M01 RR000334] Funding Source: Medline; NIA NIH HHS [P01 AG023664] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Amanna IJ, 2006, J IMMUNOL METHODS, V317, P175, DOI 10.1016/j.jim.2006.09.005; Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; BOJLEN K, 1955, Dan Med Bull, V2, P70; Cambridge G, 2003, ARTHRITIS RHEUM-US, V48, P2146, DOI 10.1002/art.11181; *CDCP, 2006, EP PREV VACC PREV DI; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; GOTTLIEB S, 1964, AM J PUBLIC HEALTH N, V54, P961, DOI 10.2105/AJPH.54.6.961; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; HERRMANN KL, 1982, JAMA-J AM MED ASSOC, V247, P193, DOI 10.1001/jama.247.2.193; Hopkins RJ, 2004, CLIN INFECT DIS, V39, P759, DOI 10.1086/422998; IPSEN J, 1946, J IMMUNOL, V54, P325; Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P; MACK TM, 1972, AM J TROP MED HYG, V21, P214, DOI 10.4269/ajtmh.1972.21.214; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; McHeyzer-Williams LJ, 2006, IMMUNOL REV, V211, P255, DOI 10.1111/j.0105-2896.2006.00397.x; Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533; Nanan R, 2001, VACCINE, V20, P498, DOI 10.1016/S0264-410X(01)00328-0; O'Connor BP, 2003, IMMUNOL REV, V194, P61, DOI 10.1034/j.1600-065X.2003.00055.x; Parker AA, 2006, NEW ENGL J MED, V355, P1184; Parker AA, 2006, NEW ENGL J MED, V355, P447, DOI 10.1056/NEJMoa060775; Quinn CP, 2004, J INFECT DIS, V190, P1228, DOI 10.1086/423937; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; SIMONSEN O, 1986, J BIOL STAND, V14, P231, DOI 10.1016/0092-1157(86)90008-9; Simonsen O, 1996, APMIS, V104, P921, DOI 10.1111/j.1699-0463.1996.tb04959.x; SIMONSEN O, 1987, VACCINE, V5, P115, DOI 10.1016/0264-410X(87)90057-0; Skendzel LP, 1996, AM J CLIN PATHOL, V106, P170; Slifka MK, 1996, ANN NY ACAD SCI, V797, P166, DOI 10.1111/j.1749-6632.1996.tb52958.x; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Slifka MK, 1996, TRENDS MICROBIOL, V4, P394, DOI 10.1016/0966-842X(96)10059-7; SLIFKA MK, 1996, THESIS U CALIFORNIA; Traggiai E, 2003, VACCINE, V21, pS35, DOI 10.1016/S0264-410X(03)00198-1; Welsh RM, 2004, ANNU REV IMMUNOL, V22, P711, DOI 10.1146/annurev.immunol.22.012703.104527; Wolters K. L., 1942, ZEITSCHR HYG U INJEKTIONSKRANKH, V124, P326, DOI 10.1007/BF02178438; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	41	785	799	3	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1903	1915		10.1056/NEJMoa066092	http://dx.doi.org/10.1056/NEJMoa066092			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989383				2022-12-28	WOS:000250732500005
J	Eigenmann, PA; Haenggeli, CA				Eigenmann, Philippe A.; Haenggeli, Charles A.			Food colourings, preservatives, and hyperactivity	LANCET			English	Editorial Material							DOUBLE-BLIND; CHILDREN		Childrens Univ Hosp, CH-1211 Geneva, Switzerland	University of Geneva	Eigenmann, PA (corresponding author), Childrens Univ Hosp, CH-1211 Geneva, Switzerland.	Philippe.Eigenmann@hcuge.ch	Eigenmann, Philippe/A-6569-2017	Eigenmann, Philippe/0000-0003-1738-1826				Bateman B, 2004, ARCH DIS CHILD, V89, P506, DOI 10.1136/adc.2003.031435; Brown RT, 2005, PEDIATRICS, V115, pE749, DOI 10.1542/peds.2004-2560; Eigenmann PA, 2004, LANCET, V364, P823, DOI 10.1016/S0140-6736(04)16996-1; Feingold B F, 1975, Am J Nurs, V75, P797, DOI 10.2307/3423460; McCann D, 2007, LANCET, V370, P1560, DOI 10.1016/S0140-6736(07)61306-3; Schab DW, 2004, J DEV BEHAV PEDIATR, V25, P423, DOI 10.1097/00004703-200412000-00007	6	18	18	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2007	370	9598					1524	1525		10.1016/S0140-6736(07)61643-2	http://dx.doi.org/10.1016/S0140-6736(07)61643-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AE	17980721				2022-12-28	WOS:000250628800005
J	Moon, RY; Horne, RSC; Hauck, FR				Moon, Rachel Y.; Horne, Rosemary S. C.; Hauck, Fern R.			Sudden infant death syndrome	LANCET			English	Review							HEART-RATE-VARIABILITY; AUTONOMIC NERVOUS-SYSTEM; CHILD-CARE SETTINGS; SLEEPING POSITION; RISK-FACTORS; MATERNAL SMOKING; PRETERM INFANTS; UNITED-STATES; CIGARETTE-SMOKING; RATE RESPONSES	Despite declines in prevalence during the past two decades, sudden infant death syndrome (SIDS) continues to be the leading cause of death for infants aged between 1 month and 1 year in developed countries. Behavioural risk factors identified in epidemiological studies include prone and side positions for infant sleep, smoke exposure, soft bedding and sleep surfaces, and overheating. Evidence also suggests that pacifier use at sleep time and room sharing without bed sharing are associated with decreased risk of SIDS. Although the cause of SIDS is unknown, immature cardiorespiratory autonomic control and failure of arousal responsiveness from sleep are important factors. Gene polymorphisms relating to serotonin transport and autonomic nervous system development might make affected infants more vulnerable to SIDS. Campaigns for risk reduction have helped to reduce SIDS incidence by 50-90%. However, to reduce the incidence even further, greater strides must be made in reducing prenatal smoke exposure and implementing other recommended infant care practices. Continued research is needed to identify the pathophysiological basis of SIDS.	Childrens Natl Med Ctr, Goldberg Ctr Community Pediat Hlth, Washington, DC 20010 USA; George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; Monash Univ, Monash Inst Med Res, Ritchie Ctr Baby Hlth Res, Melbourne, Vic 3004, Australia; Univ Virginia, Sch Med, Dept Family Med, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA	Children's National Health System; George Washington University; Monash University; University of Virginia; University of Virginia	Moon, RY (corresponding author), Childrens Natl Med Ctr, Goldberg Ctr Community Pediat Hlth, Michigan Ave NW, Washington, DC 20010 USA.	rmoon@cnmc.org		Horne, Rosemary/0000-0003-3575-0461				Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; Alm B, 2002, ARCH DIS CHILD, V86, P400, DOI 10.1136/adc.86.6.400; *AM ACAD PED COMM, 2003, PEDIATRICS, V1111, P914; American Academy of Pediatrics. Committee on Child Abuse and Neglect, 2001, Pediatrics, V107, P437; Ariagno RL, 2006, J PERINATOL, V26, P306, DOI 10.1038/sj.jp.7211490; Ariagno RL, 2003, PEDIATRICS, V111, P622, DOI 10.1542/peds.111.3.622; Arnestad M, 1997, EUR J PEDIATR, V156, P968, DOI 10.1007/s004310050753; Baird T M, 1991, J Perinatol, V11, P315; Beal SM, 2000, J PAEDIATR CHILD H, V36, P540, DOI 10.1046/j.1440-1754.2000.00563.x; Beckwith JB, 2003, ARCH PEDIAT ADOL MED, V157, P286, DOI 10.1001/archpedi.157.3.286; Bhat RY, 2006, PEDIATRICS, V118, P101, DOI 10.1542/peds.2005-1873; BJERVE KS, 1992, ESSENTIAL FATTY ACID; Blackwell CC, 2005, J LEUKOCYTE BIOL, V78, P1242, DOI 10.1189/jlb.0505253; Blackwell CC, 2004, FEMS IMMUNOL MED MIC, V42, P53, DOI 10.1016/j.femsim.2004.06.007; Blackwell CC, 1999, FEMS IMMUNOL MED MIC, V25, P51, DOI 10.1111/j.1574-695X.1999.tb01326.x; BLAIR P, 2005, ARCH DIS CHILD; Blair PS, 2006, ARCH DIS CHILD, V91, P101, DOI 10.1136/adc.2004.070391; Blair PS, 1999, BRIT MED J, V319, P1457, DOI 10.1136/bmj.319.7223.1457; Blakely Tony, 2004, N Z Med J, V117, pU995; *BOSH EIS KENK KAI, 2006, MAT CHILD HLTH STAT; Brooke H, 1997, BMJ-BRIT MED J, V314, P1516, DOI 10.1136/bmj.314.7093.1516; Browne CA, 2000, EARLY HUM DEV, V59, P209, DOI 10.1016/S0378-3782(00)00098-0; BYARD RW, 1995, J PAEDIATR CHILD H, V31, P14, DOI 10.1111/j.1440-1754.1995.tb02904.x; Byard RW, 2003, PEDIATR DEVEL PATHOL, V6, P112, DOI 10.1007/s10024-002-0205-8; Carpenter RG, 2005, LANCET, V365, P29, DOI 10.1016/S0140-6736(04)17662-9; Carpenter RG, 2004, LANCET, V363, P185, DOI 10.1016/S0140-6736(03)15323-8; *CDCP, 1996, MMWR, V45; Chang AB, 2003, ARCH DIS CHILD, V88, P30, DOI 10.1136/adc.88.1.30; Chen AM, 2004, PEDIATRICS, V113, pE435, DOI 10.1542/peds.113.5.e435; Cheruku SR, 2002, AM J CLIN NUTR, V76, P608, DOI 10.1093/ajcn/76.3.608; Chong A, 2000, ARCH DIS CHILD, V82, P253, DOI 10.1136/adc.82.3.253; COZZI F, 1979, MED HYPOTHESES, V5, P329, DOI 10.1016/0306-9877(79)90013-6; CREERY D, 2005, BMJ CLIN EVIDENCE, V13, P434; de Jonge GA, 2004, ARCH DIS CHILD, V89, P427, DOI 10.1136/adc.2003.029884; DiFranza JR, 2004, PEDIATRICS, V113, P1007; DWYER T, 1995, PEDIATR ANN, V24, P350, DOI 10.3928/0090-4481-19950701-06; Engelberts AC, 2000, ARCH DIS CHILD, V82, P267; FEWELL JE, 1989, J DEV PHYSIOL, V12, P193; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; Fleming P, 2006, ARCH DIS CHILD, V91, P799, DOI 10.1136/adc.2005.092304; FLEMING P, 1999, SUDDEN UNEXPECTED DE; Fleming PJ, 1999, ARCH DIS CHILD, V81, P112, DOI 10.1136/adc.81.2.112; FLEMING PJ, 1990, BRIT MED J, V301, P85, DOI 10.1136/bmj.301.6743.85; Fleming PJ, 1996, BMJ-BRIT MED J, V313, P191, DOI 10.1136/bmj.313.7051.191; Flick L, 2001, J PEDIATR-US, V138, P338, DOI 10.1067/mpd.2001.111428; FORD RPK, 1993, INT J EPIDEMIOL, V22, P885, DOI 10.1093/ije/22.5.885; Franco P, 2000, PEDIATR RES, V47, P215, DOI 10.1203/00006450-200002000-00011; Franco P, 2000, J PEDIATR-US, V136, P775, DOI 10.1067/mpd.2000.105365; Franco P, 2003, SLEEP MED, V4, P569, DOI 10.1016/S1389-9457(03)00107-2; Franco P, 1996, PEDIATRICS, V97, P174; Franco P, 1999, J PEDIATR-US, V135, P34, DOI 10.1016/S0022-3476(99)70324-0; Freemantle CJ, 2006, J PAEDIATR CHILD H, V42, P445, DOI 10.1111/j.1440-1754.2006.00895.x; Froen TF, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e52; Galland BC, 2000, ARCH DIS CHILD, V83, P423, DOI 10.1136/adc.83.5.423; Galland BC, 2006, J APPL PHYSIOL, V100, P933, DOI 10.1152/japplphysiol.01275.2005; Galland BC, 1998, ARCH DIS CHILD-FETAL, V78, pF189, DOI 10.1136/fn.78.3.F189; Galland BC, 2000, PEDIATR RES, V48, P360, DOI 10.1203/00006450-200009000-00017; GILBERT RE, 1995, BMJ-BRIT MED J, V310, P88, DOI 10.1136/bmj.310.6972.88; HAGLUND B, 1993, ACTA PAEDIATR, V82, P37, DOI 10.1111/j.1651-2227.1993.tb12872.x; HARPER RM, 1986, AUST PAEDIATR J, V22, P55; Hauck FR, 2005, PEDIATRICS, V116, pE716, DOI 10.1542/peds.2004-2631; Hauck FR, 2002, PEDIATRICS, V110, P772, DOI 10.1542/peds.110.4.772; Hauck FR, 2003, PEDIATRICS, V111, P1207; HAUCK FR, 2001, SUDDEN INFANT DEATH; Heininger U, 2004, PEDIATRICS, V114, pE9, DOI 10.1542/peds.114.1.e9; HOFFMAN HJ, 1988, ANN NY ACAD SCI, V533, P13, DOI 10.1111/j.1749-6632.1988.tb37230.x; HOFFMAN HJ, 1992, CLIN PERINATOL, V19, P717, DOI 10.1016/S0095-5108(18)30427-5; Horne RSC, 2004, EARLY HUM DEV, V79, P49, DOI 10.1016/j.earlhumdev.2004.04.005; HORNE RSC, 1989, AM J PHYSIOL, V256, pH434, DOI 10.1152/ajpheart.1989.256.2.H434; Horne RSC, 2004, ARCH DIS CHILD, V89, P22; Horne RSC, 2002, ARCH DIS CHILD-FETAL, V87, pF100, DOI 10.1136/fn.87.2.F100; Horne RSC, 2002, SLEEP, V25, P746, DOI 10.1093/sleep/25.7.746; HORNE RSC, 1991, AM J PHYSIOL, V260, pH1283, DOI 10.1152/ajpheart.1991.260.4.H1283; Horne RSC, 2001, J PEDIATR-US, V138, P811, DOI 10.1067/mpd.2001.114475; Horner RL, 1996, SLEEP, V19, pS193, DOI 10.1093/sleep/19.suppl_10.S193; Hoyert D L, 2001, Natl Vital Stat Rep, V49, P1; Hoyert DL, 2006, PEDIATRICS, V117, P168, DOI 10.1542/peds.2005-2587; Hunt CE, 2006, CAN MED ASSOC J, V174, P1861, DOI 10.1503/cmaj.051671; Hunt CE, 2005, ARCH DIS CHILD, V90, P48, DOI 10.1136/adc.2004.051458; HUNT CE, 1992, CLIN PERINATOL, V19, P757, DOI 10.1016/S0095-5108(18)30429-9; Jones KL, 2003, PEDIATRICS, V111, P358, DOI 10.1542/peds.111.2.358; KAHN A, 1983, PEDIATRICS, V71, P49; KAHN A, 1992, SLEEP, V15, P287, DOI 10.1093/sleep/15.4.287; Kahn A, 2002, FORENSIC SCI INT, V130, pS8; KAHN A, 1993, PEDIATRICS, V91, P1112; Kato I, 2003, AM J RESP CRIT CARE, V168, P1298, DOI 10.1164/rccm.200301-134OC; Kato I, 2006, SLEEP, V29, P785, DOI 10.1093/sleep/29.6.785; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; KELLY DH, 1986, J PEDIATR-US, V109, P249, DOI 10.1016/S0022-3476(86)80380-8; Kemp JS, 1998, J PEDIATR-US, V132, P234, DOI 10.1016/S0022-3476(98)70437-8; KEMP JS, 1993, J PEDIATR-US, V122, P874, DOI 10.1016/S0022-3476(09)90010-5; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; KLUGE KA, 1988, PEDIATR RES, V24, P667, DOI 10.1203/00006450-198812000-00005; Korachi M, 2004, FEMS IMMUNOL MED MIC, V42, P125, DOI 10.1016/j.femsim.2004.06.008; KRAUS JF, 1989, INT J EPIDEMIOL, V18, P113, DOI 10.1093/ije/18.1.113; KROUS H, 1996, J SIDS INFANT MORTAL, V1, P203; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; L'Hoir MP, 1999, EUR J PEDIATR, V158, P896, DOI 10.1007/s004310051237; Lavezzi AM, 2006, CURR MOL MED, V6, P429, DOI 10.2174/156652406777435381; LEWIS KW, 1995, J PEDIATR-US, V127, P691, DOI 10.1016/S0022-3476(95)70155-9; Li DK, 2003, AM J EPIDEMIOL, V157, P446, DOI 10.1093/aje/kwf226; MacDorman MF, 1997, AM J EPIDEMIOL, V146, P249, DOI 10.1093/oxfordjournals.aje.a009260; MALLOY MH, 1995, PEDIATRICS, V96, P464; Malloy MH, 2002, PEDIATRICS, V109, P661, DOI 10.1542/peds.109.4.661; MARKESTAD T, 1995, ACTA PAEDIATR, V84, P375, DOI 10.1111/j.1651-2227.1995.tb13653.x; MARTIN RJ, 1995, J PEDIATR-US, V127, P609, DOI 10.1016/S0022-3476(95)70125-7; *MAT CHILD HLTH BU, 2003, VAR SIDS DIAGN PROC; Mathews T J, 2006, Natl Vital Stat Rep, V54, P1; Mathews T J, 2004, Natl Vital Stat Rep, V53, P1; McGarvey C, 2003, ARCH DIS CHILD, V88, P1058, DOI 10.1136/adc.88.12.1058; McKenna JJ, 1997, PEDIATRICS, V100, P214, DOI 10.1542/peds.100.2.214; Mitchell E, 2000, AM J FOREN MED PATH, V21, P311, DOI 10.1097/00000433-200012000-00002; Mitchell E. A., 2006, Reviews on Environmental Health, V21, P81; Mitchell EA, 1999, ARCH PEDIAT ADOL MED, V153, P1136, DOI 10.1001/archpedi.153.11.1136; Mitchell EA, 2006, PEDIATRICS, V117, P1755, DOI 10.1542/peds.2005-1625; MITCHELL EA, 1993, ARCH DIS CHILD, V68, P501, DOI 10.1136/adc.68.4.501; MITCHELL EA, 1994, ARCH DIS CHILD, V70, P291, DOI 10.1136/adc.70.4.291; Mitchell EA, 1998, J PEDIATR-US, V133, P701, DOI 10.1016/S0022-3476(98)70116-7; Mitchell EA, 1997, PEDIATRICS, V100, P835, DOI 10.1542/peds.100.5.835; MITCHELL EA, 1999, WFO TFI REPORTS 1999; Moon RY, 2005, PEDIATRICS, V116, P972, DOI 10.1542/peds.2005-0924; Moon RY, 2000, PEDIATRICS, V106, P295, DOI 10.1542/peds.106.2.295; Mosko S, 1997, PEDIATRICS, V100, P841, DOI 10.1542/peds.100.5.841; Myers MM, 1998, SLEEP, V21, P343; Narita N, 2001, PEDIATRICS, V107, P690, DOI 10.1542/peds.107.4.690; Oyen N, 1997, PEDIATRICS, V100, P613, DOI 10.1542/peds.100.4.613; Panaretto KS, 2002, J PAEDIATR CHILD H, V38, P135, DOI 10.1046/j.1440-1754.2002.00760.x; Parsiow PM, 2004, RESP PHYSIOL NEUROBI, V140, P77, DOI 10.1016/j.resp.2004.01.004; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Perez-Stable EJ, 1998, JAMA-J AM MED ASSOC, V280, P152, DOI 10.1001/jama.280.2.152; PHILLIPSON EA, 1978, AM REV RESPIR DIS, V118, P807; Plant LD, 2006, J CLIN INVEST, V116, P430, DOI 10.1172/JCI25618; PONSONBY AL, 1992, BRIT MED J, V304, P277, DOI 10.1136/bmj.304.6822.277; Ponsonby AL, 1998, BRIT MED J, V316, P195; PONSONBY AL, 1995, PAEDIATR PERINAT EP, V9, P256, DOI 10.1111/j.1365-3016.1995.tb00141.x; PONSONBY AL, 1993, NEW ENGL J MED, V329, P377, DOI 10.1056/NEJM199308053290601; Ramanathan R, 2001, JAMA-J AM MED ASSOC, V285, P2199, DOI 10.1001/jama.285.17.2199; Rognum T O, 1995, Tidsskr Nor Laegeforen, V115, P85; Sahni R, 1999, ACTA PAEDIATR, V88, P1396, DOI 10.1080/080352599750030158; Sawnani H, 2004, AM J RESP CRIT CARE, V169, P733, DOI 10.1164/rccm.200305-692OC; SCHECHTMAN VL, 1992, PEDIATRICS, V89, P865; SCHECHTMAN VL, 1989, EARLY HUM DEV, V19, P167, DOI 10.1016/0378-3782(89)90077-7; Scheers NJ, 2003, PEDIATRICS, V112, P883, DOI 10.1542/peds.112.4.883; Scheers NJ, 1998, ARCH PEDIAT ADOL MED, V152, P540; SCHOENDORF KC, 1992, PEDIATRICS, V90, P905; Schwartz PJ, 1998, NEW ENGL J MED, V338, P1709, DOI 10.1056/NEJM199806113382401; SCRAGG R, 1993, BMJ-BRIT MED J, V307, P1312, DOI 10.1136/bmj.307.6915.1312; Shapiro-Mendoza CK, 2006, AM J EPIDEMIOL, V163, P762, DOI 10.1093/aje/kwj117; Skadberg BT, 1997, ARCH DIS CHILD, V76, P320, DOI 10.1136/adc.76.4.320; Sovik S, 2001, PEDIATR RES, V49, P558, DOI 10.1203/00006450-200104000-00019; Tappin D, 2002, BMJ-BRIT MED J, V325, P1007, DOI 10.1136/bmj.325.7371.1007; Tappin D, 2005, J PEDIATR-US, V147, P32, DOI 10.1016/j.jpeds.2005.01.035; Tester DJ, 2005, CARDIOVASC RES, V67, P388, DOI 10.1016/j.cardiores.2005.02.013; Tirosh E, 1996, J Perinatol, V16, P435; Tuladhar R, 2005, EARLY HUM DEV, V81, P673, DOI 10.1016/j.earlhumdev.2005.04.002; Tuladhar R, 2003, EARLY HUM DEV, V71, P157, DOI 10.1016/S0378-3782(03)00005-7; Tuohy PG, 1998, NEW ZEAL MED J, V111, P364; VEGE A, 1995, ACTA PAEDIATR, V84, P193, DOI 10.1111/j.1651-2227.1995.tb13608.x; Vennemann M, 2007, ARCH DIS CHILD, V92, P133, DOI 10.1136/adc.2006.101337; Vennemann MMT, 2007, VACCINE, V25, P336, DOI 10.1016/j.vaccine.2006.07.027; Vennemann MMT, 2005, ACTA PAEDIATR, V94, P655, DOI 10.1080/08035250410024231; Waters KA, 1999, PEDIATR RES, V45, P166, DOI 10.1203/00006450-199902000-00002; Waters KA, 1996, J PEDIATR-US, V128, P616, DOI 10.1016/S0022-3476(96)80125-9; Weese-Mayer DE, 2004, PEDIATR RES, V56, P391, DOI 10.1203/01.PDR.0000136285.91048.4A; Weese-Mayer DE, 2003, AM J MED GENET A, V117A, P268, DOI 10.1002/ajmg.a.20005; Weese-Mayer DE, 2006, JAMA-J AM MED ASSOC, V296, P2143, DOI 10.1001/jama.296.17.2143; Weiss PPW, 2001, EUR J PEDIATR, V160, P60, DOI 10.1007/s004310000638; Wennergren G, 1997, ACTA PAEDIATR, V86, P963, DOI 10.1111/j.1651-2227.1997.tb15180.x; Willinger M, 1998, JAMA-J AM MED ASSOC, V280, P329, DOI 10.1001/jama.280.4.329; Willinger M, 2003, ARCH PEDIAT ADOL MED, V157, P43, DOI 10.1001/archpedi.157.1.43; WILLINGER M, 1991, Pediatric Pathology, V11, P677; Xu FP, 1998, J APPL PHYSIOL, V85, P53, DOI 10.1152/jappl.1998.85.1.53; NATL INFANT SLEEP PO; 2006, HLTH STAT Q, P82	174	295	302	1	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2007	370	9598					1578	1587		10.1016/S0140-6736(07)61662-6	http://dx.doi.org/10.1016/S0140-6736(07)61662-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AE	17980736				2022-12-28	WOS:000250628800028
J	Koumura, M				Koumura, Masahiko			Global health and Japan's foreign policy	LANCET			English	Editorial Material									Minist Foreign Affairs, Chiyoda Ku, Tokyo 1008919, Japan		Koumura, M (corresponding author), Minist Foreign Affairs, Chiyoda Ku, Tokyo 1008919, Japan.	takehiro.kano@mofa.go.jp						Japan Anti-Tuberculosis Association, 2004, OK INF DIS IN SUMM M; *MIN FOR AFF JAP, MAT CHILD HLTH MCH H; *WHO, 2005, POL SUCC STOR	3	11	11	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					1983	1985		10.1016/S0140-6736(07)61726-7	http://dx.doi.org/10.1016/S0140-6736(07)61726-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242BD	18045681				2022-12-28	WOS:000251698600008
J	Yank, V; Rennie, D; Bero, LA				Yank, Veronica; Rennie, Drummond; Bero, Lisa A.			Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONFLICT-OF-INTEREST; CLINICAL-TRIALS; SYSTEMATIC REVIEWS; RANDOMIZED-TRIALS; QUALITY; BIAS; INDUSTRY; DRUGS; PUBLICATION; ASSOCIATION	Objective To determine whether financial ties to one drug company are associated with favourable results or conclusions in meta-analyses on anti hypertensive drugs. Design Retrospective cohort study. remained more likely to report favourable conclusions (5.11, 1.54 to 16.92). Setting Meta-analyses published up to December 2004 that were not duplicates and evaluated the effects of antihypertensive drugs compared with any comparator on clinical end points in adults. Financial ties were categorised as one drug company compared with all others. Main outcome measures The main outcomes were the results and conclusions of meta-analyses, with both outcomes separately categorised as being favourable or not favourable towards the study drug. We also collected data on characteristics of meta-analyses that the literature suggested might be associated with favourable results or conclusions. Results 124 meta-analyses were included in the study, 49 (40%) of which had financial ties to one drug company. On univariate logistic regression analyses, meta-analyses of better methodological quality were more likely to have favourable results (odds ratio 1.16, 95% confidence interval 1.07 to 1.27). Although financial ties to one drug company were not associated with favourable results, such ties constituted the only characteristic significantly associated with favourable conclusions (4.09, 1.30 to 12.83). When controlling for other characteristics of meta-analyses in multiple logistic regression analyses, meta-analyses that had financial ties to one drug company remained more likely to report favourable conclusions (5.11, 1.54 to 16.92). Conclusion Meta-analyses on antihypertensive drugs and with financial ties to one drug company are not associated with favourable results but are associated with favourable conclusions.	Stanford Univ, Stanford Med Grp, Stanford, CA 94305 USA; Univ Calif San Francisco, Clin Pharm, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yank, V (corresponding author), Stanford Univ, Stanford Med Grp, Stanford, CA 94305 USA.	vyank@stanford.edu		Bero, Lisa/0000-0003-1893-6651				Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; ASSENDELFT WJJ, 1995, JAMA-J AM MED ASSOC, V274, P1942, DOI 10.1001/jama.274.24.1942; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; BERO LA, 1992, NEW ENGL J MED, V327, P1135, DOI 10.1056/NEJM199210153271606; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Blumenthal D, 1996, NEW ENGL J MED, V335, P1734, DOI 10.1056/NEJM199612053352305; Boyd EA, 2000, JAMA-J AM MED ASSOC, V284, P2209, DOI 10.1001/jama.284.17.2209; Campbell EG, 1998, JAMA-J AM MED ASSOC, V279, P995, DOI 10.1001/jama.279.13.995; CHALMERS TC, 1987, STAT MED, V6, P733, DOI 10.1002/sim.4780060704; CHALMERS TC, 1983, NEW ENGL J MED, V309, P1358, DOI 10.1056/NEJM198312013092204; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; *COMM SPONS COCHR, 2006, COCHR COLL POL COMM; Cook D, 2001, ANN INTERN MED, V135, P205, DOI 10.7326/0003-4819-135-3-200108070-00013; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Engels EA, 2000, STAT MED, V19, P1707, DOI 10.1002/1097-0258(20000715)19:13<1707::AID-SIM491>3.0.CO;2-P; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Furberg CD, 2001, ANN INTERN MED, V135, P1074, DOI 10.7326/0003-4819-135-12-200112180-00011; Glasziou P, 2006, LANCET, V367, P2057, DOI 10.1016/S0140-6736(06)68919-8; GOTZSCHE PC, 1989, CONTROL CLIN TRIALS, V10, P31, DOI 10.1016/0197-2456(89)90017-2; GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Jadad AR, 2000, BRIT MED J, V320, P537, DOI 10.1136/bmj.320.7234.537; Jadad AR, 1996, J CLIN EPIDEMIOL, V49, P235, DOI 10.1016/0895-4356(95)00062-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Krimsky S, 1996, Sci Eng Ethics, V2, P395, DOI 10.1007/BF02583927; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lexchin J, 2006, BMJ-BRIT MED J, V332, P1444, DOI 10.1136/bmj.332.7555.1444; McDonald JWD, 2002, CAN J GASTROENTEROL, V16, P17, DOI 10.1155/2002/513758; *MIDAS, 2005, LEAD THER CLASS GLOB; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 1996, LANCET, V347, P363, DOI 10.1016/S0140-6736(96)90538-3; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Psaty BM, 2006, JAMA-J AM MED ASSOC, V295, P1704, DOI 10.1001/jama.295.14.1704; Riley RD, 2004, J CLIN EPIDEMIOL, V57, P911, DOI 10.1016/j.jclinepi.2004.01.018; ROCHON PA, 1994, JAMA-J AM MED ASSOC, V272, P108, DOI 10.1001/jama.272.2.108; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Villanueva P, 2003, LANCET, V361, P27, DOI 10.1016/S0140-6736(03)12118-6; Winslow R., 2005, WSJ             0216, pB1; 2006, COCHRANE LIB	46	168	170	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2007	335	7631					1202	+		10.1136/bmj.39376.447211.BE	http://dx.doi.org/10.1136/bmj.39376.447211.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242ER	18024482	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000251707800035
J	Decaestecker, E; Gaba, S; Raeymaekers, JAM; Stoks, R; Van Kerckhoven, L; Ebert, D; De Meester, L				Decaestecker, Ellen; Gaba, Sabrina; Raeymaekers, Joost A. M.; Stoks, Robby; Van Kerckhoven, Liesbeth; Ebert, Dieter; De Meester, Luc			Host-parasite 'Red Queen' dynamics archived in pond sediment	NATURE			English	Article							NATURAL-POPULATIONS; MEDIATED SELECTION; DAPHNIA CRUSTACEA; GENETIC-VARIATION; LOCAL ADAPTATION; RAPID EVOLUTION; VIRULENCE; ECOLOGY; BANKS; SEX	Antagonistic interactions between hosts and parasites are a key structuring force in natural populations, driving coevolution(1,2). However, direct empirical evidence of long-term host-parasite coevolution, in particular `Red Queen' dynamics-in which antagonistic biotic interactions such as host-parasite interactions can lead to reciprocal evolutionary dynamics-is rare(3-5), and current data, although consistent with theories of antagonistic coevolution, do not reveal the temporal dynamics of the process(6). Dormant stages of both the water flea Daphnia and its microparasites are conserved in lake sediments, providing an archive of past gene pools. Here we use this fact to reconstruct rapid coevolutionary dynamics in a natural setting and show that the parasite rapidly adapts to its host over a period of only a few years. A coevolutionary model based on negative frequency-dependent selection, and designed to mimic essential aspects of our host parasite system, corroborated these experimental results. In line with the idea of continuing host-parasite coevolution, temporal variation in parasite infectivity changed little over time. In contrast, from the moment the parasite was first found in the sediments, we observed a steady increase in virulence over time, associated with higher fitness of the parasite.	Katholieke Univ Leuven, Lab Aquat Ecol & Evolut Biol, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Lab Anim Biodivers & Systemat, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Interdisciplinary Res Ctr, B-8500 Kortrijk, Belgium; Univ Basel, Inst Zool, CH-4053 Basel, Switzerland; INRA, UR1282, F-37380 Nouzilly, France	KU Leuven; KU Leuven; KU Leuven; University of Basel; INRAE	Decaestecker, E (corresponding author), Katholieke Univ Leuven, Lab Aquat Ecol & Evolut Biol, Charles Beriotstr 32, B-3000 Louvain, Belgium.	ellen.decaestecker@kuleuven-kortrijk.be	Ebert, Dieter/B-5502-2009; Stoks, Robby/AAK-1227-2020; Raeymaekers, Joost/J-9538-2014; Gaba, Sabrina/H-5240-2018; Decaestecker, Ellen/ABB-1242-2020; Decaestecker, Ellen/AAB-3420-2021; Ebert, Dieter/P-6134-2019; Gaba, Sabrina/N-8428-2013; De Meester, Luc/F-3832-2015; Decaestecker, Ellen/AAQ-6099-2020; Decaestecker, Ellen/M-8949-2016	Ebert, Dieter/0000-0003-2653-3772; Raeymaekers, Joost/0000-0003-2732-7495; Gaba, Sabrina/0000-0002-7145-6713; Decaestecker, Ellen/0000-0001-6328-5283; Ebert, Dieter/0000-0003-2653-3772; Gaba, Sabrina/0000-0002-7145-6713; De Meester, Luc/0000-0001-5433-6843; Decaestecker, Ellen/0000-0001-6328-5283; Stoks, Robby/0000-0003-4130-0459				Capaul M, 2003, EVOLUTION, V57, P249, DOI 10.1111/j.0014-3820.2003.tb00260.x; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Decaestecker E, 2003, EVOLUTION, V57, P784, DOI 10.1111/j.0014-3820.2003.tb00290.x; Decaestecker E, 2004, LIMNOL OCEANOGR, V49, P1355, DOI 10.4319/lo.2004.49.4_part_2.1355; Decaestecker E, 2002, P NATL ACAD SCI USA, V99, P5481, DOI 10.1073/pnas.082543099; Duffy MA, 2007, ECOL LETT, V10, P44, DOI 10.1111/j.1461-0248.2006.00995.x; Duncan AB, 2007, EVOLUTION, V61, P796, DOI 10.1111/j.1558-5646.2007.00072.x; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Ebert D, 2004, AM NAT, V164, pS19, DOI 10.1086/424606; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Fenner F., 1999, BIOL CONTROL VERTEBR; Haag CR, 2004, P ROY SOC B-BIOL SCI, V271, P2149, DOI 10.1098/rspb.2004.2841; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Harvell D, 2004, AM NAT, V164, pS1, DOI 10.1086/424611; Kerfoot WC, 2004, LIMNOL OCEANOGR, V49, P1300, DOI 10.4319/lo.2004.49.4_part_2.1300; Kosman J, 2003, J BACTERIOL, V185, P6095, DOI 10.1128/JB.185.20.6095-6103.2003; Little TJ, 1999, J ANIM ECOL, V68, P134, DOI 10.1046/j.1365-2656.1999.00271.x; Little TJ, 2000, P ROY SOC B-BIOL SCI, V267, P2037, DOI 10.1098/rspb.2000.1246; Little TJ, 2006, EVOLUTION, V60, P31, DOI 10.1111/j.0014-3820.2006.tb01079.x; Little TJ, 2001, EVOLUTION, V55, P1146, DOI 10.1111/j.0014-3820.2001.tb00634.x; Little TJ, 2002, J EVOLUTION BIOL, V15, P1, DOI 10.1046/j.1420-9101.2002.00366.x; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; Mitchell SE, 2004, ECOL LETT, V7, P848, DOI 10.1111/j.1461-0248.2004.00639.x; *R DEV COR TEAM, 2005, R PROJ STAT COMP; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; VAVREK MC, 1991, J ECOL, V79, P645, DOI 10.2307/2260659; Wegner KM, 2003, SCIENCE, V301, P1343, DOI 10.1126/science.1088293; West SA, 1999, J EVOLUTION BIOL, V12, P1003; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569	31	454	458	12	353	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					870	U16		10.1038/nature06291	http://dx.doi.org/10.1038/nature06291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18004303	Green Published			2022-12-28	WOS:000251394900054
J	Nejentsev, S; Howson, JMM; Walker, NM; Szeszko, J; Field, SF; Stevens, HE; Reynolds, P; Hardy, M; King, E; Masters, J; Hulme, J; Maier, LM; Smyth, D; Bailey, R; Cooper, JD; Ribas, G; Campbell, RD; Clayton, DG; Todd, JA				Nejentsev, Sergey; Howson, Joanna M. M.; Walker, Neil M.; Szeszko, Jeffrey; Field, Sarah F.; Stevens, Helen E.; Reynolds, Pamela; Hardy, Matthew; King, Erna; Masters, Jennifer; Hulme, John; Maier, Lisa M.; Smyth, Deborah; Bailey, Rebecca; Cooper, Jason D.; Ribas, Gloria; Campbell, R. Duncan; Clayton, David G.; Todd, John A.		Wellcome Trust Case Control Consor	Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A	NATURE			English	Article							CD8 T-CELLS; NOD MICE; MELLITUS; REGION; ASSOCIATION; REVEALS; RISK; PREDISPOSITION; INFILTRATION; DESTRUCTION	The major histocompatibility complex (MHC) on chromosome 6 is associated with susceptibility to more common diseases than any other region of the human genome, including almost all disorders classified as autoimmune. In type 1 diabetes the major genetic susceptibility determinants have been mapped to the MHC class II genes HLA-DQB1 and HLA-DRB1(refs 1-3), but these genes cannot completely explain the association between type 1 diabetes and the MHC region(4-11). Owing to the region's extreme gene density, the multiplicity of disease-associated alleles, strong associations between alleles, limited genotyping capability, and inadequate statistical approaches and sample sizes, which, and how many, loci within the MHC determine susceptibility remains unclear. Here, in several large type 1 diabetes data sets, we analyse a combined total of 1,729 polymorphisms, and apply statistical methods-recursive partitioning and regression-to pinpoint disease susceptibility to the MHC class I genes HLA-B and HLA-A (risk ratios > 1.5; P(combined) = 2.01 X 10(-19) and 2.35 X 10(-13), respectively) in addition to the established associations of the MHC class II genes. Other loci with smaller and/or rarer effects might also be involved, but to find these, future searches must take into account both the HLA class II and class I genes and use even larger samples. Taken together with previous studies(4-8,10-16), we conclude that MHC-class-I-mediated events, principally involving HLA-B*39, contribute to the aetiology of type 1 diabetes.	Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Dept Med Genet,Cambridge Inst Med Res, Cambridge CB2 0XY, England; MRC Rosalind Franklin Ctr Genom Res, Cambridge CB10 1SB, England; Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England	University of Cambridge; University of Oxford	Howson, JMM (corresponding author), Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Dept Med Genet,Cambridge Inst Med Res, Cambridge CB2 0XY, England.	Joanna.Howson@cimr.cam.ac.uk; John.Todd@cimr.cam.ac.uk	Worthington, Jane/M-9770-2014; eyre, stephen/K-3776-2017; Mathew, Christopher G/G-3434-2015; Ribas-Despuig, Gloria/M-6190-2017; Attrill, Lauren/V-1688-2018; Brown, Matthew A/E-5749-2010; O'Donovan, Michael C/P-7005-2018; Timpson, Nicholas John/O-7548-2015; Todd, John A/A-3542-2010; Hinks, Anne/E-1853-2015; Barton, Anne/N-2053-2014; Evans, David/H-6325-2013; Prescott, Natalie/F-6490-2011; Breen, Gerome/A-5540-2010; McCarthy, Mark/M-3763-2015; Ribas, Gloria/K-3379-2013; dobson, richard/C-9269-2011; Yuldasheva, Nadira Yusupovna/GXM-9013-2022	Worthington, Jane/0000-0003-0544-042X; eyre, stephen/0000-0002-1251-6974; Mathew, Christopher G/0000-0003-4178-1838; Brown, Matthew A/0000-0003-0538-8211; O'Donovan, Michael C/0000-0001-7073-2379; Timpson, Nicholas John/0000-0002-7141-9189; Todd, John A/0000-0003-2740-8148; Hinks, Anne/0000-0001-8843-3967; Wallace, Chris/0000-0001-9755-1703; Parkes, Miles/0000-0002-6467-0631; Jones, Lisa/0000-0002-5122-8334; Barton, Anne/0000-0003-3316-2527; Thomson, Wendy/0000-0002-9022-5179; Bruce, Ian/0000-0003-3047-500X; Walker, Neil/0000-0001-9796-7688; Evans, David/0000-0003-0663-4621; Prescott, Natalie/0000-0002-5901-7371; Symmons, Deborah/0000-0002-8625-1200; Escott-Price, Valentina/0000-0003-1784-5483; Bowcock, Anne/0000-0001-8691-9090; Tobin, Martin/0000-0002-3596-7874; Kirov, George/0000-0002-3427-3950; Breen, Gerome/0000-0003-2053-1792; smyth, deborah/0000-0002-6330-2669; McCarthy, Mark/0000-0002-4393-0510; s, hema/0000-0002-3440-9475; Newport, Melanie/0000-0002-8946-7525; Hall, Alistair/0000-0003-0306-7887; Grozeva, Detelina/0000-0003-3239-8415; Ribas, Gloria/0000-0001-6883-4130; Caulfield, Mark/0000-0001-9295-3594; Howson, Joanna/0000-0001-7618-0050; Bishop, Tim/0000-0002-8752-8785; Simmonds, Matt/0000-0003-3154-3510; dobson, richard/0000-0003-4224-9245; Lango Allen, Hana/0000-0002-7803-8688; Lindgren, Cecilia/0000-0002-4903-9374; Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; Cummings, Fraser/0000-0002-9659-3247; Hardy, Matthew/0000-0001-6420-1715	MRC [G0600681, G0000934] Funding Source: UKRI; Medical Research Council [G0600681, G0000934] Funding Source: Medline; Wellcome Trust [076113] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aly TA, 2007, CLIN IMMUNOL, V123, pS133, DOI 10.1016/j.clim.2007.03.018; Aly TA, 2006, P NATL ACAD SCI USA, V103, P14074, DOI 10.1073/pnas.0606349103; Breiman L., 1984, CLASSIFICATION REGRE; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; de Jersey J, 2007, P NATL ACAD SCI USA, V104, P1295, DOI 10.1073/pnas.0610057104; FENNESSY M, 1994, DIABETOLOGIA, V37, P937, DOI 10.1007/s001250050200; FOULIS AK, 1986, DIABETOLOGIA, V29, P267, DOI 10.1007/BF00452061; Herr M, 2000, HUM MOL GENET, V9, P1291, DOI 10.1093/hmg/9.9.1291; HONEYMAN MC, 1995, MOL MED, V1, P576, DOI 10.1007/BF03401595; ITOH N, 1993, J CLIN INVEST, V92, P2313, DOI 10.1172/JCI116835; Lie BA, 1999, AM J HUM GENET, V64, P793, DOI 10.1086/302283; Marron MP, 2002, P NATL ACAD SCI USA, V99, P13753, DOI 10.1073/pnas.212221199; Nejentsev S, 2000, DIABETES, V49, P2217, DOI 10.2337/diabetes.49.12.2217; Noble JA, 1996, AM J HUM GENET, V59, P1134; Noble JA, 2002, HUM IMMUNOL, V63, P657, DOI 10.1016/S0198-8859(02)00421-4; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; R Development Core Team, 2006, LANG ENV STAT COMP; Roach JC, 2006, AM J HUM GENET, V79, P614, DOI 10.1086/507876; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Therneau T. M, 1997, 61 MAYO CLIN SECT ST; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Utsugi T, 1996, DIABETES, V45, P1121, DOI 10.2337/diabetes.45.8.1121; Valdes AM, 2005, HUM IMMUNOL, V66, P301, DOI 10.1016/j.humimm.2004.12.001; Valdes AM, 2005, TISSUE ANTIGENS, V65, P115, DOI 10.1111/j.1399-0039.2005.00348.x; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500	30	402	416	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					887	U19		10.1038/nature06406	http://dx.doi.org/10.1038/nature06406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18004301	Green Accepted			2022-12-28	WOS:000251394900058
J	Li, CY; Krishnamurthy, PC; Penmatsa, H; Marrs, KL; Wang, XQ; Zaccolo, M; Jalink, K; Li, M; Nelson, DJ; Schuetz, JD; Naren, AP				Li, Chunying; Krishnamurthy, Partha C.; Penmatsa, Himabindu; Marrs, Kevin L.; Wang, Xue Qing; Zaccolo, Manuela; Jalink, Kees; Li, Min; Nelson, Deborah J.; Schuetz, John D.; Naren, Anjaparavanda P.			Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; BETA(2) ADRENERGIC-RECEPTOR; CYSTIC-FIBROSIS; CYCLIC-NUCLEOTIDES; RESISTANCE; COMPLEX; MRP4; GLUTATHIONE; EXPRESSION; SECRETION	Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated chloride channel localized at apical cell membranes and exists in macromolecular complexes with a variety of signaling and transporter molecules. Here, we report that the multidrug resistance protein 4 (MRP4), a cAMP transporter, functionally and physically associates with CFTR. Adenosine-stimulated CFTR-mediated chloride currents are potentiated by MRP4 inhibition, and this potentiation is directly coupled to attenuated cAMP efflux through the apical cAMP transporter. CFTR single-channel recordings and FRET-based intracellular cAMP dynamics suggest that a compartmentalized coupling of cAMP transporter and CFTR occurs via the PDZ scaffolding protein, PDZK1, forming a macromolecular complex at apical surfaces of gut epithelia. Disrupting this complex abrogates the functional coupling of cAMP transporter activity to CFTR function. Mrp4 knockout mice are more prone to CFTR-mediated secretory diarrhea. Our findings have important implications for disorders such as inflammatory bowel disease and secretory diarrhea.	[Li, Chunying; Penmatsa, Himabindu; Marrs, Kevin L.; Naren, Anjaparavanda P.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Krishnamurthy, Partha C.; Schuetz, John D.] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Wang, Xue Qing; Nelson, Deborah J.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Zaccolo, Manuela] Vet Inst Mol Med, Dulbecco Telethon Inst, I-35124 Padua, Italy; [Jalink, Kees] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Li, Min] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Chicago; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Netherlands Cancer Institute; Johns Hopkins University	Naren, AP (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	anaren@utmem.edu	Zaccolo, Manuela/B-3802-2011; Schuetz, John D/N-2692-2018; Zaccolo, Manuela/AAP-6706-2020	Zaccolo, Manuela/0000-0002-0934-3662; Jalink, Kees/0000-0001-7019-3440	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI070942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080834, R01DK058545, R01DK074996, R01DK093045] Funding Source: NIH RePORTER; NIAID NIH HHS [R03 AI070942-01A1, R03 AI070942] Funding Source: Medline; NIDDK NIH HHS [R01 DK074996, R01 DK074996-01, R01 DK058545-01A2, R01 DK058545, R01 DK058545-04, R01 DK080834, R01 DK058545-05, R01 DK074996-02, R01 DK058545-03, R01 DK058545-02, R01 DK093045] Funding Source: Medline; Telethon [TCR05005] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Telethon(Fondazione Telethon)		Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jackson EK, 2004, ANNU REV PHYSIOL, V66, P571, DOI 10.1146/annurev.physiol.66.032102.111604; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lai LQ, 2002, BIOCHEM J, V361, P497, DOI 10.1042/0264-6021:3610497; LAMPRECHT G, 2006, LIVER PHYSL, V291, pG766; LAMPRECHT G, 2006, BIOCHEM J, V291, pG766; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Lohi H, 2002, AM J PHYSIOL-GASTR L, V283, pG567, DOI 10.1152/ajpgi.00356.2001; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Reddy MM, 1996, AM J PHYSIOL-CELL PH, V270, pC474, DOI 10.1152/ajpcell.1996.270.2.C474; Reid G, 2003, MOL PHARMACOL, V63, P1094, DOI 10.1124/mol.63.5.1094; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Stelzner M, 2001, BMC Gastroenterol, V1, P10, DOI 10.1186/1471-230X-1-10; Umar S, 2000, AM J PHYSIOL-GASTR L, V278, pG753, DOI 10.1152/ajpgi.2000.278.5.G753; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200	29	155	158	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 30	2007	131	5					940	951		10.1016/j.cell.2007.09.037	http://dx.doi.org/10.1016/j.cell.2007.09.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045536	Green Accepted, Bronze			2022-12-28	WOS:000251800900016
J	Yarden, Y; Shilo, BZ				Yarden, Yosef; Shilo, Ben-Zion			SnapShot: EGFR signaling pathway	CELL			English	Editorial Material							ACTIVATION		[Yarden, Yosef; Shilo, Ben-Zion] Weizmann Inst Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yarden, Y (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.		YARDEN, YOSEF/K-1467-2012	Shilo, Ben Zion/0000-0003-4903-8889				Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Freeman M, 2004, NAT REV MOL CELL BIO, V5, P188, DOI 10.1038/nrm1334; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Tsruya R, 2007, EMBO J, V26, P1211, DOI 10.1038/sj.emboj.7601581; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	12	130	137	3	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5							1018.e1	10.1016/j.cell.2007.11.013	http://dx.doi.org/10.1016/j.cell.2007.11.013			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045542	Bronze			2022-12-28	WOS:000251800900022
J	Wakeman, SE				Wakeman, Sarah Elizabeth			It's simple, really	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sarah_wakeman@brown.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2351	2351		10.1001/jama.298.20.2351	http://dx.doi.org/10.1001/jama.298.20.2351			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	18042908				2022-12-28	WOS:000251163400001
J	Zechmann, CM; Giesel, FL; Hillengass, J; Mehndiratta, A; Neben, K; Delorme, S; Moehler, T				Zechmann, Christian M.; Giesel, Frederik L.; Hillengass, Jens; Mehndiratta, Amit; Neben, Kai; Delorme, Stefan; Moehler, Thomas			Where is the primary tumour?	LANCET			English	Editorial Material							MULTIPLE-MYELOMA; FEATURES		German Canc Res Ctr, DKFZ, Dept Radiol, Heidelberg, Germany; Univ Heidelberg, Dept Haematol Oncol & Rheumatol, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Zechmann, CM (corresponding author), Deutsch Krebsforschungszentrum, Dept Radiol E010, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	c.zechmann@dkfz.de	Delorme, Stefan/AAM-7271-2021	Delorme, Stefan/0000-0002-1000-2582; Zechmann, Christian M/0000-0002-8454-0877				Damaj G, 2004, EUR J HAEMATOL, V73, P402, DOI 10.1111/j.1600-0609.2004.00331.x; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; Moulopoulos LA, 1997, BLOOD, V90, P2127, DOI 10.1182/blood.V90.6.2127	3	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 24	2007	370	9601					1800	1800		10.1016/S0140-6736(07)61747-4	http://dx.doi.org/10.1016/S0140-6736(07)61747-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234DI	18037083				2022-12-28	WOS:000251140500025
J	Lin, RC; Ding, L; Casola, C; Ripoll, DR; Feschotte, C; Wang, HY				Lin, Rongcheng; Ding, Lei; Casola, Claudio; Ripoll, Daniel R.; Feschotte, Cedric; Wang, Haiyang			Transposase-derived transcription factors regulate light signaling in Arabidopsis	SCIENCE			English	Article							PHYTOCHROME-A PHOTORECEPTOR; NUCLEAR ACCUMULATION; FHY1; FAR1; EVOLUTION; FHL	Plants use light to optimize growth and development. The photoreceptor phytochrome A ( phyA) mediates various far-red light-induced responses. We show that Arabidopsis FHY3 and FAR1, which encode two proteins related to Mutator-like transposases, act together to modulate phyA signaling by directly activating the transcription of FHY1 and FHL, whose products are essential for light-induced phyA nuclear accumulation and subsequent light responses. FHY3 and FAR1 have separable DNA binding and transcriptional activation domains that are highly conserved in Mutator-like transposases. Further, expression of FHY3 and FAR1 is negatively regulated by phyA signaling. We propose that FHY3 and FAR1 represent transcription factors that have been co-opted from an ancient Mutator-like transposase(s) to modulate phyA-signaling homeostasis in higher plants.	Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Univ Texas, Dept Biol, Arlington, TX 76019 USA; Cornell Univ, Computat Biol Serv Unit, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; University of Texas System; University of Texas Arlington; Cornell University	Wang, HY (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA.	hw75@cornell.edu	Feschotte, Cedric/C-4048-2011; Lin, Rongcheng/I-8105-2014	Lin, Rongcheng/0000-0001-8346-3390; Casola, Claudio/0000-0003-4853-1866	NIGMS NIH HHS [R01 GM077582, R01 GM077582-01A1, R01 GM77582-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077582] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen T, 2006, PLANT CELL, V18, P2506, DOI 10.1105/tpc.105.037358; Babu MM, 2006, NUCLEIC ACIDS RES, V34, P6505, DOI 10.1093/nar/gkl888; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bundock P, 2005, NATURE, V436, P282, DOI 10.1038/nature03667; Desnos T, 2001, GENE DEV, V15, P2980, DOI 10.1101/gad.205401; Hiltbrunner A, 2005, CURR BIOL, V15, P2125, DOI 10.1016/j.cub.2005.10.042; Hiltbrunner A, 2006, PLANT CELL PHYSIOL, V47, P1023, DOI 10.1093/pcp/pcj087; Hudson M, 1999, GENE DEV, V13, P2017, DOI 10.1101/gad.13.15.2017; Hudson ME, 2003, PLANT J, V34, P453, DOI 10.1046/j.1365-313X.2003.01741.x; Lin RC, 2004, PLANT PHYSIOL, V136, P4010, DOI 10.1104/pp.104.052191; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Makarova KS, 2002, TRENDS BIOCHEM SCI, V27, P384, DOI 10.1016/S0968-0004(02)02140-0; Mathews S, 2005, J HERED, V96, P197, DOI 10.1093/jhered/esi032; Miller WJ, 1999, GENETICA, V107, P197, DOI 10.1023/A:1004070603792; Nagy F, 2000, SEMIN CELL DEV BIOL, V11, P505, DOI 10.1006/scdb.2000.0202; Neff MM, 2000, GENE DEV, V14, P257; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Wang HY, 2002, EMBO J, V21, P1339, DOI 10.1093/emboj/21.6.1339; Yan T, 2005, NUCLEIC ACIDS RES, V33, pW262, DOI 10.1093/nar/gki368; Zhou QQ, 2005, PLANT J, V43, P356, DOI 10.1111/j.1365-313X.2005.02453.x	21	316	343	7	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1302	1305		10.1126/science.1146281	http://dx.doi.org/10.1126/science.1146281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033885	Green Accepted			2022-12-28	WOS:000251086600044
J	Bellingham, JG; Rajan, K				Bellingham, James G.; Rajan, Kanna			Robotics in remote and hostile environments	SCIENCE			English	Review							SENSOR NETWORKS; HIGH-RESOLUTION; VEHICLE; SYSTEM	In our continuing quest for knowledge, robots are powerful tools for accessing environments too dangerous or too remote for human exploration. Early systems functioned under close human supervision, effectively limited to executing preprogrammed tasks. However, as exploration moves to regions where communication is ineffective or unviable, robots will need to carry out complex tasks without human supervision. To enable such capabilities, robots are being enhanced by advances ranging from new sensor development to automated mission planning software, distributed robotic control, and more efficient power systems. As robotics technology becomes simultaneously more capable and economically viable, individual robots operated at large expense by teams of experts are increasingly supplemented by teams of robots used cooperatively under minimal human supervision.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Monterey Bay Aquarium Research Institute	Bellingham, JG (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholt Rd, Moss Landing, CA 95039 USA.	jgb@mbari.org						ALLEN B, 2006, MTS IEEE OC C, DOI DOI 10.1109/OCEANS.2006.306952; BELLINGHAM JG, 1993, 34D1 AUT UND VEH LAB; Bhaskaran S, 1996, P SOC PHOTO-OPT INS, V2810, P32, DOI 10.1117/12.255151; Bresina J. L., 2005, 15 INT C AUTOMATED P, P40; Brierley AS, 2002, SCIENCE, V295, P1890, DOI 10.1126/science.1068574; CASTANO R, 2006, P 2006 IEEE AER C BI, DOI DOI 10.1109/AERO.2006.1656011; Cokelet ED, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004150; CURTIN T, 2001, IEEE J OCEANIC ENG, V26, P117; Curtin T.B., 1993, OCEANOGRAPHY, V6, P86, DOI 10.5670/oceanog.1993.03; DANSON EFS, 2003, TECHNOLOGY APPL AUTO, P127; Eriksen CC, 2001, IEEE J OCEANIC ENG, V26, P424, DOI 10.1109/48.972073; Ferrini VL, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001333; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; FOX M, 2007, P AAAI 2007; GODIN MA, 2006, MTS IEEE OC C, DOI DOI 10.1109/OCEANS.2006.306919; HOBSON B, 2007, MTS IEEE OC C; ISERN A, 2006, MTS IEEE OC C, DOI DOI 10.1109/OCEANS.2006.307078; Johnson KS, 2007, CHEM REV, V107, P623, DOI 10.1021/cr050354e; Johnson KS, 2002, DEEP-SEA RES PT I, V49, P1291, DOI 10.1016/S0967-0637(02)00020-1; Kirkwood WJ, 2007, J FIELD ROBOT, V24, P487, DOI 10.1002/rob.20191; Leonard NE, 2007, P IEEE, V95, P48, DOI 10.1109/JPROC.2006.887295; Lermusiaux PFJ, 2007, PHYSICA D, V230, P172, DOI 10.1016/j.physd.2007.02.014; Marthiniussen R, 2004, OCEANS '04 MTS/IEEE TECHNO-OCEAN '04, VOLS 1- 2, CONFERENCE PROCEEDINGS, VOLS. 1-4, P846; Millard NW, 1998, UNDERWATER TECHNOL, V23, P7, DOI 10.3723/175605498783259894; Moline MA, 2005, J ATMOS OCEAN TECH, V22, P1797, DOI 10.1175/JTECH1809.1; Morison JH, 1998, J GEOPHYS RES-OCEANS, V103, P3257, DOI 10.1029/97JC02264; Muscettola N, 1998, ARTIF INTELL, V103, P5, DOI 10.1016/S0004-3702(98)00068-X; Nicholls KW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025998; NODLAND WE, 1968, 6814 APLUW; Pollack JB, 1980, J GEOPHYS RES-SPACE, V85, P8223, DOI 10.1029/JA085iA13p08223; Rajan K, 2000, FR ART INT, V54, P726; Reimers CE, 2006, GEOBIOLOGY, V4, P123, DOI 10.1111/j.1472-4669.2006.00071.x; Roemmich D, 2004, MAR TECHNOL SOC J, V38, P21, DOI 10.4031/002533204787522802; Russell S.J., 2016, ARTIF INTELL; Ryan JP, 2005, MAR ECOL PROG SER, V287, P23, DOI 10.3354/meps287023; Samson S, 2001, IEEE J OCEANIC ENG, V26, P671, DOI 10.1109/48.972110; Sherman J, 2001, IEEE J OCEANIC ENG, V26, P437, DOI 10.1109/48.972076; Sibenac M, 2002, OCEANS 2002 MTS/IEEE CONFERENCE & EXHIBITION, VOLS 1-4, CONFERENCE PROCEEDINGS, P167; Singh H, 2004, IEEE J OCEANIC ENG, V29, P872, DOI 10.1109/JOE.2004.831619; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Tobie G, 2006, NATURE, V440, P61, DOI 10.1038/nature04497; Webb DC, 2001, IEEE J OCEANIC ENG, V26, P447, DOI 10.1109/48.972077; Wick JV, 2005, AEROSP CONF PROC, P4162; WILKOW C, 2005, 9 ANN GROUND SYST AR; Willcox JS, 2001, IEEE J OCEANIC ENG, V26, P711, DOI 10.1109/48.972114; Yoerger D. R., 1999, P 11 INT S UNM UNT S; Yoerger DR, 2007, INT J ROBOT RES, V26, P41, DOI 10.1177/0278364907073773; 2007, AL MAGAZINE      SUM	48	125	128	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1098	1102		10.1126/science.1146230	http://dx.doi.org/10.1126/science.1146230			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006738				2022-12-28	WOS:000250957900035
J	Spies, M; Amitani, I; Baskin, RJ; Kowalczykowski, SC				Spies, Maria; Amitani, Ichiro; Baskin, Ronald J.; Kowalczykowski, Stephen C.			RecBCD enzyme switches lead motor Subunits in response to chi recognition	CELL			English	Article							RECOMBINATION HOTSPOT-CHI; ESCHERICHIA-COLI; DNA HELICASE; RECA PROTEIN; HOMOLOGOUS RECOMBINATION; STRAND SPECIFICITY; NUCLEASE ACTIVITY; TRANSLOCATION; SEQUENCE; MOLECULES	RecBCD is a DNA helicase comprising two motor subunits, RecB and RecD. Recognition of the recombination hotspot, chi, causes RecBCD to pause and reduce translocation speed. To understand this control of translocation, we used single-molecule visualization to compare RecBCD to the RecBCD(K177Q) mutant with a defective RecD motor. RecBCD(K177Q) paused at chi but did not change its translocation velocity. RecBCD(K177Q) translocated at the same rate as the wild-type post-chi enzyme, implicating RecB as the leadmotor after chi. P1 nuclease treatment eliminated the wild-type enzyme's velocity changes, revealing a chi-containing ssDNA loop preceding chi recognition and showing that RecD is the faster motor before chi. We conclude that before chi, RecD is the lead motor but after chi, the slower RecB motor leads, implying a switch in motors at chi. We suggest that degradation of foreign DNA needs fast translocation, whereas DNA repair uses slower translocation to coordinate RecA loading onto ssDNA.	Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cell Biol, Davis, CA 95616 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Illinois System; University of Illinois Urbana-Champaign	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Spies, Maria/0000-0002-7375-8037	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041347] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM041347, R01 GM041347-13, R01 GM041347-14, GM-41347, R01 GM041347-12] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Anderson DG, 1997, GENES CELLS, V2, P117, DOI 10.1046/j.1365-2443.1997.1130311.x; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bianco PR, 2000, NATURE, V405, P368, DOI 10.1038/35012652; BRAEDT G, 1989, P NATL ACAD SCI USA, V86, P871, DOI 10.1073/pnas.86.3.871; CHAUDHURY AM, 1984, P NATL ACAD SCI-BIOL, V81, P7850, DOI 10.1073/pnas.81.24.7850; Chedin F, 2006, J BIOL CHEM, V281, P18610, DOI 10.1074/jbc.M600882200; Churchill JJ, 1999, GENE DEV, V13, P901, DOI 10.1101/gad.13.7.901; Dillingham MS, 2005, J BIOL CHEM, V280, P37069, DOI 10.1074/jbc.M505520200; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; DIXON DA, 1991, CELL, V66, P361, DOI 10.1016/0092-8674(91)90625-9; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; DIXON DA, 1995, J BIOL CHEM, V270, P16360, DOI 10.1074/jbc.270.27.16360; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Handa N, 2005, MOL CELL, V17, P745, DOI 10.1016/j.molcel.2005.02.011; KORANGY F, 1992, J BIOL CHEM, V267, P1727; Kulkarni A, 2004, NUCLEIC ACIDS RES, V32, P3672, DOI 10.1093/nar/gkh675; LAM ST, 1974, GENETICS, V77, P425; MUSKAVITCH KMT, 1982, J BIOL CHEM, V257, P2641; MYERS RS, 1995, GENETICS, V141, P805; PONTICELLI AS, 1985, CELL, V41, P145, DOI 10.1016/0092-8674(85)90069-8; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; Romier C, 1998, PROTEINS, V32, P414, DOI 10.1002/(SICI)1097-0134(19980901)32:4<414::AID-PROT2>3.3.CO;2-5; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Spies M, 2005, J BIOL CHEM, V280, P37078, DOI 10.1074/jbc.M505521200; Spies Maria, 2005, P389; TAYLOR A, 1980, CELL, V22, P447, DOI 10.1016/0092-8674(80)90355-4; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; TAYLOR AF, 1985, CELL, V41, P153, DOI 10.1016/0092-8674(85)90070-4; Taylor AF, 1999, GENE DEV, V13, P890, DOI 10.1101/gad.13.7.890; TAYLOR AF, 1995, J BIOL CHEM, V270, P24459, DOI 10.1074/jbc.270.41.24459; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981	37	96	96	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					694	705		10.1016/j.cell.2007.09.023	http://dx.doi.org/10.1016/j.cell.2007.09.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022364	Green Accepted, Bronze			2022-12-28	WOS:000250966300017
J	Vyas, H; Krishnaswamy, G				Vyas, Harsha; Krishnaswamy, Guha			Quinolone-associated rupture of the achilles' tendon	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Wake Forest Univ, Sch Med, Winston Salem, NC 27157 USA	Wake Forest University	Vyas, H (corresponding author), Wake Forest Univ, Sch Med, Winston Salem, NC 27157 USA.	dr_harshavyas@yahoo.com	Krishnaswamy, Guha/R-9076-2019; KRISHNASWAMY, GUHA/AAR-8844-2021	KRISHNASWAMY, GUHA/0000-0002-9848-6197					0	16	16	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2007	357	20					2067	2067		10.1056/NEJMicm061227	http://dx.doi.org/10.1056/NEJMicm061227			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230RV	18003963				2022-12-28	WOS:000250894500009
J	Zhou, HY; Guan, HZ; Chi, BQ				Zhou, Houyun; Guan, Huazheng; Chi, Baoquan			Record of winter monsoon strength	NATURE			English	Letter							HIGH-RESOLUTION; ASIAN MONSOON; MAAR LAKE; CLIMATIC CHANGES; SOUTHERN CHINA; DUST; HOLOCENE; MODEL; CAVE		Chinese Acad Sci, Guangzhou Inst Geochem, Guangzhou 510640, Peoples R China; Natl Cheng Kung Univ, Earth Dynam Syst Res Ctr, Tainan 701, Taiwan; Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Geochemistry, CAS; National Cheng Kung University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, HY (corresponding author), Chinese Acad Sci, Guangzhou Inst Geochem, Guangzhou 510640, Peoples R China.	hyzhou@gig.ac.cn						Cao JJ, 2003, WATER AIR SOIL POLL, V3, P213, DOI DOI 10.1023/A:1023202926292; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; Gallet S, 1996, CHEM GEOL, V133, P67, DOI 10.1016/S0009-2541(96)00070-8; Ginoux P, 2001, J GEOPHYS RES-ATMOS, V106, P20255, DOI 10.1029/2000JD000053; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; Mingram J, 2004, QUATERN INT, V122, P85, DOI 10.1016/j.quaint.2004.02.001; Reid JS, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002493; Ren JZ, 1996, SCI CHINA SER D, V39, P449; Shao XH, 2006, CHINESE SCI BULL, V51, P221, DOI 10.1007/s11434-005-0882-6; Sun DH, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003382; Wang WY, 2000, CHINESE SCI BULL, V45, P1529, DOI 10.1007/BF02898903; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; XU YF, 2000, GEOCHIMICA, V29, P402; Yancheva G, 2007, NATURE, V445, P74, DOI 10.1038/nature05431; Zheng Z, 1999, PALAEOGEOGR PALAEOCL, V145, P339, DOI 10.1016/S0031-0182(98)00107-2; Zheng Z, 2003, CHINESE SCI BULL, V48, P497, DOI 10.1360/03tb9105	16	33	48	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					E10	E11		10.1038/nature06408	http://dx.doi.org/10.1038/nature06408			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004318				2022-12-28	WOS:000250918600040
J	Milliken, CS; Auchterlonie, JL; Hoge, CW				Milliken, Charles S.; Auchterlonie, Jennifer L.; Hoge, Charles W.			Longitudinal assessment of mental health problems among active and reserve component soldiers returning from the Iraq war	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; VETERANS; THERAPY; AFGHANISTAN; TRAUMA	Context To promote early identification of mental health problems among combat veterans, the Department of Defense initiated population-wide screening at 2 time points, immediately on return from deployment and 3 to 6 months later. A previous article focusing only on the initial screening is likely to have underestimated the mental health burden. Objective To measure the mental health needs among soldiers returning from Iraq and the association of screening with mental health care utilization. Design, Setting, and Participants Population-based, longitudinal descriptive study of the initial large cohort of 88 235 US soldiers returning from Iraq who completed both a Post-Deployment Health Assessment ( PDHA) and a Post-Deployment Health Re-Assessment (PDHRA) with a median of 6 months between the 2 assessments. Main Outcome Measures Screening positive for posttraumatic stress disorder ( PTSD), major depression, alcohol misuse, or other mental health problems; referral and use of mental health services. Results Soldiers reported more mental health concerns and were referred at significantly higher rates from the PDHRA than from the PDHA. Based on the combined screening, clinicians identified 20.3% of active and 42.4% of reserve component soldiers as requiring mental health treatment. Concerns about interpersonal conflict increased 4-fold. Soldiers frequently reported alcohol concerns, yet very few were referred to alcohol treatment. Most soldiers who used mental health services had not been referred, even though the majority accessed care within 30 days following the screening. Although soldiers were much more likely to report PTSD symptoms on the PDHRA than on the PDHA, 49% to 59% of those who had PTSD symptoms identified on the PDHA improved by the time they took the PDHRA. There was no direct relationship of referral or treatment with symptom improvement. Conclusions Rescreening soldiers several months after their return from Iraq identified a large cohort missed on initial screening. The large clinical burden recently reported among veterans presenting to Veterans Affairs facilities seems to exist within months of returning home, highlighting the need to enhance military mental health care during this period. Increased relationship problems underscore shortcomings in services for family members. Reserve component soldiers who had returned to civilian status were referred at higher rates on the PDHRA, which could reflect their concerns about their ongoing health coverage. Lack of confidentiality may deter soldiers with alcohol problems from accessing treatment. In the context of an overburdened system of care, the effectiveness of population mental health screening was difficult to ascertain.	USA, Walter Reed Army Inst Res, Div Psychiat & Neurosci, Med Res & Mat Command, Silver Spring, MD 20910 USA; USA, Ctr Hlth Promot & Prevent Med, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Milliken, CS (corresponding author), USA, Walter Reed Army Inst Res, Div Psychiat & Neurosci, Med Res & Mat Command, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	charles.milliken@us.army.mil						ADLER AB, 2007, 115 ANN CONV AM PSYC; *AM PSYCH ASS WORK, 2004, PRACT GUID TREATM AC; Bliese PD, 2007, PSYCHOL SERV, V4, P141, DOI [DOI 10.1037/1541-1559.4.3.141, 10.1037/1541-1559.4.3.141]; Bliese PD, 2005, POST DEPLOYMENT PSYC; Brown R L, 2001, J Am Board Fam Pract, V14, P95; Bryant RA, 2003, BEHAV RES THER, V41, P489, DOI 10.1016/S0005-7967(02)00179-1; Defense Health Board Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Foa E.B., 2019, PROLONGED EXPOSURE T, V2, DOI [10.1093/med-psych/9780190926939.001.0001/med-9780190926939, DOI 10.1093/MED-PSYCH/9780190926939.001.0001/MED-9780190926939]; Friedman MJ, 2007, J CLIN PSYCHIAT, V68, P711, DOI 10.4088/JCP.v68n0508; Grunebaum M, 1996, PSYCHIAT SERV, V47, P848; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Kang HK, 2005, NEW ENGL J MED, V352, P1289, DOI 10.1056/NEJMp058024; Katon WJ, 2006, J TRAUMA STRESS, V19, P611, DOI 10.1002/jts.20147; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Prigerson HG, 2002, AM J PUBLIC HEALTH, V92, P59, DOI 10.2105/AJPH.92.1.59; Prigerson HG, 2001, J NERV MENT DIS, V189, P99, DOI 10.1097/00005053-200102000-00005; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Resick P. A., 2008, COGN PROCESS; Rona RJ, 2005, JAMA-J AM MED ASSOC, V293, P1257, DOI 10.1001/jama.293.10.1257; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; THOMAS JL, 2007, 115 ANN CONV AM PSYC; *TRICARE MAN ACT, TRANS ASS MAN PROGR; *US DEP DEF, 1997, REQ MENT HLTH EV MEM; *US DEP DEF, 1985, REH REF SERV ALC DRU; *VET HLTH ADM, 2002, COMB VET AR EL MED S; WINKENWERDER W, 2005, COMMUNICATION   0310; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004; BATTLEMIND TRAINING	35	1178	1187	2	115	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2141	2148		10.1001/jama.298.18.2141	http://dx.doi.org/10.1001/jama.298.18.2141			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230II	18000197	Bronze			2022-12-28	WOS:000250869800019
J	Belizan, JM; Cafferata, ML; Belizan, M; Althabe, F				Belizan, Jose M.; Cafferata, Maria L.; Belizan, Maria; Althabe, Fernando			Health inequality in Latin America	LANCET			English	Editorial Material									Inst Clin Effectivenss & Hlth Policy, Buenos Aires, DF, Argentina; Clin & Epidemiol Res Unit Montevideo, Montevideo, Uruguay		Althabe, F (corresponding author), Inst Clin Effectivenss & Hlth Policy, Buenos Aires, DF, Argentina.	althabef@gmail.com		Belizan, Jose/0000-0002-8412-3010				Belizan JM, 2003, LANCET, V362, P916, DOI 10.1016/S0140-6736(03)14311-5; Belizan JM, 1998, PAEDIATR PERINAT EP, V12, P1, DOI 10.1046/j.1365-3016.12.s2.4.x; CDS-Government of Kerala, 2006, HUMAN DEV REPORT 200; *MIN SAL MED AMB A, 2005, PROGR MAT INF EST VI; *MIN SAL PER, 1999, SIT SAL PER IND BAS; *MIN SAL PUBL BIEN, 2002, IND BAS SAL; MUNOZ MTF, 2003, ANAL PRODUCCION CIEN; *UN CHILDR FUND, 2006, STAT WORLDS CHILDR S; UN Educ. Sci. Cult. Organ, 2005, UN DECL BIOETH HUM R; *WORLD BANK, DAT STAT COUNTR DAT	10	31	34	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2007	370	9599					1599	1600		10.1016/S0140-6736(07)61673-0	http://dx.doi.org/10.1016/S0140-6736(07)61673-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230NO	17993351				2022-12-28	WOS:000250883400010
J	Mahapatra, P; Shibuya, K; Lopez, AD; Coullare, F; Notzon, FC; Rao, C; Szreter, S				Mahapatra, Prosanta; Shibuya, Kenji; Lopez, Alan D.; Coullare, Francesca; Notzon, Francis C.; Rao, Chalapati; Szreter, Simon		MoVE Writing Grp	Civil registration systems and vital statistics: successes and missed opportunities	LANCET			English	Article							EPIDEMIOLOGIC TRANSITION; HEALTH-STATISTICS; VERBAL AUTOPSY; MORTALITY; DEATH; AMERICA	Vital statistics generated through civil registration systems are the major source of continuous monitoring of births and deaths over time. The usefulness of vital statistics depends on their quality. In the second paper in this Series we propose a comprehensive and practical framework for assessment of the quality of vital statistics. With use of routine reports to the UN and cause-of-death data reported to WHO, we review the present situation and past trends of vital statistics in the world and note little improvement in worldwide availability of general vital statistics or cause-of-death statistics. Only a few developing countries have been able to improve their civil registration and vital statistics systems in the past 50 years. International efforts to improve comparability of vital statistics seem to be effective, and there is reasonable progress in collection and publication of data. However, worldwide efforts to improve data have been limited to sporadic and short-term measures. We conclude that countries and developmental partners have not recognised that civil registration systems are a priority.	HACA Bhavan, Inst Hlth Syst, Hyderabad 500004, Andhra Pradesh, India; WHO, Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland; Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; UN Stat Div, New York, NY USA; CDC, Natl Ctr Hlth Stat, Hyattsville, MD USA; Hist Fac, Cambridge, England; St Johns Coll, Cambridge, England	World Health Organization; University of Queensland; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); University of Cambridge; University of Cambridge	Mahapatra, P (corresponding author), HACA Bhavan, Inst Hlth Syst, Hyderabad 500004, Andhra Pradesh, India.	pmahapat@ihsnet.org.in	Rao, Chalapati/H-7645-2012; Lopez, Alan/AAA-2734-2022; Lopez, Alan D/F-1487-2010	Rao, Chalapati/0000-0002-9554-0581; Lopez, Alan D/0000-0001-5818-6512; Szreter, Simon/0000-0001-6903-2447; Shibuya, Kenji/0000-0003-2528-7530; Jakob, Robert/0000-0001-6542-7548				[Anonymous], POPULATION STUDIES; *AUSTR I HLTH WELF, 2007, NAT DEATH IND; Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745; Chesnais J-C., 1992, DEMOGRAPHIC TRANSITI; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; DUNN H L, 1954, Bull World Health Organ, V11, P147; ELVERS E, 1997, ENCY STAT SCI, V3, P621; *EUR WORK GROUP AS, 2003, 6 M LUX OCT 2003; FELLEGI IP, 1995, M HANSEN LECT; FOX AJ, 1978, J EPIDEMIOL COMMUN H, V32, P73, DOI 10.1136/jech.32.2.73; GAETEDARBO A, 1964, MILBANK FUND Q, V42, P86, DOI 10.2307/3348659; Gallagher R.P., 1989, OCCUPATIONAL MORTALI; Gear H.S, 1961, INT WORK HLTH STAT 1; GOURBIN C, 1995, B WORLD HEALTH ORGAN, V73, P449; Hill K, 2007, INT J EPIDEMIOL, V36, P374, DOI 10.1093/ije/dyl257; *HLTH METR NETW, 2006, STRENGTH COUNTR HLTH; Horan JM, 2003, EPIDEMIOL REV, V25, P24, DOI 10.1093/epirev/mxg010; JAMISON DT, 2007, DIS CONTROL PRIORITI; *JAP MIN HLTH WELF, 1994, INT COMP VIT STAT; Johnson NJ, 1999, DEMOGRAPHY, V36, P355, DOI 10.2307/2648058; KANAAN SB, 2000, 50 ANN S REP; Mahapatra P, 2001, NATL MED J INDIA, V14, P154; MAHAPATRA P, 2001, ESTIMATING NATL BURD; Marshall JT, 1949, MILBANK MEML FUND Q, V27, P289, DOI 10.2307/3348071; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Milham S., 1997, OCCUPATIONAL MORTALI; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; *ORG EC COOP DEV, 2003, QUAL FRAM GUID OECD; Padmanabha P, 1993, REV EVALUATION UNFPA; RAO C, 2005, B WORLD HEALTH ORGAN, V83, P561; *REG GEN IND, 2006, MED CERT CAUS DEATH; RUZICKA L T, 1990, World Health Statistics Quarterly, V43, P249; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; SETEL P, 2007, LANCET          1029, DOI DOI 10.1016/S0140-6736(07)61307-5; Shibuya K, 2005, INT J CANCER, V117, P476, DOI 10.1002/ijc.21078; Shibuya K, 2005, B WORLD HEALTH ORGAN, V83, P722; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; *STAT CAN, 1998, STAT CAN QUAL GUID; Szreter S., 1991, SOC HIST MED, V4, P465; UEMURA K, 2007, B WORLD HEALTH ORGAN, V66, P679; *UN, 2000, PRINC REC VIT STAT S; *UN, 1992, CHILD MORT 1960S DAT; *UN DEM SOC STAT B, 2006, WORLDS WOM 2005 PROG; *UN STAT DIV, 1954, B WORLD HEALTH ORGAN, V11, P231; *UN STAT DIV DEM S, 2004, ESASTAT20043 UN STAT; *UN STAT DIV DEM S, 2004, ESASTAT20041 UN STAT; *UN STAT SECT DEM, 2004, REP EXP GROUP M REV; *UN STAT SECT DEM, 2003, EXP GROUP M REV UN D; UNICEF, 2005, MULT IND CLUST SURV; *UNICEF INN RES CT, 2002, INN DIG; United Nations Statistics Division, 2007, DEM YB; VEYS CA, 1990, ANN OCCUP HYG, V34, P349, DOI 10.1093/annhyg/34.4.349; *WHO, 2007, WHO MORT DAT BAS; *WHO, 2007, HIST DEV ICD; *WHO, 1974, 2 INT C NAT COMM VIT; Williams T, 2005, B WORLD HEALTH ORGAN, V83, P564; World Bank, 2007, HEALTHY DEVELOPMENT: THE WORLD BANK STRATEGY FOR HEALTH, NUTRITION, AND POPULATION RESULTS, P1, DOI 10.1596/978-0-8213-7193-0; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2007, WORLD HLTH STAT 2007; World Health Organization (WHO), 2005, INT STAT CLASS DIS H; WORLD HEALTH ORGANIZATION (WHO), 1952, ANN EP VIT STAT 19 1; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3	67	212	227	1	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2007	370	9599					1653	1663		10.1016/S0140-6736(07)61308-7	http://dx.doi.org/10.1016/S0140-6736(07)61308-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230NO	18029006				2022-12-28	WOS:000250883400025
J	Pegler, S; Healy, B				Pegler, Scott; Healy, Brendan.			Change page - In patients allergic to penicillin, consider second and third generation cephalosporins for life threatening infections	BRITISH MEDICAL JOURNAL			English	Article									Swansea NHS Trust, Morriston Hosp, Swansea SA6 6NL, W Glam, Wales; Univ Wales Hosp, Cardiff CF14 4XW, Wales	Morriston Hospital; Cardiff University	Pegler, S (corresponding author), Swansea NHS Trust, Morriston Hosp, Swansea SA6 6NL, W Glam, Wales.	pegler@swansea-tr.wales.nhs.uk		Healy, Brendan/0000-0002-5698-856X					0	13	13	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 10	2007	335	7627					991	991		10.1136/bmj.39372.829676.47	http://dx.doi.org/10.1136/bmj.39372.829676.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232AL	17991982	Green Published			2022-12-28	WOS:000250990400048
J	Alt, A; Lammens, K; Chiocchini, C; Lammens, A; Pieck, JC; Kuch, D; Hopfner, KP; Carell, T				Alt, Aaron; Lammens, Katja; Chiocchini, Claudia; Lammens, Alfred; Pieck, J. Carsten; Kuch, David; Hopfner, Karl-Peter; Carell, Thomas			Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase	SCIENCE			English	Article							THYMINE-THYMINE DIMER; XERODERMA-PIGMENTOSUM; ETA; MUTATIONS; DAMAGE	DNA polymerase eta (Pol eta) is a eukaryotic lesion bypass polymerase that helps organisms to survive exposure to ultraviolet (UV) radiation, and tumor cells to gain resistance against cisplatin-based chemotherapy. It allows cells to replicate across cross-link lesions such as 1,2-d(GpG) cisplatin adducts (Pt-GG) and UV-induced cis-syn thymine dimers. We present structural and biochemical analysis of how Pol eta copies Pt-GG-containing DNA. The damaged DNA is bound in an open DNA binding rim. Nucleotidyl transfer requires the DNA to rotate into an active conformation, driven by hydrogen bonding of the templating base to the dNTP. For the 3 ' dG of the Pt-GG, this step is accomplished by a Watson-Crick base pair to dCTP and is biochemically efficient and accurate. In contrast, bypass of the 5 ' dG of the Pt-GG is less efficient and promiscuous for dCTP and dATP as a result of the presence of the rigid Pt cross-link. Our analysis reveals the set of structural features that enable Pol eta to replicate across strongly distorting DNA lesions.	Univ Munich, Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany; Univ Munich, Dept Chem & Biochem, Gene Ctr, D-81377 Munich, Germany	University of Munich; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany.	hopfner@lmb.uni-muenchen.de; thomas.carell@cup.uni-muenchen.de	Carell, Thomas/G-4799-2012; Hopfner, Karl-Peter/B-6864-2014; Alt, Aaron/A-1551-2017	Carell, Thomas/0000-0001-7898-2831; Hopfner, Karl-Peter/0000-0002-4528-8357; Alt, Aaron/0000-0002-6708-9826				Albertella MR, 2005, CANCER RES, V65, P9799, DOI 10.1158/0008-5472.CAN-05-1095; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; Rothwell PJ, 2007, J BIOL CHEM, V282, P28884, DOI 10.1074/jbc.M704824200; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Washington MT, 2003, MOL CELL BIOL, V23, P5107, DOI 10.1128/MCB.23.14.5107-5112.2003; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Yang W, 2003, CURR OPIN STRUC BIOL, V13, P23, DOI 10.1016/S0959-440X(02)00003-9	16	167	169	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					967	970		10.1126/science.1148242	http://dx.doi.org/10.1126/science.1148242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991862				2022-12-28	WOS:000250788500041
J	Poon, AC; Ferrell, JE				Poon, Andy C.; Ferrell, James E., Jr.			A clock with a flip switch	SCIENCE			English	Editorial Material							ACTIVATED PROTEIN-KINASE; DUAL PHOSPHORYLATION		Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	james.ferrell@stanford.edu						Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; RUST MJ, 2007, SCIENCE         1004; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200	7	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					757	758		10.1126/science.1150740	http://dx.doi.org/10.1126/science.1150740			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975056				2022-12-28	WOS:000250583900028
J	Pospisilik, JA; Knauf, C; Joza, N; Benit, P; Orthofer, M; Cani, PD; Ebersberger, I; Nakashima, T; Sarao, R; Neely, G; Esterbauer, H; Kozlov, A; Kahn, CR; Kroemer, G; Rustin, P; Burcelin, R; Penninger, JM				Pospisilik, J. Andrew; Knauf, Claude; Joza, Nicholas; Benit, Paule; Orthofer, Michael; Cani, Patrice D.; Ebersberger, Ingo; Nakashima, Tomoki; Sarao, Renu; Neely, Gregory; Esterbauer, Harald; Kozlov, Andrey; Kahn, C. Ronald; Kroemer, Guido; Rustin, Pierre; Burcelin, Remy; Penninger, Josef M.			Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes	CELL			English	Article							APOPTOSIS-INDUCING FACTOR; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; DOWN-REGULATION; DUAL ROLES; GENE; DYSFUNCTION; DISEASE	Type-2 diabetes results from the development of insulin resistance and a concomitant impairment of insulin secretion. Recent studies place altered mitochondrial oxidative phosphorylation (OxPhos) as an underlying genetic element of insulin resistance. However, the causative or compensatory nature of these OxPhos changes has yet to be proven. Here, we show that muscle-and liver-specific AIF ablation in mice initiates a pattern of OxPhos deficiency closely mimicking that of human insulin resistance, and contrary to current expectations, results in increased glucose tolerance, reduced fat mass, and increased insulin sensitivity. These results are maintained upon high-fat feeding and in both genetic mosaic and ubiquitous OxPhos-deficient mutants. Importantly, the effects of AIF on glucose metabolism are acutely inducible and reversible. These findings establish that tissue-specific as well as global OxPhos defects in mice can counteract the development of insulin resistance, diabetes, and obesity.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; CHU Rangueil, IFR31, INSERM, U858,Equipe 2,Inst Med Mol Rangueil, F-31432 Toulouse, France; Hop Robert Debre, INSERM, U676, F-75019 Paris, France; Catholic Univ Louvain, Fac Med, Unit PMNT, B-1200 Brussels, Belgium; Max F Perutz Labs, Ctr Integrat Bioinformat Vienna, A-1030 Vienna, Austria; Med Univ Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria; Lorenz Boehler Hosp, Ludwig Boltzmann Inst Clin & Expt Traumatol, Vienna, Austria; Harvard Univ, Sch Med, Dept Med, Joslin Diabet Ctr, Boston, MA 02215 USA; INSERM, U848, F-94805 Villejuif, France; Inst Gustave Roussy, F-94805 Villejuif, France; Univ Paris 11, F-94805 Villejuif, France	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; Ludwig Boltzmann Institute; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	Kahn, Ronald/AAY-2435-2021; neely, graham/A-6511-2011; burcelin, remy/M-6013-2014; Penninger, Josef M/I-6860-2013; D., Cani Patrice/M-8055-2016; KROEMER, Guido/B-4263-2013; Neely, Greg/AAB-4642-2020; Kroemer, Guido/AAY-9859-2020	Kahn, Ronald/0000-0002-7583-9228; Penninger, Josef M/0000-0002-8194-3777; D., Cani Patrice/0000-0003-2040-2448; KROEMER, Guido/0000-0002-9334-4405; Neely, Greg/0000-0002-1957-9732; Knauf, Claude/0000-0001-5213-5378; Esterbauer, Harald/0000-0001-7343-7455; Kozlov, Andrey/0000-0002-0834-4997	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031036, R37DK031036] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31036] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6; Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Knauf C, 2005, J CLIN INVEST, V115, P3554, DOI 10.1172/JCI25764; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lane N, 2006, NATURE, V440, P600, DOI 10.1038/440600a; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Misu H, 2007, DIABETOLOGIA, V50, P268, DOI 10.1007/s00125-006-0489-8; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SOMOGYI M, 1945, J BIOL CHEM, V160, P69; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029	40	320	330	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					476	491		10.1016/j.cell.2007.08.047	http://dx.doi.org/10.1016/j.cell.2007.08.047			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981116	Bronze			2022-12-28	WOS:000250618500016
J	Orszag, PR; Ellis, P				Orszag, Peter R.; Ellis, Philip			The challenge of revising health care costs - A view from the congressional budget office	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2007, PERFORMANCE BUDGETIN; BROOK RH, 1983, NEW ENGL J MED, V309, P1426, DOI 10.1056/NEJM198312083092305; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, IMPLICATIONS REGIONA; *MCKINS GLOB I, 2007, ACC COST HLTH CAR US; NEWHOUSE JP, 1992, J ECON PERSPECT, V6, P3, DOI 10.1257/jep.6.3.3	6	126	130	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2007	357	18					1793	1795		10.1056/NEJMp078190	http://dx.doi.org/10.1056/NEJMp078190			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	225OJ	17978287				2022-12-28	WOS:000250526900001
J	Barr, FA; Gruneberg, U				Barr, Francis A.; Gruneberg, Ulrike			Cytokinesis: Placing and making the final cut	CELL			English	Review							GTPASE-ACTIVATING PROTEIN; CLEAVAGE FURROW FORMATION; CENTRAL-SPINDLE FORMATION; CELL PLATE FORMATION; CONTRACTILE RING; MITOTIC SPINDLE; AURORA-B; BREFELDIN-A; CHROMOSOME SEGREGATION; ACTIN DYNAMICS	Cytokinesis is the process by which cells physically separate after the duplication and spatial segregation of the genetic material. A number of general principles apply to this process. First the microtubule cytoskeleton plays an important role in the choice and positioning of the division site. Once the site is chosen, the local assembly of the actomyosin contractile ring remodels the plasma membrane. Finally, membrane trafficking to and membrane fusion at the division site cause the physical separation of the daughter cells, a process termed abscission. Here we will discuss recent advances in our understanding of the mechanisms of cytokinesis in animals, yeast, and plants.	[Barr, Francis A.; Gruneberg, Ulrike] Univ Liverpool, Ctr Canc Res, Liverpool L3 9TA, Merseyside, England	University of Liverpool	Barr, FA (corresponding author), Univ Liverpool, Ctr Canc Res, 200 London Rd, Liverpool L3 9TA, Merseyside, England.	fabarr@liverpool.ac.uk	Gruneberg, Ulrike/AAY-2351-2020	Gruneberg, Ulrike/0000-0001-8344-0500; Barr, Francis/0000-0001-7518-253X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Assaad FF, 2001, J CELL BIOL, V152, P531, DOI 10.1083/jcb.152.3.531; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; BOVERI T, 2007, J CELL SCI S, V121, P1, DOI DOI 10.1242/025742; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Brill JA, 2000, DEVELOPMENT, V127, P3855; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; Bringmann H, 2007, CURR BIOL, V17, P185, DOI 10.1016/j.cub.2006.11.070; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Buschmann H, 2006, CURR BIOL, V16, P1938, DOI 10.1016/j.cub.2006.08.028; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Cesario JM, 2006, J CELL SCI, V119, P4770, DOI 10.1242/jcs.03235; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; CHANG DC, 1995, J CELL BIOL, V131, P1539, DOI 10.1083/jcb.131.6.1539; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; CIAPA B, 1994, NATURE, V368, P875, DOI 10.1038/368875a0; Corson TW, 2006, INT J CANCER, V119, P1088, DOI 10.1002/ijc.21954; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Demidov D, 2005, PLANT CELL, V17, P836, DOI 10.1105/tpc.104.029710; Dhonukshe P, 2006, DEV CELL, V10, P137, DOI 10.1016/j.devcel.2005.11.015; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; EARNSHAW WC, 1991, J CELL SCI, V98, P443; Eckley DM, 1997, J CELL BIOL, V136, P1169, DOI 10.1083/jcb.136.6.1169; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Emery G, 2006, CURR OPIN CELL BIOL, V18, P407, DOI 10.1016/j.ceb.2006.06.009; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Fielding AB, 2005, EMBO J, V24, P3389, DOI 10.1038/sj.emboj.7600803; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gachet Y, 2005, J CELL SCI, V118, P4231, DOI 10.1242/jcs.02530; Gatt MK, 2006, J CELL SCI, V119, P2225, DOI 10.1242/jcs.02933; Giansanti MG, 2006, CURR BIOL, V16, P195, DOI 10.1016/j.cub.2005.12.011; Glotzer M, 2004, J CELL BIOL, V164, P347, DOI 10.1083/jcb.200310112; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Ingouff M, 2005, NAT CELL BIOL, V7, P374, DOI 10.1038/ncb1238; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Jurgens G, 2005, TRENDS CELL BIOL, V15, P277, DOI 10.1016/j.tcb.2005.03.005; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Kuriyama R, 2002, J CELL BIOL, V156, P783, DOI 10.1083/jcb.200109090; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Low SH, 2003, DEV CELL, V4, P753, DOI 10.1016/S1534-5807(03)00122-9; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Lukowitz W, 1996, CELL, V84, P61, DOI 10.1016/S0092-8674(00)80993-9; Mao GJ, 2005, PLANT J, V43, P469, DOI 10.1111/j.1365-313X.2005.02464.x; MARSLAND D, 1954, J EXP ZOOL, V125, P507, DOI 10.1002/jez.1401250307; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mishima M, 2003, CURR BIOL, V13, pR589, DOI 10.1016/S0960-9822(03)00521-9; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Muller I, 2003, NAT CELL BIOL, V5, P531, DOI 10.1038/ncb991; Muller S, 2006, CURR BIOL, V16, P888, DOI 10.1016/j.cub.2006.03.034; Muller S, 2004, CURR BIOL, V14, P412, DOI 10.1016/j.cub.2004.02.032; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; Noguchi T, 2002, MOL BIOL CELL, V13, P1263, DOI 10.1091/mbc.01-10-0501; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Oegema K, 2000, J CELL BIOL, V150, P539, DOI 10.1083/jcb.150.3.539; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Pruyne D, 2000, J CELL SCI, V113, P571; Roversi G, 2006, ONCOGENE, V25, P1571, DOI 10.1038/sj.onc.1209177; SAMUELS AL, 1995, J CELL BIOL, V130, P1345, DOI 10.1083/jcb.130.6.1345; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Saul D, 2004, J CELL SCI, V117, P3887, DOI 10.1242/jcs.01236; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Simanis V, 2003, J CELL SCI, V116, P4263, DOI 10.1242/jcs.00807; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Smertenko AP, 2006, J CELL SCI, V119, P3227, DOI 10.1242/jcs.03051; Smith LG, 2001, NAT REV MOL CELL BIO, V2, P33, DOI 10.1038/35048050; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Spitzer C, 2006, DEVELOPMENT, V133, P4679, DOI 10.1242/dev.02654; Stock A, 1999, EMBO J, V18, P5274, DOI 10.1093/emboj/18.19.5274; SZOLLOSI D, 1972, J CELL SCI, V11, P521; Toure A, 1998, J BIOL CHEM, V273, P6019, DOI 10.1074/jbc.273.11.6019; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Vanstraelen M, 2006, CURR BIOL, V16, P308, DOI 10.1016/j.cub.2005.12.035; Verbrugghe KJC, 2004, CURR BIOL, V14, P1755, DOI 10.1016/j.cub.2004.09.055; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wang YL, 2005, TRENDS CELL BIOL, V15, P581, DOI 10.1016/j.tcb.2005.09.006; Werner M, 2007, CURR BIOL, V17, P1286, DOI 10.1016/j.cub.2007.06.070; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Wong R, 2005, CURR BIOL, V15, P1401, DOI 10.1016/j.cub.2005.06.060; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Xu H, 2002, DEV BIOL, V251, P294, DOI 10.1006/dbio.2002.0830; YASUHARA H, 1995, EUR J CELL BIOL, V66, P274; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zavortink M, 2005, J CELL SCI, V118, P5381, DOI 10.1242/jcs.02652; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3; Zhang YJ, 2000, J BIOL CHEM, V275, P35600, DOI 10.1074/jbc.M005575200; Zumdieck A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000696	130	367	370	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					847	860		10.1016/j.cell.2007.11.011	http://dx.doi.org/10.1016/j.cell.2007.11.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045532	Bronze			2022-12-28	WOS:000251800900009
J	Jaffe, HW; Valdiserri, RO; De Cock, KM				Jaffe, Harold W.; Valdiserri, Ronald O.; De Cock, Kevin M.			The reemerging HIV/AIDS epidemic in men who have sex with men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; HIV-INFECTION; RISK BEHAVIORS; INTERVENTIONS; PREVENTION; RECOMMENDATIONS; TRENDS		Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; US Dept Vet Affairs, Off Publ Hlth & Environm Hazards, Washington, DC USA; WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland	University of Oxford; US Department of Veterans Affairs; World Health Organization	Jaffe, HW (corresponding author), Univ Oxford, Dept Publ Hlth, Old Rd Campus, Oxford OX3 7LF, England.	harold.jaffe@dphpc.ox.ac.uk						[Anonymous], 1981, MORBIDITY MORTALITY, V30, P250; BEZEMER D, 2007, 14 C RETR OPP INF FE; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; BROOKMEYER R, 1991, SCIENCE, V253, P37, DOI 10.1126/science.2063206; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; European Centre for the Epidemiological Monitoring of AIDS, HIV AIDS SURV EUR EN; Heffelfinger JD, 2007, AM J PUBLIC HEALTH, V97, P1076, DOI 10.2105/AJPH.2005.070417; Herbst JH, 2007, AM J PREV MED, V32, pS38, DOI 10.1016/j.amepre.2006.12.006; Herbst JH, 2007, AM J PREV MED, V32, pS36, DOI 10.1016/j.amepre.2006.12.005; Huebner DM, 2002, AM J COMMUN PSYCHOL, V30, P327, DOI 10.1023/A:1015325303002; Klausner JD, 2006, J HOMOSEXUAL, V51, P137, DOI 10.1300/J082v51n04_07; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; MacKellar DA, 2005, JAIDS-J ACQ IMM DEF, V38, P603, DOI 10.1097/01.qai.0000141481.48348.7e; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; *NAT CTR HIV EP CL, 2006, HIV AIDS VIR HEP SEX; Newell ML, 2007, LANCET, V369, P617, DOI 10.1016/S0140-6736(07)60288-8; Osmond DH, 2007, AM J PUBLIC HEALTH, V97, P1677, DOI 10.2105/AJPH.2005.062851; *PUBL HLTH AG CAN, 2006, HIV AIDS CAN SURV RE; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Steinbrook R, 2007, NEW ENGL J MED, V356, P1089, DOI 10.1056/NEJMp078009; *US DHHS, 2005, CAS HIV INF AIDS US; Valdiserri RO, 2004, AIDS EDUC PREV, V16, P426, DOI 10.1521/aeap.16.5.426.48738; van Griensven F, 2007, AIDS, V21, P1361, DOI 10.1097/QAD.0b013e328017f868	23	121	123	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2412	2414		10.1001/jama.298.20.2412	http://dx.doi.org/10.1001/jama.298.20.2412			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	18042919				2022-12-28	WOS:000251163400023
J	Dodds, DR; Gross, RA				Dodds, David R.; Gross, Richard A.			Chemicals from biomass	SCIENCE			English	Editorial Material									Dodds & Associates LLC, Manlius, NY 13104 USA; Polytech Univ, NSF Ctr Biocatalysis & Bioproc Macromol, Brooklyn, NY 11201 USA	National Science Foundation (NSF); New York University; Polytechnic University Puerto Rico	Dodds, DR (corresponding author), Dodds & Associates LLC, Manlius, NY 13104 USA.	rgross@poly.edu						Carlson TL, 2006, U.S. Patent application, Patent No. [US2006/094093 A1, 2006094093]; Chen GQ, 2001, APPL MICROBIOL BIOT, V57, P50; Donnelly M, 1998, U.S. Patent, Patent No. 5770435; EMPTAGE M, 2005, Patent No. 1586647A1; Frost JW, 1996, United States Patent, Patent No. [5,487,987, 5487987]; FROST JW, 1997, Patent No. 5629181; Guettler M. V., 1996, US patent, Patent No. 5504004; Kumar A, 2003, MACROMOLECULES, V36, P8219, DOI 10.1021/ma0351827; Lee IY, 1998, ENZYME MICROB TECH, V23, P261, DOI 10.1016/S0141-0229(98)00044-1; Lewis NS, 2007, SCIENCE, V315, P798, DOI 10.1126/science.1137014; LIPINSKY ES, 1981, SCIENCE, V212, P1465, DOI 10.1126/science.212.4502.1465; Lorenz P, 2005, TRENDS BIOTECHNOL, V23, P570, DOI 10.1016/j.tibtech.2005.10.003; Mccoy M, 2007, CHEM ENG NEWS, V85, P12, DOI 10.1021/cen-v085n012.p012; Petersen G., TOP VALUE ADDED CHEM, VI; Ritter SK, 2007, CHEM ENG NEWS, V85, P35, DOI 10.1021/cen-v085n028.p035; Tullo A, 2007, CHEM ENG NEWS, V85, P14, DOI 10.1021/cen-v085n019.p014a; [No title captured]	17	339	356	10	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2007	318	5854					1250	1251		10.1126/science.1146356	http://dx.doi.org/10.1126/science.1146356			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033870				2022-12-28	WOS:000251086600027
J	Catano, JC				Catano, Juan Carlos			Cerebral tuberculoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Antioquia, Sch Med, Medellin, Colombia	Universidad de Antioquia	Catano, JC (corresponding author), Univ Antioquia, Sch Med, Medellin, Colombia.	kataju@hotmail.com							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2166	2166		10.1056/NEJMicm066067	http://dx.doi.org/10.1056/NEJMicm066067			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	18032766				2022-12-28	WOS:000251076500008
J	Rosenthal, MB; Landon, BE; Normand, SLT; Frank, RG; Ahmad, TS; Epstein, AM				Rosenthal, Meredith B.; Landon, Bruce E.; Normand, Sharon-Lise T.; Frank, Richard G.; Ahmad, Thaniyyah S.; Epstein, Arnold M.			Employers' use of value-based purchasing strategies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGED COMPETITION; HEALTH-CARE; QUALITY; BUDGET	Context Value-based purchasing by employers has often been portrayed as the lynch-pin to quality improvement in a market-based health care system. Although a small group of the largest national employers has been actively engaged in promoting quality measurement, reporting, and pay for performance, it is unknown whether these ideas have significantly permeated employer-sponsored health benefit purchasing. Objective To provide systematic descriptions and analyses of value-based purchasing and related efforts to improve quality of care by health care purchasers. Design, Setting, and Participants We conducted telephone interviews with executives at 609 of the largest employers across 41 US markets between July 2005 and March 2006. The 41 randomly selected markets have at least 100 000 persons enrolled in health maintenance organizations, include approximately 91% of individuals enrolled in health maintenance organizations nationally, and represent roughly 78% of the US metropolitan population. Using the Dun & Bradstreet database of US employers, we identified the 26 largest firms in each market. Firms ranged in size from 60 to 250 000 employees. Main Outcome Measure The degree to which value-based purchasing and related strategies are reported being used by employers. Percentages were weighted by number of employees. Results Of 1041 companies contacted, 609 employer representatives completed the survey (response rate, 64%). A large percentage of surveyed executives reported that they examine health plan quality data (269 respondents; 65% [95% confidence interval {CI}, 57%-74%]; P <. 001), but few reported using it for performance rewards (49 respondents; 17% [ 95% CI, 7%-27%]; P=.008) or to influence employees (71 respondents; 23% [ 95% CI, 13%-33%]). Physician quality information is even less commonly examined (71 respondents; 16% [ 95% CI, 9%-23%]) or used by employers to reward performance (8 respondents; 2% [ 95% CI, 0%-3%]) or influence employee choice of providers (34 respondents; 8% [ 95% CI, 3%-12%]). Conclusion Surveyed employers as a whole do not appear to be individually implementing incentives and programs in line with value-based purchasing ideals.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Cambridge, MA 02138 USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Rosenthal, MB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mrosenth@hsph.harvard.edu		Rosenthal, Meredith/0000-0003-3410-0184; Normand, Sharon-Lise/0000-0001-7027-4769	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS013335] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS 13335] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		AARON HJ, 1993, HEALTH AFFAIR, V12, P132, DOI 10.1377/hlthaff.12.3.132; Berwick DM, 2003, HEALTH AFFAIR, V22, P8, DOI 10.1377/hlthaff.22.6.8; Ellwood P M, 1992, Health Econ, V1, P149, DOI 10.1002/hec.4730010303; Galvin RS, 2005, HEALTH AFFAIR, V24, P228, DOI 10.1377/hlthaff.24.1.228; Institute of Medicine, 2001, CROSSING QUALITY CHA; *INTERSTUDY, 2004, COMP EDG HMO DAT; *KAIS FAM FDN, 2006, EMPL HLTH BEN; Levy DE, 2006, AM J MANAG CARE, V12, P553; Maio Vittorio, 2005, Benefits Q, V21, P20; Marquis MS, 2001, HEALTH AFFAIR, V20, P220, DOI 10.1377/hlthaff.20.4.220; Maxwell J, 1998, HEALTH AFFAIR, V17, P216, DOI 10.1377/hlthaff.17.3.216; Maxwell J, 2003, HEALTH CARE MANAGE R, V28, P27, DOI 10.1097/00004010-200301000-00005; Maxwell J, 2002, J HEALTH POLIT POLIC, V27, P5, DOI 10.1215/03616878-27-1-5; Maxwell J, 2001, HEALTH AFFAIR, V20, P181, DOI 10.1377/hlthaff.20.3.181; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; MEYER JA, 1997, THEORY REALITY VALUE; *NAT BUS GROUP HLT, 2005, MAN HLTH CAR COSTS N; *NAT HLTH CAR PURC, 2001, CORP HLTH CAR PURCH; *OFF MAN BUDG, 2003, REV DEF METR STAT AR; SOFAER S, 1993, HEALTH AFFAIR, V12, P76, DOI 10.1377/hlthaff.12.suppl_1.76; STARR P, 1993, HEALTH AFFAIR, V12, P7, DOI 10.1377/hlthaff.12.suppl_1.7; U.S. Census Bureau, 2000, CENS 2000 SUMM FIL 1; WICKS EK, 1993, GARAMENDI PROPOSAL H; 2005, HLTH INSURANCE COVER	24	29	29	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2007	298	19					2281	2288		10.1001/jama.298.19.2281	http://dx.doi.org/10.1001/jama.298.19.2281			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	232XV	18029832	Bronze			2022-12-28	WOS:000251055900028
J	Foote, M; Crampton, JS; Beu, AG; Marshall, BA; Cooper, RA; Maxwell, PA; Matcham, I				Foote, Michael; Crampton, James S.; Beu, Alan G.; Marshall, Bruce A.; Cooper, Roger A.; Maxwell, Phillip A.; Matcham, Iain			Rise and fall of species occupancy in Cenozoic fossil mollusks	SCIENCE			English	Article							COMMUNITIES; MACROEVOLUTIONARY; PALEOBIOLOGY; ABUNDANCE; PATTERNS; QUALITY; RECORD	In the time between speciation and extinction, a species' ecological and biogeographic footprint-its occupancy-will vary in response to macroecological drivers and historical contingencies. Despite their importance for understanding macroecological processes, general patterns of long-term species occupancy remain largely unknown. We documented the occupancy histories of Cenozoic marine mollusks from New Zealand. For both genera and species, these show a distinct pattern of increase to relatively short-lived peak occupancy at mid-duration, followed by a decline toward extinction. Thus, species at greatest risk for extinction are those that have already been in decline for a substantial period of time. This pattern of protracted rise and fall stands in contrast to that of incumbency, insofar as species show no general tendency to stay near maximal occupancy once established.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; GNS Sci, Lower Hutt, New Zealand; Museum New Zealand Ta Papa Tongarewa, Wellington, New Zealand	University of Chicago; GNS Science - New Zealand	Foote, M (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	mfoote@uchicago.edu	Crampton, James/G-1381-2012	Crampton, James/0000-0003-3270-9981				Blackburn TM, 2006, J ANIM ECOL, V75, P1426, DOI 10.1111/j.1365-2656.2006.01167.x; Cooper R. A., 2004, I GEOLOGICAL NUCL SC, P1; Crampton JS, 2006, PALEOBIOLOGY, V32, P509, DOI 10.1666/06014.1; Crampton JS, 2006, PALAIOS, V21, P86, DOI 10.2110/palo.2004.p04-90; Crampton JS, 2003, SCIENCE, V301, P358, DOI 10.1126/science.1085075; Foote M, 2007, PALEOBIOLOGY, V33, P517, DOI 10.1666/06084.1; Frost MT, 2004, ECOGRAPHY, V27, P643; Gaston K.J., 2003, STRUCTURE DYNAMICS G; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Holland SM, 2000, PALEOBIOLOGY, V26, P148, DOI 10.1666/0094-8373(2000)26[148:TQOTFR]2.0.CO;2; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; JABLONSKI D, 1980, PALEOBIOLOGY, V6, P397, DOI 10.1017/S0094837300003584; Jablonski D, 1996, ECOLOGY, V77, P1367, DOI 10.2307/2265534; JABLONSKI D, 1987, SCIENCE, V238, P360, DOI 10.1126/science.238.4825.360; Jablonski D, 2000, PALEOBIOLOGY, V26, P15, DOI 10.1666/0094-8373(2000)26[15:MAMSAH]2.0.CO;2; Jackson JBC, 2000, PALEOBIOLOGY, V26, P221, DOI 10.1666/0094-8373(2000)26[221:LITLFM]2.0.CO;2; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jernvall J, 2004, AM NAT, V164, P614, DOI 10.1086/424967; Kiessling W, 2007, J BIOGEOGR, V34, P1473, DOI 10.1111/j.1365-2699.2007.01709.x; Liow LH, 2007, P R SOC B, V274, P2745, DOI 10.1098/rspb.2007.1006; MANN KO, 1995, SOC EC PALEONTOL MIN, V53; McPeek MA, 2007, PALAEONTOLOGY, V50, P111, DOI 10.1111/j.1475-4983.2006.00616.x; Miller AI, 1997, PALEOBIOLOGY, V23, P410, DOI 10.1017/S0094837300019813; Mora C, 2005, ECOLOGY, V86, P1771, DOI 10.1890/04-0883; Raia P, 2006, EVOL ECOL RES, V8, P181; ROSENZWEIG ML, 1991, PALEOBIOLOGY, V17, P202, DOI 10.1017/S0094837300010563	26	117	117	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1131	1134		10.1126/science.1146303	http://dx.doi.org/10.1126/science.1146303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006744				2022-12-28	WOS:000250957900044
J	Varfolomeev, E; Blankenship, JW; Wayson, SM; Fedorova, AV; Kayagaki, N; Garg, P; Zobel, K; Dynek, JN; Elliott, LO; Wallweber, HJA; Flygare, JA; Fairbrother, WJ; Deshayes, K; Dixit, VM; Vucic, D				Varfolomeev, Eugene; Blankenship, John W.; Wayson, Sarah M.; Fedorova, Anna V.; Kayagaki, Nobuhiko; Garg, Parie; Zobel, Kerry; Dynek, Jasmin N.; Elliott, Linda O.; Wallweber, Heidi J. A.; Flygare, John A.; Fairbrother, Wayne J.; Deshayes, Kurt; Dixit, Vishva M.; Vucic, Domagoj			IAP antagonists induce autoubiquitination of c-IAPs, NF-kappa B activation, and TNF alpha-dependent apoptosis	CELL			English	Article							CASPASE ACTIVATION; STRUCTURAL BASIS; ML-IAP; PROTEIN; SMAC; INHIBITOR; POTENT; UBIQUITINATION; BINDING; C-IAP1	Inhibitor of apoptosis (IAP) proteins are antiapoptotic regulators that block cell death in response to diverse stimuli. They are expressed at elevated levels in human malignancies and are attractive targets for the development of novel cancer therapeutics. Herein, we demonstrate that small-molecule IAP antagonists bind to select baculovirus IAP repeat (BIR) domains resulting in dramatic induction of autoubiquitination activity and rapid proteasomal degradation of c-IAPs. The IAP antagonists also induce cell death that is dependent on TNF signaling and de novo protein biosynthesis. Additionally, the c-IAP proteins were found to function as regulators of NF-kappa B signaling. Through their ubiquitin E3 ligase activities c-IAP1 and c-IAP2 promote proteasomal degradation of NIK, the central ser/thr kinase in the noncanonical NF-kappa B pathway.	Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Med Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA.	dixit@gene.com; domagoj@gene.com	dixit, vishva m/A-4496-2012; 高, 雨莉/HGU-8187-2022	dixit, vishva m/0000-0001-6983-0326; Blankenship, John/0000-0003-4192-7059				Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gan XQ, 2000, J BIOL CHEM, V275, P8469, DOI 10.1074/jbc.275.12.8469; GAO Z, 2007, IN PRESS J BIOL CHEM; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HOFMANN K, 2007, APOPTOSIS, V12, P1543; Johnston M D, 1981, Methods Enzymol, V78, P394; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sharma SK, 2006, INT J PEPT RES THER, V12, P21, DOI 10.1007/s10989-005-9003-2; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Sun HY, 2004, J AM CHEM SOC, V126, P16686, DOI 10.1021/ja047438+; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; Vucic D, 2005, BIOCHEM J, V385, P11, DOI 10.1042/BJ20041108; Vucic D, 2002, J BIOL CHEM, V277, P12275, DOI 10.1074/jbc.M112045200; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	50	972	1005	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					669	681		10.1016/j.cell.2007.10.030	http://dx.doi.org/10.1016/j.cell.2007.10.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022362	Bronze			2022-12-28	WOS:000250966300015
J	Wigley, DB				Wigley, Dale B.			RecBCD: The supercar of DNA repair	CELL			English	Editorial Material							RECOMBINATION; REVEALS	The DNA helicase RecBCD pauses when it reaches recombination hotspots known as Chi sites and then proceeds at a slower speed of translocation than before Chi recognition. Reporting in this issue, Spies et al. (2007) now show that this reduction in translocation velocity occurs when RecBCD changes which of its two motor subunits is in the lead.	London Res Inst, Canc Res UK Clare Hall Labs, Potters Bar EN6 3LD, Herts, England	Cancer Research UK	Wigley, DB (corresponding author), London Res Inst, Canc Res UK Clare Hall Labs, Blanche Lane, Potters Bar EN6 3LD, Herts, England.	dale.wigley@cancer.org.uk						Handa N, 2005, MOL CELL, V17, P745, DOI 10.1016/j.molcel.2005.02.011; MYERS RS, 1995, P NATL ACAD SCI USA, V92, P6244, DOI 10.1073/pnas.92.14.6244; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0	4	11	11	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					651	653		10.1016/j.cell.2007.11.004	http://dx.doi.org/10.1016/j.cell.2007.11.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022359	Bronze			2022-12-28	WOS:000250966300012
J	Alabi, AA; Bahamonde, MI; Jung, HJ; Kim, JI; Swartz, KJ				Alabi, AbdulRasheed A.; Bahamonde, Maria Isabel; Jung, Hoi Jong; Kim, Jae Il; Swartz, Kenton J.			Portability of paddle motif function and pharmacology in voltage sensors	NATURE			English	Article							DEPENDENT K+ CHANNEL; GATED ION CHANNELS; POTASSIUM CHANNEL; GATING-CHARGE; TOXIN RECEPTOR; LIPID-MEMBRANE; KVAP; HANATOXIN; MODIFIER; INHIBITOR	Voltage-sensing domains enable membrane proteins to sense and react to changes in membrane voltage. Although identifiable S1-S4 voltage-sensing domains are found in an array of conventional ion channels and in other membrane proteins that lack pore domains, the extent to which their voltage-sensing mechanisms are conserved is unknown. Here we show that the voltage-sensor paddle, a motif composed of S3b and S4 helices, can drive channel opening with membrane depolarization when transplanted from an archaebacterial voltage-activated potassium channel (KvAP) or voltage-sensing domain proteins (Hv1 and Ci-VSP) into eukaryotic voltage-activated potassium channels. Tarantula toxins that partition into membranes can interact with these paddle motifs at the protein-lipid interface and similarly perturb voltage-sensor activation in both ion channels and proteins with a voltage-sensing domain. Our results show that paddle motifs are modular, that their functions are conserved in voltage sensors, and that they move in the relatively unconstrained environment of the lipid membrane. The widespread targeting of voltage-sensor paddles by toxins demonstrates that this modular structural motif is an important pharmacological target.	NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Gwangju Institute of Science & Technology (GIST)	Swartz, KJ (corresponding author), NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	swartzk@ninds.nih.gov			Intramural NIH HHS [ZIA NS002945-13] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002945, Z01NS003017] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2004, TRENDS NEUROSCI, V27, P303, DOI 10.1016/j.tins.2004.03.008; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Herrington J, 2006, DIABETES, V55, P1034, DOI 10.2337/diabetes.55.04.06.db05-0788; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LAMPE RA, 1993, MOL PHARMACOL, V44, P451; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Ruta V, 2004, BIOCHEMISTRY-US, V43, P10071, DOI 10.1021/bi049463y; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396	49	180	185	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					370	+		10.1038/nature06266	http://dx.doi.org/10.1038/nature06266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004375	Green Accepted			2022-12-28	WOS:000250918600044
J	Hoveyda, AH; Zhugralin, AR				Hoveyda, Amir H.; Zhugralin, Adil R.			The remarkable metal-catalysed olefin metathesis reaction	NATURE			English	Review							RING-CLOSING METATHESIS; IMIDO ALKYLIDENE COMPLEXES; CHIRAL RUTHENIUM CATALYSTS; OPENING/CROSS-METATHESIS; HETEROCYCLIC CARBENES; ALLYLIC ALKYLATION; EFFICIENT; MOLYBDENUM; MECHANISM; TUNGSTEN	Catalytic olefin metathesis-through which pairs of C=C bonds are reorganized-transforms simple molecules to those that are complex and precious. This class of reactions has noticeably enriched chemical synthesis, which is the art of preparing scarce molecules with highly desirable properties (for example, medicinal agents or polymeric materials). Research in the past two decades has yielded structurally well-defined catalysts for olefin metathesis that are used to synthesize an array of molecules with unprecedented efficiency. Nonetheless, the full potential of olefin metathesis will be realized only when additional catalysts are discovered that are truly practical and afford exceptional selectivity for a significantly broader range of reactions.	Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA	Boston College	Hoveyda, AH (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu						ALDHART C, 2004, J AM CHEM SOC, V126, P3496; Alexander JB, 1998, J AM CHEM SOC, V120, P4041, DOI 10.1021/ja974353i; Anderson DR, 2006, J AM CHEM SOC, V128, P8386, DOI 10.1021/ja0618090; Barbasiewicz M, 2007, ADV SYNTH CATAL, V349, P193, DOI 10.1002/adsc.200600478; Berlin JM, 2006, ANGEW CHEM INT EDIT, V45, P7591, DOI 10.1002/anie.200602469; Bielawski CW, 2002, SCIENCE, V297, P2041, DOI 10.1126/science.1075401; Bornand M, 2005, ANGEW CHEM INT EDIT, V44, P7909, DOI 10.1002/anie.200502606; CASEY CP, 1974, J AM CHEM SOC, V96, P7808, DOI 10.1021/ja00832a032; Castarlenas R, 2005, ORGANOMETALLICS, V24, P4343, DOI 10.1021/om050569e; Chauvin Y, 2006, ANGEW CHEM INT EDIT, V45, P3740, DOI 10.1002/anie.200601234; Connon SJ, 2003, ANGEW CHEM INT EDIT, V42, P1900, DOI 10.1002/anie.200200556; Conrad JC, 2007, J AM CHEM SOC, V129, P1024, DOI 10.1021/ja067531t; COREY EJ, 1991, ANGEW CHEM INT EDIT, V30, P455, DOI 10.1002/anie.199104553; Cortez GA, 2007, ORG LETT, V9, P2871, DOI 10.1021/ol071008h; Cortez GA, 2007, ANGEW CHEM INT EDIT, V46, P4534, DOI 10.1002/anie.200605130; Deiters A, 2004, CHEM REV, V104, P2199, DOI 10.1021/cr0200872; DEVOS DE, 2000, CHIRAL CATALYST IMMO; Diver ST, 2004, CHEM REV, V104, P1317, DOI 10.1021/cr020009e; Dragutan V, 2006, J ORGANOMET CHEM, V691, P5129, DOI 10.1016/j.jorganchem.2006.08.012; Funk TW, 2006, J AM CHEM SOC, V128, P1840, DOI 10.1021/ja055994d; Garber SB, 2000, J AM CHEM SOC, V122, P8168, DOI 10.1021/ja001179g; Gillingham DG, 2007, ANGEW CHEM INT EDIT, V46, P3860, DOI 10.1002/anie.200700501; Giudici RE, 2007, J AM CHEM SOC, V129, P3824, DOI 10.1021/ja070187v; Goldman AS, 2006, SCIENCE, V312, P257, DOI 10.1126/science.1123787; Gradillas A, 2006, ANGEW CHEM INT EDIT, V45, P6086, DOI 10.1002/anie.200600641; Grela K, 2002, ANGEW CHEM INT EDIT, V41, P4038, DOI 10.1002/1521-3773(20021104)41:21<4038::AID-ANIE4038>3.0.CO;2-0; Grubbs R. H., 2003, HDB METATHESIS; GRUBBS RH, 1976, J AM CHEM SOC, V98, P3478, DOI 10.1021/ja00428a015; Grubbs RH, 2006, ANGEW CHEM INT EDIT, V45, P3760, DOI 10.1002/anie.200600680; Halbach TS, 2005, J ORG CHEM, V70, P4687, DOI 10.1021/jo0477594; Han S.-Y., 2003, HDB METATHESIS, V2, P5; HERISSON JL, 1971, MAKROMOLEKUL CHEM, V141, P161; Hock AS, 2006, J AM CHEM SOC, V128, P16373, DOI 10.1021/ja0665904; Hong SH, 2006, J AM CHEM SOC, V128, P3508, DOI 10.1021/ja058451c; Hong SH, 2007, J AM CHEM SOC, V129, P7961, DOI 10.1021/ja0713577; Hoveyda A. H., 2003, HDB METATHESIS, V2, P128; HOVEYDA AH, 2003, HDB COMBINATORIAL CH, V2, P991; Huang JK, 1999, J AM CHEM SOC, V121, P2674, DOI 10.1021/ja9831352; HUBERT AJ, 1967, J CHEM SOC C, P1984, DOI 10.1039/j39670001984; Jafarpour L, 1999, ORGANOMETALLICS, V18, P5416, DOI 10.1021/om990587u; JOHNSON HF, 1953, Patent No. 2636054; KATZ TJ, 1980, J AM CHEM SOC, V102, P7942, DOI 10.1021/ja00547a026; KATZ TJ, 1980, J AM CHEM SOC, V102, P7940, DOI 10.1021/ja00547a025; KATZ TJ, 1975, J AM CHEM SOC, V97, P1592, DOI 10.1021/ja00839a063; KATZ TJ, 2003, HDB METATHESIS, V1, P47; Kinderman SS, 2004, J AM CHEM SOC, V126, P4100, DOI 10.1021/ja039919j; Kingsbury JS, 2001, ANGEW CHEM INT EDIT, V40, P4251, DOI 10.1002/1521-3773(20011119)40:22<4251::AID-ANIE4251>3.0.CO;2-L; Kingsbury JS, 1999, J AM CHEM SOC, V121, P791, DOI 10.1021/ja983222u; KINGSBURY JS, 2003, POLYM MAT ORGANIC SY, P467; Kummer DA, 2005, ORG LETT, V7, P4621, DOI 10.1021/ol051711a; Kuramochi A, 2005, J AM CHEM SOC, V127, P14200, DOI 10.1021/ja055301t; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Layton ME, 2002, J AM CHEM SOC, V124, P773, DOI 10.1021/ja016585u; Malenfant PRL, 2007, NAT NANOTECHNOL, V2, P43, DOI 10.1038/nnano.2006.168; McGuinness DS, 1999, ORGANOMETALLICS, V18, P1596, DOI 10.1021/om9809771; Meng DF, 1997, J AM CHEM SOC, V119, P10073, DOI 10.1021/ja971946k; Mol JC, 2004, J MOL CATAL A-CHEM, V213, P39, DOI 10.1016/j.molcata.2003.10.049; Morrissey S, 2006, CHEM ENG NEWS, V84, P12; Nguyen S. T, 2003, HDB METATHESIS, P61; Nickel A, 2004, J AM CHEM SOC, V126, P16300, DOI 10.1021/ja044123l; Nicola T, 2005, ORG PROCESS RES DEV, V9, P513, DOI 10.1021/op0580015; Nicolaou K.C., 1996, CLASSICS TOTAL SYNTH, p1e19; Nicolaou KC, 1997, NATURE, V387, P268, DOI 10.1038/387268a0; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4490, DOI 10.1002/anie.200500369; Poater A, 2007, J AM CHEM SOC, V129, P8207, DOI 10.1021/ja070625y; Poirier M, 2005, J ORG CHEM, V70, P10765, DOI 10.1021/jo051706k; Romero PE, 2005, J AM CHEM SOC, V127, P5032, DOI 10.1021/ja042259d; Sanford MS, 2001, J AM CHEM SOC, V123, P6543, DOI 10.1021/ja010624k; Scholl M, 1999, ORG LETT, V1, P953, DOI 10.1021/ol990909q; SCHRADER TO, 2003, HDB METATHESIS, V2, P205; Schrock RR, 2006, ANGEW CHEM INT EDIT, V45, P3748, DOI 10.1002/anie.200600085; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; SCHROCK RR, 1990, J AM CHEM SOC, V112, P3875, DOI 10.1021/ja00166a023; Schrock RR, 2002, CHEM REV, V102, P145, DOI 10.1021/cr0103726; Schwab P, 1996, J AM CHEM SOC, V118, P100, DOI 10.1021/ja952676d; Slinn CA, 2003, ORG BIOMOL CHEM, V1, P3820, DOI 10.1039/b306940k; Smith AB, 2001, J AM CHEM SOC, V123, P5925, DOI 10.1021/ja0106164; Statsuk AV, 2004, J AM CHEM SOC, V126, P9546, DOI 10.1021/ja046588h; Stewart IC, 2007, ORG LETT, V9, P1589, DOI 10.1021/ol0705144; STRECK R, 1992, J MOL CATAL, V76, P359, DOI 10.1016/0304-5102(92)80172-D; Tallarico JA, 1997, J AM CHEM SOC, V119, P7157, DOI 10.1021/ja971285r; Thayer AM, 2005, CHEM ENG NEWS, V83, P40, DOI 10.1021/cen-v083n036.p040; TOREKI R, 1990, J AM CHEM SOC, V112, P2448, DOI 10.1021/ja00162a071; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Tsang WCP, 2004, ORGANOMETALLICS, V23, P1997, DOI 10.1021/om030636+; Tsang WCP, 2003, J AM CHEM SOC, V125, P2652, DOI 10.1021/ja0210603; Tulevski GS, 2005, SCIENCE, V309, P591, DOI 10.1126/science.1112767; Van Veldhuizen JJ, 2005, J AM CHEM SOC, V127, P6877, DOI 10.1021/ja050179j; Wakamatsu H, 2002, ANGEW CHEM INT EDIT, V41, P2403, DOI 10.1002/1521-3773(20020703)41:13<2403::AID-ANIE2403>3.0.CO;2-F; Wei XL, 2004, ORGANOMETALLICS, V23, P163, DOI 10.1021/om0342107; WESKAMP T, 1995, ANGEW CHEM INT EDIT, V37, P2490; White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232; WIBERG KB, 1986, ANGEW CHEM INT EDIT, V25, P312, DOI 10.1002/anie.198603121; Wipf P, 2005, J AM CHEM SOC, V127, P225, DOI 10.1021/ja044280k; Xu ZM, 1997, J AM CHEM SOC, V119, P10302, DOI 10.1021/ja972191k; Yee NK, 2006, J ORG CHEM, V71, P7133, DOI 10.1021/jo060285j	96	799	813	7	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					243	251		10.1038/nature06351	http://dx.doi.org/10.1038/nature06351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994091				2022-12-28	WOS:000250746200050
J	Orszag, PR; Ellis, P				Orszag, Peter R.; Ellis, Philip			Addressing rising health care costs - A view from the congressional budget office	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Congress Budget Off, Washington, DC 20515 USA	Congressional Budget Office	Orszag, PR (corresponding author), Congress Budget Off, Washington, DC 20515 USA.							Congressional Budget Office, 2004, AN LIT DIS MAN PROGR; GUTERMAN S, 2007, ENHANCING VALUE MEDI; Orszag PR, 2007, NEW ENGL J MED, V357, P1793, DOI 10.1056/NEJMp078190; Soh C, 2007, EVALUATION MEDICARE	4	84	84	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1885	1887		10.1056/NEJMp078191	http://dx.doi.org/10.1056/NEJMp078191			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228LX	17989379				2022-12-28	WOS:000250732500001
J	Coresh, J; Selvin, E; Stevens, LA; Manzi, J; Kusek, JW; Eggers, P; Van Lente, F; Levey, AS				Coresh, Josef; Selvin, Elizabeth; Stevens, Lesley A.; Manzi, Jane; Kusek, John W.; Eggers, Paul; Van Lente, Frederick; Levey, Andrew S.			Prevalence of chronic kidney disease in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; SERUM CREATININE; RISK-FACTOR; CARDIOVASCULAR OUTCOMES; HYPERTENSION; AWARENESS; EQUATION; HEALTH; TRENDS	Context The prevalence and incidence of kidney failure treated by dialysis and transplantation in the United States have increased from 1988 to 2004. Whether there have been changes in the prevalence of earlier stages of chronic kidney disease (CKD) during this period is uncertain. Objective To update the estimated prevalence of CKD in the United States. Design, Setting, and Participants Cross-sectional analysis of the most recent National Health and Nutrition Examination Surveys (NHANES 1988-1994 and NHANES 1999-2004), a nationally representative sample of noninstitutionalized adults aged 20 years or older in 1988-1994 (n = 15 488) and 1999-2004 (n = 13 233). Main Outcome Measures Chronic kidney disease prevalence was determined based on persistent albuminuria and decreased estimated glomerular filtration rate (GFR). Persistence of microalbuminuria (> 30 mg/g) was estimated from repeat visit data in NHANES 1988-1994. The GFR was estimated using the abbreviated Modification of Diet in Renal Disease Study equation reexpressed to standard serum creatinine. Results The prevalence of both albuminuria and decreased GFR increased from 1988-1994 to 1999-2004. The prevalence of CKD stages 1 to 4 increased from 10.0% (95% confidence interval [CI], 9.2%-10.9%) in 1988-1994 to 13.1% (95% CI, 12.0%-14.1%) in 1999-2004 with a prevalence ratio of 1.3 (95% CI, 1.2-1.4). The prevalence estimates of CKD stages in 1988-1994 and 1999-2004, respectively, were 1.7% (95% CI, 1.3%-2.2%) and 1.8% (95% CI, 1.4%-2.3%) for stage 1; 2.7% (95% CI, 2.2%3.2%) and 3.2% (95% CI, 2.6%-3.9%) for stage 2; 5.4% (95% CI, 4.9%-6.0%) and 7.7% (95% CI, 7.0%-8.4%) for stage 3; and 0.21% (95% CI, 0.15%-0.27%) and 0.35% (0.25%-0.45%) for stage 4. A higher prevalence of diagnosed diabetes and hypertension and higher body mass index explained the entire increase in prevalence of albuminuria but only part of the increase in the prevalence of decreased GFR. Estimation of GFR from serum creatinine has limited precision and a change in mean serum creatinine accounted for some of the increased prevalence of CKD. Conclusions The prevalence of CKD in the United States in 1999-2004 is higher than it was in 1988-1994. This increase is partly explained by the increasing prevalence of diabetes and hypertension and raises concerns about future increased incidence of kidney failure and other complications of CKD.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21287 USA; Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA USA; NIDDKD, Bethesda, MD 20892 USA; Cleveland Clin Fdn, Dept Clin Pathol, Cleveland, OH 44195 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Tufts Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cleveland Clinic Foundation	Coresh, J (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, 2024 E Monument,Ste 2-600, Baltimore, MD 21287 USA.	coresh@jhu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK076595, U01DK067651, U01DK035073, U01DK053869] Funding Source: NIH RePORTER; NIDDK NIH HHS [UO1 DK 053869, UO1 DK 067651, K01 DK076595-01, UO1 DK 35073, K01 DK076595] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], NAT HLTH NUTR EX SUR; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Gilbertson DT, 2005, J AM SOC NEPHROL, V16, P3736, DOI 10.1681/ASN.2005010112; Go AS, 2006, CURR OPIN NEPHROL HY, V15, P296, DOI 10.1097/01.mnh.0000222698.30207.aa; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hsu CY, 2003, J AM SOC NEPHROL, V14, P2902, DOI 10.1097/01.ASN.0000091586.46532.B4; KANNEL WB, 1986, CORONARY HEART DISEA, P60; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; *NAT CTR HLTH STAT, SURV OP MAN BROCH CO; National Center for Health Statistics, 1996, AN REP GUID 3 NAT HL; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; *US BUR CENS, PCT 16 GROUP QUART P; *US DEP HHS, HLTH STAT PLAN OP 3; US Renal Data Systems, 2007, USRDS 2006 ANN DAT R	33	3617	3806	7	225	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2007	298	17					2038	2047		10.1001/jama.298.17.2038	http://dx.doi.org/10.1001/jama.298.17.2038			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228GP	17986697	Bronze			2022-12-28	WOS:000250718200024
J	Amin, AN; Pistoria, MJ				Amin, Alpesh N.; Pistoria, Michael J.			Update in hospital medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PULMONARY-EMBOLISM; HIP FRACTURE; PROBABILITY; PATIENT		Univ Calif Irvine, Dept Med, Orange, CA USA; Lehigh Valley Hosp, Allentown, PA USA	University of California System; University of California Irvine; Lehigh Valley Hospital	Amin, AN (corresponding author), Univ Calif Irvine, Dept Med, 101 City Dr S,Bldg 58,Room 110,ZC-4076H, Orange, CA USA.	anamin@uci.edu						Fitzgibbons JP, 2006, ANN INTERN MED, V144, P920, DOI 10.7326/0003-4819-144-12-200606200-00010; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oosterheert JJ, 2006, BMJ-BRIT MED J, V333, P1193, DOI 10.1136/bmj.38993.560984.BE; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Rowe JW, 2006, ANN INTERN MED, V145, P695, DOI 10.7326/0003-4819-145-9-200611070-00013; Roy A, 2006, MAYO CLIN PROC, V81, P28, DOI 10.4065/81.1.28; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Wells PS, 2006, JAMA-J AM MED ASSOC, V295, P199, DOI 10.1001/jama.295.2.199; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92	12	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2007	147	9					628	632		10.7326/0003-4819-147-9-200711060-00007	http://dx.doi.org/10.7326/0003-4819-147-9-200711060-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227QM	17975185				2022-12-28	WOS:000250672900005
J	Stremmel, W; Ehehalt, R; Autschbach, F; Kamer, M				Stremmel, Wolfgang; Ehehalt, Robert; Autschbach, Frank; Kamer, Max			Phosphatidylcholine for steroid-refractory chronic ulcerative colitis - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTRAVENOUS CYCLOSPORINE; 5-AMINOSALICYLIC ACID; SHORT-TERM; AZATHIOPRINE; THERAPY; 6-MERCAPTOPURINE; QUESTIONNAIRE; MANAGEMENT; MUCUS	Background: Although long-term steroid treatment is discouraged in ulcerative colitis, alternatives are lacking when therapy with immunosuppressant drugs fails. An insufficient level of phosphatidylcholine in colonic mucus is a possible pathogenetic factor for ulcerative colitis. Objective: To see whether steroid withdrawal is easier with retarded-release phosphatidylcholine or placebo in adults with chronic steroid-refractory ulcerative colitis. Design: Randomized, double-blind, placebo-controlled trial conducted from March 2003 to January 2006. Setting: University Hospital Heidelberg, a referral center for inflammatory bowel disease. Patients: 60 patients with chronic steroid-refractory ulcerative colitis and high clinical and endoscopic disease activity indexes (score >= 5). Intervention: Phosphatidylcholine or cellulose placebo was ingested 4 times daily for 12 weeks for a total dosage of 2 g/d. The follow-up rate was 97%. Measurements: The number of patients achieving complete steroid withdrawal and either a low clinical activity index (:53) or improvement in the clinical activity index of 50% or more. Results: The primary end point was achieved in 15 of 30 (50%) phosphatidylcholine recipients and in 3 of 30 (10%) placebo recipients (difference, 40% [95% CI, 19% to 61%]; P = 0.002). Twenty-four phosphatidylcholine recipients (80%) and 3 (10%) placebo recipients discontinued steroid therapy without disease exacerbation (difference, 70% [CI, 52% to 88%]; P <0.001). Mild bloating was a common adverse event. Limitations: The sample size was small, and the study was of short duration. Conclusion: Phosphatidylcholine reduced corticosteroid dependence more than placebo in patients with chronic steroid-refractory ulcerative colitis. The next step is long-term trials to evaluate the sustainability of steroid withdrawal in these patients.	Univ Heidelberg Hosp, Dept Gastroenterol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Stremmel, W (corresponding author), Univ Heidelberg Hosp, Dept Gastroenterol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	wolfgang.stremmel@med.uni-heidelberg.de		Ehehalt, Robert/0000-0003-4252-5801; Stremmel, Wolfgang/0000-0002-8545-1753				ADLER DJ, 1990, AM J GASTROENTEROL, V85, P717; Ardizzone S, 2006, GUT, V55, P47, DOI 10.1136/gut.2005.068809; Arts J, 2004, INFLAMM BOWEL DIS, V10, P73, DOI 10.1097/00054725-200403000-00002; Croft Nick M, 2006, Gastroenterology, V130, P1003, DOI 10.1053/j.gastro.2005.11.054; D'Haens G, 2001, GASTROENTEROLOGY, V120, P1323, DOI 10.1053/gast.2001.23983; Ehehalt R, 2004, SCAND J GASTROENTERO, V39, P737, DOI 10.1080/00365520410006233; Feagan BG, 2005, NEW ENGL J MED, V352, P2499, DOI 10.1056/NEJMoa042982; Gibson PR, 2005, GUT, V54, P900, DOI 10.1136/gut.2004.058453; Hauser W, 2004, Z GASTROENTEROL, V42, P131, DOI 10.1055/s-2004-812835; Hlavaty T, 2006, INFLAMM BOWEL DIS, V12, P199, DOI 10.1097/01.MIB.0000217768.75519.32; Karner M, 2007, FALK SYMP, V153, P161; KIRK AP, 1982, BRIT MED J, V284, P1291, DOI 10.1136/bmj.284.6325.1291; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; Ogata H, 2006, GUT, V55, P1255, DOI 10.1136/gut.2005.081794; PRESENT DH, 1989, ANN INTERN MED, V111, P641, DOI 10.7326/0003-4819-111-8-641; RACHMILEWITZ D, 1989, BMJ-BRIT MED J, V298, P82, DOI 10.1136/bmj.298.6666.82; ROSENBERG JL, 1975, GASTROENTEROLOGY, V69, P96; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Shibolet O, 2005, COCHRANE DB SYST REV, DOI 10.1002/14641858.CD004277.pub2; Stremmel W, 2005, GUT, V54, P966, DOI 10.1136/gut.2004.052316; TRUELOVE SC, 1956, BRIT MED J, V1, P1315, DOI 10.1136/bmj.1.4979.1315	21	64	67	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2007	147	9					603	610		10.7326/0003-4819-147-9-200711060-00004	http://dx.doi.org/10.7326/0003-4819-147-9-200711060-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227QM	17975182				2022-12-28	WOS:000250672900002
J	Kumar, A; Godwin, JW; Gates, PB; Garza-Garcia, AA; Brockes, JP				Kumar, Anoop; Godwin, James W.; Gates, Phillip B.; Garza-Garcia, A. Acely; Brockes, Jeremy P.			Molecular basis for the nerve dependence of limb regeneration in an adult vertebrate	SCIENCE			English	Article							ESTROGEN-RECEPTOR; PATTERN-FORMATION; NEWT; BLASTEMA; GROWTH; AMPUTATION; FORELIMBS; IDENTITY; CLONING; HAG-2	The limb blastemal cells of an adult salamander regenerate the structures distal to the level of amputation, and the surface protein Prod 1 is a critical determinant of their proximodistal identity. The anterior gradient protein family member nAG is a secreted ligand for Prod 1 and a growth factor for cultured newt blastemal cells. nAG is sequentially expressed after amputation in the regenerating nerve and the wound epidermis-the key tissues of the stem cell niche-and its expression in both locations is abrogated by denervation. The local expression of nAG after electroporation is sufficient to rescue a denervated blastema and regenerate the distal structures. Our analysis brings together the positional identity of the blastema and the classical nerve dependence of limb regeneration.	UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England; Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England	University of London; University College London; MRC National Institute for Medical Research	Brockes, JP (corresponding author), UCL, Dept Biochem & Mol Biol, Gower St, London WC1E 6BT, England.	j.brockes@ucl.ac.uk		Garza-Garcia, Acely/0000-0003-0307-0138; Brockes, Jeremy/0000-0002-3395-5159; Godwin, James/0000-0002-9234-7807	MRC [G0600229, G9537983] Funding Source: UKRI; Medical Research Council [MC_U117574559, G0600229(77696), G9537983, G9537983(56733), G0600229] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; BROCKES JP, 1984, SCIENCE, V225, P1280, DOI 10.1126/science.6474177; BROCKES JP, 1986, CELL, V45, P301, DOI 10.1016/0092-8674(86)90394-6; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Carlson B. M., 2007, PRINCIPLES REGENERAT; CRAWFORD K, 1988, DEVELOPMENT, V102, P687; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; DRACHMAN DB, 1971, EXP NEUROL, V32, P1, DOI 10.1016/0014-4886(71)90159-2; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; EGAR MW, 1988, ANAT REC, V221, P550, DOI 10.1002/ar.1092210111; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; GLOBUS M, 1991, ANN NY ACAD SCI, V632, P396, DOI 10.1111/j.1749-6632.1991.tb33135.x; Goss RJ., 1969, PRINCIPLES REGENERAT; ITEN LE, 1973, ROUX ARCH DEV BIOL, V173, P263, DOI 10.1007/BF00575834; Kumar A, 2007, CR BIOL, V330, P485, DOI 10.1016/j.crvi.2007.01.006; LEMKE G, 2006, SCI STKE, pPE11; MADEN M, 1982, NATURE, V295, P672, DOI 10.1038/295672a0; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; MESCHER AL, 1976, J EXP ZOOL, V195, P117, DOI 10.1002/jez.1401950111; Mescher AL, 1997, DEV GROWTH DIFFER, V39, P677; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; PARSON A, 2007, J LIFE SCI       SEP, P60; Pecorino LT, 1996, CURR BIOL, V6, P563, DOI 10.1016/S0960-9822(02)00542-0; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; Rosel M, 1998, ONCOGENE, V17, P1989, DOI 10.1038/sj.onc.1202079; SALLEY JD, 1981, J EXP ZOOL, V215, P183, DOI 10.1002/jez.1402150208; Sidman R. L., 1951, American Journal of Physiology, V165, P257; SINGER M, 1967, J EXP ZOOL, V166, P89, DOI 10.1002/jez.1401660110; SINGER M, 1948, J EXP ZOOL, V108, P279, DOI 10.1002/jez.1401080207; SINGER MARCUS, 1952, QUART REV BIOL, V27, P169, DOI 10.1086/398873; STOCUM DL, 2001, CURR TOP MICROBIOL I, V280, P1; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; THOMS SD, 1984, DEV BIOL, V103, P319, DOI 10.1016/0012-1606(84)90320-8; THORNTON CS, 1970, J EXP ZOOL, V173, P293, DOI 10.1002/jez.1401730308; Wang LS, 2000, J NEUROBIOL, V43, P150, DOI 10.1002/(SICI)1097-4695(200005)43:2<150::AID-NEU5>3.0.CO;2-G; YNTEMA CL, 1959, J EXP ZOOL, V142, P423, DOI 10.1002/jez.1401420119	40	357	370	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					772	777		10.1126/science.1147710	http://dx.doi.org/10.1126/science.1147710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975060	Green Accepted			2022-12-28	WOS:000250583900034
J	Raberg, L; Sim, D; Read, AF				Raberg, Lars; Sim, Derek; Read, Andrew F.			Disentangling genetic variation for resistance and tolerance to infectious diseases in animals	SCIENCE			English	Article							PLASMODIUM-CHABAUDI; NATURAL ENEMIES; MORNING GLORY; MALARIA; VIRULENCE; EVOLUTION; ALPHA(+)-THALASSEMIA; COEVOLUTION; PATHOGENS; PARASITES	Hosts can in principle employ two different strategies to defend themselves against parasites: resistance and tolerance. Animals typically exhibit considerable genetic variation for resistance (the ability to limit parasite burden). However, little is known about whether animals can evolve tolerance (the ability to limit the damage caused by a given parasite burden). Using rodent malaria in laboratory mice as a model system and the statistical framework developed by plant-pathogen biologists, we demonstrated genetic variation for tolerance, as measured by the extent to which anemia and weight loss increased with increasing parasite burden. Moreover, resistance and tolerance were negatively genetically correlated. These results mean that animals, like plants, can evolve two conceptually different types of defense, a finding that has important implications for the understanding of the epidemiology and evolution of infectious diseases.	Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden	University of Edinburgh; University of Edinburgh; Lund University	Raberg, L (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	lars.raberg@zooekol.lu.se			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bisset SA, 1996, INT J PARASITOL, V26, P857, DOI 10.1016/S0020-7519(96)80056-7; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; FINEBLUM WL, 1995, NATURE, V377, P517, DOI 10.1038/377517a0; Fornoni J, 2004, EVOLUTION, V58, P1685, DOI 10.1111/j.0014-3820.2004.tb00454.x; Fortin A, 2002, GENES IMMUN, V3, P177, DOI 10.1038/sj.gene.6363841; Grech K, 2006, J EVOLUTION BIOL, V19, P1620, DOI 10.1111/j.1420-9101.2006.01116.x; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; Koskela T, 2002, EVOLUTION, V56, P899; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Mackinnon MJ, 1999, EVOLUTION, V53, P689, DOI [10.2307/2640710, 10.1111/j.1558-5646.1999.tb05364.x]; MALO D, 1994, TRENDS GENET, V10, P365, DOI 10.1016/0168-9525(94)90133-3; Martinelli A, 2005, P NATL ACAD SCI USA, V102, P814, DOI 10.1073/pnas.0405097102; Miller MR, 2006, EVOLUTION, V60, P945, DOI 10.1111/j.0014-3820.2006.tb01173.x; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; SIMMS EL, 1994, EVOLUTION, V48, P1973, DOI 10.1111/j.1558-5646.1994.tb02227.x; Simms EL, 2000, EVOL ECOL, V14, P563, DOI 10.1023/A:1010956716539; Smith JA, 1999, P ROY SOC B-BIOL SCI, V266, P1283, DOI 10.1098/rspb.1999.0776; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; STEVENSON MM, 1982, INFECT IMMUN, V38, P80, DOI 10.1128/IAI.38.1.80-88.1982; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Tiffin P, 1999, AM NAT, V154, P700, DOI 10.1086/303271; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569	27	507	524	5	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					812	814		10.1126/science.1148526	http://dx.doi.org/10.1126/science.1148526			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975068	Green Submitted			2022-12-28	WOS:000250583900045
J	Smith, J; Theodoris, C; Davidson, EH				Smith, Joel; Theodoris, Christina; Davidson, Eric H.			A gene regulatory network subcircuit drives a dynamic pattern of gene expression	SCIENCE			English	Article							SEA-URCHIN EMBRYO; NUCLEAR BETA-CATENIN; STRONGYLOCENTROTUS-PURPURATUS; ENDOMESODERM NETWORK; APPEARANCE; RATES; WNT	Early specification of endomesodermal territories in the sea urchin embryo depends on a moving torus of regulatory gene expression. We show how this dynamic patterning function is encoded in a gene regulatory network (GRN) subcircuit that includes the otx, wnt8, and blimp1 genes, the cis-regulatory control systems of which have all been experimentally defined. A cis-regulatory reconstruction experiment revealed that blimp1 autorepression accounts for progressive extinction of expression in the center of the torus, whereas its outward expansion follows reception of the Wnt8 ligand by adjacent cells. GRN circuitry thus controls not only static spatial assignment in development but also dynamic regulatory patterning.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Davidson, EH (corresponding author), CALTECH, Div Biol, 156-29, Pasadena, CA 91125 USA.	davidson@caltech.edu	Theodoris, Christina/N-4403-2016	Theodoris, Christina/0000-0003-1658-1447; Smith, Joel/0000-0003-0311-7055	EPSRC [EP/D073626/2] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-37105] Funding Source: Medline	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; CABRERA CV, 1984, J MOL BIOL, V174, P85, DOI 10.1016/0022-2836(84)90366-8; Chuang CK, 1996, DEV GENET, V19, P231, DOI 10.1002/(SICI)1520-6408(1996)19:3<231::AID-DVG6>3.0.CO;2-A; Croce JC, 2006, DEV BIOL, V300, P121, DOI 10.1016/j.ydbio.2006.08.045; Davidson E. H, 1987, GENE ACTIVITY EARLY; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Istrail S, 2005, P NATL ACAD SCI USA, V102, P4954, DOI 10.1073/pnas.0409624102; LIVANT DL, 1991, DEVELOPMENT, V113, P385; Livi CB, 2006, DEV BIOL, V293, P513, DOI 10.1016/j.ydbio.2006.02.021; Logan CY, 1999, DEVELOPMENT, V126, P345; Minokawa T, 2005, DEV BIOL, V288, P545, DOI 10.1016/j.ydbio.2005.09.047; Range RC, 2005, DEV BIOL, V279, P252, DOI 10.1016/j.ydbio.2004.12.023; SICK S, 2006, SCIENCE         1102; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045; [No title captured]	18	102	104	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					794	797		10.1126/science.1146524	http://dx.doi.org/10.1126/science.1146524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975065				2022-12-28	WOS:000250583900040
J	Overholtzer, M; Mailleux, AA; Mouneimne, G; Normand, G; Schnitt, SJ; King, RW; Cibas, ES; Brugge, JS				Overholtzer, Michael; Mailleux, Arnaud A.; Mouneimne, Ghassan; Normand, Guillaume; Schnitt, Stuart J.; King, Randall W.; Cibas, Edmund S.; Brugge, Joan S.			A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion	CELL			English	Article							PROTEIN-KINASE; CARCINOMA; CANNIBALISM; APOPTOSIS; PHOSPHATIDYLSERINE; CONTRACTION; DISRUPTION; ACTIVATION; ONCOGENE; MATRIX	Epithelial cells require attachment to extracellular matrix (ECM) to suppress an apoptotic cell death program termed anoikis. Here we describe a nonapoptotic cell death program in matrix-detached cells that is initiated by a previously unrecognized and unusual process involving the invasion of one cell into another, leading to a transient state in which a live cell is contained within a neighboring host cell. Live internalized cells are either degraded by lysosomal enzymes or released. We term this cell internalization process entosis and present evidence for entosis as a mechanism underlying the commonly observed "cell-in-cell'' cytological feature in human cancers. Further we propose that entosis is driven by compaction force associated with adherens junction formation in the absence of integrin engagement and may represent an intrinsic tumor suppression mechanism for cells that are detached from ECM.	[Overholtzer, Michael; Mailleux, Arnaud A.; Mouneimne, Ghassan; Normand, Guillaume; King, Randall W.; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Cambridge, MA 02138 USA; [Cibas, Edmund S.] Brigham & Womens Hosp, Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Schnitt, Stuart J.] Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Cambridge, MA 02138 USA.	joan_brugge@hms.harvard.edu	Normand, Guillaume/A-1975-2010; Mailleux, Arnaud/AAH-8799-2021; Mailleux, Arnaud A/J-3576-2017	Mailleux, Arnaud/0000-0003-4191-1778; Mailleux, Arnaud A/0000-0003-4191-1778; Normand, Guillaume/0000-0003-1228-3813; Overholtzer, Michael/0000-0003-3007-4986; King, Randall/0000-0001-7882-8180	NATIONAL CANCER INSTITUTE [P50CA089393, P01CA080111, T32CA009361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066492, R56GM066492] Funding Source: NIH RePORTER; NCI NIH HHS [CA080111, CA089393, T32CA09361] Funding Source: Medline; NIGMS NIH HHS [GM66492] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abodief WT, 2006, CYTOPATHOLOGY, V17, P304, DOI 10.1111/j.1365-2303.2006.00326.x; Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; BROUWER M, 1984, CANCER RES, V44, P2947; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; CRAIG ID, 1983, ACTA CYTOL, V27, P293; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; DESIMONE PA, 1980, HUM PATHOL, V11, P535; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Gupta K, 2003, DIAGN CYTOPATHOL, V28, P86, DOI 10.1002/dc.10234; HONG IS, 1981, ACTA CYTOL, V25, P277; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jin J, 2005, ONCOGENE, V24, P5459, DOI 10.1038/sj.onc.1208704; Lockshin RA, 2004, ONCOGENE, V23, P2766, DOI 10.1038/sj.onc.1207514; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; McIlroy D, 2000, GENE DEV, V14, P549; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Opitz C, 2002, MOL MICROBIOL, V45, P597, DOI 10.1046/j.1365-2958.2002.03056.x; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sauzeau V, 2001, CIRC RES, V88, P1102, DOI 10.1161/hh1101.092034; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; UEI Y, 1980, ACTA CYTOL, V24, P522; Wang M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-32; Wrobel CN, 2004, J CELL BIOL, V165, P263, DOI 10.1083/jcb.200309102	36	446	475	8	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					966	979		10.1016/j.cell.2007.10.040	http://dx.doi.org/10.1016/j.cell.2007.10.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045538	Bronze			2022-12-28	WOS:000251800900018
J	Bussel, JB; Cheng, G; Saleh, MN; Psaila, B; Kovaleva, L; Meddeb, B; Kloczko, J; Hassani, H; Mayer, B; Stone, NL; Arning, M; Provan, D; Jenkins, JM				Bussel, James B.; Cheng, Gregory; Saleh, Mansoor N.; Psaila, Bethan; Kovaleva, Lidia; Meddeb, Balkis; Kloczko, Janusz; Hassani, Habib; Mayer, Bhabita; Stone, Nicole L.; Arning, Michael; Provan, Drew; Jenkins, Julian M.			Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN THROMBOPOIETIN; MECHANISMS; AUTOANTIBODIES; ITP	Background The pathogenesis of chronic idiopathic thrombocytopenic purpura (ITP) involves antibody-mediated platelet destruction and reduced platelet production. Stimulation of platelet production may be an effective treatment for this disorder. Methods We conducted a trial in which 118 adults with chronic ITP and platelet counts of less than 30,000 per cubic millimeter who had had relapses or whose platelet count was refractory to at least one standard treatment for ITP were randomly assigned to receive the oral thrombopoietin-receptor agonist eltrombopag (30, 50, or 75 mg daily) or placebo. The primary end point was a platelet count of 50,000 or more per cubic millimeter on day 43. Results In the eltrombopag groups receiving 30, 50, and 75 mg per day, the primary end point was achieved in 28%, 70%, and 81% of patients, respectively. In the placebo group, the end point was achieved in 11% of patients. The median platelet counts on day 43 for the groups receiving 30, 50, and 75 mg of eltrombopag were 26,000, 128,000, and 183,000 per cubic millimeter, respectively; for the placebo group the count was 16,000 per cubic millimeter. By day 15, more than 80% of patients receiving 50 or 75 mg of eltrombopag daily had an increased platelet count. Bleeding also decreased during treatment in these two groups. The incidence and severity of adverse events were similar in the placebo and eltrombopag groups. Conclusions Eltrombopag increased platelet counts in a dose-dependent manner in patients with relapsed or refractory ITP. (ClinicalTrials.gov number, NCT00102739.).	Cornell Univ, Weill Cornell Med Coll, New York, NY 10065 USA; Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; Georgia Canc Specialists, Tucker, GA USA; Minist Publ Hlth Russia, Hematol Res Ctr, Moscow, Russia; Hop La Rabta, Tunis, Tunisia; Akad Med, Bialystok, Poland; GlaxoSmithKline, Greenford, Middx, England; GlaxoSmithKline, Collegeville, PA USA; Barts & London Queen Marys Sch Med & Dent, London, England	Cornell University; Chinese University of Hong Kong; Prince of Wales Hospital; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Universite de Tunis-El-Manar; Hopital La Rabta; GlaxoSmithKline; GlaxoSmithKline; University of London; Queen Mary University London	Bussel, JB (corresponding author), Cornell Univ, Weill Cornell Med Coll, 525 E 68th St,P695, New York, NY 10065 USA.	jbussel@med.cornell.edu	Provan, Drew/AAF-2766-2021	Provan, Drew/0000-0002-5110-8455; Psaila, Beth/0000-0001-8198-9663				Aledort LM, 2004, AM J HEMATOL, V76, P205, DOI 10.1002/ajh.20104; [Anonymous], 2013, GENE, DOI DOI 10.1016/j.gene.2013.03.137; BALLEM PJ, 1987, J CLIN INVEST, V80, P33, DOI 10.1172/JCI113060; Bussel JB, 2006, NEW ENGL J MED, V355, P2054; Butros LJ, 2003, J PEDIAT HEMATOL ONC, V25, P660, DOI 10.1097/00043426-200308000-00017; Cancer Therapy Evaluation Program, 2006, COMM TERM CRIT ADV E; Chang M, 2003, BLOOD, V102, P887, DOI 10.1182/blood-2002-05-1475; Chang M, 1996, BLOOD, V88, P3354, DOI 10.1182/blood.V88.9.3354.bloodjournal8893354; Cines DB, 2002, NEW ENGL J MED, V346, P995, DOI 10.1056/NEJMra010501; Cines DB, 2005, BLOOD, V106, P2244, DOI 10.1182/blood-2004-12-4598; Emmons RVB, 1996, BLOOD, V87, P4068, DOI 10.1182/blood.V87.10.4068.bloodjournal87104068; Erhardt J, 2004, BLOOD, V104, p59B, DOI 10.1182/blood.V104.11.3888.3888; ERICKSONMILLER CL, 2005, 96 ANN M AM ASS CANC; Geddis AE, 2002, CYTOKINE GROWTH F R, V13, P61, DOI 10.1016/S1359-6101(01)00030-2; GERNSHEIMER T, 1989, NEW ENGL J MED, V320, P974, DOI 10.1056/NEJM198904133201505; Jenkins JM, 2007, BLOOD, V109, P4739, DOI 10.1182/blood-2006-11-057968; Kalota A, 2004, BLOOD, V104, p796A, DOI 10.1182/blood.V104.11.2913.2913; Kosugi S, 1996, BRIT J HAEMATOL, V93, P704, DOI 10.1046/j.1365-2141.1996.d01-1702.x; Kuter DJ, 2002, BLOOD, V100, P3457, DOI 10.1182/blood.V100.10.3457; MCHUTCHINSON JG, 2006, 57 ANN M AM ASS STUD; McMillan R, 2005, INT J HEMATOL, V81, P94, DOI 10.1532/IJH97.04168; Newland A, 2006, BRIT J HAEMATOL, V135, P547, DOI 10.1111/j.1365-2141.2006.06339.x; PROVAN D, 2006, J CLIN ONCOL, V18, P18596; Sellers T, 2004, BLOOD, V104, p568A, DOI 10.1182/blood.V104.11.2063.2063; VAINCHENKER W, 1994, B ACAD NAT MED PARIS, V178, P753; von dem Borne A, 2002, BLOOD REV, V16, P57, DOI 10.1054/blre.2001.0184	26	529	565	4	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2237	2247		10.1056/NEJMoa073275	http://dx.doi.org/10.1056/NEJMoa073275			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	18046028				2022-12-28	WOS:000251176400005
J	Grimwood, K; Bines, JE				Grimwood, Keith; Bines, Julie E.			Rotavirus vaccines must perform in low-income countries too	LANCET			English	Editorial Material							INFECTION; EFFICACY; SAFETY; TIME		Univ Queensland, Royal Childrens Hosp, Dept Paediat & Child Hlth, Queensland Paediat Infect Dis Lab, Brisbane, Qld 4029, Australia; Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Paediat, Melbourne, Vic, Australia	Royal Children's Hospital Brisbane; University of Queensland; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Grimwood, K (corresponding author), Univ Queensland, Royal Childrens Hosp, Dept Paediat & Child Hlth, Queensland Paediat Infect Dis Lab, Brisbane, Qld 4029, Australia.	Keith_Grimwood@health.qld.gov.au	Grimwood, Keith/F-9334-2011	Bines, Julie/0000-0002-5452-6601; Grimwood, Keith/0000-0003-3174-9834				Cunliffe NA, 1998, B WORLD HEALTH ORGAN, V76, P525; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; Lepage P, 2006, PEDIATR INFECT DIS J, V25, pS5, DOI 10.1097/01.inf.0000197619.71659.76; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Simonsen L, 2005, J INFECT DIS, V192, pS36, DOI 10.1086/431512; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, PEDIATR INFECT DIS J, V25, P118, DOI 10.1097/01.inf.0000199288.98370.71; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664	12	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2007	370	9601					1739	1740		10.1016/S0140-6736(07)61730-9	http://dx.doi.org/10.1016/S0140-6736(07)61730-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234DI	18037071				2022-12-28	WOS:000251140500004
J	Miller, SE; Collins, BM; Mccoy, AJ; Robinson, MS; Owen, DJ				Miller, Sharon E.; Collins, Brett M.; Mccoy, Airlie J.; Robinson, Margaret S.; Owen, David J.			A SNARE-adaptor interaction is a new mode of cargo recognition in clathrin-coated vesicles	NATURE			English	Article							HOMOLOGY ENTH DOMAINS; TRANS-GOLGI NETWORK; MEMBRANE; PROTEINS; COMPLEX; FUSION; SIGNAL; EPSIN; LOCALIZATION; REFINEMENT	Soluble NSF attachment protein receptors (SNAREs) are type II transmembrane proteins that have critical roles in providing the specificity and energy for transport-vesicle fusion and must therefore be correctly partitioned between vesicle and organelle membranes(1-3). Like all other cargo, SNAREs need to be sorted into the forming vesicles by direct interaction with components of the vesicles' coats. Here we characterize the molecular details governing the sorting of a SNARE into clathrin-coated vesicles, namely the direct recognition of the three-helical bundle H-abc domain of the mouse SNARE Vti1b by the human clathrin adaptor epsinR (EPNR, also known as CLINT1). Structures of each domain and of their complex show that this interaction ( dissociation constant 22 mu M) is mediated by surface patches composed of approximately 15 residues each, the topographies of which are dependent on each domain's overall fold. Disruption of the interface with point mutations abolishes the interaction in vitro and causes Vti1b to become relocalized to late endosomes and lysosomes. This new class of highly specific, surface-surface interaction between the clathrin coat component and the cargo is distinct from the widely observed binding of short, linear cargo motifs by the assembly polypeptide (AP) complex and GGA adaptors(4) and is therefore not vulnerable to competition from standard motif-containing cargoes for incorporation into clathrin-coated vesicles. We propose that conceptually similar but mechanistically different interactions will direct the post-Golgi trafficking of many SNAREs.	Univ Cambridge, CIMR, Cambridge CB2 0XY, England; Univ Queensland, IMB, St Lucia, Qld 4075, Australia	University of Cambridge; University of Queensland	Owen, DJ (corresponding author), Univ Cambridge, CIMR, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	msr12@mole.bio.cam.ac.uk; djo30@cam.ac.uk	Collins, Brett/J-1563-2014	Collins, Brett/0000-0002-6070-3774	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fridmann-Sirkis Y, 2006, TRAFFIC, V7, P182, DOI 10.1111/j.1600-0854.2005.00374.x; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kato Y, 2002, NAT STRUCT BIOL, V9, P532, DOI 10.1038/nsb807; KRISSINEL E, 2005, DETECTION PROTEIN AS; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Peden AA, 2001, J BIOL CHEM, V276, P49183, DOI 10.1074/jbc.M106646200; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Song J, 2006, PLANT CELL, V18, P2258, DOI 10.1105/tpc.105.039123; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Tran THT, 2007, J CELL SCI, V120, P1028, DOI 10.1242/jcs.03387; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	38	96	98	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					570	U21		10.1038/nature06353	http://dx.doi.org/10.1038/nature06353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033301				2022-12-28	WOS:000251158500052
J	Farber, J; Siu, A; Bloom, P				Farber, Jeffrey; Siu, Albert; Bloom, Patricia			How much time do physicians spend providing care outside of office visits?	ANNALS OF INTERNAL MEDICINE			English	Article							TELEPHONE	Background: People with chronic illness require care outside of office visits, much of which is not reimbursed under current Medicare guidelines. Objective: To describe the amount of time geriatricians spend and the nature of care they provide outside of office visits. Design: Cross-sectional study on the time spent by physicians in clinical interactions outside of patient visits during 3 randomly sampled, 1-week periods. Setting: An academic geriatric medicine ambulatory practice. Participants: 16 physicians. Measurements: Information on the method, content, outcome, and participants in clinical interactions outside of office visits was collected on a structured form. Results: There were 472 discrete interactions, representing 296 episodes of care for 226 patients. Fifty-four percent of interactions were linked as multistep episodes, whose mean duration (range; 25th, 75th percentiles) was 18.9 minutes (3 to 70 minutes; 9, 21 minutes). Thirty-six percent of episodes involving a new medical symptom resulted in medication use, 27% resulted in an office visit, and 9% resulted in a referral to another physician. Mean time spent per physician per week was 112.2 minutes (range, 36 to 260 minutes), which represents an additional 6.7 minutes (range, 1.7 to 13.8) of care provided outside of office visits for every 30 minutes of time spent scheduled to see ambulatory patients. For a full-time physician scheduled to see 14 patients per day in 30-minute visits over a 5-day workweek, this would represent an extra 7.8 hours of clinical work per week. Limitation: Data were self-reported and were limited to an academic geriatric medicine practice. Conclusion: Physicians spend a considerable amount of time providing care outside of office visits for patients with chronic illness. This study suggests that collecting empirical data on the amount and nature of nonreimbursed care activities is feasible and should be done in more generalizable settings to inform debates about reimbursement reform.	Mt Sinai Sch Med, New York, NY 10029 USA; Bronx Vet Affairs Med Ctr, Bronx, NY USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Farber, J (corresponding author), Mt Sinai Sch Med, Box 1070, New York, NY 10029 USA.	jeffrey.farber@mssm.edu						*AM GER SOC ASS DI, 2006, GER MED CLIN IMP AG; Anderson GF, 2005, NEW ENGL J MED, V353, P305, DOI 10.1056/NEJMsb044133; *ASS DIR GER ACAD, 2006, TRAINING PRACTICE UP, V2; *ASS DIR GER ACAD, 2007, STAT GER WORKF STUD; BABBOTT SF, 2006, POLICY MONOGRAPH SOC; Delichatsios H, 1998, J GEN INTERN MED, V13, P579, DOI 10.1046/j.1525-1497.1998.00179.x; Elnicki DM, 2000, J GEN INTERN MED, V15, P337, DOI 10.1046/j.1525-1497.2000.06459.x; HALLAM L, 1989, FAM PRACT, V6, P47, DOI 10.1093/fampra/6.1.47; Loder E, 2002, HEADACHE, V42, P883, DOI 10.1046/j.1526-4610.2002.02207.x	9	67	70	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2007	147	10					693	U119		10.7326/0003-4819-147-10-200711200-00005	http://dx.doi.org/10.7326/0003-4819-147-10-200711200-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235UJ	18025445				2022-12-28	WOS:000251259500003
J	Frank, RG				Frank, Richard G.			The ongoing regulation of generic drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Frank, RG (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							*DISTR US COURT DI, ORD STIP PERM INJ; *IMS HLTH, GEN MARK EXP SOAR 80; SILVER R, 2007, 2007 GPHA ANN M PHOE	3	89	94	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2007	357	20					1993	1996		10.1056/NEJMp078193	http://dx.doi.org/10.1056/NEJMp078193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230RV	18003956				2022-12-28	WOS:000250894500001
J	Epstein, JE				Epstein, Judith E.			What will a partly protective malaria vaccine mean to mothers in Africa?	LANCET			English	Editorial Material							CIRCUMSPOROZOITE PROTEIN VACCINE; PLASMODIUM-FALCIPARUM INFECTION; EFFICACY; SAFETY; CHILDREN; DISEASE		USN, Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD 20910 USA	United States Department of Defense; United States Navy	Epstein, JE (corresponding author), USN, Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD 20910 USA.	judith.epstein@med.navy.mil						Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; BALLOU WR, 1987, LANCET, V1, P1277; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Maire N, 2006, AM J TROP MED HYG, V75, P111, DOI 10.4269/ajtmh.2006.75.111; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; YOUNG JF, 1985, SCIENCE, V228, P958, DOI 10.1126/science.2988125	11	6	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2007	370	9598					1523	1524		10.1016/S0140-6736(07)61642-0	http://dx.doi.org/10.1016/S0140-6736(07)61642-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AE	17980720				2022-12-28	WOS:000250628800004
J	Nagaosa, N				Nagaosa, Naoto			A new state of quantum matter	SCIENCE			English	Editorial Material							ROOM-TEMPERATURE; SPIN CURRENT		Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan	University of Tokyo	Nagaosa, N (corresponding author), Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan.	nagaosa@appi.t.u-tokyo.ac.jp	Nagaosa, Naoto/G-7057-2012					Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; DYAKONOV MI, 1971, JETP LETT-USSR, V13, P467; Fu L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045302; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Kimura T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.249901; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; KONIG M, 2007, SCIENCE         0920, DOI DOI 10.1126/SCIENCE.1148047; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Murakami S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.156804; Saitoh E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199473; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Valenzuela SO, 2006, NATURE, V442, P176, DOI 10.1038/nature04937; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204	16	35	35	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					758	759		10.1126/science.1150199	http://dx.doi.org/10.1126/science.1150199			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975057				2022-12-28	WOS:000250583900029
J	Ulrich, HD				Ulrich, Helle D.			SUMO teams up with ubiquitin to manage hypoxia	CELL			English	Editorial Material							TRANSCRIPTIONAL ACTIVITY; HIF-1-ALPHA; SUMOYLATION; STABILITY	Hypoxia, a condition of severe oxygen shortage, induces a transcriptional response that is important for both normal embryonic development and the growth of tumors. In this issue, Cheng et al. (2007) describe how the stability of the major transcriptional regulator of the hypoxic response, HIF1 alpha, is modulated by the interplay between the ubiquitin and the SUMO conjugation systems.	Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK London Res Inst, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Ulrich, HD (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK London Res Inst, S Mimms EN6 3LD, Herts, England.	helle.ulrich@cancer.org.uk		Ulrich, Helle D./0000-0003-0431-2223				Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Berta MA, 2007, BIOCHEM BIOPH RES CO, V360, P646, DOI 10.1016/j.bbrc.2007.06.103; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; UZUNOVA K, 2007, J BIOL CHEM; XIE Y, 2007, J BIOL CHEM	10	16	22	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					446	447		10.1016/j.cell.2007.10.026	http://dx.doi.org/10.1016/j.cell.2007.10.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981111	Bronze			2022-12-28	WOS:000250618500011
J	Massberg, S; Schaerli, P; Knezevic-Maramica, I; Kollnberger, M; Tubo, N; Moseman, EA; Huff, IV; Junt, T; Wagers, AJ; Mazo, IB; von Andrian, UH				Massberg, Steffen; Schaerli, Patrick; Knezevic-Maramica, Irina; Koellnberger, Maria; Tubo, Noah; Moseman, E. Ashley; Huff, Ines V.; Junt, Tobias; Wagers, Amy J.; Mazo, Irina B.; von Andrian, Ulrich H.			Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues	CELL			English	Article							STEM-CELLS; BONE-MARROW; SPHINGOSINE 1-PHOSPHATE; MICE DEFICIENT; T-CELLS; SPHINGOSINE-1-PHOSPHATE; MIGRATION; ORGANS; MOBILIZATION; AGONISTS	Constitutive egress of bone marrow (BM)-resident hematopoietic stem and progenitor cells (HSPCs) into the blood is a well-established phenomenon, but the ultimate fate and functional relevance of circulating HSPCs is largely unknown. We show that mouse thoracic duct (TD) lymph contains HSPCs that possess short- and long-term multilineage reconstitution capacity. TD-derived HSPCs originate in the BM, enter the blood, and traffic to multiple peripheral organs, where they reside for at least 36 hr before entering draining lymphatics to return to the blood and, eventually, the BM. HSPC egress from extramedullary tissues into lymph depends on sphingosine-1-phosphate receptors. Migratory HSPCs proliferate within extramedullary tissues and give rise to tissue-resident myeloid cells, preferentially dendritic cells. HSPC differentiation is amplified upon exposure to Toll-like receptor agonists. Thus, HSPCs can survey peripheral organs and can foster the local production of tissue-resident innate immune cells under both steady-state conditions and in response to inflammatory signals.	[Massberg, Steffen; Schaerli, Patrick; Knezevic-Maramica, Irina; Koellnberger, Maria; Tubo, Noah; Moseman, E. Ashley; Huff, Ines V.; Junt, Tobias; Wagers, Amy J.; Mazo, Irina B.; von Andrian, Ulrich H.] Harvard Med Sch, Immune Dis Inst, Dept Pathol, Boston, MA 02115 USA; [Wagers, Amy J.] Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02215 USA; [Wagers, Amy J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.; Harvard University	von Andrian, UH (corresponding author), Harvard Med Sch, Immune Dis Inst, Dept Pathol, Boston, MA 02115 USA.	uva@hms.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Junt, Tobias/AAE-4389-2021; Massberg, Steffen/AAN-6054-2021		NCRR NIH HHS [S10 RR021190-010001, S10 RR021190] Funding Source: Medline; NHLBI NIH HHS [P01 HL056949-129001, P01 HL056949-119001, P01 HL056949-099001, P01 HL056949-09, P01 HL056949-12, P01 HL056949-089001, P01 HL056949-08, P01 HL056949, P01 HL056949-10, HL56949, P01 HL056949-11, P01 HL056949-109001] Funding Source: Medline; NIAID NIH HHS [R01 AI072252, R01 AI061663-05, R01 AI069259-03, R01 AI072252-01, AI061663, R01 AI069259, R01 AI061663] Funding Source: Medline; NIAMS NIH HHS [AR42689, P30 AR042689] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021190] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069259, R01AI072252, R01AI061663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Cardier JE, 1997, HEPATOLOGY, V26, P165; Chiba K, 1998, J IMMUNOL, V160, P5037; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; FLEMING WH, 1993, P NATL ACAD SCI USA, V90, P3760, DOI 10.1073/pnas.90.8.3760; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ionac M, 2003, MICROSURG, V23, P239, DOI 10.1002/micr.10136; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; MACVITTIE TJ, 1977, J CELL PHYSIOL, V92, P203, DOI 10.1002/jcp.1040920208; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Massberg S, 2006, NEW ENGL J MED, V355, P1088, DOI 10.1056/NEJMp068159; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Papayannopoulou T, 2003, BLOOD, V101, P4739, DOI 10.1182/blood-2002-09-2741; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Singer II, 2005, J IMMUNOL, V175, P7151, DOI 10.4049/jimmunol.175.11.7151; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278	40	529	537	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					994	1008		10.1016/j.cell.2007.09.047	http://dx.doi.org/10.1016/j.cell.2007.09.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045540	Green Accepted, Bronze			2022-12-28	WOS:000251800900020
J	Jollis, JG; Roettig, ML; Aluko, AO; Anstrom, KJ; Applegate, RJ; Babb, JD; Berger, PB; Bohle, DJ; Fletcher, SM; Garvey, JL; Hathaway, WR; Hoekstra, JW; Kelly, RV; Maddox, WT; Shiber, JR; Valeri, FS; Watling, BA; Wilson, BH; Granger, CB				Jollis, James G.; Roettig, Mayme L.; Aluko, Akinyele O.; Anstrom, Kevin J.; Applegate, Robert J.; Babb, Joseph D.; Berger, Peter B.; Bohle, David J.; Fletcher, Sidney M.; Garvey, J. Lee; Hathaway, William R.; Hoekstra, James W.; Kelly, Robert V.; Maddox, William T., Jr.; Shiber, Joseph R.; Valeri, F. Scott; Watling, Bradley A.; Wilson, B. Hadley; Granger, Christopher B.		RACE Investigators	Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY MEDICAL-SERVICES; NATIONAL REGISTRY; CARE; QUALITY; INTERVENTION; PROGRAMS; THERAPY; HEALTH; TRENDS	Context Despite 2 decades of evidence demonstrating benefits from prompt coronary reperfusion, registries continue to show that many patients with ST-segment elevation myocardial infarction (STEMI) are treated too slowly or not at all. Objective To establish a statewide system for reperfusion, as exists for trauma care, to overcome systematic barriers. Design and Setting A quality improvement study that examined the change in speed and rate of coronary reperfusion after system implementation in 5 regions in North Carolina involving 65 hospitals and associated emergency medical systems ( 10 percutaneous coronary intervention [PCI] hospitals and 55 non-PCI hospitals). Patients A total of 1164 patients with STEMI ( 579 preintervention and 585 post-intervention) eligible for reperfusion were treated at PCI hospitals (median age 61 years, 31% women, 4% Killip class III or IV). A total of 925 patients with STEMI ( 518 preintervention and 407 postintervention) were treated at non-PCI hospitals ( median age 62 years, 32% women, 4% Killip class III or IV). Interventions Early diagnosis and the most expedient coronary reperfusion method at each point of care: emergency medical systems, emergency department, catheterization laboratory, and transfer. Within 5 regions, PCI hospitals agreed to provide single-call catheterization laboratory activation by emergency medical personnel, accept patients regardless of bed availability, and improve STEMI care for the entire region regardless of hospital affiliation. Main Outcome Measures Reperfusion times and rates 3 months before (July to September 2005) and 3 months after (January to March 2007) a year-long implementation. Results Median reperfusion times significantly improved according to first door-to-device ( presenting to PCI hospital 85 to 74 minutes, P <. 001; transferred to PCI hospital 165 to 128 minutes, P <,. 001), door-to-needle in non-PCI hospitals (35 to 29 minutes, P=.002), and door-in to door-out for patients transferred from non-PCI hospitals (120 to 71 minutes, P <.. 001). Nonreperfusion rates were unchanged (15%) in non-PCI hospitals and decreased from 23% to 11% in the PCI hospitals. For patients presenting to or transferred to PCI hospitals, clinical outcomes including death, cardiac arrest, and cardiogenic shock did not significantly change following the intervention. Conclusions A statewide program focused on regional systems for reperfusion for STEMI can significantly improve quality of care. Further research is needed to ensure that programs that result in improved application of reperfusion treatments will lead to reductions in mortality and morbidity from STEMI.	Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA; Duke Univ, Dept Cardiol, Durham, NC USA; Presbyterian Hosp, Dept Emergency Med, Charlotte, NC USA; Presbyterian Hosp, Dept Cardiol, Charlotte, NC USA; Wake Forest Univ, Dept Cardiol, Winston Salem, NC 27109 USA; Wake Forest Univ, Dept Emergency Med, Winston Salem, NC 27109 USA; E Carolina Univ, Dept Cardiol, Greenville, NC USA; E Carolina Univ, Dept Med & Emergency Med, Greenville, NC USA; Geisinger Hlth Syst, Ctr Clin Studies, Danville, PA USA; Forsyth Med Ctr, Dept Cardiol, Winston Salem, NC USA; Carolinas Med Ctr, Dept Emergency Med, Charlotte, NC 28203 USA; Carolinas Med Ctr, Dept Cardiol, Charlotte, NC 28203 USA; Mission Mem Hosp, Dept Cardiol, Asheville, NC USA; Beacon Hosp, Dept Cardiol, Dublin, Ireland; Carolinas Med Ctr Mercy, Dept Cardiol, Charlotte, NC USA; Carolinas Med Ctr Mercy, Dept Emergency Med, Charlotte, NC USA	Duke University; Duke University; Wake Forest University; Wake Forest University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; Geisinger Health System; Carolinas Medical Center; Carolinas Medical Center	Granger, CB (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Box 3409, Durham, NC 27710 USA.	christopher.granger@duke.edu	Granger, Christopher B/D-3458-2014	Granger, Christopher B/0000-0002-0045-3291				Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Burwen DR, 2003, ARCH INTERN MED, V163, P1430, DOI 10.1001/archinte.163.12.1430; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Garvey JL, 2006, J AM COLL CARDIOL, V47, P485, DOI 10.1016/j.jacc.2005.08.072; *GEN, 2007, NAT REG MYOC INF Q D; Henry TD, 2005, AM HEART J, V150, P373, DOI 10.1016/j.ahj.2005.01.059; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; *I MED NAT AC BOAR, 2007, EM MED SERV CROSSR; Jacobs AK, 2007, CIRCULATION, V116, P217, DOI 10.1161/CIRCULATIONAHA.107.184043; Jollis JG, 2006, AM HEART J, V152; Mackay J, 2004, ATLAS HEART DIS STRO; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Moyer P, 2007, CIRCULATION, V116, pE43, DOI 10.1161/CIRCULATIONAHA.107.184047; Nissen SE, 2006, J AM COLL CARDIOL, V48, P1911, DOI 10.1016/j.jacc.2006.10.011; Pham HH, 2006, HEALTH AFFAIR, V25, P1412, DOI 10.1377/hlthaff.25.5.1412; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Rokos IC, 2006, AM HEART J, V152, P661, DOI 10.1016/j.ahj.2006.06.001; Ting HH, 2007, CIRCULATION, V116, P729, DOI 10.1161/CIRCULATIONAHA.107.699934	20	277	286	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2371	2380		10.1001/jama.298.20.joc70124	http://dx.doi.org/10.1001/jama.298.20.joc70124			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	17982184	Bronze			2022-12-28	WOS:000251163400017
J	Kobayakawa, K; Kobayakawa, R; Matsumoto, H; Oka, Y; Imai, T; Ikawa, M; Okabe, M; Ikeda, T; Itohara, S; Kikusui, T; Mori, K; Sakano, H				Kobayakawa, Ko; Kobayakawa, Reiko; Matsumoto, Hideyuki; Oka, Yuichiro; Imai, Takeshi; Ikawa, Masahito; Okabe, Masaru; Ikeda, Toshio; Itohara, Shigeyoshi; Kikusui, Takefumi; Mori, Kensaku; Sakano, Hitoshi			Innate versus learned odour processing in the mouse olfactory bulb	NATURE			English	Article							PREDATOR ODOR; C-ELEGANS; EXPRESSION; MICE; BEHAVIOR; NEURONS; RECEPTORS; ACCURACY; FAMILY; SPEED	The mammalian olfactory system mediates various responses, including aversive behaviours to spoiled foods and fear responses to predator odours. In the olfactory bulb, each glomerulus represents a single species of odorant receptor. Because a single odorant can interact with several different receptor species, the odour information received in the olfactory epithelium is converted to a topographical map of multiple glomeruli activated in distinct areas in the olfactory bulb. To study how the odour map is interpreted in the brain, we generated mutant mice in which olfactory sensory neurons in a specific area of the olfactory epithelium are ablated by targeted expression of the diphtheria toxin gene. Here we show that, in dorsal-zone-depleted mice, the dorsal domain of the olfactory bulb was devoid of glomerular structures, although second-order neurons were present in the vacant areas. The mutant mice lacked innate responses to aversive odorants, even though they were capable of detecting them and could be conditioned for aversion with the remaining glomeruli. These results indicate that, in mice, aversive information is received in the olfactory bulb by separate sets of glomeruli, those dedicated for innate and those for learned responses.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1130033, Japan; Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; RIKEN, Brain Sci Inst, Lab Behav Genet, Saitama 3510198, Japan; Univ Tokyo, Lab Vet Ethol, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo; Osaka University; RIKEN; University of Tokyo	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	ikawa, masahito/A-5315-2009; Imai, Takeshi/L-2201-2013; Itohara, Shigeyoshi/I-8769-2012; Oka, Yoshitaka/G-4952-2014; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Imai, Takeshi/0000-0002-8449-0080; Itohara, Shigeyoshi/0000-0002-2410-9989; Oka, Yoshitaka/0000-0002-3482-3051; Kobayakawa, Reiko/0000-0001-6613-5969; Okabe, Masaru/0000-0002-0803-9044; Mori, Kensaku/0000-0001-7853-9370; Kobayakawa, Ko/0000-0001-6406-5610				Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Day HEW, 2004, BRAIN RES, V1025, P139, DOI 10.1016/j.brainres.2004.07.079; Dielenberg RA, 2001, NEUROSCI BIOBEHAV R, V25, P597, DOI 10.1016/S0149-7634(01)00044-6; Fendt M, 2003, J NEUROSCI, V23, P23; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Gurden H, 2006, NEURON, V52, P335, DOI 10.1016/j.neuron.2006.07.022; Hebb ALO, 2004, EUR J NEUROSCI, V20, P2415, DOI 10.1111/j.1460-9568.2004.03704.x; Hebb ALO, 2002, NEUROPSYCHOPHARMACOL, V27, P744, DOI 10.1016/S0893-133X(02)00354-8; HORDER TJ, 1971, J PHYSIOL-LONDON, V6, pP53; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Inaki K, 2002, EUR J NEUROSCI, V15, P1563, DOI 10.1046/j.1460-9568.2002.01991.x; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; KAY E, 1992, PHYSIOL BEHAV, V52, P105, DOI 10.1016/0031-9384(92)90439-9; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; NYBY J, 1985, J COMP PSYCHOL, V99, P479, DOI 10.1037/0735-7036.99.4.479; Oka Y, 2003, EUR J BIOCHEM, V270, P1995, DOI 10.1046/j.1432-1033.2003.03571.x; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schellinck HM, 2001, CHEM SENSES, V26, P663, DOI 10.1093/chemse/26.6.663; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Tsuboi A, 2006, EUR J NEUROSCI, V23, P1436, DOI 10.1111/j.1460-9568.2006.04675.x; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; VERNETMAURY E, 1984, J CHEM ECOL, V10, P1007, DOI 10.1007/BF00987509; Wallace KJ, 2001, J NEUROSCI, V21, P3619, DOI 10.1523/JNEUROSCI.21-10-03619.2001; WOOD RW, 1995, TOXICOL APPL PHARM, V130, P67, DOI 10.1006/taap.1995.1009; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	44	446	454	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					503	U5		10.1038/nature06281	http://dx.doi.org/10.1038/nature06281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	17989651				2022-12-28	WOS:000251158500037
J	Scott, J				Scott, James			The liver X receptor and atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MICE		Imperial Coll, London, England	Imperial College London	Scott, J (corresponding author), Imperial Coll, London, England.							Bradley MN, 2007, J CLIN INVEST, V117, P2337, DOI 10.1172/JCI31909; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	4	23	23	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2195	2197		10.1056/NEJMcibr075951	http://dx.doi.org/10.1056/NEJMcibr075951			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	18032771				2022-12-28	WOS:000251076500015
J	Ashar, BS; Ferriter, A				Ashar, Binita S.; Ferriter, Ann			Radiofrequency identification technology in health care - Benefits and potential risks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Device Evaluat, Ctr Devices & Radiol Hlth, Rockville, MD 20850 USA	US Food & Drug Administration (FDA)	Ashar, BS (corresponding author), US FDA, Off Device Evaluat, Ctr Devices & Radiol Hlth, HFZ 410,9200 Corp Blvd, Rockville, MD 20850 USA.	binita.ashar@fda.hhs.gov						[Anonymous], 2005, HLTH DEVICES, V34, P149; Austin SM, 2007, MAYO CLIN PROC, V82, P383; *AUSTR COMP EM RES, 2004, 80211 IEEE AUSTR COM; CHEVROLLIER N, US WIR NETW TECHN HE; *FED COMM COMM, FILL COMPL FCC IS EA; Gimbel JR, 2007, MAYO CLIN PROC, V82, P318; HARROP P, 2006, RFID HEALTHCARE IDTE; *US FDA, 2007, DRAFT GUID IND FDA S; *US FDA, 2005, WIR PHYS MON SYST 51; *US FDA, 2006, D SPECT CARD SCANN S; *US FDA, 2004, SURG TAG 510 K K0425; *US FDA, ADV EV REP US FDA; *US FDA, 2006, STRYK ORTH RFID INST; *US FDA, 2004, VER HLTH INF MICR SY; *US FDA, MEDW FDA SAF INF ADV; *US FDA, FDA MAUDE DAT CTR DE	16	37	37	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2007	298	19					2305	2307		10.1001/jama.298.19.2305	http://dx.doi.org/10.1001/jama.298.19.2305			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232XV	18029835				2022-12-28	WOS:000251055900031
J	Trent, JM; Touchman, JW				Trent, Jeffrey M.; Touchman, Jeffrey W.			Cancer - The gene topography of cancer	SCIENCE			English	Editorial Material									Translat Genom Res Inst, Phoenix, AZ 85004 USA	Translational Genomics Research Institute	Trent, JM (corresponding author), Translat Genom Res Inst, Phoenix, AZ 85004 USA.	jtrent@tgen.org						Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Church GM, 2006, SCI AM, V294, P46, DOI 10.1038/scientificamerican0106-46; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Senzer N, 2007, MOL CANCER THER, V6, P1478, DOI 10.1158/1535-7163.MCT-07-0125; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	8	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1079	1080		10.1126/science.1151428	http://dx.doi.org/10.1126/science.1151428			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006731				2022-12-28	WOS:000250957900028
J	Chand, K; Califano, J				Chand, Kaillash; Califano, Joseph			Should drugs be decriminalised?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Columbia Univ, Natl Ctr Addict & Subst Abuse, New York, NY 10017 USA	Columbia University		Kailash.Chand@gp-P89609.nhs.uk; info@casacolumbia.org							0	5	5	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2007	335	7627					966	967		10.1136/bmj.39360.489132.AD	http://dx.doi.org/10.1136/bmj.39360.489132.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232AL	17991976	Green Published			2022-12-28	WOS:000250990400034
J	Johnston, CA; Temple, BR; Chen, JG; Gao, YJ; Moriyama, EN; Jones, AM; Siderovski, DP; Willard, FS				Johnston, Christopher A.; Temple, Brenda R.; Chen, Jin-Gui; Gao, Yajun; Moriyama, Etsuko N.; Jones, Alan M.; Siderovski, David P.; Willard, Francis S.			Comment on "A G protein-coupled receptor is a plasma membrane receptor for the plant hormone abscisic acid"	SCIENCE			English	Editorial Material									Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Struct Bioinformat Core Facil, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Univ Nebraska, Sch Biol Sci & Plant Sci Initiat, Lincoln, NE 68588 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of British Columbia; University of Nebraska System; University of Nebraska Lincoln	Jones, AM (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu; dsiderov@med.unc.edu; fwillard@med.unc.edu	Chen, Jin-Gui/A-4773-2011; Siderovski, David Peter/AAA-9603-2019; Chen, Jin-Gui/AFV-6337-2022	Chen, Jin-Gui/0000-0002-1752-4201; Siderovski, David Peter/0000-0002-0688-8210; Chen, Jin-Gui/0000-0002-1752-4201	NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bauer H, 2000, BIOCHEM BIOPH RES CO, V275, P69, DOI 10.1006/bbrc.2000.3260; Christianson DW, 2006, SCIENCE, V311, P1382, DOI 10.1126/science.1125298; Clark WA, 2001, BIOCHEM J, V358, P389, DOI 10.1042/0264-6021:3580389; Landlinger C, 2006, BBA-BIOMEMBRANES, V1758, P1759, DOI 10.1016/j.bbamem.2006.07.018; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MAYER H, 1999, BIOCHIM BIOPHYS ACTA, V1399, P51; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Moriyama EN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r96; PARKER EM, 1991, J BIOL CHEM, V266, P519; Rich RL, 2006, J MOL RECOGNIT, V19, P478, DOI 10.1002/jmr.808; Sarramegna V, 2006, CELL MOL LIFE SCI, V63, P1149, DOI 10.1007/s00018-005-5557-6	14	76	90	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852								10.1126/science.1143230	http://dx.doi.org/10.1126/science.1143230			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991845	Green Published			2022-12-28	WOS:000250788500020
J	Lin, JH; Li, H; Yasumura, D; Cohen, HR; Zhang, C; Panning, B; Shokat, KM; LaVail, MM; Walter, P				Lin, Jonathan H.; Li, Han; Yasumura, Douglas; Cohen, Hannah R.; Zhang, Chao; Panning, Barbara; Shokat, Kevan M.; LaVail, Matthew M.; Walter, Peter			IRE1 signaling affects cell fate during the unfolded protein response	SCIENCE			English	Article							ER STRESS; RETINITIS-PIGMENTOSA; TRANSMEMBRANE PROTEIN; MESSENGER-RNA; RHODOPSIN; ATF6; TRANSLATION; PROTEOLYSIS; DEATH	Endoplasmic reticulum (ER) stress activates a set of signaling pathways, collectively termed the unfolded protein response (UPR). The three UPR branches (IRE1, PERK, and ATF6) promote cell survival by reducing misfolded protein levels. UPR signaling also promotes apoptotic cell death if ER stress is not alleviated. How the UPR integrates its cytoprotective and proapoptotic outputs to select between life or death cell fates is unknown. We found that IRE1 and ATF6 activities were attenuated by persistent ER stress in human cells. By contrast, PERK signaling, including translational inhibition and proapoptotic transcription regulator Chop induction, was maintained. When IRE1 activity was sustained artificially, cell survival was enhanced, suggesting a causal link between the duration of UPR branch signaling and life or death cell fate after ER stress. Key findings from our studies in cell culture were recapitulated in photoreceptors expressing mutant rhodopsin in animal models of retinitis pigmentosa.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lin, JH (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	Jonathan.Lin@ucsf.edu	Longo, Kenneth A/A-5631-2010	Lin, Jonathan/0000-0002-7438-6941	NATIONAL EYE INSTITUTE [R01EY020846, K08EY018313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085186] Funding Source: NIH RePORTER; NEI NIH HHS [K08 EY018313-01, K08 EY018313, R01 EY020846] Funding Source: Medline; NIGMS NIH HHS [R01 GM085186] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cohen HR, 2007, CHROMOSOMA, V116, P373, DOI 10.1007/s00412-007-0100-1; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen JS, 2005, METHODS, V35, P382, DOI 10.1016/j.ymeth.2004.10.011; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Steinberg R. H., 1996, Investigative Ophthalmology and Visual Science, V37, pS698; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	29	1011	1081	4	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					944	949		10.1126/science.1146361	http://dx.doi.org/10.1126/science.1146361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991856	Green Accepted			2022-12-28	WOS:000250788500034
J	Sturgill, D; Zhang, Y; Parisi, M; Oliver, B				Sturgill, David; Zhang, Yu; Parisi, Michael; Oliver, Brian			Demasculinization of X chromosomes in the Drosophila genus	NATURE			English	Article							SEX-BIASED GENES; EXPRESSION; EVOLUTION	X chromosomes evolve differently from autosomes, but general governing principles have not emerged(1). For example, genes with male-biased expression are under-represented on the X chromosome of D. melanogaster(2), but are randomly distributed in the genome of Anopheles gambiae(3). In direct global profiling experiments using species-specific microarrays, we find a nearly identical paucity of genes with male-biased expression on D. melanogaster, D. simulans, D. yakuba, D. ananassae, D. virilis and D. mojavensis X chromosomes. We observe the same under-representation on the neo-X of D. pseudoobscura. It has been suggested that precocious meiotic silencing of the X chromosome accounts for reduced X chromosome male-biased expression in nematodes(4), mammals(5) and Drosophila(6). We show that X chromosome genes with male-biased expression are under-represented in somatic cells and in mitotic male germ cells. These data are incompatible with simple X chromosome inactivation models. Using expression profiling and comparative sequence analysis, we show that selective gene extinction on the X chromosome, creation of new genes on autosomes and changed genomic location of existing genes contribute to the unusual X chromosome gene content.	NIDDKD, Cellular & Dev Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Sturgill, D (corresponding author), NIDDKD, Cellular & Dev Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA.	davidsturgill@niddk.nih.gov; oliver@helix.nih.gov		Sturgill, David/0000-0002-7902-3605	Intramural NIH HHS [Z01 DK015600-12] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015600] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ashburner M., 2004, DROSOPHILA LAB HDB; Bean CJ, 2004, NAT GENET, V36, P100, DOI 10.1038/ng1283; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Charif D, 2005, BIOINFORMATICS, V21, P545, DOI 10.1093/bioinformatics/bti037; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; Gupta Vaijayanti, 2006, J Biol, V5, P3, DOI 10.1186/jbiol30; Hahn MW, 2005, CURR BIOL, V15, pR192, DOI 10.1016/j.cub.2005.03.005; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wang W, 2004, NAT GENET, V36, P523, DOI 10.1038/ng1338; Wu CI, 2003, TRENDS GENET, V19, P243, DOI 10.1016/S0168-9525(03)00058-1	25	177	178	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					238	U3		10.1038/nature06330	http://dx.doi.org/10.1038/nature06330			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994090	Bronze, Green Accepted			2022-12-28	WOS:000250746200045
J	Higgins, DA; Pomianek, ME; Kraml, CM; Taylor, RK; Semmelhack, MF; Bassler, BL				Higgins, Douglas A.; Pomianek, Megan E.; Kraml, Christina M.; Taylor, Ronald K.; Semmelhack, Martin F.; Bassler, Bonnie L.			The major Vibrio cholerae autoinducer and its role in virulence factor production	NATURE			English	Article							QUORUM-SENSING SIGNAL; TO-CELL COMMUNICATION; STRUCTURAL IDENTIFICATION; GENE-EXPRESSION; COLONIZATION; PHEROMONE	Vibrio cholerae, the causative agent of the human disease cholera, uses cell-to-cell communication to control pathogenicity and biofilm formation(1,2). This process, known as quorum sensing, relies on the secretion and detection of signalling molecules called autoinducers. At low cell density V. cholerae activates the expression of virulence factors and forms biofilms. At high cell density the accumulation of two quorum-sensing autoinducers represses these traits. These two autoinducers, cholerae autoinducer-1 (CAI-1) and autoinducer-2 (AI-2), function synergistically to control gene regulation, although CAI-1 is the stronger of the two signals. V. cholerae AI-2 is the furanosyl borate diester ( 2S, 4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran borate(3). Here we describe the purification of CAI-1 and identify the molecule as ( S)-3-hydroxytridecan-4-one, a new type of bacterial autoinducer. We provide a synthetic route to both the R and S isomers of CAI-1 as well as simple homologues, and we evaluate their relative activities. Synthetic ( S)-3-hydroxytridecan-4-one functions as effectively as natural CAI-1 in repressing production of the canonical virulence factor TCP ( toxin co-regulated pilus). These findings suggest that CAI-1 could be used as a therapy to prevent cholera infection and, furthermore, that strategies to manipulate bacterial quorum sensing hold promise in the clinical arena.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Lotus Separat LLC, Princeton, NJ 08544 USA; Dartmouth Coll, Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Princeton University; Princeton University; Princeton University; Dartmouth College; Howard Hughes Medical Institute	Bassler, BL (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	bbassler@princeton.edu		Bassler, Bonnie/0000-0002-0043-746X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054442] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Simionato AVC, 2007, J MASS SPECTROM, V42, P490, DOI 10.1002/jms.1181; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Flavier AB, 1997, MOL MICROBIOL, V26, P251, DOI 10.1046/j.1365-2958.1997.5661945.x; Hall DR, 2006, J CHEM ECOL, V32, P195, DOI 10.1007/s10886-006-9360-0; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; HORINOUCHI S, 1994, MOL MICROBIOL, V12, P859, DOI 10.1111/j.1365-2958.1994.tb01073.x; LEAL WS, 1995, P NATL ACAD SCI USA, V92, P1038, DOI 10.1073/pnas.92.4.1038; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; SAKAI T, 1984, CHEM LETT, P263, DOI 10.1246/cl.1984.263; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; Taga ME, 2003, P NATL ACAD SCI USA, V100, P14549, DOI 10.1073/pnas.1934514100; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Wang LH, 2004, MOL MICROBIOL, V51, P903, DOI 10.1046/j.1365-2958.2003.03883.x; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	29	312	332	4	117	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					883	886		10.1038/nature06284	http://dx.doi.org/10.1038/nature06284			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18004304				2022-12-28	WOS:000251394900057
J	Pol, A; Heijmans, K; Harhangi, HR; Tedesco, D; Jetten, MSM; den Camp, HJMO				Pol, Arjan; Heijmans, Klaas; Harhangi, Harry R.; Tedesco, Dario; Jetten, Mike S. M.; den Camp, Huub J. M. Op			Methanotrophy below pH1 by a new Verrucomicrobia species	NATURE			English	Article							MOSBY MUD VOLCANO; PMOA-LIKE GENE; SP NOV.; METHANE MONOOXYGENASE; METHYLOCYSTIS STRAIN; ACTIVATED-SLUDGE; BACTERIA; DIVERSITY; ENVIRONMENT; SEQUENCE	Mud volcanoes, mudpots and fumaroles are remarkable geological features characterized by the emission of gas, water and/or semi-liquid mud matrices(1) with significant methane fluxes to the atmosphere ( 10(-1) to 10(3) ty(-1))(2-4). Environmental conditions in these areas vary from ambient temperature and neutral pH to high temperatures and low pH. Although there are strong indications for biological methane consumption in mud volcanoes(4,5), no methanotrophic bacteria are known that would thrive in the hostile conditions of fumaroles ( temperatures up to 70 degrees C and pH down to 1.8)(2). The first step in aerobic methane oxidation is performed by a soluble or membrane-bound methane mono-oxygenase. Here we report that pmoA ( encoding the beta-subunit of membrane-bound methane mono-oxygenase) clone libraries, made by using DNA extracted from the Solfatara volcano mudpot and surrounding bare soil near the fumaroles, showed clusters of novel and distant pmoA genes. After methanotrophic enrichment at 50 degrees C and pH 2.0 the most distant cluster, sharing less than 50% identity with any other described pmoA gene, was represented in the culture. Finally we isolated an acidiphilic methanotrophic bacterium Acidimethylosilex fumarolicum SolV belonging to the Planctomycetes/Verrucomicrobia/Chlamydiae superphylum(6), 'outside' the subphyla of the Alpha- and Gammaproteobacteria containing the established methanotrophs. This bacterium grows under oxygen limitation on methane as the sole source of energy, down to pH 0.8-far below the pH optimum of any previously described methanotroph. A. fumarolicum SolV has three different pmoA genes, with two that are very similar to sequences retrieved from the mudpot. Highly homologous environmental 16S rRNA gene sequences from Yellowstone Park show that this new type of methanotrophic bacteria may be a common inhabitant of extreme environments. This is the first time that a representative of the widely distributed Verrucomicrobia phylum, of which most members remain uncultivated(6), is coupled to a geochemically relevant reaction.	Radboud Univ Nijmegen, Dept Microbiol, IWWR, NL-6525 ED Nijmegen, Netherlands; Univ Naples 2, Dipartimento Sci Ambientali, I-81100 Caserta, Italy	Radboud University Nijmegen; Universita della Campania Vanvitelli	Jetten, MSM (corresponding author), Radboud Univ Nijmegen, Dept Microbiol, IWWR, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	m.jetten@science.ru.nl; h.opdencamp@science.ru.nl	Jetten, Mike/B-8834-2011; Camp, Huub J.M. Op den/F-5114-2011	Jetten, Mike/0000-0002-4691-7039; Camp, Huub J.M. Op den/0000-0003-1990-9030				Alain K, 2006, ENVIRON MICROBIOL, V8, P574, DOI 10.1111/j.1462-2920.2005.00922.x; Castaldi S, 2005, CHEMOSPHERE, V58, P131, DOI 10.1016/j.chemosphere.2004.08.023; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Dedysh SN, 2004, INT J SYST EVOL MICR, V54, P151, DOI 10.1099/ijs.0.02805-0; Dedysh SN, 1998, SCIENCE, V282, P281, DOI 10.1126/science.282.5387.281; Dedysh SN, 2000, INT J SYST EVOL MICR, V50, P955, DOI 10.1099/00207713-50-3-955; Dedysh SN, 2007, INT J SYST EVOL MICR, V57, P472, DOI 10.1099/ijs.0.64623-0; Dimitrov LI, 2002, EARTH-SCI REV, V59, P49, DOI 10.1016/S0012-8252(02)00069-7; Dunfield PF, 2002, FEMS MICROBIOL ECOL, V41, P17, DOI 10.1111/j.1574-6941.2002.tb00962.x; Etiope G, 2002, CHEMOSPHERE, V49, P777, DOI 10.1016/S0045-6535(02)00380-6; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; HOLMES AJ, 1995, FEMS MICROBIOL LETT, V132, P203, DOI 10.1016/0378-1097(95)00311-R; Houghton J, 2005, REP PROG PHYS, V68, P1343, DOI 10.1088/0034-4885/68/6/R02; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Stoecker K, 2006, P NATL ACAD SCI USA, V103, P2363, DOI 10.1073/pnas.0506361103; Trotsenko YA, 2002, ARCH MICROBIOL, V177, P123, DOI 10.1007/s00203-001-0368-0; Visser JM, 1997, ANTON LEEUW INT J G, V72, P127, DOI 10.1023/A:1000252126252; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; Ward N, 2004, PLOS BIOL, V2, P1616, DOI 10.1371/journal.pbio.0020303; Yimga MT, 2003, APPL ENVIRON MICROB, V69, P5593, DOI 10.1128/AEM.69.9.5593-5602.2003; [No title captured]	30	273	303	7	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					874	U17		10.1038/nature06222	http://dx.doi.org/10.1038/nature06222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18004305				2022-12-28	WOS:000251394900055
J	Weinert, T; Hopper, AK				Weinert, Ted; Hopper, Anita K.			tRNA traffic meets a cell-cycle checkpoint	CELL			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; PHOSPHORYLATION; ARREST; YEAST	The molecular pathways linking DNA-damage checkpoint proteins to cell-cycle progression remain largely unresolved. Findings by Ghavidel et al. (2007) reported in this issue suggest that tRNA trafficking and the transcription factor Gcn4 are key intermediates in the process by which yeast cells detect DNA damage and delay cell-cycle progression at the G1 to S phase transition.	[Weinert, Ted] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Hopper, Anita K.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University of Arizona; Ohio State University	Weinert, T (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Life Sci So 546, Tucson, AZ 85721 USA.	tweinert@email.arizona.edu; hopper.64@osu.edu						GHAVIDEL A, 2007, CELL; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Qiu HF, 2000, MOL CELL BIOL, V20, P2505, DOI 10.1128/MCB.20.7.2505-2516.2000; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; SIEDE W, 1993, P NATL ACAD SCI USA, V90, P7985, DOI 10.1073/pnas.90.17.7985; Wysocki R, 2006, NAT STRUCT MOL BIOL, V13, P908, DOI 10.1038/nsmb1139; Yoshihisa T, 2007, GENES CELLS, V12, P285, DOI 10.1111/j.1365-2443.2007.01056.x	9	8	9	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 30	2007	131	5					838	840		10.1016/j.cell.2007.11.014	http://dx.doi.org/10.1016/j.cell.2007.11.014			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045528	Bronze			2022-12-28	WOS:000251800900005
J	Young, TH; Lee, HS				Young, Ton-Ho; Lee, Herng-Sheng			A cobwebbing trabecular pattern	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cardinal Tien Hosp, Taipei 23137, Taiwan		Young, TH (corresponding author), Cardinal Tien Hosp, Taipei 23137, Taiwan.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					E24	E24		10.1056/NEJMicm066861	http://dx.doi.org/10.1056/NEJMicm066861			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	18046023				2022-12-28	WOS:000251176400011
J	Weber, DM; Chen, C; Niesvizky, R; Wang, M; Belch, A; Stadtmauer, EA; Siegel, D; Borrello, I; Rajkumar, SV; Chanan-Khan, AA; Lonial, S; Yu, ZN; Patin, J; Olesnyckyj, M; Zeldis, JB; Knight, RD				Weber, Donna M.; Chen, Christine; Niesvizky, Ruben; Wang, Michael; Belch, Andrew; Stadtmauer, Edward A.; Siegel, David; Borrello, Ivan; Rajkumar, S. Vincent; Chanan-Khan, Asher Alban; Lonial, Sagar; Yu, Zhinuan; Patin, John; Olesnyckyj, Marta; Zeldis, Jerome B.; Knight, Robert D.		Multiple Myeloma 009 Study	Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMBINATION THERAPY; DRUG-RESISTANCE; THALIDOMIDE; BORTEZOMIB; PHASE-2; CC-5013	Background Lenalidomide, an oral immunomodulatory drug that is similar to thalidomide but has a different safety profile, has clinical activity in relapsed or refractory multiple myeloma. Methods Patients in the United States and Canada who had received at least one previous therapy for multiple myeloma but who required additional treatment were randomly assigned to receive either 25 mg of lenalidomide or placebo on days 1 to 21 of a 28-day cycle. Both groups also received 40 mg of oral dexamethasone on days 1 to 4, 9 to 12, and 17 to 20 for the first four cycles. After the fourth cycle, 40 mg of dexamethasone was administered only on days 1 to 4. Safety, clinical response, time to progression, and overall survival were assessed. Results We assigned 177 patients to the lenalidomide group and 176 to the placebo group. Complete, near-complete, or partial responses occurred in 108 patients (61.0%) in the lenalidomide group and in 35 patients (19.9%) in the placebo group (P<0.001); complete responses occurred in 14.1% and 0.6%, respectively (P<0.001). The median time to progression was 11.1 months in the lenalidomide group and 4.7 months in the placebo group (P<0.001). Median overall survival times in the two groups were 29.6 months and 20.2 months, respectively (P<0.001). Grade 3 or 4 adverse events were reported in 85.3% of the lenalidomide group and in 73.1% of the placebo group; these events resulted in study discontinuation in 19.8% and 10.2%, respectively. Grade 3 or 4 neutropenia and venous thromboembolism were more common in the lenalidomide group than in the placebo group (41.2% vs. 4.6% and 14.7% vs. 3.4%, respectively; P<0.001 for both comparisons). Conclusions Lenalidomide plus dexamethasone is superior to placebo plus dexamethasone in patients with relapsed or refractory multiple myeloma. (ClinicalTrials.gov number, NCT00056160.) N Engl J Med 2007;357:2133-42.	Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; Weill Cornell Med Coll, New York, NY USA; Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA; Hackensack Univ, Med Ctr, Ctr Canc, Hackensack, NJ USA; Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA; Mayo Clin, Ctr Canc, Rochester, MN USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Emory Univ, Atlanta, GA 30322 USA; Celgene, Summit, NJ USA	University of Texas System; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Cornell University; University of Alberta; University of Pennsylvania; Hackensack University Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Mayo Clinic; Roswell Park Cancer Institute; Emory University; Bristol-Myers Squibb; Celgene Corporation	Weber, DM (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, 1515 Holcombe Blvd,Box 429, Houston, TX 77030 USA.	dmweber@mdanderson.org	Rajkumar, S. Vincent/AAV-1834-2021	Rajkumar, S. Vincent/0000-0002-5862-1833				American Cancer Society, 2005, CANC FACTS FIG 2005; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Hideshima T, 2000, BLOOD, V96, P2943, DOI 10.1182/blood.V96.9.2943; *NAT CANC I, COMM TOX CRIT V2 0 C; Rajkumar SV, 2007, J CLIN ONCOL, V25; Rajkumar SV, 2005, BLOOD, V106, P4050, DOI 10.1182/blood-2005-07-2817; Rajkumar SV, 2002, J CLIN ONCOL, V20, P4319, DOI 10.1200/JCO.2002.02.116; Richardson PG, 2006, BLOOD, V108, P3458, DOI 10.1182/blood-2006-04-015909; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Richardson PG, 2002, BLOOD, V100, P3063, DOI 10.1182/blood-2002-03-0996; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Singhal S, 2000, NEW ENGL J MED, V342, P364; Weber D, 2003, J CLIN ONCOL, V21, P16, DOI 10.1200/JCO.2003.03.139; Zangari M, 2001, BLOOD, V98, p775A; Zonder JA, 2006, BLOOD, V108, P403, DOI 10.1182/blood-2006-01-0154	16	984	1031	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2133	2142		10.1056/NEJMoa070596	http://dx.doi.org/10.1056/NEJMoa070596			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	18032763				2022-12-28	WOS:000251076500005
J	Halloy, J; Sempo, G; Caprari, G; Rivault, C; Asadpour, M; Tache, F; Said, I; Durier, V; Canonge, S; Ame, JM; Detrain, C; Correll, N; Martinoli, A; Mondada, F; Siegwart, R; Deneubourg, JL				Halloy, J.; Sempo, G.; Caprari, G.; Rivault, C.; Asadpour, M.; Tache, F.; Said, I.; Durier, V.; Canonge, S.; Ame, J. M.; Detrain, C.; Correll, N.; Martinoli, A.; Mondada, F.; Siegwart, R.; Deneubourg, J. L.			Social integration of robots into groups of cockroaches to control self-organized choices	SCIENCE			English	Article							DECISION-MAKING; AGGREGATION; INSECTA	Collective behavior based on self-organization has been shown in group-living animals from insects to vertebrates. These findings have stimulated engineers to investigate approaches for the coordination of autonomous multirobot systems based on self-organization. In this experimental study, we show collective decision-making by mixed groups of cockroaches and socially integrated autonomous robots, leading to shared shelter selection. Individuals, natural or artificial, are perceived as equivalent, and the collective decision emerges from nonlinear feedbacks based on local interactions. Even when in the minority, robots can modulate the collective decision-making process and produce a global pattern not observed in their absence. These results demonstrate the possibility of using intelligent autonomous devices to study and control self-organized behavioral patterns in group-living animals.	Univ Libre Bruxelles, Serv Ecol Sociale, B-1050 Brussels, Belgium; Univ Rennes 1, CNRS, UMR Ethol Evolut Ecol 6652, F-35042 Rennes, France; ETH, Swiss Fed Inst Technol, Autonomous Syst Lab, CH-8092 Zurich, Switzerland; Ecole Polytech Fed Lausanne, Swarm Intelligent Syst Grp, EPFL IC ISC GR MA, CH-1015 Lausanne, Switzerland; Ecole Polytech Fed Lausanne, Lab Syst Robot, EPFL STI IPR LSRO, CH-1015 Lausanne, Switzerland	Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Halloy, J (corresponding author), Univ Libre Bruxelles, Serv Ecol Sociale, CP231,Ave FD Roosevelt 50, B-1050 Brussels, Belgium.	jhalloy@ulb.ac.be	Siegwart, Roland/A-4495-2008; Mondada, Francesco/E-4279-2015	Siegwart, Roland/0000-0002-2760-7983; Mondada, Francesco/0000-0001-8641-8704; Halloy, Jose/0000-0003-1555-2484; Martinoli, Alcherio/0000-0002-5201-7862				Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; [Anonymous], 2014, PHEROMONES ANIMAL BE; Beni G, 2005, LECT NOTES COMPUT SC, V3342, P1; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; BROOKS RA, 1991, SCIENCE, V253, P1227, DOI 10.1126/science.253.5025.1227; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Butler Z, 2006, INT J ROBOT RES, V25, P485, DOI 10.1177/0278364906065375; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Caprari G, 2005, IEEE ROBOT AUTOM MAG, V12, P58, DOI 10.1109/MRA.2005.1458325; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; De Schutter G, 2001, ANN MATH ARTIF INTEL, V31, P223, DOI 10.1023/A:1016638723526; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; Fewell JH, 2003, SCIENCE, V301, P1867, DOI 10.1126/science.1088945; Ishii H, 2004, IEEE INT CONF ROBOT, P2758, DOI 10.1109/ROBOT.2004.1307478; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Jeanson R, 2004, ANIM BEHAV, V67, P531, DOI 10.1016/j.anbehav.2003.06.013; Martinoli A, 2004, INT J ROBOT RES, V23, P415, DOI 10.1177/0278364904042197; MICHELSEN A, 1992, BEHAV ECOL SOCIOBIOL, V30, P143, DOI 10.1007/BF00166696; Mondada F, 2004, AUTON ROBOT, V17, P193, DOI 10.1023/B:AURO.0000033972.50769.1c; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Patricelli GL, 2002, NATURE, V415, P279, DOI 10.1038/415279a; Said I, 2005, J INSECT PHYSIOL, V51, P1384, DOI 10.1016/j.jinsphys.2005.09.001; Said I, 2005, J INSECT PHYSIOL, V51, P995, DOI 10.1016/j.jinsphys.2005.04.017; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Vaughan R, 2000, ROBOT AUTON SYST, V31, P109, DOI 10.1016/S0921-8890(99)00084-6	27	339	343	8	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1155	1158		10.1126/science.1144259	http://dx.doi.org/10.1126/science.1144259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006751				2022-12-28	WOS:000250957900051
J	Nishimura, Y; Onoe, H; Morichika, Y; Perfiliev, S; Tsukada, H; Isa, T				Nishimura, Yukio; Onoe, Hirotaka; Morichika, Yosuke; Perfiliev, Sergei; Tsukada, Hideo; Isa, Tadashi			Time-dependent central compensatory mechanisms of finger dexterity after spinal cord injury	SCIENCE			English	Article							PRIMARY MOTOR CORTEX; DISYNAPTIC PYRAMIDAL EXCITATION; VENTRAL PREMOTOR CORTEX; PROPRIOSPINAL NEURONS; BRAIN-INJURY; FORELIMB MOTONEURONS; CORTICAL PLASTICITY; FUNCTIONAL RECOVERY; SUPPLEMENTARY MOTOR; MACAQUE MONKEY	Transection of the direct cortico-motoneuronal pathway at the mid-cervical segment of the spinal cord in the macaque monkey results in a transient impairment of finger movements. Finger dexterity recovers within a few months. Combined brain imaging and reversible pharmacological inactivation of motor cortical regions suggest that the recovery involves the bilateral primary motor cortex during the early recovery stage and more extensive regions of the contralesional primary motor cortex and bilateral premotor cortex during the late recovery stage. These changes in the activation pattern of frontal motor-related areas represent an adaptive strategy for functional compensation after spinal cord injury.	Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi 3320012, Japan; RIKEN, Mol Imaging Res Program, Funct Probe Res Lab, Kobe, Hyogo 6500047, Japan; Univ Gothenburg, Dept Physiol, SE-40530 Gothenburg, Sweden; Cent Res Inst Hamamatsu Photon, Hamamatsu, Shizuoka 4348601, Japan; Grad Univ Adv Studies SOKENDAI, Hayama 2400193, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); RIKEN; University of Gothenburg; Hamamatsu Photonics; Graduate University for Advanced Studies - Japan	Isa, T (corresponding author), Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan.	tisa@nips.ac.jp						Alstermark B, 1999, J NEUROPHYSIOL, V82, P3580, DOI 10.1152/jn.1999.82.6.3580; Buford JA, 2004, EXP BRAIN RES, V159, P284, DOI 10.1007/s00221-004-1956-4; Cerri G, 2003, J NEUROPHYSIOL, V90, P832, DOI 10.1152/jn.01026.2002; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Davidson AG, 2006, EXP BRAIN RES, V173, P25, DOI 10.1007/s00221-006-0374-1; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; GHOSH S, 1987, J COMP NEUROL, V259, P424, DOI 10.1002/cne.902590309; GOULD HJ, 1986, J COMP NEUROL, V247, P297, DOI 10.1002/cne.902470303; ILLERT M, 1978, EXP BRAIN RES, V33, P101; Isa T, 2006, J NEUROPHYSIOL, V95, P3674, DOI 10.1152/jn.00103.2005; Jankowska E, 2006, J PHYSIOL-LONDON, V575, P527, DOI 10.1113/jphysiol.2006.112425; Jankowska E, 2005, J NEUROSCI, V25, P7401, DOI 10.1523/JNEUROSCI.1838-05.2005; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Lacroix S, 2004, J COMP NEUROL, V473, P147, DOI 10.1002/cne.20051; MARTINO AM, 1987, BRAIN RES, V404, P307, DOI 10.1016/0006-8993(87)91384-9; Nair DG, 2007, NEUROIMAGE, V34, P253, DOI 10.1016/j.neuroimage.2006.09.010; Nishimura Y, 2007, NEUROSCI RES, V59, P243, DOI 10.1016/j.neures.2007.07.003; Nudo RJ, 1996, J NEUROSCI, V16, P785; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; ROUILLER EM, 1994, EXP BRAIN RES, V102, P227; Sasaki S, 2004, J NEUROPHYSIOL, V92, P3142, DOI 10.1152/jn.00342.2004; Schmidlin E, 2004, BRAIN RES, V1017, P172, DOI 10.1016/j.brainres.2004.05.036; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119	27	169	178	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1150	1155		10.1126/science.1147243	http://dx.doi.org/10.1126/science.1147243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006750				2022-12-28	WOS:000250957900050
J	Wiseman, RL; Powers, ET; Buxbaum, JN; Kelly, JW; Balch, WE				Wiseman, R. Luke; Powers, Evan T.; Buxbaum, Joel N.; Kelly, Jeffery W.; Balch, William E.			An adaptable standard for protein export from the endoplasmic reticulum	CELL			English	Article							MOLECULAR CHAPERONES; ER; SECRETION; ROLES; MODEL; CEREVISIAE; EXPRESSION; HSP90; CFTR; BIP	To provide an integrated view of endoplasmic reticulum (ER) function in protein export, we have described the interdependence of protein folding energetics and the adaptable biology of cellular protein folding and transport through the exocytic pathway. A simplified treatment of the protein homeostasis network and a formalism for how this network of competing pathways interprets protein folding kinetics and thermodynamics provides a framework for understanding cellular protein trafficking. We illustrate how folding and misfolding energetics, in concert with the adjustable biological capacities of the folding, degradation, and export pathways, collectively dictate an adaptable standard for protein export from the ER. A model of folding for export (FoldEx) establishes that no single feature dictates folding and transport efficiency. Instead, a network view provides insight into the basis for cellular diversity, disease origins, and protein homeostasis, and predicts strategies for restoring protein homeostasis in protein-misfolding diseases.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Dept Mol & Expt Med, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Kelly, JW (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jkelly@scripps.edu; webalch@scripps.edu		Powers, Evan/0000-0001-8185-8487; Wiseman, Luke/0000-0001-9287-6840	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046335, R01DK075295, R01DK051870, R37DK046335, R29DK046335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042336, R01GM033301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019259] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL06784] Funding Source: Medline; NIA NIH HHS [AG19259] Funding Source: Medline; NIDDK NIH HHS [DK46335, DK051870, DK075295] Funding Source: Medline; NIGMS NIH HHS [GM42336, GM33301] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Borth N, 2005, BIOTECHNOL PROGR, V21, P106, DOI 10.1021/bp0498241; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gonzalez R, 2002, J THEOR BIOL, V214, P529, DOI 10.1006/jtbi.2001.2478; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; Kumita JR, 2006, FEBS J, V273, P711, DOI 10.1111/j.1742-4658.2005.05099.x; Li MS, 2004, POLYMER, V45, P573, DOI 10.1016/j.polymer.2003.10.066; Loo Tip W., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000361; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Page LJ, 2005, EMBO J, V24, P4124, DOI 10.1038/sj.emboj.7600872; Perlmutter DH, 2006, PEDIATR RES, V60, P233, DOI 10.1203/01.pdr.0000228350.61496.90; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rakestraw A, 2006, BIOTECHNOL BIOENG, V93, P896, DOI 10.1002/bit.20780; Rieger TR, 2006, BIOPHYS J, V90, P886, DOI 10.1529/biophysj.105.066662; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Robinson AS, 1996, AICHE J, V42, P1443, DOI 10.1002/aic.690420525; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Shimizu Y, 2007, ADV EXP MED BIOL, V594, P37; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Xu P, 2005, METAB ENG, V7, P269, DOI 10.1016/j.ymben.2005.04.002; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	35	123	124	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					809	821		10.1016/j.cell.2007.10.025	http://dx.doi.org/10.1016/j.cell.2007.10.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022373	Bronze			2022-12-28	WOS:000250966300026
J	Durrheim, D				Durrheim, David			A clarion call for greater investment in global sanitation	LANCET			English	Editorial Material							DIARRHEA		Hunter New England Populat Hlth, Newcastle, NSW, Australia; James Cook Univ, Townsville, Qld 4814, Australia	James Cook University	Durrheim, D (corresponding author), Hunter New England Populat Hlth, Newcastle, NSW, Australia.	David.Durrheim@jcu.edu.au						[Anonymous], 2007, Wkly Epidemiol Rec, V82, P273; Barreto ML, 2007, LANCET, V370, P1622, DOI 10.1016/S0140-6736(07)61638-9; Durrheim D, 2004, LANCET, V363, P897, DOI 10.1016/S0140-6736(04)15748-6; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; United Nations, 2007, MILL DEV GOALS REP 2	6	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2007	370	9599					1592	1593		10.1016/S0140-6736(07)61668-7	http://dx.doi.org/10.1016/S0140-6736(07)61668-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230NO	17993346				2022-12-28	WOS:000250883400005
J	Kennedy, A; Rogers, A; Bower, P				Kennedy, Anne; Rogers, Anne; Bower, Peter			Support for self care for patients with chronic disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; COMPLEX INTERVENTIONS; ULCERATIVE-COLITIS; HEALTH-CARE; MANAGEMENT; FRAMEWORK; QUALITY		Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England	University of Manchester	Kennedy, A (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England.	anne.p.kennedy@manchester.ac.uk	Bower, Peter/A-1508-2011	Bower, Peter/0000-0001-9558-3349				Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Blakeman T, 2006, BRIT J GEN PRACT, V56, P407; BURY M, 2005, RAPID REV CURRENT ST; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Fairhurst K, 2006, ANN FAM MED, V4, P500, DOI 10.1370/afm.565; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; Griffiths C, 2007, BMJ-BRIT MED J, V334, P1254, DOI 10.1136/bmj.39227.698785.47; Howie JGR, 1996, BRIT J GEN PRACT, V46, P479; *IMPR CHRON CAR, SELF MAN SUPP; Kendall E, 2007, DISABIL SOC, V22, P129, DOI 10.1080/09687590601141535; Kennedy A, 2003, HEALTH SOC CARE COMM, V11, P64, DOI 10.1046/j.1365-2524.2003.00399.x; Kennedy AP, 2004, GUT, V53, P1639, DOI 10.1136/gut.2003.034256; May C, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-86; *NAT PRIM CAR RES, WISE APPR SELF MAN; Newbould J, 2006, CHRONIC ILLN, V2, P249, DOI 10.1179/174592006X157508; NORMAN P, 1996, PREDICTING HLTH BEHA, P197; Robinson A, 2006, GUT, V55, P643, DOI 10.1136/gut.2004.062901; Robinson A, 2001, LANCET, V358, P976, DOI 10.1016/S0140-6736(01)06105-0; Rogers A, 2005, QUAL HEALTH RES, V15, P224, DOI 10.1177/1049732304272048; SANDERS C, IN PRESS SOC SCI MED; UK Government, 2021, GP IT FUTURES SYSTEM; Wagner E H, 1998, Eff Clin Pract, V1, P2; Wagner EH, 2002, BMJ-BRIT MED J, V325, P913, DOI 10.1136/bmj.325.7370.913; Wanless, 2002, SECURING OUR FUTURE	24	199	199	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2007	335	7627					968	970		10.1136/bmj.39372.540903.94	http://dx.doi.org/10.1136/bmj.39372.540903.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	232AL	17991978	Green Published			2022-12-28	WOS:000250990400035
J	Magnussen, EB; Vatten, LJ; Lund-Nilsen, TI; Salvesen, KA; Smith, GD; Romundstad, PR				Magnussen, Elisabeth Balstad; Vatten, Lars Johan; Lund-Nilsen, Tom Ivar; Salvesen, Kjell Asmund; Smith, George Davey; Romundstad, Pal Richard			Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; LOW-DENSITY-LIPOPROTEIN; HYPERTENSIVE DISORDERS; HEART-DISEASE; PREGNANCY COMPLICATIONS; RETROSPECTIVE COHORT; CIGARETTE-SMOKING; FAMILY-HISTORY; WOMEN; CHOLESTEROL	Objective To examine the effect of cardiovascular risk factors before pregnancy on risk of pre-eclampsia. Design Population based prospective study. Setting Linkage between a Norwegian population based study (Nord-Trondelag health study, HUNT-2) and Norway's medical birth registry. Participants 3494 women who gave birth after participating in the Nord-Trondelag health study at baseline; of whom 133 (3.81%) delivered after a preeclamptic pregnancy. Main outcome measure Odds ratio of developing preeclampsia. Results After adjustment for smoking; previous preeclampsia; parity; maternal age, education, and socioeconomic position; and duration between baseline measurements and delivery, positive associations were found between prepregnancy serum levels of trigtycerides, cholesterol, low density lipoprotein cholesterol, non-high density lipoprotein cholesterol, and blood pressure and risk of pre-eclampsia. The odds ratio of developing preectampsia for women with baseline systolic blood pressures greater than 130 mm fig (highest fifth) was 7.3 (95% confidence interval 3.1 to 17.2) compared with women with systolic blood pressures less than 111 mm Hg (lowest fifth). Similar results were found for nulliparous and parous women. Women who used oral contraceptives at baseline had half the risk of pre-eclampsia compared with never or former users (0.5, 0.3 to 0.9). Conclusion Women with cardiovascular risk factors may be predisposed to pre-eclampsia.	Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7489 Trondheim, Norway; Trondheim Univ Hosp St Olav, Dept Obstet, Trondheim, Norway; Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England	Norwegian University of Science & Technology (NTNU); University of Bristol	Magnussen, EB (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7489 Trondheim, Norway.	elisabeth.b.magnussen@ntnu.no	Vatten, Lars/AFK-2073-2022; Davey Smith, George/A-7407-2013; Vatten, Lars/AAF-9380-2022	Davey Smith, George/0000-0002-1407-8314; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Romundstad, Pal Richard/0000-0003-2061-4336; s, hema/0000-0002-3440-9475				Bainbridge SA, 2005, MED HYPOTHESES, V64, P17, DOI 10.1016/j.mehy.2004.06.019; Beste LA, 2005, PAEDIATR PERINAT EP, V19, P12, DOI 10.1111/j.1365-3016.2004.00617.x; Bodnar LM, 2007, EPIDEMIOLOGY, V18, P234, DOI 10.1097/01.ede.0000254119.99660.e7; Clausen T, 2001, BRIT J OBSTET GYNAEC, V108, P1081, DOI 10.1016/S0306-5456(01)00247-9; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Craig SR, 2000, J GEN INTERN MED, V15, P395, DOI 10.1046/j.1525-1497.2000.03509.x; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; GOODE GK, 1995, LANCET, V345, P362, DOI 10.1016/S0140-6736(95)90345-3; Holmen JM K., 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI [10.5324/nje.v13i1.305, DOI 10.1093/eurheartj/eht019]; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; KLONOFFCOHEN HS, 1989, JAMA-J AM MED ASSOC, V262, P3143, DOI 10.1001/jama.262.22.3143; Ness RB, 2004, HYPERTENS PREGNANCY, V23, P227, DOI 10.1081/PRG-200030293; Ness RB, 2003, OBSTET GYNECOL, V102, P1366, DOI 10.1016/j.obstetgynecol.2003.08.011; Ness RB, 2006, AM J OBSTET GYNECOL, V195, P40, DOI 10.1016/j.ajog.2005.07.049; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Packard Chris J, 2004, J Atheroscler Thromb, V11, P6; PIJNENBORG R, 1991, BRIT J OBSTET GYNAEC, V98, P648, DOI 10.1111/j.1471-0528.1991.tb13450.x; Qiu CF, 2003, HYPERTENSION, V41, P408, DOI 10.1161/01.HYP.0000056996.25503.F5; Ray JG, 2006, BJOG-INT J OBSTET GY, V113, P379, DOI 10.1111/j.1471-0528.2006.00889.x; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Rodie VA, 2004, ATHEROSCLEROSIS, V175, P189, DOI 10.1016/j.atherosclerosis.2004.01.038; Salafia C, 1999, PLACENTA, V20, P273, DOI 10.1053/plac.1998.0378; Sattar N, 1997, J CLIN ENDOCR METAB, V82, P2483, DOI 10.1210/jc.82.8.2483; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; Sattar N, 1997, OBSTET GYNECOL, V89, P403, DOI 10.1016/S0029-7844(96)00514-5; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Thadhani R, 1999, OBSTET GYNECOL, V94, P543, DOI 10.1016/S0029-7844(99)00400-7; Thadhani R, 1999, CONTRACEPTION, V60, P145, DOI 10.1016/S0010-7824(99)00079-7; Vatten LJ, 2004, BJOG-INT J OBSTET GY, V111, P298, DOI 10.1111/j.1471-0528.2004.00071.x; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; Wolf M, 2002, J CLIN ENDOCR METAB, V87, P1563, DOI 10.1210/jc.87.4.1563	38	256	269	3	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 10	2007	335	7627					978	981		10.1136/bmj.39366.416817.BE	http://dx.doi.org/10.1136/bmj.39366.416817.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232AL	17975256	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000250990400043
J	Ferme, C; Eghbali, H; Meerwaldt, JH; Rieux, C; Bosq, J; Berger, F; Girinsky, T; Brice, P; van't Veer, MB; Walewski, JA; Lederlin, P; Tirelli, U; Carde, P; Van den Neste, E; Gyan, E; Monconduit, M; Divine, M; Raemaekers, JMM; Salles, G; Noordijk, EM; Creemers, G; Gabarre, J; Hagenbeek, A; Reman, O; Blanc, M; Thomas, J; Vie, B; Kluin-Nelemans, JC; Viseu, F; Baars, JW; Poortmans, P; Lugtenburg, PJ; Carrie, C; Jaubert, J; Henry-Amar, M				Ferme, Christophe; Eghbali, Houchingue; Meerwaldt, Jacobus H.; Rieux, Chantal; Bosq, Jacques; Berger, Francoise; Girinsky, Theodore; Brice, Pauline; van't Veer, Mars B.; Walewski, Jan A.; Lederlin, Pierre; Tirelli, Umberto; Carde, Patrice; Van den Neste, Eric; Gyan, Emmanuel; Monconduit, Mathieu; Divine, Marine; Raemaekers, John M. M.; Salles, Gilles; Noordijk, Evert M.; Creemers, Geert-Jan; Gabarre, Jean; Hagenbeek, Anton; Reman, Oumedaly; Blanc, Michel; Thomas, Jose; Vie, Brigitte; Kluin-Nelemans, Johanna C.; Viseu, Fernando; Baars, Joke W.; Poortmans, Philip; Lugtenburg, Pieternella J.; Carrie, Christian; Jaubert, Jerome; Henry-Amar, Michel		EORTC-GELA H8 Trial	Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ABVD CHEMOTHERAPY; CLINICAL-TRIALS; RADIOTHERAPY; VINBLASTINE; DOXORUBICIN; LYMPHOMA; THERAPY; CYCLES; BLEOMYCIN	Background Treatment of early-stage Hodgkin's disease is usually tailored in line with prognostic factors that allow for reductions in the amount of chemotherapy and extent of radiotherapy required for a possible cure. Methods From 1993 to 1999, we identified 1538 patients (age, 15 to 70 years) who had untreated stage I or II supradiaphragmatic Hodgkin's disease with favorable prognostic features (the H8-F trial) or unfavorable features (the H8-U trial). In the H8-F trial, we compared three cycles of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) combined with doxorubicin, bleomycin, and vinblastine (ABV) plus involved-field radiotherapy with subtotal nodal radiotherapy alone (reference group). In the H8-U trial, we compared three regimens: six cycles of MOPP-ABV plus involved-field radiotherapy (reference group), four cycles of MOPP-ABV plus involved-field radiotherapy, and four cycles of MOPP-ABV plus subtotal nodal radiotherapy. Results The median follow-up was 92 months. In the H8-F trial, the estimated 5-year event-free survival rate was significantly higher after three cycles of MOPP-ABV plus involved-field radiotherapy than after subtotal nodal radiotherapy alone (98% vs. 74%, P<0.001). The 10-year overall survival estimates were 97% and 92%, respectively (P=0.001). In the H8-U trial, the estimated 5-year event-free survival rates were similar in the three treatment groups: 84% after six cycles of MOPP-ABV plus involved-field radiotherapy, 88% after four cycles of MOPP-ABV plus involved-field radiotherapy, and 87% after four cycles of MOPP-ABV plus subtotal nodal radiotherapy. The 10-year overall survival estimates were 88%, 85%, and 84%, respectively. Conclusions Chemotherapy plus involved-field radiotherapy should be the standard treatment for Hodgkin's disease with favorable prognostic features. In patients with unfavorable features, four courses of chemotherapy plus invoved-field radiotherapy should be the standard treatment.	Inst Cancerol Gustave Roussy, Dept Med, F-94805 Villejuif, France; Inst Bergonie, Bordeaux, France; Med Spectrum Twente, Enschede, Netherlands; Ctr Francois Baclesse, F-14021 Caen, France; Univ Lyon 1, Hospices Civils Lyon, F-69365 Lyon, France; CHU St Louis, Paris, France; Dr Daniel Denhoed Canc Ctr, Rotterdam, Netherlands; Marie Sklodowska Curie Mem Inst, Ctr Oncol, Warsaw, Poland; CHU Brabois, Nancy, France; Ctr Riferimento Oncol, I-33081 Aviano, Italy; Clin Univ St Luc, B-1200 Brussels, Belgium; CHU Cochin, Paris, France; Ctr Henri Becquerel, F-76038 Rouen, France; CHU Henri Mondor, F-94010 Creteil, France; Radoubd Univ Med Ctr Nijmegen, Nijmegen, Netherlands; Leiden Univ, Med Ctr, Leiden, Netherlands; Catharina Hosp, Eindhoven, Netherlands; CHU Pitie Salpetriere, Paris, France; Univ Med Ctr Utrecht, Utrecht, Netherlands; Ctr Hosp Univ, Caen, France; Ctr Hosp Univ, Chambery, France; Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; Inst Portugues Oncol Francisco Gentil, Oporto, Portugal; Netherlands Canc Inst, Amsterdam, Netherlands; St Ignatius Hosp, Breda, Netherlands; Erasmus MC, Rotterdam, Netherlands; Ctr Leon Berard, F-69373 Lyon, France; Ctr Hosp Univ, St Etienne, France	UNICANCER; Gustave Roussy; UNICANCER; Institut Bergonie; Medical Spectrum Twente; UNICANCER; Centre Francois Baclesse; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Maria Sklodowska-Curie National Research Institute of Oncology; CHU de Nancy; IRCCS Aviano (CRO); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Henri Becquerel; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Catharina Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Utrecht University; Utrecht University Medical Center; CHU de Caen NORMANDIE; KU Leuven; University Hospital Leuven; Portuguese Institute of Oncology; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; UNICANCER; Centre Leon Berard; CHU de St Etienne	Ferme, C (corresponding author), Inst Cancerol Gustave Roussy, Dept Med, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	christophe.ferme@igr.fr	AMSELLEM, Sophie/B-3645-2012; Walewski, Jan/ABC-9523-2020; Henry-Amar, Michel/S-9358-2019; Subbiah, Vivek/O-3347-2019; Salles, Gilles/Z-2336-2019; Poortmans, P.M.P./L-4581-2015; Kluin-Nelemans, Johanna C/F-8658-2018	Subbiah, Vivek/0000-0002-6064-6837; Salles, Gilles/0000-0002-9541-8666; Kluin-Nelemans, Johanna C/0000-0003-2617-9427; GYAN, Emmanuel/0000-0002-7651-9189; Walewski, Jan/0000-0003-4247-2674; Henry-Amar, Michel/0000-0002-9357-6476				Anselmo AP, 2004, ANTICANCER RES, V24, P4045; Bonadonna G, 2004, J CLIN ONCOL, V22, P2835, DOI 10.1200/JCO.2004.12.170; *CYT SOFTW, 2004, STATXACT STAT SOFTW; DIEHL V, 2004, BLOOD, V104, P1307; Eghbali H, 2005, EUR J HAEMATOL, V75, P135, DOI 10.1111/j.1600-0609.2005.00467.x; Engert A, 2003, J CLIN ONCOL, V21, P3601, DOI 10.1200/JCO.2003.03.023; Engert A, 2007, J CLIN ONCOL, V25, P3495, DOI 10.1200/JCO.2006.07.0482; HERSON J, 1979, BIOMETRICS, V35, P775, DOI 10.2307/2530109; KLIMO P, 1988, SEMIN HEMATOL, V25, P34; Laskar S, 2004, J CLIN ONCOL, V22, P62, DOI 10.1200/JCO.2004.01.021; LEE CKK, 1980, CANCER-AM CANCER SOC, V46, P2403, DOI 10.1002/1097-0142(19801201)46:11<2403::AID-CNCR2820461116>3.0.CO;2-9; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; Meyer RM, 2005, J CLIN ONCOL, V23, P4634, DOI 10.1200/JCO.2005.09.085; Nachman JB, 2002, J CLIN ONCOL, V20, P3765, DOI 10.1200/JCO.2002.12.007; Ng AK, 2002, BLOOD, V100, P1989, DOI 10.1182/blood-2002-02-0634; Noordijk EM, 2006, J CLIN ONCOL, V24, P3128, DOI 10.1200/JCO.2005.05.2746; Press OW, 2001, J CLIN ONCOL, V19, P4238, DOI 10.1200/JCO.2001.19.22.4238; Rothman KJ., 1982, EPIDEMIOLOGIC ANAL P; *STAT, 2004, STAT STAT SOFTW REL; Straus DJ, 2004, BLOOD, V104, P3483, DOI 10.1182/blood-2004-04-1311; SUTCLIFFE SB, 1990, J CLIN ONCOL, V8, P1598; Yahalom J, 2005, EUR J HAEMATOL, V75, P90, DOI 10.1111/j.1600-0609.2005.00461.x	22	298	307	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1916	1927		10.1056/NEJMoa064601	http://dx.doi.org/10.1056/NEJMoa064601			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989384				2022-12-28	WOS:000250732500006
J	Miller, SP; McQuillen, PS; Hamrick, S; Xu, D; Glidden, DV; Charlton, N; Karl, T; Azakie, A; Ferriero, DM; Barkovich, AJ; Vigneron, DB				Miller, Steven P.; McQuillen, Patrick S.; Hamrick, Shannon; Xu, Duan; Glidden, David V.; Charlton, Natalie; Karl, Tom; Azakie, Anthony; Ferriero, Donna M.; Barkovich, A. James; Vigneron, Daniel B.			Abnormal brain development in newborns with congenital heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WHITE-MATTER DEVELOPMENT; CEREBRAL-BLOOD-FLOW; CIRCULATORY ARREST; PREMATURE NEWBORNS; MR SPECTROSCOPY; WATER DIFFUSION; ARTERIAL SWITCH; YOUNG-CHILDREN; INJURY; TRANSPOSITION	Background Congenital heart disease in newborns is associated with global impairment in development. We characterized brain metabolism and microstructure, as measures of brain maturation, in newborns with congenital heart disease before they underwent heart surgery. Methods We studied 41 term newborns with congenital heart disease - 29 who had transposition of the great arteries and 12 who had single-ventricle physiology - with the use of magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and diffusion tensor imaging (DTI) before cardiac surgery. We calculated the ratio of N-acetylaspartate to choline (which increases with brain maturation), the ratio of lactate to choline (which decreases with maturation), average diffusivity (which decreases with maturation), and fractional anisotropy of white-matter tracts (which increases with maturation). We compared these findings with those in 16 control newborns of a similar gestational age. Results As compared with control newborns, those with congenital heart disease had a decrease of 10% in the ratio of N-acetylaspartate to choline (P=0.003), an increase of 28% in the ratio of lactate to choline (P=0.08), an increase of 4% in average diffusivity (P<0.001), and a decrease of 12% in white-matter fractional anisotropy (P<0.001). Preoperative brain injury, as seen on MRI, was not significantly associated with findings on MRS or DTI. White-matter injury was observed in 13 newborns with congenital heart disease (32%) and in no control newborns. Conclusions Term newborns with congenital heart disease have widespread brain abnormalities before they undergo cardiac surgery. The imaging findings in such newborns are similar to those in premature newborns and may reflect abnormal brain development in utero.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of British Columbia; Emory University	Miller, SP (corresponding author), British Columbia Childrens Hosp, Div Neurol, K3-180,4480 Oak St, Vancouver, BC V6H 3V4, Canada.	smiller6@cw.bc.ca	McQuillen, Patrick/AAF-7119-2020; Glidden, David/AAD-4730-2020; Xu, Duan/B-3197-2013; Xu, Duan/GMW-4195-2022	Xu, Duan/0000-0003-0550-4235; Glidden, David/0000-0001-5888-1419; McQuillen, Patrick/0000-0002-8837-364X; Miller, Steven/0000-0001-9102-9105	NCRR NIH HHS [5-M01-RR-01271] Funding Source: Medline; NINDS NIH HHS [P50 NS35902, R01 NS40117] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS035902, R01NS040117] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Bartha AL, 2007, AM J NEURORADIOL, V28, P1015, DOI 10.3174/ajnr.A0521; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bellinger DC, 2003, J THORAC CARDIOV SUR, V126, P1385, DOI 10.1016/S0022-5223(03)00711-6; BELLINGER DC, 1995, NEW ENGL J MED, V332, P549, DOI 10.1056/NEJM199503023320901; Bland JM, 1996, BRIT MED J, V312, P700; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; deIpolyi AR, 2005, NEUROIMAGE, V27, P579, DOI 10.1016/j.neuroimage.2005.04.027; Donofrio MT, 2003, PEDIATR CARDIOL, V24, P436, DOI 10.1007/s00246-002-0404-0; Drobyshevsky A, 2005, J NEUROSCI, V25, P5988, DOI 10.1523/JNEUROSCI.4983-04.2005; DUMOULIN CL, 2002, MAGN RESON ENG, V15, P117; Galli KK, 2004, J THORAC CARDIOV SUR, V127, P692, DOI 10.1016/j.jtcvs.2003.09.053; GILLES FH, 1973, J NEUROPATH EXP NEUR, V32, P179; GLAUSER TA, 1990, PEDIATRICS, V85, P984; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hovels-Gurich HH, 2002, ARCH DIS CHILD, V87, P506, DOI 10.1136/adc.87.6.506; Jouannic JM, 2002, ULTRASOUND OBST GYN, V20, P122, DOI 10.1046/j.1469-0705.2002.00756.x; Karl TR, 2004, J THORAC CARDIOV SUR, V127, P213, DOI 10.1016/j.jtcvs.2003.06.001; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kinney HC, 2005, ACTA NEUROPATHOL, V110, P563, DOI 10.1007/s00401-005-1077-6; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; Limperopoulos C, 2002, J PEDIATR-US, V141, P51, DOI 10.1067/mpd.2002.125227; Limperopoulos C, 2001, PEDIATRICS, V108, P1325, DOI 10.1542/peds.108.6.1325; Mahle WT, 2002, CIRCULATION, V106, pI109, DOI 10.1161/01.cir.0000032908.33237.b1; Marshall AC, 2005, J PEDIATR-US, V147, P535, DOI 10.1016/j.jpeds.2005.04.055; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; McQuillen PS, 2007, STROKE, V38, P736, DOI 10.1161/01.STR.0000247941.41234.90; McQuillen PS, 2006, CIRCULATION, V113, P280, DOI 10.1161/CIRCULATIONAHA.105.566752; McQuillen PS, 2003, J NEUROSCI, V23, P3308; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Miller SP, 2005, J PEDIATR-US, V146, P453, DOI 10.1016/j.jpeds.2004.12.026; Miller SP, 2004, ANN THORAC SURG, V77, P1698, DOI 10.1016/j.athoracsur.2003.10.084; Miller SP, 2002, J MAGN RESON IMAGING, V16, P621, DOI 10.1002/jmri.10205; Miller SP, 2002, PEDIATR RES, V52, P71, DOI 10.1203/00006450-200207000-00014; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Partridge SC, 2006, ANN NEUROL, V59, P640, DOI 10.1002/ana.20772; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimage.2004.02.038; Prayer D, 2001, AM J NEURORADIOL, V22, P1572; RICHARDSON DK, 1993, PEDIATRICS, V91, P969; Riddle A, 2006, J NEUROSCI, V26, P3045, DOI 10.1523/JNEUROSCI.5200-05.2006; Rudolph AM, 2001, CONGENITAL DIS HEART, V2nd; Star-Lack J, 1998, J MAGN RESON, V133, P243, DOI 10.1006/jmre.1998.1458; Vigneron DB, 2006, NEUROIMAG CLIN N AM, V16, P75, DOI 10.1016/j.nic.2005.11.008; Vigneron DB, 2001, AM J NEURORADIOL, V22, P1424; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; ZEGER SL, 1989, BIOMETRICS, V45, P347; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	50	540	555	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1928	1938		10.1056/NEJMoa067393	http://dx.doi.org/10.1056/NEJMoa067393			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989385				2022-12-28	WOS:000250732500007
J	Partridge, L; Gems, D				Partridge, Linda; Gems, David			Benchmarks for ageing studies	NATURE			English	Editorial Material							LIFE-SPAN; DROSOPHILA-MELANOGASTER; EXTEND LIFE		UCL, Dept Biol, Ctr Res Ageing, London WC1E 6BT, England	University of London; University College London	Partridge, L (corresponding author), UCL, Dept Biol, Ctr Res Ageing, Darwin Bldg,Gower St, London WC1E 6BT, England.		Partridge, Linda/A-5501-2010; Partridge, Linda/E-7342-2015	Partridge, Linda/0000-0001-9615-0094; Gems, David/0000-0002-6653-4676				Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 2000, J GERONTOL A-BIOL, V55, pB215, DOI 10.1093/gerona/55.5.B215; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Miller RA, 2000, J GERONTOL A-BIOL, V55, pB117, DOI 10.1093/gerona/55.3.B117; Miller RA, 2002, EXP BIOL MED, V227, P500, DOI 10.1177/153537020222700715; Orr WC, 2003, EXP GERONTOL, V38, P227, DOI 10.1016/S0531-5565(02)00263-2; Piper M. D. W., 2005, DRUG DISCOV TODAY DI, V2, P249; Sgro CM, 2000, AM NAT, V156, P341, DOI 10.1086/303394; Smith ED, 2007, MECH AGEING DEV, V128, P106, DOI 10.1016/j.mad.2006.11.017; Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095	14	87	87	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					165	167		10.1038/450165a	http://dx.doi.org/10.1038/450165a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994065				2022-12-28	WOS:000250746200021
J	Pronovost, PJ; Berenholtz, SM; Needham, DM				Pronovost, Peter J.; Berenholtz, Sean M.; Needham, Dale M.			A framework for health care organizations to develop and evaluate a safety scorecard	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HOSPITAL QUALITY; PATIENT		Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pulm & Crit Care Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Pronovost, PJ (corresponding author), Johns Hopkins Med Inst, 1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu						Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; Detsky AS, 2007, JAMA-J AM MED ASSOC, V298, P221, DOI 10.1001/jama.298.2.221; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; McAlister FA, 2000, JAMA-J AM MED ASSOC, V283, P2829, DOI 10.1001/jama.283.21.2829; McGlynn EA, 2003, MED CARE, V41, pI39; Pronovost PJ, 2006, JAMA-J AM MED ASSOC, V296, P696, DOI 10.1001/jama.296.6.696; Rabe-Hesketh S.S.A., 2005, MULTILEVEL LONGITUDI; Skrondal A., 2004, GEN LATENT VARIABLE; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Zelman William N, 2003, J Health Care Finance, V29, P1; Zhan CL, 2007, JT COMM J QUAL PATIE, V33, P326, DOI 10.1016/S1553-7250(07)33037-7	11	15	15	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2007	298	17					2063	2065		10.1001/jama.298.17.2063	http://dx.doi.org/10.1001/jama.298.17.2063			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228GP	17986702				2022-12-28	WOS:000250718200029
J	Beshai, JF; Grimm, RA; Nagueh, SF; Baker, JH; Beau, SL; Greenberg, SM; Pires, LA; Tchou, PJ				Beshai, John F.; Grimm, Richard A.; Nagueh, Sherif F.; Baker, James H., II; Beau, Scott L.; Greenberg, Steven M.; Pires, Luis A.; Tchou, Patrick J.		RethinQ Study Investigators	Cardiac-resynchronization therapy in heart failure with narrow QRS complexes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAVENTRICULAR-CONDUCTION DELAY; BIVENTRICULAR PACING THERAPY; DYSSYNCHRONY; ASYNCHRONY; DURATION; ECHOCARDIOGRAPHY; IMPACT; ICD	Background: Indications for cardiac-resynchronization therapy (CRT) in patients with heart failure include a prolonged QRS interval (>= 120 msec), in addition to other functional criteria. Some patients with narrow QRS complexes have echocardiographic evidence of left ventricular mechanical dyssynchrony and may also benefit from CRT. Methods: We enrolled 172 patients who had a standard indication for an implantable cardioverter-defibrillator. Patients received the CRT device and were randomly assigned to the CRT group or to a control group (no CRT) for 6 months. The primary end point was the proportion of patients with an increase in peak oxygen consumption of at least 1.0 ml per kilogram of body weight per minute during cardiopulmonary exercise testing at 6 months. Results: At 6 months, the CRT group and the control group did not differ significantly in the proportion of patients with the primary end point (46% and 41%, respectively). In a prespecified subgroup with a QRS interval of 120 msec or more, the peak oxygen consumption increased in the CRT group (P=0.02), but it was unchanged in a subgroup with a QRS interval of less than 120 msec (P=0.45). There were 24 heart-failure events requiring intravenous therapy in 14 patients in the CRT group (16.1%) and 41 events in 19 patients in the control group (22.3%), but the difference was not significant. Conclusions: CRT did not improve peak oxygen consumption in patients with moderate-to-severe heart failure, providing evidence that patients with heart failure and narrow QRS intervals may not benefit from CRT. (ClinicalTrials.gov number, NCT00132977.).	Univ Chicago, Med Ctr, Chicago, IL 60637 USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Methodist Hosp, Houston, TX 77030 USA; St Thomas Hosp, Nashville, TN USA; Arkansas Heart Hosp, Little Rock, AR USA; St Francis Hosp, Roslyn, NY USA; St John Hosp & Med Ctr, Detroit, MI USA	University of Chicago; University of Chicago Medical Center; Cleveland Clinic Foundation; The Methodist Hospital System; The Methodist Hospital - Houston; Saint Thomas Hospital; St. John Hospital & Medical Center	Beshai, JF (corresponding author), Univ Chicago, Med Ctr, 5758 S Maryland Ave,MC 9024, Chicago, IL 60637 USA.		Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789				Abraham WT, 2003, CIRCULATION, V108, P2596, DOI 10.1161/01.CIR.0000096580.26969.9A; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Achilli A, 2003, J AM COLL CARDIOL, V42, P2117, DOI 10.1016/j.jacc.2003.08.024; Bax JJ, 2003, AM J CARDIOL, V92, P1238, DOI 10.1016/j.amjcard.2003.06.016; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1834, DOI 10.1016/j.jacc.2004.08.016; Beshai JF, 2007, J INTERV CARD ELECTR, V19, P149, DOI 10.1007/s10840-007-9156-3; Bleeker GB, 2006, J AM COLL CARDIOL, V48, P2243, DOI 10.1016/j.jacc.2006.07.067; Bradley DJ, 2003, JAMA-J AM MED ASSOC, V289, P730, DOI 10.1001/jama.289.6.730; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Butter C, 2001, CIRCULATION, V104, P3026, DOI 10.1161/hc5001.102229; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Ghio S, 2004, EUR HEART J, V25, P571, DOI 10.1016/j.ehj.2003.09.030; GRUPTA SN, 2003, INDIAN HEART J, V55, P619; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Hahn, 1991, STAT INTERVALS GUIDE, P82; Higgins SL, 2003, J AM COLL CARDIOL, V42, P1454, DOI 10.1016/S0735-1097(03)01042-8; Leclercq C, 2002, J AM COLL CARDIOL, V39, P194, DOI 10.1016/S0735-1097(01)01747-8; McSwain RL, 2005, J CARDIOVASC ELECTR, V16, P1168, DOI 10.1111/j.1540-8167.2005.40719.x; NAIR VN, 1984, TECHNOMETRICS, V26, P265, DOI 10.2307/1267553; Pitzalis MV, 2002, J AM COLL CARDIOL, V40, P1615, DOI 10.1016/S0735-1097(02)02337-9; Rector TS, 1987, HEART FAIL, V3, P198; Shen AYJ, 2004, AM J CARDIOL, V94, P673, DOI 10.1016/j.amjcard.2004.05.042; Turner MS, 2004, CIRCULATION, V109, P2544, DOI 10.1161/01.CIR.0000131184.40893.40; Wasserman K, 2005, PRINCIPLES EXERCISE; Westfall PH, 2001, J STAT PLAN INFER, V99, P25, DOI 10.1016/S0378-3758(01)00077-5; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; Yu CM, 2006, J AM COLL CARDIOL, V48, P2251, DOI 10.1016/j.jacc.2006.07.054; Yu CM, 2003, PACE, V26, P562, DOI 10.1046/j.1460-9592.2003.00095.x; Yu CM, 2002, CIRCULATION, V105, P438, DOI 10.1161/hc0402.102623; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	31	482	518	2	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2007	357	24					2461	2471		10.1056/NEJMoa0706695	http://dx.doi.org/10.1056/NEJMoa0706695			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240CK	17986493	Bronze			2022-12-28	WOS:000251564400007
J	Takahashi, K; Tanabe, K; Ohnuki, M; Narita, M; Ichisaka, T; Tomoda, K; Yamanaka, S				Takahashi, Kazutoshi; Tanabe, Koji; Ohnuki, Mari; Narita, Megumi; Ichisaka, Tomoko; Tomoda, Kiichiro; Yamanaka, Shinya			Induction of pluripotent stem cells from adult human fibroblasts by defined factors	CELL			English	Article							SELF-RENEWAL; HUMAN BLASTOCYSTS; MOUSE EMBRYOS; ES CELLS; LINES; DIFFERENTIATION; ACTIVATION; STAT3; GENERATION; MAINTAIN	Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells. We previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors. Here, we demonstrate the generation of iPS cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc. Human iPS cells were similar to human embryonic stem (ES) cells in morphology, proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity. Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas. These findings demonstrate that iPS cells can be generated from adult human fibroblasts.	[Takahashi, Kazutoshi; Tanabe, Koji; Ohnuki, Mari; Narita, Megumi; Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan; [Narita, Megumi; Ichisaka, Tomoko; Yamanaka, Shinya] Japan Sci & Technol Agncy, CREST, Kawagoe, Saitama 3320012, Japan; [Tomoda, Kiichiro; Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Yamanaka, Shinya] Kyoto Univ, Inst Integrat Cell Mat Sci, Kyoto 6068507, Japan	Kyoto University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes; Kyoto University	Yamanaka, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp	Takahashi, Kazutoshi/ABE-5504-2020; Wilson, Matthew H/K-3193-2013	Takahashi, Kazutoshi/0000-0002-5329-8395; 				Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; EVANS PM, 2007, J BIOL CHEM, DOI DOI 10.1074/JBC.M701847200; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Sumi T, 2007, ONCOGENE, V26, P5564, DOI 10.1038/sj.onc.1210353; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	30	13442	14889	70	3348	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 30	2007	131	5					861	872		10.1016/j.cell.2007.11.019	http://dx.doi.org/10.1016/j.cell.2007.11.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18035408	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000251800900010
J	Mackey, DC; Lui, LY; Cawthon, PM; Bauer, DC; Nevitt, MC; Cauley, JA; Hillier, TA; Lewis, CE; Barrett-Connor, E; Cummings, SR				Mackey, Dawn C.; Lui, Li-Yung; Cawthon, Peggy M.; Bauer, Douglas C.; Nevitt, Michael C.; Cauley, Jane A.; Hillier, Teresa A.; Lewis, Cora E.; Barrett-Connor, Elizabeth; Cummings, Steven R.		SOF Res Grp; MrOS Res Grp	High-trauma fractures and low bone mineral density in older women and men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OSTEOPOROTIC FRACTURES; HIP FRACTURE; POSTMENOPAUSAL WOMEN; NONVERTEBRAL FRACTURES; SUBSEQUENT FRACTURE; FRAGILITY FRACTURES; RISK-FACTORS; EPIDEMIOLOGY; PREDICTORS; COMMUNITY	Context It is widely believed that fractures resulting from high trauma are not osteoporotic; however, this assumption has not been studied prospectively. Objective To examine the association between bone mineral density (BMD) and high-trauma fracture and between high-trauma fracture and subsequent fracture in older women and men. Design, Setting, and Participants Two prospective US cohort studies in community-dwelling adults 65 years or older from geographically diverse sites. The Study of Osteoporotic Fractures followed up 8022 women for 9.1 years (1988-2006). The Osteoporotic Fractures in Men Study followed up 5995 men for 5.1 years (2000-2007). Main Outcome Measures Hip and spine BMD were assessed by dual-energy x-ray absorptiometry. Incident nonspine fractures were confirmed by radiographic report. Fractures were classified, without knowledge of BMD, as high trauma (due to motor vehicle crashes and falls from greater than standing height) or as low trauma (due to falls from standing height and less severe trauma). Results Overall, 264 women and 94 men sustained an initial high-trauma fracture and 3211 women and 346 men sustained an initial low-trauma fracture. For women, each 1-SD reduction in total hip BMD was similarly associated with an increased risk of high-trauma fracture (multivariate relative hazard [RH], 1.45; 95% confidence interval [CI], 1.23-1.72) and low-trauma fracture (RH, 1.49; 95% CI, 1.42-1.57). Results were consistent in men ( high-trauma fracture RH, 1.54; 95% CI, 1.20-1.96; low-trauma fracture RH, 1.69; 95% CI, 1.49-1.91). Risk of subsequent fracture was 34%( 95% Cl, 7%-67%) greater among women with an initial high-trauma fracture and 31%( 95% Cl, 20%-43%) greater among women with an initial low-trauma fracture, compared with women having no high- or low trauma fracture, respectively. Risk of subsequent fracture was not modeled for men. Conclusions Similar to low-trauma nonspine fractures, high- trauma nonspine fractures are associated with low BMD and increased risk of subsequent fracture in older adults. High-trauma nonspine fractures should be included as outcomes in osteoporosis trials and observational studies.	Calif Pacific Med Ctr, San Francisco Coordinating Ctr, San Francisco, CA 94107 USA; Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; NW Hawaii, Kaiser Permanente Ctr Hlth Res, Portland, OR USA; Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kaiser Permanente; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego	Mackey, DC (corresponding author), Calif Pacific Med Ctr, San Francisco Coordinating Ctr, 185 Berry St,Lobby 4,Ste 5700, San Francisco, CA 94107 USA.	dmackey@sfcc-cpmc.net	Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR045580, R01AR035582, U01AR045632, U01AR045614, U01AR045583, U01AR045654, R01AR035584, U01AR045647, R01AR035583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005394, R01AG005407, U01AG018197, U01AG027810, R01AG027574, R01AG027576] Funding Source: NIH RePORTER; NCRR NIH HHS [RR024140] Funding Source: Medline; NIAMS NIH HHS [U01 AR45654, U01 AR45647, AR35582, AR35583, U01 AR45632, U01 AR45580, U01 AR45614, U01 AR45583, AR35584] Funding Source: Medline; NIA NIH HHS [R01 AG005407, R01 AG027576-22, R01 AG005394-22A1, 2 R01 AG027574-22A1, AG05394, AG05407, U01 AG18197, U01-AG027810] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albrand G, 2003, BONE, V32, P78, DOI 10.1016/S8756-3282(02)00919-5; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; *BON HLTH OST, 2004, REP SURG GEN 2004; Center JR, 2007, JAMA-J AM MED ASSOC, V297, P387, DOI 10.1001/jama.297.4.387; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; COURTNEY AC, 1995, J BONE JOINT SURG AM, V77A, P387, DOI 10.2106/00004623-199503000-00008; Cuddihy MT, 1999, OSTEOPOROSIS INT, V9, P469, DOI 10.1007/s001980050172; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Cummings SR, 2006, J BONE MINER RES, V21, P1550, DOI 10.1359/JBMR.060708; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; Garnero P, 2000, J BONE MINER RES, V15, P1526, DOI 10.1359/jbmr.2000.15.8.1526; Hayes WC, 1996, BONE, V18, pS77, DOI 10.1016/8756-3282(95)00383-5; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; KARLSSON MK, 1993, CALCIFIED TISSUE INT, V53, P229, DOI 10.1007/BF01320906; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Meier C, 2005, J BONE MINER RES, V20, P579, DOI 10.1359/JBMR.041207; MELTON LJ, 1982, CLIN ORTHOP RELAT R, P144; Melton LJ, 1997, J BONE MINER RES, V12, P16, DOI 10.1359/jbmr.1997.12.1.16; Melton LJ, 1998, J BONE MINER RES, V13, P1915, DOI 10.1359/jbmr.1998.13.12.1915; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; OWEN RA, 1982, AM J PUBLIC HEALTH, V72, P605, DOI 10.2105/AJPH.72.6.605; Papadimitropoulos EA, 1997, CAN MED ASSOC J, V157, P1357; Papaioannou A, 2005, OSTEOPOROSIS INT, V16, P568, DOI 10.1007/s00198-004-1735-x; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; ROBINOVITCH SN, 1991, J BIOMECH ENG-T ASME, V113, P366, DOI 10.1115/1.2895414; Sanders KM, 1998, J BONE MINER RES, V13, P1337, DOI 10.1359/jbmr.1998.13.8.1337; SEELEY DG, 1991, ANN INTERN MED, V115, P837, DOI 10.7326/0003-4819-115-11-837; STEIGER P, 1992, J BONE MINER RES, V7, P625; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; WASNICH RD, 1994, OSTEOPOROSIS INT, V4, P1, DOI 10.1007/BF02352253; 2004, OSTEOPOROS INT S4, V8, pS7	33	252	255	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2381	2388		10.1001/jama.298.20.2381	http://dx.doi.org/10.1001/jama.298.20.2381			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	18042915	Bronze			2022-12-28	WOS:000251163400018
J	Illies, C; Gromada, J; Fiume, R; Leibiger, B; Yu, J; Juhl, K; Yang, SN; Barma, DK; Falck, JR; Saiardi, A; Barker, CJ; Berggren, PO				Illies, Christopher; Gromada, Jesper; Fiume, Roberta; Leibiger, Barbara; Yu, Jia; Juhl, Kirstine; Yang, Shao-Nian; Barma, Deb K.; Falck, John R.; Saiardi, Adolfo; Barker, Christopher J.; Berggren, Per-Olof			Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells	SCIENCE			English	Article							INSULIN; COMPLEX	Inositol pyrophosphates are recognized components of cellular processes that regulate vesicle trafficking, telomere length, and apoptosis. We observed that pancreatic beta cells maintain high basal concentrations of the pyrophosphate diphosphoinositol pentakisphosphate (InsP(7) or IP7). Inositol hexakisphosphate kinases (IP6Ks) that can generate IP7 were overexpressed. This overexpression stimulated exocytosis of insulin-containing granules from the readily releasable pool. Exogenously applied IP7 dose-dependently enhanced exocytosis at physiological concentrations. We determined that IP6K1 and IP6K2 were present in b cells. RNA silencing of IP6K1, but not IP6K2, inhibited exocytosis, which suggests that IP6K1 is the critical endogenous kinase. Maintenance of high concentrations of IP7 in the pancreatic b cell may enhance the immediate exocytotic capacity and consequently allow rapid adjustment of insulin secretion in response to increased demand.	Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17176 Stockholm, Sweden; Novartis Inst BioMed Res, Diabet & Metab Dis Area, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; UCL, UK Med Res Council, Cell Biol Unit, London WC1E 6BT, England; UCL, Dept Biochem & Mol Biol, Mol Cell Biol Lab, London WC1E 6BT, England	Karolinska Institutet; Novartis; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of London; University College London	Barker, CJ (corresponding author), Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17176 Stockholm, Sweden.	chris.barker@ki.se	Falck, John R/B-3030-2011; Tuluc, Petronel/C-2527-2011	Falck, John R/0000-0002-9219-7845; FIUME, ROBERTA/0000-0001-7757-4000; Berggren, Per-Olof/0000-0001-8991-413X	MRC [MC_U122680443] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER; Medical Research Council [MC_U122680443] Funding Source: Medline; NIGMS NIH HHS [GM31278] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barker CJ, 2004, BIOCHEM J, V380, P465, DOI 10.1042/BJ20031872; Barker CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1113, DOI 10.1152/ajpendo.00088.2002; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Berridge MJ, 1995, ANN NY ACAD SCI, V766, P31, DOI 10.1111/j.1749-6632.1995.tb26646.x; Efanov AM, 1997, P NATL ACAD SCI USA, V94, P4435, DOI 10.1073/pnas.94.9.4435; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Hoy M, 2003, J BIOL CHEM, V278, P35168, DOI 10.1074/jbc.M303927200; Hoy M, 2002, P NATL ACAD SCI USA, V99, P6773, DOI 10.1073/pnas.102157499; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Kamimura J, 2004, J HUM GENET, V49, P360, DOI 10.1007/s10038-004-0158-z; Larsson O, 1997, SCIENCE, V278, P471, DOI 10.1126/science.278.5337.471; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Nagata E, 2005, J BIOL CHEM, V280, P1634, DOI 10.1074/jbc.M409416200; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; Pesesse X, 2004, J BIOL CHEM, V279, P43378, DOI 10.1074/jbc.C400286200; Renstrom E, 1996, J PHYSIOL-LONDON, V494, P41, DOI 10.1113/jphysiol.1996.sp021474; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535	23	136	143	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1299	1302		10.1126/science.1146824	http://dx.doi.org/10.1126/science.1146824			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033884				2022-12-28	WOS:000251086600043
J	Iannuzzi, MC; Rybicki, BA; Teirstein, AS				Iannuzzi, Michael C.; Rybicki, Benjamin A.; Teirstein, Alvin S.			Medical progress: Sarcoidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GENOME-WIDE SEARCH; BLOOD T-CELLS; PULMONARY-HYPERTENSION; CLINICAL-FEATURES; AFRICAN-AMERICANS; SUSCEPTIBILITY; RISK; LUNG; PROGNOSIS; GENES		CUNY, Mt Sinai Med Ctr, Div Pulm Crit Care & Sleep Med, Dept Med, New York, NY 10029 USA; Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, Detroit, MI USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Henry Ford Health System; Henry Ford Hospital	Iannuzzi, MC (corresponding author), CUNY, Mt Sinai Med Ctr, Div Pulm Crit Care & Sleep Med, Dept Med, 1 Gustave Levy Pl,Box 1232, New York, NY 10029 USA.	michael.iannuzzi@mssm.edu	Rybicki, Benjamin/L-4614-2019	Rybicki, Benjamin/0000-0003-3190-3467	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL060263, R21HL077577] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL077577, HL60263] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS JS, 1989, ANN INTERN MED, V111, P437, DOI 10.7326/0003-4819-111-5-437; Agostini C, 2000, CURR OPIN RHEUMATOL, V12, P71, DOI 10.1097/00002281-200001000-00012; Annema JT, 2005, EUR RESPIR J, V25, P405, DOI 10.1183/09031936.05.00098404; [Anonymous], 1973, Tubercle, V54, P87; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P736; Arcasoy SM, 2001, CHEST, V120, P873, DOI 10.1378/chest.120.3.873; Arnett HA, 2007, J IMMUNOL, V178, P1523, DOI 10.4049/jimmunol.178.3.1523; Bachelez H, 2001, ARCH DERMATOL, V137, P69; Barnard J, 2005, J OCCUP ENVIRON MED, V47, P226, DOI 10.1097/01.jom.0000155711.88781.91; Baughman RP, 2006, AM J RESP CRIT CARE, V174, P795, DOI 10.1164/rccm.200603-402OC; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Baughman RP, 2003, BIODRUGS, V17, P425, DOI 10.2165/00063030-200317060-00005; Baughman RP, 2000, SARCOIDOSIS VASC DIF, V17, P60; Berliner AR, 2006, AM J KIDNEY DIS, V48, P856, DOI 10.1053/j.ajkd.2006.07.022; Boeck C, 1899, J CUTAN GENITOURINDI, V17, P543; Bonfioli Adriana A, 2005, Semin Ophthalmol, V20, P177, DOI 10.1080/08820530500231938; BRESNITZ EA, 1983, EPIDEMIOL REV, V5, P124, DOI 10.1093/oxfordjournals.epirev.a036255; BREWERTON DA, 1977, CLIN EXP IMMUNOL, V27, P227; Culver DA, 2007, CLIN DERMATOL, V25, P267, DOI 10.1016/j.clindermatol.2007.03.005; Denys BG, 2007, CLIN SCI, V112, P281, DOI 10.1042/CS20060094; Doyle MK, 2006, JCR-J CLIN RHEUMATOL, V12, P241, DOI 10.1097/01.rhu.0000240035.67652.9d; Dubaniewicz A, 2006, TUBERCULOSIS, V86, P60, DOI 10.1016/j.tube.2005.09.004; Eishi Y, 2002, J CLIN MICROBIOL, V40, P198, DOI 10.1128/JCM.40.1.198-204.2002; Fireman E, 2002, CLIN EXP IMMUNOL, V130, P331, DOI 10.1046/j.1365-2249.2002.t01-1-02001.x; Fisher KA, 2006, CHEST, V130, P1481, DOI 10.1378/chest.130.5.1481; Gorham ED, 2004, CHEST, V126, P1431, DOI 10.1378/chest.126.5.1431; Gray-McGuire C, 2006, HUM GENET, V120, P420, DOI 10.1007/s00439-006-0201-6; Grimm W, 2004, HERZ, V29, P348, DOI 10.1007/s00059-004-2578-0; Grunewald J, 2007, AM J RESP CRIT CARE, V175, P40, DOI 10.1164/rccm.200608-1197OC; Hajizadeh R, 2007, J CLIN IMMUNOL, V27, P445, DOI 10.1007/s10875-007-9080-4; Handa T, 2006, CHEST, V129, P1246, DOI 10.1378/chest.129.5.1246; Harder H, 2007, WORLD J GASTROENTERO, V13, P2504, DOI 10.3748/wjg.v13.i17.2504; Henry MT, 2002, EUR RESPIR J, V20, P1220, DOI 10.1183/09031936.02.00022302; Hernandez-Pando R, 2000, IMMUNOLOGY, V100, P352, DOI 10.1046/j.1365-2567.2000.00025.x; Ho LP, 2005, LANCET, V365, P1062, DOI 10.1016/S0140-6736(05)71143-0; Hoffmann AL, 2004, ACTA PAEDIATR, V93, P30, DOI 10.1080/08035250310007213; Iannuzzi MC, 2005, GENES IMMUN, V6, P509, DOI 10.1038/sj.gene.6364235; Iannuzzi MC, 2003, AM J RESP CRIT CARE, V167, P1225, DOI 10.1164/rccm.200209-1097OC; Iannuzzi Michael C, 2007, Proc Am Thorac Soc, V4, P108, DOI 10.1513/pats.200607-141JG; Idali F, 2006, EUR RESPIR J, V27, P451, DOI 10.1183/09031936.06.00067105; Izbicki G, 2007, CHEST, V131, P1414, DOI 10.1378/chest.06-2114; Judson MA, 1999, SARCOIDOSIS VASC DIF, V16, P75; Judson MA, 2003, SARCOIDOSIS VASC DIF, V20, P204; Judson MA, 2002, SEMIN RESP CRIT CARE, V23, P529, DOI 10.1055/s-2002-36517; Judson MA, 2006, CHEST, V130, P855, DOI 10.1378/chest.130.3.855; Kellinghaus C, 2004, EUR NEUROL, V51, P84, DOI 10.1159/000076534; Kikawada M, 1998, Respirology, V3, P41, DOI 10.1046/j.1440-1843.1998.d01-1.x; Kruit A, 2007, RESP MED, V101, P510, DOI 10.1016/j.rmed.2006.06.025; Kucera GP, 2003, CHEST, V123, P1527, DOI 10.1378/chest.123.5.1527; Manouvrier-Hanu S, 1998, AM J MED GENET, V76, P217, DOI 10.1002/(SICI)1096-8628(19980319)76:3<217::AID-AJMG4>3.0.CO;2-N; MARTENSTEIN H, 1923, ZENTRALBL HAUT GESCH, V7, P308; Martin WJ, 2004, AM J RESP CRIT CARE, V170, P567, DOI 10.1164/rccm.200308-1073WS; Mempel M, 2000, AM J PATHOL, V157, P509, DOI 10.1016/S0002-9440(10)64562-2; Milman N, 1990, Sarcoidosis, V7, P50; Miyara M, 2006, J EXP MED, V203, P359, DOI 10.1084/jem.20050648; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Newman LS, 1997, NEW ENGL J MED, V337, P139; Nunes H, 2007, SEMIN RESP CRIT CARE, V28, P102, DOI 10.1055/s-2007-970336; Paramothayan S, 2006, COCHRANE DB SYST REV, P3; PIETINALHO A, 1995, SARCOIDOSIS, V12, P61; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prezant DJ, 1999, CHEST, V116, P1183, DOI 10.1378/chest.116.5.1183; Rabin DL, 2004, EUR RESPIR J, V24, P601, DOI 10.1183/09031936.04.00070503; Ramos-Casals M, 2005, MEDICINE, V84, P69, DOI 10.1097/01.md.0000157577.69729.e6; Rossman MD, 2003, AM J HUM GENET, V73, P720, DOI 10.1086/378097; Rybicki BA, 2007, GENES IMMUN, V8, P379, DOI 10.1038/sj.gene.6364396; Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096; Rybicki BA, 2005, AM J HUM GENET, V77, P491, DOI 10.1086/444435; Rybicki BA, 2004, EUR RESPIR J, V24, P251, DOI 10.1183/09031936.04.00005904; Rybicki BA, 2004, SARCOIDOSIS VASC DIF, V21, P49; Rybicki BA, 2001, AM J RESP CRIT CARE, V164, P2085, DOI 10.1164/ajrccm.164.11.2106001; Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004; Sato H, 2002, AM J RESP CELL MOL, V27, P406, DOI 10.1165/rcmb.4782; SCADDING JG, 1961, BRIT MED J, V2, P1165, DOI 10.1136/bmj.2.5261.1165; Schurmann M, 2003, EUR RESPIR J, V22, P748, DOI 10.1183/09031936.03.00040602; Schurmann M, 2001, AM J RESP CRIT CARE, V164, P840, DOI 10.1164/ajrccm.164.5.2007056; Scott GC, 1997, J COMPUT ASSIST TOMO, V21, P369, DOI 10.1097/00004728-199705000-00006; Scott TF, 2007, ARCH NEUROL-CHICAGO, V64, P691, DOI 10.1001/archneur.64.5.691; Sharma OP, 1998, ARCH NEUROL-CHICAGO, V55, P1248, DOI 10.1001/archneur.55.9.1248; Shorr AF, 2001, CHEST, V120, P881, DOI 10.1378/chest.120.3.881; Shorr AF, 2003, CHEST, V124, P922, DOI 10.1378/chest.124.3.922; SILTZBACH LE, 1974, AM J MED, V57, P847, DOI 10.1016/0002-9343(74)90160-0; Silver RF, 1996, IMMUNOLOGY, V88, P516, DOI 10.1046/j.1365-2567.1996.d01-683.x; Song ZM, 2005, J EXP MED, V202, P721, DOI 10.1084/jem.20040429081505c; Spencer TS, 2005, SEMIN ARTHRITIS RHEU, V34, P649, DOI 10.1016/j.semarthrit.2004.07.011; STUDDY PR, 1989, ANN CLIN BIOCHEM, V26, P13, DOI 10.1177/000456328902600102; Uemura A, 1999, AM HEART J, V138, P299, DOI 10.1016/S0002-8703(99)70115-8; *US ORG PROC TRANS, 2006, 2006 ANN REP; Valentonyte R, 2005, NAT GENET, V37, P652, DOI 10.1038/ng0605-652a; Valentonyte R, 2005, AM J RESP CRIT CARE, V171, P1136, DOI 10.1164/rccm.200405-658OC; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Voorter CEM, 2007, TISSUE ANTIGENS, V70, P18, DOI 10.1111/j.1399-0039.2007.00842.x; Wahlstrom J, 2001, AM J RESP CRIT CARE, V163, P115, DOI 10.1164/ajrccm.163.1.9906071; Yanardag H, 2003, JCR-J CLIN RHEUMATOL, V9, P72, DOI 10.1097/01.RHU.0000062509.01658.d1; Zaidi AR, 2007, J HEART LUNG TRANSPL, V26, P714, DOI 10.1016/j.healun.2007.05.006; Zissel G, 2007, SEMIN RESP CRIT CARE, V28, P3, DOI 10.1055/s-2007-970329	97	1387	1443	1	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2153	2165		10.1056/NEJMra071714	http://dx.doi.org/10.1056/NEJMra071714			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	18032765				2022-12-28	WOS:000251076500007
J	Hill, K; Lopez, AD; Shibuya, K; Jha, P				Hill, Kenneth; Lopez, Alan D.; Shibuya, Kenji; Jha, Prabhat		MoVE Writing Grp	Who counts? 3 - Interim measures for meeting needs for health sector data: births, deaths, and causes of death	LANCET			English	Article							MATERNAL MORTALITY; CANCER-MORTALITY; REGISTRATION; STATISTICS; DESIGN; INDIA; SITE	Most developing countries do not have fully effective civil registration systems to provide necessary information about population health. Interim approaches-both innovative strategies for collection of data, and methods of assessment or estimation of these data-to fill the resulting information gaps have been developed and refined over the past four decades. To respond to the needs for data for births, deaths, and causes of death, data collection systems such as population censuses, sample vital registration systems, demographic surveillance sites, and internationally-coordinated sample survey programmes in combination with enhanced methods of assessment and analysis have been successfully implemented to complement civil registration systems. Methods of assessment and analysis of incomplete information or indirect indicators have also been improved, as have approaches to ascertainment of cause of death by verbal autopsy, disease modelling, and other strategies. Our knowledge of demography and descriptive epidemiology of populations in developing countries has been greatly increased by the widespread use of these interim approaches; although gaps remain, particularly for adult mortality. However, these approaches should not be regarded as substitutes for complete civil registration but rather as complements, essential parts of any fully comprehensive health information system. International organisations, national governments, and academia all have responsibilities in ensuring that data continue to be collected and that methods continue to be improved.	Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; WHO, Dept Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland; Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON, Canada	Harvard University; Harvard T.H. Chan School of Public Health; University of Queensland; World Health Organization; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Hill, K (corresponding author), Harvard Ctr Populat & Dev Studies, 9 Bow St, Cambridge, MA 02138 USA.	kenneth_hill@harvard.edu	Lopez, Alan/AAA-2734-2022; Lopez, Alan D/F-1487-2010	Lopez, Alan D/0000-0001-5818-6512; Shibuya, Kenji/0000-0003-2528-7530				Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; AKGUN S, 2007, EUR J PUBLIC HLTH; [Anonymous], POPULATION STUDIES; [Anonymous], WORLD FERTILITY SURV; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745; BANISTER J, 2004, POP STUD, V58, P75; Begg S, 2005, INT J EPIDEMIOL, V34, P1080, DOI 10.1093/ije/dyi101; BENNETT NG, 1981, POPUL INDEX, V47, P207, DOI 10.2307/2736447; BHAT PNM, 2007, POP STUD, V56, P119; Binka FN, 1999, J BIOSOC SCI, V31, P375, DOI 10.1017/S0021932099003752; BRASS W, 2007, ESTIMATING ADULT MOR; Brass W., 1975, LAB POPULATION STAT; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Curtin George T., 1976, POPULATION STUDIES, V30, P87; Demeny Coale AJ., 1966, REGIONAL MODEL LIFE; FAN W, 2006, B WORLD HEALTH ORGAN, V84, P168; FARGUES P, 2007, MORTALITY SOC SUBSAH, P99; Greenwood M., 1948, MED STAT GRAUNT FARR; HAKULINEN T, 1986, INT J EPIDEMIOL, V15, P226, DOI 10.1093/ije/15.2.226; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P173, DOI 10.2471/BLT.05.027714; Hill K, 1987, Asian Pac Popul Forum, V1, P8; HILL K, 1997, HLTH MORTALITY ISSUE; HILL K, 2003, NOTAS POBLACION, V76, P81; Hobcraft J, 1993, Health Transit Rev, V3, P159; *INDEPTH NETW, 2007, DEM SURV SIT ACCR IN; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; KING G, 2006, VERBAL AUTOPSY METHO; Kumar R, 2006, Indian J Public Health, V50, P90; Lopez A D, 1982, Popul Bull UN, P66; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Mathers CD, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-36; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; *NAT CTR HLTH STAT, 2007, NAT DEATH IND; Preston SH, 1976, MORTALITY PATTERNS N; PRESTON SH, 2006, POPULATION STUDIES, V84, P225; *REG GEN IND, 2006, SRS B, V40; *REG GEN IND CTR G, 2007, MAT MORT IND 1997 20; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Shibuya K, 2005, B WORLD HEALTH ORGAN, V83, P722; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; SIVANANDAN V, 2004, ASSESSMENT COMPLETEN; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; Stanton C, 2000, STUD FAMILY PLANN, V31, P111, DOI 10.1111/j.1728-4465.2000.00111.x; Stanton C, 2001, B WORLD HEALTH ORGAN, V79, P657; TIMAEUS IM, 1991, DEMOGRAPHY, V28, P213, DOI 10.2307/2061276; *UN POP DIV, 2002, ESAPWP175 UN POP DIV; *UN STAT DIV, 2007, 2010 WORLD PROGR POP; United Nations, 1983, MAN X IND TECHN DEM; WADE A, 1996, INT C AIDS JUL 7 12, V11, P401; Wagstaff A, 2004, AM J PUBLIC HEALTH, V94, P726, DOI 10.2105/AJPH.94.5.726; *WHO, 2007, MORT DAT; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3	55	102	103	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2007	370	9600					1726	1735		10.1016/S0140-6736(07)61309-9	http://dx.doi.org/10.1016/S0140-6736(07)61309-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	233LA	18029005				2022-12-28	WOS:000251091200024
J	Azoulay, P; Michigan, R; Sampat, BN				Azoulay, Pierre; Michigan, Ryan; Sampat, Bhaven N.			The anatomy of medical school patenting	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE SCIENCES	Background: Although issues related to patenting by faculty at academic medical centers have been the source of much controversy, there is little systematic evidence of the growth of these activities, their distribution among academic departments, and their relationship to faculty research efforts. Methods: We pooled data on medical school faculty, National Institutes of Health (NIH) grant activity, and patenting to examine changes in the propensity to apply for a patent during the period from 1981 through 2000 that was subsequently granted, the distribution of these activities among departments, and the relationships between patenting and variables associated with individual faculty members. These variables included sex, academic degree, years since the last academic degree was earned, patenting by departmental peers, and NIH funding history. In addition to basic descriptive statistics, we estimated Poisson regression models based on the number of patents a faculty member applied for as a function of these variables. Results: Applications for patents that were subsequently granted per medical school faculty increased dramatically during the period from 1981 through 2000. Although most patenting activity was carried out by faculty members in clinical departments, their rate of patents was low relative to that of faculty members in basic science departments. Regression results showed that persons were more likely to patent if they had recent NIH funding, were male, had Ph.D. degrees, were more experienced faculty members, and worked in departments with higher patenting rates. Conclusions: Although the number of patents granted to medical school faculty increased dramatically during this period, patent activity was concentrated among a small number of departments and faculty members. Moreover, persons who had recently received NIH funding were more likely to apply for a patent than those who had not received such funding.	Columbia Univ, Mailman Sch Publ Hlth, Int Ctr Hlth Outcomes & Innovat Res, New York, NY 10032 USA; MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA; Columbia Univ, Grad Sch Business, New York, NY 10027 USA; Columbia Univ, Dept Hlth Policy & Management, New York, NY 10032 USA	Columbia University; Massachusetts Institute of Technology (MIT); National Bureau of Economic Research; Columbia University; Columbia University	Sampat, BN (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Int Ctr Hlth Outcomes & Innovat Res, 600 W 168th St,Rm 705, New York, NY 10032 USA.	bns3@columbia.edu	McBee, David J/F-3968-2012; Azoulay, Pierre/B-1405-2008	Azoulay, Pierre/0000-0001-6511-4824	NIH HHS [N01-OD-3-1015] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Angell M., 2004, TRUTH DRUG CO; Blumenthal D, 1996, NEW ENGL J MED, V334, P368, DOI 10.1056/NEJM199602083340606; Blumenthal D, 2003, NEW ENGL J MED, V349, P2452, DOI 10.1056/NEJMhpr035460; Eisenberg RS, 2002, ACAD MED, V77, P1392, DOI 10.1097/00001888-200212001-00011; EPSTEIN RICHARD A., 2006, OVERDOSE EXCESSIVE G; Feldman MP, 2004, MINERVA, V42, P105, DOI 10.1023/B:MINE.0000030019.99709.a0; HAUSMAN J, 1984, ECONOMETRICA, V52, P909, DOI 10.2307/1911191; Krimsky S., 2004, SCI PRIVATE INTEREST; *NIH, 2007, BIOM RES DEV PRIC IN; Stossel TP, 2005, NEW ENGL J MED, V353, P1060, DOI 10.1056/NEJMsb051758; 1993, LANCET, V342, P1435	11	31	31	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2007	357	20					2049	2056		10.1056/NEJMsa067417	http://dx.doi.org/10.1056/NEJMsa067417			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230RV	18003961				2022-12-28	WOS:000250894500007
J	Gu, LC; Geders, TW; Wang, B; Gerwick, WH; Hakansson, K; Smith, JL; Sherman, DH				Gu, Liangcai; Geders, Todd W.; Wang, Bo; Gerwick, William H.; Hakansson, Kristina; Smith, Janet L.; Sherman, David H.			GNAT-like strategy for polyketide chain initiation	SCIENCE			English	Article							CYANOBACTERIUM LYNGBYA-MAJUSCULA; FATTY-ACID SYNTHASE; GENE-CLUSTER; SACCHAROPOLYSPORA-ERYTHRAEA; BACTERIAL SYMBIONT; PEPTIDE SYNTHETASE; CURACIN-A; BIOSYNTHESIS; MECHANISM; ACETYLTRANSFERASES	An unexpected biochemical strategy for chain initiation is described for the loading module of the polyketide synthase of curacin A, an anticancer lead derived from the marine cyanobacterium Lyngbya majuscula. A central GCN5-related N-acetyltransferase (GNAT) domain bears bifunctional decarboxylase/S-acetyltransferase activity, both unprecedented for the GNAT superfamily. A CurA loading tridomain, consisting of an adaptor domain, the GNAT domain, and an acyl carrier protein, was assessed biochemically, revealing that a domain showing homology to GNAT (GNAT(L)) catalyzes (i) decarboxylation of malonyl-coenzyme A (malonyl-CoA) to acetyl-CoA and (ii) direct S-acetyl transfer from acetyl-CoA to load an adjacent acyl carrier protein domain (ACP(L)). Moreover, the N-terminal adapter domain was shown to facilitate acetyl- group transfer. Crystal structures of GNAT(L) were solved at 1.95 angstroms (ligand-free form) and 2.75 angstroms (acyl-CoA complex), showing distinct substrate tunnels for acyl-CoA and holo-ACP(L) binding. Modeling and site-directed mutagenesis experiments demonstrated that histidine-389 and threonine-355, at the convergence of the CoA and ACP tunnels, participate in malonyl-CoA decarboxylation but not in acetyl-group transfer. Decarboxylation precedes acetyl- group transfer, leading to acetyl-ACP(L) as the key curacin A starter unit.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California San Diego; Scripps Institution of Oceanography	Sherman, DH (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	JanetSmith@umich.edu; davidhs@umich.edu	Gu, Liangcai/U-6908-2019; Gu, Liangcai/E-4600-2010; Hakansson, Kristina/G-9428-2016	Hakansson, Kristina/0000-0003-1926-0542	NIDDK NIH HHS [DK42303] Funding Source: Medline; NIGMS NIH HHS [GM076477] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042303, R01DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076477] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Dorrestein PC, 2006, BIOCHEMISTRY-US, V45, P12756, DOI 10.1021/bi061169d; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Hickman AB, 1999, MOL CELL, V3, P23, DOI 10.1016/S1097-2765(00)80171-9; HSIEH YJ, 1994, J BACTERIOL, V176, P714, DOI 10.1128/jb.176.3.714-724.1994; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Lau J, 2000, BIOCHEMISTRY-US, V39, P10514, DOI 10.1021/bi000602v; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Minas W, 1998, BIOTECHNOL PROGR, V14, P561, DOI 10.1021/bp980055t; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Rossi JV, 1997, J APPL PHYCOL, V9, P195, DOI 10.1023/A:1007973009869; Simunovic V, 2006, CHEMBIOCHEM, V7, P1206, DOI 10.1002/cbic.200600075; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Van Wagoner RM, 2006, STRUCTURE, V14, P1425, DOI 10.1016/j.str.2006.07.005; Verdier-Pinard P, 1998, MOL PHARMACOL, V53, P62, DOI 10.1124/mol.53.1.62; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111	23	83	83	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					970	974		10.1126/science.1148790	http://dx.doi.org/10.1126/science.1148790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991863				2022-12-28	WOS:000250788500042
J	Schmidt, B; Roberts, RS; Davis, P; Doyle, LW; Barrington, KJ; Ohlsson, A; Solimano, A; Tin, W				Schmidt, Barbara; Roberts, Robin S.; Davis, Peter; Doyle, Lex W.; Barrington, Keith J.; Ohlsson, Arne; Solimano, Alfonso; Tin, Win		Caffeine Apnea Prematurity Tria	Long-term effects of caffeine therapy for apnea of prematurity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEONATAL INTENSIVE-CARE; BIRTH-WEIGHT; METHYLXANTHINE THERAPY; AGE; RETINOPATHY; INFANTS; ADENOSINE; CHILDREN; INJURY; SYSTEM	Background Methylxanthine therapy is commonly used for apnea of prematurity but in the absence of adequate data on its efficacy and safety. It is uncertain whether methylxanthines have long-term effects on neurodevelopment and growth. Methods We randomly assigned 2006 infants with birth weights of 500 to 1250 g to receive either caffeine or placebo until therapy for apnea of prematurity was no longer needed. The primary outcome was a composite of death, cerebral palsy, cognitive delay (defined as a Mental Development Index score of <85 on the Bayley Scales of Infant Development), deafness, or blindness at a corrected age of 18 to 21 months. Results Of the 937 infants assigned to caffeine for whom adequate data on the primary outcome were available, 377 (40.2%) died or survived with a neurodevelopmental disability, as compared with 431 of the 932 infants (46.2%) assigned to placebo for whom adequate data on the primary outcome were available (odds ratio adjusted for center, 0.77; 95% confidence interval [CI], 0.64 to 0.93; P=0.008). Treatment with caffeine as compared with placebo reduced the incidence of cerebral palsy (4.4% vs. 7.3%; adjusted odds ratio, 0.58; 95% CI, 0.39 to 0.87; P=0.009) and of cognitive delay (33.8% vs. 38.3%; adjusted odds ratio, 0.81; 95% CI, 0.66 to 0.99; P=0.04). The rates of death, deafness, and blindness and the mean percentiles for height, weight, and head circumference at follow-up did not differ significantly between the two groups. Conclusions Caffeine therapy for apnea of prematurity improves the rate of survival without neurodevelopmental disability at 18 to 21 months in infants with very low birth weight.	McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; James Cook Univ Hosp, Dept Pediat, Middlesbrough, Cleveland, England	McMaster University; University of Melbourne; McGill University; University of Toronto; University of British Columbia; James Cook University Hospital	Schmidt, B (corresponding author), Henderson Res Ctr, Neonatal Trials Grp, G Wing,2nd Fl,Rm 217,711 Concess St, Hamilton, ON L8V 1C3, Canada.	barbara.schmidt@uphs.upenn.edu	Herlenius, Eric/B-7260-2008; Pfister, Riccardo E/N-7082-2014; Doyle, Lex/AAJ-5205-2021	Herlenius, Eric/0000-0002-6859-0620; Pfister, Riccardo E/0000-0002-7395-0512; Doyle, Lex/0000-0002-7667-7312; Barrington, Keith/0000-0001-9669-5094; Ringstedt, Thomas/0000-0003-0294-9351				Allen MC, 2002, MENT RETARD DEV D R, V8, P221, DOI 10.1002/mrdd.10044; ARANDA JV, 1977, J PEDIATR-US, V90, P467, DOI 10.1016/S0022-3476(77)80718-X; Bancalari E, 2006, NEW ENGL J MED, V354, P2179, DOI 10.1056/NEJMe068028; Boutilier RG, 2001, J EXP BIOL, V204, P3171; *CDCP, SAS PROGR CDC GROWTH; Clark RH, 2006, PEDIATRICS, V117, P1979, DOI 10.1542/peds.2005-1707; Donn SM, 2006, ARCH DIS CHILD-FETAL, V91, pF226, DOI 10.1136/adc.2005.082271; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Finer NN, 2006, PEDIATRICS, V117, pS47, DOI 10.1542/peds.2005-0620H; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x; GARNER A, 1984, PEDIATRICS, V74, P127; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Henderson-Smart DJ, 2001, COCHRANE DB SYST REV, V3; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; KUZEMKO JA, 1973, ARCH DIS CHILD, V48, P404, DOI 10.1136/adc.48.5.404; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LUCEY JF, 1975, PEDIATRICS, V55, P584; Martin Richard J, 2004, Paediatr Respir Rev, V5 Suppl A, pS377, DOI 10.1016/S1526-0542(04)90067-X; Millar David, 2004, Semin Neonatol, V9, P239, DOI 10.1016/j.siny.2003.11.008; Msall ME, 2000, PEDIATRICS, V106, P998, DOI 10.1542/peds.106.5.998; MUTTITT SC, 1988, PEDIATRICS, V82, P713; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pesce AJ, 1998, CLIN CHEM, V44, P1124; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; Schmidt B, 2005, BIOL NEONATE, V88, P208, DOI 10.1159/000087584; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Schmidt B, 1999, J PEDIATR-US, V135, P526, DOI 10.1016/S0022-3476(99)70180-0; Yi S.H., 1993, MANUAL BAYLEY SCALES; 1987, ARCH OPHTHALMOL, V105, P1498; 1987, ARCH OPHTHALMOL, V105, P906	30	545	579	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1893	1902		10.1056/NEJMoa073679	http://dx.doi.org/10.1056/NEJMoa073679			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989382				2022-12-28	WOS:000250732500004
J	Bodenheimer, T				Bodenheimer, Thomas			A 63-year-old man with multiple cardiovascular risk factors and poor adherence to treatment plans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PARTICIPATORY DECISION-MAKING; DIABETES SELF-MANAGEMENT; PRIMARY-CARE; GENERAL-PRACTICE; PHYSICIAN COMMUNICATION; GLYCEMIC CONTROL; PATIENT; TIME; OUTCOMES; QUALITY	Mr P has long-standing hypertension, obesity, and diabetes mellitus and has experienced life-threatening cardiovascular events. Mr P is receiving evidence-based clinical care but has adhered to his medical regimen poorly and remains at considerable risk of future catastrophic cardiovascular events. Practicing evidence-based medicine should be a 5-step process: research uncovers the evidence, clinicians learn the evidence, clinicians use the evidence at every visit for every patient, clinicians make sure patients understand the evidence, and clinicians help patients incorporate the evidence into their lives. Research demonstrates, however, that clinicians do not use the evidence at every visit, patients may misunderstand what took place in the visit, and clinicians are not always effective in helping patients incorporate the evidence into their lives. These failures reflect the difficulty faced by clinicians attempting to address multiple issues while providing sufficient information and engaging in collaborative decision making during a brief clinical visit.	Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), San Francisco Gen Hosp, Bldg 80-83,1001 Potrero Ave, San Francisco, CA 94110 USA.	tbodenheimer@fcmucsf.edu						Afonso NM, 2006, AM J MANAG CARE, V12, P589; Ammerman AS, 2002, PREV MED, V35, P25, DOI 10.1006/pmed.2002.1028; [Anonymous], 2007, DIABETES CARE, V30, pS4, DOI [10.2337/dc07-S004, DOI 10.2337/DC07-S004]; BEISECKER AE, 1990, MED CARE, V28, P19, DOI 10.1097/00005650-199001000-00004; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2007, BUILDING TEAMS PRIMA; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Campbell SM, 2001, BMJ-BRIT MED J, V323, P784, DOI 10.1136/bmj.323.7316.784; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Davidson J, 2005, AM J MED, V118, p27S, DOI 10.1016/j.amjmed.2005.07.054; Davis WA, 2006, DIABETES CARE, V29, P1764, DOI 10.2337/dc06-0268; Deveugele M, 2004, PATIENT EDUC COUNS, V54, P227, DOI 10.1016/S0738-3991(03)00239-8; Dugdale DC, 1999, J GEN INTERN MED, V14, pS34, DOI 10.1046/j.1525-1497.1999.00263.x; Fahey T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182; Funnell MM, 2000, JAMA-J AM MED ASSOC, V284, P1709, DOI 10.1001/jama.284.13.1709; Gibson PG, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001005, DOI 10.1002/14651858.CD001005]; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; Griffin S, 2000, COCHRANE DB SYST REV, V2; Grumbach K, 2002, JAMA-J AM MED ASSOC, V288, P889, DOI 10.1001/jama.288.7.889; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gwadry-Sridhar FH, 2004, ARCH INTERN MED, V164, P2315, DOI 10.1001/archinte.164.21.2315; Handley M, 2006, J AM BOARD FAM MED, V19, P224, DOI 10.3122/jabfm.19.3.224; Haynes RB., 2002, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD000011, DOI 10.1002/14651858.CD000011]; Heisler M, 2003, DIABETES CARE, V26, P738, DOI 10.2337/diacare.26.3.738; Heisler M, 2002, J GEN INTERN MED, V17, P243, DOI 10.1046/j.1525-1497.2002.10905.x; Hibbard JH, 2007, HEALTH SERV RES, V42, P1443, DOI 10.1111/j.1475-6773.2006.00669.x; Holland R, 2005, HEART, V91, P899, DOI 10.1136/hrt.2004.048389; *I MED, 2004, HLTH LIT PRESCR END; *I MED, 2003, PRIORITY AREAS NATL, P52; KAPLAN SH, 1995, MED CARE, V33, P1176, DOI 10.1097/00005650-199512000-00002; Kaplan SH, 1996, ANN INTERN MED, V124, P497, DOI 10.7326/0003-4819-124-5-199603010-00007; Krein SL, 2005, DIABETES CARE, V28, P65, DOI 10.2337/diacare.28.1.65; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; Lin CT, 2001, ARCH INTERN MED, V161, P1437, DOI 10.1001/archinte.161.11.1437; Lutfey KE, 1999, DIABETES CARE, V22, P635, DOI 10.2337/diacare.22.4.635; Marvel MK, 1999, JAMA-J AM MED ASSOC, V281, P283, DOI 10.1001/jama.281.3.283; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mead N, 2002, PATIENT EDUC COUNS, V48, P51, DOI 10.1016/S0738-3991(02)00099-X; Mechanic D, 2001, NEW ENGL J MED, V344, P198, DOI 10.1056/NEJM200101183440307; Morris LA, 1997, MED CARE, V35, P996, DOI 10.1097/00005650-199710000-00002; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; O'Brien M K, 1992, Med Care Rev, V49, P435, DOI 10.1177/002570879204900403; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Parchman ML, 2007, ANN FAM MED, V5, P196, DOI 10.1370/afm.679; Piette JD, 2003, J GEN INTERN MED, V18, P624, DOI 10.1046/j.1525-1497.2003.31968.x; ROTER DL, 1989, ANNU REV PUBL HEALTH, V10, P163, DOI 10.1146/annurev.pu.10.050189.001115; Roumie CL, 2006, ANN INTERN MED, V145, P165, DOI 10.7326/0003-4819-145-3-200608010-00004; Russell LB, 2005, J FAM PRACTICE, V54, P52; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; SCHILLINGER D, 2005, ADV PATIENT SAFETY R, V1; Shilts MK, 2004, AM J HEALTH PROMOT, V19, P81, DOI 10.4278/0890-1171-19.2.81; Stafford RS, 1999, ARCH FAM MED, V8, P26, DOI 10.1001/archfami.8.1.26; Street RL, 2005, MED CARE, V43, P960, DOI 10.1097/01.mlr.0000178172.40344.70; Thom DH, 2004, HEALTH AFFAIR, V23, P124, DOI 10.1377/hlthaff.23.4.124; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WAITZKIN H, 1984, JAMA-J AM MED ASSOC, V252, P2441, DOI 10.1001/jama.252.17.2441; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644; Wilson A, 2002, BRIT J GEN PRACT, V52, P1012; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635; Zyzanski SJ, 1998, J FAM PRACTICE, V46, P397	67	30	32	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2007	298	17					2048	2055		10.1001/jama.298.17.2048	http://dx.doi.org/10.1001/jama.298.17.2048			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228GP	17986698				2022-12-28	WOS:000250718200025
J	Sharif, J; Muto, M; Takebayashi, SI; Suetake, I; Iwamatsu, A; Endo, TA; Shinga, J; Mizutani-Koseki, Y; Toyoda, T; Okamura, K; Tajima, S; Mitsuya, K; Okano, M; Koseki, H				Sharif, Jafar; Muto, Masahiro; Takebayashi, Shin-ichiro; Suetake, Isao; Iwamatsu, Akihiro; Endo, Takaho A.; Shinga, Jun; Mizutani-Koseki, Yoko; Toyoda, Tetsuro; Okamura, Kunihiro; Tajima, Shoji; Mitsuya, Kohzoh; Okano, Masaki; Koseki, Haruhiko			The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA	NATURE			English	Article							EMBRYONIC STEM-CELLS; CYTOSINE-5 METHYLTRANSFERASE; MAMMALIAN-CELLS; BINDING-PROTEIN; REPLICATION; TRANSCRIPTION; MAINTENANCE; TARGET; DOMAIN; MARK	DNA methyltransferase (cytosine-5) 1 (Dnmt1) is the principal enzyme responsible for maintenance of CpG methylation and is essential for the regulation of gene expression, silencing of parasitic DNA elements, genomic imprinting and embryogenesis(1-4). Dnmt1 is needed in S phase to methylate newly replicated CpGs occurring opposite methylated ones on the mother strand of the DNA, which is essential for the epigenetic inheritance of methylation patterns in the genome. Despite an intrinsic affinity of Dnmt1 for such hemi-methylated DNA(5), the molecular mechanisms that ensure the correct loading of Dnmt1 onto newly replicated DNA in vivo are not understood. The Np95 ( also known as Uhrf1 and ICBP90) protein binds methylated CpG through its SET and RING finger-associated ( SRA) domain(6). Here we show that localization of mouse Np95 to replicating heterochromatin is dependent on the presence of hemi-methylated DNA. Np95 forms complexes with Dnmt1 and mediates the loading of Dnmt1 to replicating heterochromatic regions. By using Np95-deficient embryonic stem cells and embryos, we show that Np95 is essential in vivo to maintain global and local DNA methylation and to repress transcription of retrotransposons and imprinted genes. The link between hemimethylated DNA, Np95 and Dnmt1 thus establishes key steps of the mechanism for epigenetic inheritance of DNA methylation.	RIKEN Res Ctr Allergy & Immunol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; RIKEN Genom Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; TUBERO, Aoba Ku, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Sch Med, Dept Obstet & Gynecol, Aoba Ku, Sendai, Miyagi 9808574, Japan; Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 1138565, Japan; RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Prot Res Network Inc, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	RIKEN; RIKEN; Tohoku University; University of Tokyo; RIKEN; Osaka University	Koseki, H (corresponding author), RIKEN Res Ctr Allergy & Immunol, Tsurumi Ku, 1-7-22 Suehiro, Yokohama, Kanagawa 2300045, Japan.	koseki@rcai.riken.jp	Mitsuya, Kohzoh/F-4437-2010; Endo, Takaho/B-5763-2017; Suetake, Isao/D-4326-2009; Suetake, Isao/G-3144-2013; Koseki, Haruhiko/I-3825-2014	Endo, Takaho/0000-0002-2801-2463; Suetake, Isao/0000-0002-1246-8474; Koseki, Haruhiko/0000-0001-8424-5854; Mitsuya, Kohzoh/0000-0002-0950-5406				Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bonapace IM, 2002, J CELL BIOL, V157, P909, DOI 10.1083/jcb.200201025; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Carlone DL, 2005, MOL CELL BIOL, V25, P4881, DOI 10.1128/MCB.25.12.4881-4891.2005; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Damelin M, 2007, MOL CELL BIOL, V27, P3891, DOI 10.1128/MCB.00036-07; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Koberna K, 1999, CHROMOSOMA, V108, P325, DOI 10.1007/s004120050384; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lin IG, 2002, MOL CELL BIOL, V22, P704, DOI 10.1128/MCB.22.3.704-723.2002; Muto M, 2002, J BIOL CHEM, V277, P34549, DOI 10.1074/jbc.M205189200; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Papait R, 2007, MOL BIOL CELL, V18, P1098, DOI 10.1091/mbc.E06-09-0874; Pradhan S, 2002, EMBO J, V21, P779, DOI 10.1093/emboj/21.4.779; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Takebayashi S, 2007, MOL CELL BIOL, V27, P8243, DOI 10.1128/MCB.00899-07; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007	30	867	895	9	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					908	U25		10.1038/nature06397	http://dx.doi.org/10.1038/nature06397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	17994007				2022-12-28	WOS:000251394900062
J	Peile, E; George, C				Peile, Ed; George, Charles			Should all medical students be graduates first?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Warwick, Sch Med, Inst Clin Educ, Coventry CV4 7AL, W Midlands, England; BMA, Board Sci & Educ, London WC1H 9JP, England	University of Warwick	Peile, E (corresponding author), Univ Warwick, Sch Med, Inst Clin Educ, Coventry CV4 7AL, W Midlands, England.	ed.peile@warwick.ac.uk; charles_george@btinternet.com							0	7	7	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 24	2007	335	7629					1072	1073		10.1136/bmj.39283.476725.BE	http://dx.doi.org/10.1136/bmj.39283.476725.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	237UX	18033927	Green Published			2022-12-28	WOS:000251403000032
J	Allmann, BP; Shearer, PM				Allmann, Bettina P.; Shearer, Peter M.			A high-frequency secondary event during the 2004 Parkfield earthquake	SCIENCE			English	Article							SAN-ANDREAS FAULT; ENVELOPE INVERSION; RADIATION; CALIFORNIA; ENERGY; MODELS; SLIP; OKI	By using seismic records of the 2004 magnitude 6.0 Parkfield earthquake, we identified a burst of high-frequency seismic radiation that occurred about 13 kilometers northwest of the hypocenter and 5 seconds after rupture initiation. We imaged this event in three dimensions by using a waveform back-projection method, as well as by timing distinct arrivals visible on many of the seismograms. The high-frequency event is located near the south edge of a large slip patch seen in most seismic and geodetic inversions, indicating that slip may have grown abruptly at this point. The time history obtained from full-waveform back projection suggests a rupture velocity of 2.5 kilometers per second. Energy estimates for the subevent, together with long-period slip inversions, indicate a lower average stress drop for the northern part of the Parkfield earthquake compared with that for the region near its hypocenter, which is in agreement with stress-drop estimates obtained from small-magnitude aftershocks.	Univ Calif San Diego, Scripps Inst Oceanog, Cecil H & Ida M Green Inst Geophys & Planetary Ph, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Allmann, BP (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Cecil H & Ida M Green Inst Geophys & Planetary Ph, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ballmann@ucsd.edu	; Shearer, Peter/K-5247-2012	Goertz-Allmann, Bettina P./0000-0002-1571-6373; Shearer, Peter/0000-0002-2992-7630				Allmann BP, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004395; Fletcher JB, 2006, B SEISMOL SOC AM, V96, pS129, DOI 10.1785/0120050812; Ide S, 2002, B SEISMOL SOC AM, V92, P2994, DOI 10.1785/0120020028; Ishii M, 2005, NATURE, V435, P933, DOI 10.1038/nature03675; Johanson IA, 2006, B SEISMOL SOC AM, V96, pS269, DOI 10.1785/0120050818; Johnson KM, 2006, B SEISMOL SOC AM, V96, pS321, DOI 10.1785/0120050808; Kakehi Y, 1996, GEOPHYS J INT, V125, P892, DOI 10.1111/j.1365-246X.1996.tb06032.x; Kanamori H, 2006, GEOPHYS MONOGR SER, V170, P3, DOI 10.1029/170GM03; Langbein J, 2005, SEISMOL RES LETT, V76, P10, DOI 10.1785/gssrl.76.1.10; Liu PC, 2006, B SEISMOL SOC AM, V96, pS143, DOI 10.1785/0120050826; Madariaga R, 2006, GEOPHYS MONOGR SER, V170, P223, DOI 10.1029/170GM23; MADARIAGA R, 1977, GEOPHYS J ROY ASTR S, V51, P625, DOI 10.1111/j.1365-246X.1977.tb04211.x; Murray J, 2006, B SEISMOL SOC AM, V96, pS283, DOI 10.1785/0120050820; Nakahara H, 1998, J GEOPHYS RES-SOL EA, V103, P855, DOI 10.1029/97JB02676; Nakayama W, 1997, B SEISMOL SOC AM, V87, P918; Sato T, 1996, GEOPHYS RES LETT, V23, P33, DOI 10.1029/95GL03584; Shakal A, 2006, B SEISMOL SOC AM, V96, pS90, DOI 10.1785/0120050817; Simpson RW, 2006, B SEISMOL SOC AM, V96, pS28, DOI 10.1785/0120050824; SPUDICH P, 1984, B SEISMOL SOC AM, V74, P2061; Thurber C, 2006, B SEISMOL SOC AM, V96, pS38, DOI 10.1785/0120050825; Waldhauser F, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020649; ZENG YH, 1993, J GEOPHYS RES-SOL EA, V98, P11981, DOI 10.1029/93JB00346	22	48	48	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1279	1283		10.1126/science.1146537	http://dx.doi.org/10.1126/science.1146537			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033878				2022-12-28	WOS:000251086600037
J	Chambers, JQ; Fisher, JI; Zeng, HC; Chapman, EL; Baker, DB; Hurtt, GC				Chambers, Jeffrey Q.; Fisher, Jeremy I.; Zeng, Hongcheng; Chapman, Elise L.; Baker, David B.; Hurtt, George C.			Hurricane Katrina's carbon footprint on U. S. Gulf Coast forests	SCIENCE			English	Article							LAND; SINK		Tulane Univ, New Orleans, LA 70118 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA	Tulane University; University System Of New Hampshire; University of New Hampshire	Chambers, JQ (corresponding author), Tulane Univ, 400 Lindy Boggs, New Orleans, LA 70118 USA.	chambers@tulane.edu	Hurtt, George/A-8450-2012; Chambers, Jeffrey Q/J-9021-2014; Chambers, Jeffrey Q/AAU-7097-2021	Hurtt, George/0000-0001-7278-202X; Chambers, Jeffrey Q/0000-0003-3983-7847; 				Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Chambers JQ, 2007, TRENDS ECOL EVOL, V22, P414, DOI 10.1016/j.tree.2007.05.001; Chambers JQ, 2004, OECOLOGIA, V141, P596, DOI 10.1007/s00442-004-1676-2; Fisher JI, 2007, REMOTE SENS ENVIRON, V109, P261, DOI 10.1016/j.rse.2007.01.004; Hurtt GC, 2002, P NATL ACAD SCI USA, V99, P1389, DOI 10.1073/pnas.012249999; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; McNulty SG, 2002, ENVIRON POLLUT, V116, pS17, DOI 10.1016/S0269-7491(01)00242-1; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; Powell MD, 1998, J WIND ENG IND AEROD, V77-8, P53, DOI 10.1016/S0167-6105(98)00131-7	9	219	233	12	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1107	1107		10.1126/science.1148913	http://dx.doi.org/10.1126/science.1148913			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006740				2022-12-28	WOS:000250957900037
J	Couny, F; Benabid, F; Roberts, PJ; Light, PS; Raymer, MG				Couny, F.; Benabid, F.; Roberts, P. J.; Light, P. S.; Raymer, M. G.			Generation and photonic guidance of multi-octave optical-frequency combs	SCIENCE			English	Article							STIMULATED RAMAN-SCATTERING; CRYSTAL FIBERS; HYDROGEN; REGIME; STATES; LINES	Ultrabroad coherent comb-like optical spectra spanning several octaves are a chief ingredient in the emerging field of attoscience. We demonstrate generation and guidance of a three-octave spectral comb, spanning wavelengths from 325 to 2300 nanometers, in a hydrogen-filled hollow-core photonic crystal fiber. The waveguidance results not from a photonic band gap but from the inhibited coupling between the core and cladding modes. The spectrum consists of up to 45 high-order Stokes and anti-Stokes lines and is generated by driving the confined gas with a single, moderately powerful (10-kilowatt) infrared laser, producing 12-nanosecond-duration pulses. This represents a reduction by six orders of magnitude in the required laser powers over previous equivalent techniques and opens up a robust and much simplified route to synthesizing attosecond pulses.	Univ Bath, Dept Phys, Ctr Photon & Photon Mat, Bath BA2 7AY, Avon, England; Tech Univ Denmark, DK-2800 Lyngby, Denmark; Univ Oregon, Oregon Ctr Opt, Eugene, OR 97403 USA; Univ Oregon, Dept Phys, Eugene, OR 97403 USA	University of Bath; Technical University of Denmark; University of Oregon; University of Oregon	Benabid, F (corresponding author), Univ Bath, Dept Phys, Ctr Photon & Photon Mat, Bath BA2 7AY, Avon, England.	f.benabid@bath.ac.uk	Raymer, Michael/AAB-2423-2020; Light, Philip S/C-8315-2009	Light, Philip/0000-0003-3873-7991	Engineering and Physical Sciences Research Council [GR/S20178/01, EP/D058074/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Argyros A, 2007, OPT EXPRESS, V15, P7713, DOI 10.1364/OE.15.007713; Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; Benabid F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.123903; Benabid F, 2002, SCIENCE, V298, P399, DOI 10.1126/science.1076408; Benabid F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.213903; Benabid F, 2005, NATURE, V434, P488, DOI 10.1038/nature03349; Benabid F, 2006, PHILOS T R SOC A, V364, P3439, DOI 10.1098/rsta.2006.1908; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Couny F, 2006, OPT LETT, V31, P3574, DOI 10.1364/OL.31.003574; Harris SE, 1998, PHYS REV LETT, V81, P2894, DOI 10.1103/PhysRevLett.81.2894; Humbert G, 2004, OPT EXPRESS, V12, P1477, DOI 10.1364/OPEX.12.001477; Kawano H, 1997, APPL PHYS B-LASERS O, V65, P1, DOI 10.1007/s003400050240; Kawano H, 1998, IEEE J QUANTUM ELECT, V34, P260, DOI 10.1109/3.658704; KILIN SY, 1988, EUROPHYS LETT, V5, P419, DOI 10.1209/0295-5075/5/5/007; NAZARKIN A, 1999, PHYS REV LETT, V83; Roberts PJ, 2005, OPT EXPRESS, V13, P236, DOI 10.1364/OPEX.13.000236; Sali E, 2004, OPT LETT, V29, P495, DOI 10.1364/OL.29.000495; Sokolov AV, 2000, PHYS REV LETT, V85, P562, DOI 10.1103/PhysRevLett.85.562; STILLINGER FH, 1975, PHYS REV A, V11, P446, DOI 10.1103/PhysRevA.11.446; Uiberacker M, 2007, NATURE, V446, P627, DOI 10.1038/nature05648; von Neumann J, 1929, PHYS Z, V30, P467; Wasilewski W, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.063816	22	387	400	15	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1118	1121		10.1126/science.1149091	http://dx.doi.org/10.1126/science.1149091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006741				2022-12-28	WOS:000250957900040
J	Stark, A; Lin, MF; Kheradpour, P; Pedersen, JS; Parts, L; Carlson, JW; Crosby, MA; Rasmussen, MD; Roy, S; Deoras, AN; Ruby, JG; Brennecke, J; Hodges, E; Hinrichs, AS; Caspi, A; Park, SW; Han, MV; Maeder, ML; Polansky, BJ; Robson, BE; Aerts, S; van Helden, J; Hassan, B; Gilbert, DG; Eastman, DA; Rice, M; Weir, M; Hahn, MW; Park, Y; Dewey, CN; Pachter, L; Kent, WJ; Haussler, D; Lai, EC; Bartel, DP; Hannon, GJ; Kaufman, TC; Eisen, MB; Clark, AG; Smith, D; Celniker, SE; Gelbart, WM; Kellis, M				Stark, Alexander; Lin, Michael F.; Kheradpour, Pouya; Pedersen, Jakob S.; Parts, Leopold; Carlson, Joseph W.; Crosby, Madeline A.; Rasmussen, Matthew D.; Roy, Sushmita; Deoras, Ameya N.; Ruby, J. Graham; Brennecke, Julius; Hodges, Emily; Hinrichs, Angie S.; Caspi, Anat; Park, Seung-Won; Han, Mira V.; Maeder, Morgan L.; Polansky, Benjamin J.; Robson, Bryanne E.; Aerts, Stein; van Helden, Jacques; Hassan, Bassem; Gilbert, Donald G.; Eastman, Deborah A.; Rice, Michael; Weir, Michael; Hahn, Matthew W.; Park, Yongkyu; Dewey, Colin N.; Pachter, Lior; Kent, W. James; Haussler, David; Lai, Eric C.; Bartel, David P.; Hannon, Gregory J.; Kaufman, Thomas C.; Eisen, Michael B.; Clark, Andrew G.; Smith, Douglas; Celniker, Susan E.; Gelbart, William M.; Kellis, Manolis			Discovery of functional elements in 12 Drosophila genomes using evolutionary signatures	NATURE			English	Review							COMPUTATIONAL IDENTIFICATION; GENE-EXPRESSION; COMPREHENSIVE DATABASE; REGULATORY MOTIFS; RNA; SEQUENCE; MELANOGASTER; TRANSCRIPTION; DNA; MICRORNAS	Sequencing of multiple related species followed by comparative genomics analysis constitutes a powerful approach for the systematic understanding of any genome. Here, we use the genomes of 12 Drosophila species for the de novo discovery of functional elements in the fly. Each type of functional element shows characteristic patterns of change, or 'evolutionary signatures', dictated by its precise selective constraints. Such signatures enable recognition of new protein-coding genes and exons, spurious and incorrect gene annotations, and numerous unusual gene structures, including abundant stop-codon readthrough. Similarly, we predict non-protein-coding RNA genes and structures, and new microRNA (miRNA) genes. We provide evidence of miRNA processing and functionality from both hairpin arms and both DNA strands. We identify several classes of pre- and post-transcriptional regulatory motifs, and predict individual motif instances with high confidence. We also study how discovery power scales with the divergence and number of species compared, and we provide general guidelines for comparative studies.	MIT, Broad Inst, Cambridge, MA 02140 USA; Harvard Univ, Cambridge, MA 02140 USA; MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; Univ Copenhagen, Dept Mol Biol, DK-2200 Copenhagen N, Denmark; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Tartu, Inst Comp Sci, EE-50090 Tartu, Estonia; LBNL, BDGP, Berkeley, CA 94720 USA; Harvard Univ, Biol Labs, Cambridge, MA 02138 USA; Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst, Cambridge, MA 02142 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Univ Calif San Francisco, Berkeley Joint Grad Grp Bioengn, Portland, OR 97210 USA; European Bioinformat Inst, EMBL Nucleotide Sequence Submiss, Cambridge CB10 1SD, England; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Indiana Univ, Sch Informat, Bloomington, IN 47405 USA; Connecticut Coll, Dept Biol, New London, CT 06320 USA; VIB, Dept Mol & Dev Genet, Neurogenet Lab, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Sch Med, Dept Human Genet, B-3000 Louvain, Belgium; Univ Libre Bruxelles, Dept Biol Mol, B-1050 Brussels, Belgium; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Wesleyan Univ, Dept Math & Comp Sci, Middletown, CT 06459 USA; Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA; Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA; Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA; Mem Sloan Kettering Canc Ctr, Dept Dev Biol, New York, NY 10021 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Grad Grp Biophys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Agencourt Biosci Corp, Beverly, MA 01915 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); University of Copenhagen; University of California System; University of California Santa Cruz; Wellcome Trust Sanger Institute; University of Tartu; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Harvard University; University of New Mexico; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Cold Spring Harbor Laboratory; University of California System; University of California San Francisco; European Molecular Biology Laboratory (EMBL); Rutgers State University New Brunswick; Rutgers State University Medical Center; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Connecticut College; Flanders Institute for Biotechnology (VIB); KU Leuven; Universite Libre de Bruxelles; Indiana University System; Indiana University Bloomington; Wesleyan University; Wesleyan University; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Memorial Sloan Kettering Cancer Center; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Cornell University; Harvard University	Kellis, M (corresponding author), MIT, Broad Inst, Cambridge, MA 02140 USA.	manoli@mit.edu	Lai, Eric/AAO-1143-2021; van Helden, Jacques/D-8590-2013; Aerts, Stein/A-1100-2009; Han, Mira/A-1808-2011; Pedersen, Jakob/G-3382-2012; Brennecke, Julius/C-1626-2015; Stark, Alexander/D-1473-2012; Kellis, Manolis/ABE-7385-2020; Brennecke, Julius/T-5883-2019; Hannon, Gregory/AAB-3568-2019; Hinrichs, Angie S./H-9159-2019; Pedersen, Jakob/C-4985-2009; Lai, Eric C/A-3412-2008; Hassan, Bassem A/D-5221-2012	Lai, Eric/0000-0002-8432-5851; van Helden, Jacques/0000-0002-8799-8584; Aerts, Stein/0000-0002-8006-0315; Pedersen, Jakob/0000-0002-7236-4001; Brennecke, Julius/0000-0002-5141-0814; Stark, Alexander/0000-0003-2611-0841; Kellis, Manolis/0000-0001-7113-9630; Brennecke, Julius/0000-0002-5141-0814; Hinrichs, Angie S./0000-0002-1697-1130; Hassan, Bassem A/0000-0001-9533-4908; Weir, Michael/0000-0002-5999-4199; Pachter, Lior/0000-0002-9164-6231; Eisen, Michael/0000-0002-7528-738X; Hahn, Matthew/0000-0002-5731-8808; Parts, Leopold/0000-0002-2618-670X; Clark, Andrew/0000-0001-7159-8511; Han, Mira/0000-0002-0488-1170; Hodges, Emily/0000-0001-6513-610X	NHGRI NIH HHS [R01 HG002779-06, R01 HG002779-05, R01 HG004037-01A1, R01 HG004037] Funding Source: Medline; NIGMS NIH HHS [R01 GM067031, R01 GM083300, R01 GM067031-04] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779, R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083300, R01GM067031] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aerts S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001115; Allemand F, 2007, NUCLEIC ACIDS RES, V35, P3016, DOI 10.1093/nar/gkm197; Andrews J, 1996, GENETICS, V143, P1699; Ashburner M, 2005, GENOME RES, V15, P1661, DOI 10.1101/gr.3726705; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; BERGMAN CM, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0086; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Bompfunewerer AF, 2005, THEOR BIOSCI, V123, P301, DOI 10.1016/j.thbio.2005.01.002; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brent MR, 2005, GENOME RES, V15, P1777, DOI 10.1101/gr.3866105; Brogna S, 1997, EMBO J, V16, P2023, DOI 10.1093/emboj/16.8.2023; CASEY JL, 1995, J VIROL, V69, P7593, DOI 10.1128/JVI.69.12.7593-7600.1995; Castellano S, 2001, EMBO REP, V2, P697, DOI 10.1093/embo-reports/kve151; Celniker SE, 2003, ANNU REV GENOM HUM G, V4, P89, DOI 10.1146/annurev.genom.4.070802.110323; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cohen RS, 2005, RNA, V11, P1017, DOI 10.1261/rna.7218905; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Copeland PR, 2003, GENE, V312, P17, DOI 10.1016/S0378-1119(03)00588-2; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; Elnitski L, 2003, GENOME RES, V13, P64, DOI 10.1101/gr.817703; Ettwiller L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r104; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Farabaugh PJ, 1996, ANNU REV GENET, V30, P507, DOI 10.1146/annurev.genet.30.1.507; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Grimaldi E, 2005, CLIN LAB HAEMATOL, V27, P91, DOI 10.1111/j.1365-2257.2005.00676.x; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hild M, 2004, GENOME BIOL, V5; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Hoskins RA, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni184; Ivanov IP, 1998, MOL CELL BIOL, V18, P1553, DOI 10.1128/MCB.18.3.1553; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kheradpour P, 2007, GENOME RES, V17, P1919, DOI 10.1101/gr.7090407; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; KRAUT R, 1991, DEVELOPMENT, V111, P601; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; LUO GX, 1990, J VIROL, V64, P1021, DOI 10.1128/JVI.64.3.1021-1027.1990; MAEDER M, IN PRESS GENETICS; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Margulies EH, 2006, TRENDS GENET, V22, P187, DOI 10.1016/j.tig.2006.02.005; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Markstein M, 2004, DEVELOPMENT, V131, P2387, DOI 10.1242/dev.01124; Matthews KA, 2005, NAT REV GENET, V6, P179, DOI 10.1038/nrg1554; Mignone F, 2005, NUCLEIC ACIDS RES, V33, pD141, DOI 10.1093/nar/gki021; Mignone F, 2003, NUCLEIC ACIDS RES, V31, P4639, DOI 10.1093/nar/gkg483; Miller W, 2004, ANNU REV GENOM HUM G, V5, P15, DOI 10.1146/annurev.genom.5.061903.180057; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; OCHMAN H, 1990, BIO-TECHNOL, V8, P759, DOI 10.1038/nbt0890-759; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Okumura T, 2005, DEV BIOL, V278, P576, DOI 10.1016/j.ydbio.2004.11.021; PARK SW, IN PRESS GENETICS; Park Y, 2001, SCIENCE, V293, P1083, DOI 10.1126/science.1063073; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Philippakis AA, 2006, PLOS COMPUT BIOL, V2, P439, DOI 10.1371/journal.pcbi.0020053; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reese MG, 2000, GENOME RES, V10, P483, DOI 10.1101/gr.10.4.483; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Spradling AC, 1999, GENETICS, V153, P135; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; STAPLETON M, 2002, GENOME BIOL, V0003; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Steneberg P, 1998, GENE DEV, V12, P956, DOI 10.1101/gad.12.7.956; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Tompa M, 2001, GENOME RES, V11, P1143, DOI 10.1101/gr.197101; Ureta-Vidal A, 2003, NAT REV GENET, V4, P251, DOI 10.1038/nrg1043; VANDOREN M, 1994, GENE DEV, V8, P2729, DOI 10.1101/gad.8.22.2729; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; Wan KH, 2006, NAT PROTOC, V1, P624, DOI 10.1038/nprot.2006.90; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yandell M, 2005, P NATL ACAD SCI USA, V102, P1566, DOI 10.1073/pnas.0409421102; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yin ZZ, 1998, DEV GENET, V22, P187; Yuan GZ, 2003, NUCLEIC ACIDS RES, V31, P2495, DOI 10.1093/nar/gkg361; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zhang LG, 2003, GENOME RES, V13, P1190, DOI 10.1101/gr.703903; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	125	464	472	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					219	232		10.1038/nature06340	http://dx.doi.org/10.1038/nature06340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994088	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000250746200043
J	Horton, R				Horton, Richard			Counting for health	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							MAHAPATRA P, 2007, LANCET          1029; SETEL PW, 2007, LANCET          1029	2	22	23	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 3	2007	370	9598					1526	1526		10.1016/S0140-6736(07)61418-4	http://dx.doi.org/10.1016/S0140-6736(07)61418-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AE	17992726				2022-12-28	WOS:000250628800006
J	Jack, A				Jack, Andrew			Obesity plan lacks foresight	LANCET			English	Editorial Material									Financial Times, London SE1 9HL, England		Jack, A (corresponding author), Financial Times, London SE1 9HL, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				[Anonymous], 2007, FORESIGHT TACKLING O, V2nd; Boseley S., 2007, GUARDIAN        1017; *BRIT HEART FDN, 2007, FOR REP BRIT HEART F; CAMPBELL D, 2007, OBSERVER        1014	4	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2007	370	9598					1528	1529		10.1016/S0140-6736(07)61645-6	http://dx.doi.org/10.1016/S0140-6736(07)61645-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227AE	17980723				2022-12-28	WOS:000250628800008
J	Komili, S; Farny, NG; Roth, FP; Silver, PA				Komili, Suzanne; Farny, Natalie G.; Roth, Frederick P.; Silver, Pamela A.			Functional specificity among ribosomal proteins regulates gene expression	CELL			English	Article							ASH1 MESSENGER-RNA; MASS-SPECTROMETRIC ANALYSIS; SACCHAROMYCES-CEREVISIAE; BIOACTIVE COMPOUNDS; GERM PLASM; LOCALIZATION; GENOME; SCREEN; EXPORT; MUTATION	Duplicated genes escape gene loss by conferring a dosage benefit or evolving diverged functions. The yeast Saccharomyces cerevisiae contains many duplicated genes encoding ribosomal proteins. Prior studies have suggested that these duplicated proteins are functionally redundant and affect cellular processes in proportion to their expression. In contrast, through studies of ASH1 mRNA in yeast, we demonstrate paralog-specific requirements for the translation of localized mRNAs. Intriguingly, these paralog-specific effects are limited to a distinct subset of duplicated ribosomal proteins. Moreover, transcriptional and phenotypic profiling of cells lacking specific ribosomal proteins reveals differences between the functional roles of ribosomal protein paralogs that extend beyond effects on mRNA localization. Finally, we show that ribosomal protein paralogs exhibit differential requirements for assembly and localization. Together, our data indicate complex specialization of ribosomal proteins for specific cellular processes and support the existence of a ribosomal code.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02119 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02119 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Roth, FP (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02119 USA.	fritz_roth@hms.harvard.edu; pamela_silver@hms.harvard.edu	Farny, Natalie/ABD-4468-2020; Roth, Frederick P/H-6308-2011	Farny, Natalie/0000-0003-1143-4560; Roth, Frederick/0000-0002-6628-649X	NHGRI NIH HHS [R01 HG003224, HG003224, R01 HG003224-02, R01 HG003224-03, R01 HG003224-01A2] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003224] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ABOVICH N, 1984, MOL CELL BIOL, V4, P1871, DOI 10.1128/MCB.4.9.1871; Amikura R, 2001, P NATL ACAD SCI USA, V98, P9133, DOI 10.1073/pnas.171286998; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; BaudinBaillieu A, 1997, MOL CELL BIOL, V17, P5023, DOI 10.1128/MCB.17.9.5023; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Brodsky AS, 2002, METHODS, V26, P151, DOI 10.1016/S1046-2023(02)00017-8; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035; Dresselhaus T, 1999, MOL GEN GENET, V261, P416, DOI 10.1007/s004380050983; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enyenihi AH, 2003, GENETICS, V163, P47; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Gonzalez I, 1999, CURR BIOL, V9, P337, DOI 10.1016/S0960-9822(99)80145-6; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Haarer B, 2007, GENE DEV, V21, P148, DOI 10.1101/gad.1477507; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; HERRUER MH, 1987, NUCLEIC ACIDS RES, V15, P10133, DOI 10.1093/nar/15.24.10133; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Irie K, 2002, EMBO J, V21, P1158, DOI 10.1093/emboj/21.5.1158; Ito T, 2000, PLANT J, V22, P257, DOI 10.1046/j.1365-313x.2000.00728.x; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kobayashi S, 1998, CURR BIOL, V8, P1117, DOI 10.1016/S0960-9822(98)70466-X; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruse C, 2002, J CELL BIOL, V159, P971, DOI 10.1083/jcb.200207101; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; LEER RJ, 1984, FEBS LETT, V175, P371, DOI 10.1016/0014-5793(84)80771-1; LEER RJ, 1985, NUCLEIC ACIDS RES, V13, P5027, DOI 10.1093/nar/13.14.5027; Long RM, 2001, J CELL BIOL, V153, P307, DOI 10.1083/jcb.153.2.307; Louie DF, 1996, J BIOL CHEM, V271, P28189, DOI 10.1074/jbc.271.45.28189; LUCIOLI A, 1988, MOL CELL BIOL, V8, P4792, DOI 10.1128/MCB.8.11.4792; Ma ZR, 2004, PLANT J, V37, P92, DOI 10.1046/j.1365-313X.2003.01942.x; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Oka T, 1999, DEV GROWTH DIFFER, V41, P1; Page N, 2003, GENETICS, V163, P875; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Polo SE, 2006, CURR OPIN GENET DEV, V16, P104, DOI 10.1016/j.gde.2006.02.011; Revenkova E, 1999, EMBO J, V18, P490, DOI 10.1093/emboj/18.2.490; ROTENBERG MO, 1988, GENE DEV, V2, P160, DOI 10.1101/gad.2.2.160; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SELKER EU, 1985, SCIENCE, V227, P1340, DOI 10.1126/science.2579431; Tsugeki R, 1996, PLANT J, V10, P479, DOI 10.1046/j.1365-313X.1996.10030479.x; Urbinati CR, 2006, MOL GENET GENOMICS, V276, P369, DOI 10.1007/s00438-006-0151-7; Weijers D, 2001, DEVELOPMENT, V128, P4289; WILLIAMS ME, 1995, PLANT J, V8, P65, DOI 10.1046/j.1365-313X.1995.08010065.x; Zewail A, 2003, P NATL ACAD SCI USA, V100, P3345, DOI 10.1073/pnas.0530118100	59	254	258	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					557	571		10.1016/j.cell.2007.08.037	http://dx.doi.org/10.1016/j.cell.2007.08.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981122	Bronze, Green Accepted			2022-12-28	WOS:000250618500022
J	Appelbaum, PS				Appelbaum, Paul S.			Assessment of patients' competence to consent to treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DECISION-MAKING CAPACITY; PHYSICIANS LEGAL STANDARD; NURSING-HOME RESIDENTS; ALZHEIMERS-DISEASE; INFORMED-CONSENT; PSYCHIATRIC-INPATIENTS; SCHIZOPHRENIA RESEARCH; PERSONAL JUDGMENTS; MENTAL INCAPACITY; ILL PATIENTS		New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Psychiat, Div Law Eth & Psychiat, New York, NY USA	New York State Psychiatry Institute; Columbia University	Appelbaum, PS (corresponding author), New York State Psychiat Inst & Hosp, Unit 122,1051 Riverside Dr, New York, NY 10032 USA.	psa21@columbia.edu	Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042				*ABA COMM LAW AG, 2007, SURR CONS ABS ADV DI; Appelbaum PS, 1999, AM J PSYCHIAT, V156, P1380; APPELBAUM PS, 1983, JAMA-J AM MED ASSOC, V250, P1296, DOI 10.1001/jama.250.10.1296; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Appelbaum PS, 1997, PSYCHOSOMATICS, V38, P119, DOI 10.1016/S0033-3182(97)71480-4; Appelbaum PS, 1989, NEW ENGL J MED, V320, P748; Berg JW, 1996, RUTGERS LAW REV, V48, P345; BERG JW, 2001, INFORMED CONSENT LEG; Cairns R, 2005, BRIT J PSYCHIAT, V187, P379, DOI 10.1192/bjp.187.4.379; Cairns R, 2005, BRIT J PSYCHIAT, V187, P372, DOI 10.1192/bjp.187.4.372; Carol Krohm, 2002, ADV HLTH CARE DIRECT; Carpenter WT, 2000, ARCH GEN PSYCHIAT, V57, P533, DOI 10.1001/archpsyc.57.6.533; Casarett DJ, 2003, J PAIN SYMPTOM MANAG, V26, P615, DOI 10.1016/S0885-3924(03)00221-5; Charland L. C., 1998, PHILOS PSYCHIAT PSYC, V5, P67; COHEN LM, 1993, ARCH INTERN MED, V153, P2481, DOI 10.1001/archinte.153.21.2481; CULVER CM, 1990, MILBANK Q, V68, P619, DOI 10.2307/3350196; DRANE JF, 1985, HASTINGS CENT REP, V15, P17, DOI 10.2307/3560639; Dunn LB, 2006, AM J PSYCHIAT, V163, P1323, DOI 10.1176/appi.ajp.163.8.1323; Earnst KS, 2000, J AM GERIATR SOC, V48, P919, DOI 10.1111/j.1532-5415.2000.tb06888.x; Etchells E, 1999, J GEN INTERN MED, V14, P27, DOI 10.1046/j.1525-1497.1999.00277.x; Etchells E, 1997, PSYCHOSOMATICS, V38, P239, DOI 10.1016/S0033-3182(97)71460-9; FARNSWORTH MG, 1990, PSYCHOSOMATICS, V31, P60, DOI 10.1016/S0033-3182(90)72218-9; FITTEN LJ, 1990, J AM GERIATR SOC, V38, P1097, DOI 10.1111/j.1532-5415.1990.tb01372.x; FITTEN LJ, 1990, ARCH INTERN MED, V150, P1717, DOI 10.1001/archinte.150.8.1717; GOODWIN PE, 1995, BEHAV SCI LAW, V13, P405, DOI 10.1002/bsl.2370130308; GRISSO T, 1995, LAW HUMAN BEHAV, V19, P149, DOI 10.1007/BF01499323; Grisso T, 1998, ASSESSING COMPETENCE; grisso T., 1998, COMPETENCE ASSESSMEN; Gurrera RJ, 2006, NEUROLOGY, V66, P1367, DOI 10.1212/01.wnl.0000210527.13661.d1; Gurrera RJ, 2007, AM J GERIAT PSYCHIAT, V15, P168, DOI 10.1097/JGP.0b013e31802e705c; JOURDAN JB, 1991, PSYCHOSOMATICS, V32, P413, DOI 10.1016/S0033-3182(91)72043-4; Karlawish JHT, 2005, NEUROLOGY, V64, P1514, DOI 10.1212/01.WNL.0000160000.01742.9D; Kim SYH, 2007, BRIT J PSYCHIAT, V191, P38, DOI 10.1192/bjp.bp.106.033324; Kim SYH, 2006, SCHIZOPHRENIA BULL, V32, P92, DOI 10.1093/schbul/sbi062; Kim SYH, 2002, PSYCHIATR SERV, V53, P1322, DOI 10.1176/appi.ps.53.10.1322; Kim SYH, 2002, AM J GERIAT PSYCHIAT, V10, P151, DOI 10.1176/appi.ajgp.10.2.151; MARKSON LJ, 1994, J AM GERIATR SOC, V42, P1074, DOI 10.1111/j.1532-5415.1994.tb06212.x; Marson DC, 2000, J AM GERIATR SOC, V48, P911, DOI 10.1111/j.1532-5415.2000.tb06887.x; Marson DC, 1997, J AM GERIATR SOC, V45, P453, DOI 10.1111/j.1532-5415.1997.tb05170.x; MCKINNON K, 1989, HOSP COMMUNITY PSYCH, V40, P1159; Moser DJ, 2002, AM J PSYCHIAT, V159, P1201, DOI 10.1176/appi.ajp.159.7.1201; Palmer BW, 2007, J CLIN PSYCHIAT, V68, P689, DOI 10.4088/JCP.v68n0505; Palmer BW, 2005, ARCH GEN PSYCHIAT, V62, P726, DOI 10.1001/archpsyc.62.7.726; President's Commission for the Study of Ethical Problems in Medicine, 1982, MAK HLTH CAR DEC REP; PRUCHNO RA, 1995, GERONTOLOGIST, V35, P622, DOI 10.1093/geront/35.5.622; Raymont V, 2004, LANCET, V364, P1421, DOI 10.1016/S0140-6736(04)17224-3; Saks ER, 2002, AM J GERIAT PSYCHIAT, V10, P166, DOI 10.1176/appi.ajgp.10.2.166; Slobogin C, 1996, PSYCHOL PUBLIC POL L, V2, P18; Sturman ED, 2005, CLIN PSYCHOL REV, V25, P954, DOI 10.1016/j.cpr.2005.04.010; Vollmann J, 2003, PSYCHOL MED, V33, P1463, DOI 10.1017/S0033291703008389; White-Bateman SR, 2007, ARCH NEUROL-CHICAGO, V64, P785, DOI 10.1001/archneur.64.6.785; Wirshing DA, 1998, AM J PSYCHIAT, V155, P1508, DOI 10.1176/ajp.155.11.1508	52	693	704	1	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2007	357	18					1834	1840		10.1056/NEJMcp074045	http://dx.doi.org/10.1056/NEJMcp074045			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	225OJ	17978292				2022-12-28	WOS:000250526900007
J	Goldston, D				Goldston, David			Small advances	NATURE			English	Editorial Material											Goldston, D (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.							Maynard AD, 2006, NATURE, V444, P267, DOI 10.1038/444267a	1	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1141	1141		10.1038/4501141a	http://dx.doi.org/10.1038/4501141a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243HA	18097369				2022-12-28	WOS:000251786200009
J	Laine, C; Horton, R; DeAngelis, CD; Drazen, JM; Frizelle, FA; Godlee, F; Haug, C; Hebert, PC; Kotzin, S; Marusic, A; Sahni, P; Schroeder, TV; Sox, HC; Van der Weyden, MB; Verheugt, FW; Varcoe, R				Laine, Christine; Horton, Richard; DeAngelis, Catherine D.; Drazen, Jeffley M.; Frizelle, Frank A.; Godlee, Fiona; Haug, Charlotte; Hebert, Paul C.; Kotzin, Sheldon; Marusic, Ana; Sahni, Peush; Schroeder, Torben V.; Sox, Harold C.; Van der Weyden, Martin B.; Verheugt, Freek W. A.; Varcoe, Rae			Clinical trial registration: Looking back and moving ahead	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Auckland Hosp, Dept Haematol, Auckland 1, New Zealand	Auckland City Hospital	Varcoe, R (corresponding author), Auckland Hosp, Dept Haematol, Pk Rd, Auckland 1, New Zealand.	arvarcoe@xtra.co.nz		Schroeder, Torben/0000-0002-9827-9438				*INT COMM MED J ED, IS THIS CLIN TRIAL F; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; WHO, INT CLIN TRIALS REG; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234	4	40	44	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2007	147	4					275	277		10.7326/0003-4819-147-4-200708210-00166	http://dx.doi.org/10.7326/0003-4819-147-4-200708210-00166			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201AP	17548404	Green Published, Green Submitted			2022-12-28	WOS:000248804200009
J	Mattocks, C; Deere, K; Leary, S; Ness, A; Tilling, K; Blair, SN; Riddoch, C				Mattocks, Calum; Deere, Kevin; Leary, Sam; Ness, Andy; Tilling, Kate; Blair, Steven N.; Riddoch, Chris			Early life determinants of physical activity in 11 to 12 year olds: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILDREN; YOUTH; RISK; CHILDHOOD; EXERCISE; PATTERNS; FITNESS; OBESITY; BIRTH	Objective To examine factors in early life (up to age 5 years) that are associated with objectively measured physical activity in 11-12 year olds. Design Prospective cohort study. Setting Avon longitudinal study of parents and children, United Kingdom. Participants Children aged 11-12 years from the Avon longitudinal study of parents and children. Main outcome measure Physical activity levels in counts per minute (cpm) and minutes of moderate to vigorous physical activity for seven days measured with a uniaxial actigraph accelerometer. Results Valid actigraph data, defined as at least three days of physical activity for at least 10 hours a day, were collected from 5451 children. Several factors were associated with physical activity at ages 11-12 years. Regression coefficients are compared with the baseline of "none" for categorical variables: maternal brisk walking during pregnancy (regression coefficient 5.0, 95% confidence interval -8.5 to 18.5; cpm for <1 h/wk and 2:2 h/wk of physical activity 17.7, 5.3 to 30.1), maternal swimming during pregnancy (21.5, 10.9 to 32.1 and clam for <1 h/wk and >= 2 h/wk of physical activity 24.2, 7.8 to 40.7), parents' physical activity when the child was aged 21 months (28.5, 15.2 to 41.8 and cpm of physical activity for either parent active and both parents active 33.5, 17.8 to 49.3), and parity assessed during pregnancy (2.9, -7.6 to 13.4 and cpm of physical activity for 1 and >= 2 parity 21.2, 7.1 to 35.3). Conclusions Few factors in early life predicted later physical activity in 11-12 year olds. Parents' physical activity during pregnancy and early in the child's life showed a modest association with physical activity of the child at age 11-12 years, suggesting that active parents tend to raise active children. Helping parents to increase their physical activity therefore may promote children's activity.	[Mattocks, Calum; Deere, Kevin; Leary, Sam] Univ Bristol, Dept Social Med, Bristol BS8 1TQ, Avon, England; [Ness, Andy] Bristol Dent Sch, Dept Oral & Dent Sci, Bristol, Avon, England; [Tilling, Kate] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Blair, Steven N.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA; [Riddoch, Chris] Univ Bath, Sch Hlth, Bath BA2 7AY, Avon, England	University of Bristol; University of Bristol; University of Bristol; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Bath	Mattocks, C (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 1TQ, Avon, England.	c.mattocks@bristol.ac.uk	Leary, Sam/B-4456-2016; Tilling, Kate/AAY-1578-2021; Ness, Andy/M-7612-2013	Leary, Sam/0000-0002-1706-0689; Ness, Andy/0000-0003-3548-9523; Tilling, Kate/0000-0002-1010-8926; Mattocks, Calum/0000-0003-1262-5780	Medical Research Council [G9815508] Funding Source: Medline; NHLBI NIH HHS [R01HL071248-01A1] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Department of Health Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071248] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome Trust); Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Department of Health, 2004, LEAST 5 WEEK EV IMP; Ekelund U, 2001, MED SCI SPORT EXER, V33, P275; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Fisher A, 2005, PEDIATR EXERC SCI, V17, P31, DOI 10.1123/pes.17.1.31; Fisher A, 2005, MED SCI SPORT EXER, V37, P684, DOI 10.1249/01.MSS.0000159138.48107.7D; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gustafson SL, 2006, SPORTS MED, V36, P79, DOI 10.2165/00007256-200636010-00006; Hallal PC, 2006, BMJ-BRIT MED J, V332, P1002, DOI 10.1136/bmj.38776.434560.7C; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Hebestreit H, 2001, SPORTS MED, V31, P591, DOI 10.2165/00007256-200131080-00004; Helsen WF, 2000, J SPORT SCI, V18, P727; Kihlbom M, 2004, J BIOSOC SCI, V36, P561, DOI 10.1017/S002193200300628X; Kirkwood BR, 2003, ESSENTIAL MED STAT; Kristensen PL, 2008, SCAND J MED SCI SPOR, V18, P171, DOI 10.1111/j.1600-0838.2006.00622.x; Malina Robert, 2004, GROWTH MATURATION PH, DOI DOI 10.1016/j.jsams.2011.04.003; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; Mattocks C, 2007, INT J PEDIATR OBES, V2, P218, DOI 10.1080/17477160701408809; Nassis GP, 2005, METABOLISM, V54, P1472, DOI 10.1016/j.metabol.2005.05.013; *OFF POP CENS SUUR, 1991, STAND OCC CLASS; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS; Pfeiffer KA, 2006, J ADOLESCENT HEALTH, V39, P523, DOI 10.1016/j.jadohealth.2006.03.005; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Simonen RL, 2002, MED SCI SPORT EXER, V34, P1137, DOI 10.1097/00005768-200207000-00014; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Thorburn A W, 2000, Obes Rev, V1, P87, DOI 10.1046/j.1467-789x.2000.00018.x; Tremblay MS, 2005, MED SCI SPORT EXER, V37, P1187, DOI 10.1249/01.mss.0000170079.71522.a6; Treuth MS, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.4.e49; Twisk JWR, 2001, SPORTS MED, V31, P617, DOI 10.2165/00007256-200131080-00006; Wareham NJ, 1998, INT J OBESITY, V22, pS30	35	75	79	0	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2008	336	7634					26	29		10.1136/bmj.39385.443565.BE	http://dx.doi.org/10.1136/bmj.39385.443565.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250UT	18037616	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000252327500031
J	Jefferson, T; Foxlee, R; Del Mar, C; Dooley, L; Ferroni, E; Hewak, B; Prabhala, A; Nair, S; Rivetti, A				Jefferson, Tom; Foxlee, Ruth; Del Mar, Chris; Dooley, Liz; Ferroni, Eliana; Hewak, Bill; Prabhala, Adi; Nair, Sree; Rivetti, Alex			Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEALTH-CARE WORKERS; VIRUCIDAL PAPER HANDKERCHIEFS; PERSONAL PROTECTIVE EQUIPMENT; INFECTION-CONTROL STRATEGY; ALCOHOL HAND SANITIZER; SYNCYTIAL VIRUS; HONG-KONG; NOSOCOMIAL TRANSMISSION; INFLUENZA VACCINES; CONTROLLED-TRIAL	Objective To systematically review evidence for the effectiveness of physical interventions to interrupt or reduce the spread of respiratory viruses. Data extraction Search strategy of the Cochrane Library, Medline, OldMedline, Embase, and CINAHL, without language restriction, for any intervention to prevent transmission of respiratory viruses (isolation, quarantine, social distancing, barriers, personal protection, and hygiene). Study designs were randomised trials, cohort studies, case-controt studies, and controlled before and after studies. Data synthesis Of 2300 titles scanned 138 full papers were retrieved, including 49 papers of 51 studies. Study quality was poor for the three randomised controlled trials and most of the cluster randomised controlled trials; the observational studies were of mixed quality. Heterogeneity precluded meta-analysis of most data except that from six case-control studies. The highest quality cluster randomised trials suggest that the spread of respiratory viruses into the community can be prevented by intervening with hygienic measures aimed at younger children. Meta-analysis of six case-control studies suggests that physical measures are highly effective in preventing the spread of SARS: handwashing more than 10 times daily (odds ratio 0.45, 95% confidence interval 0.36 to 0.57; number needed to treat=4, 95% confidence interval 3.65 to 5.52); wearing masks (0.32, 0.25 to 0.40; NNT=6, 4.54 to 8.03); wearing N95 masks (0.09, 0.03 to 0.30; NNT=3, 2.37 to 4.06); wearing gloves (0.43,0.29 to 0.65; NNT=5,4.15 to 15.41); wearing gowns (0.23, 0.14 to 0.37; NNT=5, 3.37 to 7.12); and handwashing, masks, gloves, and gowns combined, (0.09, 0.02 to 0.35; NNT=3, 2.66 to 4.97). The incremental effect of adding virucidals or antiseptics to normal handwashing to decrease the spread of respiratory disease remains uncertain. The lack of proper evaluation of global measures such as screening at entry ports and social distancing prevent firm conclusions being drawn. Conclusion Routine long term implementation of some physical measures to interrupt or reduce the spread of respiratory viruses might be difficult but many simple and low cost interventions could be useful in reducing the spread.	[Del Mar, Chris; Dooley, Liz; Hewak, Bill; Prabhala, Adi] Bond Univ, Fac Hlth Sci & Med, Cochrane Acute Resp Infect Grp, Gold Coast, Qld 4229, Australia; [Jefferson, Tom; Rivetti, Alex] Manipal Acad Higher Educ, Dept Stat, Manipal, Karnataka, India; [Foxlee, Ruth] Publ Hlth Agcy Lazio Reg, Rome, Italy; [Ferroni, Eliana] Univ York, Dept Hlth Sci, Cochrane Wounds Grp, York YO10 5DD, N Yorkshire, England; [Nair, Sree] Cochrane Vaccines Field, Alessandria, Italy	Bond University; Manipal Academy of Higher Education (MAHE); University of York - UK	Del Mar, C (corresponding author), Bond Univ, Fac Hlth Sci & Med, Cochrane Acute Resp Infect Grp, Gold Coast, Qld 4229, Australia.	cdelmar@bond.edu.au	FERRONI, ELIANA/ABB-3304-2021; Del Mar, Chris B/B-1136-2008	Del Mar, Chris B/0000-0003-3821-8163; FERRONI, ELIANA/0000-0003-4803-2004; Al-Ansary, Lubna/0000-0001-7127-914X				Abou El Hassan MAI, 2004, J VIROL, V78, P12243, DOI 10.1128/JVI.78.22.12243-12251.2004; AGAH R, 1987, AM J DIS CHILD, V141, P695, DOI 10.1001/archpedi.1987.04460060111049; Amirav I, 2005, J PEDIATR-US, V147, P627, DOI 10.1016/j.jpeds.2005.05.035; Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; [Anonymous], 2005, Child Health Alert, V23, P1; [Anonymous], 2005, MED LETT DRUGS THER, V47, P3; [Anonymous], 2002, CLIN INFECT DIS, V34, pii; [Anonymous], 2003, MMWR-MORBID MORTAL W, V52, P29; Aragon D, 2005, AACN ADV CRIT CARE, V16, P121, DOI 10.1097/00044067-200504000-00002; Barros AJD, 1999, ACTA PAEDIATR, V88, P1113, DOI 10.1080/08035259950168180; Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729; Ben-Abraham R, 2002, J CRIT CARE, V17, P176, DOI 10.1053/jcrc.2002.35809; BLACK RE, 1981, AM J EPIDEMIOL, V113, P445, DOI 10.1093/oxfordjournals.aje.a113112; Breugelmans JG, 2004, EMERG INFECT DIS, V10, P1502, DOI 10.3201/eid1008.040093; Carabin H, 1999, EPIDEMIOLOGY, V10, P219, DOI 10.1097/00001648-199905000-00005; Carter JM, 2002, J NATL MED ASSOC, V94, pA11; Castillo-Chavez C, 2003, JAMA-J AM MED ASSOC, V290, P2876, DOI 10.1001/jama.290.21.2876; Cava MA, 2005, J NURS SCHOLARSHIP, V37, P343, DOI 10.1111/j.1547-5069.2005.00059.x; Cava MA, 2005, PUBLIC HEALTH NURS, V22, P398, DOI 10.1111/j.0737-1209.2005.220504.x; *CDC, 2003, MMWR-MORBID MORTAL W, V52, P433; *CDCP, 2007, INF CONTR GUID PREV; Centers for Disease Control and Prevention, 2005, 2004 2005 INT GUID U; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1037; Chai LYA, 2005, CLIN INFECT DIS, V40, P632, DOI 10.1086/427150; Chaovavanich Achara, 2004, Journal of the Medical Association of Thailand, V87, P1182; Chau PH, 2003, J EPIDEMIOL COMMUN H, V57, P766, DOI 10.1136/jech.57.10.766; Chia SE, 2005, OCCUP ENVIRON MED, V62, P473, DOI 10.1136/oem.2004.015024; DAVIES KJ, 1994, BRIT DENT J, V176, P262, DOI 10.1038/sj.bdj.4808430; Day R A, 1993, Clin Nurs Res, V2, P24, DOI 10.1177/105477389300200104; Day T, 2006, AM J EPIDEMIOL, V163, P479, DOI 10.1093/aje/kwj056; Dell'Omodarme M, 2005, STAT MED, V24, P2669, DOI 10.1002/sim.2131; Derrick JL, 2005, J HOSP INFECT, V59, P365, DOI 10.1016/j.jhin.2004.10.013; Desenclos JC, 2004, EMERG INFECT DIS, V10, P195, DOI 10.3201/eid1002.030351; DICK EC, 1986, J INFECT DIS, V153, P352, DOI 10.1093/infdis/153.2.352; DiGiovanni C, 2004, BIOSECUR BIOTERROR, V2, P265, DOI 10.1089/bsp.2004.2.265; DOEBBELING BN, 1992, NEW ENGL J MED, V327, P88, DOI 10.1056/NEJM199207093270205; Doherty JA, 1998, J HOSP INFECT, V38, P203, DOI 10.1016/S0195-6701(98)90275-4; Dwosh HA, 2003, CAN MED ASSOC J, V168, P1415; Dyer DL, 2000, FAM MED, V32, P633; EGGER M, 2007, COCHRANE METHODOLOGY; Falsey AR, 1999, INFECT CONT HOSP EP, V20, P200, DOI 10.1086/501612; FARR BM, 1988, AM J EPIDEMIOL, V128, P1162; Fendler EJ, 2002, AM J INFECT CONTROL, V30, P226, DOI 10.1067/mic.2002.120129; Flint J, 2003, Can Commun Dis Rep, V29, P105; Fung CP, 2004, INFECT CONT HOSP EP, V25, P1026, DOI 10.1086/502339; GALA CL, 1986, JAMA-J AM MED ASSOC, V256, P2706; Gaydos JC, 2001, AM J PREV MED, V21, P150, DOI 10.1016/S0749-3797(01)00332-4; Gensini GF, 2004, J INFECTION, V49, P257, DOI 10.1016/j.jinf.2004.03.002; Girou E, 2002, BRIT MED J, V325, P362, DOI 10.1136/bmj.325.7360.362; Glass K, 2006, EPIDEMIOL INFECT, V134, P1092, DOI 10.1017/S0950268806005863; Gore J, 2001, J Fam Pract, V50, P64; Gostin LO, 2003, JAMA-J AM MED ASSOC, V290, P3229, DOI 10.1001/jama.290.24.3229; Guinan M, 2002, AM J INFECT CONTROL, V30, P217, DOI 10.1067/mic.2002.120366; Gupta AG, 2005, J INFECTION, V50, P386, DOI 10.1016/j.jinf.2004.08.006; GWALTNEY JM, 1982, AM J EPIDEMIOL, V116, P828, DOI 10.1093/oxfordjournals.aje.a113473; GWALTNEY JM, 1980, J INFECT DIS, V142, P811, DOI 10.1093/infdis/142.6.811; HALL CB, 1981, AM J DIS CHILD, V135, P512, DOI 10.1001/archpedi.1981.02130300012006; HALL CB, 1981, J PEDIATR-US, V99, P100, DOI 10.1016/S0022-3476(81)80969-9; Han Hongbin, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35 Suppl, P86; HAYDEN GF, 1985, J INFECT DIS, V152, P403, DOI 10.1093/infdis/152.2.403; HENDLEY JO, 1988, EPIDEMIOL REV, V10, P242, DOI 10.1093/oxfordjournals.epirev.a036024; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hilburn J, 2003, AM J INFECT CONTROL, V31, P109, DOI 10.1067/mic.2003.15; Ho AS, 2003, ANN INTERN MED, V139, P564, DOI 10.7326/0003-4819-139-7-200310070-00008; ISAACS D, 1991, ARCH DIS CHILD, V66, P227, DOI 10.1136/adc.66.2.227; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson T, 2005, LANCET, V366, P803, DOI 10.1016/S0140-6736(05)67204-2; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Jefferson T, 2005, LANCET, V365, P773, DOI 10.1016/S0140-6736(05)17984-7; Jiang Shan-ping, 2003, Zhonghua Jiehe He Huxi Zazhi, V26, P594; Jiang SP, 2003, CHINESE MED J-PEKING, V116, P1293; Jones EW, 2005, CAN BULL MED HIST, V22, P57, DOI 10.3138/cbmh.22.1.57; Kaydos-Daniels SC, 2004, EMERG INFECT DIS, V10, P373, DOI 10.3201/eid1002.030748; Khan SK, 2000, UNDERTAKING SYSTEMAT; Kimel L S, 1996, J Sch Nurs, V12, P14, DOI 10.1177/105984059601200204; Kimel LS, 1996, J SCH NURS, V12, p[14, 8]; Kosugi Yoriko, 2004, Kansenshogaku Zasshi, V78, P995; KOTCH JB, 1994, PEDIATRICS, V94, P991; KRASINSKI K, 1990, J PEDIATR-US, V116, P894, DOI 10.1016/S0022-3476(05)80646-8; Krilov LR, 1996, AM J INFECT CONTROL, V24, P167, DOI 10.1016/S0196-6553(96)90008-5; Ladegaard M B, 1999, Ugeskr Laeger, V161, P4396; Lam BCC, 2004, PEDIATRICS, V114, pE565, DOI 10.1542/peds.2004-1107; Lange JH, 2004, J EPIDEMIOL COMMUN H, V58, P434; Larson EL, 2004, ANN INTERN MED, V140, P321, DOI 10.7326/0003-4819-140-5-200403020-00007; Lau JTF, 2005, J ALTERN COMPLEM MED, V11, P49, DOI 10.1089/acm.2005.11.49; Lau JTF, 2004, J EPIDEMIOL COMMUN H, V58, P988, DOI 10.1136/jech.2003.017483; Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628; LECLAIR JM, 1987, NEW ENGL J MED, V317, P329, DOI 10.1056/NEJM198708063170601; Lee GM, 2005, PEDIATRICS, V115, P852, DOI 10.1542/peds.2004-0856; Leung TF, 2004, J HOSP INFECT, V56, P215, DOI 10.1016/j.jhin.2003.11.004; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; LONGINI IM, 1988, AM J EPIDEMIOL, V128, P639, DOI 10.1093/oxfordjournals.aje.a115011; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Luckingham B, 1984, J Ariz Hist, V25, P191; Ma Huai-jian, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P741; Macartney KK, 2000, PEDIATRICS, V106, P520, DOI 10.1542/peds.106.3.520; MADGE P, 1992, LANCET, V340, P1079, DOI 10.1016/0140-6736(92)93088-5; Makris AT, 2000, AM J INFECT CONTROL, V28, P3, DOI 10.1016/S0196-6553(00)90004-X; MARIN J, 1991, ZBL HYG UMWELTMED, V191, P516; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Master D, 1997, Fam Med, V29, P336; MONSMA M, 1992, J SCHOOL HEALTH, V62, P109, DOI 10.1111/j.1746-1561.1992.tb06031.x; Morton Jennifer L, 2004, J Sch Nurs, V20, P161; MURPHY D, 1981, J PEDIATR-US, V99, P746, DOI 10.1016/S0022-3476(81)80401-5; Niffenegger J P, 1997, J Pediatr Health Care, V11, P26, DOI 10.1016/S0891-5245(97)90141-3; Nishiura H, 2005, AM J TROP MED HYG, V73, P17, DOI 10.4269/ajtmh.2005.73.17; OCALLAGHAN CA, 1993, LANCET, V341, P182, DOI 10.1016/0140-6736(93)90049-M; Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349; Ooi PL, 2005, AM J INFECT CONTROL, V33, P252, DOI 10.1016/j.ajic.2004.08.007; Ou Jian-ming, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P1093; Pang XH, 2003, JAMA-J AM MED ASSOC, V290, P3215, DOI 10.1001/jama.290.24.3215; Pang Xing-Huo, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P674; PELKE S, 1994, ARCH PEDIAT ADOL MED, V148, P1016, DOI 10.1001/archpedi.1994.02170100014004; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Prasad GVR, 2004, TRANSPLANTATION, V77, P1917, DOI 10.1097/01.TP.0000131946.36777.06; Rabenau HF, 2005, J HOSP INFECT, V61, P107, DOI 10.1016/j.jhin.2004.12.023; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Roberts L, 2000, PEDIATRICS, V105, P738, DOI 10.1542/peds.105.4.738; Rosenthal VD, 2005, AM J INFECT CONTROL, V33, P392, DOI 10.1016/j.ajic.2004.08.009; Ryan MAK, 2001, AM J PREV MED, V21, P79, DOI 10.1016/S0749-3797(01)00323-3; SAFIULIN A A, 1972, Gigiena i Sanitariya, V37, P99; Sandora TJ, 2005, PEDIATRICS, V116, P587, DOI 10.1542/peds.2005-0199; Sattar SA, 2000, INFECT CONT HOSP EP, V21, P516, DOI 10.1086/501796; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Simon A, 2006, INT J HYG ENVIR HEAL, V209, P317, DOI 10.1016/j.ijheh.2006.02.003; Sizun J, 1996, ARCH PEDIATRIE, V3, P723, DOI 10.1016/0929-693X(96)87097-7; SNYDMAN DR, 1988, INFECT CONT HOSP EP, V9, P105, DOI 10.1086/645804; Somogyi R, 2004, CHEST, V125, P1155, DOI 10.1378/chest.125.3.1155; Svoboda T, 2004, NEW ENGL J MED, V350, P2352, DOI 10.1056/NEJMoa032111; Teleman MD, 2004, EPIDEMIOL INFECT, V132, P797, DOI [10.1017/S0950268804002766, 10.1017/s0950268804002766]; Turner RB, 2004, ANTIMICROB AGENTS CH, V48, P2595, DOI 10.1128/AAC.48.7.2595-2598.2004; UENJO T, 1990, NIPPON GANKA GAKKAI, V94, P44; Wang Hong-wei, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P574; Wang JP, 2003, CHEM J CHINESE U, V24, P565; Weber JT, 2004, ANN INTERN MED, V140, P397, DOI 10.7326/0003-4819-140-5-200403020-00016; Wells G., 2005, NEWCASTLE OTTAWA SCA; White C, 2005, J AM COLL HEALTH, V53, P175, DOI 10.3200/JACH.53.4.175-181; White C, 2003, AM J INFECT CONTROL, V31, P364, DOI 10.1016/S0196-6553(03)00041-5; White C G, 2001, J Sch Nurs, V17, P258; Wilczynski Jan, 1997, Medycyna Doswiadczalna i Mikrobiologia, V49, P199; Wilder-Smith A, 2003, TROP MED INT HEALTH, V8, P1035, DOI 10.1046/j.1360-2276.2003.01133.x; Wilder-Smith Annelies, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P481; Wong TW, 2005, AM J INFECT CONTROL, V33, P580, DOI 10.1016/j.ajic.2005.05.025; Wu J, 2004, EMERG INFECT DIS, V10, P210, DOI 10.3201/eid1002.030730; Yen MY, 2006, J HOSP INFECT, V62, P195, DOI 10.1016/j.jhin.2005.02.011; Yin Wen-wu, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P18; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867; Zamora JE, 2006, CAN MED ASSOC J, V175, P249, DOI 10.1503/cmaj.060094; Zhao Z, 2003, J MED MICROBIOL, V52, P715, DOI 10.1099/jmm.0.05320-0; 2004, CONSUM REP, V69, P56; 2005, J HOPKINS MED LETT H, V17, P8	153	251	258	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2008	336	7635					77	80		10.1136/bmj.39393.510347.BE	http://dx.doi.org/10.1136/bmj.39393.510347.BE			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253BX	19773323	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000252494800028
